{"meta":{"query_hash":"d5e6cd8faae5","filters":{"topic":"Cancer Treatment and Pharmacology"},"cohort_total":1351,"direct_labels_cover":6,"predictions_cover":1351,"exported":1351,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/d5e6cd8faae5","api":"https://metacan.xera.ac/api/v1/cohort?topic=Cancer+Treatment+and+Pharmacology"},"results":[{"id":"W10896107","doi":"10.1016/s0968-0896(00)00056-0","title":"转变教育理念 端正教育导向 改变教育模式——从十八大报告中感悟教育制度改革心得体会","year":2012,"lang":"en","type":"article","venue":"课外阅读：中下","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.03841844524240467,"score_gpt":0.3888931238744794,"score_spread":0.3504746786320747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W10896107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8682793,0.005379197,0.000039864044,0.0033521745,0.0019953724,0.00046018965,0.000017366056,0.00019558558,0.12028097],"genre_scores_gemma":[0.9705674,0.00017582119,0.0003533423,0.0022167212,0.0018483956,0.0000526656,0.00005096942,0.00003028365,0.024704369],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989652,0.000032206124,0.0001739857,0.00018399839,0.00017116778,0.00047343923],"domain_scores_gemma":[0.9993086,0.00005649957,0.00005064973,0.00025321604,0.000038130274,0.00029294196],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012625479,0.00016476531,0.00026920036,0.00008090386,0.00006739504,0.000008770245,0.00007104212,0.00010447824,0.0049664015],"category_scores_gemma":[0.00001952467,0.00013672083,0.000121067445,0.0001516285,0.000061225655,0.00011072955,0.00003898633,0.0001734113,0.0016569705],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008085232,0.0021690351,0.36792386,0.00016505121,0.00056722393,0.00015031078,0.0022591357,0.000002519982,0.03228101,0.0027164426,0.55070484,0.04025207],"study_design_scores_gemma":[0.0034251257,0.00039981172,0.110478066,0.000030324016,0.00041978344,0.00014556054,0.00008287232,0.000019572028,0.014445814,0.00009694289,0.8702387,0.00021742053],"about_ca_topic_score_codex":0.000081577346,"about_ca_topic_score_gemma":0.000014040052,"teacher_disagreement_score":0.31953388,"about_ca_system_score_codex":0.000121539924,"about_ca_system_score_gemma":0.00006537358,"threshold_uncertainty_score":0.99912035},"labels":[],"label_agreement":null},{"id":"W1120767843","doi":"","title":"Visudyne Anti-VEGF Combination Therapy (VACT): A Multicentred, Retrospective Clinical Practice Review of Combination Therapy in AMD","year":2007,"lang":"en","type":"article","venue":"Investigative Ophthalmology & Visual Science","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Combination therapy; VEGF receptors; Ophthalmology; Internal medicine","score_opus":0.07950657732233785,"score_gpt":0.47712645754696337,"score_spread":0.3976198802246255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1120767843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98766005,0.0039357105,0.000003972266,0.002871303,0.0005259517,0.0016832693,0.0000045233583,0.000030252166,0.0032849684],"genre_scores_gemma":[0.9896691,0.0064306506,0.00070090895,0.0029337825,0.00007393654,0.00004555414,0.00002363564,0.000017358514,0.00010509758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99656314,0.00059856044,0.00094159,0.00070616795,0.0006861324,0.0005043848],"domain_scores_gemma":[0.9965237,0.0010459104,0.00075662177,0.00026014124,0.0011476509,0.0002659993],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.004937511,0.00026476668,0.0007500367,0.00036243518,0.00014431868,0.000013328927,0.00026404005,0.00015246992,0.00021967637],"category_scores_gemma":[0.002704205,0.000222528,0.00012466864,0.0019630922,0.0031731199,0.00052117155,0.00007055478,0.00050922873,0.00001994525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012122816,0.0065938835,0.75931174,0.00014642213,0.00013273254,0.00041995765,0.0013596481,4.4070896e-7,0.22117858,0.000886877,0.000111340254,0.008646127],"study_design_scores_gemma":[0.006580276,0.0066789016,0.8824309,0.000667625,0.000058913625,0.00022303176,0.00016559639,0.00009620509,0.10185449,0.00078297,0.0002827261,0.00017837276],"about_ca_topic_score_codex":0.0003362325,"about_ca_topic_score_gemma":0.0000068024283,"teacher_disagreement_score":0.12311918,"about_ca_system_score_codex":0.00048265298,"about_ca_system_score_gemma":0.0006853711,"threshold_uncertainty_score":0.9995397},"labels":[],"label_agreement":null},{"id":"W1159765411","doi":"10.1007/s00520-015-2873-8","title":"Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life","year":2015,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Carboplatin; Topotecan; Nausea; Quality of life (healthcare); Internal medicine; Debulking; Gynecologic oncology; Randomization; Ovarian cancer; Randomized controlled trial; Paclitaxel; Oncology; Vomiting; Chemotherapy; Cisplatin; Surgery; Cancer","score_opus":0.11104213079230227,"score_gpt":0.44755087150081274,"score_spread":0.33650874070851045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1159765411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847727,0.0024563752,0.0000045727693,0.00021059235,0.0021374892,0.0034217534,0.00019394358,0.000041488474,0.0067610955],"genre_scores_gemma":[0.99838436,0.00009217554,0.000056061606,0.00017521305,0.00035650178,0.00061686995,0.00008932415,0.00005023735,0.00017926982],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957508,0.0009872016,0.001373974,0.00059359695,0.00084770494,0.00044674458],"domain_scores_gemma":[0.9959626,0.0015927779,0.0008549832,0.00047452937,0.0007620108,0.00035305627],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010282192,0.00041886466,0.002192054,0.00032635065,0.000035038058,0.000006909969,0.00014893292,0.00020755673,0.00034908633],"category_scores_gemma":[0.0013549922,0.00036181652,0.0003709874,0.00047639868,0.00026588657,0.000095241216,0.00008420823,0.00041691962,0.000006394356],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7375678,0.0023438723,0.21074982,0.001271103,0.0024610134,0.00021396027,0.034958757,0.0003994428,0.0038095175,0.00020826388,0.0013102343,0.0047062244],"study_design_scores_gemma":[0.89501715,0.013898557,0.044193134,0.00049944245,0.0018136168,0.0000026947735,0.016723262,0.00008161917,0.026839342,0.00014082415,0.00021954696,0.0005707934],"about_ca_topic_score_codex":0.012946499,"about_ca_topic_score_gemma":0.0062140985,"teacher_disagreement_score":0.16655669,"about_ca_system_score_codex":0.0009554021,"about_ca_system_score_gemma":0.0014798328,"threshold_uncertainty_score":0.99988335},"labels":[],"label_agreement":null},{"id":"W1177680491","doi":"10.71781/12120","title":"Synthèse totale de la lépadine B : plate-forme pour la découverte de nouvelles tranformations chimiques","year":2009,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université de Montréal; Fonds Québécois de la Recherche sur la Nature et les Technologies; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Humanities; Physics; Art","score_opus":0.02108450600674212,"score_gpt":0.35985464413133206,"score_spread":0.33877013812458995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1177680491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7595164,0.001972302,0.00011184602,0.0009700059,0.0004229211,0.0010459485,0.00025348217,0.000008576268,0.23569848],"genre_scores_gemma":[0.8107759,0.004279822,0.009230449,0.00032056175,0.00067988614,0.00020849527,0.002885898,0.00007410093,0.17154491],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812806,0.00024084357,0.0005201308,0.000349159,0.00016712265,0.0005947031],"domain_scores_gemma":[0.9985806,0.0005348276,0.0002510984,0.00021528095,0.00009063858,0.00032755814],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005452443,0.0004491649,0.0006415324,0.0001932817,0.00026192307,0.00018639457,0.00036517248,0.0006391008,0.010281635],"category_scores_gemma":[0.000070289854,0.00043441993,0.00020952712,0.00018199242,0.000114199785,0.00035061117,0.00003410128,0.0005562959,0.0006747966],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004158168,0.0040358505,0.0063428693,0.00065862294,0.0020697007,0.0008708602,0.09416078,0.00035867476,0.058253605,0.0007731977,0.026364746,0.8019529],"study_design_scores_gemma":[0.015221403,0.0017484345,0.13395591,0.0036879536,0.006263101,0.0012546084,0.017522253,0.009037865,0.14429733,0.00062985497,0.66476125,0.0016200341],"about_ca_topic_score_codex":0.0012120988,"about_ca_topic_score_gemma":0.0034248305,"teacher_disagreement_score":0.8003329,"about_ca_system_score_codex":0.00056974334,"about_ca_system_score_gemma":0.0022809745,"threshold_uncertainty_score":0.99981076},"labels":[],"label_agreement":null},{"id":"W1185454313","doi":"","title":"The Visudyne Registry Database: Collecting Data from Patients Treated with Verteporfin Therapy for CNV due to AMD","year":2004,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"QLT (Canada)","funders":"","keywords":"Verteporfin; Medicine; Ophthalmology; Macular degeneration; Optometry; Choroidal neovascularization","score_opus":0.06628907457578062,"score_gpt":0.3649306742439641,"score_spread":0.2986415996681835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1185454313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921772,0.00026848383,0.0006768603,0.002777131,0.0001560625,0.0016737332,0.0007000223,0.00006981292,0.0015007205],"genre_scores_gemma":[0.9830986,0.00017733019,0.0028531572,0.0024146237,0.00030402312,0.00024658666,0.005621723,0.000044825454,0.005239113],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99905735,0.000018521592,0.0001690533,0.00036972025,0.00014888718,0.00023644927],"domain_scores_gemma":[0.998834,0.0002140112,0.00006585821,0.0006822336,0.00008880556,0.000115062554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008997546,0.00014881001,0.00021668166,0.00003066367,0.00022487844,0.000026678676,0.00019612644,0.000039939256,0.00017982983],"category_scores_gemma":[0.000050543626,0.00008117334,0.000026350142,0.00021287905,0.000037395122,0.00007245237,0.0000587259,0.00007888447,0.000016105045],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057147004,0.005630324,0.24354748,0.000067282934,0.0036265058,0.00039725314,0.0011547385,0.000033124812,0.027680123,0.00018988847,0.59137326,0.069153],"study_design_scores_gemma":[0.15054297,0.0156041095,0.168784,0.00042897995,0.0015133533,0.00008820037,0.0009196204,0.0006509105,0.13893522,0.00023810107,0.5212365,0.0010580043],"about_ca_topic_score_codex":0.003447752,"about_ca_topic_score_gemma":0.0029793244,"teacher_disagreement_score":0.1112551,"about_ca_system_score_codex":0.00013411988,"about_ca_system_score_gemma":0.00019551424,"threshold_uncertainty_score":0.5211992},"labels":[],"label_agreement":null},{"id":"W1447575175","doi":"10.1007/s10549-015-3547-4","title":"Octreotide LAR and tamoxifen versus tamoxifen in phase III randomize early breast cancer trials: NCIC CTG MA.14 and NSABP B-29","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Sunnybrook Health Science Centre; University of Toronto; Jewish General Hospital; McGill University; Queen's University","funders":"National Cancer Institute; Canadian Cancer Society Research Institute","keywords":"Medicine; Internal medicine; Breast cancer; Tamoxifen; Hazard ratio; Cancer; Oncology; Gastroenterology; Gynecology; Confidence interval","score_opus":0.18917399873553203,"score_gpt":0.4822184187308608,"score_spread":0.29304441999532876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1447575175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9641675,0.02085544,0.0000026115333,0.01015513,0.00030595742,0.002410994,0.0013003044,0.000045496796,0.00075659424],"genre_scores_gemma":[0.975111,0.019439617,0.000030960116,0.00010143597,0.0007204221,0.0018830145,0.000043696808,0.000051315117,0.002618501],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99647623,0.0005846805,0.000559091,0.00082930084,0.0006019907,0.0009486809],"domain_scores_gemma":[0.9974327,0.00071393204,0.00013520163,0.0003003181,0.00028699674,0.001130824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013955825,0.00046272308,0.0013474878,0.00041219316,0.0001901549,0.00010098678,0.000094554416,0.0001593402,0.0005901286],"category_scores_gemma":[0.0000662099,0.00030901155,0.00011883988,0.00038874874,0.00051060144,0.00022949028,0.00011997522,0.00030645318,0.000015170905],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43893838,0.0029675113,0.13062689,0.0001396791,0.0026494234,0.0012404753,0.002501198,0.000003257615,0.0023331386,0.000116265524,0.0048259217,0.41365784],"study_design_scores_gemma":[0.8095943,0.007287674,0.16282475,0.00061646145,0.0014045193,0.00075934525,0.0005823838,0.00010843259,0.0022843955,0.0004762007,0.013388473,0.00067310926],"about_ca_topic_score_codex":0.027637934,"about_ca_topic_score_gemma":0.0073076882,"teacher_disagreement_score":0.41298476,"about_ca_system_score_codex":0.0013819203,"about_ca_system_score_gemma":0.0010031245,"threshold_uncertainty_score":0.9999362},"labels":[],"label_agreement":null},{"id":"W1480235848","doi":"10.1371/journal.pone.0133133","title":"Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial","year":2015,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Fudan University; National Natural Science Foundation of China","keywords":"Bevacizumab; Medicine; Regimen; Leukopenia; Internal medicine; Metastatic breast cancer; Neutropenia; Oxaliplatin; Adverse effect; Anemia; Phases of clinical research; Progression-free survival; Gastroenterology; Febrile neutropenia; Chemotherapy regimen; Oncology; Breast cancer; Chemotherapy; Surgery; Colorectal cancer; Cancer","score_opus":0.14130538864159053,"score_gpt":0.3873994333068337,"score_spread":0.24609404466524315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480235848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950883,0.00006458529,0.0000049375526,0.001059047,0.000067670204,0.003273955,0.000113010785,0.00003944612,0.00028909638],"genre_scores_gemma":[0.9982535,0.00003568776,0.00034102923,0.0001781361,0.00006928813,0.0006336616,0.00020713624,0.000030168128,0.00025134452],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99817044,0.00023671289,0.00048390852,0.00037107768,0.000457164,0.0002806719],"domain_scores_gemma":[0.99898136,0.00013991218,0.00019830662,0.0001750456,0.00029387872,0.00021149547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024071272,0.00021777445,0.0007482516,0.0002019764,0.00003448295,0.000009546661,0.00006371027,0.0000762671,0.00008010728],"category_scores_gemma":[0.00007183619,0.00015816704,0.000038396378,0.0005144344,0.000103784296,0.00015133843,0.000024350089,0.00029755526,0.0000055093433],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5348403,0.121836774,0.33463472,0.00009575389,0.0014012327,0.00015551357,0.0020871365,0.000032156546,0.0000645418,0.000014881037,0.00016570844,0.004671298],"study_design_scores_gemma":[0.83479786,0.05047888,0.109664366,0.0005992915,0.0015894645,0.000005229851,0.00010709806,0.0016364201,0.0007703217,0.000092735034,0.000008716856,0.00024962786],"about_ca_topic_score_codex":0.0017594193,"about_ca_topic_score_gemma":0.0023747385,"teacher_disagreement_score":0.29995757,"about_ca_system_score_codex":0.00053460925,"about_ca_system_score_gemma":0.0005079429,"threshold_uncertainty_score":0.64498645},"labels":[],"label_agreement":null},{"id":"W1492054099","doi":"10.4049/jimmunol.192.supp.116.7","title":"Protein tyrosine kinase 7 promotes PI3K/AKT signaling and survival in primary and neoplastic CD4+ T-lineage cells. (HEM4P.231)","year":2014,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Protein kinase B; Cancer research; PI3K/AKT/mTOR pathway; Biology; Receptor tyrosine kinase; Tyrosine kinase; Cell biology; Jurkat cells; Cell growth; T cell; Kinase; Signal transduction; Immunology; Biochemistry","score_opus":0.01105942657080223,"score_gpt":0.250114114078076,"score_spread":0.23905468750727377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1492054099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914654,0.0061583393,0.00012230423,0.0015514459,0.00024218306,0.000268426,0.0000017807221,0.000008128405,0.00018203184],"genre_scores_gemma":[0.9985215,0.00052333955,0.00031289627,0.00018806967,0.00020222494,0.0000045361335,0.0000023623666,0.000015326688,0.00022971409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989541,0.00027434304,0.0003577595,0.00010335035,0.00009943474,0.000210996],"domain_scores_gemma":[0.99912006,0.0004129614,0.0002282182,0.00010886787,0.0000720366,0.000057875564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072433177,0.00014136921,0.00043640213,0.00013958008,0.00005952217,0.000009407624,0.00008375385,0.00008635274,0.0000520978],"category_scores_gemma":[0.00008394797,0.00008930669,0.00003682741,0.000100701785,0.00022274339,0.00005757202,0.000059972022,0.00042064965,0.0000032367761],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002704676,0.00023741425,0.0034743233,0.00009142297,0.00016201781,0.00008905203,0.0005859155,0.000010639532,0.9876908,0.000057581154,0.000064641776,0.00483153],"study_design_scores_gemma":[0.026715722,0.01402953,0.10486142,0.0008228884,0.001111774,0.003517943,0.00040601764,0.00047911576,0.843811,0.00057790574,0.0032649855,0.00040170137],"about_ca_topic_score_codex":0.00006132563,"about_ca_topic_score_gemma":0.000018131856,"teacher_disagreement_score":0.14387979,"about_ca_system_score_codex":0.00005892804,"about_ca_system_score_gemma":0.00009204621,"threshold_uncertainty_score":0.3641821},"labels":[],"label_agreement":null},{"id":"W1506197408","doi":"10.4212/cjhp.v54i1.619","title":"Concepts in Oncology Therapeutics","year":2001,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Medical physics","score_opus":0.05167590841878891,"score_gpt":0.40191812047487696,"score_spread":0.3502422120560881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1506197408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.934336,0.004311235,0.0000021096266,0.04956885,0.0011976209,0.00020598652,0.0000035296412,0.0000035588128,0.010371121],"genre_scores_gemma":[0.99286276,0.00074238965,0.000028415556,0.0051264027,0.0005426762,0.0000034576378,0.0000017057786,0.0000125013785,0.0006796884],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991955,0.000070222115,0.00027019813,0.0000684752,0.00010772097,0.00028786],"domain_scores_gemma":[0.99923897,0.00007489327,0.00012958246,0.00008353833,0.000117929776,0.00035506408],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024367138,0.00009924406,0.00023595904,0.00015859783,0.00007913047,0.000014630425,0.00015834406,0.00003700777,0.0009968688],"category_scores_gemma":[0.000015154803,0.000065923174,0.00009754786,0.0002015454,0.0001798085,0.0000782136,0.000006188118,0.000416752,0.000028846285],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015984665,0.00080873806,0.7645852,0.000018501565,0.0009135743,0.016842395,0.011637554,0.00008412659,0.0022982068,0.0005044375,0.047524244,0.15318456],"study_design_scores_gemma":[0.007935371,0.0020458365,0.042366274,0.000032502736,0.00029653884,0.0015583226,0.00034296955,0.00004777885,0.0009297059,0.0004588575,0.9438692,0.0001166499],"about_ca_topic_score_codex":0.00742632,"about_ca_topic_score_gemma":0.03506515,"teacher_disagreement_score":0.89634496,"about_ca_system_score_codex":0.0005679679,"about_ca_system_score_gemma":0.0021511512,"threshold_uncertainty_score":0.9999164},"labels":[],"label_agreement":null},{"id":"W1517956406","doi":"10.1016/j.ijpharm.2004.05.027","title":"Paclitaxel loaded poly(l-lactic acid) (PLLA) microspheres","year":2004,"lang":"en","type":"article","venue":"International Journal of Pharmaceutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); University of British Columbia","funders":"","keywords":"Paclitaxel; Kinetics; Diffusion; Dosage form; Materials science; Dispersion (optics); Chemical engineering; Microsphere; Dichloromethane; Drug carrier; Microparticle; Deposition (geology); Chemistry; Chromatography; Drug delivery; Solvent; Nanotechnology; Organic chemistry; Surgery; Chemotherapy","score_opus":0.046155434121474825,"score_gpt":0.41231550041655074,"score_spread":0.3661600662950759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1517956406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91605985,0.03397252,0.0016327965,0.033085898,0.009934607,0.00023289034,0.0000463488,0.000045475495,0.0049896385],"genre_scores_gemma":[0.99034363,0.0011015843,0.002181195,0.0034598247,0.0022354652,0.0000021100284,0.0000067468054,0.000020304647,0.000649127],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876344,0.000028034287,0.00042812625,0.00010829717,0.00048376745,0.0001883448],"domain_scores_gemma":[0.99885434,0.000057622416,0.00031426348,0.00007557877,0.0004916998,0.00020652545],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016103526,0.00014332295,0.00024238387,0.0001490964,0.000032750802,0.00003334504,0.00022146036,0.00006469738,0.0009373306],"category_scores_gemma":[0.000053110016,0.00012080882,0.00021355877,0.00009625487,0.00008349278,0.00015970062,0.00003832923,0.0003694642,0.0000699785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00519837,0.0025498145,0.018894615,0.00005754805,0.0038872166,0.0036679527,0.0011282245,0.000059310933,0.87617815,0.00077752804,0.007497572,0.0801037],"study_design_scores_gemma":[0.013921743,0.0004814156,0.002854307,0.00011261132,0.00054495066,0.0032920684,0.00013467579,0.000020577576,0.87205935,0.0006483311,0.10579907,0.00013091981],"about_ca_topic_score_codex":0.000017559298,"about_ca_topic_score_gemma":0.000003946045,"teacher_disagreement_score":0.0983015,"about_ca_system_score_codex":0.00046390106,"about_ca_system_score_gemma":0.0003482906,"threshold_uncertainty_score":0.9999759},"labels":[],"label_agreement":null},{"id":"W1518347581","doi":"10.1002/cncr.27463","title":"A prospective surveillance model for physical rehabilitation of women with breast cancer","year":2012,"lang":"en","type":"review","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Breast cancer; Rehabilitation; Cancer; Physical therapy; Physical medicine and rehabilitation; Peripheral neuropathy; Intensive care medicine; Internal medicine","score_opus":0.04279504833703277,"score_gpt":0.40727564011774536,"score_spread":0.36448059178071257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1518347581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023976974,0.99248564,0.000041518968,0.00015489083,0.00018353714,0.002988787,0.0016002412,0.000027222699,0.000120437304],"genre_scores_gemma":[0.013989953,0.9680806,0.00016016631,0.000043983222,0.0010041996,0.015321087,0.00006498017,0.000077833465,0.0012572145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988281,0.000036426405,0.00025063698,0.00034856974,0.00014999353,0.0003862731],"domain_scores_gemma":[0.9989022,0.00018069115,0.00029411487,0.00020706214,0.00027224107,0.0001437114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011128371,0.00030436204,0.0016605505,0.000074862604,0.000028958591,0.0000033651556,0.00006600406,0.00012032609,0.00015614711],"category_scores_gemma":[0.000007836987,0.00019847146,0.00022657243,0.00022256885,0.00013086757,0.000056198944,0.000015787313,0.00016035046,0.0000025695883],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026094995,0.00063296343,0.0033710985,0.040824484,0.0016474159,9.979879e-7,0.0027611987,0.00005625106,0.000008685212,0.00011491042,0.0011135234,0.94685894],"study_design_scores_gemma":[0.0070522754,0.0025673774,0.0059781633,0.012808181,0.008151808,0.000040933635,0.000071004,0.0011149123,0.0000099386,0.00016459596,0.9612002,0.0008406608],"about_ca_topic_score_codex":0.000099761935,"about_ca_topic_score_gemma":0.0001239292,"teacher_disagreement_score":0.96008664,"about_ca_system_score_codex":0.0022453798,"about_ca_system_score_gemma":0.0013152552,"threshold_uncertainty_score":0.8093431},"labels":[],"label_agreement":null},{"id":"W152180321","doi":"10.1007/978-3-662-43604-2_18","title":"Adverse Side Effects Associated with the Use of Low-Dose Metronomic Chemotherapy","year":2014,"lang":"en","type":"book-chapter","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Chemotherapy; Medicine; Adverse effect; Therapeutic index; Neutropenia; Toxicity; Oncology; Internal medicine; Therapeutic effect; Regimen; Clinical trial; Side effect (computer science); Chemotherapy regimen; Pharmacology; Drug","score_opus":0.023394503526238918,"score_gpt":0.2630178437575722,"score_spread":0.23962334023133328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W152180321","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17613997,0.00089126435,0.00018022736,0.003474539,0.0006576115,0.004725278,0.00007727395,0.00023637075,0.81361747],"genre_scores_gemma":[0.14167252,0.00020318512,0.00009334901,0.0031306057,0.00018792482,0.000026912674,0.00011042762,0.00008286146,0.8544922],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99924123,0.000027312191,0.00018251716,0.00022834037,0.00015356437,0.00016702534],"domain_scores_gemma":[0.9987235,0.0005790563,0.00025276846,0.0002998405,0.00007154094,0.00007329981],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008194907,0.00028946748,0.0006421308,0.00009078049,0.000027444743,0.0000041258763,0.00007115773,0.0002018044,0.0012142996],"category_scores_gemma":[0.000013249733,0.00015876947,0.00020198707,0.000024130195,0.00014578782,0.00002067213,0.000018030838,0.00022905704,0.00005768015],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03153157,0.0027754111,0.008540737,0.0024175243,0.07228474,0.00079196587,0.0018841347,0.00027199608,0.01865032,0.034156315,0.6708336,0.15586169],"study_design_scores_gemma":[0.03510627,0.005812582,0.015978288,0.0013787186,0.0073798154,0.00002721651,0.000011786701,0.00019714802,0.009895965,0.00018598304,0.9231627,0.0008635503],"about_ca_topic_score_codex":0.000092778566,"about_ca_topic_score_gemma":0.00021669638,"teacher_disagreement_score":0.25232908,"about_ca_system_score_codex":0.00021192912,"about_ca_system_score_gemma":0.00012545534,"threshold_uncertainty_score":0.9996987},"labels":[],"label_agreement":null},{"id":"W1522433939","doi":"10.1002/cncr.21122","title":"Capecitabine plus docetaxel combination therapy","year":2005,"lang":"en","type":"article","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Docetaxel; Medicine; Capecitabine; Quality-adjusted life year; Internal medicine; Oncology; Cost effectiveness; Chemotherapy; Surgery; Cancer; Colorectal cancer","score_opus":0.03792038833672323,"score_gpt":0.3667094676793864,"score_spread":0.32878907934266316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1522433939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9548966,0.011056591,0.000020874199,0.01542369,0.0004766838,0.0003379476,0.000008339013,0.00006503681,0.01771418],"genre_scores_gemma":[0.9700538,0.0031259435,0.00009106746,0.0039854837,0.000874665,0.0001263586,0.000023379269,0.000012815115,0.021706501],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995681,0.000009010027,0.00008652548,0.000119722055,0.00008697635,0.00012963159],"domain_scores_gemma":[0.9997559,0.000013058808,0.000028641354,0.000089009656,0.000051765437,0.00006161891],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000029404055,0.000077153345,0.00013547216,0.000039073555,0.000033224664,0.00000478233,0.000029979185,0.000038258797,0.005225546],"category_scores_gemma":[0.000002240424,0.00006161113,0.00004360386,0.00008656043,0.000028627754,0.00004965191,0.0000057453735,0.000069692454,0.00009647216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016782733,0.001013571,0.026614357,0.00004761052,0.00043207442,0.00003178701,0.0014649259,0.00014504378,0.048903696,0.001426241,0.199915,0.7183274],"study_design_scores_gemma":[0.012532792,0.00029432747,0.04021239,0.000018539675,0.00008013402,0.0000129062955,0.000014491541,0.00052816846,0.020910254,0.000059147522,0.9252308,0.00010602876],"about_ca_topic_score_codex":0.00008453197,"about_ca_topic_score_gemma":0.00006530464,"teacher_disagreement_score":0.7253158,"about_ca_system_score_codex":0.00032021877,"about_ca_system_score_gemma":0.000115455834,"threshold_uncertainty_score":0.9956838},"labels":[],"label_agreement":null},{"id":"W1542409929","doi":"10.3138/cbmh.17.1.155","title":"Poisoning the Spindle: Serendipity and Discovery of the Anti-Tumor Properties of the Vinca Alkaloids","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Health History","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Vinca; Serendipity; Scientific discovery; Key (lock); Drug discovery; Lunatic; History; Traditional medicine; Medicine; Law; Political science; Psychology; Computer science; Pharmacology; Epistemology; Philosophy; Cognitive science; Biology; Bioinformatics","score_opus":0.027472882758810685,"score_gpt":0.24718986079605756,"score_spread":0.21971697803724688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1542409929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93045735,0.05697692,2.90486e-7,0.011054445,0.0006971549,0.00020356754,0.0000115687435,0.0000010120979,0.0005976797],"genre_scores_gemma":[0.99497926,0.00040750968,0.000005389773,0.0028745763,0.00011925561,0.0000017083636,2.598993e-7,0.00000846367,0.0016035744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990793,0.00016711142,0.00036217828,0.00006546459,0.00013809883,0.00018785718],"domain_scores_gemma":[0.99923,0.000023236957,0.0003540891,0.0001698825,0.000060202092,0.00016254847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036124358,0.000081047954,0.0002876153,0.00006178993,0.00020211488,0.0000035018998,0.00015618837,0.00002679724,0.00020730817],"category_scores_gemma":[0.000027989478,0.000037202586,0.00010005384,0.00008103299,0.0004515408,0.00006312974,0.000008283344,0.0002768157,4.6269747e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010224204,0.00034866837,0.6610484,0.0016374267,0.00072051387,0.00012333805,0.03942122,0.000100209676,0.010626126,0.00038994284,0.23311679,0.051444914],"study_design_scores_gemma":[0.0015565576,0.00059242843,0.58588904,0.00078915275,0.00017051458,0.00058348017,0.0005359188,0.0000133945,0.0012778003,0.00002149871,0.4084893,0.000080930964],"about_ca_topic_score_codex":0.021919666,"about_ca_topic_score_gemma":0.021556366,"teacher_disagreement_score":0.17537251,"about_ca_system_score_codex":0.00088203244,"about_ca_system_score_gemma":0.0064155273,"threshold_uncertainty_score":0.99921715},"labels":[],"label_agreement":null},{"id":"W1542863370","doi":"10.1158/1538-7445.sabcs14-p4-15-08","title":"Abstract P4-15-08: A phase 1b study of ONT-380, an oral HER2-specific inhibitor, combined with ado-trastuzumab emtansine (T-DM1), in HER2+ metastatic breast cancer (MBC)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; La Cité Médicale","funders":"","keywords":"Lapatinib; Medicine; Taxane; Trastuzumab; Metastatic breast cancer; Internal medicine; Neratinib; Oncology; Trastuzumab emtansine; Progressive disease; Anthracycline; Cancer; Breast cancer; Pharmacology; Chemotherapy","score_opus":0.19817550286950686,"score_gpt":0.4931715194821537,"score_spread":0.29499601661264685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1542863370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99214184,0.0026184402,0.0000033139581,0.0015140333,0.00030434306,0.0027683403,0.00024362783,0.00005448202,0.00035158073],"genre_scores_gemma":[0.9970205,0.0005403601,0.00006369328,0.00010152257,0.00037930076,0.0010968467,0.000079796104,0.00009688484,0.0006210879],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99571145,0.00045088958,0.0006445188,0.0007874619,0.0014381283,0.0009675484],"domain_scores_gemma":[0.9973985,0.00014014576,0.00016108068,0.00059449516,0.000991901,0.0007138611],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011027207,0.00040244087,0.0010085827,0.00061423326,0.00011464446,0.000049966664,0.00030503486,0.00010363966,0.0019798945],"category_scores_gemma":[0.000026723244,0.00031312744,0.00007584343,0.0014825758,0.0004106844,0.00029336917,0.000093760274,0.0009217956,0.000029893796],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22961389,0.1797667,0.2605771,0.0017583703,0.0039513456,0.010073119,0.042603455,0.00087741157,0.11489595,0.00009073723,0.06282467,0.092967264],"study_design_scores_gemma":[0.41565338,0.101898864,0.40221563,0.002451054,0.0012893243,0.0003363813,0.034026213,0.00043122613,0.026166309,0.00016950656,0.01362379,0.0017383227],"about_ca_topic_score_codex":0.04247638,"about_ca_topic_score_gemma":0.08159491,"teacher_disagreement_score":0.1860395,"about_ca_system_score_codex":0.0019684958,"about_ca_system_score_gemma":0.0026671672,"threshold_uncertainty_score":0.9999321},"labels":[],"label_agreement":null},{"id":"W1543311118","doi":"","title":"Comparative pharmacokinetics, tissue distribution and excretion of free versus liposomal vincristine in rats.","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada); Cantox Health Sciences International","funders":"","keywords":"Vincristine; Pharmacokinetics; Pharmacology; Liposome; Distribution (mathematics); Chemistry; Medicine; Internal medicine; Chemotherapy; Biochemistry","score_opus":0.13425563897400392,"score_gpt":0.49710398120301547,"score_spread":0.3628483422290115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1543311118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924752,0.0034872147,0.000024191359,0.0023461161,0.00018398417,0.00050353404,0.00015084143,0.000010824604,0.00081806665],"genre_scores_gemma":[0.99776185,0.0015379431,0.000048000966,0.000017886694,0.00021631147,0.00008977838,0.00013509285,0.000007254171,0.00018586748],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990723,0.00007615529,0.0001598713,0.00019615715,0.00025721578,0.00023830126],"domain_scores_gemma":[0.9994484,0.00009930121,0.000031816606,0.00012176464,0.00019782355,0.000100877674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020495156,0.00008259466,0.00022938967,0.00011064906,0.000044833065,0.0000060996585,0.00006617344,0.000051933508,0.0003146844],"category_scores_gemma":[0.000042672476,0.00007635783,0.000018248802,0.00033166446,0.0002809582,0.00004346008,0.000064434724,0.0002678111,0.0000069247667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01459022,0.00072852866,0.007845682,0.00027849147,0.00017079696,0.00012203468,0.0016412956,0.00013991269,0.9564036,0.0010563455,0.009860483,0.007162599],"study_design_scores_gemma":[0.021230975,0.002250261,0.046124157,0.00017610184,0.000089344176,0.000008857371,0.00017261834,0.00006520769,0.91825044,0.0003456355,0.011176648,0.00010977209],"about_ca_topic_score_codex":0.0024790107,"about_ca_topic_score_gemma":0.0007228225,"teacher_disagreement_score":0.03827847,"about_ca_system_score_codex":0.0004972862,"about_ca_system_score_gemma":0.00024056464,"threshold_uncertainty_score":0.37475392},"labels":[],"label_agreement":null},{"id":"W1553189449","doi":"10.1096/fasebj.28.1_supplement.647.10","title":"Flavonoids from rooibos tea promote cell death in an osteosarcoma cell line (647.10)","year":2014,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Chemistry; Vitexin; Formazan; Luteolin; Viability assay; Cell culture; Cell growth; Pharmacology; Biochemistry; Antioxidant; Cell; Flavonoid; Biology","score_opus":0.024620339619040102,"score_gpt":0.2980593696849902,"score_spread":0.2734390300659501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1553189449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915504,0.0006019039,0.00010207279,0.0014022596,0.00034039415,0.00028749835,0.000017808581,0.00002773394,0.005669965],"genre_scores_gemma":[0.9921577,0.000103003855,0.00065213535,0.0007018179,0.001589456,0.000010050598,0.000047215526,0.000030590734,0.004708007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998664,0.00024905108,0.00031802012,0.00019840787,0.00021554476,0.00035495748],"domain_scores_gemma":[0.9991431,0.000104202576,0.00014434989,0.00028081087,0.00006057304,0.00026693975],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045045582,0.00019483623,0.0003140242,0.00010720589,0.00014067136,0.000042086427,0.00021946848,0.00009337264,0.0021857817],"category_scores_gemma":[0.000012724435,0.0001239437,0.00011049503,0.00011251202,0.00004711853,0.00010082324,0.000041492836,0.0006257216,0.00018576383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015507292,0.0013474048,0.051416595,0.00002757283,0.00007741543,0.00035991782,0.0019914776,0.00008036291,0.9270851,0.000010730724,0.0030346673,0.013018045],"study_design_scores_gemma":[0.018785324,0.005453425,0.03540132,0.000121952864,0.0007136614,0.00034154893,0.00026413632,0.0058315303,0.9164419,0.0011396853,0.015125128,0.0003803747],"about_ca_topic_score_codex":0.00018520598,"about_ca_topic_score_gemma":0.0001410255,"teacher_disagreement_score":0.017234595,"about_ca_system_score_codex":0.00013932698,"about_ca_system_score_gemma":0.00013848931,"threshold_uncertainty_score":0.99872637},"labels":[],"label_agreement":null},{"id":"W1559459501","doi":"10.1002/cncr.24359","title":"Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non‐Hodgkin lymphoma","year":2009,"lang":"en","type":"article","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Vincristine; Tolerability; Internal medicine; Gastroenterology; Refractory (planetary science); Aggressive lymphoma; Lymphoma; Chemotherapy; Surgery; Adverse effect; Rituximab; Cyclophosphamide","score_opus":0.00701641614179865,"score_gpt":0.2875676238083607,"score_spread":0.28055120766656205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1559459501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99580956,0.0012519384,0.0000031674358,0.00053628255,0.00031476322,0.0005891604,0.00003452103,0.000058659974,0.001401961],"genre_scores_gemma":[0.99694973,0.00036532237,0.000041055628,0.000839087,0.00023932247,0.00010637725,0.00012596464,0.000023342167,0.0013097753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896085,0.000037137695,0.00021186139,0.00031863275,0.00017951707,0.00029200953],"domain_scores_gemma":[0.99936324,0.000028282004,0.00017824802,0.00017053133,0.00014095234,0.00011876635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003799691,0.00021009633,0.00033287503,0.00017632327,0.000050763694,0.000009564516,0.00005122691,0.000091757276,0.00032131362],"category_scores_gemma":[0.000017684033,0.00016076755,0.000044722237,0.00037259518,0.000051661118,0.00011157926,0.0000110146475,0.0001291285,0.000015786383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008087363,0.0015333408,0.78383934,0.000057794805,0.00018515729,0.00024293098,0.0006710168,0.000077828474,0.003547669,0.0000029645287,0.006473536,0.19528106],"study_design_scores_gemma":[0.011995153,0.0031353263,0.975195,0.0003365601,0.00017762938,0.0000136620265,0.000015307796,0.000049243557,0.004796077,0.000012945324,0.004092811,0.0001802698],"about_ca_topic_score_codex":0.0009452885,"about_ca_topic_score_gemma":0.00033945774,"teacher_disagreement_score":0.1951008,"about_ca_system_score_codex":0.00082685874,"about_ca_system_score_gemma":0.00022866724,"threshold_uncertainty_score":0.655591},"labels":[],"label_agreement":null},{"id":"W1563983159","doi":"10.1158/1538-7445.sabcs14-p6-09-03","title":"Abstract P6-09-03: Development of a cardiac toxicity prediction tool for HER2 (+) breast cancer patients receiving trastuzumab","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Trastuzumab; Ejection fraction; Internal medicine; Breast cancer; Discontinuation; Oncology; Cancer; Cardiotoxicity; Cardiology; Metastatic breast cancer; Concomitant; Heart failure; Toxicity","score_opus":0.1123989428833025,"score_gpt":0.4361029065365645,"score_spread":0.32370396365326204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1563983159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941824,0.0010455599,0.000011482031,0.0005883883,0.0007524372,0.0016295662,0.0006276111,0.000034207616,0.001128341],"genre_scores_gemma":[0.9956769,0.00040984788,0.00020435598,0.0000435874,0.00062604336,0.0017723321,0.00011594016,0.00003541988,0.0011156184],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979162,0.000073504714,0.0003779889,0.00036689162,0.00073917833,0.00052622485],"domain_scores_gemma":[0.998202,0.00012586227,0.00009207894,0.0001834857,0.0011277348,0.00026881223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082360744,0.00016136664,0.00037825282,0.00018010539,0.00014229736,0.000016216105,0.00011809921,0.0001190515,0.00042865446],"category_scores_gemma":[0.000071504175,0.00014076587,0.00010134535,0.0003266111,0.00011082885,0.00011847661,0.000059090184,0.00028408176,0.000017074193],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077425134,0.0019074177,0.3860387,0.001103282,0.0011064704,0.000005392447,0.007909674,0.000058330214,0.07709157,0.000009088244,0.10958682,0.40744075],"study_design_scores_gemma":[0.0054516764,0.0007442112,0.8739556,0.00040176293,0.00012817045,0.0000022618333,0.00027185664,0.00003681558,0.08068672,0.000026260288,0.038110394,0.0001842514],"about_ca_topic_score_codex":0.0010947771,"about_ca_topic_score_gemma":0.00041872315,"teacher_disagreement_score":0.48791692,"about_ca_system_score_codex":0.0023616161,"about_ca_system_score_gemma":0.0024672176,"threshold_uncertainty_score":0.6175544},"labels":[],"label_agreement":null},{"id":"W1564497062","doi":"10.1684/bdc.2008.0628","title":"[Outpatient chemotherapy and oncology network : Onco Pays-de-la-Loire experiment].","year":2008,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Humanities; Gynecology; Art","score_opus":0.030273942759395833,"score_gpt":0.31136516344697435,"score_spread":0.2810912206875785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1564497062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9603943,0.004572014,0.000011020305,0.0028466603,0.00032605138,0.00084162975,0.0000019319161,0.000068715366,0.030937677],"genre_scores_gemma":[0.98796916,0.0028080898,0.00028474757,0.003323651,0.000650561,0.001458092,0.000009595564,0.000020800939,0.0034753152],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911034,0.00008407996,0.00014313665,0.00019655969,0.00009026983,0.0003756423],"domain_scores_gemma":[0.9994794,0.00011744188,0.00005250737,0.00011339032,0.000019260879,0.0002180015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015545092,0.0001229923,0.00026052678,0.000036173376,0.000089711575,0.0000048097704,0.000037916703,0.00012682675,0.00017919773],"category_scores_gemma":[0.000011272418,0.00010320597,0.000052379844,0.00008912661,0.00018222879,0.000027824686,0.000023138948,0.000140882,0.000005675595],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024230743,0.0016292508,0.19293106,0.00003272732,0.00043490756,0.00053688337,0.004563697,0.0000098055725,0.00063544925,0.00016951073,0.16520905,0.6314246],"study_design_scores_gemma":[0.0061507905,0.0005453582,0.39215323,0.0000054224543,0.00007712055,0.0003528401,0.000053607782,0.000018421084,0.002269591,0.000072829556,0.5981889,0.00011191904],"about_ca_topic_score_codex":0.000051658448,"about_ca_topic_score_gemma":0.0000068756694,"teacher_disagreement_score":0.63131267,"about_ca_system_score_codex":0.00039720646,"about_ca_system_score_gemma":0.00009349274,"threshold_uncertainty_score":0.42086175},"labels":[],"label_agreement":null},{"id":"W1564958769","doi":"10.1023/a:1013018218360","title":"Responsiveness of the EuroQol in breast cancer patients undergoing high dose chemotherapy","year":2001,"lang":"en","type":"article","venue":"Quality of Life Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Quality of life (healthcare); Quality of Life Research; EQ-5D; Health related quality of life; Internal medicine; Cancer; Chemotherapy; Analysis of variance; Oncology; Physical therapy; Public health; Pathology","score_opus":0.1878835862729618,"score_gpt":0.4955512457154663,"score_spread":0.3076676594425045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1564958769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833028,0.00024581794,7.3436337e-7,0.01533491,0.00008384186,0.00048862584,0.000036532605,0.000004996572,0.0005017501],"genre_scores_gemma":[0.99773985,0.0009854803,0.000012763604,0.00038806812,0.000080115715,0.000029455367,0.0000048642414,0.000011851956,0.0007475455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977007,0.00088222534,0.00035435316,0.00017235035,0.00063378486,0.00025658333],"domain_scores_gemma":[0.99837375,0.0007901969,0.00010521481,0.00025680082,0.0003912642,0.00008279427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001329803,0.000075779586,0.00030322824,0.00015594826,0.000048427653,0.000003403336,0.0001522213,0.00006181551,0.00055309694],"category_scores_gemma":[0.00023536534,0.00005349822,0.00007034692,0.00064689276,0.0002383893,0.00003488101,0.000065687185,0.00023622935,0.000003867223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008359275,0.0010671798,0.97365475,0.0002486099,0.00007493859,0.0000031993534,0.0006512945,0.0000075325606,0.011513165,0.00013438142,0.00091439363,0.0033712892],"study_design_scores_gemma":[0.0065109464,0.0002611872,0.98888916,0.00016524969,0.0000090169215,0.0000014701521,0.00014787557,0.000006725095,0.0032123046,0.00015404743,0.00059767516,0.000044354547],"about_ca_topic_score_codex":0.0071556144,"about_ca_topic_score_gemma":0.0008606064,"teacher_disagreement_score":0.015234406,"about_ca_system_score_codex":0.00019183624,"about_ca_system_score_gemma":0.0007612935,"threshold_uncertainty_score":0.9994558},"labels":[],"label_agreement":null},{"id":"W1579173109","doi":"10.4212/cjhp.v60i4.184","title":"Stability of Docetaxel Solution after Dilution in Ethanol and Storage in Vials and after Dilution in Normal Saline and Storage in Bags","year":2007,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Docetaxel; Vial; Chromatography; Dilution; Chemistry; Polyethylene; Ethanol; Drug packaging; Surgery; Medicine; Biochemistry; Organic chemistry","score_opus":0.01561378250195662,"score_gpt":0.2941140342746935,"score_spread":0.2785002517727369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1579173109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907559,0.0060552554,0.000010751817,0.002447844,0.00020628782,0.00045452177,0.000028486393,0.0000016929929,0.000039262482],"genre_scores_gemma":[0.9992255,0.00040289405,0.000028071,0.00019199109,0.00011790757,0.000010925742,0.000003896092,0.00001014036,0.0000086619575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869287,0.00014916455,0.00054319785,0.00015201981,0.00013645485,0.00032632254],"domain_scores_gemma":[0.9993721,0.00008234696,0.00015597059,0.00007360748,0.000059485494,0.00025647067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014185247,0.00014510896,0.00034181232,0.00051413174,0.000027739916,0.000013266931,0.000048121867,0.00006850681,0.00008384717],"category_scores_gemma":[0.000053036973,0.00011889137,0.000034965116,0.0002576566,0.00022564796,0.0003172392,0.000021020875,0.00043582765,3.4434348e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027856326,0.00020464748,0.9819991,0.00008422028,0.00002382856,0.0007863861,0.005218196,0.000018146682,0.00516,0.000005323593,0.00002611115,0.0036884325],"study_design_scores_gemma":[0.007244458,0.00047181136,0.989091,0.00016073255,0.000059842205,0.00007581974,0.00019634962,0.00022450418,0.002125891,0.000088105204,0.00015188848,0.0001096055],"about_ca_topic_score_codex":0.027886532,"about_ca_topic_score_gemma":0.30756897,"teacher_disagreement_score":0.27968243,"about_ca_system_score_codex":0.0006596605,"about_ca_system_score_gemma":0.00032502704,"threshold_uncertainty_score":0.97858685},"labels":[],"label_agreement":null},{"id":"W1588538733","doi":"","title":"Preferential potentiation of paclitaxel and doxorubicin cytotoxicity in drug-resistant breast tumor cells by tesmilifene.","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sudbury Regional Hospital","funders":"","keywords":"Paclitaxel; Doxorubicin; Clonogenic assay; Cytotoxicity; Anthracycline; Medicine; Chemotherapy; Breast cancer; Pharmacology; Cancer research; Internal medicine; Cancer; Oncology; In vitro; Chemistry; Biochemistry","score_opus":0.027685970481697564,"score_gpt":0.36610498746509595,"score_spread":0.3384190169833984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1588538733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460185,0.0024489888,0.0000037554091,0.0009210791,0.00006980445,0.00061840797,0.00032745424,0.000012547321,0.0009960923],"genre_scores_gemma":[0.99684536,0.00038348007,0.000023250312,0.000047490215,0.00016781161,0.00013328904,0.000065994915,0.000016568994,0.0023167732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851596,0.00015347268,0.0002676248,0.00029684367,0.0003956393,0.00037045285],"domain_scores_gemma":[0.99942946,0.000097420925,0.000057486446,0.00015032997,0.00016309581,0.000102200735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039844305,0.00011354333,0.00026994385,0.00022052276,0.000059993337,0.000012702861,0.0000709602,0.000055516226,0.0005226766],"category_scores_gemma":[0.000009719878,0.00009922056,0.000041262083,0.0003413237,0.00019578877,0.00005765936,0.000054050633,0.00026020338,0.0000053768977],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015046297,0.00047187853,0.043263346,0.00019102318,0.000033258995,0.00001777651,0.000092894625,0.0000074599257,0.9318046,0.000049973343,0.021891627,0.0006715202],"study_design_scores_gemma":[0.0042568506,0.0002778011,0.15480207,0.00013910394,0.000050953586,0.000008298709,0.000093999864,0.000057534064,0.8378002,0.00017926937,0.0022307772,0.00010311841],"about_ca_topic_score_codex":0.020707848,"about_ca_topic_score_gemma":0.0032237105,"teacher_disagreement_score":0.111538716,"about_ca_system_score_codex":0.00031501814,"about_ca_system_score_gemma":0.00023809761,"threshold_uncertainty_score":0.9858133},"labels":[],"label_agreement":null},{"id":"W1593763867","doi":"10.1186/1471-2407-4-60","title":"Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries","year":2004,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Saskatoon Medical Imaging; University of Saskatchewan","funders":"Magyar Tudományos Akadémia; Saskatchewan Cancer Agency","keywords":"Surgical oncology; Medicine; Oncology; Breast cancer; Internal medicine; Cancer","score_opus":0.05922309304366742,"score_gpt":0.3584372324348214,"score_spread":0.299214139391154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1593763867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860103,0.001862637,0.00011047336,0.0009111298,0.0005987687,0.0004928992,0.009609409,0.000034516568,0.000369837],"genre_scores_gemma":[0.9957636,0.0004822886,0.00089112634,0.00022540885,0.00043157916,0.00007096262,0.0012933852,0.000036243666,0.0008054161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988145,0.000032238142,0.0002220781,0.00036723513,0.00033521594,0.00022873507],"domain_scores_gemma":[0.99899256,0.000054935343,0.00016443209,0.0005214324,0.00015188886,0.00011475304],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000059441434,0.0001796959,0.00041412705,0.00004867396,0.000039062255,0.000009360682,0.00017646533,0.000030334473,0.0025153551],"category_scores_gemma":[0.000008607638,0.00013319646,0.00004762953,0.00019229253,0.00014278642,0.00013032653,0.000079201534,0.000105580686,0.000015376714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034637954,0.00039222604,0.9884069,0.00009701851,0.00068003143,0.000010658872,0.00018329226,0.00025704905,0.0001340683,0.000043605236,0.004795796,0.001535558],"study_design_scores_gemma":[0.026417086,0.00027308144,0.95467925,0.00026879227,0.0018342222,0.0000034649422,0.00011187025,0.000027904522,0.00090665784,0.00008006196,0.015161628,0.00023595251],"about_ca_topic_score_codex":0.024756223,"about_ca_topic_score_gemma":0.021455374,"teacher_disagreement_score":0.033727624,"about_ca_system_score_codex":0.00027194954,"about_ca_system_score_gemma":0.00083049235,"threshold_uncertainty_score":0.99839646},"labels":[],"label_agreement":null},{"id":"W1594175490","doi":"10.1158/1538-7445.sabcs14-pd2-1","title":"Abstract PD2-1: The effect on overall and disease-free survival (OS &amp; DFS) by adding bevacizumab and/or antimetabolites to standard neoadjuvant chemotherapy: NSABP Protocol B-40","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Docetaxel; Bevacizumab; Internal medicine; Capecitabine; Chemotherapy; Breast cancer; Gemcitabine; Neoadjuvant therapy; Oncology; Taxane; Gastroenterology; Cancer; Colorectal cancer","score_opus":0.09054911960160768,"score_gpt":0.46391539685108785,"score_spread":0.3733662772494802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1594175490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9367036,0.0018193761,0.0000045908264,0.013746265,0.00016684175,0.04526555,0.00049650023,0.000060879043,0.0017363935],"genre_scores_gemma":[0.89548206,0.0006509157,0.000105385625,0.0018771613,0.0013743822,0.09239396,0.00005794738,0.00013523934,0.007922934],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974744,0.00026101194,0.00020854316,0.0005185677,0.0009123007,0.00062522816],"domain_scores_gemma":[0.9977696,0.00059810595,0.000047610483,0.00049423386,0.0002007407,0.0008897052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001298285,0.00025734137,0.00044151343,0.00014438927,0.00022150106,0.000111487425,0.00022098531,0.00007718654,0.00090980844],"category_scores_gemma":[0.00044358068,0.00014895071,0.00006055167,0.00027102974,0.00024138369,0.000087631175,0.00016106546,0.00047808696,0.00003366902],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16493657,0.00042142862,0.039404698,0.00081521727,0.0005521013,0.00015547164,0.0014527487,0.000011482469,0.04393295,0.000119675366,0.6098318,0.13836583],"study_design_scores_gemma":[0.028102703,0.0053291395,0.04056122,0.00043633033,0.00012312617,0.000013166234,0.00009428567,0.000020916505,0.016018767,0.00024618002,0.90872496,0.0003292103],"about_ca_topic_score_codex":0.00053228805,"about_ca_topic_score_gemma":0.00017254516,"teacher_disagreement_score":0.29889312,"about_ca_system_score_codex":0.00040935655,"about_ca_system_score_gemma":0.0006441412,"threshold_uncertainty_score":0.9961764},"labels":[],"label_agreement":null},{"id":"W1607081374","doi":"10.4137/cmt.s3410","title":"A Review of the Impact of Lapatinib on Health-Related Quality of Life in the Management of Advanced solid Tumors","year":2009,"lang":"en","type":"review","venue":"Clinical Medicine Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Lapatinib; Medicine; Quality of life (healthcare); Clinical trial; Metastatic breast cancer; Epidermal growth factor receptor; Breast cancer; Oncology; Internal medicine; Cancer; Trastuzumab","score_opus":0.3530756171237509,"score_gpt":0.6077769786051451,"score_spread":0.2547013614813942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1607081374","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020149644,0.9897694,6.2253486e-7,0.0034727112,0.00023087063,0.0034335316,0.000050854174,0.0000062578006,0.0010207728],"genre_scores_gemma":[0.005574522,0.9900701,0.000030122741,0.00407122,0.000090991925,0.000041954892,0.000052570955,0.00002479637,0.000043724573],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9911309,0.0020754158,0.005742766,0.00029068463,0.0005197081,0.00024056602],"domain_scores_gemma":[0.9912715,0.0025717847,0.0048625963,0.0010240605,0.00016551286,0.0001045685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046280865,0.0003737203,0.0064874347,0.00011264474,0.000016396383,4.1470048e-7,0.0005016911,0.00020786292,0.00013468551],"category_scores_gemma":[0.00036352137,0.00015810429,0.0013682015,0.0008788118,0.00062756275,0.000009155742,0.000048876416,0.00082292804,0.0000013558014],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006110277,0.0018866936,0.0003085098,0.12987575,0.001910448,0.0000036206231,0.00022178008,0.0000017536375,0.000001235863,0.00014447242,0.0009058227,0.8641289],"study_design_scores_gemma":[0.0112953205,0.020964922,0.020397646,0.81007093,0.009266009,0.000016518285,0.00018514374,0.0000047567905,0.000003544594,0.00041691706,0.12711532,0.00026298504],"about_ca_topic_score_codex":0.00013559153,"about_ca_topic_score_gemma":0.0000072826842,"teacher_disagreement_score":0.8638659,"about_ca_system_score_codex":0.00011244008,"about_ca_system_score_gemma":0.0007618208,"threshold_uncertainty_score":0.64473057},"labels":[],"label_agreement":null},{"id":"W1633250892","doi":"10.1096/fasebj.26.1_supplement.lb784","title":"Skeletal muscle as a possible compartment for the sequestering of Doxorubicin following administration","year":2012,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Laurentian University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Skeletal muscle; Doxorubicin; Intramuscular injection; Chemistry; Bolus (digestion); Pharmacokinetics; Gastrocnemius muscle; Internal medicine; Medicine; Pharmacology; Intravenous bolus; Endocrinology; Chemotherapy","score_opus":0.0540137135544045,"score_gpt":0.37058505357302096,"score_spread":0.3165713400186165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1633250892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420303,0.001448615,0.00079414016,0.0018225815,0.0006584792,0.00035531822,0.000004526359,0.000007632314,0.0007056868],"genre_scores_gemma":[0.9981217,0.000052692594,0.0003081875,0.00028104408,0.0006861956,0.000022088849,0.0000054567954,0.000008350474,0.0005142961],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994152,0.00004004959,0.00017675488,0.000044255623,0.0001333545,0.00019037443],"domain_scores_gemma":[0.9995498,0.00014556463,0.000105359955,0.00009209297,0.000028574423,0.00007860352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043730933,0.000072377734,0.00013399,0.000024884175,0.00019119345,0.000015943333,0.00006458459,0.00002067318,0.0001647144],"category_scores_gemma":[0.000012267796,0.000036728696,0.000157621,0.000047452406,0.000034134147,0.00007875652,0.000010533167,0.000117205986,0.000008241661],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065506157,0.00036095787,0.01118848,0.00003744111,0.0006807692,0.000023102539,0.0023954401,0.000046566733,0.9731551,0.00037546747,0.0022018945,0.008879751],"study_design_scores_gemma":[0.007408401,0.0030696534,0.043452393,0.00015500479,0.0022575145,0.0013548762,0.0018895607,0.0004883709,0.918949,0.000361949,0.020443544,0.00016973287],"about_ca_topic_score_codex":0.000013244678,"about_ca_topic_score_gemma":0.000005053666,"teacher_disagreement_score":0.05420607,"about_ca_system_score_codex":0.00006807419,"about_ca_system_score_gemma":0.00009954586,"threshold_uncertainty_score":0.1803507},"labels":[],"label_agreement":null},{"id":"W1750189415","doi":"10.1200/jco.2005.23.16_suppl.756","title":"Subgroup analysis of a phase III trial of doxorubicin vs doxorubicin plus tesmilifene in advanced breast cancer (ABC): Tesmilifene survival benefit focused on patients with more aggressive disease","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Doxorubicin; Internal medicine; Chemotherapy; Subgroup analysis; Oncology; Breast cancer; Proportional hazards model; Survival analysis; Cancer; Gastroenterology; Confidence interval","score_opus":0.05199588958467272,"score_gpt":0.45966956780422985,"score_spread":0.40767367821955713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1750189415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916154,0.0007209105,0.000015547916,0.005422864,0.0008046847,0.00095116126,0.00032493743,0.000008715886,0.00013575797],"genre_scores_gemma":[0.9957547,0.0013477855,0.0003690191,0.0012894953,0.0009843183,0.000044139237,0.000061828294,0.000034176905,0.00011449953],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99396294,0.00045794155,0.0037909667,0.00045737004,0.0008828912,0.00044786982],"domain_scores_gemma":[0.99019176,0.002528139,0.005194977,0.00038629165,0.0009883284,0.0007104992],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013329883,0.00037701536,0.00437275,0.00088591856,0.000040422725,0.000003807668,0.00027290772,0.00034962766,0.00056683214],"category_scores_gemma":[0.0008066065,0.0002550817,0.0009968808,0.0011157463,0.00045825908,0.00016414335,0.00005735181,0.0008607984,0.0000016443872],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5966579,0.021635214,0.29629132,0.000036802023,0.0036406487,0.00033930477,0.0001909678,0.0045529883,0.00023198756,0.000012874621,0.00019762033,0.0762124],"study_design_scores_gemma":[0.40980622,0.034629155,0.5452151,0.0003289339,0.0080378065,0.000006933722,0.000053752876,0.00081718306,0.00031571864,0.000013551571,0.0006008327,0.00017483362],"about_ca_topic_score_codex":0.00036114256,"about_ca_topic_score_gemma":0.00193808,"teacher_disagreement_score":0.24892375,"about_ca_system_score_codex":0.000699086,"about_ca_system_score_gemma":0.0021905007,"threshold_uncertainty_score":0.99999017},"labels":[],"label_agreement":null},{"id":"W1783154753","doi":"10.1200/jco.2000.18.12.2385","title":"Phase III Comparative Study of Vinorelbine Combined With Doxorubicin Versus Doxorubicin Alone in Disseminated Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Vinorelbine; Metastatic breast cancer; Anthracycline; Chemotherapy; Neutropenia; Internal medicine; Doxorubicin; Surgery; Breast cancer; Toxicity; Vinca alkaloid; Cancer; Febrile neutropenia; Gastroenterology; Phases of clinical research; Cyclophosphamide; Vincristine; Cisplatin","score_opus":0.310743133948084,"score_gpt":0.5937902368847396,"score_spread":0.28304710293665564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1783154753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915551,0.0006803738,0.0000028941809,0.0021836737,0.0028121474,0.002159539,0.00021009822,0.000005777463,0.00039041648],"genre_scores_gemma":[0.9977808,0.00089096127,0.000114553804,0.0002618817,0.0006392873,0.0000994739,0.00002875002,0.000019150375,0.00016515913],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.987626,0.0030835017,0.007438636,0.00042266733,0.0010636295,0.0003655777],"domain_scores_gemma":[0.9873012,0.006321248,0.004504314,0.0002075095,0.0011787816,0.00048697682],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008246344,0.00035944663,0.0061772023,0.00027908947,0.000054427182,0.0000055748937,0.00027654986,0.00018103546,0.0015656512],"category_scores_gemma":[0.00077315106,0.00023578045,0.0003794419,0.00065036665,0.00044377174,0.00016310018,0.000046306435,0.0012249958,9.3524517e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.598758,0.16110893,0.15226984,0.0000529152,0.009406178,0.0013867632,0.0014966656,0.00084202253,0.00019841648,0.000018773448,0.0077357823,0.066725746],"study_design_scores_gemma":[0.4148371,0.23557626,0.33825746,0.00027635804,0.0052687307,0.00007683507,0.0022698427,0.0003599221,0.00012100643,0.000016596214,0.0027128975,0.0002270148],"about_ca_topic_score_codex":0.089422986,"about_ca_topic_score_gemma":0.68382764,"teacher_disagreement_score":0.59440464,"about_ca_system_score_codex":0.0008820232,"about_ca_system_score_gemma":0.00886884,"threshold_uncertainty_score":0.99934703},"labels":[],"label_agreement":null},{"id":"W1803601410","doi":"10.1093/pch/16.9.537","title":"Using pharmacogenetics to understand adverse drug reactions in children","year":2011,"lang":"en","type":"article","venue":"Paediatrics & Child Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Ototoxicity; Medicine; Chemotherapy; Cisplatin; Methotrexate; Pharmacogenetics; Adverse effect; Drug; Adverse drug reaction; Drug reaction; Osteosarcoma; Doxorubicin; Hearing loss; Pharmacotherapy; Chemotherapeutic drugs; Oncology; Internal medicine; Surgery; Intensive care medicine; Pharmacology; Audiology; Pathology; Genotype","score_opus":0.07098040104866947,"score_gpt":0.3632881871008259,"score_spread":0.2923077860521564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1803601410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98826253,0.0026678517,0.00022825871,0.0026459321,0.0005149176,0.0012871693,0.000052391537,0.00006485346,0.004276068],"genre_scores_gemma":[0.98683923,0.0038606888,0.0035988886,0.0048039085,0.0006173241,0.0000121401345,0.000037412687,0.000034954952,0.00019547684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986548,0.00006994337,0.00036366287,0.00029641922,0.00017188459,0.00044330908],"domain_scores_gemma":[0.999191,0.000031931944,0.00011477194,0.000179574,0.00003822274,0.00044453057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025618685,0.0001644577,0.00028580363,0.0003994138,0.00014497357,0.000003505082,0.000071588875,0.00005651934,0.0002668356],"category_scores_gemma":[0.000014448477,0.0001650785,0.0000766186,0.0006659119,0.00002617458,0.000045836765,0.00003877238,0.00029988927,0.000043936026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036428828,0.0010843329,0.9829516,0.000095605756,0.00011747163,0.000027829821,0.006074495,0.00013695029,0.000095244905,0.00017614,0.006507957,0.0023680918],"study_design_scores_gemma":[0.009359859,0.0007269074,0.97931445,0.000093335584,0.00048124933,0.00022163552,0.00083644665,0.00022882849,0.0005710735,0.0002123645,0.0075175604,0.00043627867],"about_ca_topic_score_codex":0.0024321075,"about_ca_topic_score_gemma":0.0002975385,"teacher_disagreement_score":0.008995571,"about_ca_system_score_codex":0.0006127483,"about_ca_system_score_gemma":0.00043583853,"threshold_uncertainty_score":0.67317057},"labels":[],"label_agreement":null},{"id":"W1814462863","doi":"10.1200/jco.2009.27.15_suppl.5148","title":"Use of pain at baseline and pain progression to predict overall survival (OS) in patients (pts) with docetaxel pretreated metastatic castration-refractory prostate cancer (CRPC): Results from the SPARC trial","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Randomization; Placebo; Docetaxel; Clinical endpoint; Prostate cancer; Analgesic; Internal medicine; Prednisone; Randomized controlled trial; Chemotherapy; Cancer; Anesthesia","score_opus":0.1391352726429714,"score_gpt":0.45676784729240283,"score_spread":0.3176325746494314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1814462863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878838,0.00025709407,0.000027989023,0.0098302495,0.00041852132,0.0013792242,0.00016376222,0.0000059469176,0.00003337976],"genre_scores_gemma":[0.99475414,0.00071097544,0.0015276447,0.0022427852,0.00051484274,0.000021018954,0.00007769393,0.000013062015,0.00013784794],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99383146,0.0030853148,0.00212692,0.00027207233,0.00045218974,0.00023202423],"domain_scores_gemma":[0.98911464,0.008363024,0.0016625647,0.00016789715,0.00039451808,0.00029738163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064762845,0.00018938821,0.0012109389,0.00009859152,0.00003831742,0.000010534718,0.000090029425,0.0001624264,0.00008929506],"category_scores_gemma":[0.0055790055,0.00010021131,0.00013965394,0.00016626382,0.00014095087,0.00013954203,0.000028203902,0.0005536908,7.7716084e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47750312,0.00505394,0.33215466,0.000013716896,0.00039286312,0.00019398033,0.00042166896,0.0001187076,0.00021194555,9.980093e-7,0.0078013614,0.17613305],"study_design_scores_gemma":[0.17956795,0.09493979,0.7124257,0.00038526274,0.00073247385,0.000007590392,0.000033582528,0.0005028303,0.0000813864,0.000028087768,0.0111878365,0.00010748863],"about_ca_topic_score_codex":0.00046924961,"about_ca_topic_score_gemma":0.002094227,"teacher_disagreement_score":0.38027108,"about_ca_system_score_codex":0.00025331264,"about_ca_system_score_gemma":0.00096954964,"threshold_uncertainty_score":0.66789937},"labels":[],"label_agreement":null},{"id":"W181489850","doi":"10.1200/jco.2012.30.27_suppl.65","title":"Acute care utilization (ACU) among women receiving adjuvant chemotherapy for early breast cancer (EBC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Ottawa Hospital; Institute for Clinical Evaluative Sciences; University Health Network; University of Toronto; Ontario Institute for Cancer Research; Health Sciences Centre; Credit Valley Hospital","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Breast cancer; Population; Taxane; Cancer; Anthracycline; Logistic regression; Cancer registry; Toxicity; Oncology; Environmental health","score_opus":0.12673114578102893,"score_gpt":0.5171077527380621,"score_spread":0.39037660695703313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W181489850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886234,0.001929009,0.00014140346,0.004815982,0.0032649653,0.00037649705,0.00003115366,0.000013727902,0.0008038717],"genre_scores_gemma":[0.9870584,0.0035342465,0.0007585817,0.002926951,0.004874647,0.000051752973,0.000007729478,0.000029955934,0.0007577453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787855,0.00016446403,0.0012116821,0.00014533289,0.00018955788,0.00041040577],"domain_scores_gemma":[0.9970321,0.0007033225,0.0011256025,0.000108888846,0.0005203249,0.0005097696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011503376,0.00014888454,0.0011671832,0.00009687309,0.000054293727,0.0000069614703,0.00010643336,0.00034587167,0.000844376],"category_scores_gemma":[0.00016468027,0.00010664009,0.00038643455,0.00011373762,0.0001294354,0.00021944629,0.000020958274,0.00047016778,0.0000060754387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008720386,0.0010944997,0.64069736,0.00003996359,0.0010724161,0.00003101665,0.0028864543,0.0000023683021,0.00036483372,0.0000076237648,0.0064852997,0.3385978],"study_design_scores_gemma":[0.014759521,0.0066688573,0.8773878,0.000072487135,0.0008805425,0.00016373653,0.00033339518,0.000023405968,0.00024742348,0.000028460146,0.09933512,0.00009920506],"about_ca_topic_score_codex":0.00003791983,"about_ca_topic_score_gemma":0.00003976458,"teacher_disagreement_score":0.3384986,"about_ca_system_score_codex":0.00064917566,"about_ca_system_score_gemma":0.0008795168,"threshold_uncertainty_score":0.92453253},"labels":[],"label_agreement":null},{"id":"W1830813972","doi":"10.1200/jco.2000.18.12.2395","title":"Palliative Effect of Chemotherapy: Objective Tumor Response Is Associated With Symptom Improvement in Patients With Metastatic Breast Cancer","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Quality of life (healthcare); Nausea; Cancer; Performance status; Lethargy; Mood; Anorexia; Metastatic breast cancer; Chemotherapy; Palliative care; Constipation; Disease; Oncology; Physical therapy","score_opus":0.02691237818351398,"score_gpt":0.4283669197826241,"score_spread":0.4014545415991101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1830813972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633497,0.00009255611,0.0000015561859,0.002538814,0.0001381621,0.0006411124,0.000053901324,0.000004270111,0.00019464937],"genre_scores_gemma":[0.996863,0.00014712325,0.000105403255,0.0024693587,0.00009490238,0.000027396753,0.0000035781873,0.000020575219,0.0002686735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971059,0.00089879555,0.0012033866,0.00019373547,0.0003666625,0.00023150192],"domain_scores_gemma":[0.9948461,0.0029619841,0.0014803142,0.00010120268,0.00042671536,0.00018366621],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018145564,0.00018971428,0.0017730326,0.00012722154,0.000019078203,0.0000027608985,0.000083652434,0.000113670234,0.0013510007],"category_scores_gemma":[0.0002444389,0.00010369955,0.000208384,0.00026796234,0.00020639841,0.000071868664,0.000009094269,0.00055742677,0.0000026774655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28648296,0.0043241167,0.6578732,0.00002054082,0.0024747541,0.00022058042,0.00040766413,0.000019342846,0.00007407003,2.725106e-7,0.00032672373,0.047775775],"study_design_scores_gemma":[0.069312364,0.11858697,0.80972886,0.00027882427,0.0011056752,0.000019372128,0.000027721027,0.000017649701,0.0004976329,0.0000075238986,0.0003365333,0.00008084659],"about_ca_topic_score_codex":0.0001163827,"about_ca_topic_score_gemma":0.00014278459,"teacher_disagreement_score":0.21717058,"about_ca_system_score_codex":0.000699872,"about_ca_system_score_gemma":0.0015128738,"threshold_uncertainty_score":0.9995619},"labels":[],"label_agreement":null},{"id":"W1835740169","doi":"10.1016/j.jsc.2010.10.001","title":"Bruno Buchberger and the world of Gröbner bases","year":2010,"lang":"fr","type":"article","venue":"Journal of Symbolic Computation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University","funders":"","keywords":"Mathematics; Algebra over a field; Pure mathematics","score_opus":0.010168701182477277,"score_gpt":0.3259391925822616,"score_spread":0.31577049139978436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1835740169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9523962,0.0149295805,0.00034258925,0.023068158,0.0063354056,0.0002070942,0.0000055973005,0.0000036284448,0.0027117415],"genre_scores_gemma":[0.99107796,0.00092245755,0.0006775745,0.00056859694,0.0025027636,0.0000016511615,0.0000022627719,0.000010777227,0.0042359517],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99894696,0.0001287551,0.00050491956,0.000074480056,0.00020434105,0.00014056465],"domain_scores_gemma":[0.99824953,0.00079053984,0.00051733386,0.000064984604,0.00027332339,0.00010431704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059895194,0.00010948148,0.00040141746,0.00018545582,0.000050819806,0.00001534278,0.00005791437,0.000058714635,0.00076577516],"category_scores_gemma":[0.000072440096,0.00006951163,0.00013922525,0.00020983344,0.0003541842,0.000102116726,0.000020616,0.00040700028,0.0000074740083],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066596786,0.0021273317,0.06278223,0.0007672162,0.002744727,0.0002662569,0.010704241,0.0018794107,0.045512922,0.027258066,0.115831755,0.72346616],"study_design_scores_gemma":[0.059250455,0.0025818762,0.6003757,0.0017823216,0.008009382,0.004303304,0.0009210724,0.026372418,0.012962727,0.015197822,0.26774675,0.0004961395],"about_ca_topic_score_codex":0.00015526162,"about_ca_topic_score_gemma":0.00014700927,"teacher_disagreement_score":0.72297,"about_ca_system_score_codex":0.00003564783,"about_ca_system_score_gemma":0.00018560297,"threshold_uncertainty_score":0.8384701},"labels":[],"label_agreement":null},{"id":"W1847026520","doi":"10.1200/jco.2009.27.15_suppl.e20514","title":"A randomized phase II trial of a new anticoagulant, apixaban, in metastatic cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada); Montreal General Hospital","funders":"","keywords":"Medicine; Apixaban; Internal medicine; Cancer; Population; Adverse effect; Surgery; Randomized controlled trial; Vitamin K antagonist; Warfarin; Oncology; Rivaroxaban","score_opus":0.29037449288737294,"score_gpt":0.6024170944603658,"score_spread":0.3120426015729929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1847026520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725571,0.002222225,0.00007513307,0.021580461,0.0016330285,0.0007659912,0.000003194596,0.0000043138275,0.0011585042],"genre_scores_gemma":[0.9885394,0.0042467653,0.0016148782,0.0030765447,0.0016604894,0.000007932925,0.0000019398467,0.000007826491,0.00084424927],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954803,0.0007364187,0.0031891877,0.00013797035,0.00025260734,0.0002035401],"domain_scores_gemma":[0.9948968,0.0024534154,0.002053657,0.00010633115,0.00017697137,0.00031276626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037260633,0.00013352734,0.003799896,0.00022621766,0.000015258737,0.0000022711545,0.00010686421,0.00018141075,0.00063236617],"category_scores_gemma":[0.0023824917,0.00008559763,0.00086848513,0.00019483973,0.00016622571,0.00006563796,0.000016259211,0.00061538996,0.000002433545],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8190559,0.014561575,0.00032826772,0.000012246805,0.0007622903,0.0006222417,0.00023559335,0.0000089713085,0.00051743916,0.00006284509,0.0073428876,0.1564897],"study_design_scores_gemma":[0.9028471,0.07637496,0.0011554732,0.00009324671,0.0023435187,0.00013439235,0.000019727542,0.0001211601,0.00022267297,0.0010967471,0.015529424,0.00006154096],"about_ca_topic_score_codex":0.00015609233,"about_ca_topic_score_gemma":0.00008552272,"teacher_disagreement_score":0.15642816,"about_ca_system_score_codex":0.00010940017,"about_ca_system_score_gemma":0.003307383,"threshold_uncertainty_score":0.6923966},"labels":[],"label_agreement":null},{"id":"W1857859295","doi":"","title":"Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Paclitaxel; Taxane; Cytotoxicity; Pharmacology; Toxicity; Conjugate; Chemistry; Monoclonal antibody; Antibody; Therapeutic index; In vivo; Cancer research; Chemotherapy; In vitro; Cancer; Medicine; Immunology; Biology; Biochemistry; Drug; Breast cancer; Internal medicine","score_opus":0.02077247025562807,"score_gpt":0.28750150077240233,"score_spread":0.26672903051677427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1857859295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98544973,0.00055210624,0.00008955548,0.002337841,0.00024934163,0.0016590403,0.000017653916,0.00012757808,0.009517164],"genre_scores_gemma":[0.99348956,0.00023790539,0.0001409487,0.0013123224,0.000288868,0.0010382803,0.000051629937,0.000024165525,0.0034163299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985425,0.00005743434,0.00022588875,0.0004057301,0.00018787837,0.00058055477],"domain_scores_gemma":[0.99924475,0.00008985197,0.00008928229,0.00018254909,0.00009467345,0.00029887073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002602055,0.00021125472,0.0004121173,0.00010267345,0.00010446531,0.000021316197,0.00006632799,0.00007167897,0.00028254063],"category_scores_gemma":[0.00009255652,0.00018214608,0.00008525953,0.00021937156,0.00013618375,0.00010549507,0.00007787111,0.00017684691,0.000022445558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003506491,0.0022078126,0.8015745,0.00022702731,0.0006645919,0.0005295994,0.0003011038,0.0000059175927,0.1377485,0.000100643905,0.005727321,0.047406457],"study_design_scores_gemma":[0.004292257,0.0004649242,0.69890785,0.000012306562,0.00023865947,0.00035757225,0.000030169267,0.00008628794,0.2879056,0.00038133067,0.007072393,0.00025064123],"about_ca_topic_score_codex":0.00016553423,"about_ca_topic_score_gemma":0.00008707872,"teacher_disagreement_score":0.15015711,"about_ca_system_score_codex":0.00014435043,"about_ca_system_score_gemma":0.000059646536,"threshold_uncertainty_score":0.74277014},"labels":[],"label_agreement":null},{"id":"W1883775064","doi":"","title":"THE EFFECT OF TEMPERATURE, PH, AND DIFFERENT SOLUBILIZING AGENTS ON STABILITY OF TAXOL","year":2005,"lang":"en","type":"article","venue":"Iranian journal of pharmaceutical sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemistry; Solubility; Polyethylene glycol; PEG ratio; Chromatography; Paclitaxel; Ethanol; Aqueous solution; Glycerol; Nuclear chemistry; Organic chemistry","score_opus":0.06613048537324216,"score_gpt":0.4060296896675298,"score_spread":0.3398992042942876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1883775064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942021,0.0022671286,0.0000016463422,0.002563984,0.0002466455,0.0002151028,0.0000035664402,0.000002640328,0.00049723656],"genre_scores_gemma":[0.99911815,0.0004988914,0.000045112403,0.0001549248,0.00016075152,0.0000016881463,1.1148079e-7,0.000003312013,0.000017086217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871564,0.00017542021,0.00037558062,0.000118356154,0.00042082145,0.00019416696],"domain_scores_gemma":[0.9988569,0.0006383238,0.00019278191,0.00006627179,0.0000635277,0.000182216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011081331,0.00010805301,0.00032994236,0.000060067185,0.00012248426,0.000014190059,0.00014180678,0.000034011202,0.00018385307],"category_scores_gemma":[0.000104468614,0.000049994735,0.00011848522,0.00014785415,0.0007233735,0.00007109016,0.000025862342,0.00023413381,8.07174e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004319359,0.0005705131,0.40636095,0.00022252605,0.00024772395,0.000025279322,0.00055991276,0.000024555598,0.49767977,0.00010813968,0.0004989978,0.08938228],"study_design_scores_gemma":[0.0047423565,0.006653367,0.07261553,0.00016174023,0.0003454889,0.000086655185,0.00008056116,0.0004230262,0.9115697,0.000038289647,0.003213174,0.00007007697],"about_ca_topic_score_codex":0.0000028818322,"about_ca_topic_score_gemma":0.000004950887,"teacher_disagreement_score":0.41388997,"about_ca_system_score_codex":0.000048641235,"about_ca_system_score_gemma":0.000054957385,"threshold_uncertainty_score":0.26652998},"labels":[],"label_agreement":null},{"id":"W1893993642","doi":"10.2147/ceor.s82194","title":"Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective","year":2015,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"Celgene","keywords":"Paclitaxel; Docetaxel; Medicine; Metastatic breast cancer; Breast cancer; Oncology; Perspective (graphical); Cancer; Internal medicine","score_opus":0.18292777179286226,"score_gpt":0.5555170525744136,"score_spread":0.3725892807815514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1893993642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651208,0.007974206,0.000017321683,0.02244996,0.00023642916,0.0015471678,0.002214838,0.000028755461,0.00041052888],"genre_scores_gemma":[0.9945793,0.0016607426,0.00038516524,0.0020983482,0.00015835706,0.00034401432,0.00026869256,0.000033095755,0.00047224917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966582,0.0005740081,0.000825814,0.0008792226,0.00031393245,0.000748814],"domain_scores_gemma":[0.99640757,0.0014889137,0.00020496975,0.00055924087,0.0005038563,0.00083544914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001895524,0.00032366937,0.001582155,0.00075556093,0.00015813917,0.00008534306,0.0002017975,0.00012493324,0.0008725246],"category_scores_gemma":[0.00037334507,0.0002358755,0.00035547742,0.0008676583,0.0003527978,0.00012849021,0.00014591041,0.00070539437,0.000030193516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004398564,0.00082381157,0.97655135,0.000098875935,0.0016312025,0.00007242735,0.0045282207,0.00006593824,0.0000024979674,0.000047704103,0.0012703898,0.010508998],"study_design_scores_gemma":[0.017122304,0.0011342769,0.9557332,0.00004615427,0.0006308527,0.000006571525,0.015195828,0.006709661,0.0000062124554,0.00058091636,0.0025588297,0.00027519464],"about_ca_topic_score_codex":0.041687932,"about_ca_topic_score_gemma":0.07391738,"teacher_disagreement_score":0.03222945,"about_ca_system_score_codex":0.0022329842,"about_ca_system_score_gemma":0.0034444802,"threshold_uncertainty_score":0.96469355},"labels":[],"label_agreement":null},{"id":"W1898942311","doi":"10.1111/j.1460-9568.2011.07652.x","title":"Terminal arbor degeneration - a novel lesion produced by the antineoplastic agent paclitaxel","year":2011,"lang":"en","type":"article","venue":"European Journal of Neuroscience","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"National Institute of Neurological Disorders and Stroke","keywords":"McGill Pain Questionnaire; History; Art; Medicine; Anesthesia","score_opus":0.11304793073527654,"score_gpt":0.31662390928996,"score_spread":0.20357597855468346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1898942311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960354,0.00014434251,0.0010806208,0.00085993815,0.00087939657,0.00012479993,0.000003160332,0.000008501721,0.0008638312],"genre_scores_gemma":[0.9976874,0.00005318201,0.00034176654,0.0010872501,0.00023256999,8.299993e-7,4.7031858e-7,0.000011796334,0.0005847604],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99905205,0.00013977001,0.00026921142,0.00015335638,0.00023423831,0.00015138609],"domain_scores_gemma":[0.9994156,0.000026893524,0.00023872376,0.00012360651,0.00008215881,0.000113046146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004608726,0.00009346744,0.00011732814,0.000059356338,0.000116414965,0.000021069305,0.00017661242,0.0000072679163,0.00002745229],"category_scores_gemma":[0.00013935253,0.000053570286,0.000060023864,0.00015869383,0.000122442,0.00010979915,0.00003224583,0.00016861851,0.00001105325],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002219156,0.00031494853,0.0010808246,0.0000057844927,0.0000039217093,0.00038256793,0.0003072371,0.0000030086003,0.99354917,0.000009753431,0.0021707416,0.001950117],"study_design_scores_gemma":[0.0034573008,0.0065639117,0.70183265,0.000101250625,0.00025939048,0.0044252975,0.000048417704,0.00045476004,0.25859854,0.0000044737153,0.024080299,0.0001737278],"about_ca_topic_score_codex":0.0000017812363,"about_ca_topic_score_gemma":3.318496e-7,"teacher_disagreement_score":0.73495066,"about_ca_system_score_codex":0.000021242351,"about_ca_system_score_gemma":0.00007997976,"threshold_uncertainty_score":0.21845329},"labels":[],"label_agreement":null},{"id":"W1915661725","doi":"10.1007/s00520-015-2941-0","title":"Treatment of taxane acute pain syndrome (TAPS) in cancer patients receiving taxane-based chemotherapy—a systematic review","year":2015,"lang":"en","type":"review","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Taxane; Amifostine; Gabapentin; Internal medicine; Randomized controlled trial; Placebo; Cancer; Chemotherapy; Oncology; Breast cancer; Pathology","score_opus":0.054903137657369656,"score_gpt":0.42459476693563314,"score_spread":0.3696916292782635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1915661725","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009046476,0.9848742,5.8133685e-7,0.00020606279,0.00062253745,0.011711899,0.0014499718,0.000031105268,0.00019900818],"genre_scores_gemma":[0.0013211478,0.9822259,0.000021199497,0.0005724363,0.00010548782,0.013499914,0.0014696016,0.0001398127,0.0006444808],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9949572,0.0008950118,0.002102514,0.00084788597,0.0005608534,0.0006365112],"domain_scores_gemma":[0.9964138,0.00033478666,0.001849746,0.00059788016,0.00056173437,0.00024201565],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052633433,0.0009451084,0.007363425,0.00055065705,0.000024197343,0.0000087787585,0.0002336765,0.00040173845,0.001174714],"category_scores_gemma":[0.00012894924,0.00068590423,0.0008254749,0.0010413134,0.00010491931,0.00007658947,0.000031545387,0.00035570268,0.000016096763],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001501579,0.0008333402,0.0040627765,0.70915276,0.0013344134,0.00061573205,0.0005773282,0.0000014775768,4.6044383e-7,2.7396212e-7,0.0013187339,0.28195253],"study_design_scores_gemma":[0.0063523822,0.0034456344,0.00017659603,0.7777904,0.013149437,0.000040348892,0.00011849725,0.0000033695526,0.000015226236,9.387034e-7,0.19826339,0.00064377347],"about_ca_topic_score_codex":0.0018143909,"about_ca_topic_score_gemma":0.0018478293,"teacher_disagreement_score":0.28130877,"about_ca_system_score_codex":0.011003255,"about_ca_system_score_gemma":0.003944006,"threshold_uncertainty_score":0.99973834},"labels":[],"label_agreement":null},{"id":"W1918344113","doi":"10.1002/3527600906.mcb.200300127","title":"Antitumor Agents: Taxol and Taxanes-Production by Yew Cell Culture","year":2006,"lang":"en","type":"reference-entry","venue":"Encyclopedia of Molecular Cell Biology and Molecular Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Taxus; Semisynthesis; Biology; Paclitaxel; Botany; Cancer; Biochemistry; Genetics","score_opus":0.008366471509278816,"score_gpt":0.2750037074870158,"score_spread":0.266637235977737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1918344113","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13374183,0.4095536,0.00037021746,0.0018733465,0.0020190454,0.0017010814,0.0002757827,0.00007043558,0.45039466],"genre_scores_gemma":[0.13847734,0.70436645,0.00066501653,0.0024713904,0.0013507085,0.00015717676,0.009509937,0.00015404796,0.14284796],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714077,0.00024137256,0.0007036196,0.0010808702,0.00031266132,0.00052069104],"domain_scores_gemma":[0.9984807,0.000040106515,0.00054518983,0.00046433148,0.00016198042,0.0003076906],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021147718,0.0007407637,0.0014791726,0.00031534556,0.000092621754,0.0000058473843,0.0001493776,0.0009859934,0.00026121616],"category_scores_gemma":[0.00007979917,0.00057881937,0.00018210291,0.00024808492,0.0007750985,0.000034156423,0.00012247358,0.0008208082,0.000007996457],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027468632,0.0006250207,0.0013260676,0.0026155552,0.00047521899,0.0009606301,0.00022677198,0.0000012001208,0.25392053,0.000055937606,0.7263257,0.013192708],"study_design_scores_gemma":[0.004511682,0.0021784683,0.00021864031,0.00054378295,0.0025275676,0.00013483419,0.00006634065,0.0000029178118,0.055208385,0.00013707056,0.933971,0.0004992948],"about_ca_topic_score_codex":0.000365405,"about_ca_topic_score_gemma":0.00000905473,"teacher_disagreement_score":0.30754673,"about_ca_system_score_codex":0.00006305449,"about_ca_system_score_gemma":0.00020089843,"threshold_uncertainty_score":0.99966633},"labels":[],"label_agreement":null},{"id":"W1924569161","doi":"10.1039/c5md90032h","title":"Correction: Identification of a novel class of autotaxin inhibitors through cross-screening","year":2015,"lang":"en","type":"article","venue":"MedChemComm","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cystic Fibrosis Canada","funders":"","keywords":"Autotaxin; Identification (biology); Class (philosophy); Computational biology; Computer science; Bioinformatics; Chemistry; Artificial intelligence; Biology; Biochemistry; Lysophosphatidic acid","score_opus":0.0887488986745686,"score_gpt":0.3935148326447293,"score_spread":0.3047659339701607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1924569161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98605883,0.00044064494,0.0032269657,0.00078029453,0.0017664031,0.00026942106,0.000015169298,0.000046756348,0.0073955413],"genre_scores_gemma":[0.9946794,0.000012969727,0.0010409806,0.000086470856,0.00021126248,0.000021472963,0.000040448154,0.000012423746,0.0038945875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991335,0.000019966144,0.0003792888,0.00014130682,0.00021365126,0.00011224737],"domain_scores_gemma":[0.9992207,0.00006233097,0.00023474969,0.00019343353,0.00022225076,0.0000664785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023229787,0.00008987868,0.0002555405,0.000055953027,0.00002389877,0.000004932987,0.000059403283,0.00007913243,0.00008408608],"category_scores_gemma":[0.00010092252,0.000082023274,0.00008110269,0.00022524076,0.0001257245,0.00008633373,0.000030520205,0.00011063088,0.000006390243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018893856,0.0026023544,0.24421157,0.0002932985,0.000480926,0.000013244911,0.007713403,0.00044311784,0.6286571,0.00036416532,0.10171606,0.011615396],"study_design_scores_gemma":[0.0057207034,0.0004361344,0.033343453,0.00009103625,0.00018937228,0.000047003137,0.0003811466,0.0023541476,0.9338725,0.000047871614,0.023416782,0.000099828845],"about_ca_topic_score_codex":0.00028339727,"about_ca_topic_score_gemma":0.000018838662,"teacher_disagreement_score":0.30521545,"about_ca_system_score_codex":0.00008346438,"about_ca_system_score_gemma":0.00010485922,"threshold_uncertainty_score":0.3344812},"labels":[],"label_agreement":null},{"id":"W1929450387","doi":"10.1200/jco.2000.18.24.4098","title":"Phase I Dose-Finding Study of a New Taxane, RPR 109881A, Administered as a One-Hour Intravenous Infusion Days 1 and 8 to Patients With Advanced Solid Tumors","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Pharmacokinetics; Toxicity; Volume of distribution; Taxane; Diarrhea; Renal cell carcinoma; Urology; Gastroenterology; Internal medicine; Pharmacology; Cancer","score_opus":0.11412075096877355,"score_gpt":0.5012709397139472,"score_spread":0.38715018874517365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1929450387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962576,0.0000933088,0.00000638584,0.0012559713,0.00033036366,0.0008961011,0.0000058601795,0.0000083048435,0.0011460929],"genre_scores_gemma":[0.99613285,0.00025629273,0.0012302403,0.00143315,0.00047600296,0.000008689064,0.0000040496693,0.000021742484,0.00043697903],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9969196,0.00024482305,0.001939648,0.00025589284,0.0003725495,0.00026748748],"domain_scores_gemma":[0.9968647,0.0006367454,0.0013380673,0.00016571261,0.00024781236,0.00074695854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066159794,0.0001917279,0.0017752022,0.00018380636,0.00005205514,0.0000072632415,0.00012729382,0.00017527584,0.0008168919],"category_scores_gemma":[0.00046675262,0.00013602375,0.00014066503,0.00020420202,0.000094008574,0.000099752855,0.000044985787,0.00056908256,0.000012351093],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09644947,0.040124368,0.08610721,0.000026912485,0.0006590733,0.00092065893,0.002767265,0.00002604968,0.0005958192,0.000002128258,0.0007220589,0.771599],"study_design_scores_gemma":[0.1197014,0.45665872,0.41059405,0.00024071969,0.0011026401,0.00022694257,0.0005064839,0.000009351156,0.00018462895,0.000034286626,0.010590808,0.00014996421],"about_ca_topic_score_codex":0.00011580183,"about_ca_topic_score_gemma":0.00021549549,"teacher_disagreement_score":0.771449,"about_ca_system_score_codex":0.000128013,"about_ca_system_score_gemma":0.0012893018,"threshold_uncertainty_score":0.89443934},"labels":[],"label_agreement":null},{"id":"W193386846","doi":"10.1200/jco.2009.27.15_suppl.598","title":"Phase II trial of neoadjuvant sequential FEC100 followed by docetaxel and capecitabine for HER2-negative locally advanced breast cancer (LABC): A multicenter study from British Columbia","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Docetaxel; Taxane; Breast cancer; Internal medicine; Capecitabine; Febrile neutropenia; Epirubicin; Population; Regimen; Oncology; Cyclophosphamide; Breast-conserving surgery; Hazard ratio; Neutropenia; Anthracycline; Surgery; Chemotherapy; Cancer; Mastectomy; Confidence interval","score_opus":0.05665022831420631,"score_gpt":0.4761407311572904,"score_spread":0.4194905028430841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W193386846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888457,0.0008745235,0.00007093925,0.0054071485,0.0021140417,0.0020543074,0.0005284651,0.000009560842,0.00009530983],"genre_scores_gemma":[0.99294585,0.0010653387,0.0013415415,0.0019921772,0.0018360056,0.000056227465,0.00002170024,0.000020987784,0.0007201588],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962142,0.00038584418,0.0024114451,0.00035620606,0.00032560958,0.00030671374],"domain_scores_gemma":[0.9955147,0.0014018477,0.0018485694,0.00013479228,0.00067438284,0.00042573296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010252501,0.00018939364,0.0023002704,0.000051369592,0.00009231997,0.000024046032,0.000140642,0.00029413286,0.0006831142],"category_scores_gemma":[0.0006198275,0.00019138279,0.0005193583,0.00010834609,0.00023988384,0.00015010562,0.00004433807,0.0005748584,6.508314e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43125448,0.07649977,0.010929194,0.00001968288,0.0020828508,0.0006243904,0.00038833465,0.00000389642,0.004498764,5.169062e-7,0.04205755,0.43164057],"study_design_scores_gemma":[0.70294064,0.2268764,0.05027998,0.00014769523,0.0028566627,0.00010344559,0.00021180874,0.000106387335,0.00015421945,0.00009559083,0.016060527,0.0001666652],"about_ca_topic_score_codex":0.0047296067,"about_ca_topic_score_gemma":0.01661633,"teacher_disagreement_score":0.4314739,"about_ca_system_score_codex":0.00022816549,"about_ca_system_score_gemma":0.0011006899,"threshold_uncertainty_score":0.9272302},"labels":[],"label_agreement":null},{"id":"W1935026499","doi":"10.1158/1538-7445.sabcs14-pd2-2","title":"Abstract PD2-2: Final efficacy results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Bevacizumab; Breast cancer; Internal medicine; Hazard ratio; Oncology; Taxane; Triple-negative breast cancer; Population; Anthracycline; Randomized controlled trial; Adjuvant therapy; Cancer; Chemotherapy; Confidence interval","score_opus":0.28649548767260063,"score_gpt":0.5366607232827357,"score_spread":0.2501652356101351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1935026499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844504,0.0042758724,0.000001210834,0.0028641669,0.00071159133,0.006008062,0.00023285451,0.000021153428,0.0014346682],"genre_scores_gemma":[0.99476784,0.001112117,0.000024465566,0.00009832242,0.0010032866,0.0016742185,0.00001921399,0.000035075995,0.0012654607],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952352,0.0013040358,0.0009185875,0.00052236044,0.0013338223,0.00068597856],"domain_scores_gemma":[0.9955649,0.0023914794,0.000367836,0.00040247312,0.0010087377,0.00026462015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062440103,0.00025812056,0.0010963073,0.0003612494,0.00016338634,0.000032183685,0.00033210622,0.00014667789,0.0005959863],"category_scores_gemma":[0.0013996941,0.00016352984,0.0002833083,0.0011448992,0.00049571245,0.00013248829,0.00009776766,0.0010149527,0.000007523936],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9209607,0.00096164533,0.0004984296,0.000029584106,0.00037554238,0.000034225024,0.007459265,0.00009718053,0.008768996,0.000008390914,0.0018384028,0.058967624],"study_design_scores_gemma":[0.9772135,0.0036791938,0.008496089,0.00039588704,0.00017748089,0.000008048656,0.0005105808,0.0003175718,0.0086958185,0.000090624104,0.00026095784,0.00015421888],"about_ca_topic_score_codex":0.031007571,"about_ca_topic_score_gemma":0.0011959765,"teacher_disagreement_score":0.058813404,"about_ca_system_score_codex":0.0012248325,"about_ca_system_score_gemma":0.0041371123,"threshold_uncertainty_score":0.97544503},"labels":[],"label_agreement":null},{"id":"W1946451131","doi":"10.18433/j3rp6z","title":"A Rapid and Sensitive HPLC Method for Quantitation of Paclitaxel in Biological Samples using Liquid-Liquid Extraction and UV Detection: Application to Pharmacokinetics and Tissues Distribution Study of Paclitaxel Loaded Targeted Polymeric Micelles in.....","year":2015,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chromatography; High-performance liquid chromatography; Pharmacokinetics; Chemistry; Extraction (chemistry); Paclitaxel; Sodium acetate; Diethyl ether; Elution; Solid phase extraction; Pharmacology; Cancer; Medicine","score_opus":0.19060485613017678,"score_gpt":0.4941516919595262,"score_spread":0.3035468358293494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1946451131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816401,0.005220641,0.011233171,0.00074511144,0.00013929991,0.0009796135,0.000030217958,0.0000062700196,0.000005578511],"genre_scores_gemma":[0.99343336,0.001437366,0.0048920866,0.000089230205,0.00011235036,0.000022478,0.000004987681,0.000006786538,0.0000013370931],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99812,0.00037327176,0.00071035075,0.00028666866,0.00028574938,0.00022393816],"domain_scores_gemma":[0.99841726,0.00062180817,0.00039395588,0.000042862004,0.0002717944,0.00025232925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016573387,0.00016648739,0.0004892407,0.00033451885,0.00006797967,0.000015520023,0.000059594215,0.00005290476,0.000008113715],"category_scores_gemma":[0.000214126,0.0001320707,0.0000459411,0.0006294124,0.0002783147,0.00024117896,0.000043418837,0.0001849947,9.990585e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01094333,0.0008830358,0.016073832,0.00008382325,0.00007310911,0.000010365363,0.0018831936,0.00015147316,0.92691964,0.000021485119,0.000009240555,0.042947453],"study_design_scores_gemma":[0.0130814295,0.010435122,0.01573522,0.00009113996,0.00058867614,0.00024180012,0.0060846903,0.027460337,0.9243277,0.00005992927,0.001697348,0.00019664498],"about_ca_topic_score_codex":0.00040968755,"about_ca_topic_score_gemma":0.00003159404,"teacher_disagreement_score":0.042750806,"about_ca_system_score_codex":0.000107783606,"about_ca_system_score_gemma":0.00010629633,"threshold_uncertainty_score":0.5385686},"labels":[],"label_agreement":null},{"id":"W1948155544","doi":"10.1093/annonc/mdu326.14","title":"Genome-Wide Association Study (Gwas) Identifies Candidate Neurotoxicity Markers in Platinum-Taxane Treated Ovarian Cancer Patients in Icon7","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Genome-wide association study; Oncology; Internal medicine; Hazard ratio; Taxane; Genetic model; Carboplatin; Odds ratio; Confidence interval; Cancer; Single-nucleotide polymorphism; Breast cancer; Genetics; Genotype; Biology; Chemotherapy","score_opus":0.038762503880015134,"score_gpt":0.3719917841676429,"score_spread":0.33322928028762777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1948155544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933705,0.00005274153,5.1601586e-7,0.0023378183,0.0003168548,0.0011801734,0.000033266675,0.000017098659,0.0026910433],"genre_scores_gemma":[0.9972498,0.00023279563,0.0000055887303,0.001447328,0.00007958152,0.00020415148,0.000071865,0.000016301445,0.00069260853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811596,0.00047247502,0.00055452134,0.0003040843,0.00019228258,0.00036065676],"domain_scores_gemma":[0.99873835,0.0004791235,0.0003875168,0.00014634166,0.00016309063,0.00008556135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006291065,0.00016717652,0.0006522668,0.00032292766,0.000031544274,0.00000617199,0.00009005898,0.00016535906,0.00036301126],"category_scores_gemma":[0.00036326965,0.00015995603,0.00006542834,0.00034111997,0.000040716437,0.00008068049,0.00004338594,0.0002241727,0.000010695477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017461983,0.0030752635,0.9866695,0.000029136994,0.00019866234,0.000050747705,0.00112273,0.00004609807,0.0011691711,0.0000013814945,0.0017850653,0.0041060797],"study_design_scores_gemma":[0.010899216,0.0048060953,0.97950095,0.000025170895,0.00010034372,5.866184e-7,0.00011991752,0.00004425594,0.0014228896,0.00003074821,0.0029412291,0.00010861683],"about_ca_topic_score_codex":0.012197133,"about_ca_topic_score_gemma":0.03469372,"teacher_disagreement_score":0.022496589,"about_ca_system_score_codex":0.0004492564,"about_ca_system_score_gemma":0.00015647223,"threshold_uncertainty_score":0.9943807},"labels":[],"label_agreement":null},{"id":"W1949239131","doi":"10.1016/j.jsc.2015.11.008","title":"Quantifier elimination by cylindrical algebraic decomposition based on regular chains","year":2015,"lang":"en","type":"article","venue":"Journal of Symbolic Computation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Natural Science Foundation of China","keywords":"Quantifier elimination; Mathematics; Maple; Algebraic number; Decomposition; Tree (set theory); Algebra over a field; Quantifier (linguistics); Algorithm; Discrete mathematics; Combinatorics; Pure mathematics; Computer science; Mathematical analysis; Artificial intelligence","score_opus":0.0341643223409559,"score_gpt":0.3701513871499987,"score_spread":0.3359870648090428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1949239131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95033526,0.00022338076,0.038297895,0.009486201,0.000613987,0.00020591753,0.0000034837326,0.000020612853,0.0008132385],"genre_scores_gemma":[0.9972821,0.000013900384,0.0011924037,0.00089251704,0.00039215642,0.0000031718605,0.00008059756,0.0000122432275,0.00013095014],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998977,0.00008953016,0.0003389592,0.00010309317,0.00038132744,0.00011006588],"domain_scores_gemma":[0.9990577,0.000091064685,0.00027001544,0.00005790381,0.0003503274,0.00017300612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030988595,0.00009885137,0.00023323101,0.00024839872,0.0000369352,0.000016269834,0.000038607195,0.00007071532,0.000031655047],"category_scores_gemma":[0.00004056587,0.00008375417,0.00009600916,0.00017554504,0.000024237694,0.00008828763,0.0000050306644,0.00015777197,0.000016455597],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017861249,0.012847506,0.015322353,0.00029383902,0.0010425287,0.000804635,0.006423521,0.07636541,0.10953937,0.0030349062,0.37076283,0.38570186],"study_design_scores_gemma":[0.038759205,0.018212233,0.12814425,0.00056320394,0.0013472597,0.0011370815,0.00041066564,0.76218,0.033333775,0.0027943244,0.012571053,0.0005469849],"about_ca_topic_score_codex":0.0000065681884,"about_ca_topic_score_gemma":9.214281e-7,"teacher_disagreement_score":0.68581456,"about_ca_system_score_codex":0.00028408482,"about_ca_system_score_gemma":0.00017031092,"threshold_uncertainty_score":0.34153956},"labels":[],"label_agreement":null},{"id":"W1949811104","doi":"10.1200/jco.2001.19.2.314","title":"Phase II Study of Docetaxel, Doxorubicin, and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer","year":2001,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"","keywords":"Medicine; Docetaxel; Metastatic breast cancer; Neutropenia; Cyclophosphamide; Febrile neutropenia; Internal medicine; Chemotherapy; Doxorubicin; Regimen; Breast cancer; Surgery; Phases of clinical research; Gastroenterology; Adverse effect; Cancer; Oncology","score_opus":0.1341035759241524,"score_gpt":0.5424805441816323,"score_spread":0.4083769682574799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1949811104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738836,0.0021827442,0.000052049312,0.021960964,0.00087341556,0.00076683075,0.000022546315,0.000006385672,0.00025143902],"genre_scores_gemma":[0.98311406,0.010691467,0.0006366586,0.0036672864,0.0011053585,0.000033779022,0.0000025689271,0.00002119593,0.0007276441],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9972617,0.00014600769,0.0019309392,0.00020693152,0.0002253716,0.00022902808],"domain_scores_gemma":[0.9959768,0.0015532564,0.0015315858,0.00013102486,0.0004786811,0.0003286214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013382088,0.00017460065,0.0018566757,0.000118996024,0.000069136426,0.0000036210188,0.00010535037,0.00014662725,0.0008294496],"category_scores_gemma":[0.00032673613,0.00011857911,0.00031772553,0.00015791504,0.00017414965,0.00007991251,0.00003165809,0.00039337183,0.0000014984482],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12532137,0.11347961,0.106308624,0.00012942485,0.0052676387,0.0010722543,0.0012423923,0.0000573147,0.0013993691,0.000029894012,0.012842275,0.6328498],"study_design_scores_gemma":[0.312093,0.40478864,0.091823414,0.00013457538,0.005389199,0.002310494,0.00052916975,0.00019530009,0.0005757895,0.0006836724,0.18126795,0.00020879002],"about_ca_topic_score_codex":0.00023567467,"about_ca_topic_score_gemma":0.00040529436,"teacher_disagreement_score":0.632641,"about_ca_system_score_codex":0.000108714376,"about_ca_system_score_gemma":0.00077384064,"threshold_uncertainty_score":0.9081892},"labels":[],"label_agreement":null},{"id":"W1951680383","doi":"","title":"BOOK REVIEW: Chemotherapy and Biotherapy Guidelines, and Recommendations for Practice 4th Edition","year":2015,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oncology nursing; Medicine; Clinical Oncology; Clinical Practice; Medical education; Best practice; Alternative medicine; Oncology; Nursing; Internal medicine; Political science; Nurse education; Pathology; Cancer","score_opus":0.41398725240106415,"score_gpt":0.6490444620350906,"score_spread":0.23505720963402643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1951680383","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028666074,0.889773,0.0004892528,0.103158146,0.0005666549,0.0016606794,0.00006825607,0.000025152456,0.0013922326],"genre_scores_gemma":[0.00057199714,0.9065934,0.002793917,0.08692255,0.0006655286,0.00015230104,0.000082925326,0.00003741322,0.002179959],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986653,0.00012238175,0.0005546276,0.00026695785,0.00021991173,0.000170874],"domain_scores_gemma":[0.9979561,0.0003312386,0.00053808524,0.00018218473,0.0007337839,0.00025862633],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001153085,0.00018605383,0.0005596184,0.00022538118,0.000111795256,0.00016556185,0.00022062096,0.00006854033,0.0053660106],"category_scores_gemma":[0.00040038783,0.0001531023,0.000071190094,0.0002489462,0.00007379831,0.001289793,0.00007704686,0.0001484017,0.0000023383488],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085373304,0.00023562298,0.005062508,0.0001912258,0.00026620898,0.0000049893074,0.00008258909,3.7056682e-7,0.004153489,0.000011665813,0.93563527,0.05350232],"study_design_scores_gemma":[0.003632539,0.00010308364,0.004522661,0.00083729083,0.0003865484,0.00008160946,0.000035118435,0.00002644526,0.00270996,0.0005177691,0.9869938,0.00015321093],"about_ca_topic_score_codex":0.00022952925,"about_ca_topic_score_gemma":0.000008304839,"teacher_disagreement_score":0.053349108,"about_ca_system_score_codex":0.000090810914,"about_ca_system_score_gemma":0.00020482969,"threshold_uncertainty_score":0.99554324},"labels":[],"label_agreement":null},{"id":"W1955302899","doi":"10.1002/jlcr.701","title":"A convenient synthesis of <sup>13</sup>C<sub>4</sub>‐Leflunomide and its primary metabolite <sup>13</sup>C<sub>4</sub>‐A77 1726","year":2003,"lang":"en","type":"article","venue":"Journal of Labelled Compounds and Radiopharmaceuticals","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Chemistry; Metabolite; Yield (engineering); Leflunomide; Bioavailability; Primary metabolite; Primary (astronomy); Stereochemistry; Radiochemistry; Biochemistry; Pharmacology","score_opus":0.022294699551875245,"score_gpt":0.29185898935229937,"score_spread":0.26956428980042413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1955302899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9375671,0.057579506,0.00003850264,0.0019005253,0.00037524718,0.0009060725,0.000096417796,0.000042267333,0.0014943673],"genre_scores_gemma":[0.9551255,0.04189645,0.00038718505,0.0017573118,0.00054458604,0.000045332,0.000013273241,0.0001001509,0.0001301845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99481195,0.0007418278,0.0019318567,0.0006716684,0.0008812021,0.00096147956],"domain_scores_gemma":[0.9954158,0.0014646043,0.0008902612,0.00037676794,0.0005823995,0.0012701703],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017236408,0.00078531087,0.0025486443,0.0006716491,0.0003125312,0.00009166923,0.0002833018,0.00036604385,0.00014088638],"category_scores_gemma":[0.0002739069,0.0006344402,0.0006054173,0.0005844339,0.000535674,0.0003603927,0.00013917434,0.0010428749,0.000022310305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055716997,0.004227749,0.0056137885,0.0012282932,0.0049376586,0.0010873982,0.001213711,0.00030018942,0.9539504,0.0007845801,0.0040824735,0.017002076],"study_design_scores_gemma":[0.040284522,0.0018268655,0.003297522,0.00070239586,0.008047077,0.005266824,0.00032661043,0.004434476,0.90001947,0.00047818746,0.03440926,0.00090676587],"about_ca_topic_score_codex":0.0000077509,"about_ca_topic_score_gemma":0.0000015044343,"teacher_disagreement_score":0.05393089,"about_ca_system_score_codex":0.00032446044,"about_ca_system_score_gemma":0.0006169448,"threshold_uncertainty_score":0.99961066},"labels":[],"label_agreement":null},{"id":"W1963774763","doi":"10.4048/jbc.2006.9.3.172","title":"The evidence for adjuvant taxanes in early breast cancer","year":2006,"lang":"en","type":"article","venue":"Journal of Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Oncology; Adjuvant; Internal medicine; Cancer","score_opus":0.03311051664040824,"score_gpt":0.373304807404305,"score_spread":0.34019429076389673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963774763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9252796,0.027941277,0.000019853598,0.04489069,0.0012029866,0.00039253896,0.00014216964,0.0000083119585,0.00012256042],"genre_scores_gemma":[0.9909066,0.00397003,0.00004793935,0.0005142326,0.0028938164,0.00011089906,0.00000104994,0.000020767266,0.0015346976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987965,0.000039084254,0.00045360986,0.00013599484,0.0002650681,0.00030970902],"domain_scores_gemma":[0.99880934,0.00022984596,0.0003720091,0.00011044965,0.00037788643,0.0001004532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029560726,0.00014491836,0.00035799187,0.00010134877,0.00008688874,0.000027992262,0.00013423957,0.000060516875,0.00030764463],"category_scores_gemma":[0.0000125069,0.00008646807,0.00018704732,0.00019326326,0.0000868345,0.0001853601,0.000015676214,0.00022418067,0.0000028437012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011716887,0.0003564743,0.82084554,0.00011427847,0.00030806637,0.00015095697,0.00023918306,0.00033263845,0.008007862,0.00006713985,0.04426007,0.11360087],"study_design_scores_gemma":[0.0042015137,0.00023645943,0.9766227,0.00072670757,0.00033896923,0.0012762789,0.000037777016,0.00006248686,0.00052236515,0.00013718153,0.015737934,0.000099606164],"about_ca_topic_score_codex":0.0053173387,"about_ca_topic_score_gemma":0.002872502,"teacher_disagreement_score":0.15577716,"about_ca_system_score_codex":0.00053707964,"about_ca_system_score_gemma":0.00061993685,"threshold_uncertainty_score":0.8038261},"labels":[],"label_agreement":null},{"id":"W1964079865","doi":"10.2146/ajhp110342","title":"Physical compatibility of calcium gluconate and magnesium sulfate injections","year":2012,"lang":"en","type":"letter","venue":"American Journal of Health-System Pharmacy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Charles-Le Moyne; Université de Montréal","funders":"","keywords":"Pharmacy; Pharmacist; Library science; Medicine; Art; Family medicine; Computer science","score_opus":0.05049993515399365,"score_gpt":0.39045579353365756,"score_spread":0.3399558583796639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964079865","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4738212,0.004916473,0.0000656013,0.51794744,0.0019225575,0.00077205454,0.00019308849,0.000035425852,0.00032619174],"genre_scores_gemma":[0.940338,0.00019368035,0.00015306789,0.05383112,0.0051775845,0.000018682795,0.00004171967,0.00005926618,0.00018685134],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962615,0.00090484763,0.0014255879,0.0002956028,0.00052420254,0.0005882714],"domain_scores_gemma":[0.99568474,0.00037191674,0.0028246522,0.00027392711,0.00043570728,0.00040907695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074475294,0.000405399,0.002364278,0.00038688016,0.00013104056,0.000011003134,0.00016345679,0.00008511136,0.00009455377],"category_scores_gemma":[0.0000128910215,0.00032274006,0.00039497018,0.00034510178,0.0005024739,0.00012424757,0.000049396796,0.0017215041,0.000009817717],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040938435,0.0021241202,0.07299718,0.015585607,0.002785007,0.00097556436,0.0033804623,0.000007762404,0.004184049,0.000022341712,0.75763154,0.13621253],"study_design_scores_gemma":[0.009418936,0.005995201,0.013267394,0.0007832786,0.0031739215,0.006092463,0.00046866547,0.00014266206,0.0018171988,0.000009844833,0.9583395,0.00049094495],"about_ca_topic_score_codex":0.0032314714,"about_ca_topic_score_gemma":0.000009246099,"teacher_disagreement_score":0.46651685,"about_ca_system_score_codex":0.0006350047,"about_ca_system_score_gemma":0.0008717196,"threshold_uncertainty_score":0.99992245},"labels":[],"label_agreement":null},{"id":"W1966160601","doi":"10.1002/chin.200133273","title":"ChemInform Abstract: The Transannular Diels—Alder Strategy: Applications to Total Synthesis","year":2001,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Chemistry; Service (business); Nanotechnology; Business; Marketing","score_opus":0.02693718241581238,"score_gpt":0.3123991488376083,"score_spread":0.2854619664217959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966160601","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03015473,0.00026812477,0.0000026254527,0.0037591895,0.00006067444,0.0009475474,0.000025117313,0.00009221006,0.9646898],"genre_scores_gemma":[0.9169713,0.00017609894,0.000021684229,0.001222608,0.00041183818,0.0011211509,0.000055045733,0.000021947719,0.079998314],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99906564,4.9733778e-8,0.00025364006,0.00017405179,0.00018407023,0.00032255554],"domain_scores_gemma":[0.99925005,0.0000939045,0.000052764823,0.00032513082,0.000064339074,0.00021378564],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008588742,0.00018445421,0.00021854542,0.000048874088,0.000117817,0.000025593377,0.00014122736,0.000103923514,0.0057722237],"category_scores_gemma":[0.00001413015,0.00012692064,0.0001353952,0.0002482839,0.000068079564,0.00010433411,0.000021250531,0.00016896136,0.00034022093],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020488442,0.00018696919,0.000109316796,0.00006348722,0.00014612231,0.00001715494,0.00072411756,0.0000011743123,0.0028228262,0.000120042925,0.042991996,0.9526119],"study_design_scores_gemma":[0.00092823076,0.00011927282,0.007038212,0.00003484836,0.0003107361,0.00020331705,0.00059499004,0.0000065509134,0.2229368,0.000046170233,0.76755714,0.00022371633],"about_ca_topic_score_codex":0.000041436295,"about_ca_topic_score_gemma":0.000013424165,"teacher_disagreement_score":0.95238817,"about_ca_system_score_codex":0.00012913065,"about_ca_system_score_gemma":0.00010894377,"threshold_uncertainty_score":0.9951366},"labels":[],"label_agreement":null},{"id":"W1966385883","doi":"10.1007/s10549-014-3221-2","title":"Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Ottawa Regional Cancer Foundation; Montreal General Hospital; Ottawa Hospital; Centre Hospitalier de l’Université de Montréal","funders":"NSABP Foundation; GlaxoSmithKline","keywords":"Pazopanib; Medicine; Cyclophosphamide; Oncology; Breast cancer; Paclitaxel; Doxorubicin; Internal medicine; Neoadjuvant therapy; Chemotherapy; Cancer","score_opus":0.048088481825683545,"score_gpt":0.43952695847675566,"score_spread":0.3914384766510721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966385883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777007,0.00957532,0.00003202394,0.0066421577,0.00024189,0.0051695816,0.00047119992,0.000053214255,0.000113889524],"genre_scores_gemma":[0.9803448,0.013599237,0.00006583873,0.00020453575,0.0003522366,0.004468222,0.000064377506,0.00005487577,0.0008459052],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99727714,0.00019990845,0.0003676276,0.0009186029,0.00046756244,0.0007691809],"domain_scores_gemma":[0.99834037,0.0003825084,0.000118628544,0.0002532693,0.00031764485,0.0005875946],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042332042,0.00046217383,0.0007506667,0.0001869428,0.0007292218,0.00009751117,0.00007710624,0.00008743512,0.00016653116],"category_scores_gemma":[0.000020416917,0.0003377354,0.000109794695,0.00025516318,0.00030589034,0.00020697991,0.00009104652,0.00021221547,0.0000035573987],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018790703,0.0049527823,0.041664477,0.00007475819,0.0014213506,0.00007333678,0.0023334688,0.0000038309668,0.003876387,0.00011650735,0.00017522967,0.9265172],"study_design_scores_gemma":[0.3151426,0.13281912,0.5107216,0.0011877113,0.001649003,0.0006059997,0.005436554,0.0010480412,0.008361682,0.0013806582,0.020408938,0.0012380361],"about_ca_topic_score_codex":0.011816245,"about_ca_topic_score_gemma":0.0030385766,"teacher_disagreement_score":0.92527914,"about_ca_system_score_codex":0.0007837396,"about_ca_system_score_gemma":0.0005274719,"threshold_uncertainty_score":0.9999075},"labels":[],"label_agreement":null},{"id":"W1966438134","doi":"10.1158/0008-5472.sabcs11-p2-14-02","title":"P2-14-02: NCIC CTG MA.27: Clinical Tolerability and Overall Survival of Racial and Ethnic Minority Women on Aromatase Inhibitor Therapy.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Aromatase inhibitor; Breast cancer; Pacific islanders; Anastrozole; Proportional hazards model; Exemestane; Cancer; Tamoxifen; Oncology; Demography; Population","score_opus":0.34842295435104587,"score_gpt":0.5226997295747786,"score_spread":0.17427677522373275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966438134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928019,0.0038532629,2.8374262e-7,0.0004948306,0.00045529453,0.00072603906,0.00010635221,0.000017392542,0.0015446334],"genre_scores_gemma":[0.99262065,0.005363172,0.000020146997,0.00021087108,0.0006321676,0.00014870394,0.000012852431,0.000015658414,0.00097577326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977636,0.00050968886,0.00036735943,0.0004746049,0.00042187911,0.00046292174],"domain_scores_gemma":[0.9985797,0.00047933112,0.00006812024,0.00032190917,0.00018951752,0.00036141396],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019280238,0.00015572763,0.0005197914,0.000117602816,0.00008001341,0.000009508528,0.00009884638,0.00017063614,0.0016074522],"category_scores_gemma":[0.0001356769,0.00012361226,0.00006768377,0.0001801661,0.0007205756,0.00006282321,0.00010874173,0.00062621885,0.000012030786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047009453,0.0033148234,0.79296225,0.0005767858,0.0005087136,0.00013644934,0.0076230876,1.9242252e-7,0.022494743,0.00020265789,0.011165476,0.11400536],"study_design_scores_gemma":[0.010317796,0.0055605727,0.9607205,0.00006841008,0.000043291166,0.0000064568017,0.00018016828,0.000008256363,0.011986302,0.00069590355,0.010240055,0.0001723317],"about_ca_topic_score_codex":0.001185202,"about_ca_topic_score_gemma":0.0003458524,"teacher_disagreement_score":0.1677582,"about_ca_system_score_codex":0.00023346,"about_ca_system_score_gemma":0.00039738844,"threshold_uncertainty_score":0.9993052},"labels":[],"label_agreement":null},{"id":"W1967669588","doi":"10.1007/s00280-005-0145-x","title":"Preferential extravasation and accumulation of liposomal vincristine in tumor comparing to normal tissue enhances antitumor activity","year":2005,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Extravasation; Vincristine; Liposome; Pharmacology; Medicine; Cancer research; Chemotherapy; Chemistry; Pathology; Internal medicine; Cyclophosphamide; Biochemistry","score_opus":0.05915090412979619,"score_gpt":0.41597934344471604,"score_spread":0.35682843931491987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967669588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99615234,0.0012566613,0.00011420414,0.0014825696,0.00022687805,0.0005130105,0.000013691174,0.000018077948,0.00022253704],"genre_scores_gemma":[0.99702775,0.0011074014,0.00027708782,0.0008319914,0.00053122663,0.0000687991,0.000010408901,0.000011965899,0.00013339259],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926114,0.000044528148,0.00019947636,0.00023756915,0.000070938644,0.0001863296],"domain_scores_gemma":[0.99967855,0.000048750546,0.000090911875,0.00004927089,0.000037692356,0.000094843774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008548128,0.00013554048,0.00033601685,0.00011966356,0.00003932595,0.000005811994,0.00003583497,0.000052743388,0.00087326096],"category_scores_gemma":[0.0000025879413,0.00013156547,0.00001983428,0.00011846517,0.0000766528,0.000114649425,0.000021448921,0.00011847441,0.0000015082469],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003351588,0.00025404498,0.057429407,0.000114784685,0.00007212449,0.000003425462,0.0007206148,0.000088314584,0.8773043,0.000008134254,0.00034449453,0.060308773],"study_design_scores_gemma":[0.00515635,0.00042143092,0.20410062,0.000031454125,0.00009078658,0.000015044918,0.000008428508,0.0016612618,0.78353846,0.0000055290016,0.004873365,0.00009725729],"about_ca_topic_score_codex":0.00031194798,"about_ca_topic_score_gemma":0.00045211733,"teacher_disagreement_score":0.1466712,"about_ca_system_score_codex":0.00008282922,"about_ca_system_score_gemma":0.000064554326,"threshold_uncertainty_score":0.95615953},"labels":[],"label_agreement":null},{"id":"W1968260891","doi":"10.1038/nrclinonc.2013.87","title":"Maintenance therapy in breast cancer—many questions remain","year":2013,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canada Research Chairs","keywords":"Medicine; Breast cancer; Oncology; Chemotherapy; Internal medicine; Clinical trial; Disease; Maintenance therapy; Cancer","score_opus":0.19734653868178328,"score_gpt":0.5794666941963679,"score_spread":0.38212015551458456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968260891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007228629,0.9780833,0.0000019698634,0.008237027,0.003302649,0.006500468,0.000112951966,0.00006459528,0.0036898188],"genre_scores_gemma":[0.0000028126094,0.978651,0.0006260754,0.008907355,0.0032143542,0.0036303229,0.0001884373,0.000096765856,0.004682882],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99152464,0.0028122682,0.0035276113,0.0011755617,0.00022181467,0.0007381141],"domain_scores_gemma":[0.99469215,0.002087632,0.0016948533,0.0008433072,0.00021596927,0.00046609645],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0026936657,0.0008553781,0.009956214,0.0003175208,0.000057948462,0.000013581514,0.00047931212,0.0043663387,0.0028663664],"category_scores_gemma":[0.0006549647,0.00051626464,0.0022809973,0.0009011139,0.0003474304,0.00007140205,0.00011531162,0.006861486,0.0009310038],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012405247,0.0013980819,0.0002864315,0.004490207,0.0003550498,0.00020486036,0.0000071456,2.1391722e-8,2.5383926e-7,0.00022171119,0.14878577,0.8441264],"study_design_scores_gemma":[0.0030380092,0.0012127869,0.00080328865,0.022548191,0.001982606,0.0006342533,0.0000015005826,0.0000015370423,3.166487e-8,0.000064566484,0.9693168,0.00039642828],"about_ca_topic_score_codex":0.0001626737,"about_ca_topic_score_gemma":0.0003043852,"teacher_disagreement_score":0.84373,"about_ca_system_score_codex":0.0016182571,"about_ca_system_score_gemma":0.0030486714,"threshold_uncertainty_score":0.9998469},"labels":[],"label_agreement":null},{"id":"W1968449590","doi":"10.1016/j.ejca.2011.06.018","title":"Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADO","year":2011,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Sanofi; F. Hoffmann-La Roche; Amgen","keywords":"Docetaxel; Bevacizumab; Medicine; Metastatic breast cancer; Neutropenia; Internal medicine; Hazard ratio; Febrile neutropenia; Adverse effect; Oncology; Breast cancer; Placebo; Population; Chemotherapy; Cancer; Confidence interval; Surgery; Pathology","score_opus":0.03946862490249079,"score_gpt":0.3032199038091107,"score_spread":0.26375127890661987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968449590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932863,0.0035279002,0.00023352994,0.0012495192,0.00015161606,0.0009072513,0.0005165437,0.0000030382398,0.00012426925],"genre_scores_gemma":[0.9955264,0.0037369998,0.0004777394,0.000046692232,0.00007390961,0.000016615617,0.000017388993,0.000022068418,0.000082188315],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99888617,0.00008935797,0.0005535306,0.00013725301,0.00021060205,0.00012311008],"domain_scores_gemma":[0.99852437,0.0001901574,0.00069792656,0.00011794232,0.00039768175,0.00007192184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018201688,0.00015117906,0.0004218364,0.00008316914,0.00003372782,0.0000040855243,0.00007416131,0.000011497507,0.00010292675],"category_scores_gemma":[0.000014355164,0.00007062708,0.0000515133,0.00012516249,0.000103469814,0.00006190329,0.000009097179,0.000081229075,2.3445224e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34312075,0.0036273014,0.057867907,0.00011077196,0.0019560475,0.000084297695,0.0064909114,0.0003043066,0.000042420303,0.000006959403,0.00025578632,0.5861325],"study_design_scores_gemma":[0.12512246,0.031740833,0.83585864,0.0010561363,0.001970265,0.000025881234,0.00011039218,0.00007550027,0.0006684512,0.0000074134355,0.0032605464,0.00010346315],"about_ca_topic_score_codex":0.0005451495,"about_ca_topic_score_gemma":0.001608377,"teacher_disagreement_score":0.77799076,"about_ca_system_score_codex":0.0001651432,"about_ca_system_score_gemma":0.00021490261,"threshold_uncertainty_score":0.28800887},"labels":[],"label_agreement":null},{"id":"W1968974195","doi":"10.1097/mph.0b013e3181d419ad","title":"Vincristine-induced Peripheral Neuropathy in a Neonate With Congenital Acute Lymphoblastic Leukemia","year":2010,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Vincristine; Peripheral neuropathy; Fulminant; Neurotoxicity; Pediatrics; Anesthesia; Surgery; Internal medicine; Chemotherapy; Toxicity; Cyclophosphamide; Endocrinology","score_opus":0.013607410682939625,"score_gpt":0.3117093861858941,"score_spread":0.2981019755029545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968974195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935487,0.0005126596,0.00008236015,0.00196152,0.0020038884,0.00032478504,0.0000063661723,0.00002844222,0.0015313106],"genre_scores_gemma":[0.99546736,0.00027333802,0.0016262284,0.000752429,0.0016468283,0.000024731886,0.0000050736894,0.000042173106,0.00016181872],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9977103,0.00019891972,0.0009543453,0.00030642576,0.00026780507,0.00056220294],"domain_scores_gemma":[0.9977146,0.0006096408,0.0007349828,0.00019533781,0.00034301766,0.00040245688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041842947,0.0003176766,0.0012095616,0.00060972146,0.00006447157,0.000011944873,0.00022242223,0.00044466465,0.00041957558],"category_scores_gemma":[0.00023432764,0.00023508415,0.00019183091,0.0005020798,0.00017230626,0.00013901367,0.00006026005,0.0014358584,0.00003470171],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033784773,0.0060654664,0.57440805,0.00030437615,0.0025708466,0.21693861,0.004224663,0.0000694221,0.13041133,0.0008774583,0.01413446,0.016210534],"study_design_scores_gemma":[0.1473426,0.08784153,0.18488948,0.00008541056,0.015787568,0.50475705,0.0012700509,0.002179106,0.0086013125,0.0005009491,0.044841178,0.0019037625],"about_ca_topic_score_codex":0.000062039886,"about_ca_topic_score_gemma":0.00029296364,"teacher_disagreement_score":0.3895186,"about_ca_system_score_codex":0.0007211929,"about_ca_system_score_gemma":0.0038220456,"threshold_uncertainty_score":0.95864534},"labels":[],"label_agreement":null},{"id":"W1969417922","doi":"10.1007/s13318-014-0205-x","title":"A metoprolol–terbinafine combination induced bradycardia","year":2014,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Metoprolol; Bradycardia; Medicine; Sinus bradycardia; Anesthesia; Terbinafine; Bisoprolol; Heart rate; Coronary artery disease; Adverse effect; Cardiology; Internal medicine; Pharmacology; Heart failure; Blood pressure; Dermatology","score_opus":0.0174463820794326,"score_gpt":0.2840406483624154,"score_spread":0.2665942662829828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969417922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98211575,0.004426457,0.0002980386,0.0026202449,0.0012996022,0.0001635608,0.00000460143,0.000020375328,0.009051387],"genre_scores_gemma":[0.9936998,0.0015869954,0.0008067798,0.0019548289,0.0014232431,0.0000011037152,0.0000063639145,0.000035053552,0.00048583667],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983959,0.0005476725,0.0004672516,0.00014519508,0.0002535308,0.000190434],"domain_scores_gemma":[0.9989953,0.00008144972,0.00031490964,0.00011801246,0.00021949648,0.00027081277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010984855,0.00018423307,0.00045734184,0.00020605474,0.000057889272,0.000027125618,0.00011075776,0.00002071951,0.00012290709],"category_scores_gemma":[0.000051382125,0.00014389542,0.00014175012,0.00016301844,0.00005751356,0.00010110339,0.000046897494,0.0003452674,0.000016465443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025985173,0.00159429,0.0076632835,0.00027625705,0.0015652215,0.0007665164,0.0037591213,0.00004330649,0.4498253,0.0014397549,0.05421735,0.4762511],"study_design_scores_gemma":[0.025237923,0.001358736,0.17090034,0.00008426663,0.00280662,0.0010304692,0.000056622997,0.00042382666,0.054131795,0.00024795008,0.7434121,0.00030934627],"about_ca_topic_score_codex":0.000002764694,"about_ca_topic_score_gemma":2.0991266e-7,"teacher_disagreement_score":0.68919474,"about_ca_system_score_codex":0.000013856444,"about_ca_system_score_gemma":0.0000348468,"threshold_uncertainty_score":0.5867885},"labels":[],"label_agreement":null},{"id":"W1970571080","doi":"10.1016/j.chroma.2011.03.010","title":"Efficient purification of paclitaxel from yews using high-performance displacement chromatography technique","year":2011,"lang":"en","type":"article","venue":"Journal of Chromatography A","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Biotechnology Research Institute","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Trifluoroacetic acid; Chemistry; Chromatography; Methanol; Solvent; Hexane; Elution; Paclitaxel; Chloroform; Aqueous solution; Acetic acid; Taxus; Acetonitrile; Organic chemistry","score_opus":0.030166633912510687,"score_gpt":0.2873817177376819,"score_spread":0.2572150838251712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970571080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951078,0.0015185747,0.0019597604,0.000049763657,0.00032920658,0.00047592618,0.000023846358,0.00002203314,0.0005130388],"genre_scores_gemma":[0.9823675,0.0004632009,0.016917136,0.00005392024,0.00014045097,0.000022496532,0.000008376432,0.000022316563,0.0000045850034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983652,0.00006463792,0.00080077787,0.00016954292,0.00037928962,0.00022055273],"domain_scores_gemma":[0.99841225,0.00003865965,0.00090372044,0.0002599382,0.00022906775,0.00015636574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030378712,0.00020181938,0.0005531112,0.00070924335,0.00005834871,0.000006807597,0.00014871224,0.00011340157,0.0002696971],"category_scores_gemma":[0.00000700628,0.00015776898,0.00038154089,0.0006393395,0.00016942887,0.00008318019,0.000022669028,0.00020419023,0.0000023562175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019620457,0.0030154383,0.24034075,0.00026430617,0.0014309178,0.00007654116,0.0014095986,0.000075073076,0.7490203,0.00017216847,0.0005600401,0.0016728215],"study_design_scores_gemma":[0.004284226,0.002509169,0.40432957,0.0007275362,0.0012048895,0.00029763245,0.00016877588,0.00038617614,0.58510786,0.00020104417,0.00057007524,0.00021305437],"about_ca_topic_score_codex":0.00016910917,"about_ca_topic_score_gemma":0.0000023254709,"teacher_disagreement_score":0.16398883,"about_ca_system_score_codex":0.00006781343,"about_ca_system_score_gemma":0.00012817197,"threshold_uncertainty_score":0.64336324},"labels":[],"label_agreement":null},{"id":"W1970591544","doi":"10.5737/1181912x153168174","title":"La fonction nerveuse périphérique et la souffrance liée aux symptômes pendant la biothérapie du mélanome malin","year":2005,"lang":"fr","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.019041825788651774,"score_gpt":0.36398372966816045,"score_spread":0.3449419038795087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970591544","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27319986,0.15004407,0.0007775354,0.41842932,0.01871694,0.00075008033,0.00021125424,0.000104127466,0.1377668],"genre_scores_gemma":[0.9366867,0.0245517,0.0013954317,0.008496143,0.010628172,0.00003209653,0.000051182844,0.00012581705,0.018032733],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99510723,0.0021758934,0.0006980601,0.00046975663,0.00022682926,0.001322211],"domain_scores_gemma":[0.9963293,0.00088181,0.00037860492,0.00025237663,0.00022241483,0.0019355059],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018949104,0.00048639026,0.00079181977,0.0007658641,0.0005923696,0.00017049145,0.00029430416,0.0011335695,0.0033993574],"category_scores_gemma":[0.00017225767,0.0005103878,0.0003193441,0.00035244809,0.001111968,0.00038344512,0.00002099185,0.002346598,0.00023838301],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000775585,0.0016500064,0.011623703,0.000091025024,0.0008802216,0.014176956,0.010078779,0.00043691925,0.001381278,0.0080859875,0.3190966,0.6317229],"study_design_scores_gemma":[0.0073796543,0.0014210623,0.025497137,0.0019532472,0.0008727367,0.039731506,0.0009966906,0.0008120084,0.00013287272,0.0004882999,0.9202989,0.0004159274],"about_ca_topic_score_codex":0.00979574,"about_ca_topic_score_gemma":0.074851155,"teacher_disagreement_score":0.66348684,"about_ca_system_score_codex":0.010405898,"about_ca_system_score_gemma":0.0177836,"threshold_uncertainty_score":0.99995506},"labels":[],"label_agreement":null},{"id":"W1971422709","doi":"10.1139/v01-125","title":"Reanalysis of the biotransformation of 4(20),11(12)-taxadiene derivatives","year":2001,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Taxane; Biotransformation; Stereochemistry; Chemistry; Terpene; Terpenoid; Diterpene; Taxoid; Organic chemistry; Biology; Enzyme; Paclitaxel","score_opus":0.01406355443019332,"score_gpt":0.2578501507101483,"score_spread":0.24378659627995494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971422709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99037486,0.00061605265,0.000019531777,0.002026795,0.00006144726,0.00004064463,0.000018019535,9.203911e-7,0.006841728],"genre_scores_gemma":[0.9988624,0.00011844447,0.00004695122,0.00008225159,0.00009569787,5.820455e-7,0.0000055486107,0.0000045912525,0.0007835515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99942064,0.000012536734,0.00030659503,0.000041927895,0.00010833019,0.00010998401],"domain_scores_gemma":[0.99921715,0.000021328,0.00028840435,0.00011172674,0.00016641435,0.00019497825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009479713,0.00006348714,0.0002221334,0.0000646121,0.000029895713,0.0000025516435,0.00010103915,0.000051946154,0.0008129635],"category_scores_gemma":[0.000043008527,0.000044431705,0.00015742239,0.00019152589,0.0001222504,0.000043261414,0.0000026538535,0.00009942697,3.1790884e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014660123,0.0000735661,0.27652758,0.0002152008,0.00057768007,0.00007523544,0.0016921728,0.00007101394,0.7144351,0.00000870368,0.0032105802,0.0029665336],"study_design_scores_gemma":[0.0014716791,0.00009142323,0.043600142,0.00018495842,0.00048061876,0.0003571806,0.0004513941,0.00001900039,0.936305,0.000056125275,0.016922409,0.000060067327],"about_ca_topic_score_codex":0.00086784386,"about_ca_topic_score_gemma":0.0033167899,"teacher_disagreement_score":0.23292746,"about_ca_system_score_codex":0.000115753646,"about_ca_system_score_gemma":0.00077370077,"threshold_uncertainty_score":0.8901381},"labels":[],"label_agreement":null},{"id":"W1971932257","doi":"10.17294/2330-0698.1169","title":"Cost-Effectiveness of Taxanes in the Treatment of Metastatic Breast Cancer: A Review of the Literature","year":2015,"lang":"en","type":"review","venue":"Journal of patient-centered research and reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Docetaxel; Paclitaxel; Medicine; Metastatic breast cancer; Oncology; Chemotherapy; Breast cancer; Cancer; Internal medicine; Quality of life (healthcare); Randomized controlled trial; Intensive care medicine","score_opus":0.3276796005693077,"score_gpt":0.5348964550708113,"score_spread":0.20721685450150357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971932257","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008508749,0.9915426,1.5529302e-7,0.0002609635,0.00022606217,0.0067129247,0.00037158997,5.337116e-7,0.000034327313],"genre_scores_gemma":[0.00018427933,0.9992308,0.000020281379,0.000031142015,0.00009511275,0.00034252144,0.000036198046,0.0000165065,0.00004317294],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919964,0.0050304923,0.0017798777,0.00018779079,0.00074971165,0.00025569322],"domain_scores_gemma":[0.9957478,0.0006338455,0.0021533296,0.00040054662,0.0009268532,0.00013760415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034653791,0.0003094362,0.0039037005,0.0003474779,0.00003350568,0.000008673362,0.00032041818,0.00008060434,0.00005331796],"category_scores_gemma":[0.00017941557,0.00011108931,0.0010135502,0.0011011133,0.0002701065,0.000052666,0.000052346448,0.000567806,6.9148837e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042368798,0.0019822025,0.00022647962,0.28020197,0.00055918924,0.00005783379,0.0005054152,6.547071e-8,0.0000071240356,0.000003145197,0.0018111027,0.7142218],"study_design_scores_gemma":[0.001566668,0.003016315,0.0000551455,0.3581546,0.0016646624,0.0006355757,0.000040490828,1.0009768e-7,0.000016372363,0.000008354171,0.63479406,0.000047679754],"about_ca_topic_score_codex":0.00005757596,"about_ca_topic_score_gemma":0.000012670911,"teacher_disagreement_score":0.7141741,"about_ca_system_score_codex":0.00035991956,"about_ca_system_score_gemma":0.0009302875,"threshold_uncertainty_score":0.4530091},"labels":[],"label_agreement":null},{"id":"W1971954228","doi":"10.3816/cbc.2004.n.032","title":"Final Results of a Phase II Clinical Trial of Weekly Docetaxel in Combination with Capecitabine in Anthracycline-Pretreated Metastatic Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Alberta","funders":"","keywords":"Medicine; Docetaxel; Capecitabine; Metastatic breast cancer; Internal medicine; Anthracycline; Discontinuation; Progressive disease; Breast cancer; Chemotherapy; Phases of clinical research; Gastroenterology; Cancer; Surgery; Oncology; Colorectal cancer","score_opus":0.09835630191254444,"score_gpt":0.4714088183810935,"score_spread":0.3730525164685491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971954228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832596,0.0004571882,0.000013732259,0.012559308,0.00069079956,0.0015391998,0.0012615238,0.000024647003,0.00019396056],"genre_scores_gemma":[0.99644667,0.0017912171,0.00027521176,0.00037106432,0.0004637088,0.00022725933,0.00013313821,0.000035768044,0.00025595902],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99523467,0.00033660437,0.002882236,0.0006913972,0.00043220108,0.00042287476],"domain_scores_gemma":[0.9972918,0.0006782177,0.0009639261,0.00039892842,0.00040610542,0.00026102594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012992582,0.00033365627,0.0017780161,0.00029738847,0.00003537842,0.000005457525,0.00017535618,0.00023916221,0.0005504732],"category_scores_gemma":[0.00024420925,0.00025381093,0.0003230107,0.0009588317,0.0006780025,0.00015100293,0.00006257349,0.0006820616,0.0000039073343],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6454203,0.052747227,0.19536646,0.00020097542,0.00073590036,0.00027084257,0.00027515745,0.00027943478,0.00055632,0.00004247126,0.00061828824,0.103486635],"study_design_scores_gemma":[0.554781,0.011569927,0.43084085,0.0008950584,0.00076262065,0.00007311091,0.000050721224,0.00029258736,0.0002735978,0.00008365595,0.0001797527,0.00019710224],"about_ca_topic_score_codex":0.0074387407,"about_ca_topic_score_gemma":0.0060306164,"teacher_disagreement_score":0.2354744,"about_ca_system_score_codex":0.0003567662,"about_ca_system_score_gemma":0.0016088637,"threshold_uncertainty_score":0.9999914},"labels":[],"label_agreement":null},{"id":"W1973471572","doi":"10.1158/0008-5472.can-12-4183","title":"A Model of Postsurgical Advanced Metastatic Breast Cancer More Accurately Replicates the Clinical Efficacy of Antiangiogenic Drugs","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Pfizer; Eli Lilly and Company","keywords":"Medicine; Pazopanib; Sunitinib; Metastatic breast cancer; Bevacizumab; Oncology; Breast cancer; Internal medicine; Cancer; Clinical trial; Chemotherapy; Phases of clinical research","score_opus":0.26187886519085657,"score_gpt":0.5499455557350358,"score_spread":0.2880666905441792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973471572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767812,0.0053855795,0.000005780944,0.0155991865,0.000101328704,0.0015131346,0.00019543419,0.000020133592,0.00039825187],"genre_scores_gemma":[0.99172235,0.0054436345,0.00013751438,0.00028575028,0.00016473608,0.0006553891,0.000016856298,0.000033663433,0.0015400908],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99753016,0.0002679305,0.0006279722,0.00043354067,0.00062785536,0.0005125289],"domain_scores_gemma":[0.997117,0.00095203205,0.00018177033,0.0005915887,0.00092354737,0.00023408934],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007926741,0.00017282677,0.00062433054,0.00014711602,0.000088743094,0.000012102143,0.00034235878,0.0000872291,0.002032229],"category_scores_gemma":[0.00010354931,0.00010518103,0.00031524358,0.000654664,0.00091691944,0.000095339456,0.00015127534,0.0004957896,0.000030031446],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016305843,0.0044314987,0.07653998,0.0011267024,0.0042978274,0.00004858722,0.0039405664,0.0024410456,0.5532556,0.0005443777,0.07111399,0.26595396],"study_design_scores_gemma":[0.052790254,0.003842357,0.6589547,0.0017759431,0.003234655,0.00019576409,0.0026791731,0.034722943,0.23199666,0.0020715902,0.0065994477,0.0011365435],"about_ca_topic_score_codex":0.002060148,"about_ca_topic_score_gemma":0.00004195293,"teacher_disagreement_score":0.5824147,"about_ca_system_score_codex":0.00015302305,"about_ca_system_score_gemma":0.0010528251,"threshold_uncertainty_score":0.99888},"labels":[],"label_agreement":null},{"id":"W1973742157","doi":"10.1634/theoncologist.2013-0359","title":"Use of Conjoint Analysis to Assess Breast Cancer Patient Preferences for Chemotherapy Side Effects","year":2014,"lang":"en","type":"article","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ottawa Hospital; Royal Victoria Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Medicine; Conjoint analysis; Breast cancer; Oncology; Chemotherapy; Internal medicine; Cancer; Preference; Statistics","score_opus":0.0910081580114505,"score_gpt":0.3948186789986069,"score_spread":0.3038105209871564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973742157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919852,0.00007769598,0.0006550067,0.005304767,0.00017859605,0.0010351073,0.00007327474,0.000023365279,0.0006669657],"genre_scores_gemma":[0.99537754,0.0000777648,0.00059360656,0.0030400094,0.00012751583,0.00041867854,0.000016410148,0.0000075231055,0.00034096203],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99929774,0.00008980313,0.00017523521,0.0001684783,0.00010624532,0.00016249983],"domain_scores_gemma":[0.99873227,0.0007516299,0.00012654181,0.00019938008,0.00011770139,0.00007248046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015405392,0.00010955726,0.00041637634,0.0000674519,0.00004784053,0.0000095638425,0.00007790407,0.000048906182,0.00012710669],"category_scores_gemma":[0.000052244934,0.00006151853,0.00014316586,0.00023523082,0.000104350715,0.000021987302,0.000022836024,0.0000550556,0.000003280652],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009106521,0.002088216,0.23651107,0.0003234262,0.007849892,0.0000075924713,0.0020640574,0.002190837,0.0756422,0.00047053045,0.022948574,0.6407971],"study_design_scores_gemma":[0.0041479226,0.0057000155,0.8547455,0.000070146896,0.005419485,0.000007875396,0.000089963156,0.0012884237,0.08078411,0.00018470942,0.04734866,0.00021318493],"about_ca_topic_score_codex":0.0015612766,"about_ca_topic_score_gemma":0.0012472556,"teacher_disagreement_score":0.64058393,"about_ca_system_score_codex":0.00013275295,"about_ca_system_score_gemma":0.000083197476,"threshold_uncertainty_score":0.25086528},"labels":[],"label_agreement":null},{"id":"W1973823302","doi":"10.1158/0008-5472.sabcs12-s6-6","title":"Abstract S6-6: A Phase III, open-label, randomized, multicenter study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines and taxanes","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Eribulin; Capecitabine; Medicine; Taxane; Internal medicine; Metastatic breast cancer; Oncology; Clinical endpoint; Anthracycline; Breast cancer; Phases of clinical research; Cancer; Randomized controlled trial; Clinical trial; Colorectal cancer","score_opus":0.09217394740378554,"score_gpt":0.4726768322864767,"score_spread":0.3805028848826912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973823302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874912,0.0028909796,0.0000018765007,0.00029722095,0.000101758014,0.008966781,0.00016615969,0.000017377954,0.000066658395],"genre_scores_gemma":[0.9944089,0.0016347775,0.00013023232,0.00004644276,0.00008274465,0.0031838305,0.00005465365,0.000055904737,0.0004024911],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99724615,0.0003262968,0.00056196185,0.0004896807,0.0006197933,0.00075610756],"domain_scores_gemma":[0.9979093,0.00054306776,0.00024660752,0.00030166877,0.0006574379,0.00034189367],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00075631123,0.0003369136,0.0012717383,0.00028459632,0.00010652886,0.00003414611,0.00018970009,0.00005319732,0.0010999871],"category_scores_gemma":[0.000070761205,0.00018986569,0.000028548711,0.00067679764,0.0004497684,0.00049399823,0.000114964154,0.000368637,0.0000026609634],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7920519,0.014505205,0.17390226,0.0002751424,0.0013511373,0.00010191687,0.0016302036,0.000034946173,0.0008509607,0.0000011632505,0.00009880265,0.015196347],"study_design_scores_gemma":[0.9054677,0.0088457195,0.08174569,0.00073976367,0.0009135953,0.0000063306397,0.0009118393,0.00008604249,0.0008807562,4.0631818e-7,0.00016012885,0.00024203752],"about_ca_topic_score_codex":0.011471941,"about_ca_topic_score_gemma":0.009888553,"teacher_disagreement_score":0.11341577,"about_ca_system_score_codex":0.00033642165,"about_ca_system_score_gemma":0.00044680806,"threshold_uncertainty_score":0.99981314},"labels":[],"label_agreement":null},{"id":"W1974524561","doi":"10.1159/000220451","title":"The Psychodynamics of Medication","year":2009,"lang":"en","type":"article","venue":"Chemotherapia","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Icon; Citation; Computer science; Download; World Wide Web; Information retrieval; Subject (documents); Library science","score_opus":0.01006196200424361,"score_gpt":0.33857599374787806,"score_spread":0.32851403174363447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974524561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9100151,0.0035171364,0.00030391203,0.039928414,0.00032658025,0.00034679237,0.0000019252407,0.000049219365,0.04551089],"genre_scores_gemma":[0.99495685,0.0009788795,0.00021480683,0.0016140377,0.00010041034,0.0000033450672,0.0000055967544,0.000003841164,0.002122244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997434,0.000005565437,0.00007738453,0.000051566556,0.000061493796,0.000060593014],"domain_scores_gemma":[0.99978215,0.00002362226,0.000035981375,0.0001128429,0.00002125753,0.000024124003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005285135,0.000035915935,0.000066909306,0.000012357559,0.000024362533,0.0000015706162,0.000037235473,0.000025107582,0.00012269986],"category_scores_gemma":[0.0000029331,0.000021759934,0.00003134222,0.000053355863,0.000039673083,0.00000796912,0.0000012094541,0.00003690161,0.0000057671054],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074191217,0.00048636814,0.0049806475,0.000019443896,0.00017460526,0.0000022086028,0.0007459309,7.0713605e-7,0.19709079,0.0036563638,0.025974445,0.7661266],"study_design_scores_gemma":[0.0097307665,0.001924589,0.40520108,0.000062700856,0.00024147266,0.000050033683,0.00011694583,0.0009275311,0.092444606,0.011415299,0.47770432,0.00018065255],"about_ca_topic_score_codex":0.000003015908,"about_ca_topic_score_gemma":0.000002147535,"teacher_disagreement_score":0.7659459,"about_ca_system_score_codex":0.000019431896,"about_ca_system_score_gemma":0.000024077939,"threshold_uncertainty_score":0.13434774},"labels":[],"label_agreement":null},{"id":"W1974584024","doi":"10.1159/000226796","title":"Phase II Study of Pirarubicin (THP-Adriamycin) in Metastatic Breast Cancer Patients","year":2009,"lang":"en","type":"article","venue":"Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Pirarubicin; Medicine; Metastatic breast cancer; Leukopenia; Nausea; Vomiting; Breast cancer; Chemotherapy; Internal medicine; Regimen; Cancer; Gastroenterology; Surgery","score_opus":0.03595685724314979,"score_gpt":0.42504412754698984,"score_spread":0.38908727030384005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974584024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945606,0.00018397951,9.1164725e-7,0.0017917205,0.00032408614,0.0009453964,0.000035631452,0.000016816532,0.00214087],"genre_scores_gemma":[0.9980799,0.00006212682,0.000049926537,0.0011128256,0.000095245596,0.00008476209,0.000026939882,0.000010035569,0.00047824302],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9988788,0.0001229118,0.00037992955,0.00023447591,0.00013850238,0.00024541316],"domain_scores_gemma":[0.9994735,0.000058176753,0.00014429829,0.00014184917,0.00008949466,0.000092652954],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001150687,0.00014214758,0.0005944416,0.00019421858,0.00003522572,0.0000014007253,0.00006838471,0.000060958988,0.0010337784],"category_scores_gemma":[0.000012044718,0.00011743252,0.000050051174,0.00027562928,0.000041084826,0.000046906785,0.000025941034,0.000153726,0.000009499836],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00960882,0.3798083,0.22750568,0.000056856432,0.0005113126,0.00049469,0.009132369,0.00003265414,0.013863849,0.00006480606,0.010549465,0.34837118],"study_design_scores_gemma":[0.14882362,0.25182778,0.58542085,0.00005852911,0.0012162295,0.00006148835,0.00075153774,0.00009523152,0.0014585124,0.00012006746,0.009932605,0.00023355734],"about_ca_topic_score_codex":0.000942996,"about_ca_topic_score_gemma":0.0015415229,"teacher_disagreement_score":0.35791516,"about_ca_system_score_codex":0.00034974224,"about_ca_system_score_gemma":0.00023518785,"threshold_uncertainty_score":0.9998794},"labels":[],"label_agreement":null},{"id":"W1975369490","doi":"10.1158/1078-0432.tcmusa10-a44","title":"Abstract A44: Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5'-DFUR, the bioactive metabolite of Xeloda®","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Gefitinib; Capecitabine; Pharmacology; Breast cancer; Chemistry; Cancer research; Thymidine phosphorylase; Growth inhibition; Cancer; Epidermal growth factor receptor; Cell growth; Medicine; Internal medicine; Colorectal cancer; Biochemistry","score_opus":0.17920524362037962,"score_gpt":0.5115915909656693,"score_spread":0.3323863473452897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975369490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694705,0.0005623463,0.0000026777839,0.0009643616,0.00015872568,0.000581233,0.00037525746,0.0000054910597,0.00040283636],"genre_scores_gemma":[0.99850965,0.0009506006,0.000019314717,0.000023355879,0.00021151162,0.0001260995,0.000031717063,0.000015836044,0.00011192052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983831,0.00016058933,0.00064631726,0.00026228832,0.00032812238,0.00021960457],"domain_scores_gemma":[0.99714375,0.0017102618,0.00030902206,0.00020321975,0.00052761566,0.00010613888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009920526,0.000114484945,0.00049761997,0.00018716833,0.00006404163,0.0000064206297,0.000080572994,0.00012334592,0.0006588032],"category_scores_gemma":[0.00008660161,0.000075014264,0.00008109559,0.00041350166,0.0011246417,0.000080390295,0.00005199457,0.0010330543,0.0000016209858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026970177,0.000706302,0.6362889,0.00022348751,0.00034343216,0.000007540229,0.00070407346,0.000013014753,0.3441392,0.00017713192,0.00017169597,0.014528235],"study_design_scores_gemma":[0.0027013181,0.00048186563,0.87502784,0.00031766557,0.00025585384,0.0000026179616,0.00026247388,0.000035364614,0.120500505,0.00022947263,0.00012035237,0.000064683605],"about_ca_topic_score_codex":0.014447162,"about_ca_topic_score_gemma":0.004906887,"teacher_disagreement_score":0.23873894,"about_ca_system_score_codex":0.000078898775,"about_ca_system_score_gemma":0.00037627912,"threshold_uncertainty_score":0.99211574},"labels":[],"label_agreement":null},{"id":"W1976585485","doi":"10.1016/s1470-2045(11)70037-7","title":"Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2, randomised, double-blind, placebo-controlled study","year":2011,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Centre hospitalier universitaire de Québec","funders":"","keywords":"Bevacizumab; Metastatic breast cancer; Medicine; Paclitaxel; Placebo; HER2 negative; Oncology; Breast cancer; Internal medicine; Open label; Double blind; Cancer; Clinical trial; Chemotherapy; Pathology; Alternative medicine","score_opus":0.24401072602498708,"score_gpt":0.47205516413850956,"score_spread":0.22804443811352249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976585485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9443246,0.0003429457,0.00018283291,0.011985638,0.00051946286,0.040701516,0.00025669424,0.00007239308,0.001613912],"genre_scores_gemma":[0.9618961,0.0010980745,0.0010320175,0.0009838972,0.0002992884,0.031606015,0.00009382014,0.000058693666,0.0029320715],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972443,0.00064238656,0.00071769353,0.00057493313,0.00021658694,0.0006041081],"domain_scores_gemma":[0.9968787,0.0017753274,0.0004890004,0.00041248876,0.000265416,0.00017910097],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011131021,0.0004666574,0.00225709,0.00016723196,0.00020684586,0.000031499447,0.00035384163,0.00010841909,0.0013381933],"category_scores_gemma":[0.00009646717,0.0002229247,0.00009697904,0.0003979815,0.00019228524,0.00013263337,0.0000779366,0.0002684081,0.000020272404],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9069812,0.046674997,0.0004682051,0.00008133917,0.003031873,0.00045772796,0.007877151,0.000020160069,0.000024326664,0.000104750114,0.0008246223,0.0334536],"study_design_scores_gemma":[0.86847365,0.12201446,0.0002290115,0.000117380056,0.0034732982,0.00024000133,0.0015210093,0.0009821403,0.00027274954,0.00027553822,0.0021634158,0.0002373496],"about_ca_topic_score_codex":0.005014015,"about_ca_topic_score_gemma":0.068269074,"teacher_disagreement_score":0.07533947,"about_ca_system_score_codex":0.00136594,"about_ca_system_score_gemma":0.0014315981,"threshold_uncertainty_score":0.9995747},"labels":[],"label_agreement":null},{"id":"W1977284775","doi":"10.3747/co.19.879","title":"Phase II Trial of a Metronomic Schedule of Docetaxel and Capecitabine with Concurrent Celecoxib in Patients with Prior Anthracycline Exposure for Metastatic Breast Cancer","year":2012,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; NOSM University; Sudbury Regional Hospital","funders":"","keywords":"Medicine; Capecitabine; Docetaxel; Metastatic breast cancer; Internal medicine; Mucositis; Breast cancer; Celecoxib; Neutropenia; Clinical endpoint; Chemotherapy; Nausea; Oncology; Cancer; Clinical trial; Gastroenterology; Surgery","score_opus":0.07069277064196859,"score_gpt":0.4318936970225765,"score_spread":0.3612009263806079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977284775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99203366,0.00407537,0.00007619679,0.00027454627,0.00067796354,0.002397949,0.00044117973,0.0000071898075,0.000015946916],"genre_scores_gemma":[0.9982731,0.00020799995,0.0006203414,0.000019584557,0.00020367261,0.0004931468,0.0001453036,0.000019987136,0.000016876178],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987504,0.00007178035,0.00048116728,0.00023191326,0.0001302859,0.00033448235],"domain_scores_gemma":[0.9989794,0.00014930208,0.00040813093,0.00012493135,0.00018687072,0.00015139084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019583522,0.00020469261,0.00089138537,0.0001890549,0.000033168435,0.0000015993293,0.00005279889,0.000053913158,0.00019168765],"category_scores_gemma":[0.00001996061,0.00013948079,0.00006193657,0.00016632337,0.00022145752,0.00009874411,0.000032582422,0.0001470341,3.70436e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19255883,0.120071195,0.46708894,0.00078173116,0.0008385295,0.0000020472107,0.0010680181,0.000006112502,0.0011614827,0.0000638163,0.00032774606,0.21603155],"study_design_scores_gemma":[0.81359214,0.06466641,0.11138925,0.00020436748,0.0021327497,0.000013204871,0.00012899851,0.00010776212,0.0022379095,0.000003726873,0.0053127552,0.00021070942],"about_ca_topic_score_codex":0.00003262561,"about_ca_topic_score_gemma":0.0001488164,"teacher_disagreement_score":0.6210333,"about_ca_system_score_codex":0.0002217155,"about_ca_system_score_gemma":0.00037035818,"threshold_uncertainty_score":0.56878614},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W1977704967","doi":"10.3747/co.19.1024","title":"Advances in the Management of Metastatic Breast Cancer: Options Beyond First-Line Chemotherapy","year":2012,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Ottawa Hospital; Centre Hospitalier de l’Université de Montréal","funders":"Eisai Canada; Eisai","keywords":"Medicine; Metastatic breast cancer; Chemotherapy; Breast cancer; Oncology; First line; Cancer; Internal medicine; Bioinformatics; Cancer research; Biology","score_opus":0.08873687054459974,"score_gpt":0.4667276146840497,"score_spread":0.37799074413945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977704967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74358857,0.19832319,0.00023772198,0.030616108,0.0042226445,0.0025245803,0.00017561398,0.000047969523,0.020263629],"genre_scores_gemma":[0.9097186,0.08869435,0.00027123315,0.0004206262,0.00031591262,0.00042342689,0.00003863509,0.000009949403,0.00010731682],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992216,0.00005882619,0.0002287802,0.0001224711,0.00011430576,0.0002540232],"domain_scores_gemma":[0.99957955,0.000088902176,0.000100416255,0.00013842348,0.000033672666,0.000059062695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021118106,0.00011219256,0.00028573404,0.00008181412,0.000035888403,0.0000017083534,0.000093342176,0.000028943125,0.0007968235],"category_scores_gemma":[0.0000013876407,0.0000738323,0.00006843585,0.00023218399,0.00009749674,0.00007846542,0.000021299687,0.00013303538,0.000012598992],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079850445,0.009200907,0.1177997,0.00075164053,0.0003476423,0.0000220738,0.0025407358,0.00005664206,0.00010983022,0.0033190195,0.004444303,0.860609],"study_design_scores_gemma":[0.008233318,0.00071378984,0.15648209,0.00013841125,0.00086707354,0.0001227633,0.0006255293,0.00005764635,0.00015522409,0.00043370877,0.8320441,0.00012633277],"about_ca_topic_score_codex":0.000022810727,"about_ca_topic_score_gemma":0.0001108568,"teacher_disagreement_score":0.8604827,"about_ca_system_score_codex":0.00019211939,"about_ca_system_score_gemma":0.0000475755,"threshold_uncertainty_score":0.87246585},"labels":[],"label_agreement":null},{"id":"W1978585178","doi":"10.1097/00001813-200606000-00014","title":"Improved anti-tumor response rate with decreased cardiotoxicity of non-pegylated liposomal doxorubicin compared with conventional doxorubicin in first-line treatment of metastatic breast cancer in patients who had received prior adjuvant doxorubicin: results of a retrospective analysis","year":2006,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Doxorubicin; Cardiotoxicity; Anthracycline; Internal medicine; Metastatic breast cancer; Cyclophosphamide; Breast cancer; Adjuvant; Randomization; Oncology; Cancer; Chemotherapy; Surgery; Randomized controlled trial; Gastroenterology","score_opus":0.008634561448113807,"score_gpt":0.2784867038953679,"score_spread":0.2698521424472541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978585178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99214184,0.0004980911,0.000029284372,0.0004458914,0.00008272074,0.0027924755,0.0039184163,0.000025529596,0.00006575514],"genre_scores_gemma":[0.99809253,0.0004481512,0.00022642723,0.00005219192,0.000053227286,0.00032919744,0.0005140632,0.000060975908,0.00022322303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99551034,0.00053000153,0.0016962324,0.00095733925,0.0006584344,0.0006476608],"domain_scores_gemma":[0.9963832,0.00040889447,0.0014956675,0.00058606546,0.00094128406,0.00018490806],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006150993,0.0006639788,0.003225038,0.0011442165,0.00007354261,0.000011086433,0.00017589016,0.00012243596,0.00015007636],"category_scores_gemma":[0.00003543459,0.00049036305,0.00040947314,0.002897575,0.00046535043,0.00017170003,0.000038474416,0.00023848376,7.8237025e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.153958,0.005867637,0.7333685,0.00023705386,0.0040235175,0.0000989336,0.0011766454,0.008109841,0.09275468,0.0000014479888,0.00003979685,0.000363938],"study_design_scores_gemma":[0.06380585,0.0038795648,0.71233255,0.0008166271,0.0033614356,0.000006069903,0.00015775267,0.004594277,0.210715,0.000002581919,0.000011886858,0.00031639764],"about_ca_topic_score_codex":0.071325615,"about_ca_topic_score_gemma":0.03148451,"teacher_disagreement_score":0.11796031,"about_ca_system_score_codex":0.0013153253,"about_ca_system_score_gemma":0.0010449756,"threshold_uncertainty_score":0.9997548},"labels":[],"label_agreement":null},{"id":"W1978871709","doi":"10.1158/0008-5472.sabcs12-p3-06-34","title":"Abstract P3-06-34: Plasma (p) VEGF-A and VEGFR-2 biomarker (BM) results from the BEATRICE phase III trial of bevacizumab (BEV) in triple-negative early breast cancer (BC)","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Bevacizumab; Taxane; Population; Oncology; Breast cancer; Anthracycline; Cancer; Clinical endpoint; Triple-negative breast cancer; Chemotherapy; Metastatic breast cancer; Randomized controlled trial; Epirubicin","score_opus":0.12452955586661835,"score_gpt":0.45668403905827626,"score_spread":0.3321544831916579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978871709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843738,0.004949208,5.5886835e-7,0.0039831363,0.0006386462,0.002163456,0.0021981362,0.000020777752,0.0016722503],"genre_scores_gemma":[0.99267566,0.0036114142,0.000017525563,0.000094279356,0.0015377996,0.0007048867,0.0000961702,0.0000407991,0.0012214741],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967733,0.0003745989,0.0006389659,0.0005310375,0.0008062879,0.0008758052],"domain_scores_gemma":[0.9968086,0.0018640882,0.00020709963,0.00043341203,0.0003242101,0.00036260826],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014647074,0.00027781478,0.00061653263,0.0003281051,0.00018606496,0.000035674682,0.0002590982,0.00021869052,0.0010680602],"category_scores_gemma":[0.00021330091,0.00019592704,0.00012217197,0.00095311244,0.00054887566,0.000247655,0.00013454647,0.0008571647,0.00003169361],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7937441,0.0030067856,0.02135821,0.00016639309,0.0011709204,0.00011198604,0.011393395,0.000003910174,0.049534965,0.00002933365,0.032564998,0.086915],"study_design_scores_gemma":[0.53998923,0.0017789471,0.41872722,0.0005662935,0.0004467716,0.000021084916,0.0012108105,0.000098875804,0.024376899,0.00008082409,0.012310509,0.00039254798],"about_ca_topic_score_codex":0.096995935,"about_ca_topic_score_gemma":0.004560823,"teacher_disagreement_score":0.397369,"about_ca_system_score_codex":0.00089028256,"about_ca_system_score_gemma":0.0009109044,"threshold_uncertainty_score":0.9998451},"labels":[],"label_agreement":null},{"id":"W1979391857","doi":"10.1023/a:1006480504790","title":"Liarozole Fumarate (R85246): In the Treatment of ER Negative, Tamoxifen Refractory or Chemotherapy Resistant Postmenopausal Metastatic Breast Cancer","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Princess Margaret Cancer Centre; Kingston General Hospital; Mount Sinai Hospital; Credit Valley Hospital; Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Internal medicine; Tamoxifen; Tolerability; Breast cancer; Chemotherapy; Refractory (planetary science); Oncology; Endocrinology; Estrogen receptor; Gastroenterology; Cancer; Adverse effect; Biology","score_opus":0.07173302003090129,"score_gpt":0.420558018104273,"score_spread":0.34882499807337175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979391857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763915,0.007422057,1.6111429e-7,0.010825792,0.00006141573,0.0022581501,0.0015996939,0.000025214533,0.0014160485],"genre_scores_gemma":[0.91859823,0.06817428,0.00005497425,0.0003034105,0.00028308996,0.0023859825,0.00005447132,0.000049387592,0.010096185],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971635,0.00037557542,0.00044008243,0.000614516,0.00059950264,0.0008068423],"domain_scores_gemma":[0.99860793,0.0003406128,0.00010165843,0.00045205164,0.00019305875,0.0003046789],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025291689,0.00044063147,0.00074881606,0.00026719042,0.00021564016,0.000044865916,0.00014563349,0.0000871596,0.008757533],"category_scores_gemma":[0.0000024723372,0.00023164238,0.00012458357,0.0006892588,0.0004537527,0.00012873705,0.000015657388,0.00019648169,0.00002573364],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12060711,0.023957683,0.03806363,0.00020068776,0.0035137732,0.0015528263,0.01049865,0.000020127804,0.008240387,0.00005672139,0.002739895,0.7905485],"study_design_scores_gemma":[0.045198582,0.028535577,0.8612804,0.0004136865,0.00090023084,0.00076059904,0.00127563,0.0000778065,0.0054873386,0.00023363707,0.055354882,0.00048163396],"about_ca_topic_score_codex":0.03624864,"about_ca_topic_score_gemma":0.011644433,"teacher_disagreement_score":0.82321674,"about_ca_system_score_codex":0.0018695021,"about_ca_system_score_gemma":0.0010621897,"threshold_uncertainty_score":0.9921486},"labels":[],"label_agreement":null},{"id":"W1979687843","doi":"10.1038/sj.bjc.6604960","title":"Cancer neurology in clinical practice, neurological complications of cancer and its treatment (2nd Edn)","year":2009,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Neurology; Medicine; Cancer; Clinical Practice; Clinical neurology; Internal medicine; Physical therapy; Psychology; Psychiatry; Neuroscience","score_opus":0.0573256548277383,"score_gpt":0.45236094634042867,"score_spread":0.39503529151269035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979687843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8745722,0.094253674,0.0000023489,0.029722575,0.00048754437,0.00031311752,0.000058754526,0.000007002911,0.0005827646],"genre_scores_gemma":[0.8249159,0.16692454,0.00011380917,0.0071950285,0.00060930615,0.00004817242,0.0000026170899,0.000011161565,0.00017947277],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99832267,0.00015756203,0.00082960655,0.00024586928,0.00019535163,0.00024895527],"domain_scores_gemma":[0.9985392,0.00027141467,0.00055085233,0.00008895212,0.00034495266,0.00020460176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022709997,0.0001459846,0.00067205564,0.000109426815,0.00004418928,0.000012533452,0.00008954832,0.00014391383,0.00045065308],"category_scores_gemma":[0.00010702774,0.00013284339,0.00014994925,0.00018371806,0.00011611416,0.00013114527,0.000017101305,0.00045548225,9.814304e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039029627,0.0022502015,0.32279682,0.000027069229,0.0004107147,0.001509456,0.00011158188,0.00018217444,0.0011253799,0.000067973364,0.003959444,0.66365623],"study_design_scores_gemma":[0.00694149,0.0037148937,0.8741591,0.00013761515,0.0006052061,0.0017340796,0.000007766523,0.00011093641,0.00019423365,0.00006274228,0.112241104,0.00009084331],"about_ca_topic_score_codex":0.0019359336,"about_ca_topic_score_gemma":0.0039298045,"teacher_disagreement_score":0.6635654,"about_ca_system_score_codex":0.00010934229,"about_ca_system_score_gemma":0.00048203405,"threshold_uncertainty_score":0.5417196},"labels":[],"label_agreement":null},{"id":"W1979995079","doi":"10.1016/j.jchromb.2008.10.055","title":"Determination of intact oxaliplatin in human plasma using high performance liquid chromatography-tandem mass spectrometry","year":2008,"lang":"en","type":"article","venue":"Journal of Chromatography B","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Chemistry; Chromatography; Tandem mass spectrometry; Liquid chromatography–mass spectrometry; Mass spectrometry; Oxaliplatin; High-performance liquid chromatography; Human plasma","score_opus":0.023687180771527077,"score_gpt":0.30194375656082767,"score_spread":0.2782565757893006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979995079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982872,0.0005024313,0.00016919202,0.00004722904,0.0002543579,0.00019854076,0.0000042075,0.000016125992,0.00052073254],"genre_scores_gemma":[0.9927506,0.00066404534,0.0062763197,0.00003731444,0.00022826552,0.0000032415219,0.0000055997425,0.000024898512,0.000009756202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998174,0.00006704988,0.0008915934,0.00015533925,0.00043780525,0.00027417345],"domain_scores_gemma":[0.99868596,0.000067454355,0.0008021183,0.0001500959,0.00016427886,0.0001301213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026462917,0.00021219146,0.00070576393,0.0018928398,0.000092166876,0.000007014004,0.0001303919,0.00013471137,0.00018153332],"category_scores_gemma":[0.000011446152,0.00018636181,0.00035216776,0.0012076931,0.00017415424,0.0002701045,0.000016817368,0.000335254,8.6402224e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006734679,0.00051881984,0.52760494,0.00015532586,0.00021902937,0.00036627657,0.00035406827,0.000027054195,0.46972832,0.000023892175,0.000084117906,0.00024466906],"study_design_scores_gemma":[0.007551959,0.0054091737,0.62592375,0.00061223685,0.00033603108,0.0029605015,0.00008978422,0.00046932275,0.3562736,0.000078698344,0.00008179774,0.00021311524],"about_ca_topic_score_codex":0.00004269467,"about_ca_topic_score_gemma":0.000008533846,"teacher_disagreement_score":0.11345472,"about_ca_system_score_codex":0.00013469458,"about_ca_system_score_gemma":0.00015125905,"threshold_uncertainty_score":0.75996137},"labels":[],"label_agreement":null},{"id":"W1980561290","doi":"10.1139/v04-061","title":"Taxol interaction with DNA and RNA Stability and structural features","year":2004,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Polynucleotide; Chemistry; DNA; RNA; Nucleic acid; Stereochemistry; Capillary electrophoresis; Base pair; Binding constant; Helix (gastropod); Binding site; In vitro; Nucleotide; Biochemistry; Chromatography","score_opus":0.010150331845352746,"score_gpt":0.2619643774082967,"score_spread":0.25181404556294396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980561290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621254,0.00097202195,0.0000013377417,0.0015733629,0.000068311434,0.000038835446,0.0000072215794,0.0000016461616,0.0011247245],"genre_scores_gemma":[0.99950415,0.000023642175,0.0000669052,0.00012897908,0.00017659423,5.861036e-7,0.0000028685163,0.0000042598062,0.0000920284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997135,0.0000036504757,0.00008340115,0.00006206478,0.000045217494,0.00009216333],"domain_scores_gemma":[0.9994525,0.000010007172,0.00006142716,0.000040416075,0.000057755384,0.00037794522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000028516495,0.000062120904,0.00011770613,0.00002212378,0.00003806776,0.0000143531415,0.000018489445,0.00003800667,0.00023335336],"category_scores_gemma":[0.000013477003,0.00004562222,0.000017413477,0.000027829337,0.00009346249,0.00005533739,0.0000021158694,0.00017351638,1.06619666e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017229436,0.00005055577,0.1945007,0.00052911346,0.0006209561,0.0021846157,0.0041263904,0.000020082727,0.7799799,0.000013882767,0.0024917547,0.013759129],"study_design_scores_gemma":[0.005690502,0.00048789533,0.15254718,0.00020151115,0.0002406825,0.011978192,0.00092308637,0.0000019589095,0.8245386,0.0002365865,0.0030168549,0.00013698258],"about_ca_topic_score_codex":0.0011315622,"about_ca_topic_score_gemma":0.0039961287,"teacher_disagreement_score":0.044558685,"about_ca_system_score_codex":0.00018981991,"about_ca_system_score_gemma":0.0005721907,"threshold_uncertainty_score":0.25550556},"labels":[],"label_agreement":null},{"id":"W1980766188","doi":"10.1158/0008-5472.sabcs-09-6093","title":"First-Line Bevacizumab (Bev) Combination Therapy in Triple-Negative (TN) Locally Recurrent/Metastatic Breast Cancer (LR/MBC): Subpopulation Analysis of Study MO19391 in &amp;gt;2000 Patients (Pts).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Bevacizumab; Taxane; Capecitabine; Population; Oncology; Regimen; Combination therapy; Clinical endpoint; Metastatic breast cancer; Anthracycline; Cancer; Gastroenterology; Breast cancer; Chemotherapy; Randomized controlled trial; Colorectal cancer","score_opus":0.11227216648163586,"score_gpt":0.47499098614583407,"score_spread":0.3627188196641982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980766188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99343675,0.0013787234,0.00001215987,0.0016216945,0.00016029601,0.0030510311,0.00022021351,0.000017406248,0.00010174643],"genre_scores_gemma":[0.9956977,0.0026170237,0.000019840607,0.00009363786,0.000064675754,0.00070510345,0.0003198021,0.000023290233,0.00045893856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99652666,0.00060402986,0.0007424219,0.00056520535,0.0010187286,0.0005429838],"domain_scores_gemma":[0.99818945,0.00026489823,0.00021036394,0.00033354393,0.0008530089,0.00014874812],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086870184,0.00025324922,0.0008122452,0.0019836684,0.00009746225,0.000021441594,0.0001874524,0.00009473456,0.0014514183],"category_scores_gemma":[0.000097073156,0.0002238037,0.00013511426,0.004946858,0.0001186298,0.00018376714,0.000035220586,0.0005180632,0.0000073594415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011515395,0.01047522,0.80678827,0.000073255855,0.00086845807,0.000025281077,0.0068564313,0.002674716,0.00069728,0.000013532094,0.00031626585,0.1596959],"study_design_scores_gemma":[0.025692737,0.0034017107,0.9666016,0.00020257325,0.00039190263,7.147371e-7,0.00020871563,0.0025115001,0.00050693506,0.00018631054,0.00011549342,0.00017982561],"about_ca_topic_score_codex":0.016403617,"about_ca_topic_score_gemma":0.077940956,"teacher_disagreement_score":0.1598133,"about_ca_system_score_codex":0.0025414843,"about_ca_system_score_gemma":0.00055764295,"threshold_uncertainty_score":0.9994614},"labels":[],"label_agreement":null},{"id":"W1981065236","doi":"10.1007/s10549-011-1695-8","title":"Final overall survival results and effect of prolonged (≥1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Institute of Cancer Research","funders":"","keywords":"Bevacizumab; Metastatic breast cancer; Breast cancer; Medicine; Oncology; Internal medicine; Cancer; Surgery; Chemotherapy","score_opus":0.1811653887197427,"score_gpt":0.43949079744762376,"score_spread":0.25832540872788107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981065236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885917,0.0027776998,0.0000010655638,0.0030309286,0.00009415328,0.004064699,0.0012291137,0.0000107450805,0.00019992236],"genre_scores_gemma":[0.9902234,0.005735765,0.000027235801,0.00003407715,0.0002770524,0.003383732,0.0000435566,0.000022436148,0.00025275338],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9982202,0.00030549636,0.00029114023,0.0003978799,0.00031675084,0.00046851864],"domain_scores_gemma":[0.998759,0.0006785983,0.00008763849,0.00020615138,0.00012978626,0.00013887932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009164378,0.00023567025,0.00053571444,0.00015465498,0.00014349901,0.00002027306,0.00008577507,0.00005734033,0.00015250483],"category_scores_gemma":[0.000019101351,0.00012840584,0.00009744597,0.00017825945,0.0002102381,0.000062504914,0.00002911289,0.00016621005,9.57565e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.797305,0.0019038034,0.067257,0.0001509614,0.0009769629,0.000090012276,0.003608569,0.0000023166301,0.00017825,0.00008400473,0.00013884161,0.1283043],"study_design_scores_gemma":[0.43198943,0.04794725,0.51586187,0.000275019,0.0005218111,0.00017944386,0.00024298907,0.00009739399,0.0015187277,0.00028797064,0.00086669414,0.00021137754],"about_ca_topic_score_codex":0.013706965,"about_ca_topic_score_gemma":0.0058794944,"teacher_disagreement_score":0.44860488,"about_ca_system_score_codex":0.0002716253,"about_ca_system_score_gemma":0.00030461,"threshold_uncertainty_score":0.99286085},"labels":[],"label_agreement":null},{"id":"W1981530875","doi":"10.1016/j.jpain.2015.01.307","title":"(388) Tetrodotoxin treatment of mechanical allodynia in rats with oxaliplatin and vincristine-induced neuropathy","year":2015,"lang":"en","type":"article","venue":"Journal of Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Duloxetine; Medicine; Allodynia; Chemotherapy-induced peripheral neuropathy; Oxaliplatin; Peripheral neuropathy; Anesthesia; Vincristine; Neuropathic pain; Dosing; Pregabalin; Chemotherapy; Pharmacology; Hyperalgesia; Internal medicine; Cancer; Nociception; Endocrinology; Cyclophosphamide; Colorectal cancer; Diabetes mellitus","score_opus":0.048251827598589536,"score_gpt":0.326349305834645,"score_spread":0.27809747823605546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981530875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979012,0.0004172717,0.000057254714,0.0011573997,0.00009813885,0.00018560665,0.0000021826952,0.0000041141925,0.00017684237],"genre_scores_gemma":[0.9984005,0.00008450461,0.0010459445,0.00015368697,0.0001807367,0.0000040799014,0.0000016481274,0.000012188308,0.00011669205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998992,0.00023504063,0.0003545911,0.0000991763,0.00019171978,0.00012746725],"domain_scores_gemma":[0.99923784,0.00016602385,0.00022184012,0.00007885936,0.00009995085,0.00019550796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061735156,0.00011628666,0.0004330162,0.00014371515,0.00000991383,0.000004319705,0.000034072873,0.000045866862,0.000030846662],"category_scores_gemma":[0.000110712965,0.00007337284,0.00005243704,0.00012071599,0.000025618045,0.000039633847,0.000008663721,0.000113849834,9.964456e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013135331,0.0036268218,0.26452085,0.00008861902,0.0004635557,0.005599229,0.0024789728,0.000033425476,0.6808493,0.00008018883,0.0024265775,0.026697105],"study_design_scores_gemma":[0.13555945,0.23614885,0.24963728,0.0010789208,0.0025772227,0.0067485827,0.0029319953,0.0040611182,0.34152842,0.0007155757,0.018172283,0.0008403028],"about_ca_topic_score_codex":0.000092464754,"about_ca_topic_score_gemma":0.00011523251,"teacher_disagreement_score":0.3393209,"about_ca_system_score_codex":0.00016230108,"about_ca_system_score_gemma":0.00020745466,"threshold_uncertainty_score":0.29920572},"labels":[],"label_agreement":null},{"id":"W1982189934","doi":"10.1002/mpo.1177","title":"A phase II study of homoharringtonine for the treatment of children with refractory or recurrent acute myelogenous leukemia: A pediatric oncology group study","year":2001,"lang":"en","type":"article","venue":"Medical and Pediatric Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Homoharringtonine; Refractory (planetary science); Toxicity; Internal medicine; Chemotherapy; Leukemia; Oncology","score_opus":0.03549899831607542,"score_gpt":0.3845588882647767,"score_spread":0.3490598899487013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982189934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98793525,0.0058505884,0.000028088929,0.0007361301,0.0004969947,0.0047713257,0.00006123221,0.00003507904,0.000085316526],"genre_scores_gemma":[0.9626988,0.03341348,0.0001056437,0.0001439818,0.002159414,0.0010644819,0.00005113028,0.000030248368,0.00033280184],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9974662,0.00026307366,0.0008035698,0.0005389828,0.000456668,0.0004714896],"domain_scores_gemma":[0.99737465,0.0013139641,0.00047166002,0.0003191173,0.00014465353,0.00037596608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005030408,0.00035546639,0.0013377347,0.00028113974,0.00024017069,0.000003451747,0.00020077519,0.00029324743,0.0004637257],"category_scores_gemma":[0.00007723893,0.00018134963,0.00013225984,0.0005950844,0.00021991777,0.000034156692,0.000090350506,0.0003352375,0.000001709034],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037584566,0.1970711,0.36415422,0.00009266491,0.002777444,0.0013868768,0.010579952,0.0000021598635,0.000025671376,0.000003080782,0.001434514,0.38488775],"study_design_scores_gemma":[0.115539,0.7768758,0.0678089,0.000005892805,0.015700968,0.0009187275,0.0016246714,0.000052177114,0.000009937645,0.000004416109,0.02125488,0.00020466329],"about_ca_topic_score_codex":0.0006357742,"about_ca_topic_score_gemma":0.0019734546,"teacher_disagreement_score":0.57980466,"about_ca_system_score_codex":0.0005059905,"about_ca_system_score_gemma":0.001599877,"threshold_uncertainty_score":0.73952234},"labels":[],"label_agreement":null},{"id":"W1982387456","doi":"10.1002/hlca.201200045","title":"New 6/8/6‐Taxanes Isolated from the Heartwood of <i>Taxus cuspidata</i>","year":2012,"lang":"en","type":"article","venue":"Helvetica Chimica Acta","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Chemistry; Stereochemistry; Organic chemistry; Botany","score_opus":0.023293382999773852,"score_gpt":0.2957230188127763,"score_spread":0.27242963581300245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982387456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96706754,0.0018793097,0.000035942503,0.022150844,0.00071955076,0.0005259556,0.00013033644,0.00008231913,0.007408221],"genre_scores_gemma":[0.99449414,0.00035034062,0.00075120863,0.0022100084,0.0009987328,0.000012257767,0.00011992721,0.000026295962,0.0010370959],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99895203,0.000063660555,0.00025350382,0.00018525915,0.00018405514,0.0003614951],"domain_scores_gemma":[0.99888945,0.000279016,0.0000967393,0.00044109832,0.00003643873,0.000257265],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009386203,0.00017331877,0.0003328541,0.00003318736,0.00006158208,0.000009325985,0.00014911353,0.00010022149,0.0033189738],"category_scores_gemma":[0.00004359654,0.00011157405,0.00013013509,0.00016428792,0.00009695545,0.00008311763,0.00007264899,0.00021662842,0.00015414915],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012073462,0.00090893626,0.04142203,0.00004018831,0.0005799585,0.000006479475,0.0017558397,1.1772449e-7,0.61827904,0.00027917998,0.33240798,0.0031129336],"study_design_scores_gemma":[0.0062000183,0.0009296609,0.12624466,0.00015962821,0.0017712513,0.00015092762,0.00015186968,0.00006192918,0.15248112,0.00023758743,0.71126026,0.00035108972],"about_ca_topic_score_codex":0.00040073073,"about_ca_topic_score_gemma":0.00003183077,"teacher_disagreement_score":0.4657979,"about_ca_system_score_codex":0.000031698724,"about_ca_system_score_gemma":0.00011781507,"threshold_uncertainty_score":0.99759215},"labels":[],"label_agreement":null},{"id":"W1982416489","doi":"10.1016/s0515-3700(12)71358-7","title":"L’éducation thérapeutique d’un patient atteint d’un cancer du poumon","year":2012,"lang":"fr","type":"article","venue":"Actualités Pharmaceutiques","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine","score_opus":0.07119127118383797,"score_gpt":0.40959497890451335,"score_spread":0.3384037077206754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982416489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7294007,0.21437338,0.000064715576,0.03425424,0.014287355,0.0013020679,0.00019372073,0.00023945486,0.0058844034],"genre_scores_gemma":[0.8961711,0.07332973,0.00026283335,0.016878981,0.008841596,0.0006840627,0.00022104365,0.00013800482,0.0034726702],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99521345,0.0009831078,0.0008902846,0.00066300016,0.0005129855,0.0017371542],"domain_scores_gemma":[0.9972264,0.0004888496,0.00043815127,0.0004951722,0.0002917543,0.0010596432],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008731193,0.00080031255,0.00079241366,0.00022467441,0.0003254709,0.000055880137,0.00026240296,0.00049879367,0.028593354],"category_scores_gemma":[0.000053129916,0.0007720305,0.00037657475,0.00042310942,0.00028194024,0.0008156846,0.00017938422,0.0009078258,0.000791477],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082875387,0.0053908373,0.07048323,0.0005205092,0.0022887036,0.00009296362,0.066476606,0.000007751972,0.029888006,0.0023031372,0.05169256,0.7700269],"study_design_scores_gemma":[0.0027923244,0.00047561826,0.014138639,0.00024929497,0.002206837,0.00020352085,0.0013174068,0.00013995577,0.3000896,0.00017174913,0.6775761,0.0006389403],"about_ca_topic_score_codex":0.0020340008,"about_ca_topic_score_gemma":0.00005124587,"teacher_disagreement_score":0.769388,"about_ca_system_score_codex":0.0018256728,"about_ca_system_score_gemma":0.000498593,"threshold_uncertainty_score":0.9999865},"labels":[],"label_agreement":null},{"id":"W1982504188","doi":"10.1002/ejoc.200800587","title":"Taxpropellane: A Novel Taxane with an Unprecedented Polycyclic Skeleton from the Needles of <i>Taxus canadensis</i>","year":2008,"lang":"en","type":"article","venue":"European Journal of Organic Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Taxane; Chemistry; Propellane; Stereochemistry; Ring (chemistry); Cycloaddition; Skeleton (computer programming); Diterpene; Organic chemistry; Bicyclic molecule; Catalysis","score_opus":0.018627405194229764,"score_gpt":0.2317929821072508,"score_spread":0.21316557691302104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982504188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942153,0.00097499765,0.000036358935,0.0011234069,0.00008752595,0.00007929998,0.000021503094,0.000012366335,0.0034492218],"genre_scores_gemma":[0.996476,0.00026272418,0.00029699405,0.0004722592,0.0007820515,3.0990356e-7,0.00002545592,0.00004619521,0.0016380157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890745,0.00006794882,0.0004056562,0.00015213479,0.00028736243,0.00017943731],"domain_scores_gemma":[0.9988166,0.00006218837,0.00050644844,0.0002710239,0.00012300073,0.00022071463],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015172796,0.00017543828,0.00034238596,0.000022034501,0.00006888384,0.000007888792,0.0002492308,0.00003106706,0.0009981857],"category_scores_gemma":[0.00004199223,0.000106911124,0.00008757449,0.00017514074,0.0001684667,0.000040772644,0.000031050968,0.0003514065,0.000008124448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009422135,0.0003375972,0.008559475,0.000020375091,0.0003686526,0.0011998954,0.00085622625,0.000002749255,0.9810586,9.1342606e-8,0.0061655706,0.0004885569],"study_design_scores_gemma":[0.011426919,0.0015432412,0.06128754,0.00031400978,0.0009007496,0.0139202615,0.0013064848,0.0000067267506,0.8870155,0.0000011087866,0.022022646,0.00025477548],"about_ca_topic_score_codex":0.00027615804,"about_ca_topic_score_gemma":0.000063864485,"teacher_disagreement_score":0.09404306,"about_ca_system_score_codex":0.00008506275,"about_ca_system_score_gemma":0.00034930796,"threshold_uncertainty_score":0.99991506},"labels":[],"label_agreement":null},{"id":"W1983346346","doi":"10.1002/jps.21061","title":"Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ethambutol Dihydrochloride**This paper reflects the scientific opinion of the authors and not the policies of regulating agencies.**A project of the International Pharmaceutical Federation FIP, Groupe BCS, http://www.fip.org/bcs.","year":2007,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Bioequivalence; Biopharmaceutics Classification System; Ethambutol; Medicine; Pharmacology; Drug; Dosage form; Active ingredient; Pharmacokinetics; Rifampicin","score_opus":0.11776486107021811,"score_gpt":0.4449384872786766,"score_spread":0.32717362620845847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983346346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789908,0.0011960899,0.00007193778,0.01641126,0.0021290465,0.00087168644,0.00003843478,0.0000064783508,0.00028426372],"genre_scores_gemma":[0.99773633,0.0005020559,0.00020252961,0.0009142543,0.00041667666,0.000012346552,0.0000026999953,0.0000094851885,0.00020362031],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99710697,0.00019420737,0.0008991551,0.00023979033,0.0011601658,0.00039973774],"domain_scores_gemma":[0.9975586,0.00089850434,0.0008264347,0.00017841943,0.0004044229,0.0001336258],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0044059586,0.00019291825,0.00035158053,0.00019146664,0.0007270325,0.000078230165,0.0006272501,0.00009121969,0.00006395667],"category_scores_gemma":[0.0005821076,0.00007857323,0.0003531071,0.0009029933,0.0032309808,0.0003487155,0.00020411945,0.0004797598,4.271473e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034301423,0.0005141377,0.03063287,0.00025699046,0.00050360156,0.0000050535027,0.007576898,0.00014054947,0.9321369,0.006277464,0.0030537501,0.015471672],"study_design_scores_gemma":[0.0046088137,0.0010679979,0.03805992,0.0003973583,0.0008730317,0.0001617335,0.0029709653,0.021769125,0.90593064,0.0007627227,0.02318721,0.00021050991],"about_ca_topic_score_codex":0.00009274649,"about_ca_topic_score_gemma":0.000058892507,"teacher_disagreement_score":0.02620626,"about_ca_system_score_codex":0.000117377436,"about_ca_system_score_gemma":0.00047803432,"threshold_uncertainty_score":0.9994817},"labels":[],"label_agreement":null},{"id":"W1983562303","doi":"10.3747/co.22.2360","title":"Systemic Treatment Approaches in her2-Negative Advanced Breast Cancer—Guidance on the Guidelines","year":2015,"lang":"en","type":"review","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Context (archaeology); Metastatic breast cancer; Disease; Cancer; Oncology; Intensive care medicine; Endocrine system; Targeted therapy; Human Epidermal Growth Factor Receptor 2; Systemic therapy; Internal medicine; Hormone","score_opus":0.586920207741529,"score_gpt":0.5595977810184571,"score_spread":0.027322426723071835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983562303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022907217,0.9875899,0.000001380561,0.002431029,0.002821821,0.004346006,0.00042767104,0.00005921227,0.0020938932],"genre_scores_gemma":[0.00022790476,0.98959464,0.000041967316,0.00014833115,0.001515046,0.007146706,0.00020748808,0.00007217526,0.001045715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965408,0.00075808354,0.0010843411,0.00080877246,0.00026246437,0.00054553186],"domain_scores_gemma":[0.99775714,0.0005559184,0.00069879025,0.0005330746,0.00024724743,0.0002078291],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046350108,0.00078974996,0.003255911,0.0002627812,0.00007092084,0.0000111525305,0.00029364062,0.0003980109,0.00020709092],"category_scores_gemma":[0.000088262976,0.000426692,0.0004914776,0.0004968914,0.00020693192,0.000036572663,0.0000784086,0.0006634835,0.00014555929],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035171615,0.0014622491,0.00017344665,0.0038600469,0.0004566075,0.000071332266,0.00031551888,0.000013813371,2.678876e-7,0.00011115178,0.012995907,0.98018795],"study_design_scores_gemma":[0.003430571,0.0014736739,0.00004291679,0.01619016,0.002053092,0.00048059117,0.00016011434,0.000036397505,0.0000014937273,0.000029607487,0.97578305,0.00031833624],"about_ca_topic_score_codex":0.00020740632,"about_ca_topic_score_gemma":0.00044263553,"teacher_disagreement_score":0.9798696,"about_ca_system_score_codex":0.0070218015,"about_ca_system_score_gemma":0.0032607308,"threshold_uncertainty_score":0.9998185},"labels":[],"label_agreement":null},{"id":"W1984083792","doi":"10.1007/s11864-012-0181-9","title":"Patients With Metastatic Breast Cancer Using Bevacizumab as a Treatment: Is There Still a Role for it?","year":2012,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bevacizumab; Medicine; Metastatic breast cancer; Oncology; Breast cancer; Clinical trial; Angiogenesis; Internal medicine; Cancer; Vascular endothelial growth factor; Biomarker; Chemotherapy; Colorectal cancer; Paclitaxel; Metastasis; VEGF receptors","score_opus":0.19670101289944478,"score_gpt":0.50025470231862,"score_spread":0.30355368941917527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984083792","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004587392,0.98080677,0.000010242895,0.00024386277,0.0010560133,0.0084339185,0.004527694,0.00005624425,0.00027788547],"genre_scores_gemma":[0.0008587619,0.982291,0.00070354267,0.00005978234,0.0004910349,0.011937161,0.0025716245,0.00014746453,0.0009396707],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99685353,0.00027900448,0.00085232523,0.00090086146,0.0002182663,0.0008960351],"domain_scores_gemma":[0.997975,0.00038094536,0.0005965356,0.0005162945,0.0001911356,0.00034006924],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008659296,0.0011019101,0.0031741536,0.00062697666,0.00016300223,0.000023654005,0.00014659739,0.0003490504,0.0015606369],"category_scores_gemma":[0.0000062081895,0.00069518306,0.0007917248,0.00052125374,0.00016399809,0.0001335735,0.000045228175,0.00027170888,0.00010601232],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000891552,0.018293114,0.002624936,0.0021875412,0.0038437962,0.000034879155,0.0008692608,0.000008087879,2.1512665e-7,0.000045834448,0.00015467759,0.9710461],"study_design_scores_gemma":[0.018270962,0.00695263,0.00027479816,0.0034435797,0.03482242,0.00026091674,0.00007985187,0.000038735343,0.0000010155042,0.000021043568,0.9353353,0.0004987703],"about_ca_topic_score_codex":0.00055997085,"about_ca_topic_score_gemma":0.0005863611,"teacher_disagreement_score":0.9705473,"about_ca_system_score_codex":0.0119738905,"about_ca_system_score_gemma":0.002975421,"threshold_uncertainty_score":0.9995499},"labels":[],"label_agreement":null},{"id":"W1984199328","doi":"10.1016/j.breast.2013.07.011","title":"Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis","year":2013,"lang":"en","type":"review","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Sunitinib; Bevacizumab; Breast cancer; Metastatic breast cancer; Oncology; Cancer; Internal medicine; Context (archaeology); Clinical trial; Paclitaxel; Chemotherapy","score_opus":0.3010749332658669,"score_gpt":0.5013807287201687,"score_spread":0.20030579545430183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984199328","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036794826,0.95761305,0.00004682616,0.00020334203,0.0004695211,0.0021201975,0.002631442,0.00003220296,0.000088579014],"genre_scores_gemma":[0.0079609165,0.9882538,0.00041875066,0.000030439362,0.00044851072,0.00008506575,0.0001318422,0.0000757386,0.0025949478],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966247,0.0006745594,0.0016546487,0.00041511533,0.00032861085,0.0003023703],"domain_scores_gemma":[0.9968813,0.0008284319,0.0013378459,0.0005636775,0.00024248709,0.00014628077],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076556497,0.00041000466,0.0026860607,0.00015041705,0.000053849795,0.000011974764,0.00027094508,0.0002717045,0.0015663909],"category_scores_gemma":[0.000019359963,0.00022180722,0.0010924233,0.0003645639,0.00039797398,0.00011054965,0.00011883637,0.00042518857,0.000022802813],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014109447,0.0006566294,0.0007218031,0.007143279,0.0044552507,0.000015645897,0.00031604012,0.0001755754,0.0000189055,0.00005117934,0.00063202844,0.9844027],"study_design_scores_gemma":[0.040318858,0.0049101673,0.051415596,0.13895853,0.31009266,0.006287142,0.00033369902,0.022957874,0.00014293991,0.0006033555,0.4187688,0.005210386],"about_ca_topic_score_codex":0.0018422782,"about_ca_topic_score_gemma":0.00007271245,"teacher_disagreement_score":0.9791923,"about_ca_system_score_codex":0.000099188735,"about_ca_system_score_gemma":0.0009480436,"threshold_uncertainty_score":0.9993463},"labels":[],"label_agreement":null},{"id":"W1985698558","doi":"10.1023/a:1026394718897","title":"Consensus on Medical Treatment of Metastatic Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Medicine; Metastatic breast cancer; Oncology; Cancer; Internal medicine","score_opus":0.11568431217018388,"score_gpt":0.4625313005886781,"score_spread":0.3468469884184942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985698558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96849304,0.009213438,9.60616e-7,0.0156184,0.00021166634,0.001437228,0.0013799928,0.000037570913,0.003607698],"genre_scores_gemma":[0.97503895,0.019273575,0.00005526936,0.00014631252,0.00021643909,0.0012239661,0.00003290848,0.000038197162,0.003974411],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973527,0.00025705644,0.00033148486,0.0005491773,0.0008141072,0.00069545256],"domain_scores_gemma":[0.99821126,0.00034885106,0.00007637966,0.000321063,0.00027232987,0.00077009934],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021249,0.00034551593,0.00070256455,0.0002769416,0.00017317865,0.000017263095,0.000061400955,0.000097562996,0.0057774703],"category_scores_gemma":[0.000014786361,0.0002210221,0.00015387767,0.00036308364,0.00051037496,0.000026590433,0.000017860193,0.00014518881,0.000034421842],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022525072,0.028571071,0.25612673,0.00031904166,0.008051134,0.0030430479,0.0013094313,0.000020734245,0.002656243,0.0037114997,0.0060900813,0.6675759],"study_design_scores_gemma":[0.13912591,0.055115305,0.58578056,0.0016476653,0.0040229564,0.012409051,0.0013351138,0.00023737097,0.058006607,0.0010807116,0.13989587,0.0013428766],"about_ca_topic_score_codex":0.010181015,"about_ca_topic_score_gemma":0.0018006378,"teacher_disagreement_score":0.66623306,"about_ca_system_score_codex":0.0014997593,"about_ca_system_score_gemma":0.0017339841,"threshold_uncertainty_score":0.99641025},"labels":[],"label_agreement":null},{"id":"W1985716194","doi":"10.5737/1181912x153161167","title":"Peripheral nerve function and symptom distress during biotherapy for malignant melanoma","year":2005,"lang":"en","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Oncology Nursing Society Foundation; Oncology Nursing Society","keywords":"Medicine; Sensation; Distress; Peripheral neuropathy; Peripheral; Orthostatic vital signs; Physical medicine and rehabilitation; Melanoma; Balance (ability); Cancer; Physical therapy; Internal medicine; Blood pressure; Diabetes mellitus; Endocrinology","score_opus":0.01633641665314523,"score_gpt":0.321700685123009,"score_spread":0.30536426846986375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985716194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96681404,0.0052407216,0.00021379841,0.024811633,0.0011953006,0.00028324637,0.00003789527,0.000017062153,0.0013863023],"genre_scores_gemma":[0.9943339,0.00027532593,0.0006456188,0.0012257828,0.0020698449,0.000018415714,0.00002608419,0.000024147055,0.0013808814],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99913085,0.000051565057,0.00018622362,0.00016533851,0.00005611622,0.00040988193],"domain_scores_gemma":[0.9991526,0.000037183487,0.00007905492,0.000065658685,0.00006231233,0.0006031865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011645317,0.0001271473,0.00024156267,0.000188678,0.000429801,0.00003160163,0.000040614286,0.00014719728,0.00042526322],"category_scores_gemma":[0.0000076556835,0.00011391147,0.000077572004,0.00005923339,0.00013142091,0.00007880429,0.0000021255405,0.00023967569,0.0000029169637],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005505696,0.00067225803,0.09577991,0.00007441916,0.0009443442,0.00091245415,0.0039469614,0.000054766024,0.047750834,0.000790408,0.055392846,0.7881751],"study_design_scores_gemma":[0.03165249,0.008128995,0.49515888,0.0007786293,0.0012878416,0.019542381,0.0010813887,0.0011420208,0.0024650549,0.00084911607,0.4373395,0.0005736866],"about_ca_topic_score_codex":0.00049541827,"about_ca_topic_score_gemma":0.008719497,"teacher_disagreement_score":0.7876014,"about_ca_system_score_codex":0.0035107802,"about_ca_system_score_gemma":0.0009202455,"threshold_uncertainty_score":0.9180568},"labels":[],"label_agreement":null},{"id":"W1985725341","doi":"10.1016/j.jpainsymman.2006.10.003","title":"Pain Management for Older Adults","year":2006,"lang":"en","type":"article","venue":"Journal of Pain and Symptom Management","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital; University of Regina; Canadian Institutes of Health Research","funders":"","keywords":"Medicine; Psychosocial; Tramadol; Pain management; Population; Coping (psychology); Intensive care medicine; Physical therapy; Psychiatry; Analgesic","score_opus":0.00677315910624999,"score_gpt":0.27291507036656826,"score_spread":0.2661419112603183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985725341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7976649,0.01106174,0.08570935,0.022773707,0.0019578796,0.0065690293,0.00001712731,0.000114426606,0.07413185],"genre_scores_gemma":[0.97430205,0.0008255161,0.0068329624,0.003103428,0.00062637735,0.00006842313,0.000016315262,0.00002278658,0.014202122],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99904394,0.00008300653,0.00035064714,0.00013778184,0.00018941217,0.00019518615],"domain_scores_gemma":[0.9995041,0.0000998565,0.00015989898,0.000092386,0.000060363112,0.00008338696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013773789,0.0001258691,0.00024804068,0.00019420651,0.000053607815,0.00001981943,0.000057825207,0.00003370352,0.00010703963],"category_scores_gemma":[0.0000058517057,0.00009658338,0.00013860545,0.000080715836,0.000023363851,0.000041286,0.000025758749,0.00006300489,0.0000023944337],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018330752,0.0014750239,0.022199087,0.0021431781,0.0016044687,0.00078577263,0.00036251167,0.000027903045,0.000065821994,0.005069197,0.39944828,0.5649857],"study_design_scores_gemma":[0.027868535,0.003272894,0.24690005,0.0011226459,0.0018392903,0.000086684144,0.0016798519,0.0015328261,0.000095973664,0.002057503,0.7132171,0.00032664585],"about_ca_topic_score_codex":0.000007695644,"about_ca_topic_score_gemma":0.000004729213,"teacher_disagreement_score":0.56465906,"about_ca_system_score_codex":0.00008502083,"about_ca_system_score_gemma":0.000008127506,"threshold_uncertainty_score":0.3938556},"labels":[],"label_agreement":null},{"id":"W1985754465","doi":"10.1016/j.jpain.2005.01.088","title":"Role of calcium in chemotherapy-evoked neuropathic pain","year":2005,"lang":"en","type":"article","venue":"Journal of Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Neuropathic pain; Anesthesia; Allodynia; Hyperalgesia; Gabapentin; Pharmacology; Chemotherapy; Calcium; Peripheral neuropathy; Nociception; Surgery; Internal medicine; Endocrinology; Pathology","score_opus":0.016782924438574286,"score_gpt":0.31247128030664323,"score_spread":0.29568835586806896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985754465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884491,0.0022633122,0.00031906334,0.007970019,0.000083396204,0.00011760884,0.0000011521647,0.000005161415,0.0007911689],"genre_scores_gemma":[0.9960714,0.00017578824,0.00037953752,0.002473446,0.00047960007,0.0000014383575,6.849186e-7,0.000010720791,0.00040739955],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884063,0.00050086627,0.000340264,0.00005670972,0.00014148283,0.000120050034],"domain_scores_gemma":[0.99935186,0.0002559874,0.00019407418,0.00006517867,0.0000592304,0.000073646486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003118019,0.000071262344,0.00027541022,0.00015057593,0.000008331868,0.0000021659796,0.000054194174,0.000047376678,0.0003186545],"category_scores_gemma":[0.0001661251,0.0000553587,0.000105333216,0.000121950216,0.000025121126,0.00003774236,0.0000051539714,0.00021180527,0.0000033267804],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015317325,0.0012520668,0.12969393,0.00006647571,0.00012868109,0.00020579307,0.001819079,0.00009662948,0.55192125,0.000023211489,0.008747877,0.30451328],"study_design_scores_gemma":[0.033831984,0.010536659,0.31538808,0.0008225387,0.00045918606,0.00067960675,0.0012141817,0.016984807,0.17784174,0.0009556253,0.44084316,0.0004424399],"about_ca_topic_score_codex":0.000021527045,"about_ca_topic_score_gemma":0.000027947795,"teacher_disagreement_score":0.4320953,"about_ca_system_score_codex":0.0000998293,"about_ca_system_score_gemma":0.00011732497,"threshold_uncertainty_score":0.34890434},"labels":[],"label_agreement":null},{"id":"W1986337659","doi":"10.1200/jco.2013.52.0288","title":"Wither the Cooperative Groups?","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.17177293971052338,"score_gpt":0.5331492846017156,"score_spread":0.36137634489119225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986337659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90580964,0.0005914827,0.000041400257,0.06720249,0.0016114189,0.0002631585,5.1343534e-7,0.0000051237207,0.024474777],"genre_scores_gemma":[0.9765913,0.00045169852,0.00046368624,0.016317414,0.0022459312,0.0000101747855,5.478646e-7,0.0000082387205,0.003911042],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983482,0.0003301164,0.0009696867,0.00007894726,0.00014186914,0.00013117469],"domain_scores_gemma":[0.9970006,0.0016824834,0.000631405,0.00009680073,0.00039679086,0.00019195971],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010688124,0.000076120086,0.00070742203,0.0000316711,0.000036774978,0.000006607734,0.00010409932,0.00016157777,0.0038408462],"category_scores_gemma":[0.00056581217,0.000034097837,0.00026429835,0.00007599565,0.00024824063,0.000076838514,0.000023133274,0.00068527757,0.00023021322],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004675586,0.004882295,0.10566771,0.000011697645,0.0019941735,0.00055061124,0.000711301,0.000012877067,0.0012557061,0.0008389414,0.5760085,0.30339062],"study_design_scores_gemma":[0.011270978,0.026094807,0.3797876,0.000023531387,0.00062045903,0.00071436237,0.00029974058,0.000065884946,0.00014392397,0.0007979138,0.5801129,0.000067928006],"about_ca_topic_score_codex":0.000030900836,"about_ca_topic_score_gemma":0.000024001318,"teacher_disagreement_score":0.30332267,"about_ca_system_score_codex":0.00006866681,"about_ca_system_score_gemma":0.000735323,"threshold_uncertainty_score":0.9970698},"labels":[],"label_agreement":null},{"id":"W1986388359","doi":"10.1517/14656560802653206","title":"Economic evaluation of docetaxel for breast cancer","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Docetaxel; Medicine; Taxane; Breast cancer; Oncology; Cancer; Internal medicine; Prostate cancer; Adjuvant; Chemotherapy; Intensive care medicine","score_opus":0.19665257186682186,"score_gpt":0.5538454632338995,"score_spread":0.35719289136707766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986388359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012223531,0.9909661,0.0000060586294,0.000918776,0.0026403118,0.0037645868,0.00095770624,0.00004286858,0.00069139246],"genre_scores_gemma":[0.000019708259,0.9923222,0.00007221224,0.0012731607,0.0032677401,0.0021906272,0.00042021766,0.00008662255,0.000347528],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981794,0.00016831922,0.00061223295,0.0004827689,0.00029420928,0.0002630821],"domain_scores_gemma":[0.9988636,0.00012563689,0.0004726454,0.00026429814,0.00014589654,0.00012794352],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035723628,0.0004545671,0.0015696443,0.00027381742,0.000049802624,0.000009266142,0.00014618767,0.00021666352,0.0057037226],"category_scores_gemma":[0.0000026848593,0.00035255813,0.00075329375,0.000105477506,0.0000417688,0.000052401603,0.000006837262,0.00017358774,0.000033854743],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063764775,0.0004518605,0.0000015436547,0.0010204338,0.0008792935,4.5304165e-7,0.00007307777,0.000007488756,0.0000866467,0.000043292785,0.06621949,0.93057877],"study_design_scores_gemma":[0.008374915,0.00052129664,0.0000095402365,0.0034879711,0.0006478212,0.00003478441,0.0000031143531,0.00017254715,0.0003786761,0.000022486027,0.9860704,0.00027646963],"about_ca_topic_score_codex":0.000053840573,"about_ca_topic_score_gemma":0.0000025745755,"teacher_disagreement_score":0.9303023,"about_ca_system_score_codex":0.00096282485,"about_ca_system_score_gemma":0.0011838544,"threshold_uncertainty_score":0.99989265},"labels":[],"label_agreement":null},{"id":"W1986429657","doi":"10.1158/0008-5472.sabcs10-p5-10-09","title":"Abstract P5-10-09: Comparison of the (Non-)Hematological Toxicity and Compliance of Different Anthracycline Containing Regimen with the Standard AC/EC in Elderly Patients with Primary Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epirubicin; Anthracycline; Medicine; Docetaxel; Regimen; Taxane; Cyclophosphamide; Doxorubicin; Internal medicine; Breast cancer; Chemotherapy; Paclitaxel; Gastroenterology; Pharmacology; Cancer","score_opus":0.07047424158493303,"score_gpt":0.43264467587703886,"score_spread":0.3621704342921058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986429657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942609,0.0004415261,0.0000027229487,0.003561059,0.00005957155,0.0010939117,0.000147297,0.0000066051016,0.00042642106],"genre_scores_gemma":[0.9994046,0.00012100591,0.000023560655,0.00006708417,0.000056165703,0.00018449922,0.000010388774,0.000016186274,0.00011651912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983375,0.0000969597,0.0002841921,0.00028835153,0.00063539075,0.0003575846],"domain_scores_gemma":[0.9986492,0.00033404565,0.00019386863,0.00030794303,0.00041130476,0.0001036292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031215223,0.00016502329,0.000580464,0.00006590213,0.00013009366,0.000012584357,0.00021513193,0.00008448626,0.00043798986],"category_scores_gemma":[0.00001772508,0.00007388957,0.000036968075,0.00027864048,0.0010696074,0.000052438634,0.0001066366,0.0008340934,4.301005e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011964525,0.0008056983,0.95418483,0.00030525576,0.00013239603,0.000007080852,0.0008078752,0.000008516852,0.022612186,0.000024291227,0.00095173495,0.008195605],"study_design_scores_gemma":[0.006843692,0.0015054002,0.9685569,0.0006067599,0.00005861585,0.000006101201,0.000289391,0.000028744813,0.021714298,0.0000128992915,0.00029009258,0.00008710066],"about_ca_topic_score_codex":0.0009469172,"about_ca_topic_score_gemma":0.0055015855,"teacher_disagreement_score":0.01437207,"about_ca_system_score_codex":0.00019228586,"about_ca_system_score_gemma":0.00045461705,"threshold_uncertainty_score":0.47956818},"labels":[],"label_agreement":null},{"id":"W1986533778","doi":"10.1007/s10600-012-0102-y","title":"A new taxane from Taxus canadensis needles","year":2012,"lang":"en","type":"article","venue":"Chemistry of Natural Compounds","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Hebei Medical University; Hebei University","keywords":"Taxane; Chemistry; Stereochemistry; Taxus; Botany; Biology","score_opus":0.017324371127557137,"score_gpt":0.28728905463954707,"score_spread":0.26996468351198993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986533778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97724986,0.010441662,0.0000021455794,0.00091840135,0.00043197663,0.000071063296,0.000027541078,0.00003227183,0.010825063],"genre_scores_gemma":[0.98761547,0.000038805978,0.000732836,0.00022936575,0.001096444,0.0000029376408,0.00020221378,0.00001104536,0.010070911],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993446,0.000006259331,0.00014971102,0.00012426105,0.00014478002,0.000230403],"domain_scores_gemma":[0.9994074,0.000062759114,0.00008117541,0.00016076534,0.0000457444,0.00024217353],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000024702347,0.00013240773,0.0002769238,0.000018346072,0.000028910752,0.0000045305933,0.00007729146,0.000089829846,0.0014317282],"category_scores_gemma":[0.000017983399,0.00011450097,0.000096824726,0.000100225676,0.00005418761,0.000046055597,0.000030181913,0.00019271832,0.000011041167],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024439502,0.000097716416,0.018590303,0.000057826313,0.00021121862,0.00001434947,0.00024401427,1.7963625e-7,0.8726346,0.0000026175207,0.10518001,0.0027227951],"study_design_scores_gemma":[0.002640049,0.000050951803,0.028442645,0.000055630237,0.0003700792,0.00012256094,0.00017493487,0.000013556502,0.90624785,0.000035372195,0.06167329,0.00017307543],"about_ca_topic_score_codex":0.0034234568,"about_ca_topic_score_gemma":0.000038629933,"teacher_disagreement_score":0.04350672,"about_ca_system_score_codex":0.0001319385,"about_ca_system_score_gemma":0.00012958863,"threshold_uncertainty_score":0.9994811},"labels":[],"label_agreement":null},{"id":"W1987122320","doi":"10.1158/0008-5472.sabcs-4118","title":"Primary analysis of study MO19391, an open-label safety study of bevacizumab (B) plus taxane-based therapy as 1st-line treatment of patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Taxane; Bevacizumab; Internal medicine; Population; Regimen; Clinical endpoint; Metastatic breast cancer; Phases of clinical research; Gastroenterology; Surgery; Oncology; Chemotherapy; Cancer; Breast cancer; Clinical trial","score_opus":0.1958622123719409,"score_gpt":0.5105737341160985,"score_spread":0.3147115217441576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987122320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988962,0.0015143579,0.000009852307,0.00046335798,0.00006471138,0.00792694,0.0009476682,0.000015573401,0.000095538446],"genre_scores_gemma":[0.99591124,0.001823245,0.00009147996,0.000118605145,0.000054467462,0.0012592775,0.0002767203,0.000041263705,0.0004236864],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9954569,0.0007976563,0.0009036894,0.00076293555,0.0015411987,0.00053765974],"domain_scores_gemma":[0.99645734,0.00023150959,0.00046046978,0.0008621329,0.00168141,0.00030711156],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00064738386,0.0003921098,0.0018163892,0.0008531954,0.00013224859,0.000020619762,0.0004689244,0.00006201364,0.0015588471],"category_scores_gemma":[0.000017333203,0.00024470984,0.00010647528,0.0027847968,0.00026259682,0.00013817832,0.00007576624,0.00023602492,0.0000013291622],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2982393,0.1953661,0.15344377,0.00021742676,0.016418539,0.00018043509,0.008258299,0.002901595,0.0042031975,0.0000040804257,0.00017821352,0.32058907],"study_design_scores_gemma":[0.19954127,0.32476282,0.4559399,0.00024848472,0.008724748,0.0000035890764,0.0031569104,0.00093318213,0.0060454393,0.000005921283,0.00026021857,0.00037752202],"about_ca_topic_score_codex":0.021476226,"about_ca_topic_score_gemma":0.015802266,"teacher_disagreement_score":0.32021153,"about_ca_system_score_codex":0.0021805156,"about_ca_system_score_gemma":0.0032701246,"threshold_uncertainty_score":0.9993539},"labels":[],"label_agreement":null},{"id":"W1987130488","doi":"10.1002/cbdv.201000017","title":"A New Taxane with an Opened Oxetane Ring from the Needles of <i>Taxus cuspidata</i>","year":2010,"lang":"en","type":"article","venue":"Chemistry & Biodiversity","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Chemistry; Oxetane; Taxane; Taxoid; Stereochemistry; Two-dimensional nuclear magnetic resonance spectroscopy; Organic chemistry; Paclitaxel","score_opus":0.015133089308162798,"score_gpt":0.2463394895889128,"score_spread":0.23120640028075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987130488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962806,0.00012218404,0.000008388585,0.0008772753,0.000082387945,0.00012725646,0.0002680177,0.000028311197,0.0022055567],"genre_scores_gemma":[0.99740666,0.000029202329,0.0011455453,0.00030813302,0.00023568666,0.0000014954421,0.00030680202,0.0000039850966,0.0005624957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994429,0.0000069288008,0.00008179891,0.00021009249,0.00012419157,0.00013409412],"domain_scores_gemma":[0.9993267,0.00003533237,0.00008223653,0.0003415041,0.000048747865,0.00016546178],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000043336222,0.000117280586,0.00019296262,0.000007376789,0.00008844183,0.000010668751,0.00020480304,0.00007805909,0.0019861832],"category_scores_gemma":[0.000010644032,0.00007863568,0.00004882491,0.00008488112,0.00014196162,0.0000687685,0.000087921166,0.0002101289,0.000020029789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010014963,0.0001470415,0.20981006,0.00002387602,0.00013963222,0.00005543479,0.00028359293,4.2520264e-7,0.7803039,6.476122e-7,0.00678883,0.0014450824],"study_design_scores_gemma":[0.004007746,0.00016792506,0.03489211,0.000022239057,0.00059784256,0.000040324037,0.0004437779,0.0000058360774,0.9466762,0.000011155864,0.013007446,0.00012738073],"about_ca_topic_score_codex":0.0033085744,"about_ca_topic_score_gemma":0.00022303859,"teacher_disagreement_score":0.17491795,"about_ca_system_score_codex":0.000023307526,"about_ca_system_score_gemma":0.00013033958,"threshold_uncertainty_score":0.99892616},"labels":[],"label_agreement":null},{"id":"W1987278392","doi":"10.1021/bm800571s","title":"Effect of Extracellular Matrix Elements on the Transport of Paclitaxel through an Arterial Wall Tissue Mimic","year":2008,"lang":"en","type":"article","venue":"Biomacromolecules","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Paclitaxel; Extracellular matrix; Arterial wall; Chemistry; Extracellular; Matrix (chemical analysis); Biophysics; Biochemistry; Biology; Medicine; Chromatography; Cardiology; Genetics; Chemotherapy","score_opus":0.024093944434701718,"score_gpt":0.34005538757409676,"score_spread":0.31596144313939506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987278392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717546,0.0010504709,0.000034478384,0.00030443838,0.00015982868,0.00065421575,0.00007368296,0.000021870843,0.0005255341],"genre_scores_gemma":[0.99892217,0.0001826347,0.00022970432,0.00005803826,0.0000924563,0.000034466255,0.0001047122,0.00002094558,0.0003549019],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895227,0.00012855319,0.00031852836,0.0002003632,0.00021214329,0.00018813598],"domain_scores_gemma":[0.9994376,0.00007845523,0.00012997129,0.00026688076,0.000032513846,0.000054594733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015159132,0.00017246694,0.00035529656,0.000045507397,0.000051593277,0.0000015355789,0.00010524813,0.00007679392,0.0004599564],"category_scores_gemma":[0.0000073732817,0.000109371504,0.00012688006,0.000106603635,0.00018715182,0.000036207417,0.000008029721,0.000058251404,0.000016586244],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022279096,0.0006132435,0.003349791,0.00013099573,0.0001971257,0.0002562812,0.0006270005,4.7930547e-7,0.9909236,0.00025232887,0.00047687578,0.0009443952],"study_design_scores_gemma":[0.0037441328,0.0065712146,0.0063388837,0.00004979834,0.0003124151,0.000074320116,0.000015545771,0.000008411888,0.97792,0.000028919741,0.004843293,0.00009305497],"about_ca_topic_score_codex":0.00018461615,"about_ca_topic_score_gemma":0.000010255667,"teacher_disagreement_score":0.0130035635,"about_ca_system_score_codex":0.000026665863,"about_ca_system_score_gemma":0.000044734796,"threshold_uncertainty_score":0.50362},"labels":[],"label_agreement":null},{"id":"W1987689517","doi":"10.1515/znc-2003-7-827","title":"Hydrogen Peroxide from the Oxidative Burst is Not Involved in the Induction of Taxol Biosynthesis in Taxus chinensis Cells","year":2003,"lang":"en","type":"article","venue":"Zeitschrift für Naturforschung C","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Cancer Institute","keywords":"Elicitor; Hydrogen peroxide; Catalase; Taxus; Superoxide dismutase; Chemistry; Biochemistry; Biosynthesis; Respiratory burst; Aspergillus niger; Oxidative stress; Biology; Enzyme; Botany","score_opus":0.023011013833779594,"score_gpt":0.29680672563203603,"score_spread":0.27379571179825646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987689517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903414,0.00223338,0.0000032511578,0.003974931,0.00031401005,0.00096088974,0.00009715059,0.000020821908,0.0020541192],"genre_scores_gemma":[0.99638194,0.000423123,0.00028426564,0.0024407206,0.00016010279,0.00007813548,0.000046737787,0.000029294744,0.00015567706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797064,0.0004036511,0.0004961263,0.00039953177,0.00037335712,0.00035666628],"domain_scores_gemma":[0.9984314,0.0007449802,0.0002236902,0.00046184578,0.000072523086,0.00006557216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006255277,0.00028232633,0.00050264376,0.00020434406,0.00009228591,0.000015364421,0.00025197177,0.00026580744,0.00039729284],"category_scores_gemma":[0.00024274622,0.00016760822,0.0001722027,0.0008905953,0.00014992445,0.000121069694,0.00003680619,0.0007542785,0.000034470966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012437991,0.0013815031,0.13066502,0.000066137174,0.0006012318,0.00008669716,0.014716243,0.000060303635,0.84003866,0.00091794424,0.0061019827,0.004120509],"study_design_scores_gemma":[0.0029165584,0.00022091126,0.062153958,0.00011127887,0.0002913754,0.000009243165,0.0021082375,0.00008052315,0.90478224,0.000071319046,0.027062608,0.00019173276],"about_ca_topic_score_codex":0.0026625856,"about_ca_topic_score_gemma":0.0012565065,"teacher_disagreement_score":0.068511054,"about_ca_system_score_codex":0.000045584806,"about_ca_system_score_gemma":0.0001500947,"threshold_uncertainty_score":0.68348646},"labels":[],"label_agreement":null},{"id":"W1988917398","doi":"10.2174/1568006033481375","title":"Selective Protein Kinase C Inhibitors and Their Applications","year":2003,"lang":"en","type":"review","venue":"Current Drug Targets - Cardiovascular & Hematological Disorders","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Protein kinase C; Gene isoform; Medicine; Clinical trial; Kinase; Pharmacology; Cancer research; Internal medicine; Cell biology; Biology; Biochemistry","score_opus":0.03009395729194943,"score_gpt":0.32358456588424717,"score_spread":0.29349060859229775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988917398","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046280107,0.98925215,0.0005447852,0.00007169295,0.00035524118,0.008130683,0.000086725864,0.00017960113,0.0013328438],"genre_scores_gemma":[0.0005239198,0.9911558,0.00011170148,0.000032981334,0.00021225569,0.0072275572,0.0005340068,0.000090381305,0.00011139895],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963562,0.0005990493,0.0007301164,0.0012883452,0.00035315639,0.00067312375],"domain_scores_gemma":[0.99839747,0.0001436148,0.00024535618,0.0007117226,0.00010429595,0.0003975163],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036256734,0.0009968791,0.003942366,0.00025289424,0.00024957914,0.000033200915,0.00019566526,0.0004424276,0.00009332663],"category_scores_gemma":[0.00006163726,0.00066469406,0.0034425955,0.00068966334,0.00037541802,0.000061930245,0.00013732344,0.0010362611,0.000082059174],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019449735,0.0008451263,0.00003876966,0.016805919,0.0037674047,0.000023282148,0.000074834694,7.1189856e-7,5.916539e-7,0.0003628193,0.0026097766,0.9754513],"study_design_scores_gemma":[0.0012471706,0.00008981743,0.0000056409735,0.0021728047,0.0044423216,0.00016104855,0.000045020413,0.0000020635462,0.00001359534,0.0006549849,0.9905361,0.0006294321],"about_ca_topic_score_codex":0.000011709104,"about_ca_topic_score_gemma":0.000004729765,"teacher_disagreement_score":0.9879263,"about_ca_system_score_codex":0.00024368826,"about_ca_system_score_gemma":0.00032643438,"threshold_uncertainty_score":0.99958044},"labels":[],"label_agreement":null},{"id":"W1990195000","doi":"10.1007/s10549-011-1756-z","title":"Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5′-DFUR, the bioactive metabolite of Xeloda®","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; Royal Victoria Regional Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Gefitinib; Metabolite; Breast cancer; Phosphorylation; Cancer research; Pharmacology; Chemistry; Medicine; Internal medicine; Cancer; Epidermal growth factor receptor; Biochemistry","score_opus":0.11291987091672188,"score_gpt":0.3855439548003682,"score_spread":0.2726240838836463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990195000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955231,0.0018529326,0.0000027226927,0.00036366459,0.000027479713,0.0007184317,0.0011274761,0.000005387264,0.0003788388],"genre_scores_gemma":[0.99716634,0.0022208295,0.000019745703,0.000006214491,0.000048349266,0.00032779734,0.000044399138,0.00001409429,0.0001522179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895906,0.00009576925,0.00027538507,0.0002335828,0.00021188386,0.00022434116],"domain_scores_gemma":[0.9991568,0.00016610147,0.00016394402,0.00013590913,0.0002751809,0.00010207406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001352335,0.00015079741,0.00039633524,0.00022695938,0.000078177036,0.0000052518662,0.00003394635,0.00004698251,0.00025444652],"category_scores_gemma":[0.000002324369,0.00009100675,0.00004287441,0.0003167166,0.00052150805,0.000082593535,0.00003040011,0.00014644938,5.390496e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072251223,0.001911234,0.8624419,0.00021432516,0.0014585536,0.000027693692,0.006573013,0.0000060123125,0.08020066,0.00034674825,0.00002744308,0.039567325],"study_design_scores_gemma":[0.004257847,0.0012853554,0.8325141,0.0003689219,0.00051104464,0.000031939868,0.0008714864,0.000016299806,0.1598862,0.000170257,0.00001633385,0.000070202004],"about_ca_topic_score_codex":0.06729486,"about_ca_topic_score_gemma":0.004562729,"teacher_disagreement_score":0.07968553,"about_ca_system_score_codex":0.0002483328,"about_ca_system_score_gemma":0.00020799953,"threshold_uncertainty_score":0.9389161},"labels":[],"label_agreement":null},{"id":"W1992769594","doi":"10.1002/rcm.2622","title":"Mass spectrometry study of hemoglobin‐oxaliplatin complexes in colorectal cancer patients and potential association with chemotherapeutic responses","year":2006,"lang":"en","type":"article","venue":"Rapid Communications in Mass Spectrometry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Oxaliplatin; Chemistry; Colorectal cancer; Mass spectrometry; High-performance liquid chromatography; Chromatography; Inductively coupled plasma mass spectrometry; Hemoglobin; Cancer; Internal medicine; Biochemistry; Medicine","score_opus":0.016617150837549673,"score_gpt":0.3119982607222098,"score_spread":0.29538110988466015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992769594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951589,0.0012834014,0.000024318895,0.0009464905,0.0000534382,0.000992878,0.000043435997,0.000032820208,0.0014643065],"genre_scores_gemma":[0.99431837,0.00071289425,0.0044615115,0.000052018477,0.000041313822,0.0001465395,0.00007934129,0.000027615813,0.00016037766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982174,0.0003398431,0.0005054419,0.00028817574,0.0003431344,0.00030602614],"domain_scores_gemma":[0.9987267,0.00038551807,0.0003076766,0.0004277534,0.00010790728,0.000044434128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003393602,0.00020794931,0.0005227166,0.0008522742,0.00009168494,0.000020389412,0.00024585635,0.00010767398,0.0001951128],"category_scores_gemma":[0.000031650135,0.00019847382,0.0000473211,0.001474276,0.00012617062,0.00008989124,0.00007720723,0.00039226617,0.0000017828997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011159582,0.0034926939,0.88934964,0.000026765301,0.00019564373,0.000004692032,0.0003147757,0.000024404608,0.10510075,0.000088504414,0.000059264923,0.00022692181],"study_design_scores_gemma":[0.01012943,0.0019347906,0.9736236,0.000049475988,0.0001963343,0.0000053844683,0.0005526157,0.0002889649,0.012698639,0.00031345038,0.000034629742,0.00017273928],"about_ca_topic_score_codex":0.0014693582,"about_ca_topic_score_gemma":0.001922235,"teacher_disagreement_score":0.09240211,"about_ca_system_score_codex":0.0010707525,"about_ca_system_score_gemma":0.000107615,"threshold_uncertainty_score":0.80935276},"labels":[],"label_agreement":null},{"id":"W1992816765","doi":"10.1177/1078155214556008","title":"Abraxane® versus Taxol® for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Breast cancer; Adverse effect; Premedication; Cancer; Paclitaxel; Emergency medicine; Internal medicine; Surgery","score_opus":0.011455966854408016,"score_gpt":0.41087533716621105,"score_spread":0.399419370311803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992816765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728353,0.0025759758,0.0003194869,0.020874998,0.00063231157,0.0012445747,0.0003242864,0.000020820537,0.0011722656],"genre_scores_gemma":[0.9922812,0.0008079643,0.004595551,0.0014501426,0.00067953847,0.000066227,0.000057857887,0.000023856657,0.00003766836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854517,0.00028674395,0.00037810835,0.00029863534,0.00025065584,0.00024068894],"domain_scores_gemma":[0.99543035,0.0012569699,0.0012544348,0.00010510511,0.0016882219,0.0002648977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030553289,0.0002134733,0.0008032903,0.00025427944,0.00014371054,0.000015799584,0.00007109833,0.000057150264,0.00017796463],"category_scores_gemma":[0.00030595277,0.00015328387,0.00015751585,0.00039641818,0.00008521198,0.0005440738,0.000021966254,0.00038794446,0.0000025968716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36274225,0.0054552895,0.39314142,0.0000954108,0.022077197,0.00009769772,0.013550458,0.0004447979,0.00063770125,0.00003078731,0.00204559,0.19968142],"study_design_scores_gemma":[0.24057765,0.039951798,0.5987189,0.00011182284,0.03746204,0.00046851634,0.0042384244,0.0016956192,0.0001715114,0.00006636497,0.07602461,0.00051272754],"about_ca_topic_score_codex":0.00075612776,"about_ca_topic_score_gemma":0.00026396962,"teacher_disagreement_score":0.2055775,"about_ca_system_score_codex":0.0018359119,"about_ca_system_score_gemma":0.0007266161,"threshold_uncertainty_score":0.6250735},"labels":[],"label_agreement":null},{"id":"W1993857407","doi":"10.1016/j.bmcl.2007.02.031","title":"Synthesis and biological evaluation of novel analogues of dictyostatin","year":2007,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Cancer Institute; Public Health Agency of Canada","keywords":"Chemistry; In vitro; Microtubule; Cell culture; Chemical synthesis; Cytotoxicity; Stereochemistry; Biological activity; Cancer cell lines; Combinatorial chemistry; Cell growth; Cancer cell; Biochemistry; Cancer; Cell biology","score_opus":0.06544543634468435,"score_gpt":0.34055084448830103,"score_spread":0.27510540814361667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993857407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656343,0.000808238,0.0001565779,0.0017938468,0.000046942558,0.0001546837,0.00001840908,0.000012782552,0.0004451017],"genre_scores_gemma":[0.9990455,0.00008082036,0.000296337,0.00035081862,0.00016721297,0.000005943402,0.00003562088,0.000007651952,0.000010088816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990014,0.000019742101,0.00030292675,0.00018264029,0.00033819125,0.0001551193],"domain_scores_gemma":[0.9992878,0.00023624605,0.0001538396,0.00011659503,0.000106782696,0.00009875925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007512141,0.00011495071,0.0003034526,0.00004404812,0.000017642013,0.000001033491,0.000051018742,0.00008525576,0.0004939653],"category_scores_gemma":[0.00029179273,0.00008797313,0.000047599344,0.0001450636,0.00030291697,0.000014298133,0.000019293264,0.00009305854,6.974604e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027805578,0.00019751812,0.023966348,0.00013404945,0.0001257881,0.000010928652,0.00016397456,2.2436048e-7,0.97039634,0.0000022250033,0.0003794574,0.004345082],"study_design_scores_gemma":[0.0022053157,0.0001111243,0.10959694,0.0001000895,0.0006084433,0.00007758,0.00024981686,0.00003346253,0.88683903,0.0000034489613,0.00010912333,0.00006562818],"about_ca_topic_score_codex":0.0000468854,"about_ca_topic_score_gemma":0.000002309268,"teacher_disagreement_score":0.085630596,"about_ca_system_score_codex":0.00008293666,"about_ca_system_score_gemma":0.0000775664,"threshold_uncertainty_score":0.5408574},"labels":[],"label_agreement":null},{"id":"W1994685129","doi":"10.1007/s10549-012-2288-x","title":"Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Capecitabine; Medicine; Metastatic breast cancer; Internal medicine; Regimen; Adverse effect; Breast cancer; Oncology; Odds ratio; Cancer; Progression-free survival; Gastroenterology; Surgery; Chemotherapy; Colorectal cancer","score_opus":0.3623807112931028,"score_gpt":0.5579478726196762,"score_spread":0.19556716132657337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994685129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96088064,0.016454263,0.000011810765,0.0028822818,0.00018263826,0.0017279321,0.0178033,0.000016756374,0.00004038798],"genre_scores_gemma":[0.9745741,0.022111567,0.00030640484,0.00021785736,0.0003694915,0.0009747774,0.0012094587,0.00003297084,0.00020336435],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9954032,0.0012536614,0.0011950497,0.0006918755,0.0007195945,0.0007366614],"domain_scores_gemma":[0.99642396,0.0017656024,0.00031310183,0.0006760199,0.00022858189,0.00059271406],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023915577,0.00032439834,0.0019354825,0.0006325386,0.00007850384,0.000028885312,0.00022457975,0.00010456096,0.0049107876],"category_scores_gemma":[0.000088394605,0.00020037455,0.00023833783,0.0012064527,0.00027053704,0.0002232115,0.00016545194,0.00026135775,0.0000075331163],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029291477,0.006052672,0.4141712,0.000028038598,0.020240992,0.00007514891,0.0006922922,0.000028573077,0.0005126228,0.000006982949,0.00064661255,0.5282534],"study_design_scores_gemma":[0.02594896,0.002191589,0.9582316,0.0001683511,0.0098326225,0.000029131827,0.00048816117,0.00050693116,0.0005040367,0.000019042773,0.0018683819,0.0002111679],"about_ca_topic_score_codex":0.02452852,"about_ca_topic_score_gemma":0.017494142,"teacher_disagreement_score":0.5440604,"about_ca_system_score_codex":0.0006263703,"about_ca_system_score_gemma":0.0009746712,"threshold_uncertainty_score":0.99599886},"labels":[],"label_agreement":null},{"id":"W1995047633","doi":"10.1016/j.ejphar.2009.08.020","title":"Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer","year":2009,"lang":"en","type":"article","venue":"European Journal of Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Associazione Italiana per la Ricerca sul Cancro; Pfizer","keywords":"Irinotecan; Oxaliplatin; Medicine; Colorectal cancer; Pharmacology; In vivo; Cancer; Vascular endothelial growth factor; Combination therapy; Cancer research; Internal medicine; Biology; VEGF receptors","score_opus":0.019697290253670244,"score_gpt":0.33267862689666106,"score_spread":0.3129813366429908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995047633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880637,0.002645752,0.000013144575,0.0054674204,0.0006105383,0.00016165218,0.0000048201673,0.0000109427465,0.003022045],"genre_scores_gemma":[0.9957271,0.0010143351,0.00031134294,0.0020038923,0.00075787044,0.0000018008797,0.0000017974694,0.000015752916,0.00016609846],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987663,0.00032298997,0.000437595,0.0001438129,0.00008843162,0.00024085572],"domain_scores_gemma":[0.9994315,0.000071404254,0.00024188957,0.000034233235,0.000063120984,0.00015787389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000480037,0.0001420106,0.00038389274,0.00026963986,0.00003168718,0.000007795187,0.000089684945,0.000028452288,0.00083328283],"category_scores_gemma":[0.000013244476,0.000120764635,0.00007836397,0.00013550528,0.00007159868,0.0000854166,0.00002372864,0.0003981412,0.000014680231],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041602845,0.0008464335,0.030153673,0.000022051,0.00033566848,0.0034887176,0.0008149142,0.00011082633,0.8122084,0.000028025834,0.023520377,0.12431061],"study_design_scores_gemma":[0.026116999,0.010212033,0.81284803,0.00008319262,0.00087553,0.0021456834,0.00009866902,0.00024647816,0.105457485,0.00004365134,0.04158333,0.00028891905],"about_ca_topic_score_codex":0.000011256883,"about_ca_topic_score_gemma":0.0000087714625,"teacher_disagreement_score":0.78269434,"about_ca_system_score_codex":0.00019275,"about_ca_system_score_gemma":0.00013003513,"threshold_uncertainty_score":0.91238624},"labels":[],"label_agreement":null},{"id":"W1995153811","doi":"10.3747/co.20.1256","title":"Evaluation of the Clinical Benefits of Nanoparticle Albumin-Bound Paclitaxel in Women with Metastatic Breast Cancer in British Columbia","year":2013,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Taxane; Medicine; Paclitaxel; Internal medicine; Breast cancer; Oncology; Metastatic breast cancer; Adjuvant; Chemotherapy; Cancer","score_opus":0.14664838490070736,"score_gpt":0.4609856244973868,"score_spread":0.3143372395966794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995153811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995293,0.0022159833,1.7474406e-7,0.0007701365,0.00044223532,0.0011297496,0.000050695973,0.0000036727167,0.000094301606],"genre_scores_gemma":[0.99879146,0.00036285515,0.000014896495,0.000085238615,0.00004965093,0.0006354091,0.0000034798284,0.000008276955,0.000048719063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998325,0.0004625442,0.00050951145,0.00019107072,0.00028021738,0.00023169068],"domain_scores_gemma":[0.9990573,0.0001748725,0.00021570116,0.00014034238,0.00034179084,0.00006999241],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010210755,0.00006838499,0.00045054956,0.000041088853,0.00001694141,0.0000069890643,0.00007578942,0.000053442305,0.0017697938],"category_scores_gemma":[0.00007749876,0.000064898115,0.00004063149,0.0002984236,0.0002466813,0.000055924695,0.000035153167,0.000169607,0.0000036709623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017663155,0.0021973308,0.66708463,0.000051440315,0.000076805816,0.0000018657599,0.00045329932,0.000053353026,0.0004706161,0.0000017915096,0.0007511241,0.3286811],"study_design_scores_gemma":[0.0106325615,0.001030751,0.98627764,0.00023004909,0.00034836127,0.000030466636,0.0003086289,0.0004863042,0.00010741507,0.00018468456,0.0003056987,0.000057456047],"about_ca_topic_score_codex":0.012714913,"about_ca_topic_score_gemma":0.18530023,"teacher_disagreement_score":0.32862365,"about_ca_system_score_codex":0.00058585865,"about_ca_system_score_gemma":0.0009099539,"threshold_uncertainty_score":0.9991427},"labels":[],"label_agreement":null},{"id":"W1995300665","doi":"10.1016/j.expneurol.2012.08.023","title":"Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy","year":2012,"lang":"en","type":"article","venue":"Experimental Neurology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research; National Institutes of Health; Louise and Alan Edwards Foundation; Canada Research Chairs","keywords":"Bortezomib; Peripheral neuropathy; Medicine; Peripheral; Physical medicine and rehabilitation; Neuroscience; Internal medicine; Psychology; Multiple myeloma; Endocrinology","score_opus":0.02297038949789539,"score_gpt":0.3203093488017512,"score_spread":0.29733895930385584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995300665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909702,0.0041970513,0.0000024784804,0.0011483459,0.0010918528,0.00038584915,0.000003279646,0.00008394745,0.0021169933],"genre_scores_gemma":[0.99258924,0.000065443055,0.00003105229,0.005875867,0.0010787464,0.00008007539,0.000011806804,0.000031922642,0.00023586556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884015,0.00012580687,0.00016938202,0.00028882702,0.00009690252,0.00047892935],"domain_scores_gemma":[0.99945164,0.000043145017,0.000048156617,0.00017161839,0.000011049753,0.00027440436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006743991,0.00020265445,0.0002847731,0.000057957724,0.00008911263,0.000007549212,0.000050773277,0.00011144108,0.0008744001],"category_scores_gemma":[0.000008017588,0.00018444748,0.0000729388,0.00006783276,0.00012539476,0.00010063119,0.00008158635,0.00024118857,0.00004600281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080744206,0.00074364676,0.07740866,0.000012587613,0.00005064212,0.00013674052,0.0006280731,3.3220977e-7,0.91747683,0.000111732195,0.0014156234,0.0012076763],"study_design_scores_gemma":[0.008564861,0.011755883,0.29414392,0.0000058900823,0.00008932153,0.0022430217,0.00009404044,0.00023508984,0.62826705,0.00000937221,0.05422214,0.0003694161],"about_ca_topic_score_codex":0.000044494554,"about_ca_topic_score_gemma":0.000005476059,"teacher_disagreement_score":0.2892098,"about_ca_system_score_codex":0.00008070547,"about_ca_system_score_gemma":0.000042666048,"threshold_uncertainty_score":0.95740676},"labels":[],"label_agreement":null},{"id":"W1995811281","doi":"10.1007/s00280-006-0362-y","title":"Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors","year":2006,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Pharmacokinetics; Tolerability; Neutropenia; Taxane; Internal medicine; Refractory (planetary science); Paclitaxel; Adverse effect; Toxicity; Pharmacology; Oncology; Chemotherapy; Gastroenterology; Cancer; Breast cancer","score_opus":0.01851690814974668,"score_gpt":0.37115694981906044,"score_spread":0.3526400416693138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995811281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932709,0.0026265795,0.000012882799,0.0016093956,0.0004171612,0.0011304581,0.000035309193,0.000029166757,0.00086816953],"genre_scores_gemma":[0.9941293,0.002438118,0.00016533748,0.0018305451,0.00037398844,0.00032152835,0.000030815416,0.000032362826,0.0006780299],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878424,0.000060481972,0.00034815044,0.00033556682,0.00011170511,0.00035987707],"domain_scores_gemma":[0.9995279,0.00005714828,0.00016178763,0.000097493285,0.000056503377,0.000099216275],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010887034,0.00023023282,0.00064764713,0.00014688767,0.000035952155,0.0000038724274,0.00006264727,0.000097799064,0.0013736713],"category_scores_gemma":[0.0000012700667,0.00018210012,0.00006376583,0.00025743604,0.00022242007,0.000059664537,0.00001174051,0.00017707734,0.0000013400553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30043536,0.0039739036,0.006155975,0.00018467456,0.00030950148,0.00025255702,0.0003982103,0.00006760702,0.6464825,0.000049423234,0.00344119,0.03824908],"study_design_scores_gemma":[0.38800737,0.0070152213,0.0013897326,0.00006266072,0.00024216494,0.000048611724,0.00003147229,0.00013634123,0.5870528,0.00008162834,0.015736196,0.00019578627],"about_ca_topic_score_codex":0.00039035984,"about_ca_topic_score_gemma":0.00020586417,"teacher_disagreement_score":0.08757202,"about_ca_system_score_codex":0.00011817521,"about_ca_system_score_gemma":0.00026461948,"threshold_uncertainty_score":0.9995392},"labels":[],"label_agreement":null},{"id":"W1995930791","doi":"10.1007/s10637-014-0171-9","title":"A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493), a folate receptor targeted chemotherapeutic agent in humans with advanced solid tumors","year":2014,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Norris Cotton Cancer Center; Bristol-Myers Squibb","keywords":"Medicine; Pharmacokinetics; Mucositis; Neutropenia; Pharmacology; Toxicity; Epothilone; Folate receptor; Cancer; Dosing; Internal medicine; Oncology; Cancer cell; Chemistry","score_opus":0.016924110530593332,"score_gpt":0.3168864988068077,"score_spread":0.29996238827621435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995930791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955881,0.00060141593,0.00020103416,0.002561544,0.000055996028,0.0005264548,0.00005001387,0.000036146623,0.0003792779],"genre_scores_gemma":[0.9941177,0.0001654976,0.0025477207,0.0019652084,0.00009586975,0.000046164863,0.00034991396,0.000028700064,0.0006832507],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99850374,0.00008375151,0.000493868,0.00037621637,0.0002884362,0.00025398436],"domain_scores_gemma":[0.99908143,0.00014211415,0.00023896614,0.0001622596,0.00009017242,0.0002850285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019299121,0.00023675498,0.0006319083,0.00042621192,0.000053685977,0.000008600945,0.000071554496,0.000059391477,0.0006961337],"category_scores_gemma":[0.000025892126,0.00020407567,0.00010299781,0.0007636847,0.00020797041,0.00009253755,0.000020246882,0.00016780628,0.000006885693],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010388962,0.0027189695,0.05086626,0.00035729926,0.0075085065,0.000045468998,0.012653838,0.004936619,0.8490097,0.0012366168,0.0012005384,0.05907723],"study_design_scores_gemma":[0.2158765,0.014802492,0.30844447,0.0014202794,0.019960687,0.00007849049,0.00039494806,0.09018638,0.30551693,0.00870997,0.03242083,0.002188022],"about_ca_topic_score_codex":0.00018766806,"about_ca_topic_score_gemma":0.000085334446,"teacher_disagreement_score":0.5434928,"about_ca_system_score_codex":0.00011650553,"about_ca_system_score_gemma":0.00024653206,"threshold_uncertainty_score":0.8321964},"labels":[],"label_agreement":null},{"id":"W1996330154","doi":"10.1038/bjc.2012.319","title":"A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Regeneron Pharmaceuticals","keywords":"Medicine; Aflibercept; Pemetrexed; Neutropenia; Internal medicine; Febrile neutropenia; Adverse effect; Cisplatin; Gastroenterology; Pharmacology; Bevacizumab; Chemotherapy","score_opus":0.015153943021905881,"score_gpt":0.3460659373982292,"score_spread":0.33091199437632335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996330154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981366,0.0010836141,0.0000044104454,0.00005488591,0.00009151422,0.0005499629,0.0000084235335,0.00000238359,0.000068252404],"genre_scores_gemma":[0.99957377,0.0001485578,0.00012860878,0.000034809324,0.000041746644,0.000022901844,0.000008220331,0.000013035716,0.000028378972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911225,0.000057599394,0.00034827003,0.00008773468,0.00024918639,0.00014493804],"domain_scores_gemma":[0.9993479,0.000029935225,0.0003296112,0.00004079517,0.00016290156,0.000088838555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014014289,0.00008710149,0.00034144014,0.00017515503,0.000017244425,0.000007607576,0.00002686175,0.00002890013,0.000070445734],"category_scores_gemma":[0.000012644635,0.00007672098,0.000017250195,0.00022478924,0.00003399395,0.00026126375,0.0000072515404,0.00015137352,9.9210226e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008212403,0.007879673,0.8751259,0.000029424138,0.0000701362,0.000061733925,0.0016274407,0.000027972923,0.00019298401,4.3593732e-7,0.00002693891,0.106745],"study_design_scores_gemma":[0.08402444,0.011109439,0.9033482,0.0005078389,0.00017292179,0.000056901077,0.00043403273,0.00001793827,0.00021899765,0.0000022642782,0.000037613427,0.0000694164],"about_ca_topic_score_codex":0.00021601153,"about_ca_topic_score_gemma":0.0024275593,"teacher_disagreement_score":0.10667558,"about_ca_system_score_codex":0.00014316045,"about_ca_system_score_gemma":0.000082996485,"threshold_uncertainty_score":0.31285906},"labels":[],"label_agreement":null},{"id":"W1996338020","doi":"10.1515/znb-2011-0721","title":"A Novel Taxatetraene Framework Formed From a New Natural Taxane from Taxus cuspidata","year":2011,"lang":"en","type":"article","venue":"Zeitschrift für Naturforschung B","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Hebei Medical University; National Natural Science Foundation of China","keywords":"Taxane; Double bond; Chemistry; Stereochemistry; Organic chemistry; Biology","score_opus":0.04225980535016611,"score_gpt":0.3213735757774767,"score_spread":0.2791137704273106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996338020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9539402,0.01699466,0.004242073,0.0015298891,0.0061418577,0.0015842902,0.0011025285,0.0006473017,0.013817203],"genre_scores_gemma":[0.926655,0.00030045354,0.062493984,0.0031538901,0.002353921,0.000060385297,0.0014746431,0.00011420601,0.0033935194],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969017,0.00004887072,0.0006168358,0.0009765013,0.0005534087,0.00090270996],"domain_scores_gemma":[0.9974709,0.0003782132,0.00035450282,0.00097074127,0.00013490982,0.00069071807],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013584999,0.00063165283,0.00090706476,0.00023625033,0.0001725299,0.00005266837,0.00053252,0.00071028166,0.0073284013],"category_scores_gemma":[0.0003390464,0.0005283074,0.00035759475,0.00055108336,0.00013693617,0.00039583558,0.00022359833,0.0017019996,0.00058598304],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027537705,0.007305052,0.15091814,0.0002859967,0.010972115,0.002509177,0.016239854,0.00000694644,0.43260035,0.023202246,0.1991736,0.12924881],"study_design_scores_gemma":[0.036347486,0.0024791386,0.35201123,0.0012782924,0.004506392,0.00029789397,0.0005583994,0.00068159454,0.2171222,0.007898571,0.37409607,0.0027227327],"about_ca_topic_score_codex":0.01689778,"about_ca_topic_score_gemma":0.000963653,"teacher_disagreement_score":0.21547817,"about_ca_system_score_codex":0.000061344304,"about_ca_system_score_gemma":0.00046208999,"threshold_uncertainty_score":0.9997169},"labels":[],"label_agreement":null},{"id":"W1996435991","doi":"10.1016/j.cvsm.2007.07.002","title":"Chemotherapy: New Uses for Old Drugs","year":2007,"lang":"en","type":"review","venue":"Veterinary Clinics of North America Small Animal Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Chemotherapy; Intensive care medicine; Computer science; Internal medicine","score_opus":0.21365287087917145,"score_gpt":0.4873636878889482,"score_spread":0.27371081700977673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996435991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001034364,0.993159,0.00016637657,0.0006462609,0.0005655071,0.0024719145,0.00020330277,0.00009277084,0.0016605274],"genre_scores_gemma":[0.000036561294,0.9706923,0.021222718,0.0033869464,0.0013541848,0.00012288729,0.0004237097,0.00016166545,0.0025990333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968006,0.00018864557,0.0014372387,0.0007618466,0.00027111298,0.0005405667],"domain_scores_gemma":[0.99149954,0.00519053,0.0020791902,0.00057870493,0.00027510183,0.00037695462],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004502613,0.0006719393,0.0028708563,0.00027051134,0.00007491168,0.000019775127,0.00034755882,0.00034329615,0.00022978414],"category_scores_gemma":[0.0005888169,0.000587492,0.0012325774,0.00053862086,0.00018868623,0.00018249064,0.00012627228,0.0007226965,0.00008230999],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008401302,0.0013135631,0.000058240013,0.0090428395,0.00166751,0.00022375525,0.000104581435,3.082696e-7,0.0000027174497,0.00000617133,0.0047173705,0.9744616],"study_design_scores_gemma":[0.0022382694,0.022130035,0.000078014855,0.0013937692,0.007014306,0.00055018923,0.00003572614,0.0000045214006,8.3145557e-7,0.0000029236605,0.9661095,0.00044190025],"about_ca_topic_score_codex":0.00023680214,"about_ca_topic_score_gemma":0.000008873435,"teacher_disagreement_score":0.97401977,"about_ca_system_score_codex":0.0001581877,"about_ca_system_score_gemma":0.0012952214,"threshold_uncertainty_score":0.99965763},"labels":[],"label_agreement":null},{"id":"W1996697383","doi":"10.1007/s00280-006-0245-2","title":"A pharmacokinetic and safety study of a novel polymeric paclitaxel formulation for oral application","year":2006,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Paclitaxel; Pharmacokinetics; Pharmacology; Medicine; Chemotherapy; Internal medicine","score_opus":0.0242078547080019,"score_gpt":0.3711345531872951,"score_spread":0.3469266984792932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996697383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915877,0.0030996385,0.001398433,0.0013493836,0.00017658134,0.002182192,0.000062111096,0.00002831503,0.000115626186],"genre_scores_gemma":[0.9960136,0.0010046335,0.00027939523,0.0012577577,0.00036056322,0.00072442624,0.000041803643,0.000022740693,0.00029511435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991786,0.000023314007,0.0002664954,0.0002760093,0.00006725169,0.00018835849],"domain_scores_gemma":[0.9995755,0.0000886194,0.00013728785,0.00006588481,0.00006691286,0.000065797736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088058725,0.00015763335,0.0003428139,0.000084730025,0.00007447029,0.0000036651816,0.000034019195,0.000066636654,0.00017277335],"category_scores_gemma":[9.298156e-7,0.00014206114,0.000041931613,0.00014335944,0.00006268979,0.000047479258,0.000012028669,0.00007262635,1.9111005e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065836934,0.0023420735,0.030315252,0.00022283132,0.0004142456,0.0000012599904,0.00076036446,0.00005205281,0.8920815,0.00012903148,0.0015868059,0.065510914],"study_design_scores_gemma":[0.20963706,0.008389143,0.16949408,0.00004680016,0.0037509347,0.000081486425,0.00038117584,0.02996518,0.4600111,0.00031743976,0.11720818,0.0007174171],"about_ca_topic_score_codex":0.0004254873,"about_ca_topic_score_gemma":0.00005474703,"teacher_disagreement_score":0.43207037,"about_ca_system_score_codex":0.000058631733,"about_ca_system_score_gemma":0.000049323746,"threshold_uncertainty_score":0.5793085},"labels":[],"label_agreement":null},{"id":"W1998636049","doi":"10.14740/jmc.v6i5.2066","title":"Prolonged Bradycardia Induced by Bevacizumab-Associated Infusion Reaction in Advanced Metastatic Colon Cancer","year":2015,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bevacizumab; Bradycardia; FOLFOX; Sinus bradycardia; Oxaliplatin; Anesthesia; Colorectal cancer; Surgery; Heart rate; Internal medicine; Cancer; Chemotherapy; Blood pressure","score_opus":0.06864916599421104,"score_gpt":0.4057790226430278,"score_spread":0.33712985664881673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998636049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866139,0.0032881775,0.0000023908867,0.008841819,0.0008352335,0.00026012078,0.000010648933,0.000012972778,0.00013472982],"genre_scores_gemma":[0.99752,0.0010998726,0.000034018754,0.0009083234,0.0002401145,0.000024908046,0.000020347024,0.000013714318,0.00013868451],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99793786,0.00020930787,0.0005146905,0.00012008691,0.0010069534,0.00021107578],"domain_scores_gemma":[0.99857676,0.00027001798,0.0003750907,0.000067824854,0.00024126175,0.00046902878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093950157,0.00012723278,0.00053276884,0.00017259424,0.000025340833,0.0000070379297,0.000078427576,0.00015191005,0.0002382169],"category_scores_gemma":[0.0018611572,0.00009400082,0.000097535485,0.00028420804,0.00004324215,0.00013978765,0.000022946206,0.00057379954,0.000004208019],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03303902,0.00841785,0.10122152,0.0002733346,0.0020023715,0.02173752,0.0038826577,0.000039105886,0.23179565,0.000012759343,0.3200122,0.277566],"study_design_scores_gemma":[0.31632507,0.06815769,0.3327676,0.006810204,0.0080134105,0.018813843,0.0053037126,0.0015834477,0.07325357,0.00075178413,0.1664713,0.0017483453],"about_ca_topic_score_codex":0.00053455087,"about_ca_topic_score_gemma":0.0005573513,"teacher_disagreement_score":0.28328606,"about_ca_system_score_codex":0.0007237724,"about_ca_system_score_gemma":0.0010807763,"threshold_uncertainty_score":0.3833242},"labels":[],"label_agreement":null},{"id":"W1998835358","doi":"10.1021/np0304565","title":"Characterization of an <i>a</i><i>beo</i>-Taxane:  Brevifoliol and Derivatives","year":2004,"lang":"en","type":"article","venue":"Journal of Natural Products","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; University of British Columbia","funders":"","keywords":"Taxane; Diterpene; Characterization (materials science); Stereochemistry; Chemistry; Nanotechnology; Materials science; Medicine; Internal medicine","score_opus":0.013493539910616987,"score_gpt":0.29663005938363246,"score_spread":0.2831365194730155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998835358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921815,0.0021907624,0.000005067167,0.0050392817,0.00037417293,0.00016570324,0.0000032363648,0.000005393787,0.000034908386],"genre_scores_gemma":[0.99726945,0.0006629187,0.0009277663,0.00035656913,0.00060963543,7.0343344e-7,0.000012940273,0.000007661791,0.00015234921],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993963,0.000028258279,0.00025558053,0.000094452334,0.00013704556,0.00008831144],"domain_scores_gemma":[0.99923325,0.000011805708,0.00032578717,0.00007127613,0.00029495856,0.00006293268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119601296,0.00008293117,0.00026020507,0.00010275633,0.000023294684,0.0000062754784,0.00004112726,0.000033855627,0.0000108515715],"category_scores_gemma":[0.000072383584,0.0000575581,0.000035727193,0.0001662169,0.000057328536,0.00022396167,0.000010771363,0.00016612062,5.95259e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006049393,0.00021723038,0.0010125386,0.00009778042,0.000083636805,0.000047509857,0.00037193875,0.000001500786,0.98796356,0.000038656624,0.00004869334,0.009512027],"study_design_scores_gemma":[0.003389266,0.001482801,0.13859783,0.00014327848,0.0001790869,0.0011857647,0.00003073791,0.0000022591926,0.8526423,0.00010022856,0.0021775714,0.00006889558],"about_ca_topic_score_codex":0.000004909025,"about_ca_topic_score_gemma":0.0000011614904,"teacher_disagreement_score":0.1375853,"about_ca_system_score_codex":0.00003957806,"about_ca_system_score_gemma":0.00012373576,"threshold_uncertainty_score":0.23471512},"labels":[],"label_agreement":null},{"id":"W1999197607","doi":"10.1093/neuonc/nos229","title":"CLIN-NEURO/MEDICAL ONCOLOGY","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Neurological Institute and Hospital; Western University; McGill University","funders":"","keywords":"Medicine; Internal medicine; Oncology; Medical physics","score_opus":0.05223163820791155,"score_gpt":0.4116295984714325,"score_spread":0.35939796026352094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999197607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.736956,0.0015630483,0.00006261559,0.064262345,0.01152512,0.0010190047,0.000015518928,0.00033550602,0.18426083],"genre_scores_gemma":[0.9222938,0.0011314254,0.00044134885,0.0697705,0.004940504,0.00017807925,0.000049798,0.000068925285,0.0011256279],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971672,0.0005123908,0.0005409215,0.00045191066,0.00037441408,0.0009531376],"domain_scores_gemma":[0.99661165,0.0017419863,0.00017999731,0.0003509106,0.00008667542,0.0010287605],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00054436456,0.00029072116,0.0008341857,0.00018424042,0.00010920145,0.000005471992,0.0002133617,0.00068932143,0.0077573042],"category_scores_gemma":[0.0006041561,0.00025028177,0.00021201586,0.0002505237,0.00035675385,0.000098278164,0.00017616742,0.0010414395,0.0016246842],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032705502,0.008864289,0.082128346,0.00008238874,0.0003265498,0.0048810346,0.0013433242,0.0000017238233,0.15683255,0.0012843756,0.4706607,0.27032417],"study_design_scores_gemma":[0.006846753,0.0068242787,0.0066002817,0.000008206355,0.00038690172,0.0038056232,0.000063102205,0.00005242713,0.005358441,0.000044326345,0.9698356,0.00017410715],"about_ca_topic_score_codex":0.000042998294,"about_ca_topic_score_gemma":0.000054354918,"teacher_disagreement_score":0.49917486,"about_ca_system_score_codex":0.0005615454,"about_ca_system_score_gemma":0.0012670171,"threshold_uncertainty_score":0.99999493},"labels":[],"label_agreement":null},{"id":"W1999935086","doi":"10.1002/cncr.27593","title":"Long‐term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project trials C‐07 and LTS‐01","year":2012,"lang":"en","type":"article","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Oxaliplatin; Fluorouracil; Adjuvant; Colorectal cancer; Adjuvant therapy; Oncology; Breast cancer; Internal medicine; Surgery; Cancer","score_opus":0.0764465076246434,"score_gpt":0.41872244330565533,"score_spread":0.34227593568101194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999935086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768799,0.015868543,0.000006048805,0.0011683566,0.00049755897,0.0033789359,0.0020663005,0.000023819597,0.00011054087],"genre_scores_gemma":[0.9905551,0.0059502004,0.000093158415,0.00055008254,0.001104462,0.0012707056,0.000118703065,0.00002685847,0.00033070918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984161,0.00017803157,0.00043320432,0.00040473058,0.00024469485,0.0003232384],"domain_scores_gemma":[0.9979823,0.0012711539,0.00022879116,0.00011596974,0.00013597026,0.00026577117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005239783,0.0002499474,0.00078813394,0.00009148912,0.000079618454,0.000017719365,0.00004674059,0.00012915758,0.00013758155],"category_scores_gemma":[0.00018687584,0.00018811096,0.00008008992,0.0001030998,0.00010704159,0.000111776026,0.000043584307,0.00012317709,0.0000011566387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13653913,0.0012845832,0.32344708,0.0009233061,0.0015691075,0.00009224443,0.005521643,0.000009215379,0.20410949,0.00010731619,0.0154503025,0.31094658],"study_design_scores_gemma":[0.05414791,0.0024878525,0.8396957,0.00047924306,0.00061292097,0.00010949872,0.000034164543,0.00008762698,0.09118223,0.00006425814,0.010745326,0.00035329768],"about_ca_topic_score_codex":0.002216564,"about_ca_topic_score_gemma":0.0003802503,"teacher_disagreement_score":0.5162486,"about_ca_system_score_codex":0.00016039667,"about_ca_system_score_gemma":0.0003383311,"threshold_uncertainty_score":0.7670942},"labels":[],"label_agreement":null},{"id":"W2000487628","doi":"10.1002/cbdv.201200032","title":"Chemical Studies on <i>Taxus canadensis</i>","year":2013,"lang":"en","type":"review","venue":"Chemistry & Biodiversity","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Taxane; Semisynthesis; Taxus; Chemistry; Propellane; Diterpene; Paclitaxel; Stereochemistry; Taxoid; Terpene; Ring (chemistry); Botany; Organic chemistry; Biology; Bicyclic molecule","score_opus":0.12960637931877345,"score_gpt":0.37748746800321475,"score_spread":0.2478810886844413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000487628","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028127655,0.9924107,1.4240832e-8,0.00019392747,0.000347388,0.00044430763,0.00030785636,0.00006577864,0.0034172141],"genre_scores_gemma":[0.00003441273,0.99309635,0.000020264688,0.00033252372,0.00040400267,0.000034272147,0.0006031849,0.000011621271,0.0054633957],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987586,0.000018089164,0.00024510542,0.00050337845,0.00018829091,0.00028651077],"domain_scores_gemma":[0.999037,0.00008782616,0.00018834532,0.00033518323,0.00009431226,0.00025731596],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000042175427,0.00043195067,0.0015279126,0.000034449346,0.00008970189,0.000009328781,0.00016995726,0.0004001142,0.0010877278],"category_scores_gemma":[0.000038019334,0.00034096706,0.00050617394,0.00013689062,0.00020570066,0.000016959999,0.00015903117,0.00048885355,0.00086179527],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086320695,0.00039504666,0.00008681632,0.033953894,0.0030876594,0.0006572027,0.000072360286,2.5352664e-8,0.00081229606,6.536296e-7,0.8008749,0.15997283],"study_design_scores_gemma":[0.00060874416,0.000038182006,0.0000011578891,0.0017574151,0.004221049,0.00010568433,0.000032019994,4.946294e-8,0.0049911803,0.0000010627841,0.9879794,0.00026407026],"about_ca_topic_score_codex":0.000121465295,"about_ca_topic_score_gemma":0.0000033512213,"teacher_disagreement_score":0.1871045,"about_ca_system_score_codex":0.0009124972,"about_ca_system_score_gemma":0.00036422466,"threshold_uncertainty_score":0.99991614},"labels":[],"label_agreement":null},{"id":"W2001030403","doi":"10.7326/0003-4819-136-4-200202190-00017","title":"Physicians' Cancer Chemotherapy Drug Manual 2001","year":2002,"lang":"en","type":"article","venue":"Annals of Internal Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Family medicine; Cancer chemotherapy; Library science; Oncology; Internal medicine","score_opus":0.06903256186356233,"score_gpt":0.4166417173557671,"score_spread":0.3476091554922048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001030403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8331645,0.011807215,0.000015412294,0.1107306,0.00083775667,0.0002573935,0.000017381317,0.00004026386,0.043129437],"genre_scores_gemma":[0.9121784,0.010382435,0.000038057664,0.034216866,0.0017879173,0.000024575078,0.0000063690736,0.000022642045,0.041342758],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989599,0.000023066203,0.00030062022,0.00018641629,0.00026037573,0.0002696009],"domain_scores_gemma":[0.999336,0.00006209053,0.00014703009,0.00016186919,0.00016220791,0.00013077326],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011110362,0.00015961342,0.00045730823,0.00011583925,0.000020228737,0.000001814088,0.00010958011,0.000041035397,0.017509162],"category_scores_gemma":[0.000021703712,0.00011596945,0.000113739115,0.0001431809,0.00018746668,0.000048491787,0.000015056167,0.00015946805,0.00005374952],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006705506,0.00048616796,0.014714921,0.00007278997,0.00047256172,0.00007867469,0.0016149738,0.0000011754859,0.014054495,0.000036979978,0.8824461,0.08535057],"study_design_scores_gemma":[0.013801151,0.004330644,0.04454445,0.0024616276,0.0004835903,0.00013027724,0.0004755035,0.0006545747,0.20901352,0.00030876065,0.72344214,0.0003537774],"about_ca_topic_score_codex":0.0013110475,"about_ca_topic_score_gemma":0.000060446648,"teacher_disagreement_score":0.19495901,"about_ca_system_score_codex":0.000028296608,"about_ca_system_score_gemma":0.000014836248,"threshold_uncertainty_score":0.98338896},"labels":[],"label_agreement":null},{"id":"W2001078258","doi":"10.1016/j.eujim.2014.06.009","title":"Recent research shows maturity in addressing safety issues associated with CAM therapies","year":2014,"lang":"en","type":"article","venue":"European Journal of Integrative Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Maturity (psychological); Medicine; Psychology; Developmental psychology","score_opus":0.126743253904005,"score_gpt":0.42695603936865806,"score_spread":0.300212785464653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001078258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86249954,0.01466761,0.00023823144,0.044144925,0.000503864,0.0004205932,0.000005706483,0.000026244865,0.077493265],"genre_scores_gemma":[0.9915044,0.0037400974,0.00035773372,0.0007684097,0.00093251467,0.0000018985492,0.0000140012735,0.00003302254,0.0026479654],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99576306,0.0026356105,0.0005675161,0.00016962185,0.0005830607,0.0002811515],"domain_scores_gemma":[0.99766743,0.0006353636,0.00031339552,0.00013815805,0.0010739021,0.00017172813],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0055125393,0.00020295398,0.0006777444,0.0003988529,0.00009138769,0.000012890931,0.00015535722,0.000031789732,0.0010473226],"category_scores_gemma":[0.0016338842,0.00009484944,0.00005723593,0.0004792118,0.00049586646,0.00008404959,0.000026124266,0.0011976083,0.000009368526],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026322592,0.0028675692,0.11493388,0.00015157838,0.0025112217,0.0054226583,0.098134905,0.000019059406,0.04423829,0.0009452274,0.18276761,0.5216854],"study_design_scores_gemma":[0.031049812,0.03341787,0.46421692,0.014314319,0.00045049825,0.00066041085,0.016275056,0.00012380768,0.0061816038,0.00040628292,0.43253696,0.00036646036],"about_ca_topic_score_codex":0.000039364484,"about_ca_topic_score_gemma":0.00025336802,"teacher_disagreement_score":0.521319,"about_ca_system_score_codex":0.00034024866,"about_ca_system_score_gemma":0.00012979205,"threshold_uncertainty_score":0.99986583},"labels":[],"label_agreement":null},{"id":"W2002137462","doi":"10.1016/s0031-9422(00)00079-0","title":"Taxoids from the needles of the Canadian yew","year":2000,"lang":"en","type":"article","venue":"Phytochemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Queen's University; Armand Frappier Museum; Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Taxus; Stereochemistry; Diterpene; Chemistry; Botany; Biology","score_opus":0.01287052676535041,"score_gpt":0.2589191486433964,"score_spread":0.24604862187804596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002137462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9022523,0.00096418004,7.6690675e-8,0.004046105,0.000068722584,0.00011623949,0.00006824701,0.000007251079,0.09247685],"genre_scores_gemma":[0.9913391,0.000042990694,0.0000135739265,0.0014074013,0.00035083888,0.000017803346,0.000022455473,0.000005736748,0.006800124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996413,0.000008230115,0.00007461304,0.000083090206,0.000079273035,0.00011346574],"domain_scores_gemma":[0.9996268,0.000034328154,0.00002172154,0.00022950856,0.000017281613,0.00007034451],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000021587146,0.00006182623,0.000090350804,0.000003777188,0.000070418195,0.0000040152377,0.00010837384,0.000045756246,0.0052673067],"category_scores_gemma":[0.000008050577,0.000034104854,0.00006557626,0.00007149915,0.00009672488,0.000007342218,0.000008301262,0.00011038975,0.00002387125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038409082,0.00030667317,0.28794417,0.000092592345,0.00060696667,0.00003653045,0.002312279,0.000017389384,0.36799586,0.000028595978,0.3008439,0.03943098],"study_design_scores_gemma":[0.0015324908,0.000036828063,0.1581416,0.00007962524,0.0002902346,0.000020934687,0.00014634347,0.000018474948,0.6261114,0.0002860325,0.21323158,0.000104464525],"about_ca_topic_score_codex":0.07396494,"about_ca_topic_score_gemma":0.020905053,"teacher_disagreement_score":0.25811553,"about_ca_system_score_codex":0.00006916376,"about_ca_system_score_gemma":0.0002674777,"threshold_uncertainty_score":0.9969609},"labels":[],"label_agreement":null},{"id":"W2002396150","doi":"10.1016/j.jval.2014.03.411","title":"A Comparison of Toxicity and Supportive Care Use Between Four Cytotoxic Agents Used in the Management of Metastatic Breast Cancer (MBC))","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Neutropenia; Internal medicine; Metastatic breast cancer; Capecitabine; Anemia; Toxicity; Gemcitabine; Adverse effect; Vinorelbine; Breast cancer; Eribulin; Cancer; Oncology; Chemotherapy; Colorectal cancer","score_opus":0.17380227733604714,"score_gpt":0.4436858291776548,"score_spread":0.26988355184160767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002396150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973216,0.00046948396,0.000022231932,0.0009902654,0.00004455117,0.00097452645,0.000121140416,0.0000042380584,0.000051976032],"genre_scores_gemma":[0.99913615,0.00023770834,0.00027709856,0.00022564104,0.000022307999,0.00005447201,0.000020153211,0.000007965919,0.00001852374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986963,0.0003255851,0.0004367549,0.0001581718,0.00018820171,0.0001949349],"domain_scores_gemma":[0.9993593,0.00019675896,0.00020908163,0.00014104153,0.000028532739,0.00006529849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041222046,0.000098405464,0.0004971567,0.00011432064,0.000020581429,0.0000029025816,0.000060936847,0.000025705956,0.000036708378],"category_scores_gemma":[0.0000057680304,0.00007159338,0.000035436893,0.00020840918,0.000051252286,0.000031887073,0.000025415193,0.000114335744,6.2628635e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016699478,0.00040091592,0.9841156,0.0018143589,0.000120587945,0.000010384161,0.008051655,0.00017836709,0.000084226456,0.000054158307,0.0001285527,0.0048741773],"study_design_scores_gemma":[0.003514856,0.00063683366,0.99236494,0.00042739947,0.00016937919,0.0000036551644,0.0014976879,0.00062535255,0.0005434588,0.00004644691,0.00011972312,0.00005027084],"about_ca_topic_score_codex":0.011122099,"about_ca_topic_score_gemma":0.0011572933,"teacher_disagreement_score":0.009964806,"about_ca_system_score_codex":0.0002030729,"about_ca_system_score_gemma":0.0000978985,"threshold_uncertainty_score":0.9954629},"labels":[],"label_agreement":null},{"id":"W2002520499","doi":"10.1139/cjc-78-6-925","title":"Synthesis of dimeric and tetrameric macrolactams with cytotoxic activity&lt;sup&gt;1&lt;/sup&gt;","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemistry; Taxoid; Stereochemistry; Taxane; Docetaxel; Cytotoxicity; Cytotoxic T cell; Paclitaxel; Side chain; In vitro; Organic chemistry; Biochemistry","score_opus":0.0064814991304868,"score_gpt":0.22852887291663082,"score_spread":0.22204737378614403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002520499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98839647,0.0017343409,0.0000026674477,0.00097010087,0.0000377355,0.000094691124,0.000033462715,0.0000058575856,0.008724672],"genre_scores_gemma":[0.9967151,0.0003977911,0.00011331535,0.0001917793,0.00022647463,0.000006410932,0.000003630523,0.000028274459,0.0023171967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990195,0.000024294377,0.00026750987,0.00016833738,0.00018182417,0.00033855974],"domain_scores_gemma":[0.99859095,0.00010350282,0.00019734801,0.00016880022,0.00008920084,0.0008501813],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009162748,0.00020197472,0.0005154771,0.00010034384,0.00006660301,0.000017132032,0.000114560535,0.000113864,0.0041460614],"category_scores_gemma":[0.00003599464,0.0001680038,0.000111731075,0.00023312638,0.0002864536,0.000086565415,0.0000045958527,0.00029359714,0.000005075595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021260052,0.00033738275,0.031263664,0.00061402255,0.0014409015,0.002823435,0.0009045715,0.00010151383,0.81391865,0.0000016275081,0.0081949,0.13827334],"study_design_scores_gemma":[0.006513955,0.001439614,0.048321545,0.0008782954,0.0018041077,0.010021677,0.00027830072,0.00016121702,0.85176486,0.000025927186,0.078152984,0.0006374957],"about_ca_topic_score_codex":0.0005763739,"about_ca_topic_score_gemma":0.0004053872,"teacher_disagreement_score":0.13763584,"about_ca_system_score_codex":0.00023707247,"about_ca_system_score_gemma":0.001324704,"threshold_uncertainty_score":0.9967643},"labels":[],"label_agreement":null},{"id":"W2003792648","doi":"10.1158/1538-7445.am10-3550","title":"Abstract 3550: Role of TNFα in the cytotoxicity of docetaxel and in docetaxel resistance in MCF-7 cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sudbury Regional Hospital","funders":"","keywords":"Docetaxel; Paclitaxel; Cytotoxicity; Taxane; Pharmacology; MCF-7; Cancer research; Tumor necrosis factor alpha; Cancer cell; Cell culture; Medicine; Cancer; Internal medicine; Biology; In vitro; Breast cancer; Biochemistry","score_opus":0.05495347651965236,"score_gpt":0.43160454713153956,"score_spread":0.3766510706118872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003792648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883351,0.003483982,7.471088e-8,0.0011607793,0.000050866656,0.0006736811,0.000032328808,0.000002816051,0.006260408],"genre_scores_gemma":[0.99798226,0.0013481204,0.000043560238,0.000058376463,0.0000703162,0.00015893739,0.00000274069,0.000010170689,0.0003255112],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985923,0.00012556376,0.0003192559,0.00023944165,0.00037477637,0.00034862664],"domain_scores_gemma":[0.9991375,0.00037446516,0.00006438072,0.00026216346,0.00009881002,0.000062648774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013349566,0.00009720225,0.0003196052,0.00033592997,0.000023324128,0.000006844232,0.00018953749,0.000105428204,0.00033701418],"category_scores_gemma":[0.00007125175,0.00007187462,0.00003462416,0.0006490835,0.0003445268,0.000057301826,0.000048893857,0.0008921214,0.0000028589586],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001493303,0.0005065408,0.13400684,0.0002789758,0.000014980554,0.000056645753,0.0020396672,0.000006025966,0.8598062,0.00019519961,0.00059250375,0.0010031048],"study_design_scores_gemma":[0.003474879,0.00011599858,0.67142206,0.00018035423,0.000009119544,0.0000022218514,0.000422529,0.0000140870325,0.32142016,0.0007885634,0.0020856494,0.000064407424],"about_ca_topic_score_codex":0.0055578733,"about_ca_topic_score_gemma":0.051091604,"teacher_disagreement_score":0.53838605,"about_ca_system_score_codex":0.00011985253,"about_ca_system_score_gemma":0.0003324342,"threshold_uncertainty_score":0.9662235},"labels":[],"label_agreement":null},{"id":"W2003894443","doi":"10.1016/s0093-7754(01)90198-8","title":"Epirubicin in combination with the taxanes","year":2001,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Epirubicin; Medicine; Anthracycline; Cardiotoxicity; Taxane; Docetaxel; Doxorubicin; Breast cancer; Oncology; Metastatic breast cancer; Pharmacology; Internal medicine; Trastuzumab; Paclitaxel; Chemotherapy; Cancer","score_opus":0.020006710689128585,"score_gpt":0.3529680784910304,"score_spread":0.33296136780190183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003894443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9488957,0.00083398225,0.0000057707525,0.024617687,0.00013983512,0.00038742987,5.8243137e-7,0.000014034236,0.025104968],"genre_scores_gemma":[0.99322104,0.0008595435,0.00012817854,0.0019192772,0.00006719754,0.00010819276,0.000012010952,0.0000085897955,0.0036759588],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99937433,0.000091050075,0.00012888669,0.00014171429,0.00007171237,0.00019232924],"domain_scores_gemma":[0.99955016,0.00024534832,0.000049464026,0.00010353017,0.000021815875,0.00002966221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022014248,0.000081157625,0.00021263793,0.00012736738,0.000024086796,0.0000020492382,0.000056772402,0.000089751455,0.0002746425],"category_scores_gemma":[0.000018985345,0.00005139524,0.000017924063,0.0003252133,0.00011407559,0.000026257481,0.000016290238,0.00020309811,0.00001948055],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003347446,0.0025095907,0.80169076,0.000023410106,0.00004791886,0.0030251243,0.004021763,0.000065284934,0.0032809838,0.0006070909,0.022961862,0.15841876],"study_design_scores_gemma":[0.016357766,0.008252813,0.34208804,0.00014386469,0.00011166643,0.0012003686,0.0018697911,0.00026481264,0.0015101103,0.0006046857,0.62742645,0.0001696346],"about_ca_topic_score_codex":0.00029618843,"about_ca_topic_score_gemma":0.0038415827,"teacher_disagreement_score":0.6044646,"about_ca_system_score_codex":0.00035376687,"about_ca_system_score_gemma":0.0001168561,"threshold_uncertainty_score":0.30071425},"labels":[],"label_agreement":null},{"id":"W2004173427","doi":"10.1021/jo0007635","title":"New Approach to Aphidicolin and Total Asymmetric Synthesis of Unnatural (11<i>R</i>)-(−)-8-Epi-11-hydroxyaphidicolin by Tandem Transannular Diels−Alder/Aldol Reactions","year":2000,"lang":"en","type":"article","venue":"The Journal of Organic Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Chemistry; Aldol reaction; Tandem; Aphidicolin; Stereochemistry; Total synthesis; Derivative (finance); Diels–Alder reaction; Stereoselectivity; Organic chemistry; Catalysis; Enzyme","score_opus":0.009316717491846045,"score_gpt":0.25021229278338447,"score_spread":0.24089557529153843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004173427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989693,0.0032191463,0.00017080853,0.003457598,0.000077653545,0.0002450913,0.000020943615,0.000018412513,0.0030973558],"genre_scores_gemma":[0.9927521,0.0018040674,0.00039529236,0.0002171699,0.00037474153,0.0000059738263,0.0000057938128,0.00003354816,0.004411346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855864,0.000060922684,0.0005783551,0.00018254427,0.00035509156,0.00026447146],"domain_scores_gemma":[0.99879,0.00025183556,0.0002536132,0.00023885166,0.00009046281,0.00037523828],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036214443,0.0002297636,0.0005757357,0.00009084333,0.000091790935,0.000013005813,0.00020018568,0.00016879565,0.0024392807],"category_scores_gemma":[0.00009051605,0.0001641974,0.0001771816,0.0006534089,0.000094779156,0.00007926173,0.000020745025,0.00042617694,0.000005681143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010036632,0.0009145843,0.0012496109,0.00020686447,0.00066347356,0.000034730918,0.0008512544,0.000035072553,0.9399972,0.0000024021203,0.03982045,0.0152207045],"study_design_scores_gemma":[0.0041896375,0.0003403984,0.0028810643,0.00019092431,0.0018483074,0.004332625,0.00040806242,0.00008120482,0.9691865,0.000038622522,0.016237862,0.00026482897],"about_ca_topic_score_codex":0.00008610094,"about_ca_topic_score_gemma":0.0000045662023,"teacher_disagreement_score":0.029189274,"about_ca_system_score_codex":0.00013788803,"about_ca_system_score_gemma":0.00024542035,"threshold_uncertainty_score":0.99847263},"labels":[],"label_agreement":null},{"id":"W2005327851","doi":"10.1002/cncr.24870","title":"A randomized phase 2 trial comparing 3‐hour versus 96‐hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer","year":2010,"lang":"en","type":"article","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Mucositis; Metastatic breast cancer; Chemotherapy; myalgia; Paclitaxel; Breast cancer; Neutropenia; Toxicity; Internal medicine; Surgery; Cancer; Gastroenterology","score_opus":0.10300853357009589,"score_gpt":0.4472047981737699,"score_spread":0.34419626460367403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005327851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870266,0.0047482303,0.00008708893,0.0015216625,0.0029609108,0.003145302,0.0003870463,0.00001737103,0.00010582043],"genre_scores_gemma":[0.9926632,0.0033795643,0.0002947066,0.000060049555,0.0007957458,0.0024398735,0.000029822993,0.00002314735,0.00031386263],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99893135,0.00006438536,0.00042649245,0.0001950374,0.00016572922,0.00021703012],"domain_scores_gemma":[0.9983064,0.0008814787,0.00031089457,0.00023094883,0.00017747699,0.00009280265],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023138244,0.00019613639,0.0009962484,0.0000773388,0.00007031234,0.000006299592,0.000081130456,0.000057292058,0.0009845212],"category_scores_gemma":[0.00004977997,0.0001112748,0.0004065825,0.0001237056,0.00023548688,0.00003970734,0.00001282176,0.000098165656,0.000001323587],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9405702,0.0017298786,0.0007731914,0.00011431905,0.0023247614,0.0000025377974,0.00085180183,0.000046478835,0.016068993,0.0002050467,0.00052301935,0.03678977],"study_design_scores_gemma":[0.96314657,0.0019662508,0.00029246006,0.00006741083,0.005150282,0.0000034277043,0.00013774665,0.0017955818,0.019672072,0.000041288207,0.0076246783,0.000102244245],"about_ca_topic_score_codex":0.0022125128,"about_ca_topic_score_gemma":0.0013633764,"teacher_disagreement_score":0.036687527,"about_ca_system_score_codex":0.00014781886,"about_ca_system_score_gemma":0.00038514604,"threshold_uncertainty_score":0.9999287},"labels":[],"label_agreement":null},{"id":"W2005513578","doi":"10.1016/j.ijpharm.2004.06.025","title":"Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel","year":2004,"lang":"en","type":"article","venue":"International Journal of Pharmaceutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); University of British Columbia","funders":"","keywords":"PLGA; Glycolic acid; Differential scanning calorimetry; Miscibility; Polymer chemistry; Drug carrier; Aqueous solution; Polymer; Nuclear chemistry; Chemical engineering; Materials science; Chemistry; Lactic acid; Drug delivery; Organic chemistry; Nanoparticle; Nanotechnology","score_opus":0.042433114254306,"score_gpt":0.39925162387110497,"score_spread":0.35681850961679895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005513578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923318,0.0015375342,0.0013312042,0.0027014536,0.0013242913,0.00013795776,0.00004047577,0.000012148741,0.0005831155],"genre_scores_gemma":[0.9960745,0.0010587004,0.00084620295,0.0011739591,0.000682571,0.0000033746458,0.000044125278,0.000019123852,0.000097431985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986643,0.00003745286,0.00053260825,0.000097304466,0.0005201501,0.00014818733],"domain_scores_gemma":[0.99861526,0.00004000983,0.0005276436,0.00007720692,0.00059796945,0.00014191792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022110576,0.00012915334,0.00030051396,0.00025305548,0.000028031138,0.000018233819,0.00017472048,0.0000637863,0.00061424926],"category_scores_gemma":[0.000056448433,0.00011478279,0.0002228236,0.00009795317,0.000067576,0.00020908154,0.00002584138,0.00026229993,0.000011837528],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019767964,0.00064606924,0.010302527,0.000032228898,0.0013589052,0.00037489666,0.0012848624,0.000024906689,0.9724602,0.00025660355,0.00004322157,0.011238783],"study_design_scores_gemma":[0.010492917,0.0006880354,0.010639604,0.0001523968,0.00050211523,0.0011494666,0.00020373845,0.00011840946,0.959049,0.00008129709,0.016816946,0.00010606049],"about_ca_topic_score_codex":0.000011754409,"about_ca_topic_score_gemma":0.0000010763572,"teacher_disagreement_score":0.016773725,"about_ca_system_score_codex":0.00025060726,"about_ca_system_score_gemma":0.00031473456,"threshold_uncertainty_score":0.6725599},"labels":[],"label_agreement":null},{"id":"W2006416360","doi":"10.14740/wjon865w","title":"A Retrospective Study of Efficacy and Safety of Albumin-bound paclitaxel in Metastatic Breast Cancer","year":2014,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Neutropenia; Metastatic breast cancer; Paclitaxel; Taxane; Internal medicine; Febrile neutropenia; Breast cancer; Chemotherapy; Toxicity; Oncology; Progressive disease; Docetaxel; Premedication; Surgery; Gastroenterology; Cancer","score_opus":0.02560222401340634,"score_gpt":0.3810440120132287,"score_spread":0.35544178799982235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006416360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953988,0.0008680181,0.000006707492,0.0018544211,0.00024925772,0.00034332386,0.000011096393,0.0000017148416,0.0012666561],"genre_scores_gemma":[0.99900824,0.00030578265,0.00016660077,0.00013324857,0.00013713348,0.0000069737703,5.9877203e-7,0.000009372059,0.00023207815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998653,0.00025364006,0.00066104974,0.00011941865,0.00016448199,0.0001484403],"domain_scores_gemma":[0.9986804,0.0003047136,0.0006207239,0.000092319286,0.00020777938,0.00009406132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006067705,0.00010908645,0.0009323501,0.0003701166,0.000019352678,0.000001767539,0.00006276523,0.000033896045,0.00028873785],"category_scores_gemma":[0.000059219394,0.00008249756,0.00006622191,0.0002979002,0.00015335169,0.000042442953,0.000027262698,0.000267801,4.90488e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014675141,0.008671573,0.9221424,0.00010632652,0.0013500737,0.00022148571,0.0055017187,0.00005354403,0.0059406417,0.0002254275,0.00095329556,0.040158376],"study_design_scores_gemma":[0.026878605,0.0108907465,0.9574258,0.00012330996,0.0008750234,0.00037285907,0.00058862363,0.000017304965,0.00017341683,0.00015564196,0.0024399725,0.000058707832],"about_ca_topic_score_codex":0.0004304035,"about_ca_topic_score_gemma":0.0040970882,"teacher_disagreement_score":0.04009967,"about_ca_system_score_codex":0.00035584328,"about_ca_system_score_gemma":0.00027064508,"threshold_uncertainty_score":0.3364153},"labels":[],"label_agreement":null},{"id":"W2006689939","doi":"10.1177/1078155206075236","title":"Stability issues of parenteral chemotherapy drugs","year":2007,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; United States Pharmacopeia","keywords":"Medicine; Chemotherapy; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.06675610146510093,"score_gpt":0.49594687242619134,"score_spread":0.42919077096109043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006689939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9474363,0.0027671747,0.000114188144,0.030881014,0.0012391417,0.00026717794,0.0000040245673,0.000012110048,0.017278882],"genre_scores_gemma":[0.9857995,0.0032525326,0.0046454733,0.0049664304,0.0010089324,0.000002132669,0.0000024300602,0.000016202566,0.00030636735],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99821913,0.00024282538,0.00084116665,0.00012949997,0.00031914725,0.00024820314],"domain_scores_gemma":[0.99649346,0.0012529088,0.001195052,0.00012775321,0.00072230794,0.00020854601],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025031178,0.0001413885,0.0005884421,0.00015696774,0.00003666753,0.0000050977105,0.00012446704,0.00007288534,0.0017326282],"category_scores_gemma":[0.00029453103,0.000112376256,0.00020750012,0.00018267757,0.00014764928,0.00040536182,0.000023841136,0.0005617868,0.000010588008],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13901943,0.019199675,0.11201785,0.0002565257,0.004105283,0.0026655076,0.0147171235,0.0000058355654,0.39263937,0.00011499294,0.05808542,0.257173],"study_design_scores_gemma":[0.017711036,0.0034967372,0.0070230532,0.000025811305,0.0010213122,0.0021645173,0.0012504274,0.000009538738,0.14420079,0.000039820836,0.82297665,0.000080312195],"about_ca_topic_score_codex":0.00007428367,"about_ca_topic_score_gemma":0.000005731306,"teacher_disagreement_score":0.7648912,"about_ca_system_score_codex":0.00039462093,"about_ca_system_score_gemma":0.0005786516,"threshold_uncertainty_score":0.9991799},"labels":[],"label_agreement":null},{"id":"W2006732130","doi":"10.1016/j.biomaterials.2007.03.022","title":"A novel trans-lymphatic drug delivery system: Implantable gelatin sponge impregnated with PLGA–paclitaxel microspheres","year":2007,"lang":"en","type":"article","venue":"Biomaterials","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); University of Toronto","funders":"Canadian Institutes of Health Research; Merck Canada","keywords":"PLGA; Lymphatic system; Drug delivery; Paclitaxel; Gelatin; Materials science; Biomedical engineering; Pharmacology; Medicine; Nanotechnology; Chemistry; Pathology; Surgery; Nanoparticle; Chemotherapy","score_opus":0.01449909306354052,"score_gpt":0.2718709677637713,"score_spread":0.25737187470023076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006732130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941555,0.0013592108,0.00014318891,0.00007420545,0.00063396053,0.0009347567,0.00028076972,0.0002338512,0.0021845454],"genre_scores_gemma":[0.9966372,0.000040675037,0.0013624945,0.00014982115,0.00026933197,0.000052691863,0.00017683078,0.000048538925,0.0012624114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984124,0.000045844714,0.00046480927,0.00033480529,0.00018551317,0.00055667193],"domain_scores_gemma":[0.9992382,0.00009554699,0.00015767942,0.00022592217,0.000078237805,0.00020439309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003993513,0.00028439445,0.000586083,0.00010259712,0.00010194571,0.0000421489,0.00009320403,0.00012803875,0.00049576664],"category_scores_gemma":[0.000004240748,0.00020753138,0.00008076446,0.00019312768,0.000087065346,0.000099737474,0.000019888237,0.000016083028,0.00007164819],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040338608,0.0003045124,0.0024354612,0.00059609173,0.00038075034,0.0002830781,0.0004270387,4.2356953e-7,0.98870426,0.00002745428,0.0022926088,0.00051442866],"study_design_scores_gemma":[0.009427823,0.00056345563,0.016654199,0.000545956,0.00072434556,0.0014048629,0.0003914301,0.0000107595,0.96654946,0.0000033775325,0.0034308834,0.0002934328],"about_ca_topic_score_codex":0.0025149942,"about_ca_topic_score_gemma":0.00044892405,"teacher_disagreement_score":0.022154817,"about_ca_system_score_codex":0.00027985568,"about_ca_system_score_gemma":0.00014216377,"threshold_uncertainty_score":0.8462884},"labels":[],"label_agreement":null},{"id":"W2006998169","doi":"10.1021/np030322r","title":"New Minor Taxane Derivatives from the Needles of <i>Taxus </i><i>c</i><i>anadensis</i>","year":2003,"lang":"en","type":"article","venue":"Journal of Natural Products","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique; McGill University; Queen's University; Université du Québec à Montréal","funders":"","keywords":"Taxane; Taxus; Paclitaxel; Chemistry; Diterpene; Stereochemistry; Botany; Biology; Chemotherapy","score_opus":0.019096833876752022,"score_gpt":0.2788099398506499,"score_spread":0.25971310597389785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006998169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9384266,0.041019075,0.000010720553,0.017914109,0.001680015,0.00023821868,0.0000074110235,0.000006704278,0.00069715094],"genre_scores_gemma":[0.99025685,0.000493635,0.00393319,0.0014137061,0.0012966754,7.3428583e-7,0.000004509598,0.0000133419635,0.0025873359],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988698,0.00009890571,0.00040951115,0.00013961176,0.00030446134,0.00017773779],"domain_scores_gemma":[0.99862707,0.00021810927,0.0004986667,0.00018769415,0.00036676932,0.000101669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019457664,0.00015021984,0.00041531122,0.00006796094,0.000046542136,0.000010393172,0.00013631569,0.00005310928,0.00017737718],"category_scores_gemma":[0.0005208831,0.000083289895,0.00013960876,0.00030391308,0.00008801096,0.00012225489,0.000016836417,0.00039478214,0.0000047443273],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010834401,0.00023333688,0.007836865,0.000042970656,0.00071197224,0.00012970765,0.0015118466,0.0000049008017,0.67967004,0.00009945673,0.30075085,0.007924593],"study_design_scores_gemma":[0.004761634,0.00081466394,0.0383567,0.00016241135,0.000818082,0.0007992694,0.00055095856,0.0000012324851,0.82099724,0.00047728771,0.1321123,0.00014821498],"about_ca_topic_score_codex":0.00014479503,"about_ca_topic_score_gemma":0.000019299674,"teacher_disagreement_score":0.16863856,"about_ca_system_score_codex":0.000054451775,"about_ca_system_score_gemma":0.0004400315,"threshold_uncertainty_score":0.33964634},"labels":[],"label_agreement":null},{"id":"W2007037292","doi":"10.3816/cbc.2009.n.044","title":"TRIO-012: A Multicenter, Multinational, Randomized, Double-Blind Phase III Study of IMC-1121B Plus Docetaxel Versus Placebo Plus Docetaxel in Previously Untreated Patients With HER2-Negative, Unresectable, Locally Recurrent or Metastatic Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Alberta","funders":"","keywords":"Docetaxel; Medicine; Metastatic breast cancer; Ramucirumab; Placebo; Internal medicine; Oncology; Chemotherapy; Randomized controlled trial; Breast cancer; Phases of clinical research; Cancer; Pathology","score_opus":0.07878283885101223,"score_gpt":0.4425120655689957,"score_spread":0.36372922671798347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007037292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98170525,0.0011337462,0.00003055452,0.0016196935,0.00094354147,0.013107935,0.0012308056,0.00007752859,0.00015093132],"genre_scores_gemma":[0.9941907,0.0015614626,0.0001932922,0.00048678424,0.00034360518,0.002143948,0.0003065005,0.000074500575,0.00069918594],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934639,0.0009042693,0.0024623703,0.001245103,0.0010272056,0.0008971879],"domain_scores_gemma":[0.994126,0.0021697641,0.0012628235,0.00054168125,0.0012751078,0.00062461576],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00095359056,0.0008257023,0.0031818508,0.00042025454,0.00013514597,0.00004676144,0.00036473072,0.00022830778,0.002270751],"category_scores_gemma":[0.0002682881,0.0005492329,0.00042679522,0.0012201504,0.00054390705,0.00033226758,0.00010345642,0.0008789704,0.000011960652],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8934966,0.03750375,0.026802061,0.00018557625,0.0032105162,0.00016139494,0.001450427,0.0010563465,0.000006030092,0.000004814436,0.0006825153,0.035440028],"study_design_scores_gemma":[0.89484096,0.007388646,0.087027036,0.0010296738,0.00452749,0.000028799346,0.0004805139,0.004021514,0.00002333801,0.0000046226364,0.000112193644,0.00051521376],"about_ca_topic_score_codex":0.010103681,"about_ca_topic_score_gemma":0.017482614,"teacher_disagreement_score":0.060224976,"about_ca_system_score_codex":0.0015400869,"about_ca_system_score_gemma":0.0022187184,"threshold_uncertainty_score":0.9996959},"labels":[],"label_agreement":null},{"id":"W2008485928","doi":"10.1111/j.1540-9740.2006.05991.x","title":"Solodyn (Minocycline HCl, USP) Extended‐Release Tablets","year":2006,"lang":"en","type":"article","venue":"SKINmed Dermatology for the Clinician","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Citation; Library science; Computer science","score_opus":0.02240229546156717,"score_gpt":0.3462515459205624,"score_spread":0.3238492504589952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008485928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8654054,0.010724881,0.0022415032,0.0937231,0.005457667,0.004208055,0.00024380955,0.0004641652,0.017531404],"genre_scores_gemma":[0.98084956,0.00026144105,0.0006122928,0.008885851,0.0011809074,0.00037579224,0.00034965764,0.00005633958,0.007428139],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997927,0.00009426802,0.0007018628,0.0004337937,0.00015469045,0.00068839046],"domain_scores_gemma":[0.9976415,0.0013196815,0.00025200273,0.00052982924,0.000106788,0.00015017543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023081315,0.0002972591,0.00067922566,0.00012983735,0.00032198874,0.000014355272,0.0002341685,0.0003092711,0.00049885426],"category_scores_gemma":[0.0001191016,0.00020746113,0.00039147108,0.00018580226,0.00040640665,0.000058320617,0.00006008358,0.00034448892,0.00023436792],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009020007,0.0050487285,0.103211366,0.00040264303,0.0022590752,0.0024068116,0.00035713182,0.00010107799,0.0045180377,0.012230897,0.8034905,0.056953706],"study_design_scores_gemma":[0.01819562,0.00088731083,0.06699628,0.00005596524,0.0026255385,0.0030850545,0.0001700119,0.0027618376,0.010048768,0.010785629,0.88388115,0.0005068072],"about_ca_topic_score_codex":0.00015653006,"about_ca_topic_score_gemma":0.00040186153,"teacher_disagreement_score":0.11544417,"about_ca_system_score_codex":0.00007735604,"about_ca_system_score_gemma":0.00018619139,"threshold_uncertainty_score":0.8460019},"labels":[],"label_agreement":null},{"id":"W2009212934","doi":"10.1111/j.1525-1438.2005.00139.x","title":"Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thames Valley Children's Centre; Université de Montréal; Hôpital Notre-Dame; Hamilton Regional Laboratory Medicine Program; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Nausea; Neutropenia; Internal medicine; Adverse effect; Vomiting; Phases of clinical research; Surgery; Chemotherapy; Gastroenterology; Cisplatin","score_opus":0.05852447160272847,"score_gpt":0.4342813146540661,"score_spread":0.3757568430513376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009212934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404466,0.0009996474,0.0000027038498,0.0040821317,0.00029382957,0.0003569404,0.000019383242,0.0000039672755,0.00019675506],"genre_scores_gemma":[0.9977951,0.0005961394,0.00039411354,0.00070232386,0.00023080908,0.000021527816,0.0000026464145,0.000007041055,0.00025031302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988646,0.00005926598,0.0005381077,0.0001580461,0.0002457512,0.00013425013],"domain_scores_gemma":[0.9991869,0.00014712667,0.00025386567,0.00004785834,0.00025588824,0.000108398825],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018058292,0.00012323057,0.00041219353,0.00014973288,0.0000275311,0.000019411502,0.00015942981,0.00006769318,0.0009489735],"category_scores_gemma":[0.000066643974,0.000087044624,0.000028377113,0.00007767456,0.00007772358,0.00015473105,0.00021619088,0.00021400092,5.681222e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029922938,0.086125754,0.54534733,0.000069956295,0.0017256897,0.0023382274,0.0049344013,0.00013429575,0.14179528,0.000114624505,0.0010197386,0.18647175],"study_design_scores_gemma":[0.16639833,0.036523763,0.77923673,0.00021417245,0.00033878416,0.00044590054,0.0005600088,0.0020631063,0.0065975077,0.000054967313,0.007347157,0.00021958213],"about_ca_topic_score_codex":0.00023652271,"about_ca_topic_score_gemma":0.0008989255,"teacher_disagreement_score":0.23388939,"about_ca_system_score_codex":0.00018065679,"about_ca_system_score_gemma":0.00007573977,"threshold_uncertainty_score":0.9999643},"labels":[],"label_agreement":null},{"id":"W2009590627","doi":"10.3816/cbc.2005.n.016","title":"Phase II Study of Pemetrexed in Patients Pretreated with an Anthracycline, a Taxane, and Capecitabine for Advanced Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shaughnessy Hospital","funders":"Eli Lilly and Company","keywords":"Medicine; Pemetrexed; Neutropenia; Internal medicine; Breast cancer; Capecitabine; Taxane; Metastatic breast cancer; Oncology; Leukopenia; Phases of clinical research; Nausea; Cancer; Gastroenterology; Chemotherapy; Surgery; Cisplatin; Colorectal cancer","score_opus":0.03156877664350103,"score_gpt":0.4302681399291997,"score_spread":0.39869936328569866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009590627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937856,0.00053893524,0.000004311114,0.0017737104,0.00020680176,0.0023666483,0.0012498274,0.00003772712,0.000036413236],"genre_scores_gemma":[0.99714804,0.00045696247,0.00026772093,0.00054439367,0.00048853585,0.0007021428,0.00010519227,0.00004895297,0.00023806642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977826,0.000089407644,0.0008378374,0.0006670714,0.00023918526,0.0003839063],"domain_scores_gemma":[0.9984443,0.00017279033,0.00034625575,0.0003067426,0.0004064106,0.00032347118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019841894,0.0003087159,0.0009484524,0.00015323173,0.000075767915,0.000006464934,0.000101247584,0.00012851528,0.0006503769],"category_scores_gemma":[0.00003108856,0.00022874083,0.000088588386,0.00039141372,0.00020222156,0.00021203342,0.00004801471,0.00024560135,8.923374e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038831424,0.030064246,0.6021574,0.000055461413,0.0002898387,0.000007568039,0.00028224388,0.000036701415,0.00015000842,8.6917225e-7,0.0002773264,0.32784688],"study_design_scores_gemma":[0.14022058,0.023703111,0.83365583,0.00017604949,0.0007234574,0.00001668616,0.00017928552,0.00058890117,0.00010352695,0.0000030082783,0.00039873843,0.00023083478],"about_ca_topic_score_codex":0.001207361,"about_ca_topic_score_gemma":0.008326407,"teacher_disagreement_score":0.32761604,"about_ca_system_score_codex":0.00018785428,"about_ca_system_score_gemma":0.00021743943,"threshold_uncertainty_score":0.932778},"labels":[],"label_agreement":null},{"id":"W2010082810","doi":"10.1097/01.coc.0000071464.83271.08","title":"Effect of Capecitabine on Mean Corpuscular Volume in Patients With Metastatic Breast Cancer","year":2004,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Capecitabine; Metastatic breast cancer; Mean corpuscular volume; Breast cancer; Oncology; Internal medicine; Cancer; Colorectal cancer; Hemoglobin","score_opus":0.02125211244019987,"score_gpt":0.4226104372930836,"score_spread":0.40135832485288375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010082810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588865,0.00009649171,0.000018851602,0.0030576156,0.00039227324,0.0003005214,0.000015703368,0.0000039635693,0.00022593499],"genre_scores_gemma":[0.99786323,0.00017037091,0.0005781744,0.0011048502,0.00021950561,0.00000990228,0.0000042646325,0.000018939149,0.000030783016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997571,0.0005599617,0.0011487892,0.00017787065,0.00031608745,0.00022632212],"domain_scores_gemma":[0.99712044,0.00091092516,0.0013217191,0.00013823177,0.00025367297,0.0002549828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001005268,0.0001656436,0.0018667935,0.0001789945,0.000013438668,0.0000016010077,0.00010548671,0.00005809596,0.00024324405],"category_scores_gemma":[0.00015950666,0.00009992305,0.00027472866,0.000312449,0.00056184724,0.000046118937,0.000015534766,0.0005339896,0.000007648401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037626393,0.0038270412,0.7214309,0.000027322423,0.0007589797,0.00032457733,0.00010246275,0.00032895617,0.000029552466,0.000007617093,0.00012991026,0.23540628],"study_design_scores_gemma":[0.04258632,0.16515665,0.7895013,0.00017771537,0.0010549062,0.00011522814,0.00003139984,0.00000640038,0.00010087155,0.000012334858,0.0011737553,0.00008311198],"about_ca_topic_score_codex":0.00039608002,"about_ca_topic_score_gemma":0.00015842753,"teacher_disagreement_score":0.23532316,"about_ca_system_score_codex":0.00035929235,"about_ca_system_score_gemma":0.0008052232,"threshold_uncertainty_score":0.40747437},"labels":[],"label_agreement":null},{"id":"W2010546902","doi":"10.1200/jco.2007.15.9772","title":"Preface to Second Review Issue on Breast Cancer","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Compendium; Cancer; Gerontology; Internal medicine","score_opus":0.22135672072834317,"score_gpt":0.574805088771253,"score_spread":0.35344836804290986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010546902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7097249,0.01778388,0.000004845315,0.23853517,0.004356915,0.00060622196,0.000027716427,0.000014606341,0.028945744],"genre_scores_gemma":[0.4776953,0.16334487,0.0012185933,0.30807802,0.014600085,0.000039186347,0.0000037287098,0.000042734795,0.0349775],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99777526,0.00023763825,0.0013992318,0.00016247058,0.00023184597,0.0001935586],"domain_scores_gemma":[0.9974872,0.0007634186,0.00074207707,0.00014273224,0.0003258568,0.0005387323],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000978295,0.00012216385,0.0014626139,0.00007365041,0.00003447736,0.0000013326672,0.00011807971,0.00018712501,0.011930549],"category_scores_gemma":[0.0004069554,0.00008032727,0.00039127728,0.00013742692,0.00009622437,0.00004606635,0.000026548809,0.00071387575,0.0002799934],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050689676,0.0021269717,0.019131213,0.000149547,0.00041940896,0.0012511188,0.00006786913,0.0000051502407,0.00013252352,0.000005868863,0.80643404,0.16520734],"study_design_scores_gemma":[0.004354101,0.012405162,0.1788497,0.00052391324,0.00040098594,0.0021578697,0.0000044911476,0.0000011329381,0.00009695886,0.000008136701,0.80113673,0.000060809936],"about_ca_topic_score_codex":0.00001541765,"about_ca_topic_score_gemma":0.000047096437,"teacher_disagreement_score":0.23202962,"about_ca_system_score_codex":0.00022168683,"about_ca_system_score_gemma":0.0015738049,"threshold_uncertainty_score":0.98897266},"labels":[],"label_agreement":null},{"id":"W2010677439","doi":"10.1016/j.pain.2013.07.032","title":"Bioenergetic deficits in peripheral nerve sensory axons during chemotherapy-induced neuropathic pain resulting from peroxynitrite-mediated post-translational nitration of mitochondrial superoxide dismutase","year":2013,"lang":"en","type":"article","venue":"Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; School of Medicine, Duke University; Saint Louis University; Leukemia and Lymphoma Research; Leukemia and Lymphoma Society","keywords":"Peroxynitrite; Peroxynitrous acid; Pharmacology; Chemistry; Hyperalgesia; Superoxide dismutase; Superoxide; Mitochondrion; Medicine; Oxidative stress; Nociception; Biochemistry","score_opus":0.01651148511230198,"score_gpt":0.25716442351415814,"score_spread":0.24065293840185614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010677439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959491,0.00029295767,0.0002997069,0.002355803,0.00016657072,0.0007355334,0.000100706144,0.00005791701,0.00004169301],"genre_scores_gemma":[0.99724466,0.000028183758,0.00075816683,0.00070556486,0.00038628196,0.00009622,0.00067157,0.000038866878,0.00007051932],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99682456,0.0017513591,0.0005258589,0.0003438981,0.00024177166,0.00031255663],"domain_scores_gemma":[0.9980736,0.0013847672,0.00011576842,0.00016697045,0.0001330765,0.00012581293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009654935,0.0002244902,0.0003515344,0.00019107685,0.000070250986,0.000018013774,0.000067586705,0.00015123608,0.00052503956],"category_scores_gemma":[0.00088644924,0.00021370861,0.00012195128,0.00027312755,0.00005753013,0.00012374696,0.0000111974205,0.00028282308,0.000013506279],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086497364,0.0003500789,0.060788725,0.00005876752,0.00005675926,0.000057249166,0.0017862752,0.00008372453,0.9312551,0.0000033469676,0.000050339626,0.00464463],"study_design_scores_gemma":[0.025805498,0.0013676883,0.62223214,0.00044516043,0.0002508579,0.00003243683,0.0015531706,0.08486798,0.262377,0.0001404816,0.0001416855,0.00078591716],"about_ca_topic_score_codex":0.0040402547,"about_ca_topic_score_gemma":0.00075653085,"teacher_disagreement_score":0.66887814,"about_ca_system_score_codex":0.00009593057,"about_ca_system_score_gemma":0.00013239126,"threshold_uncertainty_score":0.87147844},"labels":[],"label_agreement":null},{"id":"W2010922143","doi":"10.1080/13880200701729760","title":"Seasonal Changes in the Concentration of Major Taxanes in the Biomass of Wild Canada Yew (<i>Taxus canadensis</i>. Marsh.)","year":2008,"lang":"en","type":"article","venue":"Pharmaceutical Biology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Fredericton; Natural Resources Canada; Canadian Forest Service","funders":"","keywords":"Taxane; Dry weight; Seasonality; Animal science; Biology; Deciduous; Botany; Biomass (ecology); Taxus; Horticulture; Agronomy; Ecology","score_opus":0.05359541572347494,"score_gpt":0.3452448971791782,"score_spread":0.2916494814557033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010922143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9660795,0.002625632,0.0000015974624,0.029871363,0.00019228186,0.00046076256,0.000087429085,0.0000034407267,0.0006779939],"genre_scores_gemma":[0.99344736,0.0005769553,0.000012473237,0.0057171127,0.00011347499,0.00004744196,0.000058167745,0.0000047405415,0.000022277673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885094,0.00031255602,0.00024291458,0.00015694395,0.00015500578,0.00028163125],"domain_scores_gemma":[0.99922514,0.00047889637,0.00008003611,0.00011597083,0.000043194465,0.000056761128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024287142,0.00011471889,0.00028738505,0.0000463714,0.00003312482,0.0000011115375,0.00014828118,0.00007397576,0.00021652652],"category_scores_gemma":[0.000046194935,0.000066160675,0.00003741216,0.0002817064,0.00036002984,0.0000127161375,0.000017707704,0.00019859082,9.694885e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014840653,0.00073024124,0.81904066,0.00018688476,0.00020184167,0.00062262156,0.00168312,0.0000028408874,0.15510368,0.0016190421,0.01365714,0.005667856],"study_design_scores_gemma":[0.014102918,0.0014011554,0.5721353,0.000086129745,0.000593225,0.0011031739,0.0011337613,0.00072048366,0.19635183,0.00021398705,0.21178137,0.0003766403],"about_ca_topic_score_codex":0.24935342,"about_ca_topic_score_gemma":0.53759074,"teacher_disagreement_score":0.28823733,"about_ca_system_score_codex":0.00010115609,"about_ca_system_score_gemma":0.00048487834,"threshold_uncertainty_score":0.7556452},"labels":[],"label_agreement":null},{"id":"W2011223682","doi":"10.1016/j.ctrv.2008.01.008","title":"Metastatic breast cancer: The role of pegylated liposomal doxorubicin after conventional anthracyclines","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Ottawa; Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cardiotoxicity; Anthracycline; Trastuzumab; Doxorubicin; Breast cancer; Metastatic breast cancer; Oncology; Adjuvant; Internal medicine; Regimen; Adjuvant therapy; Chemotherapy; Cancer; Pharmacology","score_opus":0.07097432120529847,"score_gpt":0.42110653563821765,"score_spread":0.3501322144329192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011223682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015801383,0.99109685,5.7805244e-7,0.00041433977,0.00064951443,0.0052953693,0.0018540625,0.000040805575,0.00049047475],"genre_scores_gemma":[0.00018092532,0.98380643,0.000054347798,0.00018547088,0.00096489285,0.011140593,0.00063539884,0.00010072068,0.002931218],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963694,0.0004570479,0.0016182374,0.0007268039,0.00032615545,0.0005023295],"domain_scores_gemma":[0.9974799,0.00020630039,0.0012418537,0.0007066212,0.00014156562,0.00022375409],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012104402,0.0010391689,0.0048924624,0.00019981993,0.00013233704,0.000015512458,0.00023939135,0.00017513128,0.0051071527],"category_scores_gemma":[0.000008203574,0.0005194932,0.0023610075,0.0005945054,0.00033924344,0.00007900608,0.000055364664,0.00031726158,0.000160627],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024829476,0.0010188458,0.0010350182,0.007513968,0.0037599134,0.00012399408,0.00009513476,5.7106047e-7,0.000006832458,0.000012759077,0.0029362442,0.9832484],"study_design_scores_gemma":[0.002084185,0.00041105613,0.00023960856,0.015987817,0.021102708,0.0010604355,0.000008796152,0.0000039461966,0.000041891704,0.0000076414135,0.9586922,0.00035970338],"about_ca_topic_score_codex":0.0012813089,"about_ca_topic_score_gemma":0.00028157546,"teacher_disagreement_score":0.9828887,"about_ca_system_score_codex":0.0011329942,"about_ca_system_score_gemma":0.0015376821,"threshold_uncertainty_score":0.99972564},"labels":[],"label_agreement":null},{"id":"W2011442772","doi":"10.1002/cncr.23189","title":"Combining endocrine agents with chemotherapy: Which patients and what sequence?","year":2007,"lang":"en","type":"article","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Chemotherapy; Tamoxifen; Hormone therapy; Oncology; Internal medicine; Breast cancer; Hormonal therapy; Cancer; Randomized controlled trial; Hormone","score_opus":0.030934282053980692,"score_gpt":0.35569558850129496,"score_spread":0.32476130644731427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011442772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445915,0.0016246146,0.0000094127745,0.0013183566,0.00029080093,0.00027608313,0.0000036422427,0.000027124604,0.0019908124],"genre_scores_gemma":[0.9925992,0.0027505562,0.00008577151,0.0033837026,0.00013225904,0.00002938457,0.000023602935,0.000017610178,0.0009779126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940735,0.000006190983,0.000092653376,0.00017016334,0.00011282552,0.00021084327],"domain_scores_gemma":[0.99966043,0.000020525047,0.00004053915,0.0000762256,0.0000874112,0.00011489197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042424293,0.00010344169,0.00015634345,0.00004143362,0.000042326235,0.00001862787,0.000025538766,0.000028352832,0.00067540194],"category_scores_gemma":[0.000002761491,0.00007727861,0.000014271559,0.00013229532,0.000047819067,0.00014400147,0.000011078999,0.00008350228,0.000004990992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015334337,0.00026707997,0.7565629,0.000072783565,0.00027273895,0.00008429572,0.0013905034,0.0000018347018,0.0031542126,0.000019398005,0.0037505121,0.23289031],"study_design_scores_gemma":[0.02523077,0.0018541105,0.8158333,0.0003976932,0.00035115032,0.00006339921,0.000430731,0.000067315304,0.039153114,0.000039273324,0.11624999,0.0003291527],"about_ca_topic_score_codex":0.000107522465,"about_ca_topic_score_gemma":0.00018796256,"teacher_disagreement_score":0.23256116,"about_ca_system_score_codex":0.0001317407,"about_ca_system_score_gemma":0.000062075575,"threshold_uncertainty_score":0.7395178},"labels":[],"label_agreement":null},{"id":"W2011567222","doi":"10.1158/0008-5472.sabcs12-p1-13-03","title":"Abstract P1-13-03: Mature analysis of UK Taxotere as Adjuvant Chemotherapy (TACT) trial (CRUK 01/001); effects of treatment and characterisation of patterns of breast cancer relapse.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Docetaxel; Breast cancer; Taxane; Tact; Internal medicine; Oncology; Pertuzumab; Population; Chemotherapy; Trastuzumab; Gynecology; Cancer; Psychology","score_opus":0.04978048749687294,"score_gpt":0.42496220901939524,"score_spread":0.3751817215225223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011567222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924519,0.0047123623,9.658369e-7,0.0004731469,0.00021261409,0.0012779249,0.0007150077,0.0000063662997,0.00014969464],"genre_scores_gemma":[0.98725694,0.011499934,0.000007707276,0.000034434997,0.0003090304,0.00029679172,0.00012970195,0.00002524648,0.00044020516],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99832463,0.00013814053,0.00047714662,0.00026307476,0.00043301424,0.00036399617],"domain_scores_gemma":[0.99856865,0.00027907445,0.00038530113,0.00032095792,0.00026721915,0.00017882165],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034408362,0.000198114,0.0009684329,0.000493493,0.00003365005,0.0000046044756,0.00009454973,0.00017222273,0.0033870982],"category_scores_gemma":[0.000019199282,0.00014843322,0.00022102604,0.0005408734,0.00017796608,0.000086628424,0.00003177077,0.00021314429,0.0000016552216],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043036036,0.0017341911,0.3578415,0.0015229988,0.005213051,0.000008235515,0.0027631233,0.0000071543127,0.554,0.000014012129,0.00038178675,0.033477884],"study_design_scores_gemma":[0.02408767,0.0016382531,0.71586657,0.00032823847,0.001490168,0.0000035148325,0.0000999963,0.000010126173,0.25597623,0.0000040690597,0.0004068904,0.00008831255],"about_ca_topic_score_codex":0.016759094,"about_ca_topic_score_gemma":0.00073101703,"teacher_disagreement_score":0.35802504,"about_ca_system_score_codex":0.0004426277,"about_ca_system_score_gemma":0.00034762695,"threshold_uncertainty_score":0.99752396},"labels":[],"label_agreement":null},{"id":"W2011675167","doi":"10.1007/s12257-010-0330-6","title":"Separation of taxanes from Taxus canadensis using dynamic pressurized liquid extraction","year":2011,"lang":"en","type":"article","venue":"Biotechnology and Bioprocess Engineering","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Extraction (chemistry); Solvent; Chromatography; Dichloromethane; Methanol; Hexane; Chemistry; Taxane; Chloroform; Solvent polarity; Organic chemistry","score_opus":0.02429583185340939,"score_gpt":0.29497980327888346,"score_spread":0.27068397142547407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011675167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950244,0.0027220822,0.0016584287,0.0001802562,0.00014287248,0.00013051978,0.000013361384,0.00009955668,0.00002851444],"genre_scores_gemma":[0.996546,0.0004299779,0.0029134613,0.0000142976905,0.000024486435,0.000009585879,0.000014448526,0.000009668358,0.00003812595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995441,0.0000034715763,0.0001354127,0.00015786564,0.000042376727,0.00011680921],"domain_scores_gemma":[0.999769,0.000011885425,0.000068520196,0.0000846381,0.00003269632,0.00003331384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026422455,0.00010062578,0.00019106749,0.00015026897,0.000026981337,0.0000019554084,0.000033471024,0.00026235008,0.00004395312],"category_scores_gemma":[0.000013998323,0.000093080635,0.000022802813,0.0001274499,0.000054016993,0.000056301164,0.000016432494,0.000111539804,6.6245485e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040503935,0.00005797659,0.00084465725,0.00010666417,0.00013018146,0.000022759205,0.00012590659,0.000029552253,0.99686426,0.00004353301,0.000005569837,0.0013639],"study_design_scores_gemma":[0.00083048665,0.00032311646,0.006047438,0.00006310925,0.00026620884,0.00009397544,0.000043230222,0.009610179,0.98163503,0.000019121846,0.00095613353,0.00011195045],"about_ca_topic_score_codex":0.0012766455,"about_ca_topic_score_gemma":0.000104612234,"teacher_disagreement_score":0.015229209,"about_ca_system_score_codex":0.000032614993,"about_ca_system_score_gemma":0.000028946684,"threshold_uncertainty_score":0.37957183},"labels":[],"label_agreement":null},{"id":"W2011760818","doi":"10.1007/s00280-013-2126-9","title":"A phase I trial to determine the safety, pharmacokinetics, and pharmacodynamics of intercalated BMS-690514 with paclitaxel/carboplatin (PC) in advanced or metastatic solid malignancies","year":2013,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Carboplatin; Pharmacokinetics; Neutropenia; Pharmacodynamics; Rash; Febrile neutropenia; Adverse effect; Internal medicine; Nausea; Lung cancer; Gastroenterology; Mucositis; Pharmacology; Chemotherapy","score_opus":0.02949049664627675,"score_gpt":0.38000288019242273,"score_spread":0.350512383546146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011760818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98596174,0.0023817632,0.000098917924,0.0070984317,0.0004565202,0.0037519063,0.00009727211,0.000034578294,0.000118869764],"genre_scores_gemma":[0.9813123,0.008472497,0.00048831775,0.007647658,0.00023566069,0.0011670551,0.000021441792,0.000053449985,0.00060162426],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99811405,0.00016261986,0.00061118667,0.00046829728,0.00015928554,0.0004845791],"domain_scores_gemma":[0.9988238,0.00038619986,0.00022694595,0.00015398582,0.0001472213,0.00026185313],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021845305,0.00038956525,0.00084621366,0.00019901746,0.00007661087,0.000017054386,0.00014006102,0.00008263737,0.002958257],"category_scores_gemma":[0.00001206394,0.00024224349,0.00006754841,0.0004247466,0.00038572733,0.00012139835,0.000059312104,0.0003177695,0.000002841583],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20693201,0.0014452836,0.0008815503,0.00029962885,0.000949154,0.00008607486,0.0027745927,0.000081060294,0.626162,0.000006524559,0.0021165053,0.15826562],"study_design_scores_gemma":[0.53620195,0.017413348,0.0014585461,0.0002920993,0.0017511038,0.0002290285,0.0005350644,0.014352481,0.40668562,0.00008279611,0.020318987,0.0006789877],"about_ca_topic_score_codex":0.00020044533,"about_ca_topic_score_gemma":0.00015332772,"teacher_disagreement_score":0.32926995,"about_ca_system_score_codex":0.00012675031,"about_ca_system_score_gemma":0.00021109545,"threshold_uncertainty_score":0.9979532},"labels":[],"label_agreement":null},{"id":"W2012123298","doi":"10.2165/00003495-200262150-00010","title":"Gefitinib","year":2002,"lang":"sl","type":"article","venue":"Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Gefitinib; Pharmacotherapy; Pharmacology; Internal medicine; Cancer; Epidermal growth factor receptor","score_opus":0.03679783711843848,"score_gpt":0.30342954578173936,"score_spread":0.2666317086633009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012123298","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47176164,0.02363052,0.0000018457799,0.011257257,0.002385308,0.00035868285,0.000050998064,0.00008595369,0.4904678],"genre_scores_gemma":[0.82582176,0.0025375937,0.00002900862,0.0031754875,0.0017002197,0.000020602367,0.000021885051,0.00002259569,0.16667084],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900573,0.000039977014,0.00018898066,0.00024267095,0.00015907515,0.00036353726],"domain_scores_gemma":[0.99943185,0.000088754736,0.000055409895,0.00020830204,0.000033404696,0.00018227473],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000641904,0.00016893871,0.00026643134,0.000066255074,0.00007176254,0.000013198556,0.00007428044,0.00010754025,0.050074603],"category_scores_gemma":[0.000010840291,0.00015530651,0.000119155855,0.00015091698,0.000080425816,0.000040181836,0.000027895352,0.00019853616,0.006575006],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013027404,0.001071743,0.0051632626,0.000114997274,0.0003781252,0.0002888372,0.007491141,0.0000010463102,0.0009952489,0.0005458566,0.70318365,0.28063583],"study_design_scores_gemma":[0.006697835,0.0006114244,0.003296441,0.00009575291,0.0007790558,0.00004361206,0.0013554054,0.00059839233,0.0021667494,0.00007120407,0.9840343,0.00024983683],"about_ca_topic_score_codex":0.00010050116,"about_ca_topic_score_gemma":0.000006476415,"teacher_disagreement_score":0.3540601,"about_ca_system_score_codex":0.00011220916,"about_ca_system_score_gemma":0.000027103944,"threshold_uncertainty_score":0.9941985},"labels":[],"label_agreement":null},{"id":"W2013246214","doi":"10.1159/000048240","title":"Gemcitabine as First-Line Therapy in Patients with Metastatic Breast Cancer: A Phase II Trial","year":2002,"lang":"en","type":"article","venue":"Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Toronto; Mount Sinai Hospital","funders":"Eli Lilly and Company","keywords":"Medicine; Gemcitabine; Neutropenia; Nausea; Metastatic breast cancer; Chemotherapy; Internal medicine; Surgery; Phases of clinical research; Performance status; Breast cancer; Cancer; Vomiting; Gastroenterology","score_opus":0.04271448628610791,"score_gpt":0.3772395463558425,"score_spread":0.3345250600697346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013246214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852032,0.0006301321,0.0000021024998,0.010011745,0.00041674907,0.0014258521,0.00006562399,0.00003227711,0.0022123228],"genre_scores_gemma":[0.9938087,0.0010865219,0.000091373775,0.0021004546,0.00032980728,0.00045423643,0.00007173227,0.000025016887,0.0020321659],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99891865,0.00007564072,0.00026976687,0.00027161496,0.00014933274,0.00031501072],"domain_scores_gemma":[0.999438,0.00008924318,0.00011256674,0.00015223,0.00007786184,0.00013010646],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008058198,0.00018328131,0.00054104807,0.00014523811,0.00007073512,0.0000036107767,0.0000641861,0.000079530524,0.011463756],"category_scores_gemma":[0.000010577613,0.00012918166,0.000060040948,0.00026480504,0.00008956031,0.000055142908,0.00002087039,0.00018365851,0.000054119828],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40375677,0.086613074,0.040354438,0.000040927767,0.0009189059,0.0005518808,0.001778816,0.000025869205,0.00017996301,0.00003983049,0.016603505,0.44913602],"study_design_scores_gemma":[0.7277702,0.14255783,0.013953963,0.000032489752,0.00036080246,0.000070547794,0.00001996179,0.00015634457,0.000084936226,0.000032996235,0.114773236,0.00018668221],"about_ca_topic_score_codex":0.00045982687,"about_ca_topic_score_gemma":0.00073320675,"teacher_disagreement_score":0.44894934,"about_ca_system_score_codex":0.00040560943,"about_ca_system_score_gemma":0.00015259424,"threshold_uncertainty_score":0.9894399},"labels":[],"label_agreement":null},{"id":"W2014093910","doi":"10.1158/1535-7163.targ-13-b267","title":"Abstract B267: Inhibition of PLK4 as a therapeutic strategy for genomically unstable cancers deficient for PTEN.","year":2013,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"PTEN; Cancer; Cancer research; Biology; Centrosome; Kinase; Mitosis; Cancer cell; Cell cycle; Apoptosis; PI3K/AKT/mTOR pathway; Cell biology; Genetics","score_opus":0.049749592852205884,"score_gpt":0.34668496005035554,"score_spread":0.29693536719814967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014093910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745078,0.009949582,0.0076539773,0.002116011,0.00033239802,0.003865168,0.0001823919,0.000052354997,0.0013402831],"genre_scores_gemma":[0.9920253,0.00063375937,0.00075095147,0.0040777517,0.00012131354,0.0017694545,0.00009836171,0.00007106328,0.00045205187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986041,0.000021326847,0.00037875533,0.00034373507,0.00019792978,0.00045415328],"domain_scores_gemma":[0.99900585,0.000084345425,0.00019164996,0.0002447009,0.0003553525,0.000118080665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010550331,0.00025500517,0.00041080007,0.00009586586,0.00007917195,0.000026167203,0.00009249919,0.0001494641,0.0004975241],"category_scores_gemma":[0.0000038805506,0.0002260777,0.00026794907,0.00014376992,0.00010864184,0.000060233997,0.000014156704,0.000119272976,0.000010426732],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011701429,0.00035561374,0.0003153873,0.00031699095,0.0009447203,0.0000048024667,0.00028316013,0.0016088448,0.9397054,0.0013975363,0.0005196998,0.053377748],"study_design_scores_gemma":[0.012751413,0.0031890515,0.00338574,0.00017568361,0.0020748682,0.000013707088,0.00035572713,0.004554354,0.9112566,0.007882364,0.053779185,0.0005813149],"about_ca_topic_score_codex":0.0009552116,"about_ca_topic_score_gemma":0.000095046424,"teacher_disagreement_score":0.053259484,"about_ca_system_score_codex":0.00049480185,"about_ca_system_score_gemma":0.00074617966,"threshold_uncertainty_score":0.9219181},"labels":[],"label_agreement":null},{"id":"W2014134856","doi":"10.1159/000048244","title":"Weekly Administration of Gemcitabine Plus Docetaxel in Patients with Advanced Breast Cancer: A Phase 1 Study","year":2002,"lang":"en","type":"article","venue":"Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Docetaxel; Medicine; Gemcitabine; Regimen; Toxicity; Internal medicine; Leukopenia; Gastroenterology; Stomatitis; Metastatic breast cancer; Phases of clinical research; Breast cancer; Chemotherapy; Cancer","score_opus":0.02234177178906871,"score_gpt":0.3653930936317798,"score_spread":0.3430513218427111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014134856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480146,0.00017847113,0.0000023226203,0.0016414868,0.0001517157,0.0010791803,0.000059427635,0.000017083361,0.002068851],"genre_scores_gemma":[0.9987091,0.00006647499,0.00009798825,0.00018425507,0.000067573244,0.00020180964,0.00003768314,0.000012753879,0.0006223596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991338,0.00005632604,0.0002665302,0.00021888412,0.00013314883,0.00019126384],"domain_scores_gemma":[0.99950224,0.000039308234,0.00014299407,0.00013220926,0.000104528764,0.00007871233],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000053036976,0.00012569514,0.00043238336,0.00011416636,0.000021811335,0.00000179261,0.00004762228,0.00006387913,0.0015252107],"category_scores_gemma":[0.00000625832,0.0000995779,0.000028525516,0.0002253042,0.000065032415,0.000061898914,0.000013791171,0.00012162403,0.000009218356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03093718,0.058513474,0.76808816,0.00007153104,0.00033401008,0.0003276681,0.002031516,0.00004522905,0.00093187945,0.000014827227,0.0019586955,0.1367458],"study_design_scores_gemma":[0.12695888,0.071509,0.7963828,0.000044937,0.00042893898,0.000048958562,0.0003504722,0.00018514057,0.00023668102,0.0000040034565,0.003697317,0.00015290712],"about_ca_topic_score_codex":0.00015528938,"about_ca_topic_score_gemma":0.00097595085,"teacher_disagreement_score":0.1365929,"about_ca_system_score_codex":0.00040914197,"about_ca_system_score_gemma":0.0001927248,"threshold_uncertainty_score":0.9993875},"labels":[],"label_agreement":null},{"id":"W2015951140","doi":"10.1097/00004347-200010000-00018","title":"Mitotic Arrest of Endometrial Epithelium After Paclitaxel Therapy for Breast Cancer","year":2000,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Biotech (Canada)","funders":"","keywords":"Paclitaxel; Carcinoma; Endometrium; Breast cancer; Clear cell carcinoma; Biology; Breast carcinoma; Pathology; Cancer; Oncology; Medicine; Internal medicine; Cancer research","score_opus":0.024986378719436476,"score_gpt":0.35609183010171236,"score_spread":0.3311054513822759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015951140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866795,0.0014148426,0.00006716154,0.008189811,0.0026739768,0.00029165432,0.0002665332,0.000007305073,0.0004092037],"genre_scores_gemma":[0.99293643,0.0024185195,0.00062134,0.0019467088,0.0016761726,0.000057827456,0.000008117382,0.000011221153,0.00032367525],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99874324,0.000098315,0.0005720346,0.00015409912,0.00023811206,0.00019418671],"domain_scores_gemma":[0.99829787,0.00070637424,0.0002994967,0.00007456949,0.0005193168,0.00010235077],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002842019,0.00013232788,0.0004862882,0.00020509912,0.000018802106,0.00000683403,0.00019260275,0.00014934165,0.013376348],"category_scores_gemma":[0.00016043145,0.00008787993,0.0003546527,0.000089081674,0.00017526367,0.00006129231,0.00001713317,0.00019540077,0.0000130324515],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11107252,0.006742023,0.29001027,0.00003958393,0.0027724593,0.0040737186,0.00042123912,0.0001550467,0.05890253,0.00027846082,0.0069004656,0.5186317],"study_design_scores_gemma":[0.02232226,0.0062177805,0.9421512,0.000054395183,0.00026827943,0.002186624,0.000023984392,0.000022829798,0.002742569,0.0017973719,0.02206908,0.00014363595],"about_ca_topic_score_codex":0.000011791186,"about_ca_topic_score_gemma":0.000009869107,"teacher_disagreement_score":0.6521409,"about_ca_system_score_codex":0.00013925302,"about_ca_system_score_gemma":0.00014894152,"threshold_uncertainty_score":0.9875256},"labels":[],"label_agreement":null},{"id":"W2016078871","doi":"10.1271/bbb.80698","title":"Taxusecone, a Novel Taxane with an Unprecedented 11,12-Secotaxane Skeleton, from<i>Taxus cuspidata</i>Needles","year":2009,"lang":"en","type":"article","venue":"Bioscience Biotechnology and Biochemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Hebei Medical University; Hebei University","keywords":"Taxane; Taxus; Skeleton (computer programming); Botany; Biology; Medicine; Internal medicine; Anatomy; Cancer","score_opus":0.011889250572837134,"score_gpt":0.26492502981578375,"score_spread":0.2530357792429466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016078871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910419,0.0007567259,0.00020040278,0.0069246427,0.00009720526,0.00026809485,0.00011588501,0.0002630417,0.00033211132],"genre_scores_gemma":[0.99375683,0.00036408278,0.0032731206,0.0015600653,0.0001427647,0.000017820603,0.00017660236,0.000012566129,0.00069616985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822235,0.000010947473,0.00026071037,0.0008457525,0.00018579322,0.00047442137],"domain_scores_gemma":[0.99897647,0.000026063493,0.0001700079,0.000516068,0.000054643264,0.00025674407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010335769,0.00031923447,0.0003753197,0.00013371908,0.00018867914,0.0000344232,0.0003039757,0.00058870553,0.0001289789],"category_scores_gemma":[0.000044681074,0.00024475693,0.00004758102,0.00042327997,0.0009734823,0.00012708848,0.000066499975,0.00031825472,0.000008103898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036467594,0.0006572778,0.0080058025,0.000020424523,0.00003786721,0.000060080154,0.000037484944,1.281534e-7,0.9849654,0.00006073579,0.00042956,0.0053605665],"study_design_scores_gemma":[0.0027617542,0.0016604011,0.020879917,0.00007325818,0.00013365764,0.00046602753,0.0002735883,0.000049677023,0.96693355,0.000041171308,0.006402865,0.00032412595],"about_ca_topic_score_codex":0.00017432348,"about_ca_topic_score_gemma":0.00012142983,"teacher_disagreement_score":0.01803184,"about_ca_system_score_codex":0.00007578693,"about_ca_system_score_gemma":0.00017265024,"threshold_uncertainty_score":0.9980898},"labels":[],"label_agreement":null},{"id":"W2016664719","doi":"10.1007/s10637-008-9193-5","title":"Pemetrexed combined with paclitaxel: a dose-finding study evaluating three schedules in solid tumors","year":2008,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Pemetrexed; Medicine; Paclitaxel; Neutropenia; Pharmacokinetics; Febrile neutropenia; Mesothelioma; Pharmacology; Toxicity; Internal medicine; Chemotherapy; Oncology; Cisplatin; Pathology","score_opus":0.11158738678637896,"score_gpt":0.3833905561850204,"score_spread":0.2718031693986414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016664719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480695,0.00014715528,0.000012018286,0.0028868865,0.00008706106,0.0010656279,0.0000044951944,0.000072541465,0.0009172933],"genre_scores_gemma":[0.993434,0.0000049961045,0.0047037397,0.0006928964,0.00023517212,0.00013018891,0.00006701876,0.000029112603,0.0007028486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832207,0.000086251835,0.0003800204,0.00034773417,0.00058022153,0.00028370548],"domain_scores_gemma":[0.9990903,0.00024288207,0.00014084275,0.00016584822,0.00011006296,0.00025006328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030208347,0.00021246006,0.00038590253,0.00026222935,0.0001566024,0.000013451102,0.000088170156,0.00004892176,0.0002559149],"category_scores_gemma":[0.00014746426,0.0001760969,0.000051834646,0.00057079317,0.00018976077,0.0001290565,0.000035261495,0.00024638642,0.000040480678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010208545,0.00074094656,0.98841,0.00002477751,0.0001880022,0.00023820088,0.0044299862,0.000341088,0.0024818871,0.00069951196,0.00064983603,0.0007749069],"study_design_scores_gemma":[0.019886594,0.0035676737,0.9683311,0.00020057199,0.00017180292,0.00010305159,0.00086223497,0.001749078,0.00133672,0.0035076889,0.000045550296,0.00023790664],"about_ca_topic_score_codex":0.00073252636,"about_ca_topic_score_gemma":0.0005584456,"teacher_disagreement_score":0.020078877,"about_ca_system_score_codex":0.0002211689,"about_ca_system_score_gemma":0.0012434205,"threshold_uncertainty_score":0.7181023},"labels":[],"label_agreement":null},{"id":"W2017016310","doi":"10.1016/j.ijpharm.2003.11.005","title":"Amphiphilic dextran-graft-poly(ε-caprolactone) films for the controlled release of paclitaxel","year":2003,"lang":"en","type":"article","venue":"International Journal of Pharmaceutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Copolymer; Polymer chemistry; Caprolactone; Polymerization; Gel permeation chromatography; Paclitaxel; Amphiphile; Dimethyl sulfoxide; Crystallization; Chemistry; Ring-opening polymerization; Materials science; Nuclear chemistry; Organic chemistry; Polymer; Surgery","score_opus":0.056982591852700853,"score_gpt":0.4042646356945713,"score_spread":0.34728204384187045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017016310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8892051,0.049195014,0.012042663,0.03277627,0.009988439,0.0028560802,0.00026984946,0.00003425519,0.0036323313],"genre_scores_gemma":[0.99417573,0.0019989656,0.0010290657,0.001587499,0.00047946745,0.000023095447,0.0000059846684,0.000017942786,0.0006822263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985937,0.00007580993,0.00063191255,0.00009384106,0.00043600812,0.00016871387],"domain_scores_gemma":[0.99753267,0.0008556688,0.0005313919,0.00009723497,0.00085034803,0.0001326986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056518463,0.00013752903,0.00038987296,0.00015299814,0.000042552507,0.000014693855,0.00022256265,0.00005684282,0.0007101456],"category_scores_gemma":[0.00034383388,0.00008742053,0.00044266705,0.00008380858,0.00010363247,0.00007691117,0.000012316898,0.00025733662,0.000003842865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.096060194,0.006669693,0.0372665,0.00029213482,0.025387432,0.00062982517,0.0021487707,0.00089217525,0.71796256,0.013490555,0.028542724,0.07065745],"study_design_scores_gemma":[0.13183063,0.0018390709,0.0025717423,0.00020092314,0.005411973,0.00179303,0.00043455046,0.00586605,0.45491442,0.0021058463,0.39272943,0.0003023201],"about_ca_topic_score_codex":0.000007388261,"about_ca_topic_score_gemma":0.0000030860153,"teacher_disagreement_score":0.3641867,"about_ca_system_score_codex":0.000098662866,"about_ca_system_score_gemma":0.0002979111,"threshold_uncertainty_score":0.7775597},"labels":[],"label_agreement":null},{"id":"W2017456980","doi":"10.1016/s0968-0896(00)00056-0","title":"Taxus canadensis abundant taxane: conversion to paclitaxel and rearrangements","year":2000,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; Armand Frappier Museum; Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Taxane; Paclitaxel; Chemistry; Taxus; Stereochemistry; Pharmacology; Botany; Chemotherapy; Cancer; Internal medicine; Biology","score_opus":0.010472232468410558,"score_gpt":0.2682901490857428,"score_spread":0.2578179166173322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017456980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826508,0.0017602327,0.0000013860194,0.0061843004,0.00013379652,0.00025595882,0.000033631703,0.000050444905,0.008929437],"genre_scores_gemma":[0.977023,0.00056604645,0.000072157054,0.0026716825,0.0003707839,0.000014847372,0.00006916153,0.000022104421,0.01919019],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988493,0.0000129536365,0.0001980079,0.00035060276,0.0002752787,0.00031389412],"domain_scores_gemma":[0.9991377,0.000028786768,0.000041934127,0.00021333813,0.000047674068,0.000530541],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009556988,0.00019058872,0.00029665386,0.000031649804,0.00008276285,0.000008124187,0.00007306605,0.0001135022,0.018195705],"category_scores_gemma":[0.000032912827,0.00016429582,0.00004228613,0.00017288011,0.00010477202,0.000024234258,0.000028806686,0.00016752906,0.00018569773],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088157225,0.00021442812,0.010327802,0.00033582907,0.00023317318,0.0006248622,0.0005407149,1.01372564e-7,0.8337667,0.0000017503207,0.12898934,0.024083743],"study_design_scores_gemma":[0.0089962715,0.0009906652,0.04529911,0.00037422794,0.0010031918,0.0012977376,0.0008983948,0.000016554613,0.48184162,0.000013167895,0.4587922,0.00047682805],"about_ca_topic_score_codex":0.0013538739,"about_ca_topic_score_gemma":0.000048449827,"teacher_disagreement_score":0.35192505,"about_ca_system_score_codex":0.0002317885,"about_ca_system_score_gemma":0.0001649178,"threshold_uncertainty_score":0.9827018},"labels":[],"label_agreement":null},{"id":"W2018891796","doi":"10.1158/1535-7163.targ-09-c161","title":"Abstract C161: Modulation of thymidine phosphorylase (TP) expression in breast cancer cell lines exposed to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Thymidine phosphorylase; SKBR3; Pharmacology; Cytidine deaminase; Cell growth; Cancer research; Capecitabine; Epidermal growth factor receptor; Cancer; Growth inhibition; Chemistry; Biology; Cancer cell; Internal medicine; Biochemistry; Medicine; Colorectal cancer; Enzyme","score_opus":0.025792739691510157,"score_gpt":0.3074214845298739,"score_spread":0.28162874483836375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018891796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734811,0.011678882,0.00015324312,0.012793476,0.00051192945,0.0009831069,0.00027202745,0.00004294572,0.00008329477],"genre_scores_gemma":[0.9906705,0.003280861,0.00029255298,0.0049134144,0.00044626865,0.00014438381,0.000063655105,0.000050422717,0.00013794465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982368,0.000079470534,0.0005031836,0.00040848771,0.0003721931,0.00039989286],"domain_scores_gemma":[0.9989915,0.000048090762,0.00021465422,0.00035054504,0.00023018777,0.00016505456],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011346665,0.0003482932,0.00045701716,0.000116939555,0.0000708004,0.000018027373,0.00017089453,0.00016570078,0.0006484416],"category_scores_gemma":[0.0000067793158,0.0002540123,0.00016334596,0.00038339052,0.00005290404,0.00010626083,0.000034318044,0.000252285,0.000007652436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020993014,0.0007578163,0.0060150875,0.00007728436,0.00007881406,0.000026518379,0.00089938636,0.000995639,0.96369535,0.0000059470012,0.00084648887,0.024502369],"study_design_scores_gemma":[0.0034513108,0.00035390558,0.08985836,0.00024258823,0.00015146402,0.0000035076298,0.00007014547,0.00038583126,0.90228677,0.000021560223,0.0029319925,0.0002425754],"about_ca_topic_score_codex":0.0007114108,"about_ca_topic_score_gemma":0.0001716033,"teacher_disagreement_score":0.08384327,"about_ca_system_score_codex":0.00046585206,"about_ca_system_score_gemma":0.00020793463,"threshold_uncertainty_score":0.99999124},"labels":[],"label_agreement":null},{"id":"W2019289880","doi":"10.1016/s0040-4039(01)01286-2","title":"Synthesis of the racemic tetracyclic core of CP-225,917—a model compound lacking the sidearms of the natural product","year":2001,"lang":"en","type":"article","venue":"Tetrahedron Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemistry; Ketone; Olefin fiber; Stereochemistry; Sequence (biology); Natural product; Core (optical fiber); Organic chemistry; Catalysis; Biochemistry","score_opus":0.028857703688027325,"score_gpt":0.29662988088482106,"score_spread":0.26777217719679375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019289880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765992,0.0007952611,0.0000047306607,0.02080504,0.00043735973,0.00066274364,0.000015462258,0.000017391152,0.00066278805],"genre_scores_gemma":[0.99720323,0.000098007964,0.00005538896,0.002073797,0.00013764996,0.00002071528,0.0000027058825,0.000023847586,0.00038463643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986712,0.00009483958,0.00038740673,0.00021696808,0.0003766118,0.00025298176],"domain_scores_gemma":[0.9985669,0.0003908626,0.00032667886,0.0006220353,0.00006225082,0.000031244566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022141355,0.00018411274,0.00039072952,0.00006240407,0.000097682685,0.000004575441,0.00038580794,0.000050019356,0.000068105255],"category_scores_gemma":[0.000105195526,0.00008753119,0.0002736974,0.0003670197,0.00058613176,0.000050479386,0.000077976416,0.00035796402,0.0000019847876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042963336,0.00024147054,0.103439696,0.00016055889,0.000312416,0.0000072948396,0.0010940362,0.0013367598,0.8835944,0.00007671227,0.006004803,0.0033022298],"study_design_scores_gemma":[0.0030733743,0.00016199377,0.26701477,0.000538543,0.0014851481,0.000245468,0.0003786212,0.0045392932,0.7195941,0.0001887676,0.0024952479,0.00028463145],"about_ca_topic_score_codex":0.00028607753,"about_ca_topic_score_gemma":0.00007002108,"teacher_disagreement_score":0.16400026,"about_ca_system_score_codex":0.00010977529,"about_ca_system_score_gemma":0.000093568095,"threshold_uncertainty_score":0.35694182},"labels":[],"label_agreement":null},{"id":"W2019519157","doi":"10.1021/np000053u","title":"New Taxanes from the Needles of <i>Taxus canadensis</i>","year":2000,"lang":"en","type":"article","venue":"Journal of Natural Products","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de la Recherche Scientifique; McGill University; Queen's University; Université du Québec à Montréal","funders":"","keywords":"Taxus; Diterpene; Botany; Taxane; Biology; Stereochemistry; Chemistry","score_opus":0.01363695692924387,"score_gpt":0.27137455134761956,"score_spread":0.2577375944183757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019519157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93425953,0.027290357,2.5881087e-7,0.03681421,0.00090674334,0.00012143303,0.000006582909,0.000004236788,0.00059666275],"genre_scores_gemma":[0.98752576,0.0007612926,0.0005283551,0.0013040953,0.0026089726,2.8111504e-7,0.0000045049765,0.0000075852377,0.007259127],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992709,0.000033996323,0.00026676196,0.000085162515,0.00022384361,0.00011933454],"domain_scores_gemma":[0.9993198,0.000086884094,0.00020572942,0.00012754758,0.00018361863,0.00007640815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009287071,0.00008968295,0.00026949175,0.000037076137,0.000030727817,0.0000064437527,0.00010893693,0.00003587451,0.00072474906],"category_scores_gemma":[0.00007714004,0.000047434693,0.00008862838,0.00017059503,0.000043157826,0.00007249708,0.000008047123,0.00028679645,0.0000076527085],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020183888,0.00012858509,0.004108684,0.00002633965,0.00053291436,0.00021427164,0.0011655497,0.000015863638,0.13761419,0.000008603349,0.7443844,0.10978223],"study_design_scores_gemma":[0.006676035,0.0011863235,0.1503357,0.00026804738,0.001473606,0.0017711064,0.0002888851,0.000008819917,0.27730575,0.00039657834,0.560095,0.00019411379],"about_ca_topic_score_codex":0.002306199,"about_ca_topic_score_gemma":0.00018153487,"teacher_disagreement_score":0.18428935,"about_ca_system_score_codex":0.000048887203,"about_ca_system_score_gemma":0.00036585427,"threshold_uncertainty_score":0.7935494},"labels":[],"label_agreement":null},{"id":"W2019621848","doi":"10.1016/j.clinthera.2014.10.023","title":"Comparative Effectiveness Analysis of Monotherapy With Cytotoxic Agents in Triple-negative Metastatic Breast Cancer in a Community Setting","year":2014,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"Eisai","keywords":"Medicine; Vinorelbine; Eribulin; Internal medicine; Oncology; Gemcitabine; Capecitabine; Metastatic breast cancer; Breast cancer; Cancer; Chemotherapy; Colorectal cancer","score_opus":0.17232625910111957,"score_gpt":0.5039678140005637,"score_spread":0.33164155489944414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019621848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982893,0.00015912544,0.0002942531,0.00024259074,0.000060248745,0.0007176972,0.00006676643,0.000011719465,0.00015831356],"genre_scores_gemma":[0.9984198,0.00026962926,0.00027184768,0.00085822365,0.000024867673,0.00009810069,0.000019703233,0.000014746202,0.000023065337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634874,0.0025081066,0.0005851344,0.00021160003,0.00014472402,0.00020171628],"domain_scores_gemma":[0.9955672,0.0037486989,0.0002609993,0.00025093547,0.00010260283,0.000069573296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014466644,0.00018075673,0.0013025673,0.00027273246,0.00003894121,0.0000051360907,0.000105828294,0.00007806292,0.00010699042],"category_scores_gemma":[0.000026815358,0.00013188014,0.00018120496,0.0011549898,0.00026366962,0.000040348266,0.000020908787,0.0005503703,0.000001220881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071377754,0.0028633978,0.96670085,0.00006898173,0.0060779867,0.000007812037,0.00314237,0.001898309,0.00093331037,0.000018838873,0.0000030055257,0.011147355],"study_design_scores_gemma":[0.013279904,0.0013298056,0.9595833,0.00017435879,0.0024036905,0.0000020820887,0.00034350384,0.021414062,0.0011803365,0.00013594331,0.00003264677,0.00012036843],"about_ca_topic_score_codex":0.0008984995,"about_ca_topic_score_gemma":0.0029597334,"teacher_disagreement_score":0.019515753,"about_ca_system_score_codex":0.0001655213,"about_ca_system_score_gemma":0.00012239696,"threshold_uncertainty_score":0.53779155},"labels":[],"label_agreement":null},{"id":"W2020833122","doi":"10.1016/j.pain.2010.10.015","title":"Allopregnanolone prevents and suppresses oxaliplatin-evoked painful neuropathy: Multi-parametric assessment and direct evidence","year":2010,"lang":"en","type":"article","venue":"Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nortel (Canada)","funders":"","keywords":"Medicine; Pharmacology; Allodynia; Neurochemical; Hyperalgesia; Nociception; Endocrinology; Internal medicine; Receptor","score_opus":0.04169945097443233,"score_gpt":0.3664275901289942,"score_spread":0.32472813915456183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020833122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947832,0.0026563907,0.00020440137,0.0009690466,0.00025166833,0.00061634317,0.000008661496,0.0000694098,0.0004408591],"genre_scores_gemma":[0.99401927,0.0012104122,0.002887904,0.0004128631,0.000095124895,0.00008603126,0.00001222836,0.000019336809,0.0012568481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987279,0.0003876882,0.00017345688,0.00033714532,0.0001487274,0.00022505176],"domain_scores_gemma":[0.99794114,0.0015824501,0.000073406896,0.00019780979,0.00003818528,0.0001669962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001086903,0.00016502039,0.00027625423,0.000120081895,0.000076428354,0.000028766019,0.00005724788,0.000078546705,0.00017002219],"category_scores_gemma":[0.00081797387,0.00013753204,0.000035777546,0.00017715622,0.00009999427,0.00009464106,0.00006877837,0.00023857014,0.000004690813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013253881,0.00041023537,0.7970998,0.0001989146,0.000103394545,0.000107055006,0.00025017807,0.0000014042929,0.14616966,0.000014347402,0.0011056198,0.054406844],"study_design_scores_gemma":[0.0038204326,0.0010443318,0.96696883,0.00026829133,0.00041553105,0.00008368436,0.000038798014,0.008470973,0.010716986,0.000052501244,0.007836566,0.00028309735],"about_ca_topic_score_codex":0.00009816538,"about_ca_topic_score_gemma":0.00006126068,"teacher_disagreement_score":0.16986899,"about_ca_system_score_codex":0.000025813046,"about_ca_system_score_gemma":0.00006857867,"threshold_uncertainty_score":0.5608394},"labels":[],"label_agreement":null},{"id":"W2021067098","doi":"10.1016/s0031-9422(01)00305-3","title":"Taxines from the needles of Taxus wallichiana","year":2001,"lang":"en","type":"article","venue":"Phytochemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute; National Research Council Canada","funders":"","keywords":"Stereochemistry; Cancer cell lines; Chemistry; Traditional medicine; Taxus; Botany; Biology; Cancer; Cancer cell; Medicine","score_opus":0.02120331456052698,"score_gpt":0.29733164723402344,"score_spread":0.27612833267349646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021067098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720055,0.002552883,0.000007725783,0.002140399,0.00008234613,0.000104769926,0.000028127577,0.000021574233,0.023056658],"genre_scores_gemma":[0.9955821,0.0002517306,0.000092477356,0.00048754254,0.0006451874,0.000022990504,0.00005397323,0.000008000721,0.002855965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995787,0.0000059532986,0.00011068028,0.00011159801,0.00008608412,0.00010696931],"domain_scores_gemma":[0.99960095,0.000069895104,0.00005292116,0.00019668999,0.0000328186,0.00004670898],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000022129405,0.0000814469,0.00014775617,0.0000065166946,0.000025924108,0.0000028989034,0.000075973374,0.000042527783,0.0009978879],"category_scores_gemma":[0.000018388533,0.000053691518,0.0000705824,0.00008088559,0.00006667226,0.000012659384,0.000019420737,0.000081778875,0.000014988904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004293712,0.00030513984,0.20544566,0.000050484574,0.0002684794,0.000042396685,0.00037790913,0.000002189167,0.7514896,0.000010837594,0.036429532,0.005148421],"study_design_scores_gemma":[0.0026817045,0.000106597356,0.091805175,0.00008610949,0.00037054613,0.00005871896,0.00034097373,0.00003753541,0.84239876,0.00048842904,0.061491847,0.00013359668],"about_ca_topic_score_codex":0.00026697546,"about_ca_topic_score_gemma":0.000009690124,"teacher_disagreement_score":0.11364049,"about_ca_system_score_codex":0.000019852847,"about_ca_system_score_gemma":0.000044300366,"threshold_uncertainty_score":0.99991536},"labels":[],"label_agreement":null},{"id":"W2021094196","doi":"10.1078/0944-7113-00010","title":"The influence of ultraviolet radiation on the content of pharmacologically active taxoids in yew tissues","year":2001,"lang":"en","type":"article","venue":"Phytomedicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trent University","funders":"","keywords":"Taxus; Chemistry; Paclitaxel; Chromatography; Wax; High-performance liquid chromatography; Organic chemistry; Botany; Biology","score_opus":0.048724377100539625,"score_gpt":0.35516847161971365,"score_spread":0.30644409451917404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021094196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98650163,0.0010962766,0.000002151934,0.009833824,0.000121226985,0.0006219753,0.000008161839,0.000009588988,0.001805137],"genre_scores_gemma":[0.99382275,0.004144626,0.0000048202005,0.0013746732,0.00015090591,0.00007816457,0.000008236637,0.0000057316365,0.0004101075],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99914086,0.000077225384,0.00028770327,0.000118857155,0.00021912719,0.00015622347],"domain_scores_gemma":[0.998914,0.00063326507,0.00016533241,0.00013862984,0.00010257314,0.00004621873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026670235,0.00010061677,0.00027599276,0.000064038366,0.000035544843,0.0000013707189,0.000101186044,0.000037749636,0.0001860434],"category_scores_gemma":[0.00014025874,0.000047189696,0.000044383196,0.0002787887,0.00028059786,0.000025983822,0.000012367679,0.00017492256,0.0000057928655],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008220491,0.001363915,0.14002381,0.00007043587,0.0003600402,0.000086328866,0.0020956835,0.00016344676,0.75705105,0.0002711102,0.0040047728,0.086288914],"study_design_scores_gemma":[0.004711149,0.002083088,0.8505688,0.00015519872,0.00013671532,0.000013531473,0.0003463721,0.000038593364,0.13104254,0.0001095175,0.01074229,0.000052242616],"about_ca_topic_score_codex":0.00016678615,"about_ca_topic_score_gemma":0.000020181824,"teacher_disagreement_score":0.71054494,"about_ca_system_score_codex":0.000073528994,"about_ca_system_score_gemma":0.000050706927,"threshold_uncertainty_score":0.20370448},"labels":[],"label_agreement":null},{"id":"W2021166818","doi":"10.1016/j.cct.2015.01.012","title":"Rationale and design of a randomized double-blind clinical trial in breast cancer: Dextromethorphan in chemotherapy-induced peripheral neuropathy","year":2015,"lang":"en","type":"article","venue":"Contemporary Clinical Trials","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dextromethorphan; Peripheral neuropathy; Neuropathic pain; Breast cancer; Chemotherapy-induced peripheral neuropathy; Randomized controlled trial; Clinical trial; Anesthesia; McGill Pain Questionnaire; Chemotherapy; Internal medicine; Oncology; Cancer; Visual analogue scale; Diabetes mellitus","score_opus":0.6354221504394105,"score_gpt":0.5579869869232856,"score_spread":0.0774351635161249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021166818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758321,0.0030319681,0.00015224687,0.007846866,0.0018042905,0.010961581,0.000031323932,0.000026008294,0.00031358734],"genre_scores_gemma":[0.99264467,0.0025565745,0.0005751419,0.0013669445,0.0017353026,0.00081787416,0.000028911156,0.000032942655,0.00024165049],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9825433,0.011407127,0.0049163094,0.00059073936,0.00030278348,0.00023977693],"domain_scores_gemma":[0.98504645,0.0129734315,0.0011393175,0.00026430402,0.00018748896,0.0003890157],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.043280575,0.0002708015,0.004484918,0.00023847765,0.0000180144,0.000020739168,0.00012778265,0.00038750385,0.00020448436],"category_scores_gemma":[0.005164145,0.00020328062,0.0006406824,0.0003377127,0.00034567984,0.00014615023,0.00004459991,0.0005210307,0.000003111188],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9445464,0.002215345,0.040413894,0.000022371432,0.00039379808,0.00008230559,0.00020503903,0.0000063217612,0.00050399546,0.00002646373,0.001723429,0.0098606255],"study_design_scores_gemma":[0.9896526,0.0028233924,0.0052513783,0.00011050405,0.00027213478,0.000014067178,0.000042413158,0.0005721639,0.00013548862,0.0003251668,0.00063304376,0.00016766043],"about_ca_topic_score_codex":0.00034805518,"about_ca_topic_score_gemma":0.000027387507,"teacher_disagreement_score":0.045106176,"about_ca_system_score_codex":0.00007865442,"about_ca_system_score_gemma":0.0020653158,"threshold_uncertainty_score":0.98514396},"labels":[],"label_agreement":null},{"id":"W2021291110","doi":"10.1158/1538-7445.am2014-5008","title":"Abstract 5008: The acetylenic tricyclic bis(cyanoeneone), TBE-31 inhibits non-small cell lung cancer cell migration through direct binding with actin","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cell migration; Chemistry; Cell; Actin; Stress fiber; Cancer research; Cancer cell; Cell biology; Cancer; Biochemistry; Biology; Medicine; Internal medicine; Cytoskeleton","score_opus":0.06326090767832017,"score_gpt":0.4001251519401802,"score_spread":0.33686424426186007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021291110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9555673,0.007963498,0.000017937042,0.0047544898,0.0003884418,0.0017393255,0.000039404502,0.00006775826,0.029461851],"genre_scores_gemma":[0.9648742,0.012123988,0.00006474389,0.00040841615,0.0011170217,0.0013371288,0.00004372333,0.00008425341,0.019946527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99705136,0.0002226807,0.0003305188,0.00067651115,0.0007386641,0.0009802802],"domain_scores_gemma":[0.9981301,0.0006232008,0.00016961579,0.0005131768,0.00032198054,0.00024193962],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00080250285,0.00033888273,0.00046673528,0.00018373279,0.00051205856,0.00009570283,0.00030916202,0.000184627,0.0012746458],"category_scores_gemma":[0.000033781223,0.00021644938,0.00013976423,0.0008872338,0.00021993088,0.00023454335,0.000101213554,0.00093190576,0.00008542258],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026176039,0.00061587285,0.042251028,0.0009661889,0.00035848282,0.00004764482,0.0044671576,0.00027903178,0.8509662,0.000009332055,0.08946091,0.007960535],"study_design_scores_gemma":[0.0071160872,0.00088703155,0.014276298,0.0004777671,0.00042678966,0.000011085842,0.00058002234,0.00031113945,0.8478028,0.0000072763123,0.1277069,0.00039677793],"about_ca_topic_score_codex":0.016293535,"about_ca_topic_score_gemma":0.010950544,"teacher_disagreement_score":0.03824599,"about_ca_system_score_codex":0.0013466013,"about_ca_system_score_gemma":0.001264127,"threshold_uncertainty_score":0.9996383},"labels":[],"label_agreement":null},{"id":"W2024177131","doi":"10.1016/j.jpainsymman.2006.11.008","title":"An Open-Label, Multi-Dose Efficacy and Safety Study of Intramuscular Tetrodotoxin in Patients with Severe Cancer-Related Pain","year":2007,"lang":"en","type":"article","venue":"Journal of Pain and Symptom Management","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Western University; Baker Hughes (Canada); Royal University Hospital; Inimex Pharmaceuticals (Canada); Université de Montréal","funders":"University of Alberta; Université de Sherbrooke","keywords":"Medicine; Anesthesia; Analgesic; Cancer pain; Adverse effect; Nausea; Neuropathic pain; Cancer; Internal medicine","score_opus":0.01644011070241777,"score_gpt":0.3279065961283155,"score_spread":0.3114664854258977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024177131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771017,0.00035258714,0.000127973,0.0001469891,0.00006700247,0.0014859888,0.0000019960396,0.0000061633696,0.00010111017],"genre_scores_gemma":[0.9983046,0.0002670621,0.0010404857,0.00024615572,0.000024686668,0.000008091873,0.0000047740095,0.00001428042,0.000089876296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985161,0.0003253337,0.0005337978,0.00018447872,0.00025275326,0.00018757368],"domain_scores_gemma":[0.9992417,0.00011591293,0.000268227,0.00013153127,0.00008599337,0.00015659636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028209575,0.00015147169,0.00042456726,0.0002565392,0.00004582765,0.000018847912,0.000110013374,0.000044291286,0.000039681323],"category_scores_gemma":[0.000018181401,0.000107490305,0.000015646709,0.00022037217,0.000035074434,0.0001092789,0.000058415902,0.00016959073,1.5682195e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058282106,0.0143513465,0.86526436,0.000159312,0.0012468678,0.00029530836,0.0028384954,0.000058192174,0.00013512584,0.000014700679,0.0001360105,0.109672055],"study_design_scores_gemma":[0.070205085,0.014570788,0.9120552,0.00026460525,0.00044134422,0.000005650576,0.001545355,0.00028880485,0.000009483632,0.0000042781626,0.0004984048,0.00011101909],"about_ca_topic_score_codex":0.00011385634,"about_ca_topic_score_gemma":0.0002668974,"teacher_disagreement_score":0.10956103,"about_ca_system_score_codex":0.00015268773,"about_ca_system_score_gemma":0.00002821614,"threshold_uncertainty_score":0.43833274},"labels":[],"label_agreement":null},{"id":"W2024302667","doi":"10.1007/s10549-007-9610-z","title":"Gemcitabine in the management of metastatic breast cancer: a systematic review","year":2007,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McMaster University; Ottawa Hospital","funders":"","keywords":"Gemcitabine; Docetaxel; Medicine; Oncology; Taxane; Metastatic breast cancer; Internal medicine; Breast cancer; Capecitabine; Clinical trial; Randomized controlled trial; Chemotherapy; Anthracycline; Cancer; Colorectal cancer","score_opus":0.20374862271191702,"score_gpt":0.5221446010040509,"score_spread":0.3183959782921339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024302667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039276747,0.9844312,4.3387737e-7,0.0015979299,0.000073296855,0.011900805,0.0012565982,0.0000148458175,0.0006856319],"genre_scores_gemma":[0.00022833883,0.984049,0.000024642917,0.00013183327,0.0001294294,0.013834676,0.00015756351,0.000054219145,0.001390279],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9959501,0.00063104444,0.0010805489,0.0006388726,0.0009216101,0.00077780255],"domain_scores_gemma":[0.9980979,0.0003964603,0.0003405821,0.00070026016,0.00021679889,0.0002480082],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013767746,0.00060061127,0.0036519913,0.00053707795,0.000105705796,0.000028201912,0.00029526473,0.00010402522,0.00049594004],"category_scores_gemma":[0.0000039863708,0.0003016078,0.00046017056,0.0014177394,0.00024506403,0.00004801498,0.000101376216,0.00041854076,0.000024990906],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001973648,0.0011178261,0.000048297454,0.60377556,0.0036969755,0.0007297525,0.000059241323,5.314487e-8,6.5891655e-8,0.00011561225,0.0003901679,0.3898691],"study_design_scores_gemma":[0.0036366314,0.0007938428,0.0005893264,0.8465413,0.024752382,0.0029526367,0.00014033602,0.0000011221823,6.1802876e-7,0.000019584266,0.12029022,0.00028202077],"about_ca_topic_score_codex":0.0040831445,"about_ca_topic_score_gemma":0.00069042377,"teacher_disagreement_score":0.38958707,"about_ca_system_score_codex":0.001789393,"about_ca_system_score_gemma":0.0008983198,"threshold_uncertainty_score":0.9999436},"labels":[],"label_agreement":null},{"id":"W2024641982","doi":"10.1515/hc-2012-0035","title":"Canataxpyran A, a novel 3,8-secotaxane with a 13,17-ether bridge from needles of <i>Taxus canadensis</i>","year":2012,"lang":"en","type":"article","venue":"Heterocyclic Communications","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Japan Society for the Promotion of Science; Hebei Medical University; National Natural Science Foundation of China","keywords":"Chemistry; Bicyclic molecule; Taxane; Ether; Bridge (graph theory); Stereochemistry; Epoxy; Organic chemistry","score_opus":0.06911849081064683,"score_gpt":0.33212529342922176,"score_spread":0.2630068026185749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024641982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785649,0.005037349,0.0001563238,0.0038580436,0.00010760468,0.00046809128,0.00038204697,0.00005362132,0.011371993],"genre_scores_gemma":[0.99421835,0.00028874955,0.0028969555,0.0012310109,0.000112191905,0.00011926072,0.00031325658,0.000030844287,0.00078940584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990446,0.000057136418,0.00028451395,0.00015088725,0.00015819338,0.00030469228],"domain_scores_gemma":[0.99791336,0.00022467754,0.00016255418,0.0013824422,0.00007853338,0.00023842862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063267544,0.00017181077,0.00035892686,0.00010037893,0.00012199192,0.0000072149915,0.00030999,0.000073602154,0.0005374762],"category_scores_gemma":[0.00001370973,0.0001453733,0.000087272194,0.0001967457,0.00022422231,0.000086985776,0.000128073,0.0002340438,0.00002206518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001165576,0.0066264276,0.7160215,0.00013255907,0.0030322263,0.000016767393,0.017612308,0.000017034337,0.19782361,0.00068259274,0.046738967,0.010130461],"study_design_scores_gemma":[0.005774027,0.00030852627,0.8107204,0.00018886235,0.0011569242,0.0001523839,0.0005107308,0.00011262372,0.00678804,0.00002762562,0.17392483,0.00033504845],"about_ca_topic_score_codex":0.100483894,"about_ca_topic_score_gemma":0.08025606,"teacher_disagreement_score":0.19103557,"about_ca_system_score_codex":0.0001484536,"about_ca_system_score_gemma":0.00009974347,"threshold_uncertainty_score":0.9365269},"labels":[],"label_agreement":null},{"id":"W2025363005","doi":"10.1016/j.ejca.2008.10.031","title":"Lessons learned from independent central review","year":2008,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Ixabepilone; Human services; Food and drug administration; Clinical trial; Lapatinib; Family medicine; Pharmacology; Cancer; Internal medicine; Breast cancer; Political science","score_opus":0.13320688196963348,"score_gpt":0.39239754501226215,"score_spread":0.25919066304262867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025363005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5437597,0.37054634,0.00007299227,0.05955072,0.0017643373,0.0002264503,0.000031906286,0.00002366938,0.024023905],"genre_scores_gemma":[0.70162433,0.2877644,0.00014702951,0.005054915,0.001502892,0.0000013053469,0.0000049918876,0.00002446079,0.0038756372],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989681,0.0001717942,0.0003307945,0.000103641985,0.00025711255,0.00016855905],"domain_scores_gemma":[0.9992901,0.00002289327,0.0002499477,0.00010491787,0.00012841601,0.00020372706],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019285636,0.0000996545,0.00031722215,0.000042602176,0.000037631562,0.0000040377313,0.00009844381,0.000012918588,0.0036515805],"category_scores_gemma":[0.000025975574,0.000073231146,0.00016884113,0.0000783655,0.000045336343,0.000053843905,0.000019726114,0.0002849554,0.0000646666],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014739526,0.00052240584,0.052204695,0.00020669316,0.0012753136,0.012065416,0.0013004384,0.00003582453,0.01137473,0.000016824819,0.55658317,0.36294052],"study_design_scores_gemma":[0.0036027497,0.0003882524,0.22817153,0.0011180363,0.0005771072,0.0004903625,0.000013245605,0.0000016667932,0.0012481721,0.000009823758,0.7642933,0.00008576097],"about_ca_topic_score_codex":0.00004031337,"about_ca_topic_score_gemma":0.0000102223385,"teacher_disagreement_score":0.36285475,"about_ca_system_score_codex":0.00012697325,"about_ca_system_score_gemma":0.0002488672,"threshold_uncertainty_score":0.9972592},"labels":[],"label_agreement":null},{"id":"W2025386509","doi":"10.3816/ccc.2006.n.024","title":"Capecitabine-Induced Cerebellar Toxicity","year":2006,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Capecitabine; Medicine; Toxicity; Neurotoxicity; Cerebellar ataxia; Prodrug; Ataxia; Fluorouracil; Colorectal cancer; Internal medicine; Oncology; Chemotherapy; Pharmacology; Cancer","score_opus":0.05591288314114927,"score_gpt":0.4110532359609091,"score_spread":0.3551403528197598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025386509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696231,0.0009496654,0.0000060327543,0.0025891825,0.0015591686,0.00048975565,0.000038695736,0.00012174678,0.024622638],"genre_scores_gemma":[0.9917276,0.00023932637,0.00010338762,0.0017061548,0.0028730598,0.000121909776,0.00004148826,0.0000289102,0.0031581484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984259,0.00008049272,0.00051663857,0.00042098362,0.00020086188,0.00035513987],"domain_scores_gemma":[0.99913925,0.00025106673,0.000114714065,0.00016766958,0.00012174893,0.00020554253],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020468392,0.00019327809,0.000514674,0.00004896281,0.000081319005,0.000011639838,0.00008931413,0.00023730578,0.0030220458],"category_scores_gemma":[0.00006218035,0.00016020064,0.000288621,0.00022619215,0.0001398085,0.000045282224,0.00004667988,0.0003689158,0.00016600876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027120248,0.0019889283,0.86131704,0.00006348528,0.00025617896,0.0001763005,0.000032677664,0.000009434315,0.05003149,0.00021787778,0.07018815,0.0130063845],"study_design_scores_gemma":[0.006612175,0.0024713073,0.8721197,0.000048437047,0.00045799994,0.000030169138,0.000013735608,0.00014735234,0.06222788,0.0002693368,0.055304658,0.00029722753],"about_ca_topic_score_codex":0.0007302325,"about_ca_topic_score_gemma":0.0015140864,"teacher_disagreement_score":0.0221045,"about_ca_system_score_codex":0.00024577082,"about_ca_system_score_gemma":0.00031348507,"threshold_uncertainty_score":0.99788934},"labels":[],"label_agreement":null},{"id":"W2025705843","doi":"10.1016/j.ejon.2004.06.010","title":"Implications of capecitabine (Xeloda®) for cancer nursing practice","year":2004,"lang":"en","type":"review","venue":"European Journal of Oncology Nursing","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Capecitabine; Medicine; Docetaxel; Oncology; Colorectal cancer; Internal medicine; Oncology nursing; Quality of life (healthcare); Chemotherapy; Metastatic breast cancer; Patient education; Breast cancer; Intensive care medicine; Cancer; Nursing; Nurse education","score_opus":0.1255189562843257,"score_gpt":0.5110774936286501,"score_spread":0.3855585373443244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025705843","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002036485,0.9645177,0.0009872218,0.0063765664,0.0020446354,0.00088764884,0.000040208808,0.000012462633,0.025113152],"genre_scores_gemma":[0.00022928168,0.9876583,0.0097008385,0.0002054678,0.0017418701,0.000020059584,0.000036962727,0.00010479144,0.00030240632],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972772,0.0006012009,0.0014013913,0.00024166369,0.00015990222,0.0003186151],"domain_scores_gemma":[0.99537253,0.0006707029,0.0028315408,0.00021651054,0.0006938487,0.00021487453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00090362877,0.00031707765,0.0020600702,0.0004144547,0.00010436232,0.000009622205,0.00023177911,0.00014266487,0.000113338145],"category_scores_gemma":[0.0002173563,0.00025474775,0.00074951164,0.000299813,0.0002782401,0.000108711254,0.000012899005,0.00069661444,0.0000077769855],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053752825,0.0014810208,0.0000017435891,0.002248627,0.00082483643,0.00019237395,0.0008315317,0.000007705121,0.0000663578,0.00012402961,0.0074830228,0.9862012],"study_design_scores_gemma":[0.004074003,0.0045310585,0.00005609051,0.04724414,0.015823686,0.0063899914,0.00015701869,4.8028335e-7,0.000010677403,0.000075399694,0.9214801,0.00015732934],"about_ca_topic_score_codex":0.0000022978568,"about_ca_topic_score_gemma":7.2351827e-7,"teacher_disagreement_score":0.9860439,"about_ca_system_score_codex":0.0034797073,"about_ca_system_score_gemma":0.004063115,"threshold_uncertainty_score":0.99999046},"labels":[],"label_agreement":null},{"id":"W2025753970","doi":"10.1177/0960327108090751","title":"N,N-diethyl-2-[4-(phenylmethyl) phenoxy] ethanamine (DPPE; tesmilifene), a chemopotentiating agent with hormetic effects on DNA synthesis in vitro, may improve survival in patients with metastatic breast cancer","year":2008,"lang":"en","type":"article","venue":"Human & Experimental Toxicology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"In vitro; Metastatic breast cancer; Breast cancer; Cancer; Medicine; Internal medicine; Chemistry; DNA; Cancer research; Oncology; Pharmacology; Endocrinology; Biochemistry","score_opus":0.020750888097219762,"score_gpt":0.30167696805283145,"score_spread":0.2809260799556117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025753970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964121,0.00042668646,0.000002810885,0.0002937405,0.00031442093,0.0018673047,0.000031395834,0.000057405956,0.0005941209],"genre_scores_gemma":[0.99673074,0.000032463988,0.00036196623,0.0007708548,0.00015274857,0.0015107496,0.00007450122,0.000097470285,0.00026851543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970361,0.00033534295,0.00051702786,0.0008231244,0.0004493297,0.0008390471],"domain_scores_gemma":[0.9988476,0.00027375275,0.00024207034,0.0003333097,0.000061835,0.00024144168],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018182382,0.0005743334,0.0011108315,0.0004048939,0.00017065303,0.000011797924,0.00015768377,0.00014833132,0.00075551646],"category_scores_gemma":[0.000021878282,0.00044920342,0.00011274231,0.0004110501,0.00033395682,0.00010813772,0.00008388823,0.00036854102,0.000024424218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013121344,0.009542837,0.23611341,0.00022342794,0.0007428907,0.0010759097,0.0022613269,0.00004331372,0.7310133,0.000016716687,0.00005942274,0.005786085],"study_design_scores_gemma":[0.020191869,0.007370248,0.43073618,0.00020882695,0.00029421007,0.00004771466,0.00041562115,0.00004977693,0.54019034,0.0000041897233,0.00002878637,0.00046220355],"about_ca_topic_score_codex":0.0010489657,"about_ca_topic_score_gemma":0.00074060034,"teacher_disagreement_score":0.19462278,"about_ca_system_score_codex":0.0013259248,"about_ca_system_score_gemma":0.00017312242,"threshold_uncertainty_score":0.999796},"labels":[],"label_agreement":null},{"id":"W2025968906","doi":"10.1016/j.expneurol.2011.08.016","title":"Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy","year":2011,"lang":"en","type":"article","venue":"Experimental Neurology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":270,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Neurological Disorders and Stroke; Canada Research Chairs; Health Canada; National Institutes of Health; Louise and Alan Edwards Foundation; Canadian Institutes of Health Research; National Institute for Health and Care Research","keywords":"Peripheral neuropathy; Medicine; Oxaliplatin; Mitochondrion; Sciatic nerve; Chemotherapy; Anesthesia; Neuropathic pain; Peripheral; Paclitaxel; Internal medicine; Cancer; Endocrinology; Biology; Colorectal cancer","score_opus":0.02971140935037471,"score_gpt":0.27147217010471275,"score_spread":0.24176076075433806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025968906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949086,0.0009424123,0.000004618435,0.00050450995,0.00058841496,0.00056481553,0.000004455888,0.00004394329,0.002438278],"genre_scores_gemma":[0.9966832,0.000022218146,0.00021721,0.0022943197,0.00017166279,0.00019475807,0.000028667819,0.00003989828,0.00034810943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836814,0.00022507815,0.0002977754,0.00054435775,0.00013626432,0.00042837588],"domain_scores_gemma":[0.99953926,0.00005826042,0.000068329704,0.00016631685,0.000020654064,0.00014720128],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007257128,0.00028323688,0.0004046456,0.00016759892,0.000052685744,0.000009727666,0.000059925624,0.0001324233,0.0012584273],"category_scores_gemma":[0.000009249572,0.00024462337,0.00005388576,0.00018801035,0.00022326033,0.000115244446,0.000059227637,0.00036512842,0.0000117104555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019570483,0.001846302,0.7462777,0.000022683116,0.000058777616,0.0035962302,0.008198043,0.00003259869,0.21899548,0.00031323754,0.0007549697,0.00033348493],"study_design_scores_gemma":[0.015654394,0.01184266,0.94658506,0.000019727806,0.000032395586,0.0014737976,0.0007118645,0.0003947349,0.02181167,0.00005861723,0.0010612326,0.00035383186],"about_ca_topic_score_codex":0.00039052128,"about_ca_topic_score_gemma":0.00040328727,"teacher_disagreement_score":0.20030737,"about_ca_system_score_codex":0.000079612786,"about_ca_system_score_gemma":0.00006713852,"threshold_uncertainty_score":0.99965453},"labels":[],"label_agreement":null},{"id":"W2026136485","doi":"10.1002/cncr.26579","title":"The use of bevacizumab among women with metastatic breast cancer: A survey on clinical practice and the ongoing controversy","year":2011,"lang":"en","type":"article","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bevacizumab; Metastatic breast cancer; Breast cancer; Family medicine; Cancer; Affect (linguistics); Gerontology; Internal medicine","score_opus":0.12954690066752347,"score_gpt":0.40342977059468765,"score_spread":0.27388286992716415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026136485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99459237,0.001467826,0.000007360891,0.0023381382,0.00026856828,0.00065900787,0.00013776762,0.000011604843,0.00051738287],"genre_scores_gemma":[0.9921153,0.004619502,0.000062477426,0.0020053028,0.00011163656,0.0002854225,0.000002758781,0.000017236702,0.0007803446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987917,0.00038114365,0.00025475773,0.00018893898,0.00016607752,0.00021738876],"domain_scores_gemma":[0.9962748,0.0029542411,0.00025794026,0.00021873412,0.0001912606,0.000103022605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007530353,0.00012381913,0.00036577368,0.000020464076,0.000102408405,0.000016810855,0.00006660593,0.00003166439,0.00021513391],"category_scores_gemma":[0.0002343754,0.00005564512,0.000041831925,0.000113312584,0.0006391048,0.000106017644,0.000024418732,0.00020788045,0.0000017193464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15533416,0.00057073036,0.7481962,0.0000596807,0.004793767,0.000067780864,0.005862607,0.00002412966,0.000027210088,0.00037412555,0.012568951,0.072120704],"study_design_scores_gemma":[0.016217193,0.0010732886,0.96437037,0.00008982592,0.0010827685,0.000030908264,0.00038419783,0.00009708977,0.000048518854,0.000014579695,0.016500188,0.00009108011],"about_ca_topic_score_codex":0.016994596,"about_ca_topic_score_gemma":0.00685514,"teacher_disagreement_score":0.2161742,"about_ca_system_score_codex":0.00015269872,"about_ca_system_score_gemma":0.0003011807,"threshold_uncertainty_score":0.9895513},"labels":[],"label_agreement":null},{"id":"W2026364548","doi":"10.1158/0008-5472.sabcs-3117","title":"Incidence of postmenopausal symptoms and current mamagement: a survey of 260 breast cancer patients.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Tamoxifen; Incidence (geometry); Menopause; Cancer; Internal medicine; Gynecology; Pediatrics; Obstetrics","score_opus":0.07324103792604446,"score_gpt":0.464679967230813,"score_spread":0.39143892930476853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026364548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98861814,0.009118072,0.0000010074675,0.00072161393,0.00015095765,0.0006123734,0.00047503316,0.000008497516,0.00029428786],"genre_scores_gemma":[0.9938061,0.0056611984,0.0000063465536,0.00008286743,0.00008036423,0.00007901584,0.000046376997,0.000011281112,0.00022640255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841684,0.00016844532,0.0002648222,0.00026828292,0.0005390752,0.00034254827],"domain_scores_gemma":[0.99850917,0.00012449973,0.00009084641,0.00018698814,0.0009271271,0.00016139726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048707222,0.00011883406,0.0003259844,0.00021809553,0.000050510807,0.0000070317215,0.00011983822,0.000047569967,0.0006807849],"category_scores_gemma":[0.000040250798,0.000098593555,0.000028237058,0.0005356636,0.00026113508,0.00006912257,0.00008176908,0.00024679434,0.000003153732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021176129,0.00090523344,0.8507082,0.00029356603,0.000120841316,0.0000063986267,0.00034172556,0.00000259872,0.019091403,0.00006013067,0.003895607,0.12245667],"study_design_scores_gemma":[0.0027018792,0.0016282956,0.9878774,0.00030584415,0.00006910766,0.000002918536,0.000010689333,0.000016591986,0.0067319055,0.000037608985,0.00054167263,0.00007608242],"about_ca_topic_score_codex":0.0073744087,"about_ca_topic_score_gemma":0.0006708328,"teacher_disagreement_score":0.1371692,"about_ca_system_score_codex":0.00025731884,"about_ca_system_score_gemma":0.00047889727,"threshold_uncertainty_score":0.9992356},"labels":[],"label_agreement":null},{"id":"W2026670521","doi":"10.1186/1471-2229-13-93","title":"A fungal endophyte induces transcription of genes encoding a redundant fungicide pathway in its host plant","year":2013,"lang":"en","type":"article","venue":"BMC Plant Biology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Agriculture and Agri-Food Canada; University of Guelph","funders":"Ministry of Agriculture, Food and Rural Affairs; Ontario Ministry of Agriculture, Food and Rural Affairs; Washington State University","keywords":"Endophyte; Biology; Taxus; Fungicide; Plant use of endophytic fungi in defense; Botany; Botrytis cinerea; Host (biology); Gene; Biochemistry; Ecology","score_opus":0.05775655091710207,"score_gpt":0.28879852175319964,"score_spread":0.23104197083609757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026670521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99394965,0.0034681659,0.000010476029,0.00019134374,0.0004695261,0.0006057958,0.00040071082,0.000030407999,0.0008739164],"genre_scores_gemma":[0.9982024,0.0006721529,0.00015911495,0.00015052612,0.00019777364,0.00013228078,0.00030113777,0.00001050461,0.00017409974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988754,0.0001116974,0.0003578312,0.0002660268,0.00006783383,0.00032124558],"domain_scores_gemma":[0.999509,0.0001581046,0.00011424794,0.0001030066,0.000034195644,0.000081449856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012687361,0.00016858474,0.000439364,0.0002222391,0.000028919976,0.0000043971286,0.00007552931,0.00016819403,0.00036225587],"category_scores_gemma":[0.00001876228,0.00012711015,0.00008120575,0.00012364968,0.00006117028,0.000056245663,0.000018699446,0.00014895444,0.00004254609],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007064769,0.00019164775,0.0694776,0.00009144603,0.00005984562,0.000062550964,0.00039223052,0.0000017459616,0.9274712,0.0003248766,0.00016963616,0.0010507015],"study_design_scores_gemma":[0.0037736287,0.0013340539,0.101862304,0.00014453725,0.00007768799,0.0005334346,0.00017762362,0.00014751527,0.8878663,0.000066587294,0.0038217686,0.00019451743],"about_ca_topic_score_codex":0.0006134248,"about_ca_topic_score_gemma":0.0006300066,"teacher_disagreement_score":0.039604895,"about_ca_system_score_codex":0.00006068717,"about_ca_system_score_gemma":0.00013769715,"threshold_uncertainty_score":0.5183401},"labels":[],"label_agreement":null},{"id":"W2027376895","doi":"10.1007/s10637-005-2904-2","title":"A phase I study of T900607 given once every 3 weeks in patients with advanced refractory cancers; National Cancer Institute of Canada Clinical Trials Group (NCIC–CTG) IND 130","year":2005,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Hôpital Notre-Dame; BC Cancer Agency","funders":"","keywords":"Medicine; Pharmacokinetics; Cmax; Cardiotoxicity; Toxicity; Refractory (planetary science); Cancer; Internal medicine; Lethargy; Neutropenia; Gastroenterology","score_opus":0.07668926564023175,"score_gpt":0.42262326365263103,"score_spread":0.34593399801239927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027376895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957367,0.00028944353,0.0000035833941,0.0017089781,0.00048689367,0.0011480906,0.00021830427,0.000009583825,0.0003984087],"genre_scores_gemma":[0.9967948,0.00003427455,0.0006495861,0.0012498769,0.0005278363,0.00011207347,0.00021250886,0.000017271312,0.00040176345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708927,0.00022466166,0.0011857905,0.00034871488,0.00094201573,0.00020952366],"domain_scores_gemma":[0.99791026,0.0005437589,0.0007305128,0.00014382126,0.00040324213,0.000268392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006954065,0.00020162915,0.0007493304,0.00016106118,0.000045096236,0.0000037094865,0.0001172532,0.00008555208,0.00025092362],"category_scores_gemma":[0.0004304099,0.00017246221,0.000069718284,0.00035618068,0.00020373655,0.00026948666,0.000028217964,0.00027457406,0.0000011176601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015476694,0.010197279,0.88637465,0.00012626454,0.0012688763,0.000027595537,0.0028458266,0.008920537,0.0009401907,0.0002070781,0.03057843,0.04303659],"study_design_scores_gemma":[0.11129668,0.005199694,0.85046417,0.00047980167,0.00042033373,0.0000020051523,0.00026890542,0.00027181007,0.0010655792,0.0002320999,0.029945249,0.0003536616],"about_ca_topic_score_codex":0.13910761,"about_ca_topic_score_gemma":0.32032427,"teacher_disagreement_score":0.18121666,"about_ca_system_score_codex":0.0013705174,"about_ca_system_score_gemma":0.011562888,"threshold_uncertainty_score":0.9940406},"labels":[],"label_agreement":null},{"id":"W2028218566","doi":"10.1007/s00520-012-1384-0","title":"Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials","year":2012,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Notre-Dame","funders":"Bristol-Myers Squibb","keywords":"Ixabepilone; Medicine; Common Terminology Criteria for Adverse Events; Internal medicine; Adverse effect; Peripheral neuropathy; Oncology; Breast cancer; Cancer; Metastatic breast cancer; Surgery; Endocrinology","score_opus":0.29298144023505607,"score_gpt":0.5714225348632923,"score_spread":0.27844109462823624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028218566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758562,0.015609634,0.0000028736415,0.0021000714,0.0020348125,0.0007469383,0.0033232982,0.000028320748,0.00029786152],"genre_scores_gemma":[0.9913607,0.0026835804,0.000009166417,0.002651966,0.0015155933,0.00012939298,0.0011805854,0.000025834875,0.00044313818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975786,0.0006719918,0.0007076935,0.00041403953,0.00017992189,0.0004477358],"domain_scores_gemma":[0.9982056,0.0007602135,0.00029650822,0.0004132498,0.00011963405,0.00020481632],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018365048,0.00019234588,0.0007367295,0.000023062212,0.00014138735,0.00001767893,0.00016818171,0.00013687248,0.0020438887],"category_scores_gemma":[0.00058251375,0.00012688884,0.00011168498,0.00014005836,0.00022723361,0.0002105291,0.0002700439,0.00039240517,0.000007127055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004562459,0.0011450644,0.86260515,0.00001943492,0.00066909066,0.00011178227,0.017328808,6.154636e-7,0.0011917657,0.000004777687,0.032130938,0.080230124],"study_design_scores_gemma":[0.050469495,0.0030695081,0.76396155,0.00013636754,0.0019840575,0.000013297381,0.007929701,0.00016962647,0.0016065431,0.000022704551,0.17022704,0.00041011831],"about_ca_topic_score_codex":0.0018507334,"about_ca_topic_score_gemma":0.002760465,"teacher_disagreement_score":0.1380961,"about_ca_system_score_codex":0.00023952834,"about_ca_system_score_gemma":0.0003124159,"threshold_uncertainty_score":0.9988684},"labels":[],"label_agreement":null},{"id":"W2028542413","doi":"10.1021/np030311y","title":"A Yew in Israel, New Taxane Derivatives","year":2003,"lang":"en","type":"article","venue":"Journal of Natural Products","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique; Queen's University","funders":"","keywords":"Taxane; Taxus; Stereochemistry; Diterpene; Chemistry; Biology; Botany; Cancer; Genetics","score_opus":0.027167493220000925,"score_gpt":0.3304553827269324,"score_spread":0.3032878895069315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028542413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666075,0.017276658,0.0000021007468,0.014019621,0.00093945,0.00015446817,2.9972563e-7,0.000004989043,0.0009949306],"genre_scores_gemma":[0.9906614,0.00034488764,0.0019796274,0.0006894902,0.0006302865,5.740385e-7,9.826215e-7,0.000007760095,0.005684983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993097,0.000049073788,0.00024764726,0.000099057885,0.00014907375,0.00014543146],"domain_scores_gemma":[0.9994853,0.000034623274,0.00017140474,0.000073131974,0.00015494364,0.00008055971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016768134,0.0000888174,0.0002598389,0.00014856136,0.000014676539,0.000006272692,0.0000465465,0.0000359336,0.000109801076],"category_scores_gemma":[0.000461257,0.000060592447,0.000053183885,0.00030656904,0.00002573919,0.00012832732,0.0000064979326,0.00035078492,0.000008757624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033083116,0.0013069581,0.062393244,0.00021107028,0.00057088764,0.0021175696,0.0017798677,0.00001665125,0.6662793,0.0009956124,0.22178708,0.039233416],"study_design_scores_gemma":[0.019892706,0.0030840572,0.15048426,0.00042865842,0.00039571422,0.005860834,0.0005094987,0.000007126097,0.47809115,0.0012897945,0.33960652,0.00034966794],"about_ca_topic_score_codex":0.000021756958,"about_ca_topic_score_gemma":0.00001005729,"teacher_disagreement_score":0.1881882,"about_ca_system_score_codex":0.00012093313,"about_ca_system_score_gemma":0.0004019828,"threshold_uncertainty_score":0.24708882},"labels":[],"label_agreement":null},{"id":"W2029461912","doi":"10.1007/s10549-015-3345-z","title":"Erratum to: Platinum-based chemotherapy in triple-negative advanced breast cancer","year":2015,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Breast cancer; Triple-negative breast cancer; Oncology; Chemotherapy; Medicine; Internal medicine; Triple negative; Platinum; Cancer; Biology","score_opus":0.06377048360085881,"score_gpt":0.42867668471138654,"score_spread":0.36490620111052774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029461912","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2916198,0.12581863,0.000009224615,0.3059999,0.035199948,0.045595814,0.060829528,0.0008647688,0.13406238],"genre_scores_gemma":[0.20328364,0.047854077,0.0003280619,0.0028752396,0.008206975,0.023233872,0.0025619813,0.00058209896,0.71107405],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995128,0.00024717048,0.0005454239,0.0014245512,0.0011490986,0.0015057662],"domain_scores_gemma":[0.996962,0.00017575853,0.00017674713,0.0006030234,0.00083373644,0.001248738],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035360098,0.00090841274,0.0015433689,0.0009989054,0.00021494683,0.00008497671,0.00023280078,0.00056103646,0.0021135425],"category_scores_gemma":[0.000021133408,0.0007010808,0.00020785355,0.0012486945,0.00036406747,0.00012132418,0.00009627068,0.0012828978,0.000056837758],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.02939053,0.0027972984,0.009340457,0.00027967786,0.0011602578,0.0006149151,0.00092310744,0.000032782693,0.0002622753,0.000007816967,0.7685311,0.18665978],"study_design_scores_gemma":[0.10741247,0.011690291,0.25464782,0.0051012416,0.000843235,0.00050360034,0.0006086933,0.00040019728,0.0014690035,0.00043386852,0.6150313,0.0018583044],"about_ca_topic_score_codex":0.026836287,"about_ca_topic_score_gemma":0.022101602,"teacher_disagreement_score":0.57701164,"about_ca_system_score_codex":0.0073506925,"about_ca_system_score_gemma":0.0071065594,"threshold_uncertainty_score":0.999544},"labels":[],"label_agreement":null},{"id":"W2031196113","doi":"10.1159/000216901","title":"Therapeutic Use of Low-Molecular-Weight Heparins","year":2009,"lang":"en","type":"review","venue":"Haemostasis","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Heparin; Medicine; Antithrombotic; Deep vein; Thrombosis; Intensive care medicine; Low molecular weight heparin; Clinical trial; Surgery; Internal medicine","score_opus":0.14858017446463584,"score_gpt":0.4188657932321858,"score_spread":0.27028561876755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031196113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000065948756,0.99654233,0.000016891492,0.00013876369,0.00021093838,0.00097142893,0.00010780551,0.0000453475,0.0019005283],"genre_scores_gemma":[0.00009037208,0.9966771,0.00023686618,0.00073086726,0.00013041623,0.000060278668,0.00034059837,0.00005825048,0.0016752576],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99855566,0.00011423247,0.0004936886,0.00034694307,0.0002073307,0.00028212328],"domain_scores_gemma":[0.9989056,0.00013694911,0.00026427838,0.00048799012,0.00006875448,0.00013642729],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000058900205,0.00039373722,0.001963939,0.00020572035,0.000027728775,0.000011497334,0.00011572146,0.00028677037,0.0007101164],"category_scores_gemma":[0.000014316428,0.00029304362,0.000792269,0.00036509428,0.000073198156,0.000036622372,0.00003501973,0.00027132768,0.00008952625],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051441908,0.0003888342,0.000023664996,0.006129763,0.0010981013,0.0002888204,0.000022705402,1.03725064e-7,0.0000048888087,0.000094668394,0.0046927533,0.98720425],"study_design_scores_gemma":[0.0006302745,0.0002907582,0.000019907737,0.0045589823,0.0073579033,0.00015082635,9.499426e-7,9.56433e-7,0.0004125867,0.000019073865,0.98634803,0.0002097664],"about_ca_topic_score_codex":0.000043774617,"about_ca_topic_score_gemma":0.000007019054,"teacher_disagreement_score":0.9869945,"about_ca_system_score_codex":0.00017483174,"about_ca_system_score_gemma":0.0004027264,"threshold_uncertainty_score":0.9999522},"labels":[],"label_agreement":null},{"id":"W2031890665","doi":"10.1159/000225657","title":"In vitro Colony Assay of Peripheral Blood Mononuclear Cells – A Comparison of Breast Cancer Patients and Normal Individuals","year":2009,"lang":"en","type":"article","venue":"Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Peripheral blood mononuclear cell; Breast cancer; In vitro; Stage (stratigraphy); Internal medicine; Cancer; Immunology; Medicine; Peripheral blood; Mammary gland; Biology; Oncology; Biochemistry","score_opus":0.013060222159564995,"score_gpt":0.3405924178679459,"score_spread":0.32753219570838094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031890665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590164,0.0003938373,5.2964225e-7,0.0012965216,0.00014116504,0.00030067156,0.000100659265,0.0000058948394,0.0018590849],"genre_scores_gemma":[0.99869525,0.00013104423,0.00026933991,0.00064413284,0.000056576177,0.000015468591,0.000017506041,0.000007301897,0.00016337087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915856,0.000089094334,0.00031397038,0.00014964181,0.000098938195,0.00018982234],"domain_scores_gemma":[0.9995535,0.00006429139,0.00017927756,0.000065405606,0.000064895976,0.00007261578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010074076,0.0001032872,0.0005601685,0.00010030657,0.000016435415,0.00000155919,0.000048261958,0.00013668335,0.00044704945],"category_scores_gemma":[0.000005101549,0.00009414038,0.000041623258,0.00011486359,0.00010256309,0.000041850883,0.000024854466,0.00013802187,0.0000015326032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003912969,0.011666807,0.55828416,0.00007795677,0.00024020244,0.000032831067,0.0035292555,0.000022802811,0.38146698,0.000023036358,0.006438674,0.034304336],"study_design_scores_gemma":[0.017434984,0.010570816,0.83137405,0.000033124074,0.0005347905,0.000029751505,0.00013791624,0.0001447951,0.13361737,0.000024947427,0.005962567,0.00013485983],"about_ca_topic_score_codex":0.00042213636,"about_ca_topic_score_gemma":0.00011191446,"teacher_disagreement_score":0.27308992,"about_ca_system_score_codex":0.00010930966,"about_ca_system_score_gemma":0.00013972125,"threshold_uncertainty_score":0.4894878},"labels":[],"label_agreement":null},{"id":"W2032454683","doi":"10.1097/01.jto.0000283193.48953.cd","title":"C1-06: BO17704: a phase III study of first-line cisplatin and gemcitabine with bevacizumab or placebo in patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC)","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Royal Victoria Hospital","funders":"","keywords":"Medicine; Bevacizumab; Gemcitabine; Carboplatin; Internal medicine; Lung cancer; Oncology; Clinical endpoint; Regimen; Placebo; Progression-free survival; Chemotherapy; Cisplatin; Phases of clinical research; Surgery; Randomized controlled trial; Pathology","score_opus":0.020225855283292567,"score_gpt":0.40939970616873156,"score_spread":0.389173850885439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032454683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568164,0.0007477594,0.00025994997,0.00033094635,0.00035077444,0.0023950315,0.00002173364,0.000008477526,0.00020366962],"genre_scores_gemma":[0.99696404,0.00029372223,0.0017985293,0.00012873694,0.00021688004,0.000071352464,0.000012558899,0.000042915548,0.0004712544],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99758863,0.00011227677,0.0010974652,0.00034104686,0.00039000326,0.00047058158],"domain_scores_gemma":[0.9972708,0.0004936367,0.0012386316,0.00020349957,0.000488481,0.000304907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063270825,0.00035630807,0.0013373366,0.0005031859,0.00007495804,0.000007459958,0.00014461149,0.0001603484,0.00022982569],"category_scores_gemma":[0.000045735927,0.00020789061,0.00006532108,0.00050987897,0.00010438745,0.00013939313,0.000059138296,0.00062411744,7.5364596e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.570958,0.02292931,0.29619762,0.0005162242,0.0005490112,0.0025154117,0.0058996673,0.00034072317,0.00043330062,1.2457781e-7,0.0005123759,0.09914824],"study_design_scores_gemma":[0.40527537,0.3231502,0.25493762,0.0015358817,0.0045665395,0.0006665613,0.0035370828,0.0007676888,0.0026312543,0.000002244572,0.0023332569,0.00059631665],"about_ca_topic_score_codex":0.00013776652,"about_ca_topic_score_gemma":0.008781819,"teacher_disagreement_score":0.30022088,"about_ca_system_score_codex":0.0007636749,"about_ca_system_score_gemma":0.00082065345,"threshold_uncertainty_score":0.8477533},"labels":[],"label_agreement":null},{"id":"W2032533639","doi":"10.1158/1538-7445.am2012-2790","title":"Abstract 2790: Localization of the binding site for Peloruside A and Laulimalide on beta-tubulin by physical and biological means","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Epothilones; Tubulin; Microtubule; Epothilone; Mutant; Chemistry; Biology; Biochemistry; Cell biology; Stereochemistry; Gene","score_opus":0.15761413907772068,"score_gpt":0.46713093610348977,"score_spread":0.30951679702576906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032533639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515784,0.0018316219,0.000014615773,0.0019292483,0.00005892275,0.0005482764,0.00011669864,0.00000693068,0.00033582063],"genre_scores_gemma":[0.9983882,0.00071535143,0.000013994239,0.00016617215,0.00027688078,0.00012499899,0.000027851134,0.000009853963,0.00027672807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99924916,0.000060318762,0.000093187075,0.00015344734,0.00017396033,0.00026995497],"domain_scores_gemma":[0.9993836,0.00032758602,0.00003112511,0.000085728396,0.00006682326,0.00010510637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032566112,0.00007418252,0.00016726885,0.000048062007,0.000109908884,0.0000077350005,0.000039240218,0.000055656088,0.00008346342],"category_scores_gemma":[0.000051748386,0.000043887547,0.000038044436,0.00013478733,0.00022873253,0.000036121077,0.000043058255,0.00016582909,0.0000043352625],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021947843,0.0006582706,0.32903433,0.00033310472,0.00018320658,0.0000028214072,0.0021830485,0.000013863939,0.62052923,0.0004673487,0.030621907,0.013778101],"study_design_scores_gemma":[0.008228778,0.0026061449,0.34073225,0.00037486167,0.00029424584,0.00001609876,0.00041469658,0.00073589047,0.49816248,0.00027217387,0.14786483,0.0002975407],"about_ca_topic_score_codex":0.00013353946,"about_ca_topic_score_gemma":0.000025026873,"teacher_disagreement_score":0.12236674,"about_ca_system_score_codex":0.00008634612,"about_ca_system_score_gemma":0.000049962346,"threshold_uncertainty_score":0.17896822},"labels":[],"label_agreement":null},{"id":"W2033077240","doi":"10.3747/co.v15i2.263","title":"Managing the Toxicities of the FEC-100 Followed by Docetaxel Regimen: The Price of Success","year":2008,"lang":"en","type":"editorial","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Docetaxel; Medicine; Regimen; Quadrant (abdomen); Oncology; Internal medicine; Gynecology; Family medicine; Surgery; Chemotherapy","score_opus":0.04974530416312795,"score_gpt":0.4061019912894849,"score_spread":0.35635668712635693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033077240","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013145931,0.05245494,0.000010507063,0.010066831,0.9090872,0.0018083393,0.00030388546,0.000034527475,0.013087859],"genre_scores_gemma":[0.08454118,0.07950035,0.000022166401,0.0007566471,0.81064165,0.00087242626,0.00067731884,0.00015924829,0.022829007],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99749583,0.00046571152,0.0006208979,0.00036450362,0.00065565144,0.00039742538],"domain_scores_gemma":[0.9958303,0.0021752093,0.0009375541,0.0007010809,0.00029309932,0.000062784726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004538769,0.00036192365,0.000992263,0.00008934439,0.00022488074,0.000008297765,0.00085481256,0.0004611821,0.00019284607],"category_scores_gemma":[0.00021558448,0.00017010269,0.0004272052,0.00032631497,0.0010603424,0.000035825866,0.00028451765,0.001259053,0.0000062929057],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054481777,0.0007275186,0.00057308166,0.000329435,0.00052728713,0.000009307101,0.0013415073,0.0000023969696,0.00024138471,0.00005805736,0.9918605,0.0037846847],"study_design_scores_gemma":[0.0032090724,0.00082554395,0.00018300797,0.00020498145,0.001059244,0.000020021382,0.00023388551,0.000010639795,0.001029683,0.00007482332,0.9930087,0.00014040718],"about_ca_topic_score_codex":0.00020500718,"about_ca_topic_score_gemma":0.00007794363,"teacher_disagreement_score":0.09844552,"about_ca_system_score_codex":0.00042762037,"about_ca_system_score_gemma":0.0012104516,"threshold_uncertainty_score":0.69365865},"labels":[],"label_agreement":null},{"id":"W2033093363","doi":"10.1016/s0968-0896(02)00347-4","title":"New minor taxanes analogues from the needles of Taxus canadensis","year":2003,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; Jewish General Hospital; Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Fast atom bombardment; Paclitaxel; Taxus; High resolution; Stereochemistry; Mass spectrometry; Tubulin; Microtubule; Chromatography; Botany","score_opus":0.018574555355040337,"score_gpt":0.2613475705558914,"score_spread":0.2427730152008511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033093363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757562,0.013311434,0.000017351837,0.0040604346,0.00029684856,0.00015837104,0.000050717423,0.000030913638,0.0063177086],"genre_scores_gemma":[0.99305224,0.0002822679,0.00019486835,0.0009848643,0.0008309812,0.000005289913,0.0000855525,0.00001798762,0.0045459676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899316,0.000025550968,0.00025660414,0.00023103601,0.00026298093,0.00023066212],"domain_scores_gemma":[0.99910814,0.00016535503,0.00013090755,0.00029479904,0.000066289555,0.00023452014],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008725436,0.00018123735,0.0003522503,0.000017833574,0.00005073757,0.0000045404477,0.0001350554,0.000121272045,0.006209249],"category_scores_gemma":[0.00016866952,0.000119095,0.00009097963,0.00021155599,0.0001526346,0.000016173142,0.000018722914,0.00018172,0.000016226992],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000144425,0.00010779011,0.039288916,0.00008374958,0.00040386076,0.00011182756,0.00075308233,1.13496704e-7,0.8022791,0.000012965257,0.15445718,0.0023569916],"study_design_scores_gemma":[0.0024102873,0.00013738358,0.02598699,0.00011428711,0.00097108795,0.00020854801,0.0019147836,0.0000015395005,0.8983019,0.00007682749,0.06973344,0.00014292347],"about_ca_topic_score_codex":0.008864609,"about_ca_topic_score_gemma":0.00039951855,"teacher_disagreement_score":0.09602281,"about_ca_system_score_codex":0.00010280337,"about_ca_system_score_gemma":0.00066363614,"threshold_uncertainty_score":0.99773544},"labels":[],"label_agreement":null},{"id":"W2033631441","doi":"10.1002/chin.201007163","title":"ChemInform Abstract: A Simple and Efficient Synthesis of 1,4‐ and 1,5‐Dioxepan‐2‐one.","year":2010,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Chemistry; Simple (philosophy); Service (business); Combinatorial chemistry; Nanotechnology; Epistemology; Business; Marketing","score_opus":0.015727143404826338,"score_gpt":0.2871145182472183,"score_spread":0.27138737484239195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033631441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6735114,0.00012211586,1.5184103e-8,0.00016890523,0.000037562084,0.00015879936,0.000014148342,0.000019106223,0.32596794],"genre_scores_gemma":[0.9970965,0.000119272285,0.000045442906,0.00009543678,0.00008781587,0.000032690543,0.000015769529,0.000010095414,0.00249701],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935925,2.2066216e-8,0.00021345868,0.00012815848,0.00011644167,0.00018267377],"domain_scores_gemma":[0.99942225,0.00011934174,0.000088676556,0.00015649683,0.00004983848,0.00016339672],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000096101874,0.00012438926,0.00027197957,0.0000581772,0.000035184155,0.000008268768,0.000041571715,0.000111347246,0.0011573224],"category_scores_gemma":[0.00007404701,0.00010525702,0.000046335226,0.00006853725,0.00017013335,0.000045895118,0.000046688278,0.0001508964,0.0000074819613],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002535489,0.00020951178,0.0018628224,0.00052116293,0.00012838024,0.000007957424,0.000847693,3.443517e-8,0.1205864,0.00012594949,0.0043246225,0.8711319],"study_design_scores_gemma":[0.0014523466,0.000082679915,0.028263293,0.000042142274,0.00021648634,0.0000913153,0.00014376229,0.000028714741,0.9425717,0.000028820472,0.026949901,0.00012886469],"about_ca_topic_score_codex":0.000051028816,"about_ca_topic_score_gemma":0.000013494834,"teacher_disagreement_score":0.87100303,"about_ca_system_score_codex":0.00002290366,"about_ca_system_score_gemma":0.000059993512,"threshold_uncertainty_score":0.99975574},"labels":[],"label_agreement":null},{"id":"W2034084175","doi":"10.3747/co.v17i1.437","title":"Capecitabine-Induced Cardiotoxicity: Case Report and Review of the Literature","year":2010,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Capecitabine; Medicine; Cardiotoxicity; Coronary vasospasm; Cardiogenic shock; Adverse effect; Bradycardia; Internal medicine; Cardiology; Angina; Colorectal cancer; Cancer; Chemotherapy; Myocardial infarction; Heart rate","score_opus":0.0694152416841704,"score_gpt":0.4395758298952591,"score_spread":0.3701605882110887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034084175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9394107,0.049516182,6.284355e-7,0.004051669,0.003386614,0.0006580593,0.000016529504,0.000014490794,0.002945133],"genre_scores_gemma":[0.98774135,0.010326403,0.0000581989,0.00078176527,0.0006549822,0.00007123153,0.00002717634,0.00001073485,0.0003281541],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99922043,0.00007806422,0.00026842568,0.00019916426,0.00009602922,0.00013786423],"domain_scores_gemma":[0.99919945,0.00007420254,0.00015603635,0.00031400908,0.00016067414,0.00009562672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024375798,0.00011305987,0.0004236322,0.000039470568,0.000047362308,0.000002835503,0.00005075262,0.000116976735,0.00016933406],"category_scores_gemma":[0.00017367431,0.000068864705,0.00012443,0.00017927657,0.00010815861,0.000022786086,0.000061449675,0.0005117034,0.0000022322686],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004672294,0.0034848216,0.10644184,0.021212956,0.0008127265,0.115345545,0.0028257626,7.160505e-8,0.15580176,0.0007056713,0.13840619,0.45449543],"study_design_scores_gemma":[0.0024578278,0.0006012698,0.008609048,0.0019135792,0.0009354319,0.29635724,0.000029723193,0.000004914024,0.005447528,0.000047750018,0.6834682,0.00012748162],"about_ca_topic_score_codex":0.000017999615,"about_ca_topic_score_gemma":0.00007748714,"teacher_disagreement_score":0.545062,"about_ca_system_score_codex":0.00005789503,"about_ca_system_score_gemma":0.00025830034,"threshold_uncertainty_score":0.28082213},"labels":[],"label_agreement":null},{"id":"W2034693832","doi":"10.1016/j.clbc.2011.04.001","title":"Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group","year":2011,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Docetaxel; Bevacizumab; Capecitabine; Breast cancer; Mucositis; Internal medicine; Oncology; Cyclophosphamide; Chemotherapy; Metastatic breast cancer; Regimen; Cancer; Surgery; Colorectal cancer","score_opus":0.07746102873287435,"score_gpt":0.44725440114429066,"score_spread":0.3697933724114163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034693832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987146,0.003932501,0.000050630668,0.003860267,0.00072113634,0.0034708735,0.00067649904,0.000018026247,0.00012403441],"genre_scores_gemma":[0.9904295,0.0073934756,0.00009921895,0.0003225962,0.0004191598,0.0008819782,0.00004206807,0.000039628405,0.00037236663],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99752825,0.00022883817,0.0008151613,0.0005900492,0.00042917693,0.00040854805],"domain_scores_gemma":[0.9980739,0.00035263758,0.00047061805,0.00032893606,0.0005205286,0.000253389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007453062,0.00027486443,0.000864072,0.000067952045,0.00017385717,0.000011010793,0.00016340548,0.00016277481,0.00047673614],"category_scores_gemma":[0.00004222274,0.0001722509,0.0001877816,0.00028111044,0.0010924784,0.000121286634,0.000097259595,0.00035263936,5.9598676e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41335753,0.0050069764,0.011957479,0.00016393834,0.0009156137,0.000008825024,0.00066735776,0.0000012540452,0.017802333,0.00014683598,0.0019096679,0.5480622],"study_design_scores_gemma":[0.8406132,0.047739632,0.07356015,0.0013047282,0.0016366794,0.00021692987,0.0003480546,0.00023667394,0.015092913,0.00032282056,0.018366337,0.00056187104],"about_ca_topic_score_codex":0.0034094402,"about_ca_topic_score_gemma":0.00067646336,"teacher_disagreement_score":0.5475003,"about_ca_system_score_codex":0.0001734757,"about_ca_system_score_gemma":0.0008214139,"threshold_uncertainty_score":0.7024188},"labels":[],"label_agreement":null},{"id":"W2034911302","doi":"10.1139/v02-108","title":"Bakers yeast-catalyzed synthesis of optically pure 4-<i>tert</i>-butyl-3-hydroxy beta-lactam <i>cis</i>-(3<i>R</i>,4<i>S</i>) and <i>trans</i>-(3<i>R</i>,4<i>R</i>) diastereomers","year":2002,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemistry; Yeast; Saccharomyces cerevisiae; Stereochemistry; Catalysis; Lactam; Side chain; Beta-lactam; Absolute configuration; Organic chemistry; Antibiotics; Polymer; Biochemistry","score_opus":0.01252500284446737,"score_gpt":0.22340551412961776,"score_spread":0.2108805112851504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034911302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723326,0.007240511,0.000049416733,0.0051178853,0.00041607875,0.00032402622,0.00031253922,0.00002358221,0.014183393],"genre_scores_gemma":[0.9960273,0.0010832779,0.0004801577,0.000853378,0.00044365256,0.000016681019,0.000019775287,0.00007923722,0.0009965559],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971807,0.00006113043,0.0010827839,0.00041797172,0.0004766626,0.00078077905],"domain_scores_gemma":[0.99631643,0.00023100534,0.00055625394,0.0004440807,0.00035015267,0.0021020821],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000323368,0.00049901183,0.0012098073,0.00026134535,0.00012835674,0.00005343498,0.00038048736,0.00034375823,0.002508602],"category_scores_gemma":[0.00015342176,0.00046849012,0.00049459893,0.00039863246,0.00067447475,0.00024342418,0.000029094394,0.0006849065,0.000013427589],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084705756,0.00057499215,0.026857626,0.0013348463,0.0019374314,0.0024616418,0.00222552,0.000023645924,0.93126464,0.000010507074,0.021073539,0.011388581],"study_design_scores_gemma":[0.008494957,0.0006984075,0.0036170892,0.000980931,0.002907822,0.0058107,0.00065219007,0.00005758584,0.9141337,0.0000670293,0.06167101,0.00090854085],"about_ca_topic_score_codex":0.00038058156,"about_ca_topic_score_gemma":0.00034494436,"teacher_disagreement_score":0.040597472,"about_ca_system_score_codex":0.0002530427,"about_ca_system_score_gemma":0.0008122224,"threshold_uncertainty_score":0.99977666},"labels":[],"label_agreement":null},{"id":"W2035062443","doi":"10.1016/s0304-3959(02)00047-7","title":"Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy","year":2002,"lang":"en","type":"article","venue":"Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"National Cancer Institute","keywords":"Nortriptyline; Placebo; Medicine; Dose; Randomization; Anesthesia; Adverse effect; Tolerability; Amitriptyline; Internal medicine; Randomized controlled trial","score_opus":0.07794335937743013,"score_gpt":0.37350707511657216,"score_spread":0.29556371573914203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035062443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679834,0.00036197668,0.0011239144,0.00019097497,0.00011213811,0.0008406235,0.000026672307,0.000008963274,0.0005364153],"genre_scores_gemma":[0.9992035,0.000021835027,0.00018006063,0.000086907035,0.00010523893,0.000061396386,0.00008384337,0.000010004421,0.00024720668],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99902654,0.00021451041,0.0003392446,0.00010904164,0.00022450634,0.00008615634],"domain_scores_gemma":[0.9991361,0.0001926097,0.00023629559,0.00010928337,0.00029407453,0.000031664058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012425813,0.000073983516,0.00026529643,0.000071530274,0.000013482767,8.035975e-7,0.000029074736,0.000041734278,0.00081114226],"category_scores_gemma":[0.0002483329,0.00006655459,0.0000865848,0.000114757764,0.00002148061,0.00002715448,0.000004981129,0.000035275712,7.9909114e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013957223,0.002174029,0.0035244892,0.0002079447,0.00017594977,0.000001267873,0.001850492,0.00009483065,0.6145543,0.00004411773,0.0010357706,0.3749411],"study_design_scores_gemma":[0.07271946,0.0143633215,0.005181099,0.00011724661,0.0017479864,0.000005871985,0.0001303773,0.68259424,0.22172832,0.00010482085,0.0011431688,0.00016407263],"about_ca_topic_score_codex":0.000037015554,"about_ca_topic_score_gemma":0.000014530516,"teacher_disagreement_score":0.6824994,"about_ca_system_score_codex":0.000050763025,"about_ca_system_score_gemma":0.00004416013,"threshold_uncertainty_score":0.8881439},"labels":[],"label_agreement":null},{"id":"W2036145991","doi":"10.3816/cbc.2000.s.012","title":"Epirubicin in Breast Cancer: Present and Future","year":2000,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Epirubicin; Medicine; Anthracycline; Breast cancer; Oncology; Trastuzumab; Taxane; Internal medicine; Cyclophosphamide; Chemotherapy; Metastatic breast cancer; Doxorubicin; Cancer; Pharmacology","score_opus":0.08241764795168283,"score_gpt":0.4870500193305227,"score_spread":0.4046323713788399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036145991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024834828,0.9772361,6.1466366e-8,0.016119681,0.0018165491,0.0014432966,0.0018971966,0.000055590648,0.0011831751],"genre_scores_gemma":[0.000047896927,0.97726595,0.000010720272,0.0015601201,0.017482413,0.000879282,0.00014120835,0.00009785172,0.0025145425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963825,0.00032251253,0.0013821253,0.0010482713,0.00026260197,0.0006020336],"domain_scores_gemma":[0.9981917,0.00035744172,0.00036254092,0.00047105487,0.000075077754,0.00054219237],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030646328,0.0006687359,0.0035028858,0.00015726162,0.000054617136,0.000022834036,0.00020544225,0.0008774517,0.010908657],"category_scores_gemma":[0.000003929725,0.00048015965,0.0007235812,0.0004704547,0.00030471684,0.00006704821,0.00010174928,0.0013972509,0.00009331168],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006652409,0.00055019255,0.009709244,0.004857874,0.0006100632,0.00019130211,0.000022316983,3.4876035e-7,6.461394e-8,0.000005469627,0.03231211,0.9510758],"study_design_scores_gemma":[0.0032281291,0.00011537632,0.036102675,0.009173558,0.003343843,0.00091928616,0.0000064194187,0.0000046707933,5.9819236e-8,0.000008443669,0.9467006,0.0003969712],"about_ca_topic_score_codex":0.0017637481,"about_ca_topic_score_gemma":0.000309169,"teacher_disagreement_score":0.9506788,"about_ca_system_score_codex":0.0005601144,"about_ca_system_score_gemma":0.0015823244,"threshold_uncertainty_score":0.999765},"labels":[],"label_agreement":null},{"id":"W2036335583","doi":"10.1023/a:1006320122711","title":"Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancer","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; Alberta Cancer Foundation; Toronto General Hospital","funders":"","keywords":"Metastatic breast cancer; Medicine; Breast cancer; Oncology; Internal medicine; Cancer; Postmenopausal women; Estrogen receptor; Cancer research","score_opus":0.06413388611206063,"score_gpt":0.41164285071278633,"score_spread":0.3475089646007257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036335583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709468,0.0075733704,5.268965e-7,0.0137025695,0.00007861857,0.0022029616,0.004148801,0.000021456997,0.0013249326],"genre_scores_gemma":[0.9637543,0.029488593,0.00005467503,0.00019760632,0.0002940404,0.0025576444,0.00014777387,0.000039107676,0.0034662765],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974881,0.00022753216,0.00037551275,0.0005752255,0.00053070456,0.0008029699],"domain_scores_gemma":[0.9988043,0.00025644113,0.000077254845,0.00034694848,0.00020836585,0.00030669337],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020894896,0.0003997664,0.00065563933,0.00025948064,0.00020870053,0.000042384454,0.00012402731,0.000076588854,0.0044422583],"category_scores_gemma":[0.000001623061,0.0002359957,0.0001312837,0.00062030554,0.0003792995,0.0001171453,0.000020116784,0.00017711619,0.000047208876],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042255558,0.040341064,0.06427204,0.00017577123,0.004445504,0.0007459644,0.011672338,0.000081689024,0.022911977,0.0002238531,0.0019454497,0.81092876],"study_design_scores_gemma":[0.04148285,0.023073917,0.8958871,0.0006326445,0.0014848686,0.0017509152,0.001418559,0.00026130467,0.011089277,0.0001011302,0.022223571,0.00059389655],"about_ca_topic_score_codex":0.042761758,"about_ca_topic_score_gemma":0.004836309,"teacher_disagreement_score":0.83161503,"about_ca_system_score_codex":0.001629246,"about_ca_system_score_gemma":0.00070710166,"threshold_uncertainty_score":0.9964678},"labels":[],"label_agreement":null},{"id":"W2036614336","doi":"10.1158/0008-5472.sabcs11-p1-08-15","title":"P1-08-15: Pattern of Cardiac Monitoring and Risk of Trastuzumab Associated-Cardiac Dysfunction in a Clinical Practice: A Population Based Study.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Medicine; Trastuzumab; Internal medicine; Breast cancer; Ejection fraction; Anthracycline; Population; Cardiology; Incidence (geometry); Oncology; Logistic regression; Cancer; Gynecology; Heart failure","score_opus":0.16977714133355037,"score_gpt":0.5030539515384683,"score_spread":0.33327681020491795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036614336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965493,0.0015747113,0.0000032630971,0.00006627095,0.0004893172,0.0009850851,0.000048927814,0.000010646455,0.00027246855],"genre_scores_gemma":[0.99755853,0.0018526871,0.000044074688,0.0000058883843,0.00023272929,0.00021452188,0.000012659821,0.000017251748,0.00006165072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973899,0.0011457546,0.00045366472,0.00027705677,0.0004942727,0.00023932352],"domain_scores_gemma":[0.998434,0.00074268575,0.00020391087,0.00018898083,0.00033529638,0.000095090145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002836047,0.00009648213,0.0004750362,0.0002335288,0.000049769777,0.000004969749,0.000049680024,0.00011462498,0.00010114007],"category_scores_gemma":[0.00050945074,0.00008732831,0.00010163257,0.00036679537,0.00006882607,0.00009501742,0.00003913818,0.00051335094,0.0000020535122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018268024,0.0012511897,0.933404,0.00007212831,0.0005226266,0.000009219422,0.0014800307,0.000003094198,0.0009158707,5.5924465e-7,0.0001246383,0.060389835],"study_design_scores_gemma":[0.0031566485,0.002048876,0.9901182,0.00012287662,0.0004751035,2.4225605e-7,0.0012632946,0.000034568297,0.002593442,0.000007671542,0.00012018741,0.000058879425],"about_ca_topic_score_codex":0.025030332,"about_ca_topic_score_gemma":0.00043638013,"teacher_disagreement_score":0.060330957,"about_ca_system_score_codex":0.0003969027,"about_ca_system_score_gemma":0.00026862175,"threshold_uncertainty_score":0.98146206},"labels":[],"label_agreement":null},{"id":"W2037125902","doi":"10.1023/b:drug.0000047105.38511.2a","title":"Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98)","year":2004,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; CancerCare Manitoba; Ontario Institute for Cancer Research; AstraZeneca (Canada); Hôpital Notre-Dame; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Doxorubicin; Bolus (digestion); Toxicity; Cancer; Internal medicine; Chemotherapy; Gastroenterology; Surgery","score_opus":0.023312347774086896,"score_gpt":0.33420681025171406,"score_spread":0.31089446247762714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037125902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744356,0.00022014507,0.000010036457,0.0010846183,0.000051137074,0.001030358,0.00001966059,0.000012174709,0.0001282976],"genre_scores_gemma":[0.9967252,0.000022728815,0.0015060976,0.0009837609,0.00003623132,0.00009074796,0.000043120996,0.000014465615,0.0005776377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990452,0.000027327142,0.0002665184,0.00022446389,0.00028558032,0.00015089531],"domain_scores_gemma":[0.9994884,0.00005489356,0.00009170359,0.00009346982,0.00010097747,0.00017052038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057438978,0.0001405926,0.00029824665,0.0001198538,0.000032238975,0.00000602899,0.000042933756,0.000023873561,0.00021230483],"category_scores_gemma":[0.00002080925,0.000098817814,0.00001433722,0.00030109606,0.00010460616,0.00013263023,0.000017655188,0.00010547343,0.0000031554177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018794585,0.02066269,0.8935609,0.0003065514,0.0009742591,0.00016721086,0.020933611,0.013069506,0.004507099,0.00062427873,0.0011659442,0.025233384],"study_design_scores_gemma":[0.35935158,0.024755955,0.59314346,0.0008607078,0.0009130781,0.000017794466,0.001702355,0.00015645432,0.015003303,0.002285921,0.001290344,0.0005190796],"about_ca_topic_score_codex":0.0025833996,"about_ca_topic_score_gemma":0.0014524347,"teacher_disagreement_score":0.34055698,"about_ca_system_score_codex":0.00015105704,"about_ca_system_score_gemma":0.0008652645,"threshold_uncertainty_score":0.40296733},"labels":[],"label_agreement":null},{"id":"W2039310969","doi":"10.1038/sj.bjc.6600261","title":"Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines","year":2002,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Capecitabine; Medicine; Metastatic breast cancer; Paclitaxel; Oncology; Internal medicine; Breast cancer; Chemotherapy; Phases of clinical research; Cancer; Colorectal cancer","score_opus":0.022443216307930947,"score_gpt":0.3270490110939391,"score_spread":0.30460579478600813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039310969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905558,0.0066971453,0.000035646484,0.00057777454,0.00026664688,0.0014413915,0.00018091561,0.000019340561,0.00022531534],"genre_scores_gemma":[0.99583834,0.0022327506,0.00064970006,0.00020396894,0.00034535653,0.00018117896,0.000025537918,0.00005759532,0.0004655629],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978592,0.00009955515,0.00071271096,0.00029977495,0.0005847258,0.00044403537],"domain_scores_gemma":[0.9982397,0.00006811925,0.0006462768,0.00012755548,0.0006387285,0.0002796098],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015683423,0.0003204644,0.0012217469,0.00019682282,0.00012907565,0.00004439516,0.00010908258,0.000051083112,0.0015469525],"category_scores_gemma":[0.000018735846,0.00022534422,0.00010950568,0.00047509966,0.00018649451,0.00042962382,0.00001678829,0.0004235939,9.245576e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62377,0.0058221007,0.26802486,0.000078340985,0.0015448969,0.001419472,0.0003162973,0.0010006982,0.0000673542,6.4946767e-7,0.0010867293,0.09686862],"study_design_scores_gemma":[0.8659806,0.011711359,0.11580698,0.001857022,0.0017543287,0.0011463107,0.00007670983,0.00022491117,0.00017496955,0.0000029483056,0.0009381804,0.00032562704],"about_ca_topic_score_codex":0.0012976864,"about_ca_topic_score_gemma":0.008644492,"teacher_disagreement_score":0.24221069,"about_ca_system_score_codex":0.0003704055,"about_ca_system_score_gemma":0.00025212517,"threshold_uncertainty_score":0.99936575},"labels":[],"label_agreement":null},{"id":"W2040048266","doi":"10.1021/np049836w","title":"Taxanes from Rooted Cuttings of <i>Taxus </i><i>c</i><i>anadensis</i>","year":2004,"lang":"en","type":"article","venue":"Journal of Natural Products","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de la Recherche Scientifique; McGill University; Queen's University; Université du Québec à Montréal","funders":"","keywords":"Taxus; Cutting; Pharmacognosy; Diterpene; Botany; Stereochemistry; Biology; Chemistry; Biological activity","score_opus":0.01106316156379084,"score_gpt":0.27402822518538067,"score_spread":0.26296506362158983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040048266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96405333,0.01297679,0.0000028752,0.021277515,0.0013050726,0.0001780415,0.00000778642,0.00001317623,0.00018541148],"genre_scores_gemma":[0.9939008,0.0003025633,0.0025923676,0.0012212283,0.0014847479,7.8531593e-7,0.00001139682,0.000016415546,0.00046971918],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987475,0.00003008756,0.00050462363,0.00016685043,0.0003558644,0.00019505713],"domain_scores_gemma":[0.9984455,0.000055721048,0.0006155515,0.00016171444,0.0006160875,0.00010543553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015676615,0.00015415651,0.00050857203,0.00014286676,0.000034858316,0.00000780565,0.00011774437,0.00007520773,0.0000551475],"category_scores_gemma":[0.00023566335,0.000109803936,0.00015844115,0.0003127064,0.00008188968,0.0001536592,0.000022732585,0.00044583998,0.0000077267905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015451114,0.00045358567,0.0021660049,0.000077331715,0.0004596129,0.0004993403,0.0004770168,0.000030694388,0.972988,0.000025026588,0.018578853,0.002699419],"study_design_scores_gemma":[0.007995378,0.0011372281,0.022046339,0.00031737413,0.0007784284,0.0011885674,0.00006644069,0.0000024234184,0.9373123,0.00083781744,0.028166661,0.00015102942],"about_ca_topic_score_codex":0.0002509772,"about_ca_topic_score_gemma":0.00002142001,"teacher_disagreement_score":0.03567569,"about_ca_system_score_codex":0.00013172216,"about_ca_system_score_gemma":0.00034446173,"threshold_uncertainty_score":0.44776744},"labels":[],"label_agreement":null},{"id":"W2040951267","doi":"10.1016/j.carrev.2006.03.066","title":"Systemic nanoparticle albumin-bound paclitaxel (nab-paclitaxel) for the prevention of in-stent restenosis (SNAPIST-II): a randomized comparison of single dose and single dose plus repeat dose at 2 months","year":2006,"lang":"en","type":"article","venue":"Cardiovascular revascularization medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Victoria Heart Institute Foundation","funders":"","keywords":"Paclitaxel; Chromatography; Medicine; Protein precipitation; Albumin; Mass spectrometry; Surgery; Chemotherapy; Chemistry; Internal medicine","score_opus":0.033758904035859995,"score_gpt":0.3031790525724021,"score_spread":0.26942014853654206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040951267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85806245,0.13150188,0.0031605966,0.00074132823,0.0003611147,0.0058927783,0.000016198263,0.000041409687,0.00022223413],"genre_scores_gemma":[0.99576527,0.0019856086,0.00029828853,0.00005986951,0.00029159305,0.0005971053,0.0002754893,0.000056239413,0.0006705597],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957346,0.0007541615,0.001639503,0.00062080944,0.00085463334,0.00039632941],"domain_scores_gemma":[0.9971108,0.0007008425,0.00062586175,0.0009388001,0.0004848865,0.00013884404],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028832224,0.00038293828,0.0025623597,0.00029017526,0.00021647042,0.000015172696,0.00014415538,0.0002143942,0.000038784925],"category_scores_gemma":[0.00070441084,0.00026679615,0.0012654178,0.00062914274,0.0006871626,0.00011587809,0.000110114604,0.00015178349,0.0000013496672],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09027308,0.005131228,0.030404719,0.00871909,0.017404292,0.00012132539,0.010745071,0.0168632,0.79646456,0.0012286998,0.0022019194,0.020442806],"study_design_scores_gemma":[0.79969066,0.007002899,0.029748956,0.005545783,0.040727634,0.0005234019,0.0029429633,0.01593746,0.08731545,0.0007175424,0.008842441,0.0010048138],"about_ca_topic_score_codex":0.0010229603,"about_ca_topic_score_gemma":0.00018532905,"teacher_disagreement_score":0.7094176,"about_ca_system_score_codex":0.00056867534,"about_ca_system_score_gemma":0.00012481949,"threshold_uncertainty_score":0.9999784},"labels":[],"label_agreement":null},{"id":"W2041157986","doi":"10.1002/cmdc.200700002","title":"Overcoming Tumor Drug Resistance with High‐Affinity Taxanes: A SAR Study of C2‐Modified 7‐Acyl‐10‐Deacetyl Cephalomannines","year":2007,"lang":"en","type":"article","venue":"ChemMedChem","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Taxoid; Taxane; Paclitaxel; Drug; Drug resistance; Chemistry; Tubulin; Pharmacology; Drug discovery; Stereochemistry; Biology; Biochemistry; Microtubule; Microbiology; Cancer; Cell biology; Genetics","score_opus":0.02507772743041497,"score_gpt":0.3062801525452467,"score_spread":0.28120242511483173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041157986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878377,0.0005662365,0.000015701036,0.00044810757,0.00014154353,0.000852501,0.000009878001,0.00010386756,0.010024511],"genre_scores_gemma":[0.988981,0.0000149228745,0.0007327751,0.00026236038,0.00029983578,0.000041093528,0.000032260512,0.000044604614,0.009591161],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981958,0.00003508935,0.00046896422,0.00045392138,0.00039565034,0.00045055326],"domain_scores_gemma":[0.9985691,0.00025344733,0.00030195736,0.00046908538,0.00019706925,0.0002093877],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003622885,0.00031795172,0.00067747285,0.0001372233,0.00009541474,0.000010010579,0.0001667406,0.00007193721,0.0003354224],"category_scores_gemma":[0.00006446077,0.00025532706,0.00009187843,0.00043278097,0.00016169419,0.00008826406,0.000058589154,0.00024687755,0.000017319137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058115408,0.022685677,0.1441246,0.002395532,0.0031465164,0.003913363,0.027851911,0.000024956731,0.64906615,0.00045435136,0.08527788,0.0029436818],"study_design_scores_gemma":[0.01662224,0.0010977179,0.047289208,0.00019531215,0.0006389691,0.0000485878,0.0027179876,0.0000048765096,0.92191964,0.000034866327,0.009084613,0.00034599204],"about_ca_topic_score_codex":0.00033805828,"about_ca_topic_score_gemma":0.00062813744,"teacher_disagreement_score":0.27285352,"about_ca_system_score_codex":0.00019506205,"about_ca_system_score_gemma":0.0001318049,"threshold_uncertainty_score":0.99998987},"labels":[],"label_agreement":null},{"id":"W2042584309","doi":"10.1097/mph.0b013e318158343b","title":"Vincristine-induced Peripheral Neuropathy and Urinary Bladder Paralysis in a Child With Rhabdomyosarcoma","year":2008,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Peripheral neuropathy; Vincristine; Rhabdomyosarcoma; Peripheral; Electromyography; Urinary system; Urinary bladder; Paralysis; Chemotherapy; Urology; Anesthesia; Internal medicine; Surgery; Pathology; Physical medicine and rehabilitation; Cyclophosphamide; Sarcoma; Endocrinology","score_opus":0.024916555948842244,"score_gpt":0.31418662696045435,"score_spread":0.2892700710116121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042584309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98729724,0.004574044,0.000023790846,0.005742707,0.0003030856,0.0002691271,0.000002084419,0.000018847008,0.0017690983],"genre_scores_gemma":[0.99380666,0.0030122302,0.0013292208,0.0007627862,0.000942425,0.00002002609,0.0000030620647,0.000028486858,0.000095093084],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99793005,0.00030782286,0.00081822166,0.00029138537,0.00022250117,0.0004300208],"domain_scores_gemma":[0.99846697,0.0003188192,0.00057978946,0.00015912813,0.00016600057,0.00030930055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003102238,0.0002686943,0.0012503131,0.0006419803,0.00011111551,0.0000047126287,0.000123897,0.0002729022,0.0001933288],"category_scores_gemma":[0.00009435867,0.00019730082,0.00015556782,0.0005231581,0.00019204398,0.000118970245,0.000058525482,0.00085110514,0.000008145151],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005396321,0.003478336,0.86990976,0.000098916986,0.0004327707,0.1118503,0.0018558743,0.000008669316,0.00054400973,0.000050362254,0.004668034,0.0017066703],"study_design_scores_gemma":[0.02401084,0.025731016,0.36715195,0.000032584703,0.0019984853,0.5717879,0.00048508798,0.000104976934,0.00027414938,0.000059166632,0.008008993,0.0003548786],"about_ca_topic_score_codex":0.00003674607,"about_ca_topic_score_gemma":0.00003161934,"teacher_disagreement_score":0.5027578,"about_ca_system_score_codex":0.00024833324,"about_ca_system_score_gemma":0.0008296282,"threshold_uncertainty_score":0.80456936},"labels":[],"label_agreement":null},{"id":"W2043515009","doi":"10.1021/ac010254i","title":"Detection and Partial Structure Elucidation of Basic Taxoids from <i>Taxus wallichiana</i> by Electrospray Ionization Tandem Mass Spectrometry","year":2001,"lang":"en","type":"article","venue":"Analytical Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Biotechnology Research Institute","funders":"","keywords":"Chemistry; Electrospray ionization; Mass spectrometry; Tandem mass spectrometry; Natural product; Chromatography; Combinatorial chemistry; Organic chemistry","score_opus":0.006508868375626682,"score_gpt":0.25451031219161496,"score_spread":0.2480014438159883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043515009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921364,0.00043049315,0.0052641523,0.0004824533,0.00004031254,0.00009762886,0.00003292374,0.000028461172,0.0014871288],"genre_scores_gemma":[0.9980416,0.0002020009,0.00013010019,0.00014205545,0.0003354476,0.0000044456588,0.00032713416,0.000012469413,0.00080468954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917555,0.0000143546,0.00020745752,0.00025733138,0.00016937868,0.00017594175],"domain_scores_gemma":[0.99957335,0.000041625313,0.00008367873,0.00012584607,0.00005508359,0.00012039631],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003905268,0.0001307836,0.0002372002,0.00002688876,0.000042028692,0.000011667459,0.00003582228,0.00016502856,0.0014529587],"category_scores_gemma":[0.00003851413,0.000120999364,0.000052264193,0.0002709614,0.00006458906,0.000050723735,0.000010323707,0.00018193298,0.0000026793234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021244753,0.00008364461,0.035775695,0.00002456001,0.00013493124,0.000008511869,0.000011293059,0.0000020994894,0.96197736,0.000008112914,0.0006883595,0.0010729672],"study_design_scores_gemma":[0.0016485611,0.00017614558,0.008991315,0.00001294233,0.000494256,0.000024089075,0.000014420322,0.002632552,0.98342055,0.0002289499,0.0022436152,0.00011258922],"about_ca_topic_score_codex":0.00007255704,"about_ca_topic_score_gemma":0.000011373067,"teacher_disagreement_score":0.026784379,"about_ca_system_score_codex":0.00011644644,"about_ca_system_score_gemma":0.000040819858,"threshold_uncertainty_score":0.99945986},"labels":[],"label_agreement":null},{"id":"W2044315667","doi":"10.1139/v02-190","title":"Taxanes in rooted cuttings vs. mature Japanese yew","year":2003,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cutting; Taxus; Taxane; Bark (sound); Chemistry; Botany; Metabolite; Stereochemistry; Horticulture; Biology","score_opus":0.008443093429161608,"score_gpt":0.25373224149489587,"score_spread":0.24528914806573426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044315667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98117554,0.0023622615,2.1317297e-7,0.002454835,0.00014359245,0.00004638114,0.0000045883116,0.0000028528736,0.013809713],"genre_scores_gemma":[0.9937422,0.00003583295,0.000057639092,0.00075015443,0.00020677352,0.0000014995331,0.0000055221085,0.0000112710495,0.005189099],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99939525,0.000013136817,0.00021013158,0.00007907653,0.00007932788,0.00022307318],"domain_scores_gemma":[0.999184,0.000019729518,0.000111972135,0.0000812881,0.00008294967,0.00052006275],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010224032,0.00009485538,0.00022802048,0.0000727478,0.000024880412,0.000010313195,0.00006590289,0.00011577529,0.002083224],"category_scores_gemma":[0.00009980655,0.000085187625,0.00007270324,0.00014828691,0.00004614113,0.000035033612,0.0000015525322,0.00033217037,0.000005597146],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007015941,0.0003209717,0.3950686,0.00088089093,0.0005182392,0.022780176,0.0060444204,0.00004800437,0.3284568,0.000025765159,0.24284728,0.0023072856],"study_design_scores_gemma":[0.008843675,0.0002696804,0.03573329,0.0006432453,0.0002731191,0.012204154,0.001223176,0.0000058583087,0.27695614,0.00016907284,0.6633156,0.00036298737],"about_ca_topic_score_codex":0.001112357,"about_ca_topic_score_gemma":0.0019639868,"teacher_disagreement_score":0.4204683,"about_ca_system_score_codex":0.00026412055,"about_ca_system_score_gemma":0.0013487871,"threshold_uncertainty_score":0.998829},"labels":[],"label_agreement":null},{"id":"W2044987995","doi":"10.3747/co.v17i6.728","title":"Arterial Occlusion Precipitated by Cisplatinbased Chemotherapy","year":2010,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ototoxicity; Cisplatin; Chemotherapy; Nephrotoxicity; Gangrene; Adverse effect; Neurotoxicity; Internal medicine; Surgery; Toxicity","score_opus":0.04875093538618674,"score_gpt":0.4282600542290483,"score_spread":0.37950911884286154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044987995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840842,0.00029801409,0.000047578553,0.0032089718,0.006669137,0.0005057834,0.000029982557,0.000090369205,0.0050659776],"genre_scores_gemma":[0.9958037,0.00023166357,0.00026271376,0.0008894748,0.0013313609,0.00007019944,0.00043005243,0.000025559197,0.0009552686],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99913645,0.000038619055,0.00020931405,0.00025558553,0.00010487426,0.00025518466],"domain_scores_gemma":[0.9994265,0.0000873753,0.000088350185,0.00016588498,0.000069233065,0.00016269436],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000103487,0.00015004691,0.0003066957,0.000064587475,0.00006513165,0.000006208949,0.000070932925,0.00017318642,0.005097675],"category_scores_gemma":[0.00002303664,0.00012568494,0.00007665665,0.000102217346,0.000108144115,0.000033509277,0.000025802181,0.0003744714,0.00012743802],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017104208,0.0022411668,0.008064833,0.000022032895,0.00005644381,0.000022876267,0.00031676175,8.750406e-8,0.6715322,0.000034147663,0.2031239,0.112875104],"study_design_scores_gemma":[0.012196854,0.0016135657,0.008584742,0.0000113354845,0.000116224495,0.000076895725,0.0000106481475,0.00017640006,0.027793234,0.0000726181,0.94921774,0.00012976798],"about_ca_topic_score_codex":0.000011411523,"about_ca_topic_score_gemma":0.0000322664,"teacher_disagreement_score":0.7460938,"about_ca_system_score_codex":0.00011095297,"about_ca_system_score_gemma":0.0001898735,"threshold_uncertainty_score":0.9958118},"labels":[],"label_agreement":null},{"id":"W2045259489","doi":"10.3892/ijo.19.4.733","title":"Strategies of medical treatment for metastatic breast cancer (Review)","year":2001,"lang":"en","type":"review","venue":"International Journal of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Vinorelbine; Metastatic breast cancer; Breast cancer; Capecitabine; Oncology; Medicine; Trastuzumab; Gemcitabine; Chemotherapy; Cancer; Internal medicine; Disease; Cisplatin","score_opus":0.1794732844365756,"score_gpt":0.5749174427902647,"score_spread":0.39544415835368907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045259489","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007748068,0.9883628,0.000086806765,0.007294613,0.002243894,0.0006837545,0.00034904506,0.0000042218107,0.0009671084],"genre_scores_gemma":[0.000015520925,0.996836,0.00031844567,0.0004303327,0.0016798436,0.00017369853,0.00009862671,0.000025760603,0.00042174844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756694,0.00014492012,0.0013379643,0.00015533321,0.000626794,0.00016806007],"domain_scores_gemma":[0.99675924,0.0005767949,0.0016218058,0.00009146059,0.0007774133,0.00017327136],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042383635,0.000267047,0.0026674867,0.00032127494,0.000012269287,0.0000059471113,0.00037866348,0.00020777014,0.00400108],"category_scores_gemma":[0.000053203596,0.00016473385,0.0011132587,0.00011455131,0.000107553424,0.000060662078,0.000032250857,0.0002687633,0.000006201254],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034341164,0.0015106458,0.000008764478,0.0055779056,0.007158909,0.0009762571,0.0000248189,9.558446e-7,9.248017e-7,0.00023148886,0.017860224,0.9663057],"study_design_scores_gemma":[0.0041563623,0.002853397,0.000007878391,0.020948803,0.009462729,0.016728088,0.000030013733,0.0000035531684,0.0000014339067,0.000052506548,0.94567204,0.00008319946],"about_ca_topic_score_codex":0.00009550372,"about_ca_topic_score_gemma":0.00006410368,"teacher_disagreement_score":0.96622247,"about_ca_system_score_codex":0.0013821828,"about_ca_system_score_gemma":0.007393974,"threshold_uncertainty_score":0.9982332},"labels":[],"label_agreement":null},{"id":"W2045410360","doi":"10.1016/j.neuroscience.2011.10.010","title":"Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat","year":2011,"lang":"en","type":"article","venue":"Neuroscience","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Dorsal root ganglion; Peripheral neuropathy; Spinal cord; Sensory system; Axon; Sensory nerve; Motor neuron; Medicine; Neuropathic pain; Anatomy; Neuroscience; Anesthesia; Biology; Endocrinology","score_opus":0.07447787709038911,"score_gpt":0.31344830045294864,"score_spread":0.23897042336255953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045410360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99371284,0.000034408673,0.000006204171,0.0011940843,0.0014268913,0.00070765155,0.000011705569,0.000024131703,0.0028820646],"genre_scores_gemma":[0.99330646,0.000057870264,0.000054209857,0.005502983,0.00013119823,0.000093315924,0.0000015684593,0.000010570335,0.0008417985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980204,0.00046250637,0.00031037352,0.00045984422,0.00028478846,0.0004620983],"domain_scores_gemma":[0.99936306,0.00014039366,0.000060999137,0.000321609,0.000020515305,0.000093442446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040339387,0.00017254651,0.00025031605,0.00016588699,0.000065935186,0.000021807125,0.00027637754,0.00006365177,0.00009007255],"category_scores_gemma":[0.00021495033,0.0001270991,0.00006729746,0.00056161353,0.00029867832,0.00016177353,0.000056781766,0.00043493422,0.000010508641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002012111,0.0014553899,0.59960264,0.000029786877,0.0000015699994,0.003639702,0.0065402607,0.000020316547,0.38520354,0.00015388367,0.00034258823,0.0009982474],"study_design_scores_gemma":[0.0034419978,0.00087999686,0.98719287,0.000016419832,0.00001275351,0.00014275823,0.0001955999,0.0008054936,0.0042934264,0.000043700195,0.0028375906,0.00013737277],"about_ca_topic_score_codex":0.0009464411,"about_ca_topic_score_gemma":0.0011646937,"teacher_disagreement_score":0.3875903,"about_ca_system_score_codex":0.00010067139,"about_ca_system_score_gemma":0.00014439522,"threshold_uncertainty_score":0.5182951},"labels":[],"label_agreement":null},{"id":"W2046235081","doi":"10.1158/1535-7163.targ-09-a104","title":"Abstract A104: Safety and effectiveness of phase I solid tumor trial designs of molecularly targeted combination therapies","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Clinical trial; Cancer; Pharmacology; Oncology; Population; Internal medicine; Pharmacokinetics","score_opus":0.034705481045193866,"score_gpt":0.3695591450582382,"score_spread":0.33485366401304434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046235081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98620063,0.009144721,0.0026608498,0.00043493073,0.00014888983,0.001148922,0.000037620437,0.000023386732,0.0002000686],"genre_scores_gemma":[0.99826896,0.000787129,0.00015400008,0.00065275637,0.000031553554,0.00003669411,0.00003604294,0.000021835202,0.000011017496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889946,0.0001546087,0.0003330057,0.00021013846,0.00022146926,0.00018132446],"domain_scores_gemma":[0.9992883,0.000090128335,0.00020314562,0.00018280247,0.00017386166,0.00006172192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002410417,0.00019020317,0.0005082524,0.000107497086,0.000036682843,0.0000070533233,0.00006756124,0.0000844864,0.00006065137],"category_scores_gemma":[0.000007860622,0.00016830224,0.0001338104,0.00018156512,0.00011616379,0.00004370074,0.000009024772,0.0001233342,3.9252262e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058496058,0.0015080487,0.00020287573,0.00014638084,0.0007258428,0.00003856134,0.0003199779,0.000035091372,0.9186678,0.00039077728,0.0000031366296,0.019465439],"study_design_scores_gemma":[0.09343525,0.0060789497,0.018947568,0.00013940723,0.0007631749,0.000008035012,0.000026220052,0.0002033899,0.8789375,0.00096982333,0.00032979823,0.00016090134],"about_ca_topic_score_codex":0.000046467852,"about_ca_topic_score_gemma":0.0000022914787,"teacher_disagreement_score":0.039730325,"about_ca_system_score_codex":0.0000870313,"about_ca_system_score_gemma":0.0001638105,"threshold_uncertainty_score":0.6863166},"labels":[],"label_agreement":null},{"id":"W2046345572","doi":"10.1016/s0968-0896(00)00299-6","title":"Biotransformation of a 4(20),11(12)-taxadiene derivative","year":2001,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; Jewish General Hospital; Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Biotransformation; Hydroxylation; Stereochemistry; Derivative (finance); Isomerization; Taxane; Organic chemistry; Catalysis; Enzyme","score_opus":0.01948976701641771,"score_gpt":0.28703671716903845,"score_spread":0.26754695015262075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046345572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779531,0.00091780035,0.0001362099,0.0023962664,0.000106360916,0.00020923086,0.000015575317,0.000055362478,0.018210093],"genre_scores_gemma":[0.99667764,0.0004428837,0.00010894144,0.00034689833,0.00034007357,0.000013418368,0.000120482015,0.0000168864,0.001932775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899,0.000011992746,0.0003164568,0.0001966947,0.00024646253,0.00023841154],"domain_scores_gemma":[0.9993757,0.000040604686,0.00012892984,0.0001877998,0.00009307712,0.00017389272],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000106041494,0.00016810576,0.0003319177,0.000043836742,0.000040690178,0.0000026720968,0.000088139175,0.00013505053,0.0033515887],"category_scores_gemma":[0.000043830605,0.00013955051,0.0000813301,0.00025487118,0.00015621529,0.00005003048,0.000017185594,0.00014776306,0.000020154188],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036520278,0.0002681889,0.0144773135,0.00026614056,0.00012359107,0.00007201664,0.0005467964,1.8139875e-7,0.9796785,0.000011241027,0.0019768742,0.0022139554],"study_design_scores_gemma":[0.0038390618,0.0003385641,0.012591168,0.00016194549,0.000350464,0.00055416045,0.00047388495,0.000024883138,0.9500787,0.00002989811,0.031423744,0.0001334956],"about_ca_topic_score_codex":0.000059324117,"about_ca_topic_score_gemma":0.00001477599,"teacher_disagreement_score":0.029599767,"about_ca_system_score_codex":0.00014897532,"about_ca_system_score_gemma":0.00019306158,"threshold_uncertainty_score":0.9975595},"labels":[],"label_agreement":null},{"id":"W2046705215","doi":"10.1158/0008-5472.sabcs-903","title":"Bevacizumab (BV) maintenance therapy significantly delays disease progression (PD) or death compared with placebo (PL) in the AVADO trial (BV + docetaxel [D] vs D + PL in 1st-line HER2-negative locally recurrent [LR] or metastatic breast cancer [mBC]).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Discontinuation; Concomitant; Docetaxel; Taxane; Chemotherapy; Oncology; Gastroenterology; Cancer; Urology; Breast cancer","score_opus":0.16377481921600498,"score_gpt":0.477930570792345,"score_spread":0.31415575157634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046705215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9574084,0.004702689,0.000054647044,0.025352951,0.0003100765,0.011252538,0.0005707851,0.000064227475,0.00028368187],"genre_scores_gemma":[0.9834425,0.00704774,0.00021086146,0.0012163991,0.00057317107,0.0060174586,0.000095383504,0.00006544603,0.0013310594],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99402064,0.0013677314,0.0007445782,0.0010083901,0.001496402,0.0013622505],"domain_scores_gemma":[0.99719894,0.00085347856,0.00023507164,0.00059804774,0.00059158646,0.00052289676],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015104053,0.0005516843,0.0009981543,0.00046943864,0.00026191756,0.00010151152,0.00058257655,0.00011529427,0.0016226488],"category_scores_gemma":[0.00016429403,0.00027992285,0.00013431475,0.0017748582,0.0005563369,0.00019944173,0.000069195645,0.0013671088,0.000018388942],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9157144,0.004660061,0.0041142902,0.00022722722,0.00031351388,0.002624344,0.003440006,0.000419311,0.0006316694,0.00005457932,0.007436766,0.060363863],"study_design_scores_gemma":[0.7825587,0.04997578,0.12343827,0.008874772,0.0009369057,0.00038693528,0.004754871,0.007169075,0.0045326035,0.001081076,0.014375507,0.0019155511],"about_ca_topic_score_codex":0.0039626467,"about_ca_topic_score_gemma":0.015123206,"teacher_disagreement_score":0.13315572,"about_ca_system_score_codex":0.0019413787,"about_ca_system_score_gemma":0.0042874296,"threshold_uncertainty_score":0.9999653},"labels":[],"label_agreement":null},{"id":"W2047310696","doi":"10.1016/s0968-0896(02)00066-4","title":"Design and syntheses of putative bioactive taxanes","year":2002,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; Jewish General Hospital; Institut National de la Recherche Scientifique","funders":"","keywords":"Chemistry; Epoxide; Double bond; Stereochemistry; Acetic acid; Molecular model; Alpha (finance); BETA (programming language); Side chain; Combinatorial chemistry; Biochemistry; Organic chemistry","score_opus":0.05168079949987094,"score_gpt":0.2869162146324074,"score_spread":0.23523541513253646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047310696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745295,0.012565258,0.0006291266,0.00291658,0.00011949907,0.0004334313,0.000025862268,0.00007052566,0.008710215],"genre_scores_gemma":[0.9971353,0.00071316323,0.00040024525,0.00014084221,0.00017142048,0.000013080636,0.000006940732,0.000014213366,0.0014047927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928504,0.000022629702,0.00016755117,0.00020659967,0.00015967665,0.00015852998],"domain_scores_gemma":[0.9993312,0.00026013915,0.0001004665,0.00010810278,0.00006410286,0.00013602506],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007781538,0.00014227086,0.00030469502,0.000028448792,0.000031678686,0.000002597686,0.0000475736,0.00009061187,0.00240592],"category_scores_gemma":[0.00012713885,0.00011133962,0.00003521575,0.00012858248,0.00029375835,0.000026518373,0.000020383919,0.00012248325,0.000011311883],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024238546,0.00021491044,0.0009754325,0.00022369914,0.0002450122,0.00009992166,0.0010493137,3.1603057e-7,0.98926467,0.0000024244428,0.0014925366,0.0061894],"study_design_scores_gemma":[0.0013260803,0.00039956134,0.0011431023,0.000115284485,0.00042159847,0.0003702899,0.000643304,0.00011960694,0.99433476,0.000024348932,0.0010018812,0.0001001652],"about_ca_topic_score_codex":0.000024608791,"about_ca_topic_score_gemma":1.8163783e-7,"teacher_disagreement_score":0.0226058,"about_ca_system_score_codex":0.00006249953,"about_ca_system_score_gemma":0.00005169148,"threshold_uncertainty_score":0.998506},"labels":[],"label_agreement":null},{"id":"W2047759229","doi":"10.1159/000336892","title":"First-Line Bevacizumab-Containing Therapy for Triple-Negative Breast Cancer: Analysis of 585 Patients Treated in the ATHENA Study","year":2012,"lang":"en","type":"article","venue":"Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"GlaxoSmithKline; Pfizer","keywords":"Bevacizumab; Medicine; Triple-negative breast cancer; Internal medicine; Regimen; Metastatic breast cancer; Oncology; Population; Taxane; Breast cancer; Chemotherapy; Progression-free survival; Surgery; Cancer; Gastroenterology","score_opus":0.053962761082142416,"score_gpt":0.40723958135010396,"score_spread":0.35327682026796153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047759229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545646,0.00043066344,0.000006181859,0.0011491294,0.00019210734,0.0021014826,0.00017062602,0.000011956027,0.00048138486],"genre_scores_gemma":[0.99778473,0.00026776135,0.000028222279,0.00054280006,0.00016816096,0.0009556496,0.00010449514,0.000013502382,0.00013468559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879503,0.00022339296,0.0003513631,0.0001951021,0.00012425175,0.000310883],"domain_scores_gemma":[0.99873525,0.0006771087,0.00021002737,0.00017325075,0.00014128213,0.00006309657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003846951,0.00015722371,0.00071116956,0.0002837904,0.00006822715,0.0000026017358,0.000101684134,0.00009296516,0.00042902833],"category_scores_gemma":[0.000032250045,0.000097836535,0.00017279517,0.0007343176,0.00006436281,0.000051122133,0.000016536575,0.00011863605,0.0000018469241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008010281,0.010243989,0.93534786,0.000008888726,0.0027348022,0.0000050890676,0.01559349,0.000028131015,0.00004687465,0.000016918006,0.000299803,0.027663866],"study_design_scores_gemma":[0.024748003,0.01147783,0.9561872,0.000008397016,0.0031649317,0.0000033144745,0.0013939657,0.00023596679,0.000114706105,0.000014300718,0.0025656824,0.000085734544],"about_ca_topic_score_codex":0.0032668537,"about_ca_topic_score_gemma":0.008024998,"teacher_disagreement_score":0.027578132,"about_ca_system_score_codex":0.0003975159,"about_ca_system_score_gemma":0.00009454423,"threshold_uncertainty_score":0.49385276},"labels":[],"label_agreement":null},{"id":"W2047837456","doi":"10.1021/jo061339s","title":"Synthesis of Docetaxel and Butitaxel Analogues through Kinetic Resolution of Racemic β-Lactams with 7-<i>O</i>-Triethylsilylbaccatin III","year":2007,"lang":"en","type":"article","venue":"The Journal of Organic Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick","funders":"National Cancer Institute","keywords":"Kinetic resolution; Steric effects; Lactam; Chemistry; Stereochemistry; Resolution (logic); Docetaxel; Beta-lactam; Organic chemistry; Enantioselective synthesis; Catalysis; Antibiotics; Medicine; Biochemistry; Chemotherapy","score_opus":0.010941709479341113,"score_gpt":0.2705639883380366,"score_spread":0.2596222788586955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047837456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99296665,0.004703837,0.0003111499,0.0006531277,0.000034359087,0.000089416164,0.000005219842,0.000004846762,0.0012313629],"genre_scores_gemma":[0.9971039,0.0019309063,0.0005416232,0.000047055888,0.0001521588,5.961386e-7,0.000002110102,0.000013722426,0.00020788728],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990408,0.00002683093,0.00046848174,0.000080637845,0.00023231086,0.0001509343],"domain_scores_gemma":[0.9985579,0.00035572328,0.0006420665,0.00017065414,0.00020329763,0.00007034417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005235275,0.0001232162,0.00040745205,0.000029876739,0.000033599386,0.0000023152722,0.00011207818,0.00007975724,0.0002904964],"category_scores_gemma":[0.00010323677,0.00007464211,0.00006392782,0.0002080856,0.00024787817,0.000046526824,0.000027135058,0.00023563977,5.3927744e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027642355,0.00023267718,0.0035225824,0.00021859806,0.00033149842,0.000020664724,0.00074269844,0.0000034251782,0.99115294,0.0000037697084,0.00045041807,0.0005565143],"study_design_scores_gemma":[0.0028673555,0.0004364307,0.009470382,0.00026832518,0.0012286496,0.0011980643,0.0008089259,0.000004594984,0.9833288,0.00005951027,0.00026056316,0.000068400055],"about_ca_topic_score_codex":0.000052761163,"about_ca_topic_score_gemma":0.000011112107,"teacher_disagreement_score":0.007824119,"about_ca_system_score_codex":0.000078453864,"about_ca_system_score_gemma":0.0001629889,"threshold_uncertainty_score":0.31807318},"labels":[],"label_agreement":null},{"id":"W2048627371","doi":"10.1186/bcr3011","title":"Design of RESILIENCE: a phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Capecitabine; Sorafenib; Medicine; Internal medicine; Placebo; Oncology; Breast cancer; Surgical oncology; Hazard ratio; HER2 negative; Metastatic breast cancer; Cancer; Confidence interval; Hepatocellular carcinoma; Colorectal cancer; Pathology; Alternative medicine","score_opus":0.21281598285871361,"score_gpt":0.47633849023620417,"score_spread":0.26352250737749056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048627371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855114,0.00043585766,0.0014385489,0.0007946859,0.00014142999,0.010854999,0.00060924544,0.000025415347,0.00018836929],"genre_scores_gemma":[0.9895156,0.00064784265,0.0023923106,0.000017475852,0.000090410525,0.00619662,0.000025472486,0.000044281005,0.0010700095],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99742806,0.00034623526,0.0005695346,0.00047538188,0.00060276355,0.00057802984],"domain_scores_gemma":[0.9977087,0.00070228777,0.0002529844,0.00025946042,0.0008889997,0.00018758459],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005785835,0.00027169118,0.0009504361,0.00045568004,0.000086511085,0.000008712968,0.00016154496,0.0000676129,0.0015605724],"category_scores_gemma":[0.000044423443,0.00017032384,0.00007911879,0.0009775541,0.00044740178,0.0001560931,0.000029894756,0.0001454492,0.0000017325316],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9219335,0.008904209,0.0030920445,0.000430245,0.0005981698,0.000098288976,0.003525243,0.0005802418,0.005247551,0.000033829547,0.0001544561,0.055402245],"study_design_scores_gemma":[0.84737754,0.053632505,0.020792423,0.0014606508,0.00079457404,0.00019860886,0.0023226852,0.0067062257,0.06608811,0.00012624488,0.00010865876,0.00039180598],"about_ca_topic_score_codex":0.015624627,"about_ca_topic_score_gemma":0.011070191,"teacher_disagreement_score":0.07455596,"about_ca_system_score_codex":0.0011156625,"about_ca_system_score_gemma":0.0028680272,"threshold_uncertainty_score":0.99935216},"labels":[],"label_agreement":null},{"id":"W2048871140","doi":"10.1271/bbb.70.732","title":"Two New Alkaloidal Taxoids from the Needles of<i>Taxus canadensis</i>","year":2006,"lang":"en","type":"article","venue":"Bioscience Biotechnology and Biochemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"","keywords":"Taxus; Chemistry; Traditional medicine; Botany; Medicine; Biology","score_opus":0.008425782719421106,"score_gpt":0.24973049290683094,"score_spread":0.24130471018740984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048871140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809077,0.0046304776,0.00003132034,0.013301991,0.00014038547,0.000106380074,0.00004181001,0.00005135693,0.0007886185],"genre_scores_gemma":[0.99687654,0.00022441533,0.0007240735,0.0006213701,0.00022782001,0.0000040968853,0.00002164531,0.0000045145644,0.0012955104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992307,0.0000072420903,0.00016293504,0.00028534705,0.000103909915,0.00020988894],"domain_scores_gemma":[0.99955016,0.000047371366,0.00008104354,0.00023214909,0.00002315872,0.00006609754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059165588,0.00012408316,0.00017428628,0.00003433773,0.00010104876,0.000007948188,0.00016702584,0.0002469908,0.000046190235],"category_scores_gemma":[0.000031745378,0.00008188633,0.000045065568,0.00026651306,0.0010128148,0.000018527306,0.000071719405,0.00016382441,0.0000027943051],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046175875,0.00005494931,0.01821613,0.0000067875003,0.000018171251,0.000013178489,0.000015359135,1.04163085e-7,0.97113794,0.00017510206,0.007843378,0.0024727492],"study_design_scores_gemma":[0.00087284547,0.00009708454,0.010782519,0.000019476576,0.00007855849,0.000077929064,0.00013947283,0.0000074868126,0.9776118,0.0002559177,0.009970567,0.000086346154],"about_ca_topic_score_codex":0.009112694,"about_ca_topic_score_gemma":0.00042932073,"teacher_disagreement_score":0.015968895,"about_ca_system_score_codex":0.00003608465,"about_ca_system_score_gemma":0.0002490064,"threshold_uncertainty_score":0.9974857},"labels":[],"label_agreement":null},{"id":"W2048879818","doi":"10.1016/j.jval.2014.08.119","title":"Abraxane Versus Taxol For Patients with Advanced Breast Cancer: A Prospective Time and Motion Analysis from a Chinese Health Care Perspective","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Premedication; Breast cancer; Paclitaxel; Adverse effect; Cancer; Psychological intervention; Emergency medicine; Internal medicine; Anesthesia","score_opus":0.008759623679871185,"score_gpt":0.329815392597895,"score_spread":0.3210557689180238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048879818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99029785,0.0020842187,0.00010809279,0.0039252737,0.00015227922,0.002360392,0.0009505711,0.000038791266,0.00008252327],"genre_scores_gemma":[0.99748665,0.00024510798,0.0010168692,0.00038684075,0.00016542732,0.00029441682,0.00035910885,0.0000218073,0.000023744737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872875,0.00011979441,0.00023172077,0.0004564675,0.00016014143,0.0003031074],"domain_scores_gemma":[0.9990627,0.00017575065,0.00020443818,0.00015110114,0.0002031467,0.00020281899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011336902,0.00018114582,0.00060072273,0.00020680977,0.00011080762,0.0000072102507,0.00003401225,0.00004537123,0.000046037738],"category_scores_gemma":[0.000031581163,0.00013966914,0.000063467334,0.0005101704,0.00004299605,0.00006657954,0.000012622388,0.00012326983,0.0000016098352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015167665,0.0007021991,0.9378925,0.00024615144,0.0008681107,0.0000015912422,0.012814152,0.0018214716,0.000008608632,0.00007103348,0.00008119097,0.030325316],"study_design_scores_gemma":[0.023539666,0.0052490947,0.9642735,0.00013555338,0.00035123754,0.0000011938963,0.000558177,0.0055476073,0.0000045848656,0.00008497216,0.00011305579,0.00014136771],"about_ca_topic_score_codex":0.046662584,"about_ca_topic_score_gemma":0.0056897667,"teacher_disagreement_score":0.040972818,"about_ca_system_score_codex":0.0019470726,"about_ca_system_score_gemma":0.00037342065,"threshold_uncertainty_score":0.9596858},"labels":[],"label_agreement":null},{"id":"W2049005991","doi":"10.1002/ptr.1532","title":"<i>In Vitro</i> culture studies of FlorEssence<sup>®</sup> on human tumor cell lines","year":2005,"lang":"en","type":"article","venue":"Phytotherapy Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Research (Canada); University of British Columbia","funders":"Buddhist Compassion Relief Tzu Chi Foundation; British Columbia Institute of Technology; Lotte and John Hecht Memorial Foundation","keywords":"Jurkat cells; K562 cells; Cisplatin; In vitro; Cell culture; Cell cycle; Medicine; Pharmacology; Immunostimulant; Leukemia; Chemistry; Immunology; Molecular biology; Cancer; Biology; Chemotherapy; Internal medicine; Biochemistry; T cell; Immune system","score_opus":0.14638202588019641,"score_gpt":0.49640080514700397,"score_spread":0.3500187792668076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049005991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778722,0.010770177,3.1015082e-7,0.0044956068,0.000056095898,0.0006217259,0.000018393128,0.000022442939,0.006143049],"genre_scores_gemma":[0.9783409,0.0031870238,0.00016855184,0.0010896694,0.0011934649,0.00015321029,0.000012322392,0.000029607298,0.01582525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983661,0.0001577754,0.0002583273,0.0003082836,0.00047990202,0.00042959154],"domain_scores_gemma":[0.99916697,0.00019315933,0.00004481033,0.00025448742,0.000249155,0.000091415954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043045703,0.00016245016,0.00042206456,0.00026894346,0.00010204466,0.000008286011,0.00014272568,0.000059939255,0.00047924515],"category_scores_gemma":[0.000022331811,0.00011781258,0.000094941824,0.0004432326,0.00026071654,0.00006402538,0.00003093603,0.00043274372,0.00006684654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034471874,0.0019783562,0.002298183,0.00024324318,0.00016719216,0.00009243911,0.006181072,0.00010972682,0.90065426,0.00009654038,0.08205002,0.0026818083],"study_design_scores_gemma":[0.005216776,0.0019061776,0.0004416116,0.00010311807,0.000018935276,0.000006743641,0.0006424884,0.00013540876,0.89348465,0.00027290007,0.09765963,0.000111565256],"about_ca_topic_score_codex":0.000077437115,"about_ca_topic_score_gemma":0.000042020525,"teacher_disagreement_score":0.015609614,"about_ca_system_score_codex":0.00016498225,"about_ca_system_score_gemma":0.0000839633,"threshold_uncertainty_score":0.52473986},"labels":[],"label_agreement":null},{"id":"W2049141868","doi":"10.1002/chin.200846190","title":"ChemInform Abstract: A New pseudo‐Alkaloid Taxane and a New Rearranged Taxane from the Needles of Taxus canadensis","year":2008,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Taxane; Taxus; Computer science; Service (business); Biology; Business; Medicine; Botany; Internal medicine; Cancer","score_opus":0.03812313726011836,"score_gpt":0.2701594691624595,"score_spread":0.23203633190234113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049141868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6557126,0.003156245,1.4353294e-7,0.003718549,0.00017098825,0.0005044186,0.00008336975,0.0000561326,0.33659753],"genre_scores_gemma":[0.8939207,0.0015656664,0.00014199078,0.0014348897,0.00079714466,0.00002010569,0.00019411593,0.000027169512,0.10189821],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881065,1.3318542e-7,0.00038926236,0.0002032614,0.00026945525,0.00032725398],"domain_scores_gemma":[0.9987762,0.00016381759,0.00024214342,0.00034077326,0.00006906044,0.00040800084],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006316716,0.00025028765,0.00046660006,0.000055600056,0.00009191192,0.000010999914,0.0001430081,0.00016380889,0.0030194062],"category_scores_gemma":[0.00009148752,0.00017859208,0.00012240905,0.00020115668,0.00019874603,0.00011543913,0.00005530156,0.000246327,0.000027342861],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056172244,0.00006133649,0.0019077669,0.00006218116,0.00029617918,0.00007355363,0.00748545,6.940075e-8,0.019403607,0.0000075303697,0.6761497,0.2939909],"study_design_scores_gemma":[0.009606756,0.000353906,0.06561218,0.0001982443,0.00069700653,0.00078326906,0.0020832655,0.0000052708137,0.5675989,0.000065214634,0.35257432,0.0004216862],"about_ca_topic_score_codex":0.042184178,"about_ca_topic_score_gemma":0.0017040651,"teacher_disagreement_score":0.54819524,"about_ca_system_score_codex":0.00013192819,"about_ca_system_score_gemma":0.00076274,"threshold_uncertainty_score":0.99789196},"labels":[],"label_agreement":null},{"id":"W2049213018","doi":"10.1016/j.pain.2006.01.037","title":"Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction","year":2006,"lang":"en","type":"article","venue":"Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":523,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Canada Research Chairs; Bristol-Myers Squibb","keywords":"Paclitaxel; Peripheral neuropathy; Medicine; Allodynia; Peripheral; Neuropathic pain; Hyperalgesia; Myelin; Pathology; Anesthesia; Nociception; Chemotherapy; Internal medicine; Endocrinology; Central nervous system","score_opus":0.110283477296514,"score_gpt":0.38481727115546843,"score_spread":0.27453379385895443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049213018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926332,0.0035284585,0.0005130457,0.0015152503,0.00079974526,0.0008139473,0.0000090324265,0.00004071812,0.00014655835],"genre_scores_gemma":[0.9957453,0.00009848479,0.0006079069,0.0004147091,0.0011015872,0.00020242317,0.000018370456,0.000021083957,0.001790157],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985071,0.0005009262,0.00034345713,0.000263991,0.00013892508,0.00024561546],"domain_scores_gemma":[0.99860907,0.0009919873,0.00010296101,0.00014036101,0.00011381356,0.000041788648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078613963,0.00016084785,0.00038075793,0.00008703116,0.000049792045,0.0000071992527,0.000042050073,0.00006896056,0.00006629349],"category_scores_gemma":[0.0007386942,0.00013855177,0.00013837988,0.00014049832,0.00007234669,0.00008800935,0.000015506335,0.00010454884,0.0000016797992],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004871958,0.0005650118,0.13283187,0.0005027092,0.00015799153,0.000079468584,0.0018029812,0.00015376834,0.829863,0.000110984285,0.009862439,0.019197783],"study_design_scores_gemma":[0.07416145,0.031377103,0.62058055,0.002709575,0.0022869646,0.0001445724,0.010028751,0.03394471,0.1802547,0.0030844705,0.039116118,0.0023110448],"about_ca_topic_score_codex":0.0003452338,"about_ca_topic_score_gemma":0.0004824168,"teacher_disagreement_score":0.6496083,"about_ca_system_score_codex":0.00020155923,"about_ca_system_score_gemma":0.000086453685,"threshold_uncertainty_score":0.56499773},"labels":[],"label_agreement":null},{"id":"W2050360830","doi":"10.3747/co.v17i4.562","title":"Incidence of Taxane-Induced Pain and Distress in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Retrospective, Outcomes-Based Survey","year":2010,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Regional Municipality of Durham; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Taxane; Breast cancer; Stage (stratigraphy); Incidence (geometry); Distress; Chemotherapy; Retrospective cohort study; Oncology; Internal medicine; Cancer; Clinical psychology","score_opus":0.05603659427532817,"score_gpt":0.4185789734373806,"score_spread":0.36254237916205245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050360830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968887,0.00006687589,0.000027845586,0.00059186696,0.0009683209,0.0009656493,0.00044456113,0.000016267571,0.000029897205],"genre_scores_gemma":[0.99926,0.0000613304,0.00008245605,0.0001462915,0.0000748112,0.00021342747,0.00010438996,0.000018959716,0.000038341095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880815,0.00017680733,0.0003083953,0.00031916946,0.00012187992,0.00026560167],"domain_scores_gemma":[0.99876237,0.0005232913,0.00023678086,0.00016573278,0.00020583831,0.00010599985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006419681,0.00016979796,0.00056554604,0.00012409022,0.000036095797,0.000004810291,0.00008510162,0.00013889893,0.00013395847],"category_scores_gemma":[0.00024820634,0.00014673221,0.00006595777,0.00017154698,0.00011174025,0.00004265091,0.0000243922,0.00030635094,5.221688e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015699423,0.0013113556,0.912814,0.000110675115,0.000041392672,0.0000023814891,0.00019954125,4.702559e-7,0.001374751,0.0000051730744,0.00018945776,0.08238084],"study_design_scores_gemma":[0.01181028,0.0016825238,0.9847992,0.00006792887,0.00004365928,0.0000010800062,0.000009354067,0.00019661692,0.00051767845,0.000009563739,0.00074345316,0.00011863027],"about_ca_topic_score_codex":0.0016153924,"about_ca_topic_score_gemma":0.009895239,"teacher_disagreement_score":0.08226221,"about_ca_system_score_codex":0.0003134747,"about_ca_system_score_gemma":0.0002318104,"threshold_uncertainty_score":0.5983566},"labels":[],"label_agreement":null},{"id":"W2050379741","doi":"10.1158/0008-5472.sabcs13-p3-13-03","title":"Abstract P3-13-03: A phase III, open-label, randomized study of eribulin versus capecitabine in patients (pts) with metastatic breast cancer (MBC): Effect of post-progression anti-cancer treatments (PPT) and metastatic progression events on overall survival","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Capecitabine; Internal medicine; Eribulin; Hazard ratio; Anthracycline; Proportional hazards model; Oncology; Progression-free survival; Taxane; Breast cancer; Metastatic breast cancer; Cancer; Confidence interval; Surgery; Chemotherapy; Colorectal cancer","score_opus":0.07583385628773552,"score_gpt":0.4838298686528856,"score_spread":0.40799601236515004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050379741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818801,0.0018852205,3.438635e-7,0.000345141,0.0002712705,0.015083691,0.00044468004,0.000016285207,0.00007321258],"genre_scores_gemma":[0.9896006,0.0014064126,0.000058090514,0.00002453353,0.00005483231,0.008414169,0.00015843066,0.00007096424,0.00021196537],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99485415,0.0012669098,0.00085020514,0.00080996327,0.0014667928,0.0007519815],"domain_scores_gemma":[0.99692625,0.0010027653,0.000494985,0.00043314035,0.00079516816,0.00034772232],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013381103,0.00051716284,0.0021364684,0.0005259808,0.00014380789,0.0000439477,0.00030142357,0.00008307302,0.0018788647],"category_scores_gemma":[0.00009778065,0.00031165892,0.00009167669,0.00068681757,0.0003575728,0.00034666687,0.00022091721,0.00049699686,0.000008599051],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7652365,0.027512059,0.105675794,0.00092370703,0.0037145966,0.000088502566,0.0010472541,0.000054806456,0.02043486,0.0000016733987,0.00026570918,0.07504452],"study_design_scores_gemma":[0.8465556,0.035555307,0.10277509,0.0018971694,0.0013576864,0.0000024040482,0.00020563195,0.00020356718,0.011155102,0.0000055286146,0.000011464963,0.00027544884],"about_ca_topic_score_codex":0.023505172,"about_ca_topic_score_gemma":0.0014749331,"teacher_disagreement_score":0.081319086,"about_ca_system_score_codex":0.0007822653,"about_ca_system_score_gemma":0.00054517813,"threshold_uncertainty_score":0.99993354},"labels":[],"label_agreement":null},{"id":"W2051365306","doi":"10.1007/s00280-009-1064-z","title":"A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"Eli Lilly Canada","keywords":"Gemcitabine; Pemetrexed; Medicine; Oncology; Internal medicine; Metastatic breast cancer; Breast cancer; Phases of clinical research; Antimetabolite; Cancer; Chemotherapy; Cisplatin","score_opus":0.016613805612389933,"score_gpt":0.35902117151985685,"score_spread":0.3424073659074669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051365306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99290925,0.0025599005,0.0000016526351,0.0030067186,0.00013218226,0.0012225965,0.00009509258,0.000017609484,0.000055019278],"genre_scores_gemma":[0.99468625,0.001944398,0.000036598867,0.002889536,0.000100488265,0.0001613042,0.0000142402405,0.00001836346,0.00014885468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989548,0.00005943086,0.00026219158,0.00033751273,0.00012396746,0.00026210424],"domain_scores_gemma":[0.99952096,0.000038007496,0.00012727754,0.000087575005,0.0000927998,0.00013339604],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000077627454,0.00022536663,0.0005752095,0.00019360165,0.000060876002,0.000004048697,0.000048867314,0.000046891782,0.0012098775],"category_scores_gemma":[9.90457e-7,0.00017099183,0.000026691887,0.000327396,0.000113396854,0.000073402545,0.000015456446,0.00015970989,1.949555e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04158724,0.03124573,0.62156445,0.00018521749,0.0015157706,0.000058929465,0.005450283,0.000016240709,0.037022278,0.0000071085287,0.002418043,0.25892872],"study_design_scores_gemma":[0.21908566,0.031718314,0.7375176,0.00007093719,0.0012568368,0.000019811578,0.00020362074,0.00012967647,0.0077572935,0.00002388445,0.0019314822,0.00028491326],"about_ca_topic_score_codex":0.000368815,"about_ca_topic_score_gemma":0.00014997461,"teacher_disagreement_score":0.25864378,"about_ca_system_score_codex":0.000093338196,"about_ca_system_score_gemma":0.00012286898,"threshold_uncertainty_score":0.99970317},"labels":[],"label_agreement":null},{"id":"W2051878959","doi":"10.3816/cbc.2010.n.023","title":"Phase III Trials of Eribulin Mesylate (E7389) in Extensively Pretreated Patients With Locally Recurrent or Metastatic Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada","keywords":"Eribulin; Medicine; Metastatic breast cancer; Capecitabine; Internal medicine; Oncology; Anthracycline; Breast cancer; Taxane; Clinical endpoint; Cancer; Randomized controlled trial; Colorectal cancer","score_opus":0.08561982642156016,"score_gpt":0.46778926604650717,"score_spread":0.382169439624947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051878959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895259,0.0005237635,0.000012997226,0.0030142374,0.0014949319,0.0019879928,0.003312182,0.000045755573,0.00008224429],"genre_scores_gemma":[0.9960813,0.0010696182,0.00022534002,0.0009861498,0.00045028096,0.00046826593,0.00018172011,0.000058726477,0.00047858042],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9959332,0.00037977812,0.0020259542,0.00071040564,0.0004288311,0.0005218551],"domain_scores_gemma":[0.9964524,0.0008479437,0.00093911757,0.00040898353,0.00088216114,0.00046942386],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010408574,0.00042829165,0.0021793568,0.00017882673,0.0000467729,0.000013858361,0.00017696929,0.00021769521,0.0093478365],"category_scores_gemma":[0.00030925547,0.00026046607,0.00032770023,0.00057719345,0.00046104897,0.00012439796,0.000058932794,0.0007635176,0.000017748209],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17898147,0.012770887,0.38519505,0.00022007126,0.0018413212,0.00017015483,0.0002010465,0.000018276518,0.0012510685,0.000012887092,0.003921921,0.41541585],"study_design_scores_gemma":[0.13736372,0.004472576,0.8500146,0.00092367,0.0028627247,0.000092792514,0.000032743275,0.00028858118,0.0005649915,0.000025951505,0.0029309625,0.0004266448],"about_ca_topic_score_codex":0.0016956409,"about_ca_topic_score_gemma":0.0035298401,"teacher_disagreement_score":0.4648196,"about_ca_system_score_codex":0.00019236586,"about_ca_system_score_gemma":0.0014451094,"threshold_uncertainty_score":0.99998474},"labels":[],"label_agreement":null},{"id":"W2053269389","doi":"10.1016/s0968-0896(01)00106-7","title":"Microbial and reducing agents catalyze the rearrangement of taxanes","year":2001,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; Jewish General Hospital; Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Taxane; Derivative (finance); Stereochemistry; Double bond; Organic chemistry","score_opus":0.02277994001364311,"score_gpt":0.29191337699412795,"score_spread":0.26913343698048486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053269389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897549,0.0036986107,0.0000021968028,0.0036231866,0.000140288,0.00016823142,0.000007103759,0.000018270688,0.0025871994],"genre_scores_gemma":[0.9951907,0.0011331578,0.00002591203,0.0003543865,0.0005626971,0.000007884245,0.000034490025,0.000012420265,0.0026783857],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926513,0.000011449539,0.00019808057,0.00019032316,0.00016314488,0.00017184613],"domain_scores_gemma":[0.9995362,0.000033931363,0.000091796006,0.0001928094,0.000042230717,0.000103018545],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012873276,0.00012107357,0.00021614696,0.000016734084,0.000056331653,0.0000037476798,0.00007885512,0.00006658596,0.0015457072],"category_scores_gemma":[0.000034727447,0.000080499114,0.00004270266,0.00012402867,0.00019193089,0.000015033363,0.000042543947,0.00013162883,0.000006454757],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020346648,0.00011780538,0.006583598,0.00020023507,0.000121865996,0.00007631529,0.000478306,6.507355e-8,0.9774175,7.534208e-7,0.011924682,0.0028753958],"study_design_scores_gemma":[0.00318035,0.00018638052,0.023879362,0.00020913535,0.00064429257,0.0012742074,0.0006209261,0.000007989882,0.9134983,0.000007861119,0.05637267,0.0001185667],"about_ca_topic_score_codex":0.0002154961,"about_ca_topic_score_gemma":0.0000043907285,"teacher_disagreement_score":0.06391925,"about_ca_system_score_codex":0.00006830104,"about_ca_system_score_gemma":0.0000922143,"threshold_uncertainty_score":0.999367},"labels":[],"label_agreement":null},{"id":"W2056593463","doi":"10.1200/jco.2011.36.4281","title":"Tamoxifen Chemoprevention and Cardiac Disease","year":2011,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Tamoxifen; Disease; Internal medicine; Oncology; Breast cancer; Cancer","score_opus":0.188548134404008,"score_gpt":0.5086288547590361,"score_spread":0.3200807203550281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056593463","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06820332,0.011903008,0.000010427391,0.9043574,0.008670815,0.0004516658,0.00002888551,0.000014076854,0.0063604023],"genre_scores_gemma":[0.021643987,0.018141046,0.0011861157,0.8531069,0.066165335,0.000023067609,0.00011402564,0.00008256,0.039536934],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970636,0.0005097682,0.0017036471,0.00023315872,0.00026311039,0.00022671542],"domain_scores_gemma":[0.99615943,0.0010621265,0.0018885473,0.00017717217,0.00026635395,0.0004463369],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00132634,0.00020614525,0.0021799204,0.00013681022,0.000024500234,0.0000055091714,0.00011169057,0.0012246076,0.0008080597],"category_scores_gemma":[0.0006195988,0.00014760053,0.0010400877,0.000051948115,0.00025168585,0.00006099809,0.00005520216,0.0030862552,0.000032208933],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028252744,0.0007000224,0.018996214,0.00013658991,0.0012589343,0.004856515,0.000027735501,2.978022e-8,0.000009845473,0.000008877496,0.92502004,0.046159953],"study_design_scores_gemma":[0.0044441246,0.006696311,0.08528478,0.000115268434,0.004724642,0.00015535724,0.0000030313447,9.766582e-7,0.0000046314462,0.0007063696,0.8977582,0.00010632398],"about_ca_topic_score_codex":0.00001457466,"about_ca_topic_score_gemma":0.0000015731381,"teacher_disagreement_score":0.06628857,"about_ca_system_score_codex":0.00014474976,"about_ca_system_score_gemma":0.0018444988,"threshold_uncertainty_score":0.99921364},"labels":[],"label_agreement":null},{"id":"W2057012249","doi":"10.1016/s0040-4039(03)01120-1","title":"A stereoselective intramolecular Diels–Alder strategy for the tricyclo[9.3.1.03,8]pentadecane core of aromatic C-ring taxanes","year":2003,"lang":"en","type":"article","venue":"Tetrahedron Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Chemistry; Pentadecane; Stereoselectivity; Intramolecular force; Ring (chemistry); Diels–Alder reaction; Lewis acids and bases; Stereochemistry; Intramolecular reaction; Yield (engineering); Medicinal chemistry; Organic chemistry; Catalysis","score_opus":0.04668487841272557,"score_gpt":0.3312788759013446,"score_spread":0.284593997488619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057012249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931667,0.0011315318,0.000879296,0.002110404,0.00026862675,0.0014031613,0.000011576096,0.00003956225,0.0009891827],"genre_scores_gemma":[0.9966517,0.00006620475,0.00048142832,0.0021255896,0.000111978305,0.00020105843,0.0000171701,0.000033426295,0.00031143767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988447,0.000055122615,0.00030108777,0.00026086412,0.00018798065,0.0003502423],"domain_scores_gemma":[0.999118,0.0003761331,0.0001482578,0.00023812987,0.000036965135,0.00008252025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015851241,0.00021293235,0.00037199343,0.00009235842,0.00008581967,0.000013516795,0.00011075556,0.00006449422,0.0002244376],"category_scores_gemma":[0.00005543381,0.00015045679,0.0001699618,0.00025673173,0.00014071989,0.000051076742,0.000010378666,0.00017442681,0.000008148059],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002041218,0.0014667843,0.02521633,0.00095748535,0.0035417308,0.00024092344,0.0029219212,0.0006726545,0.91705954,0.002273977,0.021428209,0.022179231],"study_design_scores_gemma":[0.052556656,0.010005128,0.13819696,0.0007051371,0.009020088,0.0011726806,0.0037902591,0.0026634848,0.71887225,0.002694094,0.058330324,0.001992947],"about_ca_topic_score_codex":0.00011323796,"about_ca_topic_score_gemma":0.000032570857,"teacher_disagreement_score":0.19818729,"about_ca_system_score_codex":0.00014688657,"about_ca_system_score_gemma":0.000088701105,"threshold_uncertainty_score":0.61354494},"labels":[],"label_agreement":null},{"id":"W2057511062","doi":"10.1158/0008-5472.sabcs10-p6-12-01","title":"Abstract P6-12-01: A Meta Analysis of Risk of Cardiovascular Events in Patients with Metastatic Breast Cancer (MBC) Treated with Anti Vascular Endothelial Growth Factor (VEGF) Therapy — Bevacizumab","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Heart failure; Oncology; Breast cancer; Metastatic breast cancer; Cancer; Cardiology; Chemotherapy","score_opus":0.05645698675753663,"score_gpt":0.36759500238185533,"score_spread":0.3111380156243187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057511062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923133,0.0035940418,0.0000052376417,0.00006551078,0.000046643778,0.0014548975,0.0024587228,0.00001530994,0.000046297606],"genre_scores_gemma":[0.99492127,0.0042376323,0.000056588222,0.0000134726815,0.000053984055,0.00051030493,0.00011033266,0.000057128073,0.000039292252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646825,0.0003610001,0.00044364692,0.0006043079,0.0015390194,0.0005838076],"domain_scores_gemma":[0.9976974,0.00025373444,0.00022477405,0.00069183164,0.0009158902,0.00021636806],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000618667,0.0003405211,0.00184387,0.0010507536,0.00007652787,0.000009489874,0.0002518032,0.00010634453,0.0026730797],"category_scores_gemma":[0.00003141172,0.00020849778,0.00087339233,0.002017197,0.00032280997,0.00013406825,0.000039017414,0.00068179786,0.0000021001358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058312044,0.0014423411,0.7650603,0.00015061692,0.21847025,0.000030253277,0.00058428047,0.00041521262,0.005509922,0.000002169156,0.000012335576,0.0024911163],"study_design_scores_gemma":[0.014848672,0.00070066884,0.9173198,0.000048900052,0.048966397,0.0000017962233,0.00004150548,0.000020720723,0.017760305,0.0000050921603,0.00010068393,0.00018550782],"about_ca_topic_score_codex":0.06560362,"about_ca_topic_score_gemma":0.008950424,"teacher_disagreement_score":0.16950384,"about_ca_system_score_codex":0.0002750796,"about_ca_system_score_gemma":0.0006427048,"threshold_uncertainty_score":0.9982386},"labels":[],"label_agreement":null},{"id":"W2057702405","doi":"10.1016/j.phytochem.2004.08.042","title":"Taxanes with C-5-amino-side chains from the needles of Taxus canadensis","year":2004,"lang":"en","type":"article","venue":"Phytochemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University; Jewish General Hospital; Institut National de la Recherche Scientifique","funders":"","keywords":"Taxus; Side chain; Chemistry; Stereochemistry; Botany; Biology; Organic chemistry","score_opus":0.014447830628805983,"score_gpt":0.2616457562135303,"score_spread":0.24719792558472434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057702405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889686,0.0012284783,0.000014281284,0.0025374398,0.000051518324,0.00015641081,0.00007311984,0.000021824024,0.006948331],"genre_scores_gemma":[0.9977398,0.000053787062,0.00022538635,0.00056953426,0.00037410582,0.000034709818,0.0000616124,0.000012580516,0.0009285167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994395,0.000005407782,0.00011344678,0.00015449409,0.00013454292,0.00015264722],"domain_scores_gemma":[0.99950814,0.000058157864,0.000077898505,0.00022893716,0.000050221803,0.00007661888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002055316,0.00011772497,0.0001990641,0.000010353284,0.000039790066,0.000003787417,0.00007608027,0.00004995919,0.00017027452],"category_scores_gemma":[0.000015122783,0.00007391955,0.000053239168,0.00009401765,0.00013213992,0.000014320627,0.000016324431,0.00011199112,0.0000043369096],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078552513,0.0004013166,0.052941572,0.00014980427,0.00071682344,0.00023433896,0.0018590773,0.0000829041,0.9350605,0.000037156406,0.0057337494,0.0019972108],"study_design_scores_gemma":[0.0027925326,0.00013074158,0.032799724,0.00012134775,0.00033445127,0.000067378445,0.00063690834,0.0000041428098,0.9611237,0.00010479703,0.0017812952,0.00010296033],"about_ca_topic_score_codex":0.006801848,"about_ca_topic_score_gemma":0.0009458153,"teacher_disagreement_score":0.026063198,"about_ca_system_score_codex":0.00008543264,"about_ca_system_score_gemma":0.00023605018,"threshold_uncertainty_score":0.99981195},"labels":[],"label_agreement":null},{"id":"W2057735943","doi":"10.2147/ott.s63302","title":"Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer","year":2014,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institut National d'Excellence en Santé et en Services Sociaux; Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Oncology; Metastatic breast cancer; Progression-free survival; Breast cancer; Confidence interval; Population; Surrogate endpoint; Cancer; Overall survival","score_opus":0.02274941579887847,"score_gpt":0.35614130633805935,"score_spread":0.3333918905391809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057735943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848699,0.0054089604,0.000065732806,0.006883179,0.000897168,0.00084501464,0.000108793865,0.000035769935,0.00088548183],"genre_scores_gemma":[0.99199677,0.00498747,0.00046630407,0.00085729756,0.0005245088,0.00023779657,0.00004495808,0.00003551333,0.0008493604],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998926,0.00008929474,0.00019359341,0.00028438444,0.00019131078,0.0003154043],"domain_scores_gemma":[0.9994525,0.000114320304,0.000070558024,0.00015841861,0.00006693789,0.00013729822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003251637,0.00018862312,0.00042435116,0.00006927777,0.00007364711,0.000020300182,0.000072181465,0.00005501338,0.00052970316],"category_scores_gemma":[0.000011973494,0.0001341079,0.00009572764,0.00007082033,0.00006109497,0.00006297517,0.000024618572,0.00010372344,0.0000036729757],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029032191,0.0037899974,0.2936718,0.00033156617,0.0015960232,0.00019267207,0.0014370483,0.00004265625,0.031286076,0.0036536932,0.004754031,0.63021225],"study_design_scores_gemma":[0.13584727,0.0068103373,0.6146808,0.00038427167,0.0005852228,0.00020672646,0.0001600631,0.0035166957,0.003778792,0.017694315,0.21530399,0.0010315108],"about_ca_topic_score_codex":0.0009230896,"about_ca_topic_score_gemma":0.0004368643,"teacher_disagreement_score":0.6291807,"about_ca_system_score_codex":0.000050102215,"about_ca_system_score_gemma":0.00011220412,"threshold_uncertainty_score":0.57998776},"labels":[],"label_agreement":null},{"id":"W2057805566","doi":"10.1016/s0165-2370(00)00148-0","title":"Challenges in the isolation of taxanes from Taxus canadensis by fast pyrolysis","year":2001,"lang":"en","type":"article","venue":"Journal of Analytical and Applied Pyrolysis","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Pyrolysis; Isolation (microbiology); Taxus; Chemistry; Biology; Botany; Organic chemistry; Microbiology","score_opus":0.03374362426467855,"score_gpt":0.2918198612573437,"score_spread":0.2580762369926652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057805566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796777,0.005548882,0.00005144322,0.011495044,0.000024552306,0.00007868915,0.000009846159,0.0000024381834,0.0031114288],"genre_scores_gemma":[0.992597,0.006651076,0.00008684264,0.00035861842,0.00019337259,0.000003175834,0.000007828474,0.0000061025266,0.00009601724],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99900013,0.00003795669,0.00041646877,0.00013016137,0.00027303418,0.00014223893],"domain_scores_gemma":[0.99928343,0.00021862048,0.00022678317,0.00010415692,0.00006219638,0.000104829225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022573095,0.00011446366,0.0005052387,0.00015946693,0.00003085502,0.000010030045,0.00007679272,0.00007734609,0.00020722371],"category_scores_gemma":[0.000017490333,0.0000691168,0.00013834896,0.00028204476,0.00007849861,0.00003785655,0.000012037467,0.0001964823,0.0000016067919],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013098697,0.005832127,0.27414066,0.00025334652,0.009323638,0.0010675883,0.0099197915,0.0005197068,0.19479825,0.0020620304,0.03708288,0.4519013],"study_design_scores_gemma":[0.025369832,0.003924702,0.8088662,0.0002948096,0.020802246,0.000896599,0.017671715,0.006536024,0.021700226,0.003872405,0.08911615,0.00094907003],"about_ca_topic_score_codex":0.0004725016,"about_ca_topic_score_gemma":0.0006049916,"teacher_disagreement_score":0.53472555,"about_ca_system_score_codex":0.00003763898,"about_ca_system_score_gemma":0.000035489513,"threshold_uncertainty_score":0.28185013},"labels":[],"label_agreement":null},{"id":"W2057932988","doi":"10.1016/s0168-3659(02)00323-1","title":"A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration","year":2002,"lang":"en","type":"article","venue":"Journal of Controlled Release","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Paclitaxel; Emulsion; Chemistry; Pharmacokinetics; Prodrug; Pharmacology; Excipient; Drug carrier; Chromatography; Drug; Drug delivery; Biochemistry; Organic chemistry; Chemotherapy; Medicine; Surgery","score_opus":0.03384097637251466,"score_gpt":0.320878117615303,"score_spread":0.28703714124278834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057932988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893018,0.0013920135,0.00020497027,0.0075042844,0.00033207945,0.0009753265,0.0000092214805,0.000008380013,0.00027192992],"genre_scores_gemma":[0.9974686,0.00030289445,0.000322976,0.0005744119,0.0005853186,0.000062183324,0.000009464053,0.000011919342,0.0006622527],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99883777,0.00009642287,0.00064186077,0.000103685554,0.0001587796,0.00016149029],"domain_scores_gemma":[0.9987636,0.00022250527,0.0005139789,0.00007135994,0.000269932,0.00015857503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017842797,0.00012817478,0.00063618115,0.00023560577,0.000035036428,0.000012712603,0.000045197612,0.00007712108,0.00024507428],"category_scores_gemma":[0.00029359377,0.00009118472,0.00025098262,0.00016025639,0.000027639575,0.000109694396,0.000005486827,0.00020094261,0.0000052752666],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59591633,0.019770177,0.06289561,0.00045362517,0.0033635038,0.0041271825,0.0046150796,0.00039325075,0.15091118,0.00035742443,0.06613957,0.09105704],"study_design_scores_gemma":[0.8263403,0.050928105,0.029938446,0.001184157,0.0028205756,0.0017111452,0.00059471023,0.051026944,0.009286914,0.00198909,0.023534833,0.00064475765],"about_ca_topic_score_codex":0.0000051302436,"about_ca_topic_score_gemma":0.000019450734,"teacher_disagreement_score":0.23042397,"about_ca_system_score_codex":0.00015129274,"about_ca_system_score_gemma":0.00010697748,"threshold_uncertainty_score":0.37184048},"labels":[],"label_agreement":null},{"id":"W2058098342","doi":"10.1097/00001813-200210000-00004","title":"Epirubicin/docetaxel regimen in progressive breast cancer—a phase II study","year":2002,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"","keywords":"Docetaxel; Epirubicin; Medicine; Regimen; Neutropenia; Metastatic breast cancer; Febrile neutropenia; Internal medicine; Breast cancer; Chemotherapy; Adverse effect; Phases of clinical research; Oncology; Surgery; Gastroenterology; Cancer","score_opus":0.03439308193999131,"score_gpt":0.38094733083647836,"score_spread":0.34655424889648706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058098342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758689,0.009134832,5.203664e-7,0.009139092,0.00050018827,0.001720604,0.00012468513,0.000100646765,0.0034105526],"genre_scores_gemma":[0.9839664,0.0029129717,0.000018619281,0.0015644802,0.0007362084,0.0009263031,0.000018839984,0.000050500763,0.00980566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794525,0.00008068509,0.0004130727,0.0006138284,0.0003427158,0.00060446793],"domain_scores_gemma":[0.99907887,0.00003765973,0.0001895787,0.00036601757,0.00011896167,0.00020890469],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013299346,0.00034294734,0.0006970262,0.00022894278,0.00016835314,0.000019472005,0.00016863695,0.00009967555,0.0076357964],"category_scores_gemma":[0.0000052139408,0.0002921809,0.00012208556,0.00060613116,0.00013024495,0.00017942087,0.00008853129,0.00033562418,0.00008145901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026227792,0.03549938,0.52552396,0.00024747825,0.0017054356,0.0014032867,0.026676293,0.000038739374,0.009467698,0.00003687029,0.097905435,0.29887265],"study_design_scores_gemma":[0.32476437,0.022051398,0.42145255,0.002364264,0.0060759606,0.00059329707,0.010285923,0.0040542944,0.044578206,0.000106772866,0.16009293,0.0035800138],"about_ca_topic_score_codex":0.0031200505,"about_ca_topic_score_gemma":0.00040733116,"teacher_disagreement_score":0.32214162,"about_ca_system_score_codex":0.0004120816,"about_ca_system_score_gemma":0.00015295074,"threshold_uncertainty_score":0.99995303},"labels":[],"label_agreement":null},{"id":"W2059358140","doi":"10.1158/1538-7445.am2012-761","title":"Abstract 761: Phase I interaction study of docetaxel with supplementation of St. John's wort","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Docetaxel; Hyperforin; Hypericum perforatum; Pharmacokinetics; Pharmacology; Medicine; CYP3A4; Midazolam; Cancer; Internal medicine; Metabolism; Cytochrome P450","score_opus":0.20223898097076431,"score_gpt":0.5716591254635875,"score_spread":0.36942014449282323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059358140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651843,0.0003851542,0.0000038957874,0.00025324934,0.00014333092,0.0009390485,0.000041642452,0.000007310876,0.0017079468],"genre_scores_gemma":[0.9987231,0.00019581556,0.000025850275,0.000015410345,0.00024227632,0.00024848676,0.000051461146,0.000013263225,0.0004843498],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988776,0.000067031295,0.0002130479,0.00013304847,0.00045497192,0.00025433415],"domain_scores_gemma":[0.9992795,0.00009234382,0.00009246294,0.00015151498,0.00027953903,0.000104648876],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004151261,0.000075590724,0.0002051432,0.00022014408,0.0000404124,0.0000043687432,0.00005364336,0.000026520089,0.0044048773],"category_scores_gemma":[0.000011250608,0.000057021898,0.00002772067,0.0003098325,0.000077157565,0.0001522426,0.000022704238,0.00021361056,0.000006375403],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018627817,0.018275883,0.5690171,0.0005641414,0.0010870978,0.00003595189,0.010818195,0.000025973444,0.31901,0.00003516246,0.023724964,0.038777698],"study_design_scores_gemma":[0.04429057,0.015189909,0.41271648,0.0003085952,0.00058183447,0.000018210078,0.016787214,0.000017677221,0.49102053,0.000012912864,0.018860193,0.00019587483],"about_ca_topic_score_codex":0.0024552823,"about_ca_topic_score_gemma":0.00062030274,"teacher_disagreement_score":0.17201056,"about_ca_system_score_codex":0.00022818724,"about_ca_system_score_gemma":0.00017508278,"threshold_uncertainty_score":0.99650526},"labels":[],"label_agreement":null},{"id":"W2059539152","doi":"10.1517/14656566.1.2.187","title":"Chemotherapy of breast cancer: are the taxanes going to change the natural history of breast cancer?","year":2000,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Breast cancer; Natural history; Oncology; Chemotherapy; Cancer; Internal medicine","score_opus":0.08829158977714896,"score_gpt":0.42387209305990864,"score_spread":0.3355805032827597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059539152","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008709066,0.97506833,3.5399233e-7,0.015634872,0.0048956512,0.0029418522,0.0010233966,0.00005852803,0.00028991982],"genre_scores_gemma":[0.00023571371,0.9759558,0.000008725961,0.014312537,0.004746719,0.0023859236,0.00006841951,0.00016051838,0.002125642],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973258,0.00031220244,0.0007714058,0.00059195416,0.00053021434,0.0004684529],"domain_scores_gemma":[0.997941,0.00023136074,0.0008997975,0.0006072728,0.00014828378,0.00017228011],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020018568,0.0007572501,0.0019893688,0.00027384315,0.00010314379,0.000010006467,0.0006247691,0.00021453056,0.0057688705],"category_scores_gemma":[0.0000018465047,0.0004034165,0.00084044127,0.0004755924,0.00026527824,0.00007265549,0.000032873286,0.0006080674,0.000023781387],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016144001,0.00038441553,0.0000429401,0.0013291118,0.0010995833,0.0000046387304,0.002116515,0.0000012526663,0.00031163398,0.000006025845,0.15980372,0.83328575],"study_design_scores_gemma":[0.0026616396,0.00020647643,0.000216877,0.008356499,0.00021711005,0.00015194718,0.000048326074,0.000012743981,0.0002479144,8.143878e-7,0.98751587,0.00036378278],"about_ca_topic_score_codex":0.0015797515,"about_ca_topic_score_gemma":0.000041401432,"teacher_disagreement_score":0.832922,"about_ca_system_score_codex":0.0014254628,"about_ca_system_score_gemma":0.00085630734,"threshold_uncertainty_score":0.99984175},"labels":[],"label_agreement":null},{"id":"W2059784303","doi":"10.1016/j.critrevonc.2015.01.007","title":"Patients’ satisfaction in early breast cancer treatment: Change in treatment over time and impact of HER2-targeted therapy","year":2015,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Research Society; American Society for Radiation Oncology; American Association for Cancer Research","keywords":"Breast cancer; Medicine; Quality of life (healthcare); Oncology; Adjuvant; Targeted therapy; Adjuvant therapy; Cancer; Internal medicine; Human Epidermal Growth Factor Receptor 2; Nursing","score_opus":0.13091745782011374,"score_gpt":0.5000722111753172,"score_spread":0.3691547533552034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059784303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06534654,0.92871124,6.757248e-8,0.0002593237,0.0002774319,0.004890038,0.00031343367,0.0000160377,0.00018587374],"genre_scores_gemma":[0.008789579,0.9867787,0.000039108254,0.00012607628,0.0001404587,0.0037809992,0.000230345,0.00006281425,0.000051955067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953696,0.0013395615,0.0016612441,0.00077983603,0.00014377746,0.00070596224],"domain_scores_gemma":[0.99794525,0.0008803517,0.00041744942,0.00036543547,0.00010310487,0.00028838514],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003975707,0.0008169693,0.0071257465,0.0007462354,0.000021649757,0.000006472569,0.000102021644,0.0010146899,0.0011495252],"category_scores_gemma":[0.00013601812,0.00053168356,0.0005863947,0.0006300013,0.00034830393,0.00010928134,0.000047104277,0.00046191475,0.000062606035],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005209515,0.0026393156,0.20517991,0.0017787578,0.0002316017,0.00023228291,0.00042410693,3.7709626e-8,0.0000013229842,0.00004523116,0.00018268908,0.7887638],"study_design_scores_gemma":[0.024324916,0.018215531,0.31836915,0.02179665,0.0024224024,0.00092781923,0.000009698037,0.000019785939,0.00000418712,0.00012548745,0.6128882,0.0008961544],"about_ca_topic_score_codex":0.008062962,"about_ca_topic_score_gemma":0.0036146175,"teacher_disagreement_score":0.78786767,"about_ca_system_score_codex":0.005817023,"about_ca_system_score_gemma":0.0010871036,"threshold_uncertainty_score":0.99976355},"labels":[],"label_agreement":null},{"id":"W2059854615","doi":"10.1200/jco.2011.37.2326","title":"Reply to C. McCowan et al","year":2011,"lang":"fr","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.3615371352753022,"score_gpt":0.5805508081408391,"score_spread":0.21901367286553697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059854615","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21027578,0.012806483,0.00024122356,0.5981917,0.055053413,0.0004016845,0.000016438908,0.00001532362,0.12299798],"genre_scores_gemma":[0.26953056,0.012029465,0.015051795,0.668926,0.01002906,0.000008517846,0.0000028079012,0.00005117666,0.024370635],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994333,0.0012959301,0.0032380617,0.00028758124,0.00032492363,0.0005204886],"domain_scores_gemma":[0.99333245,0.0027248014,0.0017780493,0.0002528582,0.00053208467,0.0013797333],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.006840139,0.00022196172,0.002031811,0.00018226482,0.000037513077,0.0000064667456,0.0002778677,0.0004701605,0.009227332],"category_scores_gemma":[0.0030696187,0.00017482776,0.0008346026,0.0002055985,0.00036802082,0.00015638875,0.00010629555,0.001847349,0.0008810236],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010451161,0.006822437,0.027682181,0.000019481855,0.001059545,0.004660201,0.00094795093,0.0000027054973,0.00010047376,0.0009085401,0.6805051,0.26684025],"study_design_scores_gemma":[0.009280711,0.06387091,0.100379474,0.00017127926,0.0012256481,0.0012058081,0.00014820215,0.000007912561,0.00013881456,0.0005773921,0.82287204,0.000121817524],"about_ca_topic_score_codex":0.00037496065,"about_ca_topic_score_gemma":0.00013781036,"teacher_disagreement_score":0.26671842,"about_ca_system_score_codex":0.00039079267,"about_ca_system_score_gemma":0.0041279644,"threshold_uncertainty_score":0.9998969},"labels":[],"label_agreement":null},{"id":"W2060483764","doi":"10.1016/j.ijpharm.2003.10.010","title":"The characterization of novel polymeric paste formulations for intratumoral delivery","year":2003,"lang":"en","type":"article","venue":"International Journal of Pharmaceutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); University of British Columbia","funders":"","keywords":"Differential scanning calorimetry; Gel permeation chromatography; Polyethylene glycol; Polymer; Copolymer; Materials science; Dosage form; Polymer chemistry; Paclitaxel; Polycaprolactone; Drug carrier; Chemistry; Nuclear chemistry; Drug delivery; Chemical engineering; Chromatography; Organic chemistry; Composite material; Nanotechnology; Surgery","score_opus":0.05704963008698588,"score_gpt":0.3944571163726115,"score_spread":0.3374074862856256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060483764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981386,0.00048099997,0.012087973,0.002756458,0.002582389,0.0002478096,0.000067511166,0.0000049706696,0.000385907],"genre_scores_gemma":[0.9969959,0.0006250931,0.0011234818,0.00046336887,0.00041185238,0.000005795124,0.000022252543,0.00000957006,0.00034267735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99922705,0.000019194544,0.00038099202,0.000048841073,0.00022571239,0.00009820074],"domain_scores_gemma":[0.9986743,0.00014159823,0.00038656514,0.0000435275,0.0006949222,0.000059086622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001796017,0.00006949206,0.00013050465,0.000097894874,0.000048136775,0.0000146899665,0.0001052038,0.000026254187,0.000054593773],"category_scores_gemma":[0.00005260755,0.00004945725,0.00012627544,0.000077547964,0.00004639003,0.000107624626,0.000009263625,0.000102807695,7.1838247e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013627757,0.0005538384,0.0056026606,0.00001655925,0.00075280614,0.0000104622795,0.00019537951,0.00006177276,0.9706179,0.003820028,0.00023679352,0.01676905],"study_design_scores_gemma":[0.012671705,0.00061691686,0.008719504,0.00007657429,0.0006957422,0.0007052685,0.00009045038,0.005088666,0.7522199,0.00027692795,0.21871898,0.00011934725],"about_ca_topic_score_codex":0.0000013418347,"about_ca_topic_score_gemma":9.919273e-7,"teacher_disagreement_score":0.21848218,"about_ca_system_score_codex":0.00008563543,"about_ca_system_score_gemma":0.00019499971,"threshold_uncertainty_score":0.20168081},"labels":[],"label_agreement":null},{"id":"W2061010495","doi":"10.1016/j.bmcl.2011.06.034","title":"Effects of C7 substitutions in a high affinity microtubule-binding taxane on antitumor activity and drug transport","year":2011,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Ministry of Science and Technology; Ministerio de Ciencia e Innovación; National Natural Science Foundation of China; Canadian Cancer Society; Comunidad de Madrid","keywords":"Chemistry; Microtubule; Taxane; Cytotoxicity; Paclitaxel; P-glycoprotein; Affinities; Drug; Binding site; In vitro; Plasma protein binding; Stereochemistry; Biochemistry; Structure–activity relationship; Multiple drug resistance; Pharmacology; Cell biology; Cancer","score_opus":0.01337976189394388,"score_gpt":0.23701707771642486,"score_spread":0.22363731582248098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061010495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738777,0.00021627966,0.00001016232,0.0015880251,0.00014849246,0.00031768958,0.000015698144,0.000031164785,0.00028473654],"genre_scores_gemma":[0.99917114,0.00011036413,0.00006742239,0.000381259,0.00013845973,0.000021772097,0.000021891903,0.000015403779,0.00007226093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990445,0.000025012418,0.00020705181,0.0002994097,0.00017148843,0.0002525721],"domain_scores_gemma":[0.99948484,0.000090508234,0.000106681546,0.00015115298,0.000018200531,0.00014861616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012499184,0.00020037465,0.00040456507,0.00007433582,0.000043449338,0.0000016629175,0.000076762444,0.00008230854,0.0002806868],"category_scores_gemma":[0.000031604664,0.00017765374,0.000058195154,0.00020348757,0.00027341285,0.000039073824,0.000014404509,0.00030532153,0.0000050713547],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005750867,0.00057727617,0.04147608,0.0007187477,0.00008462183,0.0005613909,0.00052447093,6.483388e-8,0.95509565,0.000005096616,0.00021368265,0.000167839],"study_design_scores_gemma":[0.0034921372,0.00010255962,0.24611628,0.00027497535,0.00025549726,0.00008227422,0.00003833339,5.1559346e-7,0.7494936,0.0000018936264,0.00003952091,0.00010242745],"about_ca_topic_score_codex":0.0006512257,"about_ca_topic_score_gemma":0.000027853937,"teacher_disagreement_score":0.20560206,"about_ca_system_score_codex":0.00014861565,"about_ca_system_score_gemma":0.00010172187,"threshold_uncertainty_score":0.72445095},"labels":[],"label_agreement":null},{"id":"W2061026641","doi":"10.1097/jto.0000000000000011","title":"Patient-Reported Neuropathy and Taxane-Associated Symptoms in a Phase 3 Trial of nab-Paclitaxel Plus Carboplatin versus Solvent-Based Paclitaxel Plus Carboplatin for Advanced Non–Small-Cell Lung Cancer","year":2013,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Celgene","keywords":"Medicine; Carboplatin; Internal medicine; Taxane; Peripheral neuropathy; Neutropenia; Lung cancer; Peripheral edema; Paclitaxel; Gastroenterology; Cancer; Oncology; Toxicity; Surgery; Chemotherapy; Breast cancer; Adverse effect; Cisplatin; Diabetes mellitus","score_opus":0.02962712005654688,"score_gpt":0.41083622599818354,"score_spread":0.38120910594163665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061026641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905979,0.002009516,0.000084392144,0.0010914775,0.0025761502,0.0032643264,0.000084977626,0.000018772404,0.0002725056],"genre_scores_gemma":[0.9974371,0.00019766245,0.0009857138,0.00031535764,0.0003270676,0.00043724602,0.000043540684,0.000056220826,0.00020007078],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965269,0.00038159275,0.0017543476,0.00039161553,0.00036139277,0.00058414496],"domain_scores_gemma":[0.99501884,0.0010726284,0.0026568894,0.00023571224,0.0006614865,0.00035445942],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065555185,0.0003877012,0.0016931924,0.0004840965,0.000076053366,0.000017155526,0.0001372606,0.00037287665,0.00013660024],"category_scores_gemma":[0.0005140685,0.00033681528,0.00035765668,0.00038326185,0.00014455261,0.0001557934,0.00005129961,0.0006171976,9.877174e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.657944,0.0090907235,0.007632244,0.0008808471,0.0019765364,0.0016414089,0.0041676005,0.0020964593,0.20318945,0.0000035838495,0.0026712439,0.10870586],"study_design_scores_gemma":[0.82497597,0.09739049,0.0044789333,0.0008066253,0.006132826,0.00018807786,0.0018113579,0.032899935,0.02903883,0.000041415642,0.0015105229,0.00072499743],"about_ca_topic_score_codex":0.00068739284,"about_ca_topic_score_gemma":0.000563554,"teacher_disagreement_score":0.17415063,"about_ca_system_score_codex":0.0016688604,"about_ca_system_score_gemma":0.002620727,"threshold_uncertainty_score":0.9999084},"labels":[],"label_agreement":null},{"id":"W2063601993","doi":"10.1016/j.pain.2011.12.011","title":"Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin","year":2012,"lang":"en","type":"article","venue":"Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Neurological Disorders and Stroke; National Institute for Health and Care Research; Canadian Institutes of Health Research; Health Canada; National Institutes of Health; Louise and Alan Edwards Foundation","keywords":"Neuropathic pain; Medicine; Peripheral neuropathy; Pharmacology; Allodynia; Hyperalgesia; Anesthesia; Auranofin; Pregabalin; Oxaliplatin; Nociception; Internal medicine; Endocrinology; Cancer; Diabetes mellitus","score_opus":0.020762477767600353,"score_gpt":0.2863357563484169,"score_spread":0.26557327858081653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063601993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96240586,0.003922932,0.00024232021,0.03089382,0.0004462884,0.0016993476,0.000009210217,0.000033557106,0.000346639],"genre_scores_gemma":[0.98964983,0.00007950863,0.00001695674,0.009128759,0.00038555308,0.00010328867,0.00000533254,0.000017635826,0.0006131361],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99717885,0.0022407165,0.00011768371,0.00013007456,0.00012803811,0.00020461633],"domain_scores_gemma":[0.9959057,0.0037741268,0.00006463204,0.00018026678,0.000013615361,0.00006166389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026921541,0.000117842596,0.00015890725,0.000019877263,0.00007501536,0.000005787813,0.00005765051,0.000042519612,0.00007101831],"category_scores_gemma":[0.00087104493,0.00005942697,0.000051348637,0.00008823901,0.0000858208,0.000017066019,0.000014673629,0.00015641614,0.000008568263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072803686,0.0010969437,0.021457586,0.00029795678,0.0002864605,0.0000050253466,0.0030420602,3.0624773e-7,0.8151351,0.0004108993,0.09101774,0.066521846],"study_design_scores_gemma":[0.01217875,0.0046675634,0.07231739,0.000411841,0.0016659497,0.000036468326,0.00045436912,0.0024003058,0.7216215,0.00042166418,0.18325366,0.00057054614],"about_ca_topic_score_codex":0.000032961358,"about_ca_topic_score_gemma":0.0000020215386,"teacher_disagreement_score":0.093513645,"about_ca_system_score_codex":0.00002241119,"about_ca_system_score_gemma":0.000018872079,"threshold_uncertainty_score":0.24233614},"labels":[],"label_agreement":null},{"id":"W2063908296","doi":"10.3747/co.22.2210","title":"Use of Bevacizumab as a First-Line Treatment for Metastatic Breast Cancer","year":2015,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Celgene; AstraZeneca","keywords":"Bevacizumab; Medicine; Metastatic breast cancer; Oncology; Breast cancer; Chemotherapy; Disease; Internal medicine; Clinical trial; Cancer","score_opus":0.4695800343564018,"score_gpt":0.5319005441505176,"score_spread":0.0623205097941158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063908296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768416,0.0072251935,0.00020059619,0.00946493,0.0027855474,0.0021783444,0.00083929475,0.00005658414,0.00040789138],"genre_scores_gemma":[0.99060524,0.0033036035,0.0009232643,0.00035359274,0.0007328171,0.0015924647,0.00032431076,0.000039965424,0.0021247487],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989868,0.00005429109,0.0003116954,0.00025369573,0.00011866517,0.00027486932],"domain_scores_gemma":[0.9988725,0.00025117764,0.0001622967,0.0001747864,0.00028659203,0.00025265737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008520624,0.00018894795,0.00061727414,0.000114015726,0.000034002845,0.000004261334,0.000052041152,0.00006459158,0.00044595884],"category_scores_gemma":[0.00004977859,0.00014071837,0.00016638619,0.00012585171,0.00010011454,0.000057954618,0.000025302525,0.000074116244,0.000027280348],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020538064,0.021256808,0.051710982,0.0005818049,0.0023297234,0.00012593981,0.0034570498,0.00024285239,0.0008209281,0.00061622146,0.08183049,0.81648916],"study_design_scores_gemma":[0.025702914,0.012877234,0.0027063005,0.000078240075,0.0024962986,0.00028174222,0.000095286014,0.00078428286,0.0014914552,0.00030787935,0.9530181,0.00016025199],"about_ca_topic_score_codex":0.00052829395,"about_ca_topic_score_gemma":0.00068357214,"teacher_disagreement_score":0.8711876,"about_ca_system_score_codex":0.0010618949,"about_ca_system_score_gemma":0.0009850799,"threshold_uncertainty_score":0.57383287},"labels":[],"label_agreement":null},{"id":"W2064680741","doi":"10.1016/j.ejca.2011.11.021","title":"Safety of bevacizumab in metastatic breast cancer patients undergoing surgery","year":2011,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Bevacizumab; Surgery; Metastatic breast cancer; Incidence (geometry); Breast cancer; Adverse effect; Complication; Placebo; Breast surgery; Cancer; Chemotherapy; Internal medicine","score_opus":0.04557765805459347,"score_gpt":0.30990334728207297,"score_spread":0.2643256892274795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064680741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901105,0.0037235788,0.000016637558,0.000456901,0.0007661172,0.00011894564,0.000044237113,0.000004804804,0.0047582565],"genre_scores_gemma":[0.99507195,0.0040537566,0.00013079202,0.00025631522,0.00018798605,0.0000022762654,0.000002305332,0.000027976554,0.0002666317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861234,0.00021872202,0.0006581123,0.00010155364,0.00022766493,0.00018162421],"domain_scores_gemma":[0.99890274,0.00011903551,0.0005243054,0.000084144216,0.00025244773,0.00011731419],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041425644,0.000121538884,0.00043877604,0.00022235683,0.000019133613,0.0000029750545,0.000079858415,0.000011963061,0.0020911894],"category_scores_gemma":[0.0000348179,0.000093589646,0.00015718036,0.00019202309,0.00005303108,0.000109627144,0.00002167412,0.00017070342,0.00000601368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005214917,0.0007612496,0.9144865,0.00018092839,0.0006709282,0.0005011395,0.0017184992,0.00004196882,0.00051820703,0.0000095351725,0.0038680662,0.072028],"study_design_scores_gemma":[0.006341646,0.00044477524,0.9881008,0.0007951605,0.00043536487,0.00007809834,0.000072132134,0.0000035994085,0.0012281183,0.0000120930035,0.0023931833,0.00009502857],"about_ca_topic_score_codex":0.00018180789,"about_ca_topic_score_gemma":0.0003028116,"teacher_disagreement_score":0.07361425,"about_ca_system_score_codex":0.00024119692,"about_ca_system_score_gemma":0.00052370544,"threshold_uncertainty_score":0.998821},"labels":[],"label_agreement":null},{"id":"W2065408496","doi":"10.1017/s0317167100002043","title":"Electronic Case-Report Forms of Symptoms and Impairments of Peripheral Neuropathy","year":2002,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; National Institute of Neurological Disorders and Stroke; Eli Lilly and Company","keywords":"Medicine; Clinical trial; Peripheral neuropathy; Data entry; Audit; Patient recruitment; Medical record; Physical therapy; Medical physics; Medical emergency; Database; Surgery; Computer science; Internal medicine","score_opus":0.024941183803798735,"score_gpt":0.2872100289015597,"score_spread":0.262268845097761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065408496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934469,0.0027079945,0.0000049162954,0.001665307,0.00037531168,0.00017572426,0.00000889403,0.00000701742,0.0016079517],"genre_scores_gemma":[0.9978952,0.0007302584,0.00021992742,0.0009765654,0.00011759203,0.0000018274487,2.0542828e-7,0.000008848305,0.000049566795],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99690086,0.0003377332,0.00092185446,0.00035537264,0.00050742953,0.0009767406],"domain_scores_gemma":[0.9971753,0.00023361028,0.0008904164,0.00011518148,0.00034595063,0.0012395764],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0017000353,0.0002483348,0.0006199508,0.00067807175,0.00074982183,0.000086946355,0.000521642,0.00012441222,0.00038219691],"category_scores_gemma":[0.0004905816,0.0001592443,0.00022723507,0.00081883004,0.005061463,0.000467317,0.00004146413,0.00071779627,4.628041e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015137196,0.000106687134,0.872074,0.000018774004,0.00004658273,0.12162791,0.00046405118,0.0002232459,0.00027326873,0.00024606215,0.0002382615,0.004529769],"study_design_scores_gemma":[0.000850804,0.13017437,0.08338036,0.000030191572,0.0001431031,0.78103024,0.00014271015,0.0010844618,0.0002430961,0.0019731396,0.00078611675,0.00016140699],"about_ca_topic_score_codex":0.0010381049,"about_ca_topic_score_gemma":0.01600312,"teacher_disagreement_score":0.78869367,"about_ca_system_score_codex":0.0001759304,"about_ca_system_score_gemma":0.0014880927,"threshold_uncertainty_score":0.9976462},"labels":[],"label_agreement":null},{"id":"W2065772375","doi":"10.1271/bbb.110223","title":"Novel Taxa-4(20),12-diene and 2(3→20)<i>Abeo</i>taxane from Needles of<i>Taxus canadensis</i>","year":2011,"lang":"en","type":"article","venue":"Bioscience Biotechnology and Biochemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Hebei Medical University; National Natural Science Foundation of China","keywords":"Taxane; Diene; Stereochemistry; Taxus; Chemistry; Botany; Biology; Organic chemistry","score_opus":0.023150044056059405,"score_gpt":0.24164917574802708,"score_spread":0.21849913169196766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065772375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99318457,0.0032209896,0.000045509685,0.0018925746,0.00017347978,0.00015369625,0.00017519768,0.00007456879,0.0010793916],"genre_scores_gemma":[0.99526227,0.0008286492,0.00265216,0.00044756843,0.00006435826,0.0000109844705,0.000027694043,0.0000091502225,0.0006971731],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987842,0.000007014189,0.00024224489,0.0005250567,0.00011892372,0.0003225511],"domain_scores_gemma":[0.99930716,0.000032674678,0.00015342163,0.0002930517,0.000043622204,0.00017007702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000906784,0.00021149757,0.00033538594,0.0001048465,0.000109237524,0.0000065610143,0.00016741463,0.0005236347,0.00007077085],"category_scores_gemma":[0.000057535657,0.00017639002,0.00004505964,0.00024648066,0.0017199346,0.000041867715,0.00014723423,0.00021730691,0.000002107269],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013725099,0.00020225074,0.013593355,0.000045381497,0.00005165812,0.000030403153,0.00011596775,1.0245502e-8,0.9825206,0.000062352476,0.0004038548,0.0028369576],"study_design_scores_gemma":[0.0012146782,0.00036200086,0.009400701,0.000053069198,0.00014150931,0.00024633546,0.00033344867,0.000011494928,0.98521423,0.000067486966,0.0027773555,0.00017770221],"about_ca_topic_score_codex":0.001469191,"about_ca_topic_score_gemma":0.00023766085,"teacher_disagreement_score":0.004192654,"about_ca_system_score_codex":0.000038740396,"about_ca_system_score_gemma":0.00015290295,"threshold_uncertainty_score":0.71929765},"labels":[],"label_agreement":null},{"id":"W2066557153","doi":"10.1007/s10637-011-9673-x","title":"A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer","year":2011,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Gemcitabine; Eribulin; Medicine; Internal medicine; Pancreatic cancer; Neutropenia; Gastroenterology; Phases of clinical research; Oncology; Progressive disease; Clinical endpoint; Refractory (planetary science); Adverse effect; Cancer; Metastatic breast cancer; Chemotherapy; Breast cancer; Clinical trial","score_opus":0.04866918016163396,"score_gpt":0.34107250550963053,"score_spread":0.29240332534799657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066557153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952808,0.000608921,0.0000011755252,0.0014254827,0.00021721153,0.0008039499,0.000025313917,0.00002136496,0.0016158023],"genre_scores_gemma":[0.99518096,0.00005497014,0.00033144784,0.00072356215,0.00010532145,0.00015201214,0.000024656916,0.000016964634,0.0034100786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988371,0.000084100975,0.00038441515,0.00024486662,0.00026817244,0.00018136083],"domain_scores_gemma":[0.99929184,0.00006472622,0.00018260913,0.00023040056,0.00007997769,0.00015047623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107758766,0.00015896722,0.00031947278,0.00011453353,0.00006443946,0.0000024140359,0.00012315187,0.000051142266,0.000867384],"category_scores_gemma":[0.000054151726,0.0001153094,0.00006331398,0.00042342854,0.00013418552,0.000090878326,0.000055072916,0.0001883152,0.000006850492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007048501,0.022815514,0.7260762,0.00019150872,0.0012563654,0.00013077064,0.076186344,0.00041102903,0.13232698,0.0016906462,0.009192495,0.02267366],"study_design_scores_gemma":[0.062306453,0.008702003,0.8796339,0.00043944397,0.0009665816,0.00002247334,0.0012242638,0.0003310442,0.03085719,0.0048997793,0.010191292,0.000425544],"about_ca_topic_score_codex":0.004271796,"about_ca_topic_score_gemma":0.0014615989,"teacher_disagreement_score":0.15355773,"about_ca_system_score_codex":0.00015278083,"about_ca_system_score_gemma":0.00056661514,"threshold_uncertainty_score":0.94972473},"labels":[],"label_agreement":null},{"id":"W2066616838","doi":"10.1158/0008-5472.sabcs10-p6-11-11","title":"Abstract P6-11-11: Trastuzumab beyond Progression in HER2-Positive Advanced Breast Cancer: The Royal Marsden Experience","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Trastuzumab; Breast cancer; Internal medicine; Metastatic breast cancer; Cancer; Oncology; Chemotherapy; Disease; Adjuvant; Surgery","score_opus":0.034655863913858005,"score_gpt":0.4599737779359959,"score_spread":0.4253179140221379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066616838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98311317,0.0017446749,6.672438e-7,0.010610774,0.0007531762,0.0014778697,0.00012891533,0.00003851762,0.0021322519],"genre_scores_gemma":[0.9928734,0.00065997156,0.00003865154,0.00025361482,0.00076907995,0.0025993406,0.000024725381,0.00004237408,0.0027388756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739605,0.00012734378,0.0002822823,0.0005733674,0.0007664317,0.00085449725],"domain_scores_gemma":[0.99874973,0.00018682473,0.00007392046,0.000393459,0.00031794002,0.0002781283],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005140091,0.00023284044,0.00032959093,0.00017937717,0.00029273424,0.000051965257,0.00035779458,0.00016412308,0.0049895598],"category_scores_gemma":[0.0000343623,0.00015647626,0.00008544039,0.00057999615,0.0006499543,0.00013966375,0.00013071456,0.0012298406,0.000031682597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052576037,0.0013479029,0.35398227,0.00019583335,0.00013506034,0.000594675,0.01042197,0.00007494675,0.29666948,0.00013117775,0.016654458,0.3145346],"study_design_scores_gemma":[0.00507279,0.00039304057,0.9096799,0.00044197377,0.000047201596,0.00005945241,0.0010082052,0.0001306308,0.059238534,0.00006574986,0.023582095,0.00028046174],"about_ca_topic_score_codex":0.009621128,"about_ca_topic_score_gemma":0.021242395,"teacher_disagreement_score":0.55569756,"about_ca_system_score_codex":0.0007220951,"about_ca_system_score_gemma":0.0009664139,"threshold_uncertainty_score":0.9969739},"labels":[],"label_agreement":null},{"id":"W2067500495","doi":"10.1016/j.neuroscience.2011.12.023","title":"Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel","year":2011,"lang":"en","type":"article","venue":"Neuroscience","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Peripheral neuropathy; Medicine; Allodynia; Oxaliplatin; Neuropathic pain; Hyperalgesia; Gabapentin; Anesthesia; Vinca alkaloid; Internal medicine; Pathology; Endocrinology; Nociception; Chemotherapy; Cancer","score_opus":0.04999451438369151,"score_gpt":0.29342865993493145,"score_spread":0.24343414555123993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067500495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997653,0.000042853542,0.000028125985,0.0012474479,0.0002211423,0.0005304779,0.000005117903,0.000015848076,0.00025596007],"genre_scores_gemma":[0.99743617,0.000041744377,0.0000045901097,0.0023623256,0.000045203346,0.00003643853,0.000004507005,0.000011731324,0.000057267156],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998832,0.0002519548,0.0001885912,0.0002846662,0.0002272316,0.00021558165],"domain_scores_gemma":[0.9994795,0.00006797502,0.00013853135,0.00023057697,0.00003114299,0.00005227399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022431275,0.00013843706,0.00019141653,0.000045271714,0.00011223758,0.0000218498,0.00018016453,0.000031224245,0.000017521495],"category_scores_gemma":[0.000031927586,0.00007356711,0.000023348895,0.0004012993,0.00021637422,0.00011969641,0.000035904373,0.00023975757,9.149317e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017998203,0.00019611175,0.056321945,0.000013746442,0.000001429159,0.000021083879,0.0029311813,6.449901e-7,0.9385765,0.000024850659,0.000047130176,0.0016853637],"study_design_scores_gemma":[0.0017139973,0.0044201533,0.91250855,0.000020710266,0.00005223634,0.00007835229,0.00018717977,0.0012859199,0.07821611,0.0000031400136,0.001401325,0.00011231881],"about_ca_topic_score_codex":0.00006931013,"about_ca_topic_score_gemma":0.000043358235,"teacher_disagreement_score":0.86036044,"about_ca_system_score_codex":0.000024087996,"about_ca_system_score_gemma":0.0000839055,"threshold_uncertainty_score":0.299998},"labels":[],"label_agreement":null},{"id":"W2067505246","doi":"10.14740/jocmr1856w","title":"Risk Factors for Early-Onset Peripheral Neuropathy Caused by Vincristine in Patients With a First Administration of R-CHOP or R-CHOP-Like Chemotherapy","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Vincristine; CHOP; Concomitant; Regimen; Internal medicine; Univariate analysis; Peripheral neuropathy; Logistic regression; Chemotherapy; Surgery; Gastroenterology; Oncology; Multivariate analysis; Endocrinology; Cyclophosphamide","score_opus":0.10216501188593609,"score_gpt":0.48709542254246546,"score_spread":0.3849304106565294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067505246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99377847,0.00009728578,0.00013227868,0.004750817,0.00033961903,0.00078334066,0.0000373246,0.000005484879,0.000075357595],"genre_scores_gemma":[0.9976584,0.0006555863,0.00017645603,0.00028287026,0.00074755476,0.0000144096175,0.000024857962,0.00003205845,0.00040784074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99632406,0.0006073289,0.001481357,0.00024971826,0.0009847535,0.00035278924],"domain_scores_gemma":[0.9915064,0.0061722095,0.00072761514,0.0002192728,0.00096874207,0.000405782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036671134,0.00017891561,0.0010506744,0.00027074243,0.00007112454,0.000008423491,0.00017383191,0.00014908446,0.00035198635],"category_scores_gemma":[0.0061076297,0.000097917495,0.00015227898,0.0003725183,0.00044053502,0.00007900329,0.000018782113,0.00097194157,0.0000010906641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0521356,0.0018593505,0.9206315,0.00010956178,0.00017872041,0.00003064623,0.00035860817,0.0000015382261,0.000072900126,8.4651157e-7,0.019807048,0.004813636],"study_design_scores_gemma":[0.03901318,0.07539026,0.8726292,0.0003506923,0.00016753368,0.000010517009,0.00008042242,0.000114188864,0.00019019627,0.000021983938,0.01195236,0.00007944065],"about_ca_topic_score_codex":0.00017700407,"about_ca_topic_score_gemma":0.00019679018,"teacher_disagreement_score":0.07353091,"about_ca_system_score_codex":0.00010601536,"about_ca_system_score_gemma":0.0005337807,"threshold_uncertainty_score":0.7311845},"labels":[],"label_agreement":null},{"id":"W2067776418","doi":"10.1080/01635580701328396","title":"Evaluation of the Antiproliferative Effects of Essiac™ on In Vitro and In Vivo Models of Prostate Cancer Compared to Paclitaxel","year":2007,"lang":"en","type":"article","venue":"Nutrition and Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; British Columbia Institute of Technology; Vancouver General Hospital","funders":"","keywords":"Paclitaxel; In vivo; Cell cycle; Flow cytometry; Toxicity; Apoptosis; In vitro; Distribution (mathematics); Pharmacology; Cancer; Medicine; Chemistry; Biology; Internal medicine; Immunology; Biochemistry; Mathematics","score_opus":0.03945416510199899,"score_gpt":0.3847989550561168,"score_spread":0.34534478995411777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067776418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936984,0.0040071765,0.000003751937,0.00070787,0.00006607681,0.0012758501,0.000051826104,0.0000016340222,0.00018738529],"genre_scores_gemma":[0.99812543,0.0013634483,0.00002094484,0.00019883594,0.000022545857,0.00023735645,0.0000024796398,0.000003863131,0.000025108075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99938685,0.00006646879,0.00017295944,0.00010301084,0.00019146327,0.000079270925],"domain_scores_gemma":[0.9996615,0.000053060565,0.00007235017,0.00004887162,0.00013543472,0.000028773671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025773936,0.00006039589,0.0002147708,0.00010223507,0.000009793919,0.0000010474891,0.0000142746185,0.000033117933,0.000019525809],"category_scores_gemma":[0.000010606036,0.00004052835,0.000018218308,0.0001771652,0.000050151124,0.000029245613,0.0000073182305,0.00005104897,2.6815083e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010359458,0.0013431986,0.08875786,0.0012755513,0.00009123161,0.000002690661,0.0059002233,0.00062218966,0.85516435,0.00009540601,0.00034238223,0.036045473],"study_design_scores_gemma":[0.011194692,0.00023669878,0.17540583,0.0009776519,0.00012155425,5.9521784e-7,0.0001710346,0.0019415643,0.80950725,0.0003402971,0.000059789552,0.000043016127],"about_ca_topic_score_codex":0.0006725462,"about_ca_topic_score_gemma":0.0010455186,"teacher_disagreement_score":0.08664798,"about_ca_system_score_codex":0.000118692195,"about_ca_system_score_gemma":0.00007970407,"threshold_uncertainty_score":0.16526982},"labels":[],"label_agreement":null},{"id":"W2068166817","doi":"10.1007/s10555-013-9451-7","title":"Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors","year":2013,"lang":"en","type":"review","venue":"Cancer and Metastasis Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Regional Municipality of Durham","funders":"","keywords":"Drug; Pharmacology; Medicine; Identification (biology); Antagonism; Computational biology; Biology; Internal medicine","score_opus":0.0806551080847331,"score_gpt":0.42557438261793484,"score_spread":0.34491927453320176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068166817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029333152,0.99231386,0.000007123085,0.000047193233,0.00008018538,0.0044381195,0.000036998117,0.000008757584,0.00013444036],"genre_scores_gemma":[0.0015472473,0.9953511,0.0001761594,0.0001673546,0.00004850329,0.0024436682,0.00014703568,0.000026013247,0.000092950315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984056,0.0002874363,0.0006197854,0.00041708202,0.000084796586,0.0001853009],"domain_scores_gemma":[0.99910575,0.00013416636,0.0003952725,0.00017026906,0.00005624741,0.00013828708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017504643,0.000403211,0.0032688186,0.0002131345,0.000044039083,0.000009532007,0.000063983825,0.00011017502,0.00022025178],"category_scores_gemma":[0.000032226108,0.00021732738,0.00018409941,0.0003828434,0.00022377922,0.00004083254,0.00003243835,0.00023357764,0.0000051597835],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004946907,0.00028016153,0.00019863888,0.012638342,0.0004683604,0.000016270078,0.00018943835,2.8934597e-8,0.000015514137,0.000029400848,0.0005276295,0.98558676],"study_design_scores_gemma":[0.0026029716,0.00074886944,0.00068351766,0.009538611,0.0021880213,0.000032071428,0.000009419116,0.0000029864723,0.00005595026,0.000034543948,0.98389095,0.00021207076],"about_ca_topic_score_codex":0.00014901673,"about_ca_topic_score_gemma":0.000049422364,"teacher_disagreement_score":0.9853747,"about_ca_system_score_codex":0.000152766,"about_ca_system_score_gemma":0.00016634133,"threshold_uncertainty_score":0.88623536},"labels":[],"label_agreement":null},{"id":"W2068559390","doi":"10.3816/cbc.2004.n.025","title":"Quality of Life in Women with Advanced Breast Cancer Treated with Docetaxel","year":2004,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Docetaxel; Medicine; Quality of life (healthcare); Nausea; Breast cancer; Internal medicine; Adverse effect; Oncology; Vomiting; Clinical trial; Cancer; Nursing","score_opus":0.0456254794329484,"score_gpt":0.42091801635756826,"score_spread":0.37529253692461984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068559390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98984706,0.00081105315,0.00000867338,0.007454408,0.00013961781,0.0006165395,0.00048264104,0.00005759157,0.00058241974],"genre_scores_gemma":[0.9947458,0.0012593196,0.00014334336,0.0026142043,0.0003535139,0.0005071888,0.00001581819,0.000044490604,0.0003163201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762756,0.000106253465,0.0008573773,0.00057175325,0.00032144095,0.0005156174],"domain_scores_gemma":[0.99836946,0.00015720961,0.00037169905,0.00035089315,0.00027062293,0.00048012153],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003045384,0.0003064228,0.0011908108,0.00009563323,0.000036247508,0.0000069047633,0.00012444831,0.00016449057,0.0016659878],"category_scores_gemma":[0.000021019183,0.00020064402,0.00010833826,0.00057053287,0.00045881292,0.0001227318,0.00003124002,0.00040010776,0.000010518172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058171485,0.0019777063,0.8903866,0.0001614186,0.00061954325,0.00005664615,0.00020658222,0.00050880166,0.00057196105,0.000026769114,0.00015638156,0.0471561],"study_design_scores_gemma":[0.036162432,0.0012219972,0.9608149,0.000506886,0.0001886234,0.00006836725,0.00013222257,0.000005377015,0.0001425434,0.000030000907,0.00047756106,0.00024912655],"about_ca_topic_score_codex":0.007007781,"about_ca_topic_score_gemma":0.004039771,"teacher_disagreement_score":0.07042826,"about_ca_system_score_codex":0.0007223124,"about_ca_system_score_gemma":0.0015752857,"threshold_uncertainty_score":0.99960464},"labels":[],"label_agreement":null},{"id":"W2068882964","doi":"10.1517/14740338.6.3.315","title":"Managing cardiotoxicity in anthracycline-treated breast cancers","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cardiotoxicity; Medicine; Trastuzumab; Anthracycline; Breast cancer; Oncology; Internal medicine; Metastatic breast cancer; Cancer; Chemotherapy; Malignancy","score_opus":0.06337415341656599,"score_gpt":0.43531622394368896,"score_spread":0.37194207052712297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068882964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008517177,0.9825141,0.000009303907,0.0008133482,0.0021560113,0.0017163345,0.00017343082,0.00013462853,0.012474328],"genre_scores_gemma":[0.00010867496,0.9949698,0.00004829879,0.0006634575,0.0017311554,0.0002126655,0.0010451603,0.00010781308,0.001113002],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99699575,0.00025051352,0.0009340526,0.0008309115,0.0003709642,0.00061778974],"domain_scores_gemma":[0.9985443,0.0002989267,0.00028460915,0.0005523081,0.000050676197,0.00026921695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003992557,0.00071290386,0.0025176937,0.0006411263,0.00010459353,0.000013473525,0.00019982416,0.00038798893,0.0005492713],"category_scores_gemma":[0.000014394315,0.00057413836,0.0007202379,0.0007127483,0.00010732336,0.00006191318,0.000074836615,0.0008098571,0.00012495084],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061754085,0.0002992102,0.000099519006,0.0017808441,0.00041876113,0.00024617667,0.00019787777,0.000009399229,0.0000012466899,0.000024374156,0.013116576,0.98318845],"study_design_scores_gemma":[0.0024444307,0.00011454512,0.00016739011,0.013956867,0.00011697642,0.00024306162,0.000047687965,0.0000204167,0.000015607748,0.0000022121264,0.98242044,0.0004503708],"about_ca_topic_score_codex":0.0021583128,"about_ca_topic_score_gemma":0.00015270758,"teacher_disagreement_score":0.9827381,"about_ca_system_score_codex":0.0032249587,"about_ca_system_score_gemma":0.0005678636,"threshold_uncertainty_score":0.999671},"labels":[],"label_agreement":null},{"id":"W2069294590","doi":"10.5586/asbp.2002.025","title":"Influence of extract from shoots of Taxus baccata var. elegantissima on ultrastructure and tubulin cytoskeleton of meristematic cells of Allium cepa L. roots","year":2013,"lang":"en","type":"article","venue":"Acta Societatis Botanicorum Poloniae","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trent University","funders":"","keywords":"Ultrastructure; Meristem; Biology; Botany; Microtubule; Incubation; Taxus; Shoot; Cytoskeleton; Cell plate; Cell biology; Biochemistry; Cell division; Cell; Cytokinesis","score_opus":0.007037299769532706,"score_gpt":0.262217835123966,"score_spread":0.2551805353544333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069294590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652064,0.0012948416,0.000011447876,0.00077518105,0.00011659215,0.0007355912,0.00040325816,0.0000137003835,0.0001287235],"genre_scores_gemma":[0.99706876,0.0005986762,0.0019070413,0.00016606743,0.00003914291,0.000021804293,0.000042540654,0.000034600977,0.00012138561],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99797046,0.0001063188,0.00089172035,0.00034654068,0.000372813,0.0003121228],"domain_scores_gemma":[0.9976603,0.00058255653,0.00095793116,0.00045380733,0.00020140133,0.00014403266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012747612,0.0003004177,0.0011100937,0.00006600253,0.000034457913,0.000006592853,0.0002168838,0.00021794246,0.0006599629],"category_scores_gemma":[0.00007680544,0.0002532557,0.00019629019,0.00021897902,0.00035656014,0.00015484233,0.000057175548,0.0002426308,0.000005990164],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020808452,0.00040367787,0.045032565,0.0007655514,0.0005418788,0.0000061653363,0.0012377977,0.000025203586,0.94758415,0.00002099466,0.0029958636,0.0011780361],"study_design_scores_gemma":[0.0019065336,0.0012567451,0.5447044,0.00036952778,0.0005132746,0.000011544119,0.00021474903,0.00011512557,0.45052236,0.00017855896,0.000063797386,0.00014339093],"about_ca_topic_score_codex":0.0020777916,"about_ca_topic_score_gemma":0.00008894321,"teacher_disagreement_score":0.49967182,"about_ca_system_score_codex":0.000049306946,"about_ca_system_score_gemma":0.00014171426,"threshold_uncertainty_score":0.99999195},"labels":[],"label_agreement":null},{"id":"W2069834221","doi":"10.3747/co.v16i3.377","title":"Optimal Use of Taxanes in Metastatic Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Taxane; Metastatic breast cancer; Breast cancer; Oncology; Guideline; Internal medicine; Anthracycline; Clinical trial; Docetaxel; Cancer; Randomized controlled trial; Intensive care medicine; Pathology","score_opus":0.21199348025233017,"score_gpt":0.49222649042341693,"score_spread":0.28023301017108676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069834221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916826,0.0036113649,0.000013730243,0.003470142,0.0006101075,0.00031006412,0.00005243923,0.000016063372,0.00023350463],"genre_scores_gemma":[0.997086,0.0017145657,0.00045893795,0.00033327963,0.00015240407,0.000046509867,0.000028364753,0.000006578013,0.00017339003],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99924815,0.00006255593,0.00024310726,0.00016180938,0.000080078324,0.00020430208],"domain_scores_gemma":[0.99957854,0.00008622872,0.000098365155,0.00009541652,0.00006423306,0.00007723012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006547664,0.000105664774,0.00040279632,0.00014306439,0.000011683935,0.0000022411841,0.000042919677,0.000045411394,0.0007655394],"category_scores_gemma":[0.000014844758,0.000087234665,0.00006480862,0.0001771909,0.000070904185,0.000056195444,0.000013254798,0.00015214663,0.000009084368],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030142511,0.009064538,0.3283779,0.00020865066,0.00019705389,0.0002726143,0.0010579228,0.0003896266,0.007944333,0.00025914417,0.021362972,0.627851],"study_design_scores_gemma":[0.009172115,0.0025753835,0.74939126,0.00014023931,0.00057842396,0.0002974255,0.000068767135,0.00066771725,0.0012831887,0.000072362986,0.2355834,0.00016970104],"about_ca_topic_score_codex":0.00013704105,"about_ca_topic_score_gemma":0.00009742611,"teacher_disagreement_score":0.6276813,"about_ca_system_score_codex":0.00022660661,"about_ca_system_score_gemma":0.0002492158,"threshold_uncertainty_score":0.83821195},"labels":[],"label_agreement":null},{"id":"W2070015667","doi":"10.1016/s0968-0896(03)00425-5","title":"Corrigendum to “Design and Syntheses of Putative Bioactive Taxanes” [Bioorg. Med. Chem. (2002) 2387–2395]","year":2003,"lang":"en","type":"erratum","venue":"Bioorganic & Medicinal Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; Jewish General Hospital; Institut National de la Recherche Scientifique","funders":"","keywords":"Boulevard; Queen (butterfly); Chemistry; Suite; Library science; Research center; Archaeology; Zoology; History; Political science; Biology; Computer science","score_opus":0.04066035186318156,"score_gpt":0.30169546738533554,"score_spread":0.26103511552215397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070015667","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035889532,0.24459621,0.0038132945,0.028833542,0.11494351,0.016875546,0.005042901,0.0012917625,0.5487137],"genre_scores_gemma":[0.110058464,0.0073244465,0.0013961138,0.0024316893,0.005673927,0.00033144795,0.0011825071,0.0003930741,0.8712083],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964432,0.000111422974,0.0007741263,0.0011179055,0.0008010041,0.00075235515],"domain_scores_gemma":[0.9972561,0.00026527248,0.0006454003,0.0005817173,0.00042336487,0.0008281247],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003888039,0.00092463975,0.0018398596,0.00019443456,0.00010750767,0.000016522517,0.0003106239,0.0011112738,0.0055820374],"category_scores_gemma":[0.00083439326,0.00078764115,0.00021238955,0.0006104217,0.0006663408,0.000050554852,0.00012517467,0.0012545562,0.000070106296],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007789819,0.00034526942,0.000058087273,0.0013005353,0.0010492364,0.00036262523,0.0007447867,1.2930171e-7,0.26119933,0.0000022033685,0.73265374,0.0015050924],"study_design_scores_gemma":[0.0019117851,0.0010406885,0.00020119981,0.001179971,0.0023710127,0.00071823405,0.0010416033,0.0000098744595,0.61992204,0.000018860119,0.37097096,0.0006137836],"about_ca_topic_score_codex":0.00016220061,"about_ca_topic_score_gemma":0.0000034573168,"teacher_disagreement_score":0.36168277,"about_ca_system_score_codex":0.0006454269,"about_ca_system_score_gemma":0.0019688304,"threshold_uncertainty_score":0.9994575},"labels":[],"label_agreement":null},{"id":"W2070634470","doi":"10.1159/000225887","title":"Phase I Toxicologic Study of Lonidamine in Cancer Patients","year":2009,"lang":"en","type":"article","venue":"Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; BC Cancer Agency","funders":"","keywords":"Somnolence; Medicine; Toxicity; Cancer; Chemotherapy; Phases of clinical research; Lung cancer; Breast cancer; Adverse effect; Sarcoma; Internal medicine; Pharmacology; Gastroenterology; Pathology","score_opus":0.056954877794377225,"score_gpt":0.47114051560535686,"score_spread":0.4141856378109796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070634470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99276066,0.00019973944,4.0390384e-7,0.0010178327,0.00024294222,0.0007372324,0.000005386324,0.0000138245705,0.0050219814],"genre_scores_gemma":[0.998224,0.00007810214,0.000028970286,0.0010149388,0.00007413777,0.000072276394,0.000014497151,0.0000046201517,0.00048843643],"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992642,0.00006534901,0.00024636136,0.00016867883,0.00007949288,0.00017595026],"domain_scores_gemma":[0.9996569,0.00004974262,0.000089599955,0.00009347403,0.00005345063,0.00005682351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069483336,0.00008972866,0.00038705856,0.0001258929,0.000013941926,8.3036775e-7,0.000049006812,0.0000866257,0.0006796152],"category_scores_gemma":[0.000017132785,0.00007296133,0.000030271189,0.00019239837,0.00003141411,0.000020818485,0.000014105535,0.00011525351,0.000007607594],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025906689,0.57460815,0.28266835,0.000017422208,0.00010366289,0.00024890256,0.002015365,0.000013412341,0.014466027,0.000024219711,0.004354214,0.11888961],"study_design_scores_gemma":[0.065156445,0.4882476,0.43420482,0.000014637839,0.00023021626,0.00000697514,0.000249561,0.000031852804,0.0027310925,0.000050754625,0.008976907,0.000099146884],"about_ca_topic_score_codex":0.00019449028,"about_ca_topic_score_gemma":0.0008699833,"teacher_disagreement_score":0.15153646,"about_ca_system_score_codex":0.00032109558,"about_ca_system_score_gemma":0.00012751798,"threshold_uncertainty_score":0.74413097},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2070826508","doi":"10.1158/0008-5472.sabcs-4116","title":"Safety of bevacizumab (BV) plus docetaxel (D) in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) who developed brain metastases during the AVADO phase III study.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Metastatic breast cancer; Bevacizumab; Internal medicine; Clinical endpoint; Hazard ratio; Docetaxel; Population; Neutropenia; Taxane; Placebo; Breast cancer; Oncology; Cancer; Surgery; Chemotherapy; Clinical trial; Confidence interval; Pathology","score_opus":0.08245026851302782,"score_gpt":0.45017309410043804,"score_spread":0.3677228255874102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070826508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887038,0.0018857575,0.000015405789,0.004641645,0.00012385061,0.0039478377,0.00046971245,0.000024938809,0.00018708436],"genre_scores_gemma":[0.9953123,0.0011632795,0.00005086605,0.00033324712,0.00013116129,0.0008658696,0.000048748905,0.000040601477,0.002053929],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9959379,0.00065913505,0.0006874705,0.00062414084,0.0012369615,0.0008544272],"domain_scores_gemma":[0.99801785,0.0003218084,0.00018881644,0.00047496508,0.0007300354,0.00026650325],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001099508,0.00034786065,0.0008857755,0.0004395319,0.0002626563,0.000034305267,0.0003612442,0.000054365104,0.0018314196],"category_scores_gemma":[0.00009002518,0.00020028335,0.00008651935,0.0015885843,0.00034433164,0.00016195998,0.00012503208,0.0007114791,0.000008074273],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44487658,0.022753268,0.0724048,0.0013163378,0.0042424323,0.0013245203,0.016654583,0.0008746303,0.004974432,0.000072257055,0.014448051,0.4160581],"study_design_scores_gemma":[0.31737608,0.021098483,0.6364393,0.002339979,0.0013638694,0.00010364299,0.003719601,0.00027761282,0.009040631,0.000042417105,0.007333325,0.00086499617],"about_ca_topic_score_codex":0.0034106006,"about_ca_topic_score_gemma":0.010323325,"teacher_disagreement_score":0.5640345,"about_ca_system_score_codex":0.0020609496,"about_ca_system_score_gemma":0.0024821612,"threshold_uncertainty_score":0.999081},"labels":[],"label_agreement":null},{"id":"W2070855246","doi":"10.1038/sj.bjc.6602304","title":"Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome","year":2005,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":339,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Mastectomy; Term (time); Cancer; Surgery; Oncology; Internal medicine","score_opus":0.009585676431239868,"score_gpt":0.28726506979981525,"score_spread":0.2776793933685754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070855246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96319616,0.03318417,0.000031764263,0.0024531009,0.00051395374,0.00023763085,0.0001749049,0.000012805945,0.00019552957],"genre_scores_gemma":[0.9894319,0.006837374,0.000105012696,0.0008529351,0.000718835,0.000027850714,0.000007675754,0.000040153383,0.0019782302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985206,0.00009017755,0.0004860529,0.00016929362,0.00042457998,0.00030930972],"domain_scores_gemma":[0.99848044,0.000063333464,0.00043259506,0.000104643026,0.0006803859,0.00023862679],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031446293,0.00017665245,0.0006229111,0.00014004478,0.000047536265,0.000019298493,0.0001303263,0.00008376248,0.004366047],"category_scores_gemma":[0.00001413535,0.00015497491,0.00020788179,0.00024900583,0.00011775786,0.0002225006,0.000018023897,0.0003112911,0.0000030909375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031681228,0.00044735,0.5330929,0.00024560356,0.001338629,0.0029165621,0.00023237,0.000091716516,0.0028798708,0.0000015195657,0.0021409641,0.45344436],"study_design_scores_gemma":[0.010495258,0.0012027818,0.95552754,0.0022316123,0.0008678388,0.024389943,0.000054511835,0.0000080280115,0.001243909,0.0000021774185,0.0037867487,0.00018964802],"about_ca_topic_score_codex":0.0047365846,"about_ca_topic_score_gemma":0.048241295,"teacher_disagreement_score":0.4532547,"about_ca_system_score_codex":0.0003295492,"about_ca_system_score_gemma":0.0006296522,"threshold_uncertainty_score":0.9965441},"labels":[],"label_agreement":null},{"id":"W2071021499","doi":"10.1016/j.cjca.2011.07.128","title":"181 Prevention of Chemotherapy Induced Cardiac Dysfunction by Renin-angiotensin System Antagonism","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Research Manitoba","funders":"","keywords":"Medicine; Antagonism; Renin–angiotensin system; Chemotherapy; Pharmacology; Internal medicine; Cardiac dysfunction; Cardiology; Heart failure; Receptor; Blood pressure","score_opus":0.029821919244161294,"score_gpt":0.26869807773204235,"score_spread":0.23887615848788105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071021499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98464245,0.0017948137,0.0003904751,0.0004819182,0.0027740893,0.00025774303,0.000034807006,0.000008774928,0.009614936],"genre_scores_gemma":[0.9984703,0.00011089212,0.00011327807,0.00009258751,0.0008593641,0.0000037114708,0.000019587775,0.000017142587,0.00031312194],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990454,0.00015580049,0.00037318587,0.000115434574,0.00008523134,0.00022495181],"domain_scores_gemma":[0.9989829,0.000021302681,0.00027981077,0.00013735081,0.00025107033,0.00032756492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028975608,0.00011796289,0.0006559035,0.00024556406,0.00004060035,0.0000028310765,0.00006702018,0.00018716212,0.00005640805],"category_scores_gemma":[0.000015684645,0.00010362799,0.00032587472,0.000113762224,0.00008519297,0.00004797009,0.000003373738,0.00018701037,0.000005024919],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031025258,0.000055416192,0.27839583,0.0001169831,0.0069848667,0.0006974906,0.0021588977,0.000024698364,0.37301698,0.00040058178,0.2817541,0.053291626],"study_design_scores_gemma":[0.012770763,0.010231715,0.48726192,0.00031486992,0.0034859923,0.0039733485,0.00065682095,0.000012776245,0.19996198,0.00021317482,0.28064373,0.00047291],"about_ca_topic_score_codex":0.0023228708,"about_ca_topic_score_gemma":0.00017552642,"teacher_disagreement_score":0.2088661,"about_ca_system_score_codex":0.00031757174,"about_ca_system_score_gemma":0.00087904994,"threshold_uncertainty_score":0.4225827},"labels":[],"label_agreement":null},{"id":"W2072882746","doi":"10.1007/bf02967532","title":"The worldwide perspective in the adjuvant treatment of primary lymph node positive breast cancer","year":2001,"lang":"en","type":"review","venue":"Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Epirubicin; Medicine; Breast cancer; Oncology; Anthracycline; Internal medicine; Adjuvant; Taxane; Cancer; Adjuvant therapy; Cyclophosphamide; Chemotherapy","score_opus":0.03421385643421887,"score_gpt":0.37549236438050365,"score_spread":0.3412785079462848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072882746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011508038,0.979275,5.366245e-7,0.007560895,0.0005528173,0.0023978823,0.0032939482,0.000024648938,0.0067792195],"genre_scores_gemma":[0.00055053685,0.99034613,0.0000062907743,0.00066727865,0.0014742103,0.0032069923,0.00014979707,0.00008531988,0.0035134393],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99726385,0.0003606679,0.00066650345,0.0006490377,0.000430574,0.00062939205],"domain_scores_gemma":[0.9980463,0.00047678745,0.0005046999,0.0005801268,0.00025736622,0.00013475418],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017691676,0.00072512974,0.0022132695,0.00020331936,0.00016881751,0.000027549966,0.0003380873,0.00022662798,0.0008136497],"category_scores_gemma":[0.000004239657,0.00034824992,0.00081097666,0.00086997,0.00033440336,0.000058318852,0.000053965174,0.00033071236,0.000023213817],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011228939,0.0009729267,0.0020726933,0.0011037608,0.0018858222,0.00023414094,0.0009787519,0.0000032077696,0.0000018788845,0.00009348217,0.0017351948,0.98979527],"study_design_scores_gemma":[0.0050359885,0.00021662614,0.09960889,0.010452892,0.008941463,0.0032192743,0.0004883207,0.0000034455986,0.0000026278797,0.000027287002,0.8715258,0.0004773643],"about_ca_topic_score_codex":0.024342168,"about_ca_topic_score_gemma":0.003243793,"teacher_disagreement_score":0.9893179,"about_ca_system_score_codex":0.007972875,"about_ca_system_score_gemma":0.0030234717,"threshold_uncertainty_score":0.99989694},"labels":[],"label_agreement":null},{"id":"W2073325449","doi":"10.1007/s10725-004-2602-7","title":"In vitro stem elongation of stemless carline thistle","year":2004,"lang":"en","type":"article","venue":"Plant Growth Regulation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Biological Sciences","funders":"","keywords":"Darkness; Elongation; Biology; Botany; Plant stem; photoperiodism; Thistle; Plant physiology; Rosette (schizont appearance); Auxin; Horticulture","score_opus":0.02239550901065059,"score_gpt":0.27905394542035206,"score_spread":0.2566584364097015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073325449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974145,0.00016181765,0.00023749091,0.00087835325,0.00016334756,0.00027840317,0.000029664658,0.00001817841,0.00081821857],"genre_scores_gemma":[0.9989864,0.000025812362,0.00018128018,0.000062838924,0.00010204574,0.000013780098,0.0002957037,0.000006702499,0.0003254246],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994724,0.000019348827,0.00019273612,0.00010668447,0.00012189754,0.000086981585],"domain_scores_gemma":[0.99974906,0.0000284518,0.000079896236,0.00006696793,0.000046398593,0.000029233128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080742255,0.000065048946,0.0001637281,0.000119143304,0.000015247392,0.0000020487628,0.000020527013,0.000054832726,0.00003077641],"category_scores_gemma":[0.000004081672,0.000058158184,0.000029180397,0.00014002253,0.000018364617,0.00007421835,0.0000055545775,0.000050397786,0.0000062610957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029985148,0.0005755793,0.035577025,0.00035197168,0.00007817639,0.000056751072,0.0015586794,0.00061371434,0.94973356,0.004510964,0.00046093843,0.0034841471],"study_design_scores_gemma":[0.0054079834,0.00019692491,0.15923057,0.00009599141,0.00009215537,0.000049163416,0.000035399877,0.00058676075,0.8328001,0.0010786442,0.00034038813,0.0000859173],"about_ca_topic_score_codex":0.00026807835,"about_ca_topic_score_gemma":0.000057708214,"teacher_disagreement_score":0.12365354,"about_ca_system_score_codex":0.000171113,"about_ca_system_score_gemma":0.00005596759,"threshold_uncertainty_score":0.2371622},"labels":[],"label_agreement":null},{"id":"W2073700935","doi":"10.1038/cdd.2012.11","title":"Thromboxane A2 modulates cisplatin-induced apoptosis through a Siva1-dependent mechanism","year":2012,"lang":"en","type":"article","venue":"Cell Death and Differentiation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Sherbrooke; Université de Montréal; Université de Sherbrooke","funders":"","keywords":"XIAP; Cisplatin; Cell biology; Apoptosis; HeLa; Chemistry; Receptor; Biology; Caspase; Biochemistry; Programmed cell death; Cell","score_opus":0.0362839232068058,"score_gpt":0.2946398112300573,"score_spread":0.2583558880232515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073700935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99375623,0.0006650439,0.0009124578,0.00018057962,0.0005574217,0.00038442254,0.000007557549,0.000060496135,0.0034758046],"genre_scores_gemma":[0.99750227,0.00040788748,0.0003065357,0.00026300273,0.0003087547,0.000042192198,0.00015420928,0.000019774834,0.0009953834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913096,0.00003267605,0.00017425,0.00020742876,0.00015669217,0.0002979808],"domain_scores_gemma":[0.99954474,0.00004079771,0.000082454,0.00013522188,0.00003585106,0.00016093324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054084958,0.00017703786,0.00024835474,0.0000549197,0.000105393614,0.000020285861,0.000030723688,0.00011859366,0.00053059496],"category_scores_gemma":[0.0000065736895,0.00014456645,0.000065718996,0.000060136856,0.000010899635,0.00016572294,0.00003225279,0.00010405746,0.000043458796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021825034,0.0010674353,0.06439708,0.00015048505,0.0002122037,0.0000027678896,0.0019733445,0.0000010093913,0.9254865,0.003328919,0.00033424544,0.0028277307],"study_design_scores_gemma":[0.004090805,0.00044040175,0.15688635,0.000024206862,0.0008579729,0.00001566787,0.00011498403,0.00042835425,0.83434886,0.0023733417,0.00019589701,0.00022315246],"about_ca_topic_score_codex":0.00008962682,"about_ca_topic_score_gemma":0.0000041346866,"teacher_disagreement_score":0.09248927,"about_ca_system_score_codex":0.00006541429,"about_ca_system_score_gemma":0.000018469365,"threshold_uncertainty_score":0.5895249},"labels":[],"label_agreement":null},{"id":"W2073721747","doi":"10.3390/molecules13020360","title":"Design, Synthesis and Applications of Hyaluronic Acid-Paclitaxel Bioconjugates†","year":2008,"lang":"en","type":"review","venue":"Molecules","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fidia Farmaceutici; McGill University","keywords":"Hyaluronic acid; Paclitaxel; Combinatorial chemistry; Chemistry; Nanotechnology; Computational biology; Biology; Materials science; Medicine; Internal medicine; Cancer; Genetics","score_opus":0.05655227694326574,"score_gpt":0.3632363501123435,"score_spread":0.30668407316907775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073721747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008133095,0.99671686,0.00090872805,0.000044790282,0.000025599975,0.0014257969,0.00006460304,0.0000291179,0.0007763737],"genre_scores_gemma":[0.000047494315,0.9969896,0.0013292662,0.000044552453,0.00008749779,0.0009882794,0.0000631504,0.000039872426,0.00041028697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990231,0.000095484625,0.00032709845,0.000290849,0.00009577802,0.00016769212],"domain_scores_gemma":[0.999165,0.00025369163,0.00018252614,0.00026630788,0.000039758386,0.000092698516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049864055,0.00026008548,0.0011315482,0.0001702268,0.000041044634,0.0000044669077,0.000084908505,0.00018149377,0.00011866318],"category_scores_gemma":[0.000019050321,0.00020121686,0.00022725412,0.0001877743,0.0001649368,0.000012516209,0.00003850346,0.00013334297,0.000052975978],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018417793,0.00016171235,0.0000043803934,0.0059922985,0.00050369836,0.000031673433,0.000020683641,1.1081139e-7,0.00011452766,0.00008195306,0.0012689395,0.9918016],"study_design_scores_gemma":[0.00030224834,0.00020656569,0.000004206576,0.0017687771,0.0026908848,0.00026158892,0.0000034458612,0.0000021545154,0.0012449893,0.000052500873,0.9933031,0.00015949497],"about_ca_topic_score_codex":0.000016774859,"about_ca_topic_score_gemma":0.0000011900844,"teacher_disagreement_score":0.9920342,"about_ca_system_score_codex":0.000072776966,"about_ca_system_score_gemma":0.0003052006,"threshold_uncertainty_score":0.8205385},"labels":[],"label_agreement":null},{"id":"W2074033751","doi":"10.1001/jama.2011.856","title":"Group Releases New Guideline on Options for Treating Painful Diabetic Neuropathy","year":2011,"lang":"en","type":"article","venue":"JAMA","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Diabetic neuropathy; Intensive care medicine; Diabetes mellitus; Surgery; Endocrinology","score_opus":0.055092785895766494,"score_gpt":0.32715764294089306,"score_spread":0.27206485704512656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074033751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97299457,0.0008210968,0.0010671596,0.0071705184,0.0005698927,0.0010218218,0.00004551971,0.00019627286,0.016113175],"genre_scores_gemma":[0.97018284,0.0001758229,0.010128856,0.007867374,0.002034139,0.00016362628,0.00020100831,0.000047417223,0.009198947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993673,0.000027556076,0.00018924447,0.00017394248,0.00006491754,0.00017704837],"domain_scores_gemma":[0.9994838,0.00013666776,0.00005322092,0.00014728667,0.00004839332,0.00013061412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007847014,0.00010423219,0.00016455766,0.000060531336,0.000057464502,0.0000068543654,0.000040194627,0.000046417495,0.0008567959],"category_scores_gemma":[0.00014253352,0.000084332365,0.00009601915,0.00007685637,0.000018963445,0.000037928065,0.000011337197,0.0000740762,0.000055545537],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030235217,0.001683288,0.016690267,0.000093974355,0.00021740662,0.00015620024,0.0011987035,0.000009315077,0.015626784,0.0032197423,0.45115492,0.5069259],"study_design_scores_gemma":[0.043865077,0.021014635,0.12214112,0.00034980252,0.0022363104,0.00011670383,0.00031265756,0.0028577452,0.028437821,0.0037419416,0.77423936,0.0006868021],"about_ca_topic_score_codex":0.00019483444,"about_ca_topic_score_gemma":0.000026720256,"teacher_disagreement_score":0.50623906,"about_ca_system_score_codex":0.00004338854,"about_ca_system_score_gemma":0.000046697645,"threshold_uncertainty_score":0.9381314},"labels":[],"label_agreement":null},{"id":"W2074096414","doi":"10.1016/j.jval.2013.08.589","title":"Stage-Based Utilization of Chemotherapy Agents in a Canadian Breast Cancer Population","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Epirubicin; Medicine; Docetaxel; Breast cancer; Cyclophosphamide; Population; Chemotherapy; Internal medicine; Doxorubicin; Cancer; Stage (stratigraphy); Oncology; Regimen; Surgery","score_opus":0.09369422543786671,"score_gpt":0.40639499045647415,"score_spread":0.31270076501860744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074096414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898923,0.00028238122,0.0000036903605,0.008830184,0.00010504691,0.00073769933,0.00003741313,0.000006741427,0.00010454825],"genre_scores_gemma":[0.9971222,0.00023733392,0.00006537334,0.002264568,0.00003408469,0.000059997423,0.000065772176,0.000009608417,0.00014106269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993252,0.00006176554,0.00022128997,0.000105176005,0.00007758544,0.00020896205],"domain_scores_gemma":[0.9996751,0.000015610705,0.0000699576,0.000071883966,0.000028696602,0.00013875535],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012704717,0.000058449667,0.00016256346,0.00018898211,0.0000144606765,0.0000020827497,0.000021688586,0.000042082524,0.0014163668],"category_scores_gemma":[0.000004442836,0.000056052588,0.00001646105,0.00025939223,0.000009961702,0.00003295958,0.0000015099679,0.000057699424,0.0000036744711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005437866,0.00011725618,0.9847544,0.00016762802,0.000005712613,0.0000020143948,0.00029332977,0.0029068624,0.000051706505,0.000026161153,0.00052014244,0.011100419],"study_design_scores_gemma":[0.0022382843,0.00008811032,0.9679942,0.00014076286,0.0000031939114,9.34423e-7,0.000012736634,0.02863262,0.00006727648,0.000024237543,0.00076322583,0.000034391218],"about_ca_topic_score_codex":0.9911357,"about_ca_topic_score_gemma":0.61894906,"teacher_disagreement_score":0.37218666,"about_ca_system_score_codex":0.0011117824,"about_ca_system_score_gemma":0.00092663005,"threshold_uncertainty_score":0.99949646},"labels":[],"label_agreement":null},{"id":"W2074599258","doi":"10.1038/nrneurol.2014.77","title":"Mitotoxicity in distal symmetrical sensory peripheral neuropathies","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Neurology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute","keywords":"Medicine; Peripheral neuropathy; Sensory system; Neuropathic pain; Mitochondrion; Sensory nerve; Neurotoxicity; Peripheral; Neuroscience; Diabetes mellitus; Internal medicine; Endocrinology; Pharmacology; Toxicity; Biology","score_opus":0.04774740560998231,"score_gpt":0.409760865844193,"score_spread":0.3620134602342107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074599258","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000956927,0.99252146,0.0000027841497,0.00062016235,0.0018809559,0.002734289,0.000036705835,0.00007144517,0.002036499],"genre_scores_gemma":[0.00008659749,0.9908169,0.000046452154,0.005889095,0.0015437743,0.00037674545,0.00017113057,0.00010425569,0.00096507696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943904,0.0023180663,0.0013006801,0.0010884136,0.0002402606,0.0006621342],"domain_scores_gemma":[0.99778503,0.0007100128,0.00054136355,0.00066889747,0.00004765396,0.00024702222],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00053409743,0.0008566938,0.006074469,0.00065401266,0.00005389661,0.000014880049,0.00030379606,0.0020328683,0.00033949313],"category_scores_gemma":[0.00066909526,0.0005969978,0.0013912658,0.0009975483,0.0001884511,0.00003645931,0.00014281906,0.0056485175,0.00021383962],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016616599,0.00037899104,0.00022469557,0.024096439,0.00009602734,0.0015956918,0.000011565842,1.0259879e-7,0.0000048627944,0.00011260136,0.01218392,0.96112895],"study_design_scores_gemma":[0.00088319223,0.0010149123,0.00015807792,0.0019396595,0.0014877361,0.0023031656,1.7943265e-7,0.0000060625384,7.567156e-7,0.000006764255,0.99185693,0.00034256143],"about_ca_topic_score_codex":0.000010104762,"about_ca_topic_score_gemma":0.000033177905,"teacher_disagreement_score":0.979673,"about_ca_system_score_codex":0.00016856856,"about_ca_system_score_gemma":0.00023361872,"threshold_uncertainty_score":0.99964815},"labels":[],"label_agreement":null},{"id":"W2074605643","doi":"10.1016/j.jep.2013.02.031","title":"Yews (Taxus) along the Hindu Kush-Himalayan region: Exploring the ethnopharmacological relevance among communities of Mongol and Caucasian origins","year":2013,"lang":"en","type":"article","venue":"Journal of Ethnopharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec en Abitibi-Témiscamingue","funders":"National Natural Science Foundation of China; Rural and Environment Science and Analytical Services Division; National Science Foundation","keywords":"Traditional medicine; Ethnobotany; Geography; Hinduism; Medicine; Medicinal plants","score_opus":0.09534192733389656,"score_gpt":0.3445582829851179,"score_spread":0.24921635565122136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074605643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756105,0.003048711,0.000018734076,0.017984096,0.0017901626,0.00086501334,0.0000052940154,0.000025351275,0.0006521337],"genre_scores_gemma":[0.9905322,0.005258143,0.00020028769,0.0024369059,0.0009059519,0.00018284496,0.0000022567722,0.000034192173,0.00044720608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972963,0.00070831476,0.00094961916,0.00018943574,0.00037321178,0.00048311902],"domain_scores_gemma":[0.9963089,0.0018110857,0.0008549524,0.0003012495,0.000456679,0.00026708562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087376736,0.00032274728,0.00079551,0.0002156247,0.0004039717,0.000033373355,0.0005563176,0.00017916971,0.00078498194],"category_scores_gemma":[0.00009803677,0.00017488758,0.00026030984,0.0003477849,0.0014070155,0.00039432582,0.00020316188,0.0017589384,0.000012112803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00492463,0.0023072741,0.41840053,0.0004991349,0.0047117495,0.0029678529,0.04139689,0.00039109454,0.37257516,0.001418816,0.11012166,0.040285204],"study_design_scores_gemma":[0.02532516,0.007887421,0.6791337,0.0005288957,0.005728381,0.0043442785,0.029273031,0.0012750963,0.071056925,0.0009947023,0.17349584,0.0009565784],"about_ca_topic_score_codex":0.0011187812,"about_ca_topic_score_gemma":0.0002755564,"teacher_disagreement_score":0.30151823,"about_ca_system_score_codex":0.00020585598,"about_ca_system_score_gemma":0.00017403111,"threshold_uncertainty_score":0.85950017},"labels":[],"label_agreement":null},{"id":"W2074839878","doi":"10.1016/j.ejca.2007.07.034","title":"Endpoints and other considerations in phase I studies of targeted anticancer therapy: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT)","year":2007,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Task force; Cancer therapy; Medicine; Task (project management); Cancer; Oncology; Medical physics; Internal medicine; Engineering; Systems engineering; Political science","score_opus":0.2556496433220071,"score_gpt":0.49059934637691094,"score_spread":0.2349497030549038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074839878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9352738,0.047924057,0.002471689,0.012799348,0.0005840086,0.0005938122,0.00013888591,0.0000037762857,0.00021060443],"genre_scores_gemma":[0.98606485,0.005307385,0.005211547,0.002998143,0.0002624121,0.00002931919,0.0000027560022,0.000020158232,0.00010343144],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862266,0.00033516687,0.0006767632,0.00010541071,0.00012922683,0.00013076767],"domain_scores_gemma":[0.996243,0.0025722468,0.0005808724,0.00009243268,0.00048325644,0.000028181945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017428522,0.000120103716,0.00037353084,0.0001070376,0.0001005548,0.0000044555622,0.00007381158,0.000017921464,0.0002870463],"category_scores_gemma":[0.00018330611,0.00006172983,0.000054355918,0.0001911983,0.00024879657,0.000037742757,0.000017223692,0.00016823805,1.8925766e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009519504,0.0007521318,0.03987398,0.000045808592,0.0081169,0.00001931304,0.12701711,0.00009860412,0.22940524,0.00058283703,0.012240866,0.5723277],"study_design_scores_gemma":[0.03419523,0.003088468,0.2988421,0.0009284587,0.0006805973,0.000018694156,0.017337354,0.000025347648,0.4298196,0.0010549393,0.21372576,0.00028343432],"about_ca_topic_score_codex":0.00006151075,"about_ca_topic_score_gemma":0.0008119729,"teacher_disagreement_score":0.57204425,"about_ca_system_score_codex":0.00009211141,"about_ca_system_score_gemma":0.0002886706,"threshold_uncertainty_score":0.3142956},"labels":[],"label_agreement":null},{"id":"W2075157026","doi":"10.1097/00002820-200304000-00011","title":"Current Canadian Experience With Capecitabine","year":2003,"lang":"en","type":"review","venue":"Cancer Nursing","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Baker Hughes (Canada)","funders":"","keywords":"Capecitabine; Medicine; Psychological intervention; Intensive care medicine; Colorectal cancer; Metastatic breast cancer; Oncology; Oncology nursing; Cancer; Nursing; Breast cancer; Internal medicine; Nurse education","score_opus":0.10608860096521133,"score_gpt":0.4704851133080228,"score_spread":0.36439651234281145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075157026","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031650387,0.9896581,0.000006832052,0.00011900018,0.0027843174,0.0008919723,0.000042279607,0.000029149467,0.006436696],"genre_scores_gemma":[0.000047480808,0.9971647,0.00005184351,0.00015687098,0.0007175675,0.00052612374,0.000104848215,0.0000673563,0.0011631767],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986281,0.000040869283,0.00024929846,0.00042922524,0.00014986988,0.0005026865],"domain_scores_gemma":[0.9990369,0.00001939056,0.00012002593,0.0002602915,0.00006263925,0.00050075114],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000030011824,0.00038004518,0.0011256639,0.00022724399,0.000107974294,0.000017559782,0.000089892885,0.00013453269,0.0012728159],"category_scores_gemma":[0.0000029590237,0.00027706154,0.00016892879,0.00040385342,0.000146527,0.000037789698,0.000003874009,0.00037931933,0.000034091256],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018277407,0.00006393528,0.000090765294,0.002455316,0.000100999605,0.000072819385,0.00035691136,2.1275241e-7,1.953987e-7,0.000015244282,0.0055934684,0.99123186],"study_design_scores_gemma":[0.0006245636,0.00011950338,0.000017774066,0.0325763,0.0022810649,0.00017624217,0.00003133289,6.5375815e-7,0.0000021962821,0.0000021863232,0.96389806,0.0002701324],"about_ca_topic_score_codex":0.0051563806,"about_ca_topic_score_gemma":0.0061251475,"teacher_disagreement_score":0.99096173,"about_ca_system_score_codex":0.003339475,"about_ca_system_score_gemma":0.0038794316,"threshold_uncertainty_score":0.9999682},"labels":[],"label_agreement":null},{"id":"W2076065516","doi":"10.2310/7200.2006.033","title":"Do the Dietary Supplements Epigallocatechin Gallate or Vitamin E Cause a Radiomodifying Response on Tumors in Vivo? A Pilot Study with Murine Breast Carcinoma","year":2007,"lang":"en","type":"article","venue":"Journal of the Society for Integrative Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Epigallocatechin gallate; Medicine; Apoptosis; Angiogenesis; In vivo; Vitamin E; Immunohistochemistry; Breast cancer; Cancer; Cancer research; Radiation therapy; Pathology; Internal medicine; Antioxidant; Biology; Biochemistry","score_opus":0.06163069096969403,"score_gpt":0.391528073914909,"score_spread":0.329897382945215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076065516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98828006,0.000116264375,0.00006662718,0.0091755325,0.0003274809,0.0018879634,0.000045033696,0.000007847627,0.000093209725],"genre_scores_gemma":[0.9967986,0.000035916994,0.00053313863,0.0012501219,0.00021845412,0.00007798454,0.000002138562,0.000031574415,0.0010521148],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99789596,0.0004664026,0.00065243704,0.00023545741,0.00033147944,0.00041825973],"domain_scores_gemma":[0.9973063,0.0014966588,0.00056806114,0.00024102625,0.00026697994,0.000120975776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028922984,0.0002894689,0.0006877504,0.00013631127,0.00021764245,0.000014317828,0.00030940823,0.0000742219,0.0001145171],"category_scores_gemma":[0.00012744838,0.000116913725,0.0004776474,0.00043151958,0.00026904358,0.00007238858,0.00006703381,0.00089221884,0.0000010023747],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5985182,0.022981515,0.19992326,0.00010217373,0.007712543,0.0027714176,0.07487285,0.00014523893,0.06059194,0.0000766973,0.02877303,0.003531158],"study_design_scores_gemma":[0.06618504,0.301482,0.52323836,0.000621362,0.0029067819,0.0059256316,0.08235873,0.00017193986,0.011768252,0.00016910052,0.004744767,0.00042806382],"about_ca_topic_score_codex":0.00025794058,"about_ca_topic_score_gemma":0.0035969857,"teacher_disagreement_score":0.53233314,"about_ca_system_score_codex":0.0017638853,"about_ca_system_score_gemma":0.0008119716,"threshold_uncertainty_score":0.47676033},"labels":[],"label_agreement":null},{"id":"W2078122892","doi":"10.1038/bjc.2014.430","title":"Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Susan G. Komen; Breast Cancer Research Foundation; U.S. Department of Health and Human Services","keywords":"Bevacizumab; Medicine; Genome-wide association study; Internal medicine; Oncology; Blood pressure; SNP; Single-nucleotide polymorphism; Genotype; Biology; Chemotherapy; Genetics","score_opus":0.01655960237681365,"score_gpt":0.28424061643413523,"score_spread":0.2676810140573216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078122892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798637,0.017330362,0.000019587065,0.0013063608,0.0007833092,0.00015497112,0.0000063913253,0.000006809576,0.00052848813],"genre_scores_gemma":[0.9878447,0.008692238,0.00031837018,0.0016896642,0.001231437,0.000008125741,0.000001445602,0.000020772506,0.00019326081],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989333,0.00007213507,0.00041703388,0.00014738843,0.00021695723,0.0002131559],"domain_scores_gemma":[0.9992687,0.00006758173,0.00020529276,0.00007097808,0.00018236134,0.0002050855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022774964,0.000114891955,0.0004350239,0.00012986922,0.00003449319,0.00002772415,0.00006474665,0.000093543815,0.00036762367],"category_scores_gemma":[0.00006475002,0.00011091101,0.00007687458,0.00010311067,0.000033145843,0.00010244095,0.0000209506,0.0002764688,0.0000039910133],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011975168,0.00045786626,0.03638009,0.000098675395,0.00028576286,0.009090512,0.00020367486,0.0000599846,0.01163823,0.000006085752,0.01302879,0.9275528],"study_design_scores_gemma":[0.019141207,0.0026600221,0.89228624,0.0011726936,0.0006997639,0.025875479,0.00003061658,0.0005576372,0.0015026183,0.00019563717,0.055671364,0.0002067448],"about_ca_topic_score_codex":0.00089984393,"about_ca_topic_score_gemma":0.0021363643,"teacher_disagreement_score":0.92734605,"about_ca_system_score_codex":0.00016455275,"about_ca_system_score_gemma":0.0002411423,"threshold_uncertainty_score":0.45228195},"labels":[],"label_agreement":null},{"id":"W2078578614","doi":"10.1158/1535-7163.targ-09-b168","title":"Abstract B168: ANG1005: Results of a phase I study in patients with advanced solid tumors and metastatic brain cancer","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Angiochem (Canada)","funders":"","keywords":"Medicine; Tolerability; Neutropenia; Cancer; Internal medicine; Adverse effect; Mucositis; Oncology; Brain metastasis; Metastatic breast cancer; Taxane; Breast cancer; Metastasis; Chemotherapy","score_opus":0.02621273335514649,"score_gpt":0.38129536866898156,"score_spread":0.35508263531383505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078578614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423814,0.0030475387,0.000014932593,0.0011236534,0.000058783735,0.0012825913,0.00010284206,0.000018401584,0.00011314748],"genre_scores_gemma":[0.99721724,0.00025188216,0.00014455819,0.0021614302,0.000018727374,0.00009395704,0.00002977251,0.000026452024,0.000055987523],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99870867,0.000053188,0.00036899006,0.00032361152,0.00027252044,0.00027304844],"domain_scores_gemma":[0.99935776,0.000036761172,0.00018498657,0.00021989843,0.000108843094,0.00009175568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001048347,0.00022749456,0.00048568365,0.00013618711,0.000027791668,0.000008066865,0.00006684015,0.000036763864,0.000040265975],"category_scores_gemma":[0.0000058148667,0.00017980605,0.00004579001,0.0002868942,0.000065518034,0.000057406098,0.000011769617,0.00016269003,4.52703e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049404547,0.020215992,0.21346413,0.00023221869,0.0026416508,0.00076274684,0.008213085,0.001172461,0.13705987,0.000018371113,0.00016410284,0.5666508],"study_design_scores_gemma":[0.10695122,0.015039671,0.84472054,0.0003204831,0.001202067,0.000004288391,0.00033042702,0.00016004474,0.029549697,0.000066930115,0.001249994,0.00040463184],"about_ca_topic_score_codex":0.00025930384,"about_ca_topic_score_gemma":0.00025949438,"teacher_disagreement_score":0.6312564,"about_ca_system_score_codex":0.00014677935,"about_ca_system_score_gemma":0.00018613928,"threshold_uncertainty_score":0.7332278},"labels":[],"label_agreement":null},{"id":"W2079363235","doi":"10.1021/ol015559y","title":"Benzobicyclo[8.4.0.<sup>1,6</sup>0<sup>8,13</sup>]tetradecenones:  Ring CD-Taxoid Models by Planar Tether Controlled Cycloaddition","year":2001,"lang":"en","type":"article","venue":"Organic Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Taxoid; Chemistry; Cycloaddition; Ring (chemistry); Planar; Diol; Adduct; Stereochemistry; Organic chemistry; Catalysis; Paclitaxel","score_opus":0.013777368909596176,"score_gpt":0.24688969276280856,"score_spread":0.23311232385321237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079363235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97145045,0.0011253178,0.0008365729,0.02159387,0.0002457643,0.0013643333,0.00012864562,0.0003567236,0.0028983394],"genre_scores_gemma":[0.97587574,0.0006866606,0.0001822503,0.019255254,0.0011071448,0.00017529291,0.00053837406,0.00015920706,0.002020066],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969822,0.00017008425,0.0006478606,0.0007699991,0.00052030256,0.00090955297],"domain_scores_gemma":[0.99856323,0.0002656895,0.00020626355,0.0005205637,0.00006415322,0.0003801295],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022949286,0.0005966629,0.0010161273,0.00026513555,0.00024760552,0.000061333885,0.00026210642,0.0002869166,0.005813788],"category_scores_gemma":[0.000041105675,0.00053085585,0.0003149752,0.0004627494,0.00015184215,0.00032877055,0.00004288428,0.0005856105,0.0005036387],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003685864,0.0011713697,0.0035456237,0.0000975081,0.0019435316,0.00096054905,0.0033204595,0.003925675,0.6025224,0.00006690512,0.37677792,0.001982216],"study_design_scores_gemma":[0.35591668,0.004653227,0.0045097778,0.0012841995,0.012000634,0.00449322,0.004731798,0.1315742,0.09125866,0.0013155323,0.38113457,0.007127512],"about_ca_topic_score_codex":0.00031642025,"about_ca_topic_score_gemma":0.000033033328,"teacher_disagreement_score":0.5112637,"about_ca_system_score_codex":0.00063395815,"about_ca_system_score_gemma":0.00012675731,"threshold_uncertainty_score":0.9997143},"labels":[],"label_agreement":null},{"id":"W2079491315","doi":"10.1246/cl.2006.952","title":"Synthesis of Gemcitabine Analogues as Potential Anti-tumor Agents","year":2006,"lang":"en","type":"article","venue":"Chemistry Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada)","funders":"","keywords":"Chemistry; Gemcitabine; Bicyclic molecule; Deoxycytidine; Combinatorial chemistry; Stereochemistry; Derivative (finance); Cytidine deaminase; Organic chemistry; Chemotherapy; Internal medicine","score_opus":0.0076908165723998485,"score_gpt":0.2572107700491941,"score_spread":0.2495199534767943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079491315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99196386,0.00015088888,0.000009682137,0.0029563708,0.000090727044,0.00008440776,0.000023265547,0.000032332235,0.004688477],"genre_scores_gemma":[0.99782574,0.000015527003,0.00007643728,0.00086201885,0.00041655047,0.000015843145,0.00009552945,0.000013823167,0.00067852606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993314,0.000007923585,0.00017472052,0.00017713434,0.00013356651,0.00017523409],"domain_scores_gemma":[0.9996655,0.000024098026,0.00007930448,0.00014910552,0.000026018452,0.000055972527],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000031708154,0.000118289674,0.000242116,0.000025906653,0.000025878315,0.0000045393504,0.00006356095,0.000039849194,0.0012100963],"category_scores_gemma":[0.000013539829,0.00010963696,0.0001160097,0.00008082074,0.000098458746,0.000022600581,0.000018289607,0.00007131586,0.000026327265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009328822,0.00019860938,0.014363766,0.00015480377,0.00011281454,0.0003504939,0.000009143311,0.00001887011,0.9581648,0.0000010037895,0.02633877,0.00019362113],"study_design_scores_gemma":[0.0010932056,0.000017544387,0.028874429,0.000036569636,0.0003202231,0.00010773318,0.000012632966,0.000018762421,0.9670505,0.0000072333496,0.002368912,0.00009225462],"about_ca_topic_score_codex":0.00015512107,"about_ca_topic_score_gemma":7.1228317e-7,"teacher_disagreement_score":0.023969855,"about_ca_system_score_codex":0.000055569537,"about_ca_system_score_gemma":0.000029695591,"threshold_uncertainty_score":0.99970293},"labels":[],"label_agreement":null},{"id":"W2080049264","doi":"10.1016/j.bmcl.2008.10.010","title":"Synthesis, tubulin assembly, and antiproliferative activity against MCF7 and NCI/ADR-RES cancer cells of 10-O-acetyl-5′-hydroxybutitaxel","year":2008,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick","funders":"National Cancer Institute","keywords":"Chemistry; Paclitaxel; Tubulin; Stereochemistry; Cancer cell lines; Cell growth; Chemical synthesis; In vitro; Kinetic resolution; Cell culture; Biological activity; Cancer cell; Cancer; Microtubule; Biochemistry; Catalysis; Enantioselective synthesis; Cell biology","score_opus":0.0195359295680108,"score_gpt":0.27404566351961523,"score_spread":0.2545097339516044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080049264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98871934,0.0026829324,0.000012516938,0.0076495646,0.00011266807,0.00027186525,0.00006311957,0.00004059093,0.0004473702],"genre_scores_gemma":[0.9944533,0.003253873,0.00007195947,0.0012848501,0.00048434478,0.00003927479,0.0000152507,0.00003111144,0.00036602427],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856424,0.00004389091,0.00027709664,0.00046229115,0.00030977008,0.000342698],"domain_scores_gemma":[0.999083,0.00018426808,0.00017873934,0.00021278318,0.0000662515,0.00027496825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001321245,0.00031879367,0.0006422583,0.000049143284,0.00012218564,0.0000067358847,0.00008894889,0.00015779378,0.0005813835],"category_scores_gemma":[0.0000716207,0.00027028378,0.00007318294,0.00015522684,0.0006053741,0.00006987639,0.00006304229,0.00027345357,0.000005042788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051962206,0.00018740227,0.010444988,0.00038558486,0.00030197296,0.00020239591,0.00039007352,5.9002036e-7,0.9775251,2.93726e-7,0.008856278,0.0011856692],"study_design_scores_gemma":[0.0022415842,0.00013970314,0.016578712,0.00020727655,0.00041115267,0.00023022611,0.000090364294,0.00005160357,0.9783692,6.150156e-7,0.001461094,0.00021849727],"about_ca_topic_score_codex":0.00019471951,"about_ca_topic_score_gemma":0.000007876001,"teacher_disagreement_score":0.007395184,"about_ca_system_score_codex":0.0001682873,"about_ca_system_score_gemma":0.00023593848,"threshold_uncertainty_score":0.9999749},"labels":[],"label_agreement":null},{"id":"W2080354842","doi":"10.6000/1927-7229.2014.03.02.1","title":"Evidence for the Conversion of Docetaxel into 7-Epidocetaxel in Patients Receiving Conventional Taxotere® Based Chemotherapy","year":2014,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Docetaxel; Medicine; Paclitaxel; Chemotherapy; Pharmacology; Pharmacokinetics; Metabolite; Urine; Prostate cancer; In vivo; Cancer; Internal medicine; Oncology; Biology","score_opus":0.0694840231192574,"score_gpt":0.404555062201255,"score_spread":0.3350710390819976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080354842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95472723,0.0005536891,0.009084666,0.033795282,0.00074556767,0.0005583612,0.0000027888193,0.0000042866122,0.00052809954],"genre_scores_gemma":[0.99511385,0.0001874745,0.0018907939,0.0023966734,0.00026137845,0.000005813129,0.0000026739842,0.0000079955735,0.00013335531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987028,0.00014608078,0.00062086055,0.000115181414,0.00025323717,0.00016179841],"domain_scores_gemma":[0.9963317,0.0025760746,0.00048495695,0.00010096759,0.00040504534,0.00010127563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011880558,0.00009937456,0.00055561395,0.00016658107,0.00003621943,0.0000043888795,0.00014052309,0.00010987186,0.00043751634],"category_scores_gemma":[0.0007413863,0.000062480234,0.00027985775,0.00015148995,0.00017348754,0.00007120665,0.000017083788,0.00022960089,0.0000030141514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03262324,0.0056534302,0.87318754,0.00056161993,0.0010485981,0.00003028596,0.00039473365,0.00027932497,0.0030144597,0.000858198,0.029411009,0.05293755],"study_design_scores_gemma":[0.05374829,0.026412461,0.79855424,0.00074567494,0.0015518094,0.000044758803,0.00009259196,0.037012484,0.003163703,0.0009979102,0.077487744,0.00018835202],"about_ca_topic_score_codex":0.000022346429,"about_ca_topic_score_gemma":0.000013894263,"teacher_disagreement_score":0.07463334,"about_ca_system_score_codex":0.00031385064,"about_ca_system_score_gemma":0.0003403758,"threshold_uncertainty_score":0.4790497},"labels":[],"label_agreement":null},{"id":"W2080598783","doi":"10.1007/s10600-013-0581-5","title":"A new taxane from the needles of Taxus cuspidata","year":2013,"lang":"en","type":"article","venue":"Chemistry of Natural Compounds","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Taxane; Chemistry; Taxus; Botany; Stereochemistry; Biology","score_opus":0.01510131739661412,"score_gpt":0.27490240908803587,"score_spread":0.25980109169142174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080598783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863707,0.0050049233,0.0000027557808,0.0025073525,0.00015479061,0.00014896289,0.000037339923,0.000016507813,0.005756703],"genre_scores_gemma":[0.9940687,0.000058268062,0.00049190136,0.00019642357,0.00036966722,0.0000059741037,0.00020537004,0.0000074122604,0.00459628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994186,0.000008105869,0.00018727341,0.0001296078,0.00013874022,0.00011766711],"domain_scores_gemma":[0.99930495,0.0001448692,0.00012816857,0.00027242335,0.00007845027,0.00007111083],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000025065745,0.00010903556,0.0002579729,0.000008907963,0.000023501303,0.0000063435286,0.00018852406,0.00006418302,0.0021953697],"category_scores_gemma":[0.000028149325,0.00006903717,0.00009304043,0.00009574086,0.00011472024,0.000041065254,0.000060297116,0.00018098995,0.000012209108],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011966797,0.00006303991,0.004566857,0.00005205184,0.0001481332,0.0000026884143,0.00012696644,2.5302563e-7,0.8529688,0.0000024719275,0.13824978,0.0036992938],"study_design_scores_gemma":[0.002603159,0.00008763491,0.025969226,0.00009395411,0.0002322798,0.000032844586,0.0002362449,0.000054126675,0.9535428,0.00023115246,0.016811619,0.00010494763],"about_ca_topic_score_codex":0.0017194169,"about_ca_topic_score_gemma":0.0000059614135,"teacher_disagreement_score":0.121438175,"about_ca_system_score_codex":0.00003155357,"about_ca_system_score_gemma":0.000089269575,"threshold_uncertainty_score":0.9987168},"labels":[],"label_agreement":null},{"id":"W2080856530","doi":"10.1158/1538-7445.am10-3109","title":"Abstract 3109: Myc confers aggressive medulloblastoma phenotypes by regulating cell migration and adhesion genes","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Cancer research; Biology; Cell migration; Cell culture; Phenotype; Cell growth; Gene; Genetics","score_opus":0.045072217860446864,"score_gpt":0.40630516272781025,"score_spread":0.3612329448673634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080856530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887427,0.0059510223,0.0000010804179,0.0027144062,0.00024049723,0.00043137747,0.000025699632,0.000029242654,0.0018639741],"genre_scores_gemma":[0.9941354,0.0022527913,0.00008852143,0.000103437036,0.0004400021,0.00013199136,0.000043377077,0.00002298522,0.0027814982],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882615,0.000049992283,0.00014801325,0.00030192515,0.0003389635,0.00033495476],"domain_scores_gemma":[0.9991506,0.00017837733,0.00008160868,0.00015696426,0.00023181445,0.00020066142],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027168295,0.00011914236,0.00017739553,0.00011640844,0.00019053365,0.000033419627,0.000068731715,0.00012352962,0.0012694856],"category_scores_gemma":[0.000052168285,0.00009865665,0.000034097076,0.00014976058,0.00022964072,0.00007841071,0.000042447984,0.0004669496,0.000028048622],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048462092,0.00008475407,0.012318123,0.00011218663,0.000033947228,0.000024154448,0.00036019756,0.0000012397749,0.92805773,0.000018901159,0.020143803,0.03836036],"study_design_scores_gemma":[0.0021876954,0.00039152626,0.019864745,0.000110203924,0.00005085659,0.000015317735,0.00021273788,0.00009763563,0.93335545,0.00007484889,0.043512244,0.00012674485],"about_ca_topic_score_codex":0.0016883616,"about_ca_topic_score_gemma":0.0015021312,"teacher_disagreement_score":0.038233615,"about_ca_system_score_codex":0.000112968846,"about_ca_system_score_gemma":0.00026490187,"threshold_uncertainty_score":0.9996435},"labels":[],"label_agreement":null},{"id":"W2081296457","doi":"10.2147/bctt.s37003","title":"Lapatinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Targets and Therapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"GlaxoSmithKline","keywords":"Medicine; Lapatinib; Capecitabine; Trastuzumab; Breast cancer; Oncology; Internal medicine; Reimbursement; Health care; Cancer","score_opus":0.023805663445978318,"score_gpt":0.33990052430430395,"score_spread":0.3160948608583256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081296457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770228,0.014485239,0.000005961654,0.00487404,0.00015619726,0.00093073107,0.0024196687,0.000026669299,0.00007865067],"genre_scores_gemma":[0.99594736,0.0014002657,0.00006714536,0.0012870446,0.00038884766,0.00045126135,0.00039763295,0.000043470995,0.000016989821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843454,0.0001614942,0.00023150322,0.0004418221,0.0001876142,0.00054302585],"domain_scores_gemma":[0.99913526,0.000047160833,0.00015752563,0.00022831697,0.00008989704,0.00034187137],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000091329384,0.0003482074,0.00067724165,0.0001481825,0.0002067118,0.000046915684,0.00007665986,0.00004131433,0.0009258797],"category_scores_gemma":[4.1139418e-7,0.00018910116,0.00012691741,0.0002989503,0.00009898686,0.0003278284,0.000010411796,0.00012699419,0.0000014287554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031907384,0.0009462685,0.87432194,0.0000058085084,0.0049722595,0.000005599771,0.019005239,0.000027462296,0.0000032810167,0.000014795932,0.000022533894,0.09748408],"study_design_scores_gemma":[0.015599412,0.0015439839,0.9771261,0.00003099256,0.0010178053,0.0000087650005,0.0033302624,0.000035639732,0.000012386302,0.000004504705,0.0010653276,0.00022482821],"about_ca_topic_score_codex":0.09818997,"about_ca_topic_score_gemma":0.058417354,"teacher_disagreement_score":0.10280416,"about_ca_system_score_codex":0.0017548332,"about_ca_system_score_gemma":0.0007655775,"threshold_uncertainty_score":0.9999874},"labels":[],"label_agreement":null},{"id":"W2081493266","doi":"10.1158/1538-7445.am2011-3576","title":"Abstract 3576: Lapatinib in combination with doxorubicin is highly damaging to cardiac myocytes","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Lapatinib; Dexrazoxane; Cardiotoxicity; Doxorubicin; Pharmacology; Medicine; Myocyte; Trastuzumab; Tyrosine-kinase inhibitor; Cancer; Internal medicine; Breast cancer; Chemotherapy; Anthracycline","score_opus":0.1372126624056593,"score_gpt":0.44257092687625355,"score_spread":0.3053582644705942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081493266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97706807,0.0007060467,0.000002038508,0.0033208109,0.00015002023,0.00081656757,0.000019744914,0.000029442039,0.01788729],"genre_scores_gemma":[0.9963499,0.0003141176,0.00013216122,0.00049949734,0.00014741074,0.0004433844,0.000015699405,0.000026382315,0.002071479],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986145,0.000070347196,0.0001561536,0.00030940495,0.00040439688,0.00044520717],"domain_scores_gemma":[0.99922144,0.00009774844,0.00002696977,0.0002227155,0.00024392182,0.0001871873],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044969155,0.00011528057,0.00024540393,0.00037984469,0.000072270144,0.000015662463,0.0001083597,0.000055067085,0.0014678399],"category_scores_gemma":[0.000020612213,0.00009305379,0.00003431707,0.0006345356,0.000095415526,0.000087309476,0.000046855275,0.00037422183,0.00011050638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055470807,0.0011343092,0.7109624,0.00032949433,0.000314414,0.00040856606,0.01952455,0.000009467638,0.16153616,0.000576184,0.05021489,0.049442466],"study_design_scores_gemma":[0.004432932,0.0013337098,0.67430145,0.00031657176,0.000048869802,0.0000034694058,0.0006024856,0.0000125533015,0.29479098,0.0001407533,0.02383675,0.00017949408],"about_ca_topic_score_codex":0.009003289,"about_ca_topic_score_gemma":0.0007344746,"teacher_disagreement_score":0.13325483,"about_ca_system_score_codex":0.0004832175,"about_ca_system_score_gemma":0.00035067776,"threshold_uncertainty_score":0.99944496},"labels":[],"label_agreement":null},{"id":"W2081584264","doi":"10.3816/cbc.2004.n.030","title":"Survival Benefit with Capecitabine/Docetaxel Versus Docetaxel Alone: Analysis of Therapy in a Randomized Phase III Trial","year":2004,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Docetaxel; Capecitabine; Medicine; Chemotherapy; Internal medicine; Oncology; Vinorelbine; Hazard ratio; Randomized controlled trial; Breast cancer; Surgery; Cancer; Confidence interval; Colorectal cancer; Cisplatin","score_opus":0.06626576878013078,"score_gpt":0.4365959759552752,"score_spread":0.3703302071751444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081584264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920236,0.001490146,0.000043791897,0.0028380863,0.0010723232,0.0016363417,0.00019118562,0.00003342013,0.0006711192],"genre_scores_gemma":[0.99442536,0.0034057295,0.00010888521,0.00048278732,0.00078578107,0.00039682258,0.000108885855,0.000028841168,0.0002568885],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99722683,0.00019436934,0.0012752552,0.00054416456,0.00038600853,0.00037339146],"domain_scores_gemma":[0.9976015,0.0011018197,0.00043969473,0.00037683593,0.00022255273,0.00025758444],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00093841506,0.00030437385,0.003026443,0.00033126381,0.000036487665,0.000010169938,0.00014165974,0.00019296138,0.002256634],"category_scores_gemma":[0.00008973058,0.00020474472,0.0009938391,0.0012412221,0.0004823478,0.00007563584,0.000025831163,0.00035569194,0.000006630051],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9538747,0.0050676786,0.0111478735,0.0000136840235,0.010006495,0.00006954716,0.0001643209,0.0004336032,0.0000966679,0.00010250059,0.00005921106,0.018963719],"study_design_scores_gemma":[0.9590756,0.0028521607,0.029309362,0.00006427799,0.0078061703,0.0000065853183,0.0000377251,0.00019469603,0.00009758174,0.000043629152,0.00030851783,0.00020366142],"about_ca_topic_score_codex":0.0044587166,"about_ca_topic_score_gemma":0.0041564326,"teacher_disagreement_score":0.018760057,"about_ca_system_score_codex":0.00022913939,"about_ca_system_score_gemma":0.0006553866,"threshold_uncertainty_score":0.99865544},"labels":[],"label_agreement":null},{"id":"W2083136486","doi":"10.1002/chin.201205099","title":"ChemInform Abstract: Vinylogous Nicholas Reactions in the Synthesis of Icetexane, Faveline, and Related Ring Systems.","year":2012,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Chemistry; Ring (chemistry); Stereochemistry; Organic chemistry","score_opus":0.02206666910450063,"score_gpt":0.2922474862795188,"score_spread":0.2701808171750182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083136486","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26653054,0.0011254369,1.2964216e-8,0.00017734383,0.00015683418,0.0002901998,0.000008212094,0.00002240782,0.731689],"genre_scores_gemma":[0.9909794,0.00038269782,0.0000065582544,0.0000697249,0.0001201164,0.00008442541,0.000021326063,0.00001064226,0.008325147],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990995,2.2614897e-7,0.00041217924,0.0000904429,0.00014122832,0.000256403],"domain_scores_gemma":[0.9992048,0.0002978684,0.00016519165,0.00019928148,0.00004137777,0.00009145244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037331608,0.00013219718,0.00026662406,0.00009193141,0.00004612584,0.000009342846,0.000073362324,0.00013503601,0.00028575052],"category_scores_gemma":[0.00012141107,0.000092133734,0.000058077687,0.00018061191,0.000068922265,0.00019353237,0.000024195602,0.00023487318,0.000020929348],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010838272,0.002013607,0.03945428,0.0045357617,0.0011904082,0.00009344732,0.02276862,0.0000034682053,0.056188997,0.0013762262,0.03824992,0.8330414],"study_design_scores_gemma":[0.005587027,0.00023434723,0.27769023,0.00083476095,0.0011395029,0.0021142205,0.006225723,0.00006961379,0.52607286,0.000025227577,0.17945424,0.0005522407],"about_ca_topic_score_codex":0.00021617186,"about_ca_topic_score_gemma":0.0000061717137,"teacher_disagreement_score":0.8324892,"about_ca_system_score_codex":0.000113346476,"about_ca_system_score_gemma":0.000045665594,"threshold_uncertainty_score":0.37571046},"labels":[],"label_agreement":null},{"id":"W2083718162","doi":"10.1007/s10549-010-1102-x","title":"Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Université Laval","funders":"Bayer HealthCare","keywords":"Medicine; Breast cancer; Chemotherapy; Oncology; Metastatic breast cancer; Internal medicine; Cancer; Mammary gland; Phases of clinical research","score_opus":0.10599594354823769,"score_gpt":0.46746760014198563,"score_spread":0.3614716565937479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083718162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99009085,0.0011785112,4.0178742e-7,0.0040177046,0.00007547939,0.0043597505,0.0002294455,0.000015114167,0.000032772186],"genre_scores_gemma":[0.99781907,0.00038702338,0.00006204032,0.00004170082,0.00008664917,0.0013634962,0.00003023917,0.000033944627,0.00017583158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979021,0.00018119632,0.00026901282,0.00047201125,0.0006777019,0.00049798394],"domain_scores_gemma":[0.99897444,0.00021362996,0.00010633605,0.00029223654,0.0001976284,0.00021575113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050634606,0.0002747448,0.0005274855,0.00016892042,0.0004044847,0.000044122706,0.000085753694,0.000040956067,0.0003232928],"category_scores_gemma":[0.000008346259,0.00014874483,0.000051775594,0.00037828964,0.0003608374,0.00009848935,0.000064027794,0.00028805283,6.295607e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030073158,0.016106164,0.65005064,0.00004483257,0.0014433617,0.0000429766,0.0026665074,0.0000021636401,0.0013033903,0.000003244008,0.000024128487,0.29823947],"study_design_scores_gemma":[0.10734071,0.023314893,0.8673678,0.00019435966,0.0005282818,0.000030163,0.00035881076,0.000055111363,0.0005746311,0.000009343063,0.00009700712,0.00012886547],"about_ca_topic_score_codex":0.007308177,"about_ca_topic_score_gemma":0.0045833588,"teacher_disagreement_score":0.2981106,"about_ca_system_score_codex":0.00030809696,"about_ca_system_score_gemma":0.0005529768,"threshold_uncertainty_score":0.99930227},"labels":[],"label_agreement":null},{"id":"W2085063413","doi":"10.1159/000225889","title":"Phase II Study of Lonidamine in Cancer Patients","year":2009,"lang":"en","type":"article","venue":"Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; BC Cancer Agency","funders":"","keywords":"Medicine; Anorexia; Vomiting; Somnolence; Cancer; Nausea; Toxicity; Phases of clinical research; Prednisone; myalgia; Breast cancer; Internal medicine; Anesthesia; Adverse effect; Gastroenterology; Surgery","score_opus":0.0413515949666393,"score_gpt":0.4576175046466559,"score_spread":0.4162659096800166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085063413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932622,0.00018050766,2.4989112e-7,0.0011002073,0.0002201585,0.0005339633,0.0000052500172,0.000009534469,0.0046879523],"genre_scores_gemma":[0.99828017,0.00006016717,0.000019570261,0.00067699753,0.000078643025,0.00004559972,0.0000150524465,0.0000043699038,0.0008194339],"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99941707,0.00003821364,0.00020145377,0.00013371749,0.00007010251,0.0001394512],"domain_scores_gemma":[0.9997294,0.000025930558,0.00006849067,0.000081276,0.00004729785,0.00004762953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048408074,0.00007206081,0.00031284447,0.000104570274,0.000018065495,4.6229096e-7,0.000036419744,0.000058061454,0.00055153517],"category_scores_gemma":[0.000009202926,0.00006065938,0.0000237411,0.00015015082,0.000022796676,0.000018057612,0.000015455253,0.00008993109,0.000004255447],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034553758,0.50590014,0.21459393,0.000016766362,0.00012479504,0.00018254557,0.004769913,0.0000086070895,0.009663496,0.000021780754,0.00768404,0.2535786],"study_design_scores_gemma":[0.09389217,0.56786275,0.31034005,0.000019514573,0.0002669575,0.0000054584016,0.00022249299,0.00003063889,0.002243785,0.00003463536,0.024985684,0.000095847914],"about_ca_topic_score_codex":0.0003712903,"about_ca_topic_score_gemma":0.0010183447,"teacher_disagreement_score":0.25348276,"about_ca_system_score_codex":0.00022663739,"about_ca_system_score_gemma":0.00011234533,"threshold_uncertainty_score":0.6038923},"labels":[],"label_agreement":null},{"id":"W2085825922","doi":"10.1016/s0828-282x(06)70905-9","title":"Acute coronary syndrome induced by oral capecitabine","year":2006,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Capecitabine; Chest pain; Cardiology; Internal medicine; Acute coronary syndrome; Chemotherapy; ST segment; ST elevation; Electrocardiography; Cancer; Colorectal cancer; Myocardial infarction","score_opus":0.01641145211944604,"score_gpt":0.27297818562515413,"score_spread":0.2565667335057081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085825922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98704976,0.0017731052,0.000051515224,0.0028618253,0.0010714098,0.00011818957,0.00006566254,0.0000061171577,0.00700241],"genre_scores_gemma":[0.997268,0.000047830345,0.00006606339,0.0005921416,0.00062759704,0.0000036741374,0.00005462413,0.000016763997,0.0013233008],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99909586,0.00006926734,0.00029306373,0.00011233495,0.00008182629,0.0003476608],"domain_scores_gemma":[0.9991439,0.00003260169,0.000110179804,0.000104804894,0.0001290457,0.00047944958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011672739,0.00012817718,0.0005696435,0.0002230087,0.000055992077,0.000006435083,0.000094427494,0.00014461296,0.00027374574],"category_scores_gemma":[0.000010631498,0.0001104022,0.00018011,0.000116304254,0.00010927898,0.000052060233,0.000005682406,0.00027562078,0.000023694221],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046498197,0.000020191206,0.23576707,0.000013112975,0.0017836251,0.018463803,0.000047954894,0.0000715057,0.03514409,0.00013399559,0.704666,0.0034236165],"study_design_scores_gemma":[0.0057007414,0.002685643,0.4965541,0.000021476764,0.0010568199,0.044326276,0.000028945788,0.0000029305338,0.00072884205,0.00024071703,0.4484709,0.0001826196],"about_ca_topic_score_codex":0.002431043,"about_ca_topic_score_gemma":0.0018777954,"teacher_disagreement_score":0.260787,"about_ca_system_score_codex":0.00033731887,"about_ca_system_score_gemma":0.0011048601,"threshold_uncertainty_score":0.4502071},"labels":[],"label_agreement":null},{"id":"W2086036058","doi":"10.1007/s10549-010-1152-0","title":"Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Eli Lilly (Canada); University of Alberta; Ottawa Hospital","funders":"Eli Lilly and Company","keywords":"Capecitabine; Medicine; Internal medicine; Metastatic breast cancer; Placebo; Hazard ratio; Breast cancer; Taxane; Oncology; Anthracycline; Cancer; Colorectal cancer; Confidence interval","score_opus":0.07088188007729243,"score_gpt":0.42360677427515525,"score_spread":0.3527248941978628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086036058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98239625,0.0033531685,0.0000014282772,0.0027302438,0.00045564037,0.00952273,0.0014578288,0.000023458324,0.000059235455],"genre_scores_gemma":[0.98165303,0.008948794,0.00012070732,0.00003321262,0.0004353681,0.00782367,0.00020334114,0.00005940062,0.0007224668],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966747,0.00024645307,0.0006887964,0.00078495726,0.00079237414,0.0008127286],"domain_scores_gemma":[0.99785787,0.00048586613,0.00024257538,0.0003893472,0.00046918608,0.0005551626],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055117474,0.00055029214,0.0015894471,0.0005127019,0.00018994126,0.00004420232,0.00011007432,0.000120162025,0.0025065339],"category_scores_gemma":[0.000021784226,0.00031694188,0.00013623618,0.0005359762,0.00080484175,0.00018185332,0.0000950739,0.00048543775,0.0000023358784],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8422863,0.012525837,0.0028060137,0.00009784547,0.0015761175,0.00015015232,0.0007971101,0.000003989877,0.0002081112,0.000008734042,0.00006336169,0.13947643],"study_design_scores_gemma":[0.96607435,0.022898823,0.008323055,0.0002168545,0.0006714927,0.0000631485,0.00010792615,0.000120422905,0.0006440203,0.0000056731237,0.00059203134,0.0002821901],"about_ca_topic_score_codex":0.010491389,"about_ca_topic_score_gemma":0.019039344,"teacher_disagreement_score":0.13919424,"about_ca_system_score_codex":0.00086543727,"about_ca_system_score_gemma":0.0015014341,"threshold_uncertainty_score":0.9999283},"labels":[],"label_agreement":null},{"id":"W2086107711","doi":"10.1002/syn.20825","title":"Antipsychotic drug binding in the substantia nigra: An examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia","year":2010,"lang":"en","type":"article","venue":"Synapse","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Metoclopramide; Tardive dyskinesia; Clozapine; Raclopride; Haloperidol; Olanzapine; Substantia nigra; Dyskinesia; Internal medicine; Endocrinology; Antipsychotic; Chlorpromazine; Pharmacology; Chemistry; Striatum; Psychology; Medicine; Dopaminergic; Dopamine; Schizophrenia (object-oriented programming); Parkinson's disease; Psychiatry; Disease","score_opus":0.025935103665232797,"score_gpt":0.27756960665360103,"score_spread":0.25163450298836826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086107711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976405,0.00031189935,0.0000018510417,0.000663264,0.000111441965,0.0011485432,0.000087424334,0.000008803029,0.00002629906],"genre_scores_gemma":[0.9994303,0.00012900433,0.000053822394,0.00010336446,0.00003617787,0.00004397972,0.00018347529,0.000013400885,0.0000064929845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883986,0.00021188987,0.0002878066,0.00024649306,0.00023414785,0.00017983092],"domain_scores_gemma":[0.9991565,0.0003356351,0.00015818677,0.00017954409,0.000073206065,0.00009692613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005867983,0.00014050496,0.00022608024,0.00032913225,0.00008318712,0.000017554037,0.00010359005,0.00004912875,0.000014963981],"category_scores_gemma":[0.00017583497,0.0000963377,0.000034759098,0.0005448071,0.00008134464,0.00022703565,0.000028020262,0.00017439906,0.000001027894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005707143,0.0004850331,0.9738513,0.00007149523,0.000064394226,0.000007446953,0.005188209,0.00002219519,0.018000891,0.00020872099,0.000052949137,0.0014766327],"study_design_scores_gemma":[0.0023982427,0.00016941939,0.9937945,0.00010508115,0.00038664826,9.54725e-7,0.00048615783,0.00033557767,0.0021925287,0.000023909066,0.00001463629,0.00009236381],"about_ca_topic_score_codex":0.0002237273,"about_ca_topic_score_gemma":0.0006624694,"teacher_disagreement_score":0.019943163,"about_ca_system_score_codex":0.000019762641,"about_ca_system_score_gemma":0.00003297155,"threshold_uncertainty_score":0.39285374},"labels":[],"label_agreement":null},{"id":"W2087686137","doi":"10.1200/jco.2009.23.0607","title":"Reply to R.S. Mehta et al","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Medicine","score_opus":0.21334361164083018,"score_gpt":0.5974558753435592,"score_spread":0.384112263702729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087686137","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39239573,0.00029858135,0.0000663313,0.58210474,0.0016526391,0.00013373274,0.0000011487202,0.000009817074,0.02333729],"genre_scores_gemma":[0.47996795,0.00053008215,0.0038583635,0.5134197,0.0009890101,0.0000010548196,0.0000010654992,0.0000058901496,0.0012268893],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978196,0.00024577757,0.0014041238,0.00014156729,0.00021114474,0.00017779443],"domain_scores_gemma":[0.9975552,0.000931682,0.00062865193,0.00013280392,0.0002460056,0.0005056749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00232142,0.00009114598,0.0010274632,0.000102230566,0.000018267088,0.0000042295583,0.00010595829,0.00013917974,0.0004933667],"category_scores_gemma":[0.001401569,0.00006264632,0.00038530605,0.00011457867,0.00004997494,0.000057879966,0.000019657056,0.00070298417,0.00007488143],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068163443,0.0024745096,0.007281212,0.0000018578711,0.00019962357,0.0011891405,0.000079492645,0.000005878121,0.0007537298,0.00017023901,0.7854878,0.19554019],"study_design_scores_gemma":[0.0061587603,0.04074043,0.14698714,0.000020636047,0.00022221412,0.0005643636,0.000012970177,0.000004832279,0.00012206514,0.00034058726,0.8047801,0.000045873894],"about_ca_topic_score_codex":0.000012204532,"about_ca_topic_score_gemma":0.000009578684,"teacher_disagreement_score":0.19549432,"about_ca_system_score_codex":0.00011787594,"about_ca_system_score_gemma":0.0011502015,"threshold_uncertainty_score":0.5402019},"labels":[],"label_agreement":null},{"id":"W2090424972","doi":"10.1007/s10600-014-1033-6","title":"Two New Non-Taxoids from Leaves of Taxus cuspidata","year":2014,"lang":"en","type":"article","venue":"Chemistry of Natural Compounds","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"DEPT; Chemistry; Acetic anhydride; Heteronuclear single quantum coherence spectroscopy; Two-dimensional nuclear magnetic resonance spectroscopy; Stereochemistry; Acetic acid; Organic chemistry; Catalysis","score_opus":0.01543015514092229,"score_gpt":0.30543198112318287,"score_spread":0.2900018259822606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090424972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813199,0.0015991753,0.000014821495,0.00053710514,0.00025631962,0.00008043994,0.00003492934,0.00002179791,0.016135536],"genre_scores_gemma":[0.9931844,0.000034808814,0.0008672193,0.00012491785,0.0006694944,0.0000021656438,0.00028080356,0.000011468474,0.004824732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992404,0.000009515618,0.00023788972,0.0002018792,0.00016224325,0.00014808067],"domain_scores_gemma":[0.9992597,0.00010614243,0.00014885189,0.0003039453,0.00006914593,0.000112201196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046136578,0.00014492676,0.00040910064,0.000020897398,0.000021812206,0.0000039891756,0.00016945126,0.00007869641,0.00051713246],"category_scores_gemma":[0.000033853,0.00012352708,0.000117760654,0.00009489636,0.00013182055,0.00003862676,0.000061867846,0.00020457669,0.000007075903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035779848,0.000115516625,0.006844817,0.00012190812,0.00014771127,0.0000044143253,0.000062755695,0.0000011523414,0.96933097,0.0000057031793,0.02020449,0.002802755],"study_design_scores_gemma":[0.0044643767,0.00013153593,0.0073369723,0.000092997834,0.00020246902,0.00001681017,0.000025430409,0.00014684722,0.9728474,0.00018726112,0.014434862,0.000113018796],"about_ca_topic_score_codex":0.00043650402,"about_ca_topic_score_gemma":0.000008671356,"teacher_disagreement_score":0.011864515,"about_ca_system_score_codex":0.00004447634,"about_ca_system_score_gemma":0.00009713021,"threshold_uncertainty_score":0.5662238},"labels":[],"label_agreement":null},{"id":"W2091013260","doi":"10.1002/ejoc.200600284","title":"Novel Synthetic Strategy Towards Taxol by Macrocyclization Reaction – Conformational Requirement of Ring A","year":2006,"lang":"en","type":"article","venue":"European Journal of Organic Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Ring (chemistry); Stereochemistry; Combinatorial chemistry; Organic chemistry","score_opus":0.01808994674897337,"score_gpt":0.2647975971216491,"score_spread":0.2467076503726757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091013260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708212,0.000324054,0.0016953998,0.00030626912,0.00009821088,0.000065146436,0.000014279693,0.0000109355715,0.026664503],"genre_scores_gemma":[0.9982175,0.00006966275,0.00017799395,0.00003424676,0.00030414853,3.8580757e-7,0.000046758265,0.000016244934,0.0011330321],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99910045,0.000019795842,0.0004915774,0.00007300659,0.00021997096,0.00009520052],"domain_scores_gemma":[0.99920064,0.000012391804,0.0004913256,0.00007363428,0.00016197644,0.000060052484],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021926688,0.00009186633,0.00017079884,0.00002815854,0.00003857389,0.000007238696,0.000062759216,0.000023239318,0.00092161173],"category_scores_gemma":[0.000021560627,0.000081922444,0.00006724967,0.00007788875,0.00003374659,0.000079496385,0.0000194625,0.00012934119,0.0000050540866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013858236,0.00026028618,0.00018949703,0.000091269176,0.00007513527,0.000027302089,0.00006123142,0.000019935382,0.995699,0.0000040818823,0.0021019718,0.001331721],"study_design_scores_gemma":[0.003685657,0.00022452926,0.005252782,0.00014910797,0.00021904896,0.0011836946,0.00008912242,0.000049245926,0.979418,0.0000065221425,0.009637587,0.00008474159],"about_ca_topic_score_codex":0.000005513562,"about_ca_topic_score_gemma":3.755334e-7,"teacher_disagreement_score":0.027396325,"about_ca_system_score_codex":0.00015607697,"about_ca_system_score_gemma":0.00012664156,"threshold_uncertainty_score":0.99999166},"labels":[],"label_agreement":null},{"id":"W2091278682","doi":"10.1016/j.freeradbiomed.2010.10.187","title":"Acute Doxorubicin Toxicity Differentially Alters Cytochrome P450 Expression in the Kidney and Liver of Male Sprague Dawley Rats","year":2010,"lang":"en","type":"article","venue":"Free Radical Biology and Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cytochrome P450; Toxicity; Doxorubicin; Liver toxicity; Kidney; Pharmacology; Medicine; Internal medicine; Endocrinology; Chemotherapy; Metabolism","score_opus":0.014838064372053584,"score_gpt":0.3157234499036285,"score_spread":0.3008853855315749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091278682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847145,0.0012444354,0.000060219867,0.01247356,0.00028917275,0.0004158717,0.000038794013,0.000012132321,0.00075129094],"genre_scores_gemma":[0.9940983,0.0015733443,0.00020649692,0.0033853943,0.0004439394,0.000025411904,0.00009048552,0.000007062071,0.00016957565],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99897623,0.00013676014,0.00026770146,0.00027693558,0.00010691598,0.00023543747],"domain_scores_gemma":[0.9991136,0.00029663343,0.000078994446,0.00024400564,0.000022791217,0.00024394013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030923597,0.0001667689,0.00047967746,0.0001072474,0.00005826985,0.0000021519138,0.00013414223,0.00024143714,0.00084522046],"category_scores_gemma":[0.0001953992,0.000087725624,0.00003633763,0.00009923873,0.0012647432,0.000029930583,0.00007566488,0.00046847225,0.0000017800634],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082459213,0.00021693381,0.021611635,0.000059745173,0.0000800405,0.00014162486,0.0006063344,1.0509749e-8,0.96246564,0.00052694144,0.011246601,0.0022198807],"study_design_scores_gemma":[0.030891698,0.007880004,0.6064578,0.00056864636,0.0013051151,0.002003875,0.0001979104,0.0001144869,0.31620508,0.0021464687,0.031849995,0.0003788873],"about_ca_topic_score_codex":0.00015770367,"about_ca_topic_score_gemma":0.00016863017,"teacher_disagreement_score":0.64626056,"about_ca_system_score_codex":0.000010999,"about_ca_system_score_gemma":0.000059612958,"threshold_uncertainty_score":0.9254571},"labels":[],"label_agreement":null},{"id":"W2091417780","doi":"10.1097/01.coc.0000258125.97090.3f","title":"Survival Differences Observed in Metastatic Breast Cancer Patients Treated With Capecitabine When Compared With Vinorelbine After Pretreatment With Anthracycline and Taxane","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Statistics Canada; Alberta Cancer Foundation; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Vinorelbine; Capecitabine; Medicine; Anthracycline; Taxane; Metastatic breast cancer; Internal medicine; Oncology; Chemotherapy; Breast cancer; Cancer; Surgery; Colorectal cancer","score_opus":0.0626830552519413,"score_gpt":0.40415889236326363,"score_spread":0.34147583711132234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091417780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609673,0.00032315994,0.000055961966,0.0027115114,0.00012461183,0.00049904943,0.000046424262,0.000010829128,0.00013170889],"genre_scores_gemma":[0.9947754,0.0005651566,0.0036472175,0.0006226788,0.00020688018,0.0000335419,0.000020376403,0.000031056094,0.00009768434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971209,0.0003774038,0.0013191435,0.0003567194,0.00039495193,0.0004308625],"domain_scores_gemma":[0.9961466,0.001299836,0.0014284926,0.00015292251,0.00046004876,0.00051210576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000634951,0.00033578507,0.002250278,0.00020186683,0.000033929562,0.000009484542,0.00009950846,0.00007015147,0.0002983796],"category_scores_gemma":[0.000045174034,0.00017207873,0.00009893964,0.00038111745,0.0011564402,0.00011111837,0.000025699726,0.0005098564,0.0000010999366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.098147176,0.005891879,0.8420247,0.000020291658,0.0014075463,0.0018965714,0.00028234714,0.000008361495,0.000021864565,9.4874486e-7,0.000034806097,0.05026353],"study_design_scores_gemma":[0.03614856,0.070863396,0.8897025,0.0002317645,0.0016078125,0.00052378525,0.0003854653,0.000025355037,0.000028340846,0.0000032205505,0.000300168,0.00017963524],"about_ca_topic_score_codex":0.0018475722,"about_ca_topic_score_gemma":0.012360993,"teacher_disagreement_score":0.06497152,"about_ca_system_score_codex":0.00028253137,"about_ca_system_score_gemma":0.0005916275,"threshold_uncertainty_score":0.70171666},"labels":[],"label_agreement":null},{"id":"W2091911272","doi":"10.1158/1538-7445.am10-3661","title":"Abstract 3661: Vascular changes and potentiating secondary drug delivery in colorectal cancer with Irinophore C","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Colorectal cancer; Irinotecan; Fluorouracil; Toxicity; Pharmacology; Perfusion; Cancer; Pathology; Internal medicine","score_opus":0.035562699177785095,"score_gpt":0.38118300437124364,"score_spread":0.34562030519345854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091911272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98891926,0.0063907644,8.106714e-8,0.002454139,0.00021499362,0.000616696,0.00003542178,0.000023363813,0.0013452776],"genre_scores_gemma":[0.99393183,0.0043113553,0.00005007475,0.00018241217,0.0004525975,0.00056360615,0.000016869017,0.000031344578,0.0004599089],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985341,0.00004822111,0.00012379358,0.00037704842,0.0003656376,0.0005512341],"domain_scores_gemma":[0.99931693,0.000112017595,0.000035462694,0.00013461786,0.0001904765,0.0002104983],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045224236,0.00014405987,0.00025679282,0.00025235358,0.0001462591,0.000030163941,0.000090989124,0.00009570969,0.002218243],"category_scores_gemma":[0.000013870254,0.00011408154,0.00003230956,0.0003298078,0.0002675855,0.000079387726,0.00007584351,0.0011227456,0.000008612615],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011888487,0.00015899142,0.24087147,0.00032902125,0.0002128642,0.00034342144,0.0014203956,0.0000058447977,0.6790107,0.000010139685,0.0026135386,0.07383477],"study_design_scores_gemma":[0.0056492966,0.00038455625,0.82630754,0.00027542346,0.00008598808,0.000034944285,0.0005430456,0.000064195665,0.15481935,0.000030894564,0.011582594,0.00022216323],"about_ca_topic_score_codex":0.01350351,"about_ca_topic_score_gemma":0.076909386,"teacher_disagreement_score":0.5854361,"about_ca_system_score_codex":0.00023904622,"about_ca_system_score_gemma":0.0007563821,"threshold_uncertainty_score":0.9986939},"labels":[],"label_agreement":null},{"id":"W2093577168","doi":"10.1158/0008-5472.sabcs10-p3-15-05","title":"Abstract P3-15-05: Muscle and Joint Symptoms in Breast Cancer Patients Receiving Taxane-Based Chemotherapy","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; North York General Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Taxane; Breast cancer; Internal medicine; Cancer; Docetaxel; Joint pain; Chemotherapy; Paclitaxel; Oncology; Physical therapy","score_opus":0.04545014354277371,"score_gpt":0.40371468875381733,"score_spread":0.3582645452110436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093577168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98907113,0.00056783133,4.1741552e-7,0.007931754,0.00045696675,0.00073840236,0.00008044868,0.000030676143,0.001122354],"genre_scores_gemma":[0.9966376,0.0009987883,0.000027954868,0.000803592,0.000485933,0.0004707529,0.000021969634,0.00004308121,0.00051033316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982442,0.000056586097,0.0002387722,0.0004277032,0.00044468156,0.0005880034],"domain_scores_gemma":[0.999048,0.00012520872,0.0000615781,0.00023561757,0.0002628116,0.0002668033],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045087622,0.00017100605,0.0003024955,0.0003077676,0.000112674024,0.000034757708,0.0000994184,0.0001449152,0.004687985],"category_scores_gemma":[0.000030749597,0.00014640484,0.000054109754,0.00039822358,0.00024116354,0.000087119704,0.000042587686,0.0008951875,0.000018160803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012291962,0.00068921066,0.53659356,0.00021741338,0.000074150856,0.000046962567,0.00045166942,0.000007874075,0.26029712,0.000008076699,0.008825247,0.19155952],"study_design_scores_gemma":[0.0076551246,0.00023845,0.97119254,0.00023820267,0.000019126368,0.0000048820352,0.000029859557,0.00008443563,0.012356869,0.000025543235,0.008006442,0.00014853089],"about_ca_topic_score_codex":0.0067130653,"about_ca_topic_score_gemma":0.0040634954,"teacher_disagreement_score":0.43459898,"about_ca_system_score_codex":0.00048374117,"about_ca_system_score_gemma":0.000624506,"threshold_uncertainty_score":0.9999013},"labels":[],"label_agreement":null},{"id":"W2094140813","doi":"10.1016/j.jpain.2011.02.134","title":"Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat","year":2011,"lang":"en","type":"article","venue":"Journal of Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Sensory system; Peripheral neuropathy; Paclitaxel; Medicine; Mitochondrion; Peripheral; Nociception; Neuroscience; Internal medicine; Endocrinology; Chemotherapy; Biology; Receptor","score_opus":0.048817095471229935,"score_gpt":0.30174646784698406,"score_spread":0.25292937237575414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094140813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950354,0.00023912005,0.000027120333,0.002535665,0.0007050774,0.0003842635,0.0000059636914,0.000005270319,0.001062101],"genre_scores_gemma":[0.9960748,0.00011037481,0.0002780248,0.0024547796,0.00061587687,0.000016708502,0.0000018569042,0.000013025346,0.00043454047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997014,0.0016437976,0.00064319867,0.00014003018,0.00025694026,0.00030205832],"domain_scores_gemma":[0.9990699,0.00039881808,0.00021506142,0.000161012,0.000054975142,0.00010019429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024701322,0.00015740025,0.00042041924,0.0002518872,0.000025608842,0.000011990873,0.00015370593,0.0000943958,0.0003143428],"category_scores_gemma":[0.00030843442,0.000105887586,0.00016718668,0.00022381738,0.000071103605,0.00011398242,0.00001849437,0.00068709836,0.000004913201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015287559,0.0033164783,0.8520381,0.0001014298,0.0001001727,0.017027866,0.02346763,0.00003309512,0.077484034,0.00008399027,0.0052786786,0.005780961],"study_design_scores_gemma":[0.018327914,0.0037781054,0.9619625,0.00017080209,0.00012005264,0.00080722745,0.00291235,0.0005068642,0.0019778297,0.00026303297,0.00893352,0.00023979112],"about_ca_topic_score_codex":0.00050512917,"about_ca_topic_score_gemma":0.0014170142,"teacher_disagreement_score":0.109924406,"about_ca_system_score_codex":0.0002270039,"about_ca_system_score_gemma":0.00018818601,"threshold_uncertainty_score":0.43179703},"labels":[],"label_agreement":null},{"id":"W2094422744","doi":"10.1016/j.addr.2008.10.003","title":"Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy","year":2008,"lang":"en","type":"review","venue":"Advanced Drug Delivery Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; Montreal Heart Institute","funders":"","keywords":"Pharmacogenomics; Breast cancer; Vinca; Medicine; Chemotherapy; Pharmacokinetics; Oncology; Docetaxel; Cancer; Vindesine; Pharmacology; Internal medicine; Cyclophosphamide; Vincristine","score_opus":0.046362368245144205,"score_gpt":0.3918706415607305,"score_spread":0.34550827331558626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094422744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047541835,0.99450177,8.9620255e-7,0.0002917663,0.00053086225,0.0035884567,0.00022698217,0.000048662107,0.00033516687],"genre_scores_gemma":[0.00000519783,0.9945359,0.00032992288,0.0020505155,0.00056329364,0.0010151706,0.00017065236,0.00013450024,0.0011948054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971077,0.00021408577,0.0011489248,0.00079940207,0.00016391292,0.00056599703],"domain_scores_gemma":[0.99860746,0.00012506118,0.0005456872,0.000362071,0.000059495847,0.00030023887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016402722,0.0008443177,0.003721216,0.00029246052,0.00006751519,0.000011154499,0.00019100265,0.00015487974,0.0006529812],"category_scores_gemma":[0.0000049852906,0.0006666452,0.00062267977,0.00054115447,0.00013358583,0.00012139988,0.00008108583,0.00069410825,0.000104040075],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014626619,0.000239815,0.00009810824,0.0106044775,0.00027327318,0.00019180485,0.000073482835,0.0000014956487,0.00003996949,7.7603613e-7,0.011838135,0.9764924],"study_design_scores_gemma":[0.0034923153,0.000039959916,0.000019772897,0.010341377,0.0018632989,0.0012488726,0.0000030131246,0.000012882612,0.000017389386,0.0000022540821,0.98243415,0.0005246926],"about_ca_topic_score_codex":0.000058714177,"about_ca_topic_score_gemma":0.00002248182,"teacher_disagreement_score":0.9759677,"about_ca_system_score_codex":0.00061410625,"about_ca_system_score_gemma":0.00042575947,"threshold_uncertainty_score":0.9995785},"labels":[],"label_agreement":null},{"id":"W2094913719","doi":"10.1021/np0004449","title":"New Taxane Analogues from the Needles of <i>Taxus canadensis</i>","year":2001,"lang":"en","type":"article","venue":"Journal of Natural Products","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique; Université du Québec à Montréal","funders":"","keywords":"Taxane; Taxus; Diterpene; Stereochemistry; Chemistry; Botany; Biology; Cancer","score_opus":0.022099713228959622,"score_gpt":0.2877839887193288,"score_spread":0.2656842754903692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094913719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9256923,0.032340635,0.0000026877417,0.040120218,0.0013791154,0.00012932108,0.000007288526,0.0000050828194,0.0003233215],"genre_scores_gemma":[0.9911674,0.001164015,0.00064397807,0.0012381303,0.0029447663,2.881536e-7,0.000010228174,0.000008093695,0.0028230746],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991639,0.000040117102,0.00030390167,0.00009739717,0.00025281438,0.00014182209],"domain_scores_gemma":[0.99901134,0.000106332925,0.00033869137,0.00014308673,0.00030829734,0.00009223131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000128295,0.000101328376,0.0003161592,0.00006590879,0.000033119006,0.0000072215234,0.00012251528,0.000040756797,0.00013393255],"category_scores_gemma":[0.00017438392,0.0000545012,0.000099094825,0.00026641352,0.000049325226,0.00008297057,0.000017187505,0.00032721352,0.0000037408038],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019638566,0.00016174256,0.021177528,0.00002380549,0.00075483014,0.0006923892,0.0009350722,0.0000101137275,0.2305918,0.00001754195,0.70891273,0.0347586],"study_design_scores_gemma":[0.009395957,0.002024198,0.3779785,0.0003759206,0.0023753282,0.005197403,0.00087492436,0.000016174625,0.2181448,0.0006107784,0.38271526,0.00029074377],"about_ca_topic_score_codex":0.0029486902,"about_ca_topic_score_gemma":0.0005399189,"teacher_disagreement_score":0.356801,"about_ca_system_score_codex":0.000069694426,"about_ca_system_score_gemma":0.0003781026,"threshold_uncertainty_score":0.44575572},"labels":[],"label_agreement":null},{"id":"W2095108849","doi":"10.1039/b906862g","title":"Enhancement of docetaxel solubility via conjugation of formulation-compatible moieties","year":2009,"lang":"en","type":"article","venue":"Organic & Biomolecular Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Docetaxel; Chemistry; Prodrug; Conjugate; Solubility; Cytotoxicity; Moiety; Drug; Combinatorial chemistry; Stereochemistry; Organic chemistry; Pharmacology; In vitro; Biochemistry; Cancer","score_opus":0.009149655150587837,"score_gpt":0.2783637329378171,"score_spread":0.2692140777872292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095108849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976361,0.00060028053,0.019617159,0.00035975932,0.000037990325,0.00022208404,0.000007213216,0.000020045789,0.002774463],"genre_scores_gemma":[0.99898577,0.000042539425,0.00041813558,0.000091633745,0.000034457018,0.0000045752213,0.000106870044,0.0000072270795,0.0003088049],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992372,0.000009493043,0.00029346033,0.00016183648,0.00017524933,0.00012276554],"domain_scores_gemma":[0.999422,0.000011739366,0.00016114199,0.00022184571,0.00013080613,0.000052478936],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006966397,0.000108619475,0.00025391663,0.000022232887,0.00002146073,0.0000022598854,0.000055841843,0.00007648302,0.0013620311],"category_scores_gemma":[0.000014526694,0.000103948754,0.00008743811,0.00015779836,0.000050663333,0.000027981598,0.000014406155,0.000054888485,0.0000046480313],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012099184,0.0005566741,0.0014408533,0.00023499552,0.000084671105,0.0000032612782,0.00013038483,2.4522296e-7,0.99644876,0.000010551293,0.00012103841,0.0008476073],"study_design_scores_gemma":[0.0015613452,0.00027070814,0.004282876,0.000038344475,0.00016113766,0.000010371815,0.000021562568,0.0001136997,0.99311537,0.00024779487,0.0001021851,0.000074580705],"about_ca_topic_score_codex":0.000019564639,"about_ca_topic_score_gemma":9.1527414e-7,"teacher_disagreement_score":0.022624752,"about_ca_system_score_codex":0.000081328486,"about_ca_system_score_gemma":0.000100317324,"threshold_uncertainty_score":0.9995509},"labels":[],"label_agreement":null},{"id":"W2095584745","doi":"10.1515/znc-2009-1-208","title":"Two New 11(15→1)Abeotaxanes with a 2,20-Epoxy Ring from the Needles of Taxus canadensis","year":2009,"lang":"en","type":"article","venue":"Zeitschrift für Naturforschung C","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Japan Society for the Promotion of Science; Hebei Medical University; Chiba University","keywords":"Epoxy; Taxus; Ring (chemistry); Composite material; Materials science; Botany; Chemistry; Biology; Organic chemistry","score_opus":0.012534648864048556,"score_gpt":0.29887421295365046,"score_spread":0.28633956408960193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095584745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9629986,0.011189635,0.000029601331,0.009126638,0.00046230413,0.0007165509,0.00006416868,0.00012092483,0.015291538],"genre_scores_gemma":[0.9916619,0.00015000119,0.0016290362,0.002682126,0.00092101673,0.000011156851,0.00009269729,0.0000358752,0.0028162117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831533,0.000055474375,0.0003516296,0.00039109692,0.00041583748,0.00047065306],"domain_scores_gemma":[0.9986571,0.00025775714,0.00021235082,0.00047320622,0.00012798175,0.0002716235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000127921,0.00032826368,0.0005666179,0.00011842676,0.0001506265,0.000028072915,0.00023341898,0.0001493858,0.00042881354],"category_scores_gemma":[0.000056204888,0.00020353332,0.00015963282,0.00045192798,0.00011075834,0.00011603824,0.000038138474,0.00047882635,0.000020114205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071964096,0.0014624869,0.54875535,0.00021777439,0.0038321656,0.0016041239,0.010344221,0.00076744484,0.14459829,0.012060605,0.21524741,0.053913716],"study_design_scores_gemma":[0.026739921,0.0031815625,0.4420524,0.0011130528,0.0040654405,0.0005670261,0.0019420293,0.00050306506,0.1277404,0.00037107925,0.39051548,0.0012085473],"about_ca_topic_score_codex":0.02221165,"about_ca_topic_score_gemma":0.011147711,"teacher_disagreement_score":0.17526807,"about_ca_system_score_codex":0.000028540979,"about_ca_system_score_gemma":0.00047900423,"threshold_uncertainty_score":0.98429954},"labels":[],"label_agreement":null},{"id":"W2095704084","doi":"10.1056/nejmoa1111097","title":"Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":469,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Docetaxel; Capecitabine; Medicine; Gemcitabine; Bevacizumab; Chemotherapy; Internal medicine; Cyclophosphamide; Breast cancer; Metastatic breast cancer; Oncology; Cancer; Colorectal cancer","score_opus":0.029986808739246255,"score_gpt":0.37093735812574186,"score_spread":0.3409505493864956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095704084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7747101,0.011252199,0.0011026993,0.20722425,0.0039513186,0.0007215944,0.0000404391,0.0000217138,0.00097564753],"genre_scores_gemma":[0.9602123,0.001001545,0.0009381917,0.007814696,0.027696658,0.000012400183,0.000005992853,0.000026197935,0.00229201],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989894,0.000024833542,0.0003508924,0.00008706244,0.000251341,0.00029644926],"domain_scores_gemma":[0.9987303,0.00012867617,0.00017424792,0.00009521534,0.00019807098,0.00067346543],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004225351,0.00014441508,0.00051247614,0.00015706955,0.00003414577,0.0000028833751,0.00007278888,0.000051854928,0.0025377462],"category_scores_gemma":[0.00004535252,0.00008691132,0.000095368145,0.00013070882,0.000034350633,0.00007158509,0.0000073413967,0.00016260504,0.000005786656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010499022,0.0002494655,0.016451005,0.000045882593,0.00042955452,0.000032048596,0.0028292476,0.0000060101006,0.02485878,0.00004373702,0.23042123,0.71413404],"study_design_scores_gemma":[0.1767059,0.0042760167,0.06507036,0.0004131757,0.00092749554,0.0032861014,0.00013964235,0.000011833144,0.004350811,0.00009836685,0.7445841,0.00013621394],"about_ca_topic_score_codex":0.00011653966,"about_ca_topic_score_gemma":0.000027754442,"teacher_disagreement_score":0.7139978,"about_ca_system_score_codex":0.00014315521,"about_ca_system_score_gemma":0.00020768012,"threshold_uncertainty_score":0.99837404},"labels":[],"label_agreement":null},{"id":"W2096107960","doi":"10.1007/s00520-014-2289-x","title":"Management options for established chemotherapy-induced peripheral neuropathy","year":2014,"lang":"en","type":"review","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Nova Scotia","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Psychosocial; Pain medicine; Nursing research; Intensive care medicine; Quality of life (healthcare); Psychological intervention; Evidence-based medicine; Alternative medicine; Psychiatry; Nursing","score_opus":0.055134281002700146,"score_gpt":0.4302106633911973,"score_spread":0.37507638238849716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096107960","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012822483,0.9890093,0.000018741639,0.00025972378,0.0015707766,0.0044490113,0.00034352008,0.000055727705,0.004164983],"genre_scores_gemma":[0.00022310147,0.98695266,0.00016457097,0.0007249529,0.00085339893,0.0067339847,0.0009036027,0.00012587117,0.0033178434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980173,0.00009598267,0.00058172015,0.0006712649,0.0001715219,0.00046221985],"domain_scores_gemma":[0.9989891,0.000083309824,0.00027789475,0.00033936446,0.00017236336,0.00013797585],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011574347,0.0004815537,0.0016975167,0.00028359992,0.00005447544,0.000022078539,0.0001521728,0.00024052359,0.0013800986],"category_scores_gemma":[0.000011923024,0.0004023473,0.00064429204,0.00030454388,0.000049519942,0.000058733458,0.000042967127,0.00033028878,0.000015365837],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019110975,0.00014233097,0.000102208396,0.02242645,0.0004572591,0.00012682796,0.0003299767,0.0000010488262,0.000002150241,0.00005406877,0.006605919,0.9695606],"study_design_scores_gemma":[0.0028131993,0.0006727154,0.00013053391,0.0042922464,0.0021976053,0.000015747128,0.00014239196,0.0000032759017,0.0000097237635,0.000008360853,0.9893834,0.0003308091],"about_ca_topic_score_codex":0.0000835016,"about_ca_topic_score_gemma":0.0001929086,"teacher_disagreement_score":0.9827775,"about_ca_system_score_codex":0.0015729879,"about_ca_system_score_gemma":0.0006262667,"threshold_uncertainty_score":0.9998428},"labels":[],"label_agreement":null},{"id":"W2096607288","doi":"10.1517/14656566.3.12.1739","title":"Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Doxorubicin; Therapeutic index; Metastatic breast cancer; Breast cancer; Pharmacology; Cumulative dose; Anthracycline; Cancer; Cardiotoxicity; Liposome; Therapeutic effect; Chemotherapy; Oncology; Internal medicine; Drug","score_opus":0.1480815675914475,"score_gpt":0.45383212290448716,"score_spread":0.30575055531303963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096607288","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034481556,0.9886968,0.000006171865,0.0020804668,0.0021993641,0.0035420307,0.00019661809,0.00022776147,0.0030162951],"genre_scores_gemma":[0.000033353877,0.9813816,0.00010568468,0.0069028153,0.003957486,0.0014508703,0.0005711122,0.0003070234,0.0052900636],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99567914,0.00043634302,0.0011025107,0.0013426759,0.0005535177,0.0008857902],"domain_scores_gemma":[0.99817985,0.00012895845,0.00044895333,0.00062722166,0.00006992612,0.0005450756],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0002054806,0.0013052673,0.0030411456,0.0009060163,0.000099888755,0.000056951045,0.00044843738,0.0006725003,0.018908778],"category_scores_gemma":[0.0000019616284,0.00097194297,0.00089119765,0.0012907408,0.00009804684,0.0001339625,0.000028312023,0.0011938942,0.00031022087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001125434,0.0021739157,0.000025560019,0.00075460476,0.0011342269,0.000051469156,0.0007761372,0.0000050177605,0.00037523577,0.000020414289,0.18521614,0.80834186],"study_design_scores_gemma":[0.014358928,0.00039713515,0.000026047563,0.004667742,0.00010473985,0.0002510844,0.000012358657,0.00011520621,0.00018065714,0.0000061954934,0.9790408,0.00083909306],"about_ca_topic_score_codex":0.0007463647,"about_ca_topic_score_gemma":0.000002817038,"teacher_disagreement_score":0.80750275,"about_ca_system_score_codex":0.0009392344,"about_ca_system_score_gemma":0.00086603774,"threshold_uncertainty_score":0.9999699},"labels":[],"label_agreement":null},{"id":"W2097354398","doi":"10.1200/jco.2009.25.4342","title":"Reply to D.L. Raunig","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine","score_opus":0.20649044368908437,"score_gpt":0.5798411927725939,"score_spread":0.37335074908350957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097354398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7278074,0.00042611946,0.00009239814,0.2290552,0.0023216107,0.00017937263,8.2797914e-7,0.000012359618,0.040104724],"genre_scores_gemma":[0.83999616,0.00038567808,0.0044733486,0.1488275,0.0032487346,0.0000011074159,7.605629e-7,0.00000630049,0.0030604128],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979684,0.00017072038,0.0013972768,0.000117900745,0.0001775594,0.00016813968],"domain_scores_gemma":[0.9977146,0.00075635104,0.0006053147,0.00012684066,0.0002713786,0.0005255178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016121902,0.00008054445,0.0010220902,0.000108688444,0.000019717323,0.0000031770471,0.00010006057,0.00017051001,0.00051212474],"category_scores_gemma":[0.0014026572,0.000055163266,0.00038130628,0.0001275581,0.000047970123,0.00004424035,0.000014436332,0.0005624615,0.00008697239],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009970475,0.003350826,0.014009235,0.0000041134094,0.0002490239,0.0017772589,0.00010585986,0.000006979742,0.000891291,0.00016992613,0.4424896,0.5269754],"study_design_scores_gemma":[0.0062397933,0.04572538,0.19351318,0.000019743748,0.00027239576,0.00051323243,0.00001653754,0.0000041756502,0.00016670987,0.00043610463,0.75305057,0.00004219316],"about_ca_topic_score_codex":0.0000073806236,"about_ca_topic_score_gemma":0.0000044846397,"teacher_disagreement_score":0.5269332,"about_ca_system_score_codex":0.00012484955,"about_ca_system_score_gemma":0.00097233144,"threshold_uncertainty_score":0.56074065},"labels":[],"label_agreement":null},{"id":"W2098169322","doi":"10.1634/theoncologist.8-3-232","title":"Population-Based Pharmacoeconomic Model for Adopting Capecitabine/Docetaxel Combination Treatment for Anthracycline-Pretreated Metastatic Breast Cancer","year":2003,"lang":"en","type":"article","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Ottawa Regional Cancer Foundation","funders":"","keywords":"Docetaxel; Medicine; Capecitabine; Taxane; Oncology; Population; Metastatic breast cancer; Internal medicine; Quality-adjusted life year; Anthracycline; Breast cancer; Cost effectiveness; Cancer; Colorectal cancer; Environmental health","score_opus":0.0934897234531395,"score_gpt":0.41733139480526843,"score_spread":0.32384167135212893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098169322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716966,0.0008293407,0.008702306,0.010211421,0.0007066626,0.0058666137,0.0012599141,0.00015078981,0.0005763223],"genre_scores_gemma":[0.9890024,0.00014150677,0.0042129867,0.0010376518,0.00015016095,0.00270511,0.0004992949,0.000042260173,0.0022086445],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988165,0.00007826883,0.00037248628,0.00031199897,0.00007957335,0.00034117966],"domain_scores_gemma":[0.9987072,0.0006090915,0.00025012315,0.00019028889,0.0001491217,0.000094193645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000272956,0.000253279,0.00048004804,0.00008199555,0.00029797613,0.00002029269,0.000079138925,0.00006254788,0.0002624617],"category_scores_gemma":[0.000054100343,0.0001706062,0.00022371815,0.00011072014,0.00008073917,0.00006768435,0.000006082784,0.00007211029,0.000005516945],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029080251,0.02199086,0.3221763,0.0013004644,0.006639931,0.000044756594,0.0019265375,0.40789998,0.024421798,0.0068087406,0.022195144,0.15551525],"study_design_scores_gemma":[0.04579712,0.0019511365,0.015337827,0.000048316404,0.0038869842,0.000027064669,0.00011759779,0.9213776,0.005408615,0.0006745871,0.0050020297,0.0003711095],"about_ca_topic_score_codex":0.00067211397,"about_ca_topic_score_gemma":0.00050067034,"teacher_disagreement_score":0.5134776,"about_ca_system_score_codex":0.0012784966,"about_ca_system_score_gemma":0.0004405524,"threshold_uncertainty_score":0.6957119},"labels":[],"label_agreement":null},{"id":"W2098685433","doi":"10.1139/v03-084","title":"Canadensenes: Natural and semi-synthetic analogues","year":2003,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Taxus; Bicyclic molecule; Chemistry; Stereochemistry; Cancer cell lines; Docetaxel; Derivative (finance); Diterpene; Botany; Cancer cell; Cancer; Biology","score_opus":0.010953479958150665,"score_gpt":0.2501579515632487,"score_spread":0.23920447160509806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098685433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823045,0.008576873,8.121742e-7,0.0010436998,0.0002110446,0.000028605342,0.00000727462,0.0000020731195,0.007825096],"genre_scores_gemma":[0.99667627,0.00009237322,0.000042369422,0.00036941032,0.00015233908,6.763683e-7,0.0000034351247,0.000007741163,0.0026553934],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995318,0.0000112032285,0.00014292981,0.00007140351,0.0000637615,0.0001789051],"domain_scores_gemma":[0.9991085,0.000026911408,0.00006580486,0.000063980006,0.00008293804,0.00065184693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066071516,0.00008022336,0.00017651646,0.000037540904,0.000045208973,0.0000109088905,0.000036764926,0.00005442813,0.00065509276],"category_scores_gemma":[0.000075910444,0.0000691641,0.000051920557,0.00006287925,0.00008855029,0.000024734692,0.0000014080408,0.0001849697,0.0000013569852],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030378543,0.00014093127,0.34555584,0.00076309306,0.0016055388,0.017035289,0.0027070963,0.000016400982,0.46491107,0.000137687,0.15714256,0.009680692],"study_design_scores_gemma":[0.0055826954,0.0003081203,0.026775422,0.00039563436,0.0007594946,0.036937397,0.001370022,0.000016057955,0.4139868,0.0003616432,0.51306856,0.00043811763],"about_ca_topic_score_codex":0.0018435094,"about_ca_topic_score_gemma":0.008754987,"teacher_disagreement_score":0.355926,"about_ca_system_score_codex":0.00018705819,"about_ca_system_score_gemma":0.0016593554,"threshold_uncertainty_score":0.7172806},"labels":[],"label_agreement":null},{"id":"W2098749704","doi":"10.3747/co.v18i1.708","title":"Oxaliplatin: A Review in the Era of Molecularly Targeted Therapy","year":2011,"lang":"en","type":"review","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":424,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Oxaliplatin; Medicine; Pharmacology; Context (archaeology); Clinical trial; Targeted therapy; Pharmacokinetics; Oncology; Cancer; Colorectal cancer; Internal medicine","score_opus":0.33664024914714613,"score_gpt":0.5308158069371451,"score_spread":0.194175557789999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098749704","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018118963,0.9927679,0.0000029226535,0.00036079533,0.0008892262,0.0031432104,0.000030848285,0.000014709622,0.00277231],"genre_scores_gemma":[0.000011960194,0.9975926,0.00004566177,0.00074268377,0.00023788045,0.00094244746,0.00034364578,0.000030937925,0.000052161362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99749225,0.00088350795,0.0008543061,0.00033790857,0.00014966249,0.00028236958],"domain_scores_gemma":[0.9985564,0.000291413,0.0005613661,0.00043776757,0.00008657881,0.00006648798],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052881346,0.0003662649,0.0026919474,0.00013985495,0.000020633443,0.0000023206742,0.0003114961,0.0002780735,0.0011206147],"category_scores_gemma":[0.00005221278,0.00020531302,0.00063227984,0.00050332973,0.000128689,0.000019729438,0.000042143558,0.0010669972,0.00005818038],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053020816,0.00136263,0.000039213748,0.026076466,0.00023132772,0.0000617565,0.00026754927,3.332728e-9,8.7518964e-7,0.0000931179,0.012306462,0.9595076],"study_design_scores_gemma":[0.0014230805,0.0013418117,0.00004769333,0.025379222,0.0019988518,0.00017111975,0.0000053538693,2.3178634e-7,0.000001182313,0.000029093395,0.96945924,0.0001431118],"about_ca_topic_score_codex":0.000030059877,"about_ca_topic_score_gemma":0.000014127341,"teacher_disagreement_score":0.9593645,"about_ca_system_score_codex":0.0002025281,"about_ca_system_score_gemma":0.0009715895,"threshold_uncertainty_score":0.9997925},"labels":[],"label_agreement":null},{"id":"W2099562503","doi":"10.1200/jco.2009.22.1077","title":"Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); Saskatchewan Cancer Agency; McMaster University; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Amgen; Queen's University; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Epirubicin; Cyclophosphamide; Breast cancer; Internal medicine; Febrile neutropenia; Hazard ratio; Fluorouracil; Chemotherapy; Doxorubicin; Gastroenterology; Oncology; Cancer; Neutropenia; Confidence interval","score_opus":0.04116585421662357,"score_gpt":0.40403025614598265,"score_spread":0.3628644019293591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099562503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9517917,0.018566633,0.00002369134,0.023750503,0.003150884,0.0012313403,0.0006531342,0.00005463468,0.0007774568],"genre_scores_gemma":[0.9307961,0.060084343,0.0017292189,0.0055813226,0.0008333225,0.000057359244,0.000046537127,0.00009557536,0.00077622675],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99133694,0.0013179595,0.0039434237,0.0012976759,0.000828895,0.0012751329],"domain_scores_gemma":[0.98267424,0.01163754,0.0029808392,0.00044923605,0.00064471853,0.0016134079],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0030756097,0.0010517198,0.0044862777,0.000366934,0.00030176807,0.00006977545,0.00032146898,0.0012966227,0.00032484965],"category_scores_gemma":[0.003136309,0.0008105802,0.000570207,0.00071458827,0.0011303745,0.00058973813,0.00019141425,0.0027134477,0.000013260852],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41556364,0.0061129835,0.31567124,0.0001251674,0.0038058122,0.0046473984,0.0017160798,0.00004019644,0.008063934,0.000083405204,0.07731989,0.16685025],"study_design_scores_gemma":[0.17710459,0.042269774,0.75966364,0.00055816985,0.0041647563,0.0006625016,0.0010143971,0.00011829836,0.0026008764,0.0005256223,0.010263982,0.0010533895],"about_ca_topic_score_codex":0.00518928,"about_ca_topic_score_gemma":0.0025584593,"teacher_disagreement_score":0.4439924,"about_ca_system_score_codex":0.0011665208,"about_ca_system_score_gemma":0.0016031102,"threshold_uncertainty_score":0.9999999},"labels":[],"label_agreement":null},{"id":"W2099712757","doi":"10.1093/annonc/mdr063","title":"Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179)","year":2011,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; BC Cancer Agency; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Juravinski Cancer Centre","funders":"","keywords":"Temsirolimus; Carboplatin; Medicine; Tolerability; Paclitaxel; Adverse effect; Neutropenia; Nausea; Chemotherapy; Internal medicine; Toxicity; Common Terminology Criteria for Adverse Events; Pharmacology; Oncology; Urology; Cisplatin","score_opus":0.1238114440220481,"score_gpt":0.438953404819226,"score_spread":0.31514196079717793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099712757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99520266,0.00009950316,0.0000032674288,0.00031907516,0.000043370015,0.002356917,0.000010101347,0.000010220797,0.0019548587],"genre_scores_gemma":[0.9990917,0.00003169894,0.0002622555,0.00029326836,0.0000133061585,0.00019886049,0.00004849349,0.000018245326,0.00004219553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987277,0.00015299798,0.0004109713,0.00030696674,0.00015109695,0.00025029652],"domain_scores_gemma":[0.99921745,0.000086167034,0.0002709051,0.00015155708,0.000182149,0.00009176622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025905328,0.00017114141,0.0006069479,0.0002700852,0.000028286637,0.0000052251407,0.00007919175,0.00008808596,0.000037554877],"category_scores_gemma":[0.000029186032,0.00013262131,0.000011537544,0.00030176862,0.000105326944,0.00021564575,0.000049630744,0.00016896492,0.0000014327998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033529647,0.04501739,0.8543566,0.00004336826,0.00014590449,0.00016528655,0.006863927,0.0000069277444,0.000536404,0.00004469021,0.00007120976,0.059218638],"study_design_scores_gemma":[0.10655104,0.098369844,0.7929897,0.000096605036,0.00008370245,0.0000071188356,0.00076755846,0.00008823171,0.00073091773,0.000119409684,0.00007176368,0.00012411518],"about_ca_topic_score_codex":0.0009007268,"about_ca_topic_score_gemma":0.002621074,"teacher_disagreement_score":0.0730214,"about_ca_system_score_codex":0.000092782786,"about_ca_system_score_gemma":0.0001924173,"threshold_uncertainty_score":0.540814},"labels":[],"label_agreement":null},{"id":"W2099818449","doi":"10.1093/annonc/mdq430","title":"First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients","year":2010,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Roche","keywords":"Medicine; Bevacizumab; Taxane; Metastatic breast cancer; Internal medicine; Docetaxel; Oncology; Clinical endpoint; Neutropenia; Chemotherapy; Breast cancer; Population; Surgery; Cancer; Clinical trial","score_opus":0.13956061855920757,"score_gpt":0.48037675997332335,"score_spread":0.34081614141411576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099818449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98647106,0.00014960628,0.000012077839,0.0088367555,0.0002820626,0.0039676023,0.00021979985,0.0000104953,0.00005057163],"genre_scores_gemma":[0.9962267,0.00048908126,0.0005342645,0.0019974571,0.00006987234,0.0004940614,0.00009995386,0.000026813015,0.00006179724],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984361,0.00013162165,0.0005772617,0.00039492195,0.00012587191,0.00033425572],"domain_scores_gemma":[0.9987355,0.00040951036,0.00024639058,0.00021468574,0.00023859937,0.00015532934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047958508,0.000210373,0.0008741768,0.00020125625,0.000045909466,0.000008845242,0.000192343,0.00011204331,0.00028502214],"category_scores_gemma":[0.00006965525,0.00016523545,0.000031489646,0.0002448815,0.000114236354,0.00009262899,0.00005572503,0.0002458855,0.0000011211098],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1452561,0.07870491,0.096899,0.00021357533,0.00030535876,0.000096612195,0.0020599035,0.00012367213,0.0004936392,0.000018958572,0.00090455246,0.6749237],"study_design_scores_gemma":[0.34309596,0.105112076,0.5311501,0.00016458349,0.0003067877,0.000021882497,0.00020021049,0.0033705973,0.00055953884,0.00005165404,0.015629085,0.00033752294],"about_ca_topic_score_codex":0.0013342286,"about_ca_topic_score_gemma":0.057286344,"teacher_disagreement_score":0.6745862,"about_ca_system_score_codex":0.00016415572,"about_ca_system_score_gemma":0.0008343812,"threshold_uncertainty_score":0.9599157},"labels":[],"label_agreement":null},{"id":"W2101024529","doi":"10.1634/theoncologist.2014-0059","title":"Investigation of Adverse-Event-Related Costs for Patients With Metastatic Breast Cancer in a Real-World Setting","year":2014,"lang":"en","type":"article","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Genentech","keywords":"Medicine; Capecitabine; Metastatic breast cancer; Taxane; Adverse effect; Internal medicine; Cohort; Breast cancer; Cancer; Pharmacy; Leukopenia; Anemia; Chemotherapy; Oncology","score_opus":0.024192563102551974,"score_gpt":0.34294199914562395,"score_spread":0.318749436043072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101024529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936029,0.000023843982,0.000013714065,0.003742748,0.0001144863,0.0010664129,0.00006873802,0.000019189,0.001348006],"genre_scores_gemma":[0.99833256,0.000018729797,0.00025591487,0.0003492104,0.00003754385,0.00020424681,0.00007277768,0.000011738335,0.0007172902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928397,0.00011110507,0.00022997639,0.00012762779,0.00009737545,0.0001499503],"domain_scores_gemma":[0.9992659,0.00028228696,0.00021102336,0.00010591755,0.0000905757,0.00004429689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003048276,0.000093113194,0.00023976306,0.000068882044,0.000041797048,0.0000015512267,0.00005234037,0.000027596452,0.00008684885],"category_scores_gemma":[0.00002907668,0.000054996533,0.000037388752,0.00023003209,0.00016050815,0.000037666516,0.000013576784,0.000087914275,0.000002383203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018853846,0.00025893672,0.98350877,0.000096112206,0.00018558881,0.0000026560904,0.00052577053,0.00023639006,0.00070496264,0.0003501123,0.0013903552,0.010854961],"study_design_scores_gemma":[0.010331023,0.0010903383,0.9855129,0.00017294675,0.00048387385,0.0000030176454,0.000082084945,0.0010306285,0.00047940997,0.00021276022,0.00052199094,0.000079040954],"about_ca_topic_score_codex":0.0016896861,"about_ca_topic_score_gemma":0.0054138447,"teacher_disagreement_score":0.010775921,"about_ca_system_score_codex":0.00036727916,"about_ca_system_score_gemma":0.00015367159,"threshold_uncertainty_score":0.30210525},"labels":[],"label_agreement":null},{"id":"W2101295467","doi":"10.1177/1078155214553143","title":"The effect of race on the CYP3A-mediated metabolism of vincristine in pediatric patients with acute lymphoblastic leukemia","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"International Society of Oncology Pharmacy Practitioners","keywords":"Medicine; Vincristine; Neurotoxicity; Internal medicine; Genotyping; Acute lymphocytic leukemia; Gastroenterology; Incidence (geometry); Leukemia; Chemotherapy; Lymphoblastic Leukemia; Genotype; Toxicity; Gene","score_opus":0.010044189550483045,"score_gpt":0.34122279438766634,"score_spread":0.3311786048371833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101295467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900751,0.00065944786,0.000017491899,0.006115997,0.0007043381,0.00052729883,0.000008297383,0.000004917859,0.0018870806],"genre_scores_gemma":[0.9964905,0.0019561986,0.000117133095,0.00090352196,0.00041949475,0.000017564711,0.0000042736306,0.000020234293,0.00007108748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968828,0.0014862906,0.0007681628,0.0001383123,0.00047365582,0.00025079885],"domain_scores_gemma":[0.97973585,0.017423851,0.0020376407,0.0001829449,0.0005005506,0.00011916856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025365732,0.00020047804,0.00073985435,0.00020883446,0.00007719525,0.0000066260045,0.00024398192,0.00006976894,0.00007748198],"category_scores_gemma":[0.0028842555,0.00009170128,0.00012959802,0.0004496615,0.00017632157,0.00019135639,0.00004217649,0.00071482663,0.000010391356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39499483,0.0063567655,0.49176422,0.00035003776,0.006944184,0.0010960113,0.0017259746,0.00095869444,0.016126966,0.0002159918,0.03622774,0.0432386],"study_design_scores_gemma":[0.16611813,0.05304803,0.3878523,0.00017516543,0.02746964,0.0012810448,0.00013629721,0.0012257181,0.027540687,0.00003430328,0.33474788,0.00037077707],"about_ca_topic_score_codex":0.000045829485,"about_ca_topic_score_gemma":0.000008028076,"teacher_disagreement_score":0.29852015,"about_ca_system_score_codex":0.0003845451,"about_ca_system_score_gemma":0.00078653055,"threshold_uncertainty_score":0.37394696},"labels":[],"label_agreement":null},{"id":"W2101719282","doi":"10.1634/theoncologist.2010-0278","title":"In the End What Matters Most? A Review of Clinical Endpoints in Advanced Breast Cancer","year":2011,"lang":"en","type":"review","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; University of Alberta; Bibliographical Society of Canada; Jewish General Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"University of Toronto; Eli Lilly and Company","keywords":"Medicine; Clinical trial; Metastatic breast cancer; Clinical research; Clinical endpoint; Breast cancer; Phases of clinical research; Oncology; Drug; Food and drug administration; Cancer; Internal medicine; Intensive care medicine; Pharmacology","score_opus":0.19286006184339724,"score_gpt":0.5378821186998671,"score_spread":0.3450220568564699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101719282","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000037360303,0.979382,9.7193826e-8,0.014258152,0.0009617501,0.002720001,0.00007690419,0.000008885636,0.0025548807],"genre_scores_gemma":[0.00002491466,0.97854954,0.000019927556,0.01933411,0.0003314728,0.0010735681,0.000051338484,0.000027436176,0.0005876872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965667,0.0011882922,0.0013896679,0.00036492702,0.00018038238,0.0003100354],"domain_scores_gemma":[0.99738395,0.0011114948,0.000803435,0.00059711846,0.00004493134,0.000059061487],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021355,0.0003410028,0.0028278271,0.000091326954,0.000024421539,0.000007777063,0.00053424033,0.00024497378,0.0024828892],"category_scores_gemma":[0.00008734454,0.00015529658,0.0004982724,0.00049841637,0.0004960319,0.00008750129,0.00010120782,0.00091159815,0.0000656332],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022537439,0.0005265479,0.00012244789,0.027019687,0.00015304785,0.00014624328,0.0001226563,5.642379e-8,1.6450409e-7,0.000034754194,0.024259279,0.9473897],"study_design_scores_gemma":[0.0012791953,0.00027421888,0.0006553286,0.092566706,0.0016436094,0.0002429457,0.000055647997,1.6768155e-7,2.7516978e-7,0.000021571701,0.90313756,0.00012275638],"about_ca_topic_score_codex":0.00083410466,"about_ca_topic_score_gemma":0.0009629887,"teacher_disagreement_score":0.947267,"about_ca_system_score_codex":0.0003605595,"about_ca_system_score_gemma":0.0008999554,"threshold_uncertainty_score":0.998429},"labels":[],"label_agreement":null},{"id":"W2101857408","doi":"10.1081/cnv-100102548","title":"Mitoxantrone and Paclitaxel Combination Chemotherapy in Metastatic Breast Cancer","year":2001,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"Bristol-Myers Squibb","keywords":"Mitoxantrone; Medicine; Chemotherapy; Cardiotoxicity; Metastatic breast cancer; Internal medicine; Neutropenia; Regimen; Oncology; Breast cancer; Nausea; Doxorubicin; Paclitaxel; Cancer; Progressive disease; Surgery","score_opus":0.03761453095331926,"score_gpt":0.3490888451618517,"score_spread":0.31147431420853244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101857408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746554,0.0029540358,0.000015521277,0.021485351,0.00019480592,0.00042130562,0.000022575441,0.00003052329,0.00022047485],"genre_scores_gemma":[0.9919703,0.0038269095,0.00013191265,0.0028236662,0.00017057889,0.00027893338,0.00004472844,0.000016599093,0.00073635764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999304,0.00003782228,0.00017393516,0.00020392855,0.000116127674,0.00016416587],"domain_scores_gemma":[0.9996521,0.000029222849,0.00007233716,0.0000786413,0.00006064557,0.00010704211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000880089,0.000116724164,0.00020149024,0.00011321014,0.000037917875,0.000011738576,0.000024871679,0.000043875032,0.00048690283],"category_scores_gemma":[0.0000064997985,0.00010693759,0.00002321571,0.00027497046,0.0001077492,0.00013478474,0.0000065511204,0.00009842083,0.000004272574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052118243,0.00021708113,0.8885489,0.000115873925,0.00012452411,0.000021469685,0.001160738,0.00004296688,0.041171048,0.00036144635,0.0032395008,0.06447525],"study_design_scores_gemma":[0.007193965,0.0001333381,0.9822919,0.00014382838,0.00014813455,0.000053440424,0.00007087882,0.0014677122,0.004333536,0.0014020626,0.002635401,0.0001258002],"about_ca_topic_score_codex":0.0015886625,"about_ca_topic_score_gemma":0.0006615121,"teacher_disagreement_score":0.09374299,"about_ca_system_score_codex":0.0003214168,"about_ca_system_score_gemma":0.00014121222,"threshold_uncertainty_score":0.53312445},"labels":[],"label_agreement":null},{"id":"W2102612417","doi":"10.1158/0008-5472.can-04-0580","title":"A Comparative Analysis of Low-Dose Metronomic Cyclophosphamide Reveals Absent or Low-Grade Toxicity on Tissues Highly Sensitive to the Toxic Effects of Maximum Tolerated Dose Regimens","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Cyclophosphamide; Toxicity; Medicine; Pharmacology; Maximum tolerated dose; Toxicology; Oncology; Internal medicine; Chemotherapy; Biology","score_opus":0.06633478806082845,"score_gpt":0.4347610397646431,"score_spread":0.36842625170381466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102612417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921807,0.0010560772,0.000015203879,0.0038583865,0.00017046393,0.002197598,0.00013788429,0.000022105474,0.00036158238],"genre_scores_gemma":[0.9967578,0.00056196505,0.00007629072,0.00044904437,0.00014800533,0.00034606617,0.000039279566,0.000021228441,0.001600286],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974272,0.00042738306,0.00044436427,0.0005114985,0.00063461,0.00055493665],"domain_scores_gemma":[0.99764645,0.00091693987,0.00016686007,0.00052538124,0.00047218654,0.00027220196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056228385,0.0002538597,0.0011090892,0.0006831982,0.00012468024,0.000014923308,0.00020869906,0.00009820196,0.00020006708],"category_scores_gemma":[0.0001088562,0.0001647365,0.00021913224,0.0026881143,0.0003321759,0.00004424149,0.00010315896,0.00039425388,0.00004433658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019501125,0.0024103047,0.0016048007,0.00058539765,0.008001103,0.00041585203,0.011627115,0.013786323,0.9327729,0.00020886886,0.007715387,0.0013708647],"study_design_scores_gemma":[0.0045376057,0.0028688598,0.052610237,0.0005839329,0.0009770973,0.0000029145256,0.00043752292,0.00009735308,0.9372083,0.00004226901,0.00047899625,0.00015493677],"about_ca_topic_score_codex":0.003614356,"about_ca_topic_score_gemma":0.002008541,"teacher_disagreement_score":0.051005434,"about_ca_system_score_codex":0.0013868937,"about_ca_system_score_gemma":0.00062616786,"threshold_uncertainty_score":0.67177594},"labels":[],"label_agreement":null},{"id":"W2103672719","doi":"10.1177/107815520100600402","title":"Documentation of capecitabine usage as a third-line chemotherapy option for metastatic breast cancer patients","year":2001,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Capecitabine; Medicine; Taxane; Metastatic breast cancer; Vinorelbine; Internal medicine; Nausea; Oncology; Cancer; Breast cancer; Chemotherapy; Colorectal cancer; Cisplatin","score_opus":0.04922793063149728,"score_gpt":0.47197149728347854,"score_spread":0.42274356665198126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103672719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9589999,0.0010375096,0.0006338937,0.035403498,0.0011477635,0.000948338,0.00004521976,0.00001057098,0.0017733037],"genre_scores_gemma":[0.9708356,0.013215244,0.0065389825,0.0074476255,0.0008895134,0.000075404154,0.00003287755,0.000032431213,0.00093229086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99836814,0.00021257323,0.00075709337,0.00014619423,0.00030622425,0.00020977316],"domain_scores_gemma":[0.99620515,0.0007533889,0.0016227212,0.00007766906,0.0011820528,0.0001589909],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007529477,0.00016162316,0.00054331287,0.00020485448,0.00005693357,0.000010214113,0.00009030511,0.000051587856,0.0016137403],"category_scores_gemma":[0.0001906417,0.00012987446,0.00018347324,0.00022679135,0.00006399722,0.0008319296,0.000012796874,0.0002918082,0.000009107374],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21633725,0.029419307,0.051430557,0.0004134672,0.007820217,0.0007118995,0.0034828517,0.00039307497,0.20214528,0.00013646191,0.03932695,0.44838268],"study_design_scores_gemma":[0.13171083,0.014728833,0.016957318,0.00013187109,0.009317318,0.0068588615,0.0005920872,0.00070535555,0.026553327,0.0002478179,0.7919324,0.000263962],"about_ca_topic_score_codex":0.00017966802,"about_ca_topic_score_gemma":0.000013357605,"teacher_disagreement_score":0.75260544,"about_ca_system_score_codex":0.00055282196,"about_ca_system_score_gemma":0.0006491251,"threshold_uncertainty_score":0.99929893},"labels":[],"label_agreement":null},{"id":"W2103803683","doi":"10.1139/v03-200","title":"Part 1: Efficient strategies for the construction of variably substituted bicyclo[5.3.1]undecenones (AB taxane ring systems)","year":2004,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; Consejo Nacional de Ciencia y Tecnología; Government of Ontario","keywords":"Chemistry; Intramolecular force; Cycloaddition; Ring (chemistry); Propargyl; Lewis acids and bases; Medicinal chemistry; Bicyclic molecule; Stereochemistry; Boron trifluoride; Taxane; Organic chemistry; Catalysis","score_opus":0.019101733137865038,"score_gpt":0.2614698150398388,"score_spread":0.24236808190197376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103803683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921519,0.003672222,0.0008515404,0.0007632602,0.0009395001,0.00019491627,0.000051803632,0.000004888079,0.0013699642],"genre_scores_gemma":[0.9990459,0.00007702403,0.00017259644,0.000029332841,0.0005618448,0.000008273478,0.000008427345,0.000009201391,0.00008739182],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929565,0.0000074660393,0.00032165623,0.0000792788,0.00010655176,0.00018938445],"domain_scores_gemma":[0.99904454,0.0000680964,0.0002749041,0.000105275016,0.00025092697,0.00025624305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001501253,0.000097908975,0.00024646393,0.00005208075,0.00009356394,0.00002457223,0.000089711066,0.00007538736,0.0000977198],"category_scores_gemma":[0.000042658794,0.000071894996,0.00009566408,0.000113702416,0.00018098828,0.000036932008,0.0000029177577,0.0001435799,5.6885915e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020519106,0.000492496,0.0107012335,0.0040585245,0.004262579,0.001185589,0.003213077,0.21824123,0.7373699,0.0084477365,0.005974667,0.004001046],"study_design_scores_gemma":[0.034954317,0.0010679394,0.004531453,0.0036320772,0.0044363043,0.01759599,0.025123052,0.001358108,0.7903818,0.0011647391,0.11486451,0.00088969775],"about_ca_topic_score_codex":0.001963935,"about_ca_topic_score_gemma":0.00061352854,"teacher_disagreement_score":0.21688312,"about_ca_system_score_codex":0.0002996909,"about_ca_system_score_gemma":0.00326904,"threshold_uncertainty_score":0.5799137},"labels":[],"label_agreement":null},{"id":"W2105567212","doi":"10.1186/bcr3231","title":"Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":213,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Surgical oncology; Medicine; Breast cancer; Oncology; Cisplatin; Internal medicine; Chemotherapy; Metastatic breast cancer; Cancer; Randomized controlled trial; Open label","score_opus":0.07042442315505405,"score_gpt":0.46501667705105887,"score_spread":0.39459225389600483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105567212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986492,0.0004279234,0.0000048713614,0.0029233692,0.0001732767,0.006198028,0.0027070048,0.0000069586076,0.0010665726],"genre_scores_gemma":[0.9966008,0.0003527982,0.00014883632,0.00012675888,0.0002734064,0.0014742991,0.00012256873,0.000047634283,0.0008529134],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961859,0.0006645887,0.000850139,0.0004339252,0.0011453875,0.000720079],"domain_scores_gemma":[0.99725544,0.0006209273,0.00040665147,0.00039885042,0.0010291365,0.00028900546],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025660386,0.00026807387,0.0014487014,0.00047474043,0.00009133147,0.0000166862,0.00031433077,0.00008833096,0.0011653448],"category_scores_gemma":[0.00007336721,0.00018408136,0.000097107666,0.0011319713,0.0005951209,0.00027319143,0.00016934097,0.00040553775,0.0000041650933],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9292838,0.018641952,0.010222236,0.00012229355,0.0010586352,0.000008149474,0.0022608652,0.000004132104,0.001998302,0.000020920608,0.0019317297,0.03444697],"study_design_scores_gemma":[0.92702043,0.0048444555,0.06357855,0.0005267568,0.0003312286,0.000012487974,0.0000800334,0.00007615124,0.003204945,0.00001545639,0.00015024499,0.0001592683],"about_ca_topic_score_codex":0.018609725,"about_ca_topic_score_gemma":0.0006215135,"teacher_disagreement_score":0.05335632,"about_ca_system_score_codex":0.00053162116,"about_ca_system_score_gemma":0.001127886,"threshold_uncertainty_score":0.99974775},"labels":[],"label_agreement":null},{"id":"W2105765694","doi":"10.1093/annonc/mdp373","title":"An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer","year":2009,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham","funders":"GlaxoSmithKline","keywords":"Capecitabine; Medicine; Lapatinib; Metastatic breast cancer; Oncology; Expanded access; Internal medicine; Breast cancer; Cancer; Trastuzumab; Colorectal cancer","score_opus":0.12627047852334472,"score_gpt":0.49292940128938106,"score_spread":0.36665892276603634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105765694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971506,0.00015937215,0.0000034033349,0.00087087875,0.000043320684,0.0013480944,0.000051936648,0.00000773958,0.0003646356],"genre_scores_gemma":[0.9981062,0.00014819822,0.0004476584,0.0011119598,0.000020094987,0.00008425796,0.000021118658,0.000013215301,0.000047293444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988019,0.00014053611,0.00039557822,0.0002802155,0.00015872056,0.00022305842],"domain_scores_gemma":[0.9990472,0.00009226641,0.00029136654,0.0001807053,0.00027867334,0.00010978252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014230066,0.00015898846,0.0007521295,0.00012842238,0.000028928602,0.000010073112,0.00017398103,0.000050123803,0.00020872793],"category_scores_gemma":[0.000015286701,0.00010998409,0.000011179653,0.00024334496,0.0000838775,0.00031841206,0.000058871832,0.00010636948,2.105977e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05779705,0.053531762,0.47069547,0.000103290324,0.0003856865,0.00010834745,0.0025187102,0.00010931312,0.0051002475,0.000008475885,0.00038430365,0.40925735],"study_design_scores_gemma":[0.061378747,0.07243306,0.86376435,0.00017541014,0.00019906677,0.000011468501,0.00046471757,0.000041570638,0.0012809028,0.000033277884,0.00009299448,0.00012444805],"about_ca_topic_score_codex":0.0010021692,"about_ca_topic_score_gemma":0.0027736346,"teacher_disagreement_score":0.4091329,"about_ca_system_score_codex":0.00004633718,"about_ca_system_score_gemma":0.0003021138,"threshold_uncertainty_score":0.4485021},"labels":[],"label_agreement":null},{"id":"W2106155834","doi":"10.1200/jco.2004.01.106","title":"Determining the Relationship Between Toxicity and Quality of Life in an Ovarian Cancer Chemotherapy Clinical Trial","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Lethargy; Quality of life (healthcare); Nausea; Internal medicine; Randomized controlled trial; Clinical trial; Cancer; Ovarian cancer; Vomiting; Chemotherapy; Gynecologic oncology; Oncology","score_opus":0.6171955787318496,"score_gpt":0.6388170291255502,"score_spread":0.02162145039370056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106155834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836473,0.0001841391,0.000033350632,0.014763233,0.0008761556,0.00031732046,0.000004294738,0.0000036184363,0.00017062317],"genre_scores_gemma":[0.9925566,0.00040012816,0.00080689264,0.0032609822,0.002937594,0.0000052976225,0.0000016855304,0.000009017469,0.000021855662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947517,0.0013093464,0.0034229676,0.0001635088,0.00020253775,0.00014995373],"domain_scores_gemma":[0.9870635,0.010259568,0.0020421746,0.0001455231,0.00017946745,0.0003097177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008119476,0.00010125752,0.0015753361,0.00007325159,0.000036942427,0.000004807346,0.00012753138,0.0004291062,0.00006047097],"category_scores_gemma":[0.0063823285,0.00006275247,0.00031635936,0.00012257333,0.0003700163,0.0000948186,0.000024763558,0.0011010332,7.8602704e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047882974,0.002746653,0.91349816,0.00001173774,0.0001704686,0.000011692925,0.00019332644,0.0000048407564,0.000012463546,0.00011562931,0.000070181275,0.03528184],"study_design_scores_gemma":[0.169712,0.015592588,0.8127689,0.000033774104,0.00021510928,0.0000039757683,0.000034936595,0.0000028559202,0.000010843595,0.00075779797,0.000821036,0.00004621708],"about_ca_topic_score_codex":0.00015041308,"about_ca_topic_score_gemma":0.0008005662,"teacher_disagreement_score":0.12182903,"about_ca_system_score_codex":0.00012658145,"about_ca_system_score_gemma":0.0022106033,"threshold_uncertainty_score":0.76407045},"labels":[],"label_agreement":null},{"id":"W2109641043","doi":"10.1016/s0968-0896(02)00607-7","title":"Semi-Synthesis of an O-Glycosylated docetaxel analogue","year":2003,"lang":"fi","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Paclitaxel; Docetaxel; Taxane; Chemistry; Cytotoxicity; Potency; Moiety; Cell culture; Pharmacology; Stereochemistry; In vitro; Drug; Biochemistry; Chemotherapy; Cancer; Internal medicine","score_opus":0.017955298851129044,"score_gpt":0.28599597566968915,"score_spread":0.2680406768185601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109641043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9554664,0.0145743275,0.000011838259,0.0008976322,0.00079613045,0.0003754527,0.00020093023,0.00009106222,0.027586238],"genre_scores_gemma":[0.9889656,0.0017219211,0.00010063122,0.00038862103,0.0010789151,0.000029634817,0.00019284843,0.0000873405,0.007434488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99664634,0.00018177919,0.00092979794,0.0007897791,0.0006546725,0.00079765514],"domain_scores_gemma":[0.99734163,0.00031831194,0.00048001893,0.00078501954,0.0002547443,0.0008202998],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059830246,0.00061782874,0.0012288922,0.00010457956,0.00012037528,0.000013099339,0.00035512593,0.0006550414,0.024579214],"category_scores_gemma":[0.0006760833,0.0005635701,0.0002528163,0.00074052456,0.00052342407,0.000090432164,0.00005001776,0.0006587094,0.00013339292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006273084,0.0018628713,0.0051045055,0.0013912199,0.001098421,0.0005784024,0.0005511911,0.0000010606751,0.98009086,0.000029960174,0.0036521554,0.0050120186],"study_design_scores_gemma":[0.004794864,0.0006914897,0.0029887203,0.00061009976,0.003284901,0.00066268095,0.0012164429,0.000061486695,0.96309954,0.00004956864,0.022084856,0.00045537524],"about_ca_topic_score_codex":0.00032438146,"about_ca_topic_score_gemma":0.00002470019,"teacher_disagreement_score":0.033499215,"about_ca_system_score_codex":0.0004364482,"about_ca_system_score_gemma":0.0012345356,"threshold_uncertainty_score":0.9996816},"labels":[],"label_agreement":null},{"id":"W2110046944","doi":"10.1200/jco.2008.21.0534","title":"Efficacy Does Not Necessarily Translate to Cost Effectiveness: A Case Study in the Challenges Associated With 21st-Century Cancer Drug Pricing","year":2009,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer drugs; Drug; Drug pricing; Cancer; Intensive care medicine; Oncology; Pharmacology; Internal medicine; Actuarial science","score_opus":0.15994885631993133,"score_gpt":0.5037386611490396,"score_spread":0.3437898048291083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110046944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5566326,0.001803891,0.000001110801,0.43776062,0.0013186831,0.002117322,0.000013649684,0.000010905789,0.00034128042],"genre_scores_gemma":[0.71079534,0.004169255,0.000031704752,0.27976608,0.0049520857,0.00012925001,0.0000074285254,0.000045957153,0.000102902806],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99114716,0.0048319134,0.0022346335,0.0005227319,0.000706075,0.0005574893],"domain_scores_gemma":[0.9814682,0.015699623,0.0018902507,0.00029233444,0.000412275,0.00023732122],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0065199076,0.00048047857,0.0035424803,0.00036924798,0.0000850558,0.000023020464,0.00037803772,0.0010255249,0.000056180525],"category_scores_gemma":[0.00081228977,0.0002322457,0.0005674299,0.0003560844,0.00015459022,0.00008051368,0.00003152819,0.006389129,0.000003766433],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034489185,0.024945235,0.032755792,0.00027989602,0.0072376365,0.42873937,0.0136223985,0.00015277554,0.000022868802,0.0000024365231,0.069555506,0.38819692],"study_design_scores_gemma":[0.083627984,0.07356099,0.3525417,0.0021468461,0.010390068,0.0060345833,0.0034412455,0.000009192813,0.000016326836,0.000027146809,0.46759775,0.00060619146],"about_ca_topic_score_codex":0.0006332582,"about_ca_topic_score_gemma":0.008631624,"teacher_disagreement_score":0.4227048,"about_ca_system_score_codex":0.00079173193,"about_ca_system_score_gemma":0.0021377283,"threshold_uncertainty_score":0.9959032},"labels":[],"label_agreement":null},{"id":"W2110984210","doi":"10.2217/fon.10.163","title":"Do Anthracyclines Still Have a Role in Adjuvant Chemotherapy of Breast Cancer?","year":2010,"lang":"en","type":"review","venue":"Future Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Anthracycline; Trastuzumab; Cardiotoxicity; Medicine; Breast cancer; Taxane; Oncology; Internal medicine; Chemotherapy; Cancer; Metastatic breast cancer","score_opus":0.029723272581336946,"score_gpt":0.4338935815551031,"score_spread":0.40417030897376616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110984210","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004620576,0.9905129,3.1504868e-7,0.0022430615,0.0021392,0.0013076311,0.00042284414,0.000028586379,0.0028833754],"genre_scores_gemma":[0.00019930786,0.9930361,0.00015853056,0.0004557966,0.0046927426,0.00041813517,0.0001892418,0.00007385757,0.0007762924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801207,0.00018532491,0.00075708353,0.0005074837,0.00014761613,0.0003904357],"domain_scores_gemma":[0.9985563,0.00020944863,0.00059954665,0.00037397761,0.000111258174,0.00014948261],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021731482,0.0004803126,0.0035096905,0.00034437745,0.000020574293,0.0000039907336,0.00020709069,0.001279927,0.0022188053],"category_scores_gemma":[0.0000117053105,0.0003382387,0.00046896026,0.00028352696,0.00017744623,0.00002883212,0.000048181624,0.0011201003,0.000021380261],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000481544,0.0010385797,0.0008486987,0.0036728976,0.0003329655,0.00017308051,0.00030791046,1.0577314e-7,0.000052626543,0.000030348165,0.0032180743,0.9898432],"study_design_scores_gemma":[0.003754795,0.00066182,0.0010270512,0.002788174,0.0014903584,0.00075459684,0.00007510332,0.0000018817133,0.000014723742,0.00001813334,0.9891763,0.00023709919],"about_ca_topic_score_codex":0.00038980294,"about_ca_topic_score_gemma":0.0022225773,"teacher_disagreement_score":0.9896061,"about_ca_system_score_codex":0.00049089204,"about_ca_system_score_gemma":0.0017282227,"threshold_uncertainty_score":0.99990696},"labels":[],"label_agreement":null},{"id":"W2112901840","doi":"10.1200/jco.2006.09.7535","title":"Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, As First-Line Therapy in Patients With Metastatic Breast Cancer Previously Treated With Anthracycline Chemotherapy","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":225,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Ixabepilone; Medicine; Anthracycline; Metastatic breast cancer; Clinical endpoint; Internal medicine; Chemotherapy; Regimen; Adverse effect; Surgery; Breast cancer; Oncology; Cancer; Clinical trial","score_opus":0.13257564656467236,"score_gpt":0.5297732023901652,"score_spread":0.3971975558254929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112901840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915479,0.0004847257,0.00007856211,0.0053086737,0.00063915603,0.0017292709,0.000038587084,0.000016950464,0.00015620836],"genre_scores_gemma":[0.9873452,0.00641745,0.0015246841,0.0028502173,0.0015921405,0.000022495924,0.000046658064,0.000060551843,0.00014056254],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9924439,0.0007888508,0.00506198,0.00048885273,0.0006745994,0.0005417925],"domain_scores_gemma":[0.9913543,0.0023050986,0.0041694697,0.00037737776,0.0010281053,0.000765643],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0057181064,0.00041246234,0.0038565225,0.00037395963,0.00007070278,0.0000070794867,0.0002580623,0.00044552374,0.00094500784],"category_scores_gemma":[0.00035050153,0.00024136555,0.00052098336,0.00050984876,0.0007265422,0.00023697452,0.000028725326,0.0013179117,0.0000028851355],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4847801,0.0824802,0.24890007,0.000018550243,0.0018936024,0.0005370602,0.0001591448,0.000016463742,0.000030776733,0.0000022812053,0.00018554652,0.1809962],"study_design_scores_gemma":[0.39703542,0.32492995,0.27453515,0.000133957,0.001037921,0.00012307342,0.00002461442,0.000028140352,0.00011691514,0.000021527208,0.0018752441,0.00013809156],"about_ca_topic_score_codex":0.00038003703,"about_ca_topic_score_gemma":0.001560265,"teacher_disagreement_score":0.24244975,"about_ca_system_score_codex":0.00026666428,"about_ca_system_score_gemma":0.0020645915,"threshold_uncertainty_score":0.9999683},"labels":[],"label_agreement":null},{"id":"W2114358393","doi":"10.1051/medsci/2010265459","title":"Mécanisme d’activation de l’oncogène<i>BRAF</i>","year":2010,"lang":"fr","type":"article","venue":"médecine/sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Chemistry; Cancer research; Medicine","score_opus":0.034466896096121115,"score_gpt":0.36411555551760977,"score_spread":0.32964865942148863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114358393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.856849,0.0039610486,0.00032520012,0.045165766,0.009183413,0.0004362737,0.000018868199,0.00013819178,0.0839222],"genre_scores_gemma":[0.9605199,0.0004179317,0.004216434,0.0056025195,0.005012137,0.000044384564,0.000008051872,0.000033070355,0.02414559],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977928,0.00010603385,0.00032309812,0.0005225937,0.00041067397,0.00084481976],"domain_scores_gemma":[0.9987745,0.00049212435,0.00014707498,0.00021047673,0.00007174179,0.00030407554],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00094959745,0.00027305633,0.00033750167,0.0001913618,0.0004795402,0.00008515435,0.00031167414,0.00024580123,0.008334892],"category_scores_gemma":[0.00016845715,0.00023821855,0.00012458279,0.0005823398,0.0013172122,0.00033137115,0.00006538596,0.00052301015,0.00065343507],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019994428,0.002160178,0.23424257,0.00015727992,0.00017648617,0.00013399533,0.001946971,0.00010714164,0.4641369,0.060317706,0.1371147,0.099306114],"study_design_scores_gemma":[0.0072859,0.0038664523,0.08676676,0.00029604498,0.0006040818,0.00045792203,0.00064274186,0.0028044756,0.11517849,0.020055348,0.76141393,0.0006278312],"about_ca_topic_score_codex":0.00163491,"about_ca_topic_score_gemma":0.00037825905,"teacher_disagreement_score":0.6242992,"about_ca_system_score_codex":0.00019520959,"about_ca_system_score_gemma":0.0010588481,"threshold_uncertainty_score":0.99257165},"labels":[],"label_agreement":null},{"id":"W2116280772","doi":"10.1634/theoncologist.2008-0070","title":"Anthracyclines in Early-Stage Breast Cancer: Is It the End of an Era?","year":2009,"lang":"en","type":"review","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Sanofi; AstraZeneca; Pfizer","keywords":"Anthracycline; Medicine; Breast cancer; Oncology; Internal medicine; Adjuvant; Stage (stratigraphy); Topoisomerase; Cancer; Chemotherapy; Trastuzumab","score_opus":0.11737981977320233,"score_gpt":0.4823295088974135,"score_spread":0.36494968912421116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116280772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023267588,0.9795146,1.8208266e-7,0.010529056,0.00036697395,0.0014764812,0.0004962148,0.000022954422,0.005266751],"genre_scores_gemma":[0.0021946926,0.9894931,0.00001717643,0.0013705688,0.00080023566,0.00021942354,0.00006771428,0.00002851455,0.0058085998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99824846,0.00032990266,0.00060031126,0.00031807183,0.00019472485,0.0003085314],"domain_scores_gemma":[0.99842197,0.0004056927,0.00047519658,0.0005716888,0.0000536715,0.00007177308],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045422858,0.000348422,0.0016171734,0.000097543896,0.00008792127,0.000013471316,0.0004465875,0.00026116578,0.0015104216],"category_scores_gemma":[0.000017246335,0.00015800225,0.0003367682,0.00037060844,0.0006097388,0.000040510953,0.000065383385,0.0006516707,0.000032757638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022278837,0.00065697514,0.00031730815,0.0013403299,0.00024567192,0.0001098068,0.00040266934,0.0000015721157,0.0000023686723,0.00004242866,0.008040124,0.98861796],"study_design_scores_gemma":[0.0010307381,0.00074406044,0.0030958313,0.001902546,0.0019293408,0.00014845277,0.0000647226,0.000005305575,0.000007094534,0.000021828377,0.9908972,0.00015288884],"about_ca_topic_score_codex":0.0062509836,"about_ca_topic_score_gemma":0.0038939957,"teacher_disagreement_score":0.9884651,"about_ca_system_score_codex":0.00038937342,"about_ca_system_score_gemma":0.0008603686,"threshold_uncertainty_score":0.99940234},"labels":[],"label_agreement":null},{"id":"W2119018891","doi":"10.1093/annonc/mdi240","title":"Cyclophosphamide-methotrexate ‘metronomic’ chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluation","year":2005,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Associazione Italiana per la Ricerca sul Cancro; Oncosuisse; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Medicine; Cyclophosphamide; Metastatic breast cancer; Breast cancer; Oncology; Chemotherapy; Methotrexate; Internal medicine; Cancer; Nitrogen mustard; Clinical trial; Palliative care; Nursing","score_opus":0.25147634853736733,"score_gpt":0.5328897417986063,"score_spread":0.28141339326123893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119018891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95972323,0.009361029,0.00010958795,0.026668135,0.0002565542,0.0024669468,0.00041116282,0.000010897616,0.0009924382],"genre_scores_gemma":[0.9852735,0.01033721,0.0011700029,0.0014792994,0.00028378362,0.0010583278,0.000048570393,0.000016241764,0.0003330668],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881524,0.00015704232,0.00046883835,0.0002301907,0.00009468175,0.00023398314],"domain_scores_gemma":[0.9979942,0.00091424485,0.00051703665,0.00015441488,0.00034924838,0.000070873095],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041970416,0.00018979648,0.00079705805,0.000094476316,0.00005177307,0.0000026286398,0.000084801504,0.000051384144,0.0014932791],"category_scores_gemma":[0.000008611605,0.0001286263,0.00025924854,0.00010892558,0.0001886186,0.000058255875,0.0000090483045,0.000052780215,0.000008676243],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010894965,0.004273168,0.006186512,0.000058493206,0.006422814,0.0000015622352,0.005227744,0.0035455818,0.010304905,0.00012857538,0.009716036,0.9432396],"study_design_scores_gemma":[0.066221245,0.020124935,0.17766456,0.00006349286,0.0064189583,0.00003405685,0.0011473402,0.036758218,0.38850725,0.00047585112,0.30218765,0.0003964246],"about_ca_topic_score_codex":0.00043814105,"about_ca_topic_score_gemma":0.00023557144,"teacher_disagreement_score":0.9428432,"about_ca_system_score_codex":0.00047167874,"about_ca_system_score_gemma":0.0006130148,"threshold_uncertainty_score":0.9994195},"labels":[],"label_agreement":null},{"id":"W2119277421","doi":"10.4172/2329-6771.1000103","title":"Current Exercise Behaviors Of Breast Cancer Patients Diagnosed With Chemotherapy-induced Peripheral Neuropathy","year":2012,"lang":"en","type":"article","venue":"Journal of Integrative Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Peripheral neuropathy; Peripheral; Omics; Oncology; Chemotherapy; Internal medicine; Cancer; Bioinformatics; Physical therapy; Endocrinology","score_opus":0.019492661526661254,"score_gpt":0.3638400990499671,"score_spread":0.3443474375233059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119277421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616116,0.0013297319,0.000013267984,0.0006369481,0.001234723,0.00034684563,0.000028050079,0.0000055218297,0.00024371964],"genre_scores_gemma":[0.99758637,0.0014213827,0.00015583512,0.0002604571,0.0004460339,0.00003683136,0.0000054993407,0.000023230115,0.00006438063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988247,0.00012275515,0.00045551345,0.0001107996,0.00022798886,0.00025824114],"domain_scores_gemma":[0.99817675,0.000083118044,0.00067314587,0.00008248698,0.0007566781,0.00022784685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013665976,0.0002108927,0.00074373133,0.00016033583,0.000030883133,0.0000033538167,0.00009078172,0.00008666642,0.000860826],"category_scores_gemma":[0.000017400876,0.00011755346,0.0001762187,0.0001746446,0.00012751309,0.00015367744,0.000014626566,0.00044751746,0.0000023033217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007978113,0.008637593,0.82116216,0.000033301083,0.0002744735,0.00007053396,0.007231255,0.0000013365811,0.021241633,0.000009856593,0.0030958261,0.13026388],"study_design_scores_gemma":[0.012537156,0.012964098,0.9510184,0.0004009307,0.0009350454,0.00030721762,0.00085701025,0.000003878807,0.015892116,0.000003415889,0.004935543,0.00014516927],"about_ca_topic_score_codex":0.00009665733,"about_ca_topic_score_gemma":0.000066410365,"teacher_disagreement_score":0.13011871,"about_ca_system_score_codex":0.0005686433,"about_ca_system_score_gemma":0.0004962584,"threshold_uncertainty_score":0.9425441},"labels":[],"label_agreement":null},{"id":"W2119413329","doi":"10.1158/1078-0432.ccr-06-2377","title":"A Randomized, Double-Blind, Phase II Study of Two Doses of Pemetrexed as First-Line Chemotherapy for Advanced Breast Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Pemetrexed; Medicine; Neutropenia; Internal medicine; Breast cancer; Metastatic breast cancer; Oncology; Leukopenia; Population; Gastroenterology; Chemotherapy; Cancer; Phases of clinical research; Surgery","score_opus":0.3282812492929229,"score_gpt":0.6418834965688445,"score_spread":0.31360224727592156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119413329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829824,0.0030849061,0.000056897577,0.0049709682,0.00050420937,0.0077694817,0.00014237803,0.000027866892,0.00046090886],"genre_scores_gemma":[0.9880455,0.0058571897,0.0001263417,0.0003600206,0.0011299155,0.0021037424,0.000026732801,0.000055177745,0.0022953744],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99603766,0.00027636517,0.0015310479,0.0006309626,0.0008516476,0.00067232124],"domain_scores_gemma":[0.99332607,0.0039056344,0.0004056447,0.00048712036,0.001505787,0.00036974912],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0058895927,0.00025684302,0.0017670041,0.00038826675,0.00017939725,0.000008076201,0.0002910228,0.00016398779,0.002494153],"category_scores_gemma":[0.0003539656,0.00019168366,0.00050252,0.0009169353,0.00079059997,0.00007275961,0.00012077654,0.0005933807,0.000004115503],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87588924,0.016037734,0.009996717,0.000250852,0.0014124057,0.000020761707,0.00081426685,0.00002981369,0.002354492,0.000049431932,0.0016322349,0.09151205],"study_design_scores_gemma":[0.95967513,0.016833935,0.0010233143,0.00020534117,0.0006409567,0.000005885244,0.00035028692,0.0000914066,0.016528318,0.0001722397,0.0043092575,0.00016390232],"about_ca_topic_score_codex":0.006961498,"about_ca_topic_score_gemma":0.0063886372,"teacher_disagreement_score":0.09134815,"about_ca_system_score_codex":0.00024820364,"about_ca_system_score_gemma":0.00086054095,"threshold_uncertainty_score":0.99965125},"labels":[],"label_agreement":null},{"id":"W2120270251","doi":"10.1016/j.mehy.2005.11.005","title":"Tesmilifene may enhance breast cancer chemotherapy by killing a clone of aggressive, multi-drug resistant cells through its action on the p-glycoprotein pump","year":2006,"lang":"en","type":"article","venue":"Medical Hypotheses","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Breast cancer; Oncology; Doxorubicin; Drug resistance; Drug; Medicine; Population; Chemotherapy; Mechanism of action; Paclitaxel; Drug action; Internal medicine; Cancer; Pharmacology; Biology; Genetics; In vitro","score_opus":0.034939394025877764,"score_gpt":0.34055431159334826,"score_spread":0.3056149175674705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120270251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644235,0.0054651084,0.00011103459,0.02773333,0.0003323625,0.0007789475,0.00016735565,0.0000639839,0.00092438137],"genre_scores_gemma":[0.9833459,0.0059702084,0.00017904158,0.0029446846,0.00060886325,0.00023009926,0.000016301026,0.000043848864,0.0066609983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810505,0.00012354368,0.00038508786,0.0003591974,0.0006753146,0.00035182392],"domain_scores_gemma":[0.9986496,0.0005006525,0.0003780373,0.00024907032,0.00010081796,0.00012184862],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023608828,0.00025201737,0.00044051555,0.000045593242,0.000118037875,0.000009284286,0.00017124094,0.00015257539,0.0041071614],"category_scores_gemma":[0.000104982515,0.00015277108,0.00012817551,0.00022702407,0.00029132137,0.00005441928,0.000023307754,0.00033188035,0.000031955333],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003824502,0.0027312206,0.0014176633,0.00025429224,0.00031996076,0.00012346036,0.00045497782,0.000014063563,0.9178466,0.00010360655,0.052288868,0.020620743],"study_design_scores_gemma":[0.0028634178,0.00023699003,0.0028218157,0.0007846737,0.00011410608,0.00002380083,0.0000807831,0.00013892967,0.9671533,0.00005295342,0.025567273,0.00016195973],"about_ca_topic_score_codex":0.0026813867,"about_ca_topic_score_gemma":0.00026650683,"teacher_disagreement_score":0.049306653,"about_ca_system_score_codex":0.00015150357,"about_ca_system_score_gemma":0.00021628296,"threshold_uncertainty_score":0.9968032},"labels":[],"label_agreement":null},{"id":"W2120295366","doi":"10.3816/clc.2011.n.002","title":"Classification and Toxicities of Vascular Disrupting Agents","year":2011,"lang":"en","type":"review","venue":"Clinical Lung Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nausea; Vomiting; Headaches; Adverse effect; Pharmacology; Lung cancer; Anesthesia; Oncology; Surgery","score_opus":0.2931588339410363,"score_gpt":0.555318490067568,"score_spread":0.26215965612653164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120295366","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064770115,0.9958225,0.000003382405,0.000035559966,0.00072705897,0.0007818034,0.000045934165,0.000020410262,0.001915675],"genre_scores_gemma":[0.00029204114,0.9971447,0.00006587601,0.00012343099,0.0006478016,0.00020794303,0.00006760131,0.00003367608,0.0014169343],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984367,0.00013456478,0.00082583976,0.00034758466,0.00009846727,0.00015685009],"domain_scores_gemma":[0.99882287,0.00028840327,0.0004541164,0.00024786656,0.000059866685,0.0001268569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028455432,0.00021252918,0.0015856219,0.000067183304,0.000028374874,0.0000044865888,0.00007728043,0.00032115,0.00067661644],"category_scores_gemma":[0.0000654808,0.00015500405,0.00051838835,0.00010064423,0.0001962408,0.000025428371,0.000052550397,0.00032240408,0.00000805697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004058932,0.00016393671,0.010672512,0.014316463,0.0011912424,0.0000054254033,0.000054332515,1.5715619e-8,3.7168613e-7,0.00009049902,0.00363648,0.9698281],"study_design_scores_gemma":[0.00073728873,0.00017629734,0.00625861,0.0073889517,0.0064554457,0.0000052692913,0.000007536611,0.000016818323,4.7982746e-7,0.000009281432,0.97881186,0.00013215099],"about_ca_topic_score_codex":0.0000433632,"about_ca_topic_score_gemma":0.000009904671,"teacher_disagreement_score":0.9751754,"about_ca_system_score_codex":0.00011114702,"about_ca_system_score_gemma":0.00031809876,"threshold_uncertainty_score":0.7408476},"labels":[],"label_agreement":null},{"id":"W2120386009","doi":"10.1007/s10549-015-3342-2","title":"Overall survival (OS) endpoint: an incomplete evaluation of metastatic breast cancer (MBC) treatment outcome","year":2015,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Metastatic breast cancer; Clinical trial; Oncology; Progression-free survival; Breast cancer; Chemotherapy; Clinical endpoint; Cancer; Randomized controlled trial","score_opus":0.5563596854227307,"score_gpt":0.5889062232591702,"score_spread":0.03254653783643946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120386009","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007655107,0.9712751,7.6932173e-7,0.00078212534,0.00041943425,0.006072688,0.013036819,0.000053168333,0.00070479873],"genre_scores_gemma":[0.008573545,0.97968125,0.000051511746,0.000023134386,0.00085809093,0.0071260235,0.0016991739,0.00014267417,0.0018446144],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99302006,0.0015423098,0.0010958997,0.00125382,0.0020148337,0.0010730925],"domain_scores_gemma":[0.99590707,0.00029377034,0.0004712824,0.00086816435,0.0013786,0.0010811232],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015549026,0.0010529541,0.003764723,0.0007639128,0.00022298326,0.00007204782,0.00022716199,0.00025410697,0.003173001],"category_scores_gemma":[0.000013346953,0.0006780957,0.0006042205,0.0006001817,0.00040365203,0.0001900833,0.00012748106,0.00039045565,0.000048834867],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0020039254,0.0042426726,0.002493601,0.0030213525,0.005751782,0.00015605491,0.00028093669,0.0000073933975,0.000006541751,0.00007639031,0.00033023482,0.98162913],"study_design_scores_gemma":[0.037826847,0.011458678,0.015748614,0.0058627343,0.03865169,0.0016767061,0.000206246,0.00020501022,0.00002778067,0.00032165743,0.8867623,0.0012517311],"about_ca_topic_score_codex":0.03184845,"about_ca_topic_score_gemma":0.0066665183,"teacher_disagreement_score":0.9803774,"about_ca_system_score_codex":0.011147164,"about_ca_system_score_gemma":0.0068868957,"threshold_uncertainty_score":0.99956703},"labels":[],"label_agreement":null},{"id":"W2122242131","doi":"10.1136/ebn.12.3.93","title":"Patients with cancer believed that chemotherapy had to “hurt” or “cause side effects” to be effectiveCommentary","year":2009,"lang":"en","type":"letter","venue":"Evidence-Based Nursing","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Fraser Health","funders":"","keywords":"Chemotherapy; Medicine; Cancer; Cancer chemotherapy; Oncology; Internal medicine; Intensive care medicine","score_opus":0.04997426438819863,"score_gpt":0.36416602287555433,"score_spread":0.3141917584873557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122242131","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1327249,0.0013184486,0.0002239847,0.8574922,0.001634374,0.006184745,0.00008163519,0.00018363277,0.00015606318],"genre_scores_gemma":[0.023321249,0.00014047732,0.0013157184,0.96869224,0.0032350898,0.00097655953,0.00041493663,0.0001987687,0.001704973],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962255,0.00037433146,0.00037083725,0.0011403079,0.00089545496,0.0009935695],"domain_scores_gemma":[0.99715126,0.0013068632,0.00023388866,0.0006691612,0.00019767268,0.0004411441],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001898057,0.0009174984,0.0012504146,0.0005243804,0.00020588437,0.0000722381,0.00029259396,0.0004859251,0.0006163429],"category_scores_gemma":[0.00006464966,0.0006750537,0.00024463807,0.0005816309,0.0001134326,0.0002131464,0.00002388091,0.0011745052,0.000051535848],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01311553,0.0006944753,0.019890273,0.0005171716,0.000564283,0.0007210023,0.00063627836,0.000038977676,0.00058974203,8.822063e-8,0.8341216,0.12911057],"study_design_scores_gemma":[0.02611717,0.034792837,0.19030584,0.0547968,0.0053848443,0.000031699492,0.000028775114,0.0000181409,0.047264352,0.0000129969285,0.63911116,0.0021353886],"about_ca_topic_score_codex":0.0006628627,"about_ca_topic_score_gemma":0.00014132708,"teacher_disagreement_score":0.19501047,"about_ca_system_score_codex":0.0032465067,"about_ca_system_score_gemma":0.00059936673,"threshold_uncertainty_score":0.9995701},"labels":[],"label_agreement":null},{"id":"W2122381332","doi":"10.1139/v00-010","title":"Efficient method for the preparation of pinacols derived from aromatic and aliphatic ketones by using low-valent titanium reagents in dichloromethane-pivalonitrile","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemistry; Pinacol; Dichloromethane; Zinc; Titanium; Reagent; Chloride; Steric effects; Titanium tetrachloride; Ketone; Coupling reaction; Organic chemistry; Medicinal chemistry; Polymer chemistry; Catalysis; Solvent","score_opus":0.02096639534478933,"score_gpt":0.33322969513729217,"score_spread":0.31226329979250284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122381332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956377,0.0034150283,0.00015231167,0.00027772845,0.00007016362,0.00028708094,0.000052276126,0.0000012815581,0.00010643105],"genre_scores_gemma":[0.998539,0.000074387666,0.0010192628,0.00007728392,0.00009057309,0.0000102794575,0.000013229458,0.000009207716,0.00016681022],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993211,0.000032510605,0.00031819902,0.0000901792,0.00009793561,0.0001400687],"domain_scores_gemma":[0.9992999,0.00020558701,0.00016996654,0.0000872164,0.000045869754,0.00019146128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021218022,0.000087919194,0.00026595005,0.0000407544,0.00004105185,0.000009240173,0.000062413616,0.000057025078,0.00040754728],"category_scores_gemma":[0.00004647508,0.000068284724,0.00006406669,0.00008335125,0.00005403881,0.000020267433,0.0000028297222,0.00008319907,3.5509657e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006456516,0.00013194936,0.004536152,0.00028828793,0.00029852721,0.000056672598,0.001435476,0.001206713,0.9859722,1.7160198e-7,0.0012814192,0.004146773],"study_design_scores_gemma":[0.0065333857,0.0002773679,0.012842562,0.00074573205,0.0009899269,0.00025702777,0.00047709467,0.010914858,0.9656858,0.00008264104,0.0010289637,0.00016465921],"about_ca_topic_score_codex":0.0021163141,"about_ca_topic_score_gemma":0.00042347348,"teacher_disagreement_score":0.020286426,"about_ca_system_score_codex":0.00021043178,"about_ca_system_score_gemma":0.00045577172,"threshold_uncertainty_score":0.4462357},"labels":[],"label_agreement":null},{"id":"W2122766544","doi":"10.1136/aim.24.2.87","title":"Acupuncture Treatment for Chemotherapy-Induced Peripheral Neuropathy – a Case Series","year":2006,"lang":"en","type":"article","venue":"Acupuncture in Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Acupuncture; Chemotherapy-induced peripheral neuropathy; Chemotherapy; Peripheral neuropathy; Traditional Chinese medicine; Anesthesia; Surgery; Diabetes mellitus; Alternative medicine; Pathology","score_opus":0.027450175787195007,"score_gpt":0.3400102092653752,"score_spread":0.3125600334781802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122766544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96301216,0.002193578,0.00007940964,0.029131215,0.001025825,0.0024488403,0.00002744587,0.00012949861,0.0019520088],"genre_scores_gemma":[0.984186,0.00023368721,0.0005161858,0.005461028,0.0031071673,0.00047868633,0.00024996584,0.00006428392,0.0057030083],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982456,0.000057911642,0.00044062335,0.00053204247,0.00021740622,0.00050641206],"domain_scores_gemma":[0.9990768,0.00019538753,0.000108579436,0.00035865602,0.00010196097,0.00015866109],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001384623,0.0007215046,0.0011975084,0.00019404641,0.000110424015,0.000011493732,0.00007978064,0.00022862638,0.0006962634],"category_scores_gemma":[0.000047175614,0.000303382,0.00025374457,0.00031922603,0.00013898867,0.00008425588,0.000014519966,0.00022539255,0.000005301672],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027604712,0.0046234303,0.08139157,0.0009721669,0.0014242464,0.07112731,0.012114562,0.0001687576,0.4075888,0.0008818726,0.21042407,0.1816785],"study_design_scores_gemma":[0.057296857,0.018699238,0.014635583,0.00027208595,0.0020877863,0.041216787,0.0011424673,0.00029974323,0.021954639,0.0010686985,0.8405399,0.0007862556],"about_ca_topic_score_codex":0.0011911761,"about_ca_topic_score_gemma":0.0026211117,"teacher_disagreement_score":0.6301158,"about_ca_system_score_codex":0.0004469629,"about_ca_system_score_gemma":0.00012795799,"threshold_uncertainty_score":0.9999418},"labels":[],"label_agreement":null},{"id":"W2123732467","doi":"10.1002/1097-0142(20011001)92:7<1759::aid-cncr1691>3.0.co;2-a","title":"Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients","year":2001,"lang":"en","type":"article","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":402,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Taxane; Capecitabine; Internal medicine; Adverse effect; Metastatic breast cancer; Docetaxel; Stomatitis; Nausea; Gastroenterology; Chemotherapy; Breast cancer; Oncology; Diarrhea; Anthracycline; Surgery; Cancer","score_opus":0.032040962012839014,"score_gpt":0.3626609404434201,"score_spread":0.3306199784305811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123732467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973595,0.0006757611,8.3777365e-7,0.00014118993,0.0002592043,0.0010632391,0.00010530933,0.000016886148,0.00037803876],"genre_scores_gemma":[0.99849594,0.00010241432,0.000015876743,0.00012876195,0.000064235464,0.00019502484,0.00006394785,0.000019000381,0.000914795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901265,0.000050257513,0.0003052722,0.00023672258,0.00016485504,0.00023022095],"domain_scores_gemma":[0.99946225,0.000024927827,0.00010889372,0.00017714806,0.00012255338,0.00010423473],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000042816206,0.00015659188,0.00039331522,0.00015807246,0.00003330592,0.0000024187502,0.00005979187,0.000028446855,0.0017861233],"category_scores_gemma":[0.000009956806,0.00012984007,0.00004935737,0.00034173255,0.000037241127,0.000055081164,0.00003214772,0.000099707686,0.000005879831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044031697,0.017357137,0.9381222,0.000047427893,0.00022407265,0.00020216934,0.001959204,0.0000125407505,0.0022691395,4.842937e-7,0.0007595857,0.034642834],"study_design_scores_gemma":[0.11231701,0.009994608,0.87245494,0.00008629493,0.00082972756,0.000021716498,0.00075548666,0.00042605723,0.0015856525,0.0000015459374,0.0013544614,0.00017248024],"about_ca_topic_score_codex":0.004090102,"about_ca_topic_score_gemma":0.0018546403,"teacher_disagreement_score":0.107913844,"about_ca_system_score_codex":0.00025428107,"about_ca_system_score_gemma":0.000069637856,"threshold_uncertainty_score":0.9991264},"labels":[],"label_agreement":null},{"id":"W2124456054","doi":"10.3747/co.21.2069","title":"The Trastuzumab and Vinorelbine Combination: An Alternative to Taxane-Based Chemotherapy for Early-Stage and Locally Advanced HER2-Positive Breast Cancer","year":2014,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Vinorelbine; Trastuzumab; Internal medicine; Breast cancer; Oncology; Taxane; Febrile neutropenia; Neutropenia; Docetaxel; Cancer; Chemotherapy; Surgery","score_opus":0.040543246141059384,"score_gpt":0.41651425536986647,"score_spread":0.3759710092288071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124456054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97845656,0.00087785866,0.0029624123,0.015104851,0.00071358663,0.0015400276,0.00013726928,0.000029854173,0.00017758265],"genre_scores_gemma":[0.9963488,0.0006234964,0.0002460027,0.0015143531,0.00031739593,0.0006134592,0.00005435386,0.000022515222,0.0002596189],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99905664,0.00009863549,0.00017193635,0.00032367578,0.000095861426,0.00025327364],"domain_scores_gemma":[0.9990499,0.00033220046,0.00010456927,0.000116226074,0.0001988159,0.00019827425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016551891,0.00017279551,0.0003095851,0.000056191362,0.00016691773,0.000017850636,0.00006970263,0.00006475672,0.000054452976],"category_scores_gemma":[0.000017324666,0.00012511906,0.000038159716,0.00007882416,0.00020048917,0.000052460564,0.000020463984,0.00013296008,0.0000015973251],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006484579,0.0012179167,0.019614678,0.0000674463,0.00014020484,0.000004616454,0.0012931558,0.000030056692,0.0014529295,0.00082632655,0.0008857933,0.9679823],"study_design_scores_gemma":[0.06278987,0.03501356,0.4858483,0.00021924776,0.00048547063,0.000072240684,0.0003844743,0.014302953,0.007028281,0.00057269866,0.39272463,0.0005582713],"about_ca_topic_score_codex":0.000117034506,"about_ca_topic_score_gemma":0.00034259222,"teacher_disagreement_score":0.96742404,"about_ca_system_score_codex":0.00027168807,"about_ca_system_score_gemma":0.0001651236,"threshold_uncertainty_score":0.5102207},"labels":[],"label_agreement":null},{"id":"W2124648016","doi":"10.1093/carcin/bgn070","title":"Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling","year":2008,"lang":"en","type":"article","venue":"Carcinogenesis","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université du Québec à Montréal","funders":"Cancer Research Society","keywords":"Platelet-derived growth factor receptor; Delphinidin; Receptor; Growth factor; Anthocyanidin; Platelet-derived growth factor; Chemistry; Signal transduction; Cell biology; Growth factor receptor; Cancer research; Biochemistry; Internal medicine; Endocrinology; Biology; Medicine; Food science","score_opus":0.06176886651418375,"score_gpt":0.2881247859143794,"score_spread":0.22635591940019564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124648016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99177915,0.005151843,0.000030434245,0.000936168,0.0006289601,0.00064828474,0.000114815746,0.00024054601,0.00046981033],"genre_scores_gemma":[0.99383485,0.0023819362,0.00044771054,0.0014731538,0.00089314085,0.000094460185,0.00016551132,0.00009106414,0.00061814324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978313,0.00008176112,0.00046956533,0.0006222052,0.0003590153,0.0006361709],"domain_scores_gemma":[0.9986643,0.00016554722,0.00014285599,0.0003071732,0.00025338793,0.00046672547],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008865758,0.00045121188,0.0007458165,0.00024317046,0.0003363365,0.000015107722,0.0001533227,0.00024036398,0.001113095],"category_scores_gemma":[0.00006027748,0.00040173906,0.00035109703,0.00041683292,0.00017721232,0.0001416946,0.00008223453,0.00023567192,0.00025494175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086863094,0.00031893543,0.09238436,0.000110477944,0.00036272706,0.00053013937,0.0016065245,0.0000040500117,0.89591885,0.0000058340975,0.0065294593,0.0013600204],"study_design_scores_gemma":[0.0037830235,0.00071896426,0.06043927,0.000059880418,0.00027887902,0.00037621407,0.00011679491,0.00002792887,0.9310924,0.000011999079,0.0026965442,0.0003981194],"about_ca_topic_score_codex":0.00022331314,"about_ca_topic_score_gemma":0.000015711448,"teacher_disagreement_score":0.03517354,"about_ca_system_score_codex":0.00024337137,"about_ca_system_score_gemma":0.00030095785,"threshold_uncertainty_score":0.9998434},"labels":[],"label_agreement":null},{"id":"W2126275851","doi":"10.1056/nejmoa072113","title":"Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3053,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Sanofi; Genentech; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Medicine; Paclitaxel; Bevacizumab; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Chemotherapy; Cancer","score_opus":0.05956126811358634,"score_gpt":0.39946593754352866,"score_spread":0.3399046694299423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126275851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85080975,0.029352948,0.0069780694,0.09839192,0.009702846,0.0013100773,0.00014298638,0.000053351832,0.003258066],"genre_scores_gemma":[0.979757,0.0016459881,0.0017751639,0.0014467061,0.0130112665,0.000009847021,0.0000281694,0.000039090726,0.0022867408],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981001,0.000049812872,0.00074530137,0.00018032387,0.0004965463,0.0004279382],"domain_scores_gemma":[0.997464,0.00090462633,0.00042837707,0.00015577383,0.00040711593,0.0006400913],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012945852,0.0002405336,0.0009101901,0.0002931586,0.000069749505,0.000006275545,0.00011394944,0.00007184355,0.0011411767],"category_scores_gemma":[0.00023055176,0.00015415739,0.00018834489,0.0002302282,0.0001338724,0.00009917841,0.0000142304025,0.00034508543,0.0000051110533],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14918749,0.0006791977,0.0056468076,0.00037067308,0.0035093292,0.0018497077,0.0038804417,0.00004852611,0.011358184,0.00037301984,0.16337359,0.65972304],"study_design_scores_gemma":[0.66256404,0.014561476,0.018168712,0.00072985253,0.0061631035,0.00638003,0.0010198277,0.00008174767,0.001397782,0.00079700875,0.28783286,0.00030353997],"about_ca_topic_score_codex":0.00046570803,"about_ca_topic_score_gemma":0.0004714491,"teacher_disagreement_score":0.6594195,"about_ca_system_score_codex":0.000423964,"about_ca_system_score_gemma":0.0005951647,"threshold_uncertainty_score":0.9997719},"labels":[],"label_agreement":null},{"id":"W2126386849","doi":"10.1007/s10549-007-9584-x","title":"A Phase 2 study of perifosine in advanced or metastatic breast cancer","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Chemotherapy; Breast cancer; Nausea; Neutropenia; Regimen; Anthracycline; Gastroenterology; Progressive disease; Oncology; Toxicity; Performance status; Surgery; Cancer","score_opus":0.11632199615301068,"score_gpt":0.5141281501004372,"score_spread":0.3978061539474265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126386849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923108,0.0031566683,0.0000017309609,0.0014795369,0.00007753056,0.0022542311,0.00047479826,0.000019802585,0.00022488883],"genre_scores_gemma":[0.9939991,0.003042598,0.000045527908,0.000045433564,0.00014011461,0.0011589439,0.000021016196,0.000029616758,0.0015176506],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979238,0.000099659104,0.00037855704,0.0004714371,0.00046374902,0.0006628161],"domain_scores_gemma":[0.9989074,0.00016313593,0.00007465177,0.00024514995,0.00025181504,0.0003578786],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034770934,0.00025226473,0.0005985069,0.00045505032,0.000103134866,0.000013919349,0.000070686765,0.00004283587,0.0014107877],"category_scores_gemma":[0.0000061596984,0.00016328176,0.000055954748,0.00076699397,0.00018074489,0.00009132615,0.000047508038,0.0001850494,0.0000042723527],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08869792,0.053507354,0.24499385,0.0001863167,0.0013598029,0.0021286253,0.0032944295,0.000010388841,0.005921259,0.000027611099,0.00020729605,0.59966516],"study_design_scores_gemma":[0.14244202,0.0340783,0.8095869,0.0003826069,0.00063649355,0.00086579856,0.005136412,0.00007541336,0.0047867703,0.000027213036,0.0016873016,0.00029481135],"about_ca_topic_score_codex":0.023102198,"about_ca_topic_score_gemma":0.030269315,"teacher_disagreement_score":0.59937036,"about_ca_system_score_codex":0.0010396405,"about_ca_system_score_gemma":0.00060959713,"threshold_uncertainty_score":0.99950206},"labels":[],"label_agreement":null},{"id":"W2126891371","doi":"10.1211/jpp.59.12.0005","title":"Potentiating effect of β-caryophyllene on anticancer activity of α-humulene, isocaryophyllene and paclitaxel","year":2007,"lang":"en","type":"article","venue":"Journal of Pharmacy and Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":443,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Paclitaxel; Chemistry; Humulene; Pharmacology; Caryophyllene; Intracellular; Biochemistry; Biology; Chemotherapy; Essential oil; Food science","score_opus":0.017265793381257683,"score_gpt":0.37784785857003655,"score_spread":0.3605820651887789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126891371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99111414,0.006203516,0.000053697884,0.00065335317,0.000995042,0.00033663676,0.000023151433,0.000007162611,0.0006133201],"genre_scores_gemma":[0.993871,0.0047433847,0.00018794397,0.00045951735,0.0006557645,0.0000035648477,0.0000017692702,0.000020361831,0.00005670724],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833333,0.00023103772,0.0006590845,0.00020205419,0.00026889314,0.0003055669],"domain_scores_gemma":[0.9977096,0.0009919186,0.00076580315,0.00008047461,0.00019500246,0.0002572455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011750155,0.00024102142,0.0009261334,0.00035086364,0.000067781075,0.0000035394564,0.00008370198,0.00008721172,0.0003246659],"category_scores_gemma":[0.000039632567,0.0001853461,0.00020458743,0.00019763137,0.00027149986,0.00012443496,0.000051910563,0.00046712652,7.927352e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022166576,0.0006828367,0.057154965,0.0007552286,0.00095426117,0.00023655636,0.00031821523,0.000012371719,0.8650045,0.000017269826,0.00084153825,0.0518557],"study_design_scores_gemma":[0.02095083,0.0071032583,0.04853605,0.00010417959,0.0018823103,0.00039910022,0.00002844041,0.0001819159,0.91856635,0.000029595973,0.0020876566,0.00013034047],"about_ca_topic_score_codex":0.00004783624,"about_ca_topic_score_gemma":0.0000021522362,"teacher_disagreement_score":0.053561836,"about_ca_system_score_codex":0.00005989583,"about_ca_system_score_gemma":0.0001091377,"threshold_uncertainty_score":0.7558195},"labels":[],"label_agreement":null},{"id":"W2127276650","doi":"10.1158/0008-5472.sabcs13-p3-13-04","title":"Abstract P3-13-04: Effect of age on tolerability and efficacy of eribulin and capecitabine in patients with metastatic breast cancer treated in study 301","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Capecitabine; Eribulin; Internal medicine; Tolerability; Metastatic breast cancer; Adverse effect; Breast cancer; Gastroenterology; Post-hoc analysis; Cancer; Progression-free survival; Incidence (geometry); Toxicity; Oncology; Overall survival","score_opus":0.04003991238900451,"score_gpt":0.41036733114484597,"score_spread":0.37032741875584146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127276650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99595624,0.0005331167,2.5709376e-8,0.00022248806,0.000021027183,0.0031021615,0.000080770034,0.000004930942,0.00007926259],"genre_scores_gemma":[0.9991111,0.00014625386,0.0000035378994,0.000011836476,0.000017816821,0.00062493276,0.000014526024,0.000016225667,0.000053749485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840313,0.0002751037,0.0003111572,0.0003393882,0.00036802,0.00030322286],"domain_scores_gemma":[0.9989381,0.00050451135,0.00006612882,0.00019432584,0.00017406495,0.00012285981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050426036,0.0001585723,0.000627126,0.00028010286,0.000023934508,0.000008161961,0.000058845937,0.000040562503,0.0007031112],"category_scores_gemma":[0.000044931403,0.00010442188,0.000021882683,0.0004607321,0.00024988427,0.000061680366,0.00003875569,0.00030580943,0.000001656915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010975882,0.0025163821,0.9593055,0.00042731196,0.00015372178,0.000034036086,0.0007831901,0.0000292878,0.0028862734,3.648431e-7,0.00007226436,0.022815784],"study_design_scores_gemma":[0.026092373,0.0057812147,0.96518946,0.00028674694,0.00007287313,8.180016e-7,0.00008179087,0.000019596533,0.0023937651,0.0000030445615,0.0000056563363,0.00007266446],"about_ca_topic_score_codex":0.039728846,"about_ca_topic_score_gemma":0.007014069,"teacher_disagreement_score":0.03271478,"about_ca_system_score_codex":0.00029486738,"about_ca_system_score_gemma":0.00011187101,"threshold_uncertainty_score":0.9666657},"labels":[],"label_agreement":null},{"id":"W2127426350","doi":"10.2217/14622416.8.7.803","title":"Pharmacology, Pharmacokinetics and Pharmacogenomics of Paclitaxel","year":2007,"lang":"en","type":"article","venue":"Pharmacogenomics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; American Society of Clinical Oncology","keywords":"Pharmacogenomics; Paclitaxel; Pharmacokinetics; Pharmacology; Medicine; Pharmacodynamics; Drug; Pharmacogenetics; CYP3A4; Cytochrome P450; Internal medicine; Cancer; Biology; Metabolism","score_opus":0.023326303853351642,"score_gpt":0.35500966572802917,"score_spread":0.3316833618746775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127426350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826658,0.0067630936,0.00044591175,0.0007956349,0.0014201144,0.0010606543,0.00014110898,0.000116290634,0.0065914006],"genre_scores_gemma":[0.9845737,0.0075329575,0.002678601,0.0033010093,0.0010597712,0.00002809784,0.00006126788,0.00008944769,0.00067515316],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975765,0.000059819835,0.0008278416,0.0005358609,0.00025417717,0.0007458257],"domain_scores_gemma":[0.9983604,0.00028080805,0.00031511905,0.00021426502,0.00021155342,0.00061784167],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007660649,0.00043081937,0.0006979289,0.00037975478,0.000118659256,0.000012633756,0.00019271077,0.00015062737,0.0010559919],"category_scores_gemma":[0.000014325156,0.00043730353,0.00022329611,0.00036760524,0.00042811374,0.00011470848,0.00016586621,0.00044134006,0.000039833787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031871772,0.0008825958,0.014654437,0.00024987813,0.00096021226,0.00021026857,0.00046245882,0.000022126706,0.9419748,0.00014587838,0.007037605,0.030212544],"study_design_scores_gemma":[0.013376726,0.000544321,0.0043289037,0.000019642515,0.0024332122,0.0005082929,0.00011757655,0.00075759646,0.83268553,0.00009921242,0.14470774,0.0004212281],"about_ca_topic_score_codex":0.000036378082,"about_ca_topic_score_gemma":0.000003999961,"teacher_disagreement_score":0.13767014,"about_ca_system_score_codex":0.0002168059,"about_ca_system_score_gemma":0.00019005644,"threshold_uncertainty_score":0.9998572},"labels":[],"label_agreement":null},{"id":"W2128623632","doi":"10.1007/s00277-011-1348-3","title":"Vincristine-induced vocal cord paralysis in a patient with acute lymphoblastic leukemia","year":2011,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Stornoway Diamond (Canada); BC Cancer Agency","funders":"","keywords":"Vincristine; Medicine; Lymphoblastic Leukemia; Hematology; Internal medicine; Paralysis; Leukemia; Oncology; Cord; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.05568088296862699,"score_gpt":0.33949123928127667,"score_spread":0.28381035631264967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128623632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8426442,0.00092872203,0.000015473848,0.15161857,0.0003387997,0.00074099866,0.00006395631,0.000050041817,0.0035992248],"genre_scores_gemma":[0.73449355,0.00028747146,0.00017546106,0.26362038,0.0003010781,0.0002223975,0.00041414736,0.000070046946,0.00041544947],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977749,0.00013438902,0.00068536977,0.0005432629,0.00024494517,0.0006171278],"domain_scores_gemma":[0.99860305,0.00022733552,0.00046854437,0.00044369503,0.00015422817,0.0001031534],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000056878445,0.000447088,0.0017589629,0.0004896638,0.000025766556,0.0000034871307,0.00016417194,0.00079854665,0.00051424233],"category_scores_gemma":[0.000027882264,0.00034136075,0.00023819174,0.00028040513,0.00019861094,0.000032098513,0.0000650702,0.00080157863,0.000056951132],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005835585,0.0004715765,0.004090519,0.00064398017,0.0028434799,0.054917734,0.00040394365,0.0000011326147,0.00052329025,0.00007092159,0.92838985,0.0018079628],"study_design_scores_gemma":[0.033027887,0.062648594,0.008017805,0.0039737597,0.016760152,0.0714202,0.00021179469,0.0002589542,0.18599051,0.0016017791,0.612272,0.0038165369],"about_ca_topic_score_codex":0.0011226264,"about_ca_topic_score_gemma":0.00017444306,"teacher_disagreement_score":0.31611785,"about_ca_system_score_codex":0.000100920224,"about_ca_system_score_gemma":0.00067710737,"threshold_uncertainty_score":0.99990386},"labels":[],"label_agreement":null},{"id":"W2128941584","doi":"10.1200/jco.2005.02.027","title":"Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":547,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Docetaxel; Medicine; Paclitaxel; Metastatic breast cancer; Internal medicine; Regimen; Chemotherapy; Oncology; Taxane; Hazard ratio; Breast cancer; Population; Cancer; Confidence interval","score_opus":0.17264541902181682,"score_gpt":0.5539230823189485,"score_spread":0.38127766329713164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128941584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886082,0.0009994874,0.000029872215,0.008198516,0.00041278903,0.0009389241,0.00001126278,0.0000048819575,0.0007961062],"genre_scores_gemma":[0.996273,0.00071550114,0.0009762416,0.0010963628,0.00065243663,0.000040262516,0.0000019265035,0.00001361215,0.00023065983],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99494827,0.0011316627,0.0031815849,0.00017702603,0.00033994167,0.00022149089],"domain_scores_gemma":[0.99397993,0.0028934446,0.0022996897,0.0001396288,0.00040706474,0.00028023153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035883945,0.00016930138,0.004075596,0.00022429039,0.00001866977,0.0000032633475,0.00012382683,0.00010845973,0.0008830586],"category_scores_gemma":[0.00031476066,0.00009794416,0.00039384287,0.00022460918,0.00030771925,0.00010456447,0.000023504004,0.000700034,0.0000035260307],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85301995,0.05439378,0.03909006,0.000030459225,0.0034238147,0.0008386304,0.0012038194,0.00028805083,0.0000964395,0.000014950009,0.0017614071,0.04583862],"study_design_scores_gemma":[0.93303305,0.023768783,0.03432594,0.00009943697,0.0039626197,0.00048584427,0.0007663087,0.0004372266,0.0000295818,0.000034021767,0.002967361,0.00008984094],"about_ca_topic_score_codex":0.00039917947,"about_ca_topic_score_gemma":0.0018376373,"teacher_disagreement_score":0.08001307,"about_ca_system_score_codex":0.00020679152,"about_ca_system_score_gemma":0.0014746763,"threshold_uncertainty_score":0.9668872},"labels":[],"label_agreement":null},{"id":"W2130207808","doi":"10.1634/theoncologist.11-90001-42","title":"The Role of Capecitabine in First-Line Treatment for Patients with Metastatic Breast Cancer","year":2006,"lang":"en","type":"review","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Capecitabine; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Cancer; Colorectal cancer","score_opus":0.050020701675656275,"score_gpt":0.3936264737207917,"score_spread":0.3436057720451354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130207808","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005005748,0.99229676,0.0000014073639,0.00073163083,0.00016385941,0.0045101503,0.0010771728,0.000013253149,0.00070518366],"genre_scores_gemma":[0.0014274963,0.99234116,0.000050625902,0.0000348932,0.00022131842,0.0035230427,0.00042575784,0.000040832754,0.001934847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869454,0.000105987005,0.0005070546,0.0002445433,0.00014564452,0.00030223976],"domain_scores_gemma":[0.99818754,0.0009014758,0.00045308316,0.00031406968,0.00009906699,0.000044776058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015715256,0.0003460828,0.0014506937,0.00006594903,0.000117043346,0.00000791068,0.0001698885,0.00008681992,0.00007823724],"category_scores_gemma":[0.000012647168,0.00012935298,0.00028250183,0.00023473313,0.00026115176,0.000015108432,0.000027584529,0.0001398019,0.00000443374],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010689562,0.0019013894,0.0017711344,0.0013632129,0.0008757654,0.000008381553,0.00004496674,0.000015157766,1.10771204e-7,0.00004055935,0.0009852668,0.9919251],"study_design_scores_gemma":[0.0058554723,0.0027249206,0.0012220588,0.001167398,0.005713233,0.000016971124,0.00001660378,0.000011157899,0.0000014526307,0.000043591717,0.98310095,0.00012621889],"about_ca_topic_score_codex":0.0028020479,"about_ca_topic_score_gemma":0.01260405,"teacher_disagreement_score":0.9917989,"about_ca_system_score_codex":0.001169311,"about_ca_system_score_gemma":0.0005835936,"threshold_uncertainty_score":0.7033356},"labels":[],"label_agreement":null},{"id":"W2131280296","doi":"10.1177/1078155208096902","title":"Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration","year":2008,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Saline; Intrathecal; ThioTEPA; Anesthesia; Sterile water; Methotrexate; Ringer's solution; Surgery; Chemotherapy; Cyclophosphamide; Chemistry","score_opus":0.15626656441589343,"score_gpt":0.5113434548060312,"score_spread":0.35507689039013773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131280296","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13845496,0.85268474,0.0013371627,0.00085310533,0.0007315085,0.0054140375,0.0002495212,0.000008128881,0.00026683742],"genre_scores_gemma":[0.09985959,0.8940216,0.0055360976,0.00004899445,0.00023609222,0.00013495289,0.00012706486,0.000020245796,0.00001540749],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968074,0.0010845957,0.0014868489,0.00020556692,0.00025549144,0.00016009848],"domain_scores_gemma":[0.9942559,0.0017087286,0.0023377258,0.00007918327,0.001530765,0.00008771396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033658163,0.00020722866,0.0013745344,0.00026343935,0.00005406743,0.0000068395607,0.0000469126,0.00020888782,0.000022103677],"category_scores_gemma":[0.0008347223,0.0001594341,0.00014564011,0.00013186499,0.00017909084,0.00042335695,0.000022541175,0.0003178739,4.849859e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025795836,0.0033932065,0.00066486694,0.0099101905,0.003750693,0.00003609056,0.0032161807,0.00005895779,0.013458457,0.000028977354,0.0007888704,0.93889767],"study_design_scores_gemma":[0.06689188,0.026926875,0.001402146,0.0029304856,0.0695906,0.015851513,0.00039007422,0.00874907,0.015797704,0.00023941975,0.7906644,0.0005658375],"about_ca_topic_score_codex":0.00009008417,"about_ca_topic_score_gemma":0.000071217415,"teacher_disagreement_score":0.93833184,"about_ca_system_score_codex":0.000292761,"about_ca_system_score_gemma":0.002078259,"threshold_uncertainty_score":0.6501534},"labels":[],"label_agreement":null},{"id":"W2131765662","doi":"10.1093/annonc/mdg171","title":"A phase II study of ZD0473 given as a short infusion every 3 weeks to patients with advanced or metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group trial, IND 129","year":2003,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; Jewish General Hospital; BC Cancer Agency","funders":"AstraZeneca Canada","keywords":"Medicine; Neutropenia; Internal medicine; Docetaxel; Metastatic breast cancer; Breast cancer; Carboplatin; Cancer; Clinical trial; Oncology; Phases of clinical research; Chemotherapy; Toxicity; Cisplatin; Surgery","score_opus":0.22710454263369964,"score_gpt":0.540438615129528,"score_spread":0.31333407249582834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131765662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924194,0.00028199021,0.000004150461,0.0016071108,0.0009615864,0.0036399022,0.00064521184,0.000006057413,0.00043458902],"genre_scores_gemma":[0.99682105,0.00051796675,0.00017334684,0.0014785768,0.00012977395,0.00061785406,0.000050375136,0.000017852006,0.00019321803],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964336,0.0007247446,0.0015819551,0.00036260736,0.00060752867,0.00028953524],"domain_scores_gemma":[0.9968696,0.00075071823,0.00086265843,0.00018724705,0.0010733389,0.00025639308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015520261,0.00022854094,0.0018563144,0.00022583257,0.000065663866,0.0000018366544,0.00012254446,0.00010539899,0.0008128109],"category_scores_gemma":[0.00085624267,0.00015966345,0.00013873381,0.0004670928,0.00014404077,0.000106385545,0.00005396536,0.00018292986,4.4838103e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6184315,0.07635276,0.0452064,0.00018221074,0.0054960568,0.00013540761,0.0014312386,0.00030562654,0.0013253397,0.000048558893,0.02609609,0.22498882],"study_design_scores_gemma":[0.48263183,0.3681481,0.049324416,0.00035611793,0.0029179675,0.000028735829,0.0006092645,0.0000149614125,0.0017139826,0.000054977147,0.09381939,0.00038028075],"about_ca_topic_score_codex":0.093414076,"about_ca_topic_score_gemma":0.39616337,"teacher_disagreement_score":0.3027493,"about_ca_system_score_codex":0.00029701844,"about_ca_system_score_gemma":0.008774528,"threshold_uncertainty_score":0.9968448},"labels":[],"label_agreement":null},{"id":"W2131784126","doi":"10.1038/bjc.2015.343","title":"A phase I combination dose-escalation study of eribulin mesylate and gemcitabine in patients with advanced solid tumours: a study of the Princess Margaret Consortium","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Gemcitabine; Medicine; Eribulin; Neutropenia; Internal medicine; Cohort; Oncology; Chemotherapy; Metastatic breast cancer; Cancer; Gastroenterology; Breast cancer","score_opus":0.017153020109714832,"score_gpt":0.34147396194387003,"score_spread":0.3243209418341552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131784126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975557,0.0009660086,0.0000024179094,0.000106191124,0.00017077899,0.0011498965,0.000015011899,0.0000025502393,0.00003144876],"genre_scores_gemma":[0.9997564,0.00010910389,0.000015567357,0.000024981848,0.00003192199,0.000026733045,0.000003226386,0.000010358195,0.00002171737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877465,0.000120983386,0.00049017795,0.0001089916,0.0004022816,0.000102914084],"domain_scores_gemma":[0.99865997,0.000025623624,0.00061023806,0.00007333507,0.0005565893,0.00007427306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023575584,0.00008901807,0.00040530672,0.00008937682,0.000023756418,0.000008408262,0.00006475142,0.000025344876,0.00002148829],"category_scores_gemma":[0.00003833564,0.00006789995,0.000024809406,0.00021313103,0.000057365785,0.00013949299,0.00002528479,0.00015545335,4.304719e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065806583,0.014017359,0.957963,0.000031076066,0.00021156733,0.000055216096,0.0022240202,0.00023719661,0.00013159754,7.7146814e-7,0.0000586259,0.018488903],"study_design_scores_gemma":[0.095214315,0.015240834,0.8871813,0.00033353802,0.00035374114,0.000033335524,0.0011938812,0.000043134183,0.00030493786,0.000010679853,0.000034267567,0.000056042514],"about_ca_topic_score_codex":0.0005902519,"about_ca_topic_score_gemma":0.0029099525,"teacher_disagreement_score":0.08863366,"about_ca_system_score_codex":0.00012356807,"about_ca_system_score_gemma":0.00018732723,"threshold_uncertainty_score":0.27688795},"labels":[],"label_agreement":null},{"id":"W2132229544","doi":"10.1093/annonc/mdr043","title":"First-line bevacizumab-containing therapy for breast cancer: results in patients aged ≥70 years treated in the ATHENA study","year":2011,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"","keywords":"Medicine; Bevacizumab; Tolerability; Proteinuria; Internal medicine; Metastatic breast cancer; Breast cancer; Chemotherapy; Population; Oncology; Cancer; Adverse effect; Surgery","score_opus":0.1655933199108834,"score_gpt":0.42565664014882443,"score_spread":0.260063320237941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132229544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944444,0.00025977372,3.418929e-7,0.0022769212,0.00012182379,0.0018326684,0.00013266497,0.000011096581,0.0009203443],"genre_scores_gemma":[0.99749243,0.00069938385,0.00001689151,0.0011918026,0.00007956453,0.00039259664,0.00003966358,0.000015008641,0.00007264684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987481,0.00018970417,0.00043548612,0.00023765156,0.00010612938,0.0002828912],"domain_scores_gemma":[0.99920434,0.00027053384,0.00018029337,0.00018681565,0.00011456079,0.00004347469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005593164,0.00013560064,0.0004642473,0.00017242512,0.0000317523,0.0000021051567,0.0001368437,0.000102551494,0.00010853934],"category_scores_gemma":[0.00003487956,0.00009503038,0.00008011483,0.0002345588,0.00006084406,0.000040662053,0.000019227955,0.0001505761,0.0000022808708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053337947,0.010919724,0.7585243,0.00001435125,0.00025506932,0.00009847015,0.028894603,0.000008303725,0.000038277758,0.0000120904815,0.0014188716,0.14647797],"study_design_scores_gemma":[0.037251838,0.027398521,0.93211734,0.000031858464,0.000062916406,0.000004320897,0.00064535165,0.0000128870815,0.00017836873,0.00009316381,0.0021272965,0.000076118],"about_ca_topic_score_codex":0.0048562502,"about_ca_topic_score_gemma":0.009962357,"teacher_disagreement_score":0.17359303,"about_ca_system_score_codex":0.000091626636,"about_ca_system_score_gemma":0.000111565445,"threshold_uncertainty_score":0.734123},"labels":[],"label_agreement":null},{"id":"W2133193675","doi":"10.1634/theoncologist.12-7-785","title":"First-Line Treatment Options for Patients with HER-2–Negative Metastatic Breast Cancer: The Impact of Modern Adjuvant Chemotherapy","year":2007,"lang":"en","type":"review","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"European Society for Medical Oncology; Pfizer","keywords":"Medicine; Metastatic breast cancer; Breast cancer; Adjuvant; Oncology; Adjuvant therapy; Clinical trial; Quality of life (healthcare); Chemotherapy; Cancer; Randomized controlled trial; Internal medicine; Intensive care medicine","score_opus":0.1131886795486073,"score_gpt":0.466774363464914,"score_spread":0.35358568391630674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133193675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010851176,0.98494,0.00013144994,0.0010480393,0.0001544994,0.008474263,0.0038718802,0.000033565277,0.00026121826],"genre_scores_gemma":[0.0034031433,0.9919574,0.00025619255,0.0001079028,0.000281781,0.0023728514,0.000402886,0.00007095688,0.001146856],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99845594,0.00013969658,0.0005110796,0.00032581974,0.00019203124,0.00037540775],"domain_scores_gemma":[0.9973818,0.0011312593,0.0007146671,0.0004543749,0.00021920398,0.00009866446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021843862,0.0005403591,0.001953226,0.00008811624,0.00019751654,0.000010896681,0.00022809533,0.00012308462,0.00033387815],"category_scores_gemma":[0.000014193382,0.00019111908,0.00082739134,0.00030295126,0.00047833798,0.000027745971,0.000025945175,0.00021378914,0.000005876633],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022007027,0.002955715,0.00028941513,0.0010920017,0.005862131,0.0000076647375,0.00038609758,0.00020450268,2.346837e-7,0.000012169765,0.0012403295,0.985749],"study_design_scores_gemma":[0.033769023,0.03812722,0.007789719,0.005983018,0.042005233,0.00021973446,0.00008840701,0.00046294968,0.000009276451,0.00039587604,0.8703015,0.00084804336],"about_ca_topic_score_codex":0.0021181009,"about_ca_topic_score_gemma":0.0010824562,"teacher_disagreement_score":0.984901,"about_ca_system_score_codex":0.0021652814,"about_ca_system_score_gemma":0.0011379938,"threshold_uncertainty_score":0.779361},"labels":[],"label_agreement":null},{"id":"W2133278615","doi":"10.18433/j3g01p","title":"Emergence of power laws in the pharmacokinetics of paclitaxel due to competing saturable processes.","year":2008,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Lethbridge; University of Alberta","funders":"","keywords":"Exponent; Power law; Cmax; Pharmacokinetics; Power function; Pareto distribution; Law; Mathematics; Nonlinear regression; Power (physics); Nonlinear system; Chemistry; Statistical physics; Statistics; Thermodynamics; Physics; Regression analysis; Mathematical analysis; Pharmacology; Medicine","score_opus":0.10949692229983157,"score_gpt":0.4399396418805712,"score_spread":0.3304427195807397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133278615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830124,0.006187109,0.000052679126,0.0060892,0.00049802836,0.00043391122,0.000011719673,0.0000071231593,0.003707841],"genre_scores_gemma":[0.99375826,0.002949534,0.001108886,0.0019062185,0.0002178662,0.000008025863,6.8181095e-7,0.00001000388,0.000040524497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970797,0.00021151413,0.0010245488,0.00022288642,0.0010184837,0.00044291347],"domain_scores_gemma":[0.99806595,0.0005761662,0.0004735816,0.00010665127,0.00048680854,0.00029085032],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016564316,0.00020256235,0.0005917422,0.00030733555,0.0001317104,0.000010724011,0.0005885824,0.00003364813,0.0015327549],"category_scores_gemma":[0.00024994064,0.00012581534,0.00017922635,0.0018119157,0.00068886013,0.00024300219,0.00007046259,0.00048421838,0.000006351472],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040137754,0.0048261764,0.3081568,0.00083851186,0.00033086835,0.0014134466,0.01129455,0.0011760009,0.6303254,0.00021786617,0.017442733,0.019963915],"study_design_scores_gemma":[0.01459152,0.0036098673,0.024815511,0.00051654654,0.0009161297,0.004436969,0.003436034,0.0022190632,0.75546145,0.00012111834,0.18939713,0.00047865493],"about_ca_topic_score_codex":0.000067675435,"about_ca_topic_score_gemma":0.000008060229,"teacher_disagreement_score":0.2833413,"about_ca_system_score_codex":0.0000378018,"about_ca_system_score_gemma":0.0006165397,"threshold_uncertainty_score":0.99938},"labels":[],"label_agreement":null},{"id":"W2133324333","doi":"10.1016/j.jpain.2005.01.155","title":"Thalidomide for the treatment of refractory radiculopathic pain: An open label trial","year":2005,"lang":"en","type":"article","venue":"Journal of Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thalidomide; Refractory (planetary science); Neuropathic pain; Tolerability; Visual analogue scale; Anesthesia; Bedtime; McGill Pain Questionnaire; Opioid; Sedation; Adverse effect; Internal medicine; Multiple myeloma","score_opus":0.11698617502033305,"score_gpt":0.4249907115413579,"score_spread":0.3080045365210249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133324333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707023,0.007768844,0.00083126465,0.017344931,0.0007197922,0.002278377,0.000018939034,0.000008150142,0.00032739041],"genre_scores_gemma":[0.98702645,0.0020794736,0.0023663074,0.0021310842,0.004223048,0.00008729885,0.000009906032,0.000024002811,0.002052449],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987492,0.00046223807,0.00042346827,0.00008275902,0.0001493971,0.00013296149],"domain_scores_gemma":[0.9981207,0.0011287032,0.00038649494,0.00014627117,0.00011067592,0.000107116204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033385244,0.00010336693,0.00040771553,0.00006134671,0.000057867688,0.0000136183835,0.00015443542,0.000057385434,0.00020948678],"category_scores_gemma":[0.00015804365,0.000054426804,0.0001395074,0.00005730069,0.000042343127,0.000099354365,0.000007809583,0.00009134392,0.0000014009499],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17493454,0.012610244,0.0015175852,0.000052536438,0.001406202,0.000105563995,0.0027676611,0.000037232505,0.016947785,0.000069435584,0.04335345,0.74619776],"study_design_scores_gemma":[0.21624167,0.07439648,0.0007419691,0.00007679185,0.0010601024,0.00007661984,0.00033316773,0.00079102034,0.0032678891,0.0001257183,0.7027953,0.00009322322],"about_ca_topic_score_codex":0.00004530985,"about_ca_topic_score_gemma":0.00007074418,"teacher_disagreement_score":0.74610454,"about_ca_system_score_codex":0.00024130275,"about_ca_system_score_gemma":0.0002739287,"threshold_uncertainty_score":0.22937334},"labels":[],"label_agreement":null},{"id":"W2134169247","doi":"10.1200/jco.2005.03.0981","title":"Phase I Dose-Finding Study of Weekly Single-Agent Patupilone in Patients With Advanced Solid Tumors","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"American Society of Clinical Oncology","keywords":"Medicine; Pharmacokinetics; Urology; Taxane; Dosing; Internal medicine; Surgery; Cancer; Breast cancer","score_opus":0.15033976515414665,"score_gpt":0.517848584346359,"score_spread":0.3675088191922124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134169247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966574,0.0001388282,0.000007258217,0.0013939874,0.0005929175,0.00054696,0.0000029188466,0.0000055663177,0.00065416464],"genre_scores_gemma":[0.9976148,0.000065942055,0.0010374852,0.000625131,0.0005265203,0.000006823268,0.000003305311,0.00001716128,0.00010281146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964015,0.00031292997,0.0024776638,0.00019118926,0.00036537732,0.0002513777],"domain_scores_gemma":[0.9965741,0.000733371,0.0019671463,0.00013954188,0.00031300922,0.00027283077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010744676,0.00015549007,0.001733896,0.00022984802,0.000023498864,0.0000027817837,0.0001164302,0.00014854675,0.00018288793],"category_scores_gemma":[0.00039246972,0.000105398714,0.00018517389,0.00020799992,0.00010895858,0.00012401209,0.00003452991,0.00070023816,0.0000055745354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04677338,0.13712135,0.5381626,0.000018259052,0.0005155784,0.0005858002,0.00070067233,0.00019231884,0.00052743487,0.0000020134642,0.0005298037,0.27487078],"study_design_scores_gemma":[0.15442361,0.2744938,0.5651033,0.00011807558,0.00054203917,0.000035123903,0.000369298,0.00002895666,0.00026289278,0.00000774652,0.004520589,0.00009457183],"about_ca_topic_score_codex":0.0000120787345,"about_ca_topic_score_gemma":0.00013127076,"teacher_disagreement_score":0.27477622,"about_ca_system_score_codex":0.00034758318,"about_ca_system_score_gemma":0.0005933878,"threshold_uncertainty_score":0.4298035},"labels":[],"label_agreement":null},{"id":"W2134894982","doi":"10.4021/wjon234w","title":"Carboplatin Induced Fatal Autoimmune Hemolytic Anemia: First Reported Case","year":2010,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Carboplatin; Medicine; Autoimmune hemolytic anemia; Anemia; Hemolytic anemia; Chemotherapy; Internal medicine; Gastroenterology; Ovarian cancer; Cancer; Cisplatin","score_opus":0.036702544892686075,"score_gpt":0.36237913384895515,"score_spread":0.32567658895626905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134894982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97832245,0.00031873657,0.0000034493946,0.0073362007,0.0028753604,0.0002041014,0.0000027041983,0.000021665888,0.010915349],"genre_scores_gemma":[0.99509406,0.00003582173,0.00087000243,0.0006457367,0.00095683796,0.000006726033,0.0000060497805,0.000021307196,0.0023634396],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9985878,0.000054626584,0.0007567642,0.00015698955,0.00016827592,0.00027557753],"domain_scores_gemma":[0.99837005,0.00027106478,0.0006837995,0.00021719508,0.00021518147,0.00024271185],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042968354,0.00016521309,0.00063806534,0.0003601379,0.00009985262,0.000008562073,0.00009230079,0.00019234739,0.0017438037],"category_scores_gemma":[0.00014773448,0.00013346045,0.00017630095,0.000303069,0.00011093854,0.00007317916,0.00003907186,0.0013059245,0.00001888871],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003073153,0.0024482806,0.029186048,0.00008960137,0.0009561762,0.38800365,0.001365089,0.000011826444,0.48508486,0.00013834816,0.029200817,0.06044215],"study_design_scores_gemma":[0.01828517,0.0064726374,0.043773692,0.00007383847,0.0017343685,0.62880856,0.00018012845,0.00009529181,0.016274378,0.00010429798,0.2839282,0.00026943043],"about_ca_topic_score_codex":0.00023631401,"about_ca_topic_score_gemma":0.0037027812,"teacher_disagreement_score":0.4688105,"about_ca_system_score_codex":0.00030085724,"about_ca_system_score_gemma":0.0008186045,"threshold_uncertainty_score":0.99916875},"labels":[],"label_agreement":null},{"id":"W2136048473","doi":"10.1111/cbdd.12595","title":"Elucidating the Mechanism of Action of the Clinically Approved Taxanes: A Comprehensive Comparison of Local and Allosteric Effects","year":2015,"lang":"en","type":"article","venue":"Chemical Biology & Drug Design","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Alberta Cancer Foundation; Allard Foundation; Killam Trusts; Alberta Innovates - Technology Futures; University of Alberta","keywords":"Allosteric regulation; Mechanism (biology); Mechanism of action; Computational biology; Chemistry; Pharmacology; Biology; Biochemistry; Receptor; Physics","score_opus":0.10095903343492857,"score_gpt":0.3829406904045022,"score_spread":0.2819816569695736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136048473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99176204,0.000649597,0.006194486,0.000531717,0.00017009542,0.00059712614,0.000003836721,0.000009507009,0.00008160208],"genre_scores_gemma":[0.99873096,0.00002742919,0.00090071297,0.00024387741,0.000040082286,0.000024724217,0.000009652458,0.0000066116195,0.000015942249],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989702,0.0002885831,0.00038020208,0.00016332007,0.00007900147,0.0001186573],"domain_scores_gemma":[0.9980105,0.0012871622,0.0003449888,0.00017262647,0.00012859517,0.000056086777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024029177,0.00010878619,0.0004909235,0.000019551426,0.000018891124,9.696909e-7,0.000111074136,0.00013183903,0.0000063079933],"category_scores_gemma":[0.00014420132,0.00005807496,0.0000798547,0.000096857446,0.00061573664,0.000011201752,0.00008379031,0.00017838574,8.6152687e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011763055,0.00023427664,0.0026706546,0.00012176032,0.00016046155,6.008406e-7,0.0006862085,0.0000050800368,0.98875993,0.000099758385,0.0005467502,0.0055382163],"study_design_scores_gemma":[0.0023263663,0.00081485725,0.00041987654,0.000056090288,0.0003053271,0.000011847577,0.0006001351,0.0009817657,0.9937442,0.00056393497,0.00012702115,0.000048601432],"about_ca_topic_score_codex":0.00004181664,"about_ca_topic_score_gemma":0.000001446057,"teacher_disagreement_score":0.0069689346,"about_ca_system_score_codex":0.000026399262,"about_ca_system_score_gemma":0.00008035684,"threshold_uncertainty_score":0.23682281},"labels":[],"label_agreement":null},{"id":"W2136536672","doi":"10.1200/jco.2005.02.106","title":"Objective Response to Chemotherapy As a Potential Surrogate End Point of Survival in Metastatic Breast Cancer Patients","year":2005,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Epirubicin; Internal medicine; Hazard ratio; Breast cancer; Chemotherapy; Metastatic breast cancer; Oncology; Odds ratio; Surrogate endpoint; Cancer; Proportional hazards model; Surgery; Confidence interval","score_opus":0.1327136294108822,"score_gpt":0.5539587784090273,"score_spread":0.42124514899814514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136536672","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.101194955,0.88578725,0.000004727161,0.0060836603,0.00427663,0.0018048037,0.0002671573,0.000007644749,0.00057317264],"genre_scores_gemma":[0.010269109,0.9861728,0.00036548867,0.0012757382,0.0013549592,0.000040756568,0.000012629477,0.00005271745,0.00045579288],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916138,0.002847933,0.0043117492,0.00034616716,0.0005214012,0.00035893446],"domain_scores_gemma":[0.99082977,0.0040604905,0.0037730988,0.00019088524,0.0006530485,0.00049273623],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0046902983,0.00038318627,0.0072026765,0.0005991506,0.000017949735,0.000004922739,0.00024725226,0.00053829415,0.0018783804],"category_scores_gemma":[0.0011888664,0.00026258963,0.0016517608,0.00041816477,0.00018322097,0.00007147182,0.0000679832,0.0014317165,0.00003070042],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04731336,0.0067047216,0.0011534841,0.0005874768,0.0024193907,0.00080387463,0.00017950601,0.0000072898138,0.0000046283535,0.0000022202025,0.000976587,0.93984747],"study_design_scores_gemma":[0.026196828,0.026434133,0.03838312,0.0037932144,0.005925289,0.00078938785,0.000052350846,0.0000020316127,0.000003526611,0.000029011107,0.8981411,0.00025001113],"about_ca_topic_score_codex":0.00021966462,"about_ca_topic_score_gemma":0.00027910952,"teacher_disagreement_score":0.9395974,"about_ca_system_score_codex":0.001210922,"about_ca_system_score_gemma":0.008666298,"threshold_uncertainty_score":0.99998266},"labels":[],"label_agreement":null},{"id":"W2136970657","doi":"10.1177/1078155214525369","title":"A comparison of toxicity and health care resource use between eribulin, capecitabine, gemcitabine, and vinorelbine in patients with metastatic breast cancer treated in a community oncology setting","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Eribulin; Metastatic breast cancer; Internal medicine; Gemcitabine; Vinorelbine; Neutropenia; Oncology; Breast cancer; Anemia; Capecitabine; Adverse effect; Cancer; Toxicity; Chemotherapy; Colorectal cancer","score_opus":0.06450904396762154,"score_gpt":0.4532250343000936,"score_spread":0.38871599033247206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136970657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853946,0.0016593235,0.000013005872,0.01196365,0.00006666976,0.0006215327,0.00006963214,0.000007354847,0.00020426158],"genre_scores_gemma":[0.99517196,0.00046206886,0.00219247,0.0019903658,0.000097856115,0.000016472532,0.000037851303,0.000023581613,0.0000073982483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99564356,0.002438558,0.0011253292,0.00019998779,0.000249091,0.0003435013],"domain_scores_gemma":[0.99440986,0.0028865002,0.0017690952,0.00013928696,0.0005137061,0.00028153486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018462883,0.00024466077,0.0014816405,0.0004186388,0.00010541663,0.000012077022,0.000106200125,0.00009154802,0.000031268417],"category_scores_gemma":[0.00034174105,0.00019374999,0.000047658392,0.00038132677,0.00021430089,0.00045551243,0.000081077145,0.0014719021,2.8443344e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013858587,0.003988312,0.90781575,0.00024663442,0.00043467045,0.00007132169,0.006019519,0.000059607937,0.00023501765,0.0000021922997,0.0006303219,0.06663806],"study_design_scores_gemma":[0.051420406,0.011156066,0.9142675,0.00023169351,0.0012393651,0.00039471308,0.0020594166,0.00017417532,0.00021705255,0.000002750642,0.018696373,0.00014052789],"about_ca_topic_score_codex":0.0044241888,"about_ca_topic_score_gemma":0.0033935779,"teacher_disagreement_score":0.06649753,"about_ca_system_score_codex":0.0011637773,"about_ca_system_score_gemma":0.00070042873,"threshold_uncertainty_score":0.79008955},"labels":[],"label_agreement":null},{"id":"W2137677935","doi":"10.1039/b209312j","title":"First example of a taxane-derived propellane in Taxus canadensis needles","year":2002,"lang":"en","type":"article","venue":"Chemical Communications","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University; Institut National de la Recherche Scientifique","funders":"","keywords":"Propellane; Taxane; Biogenesis; Hertz; Chemistry; Stereochemistry; Biology; Physics; Bicyclic molecule; Biochemistry","score_opus":0.10162737066923415,"score_gpt":0.3108236084796394,"score_spread":0.20919623781040525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137677935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9646959,0.003290513,0.0000023175044,0.008523964,0.00001952408,0.00032732807,0.000017195018,0.000028210701,0.023095075],"genre_scores_gemma":[0.99682623,0.0009257155,0.0012578967,0.00019576201,0.000019455718,0.000064464286,0.000059642458,0.0000090886115,0.00064172986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99949676,0.000024428151,0.00019207803,0.000099522804,0.00006339597,0.0001238397],"domain_scores_gemma":[0.99902433,0.00016131664,0.000054067445,0.00064253993,0.000045688303,0.0000720366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033562454,0.000071465234,0.00019512058,0.00005551429,0.00003531472,0.0000024759988,0.00020615307,0.000054621443,0.00055765815],"category_scores_gemma":[0.000048347483,0.00006571528,0.000041659703,0.00020514404,0.00017425495,0.00001543679,0.00009463485,0.00015646257,0.000022973723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017596879,0.0033998603,0.038297962,0.0002482637,0.00024216203,0.000027776832,0.0067266305,0.00000906861,0.9029933,0.0006029033,0.040268157,0.0070079407],"study_design_scores_gemma":[0.011983904,0.0005371389,0.027040016,0.000485033,0.0006634686,0.00018404929,0.0011872434,0.005504967,0.5643165,0.00034922129,0.38708916,0.0006592907],"about_ca_topic_score_codex":0.0068913447,"about_ca_topic_score_gemma":0.0028730277,"teacher_disagreement_score":0.346821,"about_ca_system_score_codex":0.000096541684,"about_ca_system_score_gemma":0.000028445376,"threshold_uncertainty_score":0.9997218},"labels":[],"label_agreement":null},{"id":"W2138152567","doi":"10.1007/978-0-85729-727-3_3","title":"Chemotherapy in the Management of Cancer","year":2012,"lang":"en","type":"book-chapter","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Quarter (Canadian coin); Disease; Cancer; Cure rate; Gynecology; Demography; Internal medicine; History","score_opus":0.03906866153385057,"score_gpt":0.3592225107155671,"score_spread":0.3201538491817165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138152567","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006180839,0.009289757,0.0000010141624,0.0021196555,0.00012489563,0.00050514593,0.0000058535193,0.000006890309,0.9873287],"genre_scores_gemma":[0.015292802,0.023190578,0.00007543716,0.0023060292,0.00022816884,0.000053164644,0.000016017812,0.000018911998,0.9588189],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995922,0.0000029256482,0.000120190205,0.00008659161,0.000107765525,0.0000903226],"domain_scores_gemma":[0.9997678,0.000011623092,0.000049469403,0.00014099323,0.000011321199,0.000018799808],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005300279,0.00010656611,0.00020409905,0.000045772747,0.0000055917985,9.3158036e-7,0.00005394291,0.00007312621,0.016650815],"category_scores_gemma":[3.928719e-8,0.000060686692,0.00006985157,0.000013594111,0.000030664414,0.0000068255376,0.00001005371,0.00009813406,0.000030085363],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011143535,0.0006352769,0.005028704,0.0012225623,0.0041048187,0.00016278232,0.0013983194,6.543814e-7,0.00016715744,0.26739419,0.08715437,0.63161683],"study_design_scores_gemma":[0.0019505376,0.00009192725,0.0052146073,0.00015915968,0.00057491934,0.0000038467647,0.000019243542,4.8805083e-7,0.00018061306,0.000645417,0.9910896,0.00006962875],"about_ca_topic_score_codex":0.0001304228,"about_ca_topic_score_gemma":0.00009163277,"teacher_disagreement_score":0.90393525,"about_ca_system_score_codex":0.00006335014,"about_ca_system_score_gemma":0.000018690605,"threshold_uncertainty_score":0.9842481},"labels":[],"label_agreement":null},{"id":"W2138216054","doi":"10.1200/jco.2012.42.3301","title":"Linking Toxicity to the Target","year":2012,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Toxicity; Oncology; Internal medicine","score_opus":0.21353725129848272,"score_gpt":0.5256858018184358,"score_spread":0.3121485505199531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138216054","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009285312,0.0017641516,0.00009217328,0.96734464,0.01322902,0.00036033135,0.000011147336,0.000009995244,0.007903232],"genre_scores_gemma":[0.007977826,0.0005254255,0.0025419823,0.87532854,0.10850636,0.00000926416,0.000018580347,0.00003377111,0.005058237],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99574375,0.00081762957,0.0023125561,0.00020221555,0.00047546273,0.00044837344],"domain_scores_gemma":[0.9928217,0.004037399,0.0020921326,0.00028004835,0.00038636124,0.00038236205],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0037985563,0.0002398103,0.0022740774,0.00015045304,0.00005936666,0.000009680074,0.00037742962,0.0017741148,0.0015667912],"category_scores_gemma":[0.0011852852,0.00012818795,0.0010861795,0.00013358609,0.00015684376,0.000051849504,0.00010778874,0.007059212,0.00025758418],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012323479,0.00072996435,0.006648711,0.000039164857,0.0008484442,0.0021006193,0.00009977308,0.0000029781156,0.000016404285,0.0000047916974,0.9554788,0.032798033],"study_design_scores_gemma":[0.0029083346,0.010320789,0.006779897,0.00009604859,0.0016162856,0.0008976687,0.000007925344,0.0000027903243,0.000026242888,0.00017537695,0.977055,0.00011365002],"about_ca_topic_score_codex":0.000010908862,"about_ca_topic_score_gemma":0.000013168983,"teacher_disagreement_score":0.09527734,"about_ca_system_score_codex":0.0003317563,"about_ca_system_score_gemma":0.0020427534,"threshold_uncertainty_score":0.9995218},"labels":[],"label_agreement":null},{"id":"W2139515743","doi":"10.1016/j.bbmt.2012.11.196","title":"Impact of Bone Marrow Neuropathy on the Outcome of Autologous Stem Cell Transplantation (ASCT) for Lymphoma","year":2013,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Bone marrow; Stromal cell; Internal medicine; Haematopoiesis; Lymphoma; CD34; Stem cell; Pathology","score_opus":0.0209311755317132,"score_gpt":0.2883212969031479,"score_spread":0.2673901213714347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139515743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975863,0.00044643524,0.00014866925,0.00028091317,0.00009831486,0.0008314974,0.00035785386,0.000013146249,0.00023687846],"genre_scores_gemma":[0.9982303,0.0011905123,0.00013169722,0.00007554497,0.000026285154,0.0000692403,0.00019734871,0.0000113455235,0.00006774737],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991257,0.000089470865,0.00040495122,0.00016916907,0.00006333523,0.00014733057],"domain_scores_gemma":[0.99919105,0.00034909314,0.00023336161,0.000101164675,0.0000814629,0.000043876073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001258773,0.00014298622,0.00039869177,0.00010921662,0.000033986864,0.000001822086,0.000045665493,0.00011681678,0.000055675937],"category_scores_gemma":[0.0000035437151,0.000091317306,0.00016543822,0.000069709735,0.00014690608,0.00003733648,0.000002232193,0.000046504534,0.0000012397377],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025017606,0.00047508496,0.13768946,0.0009687334,0.00022560624,0.000007663787,0.00079570024,0.000007640793,0.8502569,0.00021940647,0.000054440454,0.0067976117],"study_design_scores_gemma":[0.009146986,0.0069302404,0.5588383,0.00007638608,0.0018265377,0.0001479961,0.00006525671,0.000077609984,0.42260012,0.00015811423,0.00001653772,0.000115940915],"about_ca_topic_score_codex":0.00026770539,"about_ca_topic_score_gemma":0.000017644234,"teacher_disagreement_score":0.4276568,"about_ca_system_score_codex":0.000008987488,"about_ca_system_score_gemma":0.000045972756,"threshold_uncertainty_score":0.37238115},"labels":[],"label_agreement":null},{"id":"W2139995836","doi":"10.1158/1535-7163.mct-07-2217","title":"Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor–induced angiogenesis","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Pharmacology; RHOA; Angiogenesis; Vascular endothelial growth factor; Chemistry; Naltrexone; Protein kinase B; Cancer research; Medicine; Receptor; Opioid; Signal transduction; Biochemistry","score_opus":0.026847572037158148,"score_gpt":0.2854884292025764,"score_spread":0.25864085716541824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139995836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99278504,0.0057191327,0.0005785487,0.00015617299,0.000083449566,0.00049681053,0.00003957586,0.000021541504,0.000119760625],"genre_scores_gemma":[0.9970636,0.0021425465,0.00020360909,0.00038482554,0.00005154053,0.00006866127,0.000013834725,0.000039867657,0.000031524833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891615,0.00009256647,0.00021709937,0.00024782948,0.00033270678,0.00019366942],"domain_scores_gemma":[0.99928373,0.00012386189,0.0001478119,0.00020371588,0.0001585908,0.00008231206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040724397,0.0002203654,0.0004745306,0.00013600662,0.000046758872,0.0000024566407,0.000042091506,0.000096046024,0.00003458422],"category_scores_gemma":[0.000011260143,0.00017333076,0.00013704482,0.00021789614,0.00013541331,0.000026760004,0.000014685784,0.00009819587,8.8226307e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012069161,0.00038470604,0.0047175996,0.0003568775,0.0014515483,0.00019580575,0.0005122257,0.000018350514,0.98526776,0.00010787045,0.0000045351126,0.0057757883],"study_design_scores_gemma":[0.0055548046,0.0025077814,0.017144145,0.00016799044,0.0013622928,0.000022371474,0.000011004688,0.000027679815,0.97289824,0.000037118785,0.00011500505,0.00015157068],"about_ca_topic_score_codex":0.0003028676,"about_ca_topic_score_gemma":0.000017569737,"teacher_disagreement_score":0.012426547,"about_ca_system_score_codex":0.00010293365,"about_ca_system_score_gemma":0.00015624227,"threshold_uncertainty_score":0.70682234},"labels":[],"label_agreement":null},{"id":"W2140982262","doi":"10.1076/1388-0209(200007)3831-sft192","title":"Paclitaxel in Combination with Coumarin as a Potentially Effective Anticancer Agent","year":2000,"lang":"en","type":"article","venue":"Pharmaceutical Biology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trent University","funders":"","keywords":"Paclitaxel; Clastogen; Coumarin; Pharmacology; Antimitotic Agent; Chemistry; Toxicology; Toxicity; Biology; Genotoxicity; Cancer; Genetics; Tubulin; Organic chemistry","score_opus":0.024577093166481708,"score_gpt":0.38981657160042604,"score_spread":0.36523947843394433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140982262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972373,0.0006093833,0.00006328331,0.0047209742,0.00015902749,0.0010750287,0.000011064544,0.000055528624,0.020932676],"genre_scores_gemma":[0.9943905,0.0007083974,0.00013465325,0.0035165208,0.00010035448,0.00020297962,0.000062924744,0.000015402411,0.0008682553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988289,0.0001654612,0.000192437,0.0003408257,0.00010020115,0.00037220016],"domain_scores_gemma":[0.9994888,0.0001581559,0.000029300134,0.000109365676,0.00004629487,0.00016810409],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015115127,0.00017005332,0.00033186082,0.00009607078,0.000042408665,0.000006044113,0.000057572084,0.0001111191,0.006750358],"category_scores_gemma":[0.000016841848,0.00012619338,0.000057475565,0.00021592907,0.00025977535,0.000038539056,0.000019563651,0.00028080138,0.00034316722],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017485436,0.0037141829,0.21424058,0.000099866236,0.0006074842,0.0006558539,0.00032509732,0.000018756704,0.04178813,0.0037543562,0.0007330332,0.71657723],"study_design_scores_gemma":[0.076889075,0.016218372,0.41803,0.00017636747,0.0015144804,0.00074217597,0.00006973096,0.0020883393,0.060784597,0.0035532445,0.41903186,0.00090176787],"about_ca_topic_score_codex":0.00023976377,"about_ca_topic_score_gemma":0.000047883655,"teacher_disagreement_score":0.7156755,"about_ca_system_score_codex":0.00019159968,"about_ca_system_score_gemma":0.00009117208,"threshold_uncertainty_score":0.9941576},"labels":[],"label_agreement":null},{"id":"W2141787758","doi":"10.1158/1535-7163.targ-09-b54","title":"Abstract B54: A phase 1 study to assess the safety, tolerability and pharmacokinetics of the ErbB-family inhibitor ARRY-334543 in patients with advanced solid tumors","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Juravinski Cancer Centre","funders":"","keywords":"Pharmacokinetics; Medicine; Dosing; Tolerability; Cmax; Capsule; Adverse effect; Pharmacology; Internal medicine; Gastroenterology","score_opus":0.027314768822341542,"score_gpt":0.3634590329814251,"score_spread":0.3361442641590836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141787758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941633,0.00086759834,0.00003710168,0.0020620995,0.00017282928,0.002497714,0.00004893331,0.000016269481,0.00013420347],"genre_scores_gemma":[0.99471176,0.00010513921,0.00006459678,0.00495414,0.000054785985,0.000060231967,0.0000065446966,0.000026062278,0.000016746893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845207,0.00011645138,0.00041006328,0.00033018965,0.00040094386,0.00029027765],"domain_scores_gemma":[0.999123,0.000052133182,0.00015966079,0.00040741285,0.00016163383,0.00009616879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018138645,0.00025677966,0.00043018674,0.00006173608,0.000076909426,0.000014758483,0.00017840082,0.000042861844,0.000029439472],"category_scores_gemma":[0.000007346815,0.0001487014,0.00006973069,0.00038929353,0.00011282663,0.00004077798,0.0000476843,0.00029381533,5.765618e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018594166,0.017318523,0.42915103,0.0001224536,0.0010001841,0.00008885856,0.0071064085,0.0027557688,0.34954533,0.000018629964,0.00011715344,0.1741815],"study_design_scores_gemma":[0.017231183,0.004200878,0.93171334,0.00011735024,0.0005240201,0.0000019057807,0.00030716485,0.00007080685,0.044374093,0.000036222606,0.001219669,0.0002033589],"about_ca_topic_score_codex":0.000059348004,"about_ca_topic_score_gemma":0.000065307155,"teacher_disagreement_score":0.50256234,"about_ca_system_score_codex":0.00018573305,"about_ca_system_score_gemma":0.00018029788,"threshold_uncertainty_score":0.60638666},"labels":[],"label_agreement":null},{"id":"W2142226415","doi":"10.1016/s1470-2045(15)70064-1","title":"Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":285,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Fudan University; Natural Science Foundation of Shanghai; Eli Lilly and Company","keywords":"Gemcitabine; Medicine; Internal medicine; Regimen; Metastatic breast cancer; Oncology; Breast cancer; Clinical endpoint; Triple-negative breast cancer; Chemotherapy; Cisplatin; Paclitaxel; Cancer; Clinical trial","score_opus":0.2756851049856489,"score_gpt":0.49839696780858883,"score_spread":0.22271186282293992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142226415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86695004,0.005018692,0.0003033056,0.08364437,0.00714631,0.028003449,0.002436406,0.00021647073,0.00628097],"genre_scores_gemma":[0.9301834,0.007571583,0.0050672423,0.010990878,0.010565735,0.019403793,0.0011680502,0.00025958256,0.014789748],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99625874,0.0007251907,0.00089014485,0.0007166208,0.00039153962,0.0010177636],"domain_scores_gemma":[0.9945408,0.0032008898,0.00063274155,0.00064059615,0.00050530356,0.0004796694],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018006056,0.00058821926,0.002434988,0.00014612584,0.00029657222,0.0000614093,0.0006509187,0.00022351062,0.0012483535],"category_scores_gemma":[0.00082038325,0.00038098334,0.00023172985,0.00044748036,0.00033938786,0.00021753041,0.0001926221,0.0005145154,0.000115539886],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90903074,0.0043578884,0.000020395695,0.00007259145,0.0023218323,0.00013445747,0.002594487,0.00010611436,0.00047393152,0.00022016901,0.059065107,0.021602282],"study_design_scores_gemma":[0.88193566,0.026291635,0.000040380193,0.000051695082,0.0020975275,0.00011891107,0.0006126682,0.0039375667,0.00037127556,0.0006003404,0.08357895,0.00036337067],"about_ca_topic_score_codex":0.0019235061,"about_ca_topic_score_gemma":0.0024116405,"teacher_disagreement_score":0.07265349,"about_ca_system_score_codex":0.0018621085,"about_ca_system_score_gemma":0.002480096,"threshold_uncertainty_score":0.9998642},"labels":[],"label_agreement":null},{"id":"W2143006403","doi":"10.1016/j.breast.2012.05.010","title":"ABC 1 (1st International consensus guidelines for advanced breast cancer): A positive step","year":2012,"lang":"en","type":"editorial","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Scopus; Metastatic breast cancer; Cancer; Disease; Oncology; Internal medicine; Family medicine; MEDLINE","score_opus":0.03580187537947058,"score_gpt":0.4063039905991022,"score_spread":0.3705021152196316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143006403","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005591713,0.0031449927,0.00003689418,0.043079942,0.9169479,0.0016740753,0.032121133,0.00010065283,0.0023352646],"genre_scores_gemma":[0.002698164,0.0007962764,0.00042030067,0.0008251515,0.97463125,0.00070822914,0.0032462478,0.00010216073,0.016572231],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981531,0.00005539799,0.0004403386,0.0003981126,0.0004999768,0.00045305456],"domain_scores_gemma":[0.9965132,0.0007520615,0.00033939365,0.0003082581,0.0019121163,0.00017495298],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025235707,0.00042053527,0.0006085875,0.00009692204,0.00015104911,0.0000263764,0.0002922812,0.00037173324,0.0008658326],"category_scores_gemma":[0.000118948905,0.00028185616,0.0002812863,0.000093923016,0.0001912682,0.000046202418,0.00009235982,0.00045971345,0.000053147436],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007129173,0.00021832039,0.0001139517,0.00008007078,0.0012489274,0.000020263398,0.00009926696,0.00000529924,0.00037287845,0.00003295188,0.95753527,0.03314366],"study_design_scores_gemma":[0.0073340638,0.00017732127,0.0009729005,0.00043389335,0.001745486,0.0009314577,0.00008256807,0.00006735334,0.000069057765,0.000030829815,0.9878568,0.00029823417],"about_ca_topic_score_codex":0.0012296541,"about_ca_topic_score_gemma":0.00028804323,"teacher_disagreement_score":0.057683364,"about_ca_system_score_codex":0.00056060136,"about_ca_system_score_gemma":0.00078612723,"threshold_uncertainty_score":0.99996334},"labels":[],"label_agreement":null},{"id":"W2143498161","doi":"10.1158/0008-5472.sabcs10-p2-16-06","title":"Abstract P2-16-06: Final Overall Survival Results, Including Analysis of Patients with Triple-Negative Disease and Aged ≥70 Years, from the ATHENA Study Evaluating First-Line Bevacizumab-Containing Therapy for Locally Recurrent/Metastatic Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Bevacizumab; Medicine; Taxane; Docetaxel; Internal medicine; Regimen; Chemotherapy; Clinical endpoint; Metastatic breast cancer; Oncology; Population; Chemotherapy regimen; Surgery; Progression-free survival; Anthracycline; Cancer; Breast cancer; Randomized controlled trial","score_opus":0.1836768031969175,"score_gpt":0.47802080924116985,"score_spread":0.29434400604425237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143498161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910782,0.001029957,0.000015403662,0.00093786337,0.0001730324,0.0030409372,0.0036945245,0.000014546892,0.000015523305],"genre_scores_gemma":[0.9974461,0.0005442898,0.00007985608,0.00007349433,0.0003255844,0.0009264414,0.0004704365,0.00003680066,0.00009697137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718976,0.00032961907,0.00046986484,0.00059070234,0.0009538016,0.00046628146],"domain_scores_gemma":[0.9960307,0.0023096136,0.00026826488,0.00037322167,0.00078673527,0.00023149958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016703943,0.0002398243,0.0006052822,0.00025705682,0.0003713598,0.00005322762,0.00021329137,0.000048771308,0.0005485648],"category_scores_gemma":[0.000393342,0.00015605988,0.00013131213,0.0007247451,0.00026615863,0.0001139738,0.000098245444,0.00065217767,8.037823e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1018384,0.0018811913,0.81926864,0.00008827846,0.006953315,0.000021842474,0.009408155,0.00028922845,0.0013255266,0.0000062482736,0.0006919367,0.05822721],"study_design_scores_gemma":[0.030424777,0.002338269,0.9630094,0.00018095026,0.0019291886,2.1770555e-7,0.00071554043,0.00096246763,0.000087889355,0.000094870935,0.000096956515,0.00015947875],"about_ca_topic_score_codex":0.0106453225,"about_ca_topic_score_gemma":0.029568871,"teacher_disagreement_score":0.14374073,"about_ca_system_score_codex":0.00035774955,"about_ca_system_score_gemma":0.00081376923,"threshold_uncertainty_score":0.9959429},"labels":[],"label_agreement":null},{"id":"W2145066018","doi":"10.4021/wjon265w","title":"A Fatal Brain Stroke in Patient with Advanced Breast Cancer Treated with Bevacizumab: A Case Report","year":2010,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Bevacizumab; Medicine; Metastatic breast cancer; Vascular endothelial growth factor; Breast cancer; Internal medicine; Stroke (engine); Paclitaxel; Chemotherapy; Oncology; Proteinuria; Colorectal cancer; Cancer; Surgery; Kidney; VEGF receptors","score_opus":0.01081711343478712,"score_gpt":0.33419057168583255,"score_spread":0.3233734582510454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145066018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886679,0.00019800973,0.0000059843055,0.008012629,0.0003108622,0.0003541192,0.000032781918,0.000011837785,0.002405897],"genre_scores_gemma":[0.9963601,0.000033183864,0.0011908751,0.00068388093,0.000258239,0.000045169792,0.0000075838448,0.000024716948,0.001396199],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99872226,0.000065578635,0.000509188,0.00020359462,0.00019982937,0.0002995646],"domain_scores_gemma":[0.9986261,0.00013122064,0.0005701278,0.00015796722,0.0002712462,0.00024334966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017874426,0.00018946432,0.00061537465,0.00040874298,0.000044308148,0.0000065116824,0.00005795377,0.0000816189,0.0007251136],"category_scores_gemma":[0.0000174278,0.00011926939,0.00007467052,0.00035422985,0.00014635746,0.00010884881,0.000017460836,0.00075865595,0.0000017976018],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020908147,0.0014750563,0.12683879,0.000019667343,0.0004277171,0.73615813,0.0005765518,0.00007649077,0.012680018,0.000011302,0.0017631818,0.09906492],"study_design_scores_gemma":[0.019921929,0.010309623,0.032878954,0.00012108346,0.0004280522,0.89171624,0.00025288077,0.00001689693,0.0018478025,0.000004043362,0.042350605,0.00015186732],"about_ca_topic_score_codex":0.000652464,"about_ca_topic_score_gemma":0.050224937,"teacher_disagreement_score":0.1555581,"about_ca_system_score_codex":0.00048236456,"about_ca_system_score_gemma":0.0010588898,"threshold_uncertainty_score":0.967106},"labels":[],"label_agreement":null},{"id":"W2146473694","doi":"10.1200/jco.2004.08.080","title":"Quality of Life in Ovarian Cancer Patients: Comparison of Paclitaxel Plus Cisplatin, With Cyclophosphamide Plus Cisplatin in a Randomized Study","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"","keywords":"Cisplatin; Medicine; Paclitaxel; Oncology; Cyclophosphamide; Internal medicine; Randomized controlled trial; Ovarian cancer; Chemotherapy; Cancer; Gynecology","score_opus":0.14607261429325288,"score_gpt":0.5286768606947838,"score_spread":0.3826042464015309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146473694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948682,0.0008088852,0.00007946041,0.0015188655,0.0006689575,0.0013865125,0.000011524267,0.0000036304973,0.00065395684],"genre_scores_gemma":[0.9978346,0.00026767008,0.0010347321,0.0005621148,0.00019850083,0.000046608973,0.000004583087,0.000017083798,0.0000340561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98996276,0.002265871,0.006721901,0.00023085119,0.00054439326,0.00027421836],"domain_scores_gemma":[0.9876339,0.006251672,0.005104192,0.00018701541,0.00054303603,0.0002802288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073130177,0.00022038227,0.0063223485,0.00029045192,0.000021941314,0.0000026887215,0.00016966707,0.00032516773,0.00014545604],"category_scores_gemma":[0.004947216,0.00014691245,0.00045575673,0.00040832727,0.0003906114,0.000093173796,0.00005037543,0.0013452697,0.0000012683741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35486874,0.01483512,0.6217692,0.00007796135,0.0006838659,0.00009300907,0.003080136,0.0019717074,0.000038975733,0.000040016104,0.00008110253,0.0024601491],"study_design_scores_gemma":[0.43948475,0.01693889,0.54171735,0.00020116067,0.0004134242,0.000003857748,0.00087103754,0.000049840062,0.00003779009,0.00016324138,0.000043519183,0.00007514982],"about_ca_topic_score_codex":0.007701736,"about_ca_topic_score_gemma":0.01436617,"teacher_disagreement_score":0.084616005,"about_ca_system_score_codex":0.0008021116,"about_ca_system_score_gemma":0.0045803376,"threshold_uncertainty_score":0.9989061},"labels":[],"label_agreement":null},{"id":"W2146512589","doi":"10.1200/jco.2007.11.8851","title":"Randomized Trial of High-Dose Chemotherapy With Autologous Peripheral-Blood Stem-Cell Support Compared With Standard-Dose Chemotherapy in Women With Metastatic Breast Cancer: NCIC MA.16","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"American Society of Clinical Oncology","keywords":"Medicine; Chemotherapy; Carboplatin; Hazard ratio; Breast cancer; Metastatic breast cancer; Surgery; Internal medicine; ThioTEPA; Oncology; Anthracycline; Autologous stem-cell transplantation; Cyclophosphamide; Cancer; Confidence interval; Cisplatin","score_opus":0.04313492712664521,"score_gpt":0.41637395395101684,"score_spread":0.3732390268243716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146512589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900371,0.00045928083,0.0002742137,0.0058520795,0.00052600924,0.002081164,0.00003463306,0.00002080275,0.00071473955],"genre_scores_gemma":[0.9903064,0.0020258243,0.0032490317,0.0029718517,0.0006130178,0.00009274804,0.000006676684,0.000070116315,0.00066436845],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9940459,0.0008604437,0.0032578236,0.00040940917,0.0007526089,0.00067377265],"domain_scores_gemma":[0.99256223,0.002378337,0.0035548,0.00029151363,0.0006322655,0.0005808478],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0059737507,0.00044523124,0.0060281553,0.00031398077,0.00004393272,0.00001211124,0.00024035598,0.00029646588,0.0014899565],"category_scores_gemma":[0.000046434696,0.00024576334,0.00037041013,0.00044351144,0.00090767554,0.00013215397,0.000017928227,0.0010551861,0.000001535343],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91803044,0.01090329,0.009282416,0.000108143584,0.0042593232,0.0021661688,0.0013958111,0.000079142716,0.00017157807,0.000009708926,0.00054197083,0.053052],"study_design_scores_gemma":[0.87128335,0.09992177,0.020352533,0.00017138,0.0020293044,0.0015938109,0.000556134,0.000015248801,0.0005360862,0.000045074044,0.003258172,0.00023710735],"about_ca_topic_score_codex":0.0003672522,"about_ca_topic_score_gemma":0.0008307095,"teacher_disagreement_score":0.08901848,"about_ca_system_score_codex":0.0011301866,"about_ca_system_score_gemma":0.0058452715,"threshold_uncertainty_score":0.99999946},"labels":[],"label_agreement":null},{"id":"W2147583204","doi":"10.1186/s40064-015-1422-8","title":"Eribulin monotherapy improved survivals in patients with ER-positive HER2-negative metastatic breast cancer in the real world: a single institutional review","year":2015,"lang":"en","type":"article","venue":"SpringerPlus","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; Eisai","keywords":"Eribulin; Metastatic breast cancer; Medicine; Oncology; Breast cancer; HER2 negative; Internal medicine; Cancer","score_opus":0.030051879067658376,"score_gpt":0.33217868778978177,"score_spread":0.3021268087221234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147583204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98911196,0.0023472914,0.000014169563,0.003815611,0.00018683649,0.0020039508,0.00015611113,0.00002152944,0.0023425177],"genre_scores_gemma":[0.9964557,0.0007820401,0.00030707457,0.0017858832,0.000085025604,0.0003427005,0.000046676076,0.000018552228,0.00017630817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987669,0.00018931855,0.00026883077,0.00025876088,0.0002617011,0.00025448579],"domain_scores_gemma":[0.9993957,0.00009376447,0.00011443404,0.00015927233,0.00014612846,0.00009067577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033291834,0.00018836028,0.00041634572,0.0001322148,0.00003301681,0.000011542457,0.00009238085,0.00002682992,0.00016414306],"category_scores_gemma":[0.000020723333,0.00011843313,0.00004679871,0.00059355464,0.00010827925,0.00009955415,0.00002075079,0.0002046149,0.000009450741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01281399,0.0046933033,0.92353076,0.00048574744,0.00071363995,0.0002662517,0.0048090713,0.00023737486,0.0002840173,0.0002614257,0.0007889576,0.051115487],"study_design_scores_gemma":[0.012752369,0.0007830652,0.9830519,0.0013027457,0.00019960685,0.000009030685,0.00006219207,0.0000715799,0.00017383549,0.00005143777,0.0013589858,0.0001832397],"about_ca_topic_score_codex":0.009241713,"about_ca_topic_score_gemma":0.0162402,"teacher_disagreement_score":0.059521176,"about_ca_system_score_codex":0.0007621362,"about_ca_system_score_gemma":0.0004465937,"threshold_uncertainty_score":0.9973558},"labels":[],"label_agreement":null},{"id":"W2148493940","doi":"10.1177/1078155208098584","title":"Economic analysis of albumin-bound paclitaxel for the treatment of metastatic breast cancer","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"","keywords":"Docetaxel; Medicine; Paclitaxel; Metastatic breast cancer; Oncology; Breast cancer; Internal medicine; Chemotherapy; Toxicity; Nab-paclitaxel; Cancer","score_opus":0.1128865310209775,"score_gpt":0.4903383100464727,"score_spread":0.3774517790254952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148493940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652643,0.010101641,0.000115084295,0.022092488,0.00089755823,0.0006237053,0.00025618533,0.0000039420734,0.0006451023],"genre_scores_gemma":[0.9524239,0.044334706,0.0012915997,0.00086537126,0.0004877332,0.000063160114,0.00000845862,0.000016918297,0.0005082085],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984121,0.00021949719,0.0008655003,0.00013869422,0.00016783497,0.00019638243],"domain_scores_gemma":[0.99317557,0.0041014175,0.0019371229,0.00016011106,0.00049872557,0.00012703231],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00056748884,0.00016487556,0.0010665025,0.0003347084,0.00008963644,0.0000036528602,0.00012310338,0.00003997106,0.0010703099],"category_scores_gemma":[0.00007603545,0.00010214202,0.00065848057,0.00028321895,0.00024487986,0.00023887446,0.00001071771,0.00015504543,0.000002924592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13429505,0.0367969,0.17640191,0.0003078633,0.32465184,0.001686392,0.014254579,0.010425856,0.047415137,0.00019544357,0.049106028,0.204463],"study_design_scores_gemma":[0.034698933,0.009355462,0.03341336,0.000021328058,0.15678443,0.005440774,0.0009448613,0.002676853,0.012079639,0.000019305675,0.74441075,0.00015430126],"about_ca_topic_score_codex":0.0010364816,"about_ca_topic_score_gemma":0.00015435136,"teacher_disagreement_score":0.6953047,"about_ca_system_score_codex":0.0008438652,"about_ca_system_score_gemma":0.0015830658,"threshold_uncertainty_score":0.9998428},"labels":[],"label_agreement":null},{"id":"W2149626092","doi":"10.1200/jco.2003.04.075","title":"Phase III Study of <i>N,N</i>-Diethyl-2-[4-(Phenylmethyl) Phenoxy]Ethanamine (BMS-217380-01) Combined With Doxorubicin Versus Doxorubicin Alone in Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Medicine; Doxorubicin; Metastatic breast cancer; Breast cancer; Cancer; Internal medicine; Oncology; Chemotherapy","score_opus":0.2747917362226942,"score_gpt":0.5594949828497567,"score_spread":0.28470324662706253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149626092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98190194,0.0013077358,0.000033736054,0.0063818046,0.0067285304,0.003170277,0.00022427461,0.000009634471,0.00024209176],"genre_scores_gemma":[0.995193,0.0014720102,0.00047215662,0.0009610047,0.001517415,0.00020599178,0.00002965975,0.00004419275,0.00010454113],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9837889,0.003376413,0.009806866,0.00067259633,0.0017138295,0.0006413902],"domain_scores_gemma":[0.9833116,0.006685628,0.0073489803,0.0003667716,0.0013892282,0.00089781743],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.015566899,0.00054192013,0.0072734295,0.00048211584,0.00008117861,0.000008903732,0.0004669891,0.00031742282,0.00043464787],"category_scores_gemma":[0.0032139788,0.00037723788,0.000653825,0.0009092126,0.0006027579,0.00022869938,0.00012803939,0.0018347828,9.2393265e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55446136,0.22178516,0.119002,0.00018854099,0.016340645,0.0028363992,0.0017739078,0.0031713052,0.00059296197,0.000099777906,0.0060694166,0.07367855],"study_design_scores_gemma":[0.60832703,0.23890713,0.13557163,0.000317425,0.008161793,0.00013028333,0.0032304432,0.000084985724,0.00022743821,0.00010258237,0.0045336764,0.00040555486],"about_ca_topic_score_codex":0.26996073,"about_ca_topic_score_gemma":0.85247415,"teacher_disagreement_score":0.5825134,"about_ca_system_score_codex":0.0020698484,"about_ca_system_score_gemma":0.019759707,"threshold_uncertainty_score":0.999868},"labels":[],"label_agreement":null},{"id":"W2150475127","doi":"10.1093/annonc/mdh278","title":"A phase I study of AMD473 and docetaxel given once every 3 weeks in patients with advanced refractory cancer: a National Cancer Institute of Canada-Clinical Trials Group trial, IND 131","year":2004,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Regional Cancer Foundation; BC Cancer Agency","funders":"AstraZeneca Canada","keywords":"Docetaxel; Medicine; Taxane; Neutropenia; Regimen; Internal medicine; Carboplatin; Cancer; Clinical trial; Prostate cancer; Phases of clinical research; Chemotherapy; Oncology; Surgery; Cisplatin; Breast cancer","score_opus":0.19890703960412862,"score_gpt":0.5251946068362316,"score_spread":0.32628756723210306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150475127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450946,0.0011525358,0.0000014024456,0.0014325934,0.00059032143,0.0018513444,0.00021773511,0.0000041566914,0.00024044352],"genre_scores_gemma":[0.99758834,0.0012807603,0.00007555133,0.0005952294,0.00015261042,0.00022204069,0.000029492867,0.0000117095005,0.000044282],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974603,0.00035106982,0.0012639917,0.00030828244,0.0003928759,0.00022344521],"domain_scores_gemma":[0.99759275,0.0005493979,0.0010933771,0.00013414575,0.00049909565,0.00013126184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011104854,0.00017153104,0.0014906737,0.00018414659,0.000028470307,0.0000013881374,0.000091496644,0.00013812097,0.00008318037],"category_scores_gemma":[0.00046023726,0.00013638055,0.000077228804,0.00025258274,0.00024479374,0.00012837761,0.000036394016,0.00023348331,1.1173784e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.548533,0.08226018,0.21897204,0.00030794495,0.0031450465,0.00013847621,0.0024953976,0.00065534655,0.0015904389,0.00006641581,0.005010811,0.13682486],"study_design_scores_gemma":[0.6104865,0.11183002,0.25913897,0.00033463349,0.00056392455,0.0000026479622,0.0002977277,0.0000056836197,0.0009414429,0.0000935754,0.016099816,0.0002050819],"about_ca_topic_score_codex":0.12758403,"about_ca_topic_score_gemma":0.3719148,"teacher_disagreement_score":0.2443308,"about_ca_system_score_codex":0.00036320603,"about_ca_system_score_gemma":0.005407495,"threshold_uncertainty_score":0.95926636},"labels":[],"label_agreement":null},{"id":"W2151725702","doi":"10.1093/jncimonographs/lgu041","title":"Clinical Practice Guidelines on the Use of Integrative Therapies as Supportive Care in Patients Treated for Breast Cancer","year":2014,"lang":"en","type":"review","venue":"JNCI Monographs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":270,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian College of Naturopathic Medicine; Ottawa Regional Cancer Foundation; University of Calgary; University of British Columbia","funders":"National Center for Complementary and Integrative Health; University of Texas MD Anderson Cancer Center; Emory University; University of Pennsylvania; University of California, San Francisco; University of Southern California","keywords":"Medicine; Breast cancer; Psychological intervention; Anxiety; Randomized controlled trial; Massage; Quality of life (healthcare); Mood; Physical therapy; Cancer; Intensive care medicine; Alternative medicine; Internal medicine; Psychiatry; Nursing","score_opus":0.20256489049932525,"score_gpt":0.5200536103894381,"score_spread":0.31748871989011285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151725702","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004198545,0.98656017,0.0000018730633,0.0012063418,0.00057680096,0.005113197,0.0020793702,0.000027286138,0.00023640136],"genre_scores_gemma":[0.0004385965,0.9948236,0.00028237174,0.0018565773,0.000263068,0.0013807232,0.0006512235,0.000055527064,0.00024830922],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735135,0.00047355084,0.0012723301,0.00043612145,0.00021944944,0.00024721786],"domain_scores_gemma":[0.9946325,0.002333092,0.0010434685,0.00035854126,0.0015469049,0.000085521526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033132476,0.00046948966,0.002031982,0.00027624375,0.000047229223,0.00001412484,0.00014437512,0.00032839918,0.0001336801],"category_scores_gemma":[0.0007668571,0.00022640348,0.0010191303,0.00043872726,0.00017356228,0.00007727849,0.000029171128,0.00043475704,0.000006689108],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022838449,0.0006975403,0.009030159,0.0013472863,0.00195235,0.000005829815,0.00075456256,2.8059497e-7,5.0151012e-8,0.00004015512,0.028065236,0.9558227],"study_design_scores_gemma":[0.0022838407,0.002692944,0.0023140633,0.0063346075,0.003301566,0.0000050818135,0.00032832482,0.000002758251,0.000002455778,0.000007725419,0.98253864,0.00018798946],"about_ca_topic_score_codex":0.0007619902,"about_ca_topic_score_gemma":0.0002884778,"teacher_disagreement_score":0.9556347,"about_ca_system_score_codex":0.00017613423,"about_ca_system_score_gemma":0.00047759307,"threshold_uncertainty_score":0.92324656},"labels":[],"label_agreement":null},{"id":"W2152362985","doi":"10.4021/wjon314w","title":"Grade III Dermatitis in a Patient Treated With Paclitaxel and Radiotherapy: Case Report and Review of the Literature","year":2011,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Paclitaxel; Radiation therapy; Docetaxel; Adjuvant; Breast cancer; Chemotherapy; Oncology; Adjuvant radiotherapy; Internal medicine; Dermatology; Cancer; Surgery","score_opus":0.022302729540432033,"score_gpt":0.3206446044662794,"score_spread":0.29834187492584735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152362985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88249457,0.11219106,0.0000012086037,0.003927156,0.000080141894,0.00028830252,0.0000030354322,0.0000017303306,0.0010127937],"genre_scores_gemma":[0.96451247,0.03216494,0.0006816467,0.0023486146,0.00004407367,0.00000806869,0.0000012467425,0.000007137506,0.0002317906],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99921805,0.0001333253,0.00040888708,0.0000766977,0.000073225165,0.000089833804],"domain_scores_gemma":[0.9992417,0.00006253155,0.00044408775,0.00008769274,0.000092825314,0.0000711425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001904044,0.00008567411,0.00045262915,0.00012539027,0.000020466208,0.0000019658348,0.0000249464,0.00003968706,0.000098210585],"category_scores_gemma":[0.000016031303,0.00004458969,0.000047649963,0.00022974584,0.00011402005,0.00004076958,0.000011183446,0.0002125052,4.0215006e-8],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024857007,0.0017433764,0.35395202,0.0019592002,0.0008778924,0.5250294,0.015291086,3.397567e-7,0.00079328124,0.00007972734,0.014864512,0.08292341],"study_design_scores_gemma":[0.008361658,0.0055166273,0.07491799,0.005545525,0.0006225296,0.8574859,0.00014658584,0.0000022662978,0.00060079497,0.00004869846,0.04667009,0.00008136862],"about_ca_topic_score_codex":0.00010847902,"about_ca_topic_score_gemma":0.00050175475,"teacher_disagreement_score":0.3324564,"about_ca_system_score_codex":0.00009833242,"about_ca_system_score_gemma":0.00013538756,"threshold_uncertainty_score":0.18183148},"labels":[],"label_agreement":null},{"id":"W2153543895","doi":"10.1093/jat/30.3.202","title":"Hydromorphone-Related Fatalities in Ontario","year":2006,"lang":"en","type":"article","venue":"Journal of Analytical Toxicology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Hydromorphone; Medicine; Internal medicine","score_opus":0.024562890978683125,"score_gpt":0.3060352812723721,"score_spread":0.281472390293689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153543895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732954,0.00023706797,0.000011105323,0.003256169,0.0003431649,0.000078936675,0.000001127162,0.0000056204954,0.022771433],"genre_scores_gemma":[0.9837926,0.000018487628,0.0001698269,0.00044407038,0.00016845933,0.0000013385055,0.000005675397,0.00000731056,0.015392232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888325,0.00005341166,0.00059283647,0.000097996955,0.00014547931,0.0002270048],"domain_scores_gemma":[0.99947596,0.000121896985,0.00015511188,0.000069608235,0.00007137415,0.000106068044],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020736705,0.000100281795,0.00050520897,0.00026575776,0.000016553915,0.0000058080323,0.000059898048,0.00014671149,0.0034364942],"category_scores_gemma":[0.000028826496,0.000078070094,0.00017034537,0.00015995426,0.00013003101,0.000055901604,0.000016233134,0.00047568535,0.00002813693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003178737,0.0044471505,0.9105342,0.0000366267,0.0008916098,0.012622655,0.000496171,0.00046738033,0.013752675,0.008279045,0.04446349,0.000830246],"study_design_scores_gemma":[0.012990832,0.0050408468,0.9012765,0.000069837435,0.0008247871,0.0052977405,0.000091682705,0.00043259686,0.0020257654,0.008866589,0.06288907,0.00019370629],"about_ca_topic_score_codex":0.0050508427,"about_ca_topic_score_gemma":0.031557705,"teacher_disagreement_score":0.026506862,"about_ca_system_score_codex":0.00057889556,"about_ca_system_score_gemma":0.00042364714,"threshold_uncertainty_score":0.9974745},"labels":[],"label_agreement":null},{"id":"W2154122152","doi":"10.1200/jco.2007.10.8399","title":"Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer","year":2008,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Sanofi; Bristol-Myers Squibb","keywords":"Taxane; Medicine; Docetaxel; Epirubicin; Internal medicine; Oncology; Hazard ratio; Paclitaxel; Cyclophosphamide; Metastatic breast cancer; Breast cancer; Anthracycline; Progression-free survival; Chemotherapy; Cancer; Confidence interval","score_opus":0.2078138191094805,"score_gpt":0.5426035441105482,"score_spread":0.33478972500106774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154122152","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06287918,0.9323711,0.000006136359,0.0024888378,0.0007451874,0.0013323284,0.000079364785,0.0000062176937,0.00009166238],"genre_scores_gemma":[0.005896131,0.992181,0.00050164864,0.0005181566,0.00053800474,0.000054611795,0.00005517254,0.000045764646,0.00020948124],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99502593,0.00060854707,0.0034019859,0.00025993743,0.00047210616,0.00023149735],"domain_scores_gemma":[0.98959035,0.003211855,0.005975296,0.00017029126,0.0008318487,0.000220361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007066498,0.00036900086,0.006405951,0.00035925081,0.000030196594,0.000003329845,0.00017300052,0.00037458175,0.0005469063],"category_scores_gemma":[0.00033326063,0.00017057577,0.0005270578,0.00045640583,0.0003877855,0.00010588816,0.000021696222,0.0009962864,0.0000040423756],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0316479,0.015390473,0.035642438,0.0014643989,0.0027799252,0.0013087706,0.00005645093,0.000007605263,5.4155272e-8,0.000002371651,0.0010043909,0.91069525],"study_design_scores_gemma":[0.051421147,0.06883681,0.054794908,0.0076214746,0.0036666258,0.0020061505,0.000012664492,0.0000032203607,9.847099e-7,0.000013644495,0.8114039,0.00021850341],"about_ca_topic_score_codex":0.00017457522,"about_ca_topic_score_gemma":0.0007464924,"teacher_disagreement_score":0.91047674,"about_ca_system_score_codex":0.00028857638,"about_ca_system_score_gemma":0.0051188692,"threshold_uncertainty_score":0.90806544},"labels":[],"label_agreement":null},{"id":"W2154472758","doi":"10.1002/mrc.1630","title":"First example of conformational exchange in a natural taxane enolate","year":2005,"lang":"en","type":"article","venue":"Magnetic Resonance in Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Royal Military College of Canada; Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada; Cancer Research Society","keywords":"Chemistry; Taxane; Conformational isomerism; Two-dimensional nuclear magnetic resonance spectroscopy; Stereochemistry; Basis set; Ab initio; Computational chemistry; Nuclear magnetic resonance spectroscopy; Molecule; Density functional theory; Organic chemistry","score_opus":0.016073112674436063,"score_gpt":0.275596492013337,"score_spread":0.25952337933890096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154472758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727502,0.017388893,3.560072e-7,0.0008514114,0.000038436207,0.00016433565,0.000012278893,0.000009259133,0.0087848175],"genre_scores_gemma":[0.99348825,0.00069202954,0.00034821485,0.00016354598,0.00012001762,0.00006315812,0.000032975902,0.000006703538,0.0050850785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992749,0.000006040746,0.00026502358,0.00014272459,0.0001276237,0.00018365317],"domain_scores_gemma":[0.99969774,0.000058485868,0.000056615212,0.00012377366,0.000026252705,0.00003715735],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007401581,0.00009571955,0.00019886211,0.000039476876,0.000010415004,0.0000028979507,0.000064603126,0.0000705765,0.0027772917],"category_scores_gemma":[0.000020551412,0.00009267745,0.00003257395,0.00014961816,0.000061917184,0.000041010513,0.000024322995,0.00016127012,0.000011210447],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029929061,0.002396416,0.30482277,0.0031969412,0.000041661995,0.0003919904,0.0069742473,0.00020802984,0.21460986,0.00008166916,0.014403224,0.4498803],"study_design_scores_gemma":[0.010748799,0.00020305683,0.43564692,0.0003859303,0.000027492459,0.00012512293,0.00008744541,0.0035774272,0.08545654,0.000045085406,0.4634652,0.000230958],"about_ca_topic_score_codex":0.00033216804,"about_ca_topic_score_gemma":0.00030213795,"teacher_disagreement_score":0.44964933,"about_ca_system_score_codex":0.00012857046,"about_ca_system_score_gemma":0.00006240966,"threshold_uncertainty_score":0.9981343},"labels":[],"label_agreement":null},{"id":"W2154812064","doi":"10.1158/1078-0432.ccr-06-1653","title":"A Phase Ib and Pharmacokinetic Trial of Patupilone Combined with Carboplatin in Patients with Advanced Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Tolerability; Nausea; Pharmacokinetics; Vomiting; Adverse effect; Phases of clinical research; Area under the curve; Neutropenia; Internal medicine; Urology; Chemotherapy; Oncology; Gastroenterology; Pharmacology; Surgery; Cisplatin","score_opus":0.14233468841941216,"score_gpt":0.5699323937793035,"score_spread":0.42759770535989133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154812064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950335,0.000962738,0.0000034113605,0.0007128049,0.00020795621,0.0024849935,0.00004237149,0.00001479737,0.00053744664],"genre_scores_gemma":[0.99756384,0.0012019613,0.00010485264,0.00018368995,0.0002487829,0.00033546513,0.000024342642,0.000031726486,0.00030532267],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99753344,0.0001949366,0.0006132409,0.0004554225,0.0006712755,0.0005316958],"domain_scores_gemma":[0.9980976,0.0007758858,0.00014348676,0.00022183388,0.00043180375,0.00032939663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012741691,0.00017356245,0.00065411057,0.0002350502,0.000048447546,0.0000067224464,0.000095457915,0.00010765099,0.00039351656],"category_scores_gemma":[0.00009700919,0.00011818695,0.000048654307,0.0006873721,0.0005851569,0.00005799932,0.00005566335,0.0007439878,0.000001601948],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56677103,0.0052139224,0.3352522,0.000105443374,0.00017481593,0.0000668491,0.00012448001,0.0000054139737,0.0005600104,0.000005227066,0.0002706108,0.091449976],"study_design_scores_gemma":[0.6025347,0.05751822,0.33515394,0.00031540502,0.00019383739,9.911564e-7,0.000040754716,0.0000484003,0.0025101032,0.000013052879,0.0015141811,0.00015640944],"about_ca_topic_score_codex":0.00092846074,"about_ca_topic_score_gemma":0.0017717123,"teacher_disagreement_score":0.091293566,"about_ca_system_score_codex":0.00020249555,"about_ca_system_score_gemma":0.0005777428,"threshold_uncertainty_score":0.4819524},"labels":[],"label_agreement":null},{"id":"W2155388118","doi":"10.1158/0008-5472.can-07-6381","title":"Genetic Variants Contributing to Daunorubicin-Induced Cytotoxicity","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of General Medical Sciences; National Institutes of Health","keywords":"Daunorubicin; Biology; International HapMap Project; Cytotoxicity; Genotype; Gene; Genetics; Gene expression; Single-nucleotide polymorphism; Molecular biology; In vitro; Leukemia","score_opus":0.1930223636851178,"score_gpt":0.4814117945314891,"score_spread":0.28838943084637125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155388118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99126333,0.00065425783,0.00003922511,0.0031982928,0.00024116598,0.0010138836,0.000025072295,0.000049840462,0.0035149115],"genre_scores_gemma":[0.99365944,0.00038216743,0.00012725081,0.0009979276,0.0008330495,0.00032801705,0.000006068371,0.00002694081,0.0036391644],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99780244,0.00014004411,0.00019759638,0.00038732833,0.0005121653,0.0009604225],"domain_scores_gemma":[0.99871325,0.00016137998,0.00002593201,0.00029184858,0.0003760442,0.00043155235],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047048053,0.00012890826,0.00029644452,0.00022067047,0.00041794273,0.000012254829,0.00014709115,0.000089486704,0.0015984875],"category_scores_gemma":[0.0001523587,0.000113784954,0.000060942377,0.0006643804,0.00009956952,0.00003535002,0.0001412884,0.00043460447,0.00033094015],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095865404,0.00023801252,0.10250665,0.000041069594,0.000132963,0.00078107085,0.0006669508,0.000012100276,0.87380713,0.00003277357,0.016953198,0.0038693997],"study_design_scores_gemma":[0.0043952074,0.0012575899,0.64713055,0.00009381739,0.00005253396,0.0001830939,0.0000626942,0.000052718315,0.33497426,0.000039200404,0.011574906,0.00018342688],"about_ca_topic_score_codex":0.0019272483,"about_ca_topic_score_gemma":0.00016444095,"teacher_disagreement_score":0.5446239,"about_ca_system_score_codex":0.0006617847,"about_ca_system_score_gemma":0.00077802164,"threshold_uncertainty_score":0.9993142},"labels":[],"label_agreement":null},{"id":"W2157717971","doi":"10.1093/annonc/mdp328","title":"N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial","year":2009,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Docetaxel; Irinotecan; Metastatic breast cancer; Internal medicine; Regimen; Taxane; Neutropenia; Breast cancer; Oncology; Febrile neutropenia; Cancer; Response Evaluation Criteria in Solid Tumors; Chemotherapy; Surgery; Phases of clinical research; Colorectal cancer","score_opus":0.09833561280837098,"score_gpt":0.44932290861313745,"score_spread":0.35098729580476645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157717971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830744,0.0028264066,0.0000018139922,0.0107907485,0.0006534662,0.0017245688,0.00038389358,0.000017607721,0.0005270808],"genre_scores_gemma":[0.98424745,0.013580033,0.000048416485,0.0008673449,0.00070644176,0.0002563528,0.0000638595,0.00001727763,0.00021284824],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978893,0.00018110286,0.00080128846,0.00039381356,0.00020868143,0.00052582246],"domain_scores_gemma":[0.99874854,0.0001961491,0.00048095937,0.00021133912,0.00010658098,0.00025640524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020262902,0.0002948908,0.0013589681,0.0002837779,0.00003541383,0.000004121684,0.00009386706,0.00013784932,0.00032346082],"category_scores_gemma":[0.000025175032,0.00024056745,0.00022325706,0.00027699588,0.00019358259,0.00010097812,0.000019942177,0.00019528573,0.0000011801056],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6105252,0.018961698,0.002351698,0.000060849565,0.0006724814,0.00021509988,0.0008487593,0.000020612628,0.0031432186,0.000034418495,0.0013789359,0.36178705],"study_design_scores_gemma":[0.7990536,0.1335287,0.03580589,0.0000884655,0.001248221,0.00006947876,0.00008470052,0.0000696138,0.00340501,0.00011457065,0.026286336,0.00024543243],"about_ca_topic_score_codex":0.006701345,"about_ca_topic_score_gemma":0.0075404528,"teacher_disagreement_score":0.3615416,"about_ca_system_score_codex":0.0003999831,"about_ca_system_score_gemma":0.00095436006,"threshold_uncertainty_score":0.9999131},"labels":[],"label_agreement":null},{"id":"W2158133583","doi":"10.3747/co.20.1202","title":"Clinical Outcomes of Women with Metastatic Breast Cancer Treated with Nab-Paclitaxel: Experience from a Single Academic Cancer Centre","year":2013,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Taxane; Paclitaxel; Internal medicine; Metastatic breast cancer; Cancer; Chemotherapy; Oncology; Dosing","score_opus":0.1344135311198215,"score_gpt":0.4759498440927138,"score_spread":0.34153631297289233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158133583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992963,0.0025106808,0.000012520364,0.002593271,0.0005548609,0.0009411417,0.00022705382,0.000057644414,0.00013981717],"genre_scores_gemma":[0.99597675,0.0013649751,0.00023165024,0.00053412694,0.0002476731,0.0010901617,0.00004664655,0.000035601395,0.0004724181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978912,0.00018564919,0.00057142146,0.0005013767,0.00024218445,0.0006081756],"domain_scores_gemma":[0.99831676,0.00036790306,0.00038561097,0.0002476076,0.00026468257,0.00041742896],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010273694,0.00030909028,0.0011525928,0.000096539814,0.000044451026,0.00000663755,0.000149819,0.00014132551,0.0056560617],"category_scores_gemma":[0.00002387391,0.00018762937,0.000090064044,0.000264275,0.00051855727,0.0001288354,0.000048341422,0.00044939088,0.000030739007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022112702,0.002097639,0.9068233,0.000055811714,0.00097429036,0.000030573774,0.0034812198,0.0000042214397,0.00095260714,0.000004239892,0.0019984453,0.0813664],"study_design_scores_gemma":[0.013484839,0.0031699357,0.9583387,0.0002614915,0.0012083295,0.00004208088,0.0020259807,0.000070221904,0.00056442164,0.000025291522,0.020530287,0.00027844266],"about_ca_topic_score_codex":0.0040838243,"about_ca_topic_score_gemma":0.00089144486,"teacher_disagreement_score":0.081087954,"about_ca_system_score_codex":0.0011200742,"about_ca_system_score_gemma":0.00064497074,"threshold_uncertainty_score":0.9952529},"labels":[],"label_agreement":null},{"id":"W2158353647","doi":"10.1158/0008-5472.can-08-1753","title":"Translymphatic Chemotherapy by Intrapleural Placement of Gelatin Sponge Containing Biodegradable Paclitaxel Colloids Controls Lymphatic Metastasis in Lung Cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Toronto","funders":"","keywords":"Paclitaxel; PLGA; Lymphatic system; Pharmacokinetics; Lymph; Medicine; Lymph node; Lung cancer; Metastasis; Chemotherapy; Pharmacology; Cancer; Urology; Pathology; Surgery; Internal medicine; Chemistry; In vitro","score_opus":0.05950563420338142,"score_gpt":0.4371428807677152,"score_spread":0.3776372465643338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158353647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95049304,0.039596062,0.000042694985,0.006634148,0.00011327946,0.0019955002,0.00018949145,0.000028329992,0.00090744003],"genre_scores_gemma":[0.9907983,0.0054839244,0.00011225543,0.00090648537,0.000113766924,0.0008275951,0.000045368437,0.00003327749,0.0016790187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99715173,0.00030416736,0.0005662256,0.00044215153,0.0006941139,0.0008416014],"domain_scores_gemma":[0.9988169,0.00035259308,0.00011587024,0.0002585935,0.00021721039,0.00023883909],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010412006,0.00026148214,0.00082233554,0.00040115937,0.00009978165,0.000025385156,0.0001850513,0.00011686278,0.0024975638],"category_scores_gemma":[0.000038913422,0.00022454384,0.00013545158,0.0009288204,0.00020802832,0.00012314977,0.000015856589,0.0002643791,0.0000032161074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021989614,0.002381305,0.08762919,0.0009007844,0.0017590856,0.000142077,0.006041404,0.00022807125,0.7154335,0.0003170779,0.026341077,0.13683683],"study_design_scores_gemma":[0.16363563,0.013572961,0.06252761,0.0030373754,0.0016339096,0.00004613481,0.0038649219,0.011366252,0.71351194,0.0005451427,0.02475295,0.0015052051],"about_ca_topic_score_codex":0.004730635,"about_ca_topic_score_gemma":0.0008188253,"teacher_disagreement_score":0.14164601,"about_ca_system_score_codex":0.0016941078,"about_ca_system_score_gemma":0.0010011295,"threshold_uncertainty_score":0.9984143},"labels":[],"label_agreement":null},{"id":"W2158925468","doi":"10.1634/theoncologist.2009-0219","title":"Commentary: Anthracyclines in Early-Stage Breast Cancer: Is It the End of an Era?","year":2009,"lang":"en","type":"letter","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Cancer; Oncology; Adjuvant; Adjuvant chemotherapy; Internal medicine","score_opus":0.04782780240256192,"score_gpt":0.3933731187100704,"score_spread":0.3455453163075085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158925468","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.114347845,0.00076987146,2.2486398e-7,0.87971824,0.0004904467,0.0008565233,0.0008453992,0.00002323307,0.0029482194],"genre_scores_gemma":[0.092410825,0.002343523,0.000024903879,0.8935205,0.00428872,0.00013473268,0.00033788604,0.000033232936,0.0069056978],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99824893,0.00030089528,0.00043830954,0.0003311581,0.00028238972,0.00039832736],"domain_scores_gemma":[0.9985587,0.00038062877,0.000341055,0.0006118043,0.00005972427,0.000048067486],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031960662,0.00033164475,0.0007366765,0.00009378151,0.000117231415,0.000017337998,0.00048270702,0.00039017404,0.0024306427],"category_scores_gemma":[0.000007039965,0.00017319061,0.00016958694,0.00020729138,0.0008630871,0.00005056927,0.00007515161,0.0015839137,0.000017639119],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067616266,0.000479774,0.0085694315,0.00006561482,0.00022272719,0.00049960415,0.00088768906,0.000005229896,0.0000901668,0.0000037632674,0.97952497,0.0089748455],"study_design_scores_gemma":[0.0026328566,0.0012337293,0.04819363,0.00012083519,0.0006445318,0.000089313115,0.00014530706,0.000026010335,0.0002908797,0.00005741433,0.9463848,0.00018073317],"about_ca_topic_score_codex":0.032468155,"about_ca_topic_score_gemma":0.007381742,"teacher_disagreement_score":0.039624196,"about_ca_system_score_codex":0.00044499332,"about_ca_system_score_gemma":0.00026797992,"threshold_uncertainty_score":0.9984813},"labels":[],"label_agreement":null},{"id":"W2160028800","doi":"10.4081/oncol.2014.255","title":"RETRACTION: Challenges of combined everolimus/endocrine therapy in hormone receptor-positive metastatic breast cancer","year":2014,"lang":"en","type":"article","venue":"Oncology Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Audience measurement; Breast cancer; Clinical Oncology; Oncology; Editorial board; Internal medicine; Metastatic breast cancer; Plagiarism detection; Cancer; Medical education; Library science; Computer science","score_opus":0.06968587968049916,"score_gpt":0.39936712464648183,"score_spread":0.32968124496598267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160028800","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5105131,0.39730486,0.000014562503,0.060290266,0.0017117228,0.0038567795,0.00006682106,0.00006432912,0.02617751],"genre_scores_gemma":[0.4494582,0.54733247,0.0003054159,0.001415331,0.0002869523,0.00045067928,0.000030268857,0.000019907697,0.0007007777],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983124,0.0005506938,0.00052207266,0.00027299972,0.000105097,0.00023674255],"domain_scores_gemma":[0.9990694,0.00021896978,0.00031435667,0.00021423481,0.00009046099,0.0000925907],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00056083495,0.00019477599,0.0011890426,0.000115757844,0.000026716092,0.000001670136,0.00007638725,0.00008870524,0.0012026454],"category_scores_gemma":[0.000033220418,0.0001449072,0.00014165441,0.00021242716,0.000106499385,0.00006108892,0.00001894598,0.00029571212,0.00006117385],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004525924,0.0026080208,0.0075554145,0.00028484318,0.00045449226,0.000047394504,0.0006473092,0.0000016728775,0.020012401,0.00050291885,0.023973623,0.939386],"study_design_scores_gemma":[0.0157767,0.008522894,0.1812404,0.00034678826,0.00048239125,0.00031007067,0.000072114206,0.000025593996,0.0020174175,0.00014234835,0.7908414,0.00022190902],"about_ca_topic_score_codex":0.0001897535,"about_ca_topic_score_gemma":0.00030065278,"teacher_disagreement_score":0.9391641,"about_ca_system_score_codex":0.00028847507,"about_ca_system_score_gemma":0.00012484848,"threshold_uncertainty_score":0.9997104},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["research_integrity"],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2160250214","doi":"10.4081/hpr.2013.e28","title":"Ten weeks of home-based exercise attenuates symptoms of chemotherapy-induced peripheral neuropathy in breast cancer patients","year":2013,"lang":"en","type":"article","venue":"Health psychology research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Quality of life (healthcare); Peripheral neuropathy; Physical therapy; Chemotherapy-induced peripheral neuropathy; Cancer; Chemotherapy; Analysis of variance; Internal medicine","score_opus":0.06070954127193492,"score_gpt":0.46254278573638935,"score_spread":0.40183324446445445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160250214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9615275,0.00051172863,3.8961326e-7,0.035866413,0.00023013816,0.001487,0.0000398409,0.000014741673,0.0003222047],"genre_scores_gemma":[0.9947606,0.0008241572,0.00003078524,0.0036128918,0.00007658129,0.00043742015,0.00002666519,0.000034101784,0.00019682528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757254,0.0004968994,0.00051345525,0.0003849582,0.0003618864,0.0006702555],"domain_scores_gemma":[0.9986867,0.00013366892,0.00015084626,0.0003373956,0.00045486935,0.0002365204],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006068913,0.00015210036,0.0005989688,0.00048054568,0.00006034901,0.000003551857,0.00016745123,0.00014836475,0.0018673989],"category_scores_gemma":[0.000014263461,0.00012685538,0.00007098524,0.0006518402,0.00027663904,0.00004485702,0.000029441882,0.0005798686,0.00002916837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026383854,0.0025082843,0.9170689,0.00037853906,0.00003843644,0.000006980323,0.00076039473,0.0000013407029,0.012268645,0.0000016826415,0.009570205,0.05475821],"study_design_scores_gemma":[0.010741939,0.0034385656,0.9840456,0.00022429661,0.000010050579,0.000005624397,0.000039544182,0.00007667409,0.0010397498,0.000020741005,0.00028053386,0.000076627475],"about_ca_topic_score_codex":0.0031760242,"about_ca_topic_score_gemma":0.0000787311,"teacher_disagreement_score":0.066976756,"about_ca_system_score_codex":0.00019713918,"about_ca_system_score_gemma":0.0005093809,"threshold_uncertainty_score":0.999045},"labels":[],"label_agreement":null},{"id":"W2160719528","doi":"10.1200/jco.2009.24.0143","title":"Phase I/II Trial of Metronomic Chemotherapy With Daily Dalteparin and Cyclophosphamide, Twice-Weekly Methotrexate, and Daily Prednisone As Therapy for Metastatic Breast Cancer Using Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor Levels As Markers of Response","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Clinical Oncology Group; University of Toronto; Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Medicine; Cyclophosphamide; Internal medicine; Metastatic breast cancer; Prednisone; Vascular endothelial growth factor; Chemotherapy; Gastroenterology; Clinical endpoint; Breast cancer; Phases of clinical research; Oncology; Progressive disease; Methotrexate; Cancer; Surgery; Clinical trial","score_opus":0.08840411151474677,"score_gpt":0.4399860116120404,"score_spread":0.3515819000972936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160719528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916575,0.0030165347,0.0003069877,0.0021831724,0.00063110667,0.0017359693,0.00043211956,0.000010795163,0.000025790021],"genre_scores_gemma":[0.97407264,0.013212669,0.010957803,0.0008591062,0.0006675549,0.000032531305,0.0000068459476,0.00006035999,0.00013049616],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99533814,0.0011099189,0.0021676198,0.00051391934,0.00043714323,0.0004332839],"domain_scores_gemma":[0.9921198,0.004246203,0.0023633698,0.00022197001,0.00054056355,0.00050810573],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029689393,0.00044291222,0.003023461,0.00031259234,0.000115339935,0.000020163277,0.00017611087,0.00033307535,0.00031390996],"category_scores_gemma":[0.0010446403,0.00031403193,0.0005817726,0.00019342422,0.0005601697,0.00028204935,0.00004178569,0.00051790284,3.0003366e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76820713,0.0071963603,0.0063708536,0.00010622295,0.006018931,0.00004690453,0.00068443577,0.0000043856785,0.1335539,0.00001911917,0.00018401559,0.07760774],"study_design_scores_gemma":[0.61076075,0.25363556,0.09459596,0.0002052459,0.0035518666,0.0003504487,0.0002288768,0.00013890717,0.029498894,0.00038987584,0.0062081763,0.0004354336],"about_ca_topic_score_codex":0.00043243263,"about_ca_topic_score_gemma":0.000020812962,"teacher_disagreement_score":0.2464392,"about_ca_system_score_codex":0.00022936691,"about_ca_system_score_gemma":0.002471365,"threshold_uncertainty_score":0.99993116},"labels":[],"label_agreement":null},{"id":"W2161255937","doi":"","title":"Efficacy of S-1 in patients with capecitabine-resistant breast cancer-Japan Breast Cancer Research Network (JBCRN) 04-1 trial.","year":2010,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Capecitabine; Breast cancer; Internal medicine; Nausea; Metastatic breast cancer; Vomiting; Adverse effect; Oncology; Cancer; Population; Surgery","score_opus":0.02927711627484918,"score_gpt":0.3232388542011592,"score_spread":0.29396173792631003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161255937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99078476,0.00024797994,1.5612694e-7,0.0029690186,0.0009359005,0.0036427437,0.0002975451,0.000030443756,0.0010914722],"genre_scores_gemma":[0.9929778,0.000103353734,0.00001803223,0.00013018739,0.0013962208,0.0043062717,0.000048734684,0.00004561839,0.000973766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973841,0.00012886459,0.00041834003,0.00043697763,0.00061310694,0.0010186647],"domain_scores_gemma":[0.9985459,0.0002019073,0.0001507508,0.0003777133,0.00038806014,0.00033571201],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006550061,0.0002270049,0.0005614896,0.00024399978,0.000094338255,0.000016734113,0.00018603148,0.00014111442,0.0009544838],"category_scores_gemma":[0.000034683468,0.00016814722,0.000085327476,0.00090466277,0.00026757794,0.00008797826,0.00006955106,0.00064233394,0.000005228345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17665936,0.0020546122,0.72954583,0.00007781598,0.00028433595,0.000014955756,0.00016058629,0.000026816331,0.0002678049,0.000038058526,0.0064038155,0.084466],"study_design_scores_gemma":[0.08741987,0.00030452333,0.9094566,0.00007117896,0.00016912393,0.0000057170405,0.000015261534,0.0000044551834,0.00012714944,0.0000098724295,0.0022675279,0.00014871116],"about_ca_topic_score_codex":0.0065638567,"about_ca_topic_score_gemma":0.009993191,"teacher_disagreement_score":0.17991076,"about_ca_system_score_codex":0.0003839539,"about_ca_system_score_gemma":0.000417203,"threshold_uncertainty_score":0.99995875},"labels":[],"label_agreement":null},{"id":"W2162143119","doi":"","title":"Unusual Isomerisation of Cubebene","year":2006,"lang":"es","type":"article","venue":"Redalyc (Universidad Autónoma del Estado de México)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Environment and Climate Change Canada; Université de Moncton","funders":"","keywords":"Chemistry; Isomerization; Methanol; Extraction (chemistry); Chromatography; Microwave irradiation; Solvent; Mass spectrometry; Nuclear chemistry; Organic chemistry","score_opus":0.014694691744423342,"score_gpt":0.2722792719765884,"score_spread":0.2575845802321651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162143119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9601409,0.0036087853,0.0007632482,0.0015225798,0.0005428688,0.0005346289,0.00015187093,0.00011853964,0.032616574],"genre_scores_gemma":[0.9856592,0.0007896303,0.00079846766,0.0001619764,0.0007041455,0.000009395331,0.00024247031,0.00006599702,0.011568744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976603,0.00017243529,0.00052587956,0.00054169836,0.00040406885,0.000695659],"domain_scores_gemma":[0.99845195,0.00018139399,0.00045911683,0.00045552207,0.00020402973,0.00024798143],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021374215,0.00043317612,0.00075682544,0.0007245221,0.00018088841,0.000036878453,0.00025248638,0.0004155471,0.0013501791],"category_scores_gemma":[0.000020514562,0.0004953485,0.0003566334,0.0009244991,0.00034904733,0.00030005738,0.000104591214,0.00034273765,0.00014406187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045060324,0.0057710637,0.5155522,0.0017482964,0.002258193,0.002421593,0.0031333927,0.0015446157,0.28957736,0.06465333,0.030044593,0.0787893],"study_design_scores_gemma":[0.015766291,0.002991682,0.8673187,0.0005907622,0.0038252356,0.0002588213,0.0027189157,0.00987376,0.045275908,0.00111788,0.049223196,0.0010388336],"about_ca_topic_score_codex":0.00409906,"about_ca_topic_score_gemma":0.00013536798,"teacher_disagreement_score":0.3517665,"about_ca_system_score_codex":0.00092485646,"about_ca_system_score_gemma":0.00071155996,"threshold_uncertainty_score":0.99974984},"labels":[],"label_agreement":null},{"id":"W2162200636","doi":"10.1634/theoncologist.2013-0160","title":"Bevacizumab for Advanced Breast Cancer: Hope, Hype, and Hundreds of Headlines","year":2013,"lang":"en","type":"article","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; Queen's University; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Bevacizumab; Breast cancer; Newspaper; Headline; Food and drug administration; Family medicine; Clinical trial; Metastatic breast cancer; Cancer; Oncology; Internal medicine; Advertising; Pharmacology; Chemotherapy","score_opus":0.024574839051825687,"score_gpt":0.35788425867525075,"score_spread":0.3333094196234251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162200636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680918,0.0026616068,0.000015573582,0.025420953,0.00022860851,0.0011832844,0.0000898693,0.00003120216,0.0022771026],"genre_scores_gemma":[0.9934361,0.0013861391,0.00046382277,0.00087076845,0.00025702832,0.0004964293,0.00001485462,0.000012679792,0.0030622077],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994471,0.000021680751,0.00016316179,0.0001352501,0.000062788575,0.00016999034],"domain_scores_gemma":[0.99940044,0.00017499698,0.00009200111,0.00014011766,0.00013305854,0.000059402348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007924684,0.00009869097,0.00028413386,0.000028656328,0.00007117541,0.000005875123,0.0000701094,0.00005316589,0.0003223216],"category_scores_gemma":[0.000018323635,0.000059837417,0.000052704574,0.00008673441,0.00025866056,0.000044583812,0.000031926844,0.000068265756,0.0000076216756],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050772442,0.0009428392,0.03313624,0.00037797683,0.00051372044,0.000009850852,0.0006863078,0.000051524523,0.060551476,0.0006691035,0.077755205,0.8202285],"study_design_scores_gemma":[0.053340115,0.011486178,0.64630514,0.00033287305,0.002811851,0.0008181471,0.0017006447,0.0017004772,0.03436203,0.0043895356,0.24195477,0.0007982104],"about_ca_topic_score_codex":0.0011536613,"about_ca_topic_score_gemma":0.0003295299,"teacher_disagreement_score":0.8194303,"about_ca_system_score_codex":0.000085744454,"about_ca_system_score_gemma":0.00011622723,"threshold_uncertainty_score":0.35291958},"labels":[],"label_agreement":null},{"id":"W2165283639","doi":"10.3747/co.v15i5.285","title":"Vera Peters and the Curability of Hodgkin Disease","year":2008,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Disease; Radiation therapy; Cure rate; Surgery; Internal medicine","score_opus":0.15817710254977507,"score_gpt":0.4499870116427799,"score_spread":0.2918099090930048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165283639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987144,0.0061809923,0.000010469892,0.004391132,0.0006806688,0.00038420135,0.0000110811925,0.000013611438,0.0011838219],"genre_scores_gemma":[0.99714863,0.0022890214,0.000024634253,0.00022223407,0.00014182994,0.000049781687,0.000012888018,0.000004296523,0.00010668768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993922,0.00012170401,0.00015448742,0.00014046041,0.00007273518,0.00011837758],"domain_scores_gemma":[0.9993916,0.00025344497,0.00006123105,0.00013827573,0.00004367419,0.00011178709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012088533,0.00007550708,0.00027015808,0.000030241714,0.00005159685,8.436491e-7,0.000041696458,0.000028836683,0.00019741918],"category_scores_gemma":[0.00006784676,0.000046017904,0.00007711289,0.000058689217,0.0006251081,0.000018333843,0.000034513192,0.00012262151,0.0000066915154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011817091,0.0028905265,0.8839103,0.00029228887,0.00020273843,0.00011361472,0.0031160507,0.0000022964916,0.00038079068,0.0016400991,0.022109099,0.07352512],"study_design_scores_gemma":[0.020838916,0.0011543862,0.69603235,0.000029219887,0.0006168457,0.00013098292,0.00006360566,0.00022521039,0.00021507667,0.0006473058,0.27994278,0.000103299855],"about_ca_topic_score_codex":0.000019081464,"about_ca_topic_score_gemma":0.0000060265775,"teacher_disagreement_score":0.2578337,"about_ca_system_score_codex":0.000076312645,"about_ca_system_score_gemma":0.000195593,"threshold_uncertainty_score":0.23032367},"labels":[],"label_agreement":null},{"id":"W2165819904","doi":"10.1002/cncr.22867","title":"The impact of new chemotherapeutic and hormone agents on survival in a population‐based cohort of women with metastatic breast cancer","year":2007,"lang":"en","type":"article","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":464,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Sanofi; Pfizer; Amgen","keywords":"Medicine; Cohort; Metastatic breast cancer; Breast cancer; Internal medicine; Proportional hazards model; Population; Oncology; Cancer; Cohort study; Survival analysis","score_opus":0.03273867528746455,"score_gpt":0.38064044840896855,"score_spread":0.347901773121504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165819904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770576,0.0013709009,0.0000063890984,0.00033998542,0.00004198552,0.00037391836,0.000033383512,0.0000044811077,0.00012322536],"genre_scores_gemma":[0.9990553,0.00042961424,0.000014497152,0.00014535282,0.000046105586,0.000042124953,0.000005543841,0.000013069152,0.00024837488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993648,0.00001600522,0.00016379112,0.000111152745,0.00013821147,0.00020604894],"domain_scores_gemma":[0.9995966,0.00006569853,0.00010129588,0.000100516554,0.000039664006,0.000096211865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017384536,0.00009958582,0.00027425133,0.00006828762,0.000017999659,0.000002449358,0.00003153586,0.00002175006,0.00029546866],"category_scores_gemma":[0.0000025578956,0.00005661495,0.00003051783,0.00021149521,0.000052639567,0.000019490717,0.000004366623,0.00006206839,2.645656e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066523817,0.00014485848,0.972804,0.00003055785,0.0005102102,0.0000041216854,0.00045708084,0.00023332384,0.0019807653,0.000004629884,0.00017776553,0.017000299],"study_design_scores_gemma":[0.005182417,0.0005570535,0.9929947,0.000059243946,0.00014638048,0.000003239374,0.000042074582,0.000115921284,0.00075584743,0.000015504002,0.00007523637,0.00005238337],"about_ca_topic_score_codex":0.016767135,"about_ca_topic_score_gemma":0.0018592931,"teacher_disagreement_score":0.020190693,"about_ca_system_score_codex":0.00068755884,"about_ca_system_score_gemma":0.0003193346,"threshold_uncertainty_score":0.9897803},"labels":[],"label_agreement":null},{"id":"W2166839079","doi":"10.1016/j.jval.2012.08.1244","title":"PCN51 Comprehensive Investigation of Adverse Event (AE)-Related Costs in Patients With Metastatic Breast Cancer (mBC) Treated With First- and Second-Line Chemotherapies","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Capecitabine; Taxane; Medicine; Internal medicine; Docetaxel; Oncology; Pharmacy; Metastatic breast cancer; Adverse effect; Cancer; Breast cancer; Colorectal cancer","score_opus":0.027592431451381228,"score_gpt":0.30222845176798424,"score_spread":0.274636020316603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166839079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606556,0.0015630424,0.0000012910014,0.0011275192,0.000045375975,0.001086329,0.000082736464,0.000013217858,0.000014945858],"genre_scores_gemma":[0.9987343,0.00034510472,0.00021991263,0.0004729147,0.00001635366,0.0000601884,0.00009187321,0.000019801748,0.000039572296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989655,0.00012308075,0.00034465734,0.00016678392,0.00014276947,0.00025722192],"domain_scores_gemma":[0.9993402,0.000101043704,0.00021811397,0.000096029384,0.0000814952,0.0001631616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121689,0.0001550606,0.00041452402,0.00017811876,0.000027438595,0.0000011700758,0.000022173614,0.00003919613,0.00015241501],"category_scores_gemma":[0.0000035550959,0.00011069745,0.000017157772,0.0003448195,0.00010470702,0.00009572687,0.000008235395,0.00012714314,0.0000011453919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018107756,0.00051440333,0.99233603,0.0005332075,0.0001637504,0.000003848793,0.0031077925,0.00064249866,0.0000775244,0.000012435506,0.000046605517,0.00075112423],"study_design_scores_gemma":[0.014444132,0.001369468,0.9821452,0.0008127916,0.000086106724,0.000014367534,0.00018324495,0.0004197418,0.00036570043,0.000007830903,0.000057238045,0.000094177885],"about_ca_topic_score_codex":0.011714443,"about_ca_topic_score_gemma":0.0021537666,"teacher_disagreement_score":0.012633357,"about_ca_system_score_codex":0.0004679698,"about_ca_system_score_gemma":0.00023504507,"threshold_uncertainty_score":0.9948666},"labels":[],"label_agreement":null},{"id":"W2167714668","doi":"10.1002/chin.200344277","title":"Synthetic Studies Related to CP‐225,917","year":2003,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemistry; Combinatorial chemistry","score_opus":0.033175939345156016,"score_gpt":0.35929669059900743,"score_spread":0.3261207512538514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167714668","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2131728,0.0016598975,1.06504565e-7,0.0012060629,0.00034046877,0.0002750744,0.000001937828,0.00006533769,0.78327835],"genre_scores_gemma":[0.8593218,0.00025097895,0.00005447069,0.0010969588,0.00003850013,0.000060193182,0.000007935008,0.00001189684,0.13915728],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994625,3.999106e-7,0.00014868258,0.000119931436,0.00008352234,0.00018498559],"domain_scores_gemma":[0.9996067,0.000046917783,0.000027867849,0.00015060973,0.00005264086,0.00011524669],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000072340474,0.00010211472,0.00020465086,0.00004686609,0.00003873914,0.0000035217229,0.00003260039,0.00005087735,0.001065553],"category_scores_gemma":[0.00011504159,0.00007988029,0.00005531342,0.00014569498,0.000041739142,0.000029391833,0.00001610356,0.00007858953,0.00041143742],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055244355,0.0005686235,0.0040623173,0.00043905262,0.0017760568,0.0002437642,0.014250734,0.0000020530572,0.022609346,0.0034927155,0.6798068,0.27219602],"study_design_scores_gemma":[0.0018638273,0.00031255145,0.00049940974,0.000070733826,0.00023790708,0.00012507058,0.00069582445,9.1008155e-7,0.40689862,0.00022635829,0.58893204,0.00013675583],"about_ca_topic_score_codex":0.0000030201727,"about_ca_topic_score_gemma":0.000001966677,"teacher_disagreement_score":0.646149,"about_ca_system_score_codex":0.0001530573,"about_ca_system_score_gemma":0.000054514952,"threshold_uncertainty_score":0.9998476},"labels":[],"label_agreement":null},{"id":"W2167856990","doi":"10.1145/2608628.2608666","title":"Quantifier elimination by cylindrical algebraic decomposition based on regular chains","year":2014,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Natural Science Foundation of China","keywords":"Quantifier elimination; Decomposition; Algebraic number; Quantifier (linguistics); Mathematics; Algebra over a field; Computer science; Discrete mathematics; Pure mathematics; Artificial intelligence; Mathematical analysis; Chemistry","score_opus":0.01181799080922886,"score_gpt":0.3242395777388102,"score_spread":0.31242158692958133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167856990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8607994,0.00007211538,0.037364766,0.042282924,0.0005257149,0.0006481246,0.0000095782925,0.00021247928,0.05808491],"genre_scores_gemma":[0.98909813,0.0000068212294,0.0004937698,0.0052825264,0.00015973348,0.000025965017,0.0002844332,0.000011610015,0.0046369988],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993789,0.000052547133,0.000113112364,0.00018146836,0.0001445255,0.00012944204],"domain_scores_gemma":[0.9996274,0.00009236649,0.00002983086,0.00012958268,0.000036363133,0.00008441588],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010910435,0.00008983512,0.00013274816,0.000077238044,0.000047375142,0.000006971627,0.00002702008,0.00007344824,0.0009762564],"category_scores_gemma":[0.000015588948,0.00007191984,0.00005648388,0.00008311556,0.000024269782,0.00002434412,0.000004598075,0.000074909025,0.00012373789],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003981971,0.006046383,0.008074336,0.00015508676,0.00023437558,0.00004639315,0.00026186588,0.00019775312,0.3827773,0.041932166,0.40790683,0.14838554],"study_design_scores_gemma":[0.01740497,0.0073968293,0.059827253,0.000099911216,0.0005697146,0.000029878378,0.000027357333,0.3803543,0.39646444,0.0005200498,0.13682462,0.00048066265],"about_ca_topic_score_codex":0.000018539473,"about_ca_topic_score_gemma":0.000007055141,"teacher_disagreement_score":0.38015655,"about_ca_system_score_codex":0.00008155175,"about_ca_system_score_gemma":0.000020484898,"threshold_uncertainty_score":0.999937},"labels":[],"label_agreement":null},{"id":"W2168503278","doi":"10.1080/07357900601063766","title":"A Systematic Review on Drug Interactions in Oncology","year":2006,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Drug; Oncology; Clinical Oncology; Internal medicine; Pharmacology; Medical physics; Cancer","score_opus":0.1370314656954665,"score_gpt":0.47981807028664536,"score_spread":0.3427866045911788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168503278","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009285002,0.9901428,4.7393067e-7,0.0012628958,0.0007357862,0.0043921643,0.000035832607,0.000046175373,0.0033745887],"genre_scores_gemma":[0.0000047730664,0.98419017,0.000023835475,0.0029570416,0.000368365,0.006138625,0.00061584235,0.000041202864,0.005660121],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.997897,0.00040479796,0.0009823962,0.00036340716,0.00015751213,0.00019484073],"domain_scores_gemma":[0.9985819,0.0003188457,0.00064184045,0.00028551856,0.000062179344,0.00010974249],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002554113,0.00033360816,0.0026416702,0.00033792463,0.000032719418,0.000008050872,0.00009251917,0.000100491925,0.00024769458],"category_scores_gemma":[0.00009334994,0.00024954288,0.0003266026,0.00055311364,0.00006556145,0.00005209676,0.000016599666,0.0005322777,0.00018160017],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000069908356,0.000100816585,0.000009460615,0.9014798,0.00019165092,0.00003909809,0.000049376667,0.0000011686492,4.8682887e-7,0.000051680203,0.04517108,0.052898407],"study_design_scores_gemma":[0.0002494853,0.000044103985,0.0000029778278,0.50565654,0.0043879943,0.000039586463,0.0000021115138,0.0000031541751,0.0000015252662,0.00001917888,0.4894903,0.0001030219],"about_ca_topic_score_codex":0.00043945218,"about_ca_topic_score_gemma":0.00083542697,"teacher_disagreement_score":0.44431922,"about_ca_system_score_codex":0.0028134228,"about_ca_system_score_gemma":0.0012308785,"threshold_uncertainty_score":0.9999957},"labels":[],"label_agreement":null},{"id":"W2169216883","doi":"10.1158/1078-0432.ccr-06-2385","title":"Dose-Escalating and Pharmacologic Study of Oxaliplatin in Adult Cancer Patients with Impaired Hepatic Function: A National Cancer Institute Organ Dysfunction Working Group Study","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Oxaliplatin; Medicine; Bilirubin; Gastroenterology; Internal medicine; Liver function tests; Liver function; Liver transplantation; Population; Cancer; Colorectal cancer; Transplantation","score_opus":0.21210268984697117,"score_gpt":0.5243792897065563,"score_spread":0.31227659985958517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169216883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454254,0.00043497235,0.0000068268187,0.00030574616,0.0009479346,0.0034999505,0.000013700571,0.000035920755,0.00021241228],"genre_scores_gemma":[0.9972874,0.00031805807,0.000027245042,0.0002703619,0.0008328736,0.001063142,0.000019377336,0.000033327466,0.00014821067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99600744,0.00048188845,0.0009995919,0.00071428024,0.0012463178,0.00055048644],"domain_scores_gemma":[0.99739915,0.0008701696,0.00027135148,0.00016678049,0.0010414814,0.00025105002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027575586,0.0002392155,0.00062928913,0.0004194556,0.00023612117,0.000023387762,0.00012213587,0.0001435069,0.00054531056],"category_scores_gemma":[0.00024963194,0.00018305007,0.000056629,0.0014632489,0.0003156294,0.0001696229,0.00013411975,0.0010093468,0.0000025146676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015478,0.008719612,0.9396569,0.00009700676,0.0005522699,0.000044999935,0.0013566939,0.00011233426,0.00025523294,0.0000054156994,0.00027030605,0.033451214],"study_design_scores_gemma":[0.031961273,0.010506468,0.9549303,0.0002559903,0.00033122138,0.0000011442812,0.001348297,0.00029812334,0.000039857838,0.000015088341,0.0001489448,0.00016330415],"about_ca_topic_score_codex":0.013259808,"about_ca_topic_score_gemma":0.08664895,"teacher_disagreement_score":0.07338914,"about_ca_system_score_codex":0.00095147296,"about_ca_system_score_gemma":0.000653598,"threshold_uncertainty_score":0.993311},"labels":[],"label_agreement":null},{"id":"W2170373770","doi":"10.1200/jco.2009.22.7504","title":"Phase II Multicenter Trial of Anthracycline Rechallenge With Pegylated Liposomal Doxorubicin Plus Cyclophosphamide for First-Line Therapy of Metastatic Breast Cancer Previously Treated With Adjuvant Anthracyclines","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Anthracycline; Metastatic breast cancer; Tolerability; Internal medicine; Breast cancer; Regimen; Cyclophosphamide; Cardiotoxicity; Surgery; Doxorubicin; Chemotherapy; Oncology; Neutropenia; Phases of clinical research; Taxane; Cancer; Adverse effect","score_opus":0.13392950609814425,"score_gpt":0.49925669367392583,"score_spread":0.3653271875757816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170373770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977602,0.0042006946,0.0001754374,0.0149160605,0.0005796363,0.0023117801,0.00012575985,0.000018666417,0.00006996141],"genre_scores_gemma":[0.96432054,0.030207954,0.003225541,0.00081123423,0.0011631604,0.00005229769,0.00003297604,0.000042638556,0.00014363167],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947332,0.00034932827,0.003676044,0.00037365087,0.00043897794,0.00042876782],"domain_scores_gemma":[0.9913203,0.0021450853,0.004456506,0.00028259234,0.0013998918,0.00039558482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001465147,0.00040149904,0.0038531914,0.0002266774,0.000076797136,0.0000043557584,0.00020887452,0.0003125055,0.0002391899],"category_scores_gemma":[0.00037769947,0.00022355437,0.00065906346,0.0003095473,0.000441955,0.00016830402,0.000021532927,0.0006420072,5.39394e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7371123,0.048668355,0.0045307237,0.00010807468,0.0028737427,0.00046150645,0.00036710897,0.00019545085,0.0024376037,0.00000512422,0.00038504176,0.202855],"study_design_scores_gemma":[0.57287806,0.39789906,0.014395643,0.00067446637,0.0034850228,0.00042558135,0.0000815599,0.0006514793,0.0056047263,0.000034403693,0.0036664458,0.00020358492],"about_ca_topic_score_codex":0.00011934403,"about_ca_topic_score_gemma":0.00037314586,"teacher_disagreement_score":0.3492307,"about_ca_system_score_codex":0.00018980159,"about_ca_system_score_gemma":0.0018258,"threshold_uncertainty_score":0.91162825},"labels":[],"label_agreement":null},{"id":"W2170649858","doi":"10.1093/annonc/mdm527","title":"Survival outcome and cost-effectiveness with docetaxel and paclitaxel in patients with metastatic breast cancer: a population-based evaluation","year":2007,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Docetaxel; Medicine; Paclitaxel; Oncology; Hazard ratio; Metastatic breast cancer; Internal medicine; Taxane; Breast cancer; Population; Confidence interval; Chemotherapy; Proportional hazards model; Survival analysis; Cancer","score_opus":0.11243892965338927,"score_gpt":0.48361352427535886,"score_spread":0.3711745946219696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170649858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99711794,0.00025167406,0.000041525233,0.00093510206,0.0000581197,0.0013431838,0.00005457761,0.000007155846,0.00019071368],"genre_scores_gemma":[0.99920064,0.000028949156,0.0001554222,0.00038314273,0.00001897587,0.00011376277,0.00007908449,0.000011407344,0.000008611952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896854,0.0001856824,0.00023718001,0.00020561086,0.00020666281,0.00019632367],"domain_scores_gemma":[0.9989561,0.00041077187,0.00015845244,0.00007969737,0.00030355278,0.000091433765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008814515,0.00012644763,0.00046085104,0.00017066501,0.000027769034,0.0000030969463,0.000020624837,0.000053646916,0.000053406697],"category_scores_gemma":[0.000028807714,0.00008903035,0.000019222505,0.00018118182,0.00009838164,0.00006417831,0.000008806765,0.00008806041,3.0986791e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008900711,0.00085848005,0.9347513,0.00011357712,0.00015542627,0.000014971333,0.0000824191,0.000086693624,0.0000355694,0.000027219885,0.000009556663,0.0549641],"study_design_scores_gemma":[0.02064289,0.0045187226,0.97393405,0.00007051061,0.00034521284,0.000010704265,0.000039478662,0.00016281706,0.000063563544,0.000032814,0.00009210482,0.00008710514],"about_ca_topic_score_codex":0.0016950442,"about_ca_topic_score_gemma":0.0038816675,"teacher_disagreement_score":0.054876994,"about_ca_system_score_codex":0.00013927302,"about_ca_system_score_gemma":0.00020373375,"threshold_uncertainty_score":0.36305523},"labels":[],"label_agreement":null},{"id":"W2171244965","doi":"10.1016/j.breast.2012.03.003","title":"1st International consensus guidelines for advanced breast cancer (ABC 1)","year":2012,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":299,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Consensus conference; Breast cancer; Medical physics; Family medicine; Cancer; Internal medicine","score_opus":0.08269649930811482,"score_gpt":0.4304189945483469,"score_spread":0.34772249524023213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171244965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5991054,0.004465705,0.00011970423,0.37683305,0.0057401867,0.0014423723,0.0020785083,0.00016219777,0.010052883],"genre_scores_gemma":[0.9841561,0.00016970957,0.00054014684,0.003969753,0.00358429,0.00021630528,0.00007106369,0.000023103164,0.007269576],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993361,0.00001523581,0.00016986372,0.000114547576,0.00011621438,0.00024802692],"domain_scores_gemma":[0.9993056,0.00008072566,0.000066807486,0.00013597381,0.00030947145,0.00010139755],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013085199,0.000114929375,0.00015417972,0.000031795535,0.000078781064,0.0000066158436,0.00008965376,0.00003600747,0.0012524526],"category_scores_gemma":[0.000018702935,0.000071166374,0.00008593183,0.000057651414,0.00007847498,0.000041376414,0.000028653223,0.000066561006,0.000046568155],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007981548,0.0008525573,0.10425535,0.00007657473,0.0011996514,0.000009844345,0.0006497621,0.00007487491,0.03304082,0.0017511599,0.5662568,0.28385103],"study_design_scores_gemma":[0.014949105,0.0001755558,0.28377613,0.00017814954,0.0010698801,0.0063900417,0.0004999405,0.000709417,0.0036815233,0.00026603317,0.68791056,0.00039365215],"about_ca_topic_score_codex":0.0001969991,"about_ca_topic_score_gemma":0.000043133157,"teacher_disagreement_score":0.38505065,"about_ca_system_score_codex":0.0001045519,"about_ca_system_score_gemma":0.0000775477,"threshold_uncertainty_score":0.99966055},"labels":[],"label_agreement":null},{"id":"W2174423882","doi":"10.1007/s10549-015-3643-5","title":"Correlation between progression-free survival and overall survival in metastatic breast cancer patients receiving anthracyclines, taxanes, or targeted therapies: a trial-level meta-analysis","year":2015,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Hazard ratio; Metastatic breast cancer; Oncology; Breast cancer; Progression-free survival; Randomized controlled trial; Clinical trial; Meta-analysis; Cancer; Overall survival; Confidence interval","score_opus":0.3655082059876479,"score_gpt":0.5081216217604009,"score_spread":0.142613415772753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174423882","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006154077,0.9711132,0.0000031789707,0.0012411913,0.0002909236,0.0067812023,0.0143079655,0.00004362248,0.000064657404],"genre_scores_gemma":[0.010927355,0.9771853,0.00009186485,0.000015560981,0.0005241415,0.0065722642,0.0024915251,0.00011518766,0.0020767765],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99319506,0.0017093999,0.0012348428,0.0013579159,0.0015010071,0.0010017921],"domain_scores_gemma":[0.99595916,0.0013050797,0.00063800084,0.00067019946,0.0006945771,0.0007329952],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001525147,0.0010191388,0.0061392942,0.0012143067,0.000259822,0.00013569323,0.00022117973,0.00029286646,0.0012242007],"category_scores_gemma":[0.00007695355,0.0005738579,0.00080200535,0.0018119651,0.00032467415,0.00021953021,0.0002261682,0.00065108796,0.000006799866],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02469307,0.00370095,0.03466239,0.0021969127,0.16481526,0.00018400566,0.0002883394,0.000003070931,2.5354902e-7,0.000008090458,0.00048491315,0.76896274],"study_design_scores_gemma":[0.1427883,0.009544821,0.13069504,0.0033842716,0.5642329,0.00014145266,0.000170889,0.000052934924,0.0000012787898,0.00012978716,0.14727843,0.0015799106],"about_ca_topic_score_codex":0.024972081,"about_ca_topic_score_gemma":0.018143449,"teacher_disagreement_score":0.76738286,"about_ca_system_score_codex":0.0021718666,"about_ca_system_score_gemma":0.0026349074,"threshold_uncertainty_score":0.99977285},"labels":[],"label_agreement":null},{"id":"W2175453042","doi":"10.1007/s10549-015-3633-7","title":"Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute; Medical Research Council; Eisai; Celgene","keywords":"Capecitabine; Medicine; Eribulin; Metastatic breast cancer; Internal medicine; Nausea; Breast cancer; Quality of life (healthcare); Randomized controlled trial; Oncology; Cancer; Surgery; Nursing","score_opus":0.1701282498210228,"score_gpt":0.486875781200225,"score_spread":0.3167475313792022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175453042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98264474,0.0016742283,0.0000026164112,0.003377606,0.00005272502,0.010677757,0.0014961994,0.000026404792,0.000047741654],"genre_scores_gemma":[0.9922891,0.00133617,0.00022562568,0.00010700582,0.000049503706,0.0048051113,0.00041211364,0.000058993577,0.0007163657],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9951771,0.0013015511,0.0011262066,0.0007750119,0.0007803199,0.0008398286],"domain_scores_gemma":[0.99713224,0.0003498573,0.0003941934,0.0003761529,0.0007221677,0.0010253898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012940458,0.0004667398,0.0025114175,0.00043337644,0.00009663305,0.00004662913,0.00017219079,0.000086494154,0.0006234852],"category_scores_gemma":[0.000056215475,0.00023926172,0.000042719916,0.0012212034,0.00048445247,0.00033001965,0.00007063529,0.00028882688,0.0000025363238],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8580164,0.024132835,0.06592083,0.00012340807,0.0012443179,0.00021323982,0.0007134143,0.000056304994,0.000029762292,0.000010294074,0.000055235745,0.049483966],"study_design_scores_gemma":[0.8900327,0.043679215,0.06474781,0.0005063728,0.0002522218,0.00003513648,0.00022463029,0.00019356469,0.000046241857,0.000014795595,0.000030271958,0.00023701446],"about_ca_topic_score_codex":0.12224705,"about_ca_topic_score_gemma":0.12047834,"teacher_disagreement_score":0.049246952,"about_ca_system_score_codex":0.0019424135,"about_ca_system_score_gemma":0.0055193314,"threshold_uncertainty_score":0.9791057},"labels":[],"label_agreement":null},{"id":"W2186928475","doi":"","title":"A single-institution chart review of breast cancer patients treated with adjuvant chemotherapy","year":2008,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Epirubicin; Cyclophosphamide; Docetaxel; Breast cancer; Chemotherapy; Internal medicine; Cancer; Incidence (geometry); Oncology; Surgery","score_opus":0.023849372199779895,"score_gpt":0.3001158674870531,"score_spread":0.2762664952872732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186928475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831658,0.0063691447,0.0000061009086,0.0019926121,0.000057204605,0.0006869084,0.000039926483,0.00004496573,0.007637328],"genre_scores_gemma":[0.9603462,0.0344346,0.00005511005,0.0031710067,0.00006537041,0.00005394624,0.00006881639,0.000011272969,0.0017936486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994607,0.000011288414,0.0001542146,0.00013066831,0.00013162063,0.000111529334],"domain_scores_gemma":[0.9996067,0.000005609664,0.000073125164,0.00009316433,0.0001587158,0.00006267309],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000018528799,0.000104291285,0.00029870743,0.000036241607,0.000027839798,6.481941e-7,0.000022608314,0.000027773853,0.0022276365],"category_scores_gemma":[0.0000015503819,0.00006359993,0.00004928747,0.00016251853,0.00007623067,0.000040388088,0.0000038038502,0.000038513,0.000009488267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023260624,0.0033760814,0.921834,0.0019373485,0.0004334645,0.00004852284,0.0001872319,4.603345e-7,0.0070752683,0.000016159021,0.02675409,0.036011297],"study_design_scores_gemma":[0.016330028,0.0027554915,0.9075374,0.006035275,0.00062900037,0.00030293906,0.0000061417095,0.000014094171,0.03606029,7.540782e-7,0.030110758,0.00021783721],"about_ca_topic_score_codex":0.00038005915,"about_ca_topic_score_gemma":0.000031242165,"teacher_disagreement_score":0.035793457,"about_ca_system_score_codex":0.000119362485,"about_ca_system_score_gemma":0.000110746885,"threshold_uncertainty_score":0.99868447},"labels":[],"label_agreement":null},{"id":"W2187105577","doi":"10.1016/j.ejca.2015.10.017","title":"Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)","year":2015,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Celgene","keywords":"Medicine; Gemcitabine; Internal medicine; Common Terminology Criteria for Adverse Events; Hazard ratio; Gastroenterology; Peripheral neuropathy; Adverse effect; Pancreatic cancer; Cancer; Surgery; Oncology; Confidence interval","score_opus":0.03435072441050757,"score_gpt":0.3016408263974451,"score_spread":0.26729010198693753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2187105577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709594,0.0013075761,0.00011265461,0.000116952906,0.00011276409,0.0010802267,0.00013412267,0.0000038294097,0.000035936984],"genre_scores_gemma":[0.99860764,0.00006465833,0.00090194814,0.000021994041,0.00014365208,0.000032638596,0.00002543548,0.000029775174,0.00017224009],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99821925,0.00034738352,0.0005752071,0.0001652132,0.000516621,0.00017633486],"domain_scores_gemma":[0.99776846,0.00010703081,0.0012170466,0.00011095686,0.00062083686,0.00017565105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046146289,0.00020538173,0.0008712917,0.000120344754,0.0000561701,0.00001251849,0.00007268448,0.0000139746035,0.0000340604],"category_scores_gemma":[0.000050282317,0.00010138977,0.0001454011,0.0002685753,0.00004091554,0.0000905463,0.000013439717,0.00008978017,1.03376834e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76456773,0.001038561,0.21246995,0.000047026057,0.011310639,0.000064052205,0.0075178053,0.0002477708,0.0013409082,3.9034117e-7,0.000022055432,0.0013730888],"study_design_scores_gemma":[0.7249625,0.011197392,0.24846616,0.00013645687,0.011869088,0.000008215167,0.0003549675,0.000103281025,0.0025613648,3.933551e-7,0.00021926223,0.00012090901],"about_ca_topic_score_codex":0.000067863104,"about_ca_topic_score_gemma":0.000198275,"teacher_disagreement_score":0.039605252,"about_ca_system_score_codex":0.0005504513,"about_ca_system_score_gemma":0.0006624731,"threshold_uncertainty_score":0.4134555},"labels":[],"label_agreement":null},{"id":"W2192078226","doi":"10.1186/s13058-015-0657-1","title":"“New” metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapy","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute; Eisai","keywords":"Eribulin; Medicine; Internal medicine; Metastatic breast cancer; Capecitabine; Oncology; Breast cancer; Chemotherapy; Progression-free survival; Cancer; Metastasis; Colorectal cancer","score_opus":0.07619784674339677,"score_gpt":0.3900244424620759,"score_spread":0.3138265957186791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2192078226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99172086,0.0007033177,0.000010091838,0.0022843753,0.000026163272,0.0023939605,0.002602669,0.00006901329,0.00018953292],"genre_scores_gemma":[0.9972005,0.00008584599,0.00041101218,0.00012593268,0.000098057084,0.0011314,0.00029271955,0.00012543265,0.0005290973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99558854,0.0005007457,0.00044993623,0.00074487325,0.0017268503,0.0009890685],"domain_scores_gemma":[0.9962447,0.00021978054,0.0003809648,0.0003352415,0.0022363157,0.0005829964],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006838791,0.00049787224,0.0011019941,0.00063904806,0.00010914122,0.00004989832,0.00023624126,0.00008303686,0.00066491426],"category_scores_gemma":[0.000051191495,0.00030386847,0.00008586984,0.0025242209,0.0004121955,0.00028074576,0.000062386745,0.000493049,0.0000031083225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042156205,0.002827498,0.94384575,0.00021608343,0.0030394127,0.00014366556,0.000679526,0.000062585306,0.000105008745,0.000010156595,0.001688335,0.0052258032],"study_design_scores_gemma":[0.03097115,0.0032082442,0.958952,0.0016514373,0.0011303141,0.00007714797,0.00038621214,0.000034877943,0.0031684663,0.000010703373,0.00006231912,0.0003470892],"about_ca_topic_score_codex":0.0637517,"about_ca_topic_score_gemma":0.016330855,"teacher_disagreement_score":0.04742084,"about_ca_system_score_codex":0.0011778604,"about_ca_system_score_gemma":0.0022511738,"threshold_uncertainty_score":0.99994135},"labels":[],"label_agreement":null},{"id":"W2199478144","doi":"10.1016/j.ijrobp.2015.07.583","title":"Ablative Therapy for Metastatic Breast Cancer: A Systematic Review","year":2015,"lang":"en","type":"review","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Ablative case; Metastatic breast cancer; Metastasectomy; Radiosurgery; Radiofrequency ablation; Oncology; Breast cancer; Randomized controlled trial; Internal medicine; Cancer; Radiation therapy; Metastasis; Ablation","score_opus":0.09074799598402321,"score_gpt":0.47193643061539403,"score_spread":0.3811884346313708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2199478144","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009043622,0.98937523,0.000617536,0.0019690641,0.003070915,0.0036551428,0.0011263267,0.00002867233,0.00014808658],"genre_scores_gemma":[0.0000451819,0.99222785,0.00063322985,0.0020279589,0.0032928165,0.00085516874,0.00060699397,0.00007663207,0.0002341395],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962787,0.0007541962,0.0019727973,0.00033603073,0.0003683631,0.0002898863],"domain_scores_gemma":[0.9917288,0.0011300141,0.0045499234,0.00021816169,0.0021525389,0.00022056221],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012770194,0.000519579,0.004713146,0.00027475413,0.00005390072,0.000022175116,0.0005316343,0.0003131887,0.00017731123],"category_scores_gemma":[0.00026196695,0.00035193152,0.0013703333,0.00028073325,0.00014237431,0.00017854151,0.000043515058,0.0006075326,0.000037280683],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004514749,0.0009438991,0.00013152839,0.106416024,0.014711472,0.00006261997,0.00016211733,0.000005856824,0.0000031908432,0.00085764204,0.015935851,0.8603183],"study_design_scores_gemma":[0.006844134,0.0018072515,0.000007197779,0.10368783,0.016087683,0.0017748071,0.000014415852,0.000048576097,0.0000032593412,0.0012409958,0.86817724,0.00030662873],"about_ca_topic_score_codex":0.000014577698,"about_ca_topic_score_gemma":0.0000023269213,"teacher_disagreement_score":0.8600117,"about_ca_system_score_codex":0.0027256035,"about_ca_system_score_gemma":0.004088307,"threshold_uncertainty_score":0.99989325},"labels":[],"label_agreement":null},{"id":"W2204893626","doi":"10.1016/j.rmr.2015.10.645","title":"Faisabilité d’un programme de téléréadaptation en oncologie pulmonaire","year":2015,"lang":"fr","type":"article","venue":"Revue des Maladies Respiratoires","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec","funders":"","keywords":"Medicine; Gynecology","score_opus":0.1156381609690303,"score_gpt":0.3508482973574824,"score_spread":0.23521013638845212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2204893626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77438575,0.18101422,0.00015775152,0.013735544,0.003043876,0.001391672,0.000048905822,0.00026903962,0.02595325],"genre_scores_gemma":[0.91185886,0.008703459,0.005834074,0.0011348545,0.0060251057,0.0006796786,0.00006452562,0.000121886165,0.06557757],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99655557,0.00063095527,0.0005858018,0.0005708354,0.00027482415,0.0013819912],"domain_scores_gemma":[0.9975829,0.00068080926,0.00019937655,0.00041475522,0.00031949327,0.00080264645],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010371944,0.00044936486,0.00069003174,0.00015960616,0.0002541722,0.000077971585,0.00024523385,0.00046218536,0.00070608634],"category_scores_gemma":[0.001716666,0.00044177275,0.0002529042,0.00046730862,0.0009014368,0.00027785427,0.00013752955,0.00043913262,0.00027708255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013423564,0.0014917712,0.11320385,0.0019638499,0.00055186555,0.0017528612,0.010659603,0.00048104048,0.001598462,0.0028388146,0.012870476,0.85124505],"study_design_scores_gemma":[0.005002177,0.006908226,0.055192646,0.001346421,0.0011296438,0.0009636988,0.0041910456,0.002794249,0.0041579125,0.0055126543,0.9121483,0.00065303536],"about_ca_topic_score_codex":0.0004880266,"about_ca_topic_score_gemma":0.00080637436,"teacher_disagreement_score":0.8992778,"about_ca_system_score_codex":0.0032836108,"about_ca_system_score_gemma":0.0012032242,"threshold_uncertainty_score":0.9998034},"labels":[],"label_agreement":null},{"id":"W2207022446","doi":"10.1023/a:1008348010437","title":"Liposomal vincristine in relapsed non-Hodgkin's lymphomas: Early results of an ongoing phase II trial","year":2000,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Vincristine; Internal medicine; Regimen; Gastroenterology; Lymphoma; Chemotherapy; Surgery; Cyclophosphamide","score_opus":0.07069277781017202,"score_gpt":0.4396739486290902,"score_spread":0.3689811708189182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2207022446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718763,0.00018949523,4.6427908e-7,0.0024349513,0.00027257073,0.00062456686,0.00007535381,0.000021918833,0.024504371],"genre_scores_gemma":[0.99670064,0.00025469402,0.00030662707,0.00063796696,0.00045650295,0.000036374895,0.00008942196,0.000019264417,0.0014985193],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99816996,0.00018336254,0.00082423276,0.00031339782,0.00016894123,0.0003401239],"domain_scores_gemma":[0.9989131,0.00024302243,0.00028120333,0.0002779435,0.00013082054,0.00015392559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052321976,0.00017046789,0.00081384886,0.00024046114,0.000042064534,0.000002202854,0.0001275373,0.00024093776,0.0008706135],"category_scores_gemma":[0.000106700856,0.0001581017,0.00014258003,0.0002887864,0.00016882707,0.000075925665,0.000031673975,0.00017354496,0.000014077532],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5535226,0.02065843,0.00054435607,0.000047770143,0.00023316294,0.00062089297,0.0028912409,0.000024010247,0.0225536,0.000030467638,0.0062418845,0.3926316],"study_design_scores_gemma":[0.5969347,0.28040972,0.011640181,0.00013529047,0.00027613936,0.00009678835,0.00008426677,0.0002926286,0.04637146,0.00015303017,0.06336974,0.00023607894],"about_ca_topic_score_codex":0.0017649058,"about_ca_topic_score_gemma":0.00037395564,"teacher_disagreement_score":0.3923955,"about_ca_system_score_codex":0.000075917706,"about_ca_system_score_gemma":0.00047479584,"threshold_uncertainty_score":0.9532607},"labels":[],"label_agreement":null},{"id":"W2218882637","doi":"10.1017/s1431927602100080","title":"Cytochemical Localization of Fungal Wall Components in Host-Pathogen Interactions: Particular Labeling with Gold-complexed Probes","year":2002,"lang":"en","type":"article","venue":"Microscopy and Microanalysis","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Canadian Forest Service","funders":"","keywords":"Host (biology); Pathogen; Fungal pathogen; Microbiology; Chemistry; Biophysics; Nanotechnology; Materials science; Biology; Genetics","score_opus":0.029383666429726108,"score_gpt":0.2976537404758159,"score_spread":0.26827007404608977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2218882637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626386,0.0026964447,0.00030768348,0.0003370763,0.000020776175,0.00026499352,0.00001868995,0.000014847302,0.00007563629],"genre_scores_gemma":[0.99724805,0.00036970404,0.001615051,0.0002454016,0.000023549688,0.000028916611,0.00011491294,0.000012744456,0.00034165676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915904,0.000042970227,0.0002904014,0.00024548467,0.000084619955,0.00017751091],"domain_scores_gemma":[0.9996099,0.000030531242,0.00009211829,0.00012559906,0.0000749857,0.000066890294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063750624,0.0001384644,0.00037724027,0.00017460235,0.000039384402,0.000012074699,0.00003944025,0.000051237363,0.00025315705],"category_scores_gemma":[0.000007656428,0.00011346174,0.0000692088,0.00034233168,0.000088597495,0.000058514397,0.000021636106,0.00010675888,0.000007665454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033220838,0.00055594626,0.10734632,0.00007757569,0.00031204874,0.000027387456,0.0006212689,0.00004171893,0.8901436,0.0000023363805,0.00028509082,0.00025455284],"study_design_scores_gemma":[0.004820161,0.00034243966,0.0069198357,0.00027895017,0.0017756613,0.000108970075,0.00018601125,0.009801315,0.9720281,0.000008919407,0.003515006,0.00021465147],"about_ca_topic_score_codex":0.0003086201,"about_ca_topic_score_gemma":0.00018305943,"teacher_disagreement_score":0.10042648,"about_ca_system_score_codex":0.00007381376,"about_ca_system_score_gemma":0.000013043496,"threshold_uncertainty_score":0.46268356},"labels":[],"label_agreement":null},{"id":"W2219488898","doi":"10.1200/jco.2012.30.15_suppl.lba671","title":"Open-label phase III randomized controlled trial comparing taxane-based chemotherapy (Tax) with lapatinib (L) or trastuzumab (T) as first-line therapy for women with HER2+ metastatic breast cancer: Interim analysis (IA) of NCIC CTG MA.31/GSK EGF 108919.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; BC Cancer Agency; Interior Health; Ottawa Hospital; Hamilton Health Sciences; University of Toronto","funders":"","keywords":"Medicine; Lapatinib; Trastuzumab; Taxane; Pertuzumab; Oncology; Internal medicine; Metastatic breast cancer; Interim analysis; Breast cancer; Interim; Chemotherapy; Clinical trial; Cancer","score_opus":0.17811336086588878,"score_gpt":0.5349206746260675,"score_spread":0.3568073137601787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2219488898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98205435,0.00070023106,0.002573482,0.005142067,0.0007211114,0.008425652,0.00006130563,0.000013467371,0.0003083396],"genre_scores_gemma":[0.98790944,0.0011820191,0.004144889,0.0025289946,0.0011697647,0.0021687117,0.00002446388,0.000056736197,0.0008149933],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9930134,0.001275507,0.0042184866,0.00036505834,0.00051759306,0.0006099977],"domain_scores_gemma":[0.9831392,0.008726741,0.0063419775,0.0002936758,0.0008214707,0.00067689025],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0078026266,0.00047134038,0.011557043,0.00039839002,0.000096005446,0.000028685366,0.00042253383,0.00024317672,0.002797169],"category_scores_gemma":[0.0006000467,0.00023893538,0.0010315706,0.00056513725,0.0005272892,0.0002245381,0.000033775967,0.00065084867,0.0000017234495],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8905068,0.040001653,0.001997892,0.00007456607,0.03872723,0.00009661402,0.0005549273,0.00014973045,0.00025273635,0.0000066575058,0.00045477608,0.027176436],"study_design_scores_gemma":[0.8526409,0.12647872,0.0005807919,0.00013942113,0.014728511,0.00016743883,0.00020299929,0.0014783831,0.00034191433,0.000019382729,0.0030004352,0.00022105951],"about_ca_topic_score_codex":0.00029067363,"about_ca_topic_score_gemma":0.00056052534,"teacher_disagreement_score":0.08647706,"about_ca_system_score_codex":0.0005679249,"about_ca_system_score_gemma":0.0042346427,"threshold_uncertainty_score":0.9981144},"labels":[],"label_agreement":null},{"id":"W2223234570","doi":"10.1200/jco.2006.24.18_suppl.2078","title":"Dose escalation phase of a phase I/II study of GTI-2501, an antisense to the R1 subunit of ribonucleotide reductase (RNR) and docetaxel in patients with metastatic hormone-refractory prostate cancer","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Docetaxel; Neutropenia; Prostate cancer; Internal medicine; Oncology; Toxicity; Cancer; Febrile neutropenia","score_opus":0.08929568132442707,"score_gpt":0.49107641314776757,"score_spread":0.4017807318233405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2223234570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970761,0.00054074434,0.000003943255,0.0009294901,0.00020468542,0.0011259263,0.00008203414,0.000002602375,0.000034505534],"genre_scores_gemma":[0.9989214,0.0002926374,0.00039163014,0.0001601788,0.00015098265,0.00001410734,0.000014341749,0.000015818521,0.000038900173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964124,0.00061057083,0.0022405672,0.0001930974,0.00036036762,0.000183003],"domain_scores_gemma":[0.9960699,0.00063838885,0.0022976985,0.000188471,0.00060386985,0.00020167533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015040761,0.00016131307,0.0014345917,0.0002592667,0.000033604676,0.000002874257,0.00009865563,0.00008385232,0.000047697773],"category_scores_gemma":[0.0002830402,0.000095950076,0.000115627096,0.0003152193,0.00026287782,0.00015192963,0.000038009915,0.00041256598,2.830514e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16164818,0.19876075,0.4755101,0.00011896276,0.0014100344,0.00046345807,0.004195979,0.0004888906,0.015638912,0.000009203586,0.0015401536,0.14021537],"study_design_scores_gemma":[0.12455975,0.22816277,0.6430393,0.0000902146,0.0018419633,0.000023542938,0.0005022121,0.00011680426,0.0005631892,0.00003099843,0.0009790711,0.00009020084],"about_ca_topic_score_codex":0.0008939523,"about_ca_topic_score_gemma":0.0010798714,"teacher_disagreement_score":0.1675292,"about_ca_system_score_codex":0.00009082002,"about_ca_system_score_gemma":0.0006551741,"threshold_uncertainty_score":0.39127305},"labels":[],"label_agreement":null},{"id":"W2225191295","doi":"10.1200/jco.2009.27.15_suppl.e19003","title":"MO19390 (SAiL): Incidence of thromboembolic events and congestive heart failure with first-line bevacizumab (Bv)-based therapy in advanced non-small cell lung cancer (NSCLC)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Heart failure; Myocardial infarction; Clinical endpoint; Deep vein; Incidence (geometry); Cardiology; Pulmonary embolism; Bevacizumab; Surgery; Chemotherapy; Thrombosis; Clinical trial","score_opus":0.04870700257340295,"score_gpt":0.44227736221896935,"score_spread":0.3935703596455664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2225191295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98221916,0.0026934159,0.00008194604,0.013881471,0.00031312765,0.00062482903,0.0000070284364,0.0000061051946,0.00017293419],"genre_scores_gemma":[0.98794776,0.004681073,0.0031490496,0.0038017468,0.00033138192,0.000017747967,0.000002718925,0.00001614038,0.000052374988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975414,0.00023935507,0.0014219742,0.0002695245,0.0002436279,0.00028410103],"domain_scores_gemma":[0.99655676,0.0013635134,0.0012247505,0.00015647503,0.0004123803,0.00028609822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008504886,0.00022078893,0.001823099,0.00016554641,0.000033846118,0.0000033410984,0.0001345671,0.0003074291,0.00015648307],"category_scores_gemma":[0.00021644727,0.00015075969,0.00021059877,0.00023072699,0.00019811744,0.00010936484,0.000019177945,0.00082436245,0.0000014197072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02470689,0.005321939,0.9197152,0.00010689835,0.0003033954,0.00040967946,0.00041412783,0.001336565,0.003539504,0.000005306881,0.0015409603,0.042599533],"study_design_scores_gemma":[0.04636535,0.044238344,0.901897,0.000568061,0.0004403223,0.00009728713,0.00005969797,0.0004387124,0.0024419853,0.00009091651,0.0032140154,0.00014829672],"about_ca_topic_score_codex":0.00012718314,"about_ca_topic_score_gemma":0.0013172034,"teacher_disagreement_score":0.042451236,"about_ca_system_score_codex":0.00023251075,"about_ca_system_score_gemma":0.0024433616,"threshold_uncertainty_score":0.6147802},"labels":[],"label_agreement":null},{"id":"W2225863772","doi":"10.1200/jco.2007.25.18_suppl.550","title":"A phase III adjuvant trial of sequenced EC + filgrastim + epoetin-alpha followed by paclitaxel compared to sequenced AC followed by paclitaxel compared to CEF in women with node-positive or high-risk node-negative breast cancer (NCIC CTG MA.21)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Hazard ratio; Paclitaxel; Gastroenterology; Proportional hazards model; Confidence interval; Cancer","score_opus":0.06350505833528398,"score_gpt":0.4623515918723846,"score_spread":0.39884653353710064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2225863772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98109186,0.00023541653,0.0009527688,0.010530946,0.0018239291,0.003099795,0.0018687032,0.00003599772,0.0003606038],"genre_scores_gemma":[0.9872481,0.00033692198,0.0047351765,0.005796981,0.00089633453,0.00027149203,0.00007674778,0.000078467565,0.00055973063],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9899444,0.0014221218,0.005272675,0.00092535914,0.0010867451,0.0013487134],"domain_scores_gemma":[0.985886,0.006417894,0.0039467607,0.00045561013,0.001263586,0.0020301857],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0047666347,0.0007583135,0.0056550098,0.00057591504,0.00014186148,0.000023124674,0.0005342914,0.00068703236,0.00092361605],"category_scores_gemma":[0.0017419925,0.000534214,0.0006179344,0.00124915,0.0006728689,0.00024426432,0.00013670062,0.0018058406,0.000020449332],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8772106,0.015891915,0.011416705,0.000050969862,0.0026200295,0.0022977842,0.003447528,0.00022338117,0.029643489,0.0000046069117,0.040740926,0.016452037],"study_design_scores_gemma":[0.76129985,0.15000351,0.064579524,0.0011300539,0.0028915848,0.0004383127,0.0034455804,0.00020761648,0.008207018,0.00009032029,0.006698458,0.0010081967],"about_ca_topic_score_codex":0.00433128,"about_ca_topic_score_gemma":0.00406796,"teacher_disagreement_score":0.1341116,"about_ca_system_score_codex":0.0029922281,"about_ca_system_score_gemma":0.004327425,"threshold_uncertainty_score":0.9999897},"labels":[],"label_agreement":null},{"id":"W2235582661","doi":"10.1200/jco.2007.25.18_suppl.5084","title":"Combination chemotherapy with gemcitabine, oxaliplatin and paclitaxel in patients with cisplatin-refractory or relapsed germ cell tumors (gct)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Oxaliplatin; Gemcitabine; Cisplatin; Chemotherapy; Refractory (planetary science); Internal medicine; Paclitaxel; Oncology; Progressive disease; Gastroenterology; Toxicity; Progression-free survival; Urology; Surgery; Cancer; Colorectal cancer","score_opus":0.04387084198947501,"score_gpt":0.4158554860321698,"score_spread":0.3719846440426948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2235582661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995159,0.00010325987,0.00005052941,0.0012834932,0.00029881997,0.00039980974,0.0000020603222,0.000007545131,0.0026955302],"genre_scores_gemma":[0.99468964,0.00015797385,0.0023968911,0.0018499506,0.00026751606,0.0000032189735,0.0000073635883,0.000023833054,0.0006036176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975402,0.00018662322,0.0014928959,0.0001962864,0.00033104888,0.00025296723],"domain_scores_gemma":[0.99555063,0.0021833389,0.0015427704,0.00010902714,0.0003222962,0.00029191526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019739766,0.00017319006,0.0010924037,0.00020406806,0.000031625164,0.000005754867,0.00006732218,0.0002702351,0.0001985521],"category_scores_gemma":[0.0003103958,0.00009792395,0.00009117348,0.00020475409,0.00020493694,0.00013196068,0.000013761,0.0008310713,0.0000029108464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06531159,0.0063496735,0.8874862,0.000033687524,0.0001654366,0.00058076525,0.00026296228,0.00000249271,0.000099123674,0.000018706864,0.00078339403,0.038905945],"study_design_scores_gemma":[0.07307945,0.0603787,0.86036974,0.000090341375,0.00019586785,0.00007265876,0.000091137204,0.000012915798,0.00009539003,0.00004072351,0.0054706815,0.00010241265],"about_ca_topic_score_codex":0.00002292951,"about_ca_topic_score_gemma":0.00017545217,"teacher_disagreement_score":0.054029025,"about_ca_system_score_codex":0.00023053201,"about_ca_system_score_gemma":0.0008308842,"threshold_uncertainty_score":0.39932227},"labels":[],"label_agreement":null},{"id":"W2236644222","doi":"10.1200/jco.2015.33.15_suppl.9612","title":"The conversion ratio (CR) for opioid rotation (OR) from strong opioids to transdermal fentanyl (TDF) in cancer patients.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Opioid; Fentanyl; Cancer pain; Constipation; Cancer; Anesthesia; Morphine; Internal medicine","score_opus":0.2160608326753055,"score_gpt":0.5227664102218722,"score_spread":0.3067055775465667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2236644222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778892,0.0004127674,0.00037290264,0.016313525,0.0040298714,0.0006957325,0.000024306039,0.000004305241,0.00025742655],"genre_scores_gemma":[0.9929501,0.0005994384,0.0008217176,0.0035291247,0.0016119875,0.000050351184,0.000020986838,0.000012263063,0.00040406923],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99786675,0.00024283293,0.0013000234,0.00014410137,0.0002385761,0.00020771513],"domain_scores_gemma":[0.9965899,0.0019762183,0.0005802596,0.0000766864,0.00042477087,0.00035216415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010871527,0.00010448464,0.0006907385,0.000068130576,0.000047005786,0.000008890277,0.00011978947,0.00019547607,0.00014466116],"category_scores_gemma":[0.00075263594,0.00006135674,0.00020347488,0.000095861236,0.000078249344,0.000103952865,0.00001832335,0.0003865302,0.000007474757],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.096694775,0.004414653,0.54574096,0.000029739202,0.0006161197,0.00012985196,0.0021122517,0.0002837035,0.00052250404,0.000067744,0.08134861,0.26803905],"study_design_scores_gemma":[0.07249316,0.049860436,0.42170095,0.000106568645,0.0007916085,0.000012848564,0.0009393625,0.0009994435,0.00092423975,0.0002767025,0.45173717,0.0001574949],"about_ca_topic_score_codex":0.00019943225,"about_ca_topic_score_gemma":0.001264036,"teacher_disagreement_score":0.37038857,"about_ca_system_score_codex":0.0005103913,"about_ca_system_score_gemma":0.0020266634,"threshold_uncertainty_score":0.35952136},"labels":[],"label_agreement":null},{"id":"W2240443346","doi":"10.1200/jco.2015.33.7_suppl.279","title":"IND 205B: A phase II study of the PI3K inhibitor PX-866 and continued abiraterone/prednisone in patients with recurrent or metastatic castration resistant prostate cancer (CRPC) with PSA progression on abiraterone/prednisone.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre; London Health Sciences Centre; Queen's University; University Health Network; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Abiraterone acetate; Clinical endpoint; Prostate cancer; Internal medicine; Nausea; Prednisone; Adverse effect; Phases of clinical research; Progressive disease; Oncology; Gastroenterology; Chemotherapy; Cancer; Urology; Androgen deprivation therapy; Clinical trial","score_opus":0.14860207523103347,"score_gpt":0.4968250447685502,"score_spread":0.34822296953751675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2240443346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953567,0.00029354834,0.0000015730399,0.0015103045,0.00056144147,0.0021979765,0.00003660479,0.000005856706,0.000036006797],"genre_scores_gemma":[0.99892855,0.0000977862,0.00033711529,0.00022572618,0.00018696567,0.00008333113,0.000007072495,0.00002450415,0.00010897543],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99622,0.0007931179,0.0018195573,0.00030935678,0.000590627,0.00026734755],"domain_scores_gemma":[0.996299,0.00032134022,0.0022674534,0.00019054097,0.0006129656,0.00030865346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012996068,0.0002509642,0.0013865893,0.0001511931,0.00006704283,0.0000137229745,0.00011217585,0.00014126503,0.000028263692],"category_scores_gemma":[0.00025473628,0.000116192314,0.00007443507,0.00025690952,0.00028020557,0.00015722994,0.00005883526,0.00070376997,5.880156e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4463268,0.048371844,0.42639104,0.000098547476,0.0009743978,0.00035670132,0.0054266592,0.00005047014,0.00075896183,0.0000029655093,0.0012168165,0.070024796],"study_design_scores_gemma":[0.15745,0.48634028,0.35140815,0.00074778154,0.0010964337,0.00003813609,0.0012748097,0.00002912574,0.0004570566,0.000013336358,0.001009236,0.00013561394],"about_ca_topic_score_codex":0.00009348697,"about_ca_topic_score_gemma":0.0031435047,"teacher_disagreement_score":0.43796846,"about_ca_system_score_codex":0.00032621733,"about_ca_system_score_gemma":0.0017718975,"threshold_uncertainty_score":0.4738185},"labels":[],"label_agreement":null},{"id":"W2241038962","doi":"10.1200/jco.2006.24.18_suppl.4557","title":"Quality of life (QOL) of patients (pts) with metastatic hormone refractory prostate cancer (mHRPC) following treatment with docetaxel or mitoxantrone in the TAX-327 study","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Docetaxel; Mitoxantrone; Quality of life (healthcare); Internal medicine; Prostate cancer; Refractory (planetary science); Cancer; Oncology; Chemotherapy","score_opus":0.15289443433840882,"score_gpt":0.5043596204495797,"score_spread":0.3514651861111709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2241038962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495167,0.0017527229,0.0000078009625,0.0015499765,0.00025427897,0.0012152245,0.00003077888,0.0000034368916,0.00023413649],"genre_scores_gemma":[0.9974766,0.00086187705,0.00066741026,0.00036363557,0.00025794926,0.00006582636,0.0000071778463,0.000018563105,0.00028096107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99490786,0.0012194203,0.0027643973,0.00022105452,0.0006234259,0.00026385],"domain_scores_gemma":[0.9936488,0.002515012,0.0030967467,0.00022020328,0.0003624064,0.00015681969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022631676,0.00022482361,0.0024342805,0.00014006987,0.000033256543,0.000004248001,0.00014779618,0.00010548362,0.00006484227],"category_scores_gemma":[0.00031908482,0.00009699478,0.00031847795,0.00029484165,0.00022836184,0.00010637324,0.000019710069,0.00047200284,6.8654106e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08614017,0.043542333,0.8455856,0.000052728665,0.0027433827,0.0006093831,0.0011957063,0.00006823073,0.00021301967,0.0000035042126,0.0007316921,0.019114258],"study_design_scores_gemma":[0.0739852,0.13470688,0.7835007,0.000064913205,0.0023040106,0.000015256247,0.0010618912,0.000005288424,0.000030964748,0.000015775866,0.0042195553,0.0000896118],"about_ca_topic_score_codex":0.0025077409,"about_ca_topic_score_gemma":0.0080056805,"teacher_disagreement_score":0.09116455,"about_ca_system_score_codex":0.00034674144,"about_ca_system_score_gemma":0.0024753583,"threshold_uncertainty_score":0.44673577},"labels":[],"label_agreement":null},{"id":"W2241118632","doi":"","title":"Les statines, causes d’impuissance","year":2000,"lang":"fr","type":"article","venue":"Médecine thérapeutique","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Postprandial; Gynecology; Ginseng; Post-prandial; Diabetes mellitus; Endocrinology","score_opus":0.03749533250432504,"score_gpt":0.35550480888038083,"score_spread":0.3180094763760558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2241118632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55007005,0.25431675,0.00014653106,0.03493701,0.0037652915,0.0012558554,0.00028297256,0.00031789014,0.15490763],"genre_scores_gemma":[0.64614236,0.028553741,0.000495394,0.0033147668,0.00319596,0.00009586691,0.000111922316,0.00008458074,0.3180054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974228,0.00023436913,0.00055389793,0.0005795698,0.00027996264,0.0009293914],"domain_scores_gemma":[0.99860543,0.00030296776,0.00011222566,0.00048182165,0.000116688636,0.00038084446],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002360473,0.0005098395,0.00069332274,0.00012888474,0.00018905307,0.00003355755,0.0002028595,0.0003247338,0.09127842],"category_scores_gemma":[0.0000221525,0.00048507168,0.00020436295,0.00047165403,0.00034765192,0.00016718541,0.00003713424,0.0005626351,0.0022649108],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013794441,0.002701298,0.047789346,0.00043166996,0.0007971539,0.000828963,0.0009321087,0.00016112113,0.00418622,0.006510587,0.07631124,0.85797083],"study_design_scores_gemma":[0.0065438715,0.0011820609,0.1314921,0.00036659176,0.000905512,0.0003126782,0.00006551551,0.00018858221,0.0051261606,0.0006705855,0.8527286,0.00041771834],"about_ca_topic_score_codex":0.0025655054,"about_ca_topic_score_gemma":0.00063065835,"teacher_disagreement_score":0.8575531,"about_ca_system_score_codex":0.00037019546,"about_ca_system_score_gemma":0.00033402146,"threshold_uncertainty_score":0.9997601},"labels":[],"label_agreement":null},{"id":"W2241202567","doi":"10.1200/jco.2009.27.15_suppl.9640","title":"Placebo and nocebo effects in randomized double-blind clinical trials for fatigue in advanced cancer patients","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Nocebo; Nausea; Nocebo Effect; Internal medicine; Randomized controlled trial; Clinical trial; Cancer-related fatigue; Physical therapy; Cancer","score_opus":0.3903949492872185,"score_gpt":0.6278195739453415,"score_spread":0.23742462465812297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2241202567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825335,0.001876181,0.00008967499,0.008533802,0.002803962,0.0036247168,0.0000042205365,0.0000052654536,0.00052863394],"genre_scores_gemma":[0.9873602,0.0054054842,0.0018530916,0.0036976468,0.0013586509,0.00016152118,0.0000066969046,0.00001392916,0.00014280554],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9903786,0.0029436476,0.005883807,0.0002890023,0.00020305954,0.00030186132],"domain_scores_gemma":[0.9582765,0.03826576,0.002720119,0.00009721927,0.00028196623,0.00035844458],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.022661485,0.00019847609,0.0059748814,0.0002747872,0.000020534115,0.0000068358854,0.00010217546,0.0005870773,0.000058153306],"category_scores_gemma":[0.019302178,0.00013043755,0.00090712943,0.00015356301,0.00019781907,0.00011155736,0.000020039577,0.0009866252,0.0000013341361],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67358613,0.0038966092,0.08252588,0.000034950852,0.00029622056,0.00009921449,0.000070011105,0.000021427823,0.000027798418,0.000042171097,0.001104315,0.23829527],"study_design_scores_gemma":[0.8347072,0.021482322,0.1367734,0.00022949415,0.0009162588,0.000011574609,0.000010951306,0.00018152369,0.0000629615,0.0007802012,0.004743408,0.000100687364],"about_ca_topic_score_codex":0.000029363642,"about_ca_topic_score_gemma":0.00021356446,"teacher_disagreement_score":0.23819457,"about_ca_system_score_codex":0.00020508,"about_ca_system_score_gemma":0.0011703378,"threshold_uncertainty_score":0.98895866},"labels":[],"label_agreement":null},{"id":"W2242231555","doi":"10.1200/jco.2009.27.15_suppl.e11556","title":"Trastuzumab and vinorelbine (TV) in early stages of breast cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Vinorelbine; Trastuzumab; Chemotherapy; Regimen; Stage (stratigraphy); Internal medicine; Surgery; Neutropenia; Breast cancer; Cancer; Oncology","score_opus":0.09143339380531963,"score_gpt":0.5095466933966074,"score_spread":0.4181132995912878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2242231555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784343,0.0015983848,0.0000033860267,0.018457659,0.00042960013,0.00010764429,0.0000083878185,0.0000027388853,0.0009578555],"genre_scores_gemma":[0.9933496,0.003847552,0.00029800727,0.001608086,0.0006643635,0.0000013629225,5.830244e-7,0.0000052816326,0.00022517529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981235,0.000150961,0.0013207025,0.000108634275,0.00014698751,0.00014920557],"domain_scores_gemma":[0.99822575,0.0005850656,0.0007551198,0.00006401356,0.00017034351,0.00019968663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082912995,0.000089244495,0.0011435042,0.00013190175,0.000009572046,0.0000019997476,0.00006222662,0.00020319977,0.00030569674],"category_scores_gemma":[0.00014970044,0.000061952225,0.00017281204,0.00011100629,0.00014417524,0.00006566585,0.000012300244,0.00053097197,0.0000012461845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008166832,0.0029959509,0.72548336,0.000019112902,0.0002071326,0.00049785996,0.00021111286,0.000005966565,0.0015631259,0.000050529416,0.0026524682,0.25814652],"study_design_scores_gemma":[0.012836566,0.021124598,0.9599675,0.00007566301,0.0002948441,0.00036105688,0.000030054536,0.000008482105,0.0001301087,0.00021080159,0.004914006,0.00004632362],"about_ca_topic_score_codex":0.00014885234,"about_ca_topic_score_gemma":0.00012338493,"teacher_disagreement_score":0.2581002,"about_ca_system_score_codex":0.00012266144,"about_ca_system_score_gemma":0.0007747556,"threshold_uncertainty_score":0.3347165},"labels":[],"label_agreement":null},{"id":"W2242712018","doi":"10.1200/jco.2004.22.90140.6145","title":"Venous thrombosis in breast cancer patients receiving tamoxifen and/or chemotherapy: A systematic review","year":2004,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Tamoxifen; Internal medicine; Chemotherapy; Oncology; Inclusion and exclusion criteria; Cancer; Grading (engineering); Grading scale; Gynecology; Surgery; Pathology; Alternative medicine","score_opus":0.18865759497152587,"score_gpt":0.5531279521266581,"score_spread":0.3644703571551322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2242712018","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002477073,0.9933073,4.1483594e-7,0.0028472636,0.0011997999,0.0021527219,0.00002216362,0.0000071629897,0.00021549696],"genre_scores_gemma":[0.00014174762,0.9946931,0.0001184327,0.0039368956,0.0007761052,0.00013147283,0.0000068609984,0.000051301864,0.00014406406],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9927147,0.0010958958,0.005260037,0.00030847886,0.00032155265,0.00029931113],"domain_scores_gemma":[0.99153143,0.0022643155,0.0053568585,0.00020866322,0.00029332258,0.00034538502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026566682,0.00038867502,0.012829104,0.00022878188,0.000025841937,0.000007792632,0.00022187272,0.000744786,0.0004261329],"category_scores_gemma":[0.0010965064,0.00021526501,0.0012031541,0.00034445635,0.00013077255,0.00007286166,0.000052927797,0.0015110252,0.000014299849],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041008522,0.0038197886,0.00071462436,0.5924372,0.0017577215,0.00030628836,0.000056316298,5.9432583e-8,4.0476692e-8,7.762963e-7,0.0013520094,0.3991451],"study_design_scores_gemma":[0.007147146,0.007544656,0.0028626958,0.8150718,0.019413702,0.0013328015,0.0000040747586,3.1211326e-7,2.913296e-8,0.000012490217,0.14641927,0.00019102899],"about_ca_topic_score_codex":0.000053032174,"about_ca_topic_score_gemma":0.000046762965,"teacher_disagreement_score":0.39895406,"about_ca_system_score_codex":0.0013507194,"about_ca_system_score_gemma":0.005676363,"threshold_uncertainty_score":0.99996054},"labels":[],"label_agreement":null},{"id":"W2243806734","doi":"10.1200/jco.2006.24.18_suppl.4505","title":"Reduced thromboembolic events with DN-101 (high-dose calcitriol) treatment of androgen-independent prostate cancer: Hypothesis for a new class of anticoagulants","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Docetaxel; Calcitriol; Internal medicine; Placebo; Prostate cancer; Adverse effect; Gastroenterology; Oncology; Cancer; Pharmacology; Urology; Vitamin D and neurology; Pathology","score_opus":0.12886978719081835,"score_gpt":0.4588298682468206,"score_spread":0.3299600810560023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2243806734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935051,0.0015447995,0.000021199854,0.0029150504,0.00073172175,0.0009863444,0.000067121706,0.0000068794748,0.00022174678],"genre_scores_gemma":[0.99130833,0.0037009662,0.0025099276,0.0002044741,0.0011750858,0.000033394397,0.000009448389,0.00003108065,0.0010272705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966089,0.00021183521,0.0022392503,0.00025709256,0.00034971198,0.00033317457],"domain_scores_gemma":[0.9953699,0.0010767952,0.0025951318,0.00019329776,0.00044190107,0.00032297074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057583494,0.00023983924,0.002792395,0.00017704745,0.00003253799,0.0000028549096,0.00012656704,0.00030501778,0.00012115381],"category_scores_gemma":[0.0001464317,0.00015019916,0.0006104234,0.00017128912,0.00018373184,0.000062593106,0.000017690512,0.00021536405,0.0000018712539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0876693,0.028607048,0.4658744,0.00025466955,0.0062913927,0.00064943184,0.0004676251,0.00024447922,0.025444094,0.00009937286,0.008048344,0.37634984],"study_design_scores_gemma":[0.09552648,0.09910391,0.737189,0.00029621855,0.006270677,0.00044281842,0.00007932868,0.00006848101,0.03704121,0.00095702003,0.022799792,0.00022505455],"about_ca_topic_score_codex":0.0013570405,"about_ca_topic_score_gemma":0.0005925064,"teacher_disagreement_score":0.37612477,"about_ca_system_score_codex":0.00037770465,"about_ca_system_score_gemma":0.0043705963,"threshold_uncertainty_score":0.775325},"labels":[],"label_agreement":null},{"id":"W2243903821","doi":"10.1200/jco.2014.32.4_suppl.109","title":"Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz + P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by age group.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cabazitaxel; Internal medicine; Docetaxel; Prostate cancer; Discontinuation; Adverse effect; Population; Cohort; Incidence (geometry); Cancer; Androgen deprivation therapy","score_opus":0.06467713322226828,"score_gpt":0.4438116790079496,"score_spread":0.3791345457856813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2243903821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948528,0.0003676004,0.00005010878,0.00073633075,0.0000903017,0.00365045,0.00004676487,0.00004552399,0.00016015496],"genre_scores_gemma":[0.9925143,0.00048732565,0.0054170378,0.00032454083,0.00010384608,0.0005982534,0.00014841613,0.0000509716,0.00035529502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952715,0.00073297106,0.0020785022,0.0006027244,0.00073398004,0.00058032916],"domain_scores_gemma":[0.9952562,0.0008117434,0.0022947118,0.0002703616,0.00066342176,0.00070354773],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011760059,0.00045683654,0.002895684,0.0003746545,0.00009917085,0.00012440457,0.00020787733,0.00023206518,0.00006826459],"category_scores_gemma":[0.00014680211,0.00025361773,0.00023423253,0.0009759473,0.0006095262,0.0005238529,0.000049212376,0.0009027904,9.631631e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04785558,0.010689672,0.8738016,0.00011324556,0.0061131776,0.0007900812,0.00022637342,0.00026351455,0.000023697985,0.000004586984,0.0005373554,0.05958115],"study_design_scores_gemma":[0.044065893,0.08823302,0.85055083,0.00025048063,0.010121429,0.00006963153,0.00003821711,0.0006025071,0.000014708926,0.0000062744048,0.0057802373,0.00026675905],"about_ca_topic_score_codex":0.0032333257,"about_ca_topic_score_gemma":0.017864678,"teacher_disagreement_score":0.07754334,"about_ca_system_score_codex":0.0004896668,"about_ca_system_score_gemma":0.0009965973,"threshold_uncertainty_score":0.9999916},"labels":[],"label_agreement":null},{"id":"W2245653899","doi":"10.1200/jco.2007.25.18_suppl.9003","title":"Donepezil for cancer-related fatigue: A double-blind, randomized, placebo-controlled study","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Contraindication; Clinical endpoint; Internal medicine; Randomized controlled trial; Donepezil; Randomization; Physical therapy; Nausea; Dementia; Disease","score_opus":0.23903560687445433,"score_gpt":0.5671675735379793,"score_spread":0.32813196666352495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2245653899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97089416,0.0017692101,0.00048744588,0.009274151,0.005735889,0.0063809045,0.0000029121086,0.00003064556,0.0054246793],"genre_scores_gemma":[0.99021965,0.00093162246,0.0015060357,0.0017992536,0.0029315674,0.0002847535,0.0000036853025,0.000030464706,0.0022929914],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934313,0.00070867816,0.004801503,0.00026941247,0.00037978194,0.00040928673],"domain_scores_gemma":[0.9811065,0.014221561,0.0031618655,0.00016641199,0.0008139589,0.0005296953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01828174,0.0002442984,0.0050260527,0.00029056903,0.000077050834,0.00000992309,0.00018353655,0.0005376761,0.0005251644],"category_scores_gemma":[0.0020408458,0.00015193356,0.0017398584,0.00020795169,0.00021959622,0.000085708074,0.000032146174,0.0010492341,0.00001040789],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9324588,0.010935151,0.0062623424,0.00002262257,0.007911663,0.0006162018,0.0005043307,0.000026774482,0.00004559538,0.000101362464,0.004290613,0.036824502],"study_design_scores_gemma":[0.93533736,0.025327638,0.0020950567,0.000038915427,0.008697984,0.00016458918,0.00024188533,0.00013939488,0.00006313377,0.00022050977,0.027548298,0.00012523464],"about_ca_topic_score_codex":0.0000878379,"about_ca_topic_score_gemma":0.00043191324,"teacher_disagreement_score":0.036699265,"about_ca_system_score_codex":0.00034562135,"about_ca_system_score_gemma":0.0021793325,"threshold_uncertainty_score":0.6336123},"labels":[],"label_agreement":null},{"id":"W2246194414","doi":"10.1200/jco.2014.32.26_suppl.157","title":"A comparative effectiveness analysis of single-agent cytotoxics in triple-negative metastatic breast cancer patients.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Internal medicine; Oncology; Metastatic breast cancer; Gemcitabine; Hazard ratio; Eribulin; Vinorelbine; Proportional hazards model; Performance status; Capecitabine; Breast cancer; Discontinuation; Chemotherapy; Cancer; Confidence interval","score_opus":0.15795871854991653,"score_gpt":0.5153220941193895,"score_spread":0.35736337556947295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2246194414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703145,0.00015861777,0.00017603123,0.00071262516,0.0007676134,0.00037841348,0.000044661236,0.0000030164194,0.00072755956],"genre_scores_gemma":[0.9985383,0.00016190513,0.00049124844,0.00054431177,0.0001914429,0.000018194205,0.000008121166,0.000008377661,0.000038088187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954292,0.0018471672,0.0020453068,0.00019074221,0.00029441464,0.00019313907],"domain_scores_gemma":[0.9903548,0.006465818,0.0021265552,0.00010804977,0.0007152586,0.00022956032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002376033,0.00015713491,0.0033244109,0.00049850484,0.000018225059,0.0000029416017,0.00010424935,0.00015353721,0.00029731865],"category_scores_gemma":[0.000938096,0.00010916766,0.00071692304,0.00078691856,0.00025101684,0.00007660923,0.000030504449,0.00051402085,0.0000028807324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026400331,0.02095693,0.90165174,0.000086444175,0.013294824,0.00010029935,0.0009406007,0.0011900134,0.0015579461,0.000053183634,0.00043313293,0.033334557],"study_design_scores_gemma":[0.022734122,0.017932128,0.9476763,0.000101620564,0.008484937,0.000016556207,0.00008697999,0.0009324292,0.0009214896,0.00011315677,0.00091356906,0.0000866974],"about_ca_topic_score_codex":0.00017986279,"about_ca_topic_score_gemma":0.0006838283,"teacher_disagreement_score":0.046024576,"about_ca_system_score_codex":0.00050718104,"about_ca_system_score_gemma":0.0007430566,"threshold_uncertainty_score":0.4451728},"labels":[],"label_agreement":null},{"id":"W2247521924","doi":"10.1200/jco.2006.24.18_suppl.4651","title":"A phase I study of ABT-751 in combination with docetaxel in patients with metastatic hormone-refractory prostate cancer","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada); BC Cancer Agency","funders":"","keywords":"Medicine; Neutropenia; Docetaxel; Febrile neutropenia; Internal medicine; Prostate cancer; Gastroenterology; Chemotherapy; Performance status; Surgery; Cancer","score_opus":0.06767201698211162,"score_gpt":0.4794413760339556,"score_spread":0.411769359051844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2247521924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975877,0.00042816048,0.0000037349798,0.00073715346,0.0001801373,0.0008502976,0.000006030755,0.0000027835445,0.00020400029],"genre_scores_gemma":[0.9991366,0.00018117945,0.0002498414,0.00020274153,0.00008755732,0.000031448002,0.000006997306,0.0000131339175,0.00009047537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972804,0.00036700198,0.0016824742,0.0001542457,0.00033947814,0.000176378],"domain_scores_gemma":[0.997289,0.0005492216,0.0015948905,0.000089418034,0.00037498202,0.000102470156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094597985,0.00012974524,0.0012707998,0.00027619392,0.000012025558,0.0000027323326,0.00006742163,0.00008464603,0.00004658677],"category_scores_gemma":[0.000098808676,0.000078319106,0.000074179814,0.00028814937,0.00011990706,0.00013148368,0.000012693911,0.0005733815,7.8847523e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056886118,0.10723658,0.80786544,0.00002432287,0.00034711938,0.0005585469,0.00046017297,0.00013123259,0.000047730424,0.000005326813,0.00037204343,0.026065337],"study_design_scores_gemma":[0.17141265,0.15104726,0.67588246,0.000060695013,0.000501476,0.00000955181,0.00016320485,0.000025573274,0.000011486439,0.000034618435,0.0007966648,0.00005438813],"about_ca_topic_score_codex":0.0007182598,"about_ca_topic_score_gemma":0.0029825307,"teacher_disagreement_score":0.13198304,"about_ca_system_score_codex":0.00028555727,"about_ca_system_score_gemma":0.0009760468,"threshold_uncertainty_score":0.31937605},"labels":[],"label_agreement":null},{"id":"W2248113534","doi":"10.1200/jco.2006.24.18_suppl.10640","title":"A population-based study of trastuzumab-mediated cardiotoxicity among early stage breast cancer patients treated with adjuvant trastuzumab","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Trastuzumab; Cardiotoxicity; Internal medicine; Regimen; Ejection fraction; Breast cancer; Oncology; Population; Adjuvant; Chemotherapy; Heart failure; Cancer; Surgery","score_opus":0.043554243560170694,"score_gpt":0.40963950692009754,"score_spread":0.36608526335992686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2248113534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979567,0.00007321997,0.000009848965,0.0002786482,0.00040378261,0.0008799082,0.0001315426,0.0000177932,0.00024858158],"genre_scores_gemma":[0.99891675,0.00002524122,0.000064420296,0.0001790944,0.0005554881,0.000028719398,0.000044667348,0.000031201587,0.00015444208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99580187,0.00058540347,0.002422994,0.00027801402,0.00061270763,0.00029902646],"domain_scores_gemma":[0.995283,0.0010039016,0.0024039957,0.00017037286,0.0008280688,0.00031062806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007234252,0.00025476236,0.002284519,0.00023700688,0.00005457406,0.00000667077,0.00012965052,0.0003020769,0.00029204393],"category_scores_gemma":[0.00013422975,0.00016680371,0.00037790672,0.0003391966,0.0001599513,0.00011678044,0.000015990108,0.0006758562,0.0000019323677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016716193,0.023037938,0.9538116,0.000027893237,0.0010914503,0.00039503977,0.00012501767,0.0004611508,0.00008498472,8.7772855e-7,0.00033148084,0.0039163884],"study_design_scores_gemma":[0.042495,0.051071726,0.904089,0.000078671066,0.0017368092,0.000017913824,0.00008694151,0.000087579894,0.000070357324,0.0000025273785,0.0001350422,0.00012843184],"about_ca_topic_score_codex":0.010199896,"about_ca_topic_score_gemma":0.0056279292,"teacher_disagreement_score":0.049722586,"about_ca_system_score_codex":0.0006413786,"about_ca_system_score_gemma":0.001322305,"threshold_uncertainty_score":0.9963913},"labels":[],"label_agreement":null},{"id":"W2248854698","doi":"10.1200/jco.2007.25.18_suppl.9548","title":"A phase Ib study of oxaliplatin in combination with fluorouracil (5FU) and leucovorin (LV) in pediatric patients (pts) with advanced solid tumors","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Oxaliplatin; FOLFOX; Bolus (digestion); Regimen; Tolerability; Toxicity; Pharmacokinetics; Fluorouracil; Internal medicine; Pediatric cancer; Colorectal cancer; Gastroenterology; Chemotherapy; Urology; Oncology; Surgery; Cancer; Adverse effect","score_opus":0.06768361388423799,"score_gpt":0.4851574908015795,"score_spread":0.4174738769173415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2248854698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983027,0.00012586836,0.000018753737,0.00034743888,0.00020645703,0.0006096673,0.0000013143299,0.000003386674,0.00038439746],"genre_scores_gemma":[0.99875873,0.00018232857,0.0006720904,0.0001626786,0.00016848069,0.000007686753,0.0000029670275,0.000011903998,0.00003310989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971217,0.00025788054,0.0019137667,0.00018111093,0.00031440586,0.00021111559],"domain_scores_gemma":[0.99661773,0.0012802331,0.001519387,0.000084993575,0.0003082388,0.00018942707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020141525,0.0001359617,0.001264106,0.00037911907,0.000016689348,0.0000024457977,0.00006593672,0.00013772515,0.000023807735],"category_scores_gemma":[0.00040530492,0.00009026581,0.000056697234,0.0003698637,0.00009004627,0.00012708458,0.000022572287,0.0006608233,6.5462535e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037772987,0.041171778,0.841649,0.000031617812,0.00009383562,0.0011314854,0.0008696434,0.00004256971,0.000041632502,0.000005045745,0.000040203333,0.07715023],"study_design_scores_gemma":[0.13342616,0.16255756,0.7027862,0.00005560047,0.0002663825,0.000057851146,0.00053806393,0.000029325496,0.000052736366,0.000021046728,0.0001447034,0.000064349755],"about_ca_topic_score_codex":0.00006072579,"about_ca_topic_score_gemma":0.0018926352,"teacher_disagreement_score":0.13886276,"about_ca_system_score_codex":0.00021458234,"about_ca_system_score_gemma":0.00057684054,"threshold_uncertainty_score":0.36809328},"labels":[],"label_agreement":null},{"id":"W2249291309","doi":"10.1200/jco.2005.23.16_suppl.818","title":"Randomized trial of adjuvant equitoxic dose-escalated anthracycline (A)-containing regimen of doxorubicin, cyclophosphamide (AC) versus cyclophosphamide, methotrexate, 5-FU (CMF) for stage I-II breast cancer (BrCa): Can equitoxicity compensate for agent selection?","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Cyclophosphamide; Anthracycline; Breast cancer; Regimen; Chemotherapy; Internal medicine; Randomized controlled trial; Radiation therapy; Oncology; Surgery; Urology; Cancer","score_opus":0.13803021745123692,"score_gpt":0.49999805762428723,"score_spread":0.3619678401730503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2249291309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97804177,0.0021532378,0.0006680764,0.0079623945,0.005973985,0.0043298802,0.00038411273,0.000034764915,0.00045175164],"genre_scores_gemma":[0.97748184,0.0059589376,0.010065554,0.0010231044,0.003991078,0.00026118945,0.00005116311,0.00007656817,0.0010905929],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.990406,0.0010996391,0.0065872013,0.0005518817,0.00059077964,0.00076450984],"domain_scores_gemma":[0.9784912,0.011335431,0.007504764,0.00030225978,0.0017579683,0.0006084133],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008713234,0.00050654495,0.006532189,0.0003492208,0.0001728599,0.000009841685,0.00035895038,0.00072632276,0.0006003045],"category_scores_gemma":[0.0032852865,0.0003791333,0.002253904,0.00041841972,0.0007012222,0.00018604401,0.00012602491,0.0009828326,0.0000012120727],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90507746,0.005862818,0.0013276412,0.00020433986,0.0048457514,0.00005905433,0.00034801103,0.0010523903,0.009813788,0.00012730905,0.002232144,0.06904929],"study_design_scores_gemma":[0.90014404,0.045966737,0.004626541,0.00027129712,0.0059053004,0.00009596519,0.00014181423,0.0033972985,0.019631587,0.00012651732,0.019383008,0.0003098716],"about_ca_topic_score_codex":0.0007264437,"about_ca_topic_score_gemma":0.001288887,"teacher_disagreement_score":0.068739414,"about_ca_system_score_codex":0.0009017387,"about_ca_system_score_gemma":0.0036174378,"threshold_uncertainty_score":0.99986607},"labels":[],"label_agreement":null},{"id":"W2250077480","doi":"10.1200/jco.2013.31.31_suppl.48","title":"Health care practitioner prescribing patterns and perspectives on oral chemotherapy management: A survey of cancer centers in Toronto, Canada.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Medical prescription; Family medicine; Nausea; Patient education; Cancer; Nursing; Internal medicine","score_opus":0.11113061659727257,"score_gpt":0.49419965760988194,"score_spread":0.38306904101260936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2250077480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97670984,0.0035472438,0.000004533149,0.017484535,0.000549991,0.0003368854,0.000020849235,0.0000018050715,0.0013443038],"genre_scores_gemma":[0.98421144,0.011151158,0.00018542822,0.0041627376,0.00016229058,0.000009445258,0.0000047606973,0.000008377027,0.000104331346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998342,0.00037269818,0.0008348708,0.00013308531,0.00016166951,0.0001557124],"domain_scores_gemma":[0.9983358,0.00044469463,0.0007506518,0.000067635076,0.00023056824,0.00017067569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061486237,0.000086029824,0.00077918416,0.00004875223,0.00001677059,0.00000323743,0.000051137013,0.00007796185,0.0006443757],"category_scores_gemma":[0.00009655871,0.00006362374,0.000068807756,0.000046212088,0.000053270956,0.000082553364,0.000015062152,0.00028526952,2.6084243e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033340799,0.0011810914,0.8249991,0.00007929281,0.00051669363,0.00007502036,0.0012995851,0.000006476967,0.000009400153,0.000018045075,0.0114179775,0.15706322],"study_design_scores_gemma":[0.0083077075,0.004639357,0.97793686,0.00012615164,0.000066965265,0.000012940988,0.0033803736,0.000011207886,0.000010864948,0.0000029102696,0.005460268,0.000044373875],"about_ca_topic_score_codex":0.8533664,"about_ca_topic_score_gemma":0.9482106,"teacher_disagreement_score":0.15701884,"about_ca_system_score_codex":0.001461504,"about_ca_system_score_gemma":0.0013800696,"threshold_uncertainty_score":0.7055462},"labels":[],"label_agreement":null},{"id":"W2256348337","doi":"10.1200/jco.2014.32.31_suppl.177","title":"Association of high symptom burden with oral oncolytic agents.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Internal medicine; Cancer; Intensive care medicine; Physical therapy; Emergency medicine","score_opus":0.09281297926713751,"score_gpt":0.48303408801951325,"score_spread":0.39022110875237576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256348337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743512,0.00008577178,0.00009707026,0.01717136,0.0013209777,0.00014294365,0.000002078944,0.00000683145,0.0068217167],"genre_scores_gemma":[0.9912698,0.00023136697,0.0016254451,0.0019645905,0.0019301089,0.0000023898108,0.0000032407002,0.000011747853,0.002961255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975311,0.00043123125,0.0014004535,0.00011453898,0.00034941998,0.0001732517],"domain_scores_gemma":[0.99460804,0.0022836265,0.0022855396,0.00010667625,0.0004856294,0.00023049697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025008365,0.00009875938,0.0014080092,0.00009128632,0.000018930483,0.0000030334677,0.00009821889,0.0003043486,0.0005734767],"category_scores_gemma":[0.0012721383,0.000063681786,0.00027613857,0.00011256693,0.00009588764,0.000059963753,0.000021022852,0.0005347921,0.000021370895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014957982,0.004699049,0.62120175,0.000074341326,0.0038961568,0.0003462948,0.00026105042,0.00014625907,0.00042465585,0.00036500854,0.085580885,0.2680466],"study_design_scores_gemma":[0.03096048,0.054915097,0.5468093,0.00009436492,0.0029430857,0.00017674355,0.0000331475,0.00017780514,0.00022032583,0.0005634149,0.36301214,0.000094095776],"about_ca_topic_score_codex":0.00006807408,"about_ca_topic_score_gemma":0.00007944965,"teacher_disagreement_score":0.27743125,"about_ca_system_score_codex":0.00036763508,"about_ca_system_score_gemma":0.0009996814,"threshold_uncertainty_score":0.6279168},"labels":[],"label_agreement":null},{"id":"W2256596578","doi":"10.1200/jco.2005.23.16_suppl.8016","title":"Do women with primary breast cancer who experience chemotherapy-induced menopause have worse symptoms than those due to natural menopause?","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Menopause; Breast cancer; Chemotherapy; Premature Menopause; Surgical Menopause; Adjuvant chemotherapy; Internal medicine; Gynecology; Clinical endpoint; Cancer; Oncology; Clinical trial","score_opus":0.0510057890791539,"score_gpt":0.4475324177660498,"score_spread":0.3965266286868959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256596578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9683451,0.00080038933,0.000009216044,0.027764969,0.0011550034,0.00048727982,0.000011839494,0.000024860685,0.001401343],"genre_scores_gemma":[0.97036475,0.000932508,0.0010911522,0.021680746,0.003941874,0.00008724453,0.0000020655013,0.00004674604,0.0018529008],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965058,0.00029977493,0.0016262132,0.0004130726,0.0005341894,0.0006209383],"domain_scores_gemma":[0.99642766,0.00068914396,0.0011375628,0.00030121286,0.0004551746,0.0009892621],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012325771,0.00033301834,0.002017061,0.000192716,0.000078883946,0.000023309909,0.00032009793,0.00033549342,0.0012688836],"category_scores_gemma":[0.00011245875,0.00021237762,0.000181057,0.00025639823,0.00022948184,0.0002703331,0.00007702521,0.0011813955,0.000025578729],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1032846,0.007060155,0.07104868,0.000052375573,0.0028618644,0.002920507,0.012763871,0.00004174133,0.021842033,0.000024902696,0.012724028,0.76537526],"study_design_scores_gemma":[0.04160051,0.050967388,0.7205322,0.00046118296,0.0008968918,0.0049680043,0.001188957,0.00003545241,0.0024893805,0.000038532264,0.17625421,0.0005673172],"about_ca_topic_score_codex":0.000052437597,"about_ca_topic_score_gemma":0.0002110127,"teacher_disagreement_score":0.76480794,"about_ca_system_score_codex":0.0014319217,"about_ca_system_score_gemma":0.0020459339,"threshold_uncertainty_score":0.9996441},"labels":[],"label_agreement":null},{"id":"W2256921387","doi":"10.1200/jco.2009.27.15_suppl.e20743","title":"The use of cannabinoids (CBs) for the treatment of chemotherapy-induced peripheral neuropathy (CIPN): A retrospective review","year":2009,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Vinca; Peripheral neuropathy; Chemotherapy; Internal medicine; Adverse effect; Retrospective cohort study; Oncology; Pharmacology","score_opus":0.38711644627992725,"score_gpt":0.5653654352153523,"score_spread":0.17824898893542507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256921387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052109594,0.9865542,0.000007705016,0.008064254,0.0018194119,0.00286009,0.00003762013,0.0000047122635,0.0001308959],"genre_scores_gemma":[0.00009222932,0.99425644,0.00025018954,0.0021132573,0.002067297,0.00010992339,0.000006491689,0.00004447667,0.0010596896],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934754,0.0011428944,0.004451382,0.00028162368,0.0003415089,0.00030723377],"domain_scores_gemma":[0.9845787,0.00712008,0.0067517166,0.00049779704,0.0008408354,0.00021084986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020878606,0.00041532595,0.007463418,0.00008384636,0.000082877676,0.000007819109,0.00034890065,0.0005238634,0.00009823268],"category_scores_gemma":[0.0015833292,0.00017276099,0.0043408293,0.0002656781,0.000366674,0.000045145476,0.000020992517,0.0008581749,0.0000013758889],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028519267,0.0030371596,0.000083531406,0.0020990863,0.003006497,0.00008125602,0.000058189304,3.678291e-7,0.000003059388,0.00002747089,0.016527496,0.97222394],"study_design_scores_gemma":[0.0056294785,0.07098272,0.0010223531,0.0044974294,0.014158315,0.0003144077,0.000006363391,0.0000048167494,0.0000038782005,0.000021145406,0.90325445,0.000104649574],"about_ca_topic_score_codex":0.000047809477,"about_ca_topic_score_gemma":0.000059710484,"teacher_disagreement_score":0.97211933,"about_ca_system_score_codex":0.00075806986,"about_ca_system_score_gemma":0.0041282466,"threshold_uncertainty_score":0.73233324},"labels":[],"label_agreement":null},{"id":"W2258401109","doi":"10.1200/jco.2007.25.18_suppl.18092","title":"Costs associated with intravenous (IV) chemotherapy administration in patients with lung cancer","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Chemotherapy; Lung cancer; Route of administration; Internal medicine; Cancer; Administration (probate law); Oncology; Intensive care medicine","score_opus":0.04721964115355841,"score_gpt":0.4744088246118512,"score_spread":0.42718918345829276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258401109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944706,0.0001450354,0.000049389153,0.003053206,0.00045381504,0.00031753563,0.0000029958817,0.0000058777114,0.001501547],"genre_scores_gemma":[0.9960976,0.00019079701,0.00034687543,0.0027033063,0.0004777028,0.000003937811,0.000009243719,0.000014721817,0.00015579548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981752,0.00012732085,0.0010784573,0.00012719988,0.00026896258,0.00022287278],"domain_scores_gemma":[0.9973858,0.0008069137,0.0011216772,0.00006522282,0.00039899236,0.000221384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013753826,0.000112717156,0.00084560766,0.00010557924,0.000019924779,0.000003805969,0.00005952578,0.0002533939,0.00021319166],"category_scores_gemma":[0.000226139,0.000069578746,0.00008962884,0.00018360374,0.00011224508,0.00006680066,0.0000052654423,0.0006328156,0.0000010319395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04119661,0.005671895,0.8706204,0.0000069583207,0.00057082466,0.0005278849,0.00010803201,0.0000052597507,0.000018020926,0.0000061680958,0.0009318712,0.08033602],"study_design_scores_gemma":[0.035877876,0.04475932,0.9158947,0.00013422823,0.00035787738,0.000033485583,0.00002250204,0.0000151676095,0.00008761707,0.0000060426,0.0027413531,0.0000698647],"about_ca_topic_score_codex":0.000041705698,"about_ca_topic_score_gemma":0.002047185,"teacher_disagreement_score":0.080266155,"about_ca_system_score_codex":0.0007994811,"about_ca_system_score_gemma":0.0017910734,"threshold_uncertainty_score":0.31772873},"labels":[],"label_agreement":null},{"id":"W2260518538","doi":"","title":"Vincristine sulfate liposomes injection concentrates vincristine in tumor tissue and bone marrow of tumor-bearing mice","year":2007,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bone marrow; Vincristine; Liposome; Pharmacology; Chemistry; Vinca; Pathology; Medicine; Internal medicine; Chemotherapy; Biochemistry; Cyclophosphamide","score_opus":0.012789799789136752,"score_gpt":0.30142284320880003,"score_spread":0.2886330434196633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2260518538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99321663,0.0017694823,0.000048937796,0.0004538566,0.00017657757,0.0003589871,0.000007965298,0.000049557108,0.003917976],"genre_scores_gemma":[0.9968244,0.00008808625,0.00077202055,0.00026988678,0.00017168307,0.00000776159,0.000024554703,0.000017481318,0.001824162],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989232,0.000026677302,0.00039580587,0.0002424659,0.00012147924,0.000290408],"domain_scores_gemma":[0.99945843,0.00013999808,0.000110843,0.00009657247,0.00007360593,0.000120544144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002900875,0.00015823203,0.00038907674,0.00018172732,0.00003416134,0.0000074070213,0.000033724893,0.000043595443,0.00047231314],"category_scores_gemma":[0.000051721512,0.00013885202,0.000029140545,0.0002556841,0.000105660925,0.00006666697,0.000036787973,0.0001475776,0.0000084523945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001617255,0.00033022018,0.2689333,0.00021709935,0.000057182402,0.0004833498,0.00028877115,0.000004051279,0.7238948,0.00018324256,0.0007714581,0.003219315],"study_design_scores_gemma":[0.0057518566,0.0011828307,0.3175464,0.00013508469,0.00016524458,0.0006608528,0.00030759673,0.00017339356,0.6707447,0.0000563554,0.0030906189,0.00018506785],"about_ca_topic_score_codex":0.0038406518,"about_ca_topic_score_gemma":0.0011009002,"teacher_disagreement_score":0.053150058,"about_ca_system_score_codex":0.0001148877,"about_ca_system_score_gemma":0.00005404116,"threshold_uncertainty_score":0.58059424},"labels":[],"label_agreement":null},{"id":"W2261976279","doi":"10.71781/11202","title":"Progrès vers la synthèse totale de la Pactamycine","year":2008,"lang":"en","type":"dissertation","venue":"Open MIND","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry","score_opus":0.030449082760624285,"score_gpt":0.4096937830550891,"score_spread":0.3792447002944648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2261976279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6561252,0.0006794772,1.4410267e-7,0.00010931731,0.00019615081,0.0006190209,0.000024165192,0.0000028719417,0.34224367],"genre_scores_gemma":[0.68236256,0.0011441564,0.0011964056,0.000081262515,0.00032229017,0.00020231058,0.0026442076,0.000059609294,0.3119872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99918747,0.00007553476,0.00015484655,0.00026671984,0.000121198354,0.00019424339],"domain_scores_gemma":[0.99944735,0.0001291503,0.00009560433,0.00015956712,0.000042170504,0.00012615067],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012847147,0.00019070448,0.00035600897,0.00007491375,0.00006042683,0.000045323308,0.00012809451,0.00028393435,0.0062780767],"category_scores_gemma":[0.000033778695,0.00017019773,0.00008814231,0.000094696916,0.000054247794,0.00005919102,0.000020827592,0.00027541452,0.0002885476],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009551431,0.0030898226,0.010164234,0.00039468298,0.0018661785,0.006422105,0.015256636,0.0000040764967,0.032482333,0.00002824283,0.10668679,0.8140535],"study_design_scores_gemma":[0.0043646856,0.00051358336,0.014544539,0.0003058667,0.0009500818,0.00039477923,0.0006326193,0.000006633573,0.026596073,0.000008021688,0.9514383,0.00024483356],"about_ca_topic_score_codex":0.00023316579,"about_ca_topic_score_gemma":0.00016809131,"teacher_disagreement_score":0.8447515,"about_ca_system_score_codex":0.00015983506,"about_ca_system_score_gemma":0.0007129012,"threshold_uncertainty_score":0.99463034},"labels":[],"label_agreement":null},{"id":"W2262014445","doi":"10.1200/jco.2009.27.15_suppl.e11515","title":"Racial differences in acute toxicities of FEC 100 chemotherapy in patients with breast cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Chemotherapy; Epirubicin; Internal medicine; Oncology; Cancer; Cyclophosphamide","score_opus":0.06449901478663041,"score_gpt":0.47127521299723507,"score_spread":0.4067761982106047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2262014445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98923767,0.00019697438,0.0000018813204,0.009470173,0.0003915751,0.00016226235,0.000008485939,0.0000021492988,0.0005288397],"genre_scores_gemma":[0.99556285,0.0012499118,0.00016684225,0.002495421,0.00040645924,0.0000026744108,0.0000014002768,0.0000054559464,0.00010895497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819845,0.00014882801,0.0011781726,0.00010715187,0.00020261841,0.0001647829],"domain_scores_gemma":[0.9984897,0.00035853146,0.0008072263,0.000059273825,0.0001737377,0.00011153909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043703985,0.00010433094,0.0012628912,0.00016026472,0.000008589963,0.0000020154407,0.00008725807,0.00019049911,0.00036188847],"category_scores_gemma":[0.000049796887,0.000063678825,0.00014103943,0.00015067715,0.00014590405,0.0000744306,0.0000075635626,0.00046767786,7.783212e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029224169,0.0043481095,0.8209163,0.000005981932,0.00020839463,0.00010946202,0.00030392205,0.0000025906031,0.00006215674,0.000009248755,0.00037151392,0.14443816],"study_design_scores_gemma":[0.02755623,0.026901046,0.94435453,0.00010554154,0.00013780207,0.000023394452,0.00003291743,0.000006244532,0.00006856085,0.00010198656,0.0006570108,0.00005471957],"about_ca_topic_score_codex":0.000079218924,"about_ca_topic_score_gemma":0.00038114836,"teacher_disagreement_score":0.14438345,"about_ca_system_score_codex":0.00017180214,"about_ca_system_score_gemma":0.0008555652,"threshold_uncertainty_score":0.3962425},"labels":[],"label_agreement":null},{"id":"W2262858020","doi":"10.1200/jco.2009.27.15_suppl.2504","title":"Uridine glucuronosyltransferase 2B7 pharmacogenetics predicts epirubicin clearance and myelosuppression","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Bilirubin; Population; Tolerability; Pharmacology; Adverse effect","score_opus":0.12026165016198466,"score_gpt":0.5070889860882271,"score_spread":0.3868273359262424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2262858020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667746,0.004264199,0.00011014209,0.02467512,0.0012748818,0.00022656829,0.000005656156,0.000014383264,0.0026544454],"genre_scores_gemma":[0.97502065,0.012633656,0.0015288313,0.008300544,0.0022150916,0.0000015428136,0.0000029082516,0.000012205443,0.000284575],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99751073,0.00029333698,0.0015114746,0.00020010846,0.00024165113,0.00024271119],"domain_scores_gemma":[0.99773455,0.0007632216,0.0005981519,0.000114784154,0.00021487557,0.00057442964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011132705,0.00016001835,0.0011599811,0.00010134783,0.000044814897,0.0000058650876,0.00010325995,0.0002854429,0.0003055165],"category_scores_gemma":[0.00039182536,0.00011414299,0.00028180686,0.000103518476,0.00017705266,0.00009006897,0.000017807986,0.000813265,0.000010000336],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031186473,0.006194765,0.042510923,0.000055917466,0.0005662799,0.0024102728,0.00021343536,0.0000450895,0.035663452,0.00007595723,0.033043563,0.84803385],"study_design_scores_gemma":[0.03695702,0.062442318,0.5458927,0.00017825911,0.0017928554,0.0015777966,0.000024082836,0.00036204924,0.012345856,0.00048122913,0.33776078,0.00018504677],"about_ca_topic_score_codex":0.0000028279303,"about_ca_topic_score_gemma":0.0000031190018,"teacher_disagreement_score":0.84784883,"about_ca_system_score_codex":0.00006598672,"about_ca_system_score_gemma":0.0006316969,"threshold_uncertainty_score":0.4654616},"labels":[],"label_agreement":null},{"id":"W2263012629","doi":"10.1200/jco.2005.23.16_suppl.890","title":"Do clinical trials of neoadjuvant chemotherapy for locally advanced breast cancer (LABC) overestimate the actual response rates observed in clinical practice?","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Anthracycline; Taxane; Breast cancer; Internal medicine; Regimen; Chemotherapy; Oncology; Clinical trial; Inflammatory breast cancer; Neoadjuvant therapy; Chemotherapy regimen; Stage (stratigraphy); Cancer; Surgery","score_opus":0.3706597621708674,"score_gpt":0.637973111732331,"score_spread":0.2673133495614636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2263012629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8340005,0.0029757866,0.00014834818,0.15826063,0.0031054867,0.0012665726,0.00007108816,0.0000110773435,0.00016046289],"genre_scores_gemma":[0.9320154,0.021492355,0.015545347,0.023228554,0.0071629165,0.00007410401,0.000006731034,0.000057254118,0.00041731],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.97756946,0.0086006345,0.012396866,0.00046064804,0.00048520396,0.0004871862],"domain_scores_gemma":[0.87659025,0.11273525,0.008502329,0.00039539332,0.0012654089,0.0005113376],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.07545433,0.00031308984,0.00492605,0.00014782866,0.000056119286,0.000016251093,0.0004208272,0.0009044686,0.0006849597],"category_scores_gemma":[0.06609322,0.00018000047,0.0021074533,0.00024630505,0.0007459704,0.00028569947,0.00007144884,0.0020030707,0.000010182533],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37369242,0.0076776617,0.05008275,0.000023942013,0.0013702019,0.00017261623,0.00013375947,0.0001443677,0.00047162877,0.0000418686,0.0140985,0.5520903],"study_design_scores_gemma":[0.085498646,0.030940702,0.5425759,0.00028529734,0.0016384281,0.0003899989,0.00018248452,0.00065132696,0.00021229478,0.00019252086,0.33725986,0.00017252986],"about_ca_topic_score_codex":0.000042352025,"about_ca_topic_score_gemma":0.00022742669,"teacher_disagreement_score":0.55191773,"about_ca_system_score_codex":0.0003168149,"about_ca_system_score_gemma":0.0068587875,"threshold_uncertainty_score":0.9987714},"labels":[],"label_agreement":null},{"id":"W2265087310","doi":"10.1200/jco.2007.25.18_suppl.14535","title":"Effect of hyperthermia on the pharmacokinetic profile of oxaliplatin administered by intraperitoneal route in rats","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Oxaliplatin; Medicine; Peritoneum; Pharmacokinetics; Hyperthermia; Perfusion; Intraperitoneal injection; Mesentery; In vivo; Chemotherapy; Pharmacology; Surgery; Internal medicine; Cancer; Colorectal cancer; Biology","score_opus":0.08793512567251474,"score_gpt":0.5115380316999573,"score_spread":0.42360290602744255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2265087310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898084,0.00040425462,0.000004323575,0.0036673367,0.00090045115,0.0004235677,0.000009112581,0.0000028778168,0.004779673],"genre_scores_gemma":[0.99744916,0.0002318999,0.0001279522,0.0013793567,0.0005348767,0.00000605482,0.0000032799617,0.0000123581385,0.00025507426],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965677,0.0007823169,0.0020646844,0.00012487303,0.00025737134,0.00020305286],"domain_scores_gemma":[0.99024385,0.007959543,0.0013863384,0.0001222977,0.00012466795,0.00016331184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047040726,0.00013426236,0.0013612382,0.000111717505,0.000014591238,0.0000014106665,0.00015110364,0.00024168887,0.0005478],"category_scores_gemma":[0.00085531373,0.00007350489,0.0003354949,0.000165009,0.00027373256,0.000027872507,0.000023745422,0.0007717447,0.0000053297026],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.119008735,0.0071602818,0.15946949,0.00019339292,0.0009524642,0.00095940736,0.0003660639,0.000009976018,0.20178667,0.000050836898,0.018194534,0.49184817],"study_design_scores_gemma":[0.05130989,0.21297571,0.20379215,0.00037975155,0.0015032319,0.00040504895,0.00010841183,0.00016594633,0.47613314,0.0000524864,0.052983474,0.00019075247],"about_ca_topic_score_codex":0.000021460872,"about_ca_topic_score_gemma":0.000024586247,"teacher_disagreement_score":0.4916574,"about_ca_system_score_codex":0.00009736211,"about_ca_system_score_gemma":0.00047149436,"threshold_uncertainty_score":0.59980255},"labels":[],"label_agreement":null},{"id":"W2267133977","doi":"10.1023/a:1008389706725","title":"Retreatment of patients with the same chemotherapy: Implications for clinical mechanisms of drug resistance","year":2001,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Breast cancer; Internal medicine; Chemotherapy regimen; Disease; Cancer; Surgery; Oncology","score_opus":0.224575961975959,"score_gpt":0.5280030167004287,"score_spread":0.30342705472446974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2267133977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060924806,0.98492444,0.00008865156,0.008606635,0.00014776598,0.0034810097,0.0005591131,0.000009402331,0.00157372],"genre_scores_gemma":[0.0003738533,0.9952201,0.0009959202,0.0007153267,0.00008751007,0.00042998418,0.00028572459,0.00003318823,0.0018583444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998325,0.0001811816,0.0009088892,0.00027713648,0.00011318351,0.00019461475],"domain_scores_gemma":[0.9964466,0.0011164022,0.0014410004,0.00044838744,0.00048243135,0.00006516906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004083698,0.00022539138,0.0022486805,0.0000889937,0.000030073394,8.8384184e-7,0.0001870442,0.0002461329,0.00008731417],"category_scores_gemma":[0.000040534993,0.00012529492,0.00058773643,0.00023839629,0.00026966192,0.0000131898905,0.000025015766,0.00014901877,0.0000012811845],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018638467,0.0039200042,0.0006668656,0.0038690818,0.0025714547,0.0000017813975,0.00010057147,5.4684847e-8,0.0000016586106,0.0013951106,0.06129009,0.9243195],"study_design_scores_gemma":[0.003217445,0.0057644383,0.0014511651,0.00092948665,0.0026191918,0.0000029775588,0.000010105163,5.8241877e-8,0.000037949787,0.0006598762,0.9852223,0.00008500243],"about_ca_topic_score_codex":0.00001573442,"about_ca_topic_score_gemma":0.000075278134,"teacher_disagreement_score":0.92423445,"about_ca_system_score_codex":0.00007251428,"about_ca_system_score_gemma":0.00068396697,"threshold_uncertainty_score":0.5109378},"labels":[],"label_agreement":null},{"id":"W2269255206","doi":"10.1200/jco.2006.24.18_suppl.6117","title":"Survival and cost-effectiveness of docetaxel (D) and paclitaxel (P) in patients with metastatic breast cancer (MBC): A population-based evaluation","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Docetaxel; Metastatic breast cancer; Taxane; Confidence interval; Internal medicine; Anthracycline; Population; Breast cancer; Paclitaxel; Log-rank test; Oncology; Chemotherapy; Cancer; Gastroenterology; Urology; Overall survival; Surgery","score_opus":0.10178530269329276,"score_gpt":0.5114907116261588,"score_spread":0.409705408932866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269255206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977717,0.00042901927,0.00003556632,0.0006989249,0.00026541666,0.0006438529,0.00002639804,0.0000017948761,0.00012733528],"genre_scores_gemma":[0.9992615,0.00006171734,0.00038751462,0.000111639005,0.00011974418,0.000022509765,0.000019689804,0.000008142991,0.0000075420644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761707,0.0008846923,0.0009534745,0.0001350821,0.00029498394,0.000114702125],"domain_scores_gemma":[0.9962925,0.0021848874,0.00086242065,0.000056625428,0.0004994172,0.000104198356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027317223,0.00009985859,0.0009801994,0.00013437645,0.000016231937,0.0000031990303,0.000027170248,0.00009844769,0.00006930911],"category_scores_gemma":[0.00025806893,0.00006619106,0.00007624505,0.00012445614,0.00012097361,0.000077949495,0.000009115013,0.00023838009,1.8317265e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014380469,0.0027446689,0.9460546,0.00008628288,0.00019439653,0.000020185269,0.000010765665,0.00029788236,0.000040730007,0.0000288139,0.000029782057,0.03611147],"study_design_scores_gemma":[0.044931028,0.006211659,0.94687873,0.00015250132,0.0009842954,0.000018710996,0.000012024718,0.00042328594,0.000013675006,0.00023233323,0.00008672207,0.00005500701],"about_ca_topic_score_codex":0.0009782694,"about_ca_topic_score_gemma":0.0009463353,"teacher_disagreement_score":0.036056463,"about_ca_system_score_codex":0.00023338739,"about_ca_system_score_gemma":0.00079232355,"threshold_uncertainty_score":0.2699193},"labels":[],"label_agreement":null},{"id":"W2270737067","doi":"10.1200/jco.2009.27.15_suppl.e15634","title":"A phase II study of Halichondrin B analog eribulin mesylate (E7389) as second-line therapy for patients with advanced pancreatic cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"","keywords":"Eribulin; Medicine; Gemcitabine; Internal medicine; Gastroenterology; Neutropenia; Pancreatic cancer; Progressive disease; Oncology; Adverse effect; Cancer; Metastatic breast cancer; Toxicity; Surgery; Chemotherapy; Breast cancer","score_opus":0.08946331562877648,"score_gpt":0.5214411670188722,"score_spread":0.43197785139009576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2270737067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99410266,0.000980088,0.000018671599,0.002491285,0.0007088448,0.0013692728,0.000028913797,0.0000089110845,0.0002913341],"genre_scores_gemma":[0.99406815,0.0012210658,0.0009803955,0.0025751386,0.00050983054,0.000043826694,0.000014018552,0.000019274617,0.00056827435],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9969514,0.00024303999,0.001997839,0.00024660418,0.00029287263,0.00026826424],"domain_scores_gemma":[0.995737,0.00091933884,0.0020518512,0.00018433582,0.0007965231,0.0003109198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000788727,0.00021375017,0.0020660614,0.00014423237,0.000059441227,0.0000032907471,0.0001445327,0.00019837233,0.0006827921],"category_scores_gemma":[0.00034207394,0.00013277745,0.00033959156,0.00019095509,0.00010218639,0.00010027235,0.000016153697,0.00048557002,0.0000015928853],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2788845,0.1131894,0.094162144,0.000030590607,0.002760898,0.00023622243,0.0008263092,0.00006156957,0.0011668209,0.000014814869,0.0023332508,0.5063335],"study_design_scores_gemma":[0.16879742,0.6576076,0.14471658,0.00006902098,0.0012579701,0.000026619937,0.00009693426,0.00003334577,0.00039455426,0.0001840244,0.026698358,0.00011754601],"about_ca_topic_score_codex":0.000028431867,"about_ca_topic_score_gemma":0.00017039645,"teacher_disagreement_score":0.5444182,"about_ca_system_score_codex":0.00013872159,"about_ca_system_score_gemma":0.0011022531,"threshold_uncertainty_score":0.7476095},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2273249800","doi":"10.1200/jco.2009.27.15_suppl.9597","title":"Is patient self-reporting more accurate than clinician reporting of symptoms for predicting survival in patients with cancer? Meta-analysis of 30 closed EORTC randomized controlled trials","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nausea; Constipation; Vomiting; Diarrhea; Internal medicine; Randomized controlled trial; Cancer","score_opus":0.27666963205692885,"score_gpt":0.5480638072808044,"score_spread":0.27139417522387554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2273249800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199265,0.0009938837,0.00007545163,0.0027273055,0.00084530027,0.0030764958,0.000046622856,0.000010771502,0.00023153248],"genre_scores_gemma":[0.99667734,0.00026911742,0.0014748821,0.0010030479,0.00040589194,0.00009855572,0.000019492045,0.000019701785,0.00003196162],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9572608,0.003043525,0.03816433,0.00038509755,0.00078446814,0.0003617976],"domain_scores_gemma":[0.84640384,0.023972182,0.1269184,0.0002648098,0.0021829552,0.00025783776],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch","metaepi_broad"],"category_scores_codex":[0.054196622,0.00033155776,0.031548742,0.00059770595,0.00004205829,0.000007386377,0.00014904578,0.00042495367,0.00024482337],"category_scores_gemma":[0.07496759,0.00017548323,0.010238685,0.0005500925,0.00016863042,0.00010390913,0.000027026073,0.0006710606,1.2078577e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34700978,0.003450645,0.42387828,0.000037070116,0.21753863,0.00007676883,0.00068166014,0.00047714968,0.000025190233,0.0000041770604,0.000054642886,0.006766002],"study_design_scores_gemma":[0.3719814,0.013898837,0.23121905,0.000071157716,0.38112164,0.000004760832,0.00014537826,0.001235465,0.00011640222,0.000045845245,0.000054290802,0.000105758954],"about_ca_topic_score_codex":0.00016586004,"about_ca_topic_score_gemma":0.00012884341,"teacher_disagreement_score":0.19265923,"about_ca_system_score_codex":0.0001859872,"about_ca_system_score_gemma":0.0020262874,"threshold_uncertainty_score":0.99967355},"labels":[],"label_agreement":null},{"id":"W2273887450","doi":"10.1200/jco.2000.18.12.2363","title":"Phase I/II Trial of Cyclophosphamide, Mitoxantrone, and Escalated Doses of Carboplatin Supported by Peripheral-Blood Stem Cells in Women With Metastatic Breast Cancer","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Mitoxantrone; Carboplatin; Cyclophosphamide; Metastatic breast cancer; Breast cancer; Peripheral blood; Oncology; Internal medicine; Cancer; Chemotherapy; Cisplatin","score_opus":0.03848341136592249,"score_gpt":0.4150591416245636,"score_spread":0.3765757302586411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2273887450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960385,0.0011729953,0.0000011948574,0.0016623752,0.0003337032,0.00047522556,0.00010834411,0.000004179063,0.00020349621],"genre_scores_gemma":[0.9944992,0.0041500567,0.0002370169,0.00037118146,0.00021093144,0.000018986342,0.0000034023053,0.00001765832,0.0004915511],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964813,0.0003857978,0.0023902352,0.00019515964,0.00026944646,0.0002780864],"domain_scores_gemma":[0.9969835,0.00084328634,0.0015408797,0.000111568195,0.00019775996,0.00032295028],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010184317,0.00018280538,0.002224028,0.00011225049,0.00002057159,0.0000026811454,0.000087684086,0.0001996126,0.0018094368],"category_scores_gemma":[0.000036736474,0.00012258458,0.00015747023,0.00023509192,0.0003209366,0.00008131924,0.000016384933,0.0005138874,4.4131005e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64675707,0.03325793,0.014921525,0.000114373564,0.0025689849,0.0007449598,0.0008286705,0.000054972745,0.027641336,0.0000013997128,0.0017913195,0.27131748],"study_design_scores_gemma":[0.7378876,0.20568818,0.03631204,0.00024665523,0.0030504775,0.00048505535,0.00031925656,0.00010097272,0.009257807,0.000022490876,0.0064318627,0.00019760881],"about_ca_topic_score_codex":0.0003095854,"about_ca_topic_score_gemma":0.0001223307,"teacher_disagreement_score":0.27111986,"about_ca_system_score_codex":0.00013996378,"about_ca_system_score_gemma":0.0014882109,"threshold_uncertainty_score":0.99910307},"labels":[],"label_agreement":null},{"id":"W2274648502","doi":"10.1161/circoutcomes.7.suppl_1.188","title":"Abstract 188: Comparison of Physician- and Patient-Assessed Impressions of Treatment Efficacy: Insights from the TERISA Clinical Trial","year":2014,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Angina; Logistic regression; Clinical trial; Internal medicine; Canadian Cardiovascular Society; Physical therapy; Visual analogue scale; Myocardial infarction","score_opus":0.1484574620663761,"score_gpt":0.4419931448863613,"score_spread":0.2935356828199852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2274648502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955692,0.0029207175,0.00015513856,0.00023052939,0.00027147433,0.00066239195,0.000025115944,0.000014133226,0.00015128369],"genre_scores_gemma":[0.9993589,0.00016487582,0.00005074119,0.00016706949,0.00016520557,0.000018197752,0.0000644122,0.000008105821,0.0000025205775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832916,0.00044085784,0.00067337387,0.0002445019,0.0002241977,0.00008788488],"domain_scores_gemma":[0.9978942,0.0013093015,0.00027212632,0.00038787618,0.00006447594,0.000071987044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002990333,0.00014119834,0.0010294914,0.000028784081,0.000081555016,0.000009263928,0.000037675305,0.000104742365,0.000011352585],"category_scores_gemma":[0.00012479935,0.000085585074,0.0006663213,0.000060672643,0.0001595695,0.000043386608,0.000023831679,0.00008787025,9.522428e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034132872,0.0014730772,0.7418641,0.00007911077,0.005297405,0.0000013625488,0.0023613651,0.000164079,0.002395748,0.00023107995,0.000051896743,0.2426675],"study_design_scores_gemma":[0.031202635,0.00045065576,0.9630077,0.000030965686,0.0013688089,4.2457816e-7,0.00021840654,0.00013085798,0.0008417333,0.00011573505,0.0025513135,0.00008077686],"about_ca_topic_score_codex":0.0005544903,"about_ca_topic_score_gemma":0.000018994386,"teacher_disagreement_score":0.24258672,"about_ca_system_score_codex":0.000029060557,"about_ca_system_score_gemma":0.0000488612,"threshold_uncertainty_score":0.3490058},"labels":[],"label_agreement":null},{"id":"W2275293745","doi":"10.1200/jco.2005.23.16_suppl.3185","title":"Altered metabolism of cyclophosphamide given in a low-dose metronomic manner does not account for eventual resistance","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cyclophosphamide; Matrigel; Pharmacology; Cancer; Chemotherapy; Perfusion; Cancer research; Angiogenesis; Internal medicine","score_opus":0.07720551855147771,"score_gpt":0.4686328702862741,"score_spread":0.39142735173479637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2275293745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97405535,0.0021113178,0.00004771627,0.020716881,0.0021022477,0.00041279366,0.000029622222,0.000004533754,0.0005195454],"genre_scores_gemma":[0.9837785,0.0014376035,0.0071831234,0.0026987633,0.0029771237,0.000024284427,0.000004169753,0.000019055828,0.0018774088],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99651545,0.0002324489,0.0025690305,0.00020702275,0.00019818498,0.00027785142],"domain_scores_gemma":[0.99547416,0.0021612665,0.0017288123,0.00015657903,0.00026724677,0.00021191238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023012834,0.00015365367,0.0018279464,0.00019856529,0.00001924567,0.0000033810625,0.00018164361,0.00027256642,0.0002706631],"category_scores_gemma":[0.00087530346,0.00010123282,0.00062478083,0.00010570049,0.00016702904,0.00013031377,0.000036514994,0.00053280266,0.000008141601],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35673603,0.033717044,0.10095508,0.0006505954,0.006383524,0.0008320309,0.0018906795,0.0009264334,0.019413074,0.0019168161,0.091775544,0.38480315],"study_design_scores_gemma":[0.04720883,0.0056440607,0.36373502,0.00015876615,0.0011999129,0.000043315675,0.00011874367,0.00013027815,0.005311467,0.0007359972,0.5755522,0.00016135388],"about_ca_topic_score_codex":0.000029804749,"about_ca_topic_score_gemma":0.0006536237,"teacher_disagreement_score":0.48377672,"about_ca_system_score_codex":0.00034265305,"about_ca_system_score_gemma":0.0011030635,"threshold_uncertainty_score":0.41281545},"labels":[],"label_agreement":null},{"id":"W2277293591","doi":"10.1200/jco.2007.25.18_suppl.11072","title":"Adjuvant trastuzumab (T) in early stage breast cancer (EBC): Is cardiac dysfunction (CD) clinically significant?","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Ejection fraction; Trastuzumab; Internal medicine; Anthracycline; Cardiotoxicity; Heart failure; Breast cancer; Regimen; Taxane; Chemotherapy; Cancer; Surgery","score_opus":0.10078801541897237,"score_gpt":0.4937749407274828,"score_spread":0.3929869253085104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277293591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98061883,0.000635978,0.000106263644,0.009275514,0.0048903013,0.00038684925,0.000051618365,0.000016432616,0.004018181],"genre_scores_gemma":[0.984702,0.0039303796,0.00039928203,0.0049595265,0.0040221154,0.000009530459,0.0000044823973,0.000031355274,0.0019413312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941135,0.0004738733,0.004048702,0.0003582615,0.00049038534,0.00051529735],"domain_scores_gemma":[0.9939547,0.00271576,0.0019275555,0.00021121364,0.0005152289,0.0006755307],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006626025,0.00024014465,0.0022873727,0.00028260215,0.000041954187,0.000009732469,0.00017619171,0.0006894411,0.0014279711],"category_scores_gemma":[0.00049710163,0.00017958095,0.0009067325,0.00032069653,0.00028642113,0.00015746594,0.000041763542,0.0018654471,0.000049562936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025976067,0.0034147555,0.74516714,0.000026709067,0.0006917417,0.001433569,0.0002760553,0.000011935447,0.00094478246,0.000017719709,0.010726393,0.21131314],"study_design_scores_gemma":[0.015223933,0.016957609,0.8890438,0.00008599246,0.0007525861,0.00011219398,0.000192497,0.000020691514,0.00014152192,0.00004826351,0.07727421,0.00014671935],"about_ca_topic_score_codex":0.00055833725,"about_ca_topic_score_gemma":0.00032695377,"teacher_disagreement_score":0.21116643,"about_ca_system_score_codex":0.00076976395,"about_ca_system_score_gemma":0.0028171442,"threshold_uncertainty_score":0.99948484},"labels":[],"label_agreement":null},{"id":"W2278581713","doi":"10.1200/jco.2013.31.15_suppl.tps664","title":"Human epidermal growth factor receptor 2 (HER2) suppression with the addition of lapatinib to trastuzumab in HER2-positive metastatic breast cancer (HALT: LPT112515).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Lapatinib; Medicine; Trastuzumab; Tolerability; Discontinuation; Internal medicine; Metastatic breast cancer; Clinical endpoint; Oncology; Breast cancer; Chemotherapy; Cancer; Adverse effect; Clinical trial","score_opus":0.07742957421473282,"score_gpt":0.46198266660637854,"score_spread":0.3845530923916457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2278581713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604602,0.0001137906,0.000027012158,0.03738217,0.0005027834,0.00067920337,0.00012265067,0.000005050135,0.0007071247],"genre_scores_gemma":[0.9948636,0.00016057793,0.0007604458,0.0030759973,0.00073617283,0.00007702653,0.00001439586,0.000019552554,0.0002921864],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967791,0.0008652142,0.0015575152,0.00020076895,0.0003253012,0.00027211494],"domain_scores_gemma":[0.9960281,0.0015803053,0.0013561344,0.00012120716,0.00059554545,0.00031870752],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008408718,0.00018207384,0.0013329247,0.0001471453,0.000050533028,0.0000070981255,0.0001568711,0.00017061242,0.0080519235],"category_scores_gemma":[0.00024767424,0.000096899654,0.0002593148,0.00020319156,0.00023385022,0.00016925571,0.000035427107,0.00079798076,0.000029092138],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032367416,0.020265551,0.26954374,0.0002713419,0.0036585934,0.00072196074,0.005308784,0.0001512391,0.02332081,0.00015385513,0.2885274,0.3557093],"study_design_scores_gemma":[0.011211645,0.021361435,0.9598702,0.00027340808,0.0005606086,0.0002305562,0.00039008464,0.00002160164,0.0015340791,0.00008120929,0.004347302,0.00011788039],"about_ca_topic_score_codex":0.0008728133,"about_ca_topic_score_gemma":0.0007354123,"teacher_disagreement_score":0.69032645,"about_ca_system_score_codex":0.00030474784,"about_ca_system_score_gemma":0.0007353666,"threshold_uncertainty_score":0.99285483},"labels":[],"label_agreement":null},{"id":"W2279192913","doi":"","title":"Vinorelbine liposomes injection results in greater tumor drug exposure compared to conventional vinorelbine in tumor-bearing nude mice","year":2007,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Vinorelbine; Pharmacokinetics; Pharmacology; Liposome; Chemistry; Volume of distribution; Internal medicine; Medicine; Chemotherapy; Biochemistry","score_opus":0.026983872306910076,"score_gpt":0.3224996452426178,"score_spread":0.29551577293570774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279192913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329334,0.0020844259,0.00013077202,0.0023681668,0.0005263956,0.00080130354,0.000027884333,0.000055312856,0.00071241293],"genre_scores_gemma":[0.9931006,0.00007157784,0.00032650062,0.0053993077,0.00021075025,0.000109875196,0.0000765538,0.00004960946,0.0006552648],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980141,0.00008056829,0.0005876554,0.0004746339,0.00032275863,0.000520282],"domain_scores_gemma":[0.9993143,0.00005261324,0.00012034347,0.00024661052,0.00011157528,0.00015457114],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034628567,0.0002882031,0.00043749824,0.00046974016,0.000047349487,0.000019851925,0.00012763699,0.00007805754,0.00012716312],"category_scores_gemma":[0.000009532198,0.00028221213,0.000111830006,0.00067225494,0.000060113536,0.000058781945,0.000053090378,0.0003565507,0.000020949274],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015622984,0.0013047094,0.47123104,0.00017871174,0.0005379473,0.0022567012,0.004397351,0.0033349968,0.4933022,0.00009961497,0.0006459402,0.0070878053],"study_design_scores_gemma":[0.023115082,0.0010251432,0.6322303,0.00046313007,0.00032982032,0.0001806413,0.00037548578,0.00079563115,0.32483825,0.00012855414,0.015924042,0.0005939654],"about_ca_topic_score_codex":0.0019005644,"about_ca_topic_score_gemma":0.003939634,"teacher_disagreement_score":0.16846396,"about_ca_system_score_codex":0.00078939286,"about_ca_system_score_gemma":0.00016174794,"threshold_uncertainty_score":0.999963},"labels":[],"label_agreement":null},{"id":"W2279610918","doi":"10.1200/jco.2006.24.18_suppl.13071","title":"Uridine glucuronosyltransferase 2B7 polymorphisms and epirubicin pharmacokinetics","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Glucuronidation; Pharmacokinetics; Anthracycline; Pharmacology; Pharmacogenetics; UGT2B7; Glucuronosyltransferase; SN-38; Genotype; Irinotecan; Colorectal cancer; Cancer; Breast cancer; Chemistry; Biochemistry; In vitro","score_opus":0.09516175521980748,"score_gpt":0.4731237570156215,"score_spread":0.377962001795814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279610918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9664051,0.0031037757,0.00012526046,0.02280975,0.0015698425,0.00017485427,0.0000064148685,0.000012511283,0.00579249],"genre_scores_gemma":[0.98668176,0.002723136,0.0014092649,0.0044659576,0.0036917187,0.0000025299012,0.0000052367463,0.000018037605,0.0010023778],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974719,0.00022694375,0.0016906831,0.00017148584,0.00020283154,0.00023613319],"domain_scores_gemma":[0.99750966,0.0012023038,0.00062582426,0.00009687563,0.00019586438,0.000369478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010782236,0.00015502407,0.0012352745,0.00012786372,0.000035434055,0.000005921049,0.00008229843,0.0002447782,0.0006591741],"category_scores_gemma":[0.00023253886,0.000112741465,0.00033150823,0.00010147852,0.00026350628,0.00006798352,0.000022343298,0.0006881434,0.00001523158],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02401085,0.013694567,0.46137464,0.00009008562,0.0014891218,0.0059967297,0.0001263627,0.000051527666,0.068644404,0.0008221358,0.115671396,0.3080282],"study_design_scores_gemma":[0.03828369,0.025607504,0.31575665,0.000052005496,0.0024460505,0.0024016548,0.000020165498,0.00015445129,0.008929061,0.0007627172,0.6053946,0.00019141848],"about_ca_topic_score_codex":0.00006757809,"about_ca_topic_score_gemma":0.00003206382,"teacher_disagreement_score":0.48972324,"about_ca_system_score_codex":0.000084710584,"about_ca_system_score_gemma":0.0006518652,"threshold_uncertainty_score":0.7217494},"labels":[],"label_agreement":null},{"id":"W2280194506","doi":"10.3747/co.23.2780","title":"Impact of Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer: A Prospective Evaluation at a Single Institution","year":2016,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"International Society of Oncology Pharmacy Practitioners","keywords":"Oxaliplatin; Medicine; Colorectal cancer; Cancer; Internal medicine; Prospective cohort study; Oncology; General surgery","score_opus":0.09138890492481176,"score_gpt":0.4341871736735143,"score_spread":0.3427982687487025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280194506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676347,0.00014866634,0.0000039850474,0.00010505261,0.0005994889,0.0014847772,0.000039336093,0.000016682185,0.00083853124],"genre_scores_gemma":[0.999518,0.00003498748,0.00000925918,0.0000093035815,0.000090181486,0.00027930783,0.000035915866,0.000010459008,0.000012637357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898636,0.00013157373,0.00022547392,0.00025128695,0.0002039775,0.00020130163],"domain_scores_gemma":[0.9992702,0.000072849725,0.00019435264,0.000085842534,0.00030454097,0.00007220656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011567819,0.0001346446,0.00032446824,0.00014696426,0.000028972667,0.0000014583368,0.000035263136,0.00007201146,0.00029585857],"category_scores_gemma":[0.00007169218,0.000079431964,0.00006046099,0.00021875509,0.0001005511,0.00007454278,0.000028630955,0.0000931193,0.000008270391],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064591533,0.0029475617,0.85984707,0.000016001643,0.00007279624,0.000004336818,0.00036927636,0.000007843023,0.026509238,0.000007858148,0.000090715446,0.103668146],"study_design_scores_gemma":[0.021723198,0.015025853,0.95788306,0.000114375754,0.00021399271,0.0000064910037,0.0000048314932,0.00006181595,0.0046408763,0.000017088068,0.00022341768,0.00008500202],"about_ca_topic_score_codex":0.00010911055,"about_ca_topic_score_gemma":0.00061716745,"teacher_disagreement_score":0.10358314,"about_ca_system_score_codex":0.004221133,"about_ca_system_score_gemma":0.00074621715,"threshold_uncertainty_score":0.9996015},"labels":[],"label_agreement":null},{"id":"W2280282551","doi":"10.1200/jco.2007.25.18_suppl.17031","title":"The Oncology Symptom Control and Information Resource (OSCIR): Using information technology to improve the management of cancer treatment-related side effects","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Documentation; Workgroup; Mucositis; Common Terminology Criteria for Adverse Events; Adverse effect; Radiation therapy; Internal medicine; Computer science","score_opus":0.02517999940861822,"score_gpt":0.45291415959047115,"score_spread":0.42773416018185295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280282551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96631527,0.0012284789,0.00066764804,0.02487213,0.0015567695,0.0012983544,0.000005962058,0.000014506329,0.004040905],"genre_scores_gemma":[0.9925506,0.002176752,0.0010182237,0.003816487,0.00027627035,0.000032689055,0.0000024484643,0.000007903797,0.00011861944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970927,0.00021963172,0.002098411,0.00009097895,0.00021134,0.0002869292],"domain_scores_gemma":[0.99448955,0.0028266709,0.0020011226,0.00017172098,0.00032506484,0.00018589833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027331524,0.00014758507,0.000861734,0.00025771552,0.00013256041,0.000011053721,0.00015160478,0.00039080236,0.000009680265],"category_scores_gemma":[0.00036701045,0.00007574595,0.00019263192,0.00030553792,0.0003365311,0.00026026194,0.00006190825,0.00048540378,0.0000065975833],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008574422,0.00039659088,0.00730976,0.000053209304,0.0019356331,0.000070775255,0.0004560719,0.00010869812,0.00067959377,0.0008657075,0.0003673601,0.9791822],"study_design_scores_gemma":[0.03955893,0.033839356,0.14597335,0.00014751498,0.0037276363,0.00037410826,0.0013816465,0.0006128703,0.0015352179,0.00037136918,0.77234286,0.00013515692],"about_ca_topic_score_codex":0.00007531538,"about_ca_topic_score_gemma":0.00007236492,"teacher_disagreement_score":0.979047,"about_ca_system_score_codex":0.0006339271,"about_ca_system_score_gemma":0.0006096348,"threshold_uncertainty_score":0.30888304},"labels":[],"label_agreement":null},{"id":"W2280900900","doi":"10.1200/jco.2014.32.26_suppl.142","title":"Overall survival (OS) in metastatic breast cancer (MBC): Are we using the right endpoint in the right way?","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical trial; Clinical endpoint; Oncology; Progression-free survival; Metastatic breast cancer; Randomized controlled trial; Cancer; Chemotherapy; Breast cancer","score_opus":0.1726119135008372,"score_gpt":0.5092724751579168,"score_spread":0.33666056165707964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280900900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.867107,0.0010884466,0.000080618884,0.12638403,0.0025500334,0.0003374974,0.000014559204,0.000004418255,0.0024333964],"genre_scores_gemma":[0.9874318,0.0017229497,0.00030503073,0.008190081,0.0021398508,0.000012119656,0.0000016272272,0.000015184926,0.00018134053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949927,0.0023045787,0.001803853,0.00019500528,0.00036718522,0.00033670667],"domain_scores_gemma":[0.9929261,0.0052714916,0.0012792376,0.00020907476,0.00015089073,0.00016317904],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0057872646,0.00017978462,0.0014386155,0.00013948308,0.00005806394,0.000012576217,0.0002975418,0.00019131902,0.0013318136],"category_scores_gemma":[0.0004184774,0.00008132763,0.0004016478,0.00021141655,0.00025389748,0.00009501713,0.000047327354,0.0014851775,0.000008468949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034011923,0.021743096,0.73826003,0.00025660617,0.0030336634,0.011123172,0.0036600137,0.0021282996,0.0010403271,0.004607062,0.05500914,0.12512666],"study_design_scores_gemma":[0.01973137,0.0033172716,0.7141136,0.000224844,0.0011467373,0.00127888,0.00029098496,0.001496076,0.00004708864,0.003037845,0.25516048,0.00015480493],"about_ca_topic_score_codex":0.00039828947,"about_ca_topic_score_gemma":0.0048775827,"teacher_disagreement_score":0.20015135,"about_ca_system_score_codex":0.00040430247,"about_ca_system_score_gemma":0.0008676486,"threshold_uncertainty_score":0.9995811},"labels":[],"label_agreement":null},{"id":"W2283778444","doi":"","title":"A phase I and pharmacokinetic (PK) study of vinorelbine liposomes injection in patients with advanced solid tumors, non-Hodgkin’s lymphoma, and Hodgkin’s disease","year":2007,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Vinorelbine; Pharmacokinetics; Medicine; Pharmacology; Lymphoma; Drug; In vivo; Paclitaxel; Internal medicine; Oncology; Cancer; Chemotherapy; Biology","score_opus":0.0105058140867031,"score_gpt":0.3312848075388701,"score_spread":0.320778993452167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283778444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99389434,0.004250157,0.00009957784,0.00011285139,0.00011438578,0.0014443594,0.000027154189,0.000022007182,0.000035176115],"genre_scores_gemma":[0.9984949,0.00049706304,0.00008671275,0.0006697413,0.000042969245,0.00010598513,0.000026227544,0.000044240693,0.00003215699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987128,0.000046181405,0.0003188448,0.00036034067,0.0002671528,0.00029470836],"domain_scores_gemma":[0.99934447,0.000028867478,0.00014416689,0.000186873,0.00011161133,0.0001839951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085573505,0.00025956583,0.00041369573,0.00022831828,0.000045419245,0.000009501456,0.000052460535,0.000047233607,0.000025053965],"category_scores_gemma":[0.000002762832,0.00021729727,0.000034367415,0.00030685458,0.00010408834,0.00006291895,0.0000362007,0.000110766785,2.9476178e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023205683,0.010792258,0.69823974,0.0002004638,0.0007663028,0.00028990424,0.0026816286,0.00015405456,0.040246192,0.0000037759337,0.000009251569,0.22341076],"study_design_scores_gemma":[0.08386487,0.013241177,0.8804952,0.00016591689,0.001398627,0.000010348818,0.00030154205,0.0004256725,0.019383434,0.000019632287,0.00038226772,0.0003113342],"about_ca_topic_score_codex":0.00021087019,"about_ca_topic_score_gemma":0.00019663872,"teacher_disagreement_score":0.22309943,"about_ca_system_score_codex":0.00016537412,"about_ca_system_score_gemma":0.00010765856,"threshold_uncertainty_score":0.8861126},"labels":[],"label_agreement":null},{"id":"W2286020305","doi":"10.1200/jco.2012.30.15_suppl.e19599","title":"Frequency, indications, outcomes, and factors associated with successful opioid rotation in cancer patients presenting to an outpatient supportive care center.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer pain; Opioid; Ambulatory; Delirium; Cancer; Brief Pain Inventory; Physical therapy; Emergency medicine; Internal medicine; Chronic pain; Intensive care medicine","score_opus":0.11283822869512349,"score_gpt":0.49259876485983006,"score_spread":0.37976053616470656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286020305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975005,0.00018479145,0.0000041048934,0.0008307151,0.00081290863,0.00046335044,0.000034753044,0.0000054291995,0.00016346065],"genre_scores_gemma":[0.9986425,0.00008386148,0.00018596346,0.0007515645,0.00019377373,0.000022728993,0.00008124894,0.000012181334,0.000026199312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978725,0.00034054005,0.0011395033,0.00014123318,0.000250274,0.0002559706],"domain_scores_gemma":[0.99724674,0.00059122953,0.0012240025,0.0000679593,0.0004232046,0.00044686208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058042485,0.0001218558,0.000751028,0.0001700484,0.000037951777,0.000006259689,0.0000698403,0.00019207402,0.00008645119],"category_scores_gemma":[0.00091020553,0.00008095743,0.000085693784,0.00014100756,0.00006465905,0.0002574999,0.000028220335,0.0004439431,0.0000010684848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004188426,0.004385095,0.9830122,0.0000145184995,0.00023481727,0.00001364318,0.0051903375,0.0000034375635,0.000011495799,0.000004282226,0.00015031958,0.0065610385],"study_design_scores_gemma":[0.007716725,0.0072631673,0.9830814,0.000057634315,0.00028613553,0.0000022516838,0.00092690164,0.0000033661352,0.00005160698,0.000009748594,0.0005249647,0.00007607956],"about_ca_topic_score_codex":0.00029215077,"about_ca_topic_score_gemma":0.0016606484,"teacher_disagreement_score":0.0072978823,"about_ca_system_score_codex":0.0005403008,"about_ca_system_score_gemma":0.0005956923,"threshold_uncertainty_score":0.33013478},"labels":[],"label_agreement":null},{"id":"W2286152207","doi":"10.1200/jco.2015.33.7_suppl.141","title":"Final analysis of COMET-2: Cabozantinib (Cabo) versus mitoxantrone/prednisone (MP) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) with moderate to severe pain who were previously treated with docetaxel (D) and abiraterone (A) and/or enzalutamide (E).","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Clinical endpoint; Prostate cancer; Docetaxel; Brief Pain Inventory; Randomization; Mitoxantrone; Internal medicine; Population; Enzalutamide; Cabazitaxel; Cabozantinib; Oncology; Cancer; Randomized controlled trial; Urology; Androgen deprivation therapy; Chemotherapy; Chronic pain; Physical therapy; Androgen receptor","score_opus":0.14749090854508987,"score_gpt":0.4478939216211045,"score_spread":0.3004030130760146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286152207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962498,0.000892875,0.00003965815,0.0017537555,0.00011833767,0.0007713788,0.00009293404,0.0000065011714,0.000074743795],"genre_scores_gemma":[0.9954915,0.0009926835,0.0025255126,0.00049212907,0.000083447536,0.000040709165,0.000025951053,0.000023415349,0.00032462802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963111,0.00076627586,0.0018074716,0.00035503486,0.00041044012,0.00034966107],"domain_scores_gemma":[0.9958315,0.0012871611,0.0014446282,0.00015515876,0.00070651417,0.00057506474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018643752,0.0002812113,0.0025512308,0.00038703697,0.000039660583,0.000019889923,0.000089027526,0.00014974637,0.000065838736],"category_scores_gemma":[0.00046818462,0.00016765963,0.00013044475,0.00065037207,0.0002532119,0.00017470609,0.000034396926,0.00044169615,6.0919575e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34433997,0.0032936854,0.6108156,0.00013902562,0.0067586866,0.00096314313,0.001418455,0.002775552,0.00028957726,0.0000072785747,0.00062974263,0.028569292],"study_design_scores_gemma":[0.15128465,0.13510188,0.6902743,0.0005486959,0.015795287,0.00013106177,0.000940042,0.0032759411,0.00024869136,0.00001576703,0.0020015198,0.0003821953],"about_ca_topic_score_codex":0.0009010533,"about_ca_topic_score_gemma":0.014938246,"teacher_disagreement_score":0.19305533,"about_ca_system_score_codex":0.0002559726,"about_ca_system_score_gemma":0.0018334563,"threshold_uncertainty_score":0.8335892},"labels":[],"label_agreement":null},{"id":"W2287841863","doi":"10.1200/jco.2012.30.15_suppl.e13126","title":"Improved 5-year overall survival (OS) in breast cancer (CA) patients from 1994 to 2008.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Vinorelbine; Trastuzumab; Internal medicine; Capecitabine; Cohort; Docetaxel; Breast cancer; Oncology; Hormonal therapy; Metastatic breast cancer; Cancer; Chemotherapy; Overall survival; Aromatase","score_opus":0.0951984904795451,"score_gpt":0.4846176165296104,"score_spread":0.3894191260500653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287841863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821668,0.00037901883,0.000006751922,0.009109112,0.0062367264,0.00023729178,0.00007482345,0.000005457723,0.0017839698],"genre_scores_gemma":[0.9870626,0.0006591456,0.00067445415,0.0063077845,0.004874229,0.000010325122,0.000012055562,0.000018874174,0.00038054038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740165,0.00032164875,0.0014751845,0.00016570032,0.00025120092,0.00038461838],"domain_scores_gemma":[0.99731296,0.0009586655,0.00070920045,0.0001259291,0.00018493432,0.00070832507],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011354017,0.00014757115,0.0012475224,0.00012366002,0.000018958412,0.000004317792,0.0001286291,0.00032372063,0.0029784823],"category_scores_gemma":[0.00030656112,0.000108645436,0.00030040377,0.000119374825,0.00006535529,0.00014010388,0.000061635576,0.00076528767,0.000060657574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011228795,0.004645822,0.90954804,0.0000061984815,0.00031627828,0.000057328736,0.0001319009,0.000003919144,0.00040859773,0.000008109677,0.03715908,0.036485914],"study_design_scores_gemma":[0.018700816,0.0038460726,0.8732861,0.00004026452,0.00029658532,0.000017620307,0.000024809711,0.000015767726,0.00003325461,0.00003415139,0.10361359,0.00009095449],"about_ca_topic_score_codex":0.0012305231,"about_ca_topic_score_gemma":0.00069054466,"teacher_disagreement_score":0.066454515,"about_ca_system_score_codex":0.00044968413,"about_ca_system_score_gemma":0.00079117174,"threshold_uncertainty_score":0.9979329},"labels":[],"label_agreement":null},{"id":"W2291072211","doi":"10.1177/0840470415607256","title":"L’émergence de la thérapeutique de précision","year":2015,"lang":"fr","type":"review","venue":"Healthcare Management Forum","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Roche (Canada); Shared Health","funders":"","keywords":"Computer science","score_opus":0.06405395527016826,"score_gpt":0.4568491839326713,"score_spread":0.39279522866250305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2291072211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049963077,0.9337901,0.00046111637,0.01456692,0.0030955991,0.0035535581,0.00008928657,0.00013788977,0.0442556],"genre_scores_gemma":[0.0010604083,0.95835847,0.0012933422,0.005021078,0.0011588243,0.00098382,0.00032774438,0.00012831493,0.03166798],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942061,0.0015933191,0.0009239861,0.0008467119,0.0005341523,0.001895731],"domain_scores_gemma":[0.99741155,0.00029527198,0.0004179634,0.0007310582,0.00014402183,0.0010001344],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0023312795,0.00075946824,0.0015959861,0.0003992335,0.000254377,0.000046052726,0.00046295917,0.0008105059,0.0015268098],"category_scores_gemma":[0.000034201905,0.00070190436,0.0005175792,0.0009183835,0.00019989058,0.00008375485,0.00041621068,0.0010743293,0.001088147],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013967135,0.00044416942,0.0017422442,0.04285643,0.0006923352,0.0011582291,0.00033199982,0.000005603676,8.976032e-7,0.017963126,0.11332611,0.8213392],"study_design_scores_gemma":[0.0015556294,0.000888637,0.00059517834,0.012433259,0.003006723,0.00031075985,0.00040727053,0.00011007525,0.000004060921,0.0018093241,0.9784137,0.000465361],"about_ca_topic_score_codex":0.0013462282,"about_ca_topic_score_gemma":0.00026963532,"teacher_disagreement_score":0.8650876,"about_ca_system_score_codex":0.0043564253,"about_ca_system_score_gemma":0.0019320239,"threshold_uncertainty_score":0.99968964},"labels":[],"label_agreement":null},{"id":"W2300122958","doi":"10.1200/jco.2005.23.16_suppl.4611","title":"First- and second-line chemotherapy with docetaxel or mitoxantrone in patients with hormone-refractory prostate cancer (HRPC): Does sequence matter?","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Docetaxel; Mitoxantrone; Medicine; Internal medicine; Chemotherapy; Oncology; Regimen; Prostate cancer; Performance status; Progression-free survival; Surgery; Gastroenterology; Cancer","score_opus":0.04831283444831135,"score_gpt":0.42675120801868766,"score_spread":0.3784383735703763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300122958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768976,0.0011683783,0.00000436263,0.021073086,0.00024325398,0.000420488,0.000018726741,0.0000064994715,0.00016760614],"genre_scores_gemma":[0.9830289,0.0057225693,0.0019242392,0.0070207166,0.0008363368,0.000021223164,0.000003894069,0.000025941434,0.0014161692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798954,0.000115443545,0.0011422953,0.00023739645,0.0002355255,0.00027981363],"domain_scores_gemma":[0.99779457,0.00054450386,0.0010193315,0.00011908528,0.00023858112,0.00028395082],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004942091,0.00019692506,0.0011856959,0.00011276988,0.000033021606,0.000008388538,0.00008893641,0.00019746479,0.0014118048],"category_scores_gemma":[0.000043757616,0.00009201564,0.000082182945,0.000120764365,0.0002874764,0.00021123081,0.000018987816,0.00072690804,0.0000047701274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08101359,0.0037696117,0.8375789,0.000052572774,0.0005382423,0.0003515425,0.00031638154,0.000036773403,0.00014695304,0.000001060271,0.0034030078,0.072791405],"study_design_scores_gemma":[0.04987787,0.031031523,0.8087394,0.0001331599,0.00028131425,0.00010898783,0.000037135127,0.000029749794,0.000072181894,0.00000994627,0.10955353,0.00012518946],"about_ca_topic_score_codex":0.000056282715,"about_ca_topic_score_gemma":0.0025075343,"teacher_disagreement_score":0.10615052,"about_ca_system_score_codex":0.00029436007,"about_ca_system_score_gemma":0.001029617,"threshold_uncertainty_score":0.99950105},"labels":[],"label_agreement":null},{"id":"W2303023826","doi":"10.1200/jco.2007.25.18_suppl.1017","title":"Central nervous system (CNS) metastases (mets) in HER2+ metastatic breast cancer (MBC) patients (pts): Patterns of relapse and impact on survival","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Metastatic breast cancer; Breast cancer; Trastuzumab; Cancer; Oncology","score_opus":0.08275607319581818,"score_gpt":0.47835817984924983,"score_spread":0.39560210665343165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2303023826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958264,0.0004770929,0.0000329113,0.00092527235,0.0019231528,0.00031338428,0.00017413328,0.000006242992,0.00032137622],"genre_scores_gemma":[0.997814,0.00083987013,0.00018094169,0.0005189704,0.0005633963,0.000003747845,0.000010242654,0.00002112517,0.00004772702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995854,0.00069108815,0.0024137849,0.00021922315,0.0004010921,0.0004208208],"domain_scores_gemma":[0.9952003,0.0022004154,0.001694823,0.00013764667,0.00029719863,0.00046961362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002852008,0.00022275255,0.00207443,0.00028167982,0.000022881264,0.00000503368,0.00011082366,0.00019835283,0.00025892333],"category_scores_gemma":[0.0003295307,0.00014193892,0.0004786027,0.00018106731,0.00012697662,0.00011215035,0.00003691101,0.00073990296,0.00000214735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018672507,0.0054984605,0.88312846,0.00014518309,0.0011881345,0.0013711079,0.00012370918,0.000083352694,0.0000715073,0.000034690223,0.0006181236,0.08906478],"study_design_scores_gemma":[0.018982109,0.016669294,0.96066594,0.0002885835,0.0012915797,0.00036559388,0.00021749377,0.000037167625,0.000074495496,0.00001088101,0.0012945381,0.00010229989],"about_ca_topic_score_codex":0.0013607033,"about_ca_topic_score_gemma":0.0011678895,"teacher_disagreement_score":0.08896247,"about_ca_system_score_codex":0.000705026,"about_ca_system_score_gemma":0.0008293617,"threshold_uncertainty_score":0.5788101},"labels":[],"label_agreement":null},{"id":"W2312199392","doi":"10.1515/hc.2011.019","title":"The first taxane peroxide from the rooted cuttings of <i>Taxus canadensis</i>","year":2011,"lang":"en","type":"article","venue":"Heterocyclic Communications","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Hebei Medical University; National Natural Science Foundation of China","keywords":"Taxane; Chemistry; Cutting; Peroxide; Botany; Organic chemistry; Biology","score_opus":0.06742542710729263,"score_gpt":0.30168422677317625,"score_spread":0.23425879966588362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312199392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93352765,0.0072975326,0.00001486806,0.043495156,0.0001582437,0.000611448,0.000057725334,0.00006182915,0.01477554],"genre_scores_gemma":[0.9952494,0.0016727683,0.0004187726,0.0019642957,0.000051315088,0.00011182621,0.00004908144,0.000014222364,0.00046834277],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992353,0.000091947055,0.0002759502,0.00011623572,0.000108150656,0.00017242628],"domain_scores_gemma":[0.99727,0.0007154604,0.00016024204,0.0017152536,0.000075134485,0.00006392535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000922092,0.000105490435,0.00017333856,0.000021058686,0.000525386,0.000009057862,0.0006553596,0.000047562782,0.00022844604],"category_scores_gemma":[0.00004939605,0.00006262509,0.00010369102,0.00013394479,0.00035695545,0.000028070242,0.00020581353,0.0002327439,0.000029580899],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001678491,0.003684714,0.4715288,0.000075141696,0.0038791301,0.00003484596,0.0550412,0.0000044175304,0.072414696,0.004736903,0.3275096,0.05941205],"study_design_scores_gemma":[0.0015262313,0.00014655522,0.2358995,0.00007621713,0.00053876213,0.000030283318,0.0007996288,0.00010526195,0.010001727,0.00037254466,0.75038165,0.00012162562],"about_ca_topic_score_codex":0.030121401,"about_ca_topic_score_gemma":0.07884808,"teacher_disagreement_score":0.42287204,"about_ca_system_score_codex":0.00006575952,"about_ca_system_score_gemma":0.000048929527,"threshold_uncertainty_score":0.9763371},"labels":[],"label_agreement":null},{"id":"W2313563487","doi":"10.1158/0008-5472.sabcs10-p5-10-23","title":"Abstract P5-10-23: Frequency and Cost of Chemotherapy-Related Serious Adverse Effects in a Canadian Population Sample of Women with Estrogen and/or Progesterone Receptor Positive Early Stage Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Breast cancer; Anthracycline; Population; Logistic regression; Chemotherapy; Cancer; Emergency department; Adverse effect; Internal medicine; Stage (stratigraphy); Estrogen receptor; Gynecology; Obstetrics","score_opus":0.017582450444357717,"score_gpt":0.3605277780415742,"score_spread":0.3429453275972165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313563487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966159,0.00035955547,1.4297011e-7,0.00056591455,0.000044398428,0.0016979007,0.00064624316,0.0000076112033,0.00006232933],"genre_scores_gemma":[0.99865067,0.0003050432,0.00007298596,0.000035044206,0.00004112998,0.0005196455,0.00005644523,0.000027287708,0.00029176215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987579,0.000060704755,0.00019204973,0.00025865843,0.0002253884,0.0005052706],"domain_scores_gemma":[0.99906695,0.00012711035,0.00008159769,0.00013421285,0.00020483293,0.0003852837],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031583977,0.00013167954,0.00032670755,0.00026535604,0.000051793126,0.000008123311,0.000056271914,0.0001184295,0.0015415864],"category_scores_gemma":[0.000026888974,0.00010279346,0.000015091554,0.0003634994,0.000241869,0.00010010998,0.000015491723,0.00035010718,0.0000013206792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067137657,0.00014844832,0.870843,0.0003873234,0.00023024266,0.00004878888,0.0031742258,0.0000036038205,0.09899436,0.00003023019,0.000042409145,0.019383596],"study_design_scores_gemma":[0.005380863,0.0011364362,0.9824457,0.0002959126,0.000029576535,0.0000134922575,0.0001258217,0.000009764735,0.010249488,0.000015174405,0.0002020243,0.00009570881],"about_ca_topic_score_codex":0.8084673,"about_ca_topic_score_gemma":0.6464693,"teacher_disagreement_score":0.161998,"about_ca_system_score_codex":0.00094223616,"about_ca_system_score_gemma":0.001208522,"threshold_uncertainty_score":0.9993711},"labels":[],"label_agreement":null},{"id":"W2313623943","doi":"10.1200/jco.2006.24.18_suppl.522","title":"Left ventricular function following adjuvant chemotherapy for breast cancer: The NCIC CTG MA5 experience","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Queen's University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Epirubicin; Ejection fraction; Breast cancer; Internal medicine; Cardiotoxicity; Cyclophosphamide; Cardiac function curve; Cancer; Chemotherapy; Oncology; Cardiology; Heart failure","score_opus":0.07001898704877614,"score_gpt":0.4792698093658994,"score_spread":0.4092508223171233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313623943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9629711,0.0033983148,0.000543247,0.027890101,0.0043769036,0.0003816886,0.000007434501,0.00001097043,0.00042022776],"genre_scores_gemma":[0.9879661,0.00070404576,0.00034798385,0.0055054803,0.0046569067,0.000025408946,0.0000031883171,0.000015838956,0.0007750215],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980813,0.00014384053,0.0011551268,0.00015771529,0.00022621088,0.0002358024],"domain_scores_gemma":[0.99777025,0.0009166868,0.000858125,0.00011569834,0.00020527255,0.00013398146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011113653,0.00012244743,0.00085227535,0.000055586177,0.00008857284,0.00000782273,0.00012295955,0.00020361009,0.0004958191],"category_scores_gemma":[0.00011883122,0.00006936867,0.0007765211,0.0000947182,0.00011240281,0.00007842221,0.0000142425015,0.00039573273,0.000004961318],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021972505,0.0040363017,0.3655133,0.000037859314,0.0015163837,0.0008401974,0.0002540559,0.00012330474,0.0025777523,0.00011731971,0.073807076,0.52920395],"study_design_scores_gemma":[0.015133307,0.005963419,0.58142334,0.000046010162,0.0010737202,0.000720846,0.00011351479,0.00012411708,0.00034957752,0.0003636295,0.39460075,0.000087771165],"about_ca_topic_score_codex":0.00008086248,"about_ca_topic_score_gemma":0.0000696233,"teacher_disagreement_score":0.52911615,"about_ca_system_score_codex":0.00023880295,"about_ca_system_score_gemma":0.00075282995,"threshold_uncertainty_score":0.5428871},"labels":[],"label_agreement":null},{"id":"W2315082559","doi":"10.1200/jco.2016.34.3_suppl.157","title":"Management of aromatase inhibitor-associated musculoskeletal symptoms: A systematic review.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Jadad scale; Randomized controlled trial; Psychological intervention; Observational study; Internal medicine; Cohort; Acupuncture; MEDLINE; Physical therapy; Cohort study; Breast cancer; Alternative medicine; Cochrane Library; Cancer; Pathology; Psychiatry","score_opus":0.06270303492056029,"score_gpt":0.48423382119029706,"score_spread":0.4215307862697368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315082559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625017,0.017301073,0.00004495197,0.01324433,0.0020210515,0.0013351012,0.000022517537,0.000019349918,0.00350995],"genre_scores_gemma":[0.9710964,0.025200218,0.00032955583,0.0017158046,0.00045611218,0.000024388619,0.000004437848,0.00001646711,0.0011565993],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.995412,0.00064001884,0.0032505873,0.00014331428,0.0003633115,0.0001907679],"domain_scores_gemma":[0.9944553,0.0016713265,0.0030629428,0.00021036093,0.00033541507,0.00026470225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033587916,0.00013701772,0.0025629296,0.00009547038,0.000015611588,0.0000014366726,0.00014830417,0.00020778857,0.00032541144],"category_scores_gemma":[0.0014835484,0.00007005168,0.0008613984,0.00014540555,0.00015864927,0.00006933637,0.000051657586,0.00026880275,0.000044733857],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014007889,0.04610268,0.052983373,0.45585114,0.044826303,0.016891966,0.00017870041,0.0000010303403,0.0029036324,0.0013042181,0.21134895,0.15360013],"study_design_scores_gemma":[0.10622259,0.11965637,0.10946022,0.55909514,0.06725016,0.0020034558,0.00019947714,0.000011264259,0.0006842206,0.000904421,0.033866394,0.00064627494],"about_ca_topic_score_codex":0.0000026896296,"about_ca_topic_score_gemma":0.000003224223,"teacher_disagreement_score":0.17748256,"about_ca_system_score_codex":0.0002601524,"about_ca_system_score_gemma":0.00041156085,"threshold_uncertainty_score":0.3563027},"labels":[],"label_agreement":null},{"id":"W2315818120","doi":"10.1007/s00520-016-3199-x","title":"A systematic review of patient-reported outcome measures of neuropathy in children, adolescents and young adults","year":2016,"lang":"en","type":"review","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Children's Hospital of Eastern Ontario","funders":"National Cancer Institute","keywords":"Medicine; Pain medicine; Nursing research; Pediatrics; Patient-reported outcome; MEDLINE; Young adult; Quality of Life Research; Physical therapy; Public health; Psychiatry; Gerontology; Quality of life (healthcare); Anesthesiology; Nursing","score_opus":0.042393964371267204,"score_gpt":0.3797277157736475,"score_spread":0.3373337514023803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315818120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004245508,0.98909825,1.1726444e-7,0.000014139221,0.00032655848,0.0058233016,0.00040907922,0.00000859617,0.00007444702],"genre_scores_gemma":[0.029021109,0.9697186,0.0000019442934,0.00011510528,0.000038555394,0.0009303989,0.00009972845,0.000044621847,0.000029985269],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9962452,0.0003356376,0.0023490773,0.0004589792,0.00035452258,0.00025658475],"domain_scores_gemma":[0.9972767,0.00006204162,0.0018322561,0.00034845524,0.0003869751,0.00009356149],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002275166,0.00040876065,0.004156405,0.00034544457,0.000008183211,0.0000018514127,0.0001032211,0.00016575075,0.000092659015],"category_scores_gemma":[0.0003149888,0.00026416752,0.00040758736,0.00037238427,0.0000950504,0.00004316823,0.000060678452,0.00026391874,0.0000020543905],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083347135,0.00010947978,0.17670567,0.7509353,0.00031028927,0.00009487867,0.00027227175,7.0851347e-9,5.377898e-7,3.7780802e-7,0.000040985124,0.071446836],"study_design_scores_gemma":[0.001719613,0.00034804933,0.008694519,0.9827801,0.0042042495,0.00011182795,0.000056098335,3.941656e-8,0.000008153155,4.5894504e-7,0.0018742252,0.00020269341],"about_ca_topic_score_codex":0.00044499806,"about_ca_topic_score_gemma":0.0002446573,"teacher_disagreement_score":0.23184477,"about_ca_system_score_codex":0.0005214392,"about_ca_system_score_gemma":0.00063729746,"threshold_uncertainty_score":0.99998105},"labels":[],"label_agreement":null},{"id":"W2317767830","doi":"10.1158/0008-5472.sabcs-77","title":"BCIRG 005 main efficacy analysis: a phase III randomized trial comparing docetaxel in combination with doxorubicin and cyclophosphamide (TAC) versus doxorubicin and cyclophosphamide followed by docetaxel (AC→T) in women with Her-2/neu negative axillary lymph node positive early breast cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; William Osler Health System","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Anthracycline; Febrile neutropenia; Breast cancer; Neutropenia; Cyclophosphamide; Regimen; Mucositis; Clinical endpoint; Metastatic breast cancer; Chemotherapy; Gastroenterology; Doxorubicin; Cancer; Oncology; Surgery; Randomized controlled trial","score_opus":0.02207255447226454,"score_gpt":0.36669337262837537,"score_spread":0.34462081815611084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317767830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98483133,0.0065525784,0.000025436333,0.0027328143,0.00011686135,0.0050255046,0.0001566245,0.00005277513,0.0005060655],"genre_scores_gemma":[0.9924546,0.004728531,0.000070301525,0.00036031078,0.00012805329,0.0017585957,0.00009508703,0.000058919308,0.0003456333],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947554,0.0008696524,0.0008431103,0.0011919423,0.0010038336,0.0013360461],"domain_scores_gemma":[0.9972172,0.0012259234,0.0003160422,0.00037412767,0.00029398466,0.0005727443],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017244436,0.00062194664,0.0023938245,0.001102807,0.00027433687,0.00014423906,0.00022617615,0.00021931717,0.00014743525],"category_scores_gemma":[0.00009162109,0.00048895774,0.00013294516,0.0031474158,0.0008136116,0.00039930988,0.00009702091,0.0009286814,0.0000018810075],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9477932,0.0020973096,0.028423654,0.00007467206,0.0024107762,0.0006006403,0.005596985,0.00038874394,0.006526337,0.000038755028,0.00019984409,0.0058490695],"study_design_scores_gemma":[0.8515703,0.003497784,0.13725959,0.0006032494,0.0011351231,0.000030751027,0.0009652709,0.0008638806,0.0034986474,0.00006353911,0.000028195484,0.00048363715],"about_ca_topic_score_codex":0.027839495,"about_ca_topic_score_gemma":0.0046625324,"teacher_disagreement_score":0.108835936,"about_ca_system_score_codex":0.0028031932,"about_ca_system_score_gemma":0.0009070759,"threshold_uncertainty_score":0.9997562},"labels":[],"label_agreement":null},{"id":"W2319042377","doi":"10.1097/01.cot.0000269629.11781.a7","title":"Advanced Breast Cancer","year":2007,"lang":"en","type":"article","venue":"Oncology Times","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Exemestane; Fulvestrant; Medicine; Breast cancer; Tolerability; Aromatase inhibitor; Aromatase; Internal medicine; Anastrozole; Oncology; Cancer; Clinical trial; Letrozole; Tamoxifen; Gynecology; Adverse effect","score_opus":0.01572584066330776,"score_gpt":0.39040154825276197,"score_spread":0.37467570758945423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319042377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50026375,0.0023402337,0.00003838854,0.017645312,0.0011559803,0.00038992465,0.00002648888,0.00014351713,0.47799644],"genre_scores_gemma":[0.8982803,0.0004252588,0.0009574518,0.004450559,0.00069238816,0.000049762875,0.000020145353,0.000019191935,0.09510493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993617,0.00001455362,0.00013205835,0.00016271968,0.00006672945,0.0002622701],"domain_scores_gemma":[0.99959266,0.00008642697,0.00004700025,0.00009646534,0.000053462845,0.0001239903],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000114320486,0.00009398127,0.00023003109,0.00006716874,0.000044619628,0.0000016576316,0.000039640105,0.00010895891,0.0084156105],"category_scores_gemma":[0.0000048233082,0.00007659841,0.00005638196,0.000109106244,0.00008710839,0.000033122156,0.000018054416,0.0001248654,0.00020749531],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037054329,0.0009943997,0.09720756,0.000030265956,0.00035774952,0.00067286467,0.00035155908,0.0000059076915,0.040828407,0.0005125499,0.20017506,0.6551582],"study_design_scores_gemma":[0.004646791,0.0007726839,0.2140318,0.000017568394,0.00024128264,0.0005089969,0.00007637194,0.000010408144,0.006340955,0.0000833158,0.7731634,0.00010647425],"about_ca_topic_score_codex":0.00007540336,"about_ca_topic_score_gemma":0.00016643974,"teacher_disagreement_score":0.65505177,"about_ca_system_score_codex":0.000299197,"about_ca_system_score_gemma":0.0002170941,"threshold_uncertainty_score":0.9924908},"labels":[],"label_agreement":null},{"id":"W2320446122","doi":"10.1139/o2012-005","title":"Oroxylin A improves the sensitivity of HT-29 human colon cancer cells to 5-FU through modulation of the COX-2 signaling pathway","year":2012,"lang":"en","type":"article","venue":"Biochemistry and Cell Biology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacology; Chemistry; In vivo; Colorectal cancer; In vitro; Cell growth; Apoptosis; Cancer cell; Cancer research; Cancer; Medicine; Biology; Internal medicine; Biochemistry","score_opus":0.02019605447864938,"score_gpt":0.30091405217028006,"score_spread":0.2807179976916307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320446122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968874,0.0016663463,0.000014955226,0.00028415426,0.00015913547,0.00024875664,0.000058222227,0.0000056959716,0.0006753293],"genre_scores_gemma":[0.99895966,0.00008051847,0.000040137096,0.0002539618,0.00023815436,0.000020236554,0.000019725545,0.0000054390134,0.00038215445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994285,0.000079486825,0.00015651368,0.000133694,0.000043912176,0.00015790957],"domain_scores_gemma":[0.9995366,0.00010010842,0.0001272547,0.00014658073,0.000047536483,0.000041922933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018548223,0.00009809308,0.00019377959,0.000007809367,0.000068791276,0.0000014245277,0.000043317148,0.00012201447,0.00005833415],"category_scores_gemma":[0.000010020784,0.000056644254,0.000057758916,0.00006909606,0.00017326673,0.000012784285,0.000051138857,0.00008831879,6.679805e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014124099,0.00014256967,0.006283349,0.00011970677,0.000043943553,5.0795217e-7,0.00051060796,0.0000059743934,0.9914007,0.000030818093,0.00016081521,0.0011597308],"study_design_scores_gemma":[0.000545011,0.00014471047,0.004111431,0.000022242093,0.00010196332,0.000004236879,0.00009661844,0.000030570172,0.9931186,0.000022460437,0.0017448887,0.000057302223],"about_ca_topic_score_codex":0.0004072138,"about_ca_topic_score_gemma":0.000021513915,"teacher_disagreement_score":0.0021719178,"about_ca_system_score_codex":0.000028641802,"about_ca_system_score_gemma":0.000050279094,"threshold_uncertainty_score":0.23098858},"labels":[],"label_agreement":null},{"id":"W2320729463","doi":"10.1097/01.cot.0000310384.88247.39","title":"Integrative Cancer Therapy","year":2007,"lang":"en","type":"article","venue":"Oncology Times","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Psychotherapist; Psychology; Internal medicine","score_opus":0.03519439393273268,"score_gpt":0.43218508489836605,"score_spread":0.3969906909656334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320729463","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30246013,0.0052526696,0.00005626331,0.008327866,0.0007191052,0.0003513729,0.0000053897634,0.00007633805,0.6827509],"genre_scores_gemma":[0.6563539,0.0027327393,0.00085584016,0.008276598,0.0008387551,0.00009032716,0.0000226062,0.000020179146,0.33080906],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99947006,0.000024708794,0.00011361247,0.00013868733,0.0000559627,0.00019695733],"domain_scores_gemma":[0.9996057,0.00013754195,0.000042662454,0.00007552641,0.00005681625,0.000081760554],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013281965,0.00009542039,0.00022754507,0.00006652326,0.000039705857,0.0000018652898,0.000037404192,0.00010826667,0.007816211],"category_scores_gemma":[0.000007698856,0.00006389165,0.000059464088,0.00010165666,0.00010828405,0.000023079316,0.000010121582,0.00014456076,0.00012921229],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002745444,0.00085069356,0.047345895,0.000006040565,0.0005020474,0.0003067774,0.0018563378,6.3822137e-7,0.026147373,0.0007894558,0.5222569,0.3971924],"study_design_scores_gemma":[0.0032973054,0.0016946282,0.030377619,0.000009970926,0.00008088302,0.000048643316,0.00018187395,0.000005997044,0.027916135,0.00016557027,0.93615216,0.00006923455],"about_ca_topic_score_codex":0.00017177577,"about_ca_topic_score_gemma":0.00029768146,"teacher_disagreement_score":0.41389522,"about_ca_system_score_codex":0.00025587014,"about_ca_system_score_gemma":0.00024103651,"threshold_uncertainty_score":0.99309075},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2320883227","doi":"10.1093/ageing/afw035","title":"66HIGHER LEVELS OF APOMORPHINE AND ROTIGOTINE PRESCRIBING SPEND REDUCE THE TOTAL HEALTHCARE COSTS FOR PARKINSON'S PATIENTS","year":2016,"lang":"en","type":"article","venue":"Age and Ageing","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Rotigotine; Apomorphine; Medicine; Parkinson's disease; Health care; Dopamine; Internal medicine; Dopaminergic","score_opus":0.05992845894006955,"score_gpt":0.3307550363964561,"score_spread":0.27082657745638655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320883227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940892,0.0010486004,0.000029035427,0.0039172564,0.00012432605,0.0005373868,0.00005593679,0.0000097140955,0.00018856063],"genre_scores_gemma":[0.9980489,0.0001689339,0.00012262692,0.00024102427,0.00016815095,0.000022650944,0.0000099016615,0.000010386387,0.0012074258],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994767,0.000024253282,0.00013042461,0.00015256272,0.000068389425,0.00014772276],"domain_scores_gemma":[0.99961084,0.0001403885,0.00006373481,0.00008005825,0.00004149584,0.00006345532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008086278,0.00008572373,0.00017396659,0.00002388458,0.000075178825,0.000006817842,0.000023829964,0.00003170015,0.00004514422],"category_scores_gemma":[0.000026059643,0.000045497785,0.000029194449,0.0000351434,0.00005298315,0.000055079978,0.0000331726,0.000043220683,5.393671e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016989518,0.0003700734,0.11835211,0.0005986302,0.0003844027,0.00054416445,0.0021961816,8.2395513e-7,0.16312473,0.0006649555,0.005939527,0.70612544],"study_design_scores_gemma":[0.0062556346,0.0007934482,0.9719125,0.00035951295,0.00014020153,0.000021073856,0.00004984594,0.000014799678,0.012123061,0.00015521173,0.008077338,0.000097383534],"about_ca_topic_score_codex":0.00017116104,"about_ca_topic_score_gemma":0.000042693202,"teacher_disagreement_score":0.8535604,"about_ca_system_score_codex":0.000023591998,"about_ca_system_score_gemma":0.00001467789,"threshold_uncertainty_score":0.1855346},"labels":[],"label_agreement":null},{"id":"W2322706468","doi":"10.1021/ol5029157","title":"PdI<sub>2</sub>-Catalyzed Regioselective Cyclocarbonylation of 2-Allyl Phenols to Dihydrocoumarins","year":2014,"lang":"en","type":"article","venue":"Organic Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Regioselectivity; Chemistry; Phenols; Catalysis; Selectivity; Organic chemistry; Medicinal chemistry; Combinatorial chemistry","score_opus":0.007673690761321302,"score_gpt":0.24181346211561458,"score_spread":0.23413977135429329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322706468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879349,0.000025492593,0.0012258609,0.009240855,0.00019131559,0.0004968717,0.0000030795327,0.000064936474,0.00081672013],"genre_scores_gemma":[0.9944424,0.000017389779,0.00012524602,0.004949071,0.00031069425,0.00003450288,0.000037108402,0.000036246245,0.000047312933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990273,0.00004628106,0.00021654066,0.00028329578,0.00018318152,0.00024341812],"domain_scores_gemma":[0.99938077,0.00008030989,0.00010117885,0.00025556132,0.000054331074,0.00012783648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010242769,0.00016150747,0.0003180995,0.00013392583,0.000041820516,0.000006479325,0.00008207859,0.00006529036,0.00010704224],"category_scores_gemma":[0.000049021113,0.00015140914,0.00007737871,0.0003333281,0.000049358354,0.000052585805,0.000035793575,0.000121413046,0.00011655282],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024961054,0.00011719033,0.004932394,0.000029860348,0.0001641781,0.00000759848,0.0006452894,0.000009516928,0.9856949,0.00004544764,0.0049658576,0.0031381869],"study_design_scores_gemma":[0.002702716,0.0003388352,0.026502104,0.000037943286,0.0002821925,0.000018776289,0.000017876717,0.000072836585,0.9685381,0.000052621348,0.0012783492,0.00015765527],"about_ca_topic_score_codex":0.00006372557,"about_ca_topic_score_gemma":0.000070455,"teacher_disagreement_score":0.02156971,"about_ca_system_score_codex":0.00025160235,"about_ca_system_score_gemma":0.00006631588,"threshold_uncertainty_score":0.6174286},"labels":[],"label_agreement":null},{"id":"W2323144712","doi":"10.6023/a15010055","title":"Synthesis and Properties of the Poly(<i>ε</i>-caprolactone)-paclitaxel Prodrug","year":2015,"lang":"en","type":"article","venue":"Acta Chimica Sinica","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"","keywords":"Chemistry; Caprolactone; Prodrug; Paclitaxel; Combinatorial chemistry; Organic chemistry; Biochemistry; Polymerization; Chemotherapy; Internal medicine","score_opus":0.05667900404789635,"score_gpt":0.29149802987153034,"score_spread":0.23481902582363398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323144712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973862,0.0016084745,1.10705386e-7,0.018305466,0.00017666623,0.00043087374,0.000010869818,0.000029087783,0.0055764304],"genre_scores_gemma":[0.9975863,0.00013996479,0.000116199095,0.00079697324,0.00011811891,0.000044146633,0.0000013885926,0.000017035443,0.0011798709],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991866,0.00007040667,0.00021270382,0.00019395963,0.00016737267,0.00016897926],"domain_scores_gemma":[0.99929804,0.00008394111,0.00010220792,0.00032145137,0.000066603316,0.00012774245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014444439,0.00012662192,0.00029127547,0.000034881126,0.000045903475,0.0000081735525,0.00011405975,0.00006755347,0.000048212023],"category_scores_gemma":[0.0002520706,0.00007023946,0.000078538775,0.000104495564,0.00025781582,0.000057704685,0.00008941456,0.0001376693,0.0000062400904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003480734,0.0015793636,0.07009728,0.0003330759,0.00071234937,0.000007890327,0.004854153,1.371371e-7,0.8708655,0.00014124911,0.040041998,0.007886217],"study_design_scores_gemma":[0.004481586,0.0007697106,0.086702935,0.0003696752,0.0011727381,0.00016174978,0.00044314293,0.000055074022,0.83543366,0.00017325713,0.06994826,0.00028818418],"about_ca_topic_score_codex":0.0000827313,"about_ca_topic_score_gemma":0.000015829897,"teacher_disagreement_score":0.03543187,"about_ca_system_score_codex":0.000038786544,"about_ca_system_score_gemma":0.00024206028,"threshold_uncertainty_score":0.2864282},"labels":[],"label_agreement":null},{"id":"W2323432289","doi":"10.1158/0008-5472.sabcs-1027","title":"Efficacy of bevacizumab (BV) plus docetaxel (D) does not correlate with hypertension (HTN) or G-CSF use in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) in the AVADO phase III study.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Taxane; Metastatic breast cancer; Bevacizumab; Docetaxel; Internal medicine; Population; Gastroenterology; Breast cancer; Oncology; Cancer; Chemotherapy","score_opus":0.12369791208952845,"score_gpt":0.4383749559649993,"score_spread":0.31467704387547085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323432289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99228966,0.0004267146,0.000004904687,0.0023566002,0.00014516116,0.004569771,0.00015025174,0.000018938801,0.00003800496],"genre_scores_gemma":[0.9966642,0.00092193065,0.000040368188,0.00054736243,0.00009215647,0.000710552,0.000038320464,0.000039412233,0.0009456799],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99617517,0.00053216546,0.0005633831,0.0006653137,0.0013069054,0.00075708784],"domain_scores_gemma":[0.9978874,0.0005454806,0.0001681666,0.0005250385,0.000663621,0.00021029195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007190439,0.00034533054,0.0008306694,0.00048120497,0.00013147607,0.000045581644,0.00030868425,0.00007392861,0.00066247286],"category_scores_gemma":[0.00008989768,0.00014859367,0.000057982455,0.0014842529,0.00033630495,0.00021079178,0.00006555235,0.0008916621,0.000007398918],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71465886,0.029146872,0.06575398,0.00035950507,0.0008600483,0.0034019356,0.011966728,0.0007340816,0.0015809619,0.000009803022,0.002867677,0.16865954],"study_design_scores_gemma":[0.3418845,0.044179343,0.603152,0.0026641774,0.0011161038,0.000163252,0.0030513841,0.0008915673,0.0014165313,0.000009894596,0.00090301223,0.00056824356],"about_ca_topic_score_codex":0.008332103,"about_ca_topic_score_gemma":0.027064841,"teacher_disagreement_score":0.53739804,"about_ca_system_score_codex":0.001136238,"about_ca_system_score_gemma":0.0016760031,"threshold_uncertainty_score":0.9982715},"labels":[],"label_agreement":null},{"id":"W2324247020","doi":"10.1097/01.cot.0000293190.23316.5f","title":"Operable Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Oncology Times","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Chemotherapy; Oncology; Internal medicine; Cancer; Concomitant; Gynecology","score_opus":0.019186749432628197,"score_gpt":0.36792120615651575,"score_spread":0.34873445672388753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324247020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47927004,0.003100754,0.000013354389,0.08333612,0.0010019093,0.00046158908,0.000044157518,0.0001536601,0.4326184],"genre_scores_gemma":[0.8908539,0.0007627641,0.00072613236,0.0066793696,0.00062985806,0.00013749445,0.000022116094,0.000019390114,0.10016901],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994813,0.000015563735,0.000095696574,0.00015442591,0.00005520244,0.0001978062],"domain_scores_gemma":[0.9997198,0.000021226275,0.000026808984,0.00009331614,0.00004180066,0.000097028846],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000043579188,0.000087062275,0.00022174057,0.000044145443,0.000055256092,0.0000033106505,0.000042148677,0.000096805816,0.011116175],"category_scores_gemma":[0.0000027101366,0.0000685018,0.00005077438,0.000086732354,0.00007919994,0.00003799825,0.000019085448,0.000115421244,0.00043386102],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031655885,0.004760722,0.09804001,0.000103225626,0.0014218994,0.0016295188,0.0017067641,0.00047083697,0.057621695,0.0044952496,0.6867248,0.1398597],"study_design_scores_gemma":[0.013198728,0.0015278547,0.06250197,0.000050608494,0.00053301355,0.0013932927,0.000084838015,0.000016873893,0.009032878,0.00067460816,0.91079384,0.00019151949],"about_ca_topic_score_codex":0.00060796406,"about_ca_topic_score_gemma":0.00013972975,"teacher_disagreement_score":0.4115838,"about_ca_system_score_codex":0.00042721353,"about_ca_system_score_gemma":0.0005738116,"threshold_uncertainty_score":0.9897878},"labels":[],"label_agreement":null},{"id":"W2324434746","doi":"10.1200/jco.2009.27.15_suppl.589","title":"Evaluation of the incidence and of risk factors associated with trastuzumab-associated cardiac toxicity in routine clinical practice","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Ejection fraction; Trastuzumab; Internal medicine; Tact; Coronary artery disease; Cancer; Surgery; Cardiology; Oncology; Breast cancer; Heart failure","score_opus":0.19299448141732994,"score_gpt":0.537578305884106,"score_spread":0.3445838244667761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324434746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953589,0.00047280797,0.000004394072,0.0025711395,0.00057593314,0.0003462505,0.000015519074,0.0000028703598,0.0006521853],"genre_scores_gemma":[0.99837947,0.0008306227,0.00013446959,0.00045543016,0.00017631084,0.0000012997214,0.0000026219334,0.0000058767478,0.000013885415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9912934,0.005092981,0.002490178,0.00015623786,0.00081121863,0.00015602045],"domain_scores_gemma":[0.98065203,0.0123754535,0.005092386,0.00012785317,0.0016074952,0.00014475788],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.023778576,0.000118429794,0.001653243,0.00007749401,0.000027363858,0.000002369787,0.00010976696,0.0004049192,0.000032486794],"category_scores_gemma":[0.065172024,0.000067215864,0.00035449458,0.000303728,0.00029233194,0.00011602033,0.000025321919,0.0011359443,1.9641804e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003420692,0.0056511844,0.9519427,0.000003061525,0.0010087597,0.000018768567,0.0004073994,0.00007035583,0.00013171445,0.000008023021,0.0003388632,0.036998525],"study_design_scores_gemma":[0.014284084,0.018381614,0.9611506,0.0001285112,0.0049557816,0.000011886248,0.0002244513,0.0002446429,0.00018894143,0.00022100181,0.00015547153,0.000053027386],"about_ca_topic_score_codex":0.00014207707,"about_ca_topic_score_gemma":0.00049716776,"teacher_disagreement_score":0.041393448,"about_ca_system_score_codex":0.00043574412,"about_ca_system_score_gemma":0.0025117872,"threshold_uncertainty_score":0.9427024},"labels":[],"label_agreement":null},{"id":"W2324535812","doi":"10.1158/1538-7445.am2012-2706","title":"Abstract 2706: Phase 2 study with pharmacokinetics (PK) analysis of sorafenib and vinorelbine in metastatic breast cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Vinorelbine; Capecitabine; Sorafenib; Internal medicine; Pharmacokinetics; Metastatic breast cancer; Oncology; Cancer; Breast cancer; Docetaxel; Chemotherapy; Concomitant; Pharmacology; Gastroenterology; Colorectal cancer; Hepatocellular carcinoma","score_opus":0.1254380671873317,"score_gpt":0.5228773848304897,"score_spread":0.39743931764315804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324535812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99188316,0.0059631243,0.0000024196663,0.00055861863,0.000066800756,0.0009978582,0.00028408007,0.000011188669,0.00023276443],"genre_scores_gemma":[0.99708354,0.0017987716,0.000025346031,0.00006712269,0.00015954563,0.00043319052,0.00003009793,0.000025391542,0.00037701277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998145,0.0001393444,0.00030857814,0.00029487585,0.0005532464,0.0005589832],"domain_scores_gemma":[0.9989633,0.00016831867,0.00008390638,0.00021704235,0.00027565967,0.00029177676],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053444767,0.0001713089,0.00060852664,0.0008749285,0.000052274117,0.000011937326,0.000094552175,0.000034851317,0.0030890983],"category_scores_gemma":[0.000010535161,0.0001255012,0.00005816467,0.0020134537,0.0002315114,0.00011327407,0.000054536467,0.00038441722,0.0000034643274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069802976,0.00676078,0.9107214,0.0002394389,0.0051629697,0.00012146579,0.0022006796,0.00021494545,0.0501299,0.0000071290547,0.0014036235,0.016057352],"study_design_scores_gemma":[0.019640625,0.0014246189,0.96121997,0.0000930875,0.005127502,0.00001627541,0.000991628,0.00023502883,0.010119295,0.0000033734993,0.0009472486,0.0001813394],"about_ca_topic_score_codex":0.0079798745,"about_ca_topic_score_gemma":0.0039761993,"teacher_disagreement_score":0.05049856,"about_ca_system_score_codex":0.00030553262,"about_ca_system_score_gemma":0.00030129708,"threshold_uncertainty_score":0.99862605},"labels":[],"label_agreement":null},{"id":"W2324736805","doi":"10.2174/1573394711309010005","title":"Going Beyond Anthracyclines and Taxanes in Breast Cancer What&amp;#8217;s Next?","year":2013,"lang":"en","type":"article","venue":"Current Cancer Therapy Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Taxane; Tolerability; Capecitabine; Anthracycline; Medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Adjuvant; Cancer; Chemotherapy; Adverse effect; Colorectal cancer","score_opus":0.1182335541980851,"score_gpt":0.43213573654346177,"score_spread":0.3139021823453767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324736805","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41096938,0.581442,0.0000018808897,0.004938458,0.001277663,0.0012564112,0.000014743353,0.000022999156,0.00007648507],"genre_scores_gemma":[0.05258186,0.9413028,0.000053865777,0.0022255394,0.0010444139,0.0021290528,0.000032399555,0.000034538836,0.00059554813],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983438,0.00011921587,0.00053589966,0.0004571046,0.00014624916,0.00039770277],"domain_scores_gemma":[0.9991773,0.000059331447,0.00022685355,0.00026699965,0.00008040824,0.00018910735],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018536163,0.00034567295,0.000827691,0.00012610464,0.000072940195,0.00010477416,0.000106328334,0.00006450737,0.005195439],"category_scores_gemma":[0.000007355938,0.00024316434,0.0001444374,0.00032051784,0.00012102909,0.00066605443,0.000032966047,0.00027346297,0.000105649626],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015217008,0.00024472867,0.10939627,0.000358718,0.000061719744,0.0000023730788,0.00038833506,9.1943684e-7,0.0047306637,0.000009310684,0.014671848,0.86998296],"study_design_scores_gemma":[0.0032315466,0.00007800245,0.05531743,0.0019741545,0.00011580992,0.00003792672,0.00003906903,0.000034176883,0.00025571525,0.000071426264,0.93856347,0.00028124425],"about_ca_topic_score_codex":0.0012368463,"about_ca_topic_score_gemma":0.00068885315,"teacher_disagreement_score":0.92389166,"about_ca_system_score_codex":0.00018364581,"about_ca_system_score_gemma":0.00013220402,"threshold_uncertainty_score":0.99571395},"labels":[],"label_agreement":null},{"id":"W2325065247","doi":"10.1158/0008-5472.sabcs12-p1-13-01","title":"Abstract P1-13-01: A randomized trial of CEF versus dose dense EC followed by paclitaxel versus AC followed by paclitaxel in women with node positive or high risk node negative breast cancer, NCIC CTG MA.21: Results of the final relapse free survival analysis.","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; Ottawa Regional Cancer Foundation; Health Sciences Centre; Saint John Regional Hospital; McMaster University; Queen's University; University of Calgary; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Epirubicin; Internal medicine; Paclitaxel; Randomized controlled trial; Taxane; Cyclophosphamide; Gastroenterology; Chemotherapy; Cancer","score_opus":0.05582360208603607,"score_gpt":0.3945439117137432,"score_spread":0.33872030962770716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325065247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97954243,0.0019175486,0.0000038570283,0.0027930152,0.0012398458,0.003639109,0.010054679,0.000024964756,0.00078453333],"genre_scores_gemma":[0.9929801,0.0026725056,0.000062123596,0.000063334905,0.000428519,0.001964314,0.00017576003,0.00007196489,0.0015813321],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9924531,0.002278302,0.0011625699,0.00082502625,0.0018018045,0.0014792086],"domain_scores_gemma":[0.98996484,0.0069772624,0.00082938356,0.0010376557,0.0006479957,0.00054283073],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0043024886,0.0005487011,0.0022298337,0.0005400588,0.0002415553,0.000028144192,0.00057754223,0.00033069885,0.00091755524],"category_scores_gemma":[0.0017755056,0.00034714368,0.00054506055,0.0026789631,0.001250365,0.00025568213,0.00023878628,0.0013039343,0.000006282328],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9553699,0.0018359208,0.005902926,0.00009639119,0.00783151,0.000053586245,0.004160038,0.00008419362,0.0053943056,0.0000097114225,0.018496681,0.0007648184],"study_design_scores_gemma":[0.93699753,0.003020354,0.04692568,0.00027775674,0.0035391832,0.0000024891092,0.0015905399,0.00003862223,0.006911995,0.00002185249,0.0003037066,0.00037027424],"about_ca_topic_score_codex":0.1246769,"about_ca_topic_score_gemma":0.027202347,"teacher_disagreement_score":0.097474545,"about_ca_system_score_codex":0.0026205082,"about_ca_system_score_gemma":0.0020671648,"threshold_uncertainty_score":0.99999577},"labels":[],"label_agreement":null},{"id":"W2325653118","doi":"10.1158/0008-5472.sabcs11-p5-19-08","title":"P5-19-08: Pooled Analysis of Individual Patient Data from Capecitabine Monotherapy Clinical Trials in Anthracycline-/Taxane-Pretreated Locally Advanced or Metastatic Breast Cancer (LA/MBC).","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Capecitabine; Internal medicine; Taxane; Metastatic breast cancer; Refractory (planetary science); Clinical trial; Anthracycline; Regimen; Oncology; Breast cancer; Cancer","score_opus":0.4927062928935304,"score_gpt":0.5873651864627961,"score_spread":0.09465889356926571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325653118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98005396,0.0076107546,0.0000787259,0.001195101,0.00030784053,0.0019492208,0.008578294,0.000037695198,0.00018842239],"genre_scores_gemma":[0.97755224,0.018383514,0.0008388876,0.0004810668,0.00026219594,0.0007596044,0.0013343294,0.000063930325,0.00032425363],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99125487,0.003644691,0.0021441248,0.001120205,0.0010923464,0.0007437548],"domain_scores_gemma":[0.9927913,0.004281795,0.00062508276,0.0012517625,0.0005542407,0.00049583457],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006512677,0.0003669559,0.0025602751,0.0011755008,0.0000833492,0.000029260587,0.0007947711,0.00022710148,0.022893796],"category_scores_gemma":[0.0013343896,0.00026098115,0.0003619636,0.0029893627,0.00059984426,0.00022211317,0.00033573597,0.00085746474,0.00001824738],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0868983,0.006520402,0.34093723,0.00018589575,0.033973873,0.00088370073,0.0041858573,0.00023667223,0.018942444,0.0000107041915,0.0088653285,0.49835962],"study_design_scores_gemma":[0.07299449,0.0050938176,0.8571241,0.001022974,0.025710367,0.000022726226,0.0026729624,0.0055844765,0.021983583,0.00014974392,0.006669563,0.0009712078],"about_ca_topic_score_codex":0.027851414,"about_ca_topic_score_gemma":0.020019034,"teacher_disagreement_score":0.5161869,"about_ca_system_score_codex":0.00045339603,"about_ca_system_score_gemma":0.0022068198,"threshold_uncertainty_score":0.99998426},"labels":[],"label_agreement":null},{"id":"W2325764269","doi":"10.1097/00001813-200303000-00008","title":"Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer","year":2003,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Doxorubicin; Pharmacokinetics; Metastatic breast cancer; Liposome; Medicine; Breast cancer; Pharmacology; Cyclophosphamide; Cancer; Chemotherapy; Chemistry; Internal medicine; Biochemistry","score_opus":0.013141340336735861,"score_gpt":0.2877310070471609,"score_spread":0.27458966671042506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325764269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943651,0.00068651926,0.00002347492,0.0010647313,0.00020882436,0.0022795354,0.0003336559,0.00005171781,0.000986435],"genre_scores_gemma":[0.9966899,0.00041608707,0.0003780544,0.00078719144,0.000040830397,0.00036093977,0.00044184824,0.00010081964,0.00078433217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99639195,0.00035162788,0.00092239515,0.0007345309,0.00085576816,0.00074370025],"domain_scores_gemma":[0.99804956,0.00013264264,0.0006299334,0.00036568596,0.0005616494,0.00026050667],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000320213,0.00064218894,0.001309061,0.0005451621,0.00009951096,0.000031948548,0.00020999809,0.00012345849,0.0014627473],"category_scores_gemma":[0.000009755715,0.0004899518,0.0000974587,0.0012631638,0.00037592027,0.00031057565,0.000033448006,0.00057892257,0.000011295413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015167907,0.006114461,0.9590454,0.0005915101,0.0013591633,0.00014585047,0.003121013,0.0016194623,0.010953253,0.00016587027,0.0007498182,0.0009662953],"study_design_scores_gemma":[0.09384657,0.0034995829,0.8102924,0.0018501318,0.0013421213,0.00005578797,0.00084118836,0.0003255169,0.086306244,0.00011213247,0.0007402237,0.000788075],"about_ca_topic_score_codex":0.0059050545,"about_ca_topic_score_gemma":0.001986487,"teacher_disagreement_score":0.14875297,"about_ca_system_score_codex":0.0006095382,"about_ca_system_score_gemma":0.0009603845,"threshold_uncertainty_score":0.9997552},"labels":[],"label_agreement":null},{"id":"W2325803459","doi":"10.1200/jco.2012.30.15_suppl.lba1000","title":"NSABP B-38: Definitive analysis of a randomized adjuvant trial comparing dose-dense (DD) AC followed by paclitaxel (P) plus gemcitabine (G) with DD AC followed by P and with docetaxel, doxorubicin, and cyclophosphamide (TAC) in women with operable, node-positive breast cancer.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Docetaxel; Gemcitabine; Paclitaxel; Adjuvant; Oncology; Internal medicine; Doxorubicin; Randomized controlled trial; Chemotherapy","score_opus":0.03819735924230556,"score_gpt":0.39348291623592246,"score_spread":0.3552855569936169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325803459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986399,0.007695861,0.00009508774,0.002897356,0.00030101853,0.0015391214,0.00015449703,0.000012551186,0.0009055014],"genre_scores_gemma":[0.9929539,0.0041743726,0.0007915882,0.0013370028,0.00030189115,0.0001811393,0.000028178605,0.00004712164,0.00018481462],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99426013,0.0012633968,0.0026554829,0.00050200114,0.0005836119,0.00073536765],"domain_scores_gemma":[0.99079597,0.004916541,0.002636763,0.0002145704,0.0005624108,0.000873738],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004024803,0.0005135082,0.0074242586,0.00041538227,0.00009397135,0.000024385456,0.00015172544,0.0003781756,0.00016509903],"category_scores_gemma":[0.0004278764,0.00029813417,0.0004025629,0.0008063667,0.0010378313,0.0003428393,0.000077042845,0.0010959572,8.1629406e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7535577,0.0030663651,0.22384888,0.00004355062,0.013768224,0.00037482704,0.0016749554,0.000076338176,0.0006436544,0.000008203855,0.0011982478,0.0017390549],"study_design_scores_gemma":[0.78772116,0.02326969,0.17062934,0.00038378534,0.015191079,0.00041725516,0.0011278231,0.00021418546,0.0001700003,0.000008120061,0.0005140674,0.00035347306],"about_ca_topic_score_codex":0.0012608009,"about_ca_topic_score_gemma":0.001076372,"teacher_disagreement_score":0.053219534,"about_ca_system_score_codex":0.0006438565,"about_ca_system_score_gemma":0.0015229619,"threshold_uncertainty_score":0.9999471},"labels":[],"label_agreement":null},{"id":"W2326269621","doi":"10.1097/00001813-200007000-00004","title":"Differential impact of Raf-1 kinase activity on tumor cell resistance to paclitaxel and docetaxel","year":2000,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Cancer Foundation","funders":"","keywords":"Docetaxel; Taxane; Paclitaxel; Cytotoxicity; Kinase; Ovarian cancer; Cancer research; Medicine; Pharmacology; Oncology; Chemotherapy; Internal medicine; Chemistry; Cancer; In vitro; Breast cancer; Biochemistry","score_opus":0.012873713282393347,"score_gpt":0.3305387008184631,"score_spread":0.31766498753606975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326269621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887982,0.0005252724,0.0000028995873,0.0010870686,0.00013008386,0.0004584902,0.00029630988,0.00003151684,0.008670135],"genre_scores_gemma":[0.9861485,0.0008507774,0.00003260611,0.00043056547,0.00023314383,0.00004765289,0.000013586443,0.00002481629,0.012218357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998825,0.00004729145,0.00021165122,0.0003867402,0.0002024359,0.0003268509],"domain_scores_gemma":[0.9992845,0.00007510566,0.00009342998,0.00027505853,0.00004568548,0.0002262322],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000060145416,0.00023519807,0.0004945555,0.0000962142,0.00006531775,0.0000122984575,0.00007243865,0.000055338696,0.0026107337],"category_scores_gemma":[0.000006193604,0.00018479116,0.00017109067,0.0001921904,0.00008981101,0.00006717035,0.000022428458,0.00015947307,0.000042264222],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040485874,0.0051276945,0.056317136,0.0006965736,0.00092692405,0.00016594268,0.003289229,0.00009061207,0.74160695,0.000050644405,0.073660895,0.07758153],"study_design_scores_gemma":[0.014857137,0.0022375593,0.44450426,0.00026853688,0.00049891125,0.000006167731,0.000043112803,0.000066777095,0.5215535,0.00003038355,0.015504595,0.00042905603],"about_ca_topic_score_codex":0.0010184936,"about_ca_topic_score_gemma":0.00008643516,"teacher_disagreement_score":0.38818714,"about_ca_system_score_codex":0.00016632801,"about_ca_system_score_gemma":0.00013954361,"threshold_uncertainty_score":0.998301},"labels":[],"label_agreement":null},{"id":"W2326276419","doi":"10.1158/1557-3125.advbc-a050","title":"Abstract A050: ARRY-380, an oral HER2 inhibitor: Final phase 1 results and conclusions","year":2013,"lang":"en","type":"article","venue":"Molecular Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lapatinib; Medicine; Neratinib; Limiting; Pharmacokinetics; Pharmacology; Adverse effect; Clinical trial; Internal medicine; Oncology; Maximum tolerated dose; Trastuzumab; Breast cancer; Cancer","score_opus":0.14719787990537644,"score_gpt":0.5059109550626726,"score_spread":0.3587130751572961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326276419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842173,0.0024844192,0.000008027693,0.008074458,0.00014331868,0.000997862,0.00008145286,0.000047611335,0.003945572],"genre_scores_gemma":[0.9953732,0.0005828225,0.00013977836,0.0006989571,0.000310463,0.00038862738,0.00010739438,0.00003681968,0.002361952],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793965,0.0001582269,0.0002488922,0.00048506047,0.00058107544,0.0005871006],"domain_scores_gemma":[0.99869144,0.00008460649,0.00004073662,0.000345242,0.00032806164,0.0005099219],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045821516,0.00017188098,0.00027518367,0.00021038209,0.00023033502,0.00006638884,0.00012176732,0.00012777434,0.0022141074],"category_scores_gemma":[0.000066911074,0.00014634858,0.000064320484,0.00031010003,0.00030251365,0.00014093674,0.00013553664,0.00059214537,0.00012044009],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021827875,0.0010732318,0.0011377827,0.00008069968,0.00015848385,0.00083022856,0.00058742607,0.0000058980686,0.87685406,0.000076284574,0.057977527,0.059035614],"study_design_scores_gemma":[0.06664723,0.011240091,0.041728854,0.000485113,0.00034642115,0.0002127158,0.00084762205,0.0011839155,0.57714957,0.0012335959,0.29798326,0.0009416019],"about_ca_topic_score_codex":0.0066503733,"about_ca_topic_score_gemma":0.00047169966,"teacher_disagreement_score":0.29970446,"about_ca_system_score_codex":0.00023142833,"about_ca_system_score_gemma":0.0004910623,"threshold_uncertainty_score":0.9999644},"labels":[],"label_agreement":null},{"id":"W2326594858","doi":"10.1249/01.mss.0000401549.15499.a0","title":"Current Exercise Behaviors of Breast Cancer Patients Diagnosed with Chemotherapy-Induced Peripheral Neuropathy","year":2011,"lang":"en","type":"article","venue":"Medicine & Science in Sports & Exercise","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Breast cancer; Quality of life (healthcare); Neuropathic pain; Physical therapy; Peripheral neuropathy; Cancer; Psychological intervention; Rehabilitation; Clinical trial; Internal medicine; Psychiatry","score_opus":0.021349114341791427,"score_gpt":0.3085764803543216,"score_spread":0.2872273660125302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326594858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968284,0.0002785825,0.0000011177366,0.00018698587,0.0010448451,0.0012205206,0.000010986378,0.000042391395,0.00038617305],"genre_scores_gemma":[0.99723727,0.0020616148,0.000055507273,0.00016800196,0.00010761172,0.00023041962,0.000011825547,0.000035052824,0.000092723814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724966,0.000018061064,0.000542891,0.00064059737,0.0009776298,0.0005711292],"domain_scores_gemma":[0.9985634,0.000014540817,0.00027539532,0.00041046625,0.00035358098,0.0003826294],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035083372,0.00033340268,0.0007658149,0.00046027126,0.00009079846,0.000005702974,0.00029524678,0.000056928522,0.0023479266],"category_scores_gemma":[0.000012355295,0.00022520755,0.00006786871,0.0013105453,0.001031407,0.0002509059,0.00004921018,0.00026461857,0.0000028458098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012127536,0.0017707958,0.82790947,0.000053865322,0.0000010373947,0.00018913757,0.0068448368,0.0000010289126,0.0012139457,4.3405373e-7,0.000164052,0.16063863],"study_design_scores_gemma":[0.0060414774,0.0010486626,0.9895928,0.001421007,0.00029816694,0.000023015777,0.00037562352,0.000019820352,0.00085828133,0.000005874,0.00010309561,0.00021221064],"about_ca_topic_score_codex":0.0024766398,"about_ca_topic_score_gemma":0.000119053555,"teacher_disagreement_score":0.16168328,"about_ca_system_score_codex":0.00023072846,"about_ca_system_score_gemma":0.0004980018,"threshold_uncertainty_score":0.99856406},"labels":[],"label_agreement":null},{"id":"W2326816428","doi":"10.2512/jspm.9.132","title":"Survey of medical care by oncologists for depression in breast cancer patients","year":2014,"lang":"en","type":"article","venue":"Palliative Care Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Research Foundation","funders":"","keywords":"Medicine; Breast cancer; Depression (economics); Family medicine; Medical care; Oncology; Cancer; Internal medicine","score_opus":0.14728590562528232,"score_gpt":0.5404868676135329,"score_spread":0.3932009619882506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326816428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906113,0.004830947,0.00002136424,0.0010436383,0.000159974,0.0010893655,0.0013369047,0.000009381495,0.0008971151],"genre_scores_gemma":[0.9977542,0.00091966457,0.000016869162,0.00009290437,0.00008486003,0.00041036925,0.00062466884,0.000015749876,0.00008070482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977806,0.00051030336,0.00021323762,0.0002886711,0.0008544678,0.00035269852],"domain_scores_gemma":[0.996609,0.0011750581,0.000054804284,0.00012490309,0.0018539956,0.00018227803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076087634,0.00010261438,0.00032510262,0.00013055214,0.000056636047,0.000004932021,0.00015731857,0.00018009257,0.0003933467],"category_scores_gemma":[0.00068524515,0.00007835267,0.000048646994,0.00030571903,0.00016759589,0.00002120307,0.00009307563,0.0003118934,0.000004131964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011457938,0.00029699766,0.9326168,0.00038341002,0.00003788792,0.000002520206,0.0016378531,0.0000011901037,0.00021458557,0.000004062693,0.0107541485,0.052904807],"study_design_scores_gemma":[0.0061821295,0.0007425202,0.98736054,0.00026687494,0.00001713293,1.248638e-7,0.00043076056,0.00012581174,0.0022609204,0.000004827475,0.002541183,0.000067186214],"about_ca_topic_score_codex":0.009597652,"about_ca_topic_score_gemma":0.0093477145,"teacher_disagreement_score":0.054743785,"about_ca_system_score_codex":0.0007086015,"about_ca_system_score_gemma":0.00053281995,"threshold_uncertainty_score":0.99699754},"labels":[],"label_agreement":null},{"id":"W2326976339","doi":"10.6000/1927-7229.2016.05.01.5","title":"A Case of Sigmoid Colon Cancer in which Somatic Pain was Rapidly Alleviated after Panitumumab Administration Despite Tumor Progression","year":2016,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Panitumumab; Oxaliplatin; Abdominal pain; Colorectal cancer; Irinotecan; Adverse effect; Internal medicine; FOLFIRI; Cancer pain; Paronychia; Cancer; Surgery; Gastroenterology; Oncology; Cetuximab","score_opus":0.027616116230245173,"score_gpt":0.39659452619573965,"score_spread":0.36897840996549447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326976339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891053,0.0005810505,0.00013101219,0.009513825,0.00016998214,0.00031928404,0.000008540252,0.000006355067,0.0001646536],"genre_scores_gemma":[0.9985191,0.00023096836,0.00041193262,0.00042841397,0.00021726663,0.00003465721,0.0000016009027,0.000013568325,0.00014249604],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.998006,0.0004322506,0.00093094,0.0001602598,0.00020697628,0.00026358725],"domain_scores_gemma":[0.99805623,0.00068624405,0.0005663846,0.00010395677,0.00036430516,0.00022290129],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009885301,0.00015318922,0.00076038245,0.0002855628,0.00002102011,0.000005160279,0.000064464046,0.00016207727,0.001183409],"category_scores_gemma":[0.00043489636,0.00008963672,0.00015040748,0.00030542517,0.00012645169,0.00010073607,0.000021074477,0.00025265355,0.0000058190744],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.087981716,0.020927457,0.28252277,0.00096345396,0.002920359,0.16759436,0.002686306,0.000047617214,0.15161024,0.00017968491,0.00560387,0.2769622],"study_design_scores_gemma":[0.18692043,0.29347256,0.26836193,0.00970206,0.013787773,0.10060769,0.0017319192,0.02515473,0.054884035,0.002048533,0.041494187,0.0018341644],"about_ca_topic_score_codex":0.000028907773,"about_ca_topic_score_gemma":0.0009659836,"teacher_disagreement_score":0.275128,"about_ca_system_score_codex":0.00063679036,"about_ca_system_score_gemma":0.0011360156,"threshold_uncertainty_score":0.99972963},"labels":[],"label_agreement":null},{"id":"W2327052483","doi":"10.1017/s0317167100018461","title":"Chemotherapy-induced Peripheral Neuropathy Among Paediatric Oncology Patients","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"American Society of Pediatric Hematology/Oncology; Leukemia and Lymphoma Society of Canada; Leukemia and Lymphoma Society","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Chemotherapy; Internal medicine; Ataxia; Vinca; Retrospective cohort study; Oncology; Surgery; Pharmacology","score_opus":0.027086059907460793,"score_gpt":0.29332702640349706,"score_spread":0.2662409664960363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327052483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851514,0.00039538875,0.000011039859,0.005465575,0.0018533228,0.0002469734,0.000004825289,0.000024077,0.0068473946],"genre_scores_gemma":[0.98751813,0.00028222663,0.000631465,0.010624416,0.00086177787,0.0000042126953,6.830532e-7,0.000019011843,0.000058064004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951342,0.0012270964,0.00091414724,0.000573126,0.0007304978,0.0014209523],"domain_scores_gemma":[0.9953114,0.0005357829,0.0008511556,0.00015268617,0.0005742148,0.0025747567],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":["sts"],"category_scores_codex":[0.0029038612,0.0003880699,0.000757382,0.000994079,0.0018341844,0.00030879898,0.0011708172,0.00027304306,0.0004584713],"category_scores_gemma":[0.0014219601,0.00025863881,0.00036132915,0.001285417,0.004324204,0.0006444953,0.000052465377,0.0014037347,0.00000615106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024665814,0.00013762184,0.97572595,0.000006325054,0.000022093871,0.0021525584,0.000311793,0.00024340895,0.00007798543,0.000109801505,0.0013510978,0.019614685],"study_design_scores_gemma":[0.0018703556,0.19578788,0.7754787,0.000019352678,0.00012053906,0.00916006,0.00006834837,0.00089770684,0.00010991357,0.0018482537,0.014341972,0.00029692755],"about_ca_topic_score_codex":0.000987871,"about_ca_topic_score_gemma":0.022095436,"teacher_disagreement_score":0.20024727,"about_ca_system_score_codex":0.0005044796,"about_ca_system_score_gemma":0.0034546661,"threshold_uncertainty_score":0.9999866},"labels":[],"label_agreement":null},{"id":"W2327085958","doi":"10.1097/00001813-200008000-00012","title":"Cost-utility analysis of second-line hormonal therapy in advanced breast cancer: a comparison of two aromatase inhibitors to megestrol acetate","year":2000,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Letrozole; Anastrozole; Megestrol acetate; Medicine; Megestrol; Aromatase; Randomized controlled trial; Oncology; Hormonal therapy; Internal medicine; Quality-adjusted life year; Breast cancer; Quality of life (healthcare); Clinical trial; Aromatase inhibitor; Cancer; Gynecology; Cost effectiveness","score_opus":0.03360241873040829,"score_gpt":0.39322030578894535,"score_spread":0.35961788705853703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327085958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921433,0.0030680203,0.0000036521524,0.0013446832,0.00012134901,0.00086921616,0.002152175,0.000025358295,0.0002722779],"genre_scores_gemma":[0.9958246,0.0026665274,0.000086014334,0.000534622,0.00010253056,0.00023464378,0.00021154914,0.000022027167,0.00031751735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980337,0.000084720516,0.00073775736,0.0004495135,0.00031536928,0.0003789242],"domain_scores_gemma":[0.9990023,0.00007682818,0.00025209563,0.0003452887,0.00013591262,0.00018759821],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018406459,0.00027415276,0.0013040194,0.0004086943,0.000036602083,0.000005464842,0.00014631801,0.000074937736,0.007602059],"category_scores_gemma":[0.0000027491678,0.00024093193,0.00027495937,0.0015132203,0.0001371939,0.0001092755,0.000025763182,0.00020618613,0.0000073342753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006134512,0.0016678838,0.65132105,0.0000818834,0.0021475295,0.000009616671,0.0025529342,0.0059149773,0.059900716,0.0000030636907,0.0014440861,0.26882178],"study_design_scores_gemma":[0.013410077,0.00061681506,0.8027509,0.00014417198,0.0015577241,0.000003156126,0.0002548352,0.0033278537,0.17275092,0.000008735839,0.004887553,0.00028729468],"about_ca_topic_score_codex":0.006021175,"about_ca_topic_score_gemma":0.005048953,"teacher_disagreement_score":0.26853448,"about_ca_system_score_codex":0.00018986924,"about_ca_system_score_gemma":0.0002507999,"threshold_uncertainty_score":0.99330515},"labels":[],"label_agreement":null},{"id":"W2327509076","doi":"10.1097/01.cot.0000285553.29225.f2","title":"Liposomal Anthracycline Formulations Spare Heart","year":2002,"lang":"en","type":"article","venue":"Oncology Times","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cardiotoxicity; Medicine; Anthracycline; Mucositis; Doxorubicin; Regimen; Breast cancer; Nausea; Internal medicine; Cancer; Oncology; Metastatic breast cancer; Population; Chemotherapy; Surgery","score_opus":0.048546594787928346,"score_gpt":0.3763951281040644,"score_spread":0.32784853331613606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327509076","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4236373,0.0027184652,0.000030179186,0.06472345,0.0007570299,0.0005960147,0.000025311692,0.00021878224,0.50729346],"genre_scores_gemma":[0.90526927,0.00019729658,0.002059955,0.0027937845,0.00053454336,0.000041364026,0.00004623448,0.0000141112905,0.08904346],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99937654,0.000029355759,0.00015745184,0.00016085312,0.00006880119,0.0002070278],"domain_scores_gemma":[0.9995666,0.00011675865,0.0000395951,0.00013140871,0.000038824146,0.000106814],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000040379924,0.00009744538,0.00025922168,0.00007135353,0.000091670874,0.0000036742272,0.00003543041,0.000116374846,0.023906909],"category_scores_gemma":[0.000019541078,0.000082857165,0.00007971,0.00010372167,0.000085179,0.000052709536,0.0000211039,0.0001276393,0.0010795649],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024439683,0.0019138982,0.063331164,0.000019903688,0.00020580416,0.00019169528,0.00040228214,0.000015886346,0.0058633066,0.0004899978,0.89707965,0.030241996],"study_design_scores_gemma":[0.0031862797,0.0015968824,0.031902444,0.000010543147,0.00023358333,0.00033621967,0.000022342447,0.0010725146,0.0014213722,0.00013291252,0.9599937,0.000091191774],"about_ca_topic_score_codex":0.000020415882,"about_ca_topic_score_gemma":0.00003208792,"teacher_disagreement_score":0.48163193,"about_ca_system_score_codex":0.00011334065,"about_ca_system_score_gemma":0.000048324022,"threshold_uncertainty_score":0.9996982},"labels":[],"label_agreement":null},{"id":"W2328243021","doi":"10.1097/01.cot.0000315327.46277.02","title":"Metronomic Timing Adds Antiangiogenic Punch","year":2002,"lang":"en","type":"article","venue":"Oncology Times","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cyclophosphamide; Chemotherapy; Docetaxel; Mitoxantrone; Paclitaxel; Lewis lung carcinoma; Oncology; Regimen; Internal medicine; Cancer; Pharmacology; Metastasis","score_opus":0.05168075247852362,"score_gpt":0.34682484796238144,"score_spread":0.29514409548385784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328243021","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43512815,0.007810944,0.00002189234,0.009015474,0.0007580421,0.00037237318,0.0000094577545,0.00014809353,0.5467356],"genre_scores_gemma":[0.87598395,0.0003786856,0.0012141648,0.0014250122,0.00046150805,0.000040065366,0.000024839614,0.000020304085,0.120451465],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992571,0.000043364384,0.00015768854,0.00021163347,0.000060079004,0.0002701493],"domain_scores_gemma":[0.9995617,0.0001016473,0.000054920514,0.00015019337,0.000024175315,0.000107365835],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000774365,0.00012187984,0.0003164277,0.00012363383,0.00006289214,0.000004534168,0.00006300229,0.00013123265,0.03306678],"category_scores_gemma":[0.000012482173,0.0001062641,0.00013377104,0.000120147255,0.00008584003,0.000041045187,0.000030081714,0.00012385634,0.0021443039],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021697412,0.0009841472,0.02040033,0.000021139409,0.00078498555,0.0003173996,0.000453142,0.0000075537523,0.0099389665,0.00019687504,0.862362,0.10431644],"study_design_scores_gemma":[0.004039794,0.0015968544,0.007515585,0.000010968106,0.000761547,0.00029857102,0.00004908587,0.0008634755,0.0038731105,0.00004646733,0.9807907,0.00015387987],"about_ca_topic_score_codex":0.00002703435,"about_ca_topic_score_gemma":0.000014306579,"teacher_disagreement_score":0.4408558,"about_ca_system_score_codex":0.00026527754,"about_ca_system_score_gemma":0.000067582456,"threshold_uncertainty_score":0.99863267},"labels":[],"label_agreement":null},{"id":"W2329318802","doi":"10.1158/0008-5472.sabcs11-p5-18-02","title":"P5-18-02: A Population Level Assessment of Emergency Room Visits and Hospitalizations for Women Undergoing Adjuvant Chemotherapy for Early Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Credit Valley Hospital; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Population; Internal medicine; Chemotherapy; Regimen; Cancer; Cancer registry; Chemotherapy regimen; Oncology","score_opus":0.2011688486938001,"score_gpt":0.4988959855576793,"score_spread":0.2977271368638792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329318802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931743,0.0012899296,0.0011685592,0.0011563818,0.00027395424,0.0019992567,0.00055489765,0.000019266801,0.0003634383],"genre_scores_gemma":[0.9906551,0.0026454998,0.0006066827,0.000054828026,0.00026261748,0.0026854754,0.00005423609,0.00003928152,0.0029962775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877197,0.00003854954,0.00024657045,0.00029298707,0.00023740511,0.00041253265],"domain_scores_gemma":[0.9990472,0.00008274874,0.00008899245,0.0001481098,0.00048016428,0.00015279118],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031031788,0.00012176219,0.00027988918,0.00017144413,0.00016265445,0.000009574238,0.000079178426,0.00007234163,0.001647948],"category_scores_gemma":[0.00001731332,0.000110170375,0.00006390101,0.0002709261,0.000029841425,0.00010299074,0.000027780496,0.00009930226,4.9099475e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023845078,0.00063486566,0.91882885,0.0013049694,0.00071856217,0.0000023340892,0.0056823674,0.000017647888,0.015538977,0.0013313543,0.0078416765,0.045713887],"study_design_scores_gemma":[0.005286678,0.0013469179,0.9871985,0.00015009158,0.00008489647,0.0000021468206,0.00029969122,0.00051441864,0.002270911,0.0017315949,0.0009824198,0.00013176857],"about_ca_topic_score_codex":0.0025096857,"about_ca_topic_score_gemma":0.0015065469,"teacher_disagreement_score":0.06836962,"about_ca_system_score_codex":0.00061519665,"about_ca_system_score_gemma":0.0005038346,"threshold_uncertainty_score":0.99926466},"labels":[],"label_agreement":null},{"id":"W2329585923","doi":"10.1016/j.jval.2014.08.2320","title":"Nab-Paclitaxel or Docetaxel as Alternatives to Solvent-Based Paclitaxel in Metastatic Breast Cancer (Mbc): A Cost Utility Analysis from a Chinese Health Care Perspective","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Docetaxel; Paclitaxel; Medicine; Metastatic breast cancer; Neutropenia; Oncology; Chemotherapy; Febrile neutropenia; Breast cancer; Internal medicine; Cancer; Pharmacology","score_opus":0.050255009929361424,"score_gpt":0.44049519122943914,"score_spread":0.3902401813000777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329585923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94440997,0.007310534,0.0005806962,0.04194781,0.00033748438,0.0029603974,0.002138941,0.00006936547,0.0002447977],"genre_scores_gemma":[0.98722136,0.00051608385,0.0015361424,0.009489974,0.00023280088,0.0006225277,0.00022158479,0.000042645333,0.00011690549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99538934,0.0012877054,0.00094440125,0.0010019596,0.000496437,0.00088016025],"domain_scores_gemma":[0.99739736,0.0006877729,0.00037891758,0.00053789193,0.00022702401,0.0007710007],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001013666,0.0004510399,0.0016484008,0.0009530402,0.00013971569,0.000027942904,0.00019675614,0.000080498845,0.000865725],"category_scores_gemma":[0.00027023154,0.00035031274,0.00028558832,0.0022620042,0.00010695745,0.00010358242,0.000054989556,0.00047634394,0.000028022434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010061047,0.0038999347,0.896757,0.0011599397,0.0018333278,0.00016878084,0.057401825,0.009725439,0.000088791625,0.00031419352,0.0009432774,0.017646445],"study_design_scores_gemma":[0.01593101,0.0031884315,0.9386417,0.00077821926,0.00060564576,0.00001563015,0.009938947,0.028217996,0.00005870972,0.00068713713,0.0014338779,0.00050264865],"about_ca_topic_score_codex":0.5626936,"about_ca_topic_score_gemma":0.15130733,"teacher_disagreement_score":0.41138625,"about_ca_system_score_codex":0.00466157,"about_ca_system_score_gemma":0.0032804913,"threshold_uncertainty_score":0.99989486},"labels":[],"label_agreement":null},{"id":"W2330319273","doi":"10.5114/wo.2011.24435","title":"Opioidy w leczeniu polineuropatii wywołanej chemioterapią","year":2011,"lang":"pl","type":"article","venue":"Współczesna Onkologia","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.13928556748638937,"score_gpt":0.30210465050981256,"score_spread":0.16281908302342318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330319273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78624994,0.0125919,0.00010637834,0.002977309,0.007786417,0.0017090336,0.00018416982,0.00054504414,0.18784979],"genre_scores_gemma":[0.96271604,0.0024694395,0.0009372719,0.004890979,0.002118275,0.000101050355,0.00017472109,0.00013084366,0.02646137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958264,0.00027476353,0.0009268716,0.0011377531,0.00040738733,0.0014268258],"domain_scores_gemma":[0.9975491,0.00021929051,0.0004002417,0.0009910597,0.00020693458,0.00063335267],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003504,0.00085535063,0.0011639672,0.00032885553,0.0002366907,0.00003645393,0.0005704576,0.0006592051,0.023261916],"category_scores_gemma":[0.00014918593,0.00076570554,0.0004298588,0.000573818,0.00054464437,0.00016534184,0.00020901243,0.0010351951,0.003459944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010792083,0.01410816,0.37097558,0.0015575647,0.0047501028,0.007249634,0.017503452,0.00000504112,0.22170635,0.0064320485,0.28524572,0.059674297],"study_design_scores_gemma":[0.025955647,0.016495453,0.39618334,0.00061454263,0.005772419,0.0012308735,0.00073857297,0.0002558874,0.24859543,0.001601611,0.2992387,0.003317503],"about_ca_topic_score_codex":0.0013646762,"about_ca_topic_score_gemma":0.00006657073,"teacher_disagreement_score":0.17646609,"about_ca_system_score_codex":0.00033256516,"about_ca_system_score_gemma":0.00046828866,"threshold_uncertainty_score":0.9994794},"labels":[],"label_agreement":null},{"id":"W2330965451","doi":"10.1158/0008-5472.sabcs12-p2-12-07","title":"Abstract P2-12-07: A review of clinical endpoints and use of quality-of-life outcomes in phase III metastatic breast cancer clinical trials","year":2012,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Clinical trial; Clinical endpoint; Quality of life (healthcare); Metastatic breast cancer; Breast cancer; Internal medicine; Cancer; Disease; Oncology; Phases of clinical research; Intensive care medicine; Nursing","score_opus":0.8964209041648008,"score_gpt":0.7636633541804825,"score_spread":0.13275754998431832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330965451","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010768729,0.98054194,6.159894e-7,0.00071390317,0.0006600493,0.004723556,0.0024958444,0.000007806367,0.00008754964],"genre_scores_gemma":[0.0019062478,0.9954867,0.000058845242,0.00028329718,0.0006007717,0.0010021814,0.00012559984,0.00006479615,0.0004715689],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97877437,0.0092189675,0.009461239,0.0007416852,0.0011374658,0.00066625816],"domain_scores_gemma":[0.9728591,0.021551015,0.0034476472,0.000797505,0.0006571382,0.00068758393],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.04112133,0.00048976607,0.014938033,0.00053897337,0.00003115634,0.000009498316,0.0003384876,0.00044491855,0.0060065305],"category_scores_gemma":[0.008486421,0.0003225365,0.0018954391,0.0006235338,0.0010159602,0.0001322828,0.00022216911,0.001856568,0.000014806378],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030488942,0.002907475,0.0148717435,0.22911713,0.0032199544,0.000025514495,0.000045099274,3.7348258e-8,0.000007304159,0.000026991787,0.0034080546,0.7433218],"study_design_scores_gemma":[0.026916245,0.00091632985,0.016809504,0.1791247,0.009986272,0.000019520665,0.000026016467,7.6487294e-7,0.0000120884115,0.000015595344,0.7657498,0.00042314988],"about_ca_topic_score_codex":0.004792968,"about_ca_topic_score_gemma":0.0005623414,"teacher_disagreement_score":0.76234174,"about_ca_system_score_codex":0.00028039076,"about_ca_system_score_gemma":0.0062302654,"threshold_uncertainty_score":0.9999227},"labels":[],"label_agreement":null},{"id":"W2331094709","doi":"10.1097/00043426-200307000-00008","title":"Phase 1 Study of Paclitaxel Administered Twice Weekly to Children With Refractory Solid Tumors: A Pediatric Oncology Group Study","year":2003,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Medicine; Neutropenia; Dosing; Refractory (planetary science); Paclitaxel; Toxicity; Chemotherapy; Maximum tolerated dose; Limiting; Internal medicine; Gastroenterology; Surgery","score_opus":0.0404686605233346,"score_gpt":0.4053002212812081,"score_spread":0.3648315607578735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331094709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99171126,0.0019241042,0.00006077942,0.0008392706,0.0010480268,0.0030835455,0.000021533822,0.000042840944,0.0012686187],"genre_scores_gemma":[0.9953987,0.00038931365,0.0014492025,0.0005725784,0.0017870297,0.00017119516,0.000009352695,0.00007971782,0.00014293766],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9931244,0.0017881246,0.0027499676,0.0007231593,0.00071409316,0.00090021105],"domain_scores_gemma":[0.9935364,0.0012361046,0.0029235603,0.0005752782,0.00079510995,0.0009335205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019858961,0.0006248861,0.0033963528,0.0017230057,0.00015428873,0.000013504906,0.00047280345,0.00050770404,0.0003769003],"category_scores_gemma":[0.0005986084,0.00048051027,0.00032060884,0.0014605145,0.00015380181,0.00019643853,0.00012896571,0.0013309709,0.00004402212],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017184205,0.16617905,0.7751278,0.00014434627,0.002381204,0.009574057,0.011255629,0.0000087692815,0.0004366865,0.00004059519,0.015247701,0.0024199449],"study_design_scores_gemma":[0.11898538,0.72653854,0.09191321,0.000025915864,0.013457499,0.018588789,0.020976111,0.0000027221788,0.00018417035,0.000041665033,0.008623708,0.00066232326],"about_ca_topic_score_codex":0.000072034665,"about_ca_topic_score_gemma":0.00021476428,"teacher_disagreement_score":0.6832146,"about_ca_system_score_codex":0.00091126485,"about_ca_system_score_gemma":0.0034911975,"threshold_uncertainty_score":0.9997647},"labels":[],"label_agreement":null},{"id":"W2331427771","doi":"10.1158/1535-7163.targ-09-c218","title":"Abstract C218: Antitumor activities of a novel oral formulation of SN38","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Tolerability; Irinotecan; Pharmacology; Pharmacokinetics; In vivo; Active metabolite; Chemistry; Prodrug; Bioavailability; SN-38; Oral administration; Bioequivalence; Medicine; In vitro; Metabolite; Colorectal cancer; Cancer; Biochemistry; Adverse effect; Internal medicine; Biology","score_opus":0.05436867551825783,"score_gpt":0.3722591213640159,"score_spread":0.3178904458457581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331427771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943987,0.002001047,0.0010462613,0.00062577083,0.00010796542,0.0002573695,0.000030593445,0.000017343153,0.0015149504],"genre_scores_gemma":[0.99754465,0.00030739442,0.00066081155,0.0013108633,0.000040672938,0.000008536378,0.000015579712,0.000012755191,0.00009875372],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993684,0.000008564115,0.00020054754,0.00011370558,0.00016923205,0.00013949878],"domain_scores_gemma":[0.9996013,0.000015117235,0.00013677882,0.00014178519,0.00007169609,0.000033290245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045857596,0.00011207864,0.00027085055,0.00007713692,0.000016315285,0.0000030848316,0.000048835827,0.000060050574,0.00008695423],"category_scores_gemma":[0.0000013960969,0.00009948503,0.00010868209,0.00012585521,0.000043127642,0.00004501418,0.000006437678,0.00007883413,5.037725e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056933914,0.0005886819,0.0028164722,0.000070464324,0.00028040455,0.000009874264,0.0002496034,0.00014186224,0.96938175,0.00046863215,0.000030799616,0.02539214],"study_design_scores_gemma":[0.0038388642,0.00073568616,0.056239065,0.00008399444,0.0004816128,0.000007182634,0.00003722579,0.00047873138,0.93572056,0.00017129157,0.0020923929,0.00011337028],"about_ca_topic_score_codex":0.00011189715,"about_ca_topic_score_gemma":0.000018733113,"teacher_disagreement_score":0.053422593,"about_ca_system_score_codex":0.000065312524,"about_ca_system_score_gemma":0.00012461943,"threshold_uncertainty_score":0.40568817},"labels":[],"label_agreement":null},{"id":"W2331485444","doi":"10.1016/j.jval.2012.08.1226","title":"PCN33 Progression-Free Survival as a Surrogate for Overall Survival in Metastatic Breast Cancer","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institut National d'Excellence en Santé et en Services Sociaux; Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Metastatic breast cancer; Progression-free survival; Oncology; Breast cancer; Linear regression; Population; Cancer; Overall survival; Statistics; Mathematics","score_opus":0.0920146967092638,"score_gpt":0.43226656311668654,"score_spread":0.3402518664074228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331485444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972137,0.00720015,0.000011674326,0.015765851,0.0019571483,0.0021544786,0.00022081137,0.000047048674,0.0005058559],"genre_scores_gemma":[0.99499,0.0012502774,0.00081741886,0.0011408177,0.00056993164,0.0006065091,0.000052248386,0.000043954587,0.000528828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978649,0.0002833306,0.00047319193,0.00027541275,0.00029442346,0.0008087545],"domain_scores_gemma":[0.9988345,0.00038833663,0.00014616238,0.00024181443,0.00005174566,0.00033744352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013823285,0.0002009452,0.00059340027,0.00018886494,0.00005457643,0.000007726173,0.000105420586,0.00006487249,0.000332765],"category_scores_gemma":[0.00006380106,0.0001670648,0.00008865481,0.00027351384,0.00004452843,0.00011464913,0.000045969933,0.00022637259,0.000016240496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035545966,0.002515382,0.96691734,0.0014567879,0.00015692817,0.000043447264,0.0028159434,0.00025716433,0.00019063934,0.0020354653,0.0028646563,0.017191624],"study_design_scores_gemma":[0.039910384,0.001962013,0.92800695,0.0016436294,0.00022362176,0.00015450019,0.00046943926,0.0026148418,0.00031946486,0.0023854251,0.021755906,0.0005538017],"about_ca_topic_score_codex":0.033168264,"about_ca_topic_score_gemma":0.002725442,"teacher_disagreement_score":0.038910393,"about_ca_system_score_codex":0.0007116293,"about_ca_system_score_gemma":0.0008793808,"threshold_uncertainty_score":0.97326994},"labels":[],"label_agreement":null},{"id":"W2331590218","doi":"10.1158/0008-5472.sabcs10-p1-13-01","title":"Abstract P1-13-01: Comparing the Effects of Denosumab and Zoledronic Acid on Pain Interference with Daily Functioning in a Randomized Phase 3 Trial of Patients with Breast Cancer and Bone Metastases","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Denosumab; Brief Pain Inventory; Breast cancer; Internal medicine; Zoledronic acid; Bone pain; Clinical endpoint; Randomized controlled trial; Oncology; Cancer; Physical therapy; Osteoporosis; Chronic pain","score_opus":0.034659930866046525,"score_gpt":0.3834066668880435,"score_spread":0.34874673602199696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331590218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585116,0.0018205721,0.000008895631,0.00024466985,0.000097114935,0.0018732394,0.000035145084,0.0000057372654,0.00006347042],"genre_scores_gemma":[0.99867344,0.0005056398,0.00001190667,0.000034211866,0.00006954802,0.0006549315,0.000011173388,0.000014726733,0.000024401024],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99863577,0.00029127966,0.00024436932,0.00024077701,0.00033868416,0.00024914643],"domain_scores_gemma":[0.9982133,0.0012469757,0.00012905062,0.00016445424,0.00015839435,0.000087826294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012345685,0.00013680596,0.0006229806,0.00019452881,0.00007298966,0.000015883397,0.00006504411,0.00004126914,0.0001264969],"category_scores_gemma":[0.00014203954,0.00007343349,0.000033435077,0.00023653434,0.0006082158,0.00006667757,0.00003872426,0.0005048329,2.3048793e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88915557,0.0008629116,0.061591323,0.00049138395,0.00041279232,0.000015548887,0.00062796735,0.000008472939,0.017884556,0.000011373269,0.00008760887,0.028850516],"study_design_scores_gemma":[0.87934476,0.004892451,0.098950095,0.001113297,0.0003355771,0.0000053965396,0.00009185952,0.00012270111,0.014985522,0.000010858642,0.000045041714,0.00010245706],"about_ca_topic_score_codex":0.0029527936,"about_ca_topic_score_gemma":0.005063256,"teacher_disagreement_score":0.037358772,"about_ca_system_score_codex":0.00008324334,"about_ca_system_score_gemma":0.00031220465,"threshold_uncertainty_score":0.44637606},"labels":[],"label_agreement":null},{"id":"W2332461257","doi":"10.1158/0008-5472.sabcs-1035","title":"Effect of anticoagulation therapy on bleeding and thromboembolic events (TEs) in the AVADO phase III study of docetaxel (D) ± bevacizumab (BV) in inoperable locally recurrent (LR) or metastatic breast cancer (mBC).","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sudbury Regional Hospital; University of Alberta; BC Cancer Agency","funders":"","keywords":"Medicine; Bevacizumab; Metastatic breast cancer; Concomitant; Docetaxel; Internal medicine; Surgery; Placebo; Phases of clinical research; Gastroenterology; Cancer; Clinical trial; Chemotherapy; Breast cancer","score_opus":0.11909703441275973,"score_gpt":0.5104941023681366,"score_spread":0.3913970679553769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332461257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924575,0.003463993,0.0000010427925,0.0008727762,0.000083083185,0.0030108348,0.000022135355,0.000006149357,0.0000824869],"genre_scores_gemma":[0.9948338,0.0044929506,0.0000030240153,0.00010273463,0.0000763688,0.0004241131,0.0000075597377,0.00001467506,0.000044722303],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99745107,0.00076235563,0.00041332302,0.00033384908,0.00065266766,0.00038675382],"domain_scores_gemma":[0.9990642,0.00037673608,0.00010111334,0.00023009325,0.00015391692,0.00007396078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016621987,0.00018568596,0.0006420494,0.00045129322,0.00007287028,0.000012684335,0.00015972172,0.000049484275,0.00028410737],"category_scores_gemma":[0.000037074267,0.00010874373,0.00004221359,0.0009737493,0.00011077606,0.00009564257,0.000028148734,0.00043784242,0.0000011147207],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.093640655,0.01894765,0.12797089,0.0007006476,0.0005740784,0.00015913624,0.022254571,0.0006650921,0.123333424,0.000050371396,0.00056296063,0.61114055],"study_design_scores_gemma":[0.19048138,0.07869168,0.67827475,0.0019227877,0.00051153946,0.00004648608,0.0021176657,0.0019953835,0.0452957,0.00014948394,0.00015304048,0.00036011782],"about_ca_topic_score_codex":0.004354134,"about_ca_topic_score_gemma":0.0014619417,"teacher_disagreement_score":0.6107804,"about_ca_system_score_codex":0.00036086328,"about_ca_system_score_gemma":0.00031425687,"threshold_uncertainty_score":0.6582178},"labels":[],"label_agreement":null},{"id":"W2332743404","doi":"10.1055/s-0030-1250333","title":"A Novel Taxane 13-Glucoside and Other Taxanes from the Leaves of<i>Taxus cuspidata</i>","year":2010,"lang":"en","type":"article","venue":"Planta Medica","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Taxane; Glycosidic bond; Glucoside; Botany; Understory; Stereochemistry; Chemistry; Biology; Medicine; Biochemistry; Canopy; Genetics","score_opus":0.021354728649073305,"score_gpt":0.28920686697144343,"score_spread":0.26785213832237015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332743404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878517,0.0013497019,0.000043239048,0.0052925753,0.0006378589,0.0002716187,0.0006776675,0.00003135254,0.003844306],"genre_scores_gemma":[0.99377793,0.00044516497,0.00053369347,0.0035141448,0.0009563955,0.000029614603,0.00011103998,0.000018754152,0.00061326835],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.999208,0.000024526318,0.00018351384,0.00020107078,0.00020478408,0.00017811243],"domain_scores_gemma":[0.9990211,0.00046625728,0.00010647107,0.00025193213,0.000018993056,0.00013523964],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017708998,0.00013076163,0.0002726007,0.000032142867,0.00005458223,0.0000075597086,0.00012516447,0.00009630709,0.0013083126],"category_scores_gemma":[0.000098972305,0.000076761986,0.000041473173,0.000062793384,0.00028531154,0.000029564317,0.000049797818,0.0002907715,0.000026571763],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000632018,0.00045375671,0.16292073,0.000065625354,0.00048721628,0.00009073784,0.0016790932,1.2757637e-7,0.74385816,0.0002038961,0.067565896,0.022042757],"study_design_scores_gemma":[0.007561912,0.00038285862,0.12656564,0.00017783364,0.0009763087,0.00075468357,0.00033142196,0.00006997871,0.09694702,0.00013146678,0.76586765,0.00023321125],"about_ca_topic_score_codex":0.0040871357,"about_ca_topic_score_gemma":0.0022193897,"teacher_disagreement_score":0.69830173,"about_ca_system_score_codex":0.000006998081,"about_ca_system_score_gemma":0.00008221482,"threshold_uncertainty_score":0.99960464},"labels":[],"label_agreement":null},{"id":"W2333373145","doi":"10.1097/01.cot.0000289963.81694.73","title":"Metastatic Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Oncology Times","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Cancer; Oncology; Metastatic breast cancer; Internal medicine","score_opus":0.027077208555881655,"score_gpt":0.39018861995654225,"score_spread":0.3631114114006606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333373145","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3423903,0.0064539826,0.000021199443,0.18126331,0.0008581686,0.0006894456,0.00010044456,0.00021814315,0.468005],"genre_scores_gemma":[0.83034056,0.0006504842,0.0022034212,0.009186299,0.0010162344,0.00016220503,0.000026608703,0.00002142115,0.15639275],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99943984,0.00003388319,0.00012113094,0.00014727101,0.00006392199,0.0001939784],"domain_scores_gemma":[0.99966675,0.000061114675,0.00004194794,0.000091602546,0.0000388415,0.00009975731],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000060129292,0.0000929524,0.00025481824,0.00005686546,0.00003912315,0.0000027249152,0.00003913571,0.000053498232,0.025377564],"category_scores_gemma":[0.0000035797375,0.00007233632,0.000061257924,0.000080263446,0.0000775903,0.000042470012,0.000016620157,0.00010590577,0.0006650999],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007255765,0.0012709309,0.017342148,0.000026879858,0.0006332507,0.00017953517,0.00036525476,0.000025743171,0.0054050353,0.00040866347,0.64047927,0.33313772],"study_design_scores_gemma":[0.0037040524,0.00048018582,0.02456955,0.0000115963085,0.00064832345,0.00065539964,0.00003324663,0.00016530226,0.0015470757,0.00006201673,0.96803397,0.00008926838],"about_ca_topic_score_codex":0.0000905157,"about_ca_topic_score_gemma":0.00014719595,"teacher_disagreement_score":0.48795027,"about_ca_system_score_codex":0.0002872393,"about_ca_system_score_gemma":0.00028743932,"threshold_uncertainty_score":0.9755134},"labels":[],"label_agreement":null},{"id":"W2333644254","doi":"10.1158/0008-5472.sabcs11-p4-01-04","title":"P4-01-04: Effects of CYP2D6 Phenotype and Drug Adherence on Tamoxifen Metabolite Levels.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"CYP2D6; Tamoxifen; Metabolite; Medicine; Genotype; Pharmacology; Internal medicine; Active metabolite; Oncology; Pharmacogenetics; Confounding; Breast cancer; Cancer; Biology; Cytochrome P450; Genetics","score_opus":0.1758046066839674,"score_gpt":0.4552985116812434,"score_spread":0.279493904997276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333644254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764974,0.011202983,0.0000042116485,0.00036438927,0.00028159507,0.00075232715,0.000028898015,0.000021962604,0.010846233],"genre_scores_gemma":[0.99209803,0.0018602941,0.00008980878,0.00020679133,0.00021713169,0.00023380062,0.000004848906,0.000022376003,0.0052668992],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986123,0.00016382514,0.00015237989,0.00031081235,0.0003725297,0.00038819623],"domain_scores_gemma":[0.9990167,0.0002805445,0.000043725966,0.00025480866,0.00019781818,0.0002064265],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035140695,0.0001301682,0.00032431446,0.00018075298,0.00006866653,0.000006821038,0.00012007477,0.000064274165,0.0013719068],"category_scores_gemma":[0.00007454908,0.00010163249,0.000049922728,0.00031126168,0.00029580318,0.00005173234,0.00007982076,0.0003512238,0.000059942395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012427573,0.002144488,0.08499625,0.003548209,0.0015445063,0.00052696664,0.022922114,0.000001952315,0.6088427,0.0072323545,0.03560954,0.22020338],"study_design_scores_gemma":[0.0053386902,0.0021348812,0.20645809,0.0003377431,0.00022892095,0.0000059989497,0.00008552361,0.000009804713,0.7671163,0.0011952067,0.016915299,0.0001735124],"about_ca_topic_score_codex":0.0028513987,"about_ca_topic_score_gemma":0.00015040557,"teacher_disagreement_score":0.22002988,"about_ca_system_score_codex":0.00011250171,"about_ca_system_score_gemma":0.00027512628,"threshold_uncertainty_score":0.999541},"labels":[],"label_agreement":null},{"id":"W2334224680","doi":"10.1158/0008-5472.sabcs11-p5-19-14","title":"P5-19-14: Platinum-Based Chemotherapy in Triple-Negative Breast Cancer.","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Credit Valley Hospital; Ottawa Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Vinorelbine; Internal medicine; Triple-negative breast cancer; Oncology; Gemcitabine; Capecitabine; Regimen; Chemotherapy; Breast cancer; Metastatic breast cancer; Cancer; Retrospective cohort study; Cisplatin; Chemotherapy regimen; Surgery; Colorectal cancer","score_opus":0.16560893439651836,"score_gpt":0.4741263035522565,"score_spread":0.30851736915573813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334224680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766263,0.0017317877,0.000008300264,0.007097638,0.00037088327,0.0015402908,0.0001792697,0.00006257749,0.0123829935],"genre_scores_gemma":[0.9889985,0.0012391252,0.00013234324,0.0013794858,0.00045717155,0.001389152,0.000016286791,0.000048170554,0.006339778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795634,0.000180522,0.00024708538,0.000447802,0.00047706554,0.0006911725],"domain_scores_gemma":[0.99888146,0.00019168263,0.000055556477,0.0002787122,0.00029154445,0.00030101894],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004857348,0.0001896441,0.0003739732,0.00039322028,0.00010986801,0.000012859964,0.00018678933,0.00013530093,0.018694565],"category_scores_gemma":[0.000038937287,0.0001613385,0.00008636645,0.00090375356,0.00032132876,0.00007665951,0.000036099766,0.0006497756,0.00006859569],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042951684,0.0030162204,0.6097325,0.0006043202,0.0007309668,0.00077047385,0.013116759,0.00004457508,0.05669332,0.0003126623,0.15169644,0.120330065],"study_design_scores_gemma":[0.05534431,0.0018153342,0.69893324,0.0006708166,0.00012310428,0.00004390049,0.00066659844,0.00047031837,0.2139943,0.000914301,0.026416782,0.00060697156],"about_ca_topic_score_codex":0.02369532,"about_ca_topic_score_gemma":0.005720858,"teacher_disagreement_score":0.15730098,"about_ca_system_score_codex":0.0013139014,"about_ca_system_score_gemma":0.0017364504,"threshold_uncertainty_score":0.98280597},"labels":[],"label_agreement":null},{"id":"W2334434334","doi":"10.1158/1538-7445.am2013-5515","title":"Abstract 5515: <i>In vivo</i> efficacy of the PARG inhibitor Gallotannin against triple negative breast cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; Triple-negative breast cancer; Cancer; Breast cancer; Cell growth; Cyclin D1; In vivo; Cell cycle checkpoint; Cancer cell; Biology; Cell cycle; Medicine; Internal medicine; Oncology; Chemistry; Biochemistry; Genetics","score_opus":0.059339270538116884,"score_gpt":0.4147771849554307,"score_spread":0.3554379144173138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334434334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98149055,0.0017037849,1.1264769e-7,0.008427714,0.00044451054,0.001869963,0.00016866965,0.000019292944,0.0058754073],"genre_scores_gemma":[0.9917183,0.0014556213,0.000008022762,0.00044518244,0.00060009625,0.0010521113,0.0000041873172,0.000033037642,0.004683441],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99792314,0.00015947115,0.00034117603,0.00035728342,0.0006065446,0.0006124177],"domain_scores_gemma":[0.9986194,0.00032469223,0.000097092496,0.00034291513,0.00041639208,0.00019953916],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003633072,0.00017472844,0.00037269318,0.00017035066,0.00011850011,0.000021471078,0.0002619847,0.00011086614,0.006303783],"category_scores_gemma":[0.00007134492,0.00011713717,0.00013284896,0.000884555,0.00042635863,0.00010890024,0.000111859845,0.000681835,0.000054291642],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001916302,0.0009525237,0.08600299,0.00024982146,0.00022280515,0.000035875662,0.0014085984,0.000081490274,0.6551069,0.00002650474,0.23227972,0.02171649],"study_design_scores_gemma":[0.009082481,0.00020044463,0.69125223,0.00065704994,0.000045731464,0.000006461529,0.0003148701,0.000047954458,0.28790513,0.00006307086,0.010256226,0.00016836324],"about_ca_topic_score_codex":0.01597976,"about_ca_topic_score_gemma":0.0020817323,"teacher_disagreement_score":0.6052492,"about_ca_system_score_codex":0.00078118633,"about_ca_system_score_gemma":0.0010638062,"threshold_uncertainty_score":0.9946046},"labels":[],"label_agreement":null},{"id":"W2335344368","doi":"10.1097/ogx.0b013e3182877729","title":"Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer","year":2013,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Jewish General Hospital","funders":"","keywords":"Docetaxel; Medicine; Capecitabine; Gemcitabine; Bevacizumab; Breast cancer; Oncology; Cyclophosphamide; Chemotherapy; Internal medicine; Doxorubicin; Cancer; Colorectal cancer","score_opus":0.04641934878625111,"score_gpt":0.35359231772341776,"score_spread":0.30717296893716667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335344368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97670394,0.001021307,0.00020415174,0.015603004,0.0011037664,0.003538491,0.0005456001,0.00018534705,0.0010943856],"genre_scores_gemma":[0.98309076,0.00016240375,0.0010090795,0.009285019,0.00029271987,0.0014104389,0.00011132768,0.00003516365,0.0046030637],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980022,0.00014784036,0.00037105364,0.00055535213,0.00024331726,0.00068023923],"domain_scores_gemma":[0.9957146,0.0029705926,0.00007468302,0.00023448616,0.00036622162,0.00063938764],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019155478,0.0002842026,0.00067441096,0.00011695747,0.00011199668,0.000037239315,0.00018026184,0.00026110504,0.021380702],"category_scores_gemma":[0.00095573557,0.00019249831,0.00021395256,0.0007139211,0.000072338466,0.00006205947,0.00006447325,0.00021859123,0.0005612674],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023037589,0.002532395,0.2723567,0.00004501508,0.00037084482,0.00004031861,0.00009309287,0.00001488623,0.005923311,0.00006812189,0.15863226,0.55761933],"study_design_scores_gemma":[0.005853456,0.0017383768,0.957203,0.000009925761,0.00007176849,0.000014502788,0.000012862902,0.00014459078,0.00045660444,0.00008875625,0.034160595,0.00024558528],"about_ca_topic_score_codex":0.0010018537,"about_ca_topic_score_gemma":0.0001635771,"teacher_disagreement_score":0.6848463,"about_ca_system_score_codex":0.00048520617,"about_ca_system_score_gemma":0.00012284066,"threshold_uncertainty_score":0.9795139},"labels":[],"label_agreement":null},{"id":"W2335421053","doi":"10.1158/1535-7163.targ-11-a95","title":"Abstract A95: The determination of the maximum tolerated dose (MTD) of MGCD265 on an intermittent schedule: Phase I study results (Study 265-102).","year":2011,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Adverse effect; Nausea; Pharmacodynamics; Pharmacokinetics; Tolerability; Internal medicine; Maximum tolerated dose; Pharmacology; Gastroenterology; Oncology","score_opus":0.08630945641426414,"score_gpt":0.38851745837937557,"score_spread":0.30220800196511144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335421053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958599,0.00039575604,0.00003346929,0.00038139863,0.00041063654,0.00207814,0.00004859154,0.000022804643,0.0007692573],"genre_scores_gemma":[0.99876547,0.0000489865,0.00003957298,0.0008014599,0.000056514808,0.0001465717,0.000011249339,0.000035397596,0.00009475667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983021,0.00025149915,0.0005172616,0.00031712648,0.0003969301,0.00021509518],"domain_scores_gemma":[0.99855864,0.000042982105,0.00035700906,0.0007489188,0.00023024408,0.00006218961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032387173,0.00024194809,0.00034859826,0.00008821722,0.00008581205,0.000010181952,0.00030998644,0.000076458615,0.0001307221],"category_scores_gemma":[0.000010664143,0.00014110327,0.00013772062,0.00030048753,0.00014221131,0.000044654753,0.000055631823,0.0002693164,0.0000025004056],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024766814,0.05532141,0.028362697,0.00011797283,0.00313404,0.00033751767,0.051304907,0.00007665215,0.45718,0.00005382388,0.00007816501,0.379266],"study_design_scores_gemma":[0.03598547,0.020280719,0.30818814,0.00017054944,0.0031934243,0.000015771784,0.005227349,0.0008052404,0.62478477,0.00012958971,0.00086038973,0.0003585819],"about_ca_topic_score_codex":0.0005351818,"about_ca_topic_score_gemma":0.00028493916,"teacher_disagreement_score":0.3789074,"about_ca_system_score_codex":0.00011596819,"about_ca_system_score_gemma":0.00016147282,"threshold_uncertainty_score":0.57540244},"labels":[],"label_agreement":null},{"id":"W2337335671","doi":"10.1200/jco.2012.30.15_suppl.539","title":"BOLERO-2: Health-related quality-of-life in metastatic breast cancer patients treated with everolimus and exemestane versus exemestane.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Exemestane; Internal medicine; Breast cancer; Aromatase inhibitor; Quality of life (healthcare); Placebo; Everolimus; Hazard ratio; Oncology; Clinical endpoint; Interim analysis; Proportional hazards model; Cancer; Randomized controlled trial; Confidence interval; Aromatase","score_opus":0.21813842384889356,"score_gpt":0.5185650640622901,"score_spread":0.3004266402133965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337335671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899223,0.0038733361,0.0000027347642,0.00445571,0.0009547204,0.00035845427,0.000024809577,0.0000070175643,0.00040093213],"genre_scores_gemma":[0.99530256,0.002772922,0.000400926,0.001156018,0.00022994619,0.000010237679,0.000010760413,0.000020406344,0.00009621618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952156,0.0009246075,0.0029601352,0.00017184044,0.0003363529,0.0003914688],"domain_scores_gemma":[0.9942317,0.001986747,0.0025933906,0.000117039745,0.00033469326,0.00073643436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023409897,0.00019084757,0.0023061652,0.0001861682,0.000028974197,0.0000028106956,0.000077294404,0.00020043607,0.00032809615],"category_scores_gemma":[0.0005263522,0.000126743,0.00018299776,0.00026773245,0.0002600217,0.00016185972,0.00002757833,0.00067227555,0.0000031836846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05517687,0.006010473,0.90505195,0.00009436855,0.0010230426,0.00008685094,0.0003462069,0.0000059171475,0.000025092433,0.000035635145,0.00079355016,0.031350024],"study_design_scores_gemma":[0.05811237,0.01854743,0.9203546,0.00014131686,0.0006575535,0.0001303896,0.0001260215,0.000012205149,0.000008191196,0.00001311173,0.0017951512,0.000101646154],"about_ca_topic_score_codex":0.0013297534,"about_ca_topic_score_gemma":0.0007422463,"teacher_disagreement_score":0.031248378,"about_ca_system_score_codex":0.0003771868,"about_ca_system_score_gemma":0.0017491155,"threshold_uncertainty_score":0.516843},"labels":[],"label_agreement":null},{"id":"W2337704846","doi":"10.1200/jco.2009.27.15_suppl.1099","title":"Cisplatin chemotherapy in the treatment of BRCA1-positive metastatic breast cancer (MBC)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Cisplatin; Regimen; Metastatic breast cancer; Anthracycline; Response Evaluation Criteria in Solid Tumors; Oncology; Breast cancer; Chemotherapy regimen; Progressive disease; Cancer; Gastroenterology; Surgery","score_opus":0.13381379519778763,"score_gpt":0.540320516122561,"score_spread":0.4065067209247734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337704846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9286628,0.0014691578,0.0000164437,0.066736,0.0004431757,0.0003223653,0.000015614638,0.000002127388,0.0023323246],"genre_scores_gemma":[0.98445964,0.0063975183,0.0005915012,0.0073988503,0.0008886216,0.0000072784915,0.0000022137515,0.0000068164277,0.00024756108],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99723494,0.0005367702,0.0016578368,0.00013101358,0.0002654461,0.00017399716],"domain_scores_gemma":[0.99601066,0.002289827,0.0012138213,0.00013298074,0.00022425123,0.00012845549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013605735,0.00013095875,0.0014283201,0.00011864876,0.00001769966,0.0000036575016,0.0001250609,0.00013202764,0.00046899548],"category_scores_gemma":[0.00011248713,0.00006668434,0.00048492628,0.0001991548,0.00013103917,0.00004896478,0.0000035616422,0.00033221938,0.000003741644],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016826069,0.025045926,0.061608408,0.000009112061,0.0011459294,0.0011095864,0.0019728343,0.00003523412,0.0008777297,0.00014009558,0.0044273906,0.88680166],"study_design_scores_gemma":[0.023976061,0.055580296,0.89377606,0.000050483442,0.0009411573,0.0007057714,0.00017739023,0.00004776121,0.00040235784,0.0006454988,0.023637122,0.000060047612],"about_ca_topic_score_codex":0.00009541633,"about_ca_topic_score_gemma":0.00013473135,"teacher_disagreement_score":0.88674164,"about_ca_system_score_codex":0.00032817808,"about_ca_system_score_gemma":0.0009498111,"threshold_uncertainty_score":0.51351714},"labels":[],"label_agreement":null},{"id":"W2337771086","doi":"10.1007/s00216-016-9412-4","title":"Phenylbutazone purity challenge","year":2016,"lang":"en","type":"article","venue":"Analytical and Bioanalytical Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Phenylbutazone; Chemistry; Medical laboratory; Environmental chemistry; Biochemical engineering; Chromatography; Engineering; Pharmacology; Medicine","score_opus":0.021560921158375265,"score_gpt":0.2990167133391603,"score_spread":0.27745579218078503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337771086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83545136,0.0011145197,0.00012302192,0.06862903,0.000052066163,0.00016478283,0.000036451485,0.00012684532,0.094301894],"genre_scores_gemma":[0.9831652,0.0006345971,0.000054707107,0.00047771863,0.00037104843,0.000006784261,0.00000741279,0.000010508627,0.015272043],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99888724,0.000009718179,0.00021394639,0.00037402022,0.00018887497,0.00032622012],"domain_scores_gemma":[0.99911255,0.00012935809,0.00002565359,0.00019015164,0.000057260168,0.00048501557],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007871428,0.00017380204,0.0003523574,0.000024007484,0.00004373128,0.000011213359,0.000055912562,0.00015779845,0.0037281353],"category_scores_gemma":[0.000077189856,0.00009674389,0.00014416275,0.00011936935,0.00040116694,0.000038516588,0.00006290964,0.00013766618,0.00009195214],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004526449,0.010046055,0.19715354,0.0018241572,0.005344978,0.0030247893,0.00012366599,1.3634066e-7,0.4216788,0.025639202,0.04028439,0.29035383],"study_design_scores_gemma":[0.037149426,0.0036366691,0.09313406,0.0008476406,0.010219497,0.0019164912,0.00018550995,0.004137749,0.27393273,0.020900052,0.55099785,0.0029423456],"about_ca_topic_score_codex":0.00000904243,"about_ca_topic_score_gemma":0.000001835653,"teacher_disagreement_score":0.51071346,"about_ca_system_score_codex":0.000063166895,"about_ca_system_score_gemma":0.00005148901,"threshold_uncertainty_score":0.9971826},"labels":[],"label_agreement":null},{"id":"W2337992458","doi":"10.1093/annonc/mdu329.21","title":"Targeted Chemotherapy with Albumin-Bound Paclitaxel (Nab-Paclitaxel) for Metastatic Breast Cancer (Mbc): Which Benefit for Which Patients? a Real World Multicenter Italian Experience on 150 Women","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Paclitaxel; Metastatic breast cancer; Nab-paclitaxel; Oncology; Chemotherapy; Internal medicine; Breast cancer; Cancer","score_opus":0.04636067163229297,"score_gpt":0.3985789024234224,"score_spread":0.35221823079112946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337992458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814598,0.00012568539,0.00007195828,0.013328861,0.00036914586,0.0024698137,0.00069346896,0.00003990095,0.0014413731],"genre_scores_gemma":[0.9856168,0.00029806476,0.0013697238,0.006580866,0.00033703365,0.0033064068,0.00023109387,0.00007660869,0.0021833745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976205,0.00009297692,0.0005684817,0.000608792,0.00026030603,0.00084891927],"domain_scores_gemma":[0.997021,0.0006356575,0.00043653185,0.00035500998,0.0012306981,0.00032107587],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036976574,0.00038696497,0.0010190717,0.0002425645,0.00013022592,0.000016754695,0.00018367641,0.00013835401,0.00057330064],"category_scores_gemma":[0.00009561849,0.0002999729,0.00015675518,0.0004121876,0.000184671,0.00013458829,0.000026735082,0.00015832591,0.0000067074707],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18496378,0.03139651,0.2719516,0.0022310955,0.007858158,0.000025482897,0.050616555,0.00020641049,0.013132496,0.0017723299,0.081184275,0.35466135],"study_design_scores_gemma":[0.09449393,0.1121999,0.27523327,0.00056106655,0.0011732418,0.000025950854,0.0023410765,0.0013809656,0.021801194,0.0010103026,0.48845223,0.0013268625],"about_ca_topic_score_codex":0.000788933,"about_ca_topic_score_gemma":0.0057691894,"teacher_disagreement_score":0.40726796,"about_ca_system_score_codex":0.00037797686,"about_ca_system_score_gemma":0.00033270224,"threshold_uncertainty_score":0.9999452},"labels":[],"label_agreement":null},{"id":"W2339221030","doi":"10.1200/jco.2009.27.15_suppl.e14525","title":"Phase I study of daily administration of MGCD265 to patients with advanced malignancies (Study 265–101)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Neutropenia; Pharmacokinetics; Toxicity; Pharmacodynamics; Internal medicine; Gastroenterology; Tyrosine-kinase inhibitor; Pharmacology; Oncology; Cancer","score_opus":0.09897926098553333,"score_gpt":0.5188007457300592,"score_spread":0.41982148474452585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339221030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968619,0.000063000436,0.00001834949,0.0010234917,0.0004478902,0.0009945187,0.0000057587613,0.000004621202,0.00058052334],"genre_scores_gemma":[0.9982459,0.000038357295,0.00076669466,0.0006145086,0.00023654003,0.000007126857,0.0000030734777,0.000008203461,0.00007959943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99683845,0.00028225945,0.0021349331,0.00017347229,0.00041723676,0.00015363329],"domain_scores_gemma":[0.9963951,0.00054191716,0.0018332867,0.00017373888,0.0008053106,0.0002506548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009057133,0.00013640839,0.0014825742,0.000147969,0.000022897075,0.0000023013522,0.00012202433,0.00011130155,0.00008342355],"category_scores_gemma":[0.000510282,0.00008996831,0.00016398412,0.00021144198,0.000070022244,0.000090318405,0.000018029637,0.00031201565,0.00000208657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10654009,0.2130676,0.53760254,0.000018058972,0.0007258052,0.00045407543,0.0016442069,0.000029098994,0.0010701093,0.0000064532255,0.0009902384,0.13785172],"study_design_scores_gemma":[0.05266565,0.42348,0.5209751,0.00003320764,0.0006942675,0.00001540846,0.00069761934,0.000001529922,0.0003055106,0.000011640221,0.0010738407,0.000046180583],"about_ca_topic_score_codex":0.000013699177,"about_ca_topic_score_gemma":0.00012298673,"teacher_disagreement_score":0.2104124,"about_ca_system_score_codex":0.00007714999,"about_ca_system_score_gemma":0.0008696758,"threshold_uncertainty_score":0.3668801},"labels":[],"label_agreement":null},{"id":"W2339550887","doi":"10.1200/jco.2009.27.15_suppl.5563","title":"A phase II study evaluating the safety and efficacy of patupilone in patients with platinum refractory/resistant ovarian, primary fallopian, or peritoneal cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Taxane; Ovarian cancer; Vomiting; Nausea; Refractory (planetary science); Fallopian tube cancer; Surgery; Internal medicine; Adverse effect; Gastroenterology; Urology; Cancer; Breast cancer","score_opus":0.13520955569290882,"score_gpt":0.5222127716911457,"score_spread":0.38700321599823684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339550887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941236,0.00034732814,0.0000033465462,0.0040241578,0.00034117498,0.00083179836,0.00001016829,0.000003911791,0.00031454992],"genre_scores_gemma":[0.9972012,0.00028085362,0.00063240185,0.0012393608,0.00043958772,0.0000066471503,0.0000041531825,0.000010737975,0.00018502856],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99651283,0.0006331003,0.0020152563,0.00020294539,0.00042876654,0.00020711348],"domain_scores_gemma":[0.99584323,0.001895952,0.0015813373,0.00015419362,0.00034676274,0.00017853822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002387038,0.00015795317,0.0014322983,0.00009456168,0.00007960771,0.0000044874355,0.00011429659,0.00016021993,0.00016758837],"category_scores_gemma":[0.00079698954,0.00007853954,0.00012304906,0.00018964347,0.00016958316,0.00007846267,0.000043429623,0.0008240984,3.198268e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3649176,0.04657432,0.2485601,0.00002165386,0.00059764093,0.00031117655,0.0013332207,0.000020390888,0.00042645322,0.000005414524,0.00026038836,0.33697164],"study_design_scores_gemma":[0.0941851,0.2875281,0.6156106,0.00008910005,0.00062400044,0.000015713564,0.00009559701,0.000026617394,0.0000046345476,0.00000674035,0.0017604263,0.00005337023],"about_ca_topic_score_codex":0.000066719396,"about_ca_topic_score_gemma":0.00027479776,"teacher_disagreement_score":0.36705053,"about_ca_system_score_codex":0.0002602392,"about_ca_system_score_gemma":0.0018506147,"threshold_uncertainty_score":0.35803434},"labels":[],"label_agreement":null},{"id":"W2340310616","doi":"10.1200/jco.2006.24.18_suppl.10728","title":"Trends in systemic management (SM) for the treatment of locally advanced breast cancer: Data from a regional cancer centre","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"","keywords":"Medicine; Anastrozole; Internal medicine; Oncology; Breast cancer; Vinorelbine; Tamoxifen; Docetaxel; Capecitabine; Exemestane; Fulvestrant; Cancer; Letrozole; Epirubicin; Gynecology; Gemcitabine; Chemotherapy; Colorectal cancer","score_opus":0.1761259780921647,"score_gpt":0.5163225580688612,"score_spread":0.3401965799766965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340310616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8753219,0.03637463,0.00016748616,0.08135104,0.0036476445,0.0011843047,0.0010700721,0.00001213756,0.000870765],"genre_scores_gemma":[0.95016724,0.04145617,0.0011259114,0.001108639,0.003280668,0.00009010029,0.000121226934,0.000024074288,0.0026259779],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99732137,0.00016525232,0.0017644952,0.00027235888,0.00023667855,0.00023984213],"domain_scores_gemma":[0.99641097,0.0016273024,0.0013241478,0.00031812978,0.00019710722,0.0001223463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054623664,0.00016568827,0.0012943138,0.00013693192,0.000029506426,0.0000036695333,0.00028227497,0.00017568698,0.0004684383],"category_scores_gemma":[0.000019244182,0.000095225696,0.00037999608,0.00017579185,0.00014655317,0.000066272114,0.00003842563,0.00021223229,0.0000016514316],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02526367,0.0066181575,0.11399168,0.000054615215,0.0020949282,0.00032933752,0.00010219335,0.0008096325,0.00016435776,0.00007180611,0.0491616,0.801338],"study_design_scores_gemma":[0.05155933,0.006691956,0.51306665,0.00044478904,0.0036373313,0.00015669558,0.000254724,0.0012929357,0.000045105477,0.0001458702,0.42257512,0.00012949265],"about_ca_topic_score_codex":0.0026158798,"about_ca_topic_score_gemma":0.009107798,"teacher_disagreement_score":0.80120856,"about_ca_system_score_codex":0.0006861664,"about_ca_system_score_gemma":0.0007853093,"threshold_uncertainty_score":0.5129071},"labels":[],"label_agreement":null},{"id":"W2342132516","doi":"10.1200/jco.2009.27.15_suppl.1083","title":"Phase II study of sagopilone (ZK-Epo) in patients with recurrent metastatic breast cancer (MBC)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Taxane; Metastatic breast cancer; Progressive disease; Internal medicine; Clinical endpoint; Adverse effect; Anthracycline; Performance status; Breast cancer; Stage (stratigraphy); Cancer; Surgery; Phases of clinical research; Oncology; Gastroenterology; Chemotherapy; Clinical trial","score_opus":0.13989923692366021,"score_gpt":0.5438389371707747,"score_spread":0.40393970024711445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342132516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938782,0.00035840165,0.0000039132497,0.0042054253,0.00075567124,0.0005389378,0.000015647374,0.0000036998526,0.00024009713],"genre_scores_gemma":[0.9979518,0.0002927617,0.00030913186,0.0009975095,0.00035431076,0.000007478494,0.0000038096186,0.000009128627,0.00007403678],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99681765,0.00037839205,0.0020446258,0.00017701511,0.00037062305,0.00021167511],"domain_scores_gemma":[0.99709445,0.00045695785,0.0016224366,0.00013185927,0.00043411297,0.00026020088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009820821,0.00015086873,0.0017183829,0.00019471465,0.000025910498,0.0000020684706,0.00010947073,0.00010173632,0.00037927562],"category_scores_gemma":[0.0001680643,0.00009387682,0.00018289975,0.00024159114,0.00009379887,0.000085616455,0.000023787448,0.0006715383,0.0000017625928],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056517832,0.18559016,0.3622244,0.000018071869,0.00082330074,0.00043877814,0.00051682006,0.000018733364,0.000049526618,0.0000044641483,0.001862661,0.39193526],"study_design_scores_gemma":[0.0960299,0.28073376,0.62031066,0.00008971023,0.0010845035,0.00004384758,0.000098543984,0.000009676155,0.000011121566,0.000029836356,0.0014986297,0.000059761715],"about_ca_topic_score_codex":0.00008043071,"about_ca_topic_score_gemma":0.00033152307,"teacher_disagreement_score":0.39187548,"about_ca_system_score_codex":0.00024736687,"about_ca_system_score_gemma":0.0009833138,"threshold_uncertainty_score":0.41528022},"labels":[],"label_agreement":null},{"id":"W2343566398","doi":"10.1007/s10549-016-3808-x","title":"Phase II clinical study of eribulin monotherapy in Japanese patients with metastatic breast cancer who had well-defined taxane resistance","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; Eisai; Ministry of Health, Labour and Welfare; Japan Agency for Medical Research and Development","keywords":"Medicine; Eribulin; Taxane; Internal medicine; Metastatic breast cancer; Tolerability; Breast cancer; Neutropenia; Febrile neutropenia; Clinical endpoint; Gastroenterology; Progressive disease; Adverse effect; Oncology; Surgery; Chemotherapy; Cancer; Clinical trial","score_opus":0.07258553034229742,"score_gpt":0.4487050927202439,"score_spread":0.37611956237794647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343566398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98957014,0.0015856604,8.387522e-7,0.004581274,0.00006952933,0.0027075582,0.0013067637,0.000020889931,0.0001573523],"genre_scores_gemma":[0.98907745,0.004769369,0.000031208212,0.00006615107,0.00013264222,0.0017078964,0.000030373203,0.000044554126,0.0041403277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971246,0.00032073565,0.0005719797,0.00071902893,0.0006268868,0.0006367431],"domain_scores_gemma":[0.9983099,0.00026747517,0.00017810475,0.00040615068,0.00044339866,0.00039493677],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033483392,0.00034264746,0.00088855333,0.00027026449,0.00015486164,0.00001527889,0.00011412074,0.000068532034,0.0011779307],"category_scores_gemma":[0.000009335334,0.00018546826,0.000073616044,0.0005393193,0.00038857144,0.00011986457,0.00005608335,0.00018230098,0.000006878767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08933979,0.052485406,0.6967527,0.00007206508,0.0016810949,0.00022860868,0.0013655251,0.0000018464951,0.0003368385,0.00000960597,0.0009793817,0.15674709],"study_design_scores_gemma":[0.18368076,0.030819839,0.7817797,0.000552695,0.00036961166,0.000024711277,0.00040771614,0.000006972338,0.00029888155,0.0000146920265,0.0018101641,0.00023427587],"about_ca_topic_score_codex":0.012558293,"about_ca_topic_score_gemma":0.019394252,"teacher_disagreement_score":0.15651281,"about_ca_system_score_codex":0.0007989737,"about_ca_system_score_gemma":0.00057060167,"threshold_uncertainty_score":0.9997351},"labels":[],"label_agreement":null},{"id":"W2343699346","doi":"10.1177/1534735415627926","title":"Phase 2 Study of Acupuncture-Like Transcutaneous Nerve Stimulation for Chemotherapy-Induced Peripheral Neuropathy","year":2016,"lang":"en","type":"article","venue":"Integrative Cancer Therapies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Acupuncture; Randomization; Peripheral neuropathy; Chemotherapy; Clinical endpoint; Clinical trial; Prospective cohort study; Anesthesia; Surgery; Physical therapy; Internal medicine","score_opus":0.04229508096388666,"score_gpt":0.3831938939705694,"score_spread":0.34089881300668273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343699346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99294174,0.0012122099,0.0010139329,0.0019157052,0.0005132578,0.0021403893,0.00014032042,0.00005601908,0.00006642514],"genre_scores_gemma":[0.99697256,0.00027562623,0.00009374319,0.00057566556,0.0002824464,0.00060916407,0.000014082624,0.000038508282,0.0011382046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988922,0.0000910412,0.000303835,0.00032859948,0.00016917576,0.00021518789],"domain_scores_gemma":[0.99905896,0.00022585253,0.00014703577,0.00018432658,0.00031407637,0.00006976924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006995938,0.0003433135,0.0005986106,0.0000909183,0.000065660555,0.0000091888405,0.00009031165,0.00007269532,0.0007794318],"category_scores_gemma":[0.000014126176,0.0001487968,0.00022131077,0.00013628036,0.000091651906,0.000086875916,0.0000055858404,0.000095174146,0.0000012145911],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014244792,0.0028203337,0.0031002052,0.000030802792,0.0011001754,0.000021461332,0.0233695,0.000006739091,0.70107234,0.00002570543,0.0004918635,0.25371608],"study_design_scores_gemma":[0.17787652,0.10256119,0.009186195,0.00047693396,0.002079526,0.00007334747,0.01056877,0.0005402636,0.6527779,0.00071426266,0.042202886,0.00094221224],"about_ca_topic_score_codex":0.00021559458,"about_ca_topic_score_gemma":0.00036623515,"teacher_disagreement_score":0.25277385,"about_ca_system_score_codex":0.0002043693,"about_ca_system_score_gemma":0.00013110792,"threshold_uncertainty_score":0.8534232},"labels":[],"label_agreement":null},{"id":"W2345610352","doi":"10.1007/s00520-016-3256-5","title":"Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer—a systematic review","year":2016,"lang":"en","type":"review","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Medicine; Taxane; Docetaxel; Breast cancer; Internal medicine; Incidence (geometry); Observational study; Retrospective cohort study; Oncology; Randomized controlled trial; Meta-analysis; Cochrane Library; Cancer","score_opus":0.025940673607040846,"score_gpt":0.39494427933038495,"score_spread":0.3690036057233441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345610352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012082602,0.9756642,0.0000073397746,0.00087174744,0.0008623456,0.016287748,0.0060700006,0.000047427926,0.00006834979],"genre_scores_gemma":[0.00046027114,0.9696844,0.000025245334,0.0026616007,0.00022342807,0.024989309,0.001099795,0.00019052096,0.00066540856],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99524343,0.0006329923,0.0018502983,0.0010041342,0.00043165666,0.000837464],"domain_scores_gemma":[0.99648726,0.000628092,0.0015616276,0.00057669345,0.00052121765,0.0002250892],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008001459,0.0009298146,0.0059630596,0.0004946841,0.00004786605,0.000015666867,0.00031743644,0.0004381383,0.002121262],"category_scores_gemma":[0.00017981978,0.0006467465,0.0009247245,0.00073924626,0.000092613445,0.000108312925,0.000039274182,0.00046344136,0.00002297065],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020442717,0.00017190205,0.0018160177,0.62560093,0.0007678441,0.00015228929,0.00008188622,1.6601788e-7,2.974375e-7,5.085154e-7,0.003339081,0.36786464],"study_design_scores_gemma":[0.00546324,0.00071979495,0.00045955292,0.8530348,0.0058602644,0.000046882775,0.000029632056,0.0000012392333,0.0000031450545,0.0000014950035,0.13374089,0.00063909695],"about_ca_topic_score_codex":0.00033098535,"about_ca_topic_score_gemma":0.00078697316,"teacher_disagreement_score":0.36722553,"about_ca_system_score_codex":0.006803627,"about_ca_system_score_gemma":0.0027606466,"threshold_uncertainty_score":0.9995984},"labels":[],"label_agreement":null},{"id":"W2351438759","doi":"10.1200/jco.2004.22.90140.773","title":"Palliative chemotherapy with vinorelbine or capecitabine in women with anthracycline and taxane refractory metastatic breast cancer","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Vinorelbine; Capecitabine; Medicine; Taxane; Anthracycline; Metastatic breast cancer; Internal medicine; Oncology; Breast cancer; Chemotherapy; Cancer; Surgery; Colorectal cancer","score_opus":0.07887157768887255,"score_gpt":0.4760803488222091,"score_spread":0.3972087711333366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2351438759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96554744,0.00095881626,0.000043974003,0.032767367,0.00019926777,0.00030157002,0.000014680209,0.0000068780255,0.00016002757],"genre_scores_gemma":[0.9789658,0.011101593,0.0038821395,0.00504928,0.0006585735,0.000029727544,0.0000020495065,0.000027011456,0.00028379247],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9978353,0.00015885776,0.0012223495,0.00022766531,0.0002533762,0.00030247952],"domain_scores_gemma":[0.99715763,0.000838756,0.001217458,0.00010906453,0.00028409425,0.00039297197],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008651546,0.00020463901,0.0016549879,0.00015321953,0.00002636248,0.000005403294,0.00007762238,0.00014462773,0.0009209123],"category_scores_gemma":[0.0001339789,0.00010351794,0.000071221424,0.00025937255,0.0003997474,0.00013115567,0.000015891063,0.00081204914,0.0000020987165],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43287912,0.01854933,0.23100473,0.00016647369,0.0043729865,0.010622286,0.002254036,0.00027429234,0.0013134835,0.00002359312,0.00091068476,0.297629],"study_design_scores_gemma":[0.10438372,0.078323,0.8004852,0.0003953665,0.00073047646,0.002079975,0.00056357,0.000014013811,0.00011990736,0.00010142841,0.012630161,0.00017318879],"about_ca_topic_score_codex":0.00022665507,"about_ca_topic_score_gemma":0.0015642392,"teacher_disagreement_score":0.5694805,"about_ca_system_score_codex":0.00065635354,"about_ca_system_score_gemma":0.0027196533,"threshold_uncertainty_score":0.9999924},"labels":[],"label_agreement":null},{"id":"W2358919324","doi":"","title":"Efficacy of Local Injection on Cervical 2 Processus Transverses and Stellate Ganglion Block for Cervicogenic Headache","year":2006,"lang":"en","type":"article","venue":"Chinese Journal of Rehabilitation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cervicogenic headache; Stellate ganglion; Significant difference; Medicine; Anesthesia; Migraine; Internal medicine","score_opus":0.008142605189700334,"score_gpt":0.30410384477267344,"score_spread":0.2959612395829731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2358919324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659127,0.0007512444,0.00052577263,0.0013822387,0.00015423443,0.00041893413,0.0000048972806,0.000007900525,0.00016353476],"genre_scores_gemma":[0.9989406,0.000026454705,0.00061579334,0.000038821232,0.00028615774,0.0000051541965,0.000009228357,0.000011282155,0.00006650385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992169,0.000042801905,0.00038410208,0.00010592662,0.00016224467,0.00008800186],"domain_scores_gemma":[0.9988661,0.0005502537,0.00020459946,0.00005459141,0.0002706303,0.00005385163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019569817,0.000107842716,0.00029397965,0.00018406431,0.000033588858,0.000004405681,0.000025922944,0.00007108281,0.000017861516],"category_scores_gemma":[0.00007214909,0.000073204974,0.00015775683,0.0001862373,0.00007135658,0.000074104515,0.000003103391,0.00010255778,4.905954e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1375389,0.01343746,0.34051812,0.008317468,0.0013176496,0.000064530264,0.011734945,0.029549852,0.17602783,0.00039001845,0.00540049,0.27570274],"study_design_scores_gemma":[0.030845886,0.031932697,0.9125072,0.00040406396,0.0010619713,0.0004855179,0.0008191387,0.0014999926,0.016711136,0.0021620726,0.0013654501,0.00020491],"about_ca_topic_score_codex":0.000020741982,"about_ca_topic_score_gemma":0.00002916686,"teacher_disagreement_score":0.57198906,"about_ca_system_score_codex":0.000089228124,"about_ca_system_score_gemma":0.00006994228,"threshold_uncertainty_score":0.29852122},"labels":[],"label_agreement":null},{"id":"W2368261462","doi":"10.1177/1078155215627502","title":"Taxane-induced arthralgia and myalgia: A literature review","year":2016,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"myalgia; Taxane; Medicine; Docetaxel; Paclitaxel; Internal medicine; Chemotherapy; Oncology; Breast cancer; Cancer","score_opus":0.09835431357604807,"score_gpt":0.5213771832342611,"score_spread":0.423022869658213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2368261462","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001007357,0.9736243,0.0000026823088,0.018168643,0.0017954834,0.0012517571,0.00002846386,0.000018363617,0.0051002284],"genre_scores_gemma":[0.0000041962053,0.9887628,0.00069151085,0.0066738985,0.0022467077,0.00006272414,0.000020608963,0.000069088084,0.0014684931],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957535,0.0014189796,0.0016572658,0.00038755313,0.0003811895,0.00040151144],"domain_scores_gemma":[0.9915381,0.0025727185,0.0042949035,0.00027875323,0.0007964907,0.0005190197],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018436436,0.0005953366,0.0039979545,0.0004258177,0.00008411842,0.000032634234,0.00024143393,0.0004270748,0.00093515526],"category_scores_gemma":[0.0012154541,0.00035268522,0.00084749423,0.00045400698,0.0001050385,0.00065552536,0.000102885424,0.0026128357,0.00012839079],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080322754,0.00060146913,0.0000022516754,0.038424715,0.0025830795,0.011284711,0.000057681285,2.0665314e-9,0.000045320816,0.00001404487,0.101361446,0.84482205],"study_design_scores_gemma":[0.004910637,0.0018018978,7.866224e-7,0.10620912,0.02341668,0.12383531,0.000006299751,8.082781e-8,0.0000062786494,0.000005363352,0.7396,0.0002075433],"about_ca_topic_score_codex":0.0000024259368,"about_ca_topic_score_gemma":4.7103904e-7,"teacher_disagreement_score":0.8446145,"about_ca_system_score_codex":0.0006855176,"about_ca_system_score_gemma":0.0030301807,"threshold_uncertainty_score":0.9999781},"labels":[],"label_agreement":null},{"id":"W2373695127","doi":"10.1200/jco.2009.27.15_suppl.3558","title":"Phase I study of temsirolimus (CCI-779), carboplatin, and paclitaxel in patients (pts) with advanced solid tumors: NCIC CTG IND 179","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; London Health Sciences Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Tolerability; Paclitaxel; Temsirolimus; Regimen; Internal medicine; Chemotherapy; Oncology; Ovarian cancer; Urology; Cancer; Adverse effect; Cisplatin","score_opus":0.07709302058253897,"score_gpt":0.5078986007350953,"score_spread":0.4308055801525563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2373695127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969475,0.00031956704,0.0000026310345,0.0009386645,0.00032388986,0.00063475786,0.000003617075,0.000005316243,0.000824052],"genre_scores_gemma":[0.99803066,0.00020616665,0.0003380939,0.0009909637,0.00035004367,0.0000061010933,0.0000030635297,0.000012797033,0.00006211148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661714,0.0003501268,0.0022243808,0.00023134831,0.000322756,0.00025427935],"domain_scores_gemma":[0.9966582,0.00082450366,0.0017034573,0.00015480023,0.00033594813,0.00032310517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010284814,0.0001847349,0.001915679,0.00022772445,0.000024623228,0.0000036998451,0.000098662684,0.0002006159,0.000049930943],"category_scores_gemma":[0.0005547638,0.00012441652,0.00013426215,0.00021039786,0.00014238793,0.00011557496,0.000026101381,0.00079869846,0.0000016663397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05019672,0.064645395,0.5813077,0.000026794329,0.00042011574,0.001121206,0.001049723,0.000032085176,0.00035675286,0.000007702866,0.00039548895,0.3004403],"study_design_scores_gemma":[0.10730536,0.2595401,0.6310833,0.00009293441,0.00042202382,0.00007837802,0.00034634725,0.000025419677,0.000062240004,0.00008636255,0.0008746597,0.00008283424],"about_ca_topic_score_codex":0.00003698732,"about_ca_topic_score_gemma":0.00013132657,"teacher_disagreement_score":0.3003575,"about_ca_system_score_codex":0.0001547482,"about_ca_system_score_gemma":0.0006399765,"threshold_uncertainty_score":0.5073558},"labels":[],"label_agreement":null},{"id":"W2376175914","doi":"","title":"Acetyl-L-carnitine prevents and reduces oxaliplation-evoked painful peripheral neuropathy","year":2011,"lang":"en","type":"article","venue":"Zhongguo linchuang yaolixue yu zhiliaoxue","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Anesthesia; Hyperalgesia; Allodynia; Oxaliplatin; Peripheral neuropathy; Peripheral; Nociception; Internal medicine; Endocrinology","score_opus":0.042361287152999284,"score_gpt":0.2864674722174345,"score_spread":0.24410618506443524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2376175914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802061,0.0012140656,0.000054358625,0.0007959002,0.0007177638,0.00078825146,0.000041341107,0.00021758459,0.01596468],"genre_scores_gemma":[0.9859737,0.00042524596,0.0007053302,0.00090858183,0.000869904,0.00011061049,0.00017036466,0.000072555405,0.010763693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980125,0.00015552135,0.00043895515,0.00059084245,0.0002762842,0.0005258988],"domain_scores_gemma":[0.99890345,0.000092640694,0.00017555866,0.00036063837,0.00011432596,0.0003533687],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025582605,0.0003837192,0.00052023155,0.0001781205,0.00020372184,0.000034228422,0.00015091973,0.000188597,0.0015435311],"category_scores_gemma":[0.00008336532,0.0003474282,0.00016610579,0.00027678866,0.00021570576,0.00023167356,0.00010918537,0.0003592575,0.00008815324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006926414,0.0054835184,0.5514703,0.0008870487,0.0022917544,0.0023374276,0.029712874,0.00002548813,0.2786659,0.0024218375,0.021723209,0.09805428],"study_design_scores_gemma":[0.02423543,0.006698433,0.74298877,0.00059794885,0.0025382913,0.0015551507,0.0013645054,0.0017570176,0.11804649,0.001432404,0.09669728,0.0020883065],"about_ca_topic_score_codex":0.00020321539,"about_ca_topic_score_gemma":0.000035887548,"teacher_disagreement_score":0.19151849,"about_ca_system_score_codex":0.00010313879,"about_ca_system_score_gemma":0.00014502314,"threshold_uncertainty_score":0.9998978},"labels":[],"label_agreement":null},{"id":"W2378005634","doi":"","title":"Chemical constituents of Taxus cuspidata from Canada","year":2009,"lang":"en","type":"article","venue":"Zhongcaoyao","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry; Taxon; Epoxy; Stereochemistry; Organic chemistry; Botany; Biology","score_opus":0.013063768458552038,"score_gpt":0.2805364599553843,"score_spread":0.2674726914968322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2378005634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976286,0.00033836433,0.00000795516,0.0016017482,0.00026841194,0.00013299425,0.00018484578,0.000015989775,0.021163724],"genre_scores_gemma":[0.9972632,0.000021048869,0.0001989184,0.0016329224,0.0001756362,0.0000024892986,0.00020680409,0.0000044798817,0.00049450615],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99944973,0.0000071616064,0.00014318507,0.00014350303,0.000118112956,0.00013829998],"domain_scores_gemma":[0.9996386,0.000032260035,0.000045698547,0.0001487519,0.000029598772,0.00010509327],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000017083792,0.00008294835,0.00021945951,0.00001763441,0.0000134669335,0.00000208974,0.0000600683,0.00004143921,0.0015621857],"category_scores_gemma":[0.000019104387,0.000072276365,0.000036389665,0.00006395156,0.00004119356,0.000021362346,0.000014415621,0.00007861294,0.000014442363],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009110367,0.00087199156,0.08914635,0.000033469845,0.00038610783,0.00037184835,0.0001018702,0.0000026651553,0.5717966,0.0003328928,0.30303514,0.033010036],"study_design_scores_gemma":[0.008981623,0.00033656214,0.12192649,0.0000922804,0.00056067656,0.000046905046,0.000041435673,0.000060765535,0.6853627,0.00030687597,0.1820023,0.00028136827],"about_ca_topic_score_codex":0.2634164,"about_ca_topic_score_gemma":0.03208894,"teacher_disagreement_score":0.23132747,"about_ca_system_score_codex":0.00010446974,"about_ca_system_score_gemma":0.00041180037,"threshold_uncertainty_score":0.99935055},"labels":[],"label_agreement":null},{"id":"W2380521128","doi":"","title":"Taxane Diterpenoids from the Rooted Cuttings of Taxus canadensis","year":2007,"lang":"en","type":"article","venue":"Tianran chanwu yanjiu yu kaifa","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Taxane; Taxus; Stereochemistry; Cutting; Botany; Geraniaceae; Chemistry; Spectral analysis; Biology; Geranium; Physics; Spectroscopy","score_opus":0.017832618961074954,"score_gpt":0.29953078052853116,"score_spread":0.2816981615674562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2380521128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852273,0.0016762356,0.00007146066,0.00678538,0.00057425216,0.000515336,0.000094864634,0.000069480026,0.0049857288],"genre_scores_gemma":[0.9914862,0.0000806493,0.00020166121,0.0030786511,0.000993879,0.000013474198,0.00014397215,0.00003868984,0.0039628507],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984809,0.00004654489,0.0003906764,0.00031196373,0.0003136207,0.00045628115],"domain_scores_gemma":[0.9987692,0.00029632016,0.00019586142,0.0004098797,0.000116231,0.00021245661],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030255536,0.00023154417,0.00044216638,0.0001051358,0.0001078908,0.000010322429,0.00018702367,0.00014707551,0.0027388455],"category_scores_gemma":[0.000051736002,0.00016464232,0.00015745912,0.00034348166,0.00016391497,0.000036333207,0.000049065453,0.00027259832,0.00008248825],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00635357,0.0018382838,0.19361824,0.0002685177,0.0030356338,0.0018684855,0.01836836,0.000012605357,0.4251476,0.00065202994,0.15217578,0.19666092],"study_design_scores_gemma":[0.013060843,0.0016972009,0.39603972,0.00038623236,0.0021008314,0.00019262185,0.001590614,0.00016529235,0.27294672,0.0005275004,0.3105582,0.00073425664],"about_ca_topic_score_codex":0.03190747,"about_ca_topic_score_gemma":0.012928038,"teacher_disagreement_score":0.20242149,"about_ca_system_score_codex":0.00014648831,"about_ca_system_score_gemma":0.00013139879,"threshold_uncertainty_score":0.99817276},"labels":[],"label_agreement":null},{"id":"W2394573321","doi":"","title":"Docetaxel plus Cyclophosphamide as Adjuvant Therapy for Early, Operable Breast Cancer","year":2012,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Docetaxel; Medicine; Cyclophosphamide; Oncology; Breast cancer; Internal medicine; Adjuvant; Chemotherapy; Cancer","score_opus":0.028999613569090556,"score_gpt":0.3607219206203284,"score_spread":0.33172230705123784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394573321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9570965,0.013761302,0.00003972984,0.0045070723,0.00092096505,0.0011437723,0.00006215998,0.00009140664,0.022377059],"genre_scores_gemma":[0.9320539,0.002780205,0.00028723446,0.004900635,0.0009722995,0.0005288458,0.000023364177,0.000031286512,0.05842223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990971,0.00001286811,0.00014874112,0.00017892661,0.000114320035,0.00044801325],"domain_scores_gemma":[0.9994556,0.00004586131,0.000036454036,0.00014977824,0.000076456236,0.00023589372],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009284236,0.00016102228,0.00029691675,0.000039098893,0.00007961623,0.000010977256,0.00005964211,0.00007160891,0.009348155],"category_scores_gemma":[0.0000032227026,0.000110098365,0.00011193356,0.00008962021,0.00003653785,0.00013274222,0.000016688582,0.000084967956,0.0001522362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011411233,0.0020371506,0.65988415,0.0001232056,0.0014321881,0.000026240661,0.0025158986,0.000022379862,0.023749169,0.0015421419,0.16196191,0.1352943],"study_design_scores_gemma":[0.024926653,0.0010557988,0.51420265,0.000049631642,0.0004052151,0.00020512349,0.00012660369,0.0000891334,0.042256825,0.0001227722,0.41617632,0.0003832875],"about_ca_topic_score_codex":0.0041037286,"about_ca_topic_score_gemma":0.0000696085,"teacher_disagreement_score":0.2542144,"about_ca_system_score_codex":0.0001880856,"about_ca_system_score_gemma":0.00019693111,"threshold_uncertainty_score":0.9915574},"labels":[],"label_agreement":null},{"id":"W2396078839","doi":"10.1038/nrclinonc.2016.64","title":"Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pharmacokinetics; Chemotherapy; Oncology; Clinical trial; Pharmacology; Drug; Colorectal cancer; Intensive care medicine; Cancer; Internal medicine","score_opus":0.1640822111862569,"score_gpt":0.5620383089072559,"score_spread":0.39795609772099905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396078839","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019222205,0.98450696,0.000011496786,0.0009875871,0.0037914705,0.0041882163,0.00012414917,0.00006121908,0.006309667],"genre_scores_gemma":[0.000008555236,0.98706335,0.001220044,0.002578655,0.006028188,0.0003293157,0.00016625183,0.00012245162,0.002483188],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919489,0.0020644427,0.004153437,0.0010146138,0.0002462659,0.0005723362],"domain_scores_gemma":[0.9921026,0.0034073608,0.0030807056,0.00077241653,0.00021353757,0.00042333064],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0013993497,0.00084761664,0.012429378,0.0003528265,0.00003905435,0.00000570754,0.0005286415,0.0037387954,0.004080292],"category_scores_gemma":[0.001254841,0.00049804663,0.0040073763,0.0006028771,0.00044297604,0.000034748504,0.0001422903,0.0035949189,0.000548794],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047250098,0.0014567949,0.000018398507,0.008207973,0.001941173,0.00007152089,0.000005269679,3.3711924e-9,0.000015648522,0.00004606629,0.054106094,0.93365854],"study_design_scores_gemma":[0.0061595584,0.0035148496,0.000049654627,0.009927162,0.011613965,0.0001705327,5.223297e-7,5.253166e-7,0.00000910167,0.000027826014,0.96815485,0.0003714332],"about_ca_topic_score_codex":0.0000060766665,"about_ca_topic_score_gemma":0.000010723115,"teacher_disagreement_score":0.93328714,"about_ca_system_score_codex":0.0008961517,"about_ca_system_score_gemma":0.003013171,"threshold_uncertainty_score":0.9997471},"labels":[],"label_agreement":null},{"id":"W2397452357","doi":"10.1385/1-59259-998-2:103","title":"High-Performance Liquid Chromatography Analysis of CYP2C8-Catalyzed Paclitaxel 6α-Hydroxylation","year":2006,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health","keywords":"Hydroxylation; Paclitaxel; Chemistry; CYP2C8; Cytochrome P450; Chromatography; Microsome; Catalysis; High-performance liquid chromatography; Enzyme; Biochemistry; CYP2C9; Biology; Cancer","score_opus":0.026395238111735782,"score_gpt":0.28826371271831674,"score_spread":0.26186847460658097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397452357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738918,0.0015003728,0.00004230059,0.000023936136,0.00010911606,0.0003363134,0.00003336883,0.00008334359,0.023979474],"genre_scores_gemma":[0.9972285,0.00011956021,0.000115440766,0.000051424537,0.000182313,0.00007089109,0.00031777768,0.0000189299,0.0018951623],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988978,0.00003416574,0.00037811903,0.00025308086,0.00021621483,0.00022064477],"domain_scores_gemma":[0.9992938,0.000039869148,0.00019162295,0.000335462,0.00007967368,0.00005956164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092755,0.00017073151,0.000495343,0.0004530907,0.00007464614,0.000009079087,0.0000875665,0.00008581523,0.00016966368],"category_scores_gemma":[0.000002316681,0.00015366059,0.0002285179,0.00016019422,0.00012523221,0.000054450782,0.000030591913,0.00008924151,0.000004541294],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016970994,0.006007857,0.08378857,0.0031730956,0.050283145,0.00029010107,0.005822978,0.010482095,0.70234567,0.056582324,0.019344393,0.044908762],"study_design_scores_gemma":[0.009801727,0.0017889444,0.29977345,0.00015304999,0.021274941,0.000011654396,0.000024796387,0.0046982514,0.64267474,0.0002541621,0.018888446,0.0006558466],"about_ca_topic_score_codex":0.0018754319,"about_ca_topic_score_gemma":0.00019565065,"teacher_disagreement_score":0.21598488,"about_ca_system_score_codex":0.000043129603,"about_ca_system_score_gemma":0.00002603168,"threshold_uncertainty_score":0.6266097},"labels":[],"label_agreement":null},{"id":"W2397893479","doi":"10.1158/1538-7445.sabcs15-ot3-01-01","title":"Abstract OT3-01-01: HERMIONE: A phase 2, randomized, open label trial comparing MM-302 plus trastuzumab with chemotherapy of physician's choice plus trastuzumab, in anthracycline naive HER2-positive, locally advanced/metastatic breast cancer patients previously treated with pertuzumab and ado-trastuzumab emtansine (T-DM1)","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Pertuzumab; Trastuzumab; Medicine; Anthracycline; Vinorelbine; Internal medicine; Oncology; Clinical endpoint; Metastatic breast cancer; Capecitabine; Hazard ratio; Breast cancer; Interim analysis; Docetaxel; Chemotherapy; Cancer; Randomized controlled trial; Confidence interval","score_opus":0.057093002480880145,"score_gpt":0.42629622262914296,"score_spread":0.3692032201482628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397893479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819883,0.0030879197,0.00009112773,0.0016382576,0.00011563387,0.011895458,0.0006463411,0.000059010283,0.00047793926],"genre_scores_gemma":[0.98794866,0.0067320624,0.00019561185,0.0002872179,0.0002901131,0.0034245919,0.0001617918,0.00018636498,0.0007735715],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9940676,0.00063916587,0.0012013856,0.0013971943,0.0012998807,0.001394756],"domain_scores_gemma":[0.995873,0.0013983592,0.0006198629,0.0005603026,0.0009938137,0.0005546983],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008968589,0.0008568705,0.003018285,0.0005353165,0.00028625765,0.00010266095,0.00042995706,0.0001749845,0.00066464284],"category_scores_gemma":[0.00009548844,0.00053590414,0.00016353313,0.0011976685,0.0015580618,0.0007078854,0.0001543991,0.00081142,0.0000068079644],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8823967,0.008499456,0.003934438,0.00062271726,0.001881621,0.00037951223,0.0019288873,0.00013259186,0.0098648835,0.000008145176,0.00043278662,0.08991824],"study_design_scores_gemma":[0.95128596,0.012528283,0.020656265,0.005883683,0.00076455576,0.00007698766,0.0003508273,0.00048065156,0.007029038,0.0000206683,0.00023408365,0.000689018],"about_ca_topic_score_codex":0.010769524,"about_ca_topic_score_gemma":0.007242533,"teacher_disagreement_score":0.08922922,"about_ca_system_score_codex":0.0037998185,"about_ca_system_score_gemma":0.003392949,"threshold_uncertainty_score":0.99970925},"labels":[],"label_agreement":null},{"id":"W2400819691","doi":"","title":"[Evaluation of cancer pain--possibility of biomarkers].","year":2007,"lang":"ja","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuropathic pain; Cancer pain; Pain assessment; McGill Pain Questionnaire; Cancer; Medicine; Pain syndrome; Rating scale; Biomarker; Physical therapy; Physical medicine and rehabilitation; Visual analogue scale; Psychology; Pain management; Internal medicine; Anesthesia","score_opus":0.08071281462433393,"score_gpt":0.37721786501529686,"score_spread":0.2965050503909629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400819691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9642844,0.022679947,0.00002912946,0.00053327106,0.0012898083,0.0024311442,0.000074605436,0.000012918145,0.008664764],"genre_scores_gemma":[0.9977679,0.0004365769,0.000028070788,0.00013232086,0.0003733054,0.0005588465,0.000019768764,0.0000146970015,0.0006684736],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99741066,0.00041762015,0.0006503395,0.00028798718,0.00079144083,0.000441947],"domain_scores_gemma":[0.99798304,0.00039167047,0.00039967027,0.00028817655,0.0007566094,0.0001808217],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.013372134,0.00016118647,0.00043589406,0.00017136542,0.000027036294,0.0000027093702,0.00008970778,0.00015096077,0.0014634519],"category_scores_gemma":[0.0005540865,0.00014486388,0.00015824178,0.00041682913,0.00023231462,0.00004415993,0.00002857992,0.00010254135,0.0000031211978],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001202469,0.0007740472,0.26384112,0.00029738713,0.001227461,0.0000033930546,0.00052906666,0.000004176558,0.0019271232,0.0000067316464,0.001135884,0.7290511],"study_design_scores_gemma":[0.0055496832,0.00017070692,0.9293894,0.000056029017,0.0037947218,6.959053e-7,0.00020365119,0.00027800555,0.059012733,0.00009309529,0.0013511004,0.00010014845],"about_ca_topic_score_codex":0.0025528304,"about_ca_topic_score_gemma":0.0016124606,"teacher_disagreement_score":0.728951,"about_ca_system_score_codex":0.00071196386,"about_ca_system_score_gemma":0.00037948726,"threshold_uncertainty_score":0.9994494},"labels":[],"label_agreement":null},{"id":"W2401148735","doi":"","title":"[Angiogenesis: from research to pathology].","year":2000,"lang":"en","type":"editorial","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Angiogenesis; Pathology; Medicine; Anatomical pathology; Immunohistochemistry; Cancer research","score_opus":0.07713436651187099,"score_gpt":0.3889384541180612,"score_spread":0.3118040876061902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401148735","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010071795,0.0041726027,6.431167e-7,0.0025121549,0.96262807,0.0027282564,0.0015066955,0.0001265395,0.016253218],"genre_scores_gemma":[0.0015437157,0.0012896135,0.000063850784,0.0004251403,0.94002193,0.010492055,0.0021451546,0.00007764862,0.04394086],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971843,0.00021315012,0.00026336656,0.0006906077,0.000809692,0.0008389335],"domain_scores_gemma":[0.9979396,0.000824425,0.000043706106,0.0004947864,0.00022559712,0.00047191657],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058598834,0.00025726002,0.0006028782,0.00042665077,0.00008282161,0.000025957861,0.00023858713,0.0008964522,0.0015731633],"category_scores_gemma":[0.00035522343,0.00022943862,0.00017757235,0.00036981402,0.000090609676,0.000022916833,0.00009805532,0.00082094996,0.00065483584],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012857752,0.00018667559,0.00013252445,0.000023204566,0.00026284147,0.00058625767,0.00008071608,2.4408135e-7,0.000016370946,4.405033e-7,0.8540124,0.14341255],"study_design_scores_gemma":[0.0014518423,0.000191794,0.010876207,0.000026738498,0.00043576077,0.000004245587,0.000008468186,9.287668e-8,0.00027265964,0.000054170436,0.9865042,0.00017384187],"about_ca_topic_score_codex":0.00079452636,"about_ca_topic_score_gemma":0.00015016604,"teacher_disagreement_score":0.14323871,"about_ca_system_score_codex":0.0004961316,"about_ca_system_score_gemma":0.00036808322,"threshold_uncertainty_score":0.9993395},"labels":[],"label_agreement":null},{"id":"W2404165994","doi":"10.1016/j.jval.2016.03.1536","title":"Evaluation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Metastatic Breast Cancer: Systematic Review and Trial Level Meta-Analysis","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Internal medicine; Oncology; Surrogate endpoint; Progression-free survival; Rank correlation; Breast cancer; Spearman's rank correlation coefficient; Hazard ratio; Metastatic breast cancer; Clinical endpoint; Meta-analysis; Proportional hazards model; Randomized controlled trial; Cancer; Overall survival; Confidence interval; Statistics","score_opus":0.34436225851649654,"score_gpt":0.48731588217820454,"score_spread":0.142953623661708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404165994","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42276165,0.45200315,0.00024704303,0.07282745,0.0009326389,0.04745064,0.0036159507,0.00005154213,0.000109930785],"genre_scores_gemma":[0.9766977,0.01650999,0.00055288407,0.00057524804,0.00008087104,0.005257634,0.000057697387,0.000033804456,0.0002341642],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99457496,0.0026241904,0.001299672,0.0003689249,0.00082689774,0.00030537008],"domain_scores_gemma":[0.9972973,0.001204053,0.0006661112,0.00037187742,0.0003225255,0.000138139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01311592,0.00020532506,0.0029734012,0.000323208,0.000028766612,0.0000053841254,0.000097433425,0.00004484788,0.00039059264],"category_scores_gemma":[0.0008958758,0.00011724674,0.00044151468,0.0004730435,0.00004381474,0.00007078127,0.00003275329,0.00008025196,0.0000014047282],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04041498,0.0051281783,0.011840764,0.7335207,0.19439982,0.000040998868,0.0020133608,0.000743353,0.00021373946,0.0026343782,0.0007222545,0.008327488],"study_design_scores_gemma":[0.1642586,0.0027811402,0.011857336,0.020999057,0.7921128,0.00003221686,0.00010019377,0.0040826863,0.00008392773,0.0032493847,0.000034055858,0.00040854767],"about_ca_topic_score_codex":0.008816417,"about_ca_topic_score_gemma":0.0033955118,"teacher_disagreement_score":0.7125216,"about_ca_system_score_codex":0.0006023488,"about_ca_system_score_gemma":0.001244295,"threshold_uncertainty_score":0.99778396},"labels":[],"label_agreement":null},{"id":"W2405961925","doi":"10.1503/cmaj.150393","title":"Blue man syndrome","year":2016,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Amiodarone; Medicine; Surgery; Internal medicine","score_opus":0.009266852023747897,"score_gpt":0.2741038932650996,"score_spread":0.2648370412413517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405961925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77747357,0.00019572463,0.000029579503,0.21480943,0.0011757916,0.00009252747,0.000018969999,0.000020024427,0.0061843726],"genre_scores_gemma":[0.96649706,0.0002427852,0.000028461467,0.019900415,0.0014107845,0.000005778546,0.0000037697034,0.000012061298,0.011898875],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986874,0.000059967686,0.00020439624,0.00009368859,0.0005992748,0.0003552997],"domain_scores_gemma":[0.9978195,0.0001008436,0.00008075948,0.000056113553,0.00014338277,0.0017993964],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004719063,0.0000736309,0.00016794442,0.00013254724,0.00010904625,0.000014895459,0.00007193501,0.00021621019,0.030073997],"category_scores_gemma":[0.00036184315,0.000047361264,0.0000836854,0.00010036323,0.000026803962,0.00005760752,0.0000054356133,0.00030772094,0.00077200006],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029248518,0.00006418395,0.2137192,0.0000056445524,0.00035803387,0.0061565186,0.00010902561,7.730831e-8,0.00021338696,0.00015121212,0.69308454,0.08610894],"study_design_scores_gemma":[0.00293541,0.00019818298,0.12701799,0.00007878746,0.000073695235,0.005510287,0.000030221756,0.0000037697896,0.000071758375,0.000087885346,0.8639142,0.000077797224],"about_ca_topic_score_codex":0.00069077936,"about_ca_topic_score_gemma":0.0087682,"teacher_disagreement_score":0.194909,"about_ca_system_score_codex":0.0016860726,"about_ca_system_score_gemma":0.0023602801,"threshold_uncertainty_score":0.9922756},"labels":[],"label_agreement":null},{"id":"W2407635643","doi":"10.1684/bdc.2013.1709","title":"Impact des toxicités cutanées associées aux thérapies ciblées sur la qualité de vie. Résultats d’une étude pilote longitudinale","year":2013,"lang":"fr","type":"article","venue":"Bulletin du Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine","score_opus":0.03498821863418844,"score_gpt":0.35376288428084246,"score_spread":0.318774665646654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407635643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8190541,0.140189,0.000039015853,0.033732057,0.0015637672,0.0008462176,0.00033326133,0.00015476446,0.0040878],"genre_scores_gemma":[0.87520784,0.08567662,0.00029347406,0.0017111794,0.0029554286,0.00066790276,0.000039505565,0.00013127724,0.033316776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959098,0.00058802916,0.00068864855,0.0007271325,0.00047716478,0.0016092379],"domain_scores_gemma":[0.996571,0.0015166682,0.0003283947,0.0004130996,0.00051654223,0.00065431336],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006795683,0.0007669883,0.001060539,0.00017667658,0.00039132463,0.00018953143,0.00034254976,0.00043341733,0.05453537],"category_scores_gemma":[0.00039201207,0.0006644561,0.0004967921,0.0004911253,0.00093720516,0.00022303808,0.00015814241,0.0005766944,0.0015005515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005862363,0.0016180559,0.4921355,0.00059560436,0.0031185304,0.00034922644,0.0055777887,0.00023556632,0.006536487,0.00020024611,0.40385044,0.08519634],"study_design_scores_gemma":[0.00496849,0.00116656,0.65715516,0.0009981574,0.0013650296,0.00022826005,0.00058530155,0.00012173542,0.0021271582,0.00044013918,0.33020148,0.0006425329],"about_ca_topic_score_codex":0.07136898,"about_ca_topic_score_gemma":0.0048358357,"teacher_disagreement_score":0.16501968,"about_ca_system_score_codex":0.0014533943,"about_ca_system_score_gemma":0.0010725006,"threshold_uncertainty_score":0.9995807},"labels":[],"label_agreement":null},{"id":"W2409847216","doi":"","title":"Successful treatment of threatening limb loss ischemia of the upper limb caused by ergotamine. A case report and review of the literature.","year":2002,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Ergotamine; Medicine; Ischemia; Limb ischemia; Limb loss; Anesthesia; Lower limb; Upper limb; Surgery; Amputation; Internal medicine; Migraine","score_opus":0.02412641172738947,"score_gpt":0.2723210946053131,"score_spread":0.24819468287792365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409847216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85381424,0.14099075,1.3949152e-7,0.0026026259,0.00012277362,0.0011876,0.000054354066,0.00000703464,0.0012204975],"genre_scores_gemma":[0.9639053,0.029432572,0.000008821804,0.00024753678,0.000060895156,0.00041945316,0.000013378875,0.000013560327,0.005898526],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989621,0.00006284973,0.00041466416,0.00019754333,0.0001717018,0.0001911349],"domain_scores_gemma":[0.9989642,0.00009194435,0.000339045,0.00042120114,0.00010873304,0.000074902135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001342752,0.0001598647,0.00047781653,0.000034176097,0.000039155497,0.000004132458,0.00006984556,0.000068523404,0.000100537545],"category_scores_gemma":[0.000073298375,0.00007831916,0.00020967462,0.00028533879,0.00015715041,0.00003548812,0.00004054536,0.00008245477,2.6042147e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080593536,0.0036414913,0.85032433,0.011031352,0.0025961976,0.009206194,0.0038083107,8.595956e-7,0.011369561,0.000033073247,0.032282263,0.074900426],"study_design_scores_gemma":[0.014825132,0.0016363357,0.29108235,0.006087708,0.0075875665,0.04006195,0.00016529407,0.000029423489,0.5753702,0.000026691961,0.06261991,0.00050746696],"about_ca_topic_score_codex":0.00011207192,"about_ca_topic_score_gemma":0.00002755787,"teacher_disagreement_score":0.5640006,"about_ca_system_score_codex":0.00007764485,"about_ca_system_score_gemma":0.000029024292,"threshold_uncertainty_score":0.31937626},"labels":[],"label_agreement":null},{"id":"W2411262239","doi":"","title":"Assessing software impact on clinical workflow and resource utilization.","year":2009,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Workflow; Usability; Capecitabine; Computer science; Software; Resource (disambiguation); Medicine; Colorectal cancer; World Wide Web; Cancer; Database; Internal medicine; Operating system","score_opus":0.15687327008463026,"score_gpt":0.4422220902907447,"score_spread":0.28534882020611446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411262239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894685,0.000887663,0.0000813345,0.002665489,0.00014033695,0.0004785419,0.0000025528907,0.00009056909,0.0061850115],"genre_scores_gemma":[0.99528545,0.000102678365,0.00024022788,0.0029794301,0.0003814675,0.000051299896,0.000020982134,0.000008083143,0.0009303757],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993371,0.000048122172,0.00015436024,0.00017101422,0.00008843633,0.00020096493],"domain_scores_gemma":[0.99949133,0.00015573773,0.00004375102,0.000105852305,0.000018814884,0.00018452026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000216473,0.00008613588,0.00019063544,0.00005243604,0.000046540285,0.000030268253,0.000024319523,0.000069384085,0.00005709291],"category_scores_gemma":[0.000119764016,0.00006221359,0.00006673518,0.00010445721,0.000034474437,0.000058265054,0.0000075019834,0.00012606,0.000004577905],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033189345,0.00019869395,0.17782496,0.0000037665184,0.000040027953,0.000024685862,0.00001912859,0.0000037196464,0.0000027135957,0.0000070644737,0.009716671,0.8118267],"study_design_scores_gemma":[0.001759057,0.00028981763,0.9818633,0.000013552714,0.000098718534,0.000017819013,0.0000060325565,0.000025535845,0.00004424152,0.00010779969,0.015719399,0.00005472952],"about_ca_topic_score_codex":0.0000028115053,"about_ca_topic_score_gemma":7.350906e-7,"teacher_disagreement_score":0.8117719,"about_ca_system_score_codex":0.00006192459,"about_ca_system_score_gemma":0.000030564956,"threshold_uncertainty_score":0.25369966},"labels":[],"label_agreement":null},{"id":"W2432860777","doi":"10.1200/jco.2013.31.15_suppl.1049","title":"A phase III, open-label, randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes: Subgroup analyses.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Capecitabine; Eribulin; Medicine; Internal medicine; Hazard ratio; Taxane; Metastatic breast cancer; Regimen; Oncology; Chemotherapy; Chemotherapy regimen; Anthracycline; Gastroenterology; Progression-free survival; Breast cancer; Cancer; Confidence interval; Colorectal cancer","score_opus":0.14060218378077016,"score_gpt":0.5207636311247795,"score_spread":0.38016144734400936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2432860777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99394125,0.0006614465,0.00002442448,0.0009392213,0.00023362288,0.004106277,0.000019588588,0.00000726327,0.00006691337],"genre_scores_gemma":[0.99602073,0.0014181765,0.0017165146,0.00030394987,0.00011861118,0.00023385703,0.000014374076,0.000030572002,0.00014319301],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9949246,0.0009807512,0.0030036215,0.00036683163,0.00039160182,0.00033256668],"domain_scores_gemma":[0.9922583,0.0029479018,0.003088342,0.00020952843,0.0010860115,0.00040990347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014495143,0.0003357737,0.0047960253,0.000248948,0.000040748724,0.00001841256,0.00021147342,0.0001386367,0.0006776248],"category_scores_gemma":[0.00058097806,0.0001649437,0.00012899132,0.00048672897,0.000474013,0.00036331252,0.00006904642,0.00054690527,0.0000014645842],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80037117,0.051300738,0.08917212,0.000048065904,0.0045490814,0.00058696495,0.00030562136,0.00006643267,0.000094765004,8.26801e-7,0.00013582809,0.05336841],"study_design_scores_gemma":[0.7702079,0.1518557,0.07128199,0.00024303905,0.0054070754,0.000076342876,0.00038773363,0.0002693122,0.000023212418,0.0000041916087,0.00009383383,0.00014971402],"about_ca_topic_score_codex":0.0024999396,"about_ca_topic_score_gemma":0.0049839974,"teacher_disagreement_score":0.10055496,"about_ca_system_score_codex":0.00018777791,"about_ca_system_score_gemma":0.001263796,"threshold_uncertainty_score":0.74195164},"labels":[],"label_agreement":null},{"id":"W2434551575","doi":"","title":"International Stroke Conference 2009. Translation of high impact targets into clinical trials. 17-20 February 2009, San Diego, CA, USA.","year":2009,"lang":"en","type":"other","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Clinical trial; Stroke (engine); Clinical neurology; Internal medicine; Psychology; Engineering; Neuroscience","score_opus":0.10233105505802366,"score_gpt":0.41123394838021693,"score_spread":0.3089028933221933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2434551575","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009940795,0.015449269,0.00040201258,0.002463507,0.006297659,0.0061921095,0.005060927,0.00019564807,0.9539981],"genre_scores_gemma":[0.29750744,0.0036174569,0.0008161864,0.00070315046,0.0059931134,0.00074396364,0.003579024,0.00023050292,0.6868092],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974581,0.00033457854,0.0010069881,0.00044810108,0.00038738272,0.00036484504],"domain_scores_gemma":[0.9983064,0.0003031156,0.00072792784,0.0002623042,0.000095016345,0.00030525352],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010104701,0.0003630716,0.0014132825,0.00038809815,0.000020968271,0.000016243925,0.00019549066,0.00053707213,0.034486935],"category_scores_gemma":[0.00014979429,0.00028867295,0.00054237596,0.00011080544,0.00013817076,0.00005850078,0.00002003737,0.00041716552,0.00004461338],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016264385,0.00051861035,0.009075145,0.00003921869,0.0012707749,0.000029519935,0.000036453646,0.000002055466,0.000061400504,0.00001356539,0.6958135,0.29151332],"study_design_scores_gemma":[0.0098967245,0.000498497,0.3833565,0.00008752782,0.0011953684,0.000011320617,0.000004454724,0.000038687536,0.00015900593,0.00011129492,0.60436064,0.00027995554],"about_ca_topic_score_codex":0.0035697918,"about_ca_topic_score_gemma":0.0045822193,"teacher_disagreement_score":0.37428135,"about_ca_system_score_codex":0.00016856189,"about_ca_system_score_gemma":0.00026023202,"threshold_uncertainty_score":0.99995655},"labels":[],"label_agreement":null},{"id":"W24563591","doi":"10.1016/j.jyp.2013.10.006","title":"Laurell Ritchie, Doris Anderson Memorial, May 12, 2007","year":2007,"lang":"en","type":"article","venue":"Canadian women's studies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Doris (gastropod); Art; Art history","score_opus":0.030972432325419044,"score_gpt":0.32251857576236215,"score_spread":0.29154614343694313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W24563591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.911609,0.0064387647,0.0000027099425,0.0023502987,0.0037834093,0.00050564733,0.00004135471,0.00007291135,0.07519589],"genre_scores_gemma":[0.96164864,0.00088977744,0.000074648415,0.0056779324,0.0022788607,0.000058991318,0.000021906166,0.00003255765,0.029316694],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848336,0.000019509858,0.00021152223,0.00028696406,0.00015493247,0.0008436955],"domain_scores_gemma":[0.9988152,0.00011453078,0.00005027922,0.00018219963,0.000098338576,0.00073946145],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029980886,0.00021969604,0.00043439545,0.00028877298,0.00023080468,0.000011190765,0.00006921097,0.00010003051,0.001478902],"category_scores_gemma":[0.00005093509,0.00019228821,0.00007190219,0.00021592576,0.00015170715,0.0000449806,0.000020724365,0.00017888422,0.00017264695],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012666794,0.0003375167,0.083858676,0.0003502266,0.003912007,0.003814219,0.023690179,0.000002444278,0.0010156373,0.0011636614,0.8706876,0.009901141],"study_design_scores_gemma":[0.0058303834,0.0010302782,0.009805872,0.000060555303,0.00040417825,0.0000716202,0.03309373,0.0000020588802,0.000909998,0.000625732,0.94773716,0.00042842372],"about_ca_topic_score_codex":0.0031304404,"about_ca_topic_score_gemma":0.09212602,"teacher_disagreement_score":0.088995576,"about_ca_system_score_codex":0.0015882367,"about_ca_system_score_gemma":0.0003667356,"threshold_uncertainty_score":0.9994339},"labels":[],"label_agreement":null},{"id":"W2460310329","doi":"10.4137/bcbcr.s39615","title":"Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Basic and Clinical Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Eribulin; Capecitabine; Medicine; Internal medicine; Metastatic breast cancer; Oncology; Breast cancer; Taxane; Cancer; Colorectal cancer","score_opus":0.2671860688400545,"score_gpt":0.5786689249457595,"score_spread":0.311482856105705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2460310329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911131,0.000996054,0.000008561862,0.0017542436,0.00017478241,0.003947169,0.0018995209,0.000018217937,0.00008833266],"genre_scores_gemma":[0.99348044,0.0042136176,0.00009083778,0.00007967315,0.00012769272,0.0013148228,0.00006625642,0.000043416898,0.00058323843],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953778,0.0012916588,0.0010586855,0.0008804068,0.00078745995,0.0006040347],"domain_scores_gemma":[0.99400294,0.0040532523,0.00029329947,0.00042719414,0.0007811936,0.0004420974],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001371307,0.00033086594,0.0018924281,0.00024915385,0.00009485738,0.00003185485,0.00028921184,0.00010116477,0.0044917846],"category_scores_gemma":[0.0003610351,0.0001648928,0.000091092996,0.00092331384,0.0007321327,0.00023509088,0.00022716071,0.00041413863,0.000007490002],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6320924,0.013038333,0.19747241,0.000037755537,0.002180723,0.00009073941,0.00016249799,0.0000014695277,0.00023678559,0.0000027783835,0.00018745079,0.15449665],"study_design_scores_gemma":[0.6878558,0.0077014444,0.30183342,0.0005377902,0.0013744319,0.0000038726307,0.0002377766,0.000101105354,0.00007848752,0.000020545533,0.00007596081,0.00017939486],"about_ca_topic_score_codex":0.0216314,"about_ca_topic_score_gemma":0.016077224,"teacher_disagreement_score":0.15431726,"about_ca_system_score_codex":0.00033422338,"about_ca_system_score_gemma":0.00093886117,"threshold_uncertainty_score":0.99641824},"labels":[],"label_agreement":null},{"id":"W2462306652","doi":"","title":"Taxol (paclitaxel) involution of articular cartilage destruction in collagen induced arthritis: an ultrastructural demonstration of an increased superficial chondroprotective layer.","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Involution (esoterism); Medicine; Articular cartilage; Paclitaxel; Ultrastructure; Cartilage; Arthritis; Glycosaminoglycan; Pathology; Internal medicine; Endocrinology; Anatomy; Chemotherapy; Osteoarthritis; Biology","score_opus":0.02382286524679875,"score_gpt":0.2636449859876192,"score_spread":0.23982212074082046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462306652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976139,0.00009871963,0.000010553082,0.000038916696,0.0001021938,0.0017776804,0.000035705696,0.000031182026,0.00029111496],"genre_scores_gemma":[0.9988569,0.000027628115,0.0001850084,0.000028503526,0.00014300669,0.0006332004,0.00009947855,0.000013869827,0.000012406236],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99867105,0.0002128671,0.0004050036,0.00024943633,0.00020075633,0.0002608767],"domain_scores_gemma":[0.9994568,0.000019982715,0.00011378096,0.00016204917,0.000098259894,0.00014908577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021899793,0.0001405471,0.00033376695,0.00016718256,0.000042448424,0.000007255145,0.00004780486,0.00014417172,0.00015421696],"category_scores_gemma":[0.00003722933,0.00014060244,0.000058105445,0.00036294974,0.000102712096,0.0003190333,0.0000048438587,0.00010499887,0.0000011560446],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031132037,0.00056548766,0.038456265,0.000042965465,0.00005473212,0.000029908366,0.0008437996,0.00008295332,0.7622907,0.00003709675,0.000005864421,0.19447702],"study_design_scores_gemma":[0.0028688482,0.0005161524,0.54738563,0.000015182375,0.00007273671,0.00004658684,0.00021228059,0.0001598834,0.44853482,0.00010707808,0.0000064272117,0.00007438293],"about_ca_topic_score_codex":0.0022698233,"about_ca_topic_score_gemma":0.0018694194,"teacher_disagreement_score":0.5089294,"about_ca_system_score_codex":0.00020135888,"about_ca_system_score_gemma":0.00009916322,"threshold_uncertainty_score":0.5733601},"labels":[],"label_agreement":null},{"id":"W2463870580","doi":"10.1200/jco.2012.30.15_suppl.e16547","title":"A review of clinical endpoints and use of quality of life outcomes in phase III metastatic breast cancer clinical trials.","year":2012,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Clinical endpoint; Clinical trial; Quality of life (healthcare); Metastatic breast cancer; Internal medicine; Breast cancer; Disease; Cancer; Oncology; Intensive care medicine","score_opus":0.8346999713139278,"score_gpt":0.7451445904102004,"score_spread":0.08955538090372739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463870580","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011715042,0.98022485,0.000008170245,0.002155099,0.0035022735,0.0018026677,0.00051766535,0.0000038680437,0.00007035841],"genre_scores_gemma":[0.0013623565,0.9926978,0.0011125223,0.002924889,0.0016963403,0.00003795664,0.000026154843,0.000042709828,0.00009926635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9271505,0.025669519,0.045617923,0.0004990414,0.00066079234,0.0004022347],"domain_scores_gemma":[0.8680835,0.08569573,0.043526374,0.00055096886,0.001016854,0.0011265803],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.092194855,0.0005558882,0.046551675,0.00039157536,0.000013979793,0.0000034474142,0.00036894504,0.0013691133,0.0013306774],"category_scores_gemma":[0.0667746,0.0003280807,0.0077566565,0.00038469752,0.0011980217,0.00016795399,0.00018788248,0.0031934741,0.000003961718],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012982778,0.019679135,0.053359225,0.05295381,0.008442193,0.00009621155,0.000019493878,6.192607e-8,4.1620194e-7,0.000025370327,0.0040996573,0.84834164],"study_design_scores_gemma":[0.057561982,0.012293609,0.037222948,0.053718373,0.046592508,0.00025937974,0.00001282398,0.0000019518816,3.3693908e-7,0.000027461965,0.7920472,0.00026143785],"about_ca_topic_score_codex":0.00024823245,"about_ca_topic_score_gemma":0.00014676005,"teacher_disagreement_score":0.8480802,"about_ca_system_score_codex":0.00015822583,"about_ca_system_score_gemma":0.010864497,"threshold_uncertainty_score":0.99992734},"labels":[],"label_agreement":null},{"id":"W2464629114","doi":"10.1007/s10600-013-0765-z","title":"A New Taxane with a 4β,20-Epoxy Ring from the Rooted Cuttings of Taxus canadensis","year":2013,"lang":"en","type":"article","venue":"Chemistry of Natural Compounds","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Hebei Medical University; Hebei University; National Science Foundation","keywords":"Taxane; Chemistry; Cutting; Ring (chemistry); Epoxy; Botany; Stereochemistry; Organic chemistry; Biology","score_opus":0.00904104337953008,"score_gpt":0.2439646613551591,"score_spread":0.23492361797562902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464629114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906505,0.0021522637,0.0000025380439,0.0035867167,0.00007178049,0.0001872221,0.000015301099,0.000022699673,0.003310978],"genre_scores_gemma":[0.99403036,0.000012647493,0.0006781178,0.00022673511,0.00024315495,0.000009105455,0.00009101733,0.000012995747,0.004695897],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992223,0.000009780091,0.00020884539,0.00017973852,0.00019903031,0.00018035385],"domain_scores_gemma":[0.9991788,0.00013861398,0.0001956643,0.0002318702,0.00014571399,0.000109320434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000028539898,0.00015228205,0.00033353476,0.000014699781,0.000042240026,0.000009068825,0.00014285816,0.0000736358,0.0008389625],"category_scores_gemma":[0.000023965402,0.00009582768,0.00007969809,0.00016222792,0.00011899035,0.000038091046,0.000036098463,0.0002615539,0.000003727997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026295317,0.00005104441,0.013711052,0.00007825864,0.00032652338,0.000017916449,0.00023007511,0.000002210815,0.949371,0.000001136983,0.03487036,0.001077482],"study_design_scores_gemma":[0.00440523,0.00015884645,0.03667108,0.0002867745,0.00046256863,0.00013333045,0.00028456878,0.00017670494,0.94867975,0.00006975375,0.008491306,0.00018011221],"about_ca_topic_score_codex":0.021907615,"about_ca_topic_score_gemma":0.00040123163,"teacher_disagreement_score":0.026379053,"about_ca_system_score_codex":0.000089735375,"about_ca_system_score_gemma":0.00019662,"threshold_uncertainty_score":0.9846056},"labels":[],"label_agreement":null},{"id":"W2466901661","doi":"10.7202/1036757ar","title":"Resvératrol et lycopène","year":2016,"lang":"fr","type":"article","venue":"Cahiers franco-canadiens de l Ouest","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.011117036749364867,"score_gpt":0.2879591776094431,"score_spread":0.27684214086007825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466901661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5725948,0.07833842,0.0012245958,0.12474096,0.036724795,0.0015552705,0.0013082968,0.0002685414,0.18324432],"genre_scores_gemma":[0.7365106,0.004291435,0.0003855579,0.011719518,0.0041817813,0.000103964216,0.00003613476,0.000106660074,0.24266438],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99665034,0.0003020212,0.00043486324,0.00063351396,0.00024843978,0.0017308401],"domain_scores_gemma":[0.99718356,0.00050324044,0.0001483868,0.0005816659,0.0001493947,0.001433773],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005394203,0.00047278573,0.0006552658,0.00025311648,0.00021703758,0.00003380582,0.00024235288,0.00061621185,0.0069906097],"category_scores_gemma":[0.00023192154,0.0003861569,0.0002693715,0.00040103524,0.0010926807,0.00019872384,0.00003361962,0.00060611655,0.0020531833],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012609126,0.0006989879,0.029533284,0.00037094927,0.001391909,0.006528835,0.011325614,0.000016198983,0.022683732,0.025179744,0.7435876,0.15742223],"study_design_scores_gemma":[0.007369799,0.0012047046,0.0071363784,0.0005556401,0.0007973459,0.00052729144,0.00021784264,0.000042257132,0.0021494164,0.00058020797,0.978964,0.00045515722],"about_ca_topic_score_codex":0.0049157287,"about_ca_topic_score_gemma":0.019661678,"teacher_disagreement_score":0.23537636,"about_ca_system_score_codex":0.0030220824,"about_ca_system_score_gemma":0.0013080271,"threshold_uncertainty_score":0.99985904},"labels":[],"label_agreement":null},{"id":"W2467528112","doi":"","title":"Current treatment and new therapies for pain management.","year":2004,"lang":"en","type":"other","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pain management; Alternative medicine; Family medicine; Political science; Physical therapy; Pathology","score_opus":0.054540166253946754,"score_gpt":0.3165853205699482,"score_spread":0.26204515431600145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2467528112","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020220093,0.29792947,0.00062349305,0.006900762,0.002356306,0.020847635,0.00017521097,0.00051526586,0.6704497],"genre_scores_gemma":[0.00045423966,0.021038085,0.00038005778,0.00036226015,0.0011489869,0.007341917,0.0001526722,0.0001926543,0.9689291],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99933785,0.000016458443,0.00008987263,0.0002509685,0.000055491488,0.00024937346],"domain_scores_gemma":[0.9996373,0.00002597656,0.00005709455,0.00012778859,0.0000049192126,0.00014693591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006327258,0.00021119478,0.00029953895,0.00014026127,0.000018203997,0.000010056506,0.00003053948,0.000079206424,0.00045187806],"category_scores_gemma":[0.0000025422416,0.00015555641,0.00008957183,0.00004125302,0.000029275294,0.000007390028,0.000010662979,0.000038222042,0.000007422243],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009500703,0.00015150844,0.00045422695,0.00018419903,0.00070022955,0.0000061891064,0.00003987157,2.5910305e-8,2.05241e-7,0.00012084805,0.39376426,0.6044834],"study_design_scores_gemma":[0.0069115395,0.00020699417,0.0052456125,0.000064648324,0.0008888537,0.0000030659503,0.000008086371,3.159284e-7,0.0000096763715,0.0002725957,0.9862673,0.00012128653],"about_ca_topic_score_codex":0.00015006166,"about_ca_topic_score_gemma":0.00012564767,"teacher_disagreement_score":0.60436213,"about_ca_system_score_codex":0.00020472103,"about_ca_system_score_gemma":0.000040710605,"threshold_uncertainty_score":0.63434064},"labels":[],"label_agreement":null},{"id":"W2468316166","doi":"10.1016/j.breast.2016.06.013","title":"A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"European Regional Development Fund; Fundação para a Ciência e a Tecnologia; Universidade do Porto","keywords":"Medicine; Breast cancer; Prospective cohort study; Taxane; Internal medicine; Peripheral neuropathy; Cancer; Chemotherapy; Odds ratio; Confidence interval; Surgery","score_opus":0.033388218821180156,"score_gpt":0.3313250317947832,"score_spread":0.297936812973603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468316166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96673167,0.0004061176,0.0000010840201,0.030480111,0.000029753199,0.0010406104,0.0011679311,0.000021003783,0.000121721816],"genre_scores_gemma":[0.9944336,0.00031711214,7.679192e-7,0.0004482792,0.000082786006,0.0044684825,0.000004766753,0.000010715848,0.00023349245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992594,0.0000775567,0.00013409741,0.00025243332,0.00012313,0.00015336522],"domain_scores_gemma":[0.99934095,0.00017948615,0.00007521732,0.00026578177,0.00007949124,0.000059063597],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000060164042,0.00013941324,0.00027145364,0.00006344045,0.0000758536,0.0000068425547,0.000087068096,0.000031136373,0.0018590828],"category_scores_gemma":[0.0000031093025,0.000053737505,0.00009521358,0.00036504766,0.0001401182,0.00002433989,0.00003758525,0.00006345693,0.000014984336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014105862,0.0011327452,0.9856599,0.0000016939131,0.0022182735,0.000010241782,0.00048562707,0.0000029268156,0.00022740233,0.00008539603,0.0002615591,0.00850366],"study_design_scores_gemma":[0.0021041695,0.0005338622,0.9936036,0.000015713396,0.003269653,0.000028260809,0.000035395806,0.000036245136,0.00011361805,0.000040679868,0.00016002767,0.00005880526],"about_ca_topic_score_codex":0.0010857636,"about_ca_topic_score_gemma":0.0019760476,"teacher_disagreement_score":0.030031832,"about_ca_system_score_codex":0.00009300759,"about_ca_system_score_gemma":0.000041146683,"threshold_uncertainty_score":0.99905336},"labels":[],"label_agreement":null},{"id":"W2468405132","doi":"","title":"Development of a very sensitive luminescence assay for the measurement of paclitaxel and related taxanes.","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Cegep de Sainte Foy","funders":"","keywords":"Paclitaxel; Taxane; Chemistry; Taxus; Monoclonal antibody; Immunoassay; Pharmacology; Chromatography; Cancer; Antibody; Biology; Medicine; Breast cancer; Immunology; Internal medicine","score_opus":0.04314077197168009,"score_gpt":0.2638961367795593,"score_spread":0.22075536480787922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468405132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312824,0.0010410465,0.000022680737,0.0009821545,0.00011182306,0.0016722265,0.000010654265,0.000011213603,0.003019989],"genre_scores_gemma":[0.99792534,0.000111646405,0.00028032582,0.00008197265,0.000023338924,0.0006046232,0.00000533577,0.0000060566153,0.0009613657],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99937373,0.000019602809,0.00020126764,0.00010854948,0.00015575891,0.00014109397],"domain_scores_gemma":[0.9995824,0.00010903707,0.000070996066,0.000079020734,0.00011115094,0.000047368725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051985536,0.000070355745,0.0001793647,0.00002734908,0.000032937674,0.0000014895681,0.000024649644,0.000034241497,0.000044049393],"category_scores_gemma":[0.000048646158,0.00004608183,0.000039240043,0.000078074314,0.00007886202,0.000016849328,0.000008235223,0.00003969739,8.2061393e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002235141,0.0003767912,0.003905636,0.00020048454,0.00092832115,0.0000092941755,0.0029016915,0.000003434978,0.008552841,0.00003199192,0.0015665591,0.9792878],"study_design_scores_gemma":[0.005472752,0.00013717936,0.84150356,0.00006490058,0.0006367473,0.000029039289,0.00025633504,0.000095532145,0.12409257,0.000032032727,0.027564973,0.000114361574],"about_ca_topic_score_codex":0.000021342556,"about_ca_topic_score_gemma":0.000019741803,"teacher_disagreement_score":0.9791735,"about_ca_system_score_codex":0.00006953673,"about_ca_system_score_gemma":0.000074823765,"threshold_uncertainty_score":0.18791625},"labels":[],"label_agreement":null},{"id":"W2474269477","doi":"10.1200/jco.2008.26.15_suppl.550","title":"Triple-negative receptor status and prognosis in the NCIC CTG MA. 21 adjuvant breast cancer trial","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Epirubicin; Internal medicine; Breast cancer; Oncology; Cyclophosphamide; Triple-negative breast cancer; Proportional hazards model; Anthracycline; Chemotherapy; Cancer","score_opus":0.18238580471422888,"score_gpt":0.510368495052706,"score_spread":0.3279826903384771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474269477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.964504,0.0017141214,0.0000014616584,0.030019373,0.0022222388,0.0006899832,0.00002302125,0.00000479716,0.0008209922],"genre_scores_gemma":[0.9766253,0.015730975,0.00044938983,0.0035393112,0.0031256583,0.000057784895,0.0000026807686,0.000012030539,0.0004568257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967923,0.00086749136,0.001572597,0.000184578,0.00029152381,0.00029150496],"domain_scores_gemma":[0.99546,0.002934111,0.0010070957,0.00008674446,0.00022684896,0.00028522528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018420629,0.00014312973,0.0013004083,0.000116843265,0.000058743066,0.0000044864414,0.00010406209,0.00027367228,0.0007169611],"category_scores_gemma":[0.0009202481,0.00007898622,0.00029590385,0.00020783504,0.0003895947,0.00008905777,0.000027905595,0.0010586629,0.000008589101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3312757,0.0069680437,0.44952247,0.000023417215,0.0006987405,0.0013441178,0.0018812509,0.000002235973,0.00009683832,0.00002784439,0.04713081,0.16102853],"study_design_scores_gemma":[0.16330965,0.025394687,0.7252119,0.00006065451,0.00056612666,0.0011359454,0.00031130685,0.000011920241,0.0000437584,0.00007830871,0.0837862,0.00008952619],"about_ca_topic_score_codex":0.00021134083,"about_ca_topic_score_gemma":0.0002850108,"teacher_disagreement_score":0.27568945,"about_ca_system_score_codex":0.00025490767,"about_ca_system_score_gemma":0.0023378972,"threshold_uncertainty_score":0.78502214},"labels":[],"label_agreement":null},{"id":"W2475393511","doi":"10.1017/cbo9781139194099","title":"Case Studies in Neurological Pain","year":2012,"lang":"en","type":"book","venue":"Cambridge University Press eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Disease; Multiple sclerosis; Intensive care medicine; Health professionals; Chronic pain; Physical therapy; Health care; Psychiatry; Pathology","score_opus":0.09143415162308934,"score_gpt":0.3052217439213441,"score_spread":0.21378759229825478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2475393511","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016274396,0.00194378,0.000005006089,0.00004895069,0.00043412065,0.000715015,0.000083972205,0.00009349824,0.9804013],"genre_scores_gemma":[0.010073693,0.0003215585,0.00002461686,0.00049495767,0.00038309794,0.000003703885,0.000056845223,0.000024986008,0.9886165],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988216,0.0002173118,0.00015170524,0.00035747935,0.00011972758,0.00033218687],"domain_scores_gemma":[0.9991034,0.00029368576,0.0000983201,0.00025077013,0.00007254237,0.00018125458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021223977,0.0002903246,0.0006074397,0.0001934736,0.000071711765,0.0000041777835,0.000102579615,0.00033703758,0.000011877657],"category_scores_gemma":[0.000024682426,0.0002829553,0.00016571317,0.000014969333,0.0003043127,0.000031751166,0.00019702967,0.00058681774,0.000010217268],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013021199,0.00021252235,0.00064958195,0.0005848032,0.0007239602,0.26309612,0.00031936483,8.0525933e-7,0.000020938165,0.015443784,0.7143867,0.0032593317],"study_design_scores_gemma":[0.0025375509,0.00046551085,0.00009842623,0.00009792442,0.0010023881,0.0039152782,0.000060877344,0.00001923849,0.000025414072,0.0000013568779,0.9915282,0.00024779662],"about_ca_topic_score_codex":0.00006867467,"about_ca_topic_score_gemma":0.000008216566,"teacher_disagreement_score":0.27714157,"about_ca_system_score_codex":0.00036498418,"about_ca_system_score_gemma":0.00018467975,"threshold_uncertainty_score":0.9999623},"labels":[],"label_agreement":null},{"id":"W2477533041","doi":"10.1158/1538-7445.am2016-2179","title":"Abstract 2179: Macrolide toxin Mycalolide B is a potent inhibitor of HER2 cancer cell invasion and is the basis of actin targeted therapy for metastatic cancers","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"SKBR3; Cancer research; Trastuzumab; Antibody-drug conjugate; Metastasis; Cancer cell; Cancer; Medicine; Biology; Breast cancer; Antibody; Immunology; Internal medicine; Monoclonal antibody","score_opus":0.11087585323305187,"score_gpt":0.439304725482549,"score_spread":0.32842887224949713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2477533041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96294326,0.017687185,0.000008648476,0.016353901,0.00020185242,0.0017548891,0.0007296128,0.0000101883625,0.00031046764],"genre_scores_gemma":[0.9578278,0.037359934,0.000087138986,0.00093189784,0.00022255555,0.0010420945,0.0000060028824,0.00004039493,0.0024821726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806553,0.00011835804,0.00038261243,0.00039491136,0.00053131353,0.0005072455],"domain_scores_gemma":[0.9981182,0.00071777886,0.00018181671,0.00032409912,0.00047500926,0.00018308203],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006413408,0.00019457388,0.00046885526,0.00013812323,0.0001167236,0.0000110691,0.00017580316,0.000084038715,0.0032723504],"category_scores_gemma":[0.00004893706,0.00010591233,0.00016241657,0.0003004726,0.00037510673,0.00009152535,0.00006200327,0.00020279162,0.0000037616287],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004751037,0.00021410653,0.0036273971,0.000483621,0.0004561811,0.000007565377,0.0019856812,0.0000031852817,0.8630498,0.0000069671623,0.054908507,0.07050594],"study_design_scores_gemma":[0.0065010837,0.0008201014,0.007681766,0.00034129672,0.00012964584,0.0000027358046,0.00044926937,0.000016160055,0.9674817,0.00014383544,0.016320722,0.00011168726],"about_ca_topic_score_codex":0.019365015,"about_ca_topic_score_gemma":0.0017117602,"teacher_disagreement_score":0.10443188,"about_ca_system_score_codex":0.0007211806,"about_ca_system_score_gemma":0.0012002783,"threshold_uncertainty_score":0.9976388},"labels":[],"label_agreement":null},{"id":"W2480091379","doi":"10.1200/jco.2006.24.18_suppl.550","title":"Updated analysis of NCIC CTG MA.17 (letrozole vs. placebo to letrozole vs placebo) post unblinding","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Letrozole; Tamoxifen; Placebo; Hazard ratio; Internal medicine; Interim analysis; Breast cancer; Oncology; Randomized controlled trial; Chemotherapy; Hormone therapy; Gynecology; Confidence interval; Cancer","score_opus":0.07343197520050578,"score_gpt":0.4740857043753304,"score_spread":0.4006537291748246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480091379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97097737,0.00034892396,0.00018989491,0.017654406,0.0014645025,0.00037917294,0.000046305748,0.00002230327,0.008917102],"genre_scores_gemma":[0.98562217,0.0001589547,0.001836747,0.0064572445,0.0017636674,0.000009237694,0.000086756365,0.00003037657,0.004034876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946511,0.0005816305,0.003362428,0.00035575798,0.0005480775,0.00050100504],"domain_scores_gemma":[0.99364096,0.00242936,0.0022717882,0.0003023189,0.00078190176,0.00057366816],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029830134,0.00027948924,0.0031299954,0.0011943814,0.00007221024,0.00001371015,0.00031138965,0.0005440103,0.0030108115],"category_scores_gemma":[0.0009320819,0.00021983804,0.0012777968,0.001290704,0.00022352769,0.00012236685,0.00009968969,0.0010623632,0.000075347816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14455925,0.009470393,0.50320625,0.00006947134,0.013021816,0.002238769,0.00026311819,0.004362408,0.010477349,0.00022086872,0.2967374,0.015372905],"study_design_scores_gemma":[0.036835752,0.028793432,0.57495,0.000090905545,0.015972367,0.0002657375,0.00016509688,0.00083658873,0.0017388692,0.00006445678,0.33996898,0.00031782227],"about_ca_topic_score_codex":0.00033446366,"about_ca_topic_score_gemma":0.0009046296,"teacher_disagreement_score":0.10772349,"about_ca_system_score_codex":0.00050318724,"about_ca_system_score_gemma":0.001383111,"threshold_uncertainty_score":0.99790055},"labels":[],"label_agreement":null},{"id":"W2480777294","doi":"10.1017/cbo9781107280250.003","title":"Practical issues in the use of systemic anti-cancer therapy drugs","year":2015,"lang":"en","type":"book-chapter","venue":"Cambridge University Press eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Compendium; Medicine; Pharmacy; Cancer treatment; Cancer; Alternative medicine; Regimen; Cancer chemotherapy; Systemic therapy; Intensive care medicine; Drug; Family medicine; Pharmacology; Medical physics; Internal medicine; Pathology; Breast cancer","score_opus":0.1603843530878858,"score_gpt":0.3449275385156487,"score_spread":0.18454318542776293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480777294","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01998742,0.004916365,0.000009235078,0.0005953224,0.00031637336,0.0016955769,0.00034389572,0.000052729072,0.9720831],"genre_scores_gemma":[0.0139190545,0.0069301296,0.00003718436,0.00022496295,0.00019211763,0.0000034291988,0.000047441405,0.00002902024,0.97861665],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989638,0.000096707845,0.00018643492,0.0002791961,0.00029819182,0.00017566798],"domain_scores_gemma":[0.9989718,0.00016364444,0.00021185119,0.00036897763,0.00019857222,0.00008510655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001286986,0.00024740992,0.00056733156,0.0001470538,0.0000359414,0.000011990104,0.000164196,0.00026347837,0.000022341454],"category_scores_gemma":[0.0000070541405,0.00019320715,0.0001545439,0.000011920423,0.00022323105,0.00007001449,0.00007181318,0.00042221593,0.0000049586074],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034591248,0.00025258123,0.00028542473,0.00042187213,0.0012332108,0.0015128815,0.0016998756,0.000006560689,0.0011117053,0.23192324,0.75572264,0.0023708767],"study_design_scores_gemma":[0.0028794059,0.00022110679,0.00005893489,0.00041261056,0.0005495684,0.00006461576,0.00013507344,0.000014763415,0.000539013,0.000001256218,0.9949555,0.00016818743],"about_ca_topic_score_codex":0.0010154444,"about_ca_topic_score_gemma":0.0000050575895,"teacher_disagreement_score":0.23923281,"about_ca_system_score_codex":0.0002451156,"about_ca_system_score_gemma":0.0003308786,"threshold_uncertainty_score":0.7878759},"labels":[],"label_agreement":null},{"id":"W2488156982","doi":"10.1158/1538-7445.am2016-3060","title":"Abstract 3060: Molecular mechanisms of the cardiotoxicity of the proteasomal-targeted anticancer drugs bortezomib and carfilzomib","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Carfilzomib; Dexrazoxane; Bortezomib; Cardiotoxicity; Doxorubicin; Pharmacology; Chemistry; Myocyte; Medicine; Toxicity; Cancer; Multiple myeloma; Anthracycline; Internal medicine; Chemotherapy","score_opus":0.037619731588595405,"score_gpt":0.3877342246302499,"score_spread":0.35011449304165454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488156982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98997587,0.0018006823,0.000016096295,0.0047509572,0.00020299062,0.0018493127,0.000115464885,0.000009728963,0.0012788692],"genre_scores_gemma":[0.9979414,0.00047156343,0.000025503512,0.00013247669,0.00009033033,0.00040437968,7.404769e-7,0.000022147045,0.0009114799],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981912,0.00019220894,0.00023538675,0.00028147709,0.00073560036,0.00036412393],"domain_scores_gemma":[0.99878144,0.00014102818,0.000107045904,0.0005127301,0.00034986823,0.000107907625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056688813,0.00013047647,0.00033390702,0.000070303504,0.00010714705,0.0000057631896,0.00025698508,0.00009521994,0.00043685935],"category_scores_gemma":[0.00010364516,0.00005907334,0.00016036967,0.00038651098,0.00069173414,0.00003881872,0.00019352032,0.00028384003,0.0000022224865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039833327,0.000096533884,0.011555117,0.00017449561,0.00023125068,0.000006308341,0.0002076451,0.0000018277588,0.98190904,0.0005852163,0.0008740677,0.0039601726],"study_design_scores_gemma":[0.002069601,0.0001305219,0.100005805,0.0002859631,0.00009283864,0.0000046074656,0.00005922549,0.0000034886543,0.89520746,0.0008648702,0.0012121747,0.00006343001],"about_ca_topic_score_codex":0.0012201918,"about_ca_topic_score_gemma":0.00007488935,"teacher_disagreement_score":0.088450685,"about_ca_system_score_codex":0.00023926007,"about_ca_system_score_gemma":0.000726139,"threshold_uncertainty_score":0.47833037},"labels":[],"label_agreement":null},{"id":"W2488303827","doi":"10.1016/j.clgc.2016.07.018","title":"A Systematic Review of the Incidence and Risk Factors for Taxane Acute Pain Syndrome in Patients Receiving Taxane-Based Chemotherapy for Prostate Cancer","year":2016,"lang":"en","type":"review","venue":"Clinical Genitourinary Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Taxane; myalgia; Prostate cancer; Incidence (geometry); Internal medicine; Cabazitaxel; Cancer; Clinical trial; Oncology; Chemotherapy; Observational study; Breast cancer; Androgen deprivation therapy","score_opus":0.0528981432978041,"score_gpt":0.4295533392958634,"score_spread":0.3766551959980593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488303827","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014478608,0.9632827,0.000012442066,0.00041901495,0.0008864976,0.01900285,0.001895489,0.000018992976,0.0000034023287],"genre_scores_gemma":[0.0004098007,0.986256,0.000094070085,0.0008369484,0.00025067432,0.011171384,0.00009625441,0.0001000064,0.0007848502],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9953942,0.0009673436,0.0022204483,0.00070756976,0.00027316035,0.0004372798],"domain_scores_gemma":[0.9917677,0.004593951,0.0026256498,0.0005748802,0.00026324173,0.00017459766],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001872828,0.00057436613,0.004418647,0.000117878786,0.00008447766,0.000008949368,0.00032209427,0.00036259816,0.00008571693],"category_scores_gemma":[0.0015135229,0.00030197957,0.001240811,0.0003131311,0.0002026094,0.000051233823,0.00007320615,0.00042779912,0.0000012240296],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044684223,0.00033382737,0.021191537,0.7518571,0.0015508794,0.000008627671,0.000027246131,2.3038884e-7,2.9365742e-7,1.7623664e-7,0.0017239406,0.22285928],"study_design_scores_gemma":[0.0058196117,0.002303604,0.0030035574,0.90201426,0.012621767,0.000008484024,0.0000044968406,0.0000111325635,0.0000036725548,0.0000075676594,0.07379684,0.00040503684],"about_ca_topic_score_codex":0.00010889815,"about_ca_topic_score_gemma":0.000052661362,"teacher_disagreement_score":0.22245423,"about_ca_system_score_codex":0.0005602708,"about_ca_system_score_gemma":0.0012410145,"threshold_uncertainty_score":0.99994326},"labels":[],"label_agreement":null},{"id":"W2488495429","doi":"10.3821/1913-701x-143.sp2.s17a","title":"Hormonothérapie bio-identique: synthèse pratique à l'intention des pharmaciens","year":2010,"lang":"fr","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Humanities; Psychology; Business administration; Business; Art","score_opus":0.023606756511159926,"score_gpt":0.2947688258378267,"score_spread":0.27116206932666675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488495429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89924544,0.03682058,0.0003001238,0.0020277994,0.05147892,0.0018526034,0.0023635582,0.00013023827,0.0057807686],"genre_scores_gemma":[0.86974007,0.09480619,0.0006196897,0.0052197506,0.008981298,0.00011573318,0.00019378554,0.00025384713,0.020069614],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9909696,0.00070386275,0.0018483874,0.0013013902,0.0010240198,0.004152731],"domain_scores_gemma":[0.9863175,0.00038773534,0.00089012535,0.00068415207,0.0020878343,0.009632662],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0019946154,0.0014724422,0.0013411205,0.0013516685,0.002559477,0.0007139053,0.0012707588,0.0005458303,0.01926031],"category_scores_gemma":[0.0006052535,0.0016432073,0.00080666225,0.0018314675,0.0020542934,0.0016010281,0.0001417757,0.004695388,0.00034072765],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00082788646,0.0008349992,0.008124977,0.0012109809,0.0024004155,0.27537623,0.003136305,0.00023739936,0.18336636,0.00045947728,0.21515675,0.30886823],"study_design_scores_gemma":[0.0070450823,0.00030938062,0.00015505466,0.00016586695,0.0024502168,0.63845414,0.000040558185,0.0027363044,0.033539116,0.00019884735,0.3136157,0.0012897081],"about_ca_topic_score_codex":0.071432024,"about_ca_topic_score_gemma":0.37196475,"teacher_disagreement_score":0.3630779,"about_ca_system_score_codex":0.010447002,"about_ca_system_score_gemma":0.021599147,"threshold_uncertainty_score":0.9998025},"labels":[],"label_agreement":null},{"id":"W2492595798","doi":"10.1200/jco.2016.34.15_suppl.1016","title":"Anthracycline-induced cardiotoxicity in patients with early stage breast cancer: The Canadian cancer trials group (NCIC CTG) MA.21 experience.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saint John Regional Hospital; Sunnybrook Health Science Centre; Queen's University; McMaster University; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Epirubicin; Ejection fraction; Cardiotoxicity; Anthracycline; Heart failure; Breast cancer; Internal medicine; Cyclophosphamide; Cardiology; Randomized controlled trial; Chemotherapy; Cancer; Surgery; Gastroenterology","score_opus":0.16339496123548153,"score_gpt":0.5082006822034575,"score_spread":0.34480572096797596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2492595798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719383,0.00034653145,0.000005898384,0.023867775,0.0026412283,0.00068965595,0.00013480012,0.000006634148,0.00036917365],"genre_scores_gemma":[0.9929906,0.0014288404,0.00006935746,0.002959617,0.0021349513,0.000074604606,0.0000019558338,0.000023983537,0.00031605383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952724,0.0011631058,0.0022752117,0.00029539902,0.00048679995,0.0005071107],"domain_scores_gemma":[0.9945587,0.0021575405,0.0018186874,0.00024314901,0.0004892572,0.00073269143],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035408314,0.00023111766,0.002178557,0.00019858526,0.0001081473,0.000012877936,0.00025193818,0.00040644826,0.0012983324],"category_scores_gemma":[0.0008690323,0.00010215067,0.00043958114,0.00025210812,0.00037038873,0.00019114802,0.000034326396,0.0008585639,0.000007929038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013848046,0.00094943814,0.86945546,0.0000075377316,0.0005767233,0.00032600548,0.00028388502,0.0000035460241,0.00027318986,0.000012183443,0.0013381658,0.11292585],"study_design_scores_gemma":[0.025448104,0.0066684023,0.9317449,0.00016727537,0.00046807766,0.000038938153,0.000066519555,0.0000026930716,0.00015147118,0.000013958064,0.035099342,0.00013032452],"about_ca_topic_score_codex":0.092609316,"about_ca_topic_score_gemma":0.43037033,"teacher_disagreement_score":0.33776104,"about_ca_system_score_codex":0.001656892,"about_ca_system_score_gemma":0.006110328,"threshold_uncertainty_score":0.9996146},"labels":[],"label_agreement":null},{"id":"W2495512985","doi":"10.1200/jco.2016.34.4_suppl.192","title":"Phase III randomized study of sorafenib plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC): CALGB 80802 (Alliance).","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); Ottawa Hospital; McGill University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sorafenib; Clinical endpoint; Interim analysis; Hazard ratio; Hepatocellular carcinoma; Internal medicine; Randomized controlled trial; Phases of clinical research; Oncology; Gastroenterology; Progression-free survival; Surgery; Chemotherapy; Confidence interval","score_opus":0.09144095418322526,"score_gpt":0.4539521059192045,"score_spread":0.36251115173597925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495512985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99369764,0.000519942,0.00007149702,0.0014428464,0.0018078302,0.0020252513,0.000009314782,0.000010378156,0.00041529353],"genre_scores_gemma":[0.99804336,0.000438167,0.00043700458,0.00027450098,0.0004362306,0.000048621514,0.0000054201537,0.000031785785,0.00028491102],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99379575,0.0011506565,0.0036809056,0.00037224227,0.00058397837,0.00041643775],"domain_scores_gemma":[0.99143195,0.0042040264,0.002936865,0.00030967782,0.0006884864,0.00042901537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025598945,0.0003086816,0.0046649603,0.00022906317,0.000036317022,0.0000037800298,0.00024208297,0.00033198623,0.000339951],"category_scores_gemma":[0.0012336393,0.00016702278,0.0005433256,0.00026588075,0.00046674765,0.00017390925,0.00006183826,0.000710975,0.000010221005],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75632375,0.024943324,0.18405491,0.000023377734,0.0010643794,0.0009913186,0.0003750847,0.00001237128,0.0004211707,0.0000131663855,0.0003548265,0.0314223],"study_design_scores_gemma":[0.8415822,0.11129418,0.042577665,0.00013767136,0.0016226838,0.000015229552,0.00020231384,0.00006609243,0.00037925196,0.00003259125,0.0019316319,0.00015847724],"about_ca_topic_score_codex":0.000095080686,"about_ca_topic_score_gemma":0.00017920736,"teacher_disagreement_score":0.14147726,"about_ca_system_score_codex":0.00052582385,"about_ca_system_score_gemma":0.0016577959,"threshold_uncertainty_score":0.6810991},"labels":[],"label_agreement":null},{"id":"W2505248710","doi":"10.1177/1078155216660184","title":"Safe administration of docetaxel after weekly paclitaxel-induced acute pancreatitis","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Acute pancreatitis; Docetaxel; Carboplatin; Paclitaxel; Pancreatitis; Adverse effect; Chemotherapy; Pancreatic cancer; Internal medicine; Gastroenterology; Cancer; Cisplatin","score_opus":0.04567577280500804,"score_gpt":0.4385017096093566,"score_spread":0.3928259368043485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2505248710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91077083,0.0008648967,0.00014767464,0.069878034,0.0012748635,0.00033205637,0.000033420176,0.000012653495,0.016685586],"genre_scores_gemma":[0.98648137,0.004531278,0.0032219228,0.0028679427,0.00093852833,0.000023488921,0.0000029780897,0.00002150051,0.0019110041],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99792635,0.00039828822,0.00088955,0.00017887907,0.0003454872,0.0002614147],"domain_scores_gemma":[0.99591804,0.0013773716,0.0015083441,0.00016349593,0.00076693465,0.0002658266],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00082957745,0.00019009512,0.00067002507,0.00020308243,0.00004171879,0.000008773291,0.00012128481,0.00011953206,0.0022678534],"category_scores_gemma":[0.00049215124,0.0001239171,0.0002406962,0.00016918537,0.00011685819,0.0008633482,0.000031517153,0.00039963156,0.00006497234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09226061,0.00468304,0.016777342,0.000084936095,0.0047217906,0.012122131,0.00057518954,3.4915556e-7,0.67120385,0.00010802885,0.035227336,0.16223542],"study_design_scores_gemma":[0.030352915,0.01429201,0.012629134,0.00014286248,0.0074449754,0.024530366,0.00014696752,0.0000049186883,0.1365417,0.00009001078,0.7736371,0.00018702498],"about_ca_topic_score_codex":0.000024423205,"about_ca_topic_score_gemma":0.000008411143,"teacher_disagreement_score":0.73840976,"about_ca_system_score_codex":0.00040793276,"about_ca_system_score_gemma":0.0014623472,"threshold_uncertainty_score":0.99864423},"labels":[],"label_agreement":null},{"id":"W2510092860","doi":"10.1249/01.mss.0000486011.64680.fa","title":"Comparing Indices of Neuromuscular Fatigue with Subjective Fatigue in Cancer Survivors","year":2016,"lang":"en","type":"article","venue":"Medicine & Science in Sports & Exercise","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Isometric exercise; Medicine; Physical medicine and rehabilitation; Cancer-related fatigue; Physical therapy; Rehabilitation; Quality of life (healthcare); Cancer; Muscle fatigue; Internal medicine; Electromyography","score_opus":0.045975488166281955,"score_gpt":0.34462630954375284,"score_spread":0.2986508213774709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510092860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603,0.00031215427,0.000026571543,0.0009846614,0.00038489263,0.00070528465,0.000002262815,0.000023132425,0.001531083],"genre_scores_gemma":[0.9985878,0.00086788763,0.000056941444,0.000101771024,0.00006646941,0.00010683284,0.0000027429987,0.000015417036,0.0001941704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977124,0.00003171431,0.0004671326,0.0005290427,0.00079536566,0.00046435266],"domain_scores_gemma":[0.9990501,0.0000965564,0.00021971963,0.00029432462,0.0001457452,0.00019356821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008220551,0.00021768094,0.00073937967,0.00079138926,0.00005302888,0.000004187871,0.00022869639,0.00004918104,0.00044037582],"category_scores_gemma":[0.00006238064,0.00012153025,0.000034720935,0.0017694355,0.0014644738,0.00026811735,0.00004958693,0.00017207883,0.000001180214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041735472,0.00022347317,0.9738751,0.000057719848,0.0000017569757,0.00029140303,0.0031254014,0.0000724362,0.003247445,0.0000042670918,0.0000297898,0.018653827],"study_design_scores_gemma":[0.0036876837,0.00047035297,0.9908269,0.0022687332,0.00008785228,0.000016456284,0.00068590755,0.00007958684,0.0015941915,0.00003398913,0.00011082304,0.00013753067],"about_ca_topic_score_codex":0.015622338,"about_ca_topic_score_gemma":0.009784978,"teacher_disagreement_score":0.018516297,"about_ca_system_score_codex":0.00027269003,"about_ca_system_score_gemma":0.00047188095,"threshold_uncertainty_score":0.9909327},"labels":[],"label_agreement":null},{"id":"W2513422618","doi":"10.1200/jco.2012.30.15_suppl.e21099","title":"Gene expression combined with gene set enrichment analysis to identify markers of vinorelbine efficacy in breast cancer patients.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Gene; Gene expression; Cancer research; Breast cancer; Gene expression profiling; Biology; Transcription factor; Microarray analysis techniques; Cancer; Medicine; Genetics","score_opus":0.0677473818523388,"score_gpt":0.48026202625263503,"score_spread":0.4125146444002962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513422618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951707,0.00037752755,0.00003252632,0.0030740034,0.0008327586,0.00033499292,0.000030765823,0.000004003939,0.00014270264],"genre_scores_gemma":[0.99595195,0.0007059177,0.0014562056,0.0012082796,0.00053811196,0.00001564131,0.000023612862,0.0000140124275,0.000086251726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687815,0.0003833096,0.001843336,0.00018385841,0.0004010778,0.00031026118],"domain_scores_gemma":[0.99673575,0.0007535159,0.0013766858,0.00016948431,0.0004047462,0.0005598014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014542427,0.00016413057,0.0016759122,0.00043068948,0.00002029582,0.0000028736306,0.00013459683,0.00021090075,0.00078572624],"category_scores_gemma":[0.00016490665,0.000105493426,0.00040145355,0.0006169571,0.00009535638,0.0000961421,0.000065635104,0.000433594,0.0000057527313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037924364,0.010706904,0.92824787,0.000017675773,0.0023755871,0.00007788343,0.00019653897,0.00018549187,0.005063298,9.773527e-7,0.0047237137,0.010479666],"study_design_scores_gemma":[0.020894969,0.0133006545,0.957497,0.000062697974,0.0033779172,0.000032417796,0.00003461172,0.0000128229385,0.0028333303,0.0000018685861,0.0018575259,0.00009419926],"about_ca_topic_score_codex":0.00013784152,"about_ca_topic_score_gemma":0.00008408102,"teacher_disagreement_score":0.029249087,"about_ca_system_score_codex":0.0003769668,"about_ca_system_score_gemma":0.00049256603,"threshold_uncertainty_score":0.8603151},"labels":[],"label_agreement":null},{"id":"W2518518788","doi":"","title":"Development of highly efficacious hydrophobic paclitaxel prodrugs delivered in nanoparticles for fixed-ratio drug combination applications","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Paclitaxel; Prodrug; Drug; Pharmacokinetics; Pharmacology; Drug delivery; Chemistry; In vivo; Bioavailability; Micelle; Drug carrier; Targeted drug delivery; Cancer; Aqueous solution; Medicine; Organic chemistry","score_opus":0.09150125931938934,"score_gpt":0.4202588927023295,"score_spread":0.3287576333829402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518518788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950334,0.0011270394,0.000051110263,0.0011853002,0.000039896313,0.0023067968,0.000020613465,0.000020605085,0.0002152505],"genre_scores_gemma":[0.992539,0.0003311937,0.0010284705,0.00003503573,0.000060019494,0.00462408,0.00006158073,0.000016124253,0.0013045229],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987944,0.000060041257,0.00029430696,0.00024513027,0.0003062106,0.00029993037],"domain_scores_gemma":[0.999181,0.0001635295,0.000051996503,0.00015981044,0.0003521222,0.00009154732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036543672,0.00008687704,0.00020765574,0.00021402998,0.00017707857,0.000004560692,0.00009237593,0.00004556339,0.00005808175],"category_scores_gemma":[0.000022553113,0.00008014053,0.000037529117,0.0004707258,0.0001562966,0.000043984084,0.00003242666,0.00013908769,0.000015308835],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009574767,0.0012781811,0.005052744,0.00028874498,0.00007619321,0.000008672714,0.0059152115,0.00003675107,0.97249866,0.00046314776,0.0036656493,0.009758555],"study_design_scores_gemma":[0.006616022,0.00028803115,0.015648302,0.0000800469,0.0000284739,0.0000051019883,0.00037970766,0.00023020113,0.95831096,0.00016252228,0.018136518,0.00011411726],"about_ca_topic_score_codex":0.00019587463,"about_ca_topic_score_gemma":0.00039449934,"teacher_disagreement_score":0.014470869,"about_ca_system_score_codex":0.00052089273,"about_ca_system_score_gemma":0.0008873425,"threshold_uncertainty_score":0.3268036},"labels":[],"label_agreement":null},{"id":"W2518731549","doi":"","title":"Comparison of physicochemical characteristics and stability of three novel formulations of paclitaxel: Abraxane, Nanoxel, and Genexol PM","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Paclitaxel; Diluent; Chromatography; Chemistry; Particle size; Nuclear chemistry; Medicine; Surgery; Chemotherapy","score_opus":0.26442089054524215,"score_gpt":0.4898383494715776,"score_spread":0.22541745892633547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518731549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974205,0.0015357963,0.00004227133,0.0001997723,0.000026719357,0.00038271825,0.00019477464,0.0000043215978,0.00019312356],"genre_scores_gemma":[0.9989852,0.000608267,0.0002378044,0.000007734762,0.000066728084,0.000036593905,0.000022782211,0.000008569877,0.000026350854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991034,0.000026044167,0.00027937672,0.00016044584,0.0002633834,0.00016729382],"domain_scores_gemma":[0.9990588,0.00023254397,0.00009193586,0.0001670685,0.00035995836,0.00008972624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015954682,0.00007305223,0.00040266287,0.00007537075,0.000049006976,0.000001499329,0.000046667392,0.00005846759,0.000115151895],"category_scores_gemma":[0.000056176552,0.00006311333,0.00003590893,0.00017995537,0.000693867,0.00003458703,0.000062608655,0.00016028357,2.613019e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041609487,0.00038229025,0.4392956,0.0003298062,0.00005571932,6.9192146e-7,0.0006647666,2.1406616e-7,0.5574662,0.00010949683,0.00016296984,0.0011161357],"study_design_scores_gemma":[0.0016334644,0.0004682608,0.47779033,0.00006027303,0.000054639448,0.0000042217584,0.00006572967,0.00020669203,0.51938635,0.00007526395,0.00021214645,0.000042617517],"about_ca_topic_score_codex":0.0005036653,"about_ca_topic_score_gemma":0.00007984549,"teacher_disagreement_score":0.038494732,"about_ca_system_score_codex":0.00006252869,"about_ca_system_score_gemma":0.00023050357,"threshold_uncertainty_score":0.2573687},"labels":[],"label_agreement":null},{"id":"W2520703434","doi":"10.1097/01.jto.0000284321.19705.61","title":"P1-223: Costs associated with intravenous chemotherapy administration in patients with lung cancer","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Etoposide; Carboplatin; Chemotherapy; Irinotecan; Lung cancer; Cisplatin; Oncology; Internal medicine; Topotecan; Route of administration; Cancer; Colorectal cancer","score_opus":0.012162735568057003,"score_gpt":0.4152775145712979,"score_spread":0.4031147790032409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520703434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959205,0.00026887853,0.000081758066,0.0018674426,0.0002835534,0.00036091017,0.0000048152065,0.000008050718,0.0012041414],"genre_scores_gemma":[0.99808896,0.0000848967,0.00044178872,0.00089454325,0.00022834963,0.000006343586,0.000014856657,0.000018427801,0.00022183324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989226,0.00007620506,0.00038835953,0.00011598497,0.00024189822,0.0002549632],"domain_scores_gemma":[0.99883693,0.00013058478,0.00054339826,0.00006543952,0.00028566006,0.00013798059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046055033,0.0001306178,0.0004571688,0.0001932507,0.000031551823,0.0000060445564,0.000059086848,0.0001481708,0.0002092847],"category_scores_gemma":[0.00002327087,0.000087309294,0.000042702275,0.00025930227,0.00006651787,0.000082483464,0.0000051879774,0.00036200482,8.148499e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042544153,0.004607381,0.80767554,0.000026397238,0.0006104476,0.000892605,0.0006280571,0.000014346314,0.00035735188,0.0000036281347,0.0009860285,0.14165404],"study_design_scores_gemma":[0.012031337,0.019045899,0.96361685,0.00025012955,0.000493164,0.00016450055,0.00008736668,0.00001624134,0.0021325368,0.0000057518914,0.0020479227,0.00010827694],"about_ca_topic_score_codex":0.000044124197,"about_ca_topic_score_gemma":0.0018455774,"teacher_disagreement_score":0.15594132,"about_ca_system_score_codex":0.0019034058,"about_ca_system_score_gemma":0.0008150508,"threshold_uncertainty_score":0.497734},"labels":[],"label_agreement":null},{"id":"W2520992272","doi":"10.1212/wnl.86.16_supplement.s17.003","title":"Tetrodotoxin (TTX) for Chemotherapy Induced Neuropathic Pain (CINP): A Randomized, Double-Blind, Dose-Finding, Placebo Controlled, Multicenter Study (S17.003)","year":2016,"lang":"en","type":"article","venue":"Neurology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Neuropathic pain; Medicine; Placebo; Multicenter study; Double blind; Anesthesia; Randomized controlled trial; Multicenter trial; Chemotherapy; Tetrodotoxin; Surgery; Internal medicine; Pathology; Alternative medicine","score_opus":0.048113793392347316,"score_gpt":0.35017559203278814,"score_spread":0.3020617986404408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520992272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96677315,0.00016534631,0.00060093444,0.014819006,0.0014204751,0.015550534,0.000012257776,0.00017305154,0.00048525678],"genre_scores_gemma":[0.98004764,0.00011060584,0.000051949773,0.013052175,0.0008037546,0.004546287,0.00001118384,0.00009334223,0.0012830411],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99514455,0.0021773379,0.00078707415,0.00087755796,0.00025843314,0.0007550256],"domain_scores_gemma":[0.99413294,0.0046259435,0.00035565556,0.0004976026,0.00014523986,0.0002426422],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003119827,0.0004951597,0.0018193908,0.00035750578,0.00014147157,0.00002260091,0.00022653521,0.00029872885,0.0006159874],"category_scores_gemma":[0.0007432716,0.00030662175,0.0004997399,0.00017981074,0.00019585852,0.00007516029,0.000057910762,0.00042412424,0.00007460252],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9373632,0.0021393443,0.013754933,0.00003214108,0.00086927135,0.00020068126,0.00041288816,0.0000011978809,0.036980934,0.000049857616,0.0011338415,0.007061702],"study_design_scores_gemma":[0.9741739,0.01164135,0.0010291531,0.000017232158,0.0009343018,0.000057641428,0.000017519327,0.00042703978,0.0025860334,0.000046501198,0.008813012,0.00025632884],"about_ca_topic_score_codex":0.00010158674,"about_ca_topic_score_gemma":0.0001263196,"teacher_disagreement_score":0.03681068,"about_ca_system_score_codex":0.0000701595,"about_ca_system_score_gemma":0.00014083063,"threshold_uncertainty_score":0.9999386},"labels":[],"label_agreement":null},{"id":"W2532290530","doi":"10.1200/jco.2006.24.18_suppl.10627","title":"Pegylated liposomal doxorubicin (PLD) with cyclophosphamide (C) as 1<sup>st</sup>-line chemotherapy for metastatic breast cancer (MBC) patients previously treated with adjuvant anthracyclines","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Cardiotoxicity; Metastatic breast cancer; Anthracycline; Internal medicine; Doxorubicin; Cyclophosphamide; Epirubicin; Mucositis; Gastroenterology; Oncology; Chemotherapy; Neutropenia; Adjuvant; Regimen; Breast cancer; Febrile neutropenia; Discontinuation; Cancer","score_opus":0.042250708226388774,"score_gpt":0.4239758659361589,"score_spread":0.3817251577097701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532290530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875559,0.001102417,0.00010168562,0.0089020105,0.00036328752,0.0014203893,0.00012744084,0.000040808867,0.00038604246],"genre_scores_gemma":[0.98862684,0.0014993439,0.002978833,0.0035003882,0.001777482,0.00009609719,0.00011547202,0.000093705676,0.0013118603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955199,0.00040630793,0.0025688035,0.00042446406,0.00048053227,0.00060000265],"domain_scores_gemma":[0.993861,0.0016373348,0.0024027498,0.00023955297,0.0013690195,0.0004903496],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009774539,0.00046775324,0.002737333,0.00019177527,0.00012630994,0.000017613935,0.00019906458,0.0003285078,0.0005106163],"category_scores_gemma":[0.00021072141,0.00026784322,0.0005103265,0.00036232616,0.00039926372,0.00019457415,0.000021781325,0.00092041964,0.000008555785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1635033,0.024364347,0.6822195,0.00021265693,0.004543437,0.001311864,0.00023680952,0.0017033934,0.00048012123,0.000019911055,0.010686524,0.11071812],"study_design_scores_gemma":[0.15905122,0.14909202,0.64141494,0.00073545607,0.008326995,0.0024634444,0.00015103864,0.0010521231,0.0018453193,0.00022224376,0.035058085,0.00058709196],"about_ca_topic_score_codex":0.0012953484,"about_ca_topic_score_gemma":0.0009465645,"teacher_disagreement_score":0.124727674,"about_ca_system_score_codex":0.00038314087,"about_ca_system_score_gemma":0.002068254,"threshold_uncertainty_score":0.99997735},"labels":[],"label_agreement":null},{"id":"W2541318692","doi":"10.1200/jco.2009.27.15_suppl.e16529","title":"Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: A phase II randomized study","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Ontario Clinical Oncology Group; BC Cancer Agency","funders":"","keywords":"Medicine; Randomized controlled trial; Ovarian cancer; Low molecular weight heparin; Chemotherapy; Heparin; Surgery; Internal medicine; Taxane; Cancer; Gastroenterology; Breast cancer","score_opus":0.08121915640578144,"score_gpt":0.5341580470062968,"score_spread":0.45293889060051534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541318692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9664441,0.001557357,0.00008591895,0.025146611,0.0017055406,0.0011195684,0.0000024520414,0.000011193605,0.0039273086],"genre_scores_gemma":[0.9902233,0.0013588868,0.000676888,0.005774321,0.0013068083,0.00003601409,0.0000031003176,0.0000152404255,0.00060544757],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9942937,0.0014449456,0.0032558525,0.00029207423,0.00035990382,0.00035352568],"domain_scores_gemma":[0.99613374,0.0014255833,0.0015122637,0.00021472295,0.00024582204,0.00046789178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005158073,0.00022735151,0.0036363308,0.000290162,0.0000519196,0.0000073564324,0.00020672627,0.00033890005,0.0006833649],"category_scores_gemma":[0.0012713701,0.00015888868,0.00077646534,0.000286887,0.0001696417,0.00009275907,0.0000506115,0.0012599303,0.000008944953],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65441835,0.07859825,0.025543077,0.000016931175,0.0019465317,0.012001441,0.00076516054,0.0000629527,0.0018584625,0.00023990766,0.006912743,0.21763621],"study_design_scores_gemma":[0.8698382,0.072031364,0.029886603,0.00009336479,0.00218914,0.00026741592,0.00006580756,0.0003306415,0.0003782604,0.0009803425,0.023767196,0.00017166579],"about_ca_topic_score_codex":0.00020855472,"about_ca_topic_score_gemma":0.00028352393,"teacher_disagreement_score":0.21746454,"about_ca_system_score_codex":0.00034651693,"about_ca_system_score_gemma":0.002002619,"threshold_uncertainty_score":0.74823666},"labels":[],"label_agreement":null},{"id":"W2544016569","doi":"10.1016/j.jval.2016.09.1552","title":"A Real-World Outcome Research Study On Quality of Life, Work Productivity And Healthcare Resource Utilization In Metastatic Breast Cancer For Patients And Caregivers","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre intégré de santé et de services sociaux de la Montérégie-Centre; Santé Montérégie; Université de Montréal; Pfizer (Canada); Hôpital Maisonneuve-Rosemont; Centre hospitalier universitaire de Québec; Kingston General Hospital","funders":"","keywords":"Medicine; Metastatic breast cancer; Quality of life (healthcare); Work productivity; Cohort; Breast cancer; Internal medicine; Cancer; Prospective cohort study; Disease; Cohort study; Physical therapy; Oncology; Productivity; Nursing","score_opus":0.35795054518969815,"score_gpt":0.5272409181921662,"score_spread":0.16929037300246808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544016569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804343,0.00040967748,0.0000011424821,0.015859379,0.00007045015,0.0030680697,0.0001324545,0.000007727791,0.000016818973],"genre_scores_gemma":[0.99912435,0.0003285998,0.000030153595,0.000108958804,0.00003832651,0.00022083655,0.000008109273,0.000012465979,0.0001281726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975664,0.0010812922,0.00045411344,0.0003555306,0.0002618917,0.00028077728],"domain_scores_gemma":[0.9986443,0.0007632035,0.000151213,0.00015681668,0.0001327182,0.0001517547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020702805,0.00009678146,0.00044124085,0.00034254914,0.000058758444,0.0000029607647,0.000031886386,0.000026467878,0.00000538573],"category_scores_gemma":[0.00024392159,0.00006928396,0.000017251692,0.00050607184,0.000083751256,0.000039738898,0.000027670994,0.00013230222,1.802222e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003934147,0.0010723547,0.9769462,0.000933642,0.000023356015,0.0000011375618,0.0037973342,0.000008210493,0.0000069489934,0.00008946778,0.00016982568,0.013017422],"study_design_scores_gemma":[0.007144504,0.0016810425,0.9898128,0.00036189237,0.0000124372045,2.5379978e-7,0.0007082408,0.0000110803485,0.000007170324,0.00007593914,0.000133401,0.00005127548],"about_ca_topic_score_codex":0.06736298,"about_ca_topic_score_gemma":0.01755908,"teacher_disagreement_score":0.0498039,"about_ca_system_score_codex":0.0006596205,"about_ca_system_score_gemma":0.0003888069,"threshold_uncertainty_score":0.9798379},"labels":[],"label_agreement":null},{"id":"W2550310472","doi":"10.1182/blood.v118.21.206.206","title":"Venous Thromboembolism (VTE) Prevention with Semuloparin in Cancer Patients Initiating Chemotherapy: Benefit-Risk Assessment by VTE Risk in SAVE-ONCO","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University Health Centre","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Cancer; Pulmonary embolism; Deep vein; Chemotherapy regimen; Surgery; Gastroenterology; Thrombosis; Oncology","score_opus":0.019118421167395414,"score_gpt":0.3078781504209401,"score_spread":0.28875972925354465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550310472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951552,0.00060998317,0.000010053711,0.000046433557,0.00011987477,0.0008312101,0.0000632671,0.000033946573,0.0031300115],"genre_scores_gemma":[0.99702024,0.0015195754,0.00069560425,0.00018375044,0.00008887382,0.00026815894,0.00008403982,0.00003794265,0.00010179927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876213,0.00008642404,0.00031337517,0.0003259729,0.00019047924,0.00032159916],"domain_scores_gemma":[0.99942654,0.00003485652,0.00024727374,0.00015799903,0.00005324789,0.00008010037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015993348,0.00020337534,0.0004256313,0.00011686876,0.00005427344,0.000008733236,0.00006836337,0.00010122299,0.00035148865],"category_scores_gemma":[0.000007838209,0.00017507724,0.000049388367,0.00022893432,0.00003201758,0.00010539068,0.000026045564,0.00032242158,0.0000052150785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029433653,0.008384346,0.9693446,0.000040628085,0.00028870656,0.000019272085,0.0034805415,0.000008591415,0.0005131282,0.000006113925,0.000078797355,0.017540945],"study_design_scores_gemma":[0.021472238,0.002188729,0.96889985,0.00020316293,0.0005310702,0.00000383625,0.00010747374,0.000055960994,0.0059923823,0.00018479479,0.0001751706,0.00018536524],"about_ca_topic_score_codex":0.006947364,"about_ca_topic_score_gemma":0.0050102025,"teacher_disagreement_score":0.021177901,"about_ca_system_score_codex":0.00022884297,"about_ca_system_score_gemma":0.00015201476,"threshold_uncertainty_score":0.99966544},"labels":[],"label_agreement":null},{"id":"W2554811589","doi":"10.1590/1982-0194201600055","title":"Indução da dor pelo quimioterápico docetaxel em mulheres com câncer de mama","year":2016,"lang":"pt","type":"article","venue":"Acta Paulista de Enfermagem","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Fundação de Amparo à Pesquisa do Estado de Minas Gerais; McGill University","keywords":"Medicine; Docetaxel; Brief Pain Inventory; Gynecology; Internal medicine; Oncology; Cancer; Physical therapy; Chronic pain","score_opus":0.055037812953116313,"score_gpt":0.3600723752270384,"score_spread":0.30503456227392206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554811589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96184283,0.0031200275,0.00037692557,0.021302653,0.0020515248,0.001035686,0.0005797611,0.0002762351,0.009414371],"genre_scores_gemma":[0.91351336,0.0010998918,0.00016170487,0.005816205,0.0017787287,0.00012330242,0.000105612824,0.00014660845,0.0772546],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99560404,0.00052545633,0.00075936015,0.00091789843,0.00050510897,0.0016881262],"domain_scores_gemma":[0.9967918,0.0007475094,0.00036047536,0.0010155195,0.00017483886,0.00090986915],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00053501275,0.00081101205,0.0010149456,0.00027202177,0.0002676172,0.00021118093,0.00065250247,0.0006504058,0.018137602],"category_scores_gemma":[0.00021156613,0.0006108926,0.00037372168,0.0003462713,0.0003370807,0.00040238225,0.00026916395,0.0007745047,0.0016050149],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034128446,0.0024842664,0.12983887,0.00053752493,0.0019884447,0.0036470727,0.00967927,0.0000034359714,0.16700289,0.0004264988,0.63373256,0.047246303],"study_design_scores_gemma":[0.033140033,0.002644422,0.24444492,0.0014063529,0.0037186274,0.00074348913,0.0028353317,0.0004776975,0.04455859,0.00035113987,0.66356534,0.002114062],"about_ca_topic_score_codex":0.00065755757,"about_ca_topic_score_gemma":0.00057821494,"teacher_disagreement_score":0.122444294,"about_ca_system_score_codex":0.0013900959,"about_ca_system_score_gemma":0.0009334529,"threshold_uncertainty_score":0.99963427},"labels":[],"label_agreement":null},{"id":"W2556113048","doi":"","title":"An Investigation of Selective Galena Recovery Following Its Depression","year":2015,"lang":"en","type":"dissertation","venue":"QSpace (Queen's University Library)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University","keywords":"Depression (economics); Galena; Psychology; Psychiatry; Medicine; Geology; Keynesian economics; Geochemistry; Economics","score_opus":0.011700668803335751,"score_gpt":0.2567573146432211,"score_spread":0.24505664583988535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556113048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97958267,0.00019786754,0.000003096769,0.0017925628,0.00053590955,0.00059052143,0.000054708355,0.00015872715,0.017083913],"genre_scores_gemma":[0.82483596,0.00041897164,0.0005284664,0.000099300654,0.00016076224,0.0000028446107,0.0043604844,0.000059633607,0.1695336],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987624,0.00016108085,0.00015716322,0.0004255335,0.0002812101,0.00021257515],"domain_scores_gemma":[0.998999,0.000061819046,0.00028470438,0.00023042543,0.00013971116,0.0002843523],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000043111675,0.00027246837,0.00049564085,0.00047053368,0.00009213492,0.0000137404795,0.00015753138,0.00041044463,0.00024425334],"category_scores_gemma":[0.000016069527,0.00029518214,0.00020830357,0.0004747935,0.000029325483,0.0011591227,0.00003268701,0.0003436653,0.000016087573],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013701907,0.0007269717,0.2596759,0.0012268589,0.0018920489,0.0007762849,0.008684009,0.00006953007,0.0099927075,0.0001200506,0.7003492,0.0027845574],"study_design_scores_gemma":[0.013158422,0.0056775785,0.3816181,0.002812955,0.006451402,0.0000037617392,0.009105981,0.00004524657,0.54289085,0.0012100096,0.035320718,0.0017049797],"about_ca_topic_score_codex":0.0015328836,"about_ca_topic_score_gemma":0.00009187304,"teacher_disagreement_score":0.66502845,"about_ca_system_score_codex":0.0002470066,"about_ca_system_score_gemma":0.0010713439,"threshold_uncertainty_score":0.99995005},"labels":[],"label_agreement":null},{"id":"W2556811127","doi":"10.1182/blood.v110.11.3995.3995","title":"Venous Thromboembolism and Non-Small Cell Lung Cancer: A Pooled Analysis of National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Trials.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre; University Health Network; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Internal medicine; Lung cancer; Vinorelbine; Oncology; Erlotinib; Randomized controlled trial; Cancer; Bevacizumab; Clinical trial; Chemotherapy; Surgery; Cisplatin","score_opus":0.07261791559963969,"score_gpt":0.4240663307849462,"score_spread":0.3514484151853065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556811127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98707753,0.009445608,0.000038275186,0.00031556323,0.0009867304,0.0007155186,0.00043239605,0.000008859339,0.0009795295],"genre_scores_gemma":[0.9958675,0.0023476428,0.00017512712,0.0004778869,0.00078735116,0.00005700159,0.00007940689,0.000013375969,0.00019468725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738175,0.00023114245,0.0014779131,0.0002909407,0.00036457006,0.00025367984],"domain_scores_gemma":[0.99746615,0.0010876395,0.00081941346,0.00014474544,0.00024745558,0.00023458664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003925226,0.00017423634,0.0023045859,0.00026863228,0.000047642392,0.0000043540294,0.00008405587,0.00014485845,0.00036431671],"category_scores_gemma":[0.0005036001,0.00014176352,0.0003744853,0.00054948364,0.000100873105,0.00003431186,0.000028684655,0.00015952608,1.7495128e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053802026,0.008309499,0.8237123,0.0009524447,0.069994815,0.00021369201,0.001440576,0.00035911243,0.06271841,0.0001563101,0.013453532,0.013309125],"study_design_scores_gemma":[0.043469045,0.0009033372,0.8083257,0.00018620346,0.106850125,0.000008761952,0.000085426254,0.00048387598,0.034627307,0.000032738204,0.004691552,0.00033594537],"about_ca_topic_score_codex":0.28436103,"about_ca_topic_score_gemma":0.5459589,"teacher_disagreement_score":0.26159784,"about_ca_system_score_codex":0.0001796017,"about_ca_system_score_gemma":0.0034796712,"threshold_uncertainty_score":0.72040445},"labels":[],"label_agreement":null},{"id":"W2557455638","doi":"10.1016/j.ejca.2016.11.002","title":"Plasma vascular endothelial growth factor as a predictive biomarker: Door closed?","year":2016,"lang":"en","type":"letter","venue":"European Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Bevacizumab; Medicine; Metastatic breast cancer; Internal medicine; Oncology; Vascular endothelial growth factor; Paclitaxel; Breast cancer; Chemotherapy; Angiogenesis; Progression-free survival; Cancer; Surgery; VEGF receptors","score_opus":0.022528321830941903,"score_gpt":0.29928357593077204,"score_spread":0.27675525409983015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557455638","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050692108,0.015675662,0.00011170982,0.8531519,0.012591272,0.0011938515,0.0018311392,0.00010847363,0.06464389],"genre_scores_gemma":[0.097736664,0.02600041,0.00023517267,0.67353696,0.13288714,0.0000300198,0.00010809141,0.0007324165,0.06873312],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969779,0.0005835756,0.0007434974,0.0003678653,0.00082086783,0.0005062924],"domain_scores_gemma":[0.99777484,0.00021663301,0.0009205265,0.00026498645,0.0005564479,0.00026658142],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032165297,0.00049290527,0.0009063617,0.00037964268,0.000066791144,0.00003374856,0.00035161967,0.000206974,0.005805619],"category_scores_gemma":[0.000096476695,0.00031552973,0.0007954335,0.0001223033,0.00017748447,0.00012508634,0.00006467602,0.0015176734,0.00029674245],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002730078,0.000071142946,0.0009620814,0.00014736595,0.0042840126,0.013627808,0.00026041703,3.1841535e-7,0.004415933,0.0000015826313,0.9464643,0.02703498],"study_design_scores_gemma":[0.0099573415,0.0024986875,0.0036581142,0.000864436,0.0019357179,0.0007637817,0.0000070655033,0.0000012860413,0.0032212322,0.00001819198,0.9767809,0.00029325634],"about_ca_topic_score_codex":0.000032286687,"about_ca_topic_score_gemma":0.0000025842928,"teacher_disagreement_score":0.17961493,"about_ca_system_score_codex":0.00055869005,"about_ca_system_score_gemma":0.00078085094,"threshold_uncertainty_score":0.99992967},"labels":[],"label_agreement":null},{"id":"W2558801610","doi":"10.1093/jjco/hyw175","title":"Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma†","year":2016,"lang":"en","type":"article","venue":"Japanese Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada","keywords":"Eribulin; Medicine; Soft tissue sarcoma; Trabectedin; Soft tissue; Metastatic breast cancer; Oncology; Sarcoma; Internal medicine; Radiology; Cancer; Pathology; Breast cancer","score_opus":0.08470213998850884,"score_gpt":0.4914355898573078,"score_spread":0.40673344986879895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558801610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977992,0.000059146492,0.00001615544,0.00083926076,0.00019498452,0.0009862116,0.0000042680836,0.000007999521,0.00009276514],"genre_scores_gemma":[0.99852294,0.000067165376,0.00071298284,0.00024654483,0.00010403531,0.000024263094,0.0000025595984,0.000016380713,0.0003031527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99665254,0.0006142905,0.0019778747,0.00020703906,0.0002931392,0.00025514257],"domain_scores_gemma":[0.9955595,0.002339654,0.0012141141,0.00017930953,0.0004249769,0.00028246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010317599,0.00016892844,0.0016588545,0.00017950969,0.000018847593,0.000001884917,0.00013364274,0.00009284735,0.00057738356],"category_scores_gemma":[0.0009641051,0.00007625281,0.000120688135,0.0002655822,0.00016502493,0.00013546295,0.000027191109,0.00026848228,0.000009715096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1309387,0.0654576,0.56448644,0.000023723356,0.00062696397,0.0010695446,0.00095134455,0.000008892208,0.001377772,9.096643e-7,0.000103343766,0.23495476],"study_design_scores_gemma":[0.25312245,0.3349892,0.4075604,0.00012020498,0.000889963,0.0001367483,0.00041843232,0.0000059201084,0.00043573952,0.000013910541,0.0022065444,0.000100480254],"about_ca_topic_score_codex":0.000029830398,"about_ca_topic_score_gemma":0.00024795654,"teacher_disagreement_score":0.2695316,"about_ca_system_score_codex":0.00015189423,"about_ca_system_score_gemma":0.00046308548,"threshold_uncertainty_score":0.6321945},"labels":[],"label_agreement":null},{"id":"W2559295313","doi":"10.1182/blood.v106.11.5171.5171","title":"A Supervised Group Exercise Program for Patients with Multiple Myeloma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Physical therapy; Aerobic exercise; Depression (economics); Quality of life (healthcare); Anxiety","score_opus":0.011162306660536182,"score_gpt":0.27557070673184675,"score_spread":0.26440840007131056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559295313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662375,0.00026534774,0.00001085748,0.00025055624,0.000047613565,0.002286047,0.000025778329,0.00011141634,0.00037861368],"genre_scores_gemma":[0.98315483,0.000025084208,0.014756651,0.00019274927,0.00021925631,0.0010539552,0.00023792942,0.000023623112,0.0003359294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994203,0.0000055075675,0.00009971625,0.00017277188,0.000094819145,0.00020689542],"domain_scores_gemma":[0.9996646,0.000033501372,0.000026184336,0.000116322146,0.000060539995,0.000098860444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000022236754,0.00010725882,0.00017533536,0.000036729638,0.000043135886,0.000007094519,0.00003636482,0.000042928732,0.00010952155],"category_scores_gemma":[0.000006986049,0.0000776312,0.000056788947,0.00007281538,0.00002484871,0.000045114346,0.000009736807,0.000044274395,0.000017354641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030011851,0.019016897,0.7290415,0.00012377287,0.00028480554,0.0000114501945,0.00030605594,7.056673e-7,0.0006805188,0.0000155007,0.0017052244,0.24581236],"study_design_scores_gemma":[0.16385305,0.012286691,0.6775385,0.00016322262,0.0028794568,0.000013746211,0.000041032825,0.0003584245,0.010837781,0.000018016968,0.13162632,0.00038374064],"about_ca_topic_score_codex":0.000011575722,"about_ca_topic_score_gemma":0.000052714735,"teacher_disagreement_score":0.2454286,"about_ca_system_score_codex":0.000022018394,"about_ca_system_score_gemma":0.000027627459,"threshold_uncertainty_score":0.31657085},"labels":[],"label_agreement":null},{"id":"W2560635244","doi":"10.1093/annonc/mdw544","title":"3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2062,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Oncology; Metastatic breast cancer; Internal medicine; Cancer; Male breast cancer","score_opus":0.2306265813022292,"score_gpt":0.5370334859628867,"score_spread":0.30640690466065745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560635244","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38615918,0.001269282,0.00012667019,0.6005257,0.0021932835,0.00058954355,0.0007294832,0.000045066605,0.008361828],"genre_scores_gemma":[0.9652876,0.0034551779,0.002380011,0.016168797,0.0013902182,0.00028308528,0.00003949986,0.000027177543,0.010968384],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909484,0.000025608551,0.00035207078,0.00020458587,0.00009809203,0.00022478687],"domain_scores_gemma":[0.99810326,0.0003150466,0.00018424321,0.00011662088,0.0011880802,0.000092764625],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015083504,0.000114959046,0.00035998356,0.000090726375,0.000026895661,0.0000014486982,0.00008897664,0.000107306536,0.0012860763],"category_scores_gemma":[0.00015676826,0.000075804215,0.00013213973,0.00005371514,0.00015579791,0.000032532847,0.00002962347,0.00004375785,0.000016024745],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004780488,0.0004627411,0.007269146,0.00002771368,0.0004922017,0.000026459658,0.0000454639,0.000008086417,0.043121543,0.00044770484,0.47714254,0.4661759],"study_design_scores_gemma":[0.010007045,0.0022722604,0.009419343,0.00009414365,0.00014060551,0.00014541647,0.000036952963,0.00003552597,0.024102574,0.0006882215,0.9529472,0.00011072889],"about_ca_topic_score_codex":0.00010674719,"about_ca_topic_score_gemma":0.00015748735,"teacher_disagreement_score":0.58435684,"about_ca_system_score_codex":0.00008388021,"about_ca_system_score_gemma":0.00035613976,"threshold_uncertainty_score":0.9996269},"labels":[],"label_agreement":null},{"id":"W2561681743","doi":"10.1055/s-0036-1596315","title":"Anticancer natural products from traditionally used Canadian medicinal plants","year":2016,"lang":"en","type":"article","venue":"Planta Medica","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Moncton; University of New Brunswick","funders":"","keywords":"Medicinal plants; Traditional medicine; Bioassay; Natural product; Drug discovery; Biology; Population; Medicine; Pharmacology; Bioinformatics; Biochemistry","score_opus":0.02608279933613329,"score_gpt":0.2827766905959727,"score_spread":0.25669389125983944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561681743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9230691,0.0014961619,0.0000059406784,0.065459706,0.0023568256,0.00037767453,0.001275112,0.00007543873,0.0058840206],"genre_scores_gemma":[0.99131894,0.0005733298,0.00010311664,0.0034065656,0.002031628,0.000031456068,0.0007767702,0.000017780043,0.0017403848],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985649,0.000033578057,0.00020150107,0.00034465254,0.00044024579,0.00041510235],"domain_scores_gemma":[0.99899685,0.00020225869,0.000052215844,0.00018435436,0.000042609314,0.00052173063],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000107795815,0.00016864146,0.00030415197,0.0001371588,0.00007454066,0.000005678387,0.000117686046,0.00009296934,0.0049042637],"category_scores_gemma":[0.00008630241,0.00010138723,0.000042095195,0.00008733043,0.00016760666,0.000067912035,0.000010187833,0.00017865223,0.00025485028],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017466608,0.00032911086,0.05841229,0.000063066174,0.0010116366,0.0036858357,0.0012841873,3.5955033e-8,0.17401625,0.00022767737,0.7145993,0.044623945],"study_design_scores_gemma":[0.014547293,0.0006047768,0.39559653,0.0008457904,0.0006393789,0.0010301728,0.000099054334,0.000029587605,0.039307542,0.00034252982,0.54649943,0.00045792235],"about_ca_topic_score_codex":0.023864016,"about_ca_topic_score_gemma":0.03548454,"teacher_disagreement_score":0.33718425,"about_ca_system_score_codex":0.0002887777,"about_ca_system_score_gemma":0.0012773005,"threshold_uncertainty_score":0.9960054},"labels":[],"label_agreement":null},{"id":"W2563401770","doi":"10.1371/journal.pone.0167906","title":"Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer","year":2016,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"McGill University; Bayer Corporation","keywords":"Medicine; Vinorelbine; Sorafenib; Metastatic breast cancer; Internal medicine; Discontinuation; Neutropenia; Breast cancer; Oncology; Cohort; Surgery; Cancer; Gastroenterology; Chemotherapy; Hepatocellular carcinoma","score_opus":0.05820120234686946,"score_gpt":0.35043232440642885,"score_spread":0.29223112205955937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563401770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801233,0.00013298138,0.00007557788,0.017588645,0.000043234442,0.0017998294,0.00013969158,0.00001846896,0.000078290446],"genre_scores_gemma":[0.9962149,0.0004964509,0.00042976925,0.0002731732,0.00015620004,0.00059147057,0.000042154606,0.000022465465,0.0017733771],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992907,0.000016741018,0.00021666501,0.0001582629,0.00016857652,0.00014907886],"domain_scores_gemma":[0.999478,0.00011038487,0.000117073745,0.00010979508,0.00012916139,0.000055592784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008947521,0.00011089022,0.0003961966,0.00009931044,0.000025610632,0.0000017892999,0.000038176026,0.00003232259,0.0008328394],"category_scores_gemma":[0.000017908262,0.00006812027,0.00004377256,0.00013209699,0.00005267385,0.000053888685,0.000006781593,0.000040761468,0.0000033196568],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5483597,0.13251817,0.0033212479,0.0005524474,0.0022824265,0.000018520102,0.000615835,0.000002141913,0.26439193,0.00019505383,0.00070890377,0.047033638],"study_design_scores_gemma":[0.7627303,0.033259213,0.000737341,0.00053887995,0.0011304356,0.0000060134935,0.000009832172,0.00016673292,0.2005117,0.0003464447,0.0004380771,0.0001250116],"about_ca_topic_score_codex":0.00019807633,"about_ca_topic_score_gemma":0.0002842666,"teacher_disagreement_score":0.21437062,"about_ca_system_score_codex":0.00012483222,"about_ca_system_score_gemma":0.0001270894,"threshold_uncertainty_score":0.91190076},"labels":[],"label_agreement":null},{"id":"W2564540330","doi":"10.1182/blood.v116.21.5117.5117","title":"Chemotherapy, but Not Bevacizumab, Increases Tissue Factor Activity Levels In Endothelial Cells, Blood Monocytes, and Non-Small Cell Lung Cancer Cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Lung cancer; Medicine; Carboplatin; Gemcitabine; Bevacizumab; Chemotherapy; Angiogenesis; Tissue factor; Paclitaxel; Cisplatin; Cancer research; Cancer cell; Cancer; Oncology; Pharmacology; Immunology; Internal medicine; Coagulation","score_opus":0.017043797399942454,"score_gpt":0.2901981074395221,"score_spread":0.2731543100395797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564540330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996198,0.0008676153,0.0000048091765,0.00020748867,0.0004243322,0.00098967,0.00070048583,0.000057318597,0.00055026636],"genre_scores_gemma":[0.99500334,0.0011750213,0.00048632393,0.00035786032,0.00055270875,0.00013733131,0.000011541245,0.00005913721,0.0022167303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985708,0.000046868183,0.00024171887,0.00050770544,0.0001701126,0.00046277707],"domain_scores_gemma":[0.99911356,0.00016572705,0.00012323879,0.00029229652,0.000046653277,0.00025853456],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008586765,0.0003507005,0.0005318152,0.0001372564,0.00007297838,0.000029762989,0.00012812357,0.0002410811,0.0010996604],"category_scores_gemma":[0.0000079476085,0.00032059156,0.00008137061,0.00012397,0.00008597424,0.00008504982,0.00006467676,0.00047984874,0.000015351616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045690287,0.0029442718,0.040418018,0.00019580663,0.00020082053,0.00015298203,0.000483863,8.5400796e-7,0.9512412,0.000001431831,0.0001482239,0.003755622],"study_design_scores_gemma":[0.020702526,0.00038689276,0.06301988,0.00003864684,0.00068309193,0.000033370612,0.0000147553255,0.00003971836,0.9131353,0.0000041546136,0.0016630238,0.0002786489],"about_ca_topic_score_codex":0.008112271,"about_ca_topic_score_gemma":0.0027758377,"teacher_disagreement_score":0.038105913,"about_ca_system_score_codex":0.000055116554,"about_ca_system_score_gemma":0.00031105446,"threshold_uncertainty_score":0.9999246},"labels":[],"label_agreement":null},{"id":"W2564840758","doi":"10.1158/1538-7445.panca16-b83","title":"Abstract B83: Targeting TRPV6 oncochannel for the treatment of pancreatic cancer: A Phase I trial experience","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton; London Health Sciences Centre","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Phases of clinical research; Prostate cancer; Gastroenterology; Cancer; Adverse effect; Urology; Toxicity; Oncology","score_opus":0.25103753202063767,"score_gpt":0.5556311703651444,"score_spread":0.30459363834450676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564840758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97597253,0.014621167,0.00005424272,0.0050471397,0.0006298046,0.0031899074,0.00020197786,0.000021829277,0.00026140994],"genre_scores_gemma":[0.9632296,0.022742754,0.000033610042,0.000059550977,0.0018025038,0.007725565,0.000009111994,0.000029092811,0.004368227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829924,0.00006897876,0.0003206777,0.0003481552,0.00040169866,0.0005612475],"domain_scores_gemma":[0.99776685,0.0013710824,0.00010103484,0.00028913753,0.00030323202,0.00016867055],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038708965,0.00016450183,0.00040695324,0.000111211775,0.00019889754,0.000012675014,0.00016110372,0.00007028178,0.0021978808],"category_scores_gemma":[0.00010556112,0.00007964868,0.00018745089,0.00024431173,0.0003446315,0.00006252471,0.000020209343,0.00009641216,0.000011207072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16254261,0.0028882327,0.0011962851,0.00018900375,0.00080872414,0.000034208755,0.006330673,0.000007332329,0.49761605,0.00005854834,0.01491426,0.31341407],"study_design_scores_gemma":[0.23931468,0.014185225,0.0007489684,0.00041624942,0.00045949558,0.0000039938154,0.0011803346,0.000088486995,0.5080697,0.00011871605,0.23519862,0.00021553074],"about_ca_topic_score_codex":0.0030433647,"about_ca_topic_score_gemma":0.0002556813,"teacher_disagreement_score":0.31319854,"about_ca_system_score_codex":0.0009315705,"about_ca_system_score_gemma":0.0008138774,"threshold_uncertainty_score":0.99871427},"labels":[],"label_agreement":null},{"id":"W2566864507","doi":"10.1158/1538-7445.am2015-524","title":"Abstract 524: Assessing the interaction between acetylenic tricyclic bis-(cyano enone) and cysteine residues of actin to inhibit non-small cell lung cancer cell migration","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Actin; Cell migration; Actin cytoskeleton; Cell biology; Cytoskeleton; MDia1; Actin-binding protein; Lamellipodium; Actin remodeling; Chemistry; Cell; A549 cell; Stress fiber; Biology; Biochemistry","score_opus":0.14258017605746467,"score_gpt":0.4768796802546522,"score_spread":0.33429950419718757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566864507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828098,0.006047787,0.000018605455,0.006241284,0.00024887483,0.0011325254,0.000044138716,0.00002126616,0.003435745],"genre_scores_gemma":[0.9923681,0.0016761799,0.000058250185,0.00010245621,0.000748832,0.00033879056,0.00003569653,0.000030192767,0.004641506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814636,0.00019097471,0.00035088562,0.00038115124,0.0005024895,0.0004281446],"domain_scores_gemma":[0.99834466,0.0004492178,0.00018743779,0.0002731849,0.0004554468,0.00029005457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009357202,0.00018197745,0.00035776864,0.0002620471,0.00014773429,0.00006694975,0.00014433911,0.00012375174,0.00023288747],"category_scores_gemma":[0.00006744337,0.00013269995,0.000063769025,0.00054527936,0.000100819576,0.00022000507,0.00011117896,0.0005422069,0.000012614207],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008376237,0.0002754521,0.1862438,0.00062082335,0.0001292475,0.000019633653,0.004989683,0.00008483668,0.75510746,9.731715e-7,0.03860173,0.013088735],"study_design_scores_gemma":[0.0047723697,0.0010682282,0.102481216,0.0005300019,0.00036848488,0.000006901206,0.0029313865,0.00010947269,0.8587873,0.000008029417,0.028709188,0.00022742915],"about_ca_topic_score_codex":0.023540566,"about_ca_topic_score_gemma":0.0046844804,"teacher_disagreement_score":0.10367984,"about_ca_system_score_codex":0.0009608066,"about_ca_system_score_gemma":0.0009756207,"threshold_uncertainty_score":0.9829618},"labels":[],"label_agreement":null},{"id":"W2567998180","doi":"10.1016/j.clinph.2016.11.022","title":"Corrigendum to “Intracortical inhibition abnormality during the remission phase of multiple sclerosis is related to upper limb dexterity and lesions” [Clin. Neurophysiol. 127 (2016) 1503–1511]","year":2017,"lang":"en","type":"erratum","venue":"Clinical Neurophysiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Abnormality; Multiple sclerosis; Medicine; Neuroscience; Psychology; Psychiatry","score_opus":0.11365371532675116,"score_gpt":0.4046147410091311,"score_spread":0.2909610256823799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567998180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751122,0.0002600514,0.000005069104,0.00415876,0.018196722,0.0015410903,0.00032242315,0.00008369353,0.00031997816],"genre_scores_gemma":[0.94940597,0.007254092,0.000117953525,0.0075659044,0.0026194465,0.000115815536,0.00032043562,0.0001356101,0.032464754],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99472857,0.00085868826,0.0017880329,0.001569195,0.00033831358,0.00071723433],"domain_scores_gemma":[0.9957551,0.000733191,0.00073111086,0.0015478459,0.0003461343,0.0008866468],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00032359644,0.00065222534,0.0018746539,0.00018797607,0.00051570684,0.00003286826,0.0004243299,0.0010529533,0.0005207521],"category_scores_gemma":[0.002178105,0.00046557435,0.00067286106,0.00023133367,0.00091122015,0.00008672228,0.00086004246,0.0024353433,0.00020589668],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014458468,0.003088711,0.0019276973,0.0004552275,0.00028180509,0.0004325845,0.00015864993,0.0000037245054,0.5895878,0.000006666925,0.37752464,0.012074049],"study_design_scores_gemma":[0.0075069233,0.012578403,0.88825476,0.00093738956,0.0009528098,0.000109080655,0.000014484456,0.00032978723,0.005077942,0.00011282269,0.0835244,0.00060117495],"about_ca_topic_score_codex":0.0001199909,"about_ca_topic_score_gemma":0.000008246501,"teacher_disagreement_score":0.8863271,"about_ca_system_score_codex":0.00007545359,"about_ca_system_score_gemma":0.00032564902,"threshold_uncertainty_score":0.99986607},"labels":[],"label_agreement":null},{"id":"W2568608113","doi":"10.1016/j.jtho.2016.11.034","title":"ED06.03 Pain Management","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Referred pain; Cancer pain; Chronic pain; Palliative care; Nociceptor; Visceral pain; Hyperalgesia; Neuropathic pain; Disease; Cancer; Nociception; Anesthesia; Physical therapy; Internal medicine","score_opus":0.04628104484605768,"score_gpt":0.49795082124000295,"score_spread":0.4516697763939453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568608113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7066799,0.0016238893,0.00047296353,0.058926668,0.0045291865,0.00044824855,0.0000035175574,0.000022655495,0.22729301],"genre_scores_gemma":[0.9799075,0.00064629834,0.0048591522,0.002241983,0.0012356763,0.0000069739162,0.0000016024009,0.000013429279,0.011087387],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990808,0.00014736116,0.00032586313,0.00009996961,0.00015675563,0.00018928111],"domain_scores_gemma":[0.9987848,0.00009537426,0.0005940664,0.00025130544,0.000116716015,0.00015775736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011425042,0.000098024524,0.00041564647,0.00013639606,0.000140033,0.000018953928,0.0002119096,0.00009853244,0.0007012804],"category_scores_gemma":[0.00007878721,0.000073011826,0.0001664475,0.00003174858,0.00010133393,0.0000927654,0.00006401493,0.000258629,0.00006430879],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032543992,0.0010476444,0.012461612,0.00011368008,0.00076428085,0.0053779786,0.00017432969,0.0000029053808,0.001482454,0.00015022306,0.110105,0.8650655],"study_design_scores_gemma":[0.0028846313,0.005599323,0.068034336,0.00011790491,0.001195048,0.0016253573,0.00017597809,0.00003182805,0.0013756021,0.0008809909,0.9179787,0.00010028501],"about_ca_topic_score_codex":0.000008252238,"about_ca_topic_score_gemma":0.000013066278,"teacher_disagreement_score":0.8649652,"about_ca_system_score_codex":0.0002893415,"about_ca_system_score_gemma":0.0001587383,"threshold_uncertainty_score":0.7678529},"labels":[],"label_agreement":null},{"id":"W2569754140","doi":"10.1139/bcb-2016-0141","title":"Use of substitute Nonidet P-40 nonionic detergents in intracellular tubulin polymerization assays for screening of microtubule targeting agents","year":2017,"lang":"en","type":"article","venue":"Biochemistry and Cell Biology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Microtubule; Intracellular; Tubulin; Polymerization; Chemistry; Biophysics; Biochemistry; Cell biology; Biology; Organic chemistry; Polymer","score_opus":0.03911644318682717,"score_gpt":0.3098415614391623,"score_spread":0.27072511825233514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569754140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977378,0.0013433439,0.00031192397,0.00008036618,0.00011078507,0.0002255032,0.00006967378,0.000004531434,0.000116046314],"genre_scores_gemma":[0.9974243,0.0004478263,0.0013579237,0.00002766535,0.0000722914,0.00001746625,0.00033027824,0.000008023627,0.0003142009],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99931103,0.000018503692,0.0002651932,0.00020781274,0.00003173147,0.00016574227],"domain_scores_gemma":[0.99944425,0.000046848905,0.00025453247,0.000160318,0.000043670778,0.000050360628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010627525,0.000106843865,0.00025805258,0.0000350011,0.000068099806,0.000005620164,0.000072600975,0.00016283756,0.00005831107],"category_scores_gemma":[0.000057643094,0.00010172011,0.000057158697,0.000029147759,0.00014411735,0.000034287506,0.00004670036,0.00006379985,4.1742652e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005424897,0.00013435067,0.094622284,0.00021697361,0.00004323453,0.000004455938,0.000036246387,0.0000035680403,0.90263903,0.0000036025529,0.000060803188,0.0016929449],"study_design_scores_gemma":[0.002306417,0.00018730845,0.006700024,0.00005757161,0.00007791254,0.0000038673643,0.00001498006,0.00043032595,0.98860276,0.000006180487,0.0015340075,0.0000786492],"about_ca_topic_score_codex":0.00015083911,"about_ca_topic_score_gemma":0.0000058490473,"teacher_disagreement_score":0.08792226,"about_ca_system_score_codex":0.00001615666,"about_ca_system_score_gemma":0.000047959613,"threshold_uncertainty_score":0.41480258},"labels":[],"label_agreement":null},{"id":"W2577893310","doi":"10.71781/11913","title":"Développement de méthodes de synthèse pour les acides aminés indolizidin-9-ones substitués et utilisation des acides aminés azabicycloalcanes en tant que mimes peptidiques","year":2004,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; Centre National de la Recherche Scientifique; Fonds Québécois de la Recherche sur la Nature et les Technologies","keywords":"Chemistry; Medicinal chemistry","score_opus":0.09524947472592898,"score_gpt":0.43153302901486695,"score_spread":0.33628355428893797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577893310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97484976,0.013698684,0.00064352964,0.0025689644,0.0009439983,0.0026596729,0.00030767013,0.000033162873,0.00429455],"genre_scores_gemma":[0.9069745,0.017268317,0.05671439,0.00020543556,0.0009417775,0.00082602614,0.0027579584,0.00017450591,0.014137087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940648,0.001408656,0.0012693664,0.0012805108,0.00054764264,0.0014290021],"domain_scores_gemma":[0.99627143,0.0013562194,0.0008134947,0.0005123618,0.00046252512,0.0005839572],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0020234264,0.0012829885,0.0015361389,0.0005416292,0.0006751257,0.00048165015,0.00087451097,0.0010469289,0.006178309],"category_scores_gemma":[0.00080559775,0.0012476328,0.00040519313,0.0004353539,0.0005502629,0.000776779,0.00021834655,0.00080392224,0.000337269],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003886317,0.0026509024,0.22572875,0.0018483105,0.0024820354,0.0010582394,0.0794816,0.00049667124,0.39686617,0.0014769975,0.001020684,0.2830033],"study_design_scores_gemma":[0.0044586374,0.00092043437,0.18884781,0.0052388147,0.003075671,0.0003423641,0.033076163,0.0001521712,0.7526752,0.0025703886,0.0073973415,0.0012450013],"about_ca_topic_score_codex":0.016826734,"about_ca_topic_score_gemma":0.053173985,"teacher_disagreement_score":0.355809,"about_ca_system_score_codex":0.0035125865,"about_ca_system_score_gemma":0.005444656,"threshold_uncertainty_score":0.9999922},"labels":[],"label_agreement":null},{"id":"W2580256571","doi":"10.18203/2320-6012.ijrms20170141","title":"Preserving of intercostobrachial nerve relieves breast carcinoma patients from postmastectomy pain syndrome","year":2017,"lang":"en","type":"article","venue":"International Journal of Research in Medical Sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Surgery; Mastectomy; Complication; Etiology; Nerve injury; Cancer; Internal medicine","score_opus":0.098177984357611,"score_gpt":0.47246108316360125,"score_spread":0.37428309880599026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580256571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788808,0.00027980495,0.000007976222,0.018590838,0.0008898882,0.00011753427,0.000020857427,0.0000022598142,0.0012100472],"genre_scores_gemma":[0.99902916,0.000103177146,0.00025409396,0.00010595359,0.0004356027,0.0000037380908,0.00000473252,0.000004482466,0.000059065642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99557275,0.0003761773,0.0004927714,0.00017379565,0.0031315691,0.00025294547],"domain_scores_gemma":[0.99773127,0.0008987022,0.00032088876,0.00013587007,0.0006369835,0.00027625845],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0049962597,0.00007790908,0.00026051112,0.00048414688,0.0001213239,0.00007569284,0.0015180245,0.00007803061,0.0012338053],"category_scores_gemma":[0.0025752725,0.000053099637,0.0000971142,0.00014637335,0.0010445343,0.00036251982,0.0003732336,0.00059007696,0.0000045048646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007674516,0.00056999706,0.9682562,0.000016511856,0.000088117755,0.002030515,0.00018418695,0.0000015742945,0.0003642965,0.000050065566,0.00094017695,0.02673095],"study_design_scores_gemma":[0.0038518955,0.0018643711,0.9898243,0.001104299,0.000012433313,0.00055313326,0.00014734386,0.0004257868,0.00041632235,0.0013678216,0.00038193198,0.000050384006],"about_ca_topic_score_codex":0.0029799526,"about_ca_topic_score_gemma":0.0002767375,"teacher_disagreement_score":0.026680566,"about_ca_system_score_codex":0.00017289333,"about_ca_system_score_gemma":0.0007002318,"threshold_uncertainty_score":0.9996792},"labels":[],"label_agreement":null},{"id":"W2581196465","doi":"","title":"Non-pegylated liposomal doxorubicin use in the treatment of bilateral breast cancer","year":2010,"lang":"en","type":"article","venue":"Oncology in Clinical Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cardiotoxicity; Metastatic breast cancer; Breast cancer; Cancer; Adverse effect; Doxorubicin; Regimen; Oncology; Internal medicine; Disease; Chemotherapy; Intensive care medicine","score_opus":0.09959809583881518,"score_gpt":0.5210946399816377,"score_spread":0.42149654414282256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581196465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633765,0.000112133486,3.3726386e-7,0.029761093,0.0016294104,0.0007515521,0.000022589818,0.000012081358,0.004334307],"genre_scores_gemma":[0.99276435,0.001893578,0.00047447847,0.0033977514,0.0006436647,0.00014593382,0.000016381251,0.000015102183,0.0006487799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783266,0.00047681504,0.00091246667,0.00033488913,0.00014768956,0.00029545845],"domain_scores_gemma":[0.99262965,0.006461586,0.0003546407,0.00033079123,0.00012250879,0.00010082464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010292861,0.00017156181,0.00062422204,0.00011194753,0.000030480634,0.000007379758,0.00012514737,0.00042086383,0.0007794417],"category_scores_gemma":[0.00046386282,0.000106496205,0.00014924962,0.00031650174,0.0002768158,0.00019210478,0.000021773323,0.0009162389,0.000036701906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011525375,0.020396704,0.9263642,0.000015352898,0.00029044203,0.0012392523,0.0013572575,0.000009945825,0.00589414,0.00006162013,0.0022487037,0.030597052],"study_design_scores_gemma":[0.012029061,0.005828766,0.8248312,0.000022847848,0.0005735496,0.00046316942,0.00014295054,0.00013293453,0.00026741793,0.000028736278,0.15558295,0.00009645629],"about_ca_topic_score_codex":0.0064252187,"about_ca_topic_score_gemma":0.012810395,"teacher_disagreement_score":0.15333425,"about_ca_system_score_codex":0.00022380131,"about_ca_system_score_gemma":0.0005469012,"threshold_uncertainty_score":0.9713052},"labels":[],"label_agreement":null},{"id":"W2581392984","doi":"10.1111/jpi.12393","title":"Melatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin‐evoked peripheral neuropathy","year":2017,"lang":"en","type":"article","venue":"Journal of Pineal Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Medical Association; University of Alberta","funders":"University of Manchester","keywords":"Oxaliplatin; Melatonin; Neuroprotection; Neurotoxicity; Peripheral neuropathy; Pharmacology; Oxidative stress; Medicine; Autophagy; Endocrinology; Internal medicine; Apoptosis; Chemistry; Colorectal cancer; Cancer; Toxicity; Biochemistry","score_opus":0.058519359179111004,"score_gpt":0.4010384903521212,"score_spread":0.3425191311730102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581392984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964898,0.00036396744,0.000025916888,0.0013404182,0.0008346576,0.00044827542,0.0000029750754,0.000010771814,0.00048320123],"genre_scores_gemma":[0.9951078,0.00022502434,0.00014606299,0.000018119279,0.0014915417,0.0000140152215,0.0000020425296,0.000022750544,0.0029726175],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99828804,0.00024651567,0.00033611173,0.00021164028,0.0006063223,0.0003113813],"domain_scores_gemma":[0.99892956,0.00006657192,0.00029505746,0.00019215334,0.00029259385,0.00022408422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062871975,0.0001227759,0.00027644337,0.00021233106,0.0006178664,0.00013286198,0.00012799246,0.000095807176,0.00016639703],"category_scores_gemma":[0.0005827932,0.00009891726,0.000080294536,0.00009629555,0.000131714,0.00033407332,0.000097659504,0.00096886617,0.00000326593],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031021058,0.0002574909,0.009496224,0.000091487935,0.00010043357,0.00033729186,0.0003322816,0.0000047022486,0.97628355,0.0000039982847,0.0012446835,0.008745771],"study_design_scores_gemma":[0.021080706,0.010819771,0.5331736,0.00042566453,0.00021547054,0.0026381812,0.00010675453,0.0013514024,0.42613032,0.00020414196,0.0036224131,0.00023157171],"about_ca_topic_score_codex":0.00017425766,"about_ca_topic_score_gemma":0.000010477611,"teacher_disagreement_score":0.5501532,"about_ca_system_score_codex":0.00019700696,"about_ca_system_score_gemma":0.00018265272,"threshold_uncertainty_score":0.47521913},"labels":[],"label_agreement":null},{"id":"W2581498950","doi":"10.2147/bctt.s124646","title":"Docetaxel-associated myalgia&amp;ndash;arthralgia syndrome in patients with breast cancer","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Targets and Therapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Sault Area Hospital","funders":"","keywords":"Docetaxel; Medicine; myalgia; Internal medicine; Breast cancer; Adverse effect; Cancer; Oncology","score_opus":0.013863670213873771,"score_gpt":0.2923748236786982,"score_spread":0.27851115346482447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581498950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867934,0.0052135056,8.40896e-7,0.005708064,0.0003879917,0.0006898711,0.00082259806,0.00004759785,0.0003361421],"genre_scores_gemma":[0.99159545,0.0056708544,0.000018823917,0.0007374251,0.00015612479,0.00022133929,0.0000852194,0.000053161668,0.0014615875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984519,0.000039389713,0.0002396932,0.00047250828,0.00027575425,0.00052078173],"domain_scores_gemma":[0.998961,0.000016546159,0.0002463652,0.0003579396,0.0001848579,0.00023332308],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000932049,0.00034748728,0.0005808092,0.000104253435,0.00031918526,0.00007325271,0.00014981469,0.00013395514,0.0023076807],"category_scores_gemma":[0.0000026388454,0.00024459886,0.00007863163,0.000112984984,0.00019873967,0.00023948101,0.00004046406,0.00023859259,0.000010530751],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003757053,0.0008333865,0.9396378,0.00003797939,0.00057629094,0.000051390492,0.00027414525,0.0000033034983,0.000125446,0.000012147455,0.00094491814,0.053746164],"study_design_scores_gemma":[0.02080845,0.00035564243,0.9725803,0.00027069848,0.00011674344,0.000085998014,0.0000071654476,0.00000874822,0.00003188221,0.00003654586,0.0053989775,0.00029883452],"about_ca_topic_score_codex":0.0061236806,"about_ca_topic_score_gemma":0.0018508208,"teacher_disagreement_score":0.05344733,"about_ca_system_score_codex":0.00024363483,"about_ca_system_score_gemma":0.00022190851,"threshold_uncertainty_score":0.99860436},"labels":[],"label_agreement":null},{"id":"W2583561389","doi":"10.1016/s0167-8140(15)41173-9","title":"EP-1181: SBRT in oligometastatic/oligorecurrent NSCLC cancer patients: a new therapeutic approach","year":2015,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Oncology; Internal medicine","score_opus":0.06233108121761415,"score_gpt":0.38355184787345803,"score_spread":0.32122076665584387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583561389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9224354,0.05961781,0.00079670973,0.0062763607,0.0013468417,0.001582677,0.000024912193,0.0000721867,0.0078471],"genre_scores_gemma":[0.96020377,0.017274257,0.0046546976,0.012201573,0.0012141358,0.00045292024,0.000101711514,0.00007872946,0.0038182149],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987603,0.00014113369,0.00027988583,0.0003241653,0.00014347519,0.00035105567],"domain_scores_gemma":[0.9993216,0.00008538225,0.0000891613,0.00012787062,0.00005423874,0.00032178868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017291587,0.0002090016,0.00056521286,0.00019116534,0.000030976767,0.000010015411,0.00007135577,0.00014792045,0.0003374935],"category_scores_gemma":[0.000009947231,0.00016454405,0.00006305364,0.00025255492,0.0001122974,0.000064260224,0.000015427182,0.00021738863,0.000007962047],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005414202,0.004923511,0.23837209,0.000090543545,0.00073493086,0.00005875935,0.011816228,0.000050846105,0.00079241174,0.00066764985,0.029396303,0.70768255],"study_design_scores_gemma":[0.056414228,0.010339893,0.08091158,0.000065922664,0.00043559613,0.00012273039,0.00044272898,0.0014230183,0.0002908609,0.0007556497,0.8483339,0.0004639194],"about_ca_topic_score_codex":0.00060411607,"about_ca_topic_score_gemma":0.00033691066,"teacher_disagreement_score":0.8189376,"about_ca_system_score_codex":0.0012007487,"about_ca_system_score_gemma":0.0006921702,"threshold_uncertainty_score":0.6709912},"labels":[],"label_agreement":null},{"id":"W2585196464","doi":"10.1016/j.jchromb.2016.12.015","title":"Simultaneous quantification of reparixin and paclitaxel in plasma and urine using ultra performance liquid chromatography-tandem mass spectroscopy (UHPLC–MS/MS): Application to a preclinical pharmacokinetic study in rats","year":2017,"lang":"en","type":"article","venue":"Journal of Chromatography B","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Chemistry; Chromatography; Protein precipitation; Tandem mass spectrometry; Formic acid; Electrospray ionization; Selected reaction monitoring; Mass spectrometry; Sample preparation; Pharmacokinetics; Atmospheric-pressure chemical ionization; Electrospray; Liquid chromatography–mass spectrometry; High-performance liquid chromatography; Chemical ionization; Ionization; Ion; Pharmacology","score_opus":0.03125546455160806,"score_gpt":0.37509444058503233,"score_spread":0.3438389760334243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585196464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975047,0.00076728,0.00010357739,0.00028402446,0.000120170575,0.0010855611,0.0000061072997,0.000010595499,0.00011797944],"genre_scores_gemma":[0.99702966,0.0015445788,0.0012193504,0.00003306683,0.00011871485,0.000027865026,0.0000025291886,0.000020606498,0.0000036374554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803126,0.000105866544,0.0010022493,0.000318978,0.000292217,0.00024940315],"domain_scores_gemma":[0.9983103,0.0002035688,0.00085073675,0.00031085152,0.00013176574,0.00019273307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007001013,0.00021856396,0.00072847115,0.00074782636,0.00009749866,0.000036575766,0.0001614604,0.00009925148,0.000013073054],"category_scores_gemma":[0.00007675526,0.00019348078,0.000116975134,0.00040341273,0.00018505836,0.00020041356,0.000030507033,0.0003019886,4.545398e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029802278,0.0010050592,0.6000854,0.00013933347,0.00014556239,0.000075416,0.00055156986,0.00014851672,0.39410487,0.0000029470998,0.000017865037,0.00074325135],"study_design_scores_gemma":[0.010609297,0.0064410246,0.8836413,0.0005089302,0.00044690561,0.00036707995,0.00021025316,0.006082229,0.09134623,0.000039982184,0.00009422804,0.00021256508],"about_ca_topic_score_codex":0.00015069335,"about_ca_topic_score_gemma":0.00016369938,"teacher_disagreement_score":0.30275863,"about_ca_system_score_codex":0.000060832597,"about_ca_system_score_gemma":0.000092911716,"threshold_uncertainty_score":0.7889917},"labels":[],"label_agreement":null},{"id":"W2586820597","doi":"10.1007/s11240-017-1175-x","title":"Erratum to: Taxol from Corylus avellana: paving the way for a new source of this anti-cancer drug","year":2017,"lang":"en","type":"erratum","venue":"Plant Cell Tissue and Organ Culture (PCTOC)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Drug; Biology; Pharmacology","score_opus":0.02112164512727339,"score_gpt":0.29121745295243834,"score_spread":0.27009580782516496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586820597","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06633589,0.45920637,0.00059144816,0.042834617,0.120560855,0.028771408,0.030267624,0.0007352676,0.25069654],"genre_scores_gemma":[0.009246365,0.011218503,0.00021436004,0.001171348,0.00765972,0.00012007503,0.0030180924,0.0001008868,0.96725065],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998113,0.000047186946,0.00038935486,0.000670179,0.0003048104,0.00047547574],"domain_scores_gemma":[0.99834824,0.00015065966,0.0004958768,0.0005509278,0.00012521907,0.00032907698],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000109079956,0.0005768952,0.0011630356,0.0000798663,0.00037612845,0.000080230566,0.00040461664,0.0005696495,0.001362831],"category_scores_gemma":[0.000042148677,0.00036018176,0.00017756948,0.000094097915,0.000112760215,0.00004725423,0.00014276632,0.0007996845,0.00004896699],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034244504,0.00010469569,0.00047106814,0.00049360783,0.00048937387,0.0000522697,0.006508799,8.266961e-7,0.032255378,0.0000035779979,0.9566082,0.0026698008],"study_design_scores_gemma":[0.0024176205,0.00033302,0.0004153005,0.0006631217,0.0017975611,0.000029189881,0.00027498047,0.000014249304,0.041552328,0.000030767802,0.9520732,0.0003986319],"about_ca_topic_score_codex":0.006117154,"about_ca_topic_score_gemma":0.0024650434,"teacher_disagreement_score":0.7165541,"about_ca_system_score_codex":0.000081955215,"about_ca_system_score_gemma":0.00040491385,"threshold_uncertainty_score":0.999885},"labels":[],"label_agreement":null},{"id":"W2586986791","doi":"10.1200/jco.2012.30.30_suppl.87","title":"Biopsy-driven study to identify biomarkers of drug resistance in patients with triple-negative breast cancer.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec - Clinical Research Organization in Cancer; Hôtel-Dieu de Montréal; Hôpital du Saint-Sacrement; Hôpital du Sacré-Cœur de Montréal; Royal Victoria Hospital; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Breast cancer; Triple-negative breast cancer; Chemotherapy; Drug resistance; Liquid biopsy; Oncology; Paclitaxel; Biopsy; Internal medicine; Cancer; Cancer research; Pathology; Biology","score_opus":0.07309021360902741,"score_gpt":0.4978080930385941,"score_spread":0.4247178794295667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586986791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933346,0.00021182283,0.000004396119,0.0037768444,0.0014131322,0.0006993332,0.000025163175,0.0000036481565,0.00053106237],"genre_scores_gemma":[0.9975222,0.00007271148,0.0011533371,0.000478282,0.00046593643,0.000014612316,0.0000016337889,0.000014339457,0.00027695973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969214,0.000571645,0.0017021251,0.00016576661,0.00036335975,0.00027569663],"domain_scores_gemma":[0.9964769,0.0010217818,0.0014495305,0.00013858601,0.0005017831,0.00041145278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017309608,0.00014331413,0.0013763041,0.00024410311,0.00002232665,0.0000027633953,0.00014259256,0.00010893002,0.00023354404],"category_scores_gemma":[0.0003974481,0.000094865296,0.00018851708,0.00040812005,0.00016251783,0.00014513695,0.000043697193,0.00045532998,0.0000060931898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0455118,0.0147400005,0.9267166,0.000021877351,0.0010194341,0.00009247838,0.0014845029,0.0000027461538,0.00004979737,0.0000042762654,0.005150011,0.0052064685],"study_design_scores_gemma":[0.030272013,0.008404465,0.95860106,0.0001405376,0.0006450495,0.000016030363,0.00049869245,7.0903775e-7,0.000038421145,0.000013547966,0.0012867863,0.00008270811],"about_ca_topic_score_codex":0.00022524878,"about_ca_topic_score_gemma":0.001375829,"teacher_disagreement_score":0.03188443,"about_ca_system_score_codex":0.0003782778,"about_ca_system_score_gemma":0.00079338346,"threshold_uncertainty_score":0.38684946},"labels":[],"label_agreement":null},{"id":"W2588199706","doi":"10.1093/annonc/mdw390.28","title":"A multi-centre study to investigate the natural history of taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast or prostate cancer","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Taxane; Discontinuation; Prostate cancer; Breast cancer; myalgia; Chemotherapy; Internal medicine; Brief Pain Inventory; Cancer; Oncology; Physical therapy; Chronic pain","score_opus":0.059749570670552574,"score_gpt":0.37985821728456703,"score_spread":0.32010864661401445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588199706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97297496,0.00030424967,0.000005853352,0.023375282,0.00042214955,0.0027256326,0.00016109066,0.000014582149,0.000016210184],"genre_scores_gemma":[0.9902158,0.00012305648,0.00029878365,0.005958105,0.000042539898,0.00036137825,0.000013999286,0.000027160211,0.0029591934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847513,0.00029785105,0.00043788322,0.00028962607,0.00014922608,0.00035028468],"domain_scores_gemma":[0.9985505,0.00046592765,0.00035504482,0.00020728767,0.00030552133,0.00011574212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061653403,0.00018705653,0.000611958,0.00015963208,0.000022570384,0.0000014099807,0.00014588611,0.00007478992,0.00022167755],"category_scores_gemma":[0.00016479025,0.000102436155,0.000096804244,0.00016341486,0.00017397534,0.000046974583,0.000030474443,0.00010715301,0.0000025379018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029381061,0.010588875,0.5332202,0.00021523495,0.0010983751,0.00012701,0.009196457,0.0000131259,0.021768823,0.0000017130182,0.042780478,0.3516087],"study_design_scores_gemma":[0.07394155,0.033651054,0.83813155,0.00065150164,0.00044715984,0.00002839984,0.0005673863,0.0001515376,0.0054333066,0.000010246009,0.04660772,0.0003786145],"about_ca_topic_score_codex":0.0006022973,"about_ca_topic_score_gemma":0.0021030088,"teacher_disagreement_score":0.35123006,"about_ca_system_score_codex":0.0005463707,"about_ca_system_score_gemma":0.00088514,"threshold_uncertainty_score":0.41772252},"labels":[],"label_agreement":null},{"id":"W2588218255","doi":"10.1093/neuonc/now212.478","title":"MPTH-41. MGMT STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 0424: A PHASE II TRIAL OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY FOR HIGH RISK LOW-GRADE GLIOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Princess Margaret Cancer Centre; University Health Network; London Health Sciences Centre; Western University","funders":"","keywords":"Temozolomide; Oncology; Glioma; Internal medicine; Medicine; Chemoradiotherapy; Hazard ratio; Methyltransferase; Methylation; Proportional hazards model; Biomarker; Radiation therapy; Oligodendroglioma; O-6-methylguanine-DNA methyltransferase; Astrocytoma; Cancer research; Biology; Confidence interval; Gene","score_opus":0.03660164644227795,"score_gpt":0.3806421536693743,"score_spread":0.34404050722709634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588218255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777722,0.00025162275,0.00018396054,0.012252733,0.004189058,0.004071914,0.0006884437,0.00013560391,0.00045450736],"genre_scores_gemma":[0.9937429,0.00083034614,0.00083611463,0.0020390889,0.0010186087,0.0010715828,0.00010603516,0.000100096055,0.00025523684],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958192,0.0007663528,0.0011885252,0.0008552341,0.0003503921,0.0010202589],"domain_scores_gemma":[0.9935759,0.004490469,0.0007818952,0.00056698424,0.00017806991,0.0004067111],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007783374,0.0005164794,0.002313638,0.0005679969,0.00012315939,0.000006516964,0.00027366562,0.00064973335,0.00048535675],"category_scores_gemma":[0.0007844863,0.00037145033,0.0004203154,0.00040896607,0.0005166736,0.000099949735,0.00007351342,0.00044636757,0.000014983887],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33848214,0.0244433,0.05194776,0.00013189783,0.0006798568,0.00065929815,0.0006070897,0.000013243246,0.46957853,0.00011680046,0.007657505,0.10568258],"study_design_scores_gemma":[0.6432549,0.10155179,0.0063088094,0.000044441822,0.0007697686,0.000040213203,0.000044214477,0.00011771027,0.10211789,0.00027759175,0.14512624,0.00034647167],"about_ca_topic_score_codex":0.00050055777,"about_ca_topic_score_gemma":0.0008803997,"teacher_disagreement_score":0.36746064,"about_ca_system_score_codex":0.0013330196,"about_ca_system_score_gemma":0.0021734575,"threshold_uncertainty_score":0.99987376},"labels":[],"label_agreement":null},{"id":"W258852898","doi":"","title":"[New regimens for the treatment of gynecologic cancers].","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carboplatin; Medicine; Regimen; Oncology; Internal medicine; Paclitaxel; Gynecologic oncology; Cisplatin; Chemotherapy; Ovarian cancer; Clinical trial; Cyclophosphamide; Cervical cancer; Cancer","score_opus":0.04817056156020977,"score_gpt":0.3049125849131081,"score_spread":0.2567420233528983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W258852898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9176799,0.015932454,0.00003996932,0.017065281,0.0009398097,0.008491575,0.00007805884,0.000089512694,0.039683435],"genre_scores_gemma":[0.8778948,0.0039345794,0.00017639446,0.00058686815,0.0004712207,0.0054471763,0.000016410793,0.000011821613,0.11146073],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995076,0.000009346353,0.0001044373,0.000115859686,0.00005418467,0.00020857994],"domain_scores_gemma":[0.9995395,0.00019033735,0.000032899887,0.00013957165,0.000017332812,0.000080339385],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00004219019,0.000078851444,0.00017871779,0.000019765346,0.000043188833,0.0000024602946,0.000039135975,0.000034815395,0.0016232579],"category_scores_gemma":[0.000005970615,0.000043789645,0.000106683314,0.00006951379,0.00003871592,0.000011822153,0.0000019234317,0.000019543544,0.000008428923],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093821716,0.00023167803,0.0022070948,0.000009126168,0.000328974,0.000004542654,0.00024439936,0.000017578663,0.000027678012,0.00003781703,0.0353421,0.9606108],"study_design_scores_gemma":[0.0057732193,0.0010929038,0.14536017,0.0000017918206,0.0006353156,0.000007421274,0.000021751746,0.000022536262,0.0035830685,0.000097444135,0.8433539,0.000050456845],"about_ca_topic_score_codex":0.00050882524,"about_ca_topic_score_gemma":0.00019797322,"teacher_disagreement_score":0.9605603,"about_ca_system_score_codex":0.00028732704,"about_ca_system_score_gemma":0.00009038402,"threshold_uncertainty_score":0.9992894},"labels":[],"label_agreement":null},{"id":"W2588844395","doi":"10.1158/1538-7445.sabcs16-pd4-04","title":"Abstract PD4-04: Effectiveness of myofascial techniques in addition to a standard physical therapy program as postoperative intervention for upper limb pain in breast cancer patients: A randomized controlled trial","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Randomized controlled trial; Breast cancer; Physical therapy; Blinding; Visual analogue scale; Placebo; Surgery; Cancer; Internal medicine","score_opus":0.03877268631580662,"score_gpt":0.492489072785143,"score_spread":0.4537163864693364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588844395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9661467,0.00016312432,0.000015194113,0.0016080863,0.00019053879,0.031411737,0.0002706173,0.00001703658,0.00017698103],"genre_scores_gemma":[0.92249525,0.00032286,0.000026011252,0.000052489475,0.0003067645,0.076652914,0.00006233559,0.000022312797,0.000059059428],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99741477,0.0010638568,0.0004082445,0.00034302793,0.0004176763,0.0003524056],"domain_scores_gemma":[0.9976437,0.0011404377,0.0001657428,0.00017818005,0.00078032375,0.00009159806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004220586,0.00017348256,0.0012668415,0.0003793264,0.000111554196,0.00004893006,0.00014129143,0.000105293046,0.0002666775],"category_scores_gemma":[0.0007250017,0.00012153859,0.00038150017,0.0001717508,0.00024080367,0.00013946155,0.00003920933,0.00030209956,0.0000013343154],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83393586,0.0029430643,0.002049435,0.00013269902,0.00024422325,0.000005249588,0.00055539893,0.000001972681,0.011227142,0.000026825439,0.00033540663,0.1485427],"study_design_scores_gemma":[0.9259991,0.012415989,0.023505522,0.0014703932,0.000052344054,2.871836e-7,0.00005222062,0.000055235974,0.035647936,0.0002470537,0.00043908216,0.00011485912],"about_ca_topic_score_codex":0.0042865146,"about_ca_topic_score_gemma":0.00089457387,"teacher_disagreement_score":0.14842784,"about_ca_system_score_codex":0.00090869894,"about_ca_system_score_gemma":0.0005534476,"threshold_uncertainty_score":0.6479956},"labels":[],"label_agreement":null},{"id":"W2589081531","doi":"","title":"In vitro combination studies of Troxacitabine (Troxatyl™, SGX-145) against human tumor cell lines.","year":2006,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clonogenic assay; Doxorubicin; Antagonism; Paclitaxel; Pharmacology; Cancer; Combination therapy; Medicine; Breast cancer; Cancer cell; Bone cancer; Cancer research; Bone metastasis; Metastasis; Chemotherapy; In vitro; Chemistry; Internal medicine; Receptor; Biochemistry","score_opus":0.02556507897193268,"score_gpt":0.34218975713007155,"score_spread":0.3166246781581389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589081531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788417,0.0013094486,0.000006461772,0.0012843463,0.00016750254,0.00037321475,0.000007260516,0.00003441882,0.017975612],"genre_scores_gemma":[0.989194,0.00009677357,0.00020129024,0.0005650595,0.00017259027,0.00004214407,0.00009572699,0.000013554376,0.009618888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991404,0.00002881057,0.00034836063,0.00017142997,0.00013166254,0.00017932674],"domain_scores_gemma":[0.99956715,0.000074037496,0.00010051791,0.00011311972,0.00011174789,0.000033429493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098816265,0.000134085,0.00039637435,0.00018498924,0.000032899,0.0000027721564,0.00004163908,0.00003687365,0.00016347854],"category_scores_gemma":[0.000011692076,0.000108846034,0.000073382274,0.00019780497,0.00008073645,0.000059375456,0.000022622007,0.000090962494,0.00001281502],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039230776,0.002146886,0.013547717,0.00016724713,0.000067443594,0.00007888667,0.00018674563,0.00001770785,0.9706151,0.000558682,0.01184788,0.00037339467],"study_design_scores_gemma":[0.0139880255,0.0007256719,0.018234478,0.000035695644,0.00013108781,0.000004287253,0.00023603153,0.00016944385,0.9623417,0.0005504852,0.003436907,0.0001461413],"about_ca_topic_score_codex":0.0003594804,"about_ca_topic_score_gemma":0.00019033189,"teacher_disagreement_score":0.013595718,"about_ca_system_score_codex":0.00014732179,"about_ca_system_score_gemma":0.000034041324,"threshold_uncertainty_score":0.44386125},"labels":[],"label_agreement":null},{"id":"W2589189560","doi":"10.1200/jco.2013.31.15_suppl.e14715","title":"Efficacy and safety of single agent (SA) or combination (CO) adjuvant chemotherapy (AC) in elderly patients with colon cancer: A Canadian Cancer Institute experience.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Discontinuation; Cancer; Internal medicine; Colorectal cancer; Toxicity; Surgery","score_opus":0.10120572763960713,"score_gpt":0.457852425946238,"score_spread":0.35664669830663087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589189560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99040574,0.0004534828,0.0000042903894,0.007207122,0.0008473449,0.000686689,0.000010040472,0.0000030530375,0.00038222593],"genre_scores_gemma":[0.9947853,0.0025374615,0.00023885777,0.0020240687,0.00019440302,0.000042632804,0.0000059190124,0.000011493808,0.00015986567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814004,0.00012825927,0.0011452698,0.00016069398,0.00019879035,0.00022696727],"domain_scores_gemma":[0.997941,0.00033863974,0.00088410074,0.00008271231,0.00035754035,0.00039600048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033461076,0.00012773805,0.000975242,0.00016612353,0.00003535538,0.0000056852514,0.000085113745,0.00020462296,0.0007802225],"category_scores_gemma":[0.00017446373,0.00008165544,0.00007586213,0.0001643139,0.0002866199,0.00015676173,0.000010560095,0.00034702668,0.000001632018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013259031,0.0033014969,0.624049,0.000027426888,0.00026486424,0.00008314452,0.0011188126,0.000022076441,0.0002804117,0.0000074426152,0.0019521476,0.35563415],"study_design_scores_gemma":[0.03952431,0.024536463,0.8888916,0.00019324964,0.0001528146,0.000017924458,0.00008821352,0.00003078484,0.00019274911,0.000014147907,0.046272825,0.00008491617],"about_ca_topic_score_codex":0.034737494,"about_ca_topic_score_gemma":0.13693848,"teacher_disagreement_score":0.35554925,"about_ca_system_score_codex":0.0007327107,"about_ca_system_score_gemma":0.0028627212,"threshold_uncertainty_score":0.9716903},"labels":[],"label_agreement":null},{"id":"W2589370503","doi":"10.1200/jco.2014.32.4_suppl.222","title":"Pain palliation as an oncology label indication: Lessons learned in custirsen phase III development.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Docetaxel; Taxane; Placebo; Cabazitaxel; Internal medicine; Prostate cancer; Regimen; Oncology; Phases of clinical research; Surgery; Clinical trial; Cancer; Breast cancer; Androgen deprivation therapy","score_opus":0.31248239554376095,"score_gpt":0.599375163075988,"score_spread":0.2868927675322271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589370503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94877124,0.00014936997,0.00058204256,0.042623587,0.0010574041,0.00026720008,0.0000010707047,0.000016425922,0.0065316823],"genre_scores_gemma":[0.98273593,0.00069074536,0.005586322,0.008848467,0.0013668154,0.000019897774,0.000032982676,0.000017614228,0.0007012379],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949552,0.001898275,0.0023326657,0.00025720632,0.00027204197,0.0002846215],"domain_scores_gemma":[0.9941141,0.0031341636,0.0018169333,0.00015980516,0.00029638008,0.00047862166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009710211,0.00015630186,0.0013750074,0.00027452759,0.00006129537,0.0000073811198,0.00017899337,0.00061407214,0.0006275432],"category_scores_gemma":[0.0033624552,0.00012444452,0.00015746639,0.00022296415,0.00016459082,0.00013962711,0.000035822522,0.0010741717,0.00006900749],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008946075,0.011816453,0.02764896,0.000017556076,0.0002608945,0.00036710367,0.00078627374,0.0000112579755,0.00064175273,0.0005515048,0.0040755346,0.9448766],"study_design_scores_gemma":[0.07615974,0.047972254,0.08402041,0.00006669946,0.0004093996,0.00019699335,0.000250715,0.00085928926,0.00021863874,0.0019166946,0.7877617,0.0001674882],"about_ca_topic_score_codex":0.000035170822,"about_ca_topic_score_gemma":0.00047346964,"teacher_disagreement_score":0.9447091,"about_ca_system_score_codex":0.00058528315,"about_ca_system_score_gemma":0.0043346076,"threshold_uncertainty_score":0.7689408},"labels":[],"label_agreement":null},{"id":"W2589549609","doi":"10.1200/jco.2005.23.16_suppl.695","title":"Phase I-II study of DalCM-P [daily dalteparin (Dal), cyclophosphamide (C) and prednisone (P) and bi-weekly methotrexate (M)] as therapy for metastatic breast cancer (MBC)","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Chemotherapy; Cyclophosphamide; Gastroenterology; Regimen; Breast cancer; Chemotherapy regimen; Progression-free survival; Phases of clinical research; Cancer; Surgery","score_opus":0.15506704465995005,"score_gpt":0.5456303374866971,"score_spread":0.39056329282674707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589549609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780429,0.0055327024,0.00004131804,0.014493983,0.0005823476,0.001030696,0.000055172357,0.000008093402,0.00021276262],"genre_scores_gemma":[0.97908676,0.011952312,0.0050837155,0.0021080922,0.000976287,0.000060994236,0.000005015051,0.000028691613,0.0006981299],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99658877,0.0004771678,0.0020866615,0.00030941097,0.00025625195,0.00028172834],"domain_scores_gemma":[0.99502087,0.0022964212,0.0016947218,0.00016184745,0.00038999814,0.00043613015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00242195,0.00023461421,0.0020817143,0.0001634308,0.00009278671,0.000008415903,0.000120787125,0.00017879467,0.00033424495],"category_scores_gemma":[0.00035132328,0.00016079715,0.0002741148,0.00015058643,0.0002631544,0.00014991369,0.00006426854,0.00048044274,0.000001074848],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067599155,0.04947258,0.041820582,0.00008004594,0.004180653,0.0002477613,0.0015489359,0.000027816284,0.0030413028,0.000039648272,0.005395122,0.8265464],"study_design_scores_gemma":[0.2895896,0.36355364,0.19169158,0.000121806,0.006133969,0.0015450448,0.0009956344,0.00049506954,0.0012175675,0.000742135,0.14358695,0.0003269828],"about_ca_topic_score_codex":0.00028373534,"about_ca_topic_score_gemma":0.0003974039,"teacher_disagreement_score":0.82621944,"about_ca_system_score_codex":0.0001148997,"about_ca_system_score_gemma":0.0011520929,"threshold_uncertainty_score":0.65571177},"labels":[],"label_agreement":null},{"id":"W2589567505","doi":"10.1200/jco.2014.32.31_suppl.190","title":"The McGill University Health Centre interdisciplinary approach to cancer pain management: Description of treatments and outcomes.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Palliative care; Medical prescription; Opioid; Psychosocial; Brief Pain Inventory; Cancer pain; Morphine; McGill Pain Questionnaire; Cancer; Internal medicine; Physical therapy; Chronic pain; Visual analogue scale; Nursing; Psychiatry","score_opus":0.12629462847540376,"score_gpt":0.47474995244364865,"score_spread":0.34845532396824486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589567505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8858639,0.0006253078,0.00073225977,0.10237818,0.001466577,0.0007230042,0.000043197728,0.000010173027,0.008157392],"genre_scores_gemma":[0.9856239,0.002786297,0.0023673535,0.004043637,0.0002016789,0.0000019612169,0.0000027232704,0.0000083980485,0.0049640457],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99821913,0.00065791176,0.0007201113,0.0001262625,0.00012553958,0.00015105553],"domain_scores_gemma":[0.9980895,0.0007722026,0.00068887486,0.00009593054,0.000093805036,0.00025970564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022318447,0.00008487421,0.00073024386,0.000076665565,0.00009453433,0.0000013387961,0.00008902419,0.00008611235,0.0000151306285],"category_scores_gemma":[0.000102444945,0.000049950828,0.00018594335,0.00008415078,0.00009332753,0.00003865556,0.00010070501,0.00021548283,0.000001426304],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005230659,0.002688835,0.15479463,0.00007742258,0.0013759787,0.000045634166,0.00033529548,0.000016723825,0.000012179935,0.00038247588,0.037627228,0.79741293],"study_design_scores_gemma":[0.011192094,0.011013075,0.6327483,0.000081536586,0.0007608492,0.00002433728,0.0007968767,0.00018935453,0.0000043936047,0.00028630465,0.34284216,0.000060753202],"about_ca_topic_score_codex":0.00008344282,"about_ca_topic_score_gemma":0.00019101617,"teacher_disagreement_score":0.7973522,"about_ca_system_score_codex":0.0003947066,"about_ca_system_score_gemma":0.00014753125,"threshold_uncertainty_score":0.20369357},"labels":[],"label_agreement":null},{"id":"W2589748065","doi":"10.1200/jco.2012.30.34_suppl.249","title":"Quality of systemic cancer therapy in routine care: What are we measuring?","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cancer; Population; MEDLINE; Clinical trial; Family medicine; Internal medicine; Cancer registry; Breast cancer; Intensive care medicine; Oncology","score_opus":0.4384824179354035,"score_gpt":0.5850279326458419,"score_spread":0.14654551471043836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589748065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90288794,0.085616075,0.000004811276,0.007304505,0.0035094197,0.00020540404,0.0000030814588,0.000004217857,0.00046453063],"genre_scores_gemma":[0.9250671,0.07139473,0.000105327825,0.0012809739,0.0020174382,0.000009483825,8.500383e-7,0.000011085629,0.000112964284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962173,0.00083080854,0.002304906,0.00011204997,0.00028683624,0.0002480978],"domain_scores_gemma":[0.9955422,0.0013666555,0.00227204,0.00013507715,0.00041429148,0.0002696995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034679258,0.000121007615,0.0018228374,0.00011430865,0.000013794579,0.0000032366454,0.00011221003,0.00031599842,0.000264695],"category_scores_gemma":[0.00042875382,0.000081332226,0.00041839047,0.00013251368,0.00011835769,0.00019276072,0.000023803535,0.0006700773,0.0000039976408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070665553,0.0022262493,0.8562862,0.00012749582,0.00038402824,0.000057168225,0.0013381641,0.00001079021,0.0011190221,0.000018534516,0.0010322214,0.13033357],"study_design_scores_gemma":[0.022305563,0.006066973,0.9386306,0.0007343615,0.0002584951,0.00016071876,0.002406487,0.0000024903595,0.0008935239,0.000034091987,0.028409608,0.000097081545],"about_ca_topic_score_codex":0.00017845098,"about_ca_topic_score_gemma":0.0002553537,"teacher_disagreement_score":0.13023649,"about_ca_system_score_codex":0.00046902962,"about_ca_system_score_gemma":0.0010648043,"threshold_uncertainty_score":0.3316632},"labels":[],"label_agreement":null},{"id":"W2590030891","doi":"10.1200/jco.2015.33.29_suppl.182","title":"The Opioid Rotation Ratio (ORR) from transdermal fentanyl (TDF) to strong opioids in cancer patients.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fentanyl; Opioid; Cancer pain; Cancer; Transdermal; Morphine; Anesthesia; Internal medicine; Pharmacology","score_opus":0.17791441831879826,"score_gpt":0.5153400393633385,"score_spread":0.3374256210445402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590030891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778073,0.0008035483,0.000109512825,0.01587376,0.003931059,0.00037622458,0.0000119514425,0.00000489277,0.0010817533],"genre_scores_gemma":[0.9930909,0.00060456706,0.00044635803,0.0035884487,0.0018826209,0.0000279422,0.00001146774,0.000011947517,0.0003357318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974122,0.0003628953,0.0015400819,0.00014987164,0.00030807004,0.00022685555],"domain_scores_gemma":[0.99728054,0.0012076214,0.0006033452,0.0000972266,0.00037396012,0.00043729323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012103297,0.00011396017,0.00074712245,0.00007751884,0.00003954767,0.000011016198,0.00014226353,0.00019668821,0.00015625726],"category_scores_gemma":[0.00065662706,0.00007152467,0.00020052951,0.00013170883,0.00009164939,0.00010943643,0.000023293525,0.00062464323,0.000019171675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0146845905,0.0032214688,0.6401669,0.0000069347957,0.00037813178,0.00016848146,0.001543303,0.0002779568,0.00027771696,0.000055842927,0.033883497,0.30533522],"study_design_scores_gemma":[0.025989763,0.016868796,0.72614926,0.000055435412,0.00040027857,0.000011371205,0.00042967507,0.00025711948,0.00026282037,0.00025815782,0.22921626,0.00010104654],"about_ca_topic_score_codex":0.00034857716,"about_ca_topic_score_gemma":0.0016208845,"teacher_disagreement_score":0.30523416,"about_ca_system_score_codex":0.0005122432,"about_ca_system_score_gemma":0.0023144195,"threshold_uncertainty_score":0.4105681},"labels":[],"label_agreement":null},{"id":"W2590234373","doi":"10.1200/jco.2014.32.3_suppl.429","title":"Are the cardiovascular side effects of bevacizumab caused by autonomic nervous system toxicity?","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Cancer Care South East; University of Manitoba; Queen's University","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Adverse effect; Cardiology; Heart rate variability; Toxicity; Heart rate; Vascular endothelial growth factor; Aldosterone; Autonomic nervous system; Analysis of variance; Heart failure; Sinus rhythm; Plasma renin activity; Hormone; Blood pressure; Endocrinology; Renin–angiotensin system; Chemotherapy; VEGF receptors","score_opus":0.051790235838715636,"score_gpt":0.4022700080996506,"score_spread":0.35047977226093496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590234373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98659366,0.0039174454,0.00023939488,0.003977341,0.002783894,0.00035447255,0.0000034965342,0.00001433381,0.0021159751],"genre_scores_gemma":[0.99591887,0.00032938807,0.00010126826,0.0017509673,0.0016622694,0.000009048694,0.0000013127138,0.000017857114,0.0002090429],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99643886,0.0012090342,0.0016648262,0.00017125635,0.0002968491,0.00021917037],"domain_scores_gemma":[0.99282676,0.004278327,0.0020882213,0.00031281085,0.00024103481,0.0002528315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029531254,0.00015145431,0.002251611,0.00006838064,0.000046039364,0.0000044251597,0.00020679335,0.00033497607,0.000017671604],"category_scores_gemma":[0.0015054984,0.000087923276,0.001283396,0.00009027361,0.00021363574,0.000041923075,0.000044712535,0.0006982831,0.00001626278],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015972247,0.010236756,0.099485494,0.0024959429,0.03628134,0.005195042,0.00071397336,0.0013238159,0.018168513,0.00063842454,0.119857304,0.68963116],"study_design_scores_gemma":[0.049594734,0.03723815,0.36624908,0.00057449896,0.01269305,0.0013806459,0.00032261497,0.00072527456,0.009372935,0.00011927206,0.5214465,0.0002832395],"about_ca_topic_score_codex":0.00004504314,"about_ca_topic_score_gemma":0.000022910239,"teacher_disagreement_score":0.6893479,"about_ca_system_score_codex":0.0003218176,"about_ca_system_score_gemma":0.0005970979,"threshold_uncertainty_score":0.3585407},"labels":[],"label_agreement":null},{"id":"W2590373457","doi":"10.1200/jco.2016.34.4_suppl.601","title":"Oxaliplatin associated neurotoxicity outcomes among older adults with colorectal cancer: A population-based study.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Women's College Hospital; Queen's University; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Oxaliplatin; Medicine; Hazard ratio; Internal medicine; Colorectal cancer; Cohort; Regimen; Cancer registry; Population; Incidence (geometry); Cancer; Surgery; Oncology; Confidence interval","score_opus":0.06502031611701335,"score_gpt":0.46263581986832353,"score_spread":0.39761550375131016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590373457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99187547,0.000029392519,0.000015754245,0.006011635,0.001015045,0.000820965,0.00001320311,0.00002350458,0.00019504367],"genre_scores_gemma":[0.99742705,0.000030239597,0.00012756011,0.0015600811,0.0004810711,0.000046646455,0.0000033148797,0.000022291015,0.00030173396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968237,0.0006379139,0.0016353633,0.00023748183,0.00040653095,0.00025897485],"domain_scores_gemma":[0.99351025,0.0036047031,0.0019694383,0.000114060334,0.00045175554,0.00034979775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011829784,0.00018840474,0.0015889793,0.00012456399,0.000054643806,0.0000056879426,0.000117501346,0.0002802596,0.0007023737],"category_scores_gemma":[0.0015755651,0.0000938737,0.00036435542,0.00016415934,0.000121530065,0.00009912281,0.000021868353,0.0005402873,0.000005748842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011377881,0.0072074602,0.96131533,0.000008760347,0.000892087,0.0005712863,0.00010089726,0.000013035617,0.000053977106,0.0000014310898,0.0008328414,0.017624985],"study_design_scores_gemma":[0.04676094,0.028153602,0.9235077,0.00017992753,0.0008691511,0.000018929184,0.000045526045,0.000042945194,0.00006169949,0.000008817648,0.00024730034,0.000103500504],"about_ca_topic_score_codex":0.0004724913,"about_ca_topic_score_gemma":0.004809037,"teacher_disagreement_score":0.037807696,"about_ca_system_score_codex":0.00042700965,"about_ca_system_score_gemma":0.0012963334,"threshold_uncertainty_score":0.76904994},"labels":[],"label_agreement":null},{"id":"W2590425344","doi":"10.1200/jco.2014.32.30_suppl.64","title":"Involving patients to improve their care through real-time patient reported outcome (PRO)-CTCAE chemotoxicity surveys in an outpatient chemodaycare (DC) setting: Evaluating patient acceptability.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Dysgeusia; Nausea; Feeling; Patient-reported outcome; Quality of life (healthcare); Family medicine; Constipation; Physical therapy; Vomiting; Nursing; Adverse effect; Surgery; Psychology; Internal medicine","score_opus":0.16592804291243962,"score_gpt":0.49369897234723903,"score_spread":0.3277709294347994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590425344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929381,0.00008027615,0.00003905573,0.0010538527,0.0022904815,0.0018524702,0.000028885754,0.00003958674,0.0016772626],"genre_scores_gemma":[0.9915371,0.000035269582,0.0049002552,0.0026072864,0.00068989996,0.000065959895,0.00007809553,0.000058582336,0.000027564816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9874754,0.0041673244,0.0059942952,0.00079907296,0.0008795303,0.0006843551],"domain_scores_gemma":[0.98955166,0.0025703404,0.0041022985,0.00066856155,0.0023255928,0.0007815598],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008363489,0.00047061677,0.002726375,0.0002696897,0.00011479197,0.000025167294,0.00031341042,0.0006779686,0.00029569492],"category_scores_gemma":[0.010773391,0.00035080177,0.0007023824,0.00043064318,0.00015754146,0.00031528593,0.00028923652,0.0014471785,0.000014563681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021114533,0.0045757922,0.6418937,0.00007962482,0.00014585107,0.000061216946,0.0069421562,0.00009928253,0.0018083751,0.0000013245539,0.0001835188,0.3420977],"study_design_scores_gemma":[0.013046327,0.08327127,0.89523816,0.00013288429,0.00037991838,0.00002360578,0.001797256,0.0005595616,0.003096526,0.00010418775,0.0019951917,0.00035510943],"about_ca_topic_score_codex":0.0003150541,"about_ca_topic_score_gemma":0.0003406552,"teacher_disagreement_score":0.3417426,"about_ca_system_score_codex":0.0017157563,"about_ca_system_score_gemma":0.0012906237,"threshold_uncertainty_score":0.9998944},"labels":[],"label_agreement":null},{"id":"W2590660749","doi":"10.1200/jco.2013.31.26_suppl.174","title":"Real-world analysis of eribulin in metastatic breast cancer (MBC): An assessment of time to treatment failure (TTF) in a community oncology setting.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Eribulin; Medicine; Metastatic breast cancer; Anthracycline; Discontinuation; Internal medicine; Oncology; Breast cancer; Toxicity; Cancer; Surgery","score_opus":0.11903135798488274,"score_gpt":0.5668154112911684,"score_spread":0.4477840533062857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590660749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815689,0.00006791869,0.000011616821,0.015869591,0.00018184815,0.0006185415,0.00006897892,0.0000048567244,0.0016078044],"genre_scores_gemma":[0.9908587,0.0005685281,0.0068355617,0.0010864105,0.00016866464,0.00007488532,0.000032327396,0.000016705395,0.00035824376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927034,0.0029718995,0.0034923702,0.00021799345,0.00028582613,0.0003285039],"domain_scores_gemma":[0.992708,0.0037495361,0.0022600845,0.00032296107,0.0005181779,0.00044122493],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036782385,0.0002249932,0.003904334,0.0012163139,0.000025613685,0.0000043327072,0.00024281212,0.00025151006,0.004452164],"category_scores_gemma":[0.0002486002,0.0001629733,0.0005884451,0.0012380636,0.00021462658,0.00012631652,0.00007367981,0.0010131502,0.000010617501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004574214,0.029221727,0.8165567,0.00006204432,0.0058977692,0.00035002286,0.001334531,0.0023804626,0.0038837222,0.00001831331,0.0019545231,0.13376598],"study_design_scores_gemma":[0.012467541,0.030649278,0.94536424,0.00010147632,0.004671334,0.000048450944,0.00045160932,0.0019907583,0.000092068854,0.000058848516,0.003994764,0.00010962231],"about_ca_topic_score_codex":0.018582378,"about_ca_topic_score_gemma":0.09178293,"teacher_disagreement_score":0.13365635,"about_ca_system_score_codex":0.0018987393,"about_ca_system_score_gemma":0.0034075973,"threshold_uncertainty_score":0.9964579},"labels":[],"label_agreement":null},{"id":"W2590746369","doi":"10.1200/jco.2012.30.34_suppl.290","title":"The use of technology to improve the delivery process of ambulatory chemotherapy at the Odette Cancer Centre (OCC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Chemotherapy; Staffing; Ambulatory; Cancer; Intensive care medicine; Medical emergency; Emergency medicine; Nursing; Internal medicine","score_opus":0.11123374671555956,"score_gpt":0.4987429479297216,"score_spread":0.38750920121416205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590746369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8803078,0.0040817987,0.000005490001,0.11347565,0.0015639438,0.00040807528,0.000008936881,0.0000046748273,0.00014361713],"genre_scores_gemma":[0.98170173,0.00428476,0.00013722655,0.01138198,0.0012346039,0.000018203225,4.7571234e-7,0.000017407641,0.0012236111],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99762577,0.00027047622,0.0014012603,0.00011881473,0.00026959507,0.00031406857],"domain_scores_gemma":[0.99432224,0.0029783614,0.0016698875,0.00029809977,0.0005595583,0.00017182752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001675087,0.0001334562,0.0008707266,0.00006709466,0.00009326937,0.0000032599985,0.0003119158,0.00029372776,0.00024627338],"category_scores_gemma":[0.0007073452,0.00005421288,0.00036375356,0.00021966474,0.00073494186,0.00007092099,0.00008950238,0.0007049922,0.000006589091],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018015977,0.0027358783,0.38948786,0.000061316685,0.0024797025,0.000030311796,0.0015225097,0.000086140695,0.013298142,0.00016042964,0.11567395,0.45644778],"study_design_scores_gemma":[0.0058039436,0.004787669,0.09667664,0.000059926122,0.0009414242,0.0001014538,0.00038244456,0.0000325847,0.014506806,0.00009525662,0.8765318,0.00008009369],"about_ca_topic_score_codex":0.00006542132,"about_ca_topic_score_gemma":0.0002896049,"teacher_disagreement_score":0.7608578,"about_ca_system_score_codex":0.00019559928,"about_ca_system_score_gemma":0.0009424699,"threshold_uncertainty_score":0.30628797},"labels":[],"label_agreement":null},{"id":"W2590797467","doi":"10.1200/jco.2005.23.16_suppl.8045","title":"Patient controlled methyphenidate [PCM] for cancer-related fatigue [CRF]: A randomized controlled trial","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Randomized controlled trial; Somnolence; Nausea; Cancer-related fatigue; Internal medicine; Cancer; Physical therapy; Adverse effect","score_opus":0.12855012789128675,"score_gpt":0.5252281053468183,"score_spread":0.39667797745553157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590797467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8969641,0.0077432534,0.00044362544,0.05899669,0.011085135,0.01686244,0.000016171158,0.000049643426,0.007838982],"genre_scores_gemma":[0.9670198,0.0058882996,0.0069103497,0.008074396,0.0069859223,0.0019129779,0.000010503491,0.000046205878,0.0031515548],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98935294,0.0024062821,0.007140868,0.00027894147,0.0004177982,0.00040318543],"domain_scores_gemma":[0.96858954,0.023872185,0.0058949133,0.00016649123,0.0009589901,0.00051786145],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007764966,0.00030575533,0.011205423,0.00022511557,0.0000709761,0.000012354083,0.00015121467,0.000636446,0.001254069],"category_scores_gemma":[0.010178971,0.00017368866,0.0046247966,0.00012987872,0.0002552193,0.00010676128,0.000028299339,0.0009272983,0.000013008461],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9100471,0.006911832,0.000081465114,0.000014287978,0.011431091,0.00009542461,0.00023829905,0.00010726272,0.00014040853,0.000159145,0.011291522,0.05948214],"study_design_scores_gemma":[0.8471893,0.029085401,0.000049172093,0.00004738502,0.011765825,0.00006235706,0.000027281816,0.0022136143,0.00009195421,0.0003759729,0.10896289,0.00012883906],"about_ca_topic_score_codex":0.000022466917,"about_ca_topic_score_gemma":0.00007189764,"teacher_disagreement_score":0.09767137,"about_ca_system_score_codex":0.0004049805,"about_ca_system_score_gemma":0.0032407488,"threshold_uncertainty_score":0.99965894},"labels":[],"label_agreement":null},{"id":"W2590936583","doi":"10.1200/jco.2016.34.2_suppl.340","title":"Metformin (Met): A cost-effective adjunct therapy with enzalutamide (Enza) for metastatic castrate-resistant prostate cancer (mCRPC)?","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Prostate cancer; Quality-adjusted life year; Enzalutamide; Cancer; Actuarial science; Cost effectiveness; Internal medicine; Risk analysis (engineering); Economics","score_opus":0.1878538938582237,"score_gpt":0.5275029001028327,"score_spread":0.33964900624460903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590936583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98120785,0.0034489315,0.00071903225,0.009001045,0.0012845612,0.0037110213,0.00010112233,0.000015198943,0.00051123125],"genre_scores_gemma":[0.9828854,0.005333429,0.005350835,0.0025103688,0.0012561777,0.0009983589,0.000004558598,0.000053079795,0.0016077843],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967863,0.00048758992,0.0016646228,0.00030048296,0.0003195916,0.00044140278],"domain_scores_gemma":[0.9910998,0.0057160575,0.0017755355,0.00016713256,0.00077416335,0.00046734314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025233815,0.00027076225,0.001994927,0.00016072547,0.000059774608,0.000009223045,0.00013947768,0.00019339952,0.00041713775],"category_scores_gemma":[0.00072111835,0.00012413187,0.0005816585,0.00017472779,0.00034536168,0.00017818343,0.000019002784,0.00046684887,0.000009193918],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13571672,0.002841779,0.010271254,0.000056038676,0.0037916773,0.0011156813,0.00018080509,0.000010357155,0.015449319,0.00010321647,0.0038681985,0.82659495],"study_design_scores_gemma":[0.12106207,0.20267871,0.040615458,0.00043280676,0.0038253802,0.0009974648,0.00020720779,0.000022123972,0.019215828,0.00092098,0.60969484,0.00032711803],"about_ca_topic_score_codex":0.00006974318,"about_ca_topic_score_gemma":0.00047635962,"teacher_disagreement_score":0.82626784,"about_ca_system_score_codex":0.0005133442,"about_ca_system_score_gemma":0.0032014332,"threshold_uncertainty_score":0.5679205},"labels":[],"label_agreement":null},{"id":"W2591022134","doi":"10.1200/jco.2009.27.15_suppl.1033","title":"Safety and efficacy of first-line bevacizumab (B) plus chemotherapy (CT) for locally recurrent or metastatic breast cancer (LR/mBC): Analysis of MO19391 according to CT","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Taxane; Vinorelbine; Metastatic breast cancer; Internal medicine; Docetaxel; Capecitabine; Bevacizumab; Clinical endpoint; Population; Oncology; Trastuzumab; Surgery; Chemotherapy; Gastroenterology; Breast cancer; Cancer; Clinical trial; Colorectal cancer","score_opus":0.12530062789995866,"score_gpt":0.5168701766002968,"score_spread":0.3915695487003381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591022134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9691266,0.0014895969,0.0024665054,0.025390489,0.00060245674,0.0007113251,0.00011912019,0.0000062977465,0.00008761448],"genre_scores_gemma":[0.987717,0.0060069496,0.0034512584,0.0021309394,0.0005204606,0.000009147501,0.00001009356,0.000015256569,0.00013894645],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99637794,0.00017856505,0.002668824,0.00025008302,0.00026906782,0.00025552572],"domain_scores_gemma":[0.99364734,0.0033308547,0.001902564,0.00017000812,0.00057029136,0.00037893382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015836601,0.0001985602,0.0031000762,0.00037334612,0.000038472037,0.0000040261193,0.0001549926,0.000086719694,0.00044573421],"category_scores_gemma":[0.00079601206,0.00013027477,0.00081061525,0.0005822272,0.00013330783,0.00006148231,0.000028092563,0.00035609913,5.702097e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14494984,0.0047732987,0.017771406,0.000114138915,0.008955531,0.00019264055,0.00022596242,0.0020875202,0.00030401975,0.000026347254,0.0014896366,0.8191097],"study_design_scores_gemma":[0.17035282,0.13318634,0.5730497,0.0008314012,0.049777668,0.0011101014,0.00040612067,0.010513984,0.0012356205,0.00021012759,0.058816344,0.00050973817],"about_ca_topic_score_codex":0.00009133756,"about_ca_topic_score_gemma":0.00048064018,"teacher_disagreement_score":0.81859994,"about_ca_system_score_codex":0.00035705144,"about_ca_system_score_gemma":0.0012648907,"threshold_uncertainty_score":0.53124505},"labels":[],"label_agreement":null},{"id":"W2591143777","doi":"10.1200/jco.2016.34.4_suppl.196","title":"A phase Ib/II study of BBI608 combined with weekly paclitaxel in advanced pancreatic cancer.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; St Mary's Hospital Centre","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Gemcitabine; Taxane; Irinotecan; Paclitaxel; Pancreatic cancer; Capecitabine; Gastroenterology; Oncology; Performance status; Cancer; Nausea; Neutropenia; Chemotherapy; Adverse effect; Breast cancer; Colorectal cancer","score_opus":0.12730128512111996,"score_gpt":0.5383634431411422,"score_spread":0.4110621580200222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591143777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98696315,0.0004974119,0.000014593285,0.010492742,0.00066572556,0.000607957,0.000007457539,0.0000070712026,0.0007438684],"genre_scores_gemma":[0.9964506,0.0010994198,0.00040296445,0.0006555953,0.00039056028,0.000037876835,7.4958973e-7,0.000017495244,0.00094474613],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9966134,0.00045607175,0.0021682656,0.00020993502,0.00029734062,0.00025499772],"domain_scores_gemma":[0.99519,0.0022188707,0.0017485537,0.00018894605,0.0003583379,0.00029524896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013081091,0.0001670186,0.0021515652,0.00018002732,0.00002769982,0.0000015144992,0.00013959061,0.00018157151,0.000397864],"category_scores_gemma":[0.0007000338,0.00008583207,0.00021632688,0.00022611879,0.00021803606,0.00010652606,0.000040852294,0.0004737489,0.0000034913517],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15621784,0.07370953,0.49599978,0.000047307625,0.0015648536,0.0017837081,0.0007837121,0.000010333191,0.00432057,0.000029814075,0.0025023906,0.26303014],"study_design_scores_gemma":[0.25127783,0.50625634,0.22948526,0.00040497526,0.0014125757,0.00012705749,0.00064562354,0.000011797681,0.00035158687,0.00013446365,0.009771744,0.00012074996],"about_ca_topic_score_codex":0.00012210592,"about_ca_topic_score_gemma":0.0010105232,"teacher_disagreement_score":0.43254682,"about_ca_system_score_codex":0.00027685834,"about_ca_system_score_gemma":0.0015841728,"threshold_uncertainty_score":0.43563318},"labels":[],"label_agreement":null},{"id":"W2591158495","doi":"10.1200/jco.2014.32.4_suppl.242","title":"Regional analysis of a cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz + P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D).","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cabazitaxel; Medicine; Cohort; Mitoxantrone; Prostate cancer; Population; Interim analysis; Internal medicine; Prednisone; Cancer; Clinical trial; Androgen deprivation therapy; Chemotherapy","score_opus":0.10024579945243786,"score_gpt":0.4656482243335842,"score_spread":0.3654024248811464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591158495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956519,0.00026962618,0.000024323423,0.0009772084,0.000064926695,0.0028416477,0.00003390124,0.000024588533,0.00011189291],"genre_scores_gemma":[0.9930231,0.0004356142,0.0055679884,0.0002157847,0.000081023325,0.00038766357,0.00006681586,0.000035584293,0.0001864076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995609,0.0006028291,0.00212918,0.00047922583,0.00074567157,0.00043409012],"domain_scores_gemma":[0.99420476,0.0009593894,0.0028129967,0.00024237554,0.0012701736,0.0005103304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010842494,0.00036122787,0.0028657606,0.00050993444,0.00006430973,0.00005231981,0.00017696586,0.00019396743,0.00005591285],"category_scores_gemma":[0.00017712612,0.00019929999,0.0002439695,0.0010349373,0.00066821097,0.00039203593,0.000040425824,0.00068402017,4.481618e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06597844,0.009728292,0.87269,0.00013356328,0.009080224,0.00036272992,0.0002932076,0.00079879956,0.000016218812,0.000011009825,0.00020247849,0.040705033],"study_design_scores_gemma":[0.03791686,0.07780869,0.8670352,0.00038272282,0.013399619,0.00008307354,0.00004594586,0.0012357023,0.000014183521,0.0000070744313,0.0018774577,0.00019343256],"about_ca_topic_score_codex":0.0020314115,"about_ca_topic_score_gemma":0.010191107,"teacher_disagreement_score":0.0680804,"about_ca_system_score_codex":0.00036548983,"about_ca_system_score_gemma":0.0019621605,"threshold_uncertainty_score":0.8127217},"labels":[],"label_agreement":null},{"id":"W2591241287","doi":"10.1200/jco.2013.31.26_suppl.64","title":"Impact of endocrine therapy in early-stage breast cancer on time to locoregional recurrence.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Statistics Canada; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Lumpectomy; Tamoxifen; Cancer; Lymph node; Internal medicine; Stage (stratigraphy); Oncology; Univariate analysis; Median follow-up; Gynecology; Surgery; Chemotherapy; Mastectomy; Multivariate analysis","score_opus":0.13539720691474938,"score_gpt":0.5325383420881753,"score_spread":0.3971411351734259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591241287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98333395,0.00019826757,0.000002090632,0.013460277,0.00045686492,0.0003662063,0.000015220273,0.000003307622,0.0021638442],"genre_scores_gemma":[0.9941306,0.0013382685,0.00015654706,0.0020760223,0.0010158435,0.000020873485,0.000001969834,0.000011771541,0.0012481086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978422,0.00022607394,0.0013194383,0.00014856103,0.00022882418,0.00023492867],"domain_scores_gemma":[0.9973299,0.0010212425,0.00078870263,0.000115366514,0.00037161866,0.00037319295],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005835228,0.00013408775,0.0011767723,0.00021068064,0.000010205016,0.0000033074996,0.00013034775,0.00015328881,0.012151527],"category_scores_gemma":[0.00018727838,0.00008218344,0.00046214528,0.00018711168,0.00011918582,0.000075697426,0.000022317028,0.000619701,0.00017932683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016423743,0.004784027,0.61066484,0.0000071131285,0.0005091957,0.00025312518,0.00010876203,0.000105649226,0.0010671638,0.000009381715,0.03007228,0.33599472],"study_design_scores_gemma":[0.010620476,0.039104175,0.9368701,0.000078176265,0.00005618996,0.00014865382,0.0000060669704,0.000047028934,0.00006863377,0.000054839875,0.012881552,0.00006411956],"about_ca_topic_score_codex":0.0007461918,"about_ca_topic_score_gemma":0.000059092294,"teacher_disagreement_score":0.3359306,"about_ca_system_score_codex":0.00031524926,"about_ca_system_score_gemma":0.0013139648,"threshold_uncertainty_score":0.9887515},"labels":[],"label_agreement":null},{"id":"W2591450482","doi":"10.1200/jco.2009.27.15_suppl.1032","title":"Tolerability and efficacy of first-line bevacizumab (B) plus chemotherapy (CT) in elderly patients with advanced breast cancer (aBC): Subpopulation analysis of the MO19391 study","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Tolerability; Taxane; Bevacizumab; Internal medicine; Population; Clinical trial; Breast cancer; Cohort; Randomized controlled trial; Oncology; Adverse effect; Cancer; Chemotherapy","score_opus":0.05015774311574187,"score_gpt":0.45404138520252485,"score_spread":0.40388364208678296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591450482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484694,0.00021121532,0.000009305586,0.004124249,0.00017758601,0.0005850372,0.000012877253,0.0000021910218,0.000030626652],"genre_scores_gemma":[0.9992132,0.00028463494,0.00009211802,0.0002886426,0.000094537376,0.000003988716,0.0000032727291,0.0000058487635,0.0000137615925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974354,0.00027251767,0.0017058267,0.00017570618,0.00028414282,0.00012639507],"domain_scores_gemma":[0.9969214,0.00071360875,0.0016659566,0.00018170991,0.00041435615,0.0001029674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007757966,0.00012207942,0.0016671411,0.00016156724,0.00002448503,0.0000017440427,0.000099501,0.00009404007,0.000112169524],"category_scores_gemma":[0.00020858292,0.000068672794,0.00027376495,0.0005335392,0.0001429818,0.00006724962,0.000015257939,0.0003617588,6.4112186e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023613127,0.008988264,0.8062071,0.000011067598,0.0010206684,0.000012179716,0.00028222983,0.0017789855,0.000021322714,0.0000010490294,0.00001618066,0.1580478],"study_design_scores_gemma":[0.042905707,0.022578767,0.9313983,0.00005132669,0.0024257652,0.000008360611,0.000051731953,0.0003782611,0.000020280318,0.000025779276,0.00010390768,0.00005182821],"about_ca_topic_score_codex":0.00030293223,"about_ca_topic_score_gemma":0.0035424412,"teacher_disagreement_score":0.15799597,"about_ca_system_score_codex":0.00023954557,"about_ca_system_score_gemma":0.00040056976,"threshold_uncertainty_score":0.28003952},"labels":[],"label_agreement":null},{"id":"W2591471662","doi":"10.1200/jco.2014.32.3_suppl.423","title":"Dose intensity and survival outcomes with adjuvant FOLFOX for colon cancer.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"FOLFOX; Medicine; Oxaliplatin; Colorectal cancer; Internal medicine; Neutropenia; Oncology; Proportional hazards model; Chemotherapy; Cancer; Surgery","score_opus":0.18572815130798548,"score_gpt":0.5404889401147074,"score_spread":0.3547607888067219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591471662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96820843,0.0003715336,0.00020696578,0.027849983,0.0021881256,0.0002634841,0.000005379051,0.000007541606,0.0008985303],"genre_scores_gemma":[0.9898916,0.00065363094,0.0020035736,0.0054922607,0.0012973576,0.0000121828025,0.0000019239344,0.000012828944,0.0006346509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842817,0.00016588862,0.00092218403,0.00015183167,0.00014690107,0.00018505649],"domain_scores_gemma":[0.9955557,0.0027799553,0.0008287897,0.00008799162,0.00044270387,0.0003048572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017254502,0.000118504446,0.001696385,0.00005584598,0.000039910392,0.000004370623,0.000065032444,0.00020438187,0.00006827116],"category_scores_gemma":[0.0009673024,0.00006823584,0.00024037946,0.000046949142,0.00021694023,0.000047621175,0.000026951684,0.00042462,0.000001824961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030791676,0.0014153348,0.8154528,0.000045220924,0.00096165907,0.00014089496,0.000084893516,0.000004008778,0.00018303559,0.00015550698,0.009300172,0.14146478],"study_design_scores_gemma":[0.028866401,0.04521607,0.7457584,0.000046108154,0.0013617825,0.00019727409,0.000046558795,0.00010905196,0.00008654735,0.00024592542,0.17798272,0.00008316959],"about_ca_topic_score_codex":0.00006743682,"about_ca_topic_score_gemma":0.0005583566,"teacher_disagreement_score":0.16868255,"about_ca_system_score_codex":0.00009878222,"about_ca_system_score_gemma":0.0007339405,"threshold_uncertainty_score":0.27825767},"labels":[],"label_agreement":null},{"id":"W2591486309","doi":"10.1200/jco.2014.32.3_suppl.644","title":"Patterns of systemic therapy in metastatic colorectal cancer (mCRC): Use of intermittent and stop-and-go strategies in a population-based setting.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; FOLFOX; Bevacizumab; FOLFIRI; Internal medicine; Capecitabine; Population; Colorectal cancer; Systemic therapy; Cancer; Cohort; Oncology; Chemotherapy; Irinotecan; Breast cancer; Oxaliplatin","score_opus":0.12366162210276459,"score_gpt":0.480810905861421,"score_spread":0.3571492837586564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591486309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976212,0.00069319963,0.000032435826,0.001113284,0.00028508055,0.00023251852,0.000008045031,0.0000016659775,0.00001259174],"genre_scores_gemma":[0.9978843,0.0012715851,0.00029708046,0.00042618165,0.00009238282,0.000009461869,0.0000024702679,0.0000071991117,0.000009381929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997508,0.0005749607,0.0015738902,0.000110652225,0.00012231492,0.000110172165],"domain_scores_gemma":[0.9958743,0.00268591,0.0011764623,0.000053407548,0.00012508352,0.00008482623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012620428,0.00009361118,0.0011899386,0.00019091708,0.000006353656,0.0000037079712,0.000044121316,0.00011633675,0.00003941453],"category_scores_gemma":[0.00035646762,0.00006510682,0.000115811345,0.00007125346,0.00007728324,0.00007289907,0.000013799699,0.00032316367,1.0699449e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004264803,0.00079653034,0.93935084,0.00013345256,0.00017195195,0.000057729998,0.00041818654,0.00018734518,0.0013571986,0.000029459969,0.000024010616,0.053208463],"study_design_scores_gemma":[0.012777683,0.009413087,0.97539634,0.00045818658,0.00018571511,0.00006835718,0.0002571241,0.0010007012,0.00016973708,0.00006734002,0.00015802398,0.000047735273],"about_ca_topic_score_codex":0.0011889099,"about_ca_topic_score_gemma":0.0020739739,"teacher_disagreement_score":0.053160727,"about_ca_system_score_codex":0.000097820695,"about_ca_system_score_gemma":0.0006005113,"threshold_uncertainty_score":0.2654979},"labels":[],"label_agreement":null},{"id":"W2591511288","doi":"10.1200/jco.2016.34.7_suppl.63","title":"Quality of life (QoL) by response: An interim analysis of patients (pts) with squamous (SCC) NSCLC treated with <i>nab</i>-paclitaxel/carboplatin (<i>nab</i>-P/C) induction therapy in the phase III ABOUND.sqm study.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Induction chemotherapy; Interim analysis; Quality of life (healthcare); Carboplatin; Response Evaluation Criteria in Solid Tumors; Maintenance therapy; Oncology; Surgery; Phases of clinical research; Randomized controlled trial; Gastroenterology; Chemotherapy","score_opus":0.15138756162189743,"score_gpt":0.515527758474879,"score_spread":0.36414019685298155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591511288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626327,0.00021129883,0.000050130304,0.0022470409,0.00019434672,0.0008261671,0.000058524165,0.000008601653,0.0001406047],"genre_scores_gemma":[0.9983985,0.00020878315,0.000094681825,0.0009502935,0.0001881088,0.00002817585,0.00001996166,0.000022605564,0.00008890523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9908233,0.0044671674,0.0033714706,0.0003544527,0.00070220575,0.00028139446],"domain_scores_gemma":[0.9897787,0.004749182,0.0038930473,0.0004434537,0.00084143516,0.00029419782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064827646,0.0002798461,0.002771857,0.0004815154,0.00004231509,0.000008246151,0.0002953503,0.00030468195,0.00024431577],"category_scores_gemma":[0.0010929789,0.00012544863,0.0004203289,0.0010180444,0.0005716711,0.00021940842,0.00002600924,0.00063853903,8.1219747e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32354432,0.035293914,0.58037966,0.000009178695,0.0035835363,0.000077994984,0.001622153,0.000011358813,0.004572772,0.0000030483823,0.00046789972,0.05043416],"study_design_scores_gemma":[0.100705184,0.18436666,0.70945436,0.000043326017,0.002291754,0.0000122537695,0.0011647759,0.000011056076,0.0003702976,0.000010856346,0.00144171,0.00012773919],"about_ca_topic_score_codex":0.0007130864,"about_ca_topic_score_gemma":0.0012019271,"teacher_disagreement_score":0.22283913,"about_ca_system_score_codex":0.00025567942,"about_ca_system_score_gemma":0.0012019394,"threshold_uncertainty_score":0.5115647},"labels":[],"label_agreement":null},{"id":"W2591566448","doi":"10.1200/jco.2015.33.29_suppl.181","title":"The Opioid Rotation Ratio (ORR) to transdermal fentanyl (TDF) in cancer patients.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Opioid; Cancer pain; Fentanyl; Cancer; Palliative care; Constipation; Anesthesia; Internal medicine","score_opus":0.1952582740294113,"score_gpt":0.5363013727625947,"score_spread":0.3410430987331834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591566448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658537,0.00061462383,0.00004504256,0.02785429,0.0034824247,0.0003584688,0.000002985737,0.000003975295,0.0017844844],"genre_scores_gemma":[0.990911,0.0006869917,0.00028942112,0.0061578904,0.0013262164,0.000025684514,0.0000032194855,0.000009376319,0.0005902067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774486,0.0003081302,0.0013820989,0.00011057861,0.00025935267,0.00019499016],"domain_scores_gemma":[0.9976717,0.00091808446,0.00053351006,0.0000739211,0.00041232322,0.00039042285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015881936,0.00008865326,0.0006260665,0.00007896325,0.000033110275,0.0000072542366,0.00010824996,0.00015901246,0.00009457468],"category_scores_gemma":[0.00082408066,0.000053192256,0.00017842714,0.00014538194,0.00008110018,0.00008323092,0.00001603616,0.00051279966,0.000020463065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016723521,0.00399784,0.5200084,0.000011146931,0.0002677474,0.00021260566,0.0014943746,0.00019148852,0.00018957526,0.00007178858,0.06927378,0.38755774],"study_design_scores_gemma":[0.020884981,0.019232722,0.51526654,0.00003604943,0.00025515343,0.00003218191,0.00021017661,0.00009883886,0.00018986156,0.00018610762,0.44353622,0.00007114685],"about_ca_topic_score_codex":0.000089956244,"about_ca_topic_score_gemma":0.0008119304,"teacher_disagreement_score":0.3874866,"about_ca_system_score_codex":0.00041739387,"about_ca_system_score_gemma":0.0022540535,"threshold_uncertainty_score":0.3998594},"labels":[],"label_agreement":null},{"id":"W2591643510","doi":"10.1158/1538-7445.sabcs16-s5-06","title":"Abstract S5-06: Randomized, placebo-controlled trial of duloxetine for aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS) in early stage breast cancer (SWOG S1202)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dr. H. Bliss Murphy Cancer Centre","funders":"","keywords":"Medicine; Duloxetine; Brief Pain Inventory; Breast cancer; Internal medicine; Placebo; Randomized controlled trial; Discontinuation; Aromatase inhibitor; Cancer; Oncology; Physical therapy; Chronic pain; Tamoxifen","score_opus":0.04056827726578983,"score_gpt":0.4423527158761176,"score_spread":0.40178443861032775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591643510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785505,0.0009503903,0.000002040852,0.00486069,0.00088451913,0.012199353,0.0017470599,0.000038083777,0.0007673709],"genre_scores_gemma":[0.9808524,0.0010776875,0.000008005139,0.00007727169,0.0014603259,0.0111318715,0.00016566852,0.00007292243,0.005153821],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995943,0.00044556864,0.00094161514,0.00064937316,0.0009245005,0.0010959416],"domain_scores_gemma":[0.99636114,0.0013787624,0.0005421562,0.0006670863,0.000700993,0.00034986256],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037949216,0.00036496416,0.0020007691,0.00047590042,0.00038174572,0.00009942887,0.00042372601,0.00030315912,0.0016912017],"category_scores_gemma":[0.001052277,0.00028757247,0.00063935947,0.0002619216,0.00073201855,0.00025369067,0.00015673605,0.0008194062,0.000022875376],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.970678,0.0014075756,0.0066566346,0.0004264687,0.0012640506,0.00009410144,0.00029526945,0.00001732747,0.010765907,0.000054015447,0.0058326563,0.0025080456],"study_design_scores_gemma":[0.97459173,0.0010529313,0.018329445,0.0004906254,0.0004479243,0.0000025229078,0.000046399826,0.0001756059,0.0035054113,0.00006166362,0.0010445693,0.00025115663],"about_ca_topic_score_codex":0.016299805,"about_ca_topic_score_gemma":0.003563973,"teacher_disagreement_score":0.0127358325,"about_ca_system_score_codex":0.000954186,"about_ca_system_score_gemma":0.001562129,"threshold_uncertainty_score":0.9999576},"labels":[],"label_agreement":null},{"id":"W2591925750","doi":"10.1200/jco.2013.31.15_suppl.1055","title":"Quality of life (QoL) and content validity in objective tumor response.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Capecitabine; Quality of life (healthcare); Eribulin; Internal medicine; Breast cancer; Metastatic breast cancer; Multivariate analysis; Health related quality of life; Oncology; Cancer; Physical therapy; Disease; Colorectal cancer","score_opus":0.5428370661455958,"score_gpt":0.5661834348095452,"score_spread":0.023346368663949457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591925750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865022,0.00045778663,0.000009261958,0.011142549,0.00066708773,0.00026988762,0.0000031918282,0.0000028220586,0.000945268],"genre_scores_gemma":[0.9954784,0.00034512504,0.00054460147,0.0030259888,0.0003680625,0.000006990814,4.3643033e-7,0.0000057367542,0.0002246413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956762,0.0016878454,0.0021835067,0.00012753539,0.00017959438,0.00014527942],"domain_scores_gemma":[0.98995584,0.007670825,0.0015038142,0.00009555649,0.00044374523,0.00033023205],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0054033636,0.00008914585,0.0015822477,0.000110048735,0.000012476762,0.0000024744227,0.00006573727,0.00018178589,0.00038171312],"category_scores_gemma":[0.008725867,0.000060982515,0.00025570605,0.000085328975,0.000276399,0.00007711159,0.000037703903,0.0006087354,0.000008239286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04818563,0.003217381,0.92263865,0.000036434787,0.0003096483,0.00017971426,0.00024458184,0.00000120074,0.004841828,0.00005002448,0.004084843,0.016210075],"study_design_scores_gemma":[0.015828248,0.017060354,0.96212894,0.00003320584,0.00011668629,0.00008763008,0.0003410679,0.000012006763,0.00026212688,0.0003784991,0.0037029467,0.000048276896],"about_ca_topic_score_codex":0.0003914311,"about_ca_topic_score_gemma":0.00013799322,"teacher_disagreement_score":0.039490316,"about_ca_system_score_codex":0.00014654154,"about_ca_system_score_gemma":0.0015162427,"threshold_uncertainty_score":0.9996241},"labels":[],"label_agreement":null},{"id":"W2592319793","doi":"10.71781/31184","title":"Effets des polyphénols du thé vert et de la radiothérapie sur la progression et la résistance tumorale dans un modèle in vivo de glioblastome","year":2004,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Glioblastoma; Medicine; Nuclear medicine; Cancer research","score_opus":0.014955934240725902,"score_gpt":0.36934725917862943,"score_spread":0.35439132493790354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592319793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94890976,0.0046554287,0.00005720705,0.00032724853,0.00032211374,0.0014582431,0.0001591374,0.000008991518,0.04410184],"genre_scores_gemma":[0.98239404,0.0024304097,0.004868192,0.00012743125,0.00014846565,0.00042012567,0.00045566726,0.0001031678,0.009052521],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966885,0.0012375442,0.0004732034,0.0006349497,0.00028125502,0.00068455876],"domain_scores_gemma":[0.9981646,0.0009494001,0.00027515512,0.00024061746,0.0000738656,0.00029634841],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012464287,0.00053051795,0.00079337123,0.00021064424,0.00014881659,0.00020004202,0.00045151744,0.0005858713,0.0017174755],"category_scores_gemma":[0.00013429648,0.0005188542,0.00015291767,0.00041087472,0.00032366643,0.0003430796,0.00008931065,0.0007318483,0.00007162194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012697003,0.008537563,0.28742942,0.0015457504,0.0009681621,0.010574241,0.092834964,0.0016902325,0.5117771,0.0009942376,0.0014849348,0.06946641],"study_design_scores_gemma":[0.037238814,0.0020666397,0.34580952,0.014477489,0.0015804002,0.0014675871,0.002921284,0.00082585117,0.5432129,0.0007871891,0.04819007,0.001422263],"about_ca_topic_score_codex":0.0030974906,"about_ca_topic_score_gemma":0.0075122844,"teacher_disagreement_score":0.08991368,"about_ca_system_score_codex":0.0011965228,"about_ca_system_score_gemma":0.0026737396,"threshold_uncertainty_score":0.9997263},"labels":[],"label_agreement":null},{"id":"W2592985951","doi":"10.1097/cad.0000000000000493","title":"A systematic review and pooled analysis of retrospective series of eribulin in metastatic breast cancer","year":2017,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sault Area Hospital","funders":"","keywords":"Medicine; Eribulin; Capecitabine; Internal medicine; Breast cancer; Metastatic breast cancer; Oncology; Clinical trial; Confidence interval; Retrospective cohort study; Cancer; Surgery","score_opus":0.04661719267652718,"score_gpt":0.4187347429406821,"score_spread":0.3721175502641549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592985951","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029449366,0.994375,4.886851e-7,0.00028563643,0.00010236824,0.0028109965,0.0019722348,0.000010288978,0.00014852316],"genre_scores_gemma":[0.0014714987,0.9959885,0.000017792127,0.000103853396,0.000042461896,0.0010762347,0.00012808417,0.000038669925,0.0011329427],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99730676,0.0002582861,0.0014144849,0.0004861,0.00027538976,0.00025896553],"domain_scores_gemma":[0.99682474,0.00012098954,0.0020924227,0.0006256526,0.00024561357,0.0000905765],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047175118,0.00046373607,0.010637749,0.0005953316,0.000038236518,0.000010626953,0.00020532482,0.00012597784,0.00063697307],"category_scores_gemma":[0.000054924916,0.0003265738,0.00086274464,0.0010918397,0.000228672,0.000102076556,0.00007449739,0.00025748453,0.0000027123708],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042051648,0.00017646236,0.0011976663,0.95339894,0.03092316,0.000020013393,0.00022964655,4.37096e-7,0.000003614066,0.000022740187,0.00017687307,0.013808393],"study_design_scores_gemma":[0.0010030479,0.000107220236,0.0019737808,0.55541193,0.4347702,0.000039456754,0.000037649424,0.0000056176136,0.000010966867,0.0000049952396,0.0063451123,0.00029001455],"about_ca_topic_score_codex":0.0023554733,"about_ca_topic_score_gemma":0.0007987909,"teacher_disagreement_score":0.403847,"about_ca_system_score_codex":0.0003666506,"about_ca_system_score_gemma":0.0006727533,"threshold_uncertainty_score":0.99991864},"labels":[],"label_agreement":null},{"id":"W2593744678","doi":"10.1158/1538-7445.sabcs16-p5-14-05","title":"Abstract P5-14-05: Capecitabine in early breast cancer: A meta-analysis of randomized controlled trials","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Capecitabine; Medicine; Internal medicine; Oncology; Breast cancer; Hazard ratio; Triple-negative breast cancer; Anthracycline; Taxane; Fluorouracil; Randomized controlled trial; Chemotherapy; Cancer; Confidence interval; Colorectal cancer","score_opus":0.28977627776189213,"score_gpt":0.5348622269796955,"score_spread":0.2450859492178034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593744678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9421445,0.029288577,0.0000026907608,0.01798848,0.00033803115,0.0053417115,0.0007366014,0.0000185857,0.0041407975],"genre_scores_gemma":[0.98065615,0.006689601,0.000016159445,0.00011402454,0.00036928518,0.0055227345,0.000022445207,0.000027569027,0.0065820296],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946867,0.0015360244,0.0015916957,0.0005113594,0.0010556524,0.0006185513],"domain_scores_gemma":[0.9931241,0.003952015,0.0008936574,0.00081001665,0.000969401,0.0002508014],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.015302081,0.0002793737,0.011523407,0.001302603,0.0001941267,0.00008652464,0.0004036171,0.00016214061,0.020671705],"category_scores_gemma":[0.0021344246,0.0001658056,0.0041759214,0.0006849687,0.00063593365,0.00013939252,0.00009411166,0.0005594815,0.000015951648],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51184154,0.0006149035,0.010440876,0.00013415872,0.4525256,0.0001546351,0.00060417264,0.0001032704,0.017533774,0.00012112275,0.0035339824,0.0023920166],"study_design_scores_gemma":[0.58495486,0.00015739298,0.0789163,0.000063386644,0.3315175,0.0000033766466,0.000047109963,0.00018122568,0.0032570076,0.000115960116,0.00059582473,0.00019006793],"about_ca_topic_score_codex":0.058821496,"about_ca_topic_score_gemma":0.009692314,"teacher_disagreement_score":0.1210081,"about_ca_system_score_codex":0.0004213551,"about_ca_system_score_gemma":0.00095086294,"threshold_uncertainty_score":0.98022354},"labels":[],"label_agreement":null},{"id":"W2594164534","doi":"10.1182/blood.v104.11.1860.1860","title":"Comparison of the Anticoagulant Effect of Melagatran and Lmwh in an Acquired Antithrombin Deficiency in Children with All Treated with L-Asparaginase.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital","funders":"","keywords":"Ximelagatran; Direct thrombin inhibitor; Asparaginase; Anticoagulant; Medicine; Antithrombin; Thrombosis; Population; Low molecular weight heparin; Warfarin; Discovery and development of direct thrombin inhibitors; Pharmacology; Heparin; Internal medicine; Surgery; Immunology; Thrombin; Leukemia; Lymphoblastic Leukemia; Platelet","score_opus":0.014549307280928167,"score_gpt":0.3135924123303691,"score_spread":0.2990431050494409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594164534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99823606,0.00083770225,0.000001020179,0.00009037968,0.000007397447,0.0007427747,0.0000066341936,0.000009471196,0.00006856245],"genre_scores_gemma":[0.9998516,0.00002722083,0.00005634468,0.000016203881,0.000006185371,0.000012457894,0.000015454216,0.000010789712,0.0000037451985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992925,0.00006593659,0.00018156489,0.00017771992,0.00012508556,0.00015717585],"domain_scores_gemma":[0.999673,0.000022981183,0.00008439073,0.00016075329,0.00001630549,0.00004253682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008242095,0.00013025178,0.0004590799,0.000091830625,0.000014570159,0.0000029328385,0.00006052057,0.000044869677,0.000005803518],"category_scores_gemma":[0.0000026197217,0.000070057664,0.000022492188,0.00028247375,0.0001618396,0.0000385142,0.000011213725,0.000069337504,2.2293936e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007630932,0.0024928544,0.9551597,0.000064181884,0.0001113614,0.000023030705,0.0006734762,0.00008614768,0.04051258,0.00001353684,0.0000013588811,0.000098676705],"study_design_scores_gemma":[0.01968837,0.0053489483,0.69471323,0.0001609551,0.0005182137,0.00007743838,0.00002359856,0.000013051526,0.2793986,0.0000032462333,3.3667305e-7,0.000053986434],"about_ca_topic_score_codex":0.0011927326,"about_ca_topic_score_gemma":0.0014967194,"teacher_disagreement_score":0.26044643,"about_ca_system_score_codex":0.00002032886,"about_ca_system_score_gemma":0.00005989181,"threshold_uncertainty_score":0.28568688},"labels":[],"label_agreement":null},{"id":"W2594239688","doi":"10.1016/j.addr.2017.02.003","title":"The battle of “nano” paclitaxel","year":2017,"lang":"en","type":"review","venue":"Advanced Drug Delivery Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":397,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Carleton University","keywords":"Paclitaxel; Battle; Nano-; Pharmacology; Chemistry; Medicine; Internal medicine; Chemotherapy; Engineering; Chemical engineering; History; Ancient history","score_opus":0.14799676776173568,"score_gpt":0.4581610657877207,"score_spread":0.310164298025985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594239688","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000517834,0.99115825,0.0000014327582,0.00010660369,0.0015819957,0.002413372,0.00006567428,0.000023543409,0.0046439543],"genre_scores_gemma":[0.000001938005,0.98480916,0.0002099797,0.000075341755,0.00034281056,0.00059644086,0.00012996905,0.00005650766,0.013777839],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975218,0.00028638175,0.0011631662,0.00044053665,0.00019136738,0.00039672406],"domain_scores_gemma":[0.9958704,0.000978545,0.0015004094,0.0013982761,0.000100795514,0.00015157077],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006010565,0.0005058024,0.0035753516,0.00007749203,0.00023812063,0.00001721526,0.0004721753,0.000121442004,0.00018982346],"category_scores_gemma":[0.0003299818,0.00026932423,0.0014659537,0.00014737195,0.00023948002,0.00009278043,0.00012860745,0.0003864457,0.0005090094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003241161,0.0000761142,0.0000033582678,0.01373568,0.00025648903,0.000018798984,0.000015702768,3.7954184e-8,0.0000032484866,0.000024979112,0.023040736,0.96279246],"study_design_scores_gemma":[0.00057341147,0.000117059615,0.0000015730145,0.019122308,0.0033336396,0.000057503967,0.000004447531,2.6988684e-7,0.00000974193,0.000018176986,0.9765483,0.00021354688],"about_ca_topic_score_codex":0.000020626501,"about_ca_topic_score_gemma":0.000040591287,"teacher_disagreement_score":0.9625789,"about_ca_system_score_codex":0.00018153214,"about_ca_system_score_gemma":0.00040039848,"threshold_uncertainty_score":0.9999759},"labels":[],"label_agreement":null},{"id":"W2594425395","doi":"10.1145/3055282.3055299","title":"Fermat benchmarks for rational expressionals in maple","year":2017,"lang":"en","type":"article","venue":"ACM communications in computer algebra","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Maple; Fermat's Last Theorem; Benchmark (surveying); Set (abstract data type); Undo; Factor (programming language); Computer science; Fermat number; Mathematics; Algebra over a field; Discrete mathematics; Programming language; Pure mathematics","score_opus":0.10578383142872837,"score_gpt":0.43353890776434156,"score_spread":0.3277550763356132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594425395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84417427,0.0023025891,0.0030452816,0.13846445,0.00089239556,0.0025295417,0.00008305352,0.00006858972,0.008439822],"genre_scores_gemma":[0.9217191,0.00022896734,0.07578137,0.0010722608,0.00013727606,0.00039675503,0.00046020185,0.000009618911,0.00019449003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928796,0.00005841524,0.00025389137,0.0001634733,0.000084725594,0.00015151195],"domain_scores_gemma":[0.997201,0.0004937564,0.00009440929,0.0021045895,0.000060439637,0.000045807054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019973189,0.00009458236,0.00019828472,0.00012348655,0.000249118,0.0000400159,0.0010225073,0.000065831184,0.00019693958],"category_scores_gemma":[0.00008433444,0.00009087307,0.00005906816,0.00005467319,0.000111744004,0.00014715297,0.0007317266,0.00017133002,0.000011130283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006838972,0.004242563,0.64666986,0.00015255195,0.00025930762,0.000033045875,0.0031115278,0.00015275467,0.002955736,0.033829734,0.17743133,0.13047771],"study_design_scores_gemma":[0.009720353,0.00022962938,0.8364772,0.00032736943,0.000057286547,0.00003326174,0.000034768575,0.024604259,0.000716532,0.03316564,0.09435808,0.0002756245],"about_ca_topic_score_codex":0.00008480562,"about_ca_topic_score_gemma":0.0003741399,"teacher_disagreement_score":0.18980736,"about_ca_system_score_codex":0.00010006351,"about_ca_system_score_gemma":0.00010600975,"threshold_uncertainty_score":0.37056965},"labels":[],"label_agreement":null},{"id":"W2595403935","doi":"10.1200/jco.2012.30.15_suppl.9131","title":"Prevalence of cancer-related fatigue in a population-based sample of colorectal, breast, and prostate cancer survivors.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cancer; Breast cancer; Survivorship curve; Population; Quality of life (healthcare); Internal medicine; Prostate cancer; Depression (economics); Colorectal cancer; Physical therapy; Disease; Oncology","score_opus":0.10282846162688326,"score_gpt":0.4932229183544065,"score_spread":0.39039445672752326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595403935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222356,0.0043598865,0.000004228334,0.0021088363,0.00083739765,0.0003078716,0.00007192453,0.000004027346,0.000082255865],"genre_scores_gemma":[0.9954004,0.0033946936,0.00073682243,0.00019566252,0.00019058178,0.000016398022,0.0000041349604,0.000010024117,0.000051279214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738103,0.00034568543,0.0017710859,0.00011186501,0.00019116032,0.00019920067],"domain_scores_gemma":[0.995364,0.0023243898,0.0017408858,0.000072490526,0.00028532156,0.00021291125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014898191,0.00010682089,0.0011310616,0.00014544201,0.000013194132,0.0000010885335,0.00006634751,0.0002272192,0.0004530992],"category_scores_gemma":[0.0004870827,0.000079436395,0.00016459447,0.00019245264,0.00015934324,0.00009083782,0.000019256246,0.00038827516,3.0082194e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048364596,0.0023601577,0.9698836,0.00028682657,0.00027584026,0.00001202055,0.0003644209,0.00012602475,0.00040292245,0.00001738791,0.00013633909,0.021297969],"study_design_scores_gemma":[0.008454742,0.00384149,0.9854022,0.00025419588,0.000620154,0.00003315294,0.000021028958,0.0002802014,0.00034597385,0.0000613483,0.00062430324,0.00006118675],"about_ca_topic_score_codex":0.007679241,"about_ca_topic_score_gemma":0.002784977,"teacher_disagreement_score":0.021236781,"about_ca_system_score_codex":0.00018632262,"about_ca_system_score_gemma":0.0012505064,"threshold_uncertainty_score":0.9989287},"labels":[],"label_agreement":null},{"id":"W2596486877","doi":"10.1200/jco.2004.22.90140.630","title":"A multi-centre phase II trial of pegylated liposomal doxorubicin and trastuzumab in HER-2 over-expressing metastatic breast cancer (MBC)","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Metastatic breast cancer; Anthracycline; Trastuzumab; Ejection fraction; Cardiotoxicity; Doxorubicin; Internal medicine; Breast cancer; Cancer; Heart failure; Oncology; Chemotherapy","score_opus":0.1422473115020502,"score_gpt":0.5265052184546788,"score_spread":0.3842579069526286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596486877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99043995,0.0012552956,0.00003178978,0.006603307,0.0010958283,0.00044681967,0.000029049279,0.0000064063356,0.00009152367],"genre_scores_gemma":[0.99503076,0.0011781995,0.0022427726,0.0006525,0.0007700377,0.000006375863,0.0000033531153,0.000017583736,0.000098392804],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965832,0.0003786921,0.0022874288,0.00021734096,0.00025516588,0.00027817077],"domain_scores_gemma":[0.9970823,0.0007838467,0.0014980165,0.000102932805,0.00019922701,0.00033369518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011025096,0.00018500272,0.0018800473,0.00020264446,0.000039781335,0.000005319939,0.000091832124,0.00025145325,0.00033776846],"category_scores_gemma":[0.00037533362,0.00013405642,0.00035133923,0.00019095534,0.00025266412,0.00012990047,0.000045029385,0.0008000253,0.0000011227272],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5181255,0.10322281,0.021914313,0.00016414956,0.0022832528,0.003680516,0.0023287917,0.00025314078,0.050818797,0.00002169203,0.00076142274,0.29642567],"study_design_scores_gemma":[0.86726236,0.06480657,0.059053693,0.0005383471,0.002188121,0.00093372347,0.000259558,0.00035530803,0.0015711962,0.00010655754,0.0027525981,0.00017193721],"about_ca_topic_score_codex":0.00043846926,"about_ca_topic_score_gemma":0.00062989676,"teacher_disagreement_score":0.34913695,"about_ca_system_score_codex":0.00037963895,"about_ca_system_score_gemma":0.002233856,"threshold_uncertainty_score":0.5466662},"labels":[],"label_agreement":null},{"id":"W2596681760","doi":"10.1200/jco.2013.31.15_suppl.e20568","title":"Differences in pain, symptom burden, and opioid use among cancer pain patients with active versus non-active disease.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Disease; Opioid; Anxiety; Cancer pain; Depression (economics); Cancer; Internal medicine; Physical therapy; Psychiatry","score_opus":0.0815141294209158,"score_gpt":0.42356041457200744,"score_spread":0.34204628515109164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596681760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949881,0.00016984707,0.000014425498,0.0034009921,0.000771219,0.00050965976,0.000012580824,0.000004734482,0.00012846249],"genre_scores_gemma":[0.99675673,0.00095316494,0.0001296339,0.0011780707,0.00076889124,0.000056242636,0.0000065766817,0.000013536014,0.00013717297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977626,0.0006964563,0.0008426594,0.00021632561,0.0002361641,0.00024576715],"domain_scores_gemma":[0.9928044,0.005314431,0.0008548508,0.00009197053,0.00040970606,0.00052463287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072200847,0.0001690375,0.0010475486,0.00011741652,0.000034031804,0.0000134791935,0.000083430525,0.0002019841,0.0003958226],"category_scores_gemma":[0.0014669606,0.000104935796,0.00013712297,0.00010958105,0.000337642,0.00028436113,0.0000358272,0.00066339964,0.0000031161542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018476339,0.0009789142,0.7659187,0.000016634558,0.0005063172,0.00011842796,0.00028576795,0.000002710583,0.0000059265894,0.0000013011608,0.0013196991,0.21236928],"study_design_scores_gemma":[0.020831,0.016924623,0.9585646,0.00016705094,0.00045436085,0.0000013405388,0.00024086414,0.00020893614,0.000006472956,0.000037965758,0.0024573423,0.000105492494],"about_ca_topic_score_codex":0.0009996569,"about_ca_topic_score_gemma":0.00066513394,"teacher_disagreement_score":0.2122638,"about_ca_system_score_codex":0.0002849421,"about_ca_system_score_gemma":0.0008663376,"threshold_uncertainty_score":0.433398},"labels":[],"label_agreement":null},{"id":"W2596927554","doi":"","title":"Professor Hope S. Rugo: Reversing resistance and hormone therapy for metastatic breast cancer","year":2013,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian College of Osteopathy","funders":"","keywords":"Reversing; Metastatic breast cancer; Medicine; Breast cancer; Cancer; Acquired resistance; Hormone therapy; Oncology; Internal medicine; Engineering","score_opus":0.03014076374366816,"score_gpt":0.3482695949574836,"score_spread":0.31812883121381547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596927554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91814667,0.015641674,0.00012717675,0.058886427,0.0002116618,0.0030696157,0.00006928601,0.00006975591,0.0037777605],"genre_scores_gemma":[0.92504776,0.004164025,0.004232442,0.003722098,0.00019798393,0.00095064915,0.00002021237,0.000027442897,0.061637383],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.999437,0.00001795011,0.00011443492,0.00017345906,0.00006883367,0.0001883653],"domain_scores_gemma":[0.9996246,0.00006485041,0.000041057727,0.00009069995,0.000092200105,0.00008658969],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000612162,0.00010427399,0.00021101479,0.000037007438,0.0000858437,0.000013676052,0.000026586496,0.000026685013,0.0010253029],"category_scores_gemma":[0.000003510702,0.00007198747,0.000038771675,0.00007331629,0.000049195587,0.00009699111,0.000008742681,0.000052960728,0.000009872179],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059754527,0.0007763647,0.010354311,0.0004138025,0.0011552899,0.000016768625,0.0013124703,5.0152033e-7,0.1134057,0.00061417616,0.7728245,0.09315065],"study_design_scores_gemma":[0.0655007,0.002248615,0.5530688,0.00037256617,0.0016157312,0.00015221104,0.0012721921,0.00040584258,0.021381902,0.0024748517,0.3505806,0.0009259827],"about_ca_topic_score_codex":0.00043989974,"about_ca_topic_score_gemma":0.00017514157,"teacher_disagreement_score":0.5427145,"about_ca_system_score_codex":0.00006372617,"about_ca_system_score_gemma":0.000057096342,"threshold_uncertainty_score":0.9998879},"labels":[],"label_agreement":null},{"id":"W2597223639","doi":"10.1200/jco.2007.25.18_suppl.1099","title":"Randomized phase II study of biweekly gemcitabine (gem)-paclitaxel (pac), gem-carboplatin (carb) and gem-cisplatin (cis) as first-line treatments in metastatic breast cancer (MBC) after anthracycline failure","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Clinical endpoint; Metastatic breast cancer; Interim analysis; Internal medicine; Carboplatin; Gemcitabine; Anthracycline; Breast cancer; Phases of clinical research; Surgery; Performance status; Chemotherapy; Oncology; Urology; Cancer; Randomized controlled trial; Gastroenterology; Cisplatin","score_opus":0.09059287299246062,"score_gpt":0.5155515087569532,"score_spread":0.4249586357644926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597223639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98404956,0.0028142359,0.00007634363,0.009640361,0.0009981575,0.0020028544,0.000084924126,0.000014983033,0.00031858997],"genre_scores_gemma":[0.9922102,0.0033531126,0.0015705072,0.0010502622,0.0010292698,0.00009645179,0.000016860486,0.000051708306,0.00062161736],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99163806,0.0010585121,0.005525913,0.0005364032,0.00064612087,0.000595013],"domain_scores_gemma":[0.9891904,0.0061301943,0.0031487958,0.00032155952,0.0005359807,0.0006730451],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0063300417,0.0005159233,0.005292076,0.0006628984,0.00008629977,0.000011935303,0.00018962371,0.00042039168,0.0013873888],"category_scores_gemma":[0.0014757706,0.0003504001,0.00074348436,0.0005138485,0.00055568496,0.0002420939,0.00014039206,0.0012094023,0.0000068435925],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7342618,0.061567247,0.10182502,0.00012866045,0.0055462955,0.005908987,0.0018486015,0.000068413574,0.000784821,0.000011657004,0.0007901361,0.08725835],"study_design_scores_gemma":[0.7625472,0.07442766,0.15033181,0.00029773053,0.0078345435,0.0008566406,0.0007114634,0.0003991197,0.00012462572,0.00023717126,0.0019453826,0.0002866741],"about_ca_topic_score_codex":0.0012388753,"about_ca_topic_score_gemma":0.005645954,"teacher_disagreement_score":0.08697168,"about_ca_system_score_codex":0.00038571662,"about_ca_system_score_gemma":0.00084966514,"threshold_uncertainty_score":0.9998948},"labels":[],"label_agreement":null},{"id":"W2597562859","doi":"10.1200/jco.2017.35.5_suppl.219","title":"A preliminary evaluation of the TrueNTH androgen deprivation therapy educational program.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; University Health Network; Baker Hughes (Canada); Prostate Cancer Canada; University of British Columbia","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Quality of life (healthcare); Adverse effect; Internal medicine; Oncology; Cancer; Physical therapy; Nursing","score_opus":0.3617694813062418,"score_gpt":0.6086548668789356,"score_spread":0.24688538557269374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597562859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9626657,0.0007652368,0.0000027869746,0.029848196,0.0016480335,0.00054343964,0.0000012803979,0.000002054793,0.004523318],"genre_scores_gemma":[0.99698937,0.00046311656,0.0006358709,0.00052063336,0.0011730707,0.000025043246,0.000002152138,0.000005616034,0.00018510192],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99798155,0.00039252493,0.00094181445,0.000088493536,0.00051197817,0.000083643594],"domain_scores_gemma":[0.9956652,0.0006010874,0.002303889,0.00023024036,0.0011123278,0.000087284905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003825829,0.00006317838,0.00046596114,0.0000402998,0.00008788219,0.0000064790015,0.00019865723,0.00015381006,0.00034622304],"category_scores_gemma":[0.0029644913,0.000035441222,0.00032189785,0.000039019134,0.00023634147,0.00008852396,0.000032571017,0.00028846267,0.000002766788],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003609181,0.0040035504,0.3338095,0.000006943536,0.00035329998,0.0000040633113,0.00009687014,0.000007036373,0.0002688687,0.00006463353,0.0040103043,0.65376574],"study_design_scores_gemma":[0.010852973,0.010597314,0.9417555,0.000036935482,0.0006860425,0.00010139822,0.00001507156,0.0001856529,0.0006228656,0.0014556402,0.03366138,0.00002922345],"about_ca_topic_score_codex":0.000014101577,"about_ca_topic_score_gemma":0.000019956493,"teacher_disagreement_score":0.65373653,"about_ca_system_score_codex":0.00015669364,"about_ca_system_score_gemma":0.0037846216,"threshold_uncertainty_score":0.67137563},"labels":[],"label_agreement":null},{"id":"W2597837743","doi":"10.1200/jco.2013.31.15_suppl.e13503","title":"Development of a new equation to estimate GFR in cancer patients.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Carboplatin; Medicine; Renal function; Body surface area; Urology; Dosing; Lung cancer; Creatinine; Pharmacokinetics; Lean body mass; Internal medicine; Oncology; Nuclear medicine; Chemotherapy; Cisplatin; Body weight","score_opus":0.2701873512720473,"score_gpt":0.5754353173007194,"score_spread":0.3052479660286721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597837743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908862,0.000120493314,0.0001279392,0.0068617486,0.0008834053,0.0002787363,5.0642825e-7,0.0000022631118,0.0008386836],"genre_scores_gemma":[0.9711263,0.0000902595,0.025893005,0.0019708404,0.00038759143,0.000015912787,0.0000021247108,0.0000072571597,0.0005067066],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978403,0.00007546866,0.0016884779,0.00008815736,0.00017314321,0.00013445303],"domain_scores_gemma":[0.99819076,0.00038458442,0.0007917936,0.00004950465,0.0003000361,0.00028330905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064116914,0.000070175636,0.00075127266,0.00012786535,0.000008997078,0.000001852054,0.00006523577,0.00013513354,0.00087760127],"category_scores_gemma":[0.00057170296,0.000049972965,0.000108085645,0.000121336416,0.00002760418,0.00006275286,0.000026052196,0.00025524708,0.00003824649],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001616596,0.0025489104,0.33584803,0.000017812448,0.00015421877,0.000018385492,0.00075689174,0.00005606145,0.000649294,0.000013582544,0.013033093,0.6452871],"study_design_scores_gemma":[0.0096062,0.006754829,0.91211337,0.000090786816,0.00011810421,0.000005115921,0.000024947582,0.00006795839,0.00061079056,0.00013286284,0.070426434,0.000048583912],"about_ca_topic_score_codex":0.00020815573,"about_ca_topic_score_gemma":0.00045365508,"teacher_disagreement_score":0.6452385,"about_ca_system_score_codex":0.00028370405,"about_ca_system_score_gemma":0.0024894844,"threshold_uncertainty_score":0.9609118},"labels":[],"label_agreement":null},{"id":"W2598128017","doi":"10.1200/jco.2013.31.15_suppl.e14556","title":"Are XELOX and FOLFOX equivalent in colorectal cancer? Dose intensity, toxicity, and treatment duration in clinical practice.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"FOLFOX; Oxaliplatin; Medicine; Capecitabine; Internal medicine; Nausea; Colorectal cancer; Cumulative dose; Gastroenterology; Surgery; Oncology; Cancer","score_opus":0.20942390221721394,"score_gpt":0.5424612950939143,"score_spread":0.3330373928767003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598128017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95394546,0.0013752757,0.0000023589857,0.04235302,0.0011602518,0.00055786356,0.0000024261653,0.0000051598645,0.0005981584],"genre_scores_gemma":[0.97994316,0.014298771,0.0007182378,0.003935898,0.00096305786,0.00003292056,0.0000016442373,0.000010787534,0.00009550739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961928,0.0006323572,0.0024903645,0.000264161,0.00018136433,0.00023895767],"domain_scores_gemma":[0.99408054,0.0032909417,0.0018541504,0.00007747176,0.00032932175,0.00036754488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022749046,0.00016478903,0.0016154296,0.00017398236,0.000024927114,0.000014994538,0.000057703146,0.00041921771,0.00014021959],"category_scores_gemma":[0.0027705284,0.00011594033,0.00018903746,0.00012305474,0.00026495894,0.00024170196,0.00008079748,0.000809158,0.00000739375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008960657,0.0062723956,0.7877497,0.000015810383,0.00029228296,0.0011824423,0.00021182034,0.0000025995048,0.0003798109,0.000015603264,0.0018716701,0.19304523],"study_design_scores_gemma":[0.024402052,0.023172697,0.9418922,0.000102276186,0.0004032648,0.0005631663,0.00033536783,0.00021435936,0.00010627256,0.00021551421,0.008501733,0.00009106266],"about_ca_topic_score_codex":0.000611422,"about_ca_topic_score_gemma":0.004050855,"teacher_disagreement_score":0.19295417,"about_ca_system_score_codex":0.0005179731,"about_ca_system_score_gemma":0.00080222276,"threshold_uncertainty_score":0.47279096},"labels":[],"label_agreement":null},{"id":"W2598143957","doi":"10.1200/jco.2013.31.15_suppl.6595","title":"Patient perceptions about potential side effects and benefits from chemotherapy agents.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; McGill University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Nausea; Medicine; Mucositis; Side effect (computer science); Vomiting; Quality of life (healthcare); Chemotherapy; Internal medicine; Surgery","score_opus":0.06326017516239979,"score_gpt":0.4419449892995883,"score_spread":0.3786848141371885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598143957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98517704,0.0013549882,0.000029623008,0.010067396,0.0016819296,0.00029511558,0.0000044379626,0.000008004929,0.0013814701],"genre_scores_gemma":[0.9825305,0.003866775,0.0017491232,0.009976095,0.0016421048,0.000010765098,0.0000056911786,0.000013426228,0.00020553655],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982678,0.00020695818,0.0010267261,0.00015244672,0.00017470487,0.000171341],"domain_scores_gemma":[0.99773884,0.00093951344,0.00062574906,0.00009583864,0.0002049304,0.00039510202],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002771441,0.000117631345,0.0008816583,0.00006591389,0.00004143728,0.000009603114,0.000056382545,0.0002704471,0.002019325],"category_scores_gemma":[0.00023188746,0.00008171839,0.00030358764,0.000045928497,0.00013845981,0.00008775182,0.000029427705,0.00049791986,0.000071716895],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017774432,0.0028911096,0.07543372,0.000017353628,0.0008469724,0.00030271814,0.000398747,0.000014464439,0.0029010028,0.000010353053,0.03246213,0.882944],"study_design_scores_gemma":[0.011398586,0.013034549,0.94743437,0.000051675626,0.00054528576,0.00016199099,0.000068198635,0.000085420266,0.00013508757,0.0003040246,0.026710479,0.00007031762],"about_ca_topic_score_codex":0.00016793954,"about_ca_topic_score_gemma":0.000020950889,"teacher_disagreement_score":0.88287365,"about_ca_system_score_codex":0.000085901294,"about_ca_system_score_gemma":0.00028298996,"threshold_uncertainty_score":0.99889296},"labels":[],"label_agreement":null},{"id":"W2598864615","doi":"10.1200/jco.2012.30.15_suppl.e13598","title":"Pharmacodynamic evaluation of pCDC2 as the target engagement biomarker to assess activity of MK-1775 a Wee1 tyrosine kinase inhibitor.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Gemcitabine; Wee1; Pharmacodynamics; Pharmacology; Oncology; Chemotherapy; Cisplatin; Biomarker; Tolerability; Internal medicine; Urology; Pharmacokinetics; Cancer; Cyclin-dependent kinase 1; Adverse effect","score_opus":0.39022315236694166,"score_gpt":0.585126215296599,"score_spread":0.19490306292965737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598864615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98256737,0.0010052248,0.00012395423,0.009198581,0.0032154045,0.0006361096,0.000011414444,0.000004666471,0.0032372454],"genre_scores_gemma":[0.9959815,0.00029919224,0.0008520537,0.0013151813,0.001374755,0.000022159846,0.0000038160333,0.00001462315,0.00013668869],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9950837,0.0021273608,0.0016297827,0.00014296664,0.00075688487,0.00025932194],"domain_scores_gemma":[0.99421936,0.002485862,0.0018201787,0.00018983726,0.00094245933,0.00034231134],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.014309386,0.00015146783,0.0011454769,0.00016359695,0.00004173502,0.000003051676,0.00016085444,0.00020913953,0.0012897744],"category_scores_gemma":[0.002245727,0.000093413444,0.00043109266,0.00025014085,0.00019520136,0.00014582586,0.00008963667,0.0006697937,0.0000150421265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025922459,0.022881955,0.12025208,0.000148443,0.003014915,0.00008191609,0.00088767544,0.0001444092,0.3520206,0.00010202515,0.029748898,0.44479463],"study_design_scores_gemma":[0.02703834,0.017595991,0.77372825,0.00015472976,0.0059932787,0.00015806191,0.00020879244,0.0010975308,0.06999875,0.0001881868,0.10366192,0.00017616306],"about_ca_topic_score_codex":0.000048791906,"about_ca_topic_score_gemma":0.000014448986,"teacher_disagreement_score":0.6534762,"about_ca_system_score_codex":0.0003563054,"about_ca_system_score_gemma":0.0017236761,"threshold_uncertainty_score":0.9996232},"labels":[],"label_agreement":null},{"id":"W2599063392","doi":"10.1200/jco.2017.35.4_suppl.789","title":"ECOG performance status as a predictor of adjuvant chemotherapy (AC) toxicities in stage III colorectal cancer (CRC) patients.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Capecitabine; Nausea; Performance status; FOLFOX; Cohort; Anemia; Cancer; Adjuvant therapy; Vomiting; Univariate analysis; Colorectal cancer; Gastroenterology; Oncology; Surgery; Oxaliplatin; Multivariate analysis","score_opus":0.08958946198783549,"score_gpt":0.48544376314409,"score_spread":0.39585430115625453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599063392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890223,0.0006510764,0.0000011226234,0.0017703874,0.0022055644,0.0003473274,0.000038839215,0.0000054718234,0.0059579154],"genre_scores_gemma":[0.9837169,0.013147773,0.00015542406,0.0010935547,0.000809816,0.000016643235,0.0000047992107,0.000018082426,0.0010369914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971685,0.00015177108,0.0018520954,0.00017968328,0.0003155841,0.00033240052],"domain_scores_gemma":[0.9959268,0.0005982907,0.002600714,0.00018619694,0.0003859556,0.00030207308],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009249876,0.00016570943,0.0016374089,0.00013640436,0.000063340536,0.000007936286,0.00023034887,0.00031369168,0.0013204365],"category_scores_gemma":[0.0006393688,0.00011995226,0.0003217848,0.000054881944,0.0004685379,0.0002324228,0.000060520357,0.00073373877,0.0000056791123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021274282,0.003109576,0.8880686,0.00006189277,0.0004319079,0.00012727086,0.00061333115,0.000012860668,0.00038358214,0.00001574336,0.0016636659,0.08423729],"study_design_scores_gemma":[0.034962606,0.027637558,0.9008269,0.000152618,0.00021966182,0.00001729182,0.00010349742,0.00010901314,0.0018810859,0.000030747928,0.033966884,0.00009218805],"about_ca_topic_score_codex":0.00046333132,"about_ca_topic_score_gemma":0.00063461706,"teacher_disagreement_score":0.08414511,"about_ca_system_score_codex":0.000387534,"about_ca_system_score_gemma":0.0025132373,"threshold_uncertainty_score":0.9995925},"labels":[],"label_agreement":null},{"id":"W2599371299","doi":"10.1200/jco.2013.31.15_suppl.e11597","title":"Bevacizumab for advanced breast cancer: Hope, hype, and hundreds of headlines.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; Queen's University; University of Toronto","funders":"","keywords":"Medicine; Bevacizumab; Breast cancer; Newspaper; Headline; Food and drug administration; Family medicine; Clinical trial; Cancer; Oncology; Internal medicine; Advertising; Pharmacology; Chemotherapy","score_opus":0.10516201181284197,"score_gpt":0.5141664109434135,"score_spread":0.40900439913057157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599371299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655775,0.0028269922,0.000045662615,0.02900522,0.0012247503,0.00046341747,0.000025676478,0.000005565765,0.00082523096],"genre_scores_gemma":[0.9852323,0.0062379357,0.0038290115,0.0024174198,0.0015434021,0.00003553233,0.0000032244611,0.000016917522,0.0006842551],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978589,0.00009958507,0.0015603761,0.00014329224,0.00014275814,0.00019509287],"domain_scores_gemma":[0.9961723,0.0013941881,0.0012136636,0.00009946353,0.00080485945,0.00031554507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066488975,0.00011563627,0.001419522,0.000095477284,0.000026007096,0.00000351186,0.00008667614,0.0002441953,0.00047015937],"category_scores_gemma":[0.0003783687,0.000081839535,0.00031806072,0.00009382373,0.0002218057,0.00011922101,0.000029299687,0.0003654028,0.0000041308153],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011099513,0.002045567,0.054441158,0.00011305334,0.00070984976,0.000046930196,0.00007627606,0.0000125966635,0.0026739445,0.000060617436,0.025917301,0.9028032],"study_design_scores_gemma":[0.074511446,0.045637045,0.6357581,0.00025425674,0.0022962561,0.0019001167,0.00019900061,0.00033816256,0.0010711544,0.001519709,0.23627742,0.00023731306],"about_ca_topic_score_codex":0.00010221549,"about_ca_topic_score_gemma":0.00006739268,"teacher_disagreement_score":0.9025659,"about_ca_system_score_codex":0.00010122053,"about_ca_system_score_gemma":0.0011370344,"threshold_uncertainty_score":0.51479155},"labels":[],"label_agreement":null},{"id":"W2599456777","doi":"10.1200/jco.2006.24.18_suppl.14513","title":"Randomized phase II trial of irofulven (IROF)/prednisone (P), IROF/capecitabine (C)/P or mitoxantrone (M)/P in docetaxel-pretreated hormone refractory prostate cancer (HRPC) patients (pts)","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Docetaxel; Mitoxantrone; Clinical endpoint; Capecitabine; Internal medicine; Prostate cancer; Urology; Refractory (planetary science); Gastroenterology; Phases of clinical research; Chemotherapy; Randomized controlled trial; Surgery; Oncology; Cancer","score_opus":0.07944983119989771,"score_gpt":0.4741449583049285,"score_spread":0.39469512710503074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599456777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98540914,0.004498625,0.000010563308,0.003986046,0.0026699672,0.0022383947,0.00008245807,0.000019036468,0.0010857729],"genre_scores_gemma":[0.98183435,0.011635375,0.0005364783,0.0005348386,0.0025400005,0.00011879973,0.00007067904,0.00004751969,0.0026819557],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9908928,0.0014302112,0.006040892,0.00041614904,0.0006650098,0.0005548815],"domain_scores_gemma":[0.9904366,0.0034239509,0.0047072363,0.00028713632,0.0007421297,0.00040291942],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003405782,0.0004032891,0.0053793364,0.00045953772,0.00006591644,0.000007819259,0.00024412558,0.00056986004,0.0010658506],"category_scores_gemma":[0.0023967181,0.00025920908,0.001063445,0.00044899643,0.00059062126,0.00021293992,0.00009285713,0.0012659286,0.000008427448],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87562376,0.050129697,0.0068124975,0.000051419695,0.0010077155,0.0006928103,0.00019482817,0.000020099815,0.0026218737,0.000005865413,0.01249444,0.05034501],"study_design_scores_gemma":[0.8671007,0.089233354,0.013081408,0.00015022226,0.002301267,0.000044206037,0.000031935866,0.00010288891,0.00041747067,0.00011189233,0.027221167,0.00020348644],"about_ca_topic_score_codex":0.0006185713,"about_ca_topic_score_gemma":0.0004535688,"teacher_disagreement_score":0.050141525,"about_ca_system_score_codex":0.00061647885,"about_ca_system_score_gemma":0.0022515582,"threshold_uncertainty_score":0.999986},"labels":[],"label_agreement":null},{"id":"W2599524623","doi":"10.1200/jco.2012.30.15_suppl.587","title":"Endocrine therapy in early breast cancer: Encouraging observations in a nontrial setting.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Letrozole; Exemestane; Tamoxifen; Breast cancer; Internal medicine; Cancer; Aromatase inhibitor; Metastatic breast cancer; Surgery; Oncology; Gynecology","score_opus":0.20944872204652545,"score_gpt":0.5267936544192303,"score_spread":0.3173449323727049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599524623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666317,0.0015564187,0.000004178515,0.028412107,0.002551725,0.00022957235,0.000006116028,0.0000053333565,0.00060284423],"genre_scores_gemma":[0.98822415,0.0033060599,0.00062250806,0.0031261947,0.0045613986,0.000017564007,0.0000017558181,0.000011628963,0.0001287663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728996,0.0003945265,0.0016741861,0.00010937312,0.00018229132,0.00034964815],"domain_scores_gemma":[0.9970739,0.0016183752,0.00080491946,0.000082915314,0.00015970148,0.00026020422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023006187,0.00011130955,0.0010258993,0.0002102768,0.000019417064,0.0000041881485,0.00009713548,0.00017492515,0.00033651697],"category_scores_gemma":[0.00043069775,0.00008149909,0.0002471969,0.0002422987,0.0000729084,0.00019892778,0.000022934699,0.0009464094,0.0000059814674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060954853,0.002850697,0.8684906,0.000005274908,0.00013901647,0.00029495676,0.0004380601,0.000012166999,0.0003644609,0.0000232467,0.0016664001,0.11961965],"study_design_scores_gemma":[0.02601448,0.0030839732,0.9347832,0.000066300774,0.000104509956,0.0003537725,0.000052791507,0.000034848348,0.000034700417,0.00006381114,0.035344314,0.00006326363],"about_ca_topic_score_codex":0.00065586047,"about_ca_topic_score_gemma":0.0005988662,"teacher_disagreement_score":0.11955639,"about_ca_system_score_codex":0.00037505027,"about_ca_system_score_gemma":0.0012708894,"threshold_uncertainty_score":0.41117308},"labels":[],"label_agreement":null},{"id":"W2600242980","doi":"10.1200/jco.2012.30.15_suppl.1099","title":"Phase II trial of sorafenib (S) and vinorelbine (V) in metastatic breast cancer (mBC) with pharmacokinetics (PK) analysis.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Pharmacokinetics; Tolerability; Metastatic breast cancer; Vinorelbine; Internal medicine; Toxicity; Gastroenterology; Neutropenia; Urology; Pharmacology; Cancer; Breast cancer; Oncology; Chemotherapy; Adverse effect","score_opus":0.15162748440593077,"score_gpt":0.5508904711779373,"score_spread":0.39926298677200656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600242980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99127096,0.0018768214,0.000052203286,0.005325854,0.0007818445,0.00031681612,0.000033250453,0.000003321646,0.0003389304],"genre_scores_gemma":[0.9936383,0.002881127,0.0011002214,0.0009166497,0.0012901849,0.00001031626,0.000005676325,0.000012559872,0.0001450141],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969498,0.0003899482,0.0019672336,0.00014410577,0.0002760437,0.00027285866],"domain_scores_gemma":[0.99656314,0.0010102192,0.001627549,0.00011164001,0.00025911277,0.0004283636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002118713,0.00015783482,0.0022489761,0.0003551172,0.000022720675,0.000002436441,0.00008610429,0.00014210251,0.0006658548],"category_scores_gemma":[0.00017807336,0.00009926077,0.00034574035,0.00048467316,0.0002719987,0.00011925228,0.000040712315,0.0006131186,9.971125e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5385034,0.07547046,0.20232365,0.00008315123,0.0119513655,0.0005630925,0.000569301,0.00013302334,0.001940933,0.00004675779,0.002999798,0.16541508],"study_design_scores_gemma":[0.68414444,0.1108754,0.1504473,0.00007766618,0.03154917,0.0006340493,0.0000999152,0.00039068703,0.00070987357,0.000041097323,0.020839246,0.0001911962],"about_ca_topic_score_codex":0.000110798406,"about_ca_topic_score_gemma":0.00018895473,"teacher_disagreement_score":0.1652239,"about_ca_system_score_codex":0.00012304951,"about_ca_system_score_gemma":0.00087138655,"threshold_uncertainty_score":0.7290643},"labels":[],"label_agreement":null},{"id":"W2600898566","doi":"10.1200/jco.2012.30.15_suppl.540","title":"BOLERO-2: Everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone receptor-positive breast cancer.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Exemestane; Medicine; Everolimus; Internal medicine; Dysgeusia; Letrozole; Aromatase inhibitor; Anastrozole; Breast cancer; Oncology; Clinical endpoint; Adverse effect; Placebo; Population; Progression-free survival; Cancer; Clinical trial; Aromatase; Chemotherapy; Pathology","score_opus":0.05317573863883323,"score_gpt":0.4219023762950248,"score_spread":0.36872663765619157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600898566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857951,0.00073085225,0.000014662044,0.0074647614,0.0014816484,0.00055561773,0.000045497214,0.00001353189,0.0038983738],"genre_scores_gemma":[0.99348897,0.0014139091,0.0021780194,0.0011524683,0.0014018499,0.000027322505,0.00002156288,0.00004318661,0.00027274218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966047,0.00048186802,0.0014887273,0.0002746388,0.0005456157,0.0006044661],"domain_scores_gemma":[0.9955973,0.0012114368,0.0015263503,0.00018021831,0.00070226524,0.0007824283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009973901,0.00030897855,0.001809295,0.00018568448,0.00005352595,0.000007497821,0.00014964426,0.00036422675,0.00054319185],"category_scores_gemma":[0.00021788903,0.00019567748,0.00020417197,0.00038606903,0.00041752344,0.0003488736,0.000041731862,0.0012366165,0.000019415113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21664825,0.009610907,0.69661987,0.00002006757,0.0014023328,0.0005639978,0.00057414395,0.000008852405,0.00007952012,0.000016533568,0.0044226944,0.07003286],"study_design_scores_gemma":[0.07111125,0.04624558,0.87279993,0.000194265,0.00096143625,0.0002712057,0.00023586313,0.0000035235357,0.00007106534,0.0000075752846,0.007901989,0.0001963264],"about_ca_topic_score_codex":0.00033486672,"about_ca_topic_score_gemma":0.00075119094,"teacher_disagreement_score":0.17618008,"about_ca_system_score_codex":0.0008973637,"about_ca_system_score_gemma":0.0014753285,"threshold_uncertainty_score":0.7979496},"labels":[],"label_agreement":null},{"id":"W2601214088","doi":"10.1200/jco.2012.30.15_suppl.7590","title":"Weekly nab-paclitaxel in combination with carboplatin as first-line therapy in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Internal medicine; Carboplatin; non-small cell lung cancer (NSCLC); Clinical endpoint; Gastroenterology; Lung cancer; Population; Paclitaxel; Performance status; Cancer; Surgery; Chemotherapy; Oncology; Randomized controlled trial; Cisplatin","score_opus":0.04936182536150489,"score_gpt":0.43175248352997503,"score_spread":0.3823906581684701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601214088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99025846,0.0017183134,0.000030658863,0.004071122,0.0008527808,0.0007899956,0.0000034873988,0.000006412135,0.0022687865],"genre_scores_gemma":[0.9938082,0.002744321,0.00095167826,0.0015687986,0.0004904044,0.000057794106,0.000008542783,0.000029961697,0.00034027552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973809,0.00027066676,0.0014286198,0.00020948166,0.00030346375,0.000406845],"domain_scores_gemma":[0.9968634,0.0010667697,0.0012562679,0.00013244085,0.00035897843,0.0003221196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010835773,0.00021941354,0.0012427833,0.00023076235,0.00003031876,0.0000051300985,0.00011663414,0.00030872182,0.00019136102],"category_scores_gemma":[0.00014786208,0.00014117894,0.0001389361,0.00028994342,0.00010577801,0.00021182606,0.000019313822,0.0010123644,0.0000050882118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02144616,0.010446432,0.87859935,0.00004291625,0.00018518305,0.00018398777,0.0008332558,0.00014412159,0.00009340791,0.000006269678,0.00045754248,0.087561354],"study_design_scores_gemma":[0.08793366,0.0736034,0.8296123,0.00029783286,0.00024753544,0.000035887268,0.00013311893,0.00011824516,0.000250145,0.000026267084,0.00758304,0.00015854875],"about_ca_topic_score_codex":0.00039416863,"about_ca_topic_score_gemma":0.0023508423,"teacher_disagreement_score":0.087402806,"about_ca_system_score_codex":0.0005591546,"about_ca_system_score_gemma":0.0013520615,"threshold_uncertainty_score":0.575711},"labels":[],"label_agreement":null},{"id":"W2601596974","doi":"10.1200/jco.2013.31.15_suppl.6585","title":"Identification of knowledge translation opportunities in the treatment of locally advanced breast cancer: Results of a national survey of physicians.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; University of Toronto; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Knowledge translation; Psychological intervention; Family medicine; Clinical Practice; Medical physics; Cancer; Internal medicine; Nursing; Knowledge management","score_opus":0.36150451644383275,"score_gpt":0.5286172422382871,"score_spread":0.16711272579445435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601596974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929516,0.0012434028,0.000027296403,0.0040596947,0.00034585854,0.00037328672,0.0001753082,0.0000011161832,0.0008224581],"genre_scores_gemma":[0.9943025,0.005212111,0.00010558074,0.00008665375,0.00015187371,0.000016226437,0.00002500008,0.000005291363,0.000094760755],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99621195,0.0006412196,0.002697855,0.000092467715,0.00027117424,0.000085309475],"domain_scores_gemma":[0.9921154,0.003178925,0.0028925147,0.00009964094,0.0016727949,0.000040722884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020389548,0.00008524259,0.0010206973,0.00015059767,0.000008898328,9.878213e-7,0.00010508784,0.00012951432,0.000055091532],"category_scores_gemma":[0.00028346866,0.000054632845,0.00024655685,0.00020260773,0.0002838359,0.00009113114,0.0000044667217,0.00013571081,6.3087737e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01946627,0.017634863,0.06783246,0.0001419799,0.00075995893,0.000008790684,0.0033427018,0.0002846502,0.012273585,0.000098064935,0.0015275585,0.8766291],"study_design_scores_gemma":[0.015290839,0.01070384,0.9685389,0.00013383059,0.00028124935,0.000015186413,0.00034104675,0.00026827975,0.0029360012,0.00018212582,0.0012691269,0.00003962351],"about_ca_topic_score_codex":0.0006503604,"about_ca_topic_score_gemma":0.0014231106,"teacher_disagreement_score":0.9007064,"about_ca_system_score_codex":0.00012455278,"about_ca_system_score_gemma":0.0015693133,"threshold_uncertainty_score":0.27838945},"labels":[],"label_agreement":null},{"id":"W2601703087","doi":"10.1200/jco.2012.30.15_suppl.6083","title":"Chemotherapy in the oldest old: The feasibility of cytotoxic therapy in the 80+ population.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Discontinuation; Cancer; Lung cancer; Population; Internal medicine; Performance status; Chemotherapy; Surgery; Retrospective cohort study","score_opus":0.293374716593269,"score_gpt":0.5595872208055418,"score_spread":0.26621250421227277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601703087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9539471,0.0014085642,0.0000026029209,0.042539936,0.00060717145,0.00055261306,0.0000012575797,0.0000018005761,0.0009389128],"genre_scores_gemma":[0.9810197,0.0018631951,0.00009010296,0.015647085,0.0013082155,0.000013349659,0.0000014936546,0.0000071134996,0.000049767754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958258,0.0020921614,0.0014824942,0.000093140996,0.0002921958,0.00021415803],"domain_scores_gemma":[0.99306446,0.005609063,0.0009071731,0.0002637271,0.00008684074,0.00006875848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0115090795,0.00010601125,0.0007615784,0.00006882505,0.000038652866,0.000004508172,0.00032262123,0.00020467602,0.00024099575],"category_scores_gemma":[0.0006766343,0.00004037219,0.0003383857,0.00028431285,0.00022297504,0.00008021264,0.000013116741,0.001087674,0.0000036080874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036380275,0.005604082,0.9519782,0.0000065414615,0.00009830799,0.000027759255,0.0027648131,0.0000044689077,0.00021945534,0.00022253157,0.0022690017,0.033166777],"study_design_scores_gemma":[0.009430514,0.0058167176,0.9659628,0.000016500766,0.000083095525,0.00015634307,0.0005280987,0.000008176461,0.00004319042,0.00067870115,0.017239362,0.00003645838],"about_ca_topic_score_codex":0.00015227759,"about_ca_topic_score_gemma":0.00024777537,"teacher_disagreement_score":0.03313032,"about_ca_system_score_codex":0.00012569873,"about_ca_system_score_gemma":0.00030960707,"threshold_uncertainty_score":0.47254628},"labels":[],"label_agreement":null},{"id":"W2602364135","doi":"10.1200/jco.2013.31.15_suppl.e14595","title":"Retrospective analysis of dose intensity, toxicity, and clinical outcomes in 5-fluorouracil based regimens in the treatment of metastatic colorectal cancer.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Oxaliplatin; Capecitabine; Internal medicine; Colorectal cancer; Oncology; Retrospective cohort study; Fluorouracil; Toxicity; Progression-free survival; Chemotherapy; Cancer","score_opus":0.1454874759263934,"score_gpt":0.5129613173902648,"score_spread":0.3674738414638714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602364135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894823,0.00038397178,0.0000049922173,0.00901392,0.00036183855,0.00051398366,0.000015398356,0.0000020450314,0.00022154237],"genre_scores_gemma":[0.99558514,0.0025738725,0.00059873017,0.0010524571,0.000112477916,0.000022191638,0.0000033171286,0.000006918299,0.000044907803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954116,0.0010202567,0.0028742682,0.000210008,0.00028877074,0.0001951203],"domain_scores_gemma":[0.9916473,0.005716798,0.0018730676,0.00016028562,0.00044183488,0.00016073068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002624148,0.00016258485,0.0035077587,0.0004203821,0.000014473133,0.000004136254,0.00012786516,0.00021336207,0.00024941127],"category_scores_gemma":[0.0011793773,0.00008919736,0.00090666395,0.00057410385,0.0004690262,0.0000666645,0.000027532502,0.0005127351,0.0000011370781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004209029,0.014471668,0.9601664,0.000011976031,0.004602947,0.00025982774,0.00051739503,0.00003233541,0.00012791457,0.000015625978,0.00025147822,0.015333427],"study_design_scores_gemma":[0.01743137,0.038240246,0.9367834,0.00002930022,0.005991541,0.000024402627,0.00030938396,0.00071129366,0.000119137985,0.00013973427,0.0001603977,0.00005982749],"about_ca_topic_score_codex":0.0016990528,"about_ca_topic_score_gemma":0.0074181813,"teacher_disagreement_score":0.023768578,"about_ca_system_score_codex":0.0003993211,"about_ca_system_score_gemma":0.00082429725,"threshold_uncertainty_score":0.41395193},"labels":[],"label_agreement":null},{"id":"W2602386620","doi":"10.1016/j.jpain.2017.02.267","title":"(417) The use of the Edmonton Classification system for Cancer Pain adds clinical complexity to the Breakthrough Cancer Pain assessment","year":2017,"lang":"en","type":"article","venue":"Journal of Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer pain; Addiction; Morphine; Cancer; Lung cancer; Neuropathic pain; Observational study; Distress; Physical therapy; Internal medicine; Anesthesia; Psychiatry; Clinical psychology","score_opus":0.3948974510212561,"score_gpt":0.5161124588866398,"score_spread":0.1212150078653837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602386620","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45844477,0.0019512613,0.027901335,0.49996796,0.006029908,0.0048394264,0.0003586275,0.000027486098,0.00047921084],"genre_scores_gemma":[0.9900712,0.00032896572,0.00075723353,0.0058585387,0.002115475,0.00019242405,0.000003761286,0.000019223038,0.00065322994],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9961902,0.0022644596,0.00078320655,0.00016077829,0.0003821014,0.00021928371],"domain_scores_gemma":[0.99508137,0.0024346982,0.0013660309,0.0005867806,0.00041806308,0.00011304587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0119025335,0.00015070422,0.000477438,0.000030884657,0.00044897443,0.000060502072,0.00048018232,0.00009283281,0.00009495771],"category_scores_gemma":[0.0009920533,0.000065526976,0.00039280247,0.00008019984,0.00023733218,0.000090496855,0.000057949608,0.00037687473,7.337695e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016413211,0.00055368687,0.38759044,0.0002705585,0.0011320454,0.0000081224025,0.00084992195,0.00023287992,0.002212451,0.0008023581,0.4082994,0.19640681],"study_design_scores_gemma":[0.0022449114,0.00090577215,0.6218173,0.0005829862,0.0006957907,0.000008290072,0.0006359964,0.009900799,0.00019142957,0.000061727296,0.36286777,0.000087218716],"about_ca_topic_score_codex":0.0021280216,"about_ca_topic_score_gemma":0.0056975996,"teacher_disagreement_score":0.53162634,"about_ca_system_score_codex":0.0005520905,"about_ca_system_score_gemma":0.0006147984,"threshold_uncertainty_score":0.4125204},"labels":[],"label_agreement":null},{"id":"W2603056587","doi":"10.1200/jco.2014.32.15_suppl.1058","title":"Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel (WP) or eribulin (E) followed by doxorubicin and cyclophosphamide (AC) in women with locally advanced HER2-negative breast cancer (LABC): NSABP FB-9.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Eribulin; Taxane; Febrile neutropenia; Mucositis; Neutropenia; Anthracycline; Clinical endpoint; Cyclophosphamide; Gastroenterology; Chemotherapy; Surgery; Oncology; Cancer; Metastatic breast cancer; Clinical trial","score_opus":0.05818724985628228,"score_gpt":0.4897362801187247,"score_spread":0.43154903026244246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603056587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96716404,0.0006737357,0.00034352895,0.027929815,0.0010875922,0.0024433404,0.000027810553,0.000024596138,0.00030552718],"genre_scores_gemma":[0.9761245,0.005067744,0.006619383,0.0088858465,0.0017537987,0.0002957639,0.0000066893463,0.00007715244,0.0011690833],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9898903,0.0033364724,0.004684215,0.0006995883,0.00066502084,0.000724424],"domain_scores_gemma":[0.9810283,0.013017861,0.004066813,0.0003030764,0.00066342537,0.00092048646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.014799401,0.0005224044,0.006007043,0.00016577441,0.000120361845,0.000020513897,0.00022876341,0.0005959865,0.000600713],"category_scores_gemma":[0.0037768576,0.00028957915,0.00045637912,0.00036773933,0.0012022821,0.00021014182,0.00006507953,0.0018172974,0.0000032044875],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70386887,0.00885731,0.0028033264,0.000026961605,0.0015235223,0.00036447507,0.0005708588,0.000027121265,0.00034402215,0.000004735477,0.001958588,0.2796502],"study_design_scores_gemma":[0.75207436,0.22951601,0.0061284103,0.00047864774,0.0011016557,0.0003010801,0.0003391967,0.00050291535,0.00010931233,0.00010205337,0.0090687,0.00027766553],"about_ca_topic_score_codex":0.00024135537,"about_ca_topic_score_gemma":0.0006381234,"teacher_disagreement_score":0.27937254,"about_ca_system_score_codex":0.00059516926,"about_ca_system_score_gemma":0.0038702236,"threshold_uncertainty_score":0.99995565},"labels":[],"label_agreement":null},{"id":"W2603068525","doi":"10.1200/jco.2012.30.15_suppl.e19527","title":"Palliative inpatient chemotherapy: Clinical benefit or harm?","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Palliative care; Lung cancer; Performance status; Cancer; Regimen; Chemotherapy; Internal medicine","score_opus":0.35669271422426807,"score_gpt":0.5980000917517748,"score_spread":0.24130737752750675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603068525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696599,0.0011911392,0.000063537904,0.015852572,0.0066799503,0.00029353026,0.000005708136,0.000014132248,0.006239516],"genre_scores_gemma":[0.95673794,0.0055097262,0.0042938194,0.021273749,0.009401963,0.000008059881,0.000004674464,0.000026516167,0.0027435436],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956671,0.00042434386,0.0030428874,0.00017313332,0.00031468083,0.00037788207],"domain_scores_gemma":[0.9926888,0.003776295,0.00207791,0.0001679057,0.00041524513,0.00087389234],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037544298,0.00017570655,0.0018856607,0.000093588525,0.000038294587,0.0000045729485,0.00014999461,0.00053415424,0.003027788],"category_scores_gemma":[0.0014825406,0.00010438917,0.00081981794,0.00014288278,0.00026011543,0.00013730788,0.000048271893,0.0012399759,0.00011341645],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020852873,0.011119608,0.6108832,0.000016955779,0.0012652108,0.00022059944,0.00033458683,0.0000010488469,0.000032952656,0.00010291168,0.050889555,0.30428055],"study_design_scores_gemma":[0.014556244,0.024751494,0.4693545,0.000033782122,0.0005978698,0.0001329736,0.000060463346,0.0000107566275,0.00007880856,0.00008568947,0.49026188,0.0000755507],"about_ca_topic_score_codex":0.000008344807,"about_ca_topic_score_gemma":0.000016088194,"teacher_disagreement_score":0.4393723,"about_ca_system_score_codex":0.00023572108,"about_ca_system_score_gemma":0.0013249628,"threshold_uncertainty_score":0.99788356},"labels":[],"label_agreement":null},{"id":"W2603191492","doi":"10.1200/jco.2012.30.15_suppl.1025","title":"NSABP FB-6: Phase II trial of weekly paclitaxel (WP) and pazopanib following doxorubicin and cyclophosphamide (AC) as neoadjuvant therapy for HER2-negative locally advanced breast cancer (LABC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Montreal General Hospital; Ottawa Hospital; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Pazopanib; Medicine; Internal medicine; Breast cancer; Clinical endpoint; Regimen; Oncology; Phases of clinical research; Chemotherapy; Tyrosine-kinase inhibitor; Cancer; Urology; Gastroenterology; Clinical trial","score_opus":0.08320078400952502,"score_gpt":0.5089545598580594,"score_spread":0.42575377584853435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603191492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745939,0.008811336,0.00007096719,0.011783439,0.0031600546,0.0011852327,0.000049713282,0.000009813937,0.0003355595],"genre_scores_gemma":[0.9801178,0.012405531,0.0018678408,0.0027439615,0.0024029615,0.00006308753,0.0000037724515,0.000033121854,0.0003619467],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964991,0.0003521979,0.0021371746,0.00027335776,0.00029056385,0.000447564],"domain_scores_gemma":[0.993584,0.0035150014,0.0017542572,0.00014231242,0.0003661791,0.0006382557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002521484,0.00027472092,0.00227836,0.00011531286,0.00010439145,0.000006902625,0.00010947378,0.00038372356,0.0001853779],"category_scores_gemma":[0.00093259383,0.00019004742,0.00059437944,0.0001289382,0.00035693476,0.00025571787,0.000057084926,0.00062341645,0.0000012595356],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3739698,0.0089566205,0.01839556,0.000045515484,0.0016269037,0.000117114796,0.000777007,0.0000029308524,0.0050234674,0.000064431304,0.0016992483,0.5893214],"study_design_scores_gemma":[0.64721805,0.18179138,0.08786863,0.0003613405,0.0022514635,0.0005147575,0.0007275088,0.00004134967,0.0035913538,0.0008509126,0.07446071,0.00032257714],"about_ca_topic_score_codex":0.00017179383,"about_ca_topic_score_gemma":0.00007000372,"teacher_disagreement_score":0.5889988,"about_ca_system_score_codex":0.00016783712,"about_ca_system_score_gemma":0.0012498224,"threshold_uncertainty_score":0.77499086},"labels":[],"label_agreement":null},{"id":"W2603575264","doi":"10.1200/jco.2012.30.15_suppl.3047","title":"Clinical and correlative science results in a phase II study of UCN-01in combination with irinotecan in recurrent triple-negative breast cancer (TNBC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Triple-negative breast cancer; Irinotecan; Taxane; Neutropenia; Internal medicine; Oncology; Phases of clinical research; Cancer; Vomiting; Peripheral blood mononuclear cell; Breast cancer; Gastroenterology; Chemotherapy","score_opus":0.1677929814383985,"score_gpt":0.5610055274139666,"score_spread":0.3932125459755681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603575264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939078,0.0002818778,0.000004049442,0.0031801024,0.0013518662,0.0007311935,0.00001589404,0.0000028485522,0.0005243492],"genre_scores_gemma":[0.99849826,0.0005950475,0.00021913933,0.00023649416,0.00036403266,0.000016353712,0.000001276908,0.000007748375,0.00006167044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953708,0.00091041595,0.0027821572,0.0002602118,0.0003877057,0.00028873162],"domain_scores_gemma":[0.9943662,0.0025550292,0.0020682602,0.00011756256,0.00051487534,0.0003780324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007428942,0.00014455267,0.0015267789,0.00039498816,0.000046844336,0.0000033204772,0.00012161929,0.00019144238,0.00004416487],"category_scores_gemma":[0.0017851031,0.00009687087,0.00010221697,0.0006273568,0.0009762917,0.00027113824,0.00007854782,0.0012235002,7.7222427e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.066388585,0.059863545,0.6962265,0.000010792336,0.00017223481,0.00017276363,0.004118524,0.000007688118,0.000031050968,0.000028362461,0.00022553132,0.17275447],"study_design_scores_gemma":[0.11115437,0.11680587,0.7698147,0.00016864773,0.0002869925,0.00011057338,0.0010414136,0.00016884285,0.000024068868,0.000042770745,0.00031108814,0.000070622635],"about_ca_topic_score_codex":0.00037206316,"about_ca_topic_score_gemma":0.0018874727,"teacher_disagreement_score":0.17268384,"about_ca_system_score_codex":0.00036817102,"about_ca_system_score_gemma":0.002049512,"threshold_uncertainty_score":0.5315568},"labels":[],"label_agreement":null},{"id":"W2603616054","doi":"10.1200/jco.2012.30.15_suppl.tps7618","title":"Weekly <i>nab</i>-paclitaxel in combination with carboplatin as first-line therapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): Analysis of patient-reported neuropathy and taxane-associated symptoms.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Taxane; Internal medicine; Tolerability; Carboplatin; Common Terminology Criteria for Adverse Events; Clinical endpoint; Paclitaxel; Oncology; Lung cancer; Adverse effect; Peripheral neuropathy; Gastroenterology; Cancer; Chemotherapy; Clinical trial; Breast cancer; Diabetes mellitus","score_opus":0.027568258179016925,"score_gpt":0.38018836991791655,"score_spread":0.3526201117388996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603616054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969809,0.0009773584,0.000007366591,0.00069266604,0.0003376538,0.0006660537,0.000009959455,0.000005409426,0.00032260647],"genre_scores_gemma":[0.99717516,0.0017134888,0.0001629366,0.0007526144,0.00006871425,0.000029169552,0.000024528737,0.00002393109,0.000049445684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99669415,0.0004049139,0.0019763347,0.00023929421,0.00035602137,0.00032928688],"domain_scores_gemma":[0.9949512,0.0010166175,0.0030766225,0.00014343894,0.000541381,0.0002707581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009967433,0.000221965,0.0018017141,0.00049960735,0.000026176187,0.0000040605673,0.0000786976,0.0002582475,0.00005971411],"category_scores_gemma":[0.00030151152,0.00015068844,0.00018937112,0.00087753485,0.00012650916,0.0001538863,0.000025725383,0.00065647636,3.0425872e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015970733,0.011107185,0.9420346,0.000028086513,0.0015654,0.0001659476,0.0009136789,0.0004672928,0.00015910766,0.0000012947697,0.000048291957,0.027538406],"study_design_scores_gemma":[0.050621215,0.04322054,0.9024109,0.0001592256,0.002397205,0.000011257496,0.000095048155,0.00047590886,0.000207899,0.0000033902234,0.00026739232,0.00013002164],"about_ca_topic_score_codex":0.0005552099,"about_ca_topic_score_gemma":0.0017368679,"teacher_disagreement_score":0.039623678,"about_ca_system_score_codex":0.00034924728,"about_ca_system_score_gemma":0.0007092299,"threshold_uncertainty_score":0.6144896},"labels":[],"label_agreement":null},{"id":"W2604055952","doi":"10.1016/j.clcc.2017.03.013","title":"Neurotoxicity Outcomes in a Population-based Cohort of Elderly Patients Treated With Adjuvant Oxaliplatin for Colorectal Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Oxaliplatin; Medicine; Colorectal cancer; Oncology; Internal medicine; Neurotoxicity; Adjuvant; Cohort; Population; Cancer; Toxicity; Environmental health","score_opus":0.05068831074772731,"score_gpt":0.416747593082448,"score_spread":0.36605928233472074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604055952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450797,0.000073812,0.0000036760828,0.00069200277,0.0005449687,0.0034212365,0.0004885907,0.000037635367,0.0002301215],"genre_scores_gemma":[0.9968768,0.0000576435,0.00009323646,0.0003823408,0.00015607987,0.0020596876,0.00015542221,0.00004223581,0.00017657415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793655,0.00009663436,0.000787606,0.0005342787,0.00027867145,0.00036623506],"domain_scores_gemma":[0.9979559,0.0006626453,0.000633246,0.00025287032,0.000303697,0.0001916453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000245549,0.00028554208,0.001138052,0.00009676605,0.00015547898,0.000019260242,0.00017978073,0.0002257647,0.00030306293],"category_scores_gemma":[0.00039595415,0.00021054402,0.0002704461,0.00012139861,0.00026874527,0.00009528985,0.00003689694,0.00028069603,0.0000019001626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015285037,0.0013786103,0.97701174,0.00009113896,0.00030329564,0.00001342233,0.000026343225,0.000046380454,0.0003808341,0.0000064228634,0.00025617558,0.0052005956],"study_design_scores_gemma":[0.01807622,0.0067104152,0.9698585,0.00015568109,0.0005093856,6.3566006e-7,0.000002962671,0.0008627222,0.0034602894,0.000012312113,0.0001366261,0.00021424623],"about_ca_topic_score_codex":0.007722595,"about_ca_topic_score_gemma":0.01936712,"teacher_disagreement_score":0.0116445245,"about_ca_system_score_codex":0.00032239023,"about_ca_system_score_gemma":0.000485741,"threshold_uncertainty_score":0.9988851},"labels":[],"label_agreement":null},{"id":"W2604489617","doi":"10.1200/jco.2004.22.14_suppl.624","title":"Risk of radiation pneumonitis in breast cancer patients treated with adjuvant taxanes and radiation","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Pneumonitis; Paclitaxel; Internal medicine; Adjuvant; Cancer; Oncology; Retrospective cohort study; Concomitant; Chemotherapy; Radiation Pneumonitis; Surgery; Lung","score_opus":0.03415493484110391,"score_gpt":0.41780437077431004,"score_spread":0.3836494359332061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604489617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523294,0.0008737737,0.000003994965,0.003257917,0.0002788068,0.0001863353,0.000028532822,0.0000028546312,0.00013486974],"genre_scores_gemma":[0.9873353,0.011884627,0.0001069124,0.0003197114,0.00031335338,0.000005728511,0.0000075033445,0.000007793403,0.000019025962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844134,0.00019005277,0.00100281,0.000106088686,0.00014826357,0.00011146089],"domain_scores_gemma":[0.9977469,0.0004086467,0.0014459108,0.00004695384,0.00020821978,0.00014336282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045050884,0.00008674656,0.00079832674,0.00013933059,0.000015967038,0.0000020162895,0.000032291704,0.00016345414,0.00005980201],"category_scores_gemma":[0.0001664133,0.000057155725,0.0000925219,0.0001333077,0.00011130858,0.00009143527,0.000007357974,0.00032640382,9.312397e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047318614,0.0015671535,0.7407843,0.000011811695,0.00020532185,0.000083603234,0.000109498724,0.00009442799,0.000071279974,0.000003327534,0.00010558188,0.2522318],"study_design_scores_gemma":[0.029471703,0.01224206,0.95596373,0.000086108834,0.00064171193,0.00012949109,0.00002340558,0.000020943196,0.00026184414,0.000044985405,0.0010660643,0.000047931324],"about_ca_topic_score_codex":0.0007959357,"about_ca_topic_score_gemma":0.00037783317,"teacher_disagreement_score":0.25218388,"about_ca_system_score_codex":0.00025220294,"about_ca_system_score_gemma":0.000680392,"threshold_uncertainty_score":0.23307428},"labels":[],"label_agreement":null},{"id":"W2604716799","doi":"10.1200/jco.2013.31.15_suppl.555","title":"A prognostic factor (PF) index for overall survival in a HER2-negative endocrine-resistant metastatic breast cancer (MBC) population: Analysis from the ATHENA trial.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Metastatic breast cancer; Population; Breast cancer; Taxane; Progression-free survival; Clinical endpoint; Anthracycline; Cancer; Chemotherapy; Clinical trial","score_opus":0.16179686464203244,"score_gpt":0.4976812030909953,"score_spread":0.3358843384489628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604716799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97438,0.0003394961,0.0001429104,0.022122132,0.0012118847,0.0015494822,0.00016379068,0.000006746284,0.00008353512],"genre_scores_gemma":[0.9950598,0.00029971375,0.00078604004,0.0016866851,0.001688785,0.00021690788,0.000020544228,0.000017259705,0.0002242658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960032,0.00090875325,0.0021985488,0.00025218527,0.0003403815,0.00029689295],"domain_scores_gemma":[0.9870951,0.010372573,0.0016437572,0.00016679356,0.00046891562,0.00025285565],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001075463,0.00019812713,0.0020216648,0.00017413212,0.000048450245,0.000020778847,0.0001784787,0.00015121784,0.0020402428],"category_scores_gemma":[0.0018928426,0.00011034224,0.00092133175,0.0003587627,0.00012311112,0.00013258972,0.000035404715,0.00064054114,0.0000064400424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09358069,0.003895354,0.8657594,0.000021158428,0.008047637,0.00016040713,0.00035086164,0.000114048096,0.000058641326,0.00004296003,0.002096719,0.025872126],"study_design_scores_gemma":[0.07601727,0.006106851,0.9079735,0.00004795566,0.0049414653,0.00001783078,0.00012148021,0.00068031496,0.0000049382115,0.0013869777,0.0026029872,0.00009842646],"about_ca_topic_score_codex":0.0111132,"about_ca_topic_score_gemma":0.011630175,"teacher_disagreement_score":0.04221411,"about_ca_system_score_codex":0.000408261,"about_ca_system_score_gemma":0.0010583128,"threshold_uncertainty_score":0.99887204},"labels":[],"label_agreement":null},{"id":"W2604888638","doi":"10.1200/jco.2004.22.90140.706","title":"Trastuzumab (T) and docetaxel (D) for the treatment of HER2 metastatic breast cancer (MBC): A literature based (LB) and individual patient data (IPD) meta-analysis (MA) of phase II trial","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Metastatic breast cancer; Oncology; Trastuzumab; Breast cancer; Meta-analysis; Clinical trial; Cochrane Library; MEDLINE; CINAHL; Cancer","score_opus":0.41150323797398336,"score_gpt":0.5572722318948445,"score_spread":0.14576899392086118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604888638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9581158,0.024078824,0.00027585283,0.013385493,0.00043279852,0.0012051096,0.0024873638,0.0000029009122,0.000015832156],"genre_scores_gemma":[0.9913009,0.0037066392,0.0034641966,0.0008969053,0.0004296215,0.0000672515,0.00008257901,0.000012557541,0.000039386607],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967717,0.0003809847,0.0020522259,0.00028299194,0.00032801184,0.00018409333],"domain_scores_gemma":[0.9938357,0.0031367894,0.0021201172,0.00031802637,0.00035271712,0.00023665019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015583694,0.00021649135,0.003256429,0.00020347194,0.00006672379,0.000010479887,0.00016916127,0.00016878241,0.00026895225],"category_scores_gemma":[0.00025963737,0.00010646851,0.0012888903,0.00029226491,0.00033485188,0.00010065134,0.000046981993,0.00026998232,8.526083e-8],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25485927,0.063628174,0.0013024547,0.0001389265,0.41486838,0.00025486213,0.002326732,0.00028635628,0.00018877423,0.000044957196,0.0013564407,0.26074466],"study_design_scores_gemma":[0.27333868,0.1566664,0.0042770873,0.000025295016,0.55224633,0.00016040477,0.00016514743,0.0003785396,0.00020643424,0.00011413496,0.01231699,0.000104557905],"about_ca_topic_score_codex":0.00014532222,"about_ca_topic_score_gemma":0.00032527448,"teacher_disagreement_score":0.26064008,"about_ca_system_score_codex":0.0001151769,"about_ca_system_score_gemma":0.0014067305,"threshold_uncertainty_score":0.43416598},"labels":[],"label_agreement":null},{"id":"W2605117686","doi":"10.1200/jco.2017.35.8_suppl.190","title":"Utilizing patient reported outcomes for patients recieving oral chemotherapy.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Capecitabine; Chemotherapy; Quality of life (healthcare); Intensive care medicine; Physical therapy; Internal medicine; Cancer; Nursing; Colorectal cancer","score_opus":0.30154577000438787,"score_gpt":0.5701173914839619,"score_spread":0.26857162147957403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605117686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97968066,0.0000906671,0.000029655163,0.011369975,0.0043038246,0.0003949314,0.0000029717519,0.000008004215,0.0041193],"genre_scores_gemma":[0.98929876,0.00032358375,0.0047379294,0.0042547267,0.0007396414,0.0000089588475,0.0000033951912,0.000018031556,0.0006149699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729556,0.000111132096,0.0019897667,0.00016898426,0.00021765711,0.00021687573],"domain_scores_gemma":[0.99385977,0.0012409048,0.0037790886,0.00027020762,0.00058856426,0.00026144992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014939532,0.00012571765,0.0013734251,0.000064392785,0.00014209026,0.000015441821,0.00015992412,0.0002578701,0.00014671376],"category_scores_gemma":[0.0058170073,0.00008354499,0.0006849974,0.000023861967,0.00014816415,0.00012309002,0.00004484585,0.00041404794,0.000003569305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004241265,0.002360392,0.6356716,0.000011593835,0.0005987754,0.00011989019,0.000060215432,2.8728664e-7,0.00004298429,0.000011387651,0.009929104,0.34695247],"study_design_scores_gemma":[0.019091971,0.01729458,0.71136326,0.00004101917,0.0004993448,0.00004929821,0.000025015988,0.000017471903,0.00008181387,0.00016860144,0.25130367,0.000063956795],"about_ca_topic_score_codex":0.000017502245,"about_ca_topic_score_gemma":0.00001696122,"teacher_disagreement_score":0.3468885,"about_ca_system_score_codex":0.00015768023,"about_ca_system_score_gemma":0.0006736752,"threshold_uncertainty_score":0.6963921},"labels":[],"label_agreement":null},{"id":"W2605305617","doi":"10.1200/jco.2012.30.15_suppl.6619","title":"Initial characterization of the toxicity and efficacy of elacytarabine (CP-4055), a novel antileukemic agent, using a multidimensional exposure-response relationship model.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacokinetics; Medicine; Toxicity; Dosing; Pharmacology; Population; Pharmacodynamics; Oncology; Internal medicine","score_opus":0.265419063122809,"score_gpt":0.5002150856960331,"score_spread":0.23479602257322413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605305617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968304,0.0001796278,0.0008036034,0.0010429843,0.000845784,0.0002419358,0.000018930152,0.0000028731588,0.000033838536],"genre_scores_gemma":[0.99617916,0.00006844864,0.002634281,0.00052045553,0.0005266845,0.0000014036683,0.0000039463675,0.000010576339,0.000055045828],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973642,0.00054922263,0.0015983463,0.00009955997,0.00023490813,0.00015372805],"domain_scores_gemma":[0.9949605,0.0026542807,0.0018048934,0.00011799707,0.00028207188,0.00018029466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002370769,0.000107339336,0.00082786335,0.000110755296,0.000043965265,0.0000013518377,0.000067935434,0.00026018897,0.000042619886],"category_scores_gemma":[0.002306301,0.000070107206,0.00028635593,0.00013393503,0.00027245312,0.0001332849,0.000055603297,0.00048219954,5.433653e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029518519,0.0053046304,0.30450726,0.000030303398,0.00027766608,0.000010803438,0.00046606892,0.00027051102,0.6574069,0.00007908444,0.000055986373,0.002072241],"study_design_scores_gemma":[0.018550007,0.0037101742,0.9609979,0.000106070016,0.0008127487,0.00030202346,0.000016739255,0.005206479,0.009816191,0.000020255751,0.00040034193,0.0000610973],"about_ca_topic_score_codex":0.000009729388,"about_ca_topic_score_gemma":0.0000027837636,"teacher_disagreement_score":0.6564906,"about_ca_system_score_codex":0.0001294174,"about_ca_system_score_gemma":0.0012192919,"threshold_uncertainty_score":0.28588888},"labels":[],"label_agreement":null},{"id":"W2605718406","doi":"10.71781/11823","title":"Progrès dans la synthèse de l'analogue [Val₆ (6S)-Mel²aa₄₋₅] de l'auréobasidine B","year":2004,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chemistry; Physics","score_opus":0.0062520766491072025,"score_gpt":0.21535318497763914,"score_spread":0.20910110832853193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605718406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88936085,0.054714713,0.00036748216,0.0011301872,0.0022823513,0.0010340898,0.00023919437,0.00022933328,0.05064178],"genre_scores_gemma":[0.9130818,0.0038081359,0.0011577258,0.00029341248,0.0010625843,0.0001584478,0.0017660373,0.00009563929,0.078576215],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9962011,0.0003786158,0.0005945826,0.0009319076,0.0006918482,0.0012019302],"domain_scores_gemma":[0.99743706,0.0002894067,0.00046009058,0.00046768133,0.00033237127,0.0010134162],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0003909604,0.00083527196,0.0008662624,0.00045867235,0.0045437356,0.00006642357,0.00046797088,0.0010902559,0.00031215267],"category_scores_gemma":[0.00011066103,0.0009626616,0.00067176117,0.0005279399,0.00071071304,0.00031097358,0.00013387733,0.0009999075,0.00017193345],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.011226611,0.005826002,0.28053027,0.0026438497,0.006897817,0.09228112,0.18245842,0.016109299,0.30183432,0.0843089,0.0035262005,0.012357193],"study_design_scores_gemma":[0.019220162,0.0023016033,0.41814378,0.0046101646,0.014844187,0.026763132,0.09894969,0.003581146,0.17371936,0.0013838479,0.2335775,0.0029054228],"about_ca_topic_score_codex":0.10832881,"about_ca_topic_score_gemma":0.038472176,"teacher_disagreement_score":0.2300513,"about_ca_system_score_codex":0.036233556,"about_ca_system_score_gemma":0.013045084,"threshold_uncertainty_score":0.99928236},"labels":[],"label_agreement":null},{"id":"W2605759430","doi":"10.2217/fon-2017-0062","title":"ESAS and FACT-B in eribulin-treated metastatic breast cancer patients: a multicenter, prospective and observational study","year":2017,"lang":"en","type":"article","venue":"Future Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Eribulin; Metastatic breast cancer; Observational study; Internal medicine; Quality of life (healthcare); Oncology; Breast cancer; Prospective cohort study; Cancer; Nursing","score_opus":0.05307339089581799,"score_gpt":0.408731362008138,"score_spread":0.35565797111232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605759430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926674,0.00039512652,3.7088793e-7,0.0045914873,0.00038492444,0.0013844843,0.00013070098,0.000014626559,0.0004308736],"genre_scores_gemma":[0.9982891,0.00023206964,0.00011782741,0.0004544971,0.00024991744,0.00029756737,0.00004483588,0.0000122121655,0.00030196054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916035,0.000071553,0.0001864295,0.000302913,0.00009155684,0.00018718134],"domain_scores_gemma":[0.99944526,0.00006405506,0.00014260333,0.00013147107,0.00011955058,0.00009704094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007786657,0.00015427476,0.00039412055,0.00006811467,0.00014277699,0.0000191023,0.00005278556,0.00007358387,0.00021533051],"category_scores_gemma":[0.000025632147,0.00011907112,0.00002196769,0.00004833073,0.00011924533,0.00011227966,0.00006658384,0.00017454411,0.000003249697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019456878,0.0029973725,0.9841417,0.000029294424,0.00027285086,0.000116315176,0.0018383423,3.019581e-7,0.0001586655,0.000025845682,0.00052930746,0.007944298],"study_design_scores_gemma":[0.02135665,0.0020950437,0.9720283,0.000022568198,0.0003346291,0.00002828362,0.000526806,0.000040977495,0.000028097395,0.000024235844,0.003421088,0.00009327665],"about_ca_topic_score_codex":0.0012558725,"about_ca_topic_score_gemma":0.0062267934,"teacher_disagreement_score":0.019410962,"about_ca_system_score_codex":0.0002798357,"about_ca_system_score_gemma":0.00012359144,"threshold_uncertainty_score":0.48555794},"labels":[],"label_agreement":null},{"id":"W2607020465","doi":"10.1016/s0016-5085(17)31573-1","title":"No Increase in Immunomodulator Use in Combination with Anti-TNF Therapy in the Post Sonic ERA","year":2017,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Tumor necrosis factor alpha; Medicine; Pharmacology; Immunology","score_opus":0.017411025760797293,"score_gpt":0.2900728645555634,"score_spread":0.27266183879476613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607020465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99483544,0.000056479883,0.0000020974578,0.0042768056,0.00013090108,0.0005442682,0.0000058999312,0.000007592584,0.00014049631],"genre_scores_gemma":[0.9968217,0.00013587927,0.00004409561,0.002747018,0.00004275346,0.00008844993,0.000043021126,0.000011447165,0.00006564014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990449,0.00018107469,0.00018675538,0.00020126358,0.00007968682,0.0003063499],"domain_scores_gemma":[0.99943984,0.000049502552,0.00009850515,0.0003397552,0.00004004994,0.00003232497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022531943,0.00012700286,0.00027304507,0.00016600109,0.000049601847,0.000023746103,0.00016812402,0.00006006931,0.00007832073],"category_scores_gemma":[0.000028777868,0.000084824955,0.00003253328,0.000049235812,0.00012520855,0.00014266612,0.000030629926,0.00028138887,0.000013687685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006962381,0.001014928,0.98807997,0.0000060294856,0.000035050834,0.00033134696,0.0003460163,0.0000056273625,0.0023271772,0.000021866175,0.00010183841,0.000767746],"study_design_scores_gemma":[0.019596322,0.0040497393,0.9756642,0.00002952441,0.000015487056,0.00010989633,0.000029320317,0.00010253834,0.00005730498,0.000016268074,0.0002897117,0.000039676026],"about_ca_topic_score_codex":0.0049543995,"about_ca_topic_score_gemma":0.01284379,"teacher_disagreement_score":0.01263394,"about_ca_system_score_codex":0.00010133911,"about_ca_system_score_gemma":0.000053896256,"threshold_uncertainty_score":0.7489603},"labels":[],"label_agreement":null},{"id":"W2607070724","doi":"","title":"Quantifying and predicting upper limb capability and dysfunction of breast cancer survivors","year":2014,"lang":"en","type":"dissertation","venue":"UWSpace (University of Waterloo)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Cancer; Oncology; Physical medicine and rehabilitation; Internal medicine","score_opus":0.01527177311949994,"score_gpt":0.25501806065362914,"score_spread":0.2397462875341292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607070724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801445,0.0005534776,0.0000012597959,0.0005840967,0.0003132047,0.00027376565,0.00008416451,0.000022295724,0.00015331239],"genre_scores_gemma":[0.96356565,0.0010153906,0.00008041217,0.000009935012,0.000057542427,7.586411e-7,0.00020128151,0.000014887405,0.03505416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992736,0.00004841443,0.00011301956,0.00028698155,0.00013633727,0.00014163404],"domain_scores_gemma":[0.99936265,0.00005562746,0.00021293116,0.00012205994,0.00015931248,0.00008744692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012456962,0.00016148036,0.00046048485,0.00017161829,0.00009865622,0.0000040705227,0.000041760883,0.00020578058,0.00024281756],"category_scores_gemma":[0.000006872099,0.0001668899,0.000082371516,0.00008318892,0.00012552204,0.00008384546,0.000025764577,0.00016241439,0.00000104423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022472881,0.00013267166,0.9292978,0.0027584916,0.00034781845,0.000007600578,0.039970167,0.000004123766,0.017223107,0.000016788194,0.00019462212,0.007799525],"study_design_scores_gemma":[0.0018875508,0.00033981662,0.958457,0.00042251704,0.0012064641,0.0000126816085,0.035694428,0.00023596623,0.0014337489,0.0000086451855,0.0001548128,0.0001463821],"about_ca_topic_score_codex":0.2067822,"about_ca_topic_score_gemma":0.24614212,"teacher_disagreement_score":0.039359912,"about_ca_system_score_codex":0.000067057175,"about_ca_system_score_gemma":0.0000700217,"threshold_uncertainty_score":0.7984999},"labels":[],"label_agreement":null},{"id":"W2607528826","doi":"","title":"Preclinical assessment of a fixed dose combination of novel liposome formulations of idarubicin and gemcitabine showing improved antitumor activity","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Gemcitabine; Pharmacology; Drug; Idarubicin; Medicine; Liposome; Therapeutic index; Pharmacokinetics; Chemotherapy; Cytarabine; Chemistry; Internal medicine","score_opus":0.2040143750113472,"score_gpt":0.5404268104338324,"score_spread":0.3364124354224852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607528826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964862,0.000337131,0.00017262291,0.0015155029,0.00005326966,0.00075549295,0.00005867627,0.000006769218,0.00061432703],"genre_scores_gemma":[0.998121,0.00026770076,0.0011398353,0.000016834007,0.00008537654,0.00008198099,0.000012982648,0.000010342034,0.00026395408],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99893606,0.00006726021,0.0003088736,0.00018018897,0.00032007872,0.00018752507],"domain_scores_gemma":[0.9988438,0.00037283165,0.00012547943,0.00016828741,0.0004094962,0.00008014039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062895863,0.00007617265,0.0003446375,0.0002071769,0.000043800388,0.0000037372183,0.00006144183,0.0000636,0.00016227247],"category_scores_gemma":[0.000095762465,0.00006627323,0.000060717248,0.00029013687,0.00020893327,0.00011527771,0.00007094109,0.00023245436,2.1810756e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084058597,0.0016168158,0.0455864,0.00035771378,0.00013620673,7.600405e-7,0.00026121287,0.000023937471,0.937836,0.00048761413,0.00007078804,0.012781971],"study_design_scores_gemma":[0.011059665,0.0017218632,0.6240474,0.00019427144,0.00012879075,0.0000026618145,0.000045002376,0.011490284,0.35102215,0.000047611,0.00017358258,0.00006670695],"about_ca_topic_score_codex":0.0006049274,"about_ca_topic_score_gemma":0.00018562026,"teacher_disagreement_score":0.5868138,"about_ca_system_score_codex":0.00018716113,"about_ca_system_score_gemma":0.00047299714,"threshold_uncertainty_score":0.27025437},"labels":[],"label_agreement":null},{"id":"W2610037390","doi":"10.1021/acs.bioconjchem.7b00165","title":"Comparison of Tumor Penetration of Podophyllotoxin–Carboxymethylcellulose Conjugates with Various Chemical Compositions in Tumor Spheroid Culture and In Vivo Solid Tumor","year":2017,"lang":"en","type":"article","venue":"Bioconjugate Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of British Columbia","funders":"Canadian Institutes of Health Research; National Institutes of Health; Natural Sciences and Engineering Research Council of Canada; University of British Columbia","keywords":"In vivo; Chemistry; Conjugate; Podophyllotoxin; Penetration (warfare); Polyethylene glycol; Spheroid; PEG ratio; Biophysics; Drug delivery; Carboxymethyl cellulose; Nanoparticle; In vitro; Chromatography; Stereochemistry; Biochemistry; Nanotechnology; Organic chemistry; Materials science","score_opus":0.017564636617805725,"score_gpt":0.32496209587121255,"score_spread":0.30739745925340684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610037390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648863,0.0006932957,0.000001706601,0.00014668421,0.00003256332,0.0004938117,0.000070262526,0.000022452647,0.0020505642],"genre_scores_gemma":[0.9990933,0.000036828766,0.00047048237,0.000063987565,0.00007259281,0.00005893866,0.000054174565,0.000026683541,0.00012302476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874866,0.000021781038,0.00049083814,0.0003395295,0.00016226215,0.00023692052],"domain_scores_gemma":[0.99900293,0.000046024015,0.00041251886,0.0003215497,0.00009345569,0.00012351784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008975749,0.00023969574,0.0007168059,0.000043896638,0.0000479804,0.000020547574,0.00014545776,0.00009670702,0.000117072486],"category_scores_gemma":[0.00003267633,0.00020799677,0.00006137832,0.00009273393,0.0004562322,0.00007362709,0.00005938196,0.00026577196,9.060943e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011197589,0.0008474141,0.12771246,0.00054408034,0.000059373975,0.000121716555,0.00032604535,0.0000069923735,0.86914337,0.000009097196,0.00008740922,0.000022292912],"study_design_scores_gemma":[0.0055164252,0.0003520976,0.020405326,0.00036452926,0.00012948354,0.000107137115,0.000240641,0.00029128202,0.9722677,0.000034053806,0.000106562125,0.00018480449],"about_ca_topic_score_codex":0.0003575414,"about_ca_topic_score_gemma":0.000104017985,"teacher_disagreement_score":0.107307136,"about_ca_system_score_codex":0.00009117308,"about_ca_system_score_gemma":0.00015456327,"threshold_uncertainty_score":0.84818625},"labels":[],"label_agreement":null},{"id":"W2610690192","doi":"10.25011/cim.v31i4.4827","title":"THE DYNACTOME: INVESTIGATING DYNAMIC KINASE NETWORKS IN CELLULAR DECISION-MAKING","year":2008,"lang":"en","type":"article","venue":"Clinical and investigative medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Kinase; Phosphorylation; Context (archaeology); Cell biology; Annexin; Apoptosis; Signal transduction; Biology; Carcinogenesis; Chemistry; Cancer research; Computational biology; Biochemistry; Gene","score_opus":0.12688458924266033,"score_gpt":0.40422873931195386,"score_spread":0.2773441500692935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610690192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97286713,0.0068433294,0.00025840124,0.018020097,0.0007354727,0.00043932805,0.0000014376544,0.000039914055,0.00079488114],"genre_scores_gemma":[0.9900926,0.0031691282,0.00073605304,0.004936181,0.0005746791,0.000035506986,0.000017430788,0.000021467995,0.00041698318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783826,0.00023539366,0.00088643545,0.0004324256,0.00024564797,0.0003618246],"domain_scores_gemma":[0.9967438,0.0022904982,0.00019781334,0.0002496258,0.00009267915,0.00042560216],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00095561374,0.00023770254,0.0006391154,0.000093554685,0.00032930725,0.000007269476,0.000119681725,0.00015784305,0.000082352286],"category_scores_gemma":[0.002958414,0.00013566976,0.0000834947,0.0004705017,0.011999764,0.00008062405,0.00009233571,0.0008044406,0.000008882468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033774524,0.0002012572,0.9299251,0.00003852084,0.00012968488,0.00065385515,0.0010079695,0.00003741598,0.0011297809,0.0011216574,0.0064197294,0.058997277],"study_design_scores_gemma":[0.007425405,0.0020923007,0.9242328,0.0014910112,0.00020635217,0.00014030572,0.0003379082,0.026464842,0.00008382114,0.030163096,0.0070930566,0.0002691145],"about_ca_topic_score_codex":0.00007790663,"about_ca_topic_score_gemma":0.00016972408,"teacher_disagreement_score":0.058728162,"about_ca_system_score_codex":0.00006907749,"about_ca_system_score_gemma":0.00016771843,"threshold_uncertainty_score":0.990689},"labels":[],"label_agreement":null},{"id":"W2613801984","doi":"10.1200/jco.2013.31.15_suppl.7071","title":"Quality of life (QOL) and physical function in one-year adult and elderly survivors of acute myeloid leukemia (AML).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Quality of life (healthcare); Grip strength; Prospective cohort study; Internal medicine; Myeloid leukemia; Longitudinal study; Physical therapy; Pathology","score_opus":0.10019789548511553,"score_gpt":0.4559775932760604,"score_spread":0.35577969779094487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613801984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953991,0.0002348279,0.000018241326,0.0029954386,0.00041924103,0.00018651728,0.000004652634,0.0000029124335,0.00073903624],"genre_scores_gemma":[0.9966933,0.0015687756,0.00042892745,0.00067038066,0.00052911794,0.0000038764806,0.0000018714136,0.0000076869155,0.00009603153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997435,0.0004325812,0.0016477304,0.00014386566,0.00020223753,0.00013861984],"domain_scores_gemma":[0.9961619,0.0018667219,0.0012398908,0.000092539354,0.00038125084,0.0002577065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012089615,0.00010186395,0.0015371686,0.000100858364,0.000011980707,0.000002598329,0.000054382323,0.00025997663,0.00012213257],"category_scores_gemma":[0.0007396223,0.000075250755,0.00019646139,0.00010048011,0.00031237132,0.00011074351,0.000035495486,0.00056288147,0.0000033443755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016425896,0.0030530563,0.8611384,0.00015692407,0.001282404,0.000024113753,0.00046532243,0.0000032078713,0.012062103,0.00030432612,0.0017034939,0.10338073],"study_design_scores_gemma":[0.014414818,0.020860344,0.9619084,0.00004805862,0.0005257184,0.000018304558,0.00019413584,0.000054822183,0.00027004085,0.0009411416,0.00070257444,0.00006164147],"about_ca_topic_score_codex":0.0008910211,"about_ca_topic_score_gemma":0.00035608932,"teacher_disagreement_score":0.10331909,"about_ca_system_score_codex":0.00008099429,"about_ca_system_score_gemma":0.0007420536,"threshold_uncertainty_score":0.3068637},"labels":[],"label_agreement":null},{"id":"W2613988704","doi":"10.71781/3705","title":"Caractérisation moléculaire de la mPGES-1 canine et son expression dans les carcinomes spinocellulaires","year":2006,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Molecular biology; Biology","score_opus":0.00701282763369151,"score_gpt":0.2224989457946554,"score_spread":0.21548611816096389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613988704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89659053,0.062009603,0.00021394962,0.00041366956,0.0013723146,0.0005634532,0.00011690374,0.00012683365,0.038592767],"genre_scores_gemma":[0.9358562,0.0020789802,0.0003247522,0.000087479704,0.00072075636,0.00006697061,0.0026021835,0.000063224485,0.058199435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696213,0.00052532455,0.0004952351,0.0007374193,0.0006414123,0.000638497],"domain_scores_gemma":[0.9982787,0.00022557566,0.00050755223,0.00033985218,0.00023540891,0.00041291452],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00027338645,0.0006600442,0.0006379727,0.00038300542,0.0044206297,0.000055797824,0.0002593878,0.000868967,0.00016013939],"category_scores_gemma":[0.000041935677,0.00072585826,0.00044423316,0.00027876667,0.00042040908,0.00029763603,0.00009506603,0.0007280866,0.00002937422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018226304,0.0007950047,0.46257034,0.0006059063,0.0005358954,0.0066562337,0.061565943,0.008843264,0.44809762,0.0025354947,0.0018747551,0.0040969234],"study_design_scores_gemma":[0.0034886072,0.000327865,0.7748281,0.0011039177,0.001935019,0.0012861666,0.021756517,0.0021474075,0.16563934,0.00006100378,0.026778705,0.00064738013],"about_ca_topic_score_codex":0.4299361,"about_ca_topic_score_gemma":0.06012572,"teacher_disagreement_score":0.3698104,"about_ca_system_score_codex":0.016169835,"about_ca_system_score_gemma":0.004362477,"threshold_uncertainty_score":0.9995192},"labels":[],"label_agreement":null},{"id":"W2615601352","doi":"10.3390/cancers9050052","title":"Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways","year":2017,"lang":"en","type":"review","venue":"Cancers","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1973,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; University of Alberta","keywords":"Cyclin-dependent kinase 8; Cancer research; Epidermal growth factor receptor; Signal transduction; Protein kinase B; MAPK/ERK pathway; ERBB3; Receptor tyrosine kinase; Biology; PI3K/AKT/mTOR pathway; Growth factor receptor; Cell cycle; Cell biology; Cancer; Notch signaling pathway","score_opus":0.15740548245471456,"score_gpt":0.3949922547634476,"score_spread":0.23758677230873307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615601352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010138109,0.99164224,0.000010295382,0.00005844477,0.0016383305,0.001527412,0.00024073792,0.00007183988,0.0047093467],"genre_scores_gemma":[0.00041641964,0.99144477,0.00010137461,0.00018271766,0.0022424543,0.00049152964,0.0006073869,0.00007492995,0.004438441],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99849963,0.000089126894,0.00042454954,0.00045637012,0.00018271864,0.00034760693],"domain_scores_gemma":[0.9987764,0.00008815735,0.00049367046,0.0003292262,0.000095686366,0.00021690316],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000965449,0.00041522994,0.001515318,0.00014117356,0.00017328854,0.000038716058,0.0001667564,0.0003325515,0.0013843309],"category_scores_gemma":[0.000039537106,0.00032818128,0.0004908908,0.00008663382,0.00007116147,0.00008645957,0.000031064123,0.00042382578,0.00023631746],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008453607,0.00004357718,0.00005723248,0.021619804,0.00044095033,0.00007421304,0.00023937623,0.0000012126715,0.00008984896,0.000018654058,0.023506109,0.95382446],"study_design_scores_gemma":[0.00087952433,0.00024277586,0.0000024040385,0.0038771972,0.001529585,0.00001997948,0.0000069201683,0.0000045029933,0.00044528136,0.0000043148007,0.992704,0.00028355987],"about_ca_topic_score_codex":0.00010857494,"about_ca_topic_score_gemma":0.000009817508,"teacher_disagreement_score":0.96919787,"about_ca_system_score_codex":0.0027380697,"about_ca_system_score_gemma":0.0037080084,"threshold_uncertainty_score":0.99991703},"labels":[],"label_agreement":null},{"id":"W2625687193","doi":"10.1158/1078-0432.ccr-16-3224","title":"Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Common Fund; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Cancer Institute; NIH Office of the Director; National Human Genome Research Institute; National Institute of Mental Health; National Heart, Lung, and Blood Institute; National Institutes of Health; Université de Genève; University of Pennsylvania; RIKEN; Broad Institute; Harvard University; National Institute on Drug Abuse; University of Miami","keywords":"Medicine; Internal medicine; Cancer; Imputation (statistics); Peripheral neuropathy; Cisplatin; Genome-wide association study; Oncology; Diabetes mellitus; Body mass index; Single-nucleotide polymorphism; Genotype; Chemotherapy; Endocrinology; Genetics; Gene; Biology","score_opus":0.28480858156993494,"score_gpt":0.5834587144445557,"score_spread":0.2986501328746207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625687193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473804,0.00097486854,0.0000014815953,0.0024991548,0.00041808453,0.0005205245,0.00012732075,0.000007649895,0.00071286684],"genre_scores_gemma":[0.9877505,0.010886219,0.000038885493,0.0003156018,0.0003050785,0.00010546451,0.000015756343,0.000023493576,0.0005590589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99618757,0.00086635223,0.0013220756,0.00062870927,0.00053802616,0.00045726507],"domain_scores_gemma":[0.99575686,0.0020737213,0.00039517588,0.00078539975,0.00064602616,0.0003428038],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003077583,0.0001664371,0.0013725732,0.00039497556,0.00012826094,0.000020602745,0.000363581,0.00024394567,0.000985344],"category_scores_gemma":[0.0021810355,0.00013871622,0.00038490933,0.0006266143,0.0014436089,0.00007357995,0.00028148474,0.0010097871,0.0000029979815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037311816,0.0006299384,0.97730476,0.00011275633,0.0010122547,0.00007261262,0.00021350851,0.000011696751,0.00081951526,0.000011744586,0.0002480281,0.015832027],"study_design_scores_gemma":[0.0048372224,0.0013085424,0.99115115,0.000094533716,0.0007683776,9.4702665e-7,0.000060407125,0.0006816685,0.00028531117,0.000028987455,0.00067633495,0.0001064989],"about_ca_topic_score_codex":0.0195747,"about_ca_topic_score_gemma":0.03467747,"teacher_disagreement_score":0.015725529,"about_ca_system_score_codex":0.00010291206,"about_ca_system_score_gemma":0.0007851131,"threshold_uncertainty_score":0.9999279},"labels":[],"label_agreement":null},{"id":"W2630601502","doi":"10.1200/jco.2017.35.15_suppl.e12030","title":"Rates of trastuzumab-associated cardiotoxicity in patients with HER2-positive breast cancer at a tertiary cancer centre.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Trastuzumab; Cardiotoxicity; Internal medicine; Oncology; Breast cancer; Clinical trial; Discontinuation; Cancer; Disease; Metastatic breast cancer; Chemotherapy","score_opus":0.057735540386877116,"score_gpt":0.46763188812585477,"score_spread":0.40989634773897765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2630601502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918546,0.00033502557,7.186326e-7,0.005809155,0.00092286064,0.00032731143,0.00014670259,0.0000032141552,0.00060039107],"genre_scores_gemma":[0.9973953,0.00085327873,0.00003957256,0.0008953354,0.00045419156,0.000009190746,0.00000722135,0.000016229258,0.0003296831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976371,0.00033880412,0.001260777,0.00019256574,0.00030117863,0.00026955258],"domain_scores_gemma":[0.99589425,0.0006037674,0.0024542138,0.00016116996,0.00063122925,0.0002553955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007186647,0.00016308374,0.0016426183,0.00008273123,0.000074551404,0.000005777799,0.00016604846,0.00029500373,0.0004766163],"category_scores_gemma":[0.00028491288,0.00010670832,0.0003258347,0.00006591154,0.00035840654,0.00012147633,0.00006348413,0.00059610483,0.0000021280093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017711373,0.004728883,0.9492362,0.000021008205,0.0015648573,0.00025251,0.00018217476,0.000018443243,0.00012913313,9.661808e-7,0.0025790203,0.023575442],"study_design_scores_gemma":[0.026165439,0.0056825615,0.9653618,0.00035661462,0.0008907818,0.00002390757,0.00002118976,0.000015533058,0.00047443275,0.000007809234,0.00090685143,0.00009310452],"about_ca_topic_score_codex":0.0018198554,"about_ca_topic_score_gemma":0.0063250223,"teacher_disagreement_score":0.023482338,"about_ca_system_score_codex":0.0009858256,"about_ca_system_score_gemma":0.0014864479,"threshold_uncertainty_score":0.52186143},"labels":[],"label_agreement":null},{"id":"W2637410905","doi":"10.1634/theoncologist.2017-0235","title":"Pregabalin for the Prevention of Oxaliplatin-Induced Painful Neuropathy: A Randomized, Double-Blind Trial","year":2017,"lang":"en","type":"article","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pregabalin; Neuropathic pain; Oxaliplatin; Anesthesia; Allodynia; Placebo; Analgesic; Chronic pain; Duloxetine; Peripheral neuropathy; Randomized controlled trial; Nociception; Internal medicine; Colorectal cancer; Hyperalgesia; Cancer; Physical therapy","score_opus":0.2068603240696497,"score_gpt":0.45655941135312983,"score_spread":0.24969908728348014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2637410905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9640816,0.0002804282,0.00026178473,0.013797821,0.0016253738,0.010705898,0.000012469121,0.000031966916,0.009202698],"genre_scores_gemma":[0.99189645,0.00011125721,0.000072805306,0.00021864328,0.00096865115,0.0013582555,0.0000145387585,0.000013724922,0.0053456803],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989334,0.00024067027,0.0003492833,0.00016586234,0.00013996492,0.00017082343],"domain_scores_gemma":[0.9971223,0.0016266798,0.00057457393,0.0005480059,0.000091005444,0.000037459682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019311749,0.00012709852,0.00051284384,0.000024923325,0.0004116987,0.00003378392,0.00029600298,0.00008600718,0.00010622031],"category_scores_gemma":[0.00057786464,0.00005904128,0.00034251102,0.000037462192,0.00043589622,0.000045932557,0.00006853008,0.00014778515,0.00000700684],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9843045,0.0003952004,0.00006897576,0.000027213042,0.00033014503,0.0000046104365,0.0002470378,0.000006673038,0.0023989049,0.00095991493,0.0016163884,0.009640456],"study_design_scores_gemma":[0.9826572,0.002725803,0.00042956212,0.000026172982,0.001712452,0.0000109940365,0.00005676545,0.00040230103,0.0055252886,0.00077319413,0.0056129876,0.000067301284],"about_ca_topic_score_codex":0.00031195622,"about_ca_topic_score_gemma":0.0001865757,"teacher_disagreement_score":0.027814882,"about_ca_system_score_codex":0.000052731015,"about_ca_system_score_gemma":0.00021462532,"threshold_uncertainty_score":0.31664953},"labels":[],"label_agreement":null},{"id":"W2640351411","doi":"10.1200/jco.2017.35.15_suppl.2534","title":"Validation of RECIST 1.1 for use with cytotoxic agents and targeted cancer agents (TCA): Results of a RECIST Working Group analysis of a 50 clinical trials pooled individual patient database.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Response Evaluation Criteria in Solid Tumors; Clinical trial; Progressive disease; Lung cancer; Cancer; Oncology; Target lesion; Internal medicine; Placebo; Clinical endpoint; Lesion; Chemotherapy; Radiology; Phases of clinical research; Pathology","score_opus":0.5320876877449999,"score_gpt":0.5820127522052523,"score_spread":0.049925064460252355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2640351411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956562,0.0002450984,0.00021695212,0.0009986387,0.0011486153,0.00084906124,0.00078583177,0.0000031313657,0.00009648871],"genre_scores_gemma":[0.99015313,0.002178961,0.0064641796,0.00036043726,0.0005548975,0.00002469329,0.0001747467,0.000018061146,0.00007086302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9905296,0.001773768,0.006557789,0.00036738216,0.0005443227,0.00022712848],"domain_scores_gemma":[0.9732302,0.009856538,0.015355673,0.000455533,0.0007790031,0.00032306922],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013765403,0.00020262116,0.0041865627,0.00040553854,0.00008134504,0.00001588963,0.00026739525,0.0004011452,0.00010485577],"category_scores_gemma":[0.01679241,0.00013706293,0.0010020657,0.0002547781,0.0006348662,0.00018264937,0.00011866302,0.0005104772,2.2605936e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14855893,0.005701217,0.65810543,0.00010170845,0.022655673,0.00010778953,0.0004338306,0.00006737642,0.0015915892,0.000008168281,0.0059344675,0.1567338],"study_design_scores_gemma":[0.05759104,0.030291488,0.8595366,0.00057342905,0.03437845,0.000017570643,0.00011274724,0.00044092123,0.0017892732,0.00002527613,0.015093775,0.00014942947],"about_ca_topic_score_codex":0.0003965393,"about_ca_topic_score_gemma":0.0005134796,"teacher_disagreement_score":0.20143114,"about_ca_system_score_codex":0.00011101862,"about_ca_system_score_gemma":0.0008930636,"threshold_uncertainty_score":0.9914896},"labels":[],"label_agreement":null},{"id":"W2702220459","doi":"10.1200/jco.2016.34.15_suppl.1014","title":"Disease-free (DFS) and overall survival (OS) at 3.4 years (yrs) for neoadjuvant bevacizumab (Bev) added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide (D-FEC), for women with HER2 negative early breast cancer: The ARTemis trial.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Epirubicin; Fluorouracil; Hazard ratio; Breast cancer; Neoadjuvant therapy; Oncology; Bevacizumab; Gastroenterology; Chemotherapy; Cancer; Confidence interval","score_opus":0.049282086248313914,"score_gpt":0.40586575050859663,"score_spread":0.3565836642602827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2702220459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9438598,0.0009372283,0.000077058336,0.051479395,0.00096200383,0.0019396696,0.00063281495,0.000011751514,0.00010027412],"genre_scores_gemma":[0.98703474,0.0028372526,0.00061366893,0.0034017256,0.0016747062,0.00043241555,0.000005190741,0.000048989907,0.0039513027],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9972147,0.0003114041,0.0012579104,0.00040197626,0.00031631446,0.0004977021],"domain_scores_gemma":[0.99117905,0.0062527293,0.0010352455,0.00025579726,0.00034072177,0.0009364357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017317319,0.0002738177,0.001627282,0.00006742817,0.000120621546,0.000020217616,0.0002106485,0.00022489313,0.0001884738],"category_scores_gemma":[0.0010806749,0.00014084563,0.00029281856,0.00008720881,0.00032884526,0.00014296258,0.00008635518,0.00030198874,0.0000030242606],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73186225,0.0012475979,0.037422016,0.000055820798,0.0018275543,0.00016175836,0.00060373324,0.0000024969218,0.0014179122,0.000038045724,0.08588771,0.13947311],"study_design_scores_gemma":[0.36748862,0.053922944,0.3973469,0.00021973194,0.0018911442,0.00017160102,0.00018944404,0.000017810322,0.00018032182,0.0010589482,0.17718881,0.00032372],"about_ca_topic_score_codex":0.00014185869,"about_ca_topic_score_gemma":0.00057649746,"teacher_disagreement_score":0.36437362,"about_ca_system_score_codex":0.0005748393,"about_ca_system_score_gemma":0.0011092894,"threshold_uncertainty_score":0.5743518},"labels":[],"label_agreement":null},{"id":"W2724602822","doi":"10.1007/s10637-017-0486-4","title":"Safety and effectiveness of eribulin in Japanese patients with locally advanced or metastatic breast cancer: a post-marketing observational study","year":2017,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; Eisai","keywords":"Eribulin; Medicine; Observational study; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Cancer","score_opus":0.03159839853472978,"score_gpt":0.33611036699038593,"score_spread":0.30451196845565615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2724602822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996691,0.000065250904,0.0000026170924,0.0016970937,0.00006034512,0.0012113249,0.00019722854,0.000009447436,0.00006571372],"genre_scores_gemma":[0.9986223,0.000011028379,0.0006796983,0.0002532074,0.000040798957,0.00009840972,0.00013053046,0.000014598477,0.00014945303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988654,0.00015721109,0.00027624072,0.00025299494,0.0003100096,0.00013810516],"domain_scores_gemma":[0.9985608,0.0006209947,0.00022981451,0.00014627431,0.00030158705,0.00014055845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003811712,0.00015026738,0.00034692648,0.000071386865,0.00011260177,0.000014119345,0.00008077784,0.000026535894,0.00011453923],"category_scores_gemma":[0.00025440767,0.0001095237,0.00002286921,0.00011357331,0.00019064096,0.00016526421,0.000043668068,0.000099862154,0.0000011062072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021084297,0.0005989115,0.9722179,0.00020144162,0.00020886936,0.00001760711,0.0008637649,0.00036336068,0.00063194096,0.000038037288,0.000016094018,0.0037577704],"study_design_scores_gemma":[0.018856512,0.000682236,0.97910154,0.00054429437,0.00015477264,0.000010384966,0.00019280954,0.00015575314,0.00010020252,0.000072614486,0.000021077702,0.00010777986],"about_ca_topic_score_codex":0.0018327595,"about_ca_topic_score_gemma":0.0008038004,"teacher_disagreement_score":0.006883657,"about_ca_system_score_codex":0.00013219478,"about_ca_system_score_gemma":0.0008643629,"threshold_uncertainty_score":0.4466247},"labels":[],"label_agreement":null},{"id":"W2725508151","doi":"10.1080/10833196.2017.1343539","title":"Measurement of objective shoulder function following breast cancer surgery: a scoping review protocol","year":2017,"lang":"en","type":"review","venue":"Physical Therapy Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Saskatchewan","funders":"","keywords":"Medicine; Breast cancer; Protocol (science); Quality of life (healthcare); Physical therapy; Range of motion; Narrative review; Cancer; Physical medicine and rehabilitation; Breast surgery; Medical physics; Alternative medicine; Intensive care medicine; Pathology; Internal medicine; Nursing","score_opus":0.35073191356258687,"score_gpt":0.5373454591521603,"score_spread":0.18661354558957338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2725508151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.8701916e-7,0.79211384,0.0000045082734,0.000097572025,0.00030945824,0.20709641,0.000019703533,0.000028817683,0.00032927626],"genre_scores_gemma":[0.0000023653274,0.6766987,0.0000041678104,0.00024866883,0.00081082206,0.3220748,0.00002194053,0.0000625865,0.00007595145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963026,0.0007401048,0.0013073899,0.00067022914,0.00060438627,0.000375314],"domain_scores_gemma":[0.99680775,0.0001355803,0.0018468238,0.00084085186,0.00020785576,0.00016114839],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001306154,0.0007576556,0.008272535,0.00011192762,0.00012029329,0.00001953177,0.00021134435,0.00012777078,0.0004346525],"category_scores_gemma":[0.00007854191,0.0004549281,0.004251344,0.00034014054,0.000074958145,0.00011880297,0.00004706002,0.00044075277,0.00004489414],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001100011,0.00044850056,0.000014818953,0.2646936,0.0010887674,0.0000052353025,0.000009811705,1.1491677e-8,0.000006849533,0.0000012309473,0.0024104055,0.73121077],"study_design_scores_gemma":[0.000501214,0.0001228302,0.000011696164,0.4460536,0.0036137844,0.000012134942,1.6518796e-7,1.5302729e-7,0.0000054236534,0.0000040882255,0.549473,0.0002018964],"about_ca_topic_score_codex":0.00004859408,"about_ca_topic_score_gemma":0.000010128782,"teacher_disagreement_score":0.7310089,"about_ca_system_score_codex":0.00047442483,"about_ca_system_score_gemma":0.0014752954,"threshold_uncertainty_score":0.99979025},"labels":[],"label_agreement":null},{"id":"W2730598197","doi":"10.1159/000477841","title":"Chronic Oxaliplatin-Based Chemotherapy in a Primary Ampullary Adenocarcinoma Patient without Significant Peripheral Neuropathy: Case Report and Literature Review","year":2017,"lang":"en","type":"article","venue":"Case Reports in Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Oxaliplatin; Medicine; Peripheral neuropathy; FOLFIRINOX; Irinotecan; Chemotherapy; Adenocarcinoma; Chemotherapy-induced peripheral neuropathy; Internal medicine; Oncology; Peripheral; Surgery; Cancer; Colorectal cancer","score_opus":0.02013752150172025,"score_gpt":0.3431272344386827,"score_spread":0.32298971293696244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2730598197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93745804,0.055555418,0.0000019386416,0.002854021,0.00053477107,0.0017270398,0.000008017269,0.00003191366,0.0018288173],"genre_scores_gemma":[0.9891613,0.006351555,0.00033346371,0.0031795236,0.00030475255,0.0002966576,0.00008465223,0.000044193646,0.00024387795],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9975069,0.00021093205,0.0009786212,0.0007540957,0.00015846267,0.00039094823],"domain_scores_gemma":[0.99783576,0.00010310982,0.0008363722,0.00091066764,0.0001052586,0.00020885213],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000619474,0.00031718684,0.00097543636,0.00016051145,0.00015025676,0.00003216401,0.000045862525,0.00025104242,0.0001288507],"category_scores_gemma":[0.00020585899,0.0002737102,0.00011073451,0.0001404475,0.00025110604,0.000094327275,0.000069942354,0.00055833836,7.592473e-7],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034400556,0.00038104743,0.17316322,0.0009424957,0.000032255954,0.80237347,0.000401167,0.0000044533435,0.0008096672,0.0000013825507,0.0005168088,0.021030035],"study_design_scores_gemma":[0.003763476,0.0020219367,0.054270044,0.0013565662,0.000168009,0.92444694,0.000034639743,0.00012358869,0.00015616132,0.000008248336,0.013426447,0.00022392556],"about_ca_topic_score_codex":0.000348563,"about_ca_topic_score_gemma":0.00054211443,"teacher_disagreement_score":0.122073494,"about_ca_system_score_codex":0.0011349415,"about_ca_system_score_gemma":0.001336765,"threshold_uncertainty_score":0.9999715},"labels":[],"label_agreement":null},{"id":"W2732921111","doi":"10.1093/annonc/mdx261.301","title":"Incidence of oxaliplatin-induced peripheral sensory neuropathy in patients with colorectal cancer treated by FOLFOX regimen at a regional community hospital in Québec","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Université de Sherbrooke","funders":"","keywords":"Medicine; Oxaliplatin; FOLFOX; Bevacizumab; Regimen; Internal medicine; Discontinuation; Colorectal cancer; Peripheral neuropathy; Surgery; Fluorouracil; Chemotherapy; Gastroenterology; Cancer; Diabetes mellitus","score_opus":0.06442179793898725,"score_gpt":0.3751321489538139,"score_spread":0.3107103510148267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732921111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947391,0.00017497454,4.764444e-8,0.003231376,0.000087036184,0.0005234662,0.000051235234,0.000008406883,0.0011843609],"genre_scores_gemma":[0.9989734,0.00012842355,0.000014245993,0.000463745,0.000026275731,0.00006804859,0.000044236895,0.000017020948,0.00026456252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987078,0.00029672604,0.00035904002,0.00020437759,0.00016642186,0.00026567516],"domain_scores_gemma":[0.9987319,0.00019179484,0.00049110537,0.0002882771,0.00021069615,0.00008619433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019317395,0.00017010525,0.0006261747,0.00010382429,0.000103478706,0.0000030666904,0.00018480727,0.00014918871,0.00009932652],"category_scores_gemma":[0.0000860244,0.00014510915,0.000063030035,0.00009176399,0.00038048674,0.000100168574,0.000103783364,0.00032755424,0.0000014161537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008472471,0.0028746475,0.9671594,0.000031183095,0.00010623448,0.00007904481,0.0026267548,0.0000040079567,0.012647055,0.0000029782009,0.0024610045,0.0035352104],"study_design_scores_gemma":[0.009980269,0.016226564,0.9622043,0.00009155488,0.0000527393,0.0000079547735,0.00009963626,0.000021424063,0.010471796,0.0000070646042,0.0007180986,0.000118645454],"about_ca_topic_score_codex":0.11334995,"about_ca_topic_score_gemma":0.11995893,"teacher_disagreement_score":0.013351915,"about_ca_system_score_codex":0.00036372602,"about_ca_system_score_gemma":0.0005229258,"threshold_uncertainty_score":0.8960995},"labels":[],"label_agreement":null},{"id":"W2734560446","doi":"10.1200/jco.2013.31.15_suppl.e12031","title":"Quality of life (QoL) and symptoms evaluation in metastatic breast cancer (MBC) patients (pts) treated with eribulin: Preliminary results of a prospective observational study.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Eribulin; Tolerability; Internal medicine; Taxane; Metastatic breast cancer; Capecitabine; Anthracycline; Neutropenia; Breast cancer; Adverse effect; Surgery; Gastroenterology; Chemotherapy; Cancer","score_opus":0.2666592212623247,"score_gpt":0.5288009329294016,"score_spread":0.26214171166707684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734560446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597996,0.00022050075,0.0000026854555,0.00199131,0.0001495897,0.001436645,0.000053623407,0.0000024352487,0.00016327301],"genre_scores_gemma":[0.99901414,0.00010032725,0.00037003093,0.00023914022,0.00012464297,0.00008537045,0.000016308333,0.000008519826,0.00004154349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956146,0.0009844945,0.002559523,0.00019605739,0.00051705487,0.00012828046],"domain_scores_gemma":[0.99316084,0.0019313573,0.0026122518,0.00010638439,0.0020156885,0.00017348585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002734213,0.00012685741,0.0014268359,0.00012616826,0.00001591091,0.0000025638342,0.000064893495,0.000116291,0.00019230919],"category_scores_gemma":[0.0015330865,0.00008097601,0.000113769485,0.00022240196,0.00020518914,0.00015235889,0.000027979995,0.00033057242,8.469441e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061170947,0.012786715,0.89465225,0.000049587736,0.0010462821,0.000012339693,0.00051913573,0.0000811925,0.00006348963,0.0000049659307,0.00031977153,0.02929333],"study_design_scores_gemma":[0.056374826,0.05926524,0.88264215,0.00009577848,0.0008920826,0.000013976579,0.00023839473,0.00029270985,0.00001978954,0.00008430119,0.000023256815,0.000057471618],"about_ca_topic_score_codex":0.0012343691,"about_ca_topic_score_gemma":0.0005312717,"teacher_disagreement_score":0.046478525,"about_ca_system_score_codex":0.00027260763,"about_ca_system_score_gemma":0.0018658042,"threshold_uncertainty_score":0.33098564},"labels":[],"label_agreement":null},{"id":"W2734681090","doi":"10.1200/jco.2016.34.15_suppl.4543","title":"Genome-wide association study of cisplatin-induced peripheral neuropathy (CIPN) in testicular cancer survivors.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Internal medicine; Genome-wide association study; Imputation (statistics); Single-nucleotide polymorphism; Cumulative dose; Oncology; Sensory neuropathy; Cancer; Cisplatin; Chemotherapy; Genotype; Gene; Genetics; Endocrinology; Diabetes mellitus","score_opus":0.1284873427186085,"score_gpt":0.47914271761906174,"score_spread":0.35065537490045323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734681090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910848,0.00020686534,0.0000097679485,0.006164819,0.0017162268,0.00032153894,0.0000033239269,0.000005277694,0.00048739376],"genre_scores_gemma":[0.99700415,0.0005489505,0.0000807935,0.0010298456,0.00089198194,0.000011271826,5.513343e-7,0.000015225316,0.000417239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99631935,0.0008630341,0.0020670977,0.00017793881,0.0003459204,0.00022666938],"domain_scores_gemma":[0.99239224,0.00480921,0.0020211055,0.00012215742,0.0004585133,0.00019675419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024640136,0.0001267848,0.0014366786,0.0001404654,0.000018782921,0.00000267524,0.000115416384,0.00025092825,0.00045469575],"category_scores_gemma":[0.0045466665,0.00007731221,0.00025070168,0.00018123872,0.000046740148,0.00008302677,0.00003643573,0.0005225291,0.00000622872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031036707,0.0058113686,0.9654568,0.000010593202,0.0003862002,0.00061998895,0.00032113306,0.000017526616,0.0060945894,0.0000015468584,0.00027925934,0.017897334],"study_design_scores_gemma":[0.019870803,0.026221685,0.9477249,0.000046986293,0.00051409553,0.000018769915,0.000100642974,0.000011795596,0.00011788409,0.000029863684,0.005273379,0.00006922763],"about_ca_topic_score_codex":0.0004074998,"about_ca_topic_score_gemma":0.0024401296,"teacher_disagreement_score":0.020410316,"about_ca_system_score_codex":0.0006879734,"about_ca_system_score_gemma":0.0010630045,"threshold_uncertainty_score":0.5443113},"labels":[],"label_agreement":null},{"id":"W2734686113","doi":"10.1016/j.ctrv.2017.06.007","title":"Influence of non-measurable disease on progression-free survival in patients with metastatic breast cancer","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Metastatic breast cancer; Hazard ratio; Oncology; Chemotherapy; Disease; Cancer; Clinical trial; Confidence interval; Bone disease; Progression-free survival; Osteoporosis","score_opus":0.10435938010052802,"score_gpt":0.45080077233445087,"score_spread":0.34644139223392284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734686113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034759021,0.9849728,1.5719495e-7,0.00013085893,0.00026879887,0.008935808,0.0018453964,0.00001954846,0.00035073084],"genre_scores_gemma":[0.0005746347,0.9869437,0.000040188017,0.000069540794,0.00015592984,0.010773775,0.00040594596,0.00009857379,0.00093769096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965921,0.00029293218,0.0011036473,0.0008870848,0.000589495,0.0005347065],"domain_scores_gemma":[0.99612826,0.00011459163,0.0015464755,0.0016032517,0.0001819851,0.00042544512],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024155724,0.0010327746,0.005129432,0.0002797805,0.00010453359,0.000023625635,0.00042016397,0.00010481584,0.00036653987],"category_scores_gemma":[0.000042169195,0.00055000704,0.00069905526,0.0003699065,0.00018766646,0.000139573,0.000068542504,0.00031698126,0.000044198998],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010503436,0.0025148448,0.061272908,0.02511811,0.0011149901,0.00013054322,0.000027192144,0.00002160633,9.109906e-8,0.0000016186711,0.0006482729,0.9080995],"study_design_scores_gemma":[0.00817837,0.001308398,0.047277734,0.11829859,0.011438401,0.0000061154956,8.881542e-7,0.000001122491,0.000001474522,0.0000024786864,0.8130292,0.00045719004],"about_ca_topic_score_codex":0.0010542963,"about_ca_topic_score_gemma":0.00046211897,"teacher_disagreement_score":0.9076423,"about_ca_system_score_codex":0.002106648,"about_ca_system_score_gemma":0.002346607,"threshold_uncertainty_score":0.9996951},"labels":[],"label_agreement":null},{"id":"W2734944762","doi":"10.3821/1913-701x-143.sp2.s17b","title":"Définition de l'hormonothérapie bio-identique","year":2010,"lang":"fr","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Geography; Humanities; Philosophy","score_opus":0.02217914826354529,"score_gpt":0.2913826089282291,"score_spread":0.2692034606646838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734944762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9079496,0.022901312,0.00013836278,0.003939795,0.050355967,0.0009590559,0.0018773378,0.000069447866,0.011809114],"genre_scores_gemma":[0.91649216,0.043999504,0.0004698667,0.008780289,0.014322263,0.000054561715,0.00014463859,0.00016326923,0.015573424],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99439555,0.0003867423,0.001031469,0.00068997213,0.0005591087,0.0029371309],"domain_scores_gemma":[0.9903089,0.00027013264,0.00045079621,0.00041446768,0.0008214545,0.0077342885],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012784236,0.00081712526,0.0007878029,0.0008092934,0.0013395417,0.0003496423,0.00075262657,0.00039018062,0.021263367],"category_scores_gemma":[0.00027900876,0.00096279854,0.00043115357,0.0009630754,0.00073199725,0.0006506404,0.00006119915,0.0034012129,0.00021756039],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00048468594,0.00043809114,0.0075582657,0.00070367876,0.0014100529,0.34514365,0.001983096,0.00020687796,0.0948833,0.0007056177,0.32572782,0.22075489],"study_design_scores_gemma":[0.0046520657,0.00015620739,0.00015918071,0.00006676615,0.0012623534,0.55672574,0.000014077653,0.0018262294,0.014796029,0.0003245008,0.41932672,0.0006901478],"about_ca_topic_score_codex":0.13845651,"about_ca_topic_score_gemma":0.5317869,"teacher_disagreement_score":0.39333043,"about_ca_system_score_codex":0.008856714,"about_ca_system_score_gemma":0.025786277,"threshold_uncertainty_score":0.9999606},"labels":[],"label_agreement":null},{"id":"W2735078344","doi":"10.1097/01.cot.0000521885.70331.34","title":"Less Chemotherapy Recommended After Surgery for Low-Risk Colon Cancer","year":2017,"lang":"en","type":"article","venue":"Oncology Times","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oxaliplatin; FOLFOX; Capecitabine; Colorectal cancer; Discontinuation; Internal medicine; Chemotherapy; Surgery; Oncology; Cancer","score_opus":0.047280403653568656,"score_gpt":0.400188093446682,"score_spread":0.3529076897931133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735078344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94072133,0.0012374276,0.000018482455,0.042058352,0.0018574836,0.00082107075,0.00010154175,0.00005729697,0.01312702],"genre_scores_gemma":[0.9353773,0.0031765522,0.0005637531,0.00567021,0.0011725584,0.0015548432,0.00004759306,0.00004335799,0.05239383],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99913526,0.000050475308,0.00018809419,0.00026398298,0.000058795053,0.00030338025],"domain_scores_gemma":[0.9988898,0.00039197865,0.00023683526,0.00030255129,0.00007553548,0.000103275386],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022833447,0.00015416584,0.0005198275,0.000061080624,0.00023559357,0.000016429902,0.00009723658,0.00020746441,0.0029809265],"category_scores_gemma":[0.000049660357,0.00012912825,0.00017862766,0.000024692556,0.000135292,0.000061335326,0.000028533155,0.0001413618,0.000034921555],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006440703,0.0005978369,0.22861801,0.000065544744,0.00053978176,0.00007042464,0.00024868423,5.292603e-7,0.0009568629,0.000014850415,0.4949051,0.26754165],"study_design_scores_gemma":[0.008204322,0.0009146639,0.14096718,0.00006340669,0.00055263325,0.000023832847,0.0000511478,0.00008437851,0.008348515,0.0002854066,0.8402995,0.00020504711],"about_ca_topic_score_codex":0.00034241306,"about_ca_topic_score_gemma":0.00065782684,"teacher_disagreement_score":0.34539434,"about_ca_system_score_codex":0.000267707,"about_ca_system_score_gemma":0.00039691912,"threshold_uncertainty_score":0.99793047},"labels":[],"label_agreement":null},{"id":"W2735604277","doi":"10.1016/s0167-8140(17)31634-1","title":"EP-1198: Low risk breast cancer patients’ supportive care needs and perceptions of follow-up care options","year":2017,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Breast cancer; Medicine; Perception; Risk perception; Oncology; Family medicine; Nursing; Intensive care medicine; Gynecology; Cancer; Internal medicine; Psychology","score_opus":0.01174667352165648,"score_gpt":0.34309083865636325,"score_spread":0.33134416513470677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735604277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98996127,0.006221892,0.00001327425,0.0012121766,0.0005289078,0.00045548574,0.0006699404,0.0000162133,0.0009208678],"genre_scores_gemma":[0.9815996,0.01674024,0.00017558975,0.0002894993,0.00027639294,0.00008694128,0.00008069016,0.000018147417,0.0007328952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999282,0.00006461238,0.00017998417,0.00020722211,0.00007170332,0.000194451],"domain_scores_gemma":[0.999238,0.00005495549,0.00019259911,0.00019296313,0.00018092454,0.00014052146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000038284754,0.00014905924,0.00041946623,0.00010721654,0.00036707983,0.000012463744,0.00006384957,0.00016602241,0.00089459744],"category_scores_gemma":[0.0000070293295,0.00012556644,0.00008860917,0.00004660129,0.00039128482,0.00007716349,0.000024244444,0.000151286,0.0000014591448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010244142,0.0002642182,0.884805,0.00010290903,0.00032128158,0.000008924072,0.02399633,0.0000016834482,0.0015068661,0.000046770157,0.0015170678,0.08640454],"study_design_scores_gemma":[0.012105231,0.0025512844,0.96160316,0.000047843932,0.0005618643,0.000045953788,0.0048874584,0.00002159841,0.0001952073,0.000014161989,0.017832596,0.0001336584],"about_ca_topic_score_codex":0.0013671245,"about_ca_topic_score_gemma":0.0033461284,"teacher_disagreement_score":0.086270876,"about_ca_system_score_codex":0.0003941995,"about_ca_system_score_gemma":0.0002142705,"threshold_uncertainty_score":0.97952145},"labels":[],"label_agreement":null},{"id":"W2737376100","doi":"10.1186/s40780-017-0089-4","title":"Objective evaluation of chemotherapy-induced peripheral neuropathy using quantitative pain measurement system (Pain Vision®), a pilot study","year":2017,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Health Care and Sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Japan Society for the Promotion of Science","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Common Terminology Criteria for Adverse Events; Cancer pain; Chemotherapy; Visual analogue scale; McGill Pain Questionnaire; Adverse effect; Anesthesia; Physical therapy; Internal medicine; Cancer","score_opus":0.36647353161493473,"score_gpt":0.5416819143141665,"score_spread":0.17520838269923172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737376100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916707,0.005212078,0.00019480287,0.0014161763,0.00045784362,0.000843235,0.000002393752,0.0000045752386,0.00019819054],"genre_scores_gemma":[0.99863726,0.00012963351,0.00046552494,0.00060049223,0.00015347131,0.0000059595723,1.6032276e-7,0.000006193733,0.0000012907278],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9961004,0.0017229151,0.00049072003,0.00019260835,0.0012808471,0.00021245595],"domain_scores_gemma":[0.99773985,0.00017831918,0.0006318095,0.000093730865,0.0011246466,0.0002316501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01583065,0.00012058419,0.00043149773,0.00013402893,0.00054078334,0.000046042904,0.00012644788,0.00002026563,0.000021058051],"category_scores_gemma":[0.00037515868,0.00008271162,0.00006455547,0.00012004345,0.00021755743,0.00017505435,0.000023552426,0.00019272217,1.8211225e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013721356,0.0064938315,0.18021928,0.0022539275,0.0009523896,0.0001777578,0.053261638,0.00022736615,0.17709428,0.00017294555,0.00049177126,0.5649335],"study_design_scores_gemma":[0.042556368,0.35837665,0.28361204,0.003218237,0.002419651,0.0003802233,0.121463105,0.17745245,0.009593786,0.00009149814,0.00031503304,0.00052095344],"about_ca_topic_score_codex":0.0002460304,"about_ca_topic_score_gemma":0.000065829765,"teacher_disagreement_score":0.56441253,"about_ca_system_score_codex":0.00063196395,"about_ca_system_score_gemma":0.0015035212,"threshold_uncertainty_score":0.54866195},"labels":[],"label_agreement":null},{"id":"W2737551266","doi":"10.1007/s00520-017-3836-z","title":"A prospective study of docetaxel-associated pain syndrome","year":2017,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; North York General Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pain medicine; Docetaxel; Nursing research; Prospective cohort study; Oncology; Internal medicine; Cancer; Anesthesia; Anesthesiology; Nursing","score_opus":0.031177374636377958,"score_gpt":0.394488387934553,"score_spread":0.36331101329817506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737551266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99328095,0.0007875119,3.8312766e-7,0.00028663548,0.0003156102,0.0013871602,0.00008997548,0.000019723466,0.0038320436],"genre_scores_gemma":[0.9982941,0.000082780214,0.000004998675,0.00011745979,0.000051908886,0.00053040945,0.000018874189,0.000018567389,0.0008808898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989196,0.00008939377,0.00026435507,0.00029460946,0.0001955994,0.00023641661],"domain_scores_gemma":[0.998984,0.00005441713,0.0002916485,0.00029082512,0.00030934333,0.00006980727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021503083,0.00014667206,0.00047757747,0.000096562886,0.00008584756,0.000009707244,0.00011360402,0.00007263059,0.00075827],"category_scores_gemma":[0.00016650456,0.00012733424,0.000078100566,0.000107495325,0.000105657164,0.00009091501,0.000052149353,0.00017462167,0.000004418968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055848854,0.0012993405,0.9828715,0.000071214046,0.0003908506,0.00065492996,0.010179826,0.0000026933737,0.00022335457,0.000004898372,0.00065269135,0.0030902294],"study_design_scores_gemma":[0.008216172,0.004358931,0.9788963,0.00016254644,0.0002651803,0.0000064057194,0.0067123477,0.0000052107957,0.00095621543,0.00003338677,0.00027103128,0.00011624156],"about_ca_topic_score_codex":0.003620209,"about_ca_topic_score_gemma":0.011947997,"teacher_disagreement_score":0.008327788,"about_ca_system_score_codex":0.0007603426,"about_ca_system_score_gemma":0.00033406788,"threshold_uncertainty_score":0.83025247},"labels":[],"label_agreement":null},{"id":"W2739249765","doi":"","title":"The Role of Albumin-bound Paclitaxel (Abraxane) in the Treatment of Metastatic Breast Cancer","year":2012,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Metastatic breast cancer; Paclitaxel; Cancer; Breast cancer; Oncology; Family medicine; Internal medicine","score_opus":0.0280889884611054,"score_gpt":0.3565047013326134,"score_spread":0.328415712871508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739249765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742064,0.015077958,9.745805e-7,0.00253975,0.00012053862,0.0005044786,0.00004394367,0.0000050706553,0.0075009256],"genre_scores_gemma":[0.9958888,0.0020006315,0.000032765904,0.00016339375,0.0001078068,0.00013700136,0.0000066009648,0.0000071476247,0.0016558067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999298,0.000075404336,0.0002065241,0.000074402844,0.00013467789,0.00021099429],"domain_scores_gemma":[0.9993615,0.00029602114,0.00007755918,0.00018608887,0.000032096916,0.000046698147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015527042,0.00009990492,0.00023334364,0.000035207235,0.000034768553,0.0000031512413,0.0000612434,0.000020363843,0.0006999395],"category_scores_gemma":[0.000003512124,0.000041792267,0.0000901819,0.00012990348,0.000113931565,0.000035013734,0.000006485348,0.000037585476,0.000006957498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016346468,0.008015979,0.7845793,0.00008205795,0.0014413294,0.000010839852,0.017346585,0.0000053421672,0.019141767,0.0046536485,0.0026418744,0.16044666],"study_design_scores_gemma":[0.00961295,0.0023237623,0.7463402,0.000052293613,0.0021779956,0.00014841145,0.009589775,0.00009069097,0.06653113,0.00069066125,0.16225928,0.00018281901],"about_ca_topic_score_codex":0.004526305,"about_ca_topic_score_gemma":0.0013996208,"teacher_disagreement_score":0.16026384,"about_ca_system_score_codex":0.00010106978,"about_ca_system_score_gemma":0.00007407833,"threshold_uncertainty_score":0.76638466},"labels":[],"label_agreement":null},{"id":"W2741428492","doi":"10.1158/1538-7445.am2017-ct055","title":"Abstract CT055: A randomized, double-blinded, controlled study of tucatinib (ONT-380) vs. placebo in combination with capecitabine (C) and trastuzumab (Tz) in patients with pretreated HER2+ unresectable locally advanced or metastatic breast carcinoma (MBC) (HER2CLIMB)","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Capecitabine; Internal medicine; Rash; Trastuzumab; Placebo; Taxane; Gastroenterology; Adverse effect; Population; Diarrhea; Oncology; Pertuzumab; Progression-free survival; Cancer; Chemotherapy; Breast cancer; Colorectal cancer; Pathology","score_opus":0.05602476690837405,"score_gpt":0.39824079362522813,"score_spread":0.3422160267168541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741428492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837898,0.00033419253,0.0000024723277,0.0004276082,0.00005671957,0.014625453,0.000043483607,0.000015454785,0.00070482097],"genre_scores_gemma":[0.99471503,0.00013786588,0.000047163765,0.000018141282,0.000026946434,0.0043541286,0.000041150728,0.0000544829,0.000605084],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99661255,0.0004645906,0.00068412645,0.0006363337,0.00093087705,0.00067153247],"domain_scores_gemma":[0.997279,0.0007913662,0.0003781242,0.0005222016,0.0008036681,0.00022565124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014133133,0.0003499705,0.0017224024,0.00061759556,0.00020021752,0.0000756174,0.00024771382,0.00008968666,0.00038713854],"category_scores_gemma":[0.00016317572,0.00021762426,0.00005748091,0.00054945174,0.00049594755,0.00030612227,0.00007496726,0.0006217095,0.0000021238384],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65411806,0.0053905686,0.33470342,0.00024469188,0.0005301547,0.00015896815,0.0015743836,0.0000932452,0.00015031555,0.000004001808,0.000021395905,0.0030107978],"study_design_scores_gemma":[0.56643057,0.006620121,0.4249361,0.00037441807,0.00021847607,0.000008129578,0.0008397006,0.00013340861,0.00029649033,0.0000059590884,0.0000039706347,0.00013266846],"about_ca_topic_score_codex":0.024300953,"about_ca_topic_score_gemma":0.05457018,"teacher_disagreement_score":0.09023268,"about_ca_system_score_codex":0.00075365667,"about_ca_system_score_gemma":0.001160577,"threshold_uncertainty_score":0.98219633},"labels":[],"label_agreement":null},{"id":"W2746271885","doi":"","title":"Pharmacokinetics of once daily IV busulfan: Implications of fixed-infusion rate dosing","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Busulfan; Dosing; Pharmacokinetics; Body surface area; Medicine; Pharmacology; Urology; Transplantation; Dose rate; Hematopoietic stem cell transplantation; Chemistry; Internal medicine","score_opus":0.12647436966958656,"score_gpt":0.507927610903224,"score_spread":0.38145324123363744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746271885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98824763,0.0021236718,0.00013517994,0.002314836,0.00015957162,0.00051157264,0.0000397126,0.000016865613,0.006450962],"genre_scores_gemma":[0.995419,0.0023957016,0.00018737344,0.00013358901,0.00026886328,0.000048162787,0.000018547846,0.000018069306,0.0015106496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872947,0.000073815274,0.0003084076,0.00020997529,0.0003119015,0.0003664171],"domain_scores_gemma":[0.9985735,0.00033193483,0.00009133825,0.00025436183,0.00060061016,0.00014827232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009049159,0.00008871149,0.0002365261,0.00025910322,0.00008448552,0.000004492414,0.00013641124,0.00006285097,0.0008101928],"category_scores_gemma":[0.000052458636,0.00007905314,0.00006246689,0.000751715,0.00025845706,0.00004051605,0.0000787365,0.0002821784,0.000009208709],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096173486,0.00020507231,0.013284551,0.00017682152,0.00007436425,0.000009942697,0.0003925458,0.00003262868,0.9368471,0.00017433157,0.007010621,0.040830325],"study_design_scores_gemma":[0.0027358842,0.00040765473,0.08249295,0.000155356,0.00009671024,0.000006645837,0.00009020866,0.000102294754,0.88528544,0.00008334784,0.028471204,0.000072307485],"about_ca_topic_score_codex":0.00057050464,"about_ca_topic_score_gemma":0.000084839405,"teacher_disagreement_score":0.0692084,"about_ca_system_score_codex":0.00023995627,"about_ca_system_score_gemma":0.00038418022,"threshold_uncertainty_score":0.8871043},"labels":[],"label_agreement":null},{"id":"W2747379890","doi":"10.1093/jnci/djx162","title":"Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30","year":2017,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Docetaxel; Taxane; Chemotherapy-induced peripheral neuropathy; Oncology; Peripheral neuropathy; Internal medicine; Breast cancer; Chemotherapy; Cancer; Quality of life (healthcare); Adjuvant","score_opus":0.03815278462749991,"score_gpt":0.3711577391902169,"score_spread":0.33300495456271695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747379890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840227,0.00041279258,0.0000017434354,0.012112156,0.001823479,0.00034058138,0.00014120566,0.0000067376,0.0011386254],"genre_scores_gemma":[0.99388677,0.00086562923,0.000024931645,0.0031349617,0.0014139762,0.000039267394,0.0000072084085,0.000022292079,0.0006049817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985589,0.00005197185,0.0003820192,0.00018092203,0.00060399796,0.00022223112],"domain_scores_gemma":[0.99825627,0.00002208198,0.00072252046,0.00014562452,0.0007302712,0.00012323027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015908154,0.00019744739,0.0004099373,0.00011877892,0.0002366845,0.00003788788,0.00033833683,0.00008711331,0.00060030556],"category_scores_gemma":[0.000027325103,0.0001165612,0.00014505765,0.0001235671,0.00025965684,0.0003578322,0.000043534834,0.00041192136,0.000003172212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004456675,0.0007560336,0.9725877,0.000025710591,0.00033103177,0.00013967679,0.00020129494,0.00030869397,0.0009876555,0.000010164642,0.003357046,0.016838284],"study_design_scores_gemma":[0.013568041,0.00048503364,0.9779973,0.00032429377,0.00022223553,0.00030294614,0.0000030182164,0.000040816496,0.0006284848,0.000012608301,0.006294868,0.00012035835],"about_ca_topic_score_codex":0.0004956786,"about_ca_topic_score_gemma":0.0012296537,"teacher_disagreement_score":0.016717928,"about_ca_system_score_codex":0.0019206852,"about_ca_system_score_gemma":0.0015720063,"threshold_uncertainty_score":0.65729254},"labels":[],"label_agreement":null},{"id":"W2748791006","doi":"10.1200/jco.2012.30.15_suppl.1557","title":"A comparison of simple single-item measures and the NCI Common Toxicity Criteria version 3.0 measure of peripheral neuropathy.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Clinical trial; Physical therapy; Adverse effect; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Patient-reported outcome; Psychological intervention; Randomized controlled trial; Quality of life (healthcare); Internal medicine","score_opus":0.26279268825581004,"score_gpt":0.5315475255132972,"score_spread":0.26875483725748717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748791006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99096745,0.0032161784,0.000033903027,0.0030697954,0.0011128741,0.00017835117,0.000005309012,0.0000037508419,0.0014123601],"genre_scores_gemma":[0.9977664,0.00026674985,0.00025054868,0.00087823544,0.0007971932,0.0000013413066,0.0000016177028,0.00000908148,0.000028832303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657583,0.0011580153,0.0016777784,0.000089241854,0.00031890222,0.00018024688],"domain_scores_gemma":[0.9948858,0.0028214932,0.0015825209,0.00012875478,0.0003544036,0.00022705365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032528501,0.000114874965,0.0017225108,0.000057408262,0.00004049408,0.00000330747,0.000114426904,0.00020919494,0.00019042661],"category_scores_gemma":[0.0015651895,0.00006621933,0.00036584635,0.0000847706,0.0005451681,0.000087656284,0.000057272588,0.00055995287,8.728469e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035761155,0.006177614,0.8558465,0.00006883637,0.0004839458,0.00003244623,0.0014723989,0.0000054263683,0.02758299,0.00005252591,0.009913365,0.0626028],"study_design_scores_gemma":[0.037864458,0.036123898,0.82975465,0.00013043523,0.0024962858,0.0004473617,0.00070992386,0.0003872067,0.010378338,0.00015906488,0.08141416,0.00013420964],"about_ca_topic_score_codex":0.000038001544,"about_ca_topic_score_gemma":0.00004053002,"teacher_disagreement_score":0.07150079,"about_ca_system_score_codex":0.00007757605,"about_ca_system_score_gemma":0.000261237,"threshold_uncertainty_score":0.27003458},"labels":[],"label_agreement":null},{"id":"W2749034238","doi":"10.14740/wjon1043w","title":"Visceral Crisis Means Short Survival Among Patients With Luminal A Metastatic Breast Cancer: A Retrospective Cohort Study","year":2017,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Metastatic breast cancer; Retrospective cohort study; Breast cancer; Chemotherapy; Internal medicine; Cancer; Cohort; Oncology","score_opus":0.021866324517359596,"score_gpt":0.3615178261924824,"score_spread":0.3396515016751228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749034238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907887,0.00006008078,0.00001153481,0.0029123074,0.0015745157,0.00084714824,0.000045067325,0.000010540587,0.0037500863],"genre_scores_gemma":[0.9978794,0.000065337306,0.0001650157,0.00024786507,0.00072489626,0.00005585848,0.0000053297654,0.000030152582,0.00082616875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980746,0.00019977933,0.00053169794,0.00027874144,0.0005635029,0.00035168062],"domain_scores_gemma":[0.9978542,0.00007154756,0.00074239646,0.0003013221,0.0007439912,0.00028657206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056670484,0.00024538828,0.0011843045,0.0002890942,0.00027819458,0.000038271075,0.0002470724,0.00004781383,0.00080523663],"category_scores_gemma":[0.000028652436,0.00017065034,0.00017473706,0.00015157262,0.00027005555,0.00023179056,0.00006471146,0.0005555413,0.000003808542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005682786,0.0043532224,0.9740614,0.000012687857,0.0031954367,0.00086029584,0.0006311323,0.000008101309,0.000024524536,0.0000065239155,0.008115649,0.0030482032],"study_design_scores_gemma":[0.012226766,0.00949093,0.9715352,0.000055185268,0.0040727034,0.00023923277,0.00036638996,0.000008528906,0.000024389612,0.00001548606,0.0018152348,0.00014992342],"about_ca_topic_score_codex":0.0013636886,"about_ca_topic_score_gemma":0.012797602,"teacher_disagreement_score":0.011433913,"about_ca_system_score_codex":0.0012756573,"about_ca_system_score_gemma":0.0005429102,"threshold_uncertainty_score":0.8816777},"labels":[],"label_agreement":null},{"id":"W2752175334","doi":"10.1007/s12282-017-0798-4","title":"Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study","year":2017,"lang":"en","type":"article","venue":"Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chugai Pharmaceutical; Eisai Canada; Japan Society of Clinical Oncology","keywords":"Capecitabine; Eribulin; Medicine; Metastatic breast cancer; Dosing; Internal medicine; Pharmacokinetics; Breast cancer; Neutropenia; Taxane; Anthracycline; Oncology; Gastroenterology; Toxicity; Pharmacology; Cancer; Urology; Colorectal cancer","score_opus":0.07959678551480229,"score_gpt":0.4405309141356356,"score_spread":0.3609341286208333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752175334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910805,0.0011663232,0.0000069623115,0.0019033956,0.0006222795,0.003321914,0.0016936117,0.000034498065,0.00017050903],"genre_scores_gemma":[0.9964273,0.0002385172,0.000056059405,0.00013519474,0.0006132739,0.0015556787,0.000021966312,0.00005317782,0.00089884317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982547,0.000060218023,0.0004382946,0.00053876016,0.00028940034,0.00041862132],"domain_scores_gemma":[0.998521,0.0000783802,0.00040232192,0.0005065984,0.0002547664,0.00023694953],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023538937,0.00033107787,0.00085477385,0.00013463761,0.00037519474,0.000048762442,0.00019616955,0.000050149305,0.0016940424],"category_scores_gemma":[0.000015589014,0.0002721863,0.000099901365,0.00011664531,0.00014145143,0.00017046185,0.0000991527,0.00015334201,0.0000030848691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015828995,0.02720553,0.71239823,0.00054247363,0.0042902627,0.0002275403,0.006328704,0.000025967583,0.009306124,0.000016573948,0.004759219,0.21907039],"study_design_scores_gemma":[0.09904066,0.004721361,0.88586533,0.00017089801,0.004370723,0.000257191,0.0031563947,0.00029879453,0.00042172312,0.000013428463,0.0013293122,0.00035419562],"about_ca_topic_score_codex":0.01176705,"about_ca_topic_score_gemma":0.0064242315,"teacher_disagreement_score":0.2187162,"about_ca_system_score_codex":0.00024668037,"about_ca_system_score_gemma":0.00031855528,"threshold_uncertainty_score":0.99997306},"labels":[],"label_agreement":null},{"id":"W2752563952","doi":"10.1200/jco.2017.73.3246","title":"First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"National Cancer Institute; Pfizer; Eli Lilly and Company","keywords":"Medicine; Tamoxifen; Fulvestrant; Internal medicine; Metastatic breast cancer; Breast cancer; Oncology; Pharmacokinetics; Cancer; Gastroenterology; Pharmacology; Urology","score_opus":0.12391452297016595,"score_gpt":0.5287560360576353,"score_spread":0.4048415130874694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752563952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912048,0.00040411254,8.5530144e-7,0.006487004,0.00077399105,0.00059233187,0.000017097427,0.000002685589,0.0005171065],"genre_scores_gemma":[0.9979376,0.0004363625,0.000074426294,0.00067168626,0.0005241108,0.000057407422,3.9962035e-7,0.000017294387,0.00028070412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99663377,0.0005671503,0.0019126202,0.00020825179,0.00035338505,0.0003247973],"domain_scores_gemma":[0.99563426,0.0008344847,0.0026506332,0.00041098197,0.00022673143,0.00024289242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018238653,0.00017753577,0.0019464318,0.00017342965,0.000086085216,0.000009693656,0.00042168234,0.00008946577,0.00039671917],"category_scores_gemma":[0.00041409035,0.00009568027,0.00020262106,0.00012842125,0.0003380509,0.0001767795,0.00010115462,0.0009858004,0.0000013525911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029371668,0.0367603,0.8799882,0.00006266203,0.0017120289,0.0024062213,0.0020835195,0.000086122745,0.0006206665,0.000017039863,0.00045333995,0.046438247],"study_design_scores_gemma":[0.07653665,0.021724219,0.8918645,0.0001118974,0.0009300001,0.0002408926,0.00046444923,0.00001587887,0.00006835238,0.0001147179,0.007846452,0.000082003404],"about_ca_topic_score_codex":0.0011707708,"about_ca_topic_score_gemma":0.0040149107,"teacher_disagreement_score":0.047164984,"about_ca_system_score_codex":0.00038274706,"about_ca_system_score_gemma":0.0012336522,"threshold_uncertainty_score":0.43437967},"labels":[],"label_agreement":null},{"id":"W2753082865","doi":"10.1182/blood.v128.22.4991.4991","title":"Efficacy of Dabigatran Etexilate in a Murine Model of Cancer Associated Thrombosis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Dabigatran; Cancer; Pulmonary embolism; Rivaroxaban; Direct thrombin inhibitor; Thrombosis; Low molecular weight heparin; Warfarin; Discovery and development of direct thrombin inhibitors; Lung cancer; Apixaban; Intensive care medicine; Internal medicine; Thrombin; Atrial fibrillation","score_opus":0.04375751817295521,"score_gpt":0.3513237967834105,"score_spread":0.3075662786104553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753082865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978265,0.00047017113,0.0000024926749,0.0005474458,0.000036390276,0.00019632575,0.000063453575,0.000013433287,0.0008437537],"genre_scores_gemma":[0.9986629,0.0007063034,0.000061463536,0.00005172801,0.000025801268,0.000022363593,0.000004676889,0.0000108092145,0.00045394758],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994289,0.000017958122,0.00020865751,0.00011590803,0.00009531897,0.00013320126],"domain_scores_gemma":[0.99965787,0.00006272513,0.00008993683,0.00010519623,0.00004334429,0.00004094685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006005151,0.00007627751,0.0003039152,0.00006668449,0.0000061272453,4.6092782e-7,0.00004186943,0.000058471673,0.00024208945],"category_scores_gemma":[0.000018873216,0.00005034082,0.00007118305,0.00012351642,0.000049435228,0.000020539657,0.000014093444,0.000044849396,0.000001960394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025304666,0.0022539096,0.2627045,0.000045513974,0.0004050788,0.0000048233233,0.000281973,0.000029382423,0.7320354,0.000023950866,0.000087286244,0.001875126],"study_design_scores_gemma":[0.028400058,0.0003792312,0.4144846,0.00030569907,0.0007749987,0.0000010103406,0.0000042951965,0.00014899597,0.5553181,0.000082891864,0.00002756369,0.00007253719],"about_ca_topic_score_codex":0.0004408064,"about_ca_topic_score_gemma":0.00035075785,"teacher_disagreement_score":0.17671727,"about_ca_system_score_codex":0.000041534528,"about_ca_system_score_gemma":0.00010054498,"threshold_uncertainty_score":0.26507097},"labels":[],"label_agreement":null},{"id":"W2757511999","doi":"10.1016/j.breast.2016.10.001","title":"3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3)","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Metastatic breast cancer; Overall survival; Cancer","score_opus":0.06115132011510013,"score_gpt":0.41052325189541666,"score_spread":0.34937193178031656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757511999","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29875684,0.00096943637,0.00029256646,0.68920153,0.0027152267,0.0010612662,0.0023854538,0.00014663216,0.0044710375],"genre_scores_gemma":[0.9685898,0.0003143483,0.0004662992,0.004248355,0.0022364473,0.00028027678,0.000035101937,0.000031592688,0.02379781],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99923265,0.000018047598,0.0002058635,0.00019360901,0.00013455377,0.0002152633],"domain_scores_gemma":[0.9990577,0.00015525828,0.00008188152,0.0001784327,0.00044545176,0.00008128181],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001078327,0.00013492306,0.00018189916,0.00003949988,0.0000752797,0.0000069958514,0.00012639342,0.000043078173,0.0015790482],"category_scores_gemma":[0.000032371292,0.00006656247,0.000102300975,0.000055393284,0.00012678251,0.00003304771,0.00003469087,0.000048738228,0.00005708786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008039902,0.00028931038,0.020111643,0.000033372155,0.0008071596,0.000024343923,0.00012175934,0.000021275164,0.053775165,0.0008907267,0.4190407,0.49684465],"study_design_scores_gemma":[0.035947215,0.00043538222,0.15867129,0.000632483,0.001100365,0.005780329,0.00021556376,0.0005015818,0.010599392,0.0017334156,0.78381383,0.0005691349],"about_ca_topic_score_codex":0.00019354424,"about_ca_topic_score_gemma":0.00012558323,"teacher_disagreement_score":0.68495315,"about_ca_system_score_codex":0.00013898454,"about_ca_system_score_gemma":0.00013386835,"threshold_uncertainty_score":0.9993336},"labels":[],"label_agreement":null},{"id":"W2757829418","doi":"10.1200/jco.2009.27.15_suppl.557","title":"Cost-effectiveness of zoledronic (ZOL) acid plus endocrine therapy (ET) in premenopausal women with early breast cancer (EBC) from a Canadian perspective","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Anastrozole; Breast cancer; Tamoxifen; Cost effectiveness; Gynecology; Goserelin; Internal medicine; Randomized controlled trial; Quality-adjusted life year; Oncology; Cancer","score_opus":0.10414754638523868,"score_gpt":0.49166512905062587,"score_spread":0.38751758266538716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757829418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872015,0.0016976709,0.000008414926,0.008575525,0.000458683,0.00068431615,0.000048681137,0.000006002079,0.0013191954],"genre_scores_gemma":[0.99520975,0.0019151383,0.00013325553,0.0020495162,0.00056863786,0.00004839536,0.0000033246802,0.000017476485,0.00005448693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726975,0.0007521312,0.0010450226,0.0002494791,0.0002555098,0.00042812934],"domain_scores_gemma":[0.9970815,0.00092611293,0.0007689154,0.00014431658,0.0005223654,0.00055679574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00132018,0.00019839477,0.0016746831,0.00024935644,0.000024590667,0.000006207995,0.00016032186,0.00020345172,0.0006049038],"category_scores_gemma":[0.00012870452,0.00013651494,0.0001388861,0.00024067552,0.00018346791,0.00013478473,0.000013660061,0.00096621667,0.000003330068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2709337,0.0081098005,0.5631207,0.0000346329,0.003762292,0.005023785,0.0058572623,0.0002692936,0.011887003,0.00030340248,0.00051683147,0.13018125],"study_design_scores_gemma":[0.039517432,0.03932878,0.9167021,0.00018095692,0.00023817945,0.00030127924,0.0003532306,0.000012233498,0.00054688106,0.0005312077,0.0021721849,0.00011552108],"about_ca_topic_score_codex":0.07535961,"about_ca_topic_score_gemma":0.0936233,"teacher_disagreement_score":0.35358137,"about_ca_system_score_codex":0.0037327765,"about_ca_system_score_gemma":0.009876975,"threshold_uncertainty_score":0.9957361},"labels":[],"label_agreement":null},{"id":"W2761819177","doi":"10.1093/annonc/mdx365.080","title":"IMpassion131: Phase III study comparing 1L atezolizumab with paclitaxel vs placebo with paclitaxel in treatment-naive patients with inoperable locally advanced or metastatic triple negative breast cancer (mTNBC)","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Atezolizumab; Paclitaxel; Triple-negative breast cancer; Oncology; Placebo; Internal medicine; Breast cancer; Chemotherapy; Cancer; Immunotherapy; Pathology; Pembrolizumab","score_opus":0.09233901511981349,"score_gpt":0.44344857244973124,"score_spread":0.3511095573299178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761819177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99167335,0.0001617458,0.000021878663,0.0019030281,0.00012883541,0.004307784,0.00024732298,0.00003292636,0.0015231506],"genre_scores_gemma":[0.9961627,0.00029457986,0.00046885438,0.00040190128,0.00005903933,0.0013523663,0.000070404276,0.00005816795,0.0011319749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732,0.00027170577,0.0006225035,0.00068589265,0.00037270004,0.0007272063],"domain_scores_gemma":[0.9972884,0.00032141863,0.0008426503,0.0005978629,0.0006182989,0.00033134132],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002171877,0.0005455527,0.0018624504,0.00025733712,0.00031425047,0.00003150993,0.00023745713,0.000101652804,0.0003919275],"category_scores_gemma":[0.000049131857,0.00030236455,0.00008430394,0.00028740198,0.0005030775,0.0004290474,0.000077247794,0.00029577236,0.0000065977874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40682063,0.02664079,0.5088013,0.00009645715,0.0031382297,0.0011253441,0.0058659352,0.0003311109,0.000106580475,0.000011945567,0.00072476,0.046336927],"study_design_scores_gemma":[0.3818388,0.19682162,0.41159344,0.00061986677,0.0015760721,0.00011760952,0.004001658,0.0002462037,0.0013248302,0.00001855376,0.0013222456,0.0005190792],"about_ca_topic_score_codex":0.009652377,"about_ca_topic_score_gemma":0.031873785,"teacher_disagreement_score":0.17018083,"about_ca_system_score_codex":0.00060616306,"about_ca_system_score_gemma":0.0015717563,"threshold_uncertainty_score":0.99994284},"labels":[],"label_agreement":null},{"id":"W2765099943","doi":"10.1016/s0960-9776(17)30667-7","title":"Creating a Novel Drug Navigation Tool for Metastatic Breast Cancer Drugs in Canada","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Drug; Metastatic breast cancer; Breast cancer; Oncology; Cancer drugs; Cancer; Internal medicine; Medical physics; Intensive care medicine; Pharmacology","score_opus":0.022026568746454204,"score_gpt":0.329341557099641,"score_spread":0.3073149883531868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765099943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832951,0.00011655751,0.00001578841,0.014203537,0.0002656357,0.00068563607,0.0007026812,0.000011035306,0.0007040276],"genre_scores_gemma":[0.99728554,0.0000136662175,0.00011886063,0.00046401317,0.00027073894,0.00028856995,0.00004567711,0.00001726142,0.0014956417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992814,0.000018534662,0.00016800199,0.00015840388,0.00013910013,0.00023455359],"domain_scores_gemma":[0.999359,0.000118321186,0.00014023864,0.00025903515,0.0000665344,0.00005687397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001715978,0.00011869562,0.0002170186,0.0000219652,0.00025850857,0.000027030577,0.00013676075,0.000014305371,0.00016418633],"category_scores_gemma":[0.000011842451,0.00008065162,0.000048457183,0.0000448373,0.000049855862,0.000084147105,0.00003096329,0.000102386424,0.0000030171952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005551584,0.0009875842,0.7054583,0.00079785485,0.0012413397,0.00009127846,0.008236945,0.00032676663,0.016963853,0.0010261623,0.019304043,0.2400143],"study_design_scores_gemma":[0.0083317375,0.00003414774,0.98371124,0.00036181972,0.00054750615,0.00057513133,0.00069583056,0.003203454,0.00091713027,0.00011878491,0.0013091583,0.00019407514],"about_ca_topic_score_codex":0.9226085,"about_ca_topic_score_gemma":0.77391034,"teacher_disagreement_score":0.27825293,"about_ca_system_score_codex":0.00064550363,"about_ca_system_score_gemma":0.0010373556,"threshold_uncertainty_score":0.32888776},"labels":[],"label_agreement":null},{"id":"W2765390782","doi":"10.1007/s11103-017-0674-9","title":"Correction to: CYP79 P450 monooxygenases in gymnosperms: CYP79A118 is associated with the formation of taxiphyllin in Taxus baccata","year":2017,"lang":"en","type":"erratum","venue":"Plant Molecular Biology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Taxus; Biology; Monooxygenase; Botany; Computational biology; Biochemistry; Enzyme; Cytochrome P450","score_opus":0.018032710405198816,"score_gpt":0.30772900941034637,"score_spread":0.28969629900514754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765390782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87426704,0.014232388,0.0008831411,0.012158052,0.031381134,0.00845726,0.005563492,0.00015357322,0.0529039],"genre_scores_gemma":[0.96352535,0.0019285132,0.00005300121,0.0018600656,0.00039528802,0.0003781871,0.014344376,0.000064693755,0.017450495],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984827,0.00019985242,0.0004007138,0.00039815708,0.00014876071,0.000369839],"domain_scores_gemma":[0.9987991,0.00015395338,0.0004792521,0.00040933234,0.000091457194,0.00006690329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024381444,0.00031834038,0.0007761961,0.0003780444,0.000054102624,0.000011579642,0.0002522278,0.0004982064,0.00007317307],"category_scores_gemma":[0.00020402364,0.00021607034,0.00010487061,0.00023536928,0.00011085302,0.000038263188,0.00006888875,0.00068924145,0.000015062553],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018091581,0.0005365962,0.0056809494,0.0001269476,0.00046576688,0.00056905654,0.0010169458,0.000046121702,0.023911264,0.000030597144,0.9637785,0.0020280806],"study_design_scores_gemma":[0.01988325,0.011622594,0.11475879,0.00594926,0.0021320917,0.00091511384,0.0005229085,0.006311342,0.07650952,0.00030796355,0.7589508,0.00213633],"about_ca_topic_score_codex":0.0023827704,"about_ca_topic_score_gemma":0.010331584,"teacher_disagreement_score":0.20482768,"about_ca_system_score_codex":0.00029912873,"about_ca_system_score_gemma":0.00031917644,"threshold_uncertainty_score":0.8811093},"labels":[],"label_agreement":null},{"id":"W2766182174","doi":"10.1016/j.jval.2017.08.2594","title":"Supporting Individual Reflection and Patient-Clinician Shared Decision-Making on GEP-NET Management Options Using Reflective Multi-Criteria Decision Analysis","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Decision quality; Lanreotide; Watchful waiting; Population; Actuarial science; Family medicine; Psychology; Nursing; Patient satisfaction; Internal medicine; Business","score_opus":0.1712701435847904,"score_gpt":0.5248776480838744,"score_spread":0.35360750449908396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766182174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955692,0.0004162513,0.0018650887,0.00043017702,0.00054201006,0.00081819255,0.0000463851,0.000030356163,0.0002823089],"genre_scores_gemma":[0.9465986,0.0003833712,0.052107777,0.0007029424,0.000091654794,0.000031036023,0.00003659521,0.000019454965,0.000028566978],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99797523,0.00017233577,0.00067199866,0.0005136386,0.00028450842,0.00038228257],"domain_scores_gemma":[0.9985543,0.00031494992,0.00053572556,0.00038734634,0.000058985843,0.00014872682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079893385,0.00017414233,0.00045490172,0.00078930135,0.00065332116,0.00009219893,0.000099834186,0.00009474558,0.0001231019],"category_scores_gemma":[0.00022631368,0.00016467659,0.00010263165,0.0003869269,0.00004443451,0.00014649674,0.00012236382,0.00023120348,0.0000064567716],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036541088,0.0017084519,0.33348462,0.0002348816,0.0014668187,0.00034700404,0.008225986,0.010741409,0.0002835815,0.000101985504,0.0009888497,0.6387623],"study_design_scores_gemma":[0.0049942113,0.0016193459,0.90613127,0.0015627274,0.00092384464,0.000028468228,0.0006747501,0.08207425,0.000053304393,0.00094517064,0.0007467855,0.0002458534],"about_ca_topic_score_codex":0.0013557589,"about_ca_topic_score_gemma":0.0007228177,"teacher_disagreement_score":0.6385164,"about_ca_system_score_codex":0.0006329984,"about_ca_system_score_gemma":0.00011131145,"threshold_uncertainty_score":0.6715317},"labels":[],"label_agreement":null},{"id":"W2766393924","doi":"","title":"Squalene protects mice bone marrow hematopoietic and mesenchymal stem cells against high-dose cisplatin in vivo by restoring antioxidant balance: implications in cancer chemotherapy","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cisplatin; Bone marrow; Pharmacology; Toxicity; In vivo; Medicine; Stem cell; Squalene; Mesenchymal stem cell; Cancer research; Chemotherapy; Chemistry; Immunology; Pathology; Biology; Internal medicine; Biochemistry","score_opus":0.042422883180788885,"score_gpt":0.3845504276158072,"score_spread":0.3421275444350183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766393924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98132247,0.0104943635,0.000004475457,0.005686236,0.00011698,0.001794977,0.000098306125,0.000031711344,0.00045049598],"genre_scores_gemma":[0.9854719,0.007099397,0.00007611461,0.00018777935,0.0002509682,0.00209139,0.000010960829,0.000046941816,0.0047645485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977596,0.0001621379,0.00038854568,0.0005734919,0.00040292385,0.0007133064],"domain_scores_gemma":[0.9991924,0.00015270017,0.00008176936,0.00028552793,0.00013108132,0.00015648105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055929285,0.0002124593,0.00043753308,0.00036119932,0.00011458298,0.000030121655,0.00012659065,0.0001419855,0.00025578562],"category_scores_gemma":[0.000007784135,0.0002022876,0.000038910126,0.0009106743,0.00017936621,0.00009659432,0.000059297934,0.00056059397,0.0000058155597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060520973,0.00038043305,0.05122532,0.00034219466,0.000025075817,0.000073839656,0.00037112317,0.00006507272,0.9338802,0.00007091253,0.009309391,0.0036512176],"study_design_scores_gemma":[0.010904508,0.00032082462,0.08566927,0.00075093657,0.000024207257,0.000019045614,0.00014814662,0.0002030357,0.8911239,0.00016972881,0.010334856,0.0003315509],"about_ca_topic_score_codex":0.011547275,"about_ca_topic_score_gemma":0.003199619,"teacher_disagreement_score":0.04275632,"about_ca_system_score_codex":0.001134247,"about_ca_system_score_gemma":0.00044728653,"threshold_uncertainty_score":0.99503493},"labels":[],"label_agreement":null},{"id":"W2767214300","doi":"10.1093/neuonc/nox168.247","title":"DDIS-11. TTI-2341: A NOVEL, ORALLY BIOAVAILABLE, BRAIN-PENETRANT, COVALENT EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITOR FOR TREATMENT OF GLIOBLASTOMA MULTIFORME (GBM) AND BRAIN METASTASES OF NON-SMALL CELL LUNG CANCER (NSCLC)","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"Erlotinib; Afatinib; Epidermal growth factor receptor; Pharmacology; Bioavailability; EGFR inhibitors; Blood–brain barrier; Cancer research; Gefitinib; Medicine; Cancer; Central nervous system; Internal medicine","score_opus":0.03715621773001542,"score_gpt":0.34614006948822057,"score_spread":0.30898385175820514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767214300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831252,0.0014154331,0.00016856572,0.007980687,0.0012434223,0.003258498,0.00248606,0.0000422897,0.00027984992],"genre_scores_gemma":[0.99117994,0.0017070546,0.0032483998,0.0015470607,0.00060948986,0.00073699554,0.00011585935,0.000103939594,0.00075128203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99726385,0.00015055298,0.000878196,0.0007783954,0.0002292884,0.0006997332],"domain_scores_gemma":[0.99625105,0.0015595042,0.00095920183,0.0005226953,0.0003332136,0.00037433175],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022818359,0.00055516267,0.0015991138,0.00029182635,0.00023514283,0.00002437984,0.0002571165,0.00030187704,0.00052726024],"category_scores_gemma":[0.00024628956,0.000456868,0.0003686588,0.00012984495,0.0005057572,0.00015914388,0.0001203794,0.00014864592,0.000006721793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006788039,0.0034100448,0.0369634,0.00089000055,0.0005867465,0.00009789662,0.0010180166,0.000006525735,0.9193825,0.00002071696,0.019013152,0.01182297],"study_design_scores_gemma":[0.039273992,0.022285823,0.012247246,0.00013860932,0.0013592988,0.000094363066,0.00010748924,0.0005641274,0.7986197,0.0000040111518,0.12491741,0.00038794143],"about_ca_topic_score_codex":0.0016434095,"about_ca_topic_score_gemma":0.0025852367,"teacher_disagreement_score":0.1207628,"about_ca_system_score_codex":0.0005003864,"about_ca_system_score_gemma":0.0010332708,"threshold_uncertainty_score":0.9997883},"labels":[],"label_agreement":null},{"id":"W2767766110","doi":"10.1093/neuonc/nox168.1104","title":"SCDT-21. CEREBRAL INTRAARTERIAL CHEMOTHERAPY IN THE TREATMENT OF MALIGNANT GLIOMAS: READY TO RISE AGAIN","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Temozolomide; Carboplatin; Chemotherapy; Complication; Glioma; Concomitant; Cohort; Surgery; Radiation therapy; Oncology; Internal medicine; Cisplatin","score_opus":0.04201072693010514,"score_gpt":0.3734141479719171,"score_spread":0.3314034210418119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767766110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728482,0.00011406438,0.0000021281264,0.020047171,0.0011929193,0.0012172619,0.000024546449,0.000020415191,0.004533336],"genre_scores_gemma":[0.9947555,0.00042564867,0.00015619143,0.0033138439,0.0008632525,0.00025040214,0.00001751427,0.000024989884,0.0001926484],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986132,0.00020698275,0.0003375537,0.00035012525,0.00014158244,0.00035060043],"domain_scores_gemma":[0.9988061,0.00020153548,0.00019365996,0.0006350879,0.000042108,0.00012146206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018580168,0.00019437967,0.00057183864,0.00011689655,0.00011608451,0.000025025614,0.00022450913,0.0001481626,0.00039054677],"category_scores_gemma":[0.00003987677,0.00013502431,0.00011071631,0.000091862865,0.00017700618,0.000045226272,0.000028804185,0.0001146805,0.000036646168],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071361037,0.006252117,0.038905498,0.00002919327,0.00019774187,0.0029039804,0.007929841,0.000003447682,0.7681866,0.00011740523,0.022040127,0.14629793],"study_design_scores_gemma":[0.019155439,0.032019354,0.065099806,0.000023365405,0.0002678771,0.0004532543,0.00023051404,0.000028797074,0.08972976,0.00015002761,0.79265743,0.00018437563],"about_ca_topic_score_codex":0.0010692477,"about_ca_topic_score_gemma":0.001546658,"teacher_disagreement_score":0.7706173,"about_ca_system_score_codex":0.00029978587,"about_ca_system_score_gemma":0.00022185559,"threshold_uncertainty_score":0.5506131},"labels":[],"label_agreement":null},{"id":"W2769968157","doi":"10.1200/jco.2017.35.31_suppl.119","title":"Impact of pharmacy interventions on pain management in an oncology palliative medicine (PM) outpatient clinic.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical endpoint; Pharmacy; McNemar's test; Pharmacist; Regimen; Palliative care; Physical therapy; Psychological intervention; Quality of life (healthcare); Cancer pain; Internal medicine; Outpatient clinic; Performance status; Cancer; Clinical trial; Family medicine; Nursing","score_opus":0.48154132006747746,"score_gpt":0.6737666908397559,"score_spread":0.19222537077227847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769968157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9678017,0.00035826347,0.000055095028,0.011958831,0.002380109,0.00059635146,0.000009760459,0.0000063639754,0.01683352],"genre_scores_gemma":[0.99341077,0.0021691278,0.00081690855,0.0017519337,0.001211815,0.00001892551,0.0000100419165,0.000017721046,0.0005927437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993805,0.0016707382,0.0036309205,0.00027318185,0.00032428544,0.00029590598],"domain_scores_gemma":[0.9910542,0.0028477055,0.0048138793,0.00039762497,0.00041655864,0.00047005466],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0080348225,0.0002129718,0.002261819,0.00037439202,0.00006895273,0.0000056629183,0.00040947617,0.00029367683,0.0020133317],"category_scores_gemma":[0.0026718567,0.00013865888,0.0011059928,0.00009474282,0.00057678536,0.00014627843,0.00010132926,0.0012329598,0.000022303027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023563549,0.018927593,0.5056474,0.00008071072,0.0015919895,0.0013872413,0.00040449033,0.000025285923,0.00004848475,0.00007751725,0.010952869,0.43729284],"study_design_scores_gemma":[0.03953963,0.19872682,0.736022,0.000454491,0.001058016,0.000026394222,0.00020142167,0.000151668,0.000012606199,0.00039991547,0.023315638,0.00009141554],"about_ca_topic_score_codex":0.00021240074,"about_ca_topic_score_gemma":0.00040851394,"teacher_disagreement_score":0.4372014,"about_ca_system_score_codex":0.000778975,"about_ca_system_score_gemma":0.0009442871,"threshold_uncertainty_score":0.998899},"labels":[],"label_agreement":null},{"id":"W2771979038","doi":"10.1016/j.jpba.2017.12.002","title":"HPLC–MS/MS analysis of mesupron and its application to a pharmacokinetic study in rats","year":2017,"lang":"en","type":"article","venue":"Journal of Pharmaceutical and Biomedical Analysis","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Ministry of Trade, Industry and Energy","keywords":"Chemistry; Chromatography; Protein precipitation; Pharmacokinetics; Bioanalysis; Selected reaction monitoring; Tandem mass spectrometry; High-performance liquid chromatography; Formic acid; Acetonitrile; Analyte; Mass spectrometry; Pharmacology","score_opus":0.04355072442007977,"score_gpt":0.43860806719783585,"score_spread":0.39505734277775606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771979038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99251676,0.0010498475,0.0002350805,0.005639474,0.000062118605,0.00036751377,0.000018295637,0.0000043252967,0.00010658517],"genre_scores_gemma":[0.99830174,0.00091242825,0.00010708848,0.00035820637,0.00017437112,0.000015283296,0.000009082783,0.000006361323,0.000115421804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980886,0.00011129576,0.000768846,0.00028603358,0.00051539316,0.00022984744],"domain_scores_gemma":[0.99849886,0.00012540958,0.00037642394,0.00016867866,0.00018129723,0.0006493213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008147438,0.0001724728,0.0011155462,0.0014913447,0.0000837602,0.000023916016,0.0001754755,0.000080495505,0.0005042275],"category_scores_gemma":[0.00009213791,0.000117403564,0.00029955799,0.0016186319,0.00021304438,0.00009226699,0.00011121817,0.00027914526,0.0000020261712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031930043,0.005458395,0.7305919,0.00014850615,0.028306965,0.00038521862,0.0010101655,0.00005805388,0.15373516,0.000025409934,0.0002499779,0.076837264],"study_design_scores_gemma":[0.0067597963,0.0016434304,0.87443995,0.00003367325,0.07336691,0.00003149428,0.00012837158,0.03409722,0.0056322,0.000025813364,0.0036726948,0.00016844786],"about_ca_topic_score_codex":0.00013957682,"about_ca_topic_score_gemma":0.00010008242,"teacher_disagreement_score":0.14810295,"about_ca_system_score_codex":0.000056627294,"about_ca_system_score_gemma":0.00005417194,"threshold_uncertainty_score":0.55209374},"labels":[],"label_agreement":null},{"id":"W2772380982","doi":"","title":"Tamoxifen and Turmeric","year":2017,"lang":"en","type":"article","venue":"Ars Medica","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Internal medicine; Cancer","score_opus":0.024947650332301882,"score_gpt":0.36027469349740054,"score_spread":0.33532704316509865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772380982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90541124,0.0013368779,0.0000037993225,0.017888281,0.00044826578,0.00013202595,0.00000199909,0.00002650904,0.07475102],"genre_scores_gemma":[0.99266905,0.0007103943,0.00012867025,0.001503843,0.00018310291,0.000011355435,0.000004665589,0.0000057822713,0.0047831177],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9996496,0.0000060921807,0.000054340413,0.00010205606,0.00008139706,0.000106532745],"domain_scores_gemma":[0.9996231,0.000021384287,0.00003698408,0.00017761684,0.000010291638,0.00013062624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052268315,0.000050392642,0.00011565375,0.00001835431,0.00011427899,0.000008790505,0.000049648657,0.00003290046,0.0005234204],"category_scores_gemma":[0.00005135971,0.00003773589,0.000019684829,0.000011560289,0.0001631147,0.000030051544,0.00003228674,0.00006696872,0.000049047412],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035413128,0.00029970694,0.27806687,0.00007311693,0.00035561566,0.0007246955,0.0013275604,3.9109057e-8,0.014184452,0.00036640014,0.36544624,0.33880118],"study_design_scores_gemma":[0.0046021,0.00046779518,0.58008206,0.00003862617,0.00027875352,0.0001791635,0.000025259213,0.00004089627,0.0026917653,0.0007060719,0.41078776,0.000099766155],"about_ca_topic_score_codex":0.00008553548,"about_ca_topic_score_gemma":0.0000068361237,"teacher_disagreement_score":0.3387014,"about_ca_system_score_codex":0.0000127789635,"about_ca_system_score_gemma":0.00004316225,"threshold_uncertainty_score":0.5731086},"labels":[],"label_agreement":null},{"id":"W2779612734","doi":"10.1097/fpc.0000000000000318","title":"Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci","year":2017,"lang":"en","type":"review","venue":"Pharmacogenetics and Genomics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Taxane; Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Internal medicine; Oncology; Odds ratio; Common Terminology Criteria for Adverse Events; Breast cancer; Genome-wide association study; Confidence interval; Cancer; Pharmacogenetics; Diabetes mellitus; Genetics; Single-nucleotide polymorphism; Genotype; Biology; Gene; Endocrinology","score_opus":0.44997370352963967,"score_gpt":0.48725786600588017,"score_spread":0.0372841624762405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2779612734","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008970496,0.98742634,0.00001772471,0.00012972223,0.00075430836,0.0014615667,0.00066658837,0.000053638767,0.0005196138],"genre_scores_gemma":[0.0026854854,0.99051005,0.00012623062,0.00047170257,0.00070908526,0.00021067187,0.0008118313,0.00018375381,0.00429118],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969265,0.00018741915,0.001018612,0.00093019265,0.00030395723,0.0006333161],"domain_scores_gemma":[0.9974263,0.00017920148,0.0011077346,0.00066030497,0.00018738896,0.00043911726],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003607181,0.0009889811,0.004052242,0.00027505512,0.0004040539,0.00021818644,0.00043539106,0.00036067996,0.0005666803],"category_scores_gemma":[0.0000769592,0.00078415073,0.0017647361,0.00016198654,0.00017329719,0.000057046887,0.00030479027,0.00062962086,0.00004713831],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030057304,0.0021234127,0.00023120396,0.014629499,0.1499999,0.0012868172,0.0006687234,0.000045713765,0.030258575,0.000008392613,0.003125218,0.797322],"study_design_scores_gemma":[0.0016165448,0.00020435892,0.00013502564,0.0001280117,0.13952217,0.00015980423,0.00000813435,0.000046026536,0.00028621138,0.0000069784105,0.85730916,0.00057758944],"about_ca_topic_score_codex":0.00007774172,"about_ca_topic_score_gemma":0.00003697969,"teacher_disagreement_score":0.8541839,"about_ca_system_score_codex":0.00032664658,"about_ca_system_score_gemma":0.0006037108,"threshold_uncertainty_score":0.99946094},"labels":[],"label_agreement":null},{"id":"W2781298674","doi":"","title":"[Pierre Famel, his pharmacy, laboratories and pharmaceutical products].","year":2010,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemist; Exhibition; Management; Pharmacy; Art history; Library science; Political science; Art; Law; Chemistry","score_opus":0.037106036409613484,"score_gpt":0.32841157260984505,"score_spread":0.2913055362002316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781298674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97058773,0.0024752382,9.3252817e-7,0.014279673,0.0017109582,0.0010569842,0.000024734745,0.00012604208,0.009737728],"genre_scores_gemma":[0.9907236,0.00048250603,0.00014801671,0.0016050886,0.001227448,0.0010025693,0.00001952035,0.000021777938,0.004769447],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990529,0.000022757138,0.00013938194,0.0002856267,0.00013773495,0.00036162],"domain_scores_gemma":[0.99935013,0.000042963624,0.000034595017,0.00015276474,0.00010540961,0.00031413627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016561197,0.00014637917,0.00021414662,0.00006061209,0.00006694422,0.000022891427,0.00005249228,0.000054843957,0.00028248204],"category_scores_gemma":[0.00009173197,0.000120560646,0.000028265562,0.00021734134,0.00018671257,0.00010062971,0.000038650163,0.00035281497,0.000019854822],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012298451,0.00070439285,0.27796066,0.0002359772,0.00036778848,0.00017346535,0.00039564562,6.571227e-8,0.05644396,0.0012016412,0.05401535,0.6072712],"study_design_scores_gemma":[0.0032655473,0.00003493845,0.16983901,0.000002062554,0.00028822382,0.000098139,0.000013205517,0.000010551863,0.06653435,0.000028681254,0.75976896,0.000116297466],"about_ca_topic_score_codex":0.000025827503,"about_ca_topic_score_gemma":0.000015623456,"teacher_disagreement_score":0.7057536,"about_ca_system_score_codex":0.000032565687,"about_ca_system_score_gemma":0.000088889334,"threshold_uncertainty_score":0.49163204},"labels":[],"label_agreement":null},{"id":"W2782518332","doi":"10.5152/ejbh.2017.3563","title":"A Systematic Review and Pooled Analysis of Studies of Oral Etoposide in Metastatic Breast Cancer","year":2018,"lang":"en","type":"review","venue":"European Journal of Breast Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sault Area Hospital; NOSM University","funders":"","keywords":"Medicine; Etoposide; Metastatic breast cancer; Oncology; Breast cancer; Internal medicine; Cancer; Population; Chemotherapy","score_opus":0.10476779183695265,"score_gpt":0.46854089920727754,"score_spread":0.36377310737032487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782518332","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016065576,0.99737096,0.0000030769127,0.0009834726,0.000104684805,0.0011041935,0.00023868687,0.000003034014,0.000031225],"genre_scores_gemma":[0.00071570947,0.9985151,0.00013674996,0.00042520044,0.00007570668,0.00001103919,0.00001281461,0.000037648508,0.000070020884],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9931021,0.0028596306,0.003290569,0.00020988779,0.0003045612,0.00023329385],"domain_scores_gemma":[0.9939336,0.00023139676,0.004863292,0.0002538412,0.00049158424,0.0002262808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003788102,0.00033638603,0.00946704,0.0009780852,0.000025198322,0.000004467844,0.00016361199,0.000024003444,0.00009557327],"category_scores_gemma":[0.00008330576,0.00020459962,0.00080341374,0.0012180386,0.00014916876,0.00004818021,0.000055205666,0.00032534497,0.0000028051952],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008563003,0.00024492692,0.0000899113,0.92982715,0.028432984,0.00017394187,0.0003616375,5.8532436e-7,3.3820123e-7,0.000002456604,0.0006882317,0.04009219],"study_design_scores_gemma":[0.0012275398,0.00080206577,0.0014096692,0.7695832,0.22036804,0.0042580585,0.00008915838,0.0000021105188,9.394942e-8,9.729707e-7,0.0021352354,0.00012380126],"about_ca_topic_score_codex":0.00013091722,"about_ca_topic_score_gemma":0.00010695094,"teacher_disagreement_score":0.19193506,"about_ca_system_score_codex":0.0003545543,"about_ca_system_score_gemma":0.0009720278,"threshold_uncertainty_score":0.83433306},"labels":[],"label_agreement":null},{"id":"W2788763033","doi":"10.1007/s12035-018-0920-4","title":"Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy","year":2018,"lang":"en","type":"article","venue":"Molecular Neurobiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women and Children’s Health Research Institute","funders":"","keywords":"Oxaliplatin; Neuroprotection; Medicine; Neuroinflammation; Pharmacology; Oxidative stress; Peripheral neuropathy; Colorectal cancer; Internal medicine; Endocrinology; Cancer; Inflammation","score_opus":0.016117479649149852,"score_gpt":0.29154537907418376,"score_spread":0.27542789942503393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788763033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643165,0.000033418295,0.00009906061,0.0011738113,0.0012915108,0.00039508447,0.0000024420542,0.000046013825,0.0005270005],"genre_scores_gemma":[0.9971771,0.000010798149,0.000115082104,0.0018996091,0.0006038051,0.000036978923,0.000046870435,0.00002386294,0.00008587229],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883485,0.00017547059,0.00022004005,0.00042934183,0.00006397774,0.00027631506],"domain_scores_gemma":[0.9996196,0.000025219517,0.00007093429,0.00015128487,0.000052546875,0.00008041614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047781647,0.00018226616,0.00026269152,0.00013075204,0.00006239695,0.000012495925,0.00004856791,0.00015149378,0.00012848142],"category_scores_gemma":[0.00006167406,0.00017177712,0.000057923953,0.0001605029,0.00014746725,0.000054053813,0.000052293173,0.0002343864,0.000018122475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027041654,0.0001197556,0.007043423,0.00001272957,0.000027945778,0.00008493514,0.00007907923,0.0000011939072,0.9870061,0.00006475133,0.0001329907,0.0027229057],"study_design_scores_gemma":[0.010175243,0.010310665,0.14249161,0.00002931133,0.00011271053,0.00027137628,0.000016641416,0.00019134556,0.8339294,0.00018098332,0.002059392,0.00023132456],"about_ca_topic_score_codex":0.00009385297,"about_ca_topic_score_gemma":0.00005836271,"teacher_disagreement_score":0.15307672,"about_ca_system_score_codex":0.000058773127,"about_ca_system_score_gemma":0.00006470347,"threshold_uncertainty_score":0.7004868},"labels":[],"label_agreement":null},{"id":"W2789053561","doi":"10.1007/s00520-018-4071-y","title":"Physical interventions for patients suffering from chemotherapy-induced polyneuropathy","year":2018,"lang":"en","type":"letter","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Pain medicine; Polyneuropathy; Chemotherapy; Nursing research; Psychological intervention; Physical therapy; Intensive care medicine; Internal medicine; Nursing; Pathology; Anesthesiology","score_opus":0.048538357206483494,"score_gpt":0.4007359995306597,"score_spread":0.3521976423241762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789053561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9132068,0.0009428185,0.000007300644,0.07584747,0.0035572946,0.0022261087,0.0035157073,0.00006486523,0.00063163653],"genre_scores_gemma":[0.6813045,0.0003042223,0.000064664484,0.28622884,0.01914639,0.0026145752,0.008013244,0.00023591575,0.002087606],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983126,0.000053389915,0.00036230445,0.00062158983,0.00021723338,0.00043289026],"domain_scores_gemma":[0.99894685,0.00013350726,0.00022596934,0.0002560004,0.00036734415,0.00007035434],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00002659377,0.000365284,0.0007182073,0.00017665514,0.000043758395,0.000014382177,0.00012861133,0.00033672244,0.0012836338],"category_scores_gemma":[0.000028976243,0.0003371646,0.00057924533,0.00012755489,0.00007674764,0.000059345122,0.000045712044,0.00070018094,0.000024575282],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010150449,0.0005670837,0.040800974,0.0010687483,0.00058328576,0.0001942264,0.0033682142,1.4218688e-7,0.00087286363,5.046867e-7,0.9335254,0.018003508],"study_design_scores_gemma":[0.013706368,0.0064740693,0.051141642,0.0025854104,0.0015957269,0.0000024356982,0.00024741725,0.000016189795,0.015066622,0.0000915838,0.9082402,0.00083236425],"about_ca_topic_score_codex":0.0006982468,"about_ca_topic_score_gemma":0.0004124585,"teacher_disagreement_score":0.23190226,"about_ca_system_score_codex":0.0009424653,"about_ca_system_score_gemma":0.0002883459,"threshold_uncertainty_score":0.99990803},"labels":[],"label_agreement":null},{"id":"W2791622018","doi":"10.1158/1538-7445.sabcs17-p3-17-02","title":"Abstract P3-17-02: Influence of non-measurable disease on progression-free survival in patients with metastatic breast cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Metastatic breast cancer; Breast cancer; Meta-analysis; Confidence interval; Oncology; Clinical endpoint; Randomized controlled trial; Cancer; Progression-free survival; Clinical trial; Disease; Chemotherapy","score_opus":0.05747750975229474,"score_gpt":0.4432716736565262,"score_spread":0.38579416390423144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791622018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567103,0.0003435265,4.1065442e-7,0.001215704,0.00012644642,0.0012135624,0.00036143785,0.000014987454,0.0010528693],"genre_scores_gemma":[0.99827623,0.00014170478,0.000029118379,0.00013582341,0.00017956886,0.000636284,0.000023136525,0.00003360031,0.00054453756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973197,0.000103080754,0.00026224973,0.00041558352,0.0013119112,0.0005874762],"domain_scores_gemma":[0.9979754,0.00015878535,0.000092265596,0.00048101097,0.000934444,0.00035810212],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005036546,0.00018483558,0.00036246603,0.0002919029,0.00010481828,0.000015580998,0.00025269348,0.000042981836,0.0019866887],"category_scores_gemma":[0.00007788219,0.00012818414,0.000045592536,0.00071954174,0.0005263799,0.00013427847,0.00008286077,0.00043596554,0.00002950521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021376332,0.0016702403,0.9583722,0.00040915437,0.00018414589,0.00008727353,0.00022951218,0.00019653667,0.0024521637,0.000007816145,0.005736166,0.009278483],"study_design_scores_gemma":[0.007806742,0.0014042126,0.98629385,0.0012491937,0.000070082875,8.386821e-7,0.00002618364,0.000025319418,0.002532922,0.00003710003,0.00042596055,0.00012757353],"about_ca_topic_score_codex":0.0037128741,"about_ca_topic_score_gemma":0.0017767408,"teacher_disagreement_score":0.027921695,"about_ca_system_score_codex":0.0005630495,"about_ca_system_score_gemma":0.0012672173,"threshold_uncertainty_score":0.9989256},"labels":[],"label_agreement":null},{"id":"W2791921511","doi":"10.1007/s00520-018-4161-x","title":"Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study","year":2018,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Regional Cancer Foundation; Ontario Clinical Oncology Group; University of Alberta; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Taxane; Common Terminology Criteria for Adverse Events; Docetaxel; Prostate cancer; Breast cancer; Chemotherapy; Internal medicine; Prospective cohort study; Cancer; Oncology; myalgia","score_opus":0.01928164644181161,"score_gpt":0.37467566867815427,"score_spread":0.35539402223634264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791921511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98951715,0.0002816662,0.0000072510666,0.00070139364,0.0006784568,0.007341453,0.0013337301,0.000042663065,0.0000962162],"genre_scores_gemma":[0.9911353,0.0003031692,0.000114554714,0.0009867857,0.00020988527,0.0058866795,0.00011779945,0.000071811664,0.001174028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978989,0.000117074145,0.00046247742,0.0006948103,0.0002260932,0.0006006608],"domain_scores_gemma":[0.998778,0.00006677137,0.00021288182,0.00020301272,0.0006124511,0.00012687406],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024825762,0.00033395886,0.0006288927,0.00022536726,0.0000684376,0.00001555062,0.00010699245,0.00010148528,0.00096066145],"category_scores_gemma":[0.00003847907,0.0002652193,0.000094802126,0.00046643932,0.0001256433,0.00015611923,0.000041903124,0.00022314684,0.0000059560466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012542228,0.0029899492,0.89480513,0.00014114086,0.0004543902,0.00017964776,0.020126648,0.0000012658791,0.00007194634,2.2029691e-7,0.0010243605,0.067663044],"study_design_scores_gemma":[0.04913415,0.008635699,0.9358769,0.0004619981,0.00018334629,0.000015995784,0.0033175438,0.000038055616,0.000560039,0.0000036124827,0.0014727204,0.00029992044],"about_ca_topic_score_codex":0.0017108403,"about_ca_topic_score_gemma":0.02959038,"teacher_disagreement_score":0.06736312,"about_ca_system_score_codex":0.0024052425,"about_ca_system_score_gemma":0.0005829189,"threshold_uncertainty_score":0.99998},"labels":[],"label_agreement":null},{"id":"W2792339230","doi":"10.1016/j.bmcl.2018.01.053","title":"Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization","year":2018,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"ADME; Chemistry; In vivo; Pharmacology; Pharmacokinetics; Bioavailability; Microtubule polymerization; Microtubule; In vitro; Biochemistry; Tubulin; Biology; Cell biology","score_opus":0.01528710306998185,"score_gpt":0.2838546049290552,"score_spread":0.2685675018590733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792339230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883386,0.0010000753,0.000013018442,0.009680034,0.00024077062,0.00026798173,0.000011239383,0.000036950012,0.00041133445],"genre_scores_gemma":[0.99571544,0.0002522027,0.000046271038,0.0028439884,0.00092742575,0.000012431579,0.00003363664,0.000025232444,0.00014337146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988752,0.00002563513,0.0003009326,0.0003314146,0.00017620629,0.00029060466],"domain_scores_gemma":[0.99945027,0.0000798837,0.00013907922,0.00014161096,0.000041626692,0.0001475127],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011503304,0.00020883199,0.00039447105,0.00007331141,0.00004060336,0.000004150872,0.000085413856,0.00011285871,0.002292585],"category_scores_gemma":[0.00003303471,0.00018805436,0.000047727408,0.0002697251,0.0005474114,0.000042808602,0.000048684065,0.00017299833,0.000006077069],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009083033,0.00020806215,0.019143034,0.00021366225,0.00009724822,0.00007242354,0.00032777715,2.1903688e-7,0.97185326,6.0092606e-7,0.0067516756,0.00042371277],"study_design_scores_gemma":[0.006113815,0.00018894213,0.013146462,0.00013106327,0.0002876942,0.0001842545,0.00008463796,0.000024538374,0.9778927,0.0000014958255,0.0018089095,0.00013549798],"about_ca_topic_score_codex":0.00009006397,"about_ca_topic_score_gemma":0.0000066375455,"teacher_disagreement_score":0.007376844,"about_ca_system_score_codex":0.00012399723,"about_ca_system_score_gemma":0.00009345942,"threshold_uncertainty_score":0.99861944},"labels":[],"label_agreement":null},{"id":"W2793337941","doi":"10.1158/1538-7445.sabcs17-p6-12-26","title":"Abstract P6-12-26: The axonal damage marker, serum phosphorylated neurofilament heavy subunit, as a potential marker of chemotherapy-induced neuropathy","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Breast cancer; Peripheral neuropathy; Internal medicine; Oncology; Biomarker; Cancer; Gastroenterology; Endocrinology","score_opus":0.06557520019117179,"score_gpt":0.40540570186538544,"score_spread":0.33983050167421364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793337941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818095,0.00077153073,0.000001249148,0.00879268,0.0007434291,0.0012049424,0.00004156938,0.000057410252,0.0065777074],"genre_scores_gemma":[0.9904034,0.0012299304,0.0000116344445,0.0016263892,0.00090870383,0.00017361794,0.000015318054,0.000089284345,0.0055416864],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969926,0.0003476455,0.00038172162,0.00052011455,0.0009627007,0.0007952134],"domain_scores_gemma":[0.9982277,0.00020640764,0.00011780221,0.0006036536,0.0005667977,0.00027762112],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010030122,0.0002633154,0.00037855134,0.00021086224,0.0003022363,0.000044330733,0.00038061413,0.00013710835,0.01398255],"category_scores_gemma":[0.000058986236,0.00018967221,0.00017076841,0.00062538433,0.000640308,0.000081532984,0.00016435666,0.0008719355,0.00019790466],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020469502,0.00097447087,0.014402402,0.00017042307,0.0005703057,0.0005045291,0.0010605137,0.000003686597,0.88432485,0.000028122004,0.046017636,0.03147358],"study_design_scores_gemma":[0.0060619772,0.0025602872,0.57981807,0.00012430208,0.00012613047,0.00006918477,0.00019935341,0.00023701062,0.37191907,0.0000663527,0.038601723,0.00021657374],"about_ca_topic_score_codex":0.0022944433,"about_ca_topic_score_gemma":0.00021900551,"teacher_disagreement_score":0.5654156,"about_ca_system_score_codex":0.00027632504,"about_ca_system_score_gemma":0.0009449072,"threshold_uncertainty_score":0.9869188},"labels":[],"label_agreement":null},{"id":"W2793419309","doi":"10.1158/1538-7445.sabcs17-p3-14-06","title":"Abstract P3-14-06: The prevention and management of chemotherapy-induced peripheral neuropathy in breast cancer patients: A systematic review","year":2018,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Breast cancer; Internal medicine; Observational study; Adverse effect; Systematic review; Peripheral neuropathy; Randomized controlled trial; Cancer; Oncology; Physical therapy; MEDLINE","score_opus":0.11496525183868346,"score_gpt":0.4825476662749586,"score_spread":0.36758241443627515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793419309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002995997,0.98632854,1.0958302e-7,0.00061414053,0.00018011685,0.009504159,0.000082188664,0.000010839541,0.00028392143],"genre_scores_gemma":[0.00090095523,0.99136984,0.000003083873,0.00018888483,0.00020085921,0.0059106136,0.0000463806,0.000062067615,0.0013173104],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969761,0.0006099044,0.0008450539,0.0005023154,0.00063902774,0.00042759295],"domain_scores_gemma":[0.99856156,0.00012073903,0.00038879973,0.0004912515,0.00033037915,0.00010725519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001200615,0.00033142115,0.0018255259,0.00021122975,0.000083818246,0.000022943132,0.000290496,0.00013496558,0.0007515052],"category_scores_gemma":[0.000017385473,0.0001956051,0.0002762074,0.0007437053,0.00018084637,0.000055682034,0.00012060122,0.0005849633,0.000018216031],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010749682,0.00031665488,0.00007927881,0.8730903,0.00067430374,0.000022879382,0.0000940628,2.3505658e-8,0.0000053818544,0.00000485673,0.0031579155,0.122446805],"study_design_scores_gemma":[0.001824436,0.00038087612,0.0011389289,0.9143188,0.0027539067,0.000025929856,0.00002485451,0.0000013601976,0.0000043735245,0.000006104594,0.07932142,0.00019901799],"about_ca_topic_score_codex":0.00035234354,"about_ca_topic_score_gemma":0.000094182404,"teacher_disagreement_score":0.122247785,"about_ca_system_score_codex":0.0008792915,"about_ca_system_score_gemma":0.0005032445,"threshold_uncertainty_score":0.82284546},"labels":[],"label_agreement":null},{"id":"W2793551130","doi":"10.5858/arpa.2017-0401-ed","title":"The Lifecycle of an Evidence-Based Laboratory Practice Guideline: Origin, Update, Affirmation, and Impact!","year":2018,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Guideline; Medicine; Business; Pathology","score_opus":0.02259983158137919,"score_gpt":0.3903342743051524,"score_spread":0.3677344427237732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793551130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97114974,0.01200363,0.00020163647,0.015033079,0.000400787,0.00047137626,0.00009514296,0.000044635446,0.00059994974],"genre_scores_gemma":[0.98528534,0.002818409,0.0049181357,0.006037204,0.00078197254,0.000030845353,0.00006425618,0.000027454362,0.000036390433],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997857,0.0006486211,0.00067131984,0.00030379326,0.00025127808,0.0002680335],"domain_scores_gemma":[0.99597734,0.0018011949,0.00051430956,0.0005403055,0.00093962526,0.00022720761],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0011834044,0.00021303433,0.00051152566,0.00020159272,0.00014970775,0.000004446744,0.00017460166,0.000092026174,0.00016918838],"category_scores_gemma":[0.0017850657,0.0001322263,0.00004713103,0.00044812632,0.0028469283,0.0002581077,0.000045116834,0.00021287442,0.0000069597622],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014382938,0.0012302621,0.05689453,0.00037081976,0.0007642919,0.0005278087,0.006402577,0.000024923047,0.83693105,0.0016209994,0.056299053,0.024550745],"study_design_scores_gemma":[0.025117515,0.039666407,0.27550262,0.0015863925,0.0039432785,0.0005167519,0.0043177544,0.0018867715,0.1575313,0.0010179234,0.48816365,0.0007496529],"about_ca_topic_score_codex":0.00006948871,"about_ca_topic_score_gemma":0.00004644956,"teacher_disagreement_score":0.6793997,"about_ca_system_score_codex":0.000032518226,"about_ca_system_score_gemma":0.00092866423,"threshold_uncertainty_score":0.9998667},"labels":[],"label_agreement":null},{"id":"W2800423321","doi":"10.1016/j.lfs.2018.04.058","title":"Therapeutic potential of patupilone in epithelial ovarian cancer and future directions","year":2018,"lang":"en","type":"review","venue":"Life Sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Department of Medical Biophysics, University of Toronto","keywords":"Epothilones; Ixabepilone; Epothilone; Ovarian cancer; Taxane; In vivo; Cancer research; Cancer; Medicine; Microtubule; Paclitaxel; Pharmacology; Drug; Malignancy; Oncology; Biology; Internal medicine; Chemistry; Breast cancer; Metastatic breast cancer; Cell biology","score_opus":0.06182321546841823,"score_gpt":0.4048664378634616,"score_spread":0.34304322239504337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800423321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068031217,0.995811,6.5081974e-7,0.0007762989,0.0016080808,0.00039556602,0.000057429246,0.000010875077,0.00065980613],"genre_scores_gemma":[0.00037382697,0.9970645,0.00006678772,0.00013463323,0.0019566475,0.00006718451,0.000007420318,0.000008015457,0.0003210195],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99906135,0.00006967117,0.00025622587,0.00028460432,0.00015574414,0.00017238826],"domain_scores_gemma":[0.9996112,0.00004513798,0.00014702644,0.00009034146,0.000027566633,0.000078698926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019709299,0.00015420537,0.0007186073,0.00021776672,0.00008389559,0.000008529497,0.00009352887,0.00012774921,0.00039068246],"category_scores_gemma":[0.000006720303,0.000097565884,0.00011452026,0.0005468489,0.00044043726,0.00004037377,0.000027353253,0.00014122171,0.000005162546],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029481598,0.00010759977,0.00033203445,0.0014394289,0.00014247121,0.000006907713,0.00015479329,8.01449e-8,0.000012175498,0.00006413719,0.0003842314,0.9973267],"study_design_scores_gemma":[0.00047541244,0.000301667,0.0010730852,0.0011650814,0.0008618836,0.000027428723,0.000030089717,0.0000048821994,0.000003987619,0.00003703029,0.9959262,0.00009323094],"about_ca_topic_score_codex":0.00050902605,"about_ca_topic_score_gemma":0.0002133207,"teacher_disagreement_score":0.99723345,"about_ca_system_score_codex":0.000040321163,"about_ca_system_score_gemma":0.0007177102,"threshold_uncertainty_score":0.4277699},"labels":[],"label_agreement":null},{"id":"W2801860620","doi":"10.1021/acschemneuro.8b00013","title":"Protective Effect of a Mitochondria-Targeted Peptide against the Development of Chemotherapy-Induced Peripheral Neuropathy in Mice","year":2018,"lang":"en","type":"article","venue":"ACS Chemical Neuroscience","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"National Institute on Drug Abuse; Japan Society for the Promotion of Science; Canadian Institutes of Health Research","keywords":"Oxaliplatin; Peripheral neuropathy; Medicine; Neuropathic pain; Chemotherapy; Sciatic nerve; Chemotherapy-induced peripheral neuropathy; Mitochondrion; Cancer; Peripheral; Pharmacology; Internal medicine; Endocrinology; Colorectal cancer; Biology","score_opus":0.016252643737455042,"score_gpt":0.299004097311289,"score_spread":0.28275145357383397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801860620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828744,0.000019808722,0.000018180082,0.000318922,0.00019578272,0.00082625507,0.0000017970845,0.00001636702,0.00031544364],"genre_scores_gemma":[0.99887305,0.0000044372946,0.00020386079,0.00070731324,0.00007103979,0.00008130955,0.0000013516337,0.00001273522,0.00004490696],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987995,0.00008575948,0.0002974035,0.00032761678,0.0002440874,0.00024565565],"domain_scores_gemma":[0.9994305,0.00013115745,0.00012265118,0.00017905793,0.0000705086,0.00006612316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018432701,0.00015182325,0.0002929036,0.000056635978,0.000048596434,0.000004771433,0.00022693728,0.00005197463,0.000013131175],"category_scores_gemma":[0.00023196531,0.000097252196,0.000058655838,0.00052660104,0.00040644524,0.000047091282,0.000066298206,0.00019813275,0.0000020475115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009116918,0.0001912943,0.0027078611,0.000037619728,0.0000064258124,0.0000063557495,0.0014026721,6.15607e-7,0.99156386,9.759971e-7,0.000044102395,0.0031265193],"study_design_scores_gemma":[0.002114876,0.0010198705,0.020085711,0.00004306536,0.000016119902,0.000010581662,0.000018741506,0.00016127255,0.9762466,0.0000048379816,0.00020382444,0.000074509706],"about_ca_topic_score_codex":0.000017653832,"about_ca_topic_score_gemma":0.0000090505255,"teacher_disagreement_score":0.01737785,"about_ca_system_score_codex":0.00007114399,"about_ca_system_score_gemma":0.00015716885,"threshold_uncertainty_score":0.39658293},"labels":[],"label_agreement":null},{"id":"W2802054964","doi":"10.1200/jco.2018.36.4_suppl.685","title":"Platinum deposition in skin as a possible mechanism for peripheral sensory neuropathy (PSN) in patients (pts) with colorectal cancer (CRC) following oxaliplatin-based therapy.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fluidigm (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Oxaliplatin; Medicine; FOLFOX; Internal medicine; Colorectal cancer; Gastroenterology; Peripheral neuropathy; Cancer; Cetuximab; Oncology; Urology; Endocrinology","score_opus":0.06722822838202357,"score_gpt":0.440695205084386,"score_spread":0.3734669767023624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802054964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955241,0.00008376284,0.000073370575,0.0015298068,0.0015462448,0.0007466815,0.000007889072,0.000009103557,0.00047904614],"genre_scores_gemma":[0.99222624,0.000068800895,0.0021999083,0.004391382,0.00093547074,0.00005871343,0.000008351206,0.000031039126,0.00008010698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740314,0.00041288536,0.0013375542,0.0002532784,0.00027130422,0.0003218321],"domain_scores_gemma":[0.9975335,0.0009931484,0.0008513014,0.000081869875,0.00034959623,0.00019060333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000874442,0.00018610792,0.0010646686,0.0002032808,0.000054474054,0.000009322057,0.00009173981,0.0003026375,0.00016071317],"category_scores_gemma":[0.00032183464,0.00013464296,0.00031915845,0.00020041387,0.00009913259,0.00010658774,0.000014401913,0.0005849799,0.0000031993122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10337307,0.0066603334,0.8216235,0.000026419742,0.00040806574,0.0009091425,0.000792053,0.00009528701,0.006803549,0.000038655253,0.00030749245,0.05896244],"study_design_scores_gemma":[0.11722874,0.15976481,0.7095952,0.00026645605,0.0004047982,0.000097895754,0.00012431081,0.0032432638,0.007830713,0.0002841335,0.00090678583,0.00025287885],"about_ca_topic_score_codex":0.00026883747,"about_ca_topic_score_gemma":0.0022378033,"teacher_disagreement_score":0.15310447,"about_ca_system_score_codex":0.00046621414,"about_ca_system_score_gemma":0.0015885568,"threshold_uncertainty_score":0.5490581},"labels":[],"label_agreement":null},{"id":"W2803060236","doi":"10.1200/jco.2018.36.4_suppl.414","title":"Folfirinox (FFX) versus gemcitabine with nab‐paclitaxel (GNP) in the first line treatment (1LTx) of metastatic pancreatic cancer (mPC): A tertiary center experience.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Gemcitabine; Internal medicine; Pancreatic cancer; Gastroenterology; Neutropenia; Discontinuation; Progression-free survival; Surgery; Chemotherapy; Cancer","score_opus":0.1971894995990235,"score_gpt":0.521799951063017,"score_spread":0.32461045146399353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803060236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98043334,0.0015040523,0.00002489067,0.014572231,0.001290332,0.0005304873,0.000014248619,0.000006064206,0.0016243351],"genre_scores_gemma":[0.9921162,0.002431206,0.00083143375,0.0028251596,0.0014342739,0.000087168984,0.0000046212235,0.000019831075,0.00025006625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967623,0.00039176867,0.0018806168,0.00024661768,0.00036845112,0.00035028337],"domain_scores_gemma":[0.99549735,0.002446493,0.0012375276,0.00027605155,0.0003232437,0.00021933322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010105863,0.00024227085,0.0016342296,0.00016065176,0.000053838867,0.0000068518193,0.00022499802,0.00015539567,0.0007136793],"category_scores_gemma":[0.00036204513,0.00011992755,0.0003864531,0.00027202375,0.0006634629,0.0001099702,0.000035267636,0.0004367215,0.000011206975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08543109,0.019394021,0.7829882,0.000119028824,0.003931005,0.0024999103,0.0072871847,0.000024735607,0.0002843577,0.000058244645,0.0052491548,0.09273309],"study_design_scores_gemma":[0.10667845,0.17988667,0.53883696,0.00044426834,0.004358431,0.0007970344,0.0014312986,0.00013052061,0.00085125474,0.00011278622,0.16621888,0.00025343828],"about_ca_topic_score_codex":0.00044390603,"about_ca_topic_score_gemma":0.0037456525,"teacher_disagreement_score":0.24415119,"about_ca_system_score_codex":0.0004064009,"about_ca_system_score_gemma":0.0011206077,"threshold_uncertainty_score":0.7814288},"labels":[],"label_agreement":null},{"id":"W2803537745","doi":"10.5603/gp.a2018.0034","title":"Effectiveness of gabapentin pharmacotherapy in chemotherapy-induced peripheral neuropathy","year":2018,"lang":"en","type":"article","venue":"Ginekologia Polska","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gabapentin; Peripheral neuropathy; Chemotherapy-induced peripheral neuropathy; Chemotherapy; Neuropathic pain; Discontinuation; Internal medicine; Carboplatin; Exacerbation; Quality of life (healthcare); Ovarian cancer; Neurotoxicity; Anesthesia; Oncology; Cancer; Toxicity; Cisplatin; Diabetes mellitus","score_opus":0.021844470987754175,"score_gpt":0.34842249194884056,"score_spread":0.3265780209610864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803537745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99432135,0.0002352891,0.000029973124,0.0004620749,0.0005156469,0.00062011677,0.000005187329,0.00006225277,0.0037481012],"genre_scores_gemma":[0.9982619,0.00010274398,0.00012924723,0.0008061737,0.00027159584,0.000053363612,0.00001094161,0.00003029649,0.00033372917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988484,0.00019035074,0.00023671547,0.0002931776,0.00012065041,0.00031072216],"domain_scores_gemma":[0.9994749,0.00010122767,0.00008079795,0.00019402883,0.00007448247,0.00007455935],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026535967,0.00018920178,0.00042296873,0.00014766405,0.00002832475,0.000004789716,0.00010484402,0.00009220274,0.0014412225],"category_scores_gemma":[0.000017509188,0.00015864457,0.000104027895,0.00031857326,0.00015409554,0.000047314268,0.000022005013,0.00016683436,0.000034058507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032066514,0.0005727535,0.12035443,0.00009493282,0.000086709064,0.000058456062,0.00026298975,0.0000012404088,0.86848134,0.00005380855,0.00037416606,0.00645252],"study_design_scores_gemma":[0.008993442,0.0021441346,0.4332178,0.00006146683,0.000047046164,0.000043736145,0.00001703656,0.00009724334,0.553724,0.000046241363,0.0014824184,0.00012544499],"about_ca_topic_score_codex":0.00016509742,"about_ca_topic_score_gemma":0.00001546092,"teacher_disagreement_score":0.31475735,"about_ca_system_score_codex":0.00009966503,"about_ca_system_score_gemma":0.00009279799,"threshold_uncertainty_score":0.9994716},"labels":[],"label_agreement":null},{"id":"W2808815218","doi":"10.1016/j.bulcan.2018.04.012","title":"Nouvelles définitions de la maladie oligométastatique et nouveaux concepts de prise en charge globale de la maladie métastatique","year":2018,"lang":"fr","type":"review","venue":"Bulletin du Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ablative case; Systemic therapy; Quality of life (healthcare); Metastasis; Disease; Oncology; Ablation; Radiation therapy; Internal medicine; Cancer","score_opus":0.02022754080206572,"score_gpt":0.38122237195670516,"score_spread":0.36099483115463943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808815218","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004294602,0.9141165,0.0008413586,0.009133441,0.0017975165,0.0028459528,0.0074568964,0.00022610842,0.05928762],"genre_scores_gemma":[0.0019292191,0.95575345,0.0059158974,0.00693543,0.0046853796,0.0038010576,0.0007773682,0.00027855122,0.019923626],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9902904,0.0052137678,0.0011193232,0.0011036927,0.0003830404,0.0018897973],"domain_scores_gemma":[0.9928379,0.0045191697,0.00073292776,0.0005927336,0.0003123698,0.0010048869],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0026565557,0.0012762556,0.002132891,0.00025466003,0.00036308845,0.00015549187,0.0006154283,0.0014305719,0.07423566],"category_scores_gemma":[0.00064432673,0.0012487725,0.000782679,0.00041049405,0.0015188421,0.00006640747,0.00025235667,0.0017423013,0.0015097072],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0006292604,0.0020739788,0.0054733856,0.017071845,0.0029956163,0.0028623214,0.009619496,0.00006552585,0.0001371753,0.016663674,0.9051241,0.037283618],"study_design_scores_gemma":[0.0041176043,0.0005645751,0.0015682441,0.013726983,0.003955574,0.0015892892,0.00026921864,0.000055654764,0.00022611715,0.00025347658,0.97268885,0.0009844383],"about_ca_topic_score_codex":0.0032054947,"about_ca_topic_score_gemma":0.00038045374,"teacher_disagreement_score":0.07272596,"about_ca_system_score_codex":0.004734,"about_ca_system_score_gemma":0.010883022,"threshold_uncertainty_score":0.9999989},"labels":[],"label_agreement":null},{"id":"W2810376202","doi":"10.1097/01.reo.0000000000000111","title":"Physical Therapy–Based Interventions Improve Balance, Function, Symptoms, and Quality of Life in Patients With Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review","year":2018,"lang":"en","type":"review","venue":"Rehabilitation Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Psychological intervention; Physical therapy; Quality of life (healthcare); Balance (ability); Physical medicine and rehabilitation; Peripheral neuropathy; Randomized controlled trial; Observational study; Internal medicine; Psychiatry","score_opus":0.04313003745739118,"score_gpt":0.4036203973133361,"score_spread":0.3604903598559449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810376202","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04578407,0.9455335,0.000013854371,0.00025763974,0.00022583672,0.008045974,0.000043469234,0.00003285793,0.000062805106],"genre_scores_gemma":[0.017471554,0.97822857,0.00014999276,0.0009904386,0.00015353953,0.0025919233,0.00026993212,0.00007180079,0.00007222781],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99605054,0.0016088596,0.001421577,0.00049447437,0.00022707404,0.0001974778],"domain_scores_gemma":[0.9966512,0.001244266,0.0011986052,0.00040198158,0.00039436895,0.00010958985],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069113146,0.00036772157,0.003823605,0.00022375167,0.000033230233,0.00000580451,0.00008980646,0.00020759567,0.00008739142],"category_scores_gemma":[0.0005086309,0.00024531872,0.0005701654,0.00043342574,0.0002045367,0.00005978427,0.000019136818,0.00027470407,0.000006248188],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010056044,0.0037364669,0.005272325,0.94216937,0.0006171724,8.844839e-7,0.00023987748,9.504529e-8,0.0000060205166,0.000039835788,0.00013076184,0.04678157],"study_design_scores_gemma":[0.03320945,0.093383655,0.049913637,0.7620236,0.009977298,0.000007420423,0.000077695746,0.000042820484,0.0000015861241,0.000038221246,0.05038522,0.00093935954],"about_ca_topic_score_codex":0.000028716468,"about_ca_topic_score_gemma":0.000026831169,"teacher_disagreement_score":0.18014576,"about_ca_system_score_codex":0.000451683,"about_ca_system_score_gemma":0.0007067451,"threshold_uncertainty_score":0.9999999},"labels":[],"label_agreement":null},{"id":"W2810686894","doi":"10.1017/cjn.2018.154","title":"P.052 Case Report: Brentuximab associated toxic neuropathy","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Saskatoon Medical Imaging","funders":"","keywords":"Medicine; Brentuximab vedotin; Vincristine; Pathology; Internal medicine; Oncology; Lymphoma; Cyclophosphamide; Chemotherapy","score_opus":0.04705391630050084,"score_gpt":0.3241820456953859,"score_spread":0.27712812939488507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810686894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827755,0.0009151652,0.0000110669025,0.0065231198,0.0023436556,0.00021107765,0.000014522849,0.000032139367,0.007173729],"genre_scores_gemma":[0.99138904,0.00016915458,0.00054394436,0.0067272675,0.0009566009,0.0000027327437,7.668231e-7,0.000017110477,0.00019337414],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99505645,0.00090487004,0.0010949025,0.00064028497,0.00076104444,0.0015424631],"domain_scores_gemma":[0.9946788,0.00046103421,0.001039463,0.0001935223,0.00092057034,0.002706616],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":["sts"],"category_scores_codex":[0.0037614577,0.00038214683,0.0006951655,0.0010563707,0.0031615235,0.00044886337,0.0009767957,0.00023222395,0.0008358025],"category_scores_gemma":[0.002947016,0.00025753316,0.0003535313,0.001743997,0.009039763,0.0006817289,0.00006833724,0.0012880779,0.000012439922],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019158622,0.000119883014,0.42860714,0.000004613958,0.000041640953,0.5628693,0.00031268204,0.00006971617,0.00013018813,0.000106896696,0.0037173296,0.0038290212],"study_design_scores_gemma":[0.0008098994,0.11473065,0.07071215,0.000031609266,0.00015485115,0.804186,0.00011899664,0.0004628601,0.0002083961,0.0021282574,0.0062164464,0.00023992945],"about_ca_topic_score_codex":0.0020681333,"about_ca_topic_score_gemma":0.093373574,"teacher_disagreement_score":0.357895,"about_ca_system_score_codex":0.00042400218,"about_ca_system_score_gemma":0.005055538,"threshold_uncertainty_score":0.99998766},"labels":[],"label_agreement":null},{"id":"W2814722636","doi":"","title":"Metronomic ABI-007 therapy: antiangiogenic and antitumor activity of a nanoparticle albumin-bound paclitaxel","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Paclitaxel; Medicine; Pharmacology; Chemotherapy; Angiogenesis; Cancer; Toxicity; Cancer research; Internal medicine","score_opus":0.11926687460562532,"score_gpt":0.46720650383466705,"score_spread":0.34793962922904176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2814722636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98185015,0.01376056,0.000002041191,0.0032526231,0.00007305421,0.0005010408,0.000025052046,0.000017458444,0.0005180261],"genre_scores_gemma":[0.9943455,0.0035735506,0.00005772651,0.00010948549,0.0002969184,0.00010612973,0.000002812259,0.000020553558,0.0014873138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878055,0.0001115076,0.0001500729,0.00028071905,0.00025518378,0.00042199367],"domain_scores_gemma":[0.99929774,0.00014089735,0.000043220636,0.0002267364,0.00012083415,0.0001705761],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004726248,0.00010960236,0.00028377652,0.0001894435,0.00010054808,0.000015916376,0.00008288428,0.000054005042,0.0010133652],"category_scores_gemma":[0.000020584685,0.00009197027,0.00007848094,0.00032426036,0.0003639701,0.00010380414,0.00005761507,0.00019638643,0.000032511263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013792162,0.0004131678,0.03964074,0.000055112298,0.0002305695,0.000011849951,0.00032637766,0.0000024675367,0.90473706,0.000049332204,0.0025595932,0.05059454],"study_design_scores_gemma":[0.004063277,0.00076800614,0.09537591,0.00003549594,0.00006076738,0.00001373986,0.000056282213,0.000094667455,0.88037485,0.00003559901,0.019026734,0.00009466408],"about_ca_topic_score_codex":0.0013049048,"about_ca_topic_score_gemma":0.00032174907,"teacher_disagreement_score":0.05573517,"about_ca_system_score_codex":0.00026573104,"about_ca_system_score_gemma":0.00036440883,"threshold_uncertainty_score":0.99989986},"labels":[],"label_agreement":null},{"id":"W2834973095","doi":"10.1002/cpt.1179","title":"Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; BC Children’s Hospital Foundation; BC Children's Hospital; Children's Hospital Foundation; London Health Sciences Centre","keywords":"Pharmacogenomics; Peripheral neuropathy; Pharmacokinetics; Medicine; Pharmacogenetics; Pharmacology; Vincristine; Gene; Bioinformatics; Internal medicine; Genetics; Biology; Chemotherapy; Genotype; Endocrinology","score_opus":0.24322484068939612,"score_gpt":0.5059146346413825,"score_spread":0.26268979395198644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2834973095","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055563435,0.93542457,0.000009218918,0.0007774013,0.0048722355,0.002747333,0.00023062654,0.00018770847,0.00018745918],"genre_scores_gemma":[0.0018057849,0.97606915,0.00018606761,0.016591644,0.0042580673,0.00025689663,0.00018802755,0.00032298092,0.00032140673],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99276847,0.0016659714,0.0028124177,0.0015256439,0.0002959053,0.00093159877],"domain_scores_gemma":[0.99538726,0.0014425886,0.0014595714,0.00062981975,0.00041443395,0.0006663282],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00072969816,0.0012852929,0.0045173666,0.00037399514,0.00018479677,0.000029740562,0.00065555796,0.0009078182,0.00083180156],"category_scores_gemma":[0.000026501335,0.00108316,0.0013434268,0.00064378226,0.0014871127,0.000072454626,0.00047906424,0.0018709267,0.000090713445],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020019661,0.0029033392,0.00097529584,0.0075844796,0.0071363556,0.00047835705,0.00012342402,7.03406e-7,0.02025038,0.0000022964068,0.009876439,0.948667],"study_design_scores_gemma":[0.006518679,0.0036027795,0.0002956828,0.00053024426,0.040618096,0.0007503845,0.0000081949065,0.000287795,0.0008444624,0.00000833715,0.9457983,0.00073705503],"about_ca_topic_score_codex":0.000010232791,"about_ca_topic_score_gemma":0.0000011818017,"teacher_disagreement_score":0.9479299,"about_ca_system_score_codex":0.00017001822,"about_ca_system_score_gemma":0.0008473336,"threshold_uncertainty_score":0.99998987},"labels":[],"label_agreement":null},{"id":"W2883308915","doi":"10.1016/j.ijpharm.2018.07.046","title":"Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski’s Rule of Five","year":2018,"lang":"en","type":"review","venue":"International Journal of Pharmaceutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Adverse effect; Lipinski's rule of five; Drug; Cancer; Pharmacology; Breast cancer; Drug reaction; Medicine; Anticancer drug; Bioinformatics; Intensive care medicine; Chemistry; Internal medicine; Biology","score_opus":0.07611744742011885,"score_gpt":0.4324239561494103,"score_spread":0.3563065087292915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883308915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011444478,0.9859412,0.000013423496,0.0004385586,0.0012824778,0.00039556672,0.00004630747,0.000004151321,0.00043387152],"genre_scores_gemma":[0.0053357272,0.99202305,0.0007018623,0.00024451272,0.001378703,0.000011013928,0.000016947282,0.00002076419,0.00026744718],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982817,0.00017149685,0.0009840783,0.00011506881,0.00034306615,0.00010459759],"domain_scores_gemma":[0.9963278,0.001278324,0.0016128614,0.00009198755,0.00061200163,0.000077006465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006948796,0.00021803411,0.00089315185,0.00030002487,0.000036866062,0.0000056923345,0.00023247965,0.00005857772,0.000107952575],"category_scores_gemma":[0.00018894419,0.00012146274,0.00036275887,0.00010892627,0.000092669085,0.00005424325,0.00007120972,0.00039425722,0.000005311141],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036434364,0.00030467092,0.00009597226,0.0065579675,0.0073029436,0.000038664606,0.001594055,0.0000014299975,0.0010218027,0.00011047285,0.00071475573,0.98189294],"study_design_scores_gemma":[0.0011469829,0.00008394666,0.000038144954,0.015812013,0.001910394,0.00023085445,0.00010515407,0.000011622289,0.026870793,0.000037548354,0.953666,0.00008654588],"about_ca_topic_score_codex":0.0000027312133,"about_ca_topic_score_gemma":5.8384194e-7,"teacher_disagreement_score":0.9818064,"about_ca_system_score_codex":0.00017879953,"about_ca_system_score_gemma":0.0004800356,"threshold_uncertainty_score":0.4953107},"labels":[],"label_agreement":null},{"id":"W2883816907","doi":"10.2147/ott.s166399","title":"Outcome of eribulin as a late treatment line for Thai metastatic breast cancer patients","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Emergency Physicians","funders":"","keywords":"Eribulin; Medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Radiomics; Cancer; Radiology","score_opus":0.04725875636328954,"score_gpt":0.3979276726502522,"score_spread":0.3506689162869627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883816907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453574,0.0024004467,0.000011136983,0.0014181259,0.0002633056,0.00072225835,0.00033442982,0.000014823257,0.00029974993],"genre_scores_gemma":[0.9921308,0.003767423,0.000372239,0.0008689519,0.00024927585,0.00014522429,0.00005945812,0.000019872077,0.0023867537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999375,0.000015723052,0.00019661659,0.00017107098,0.00007515637,0.0001664238],"domain_scores_gemma":[0.9995851,0.000038511236,0.00008469718,0.00009095223,0.00011291605,0.00008783846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039159568,0.00014365799,0.00035905375,0.000041919797,0.00005281958,0.0000045200345,0.000025668829,0.000031471267,0.00088803953],"category_scores_gemma":[0.000002452863,0.00008942097,0.000088479894,0.000052846444,0.00007526821,0.000028902503,0.0000067195997,0.000026744361,0.0000065144354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011665721,0.004645399,0.7086776,0.00010368082,0.002226837,0.000012041842,0.0026325856,0.0000020336292,0.010818499,0.00013351791,0.0011982733,0.25788385],"study_design_scores_gemma":[0.094009005,0.055274546,0.45355564,0.000132053,0.0014745807,0.000036164118,0.00008223192,0.0005501282,0.052355114,0.0013120392,0.34064934,0.00056913943],"about_ca_topic_score_codex":0.0005794236,"about_ca_topic_score_gemma":0.00010411682,"teacher_disagreement_score":0.33945107,"about_ca_system_score_codex":0.000059745937,"about_ca_system_score_gemma":0.000057891393,"threshold_uncertainty_score":0.972341},"labels":[],"label_agreement":null},{"id":"W2883844854","doi":"10.1007/s00520-018-4361-4","title":"Letter to the editor—comments on Kleckner et al. (2018) “Effects of exercise during chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial”","year":2018,"lang":"en","type":"letter","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Athabasca University","funders":"","keywords":"Medicine; Pain medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Randomized controlled trial; Peripheral; Chemotherapy; Nursing research; Physical therapy; Internal medicine; Anesthesia; Anesthesiology; Pathology; Diabetes mellitus; Endocrinology","score_opus":0.014082505227358391,"score_gpt":0.33399141967379414,"score_spread":0.31990891444643577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883844854","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23770738,0.0017818025,0.000002478619,0.6978047,0.034439664,0.027575212,0.0001433991,0.000055391007,0.00049000076],"genre_scores_gemma":[0.06169079,0.0014109726,0.000013025454,0.89413244,0.025823848,0.013632039,0.00018290573,0.00017179821,0.0029421933],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995822,0.00097499863,0.0010144174,0.00081876724,0.00070704916,0.000662761],"domain_scores_gemma":[0.9972555,0.00092209695,0.0007046459,0.00059900817,0.00039870053,0.0001200692],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046217794,0.0007265929,0.0030964562,0.00033121277,0.0000702908,0.000028584009,0.00028336814,0.00043785208,0.0010213256],"category_scores_gemma":[0.00024083533,0.0004507207,0.00092276244,0.00020189663,0.00016513155,0.00006721509,0.00007999674,0.0014251514,0.000026544827],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4605628,0.00019936124,0.000074689924,0.0002732892,0.00054945255,0.00025874376,0.0020759238,0.0000014246641,0.0007745847,4.6056797e-8,0.53497076,0.00025889723],"study_design_scores_gemma":[0.58077455,0.0012096823,0.00010718689,0.0010310682,0.00081009977,0.000001530474,0.000026891483,0.0000049391547,0.0048205024,5.951305e-7,0.41096845,0.0002445341],"about_ca_topic_score_codex":0.0004010902,"about_ca_topic_score_gemma":0.000085498206,"teacher_disagreement_score":0.19632775,"about_ca_system_score_codex":0.0009155897,"about_ca_system_score_gemma":0.0004193542,"threshold_uncertainty_score":0.9998919},"labels":[],"label_agreement":null},{"id":"W2884184285","doi":"10.5737/23688076283178183","title":"Potential mediators of improvement in painful chemotherapy-induced peripheral neuropathy via a web-based cognitive behavioural intervention","year":2018,"lang":"en","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; University of Michigan; Damon Runyon Cancer Research Foundation; U.S. Department of Defense","keywords":"Medicine; Anxiety; Depression (economics); Cognition; Intervention (counseling); Chronic pain; Peripheral neuropathy; Physical therapy; Cognitive behavioral therapy; Sleep disorder; Randomized controlled trial; Psychiatry; Internal medicine","score_opus":0.016934642626548594,"score_gpt":0.32965668123580405,"score_spread":0.31272203860925546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884184285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924052,0.0001710286,0.00022266076,0.0042262375,0.002145255,0.0003642002,0.000014405818,0.000011259517,0.0004397735],"genre_scores_gemma":[0.997222,0.0000164497,0.000118438336,0.0018799629,0.00064065325,0.000015258032,0.000023170987,0.000026452828,0.000057583537],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99855065,0.00020180858,0.00043711078,0.00019810497,0.00014881739,0.00046352186],"domain_scores_gemma":[0.99889326,0.00003313873,0.00024061742,0.00007966857,0.0002448134,0.0005084714],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035739734,0.00016834903,0.00036434093,0.0005418102,0.000121657926,0.000013005484,0.00008364085,0.00018078671,0.0011789966],"category_scores_gemma":[0.000029401133,0.00016530117,0.00017056335,0.00020259997,0.00029694272,0.000064915395,0.000004784758,0.00044771735,0.0000054196544],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005309865,0.0022466567,0.11585913,0.000032236567,0.0002605728,0.0023358886,0.003752583,0.0000031450475,0.1275492,0.0000053676276,0.003253767,0.73939157],"study_design_scores_gemma":[0.094854064,0.057744294,0.7640046,0.0023628543,0.0017089056,0.0032968882,0.002990191,0.007933776,0.06208603,0.00020663573,0.0020615207,0.000750254],"about_ca_topic_score_codex":0.004345678,"about_ca_topic_score_gemma":0.028734373,"teacher_disagreement_score":0.7386413,"about_ca_system_score_codex":0.00359876,"about_ca_system_score_gemma":0.0030210789,"threshold_uncertainty_score":0.99973404},"labels":[],"label_agreement":null},{"id":"W2884248669","doi":"10.5737/23688076283184190","title":"Médiateurs potentiels d’amélioration de la neuropathie périphérique chimio-induite douloureuse par une intervention cognitivocomportementale en ligne","year":2018,"lang":"fr","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine","score_opus":0.013454360155232025,"score_gpt":0.3647698676303381,"score_spread":0.35131550747510604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884248669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8643115,0.018306833,0.0020067762,0.05863994,0.024946075,0.0009694726,0.00013170844,0.000063166124,0.03062449],"genre_scores_gemma":[0.97932464,0.002650956,0.0005218252,0.0036103355,0.009131919,0.00002770155,0.00010540578,0.000084992746,0.004542249],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950465,0.0022670208,0.0007907575,0.00042089698,0.00021676772,0.0012580786],"domain_scores_gemma":[0.9969591,0.0002642923,0.0005183257,0.00020863271,0.00031829296,0.0017313588],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018941235,0.00040129104,0.0005912767,0.00077563495,0.0008342945,0.00015984893,0.00024633235,0.00077719905,0.0024790263],"category_scores_gemma":[0.00016921108,0.00045326812,0.0002932475,0.0005034866,0.0013294257,0.0003388209,0.000023056662,0.0015401805,0.00022742581],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0012298311,0.00356902,0.020019371,0.00011283741,0.00095468794,0.019496005,0.013687504,0.00003282963,0.022638192,0.00047885196,0.29488114,0.6228998],"study_design_scores_gemma":[0.029962651,0.020951651,0.17780958,0.009325129,0.005636052,0.06701835,0.0073475833,0.0018736741,0.011684618,0.0048913425,0.6622278,0.00127152],"about_ca_topic_score_codex":0.009020346,"about_ca_topic_score_gemma":0.026917446,"teacher_disagreement_score":0.6216282,"about_ca_system_score_codex":0.0104795545,"about_ca_system_score_gemma":0.00610514,"threshold_uncertainty_score":0.9997919},"labels":[],"label_agreement":null},{"id":"W2885680330","doi":"10.1158/1538-7445.am2018-ct096","title":"Abstract CT096: Trastuzumab emtansine (T-DM1) + capecitabine in HER2-positive metastatic breast cancer (mBC) and HER2-positive locally advanced (LA)/metastatic gastric cancer (mGC): Results from the phase I/randomized phase II TRAXHER2 study","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Capecitabine; Medicine; Metastatic breast cancer; Internal medicine; Trastuzumab; Gastroenterology; Breast cancer; Cancer; Phases of clinical research; Trastuzumab emtansine; Oncology; Toxicity; Colorectal cancer","score_opus":0.05435336479656514,"score_gpt":0.4505987041799581,"score_spread":0.39624533938339296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885680330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636332,0.010852214,0.00006985568,0.009448481,0.00044477676,0.007875631,0.0069392,0.000066710345,0.0006699311],"genre_scores_gemma":[0.9857473,0.006696987,0.00016918458,0.00064628205,0.00093799585,0.0042684395,0.00031509838,0.00013738076,0.0010813392],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9921268,0.0019967868,0.0013866844,0.0015865329,0.0014109395,0.0014922043],"domain_scores_gemma":[0.99334115,0.003713487,0.0004022305,0.0006903663,0.0012147981,0.0006379474],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027758675,0.0008121424,0.0019713335,0.0005757457,0.0007084128,0.00014073914,0.0004586998,0.00014420731,0.0031417098],"category_scores_gemma":[0.0003949198,0.0005714371,0.00025610605,0.0019332335,0.002097488,0.0003754412,0.0002109334,0.0015318273,0.000025166924],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63614243,0.021027142,0.0010572803,0.00021846617,0.0054295477,0.002639926,0.030585868,0.00015669291,0.050178792,0.000020515168,0.0058579734,0.24668536],"study_design_scores_gemma":[0.9116795,0.015149681,0.044032343,0.002526116,0.0035754875,0.00017658417,0.008174412,0.0012745329,0.010333471,0.0001906241,0.001837298,0.0010499385],"about_ca_topic_score_codex":0.062491197,"about_ca_topic_score_gemma":0.044038177,"teacher_disagreement_score":0.27553707,"about_ca_system_score_codex":0.0019274931,"about_ca_system_score_gemma":0.0025945415,"threshold_uncertainty_score":0.9996737},"labels":[],"label_agreement":null},{"id":"W2888335003","doi":"10.1200/jco.2007.25.18_suppl.1047","title":"A phase II study of pemetrexed and doxorubicin in patients with advanced or metastatic breast cancer (MBC)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Metastatic breast cancer; Pemetrexed; Doxorubicin; Neutropenia; Breast cancer; Internal medicine; Chemotherapy; Phases of clinical research; Febrile neutropenia; Oncology; Gastroenterology; Surgery; Cancer; Cisplatin","score_opus":0.11186106138756197,"score_gpt":0.5453082906213601,"score_spread":0.43344722923379814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888335003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975948,0.00024089032,0.000010351965,0.0010758764,0.00037865678,0.0005680283,0.000010512544,0.0000028497518,0.000118082804],"genre_scores_gemma":[0.99792135,0.00022880652,0.00088014605,0.0006778636,0.00016614863,0.000006647626,0.0000014875751,0.000011831784,0.00010569798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974017,0.00020776324,0.0017433375,0.00016226733,0.00027851484,0.00020641989],"domain_scores_gemma":[0.9967718,0.0012135005,0.001302859,0.00009419405,0.00036048907,0.0002571268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015547517,0.0001311986,0.0014986165,0.00024215718,0.000024393621,0.0000015328659,0.00006773714,0.000089865316,0.00027269023],"category_scores_gemma":[0.00028895534,0.000073654766,0.00009262909,0.00028518017,0.00013474477,0.00008665681,0.000033766406,0.00047363635,4.1757227e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13324817,0.06426715,0.5043641,0.000027585418,0.0007206742,0.0006810005,0.0005656406,0.0000072655484,0.00015441638,0.0000015061792,0.00025783345,0.2957047],"study_design_scores_gemma":[0.14484291,0.2233606,0.6289445,0.00007309822,0.0009350237,0.0000733599,0.00047936977,0.0000061270184,0.00004908642,0.0000064826936,0.0011739165,0.00005548901],"about_ca_topic_score_codex":0.00013995988,"about_ca_topic_score_gemma":0.0022987088,"teacher_disagreement_score":0.2956492,"about_ca_system_score_codex":0.00015971404,"about_ca_system_score_gemma":0.0007139472,"threshold_uncertainty_score":0.30035543},"labels":[],"label_agreement":null},{"id":"W2888793209","doi":"10.1016/s1470-2045(18)30418-2","title":"Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review","year":2018,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"European Organisation for Research and Treatment of Cancer; Boehringer Ingelheim","keywords":"Medicine; Breast cancer; Randomized controlled trial; Sample size determination; MEDLINE; Systematic review; Clinical trial; Quality of life (healthcare); Meta-analysis; Missing data; Data quality; Medical physics; Alternative medicine; Cancer; Family medicine; Internal medicine; Pathology; Statistics","score_opus":0.23198629264013598,"score_gpt":0.520737163619044,"score_spread":0.288750870978908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888793209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001158571,0.98224705,0.000045519922,0.0005047159,0.00018899425,0.013826786,0.0029697616,0.000011450715,0.00008986007],"genre_scores_gemma":[0.00034651317,0.99545026,0.00032628988,0.00046769722,0.00008876596,0.0023094,0.0009413524,0.000026293577,0.000043411575],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9859836,0.0065878555,0.0062744007,0.00050636544,0.0003234532,0.00032432313],"domain_scores_gemma":[0.9782687,0.013677434,0.0064431974,0.0012700097,0.00023799154,0.000102673206],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.010686419,0.0004439817,0.039217856,0.0004292073,0.000022335442,0.0000045526685,0.00042052555,0.0001662198,0.00053518673],"category_scores_gemma":[0.0061093695,0.00021034095,0.0009393116,0.0009147972,0.0003510597,0.000032893164,0.00016157971,0.00031368938,0.0000023537689],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01724589,0.0006573306,0.00018356531,0.8571489,0.059263323,0.00013918665,0.00009625149,0.0000014448359,0.0000017009378,0.000046605262,0.0008594001,0.064356424],"study_design_scores_gemma":[0.110653706,0.0009865885,0.0000864222,0.19581266,0.6736194,0.00025495375,0.000030313211,0.0001518646,2.5360234e-7,0.000017519358,0.018152291,0.00023401785],"about_ca_topic_score_codex":0.00022450619,"about_ca_topic_score_gemma":0.00039884835,"teacher_disagreement_score":0.6613362,"about_ca_system_score_codex":0.00024963697,"about_ca_system_score_gemma":0.0011185182,"threshold_uncertainty_score":0.975046},"labels":[],"label_agreement":null},{"id":"W2889295856","doi":"10.1007/s00520-018-4424-6","title":"Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study","year":2018,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; School of Medicine and Dentistry, University of Rochester; McGill University; University of Rochester; Foundation for Neuromuscular Reconstruction","keywords":"Chemotherapy-induced peripheral neuropathy; Medicine; Transcutaneous electrical nerve stimulation; Peripheral neuropathy; Neuropathic pain; Quality of life (healthcare); Chemotherapy; Anesthesia; Physical therapy; Physical medicine and rehabilitation; Internal medicine; Nursing","score_opus":0.11121526679803206,"score_gpt":0.46079997560637165,"score_spread":0.3495847088083396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889295856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99357253,0.00020900407,0.000023268503,0.00047992717,0.00041346572,0.004904382,0.000080114616,0.00004809705,0.00026918075],"genre_scores_gemma":[0.9971859,0.000022127697,0.00010492982,0.0011364375,0.0005188703,0.00076346693,0.000099164165,0.000046136764,0.00012297524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823797,0.00015462123,0.00036248597,0.0006626507,0.00019364583,0.0003886259],"domain_scores_gemma":[0.9987498,0.00007353329,0.000106661806,0.00033890616,0.0005753178,0.00015576658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017167309,0.00024206396,0.00047090303,0.00007721,0.00010721357,0.00003170476,0.00022662,0.00010657754,0.0005609967],"category_scores_gemma":[0.00003090948,0.00021861556,0.000052992,0.00032543342,0.00006608898,0.00018990663,0.000031462307,0.00019093839,0.000002517314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03642632,0.008448531,0.6372982,0.00014121874,0.00029038268,0.0003427123,0.026712542,0.000018240718,0.11469879,0.000011925136,0.00048110046,0.17513001],"study_design_scores_gemma":[0.09244202,0.11726507,0.71403587,0.000116783616,0.0011468505,0.00008080416,0.005131818,0.0073328777,0.058441125,0.0001267139,0.0027921658,0.0010879003],"about_ca_topic_score_codex":0.0014026195,"about_ca_topic_score_gemma":0.009557385,"teacher_disagreement_score":0.1740421,"about_ca_system_score_codex":0.0010161701,"about_ca_system_score_gemma":0.0006680616,"threshold_uncertainty_score":0.8914884},"labels":[],"label_agreement":null},{"id":"W2889309405","doi":"","title":"UJI DIAGNOSTIK TORONTO CLINICAL SCORING SYSTEM TERHADAP DIAGNOSIS NEUROPATI PERIFER TERINDUKSI KEMOTERAPI","year":2014,"lang":"id","type":"article","venue":"Neurona (Majalah Kedokteran Neuro Sains Perhimpunan Dokter Spesialis Saraf Indonesia)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Chemotherapy; Oncology; Adverse effect; Intensive care medicine; Internal medicine; Physical therapy; Diabetes mellitus","score_opus":0.03264343874443765,"score_gpt":0.31949612912851016,"score_spread":0.2868526903840725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889309405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94524527,0.0040955534,0.0001773931,0.0056996583,0.02715329,0.005361327,0.00027820625,0.0013556214,0.0106337],"genre_scores_gemma":[0.95240307,0.008016887,0.00020289069,0.018119032,0.015717406,0.0009589781,0.000318011,0.0010900241,0.0031736777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97701675,0.0055258595,0.00535267,0.0055268435,0.0024779371,0.0040999516],"domain_scores_gemma":[0.9861831,0.004129808,0.001923216,0.0041600224,0.0005896378,0.0030142004],"candidate_categories":["metaepi_narrow","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0017654148,0.0037611197,0.005080158,0.00067089475,0.0012789324,0.0012314318,0.0024328025,0.0014936605,0.0016096146],"category_scores_gemma":[0.00076160603,0.0037224698,0.0026347642,0.00083993614,0.0011503848,0.0015760732,0.0012223987,0.0032381923,0.00073999225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00603165,0.008178577,0.804301,0.003640519,0.0019168752,0.012362291,0.0038967265,0.00008295131,0.0074214186,0.0006824,0.041841142,0.10964445],"study_design_scores_gemma":[0.022558935,0.014039031,0.64932656,0.0020843653,0.0040459502,0.0023429901,0.00024079501,0.002617796,0.003304075,0.000006663228,0.29575983,0.0036730133],"about_ca_topic_score_codex":0.0018830315,"about_ca_topic_score_gemma":0.0006864657,"teacher_disagreement_score":0.25391868,"about_ca_system_score_codex":0.0016805748,"about_ca_system_score_gemma":0.0006478111,"threshold_uncertainty_score":0.9998054},"labels":[],"label_agreement":null},{"id":"W2889620472","doi":"10.1200/jco.2017.35.15_suppl.10123","title":"Trastuzumab-related subclinical cardiotoxicity in patients with early stage HER2-positive breast cancer: A retrospective single-center cohort study.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Ejection fraction; Internal medicine; Breast cancer; Asymptomatic; Cardiotoxicity; Cancer; Surgery; Heart failure; Chemotherapy","score_opus":0.05702956444858435,"score_gpt":0.44346861963295403,"score_spread":0.38643905518436966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889620472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919034,0.00004454133,0.0000026465195,0.002363428,0.0016344159,0.0013734476,0.00009423838,0.000010340753,0.0025734988],"genre_scores_gemma":[0.99815667,0.00020790054,0.000057530957,0.0004583467,0.0007024287,0.000026047686,0.0000061517712,0.00003087353,0.00035407557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99555176,0.00076746073,0.0022374506,0.0004450056,0.00061032496,0.00038797347],"domain_scores_gemma":[0.99480337,0.0007334407,0.0027508666,0.00036906844,0.00088378723,0.00045945018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022953532,0.0002657672,0.0026688278,0.00013922919,0.00013119397,0.000030198196,0.00028919772,0.00045191156,0.00033078174],"category_scores_gemma":[0.000650672,0.00018233698,0.00049556815,0.00011871264,0.000570708,0.0002540041,0.00009620582,0.0018724945,0.000008976732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033289663,0.02725981,0.9264589,0.000007349578,0.0026935115,0.001513579,0.00029152204,0.0000037568589,0.0000052976006,0.0000034819238,0.00043941016,0.008033724],"study_design_scores_gemma":[0.05335538,0.06052835,0.8841667,0.00012899867,0.0010726352,0.000084440115,0.000056177072,0.0000048839784,0.0000062627414,0.0000116749625,0.00043849455,0.0001459701],"about_ca_topic_score_codex":0.0011006086,"about_ca_topic_score_gemma":0.0019348937,"teacher_disagreement_score":0.042292163,"about_ca_system_score_codex":0.0014141188,"about_ca_system_score_gemma":0.0012722039,"threshold_uncertainty_score":0.8135161},"labels":[],"label_agreement":null},{"id":"W2889735799","doi":"10.1096/fasebj.30.1_supplement.1107.6","title":"Delivery of paclitaxel and cetuximab by nanodiamond enhances mitotic catastrophe and tumor inhibition in colorectal cancer","year":2016,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mitotic catastrophe; Cetuximab; Cancer research; Paclitaxel; Colorectal cancer; Apoptosis; Mitosis; Growth inhibition; Cancer cell; Cancer; Medicine; Chemistry; Biology; Cell biology; Internal medicine; Biochemistry","score_opus":0.009571856826938036,"score_gpt":0.2627064195749662,"score_spread":0.25313456274802815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889735799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918361,0.0063442183,0.0000060120055,0.0014439776,0.000112540096,0.00012743262,0.00007446724,0.0000030898325,0.00005217528],"genre_scores_gemma":[0.99642056,0.0031778389,0.000027508953,0.00012551832,0.00011682895,0.000010555222,0.0000025492918,0.000005943477,0.000112700225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945945,0.000058300127,0.00016121162,0.00008810225,0.000092840804,0.00014009734],"domain_scores_gemma":[0.9996581,0.000099318066,0.00010016598,0.00003459125,0.000034400495,0.000073393734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013220138,0.00007925786,0.00017378677,0.00005106642,0.000053217216,0.00000743678,0.000020821048,0.000023613055,0.00016468675],"category_scores_gemma":[0.000011437842,0.000040626644,0.00002505758,0.000053406577,0.00018615936,0.00007658708,0.00001749666,0.000104083716,0.0000012947255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073112466,0.00008475095,0.03421048,0.000017756647,0.000048158596,0.0000538876,0.00029052282,2.3013133e-7,0.95736414,0.0000029730631,0.001913194,0.005282799],"study_design_scores_gemma":[0.0055590807,0.00075496815,0.038571663,0.00023586585,0.00014695317,0.00060053245,0.00019615398,0.0000094025045,0.95362324,0.00009497784,0.00014352691,0.00006361918],"about_ca_topic_score_codex":0.00016628293,"about_ca_topic_score_gemma":0.00012881865,"teacher_disagreement_score":0.0052191797,"about_ca_system_score_codex":0.0000760222,"about_ca_system_score_gemma":0.00008266863,"threshold_uncertainty_score":0.18032044},"labels":[],"label_agreement":null},{"id":"W2889855746","doi":"10.1200/jco.2017.35.15_suppl.e18297","title":"Strategies to minimize wastage of expensive drugs in expensive times: Cabazitaxel, a single center experience.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cabazitaxel; Vial; Medicine; Prostate cancer; Drug; Cancer; Internal medicine; Pharmacology; Androgen deprivation therapy","score_opus":0.19456911130182628,"score_gpt":0.533104279183883,"score_spread":0.33853516788205673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889855746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738462,0.0002860152,0.00002501171,0.007408285,0.0018785084,0.0003036197,0.000007181883,0.0000041762364,0.016240988],"genre_scores_gemma":[0.9938138,0.0003016154,0.0023694176,0.0019143737,0.00076445955,0.000013365828,0.0000017722839,0.000015236392,0.0008059227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969977,0.0002459365,0.0019439246,0.00023427715,0.00028078764,0.00029736361],"domain_scores_gemma":[0.99553645,0.0012252767,0.0020036204,0.00032256168,0.00054169376,0.00037038975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007486778,0.00017473714,0.0017667495,0.00018342823,0.000053248656,0.00002009878,0.00030833416,0.00027862965,0.0006814749],"category_scores_gemma":[0.0015951712,0.00013001928,0.0004017514,0.00006116037,0.0004583082,0.00026735236,0.00012836323,0.0005200288,0.000020975644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09559775,0.033766292,0.48672596,0.00021606035,0.0024562737,0.014431458,0.08077514,0.000071007176,0.05711388,0.0005856684,0.10664318,0.121617325],"study_design_scores_gemma":[0.093924075,0.08520821,0.5332837,0.0011848467,0.00090647856,0.0013182882,0.100944005,0.000050645365,0.018510334,0.0009030298,0.16306113,0.0007052171],"about_ca_topic_score_codex":0.00013391045,"about_ca_topic_score_gemma":0.00015506998,"teacher_disagreement_score":0.120912105,"about_ca_system_score_codex":0.00019775722,"about_ca_system_score_gemma":0.0012300737,"threshold_uncertainty_score":0.74616724},"labels":[],"label_agreement":null},{"id":"W2891363159","doi":"10.1200/jco.2017.35.15_suppl.e18237","title":"Baseline characteristics as predictors of adjuvant chemotherapy (AC) toxicities in stage III colorectal cancer (CRC) patients.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Baker Hughes (Canada); University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; FOLFOX; Capecitabine; Anemia; Cohort; Univariate analysis; Cancer; Colorectal cancer; Population; Oncology; Gastroenterology; Multivariate analysis; Oxaliplatin","score_opus":0.08234248336522221,"score_gpt":0.48125398293434235,"score_spread":0.39891149956912014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891363159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900018,0.00031704723,0.0000046443615,0.0035538098,0.0034106253,0.00029196969,0.00006838272,0.0000052614487,0.002346483],"genre_scores_gemma":[0.9890398,0.0064688004,0.0001382299,0.0016434834,0.0016658272,0.000010200812,0.000011779124,0.000019254705,0.0010026591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968506,0.00022808464,0.0022099195,0.00017167753,0.00030001462,0.00023967693],"domain_scores_gemma":[0.9949022,0.00094935624,0.0031822317,0.0001865389,0.00051379454,0.0002658736],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014797249,0.00016614945,0.0018489956,0.00013186697,0.000051568335,0.00000813483,0.00023755334,0.00034409857,0.0012582927],"category_scores_gemma":[0.0017867729,0.00012130093,0.0003549865,0.000050452843,0.00044151445,0.0001534926,0.000057263107,0.0007134481,0.0000042894576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017343642,0.0041065123,0.9055763,0.00004532427,0.00050639245,0.00028188393,0.00035807522,0.0000028725947,0.0007270492,0.000020660727,0.0027035824,0.06832769],"study_design_scores_gemma":[0.024818417,0.017396329,0.91191244,0.00014469601,0.00032874796,0.0000184082,0.00006759354,0.00006375873,0.0015048033,0.000025686228,0.04362776,0.00009132745],"about_ca_topic_score_codex":0.00031226748,"about_ca_topic_score_gemma":0.00035581252,"teacher_disagreement_score":0.068236366,"about_ca_system_score_codex":0.00026646888,"about_ca_system_score_gemma":0.0017613709,"threshold_uncertainty_score":0.9996547},"labels":[],"label_agreement":null},{"id":"W2891861168","doi":"10.1038/s41571-018-0101-4","title":"Why patients receive treatments that are minimally effective?","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network; Queen's University","funders":"","keywords":"Medicine; MEDLINE; Medical physics; Intensive care medicine; General surgery; Family medicine","score_opus":0.17794357545937708,"score_gpt":0.5473828599332276,"score_spread":0.36943928447385044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891861168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046576555,0.97486866,7.3747833e-7,0.00066369754,0.0064684083,0.011469406,0.0001700937,0.00008787696,0.0062245647],"genre_scores_gemma":[0.0000030661795,0.9772383,0.00050816796,0.011401774,0.0037524868,0.002113279,0.0011689715,0.0001433459,0.0036706172],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9900374,0.004141003,0.002891344,0.00175743,0.0004050306,0.000767818],"domain_scores_gemma":[0.9900179,0.0042616995,0.0036155945,0.0010340952,0.00037909113,0.00069163257],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0017635265,0.0012848827,0.012713738,0.00022987758,0.00012380931,0.000017266933,0.00051364006,0.0059504495,0.0010842567],"category_scores_gemma":[0.0023659617,0.0007858454,0.004314402,0.00058697426,0.00048640693,0.0000785286,0.00023961718,0.0042340043,0.002235879],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037732325,0.0033470998,0.0026801005,0.007886485,0.0018973122,0.0001638493,0.000009233375,4.7834836e-10,1.9266656e-8,0.000002918556,0.28658536,0.6970503],"study_design_scores_gemma":[0.0058388235,0.012014478,0.0023269334,0.018553233,0.022756666,0.000098050594,0.0000014295896,1.1055855e-7,3.51481e-7,0.000012052571,0.93788445,0.000513395],"about_ca_topic_score_codex":0.000009682442,"about_ca_topic_score_gemma":0.00006483609,"teacher_disagreement_score":0.6965369,"about_ca_system_score_codex":0.0017593938,"about_ca_system_score_gemma":0.0009921086,"threshold_uncertainty_score":0.9999903},"labels":[],"label_agreement":null},{"id":"W2891887155","doi":"10.1200/jco.18.00242","title":"National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Achieve Life Sciences (Canada)","funders":"AstraZeneca","keywords":"Medicine; Breast cancer; Clinical trial; Metastatic breast cancer; Cancer; Oncology; Internal medicine; Family medicine; Medical physics","score_opus":0.4241682816083695,"score_gpt":0.5935647420298819,"score_spread":0.16939646042151235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891887155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93856823,0.0013943359,0.00020561292,0.04722469,0.010580048,0.0010127975,0.00014369827,0.000017488937,0.000853079],"genre_scores_gemma":[0.97153145,0.005334015,0.0026461629,0.0073203733,0.01276195,0.00012824647,0.000010777004,0.000033926557,0.00023307816],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.992332,0.0012836213,0.0050238846,0.00046407554,0.00050470605,0.00039170578],"domain_scores_gemma":[0.98875153,0.0060566138,0.0038181415,0.0001486454,0.0007959633,0.00042910723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02117581,0.00027093076,0.0031239134,0.00026283102,0.00009238865,0.000022301325,0.00016525046,0.00037146622,0.00047937446],"category_scores_gemma":[0.0034804114,0.00019337484,0.0006324108,0.00021765874,0.00048998214,0.00018908337,0.000059089834,0.001130485,0.0000027272515],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03302797,0.0029027865,0.37648535,0.00007426592,0.002386619,0.0007569823,0.00016955072,0.000055157117,0.0001424039,0.00026864436,0.008761339,0.57496893],"study_design_scores_gemma":[0.034993973,0.006893303,0.8651371,0.00091355393,0.002032024,0.0017386765,0.00005061773,0.0005453727,0.000026407926,0.0011397921,0.08627906,0.0002501051],"about_ca_topic_score_codex":0.00049768446,"about_ca_topic_score_gemma":0.003717464,"teacher_disagreement_score":0.57471883,"about_ca_system_score_codex":0.0006991447,"about_ca_system_score_gemma":0.0032599536,"threshold_uncertainty_score":0.78855973},"labels":[],"label_agreement":null},{"id":"W2892272740","doi":"10.1200/jco.2016.34.15_suppl.e16540","title":"Effect of abiraterone acetate (AA) and enzalutamide (EZ) administration on chemotherapy-naïve metastatic castration-resistant prostate cancer (CN-mCRPC) patient’s symptom burden.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Enzalutamide; Prostate cancer; Internal medicine; Multivariate analysis; Abiraterone acetate; Univariate analysis; Cancer; Chemotherapy; Oncology; Androgen deprivation therapy","score_opus":0.0626399407867444,"score_gpt":0.47133645379068634,"score_spread":0.40869651300394194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892272740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863009,0.0006899023,0.00001238972,0.011303309,0.0008010799,0.0005541769,0.000034951172,0.000008040785,0.0002952485],"genre_scores_gemma":[0.9953982,0.0024981766,0.00028859483,0.00077168696,0.0004765321,0.000029963041,0.0000037215516,0.000021626982,0.0005114726],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9967756,0.0006673106,0.0017721335,0.0002338872,0.00031838982,0.00023266923],"domain_scores_gemma":[0.9946959,0.002790682,0.0018031674,0.00013750623,0.00028848185,0.0002842441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014869863,0.00021106952,0.0013770235,0.000119904136,0.000036373072,0.000008266493,0.00007261838,0.00017367642,0.00029094552],"category_scores_gemma":[0.0005174746,0.00011548426,0.000258403,0.00009016384,0.0002800155,0.00012045594,0.00001623793,0.00033131588,0.000007467432],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06798438,0.0015506038,0.018352536,0.00021250594,0.0016052986,0.0005707519,0.0005215422,0.000018108578,0.085047126,0.000045884583,0.0018599535,0.8222313],"study_design_scores_gemma":[0.09359007,0.39285463,0.27423576,0.0012892395,0.0045144204,0.0006383683,0.00015184678,0.00007866859,0.19529805,0.00039003015,0.036521524,0.00043738243],"about_ca_topic_score_codex":0.000047424135,"about_ca_topic_score_gemma":0.00010440045,"teacher_disagreement_score":0.8217939,"about_ca_system_score_codex":0.00020764797,"about_ca_system_score_gemma":0.0010784538,"threshold_uncertainty_score":0.47093114},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2893222431","doi":"10.1097/dss.0000000000001652","title":"Deoxycholic Acid for Submental Fullness and More: Real-World Experience With 202 Patients","year":2018,"lang":"en","type":"letter","venue":"Dermatologic Surgery","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Deoxycholic acid; Medicine; Internal medicine; Bile acid","score_opus":0.04052946934720248,"score_gpt":0.322874403195509,"score_spread":0.2823449338483065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893222431","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89280295,0.00049163116,0.000007849406,0.10262559,0.0014289636,0.0012979339,0.00015396609,0.00012138401,0.0010697042],"genre_scores_gemma":[0.43430465,0.00047033167,0.00013236792,0.5556002,0.001995731,0.001929116,0.0031822524,0.00010046769,0.0022848358],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979913,0.000070503374,0.00039573887,0.0006394967,0.00028222514,0.0006206844],"domain_scores_gemma":[0.9986455,0.0004989946,0.00026679834,0.0003295173,0.00012690152,0.00013231642],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007509576,0.00045645775,0.000976427,0.00030035115,0.00014860822,0.000022750057,0.000101790036,0.00040960583,0.00029254024],"category_scores_gemma":[0.000028686174,0.00033077487,0.00016827101,0.00022449617,0.00043713665,0.000088261644,0.00005506715,0.0004023981,0.000020612115],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040264076,0.000102957885,0.35277787,0.00023228872,0.00017447754,0.000744476,0.00017587713,8.271239e-9,0.000008119263,9.386649e-7,0.6448,0.00058035535],"study_design_scores_gemma":[0.002754538,0.0002975094,0.09951638,0.00022706097,0.00062247727,0.0007765018,0.000066366156,0.000005964684,0.0024287514,0.000018276887,0.8926671,0.00061905535],"about_ca_topic_score_codex":0.00006663928,"about_ca_topic_score_gemma":0.000025368185,"teacher_disagreement_score":0.4584983,"about_ca_system_score_codex":0.00014207278,"about_ca_system_score_gemma":0.00013084403,"threshold_uncertainty_score":0.9999144},"labels":[],"label_agreement":null},{"id":"W2894254476","doi":"10.1200/jco.2018.36.30_suppl.151","title":"Assessment of scheduled pharmacy follow-up for patients receiving oral chemotherapy.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacist; Pharmacy; Psychological intervention; Chemotherapy; Patient education; Audit; Intervention (counseling); Intensive care medicine; Physical therapy; Family medicine; Internal medicine; Nursing","score_opus":0.18655034475399465,"score_gpt":0.5783130633114408,"score_spread":0.39176271855744615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894254476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861733,0.00008948936,0.00029943942,0.004186213,0.004985388,0.00042030003,0.0000055268506,0.000006806818,0.0038335605],"genre_scores_gemma":[0.976986,0.00042210546,0.016698852,0.0029851557,0.002307847,0.000009426743,0.0000054733796,0.0000191258,0.00056603894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731094,0.0002282799,0.0018380457,0.0001579189,0.00024581296,0.0002190031],"domain_scores_gemma":[0.99522156,0.0014971165,0.0017787104,0.000116143296,0.0011355961,0.00025085217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002046539,0.00012615585,0.0013711845,0.00010868155,0.000038623017,0.00000352567,0.0001353445,0.00018193662,0.0007814909],"category_scores_gemma":[0.0010131703,0.000090569265,0.00059670454,0.000110632085,0.0002233161,0.00008517161,0.000028426737,0.00040247294,0.0000049782657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014894804,0.006399454,0.6115912,0.000047681344,0.0013318346,0.000018991055,0.00010156231,6.040763e-7,0.0016312696,0.000045500725,0.02083575,0.34310132],"study_design_scores_gemma":[0.09314562,0.061916754,0.6003961,0.00008315239,0.0011779204,0.000030073943,0.000027461112,0.00026986425,0.0018653595,0.00025114065,0.24073268,0.00010385545],"about_ca_topic_score_codex":0.000011311747,"about_ca_topic_score_gemma":0.000024310775,"teacher_disagreement_score":0.34299746,"about_ca_system_score_codex":0.00018193343,"about_ca_system_score_gemma":0.0016408216,"threshold_uncertainty_score":0.85567766},"labels":[],"label_agreement":null},{"id":"W2897563735","doi":"","title":"Metilfenidato para aliviar astenia de pacientes con cáncer avanzado. Ensayo clínico aleatorizado, estratificado, doble ciego, controlado con placebo y multicéntrico","year":2018,"lang":"es","type":"dissertation","venue":"Deposito Adademico Digital Universidad De Navarra (University of Navarra)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Humanities; Gynecology; Philosophy","score_opus":0.014018352460871825,"score_gpt":0.27221276155654095,"score_spread":0.25819440909566915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897563735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97289723,0.0023401126,0.0020430835,0.0005173683,0.0013103896,0.0024700044,0.002201296,0.0003404167,0.015880082],"genre_scores_gemma":[0.97136796,0.0013397255,0.0011711033,0.00022042451,0.0005740912,0.000006603851,0.0032147039,0.00019164196,0.021913726],"study_design_codex":"bench_or_experimental","study_design_gemma":"qualitative","domain_scores_codex":[0.99290353,0.0005312927,0.0010955527,0.0020576776,0.0013849192,0.002027006],"domain_scores_gemma":[0.9929665,0.0011422876,0.0018860021,0.0010741008,0.0012907159,0.0016404241],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0005373632,0.0016751628,0.002617137,0.0013020989,0.00097560976,0.0003201666,0.0015664217,0.0023327922,0.0012745265],"category_scores_gemma":[0.00025553763,0.00208871,0.0013016207,0.0013725304,0.0014557577,0.0016894074,0.0002969979,0.0018232322,0.00055119424],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.081650734,0.0076184464,0.2637022,0.0042123143,0.01725231,0.011079464,0.03740836,0.00031564204,0.50381166,0.0024783064,0.053932007,0.01653851],"study_design_scores_gemma":[0.16629611,0.020415787,0.13797875,0.011653876,0.04780689,0.0036861023,0.23831159,0.024433343,0.15330477,0.0005544997,0.18166667,0.0138916345],"about_ca_topic_score_codex":0.0028418542,"about_ca_topic_score_gemma":0.0005302512,"teacher_disagreement_score":0.3505069,"about_ca_system_score_codex":0.0024097117,"about_ca_system_score_gemma":0.0024069552,"threshold_uncertainty_score":0.99963844},"labels":[],"label_agreement":null},{"id":"W2900133207","doi":"10.1093/neuonc/noy148.1135","title":"TMOD-23. DYNAMIC PATTERNS OF GLIOBLASTOMA CLONAL EVOLUTION IN RESPONSE TO CHEMORADIOTHERAPY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Temozolomide; Chemoradiotherapy; Radiation therapy; Somatic evolution in cancer; Oncology; Glioblastoma; Medicine; Stem cell; Biology; Cancer research; Bioinformatics; Internal medicine; Cancer; Genetics","score_opus":0.013840688834285457,"score_gpt":0.3489778122568107,"score_spread":0.3351371234225252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900133207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909335,0.000080306214,0.00016108606,0.0070485063,0.0007150686,0.00049918785,0.000022483653,0.00003543184,0.0005044553],"genre_scores_gemma":[0.9959161,0.000040359588,0.00024893397,0.003145264,0.0002862841,0.00006413458,0.000007693473,0.000024866831,0.00026633494],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99871826,0.00025000641,0.0002946285,0.0003071157,0.00013567,0.00029430116],"domain_scores_gemma":[0.99921083,0.0002865574,0.00009374998,0.0002093902,0.0000897689,0.00010972764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023184934,0.0001430991,0.0004381726,0.0003224059,0.000027548967,0.0000021645874,0.00009656152,0.00015696153,0.00056408264],"category_scores_gemma":[0.00007518852,0.00013729738,0.00006998428,0.0003043543,0.000116486735,0.000032842014,0.000037172777,0.00017926376,0.00008617152],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031756077,0.00071217935,0.029972596,0.000019531091,0.000035798035,0.00022479487,0.00086791144,0.000006713089,0.92783123,0.00003639388,0.0015057202,0.0070310673],"study_design_scores_gemma":[0.020894911,0.0618299,0.6038972,0.000070666654,0.00014737814,0.00080305897,0.00016862342,0.0010719512,0.1429121,0.00013742347,0.16776845,0.00029833618],"about_ca_topic_score_codex":0.00009783112,"about_ca_topic_score_gemma":0.0008956546,"teacher_disagreement_score":0.78491914,"about_ca_system_score_codex":0.0008482406,"about_ca_system_score_gemma":0.0003999123,"threshold_uncertainty_score":0.6176309},"labels":[],"label_agreement":null},{"id":"W2900342617","doi":"10.1093/neuonc/noy148.313","title":"DRES-06. PREVENTING THE EMERGENCE OF TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA BY PARP-1 INHIBITION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Temozolomide; MSH6; Cancer research; Biology; PARP inhibitor; DNA repair; Synthetic lethality; MSH2; Methyltransferase; Poly ADP ribose polymerase; MLH1; DNA mismatch repair; Molecular biology; Gene; Genetics; Methylation; Polymerase; Glioblastoma","score_opus":0.01949112033093168,"score_gpt":0.3336514222823488,"score_spread":0.3141603019514171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900342617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98302203,0.00072889274,0.000017016639,0.005749325,0.00046112452,0.0005276487,0.000013343259,0.000029840321,0.009450795],"genre_scores_gemma":[0.9969975,0.00025355618,0.00011332893,0.0015894425,0.00029945458,0.00008231608,0.000008659195,0.00001664334,0.0006391526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864405,0.00025171653,0.0003967323,0.00028320582,0.00013712523,0.0002871388],"domain_scores_gemma":[0.9990931,0.00033359264,0.00021490757,0.00021456732,0.00008312366,0.000060665927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027985938,0.00012883391,0.00031992394,0.000087109926,0.00007347999,0.000002908306,0.00009745124,0.00011685806,0.00052186585],"category_scores_gemma":[0.00013624487,0.00009895449,0.000067669345,0.00033916553,0.0003103439,0.000051602998,0.000058762413,0.00023732145,0.000045601206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015336872,0.00047476575,0.009925197,0.000048880796,0.00003264681,0.00009291245,0.00091887714,0.0000010438748,0.83666056,0.00011542588,0.14731033,0.002885659],"study_design_scores_gemma":[0.004579785,0.0047862814,0.0076568876,0.00008872852,0.00015907486,0.00008525081,0.00024664085,0.00006501972,0.600489,0.00045191997,0.3812474,0.000144025],"about_ca_topic_score_codex":0.00006429793,"about_ca_topic_score_gemma":0.0016209366,"teacher_disagreement_score":0.23617159,"about_ca_system_score_codex":0.0001053098,"about_ca_system_score_gemma":0.0001641984,"threshold_uncertainty_score":0.57140654},"labels":[],"label_agreement":null},{"id":"W2901231757","doi":"10.7759/cureus.3625","title":"Phenytoin Toxicity During Neoadjuvant Concurrent Capecitabine and Radiation Therapy for Rectal Adenocarcinoma: Case Report of a Drug Interaction","year":2018,"lang":"en","type":"article","venue":"Cureus","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Capecitabine; Medicine; Phenytoin; Toxicity; Colorectal cancer; Drug; Internal medicine; Oncology; Pharmacology; Cancer; Epilepsy","score_opus":0.028584153908152766,"score_gpt":0.34697019951457675,"score_spread":0.318386045606424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901231757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392533,0.004021822,0.000042830805,0.00036088022,0.00081696635,0.00059449516,0.000019519473,0.000021842276,0.00019628994],"genre_scores_gemma":[0.9984395,0.00029067928,0.00010123379,0.00004715308,0.00072747475,0.000057476114,0.000040429957,0.000010978721,0.00028507822],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99940175,0.00002057392,0.00021663906,0.00018540387,0.00006108164,0.0001145266],"domain_scores_gemma":[0.99953884,0.000049968563,0.00013983245,0.00010635081,0.00010225993,0.00006272339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092051036,0.00009344443,0.00019729868,0.000042277083,0.00006174245,0.0000047767694,0.000017043767,0.00003727466,0.00015461251],"category_scores_gemma":[0.000032608954,0.00007911356,0.00005211632,0.000050140974,0.000059769576,0.000071893606,0.0000120693185,0.0000576359,0.0000011748539],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012761194,0.0031753744,0.1656099,0.00067292637,0.0015195254,0.012620106,0.022837639,0.0000030768588,0.5814639,0.00017698326,0.02251928,0.17664011],"study_design_scores_gemma":[0.02514273,0.0050276,0.122844644,0.00012186128,0.0005764569,0.054486036,0.00095667114,0.0012213043,0.7761326,0.00008042518,0.013068247,0.00034142117],"about_ca_topic_score_codex":0.000270386,"about_ca_topic_score_gemma":0.00020158206,"teacher_disagreement_score":0.19466871,"about_ca_system_score_codex":0.00012152368,"about_ca_system_score_gemma":0.000046040674,"threshold_uncertainty_score":0.32261574},"labels":[],"label_agreement":null},{"id":"W2903040004","doi":"10.1200/jco.2018.36.34_suppl.216","title":"Prediction of hospitalizations in patients with cancer age 70 and older receiving chemotherapy.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sault Area Hospital","funders":"","keywords":"Medicine; Chemotherapy; Multivariate analysis; Internal medicine; Cancer; Univariate analysis; Population; Exact test; Disease; Surgery","score_opus":0.0690542074008144,"score_gpt":0.4530315156451838,"score_spread":0.3839773082443694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903040004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962221,0.00017357402,0.000038843948,0.0019111186,0.00061434705,0.00016059206,0.000004602041,0.000002589424,0.00087226235],"genre_scores_gemma":[0.9970762,0.00088050595,0.0005005129,0.00082771434,0.000554906,0.0000031360507,0.0000025524018,0.0000075370185,0.00014691173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998888,0.00008232856,0.00074504054,0.000085038955,0.000114598355,0.00008500712],"domain_scores_gemma":[0.9987312,0.00023550709,0.00060240075,0.000051429644,0.0002886531,0.000090822025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004122196,0.000057448156,0.0005293172,0.00008306405,0.000014524606,0.0000015891147,0.000031284857,0.00013004176,0.0002845451],"category_scores_gemma":[0.0001556384,0.00003801581,0.00005562569,0.000110158624,0.00020622609,0.000060333623,0.000009331921,0.00020062775,4.702623e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002562988,0.0015679683,0.9540503,0.00001338696,0.00019358876,0.000015906508,0.00034866668,0.0000018495357,0.000048925045,0.000005464094,0.002213588,0.038977366],"study_design_scores_gemma":[0.01534873,0.017039884,0.9603409,0.000119735385,0.00020332877,0.0000074644895,0.000020822328,0.000019432344,0.0000612382,0.0000320527,0.0067791296,0.000027251739],"about_ca_topic_score_codex":0.000039886294,"about_ca_topic_score_gemma":0.00014876759,"teacher_disagreement_score":0.038950115,"about_ca_system_score_codex":0.00008123294,"about_ca_system_score_gemma":0.00035263188,"threshold_uncertainty_score":0.31155694},"labels":[],"label_agreement":null},{"id":"W2903375916","doi":"10.1139/cjc-2018-0455","title":"A three-step synthesis of estra-4,9-diene-3,17-dione","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Sichuan University; Opening Project of Key Laboratory of Green Chemistry of Sichuan Institutes of Higher Education","keywords":"Chemistry; Diene; Yield (engineering); Lactone; Reagent; Domino; Combinatorial chemistry; Stereochemistry; Organic chemistry; Catalysis","score_opus":0.017228609708923506,"score_gpt":0.2725648644479866,"score_spread":0.25533625473906313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903375916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975501,0.0010202314,0.000031938198,0.0013414406,0.00025802283,0.00005015667,0.000026586707,0.0000034756213,0.021767154],"genre_scores_gemma":[0.9977694,0.000026116806,0.00031675075,0.0001653782,0.000924798,0.0000019521763,0.0000022301858,0.000011619599,0.00078172085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993238,0.0000058216874,0.00027287507,0.00008298665,0.00011028309,0.00020426085],"domain_scores_gemma":[0.99879676,0.00004583475,0.00018403621,0.0001324746,0.0002474704,0.0005934195],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010599816,0.000095124065,0.00028917287,0.000066704124,0.000040514078,0.0000054285997,0.00010809052,0.000088467896,0.003472347],"category_scores_gemma":[0.0000878231,0.00008371516,0.00012406148,0.000108103646,0.00022104017,0.000030662035,0.0000043769082,0.00014503975,0.0000070189017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008482596,0.00026893464,0.08406694,0.00053706695,0.0014331177,0.002251106,0.00072440214,0.000004312184,0.6194654,0.000019198867,0.2570526,0.03332862],"study_design_scores_gemma":[0.0016861947,0.0004135755,0.0101451585,0.00036418944,0.00046567063,0.0016394441,0.00013367794,0.000018372897,0.9310566,0.00008076477,0.053865124,0.0001312263],"about_ca_topic_score_codex":0.0016912844,"about_ca_topic_score_gemma":0.006152908,"teacher_disagreement_score":0.31159118,"about_ca_system_score_codex":0.00017734984,"about_ca_system_score_gemma":0.0016693657,"threshold_uncertainty_score":0.9974386},"labels":[],"label_agreement":null},{"id":"W2907322496","doi":"10.1200/jco.2014.32.15_suppl.e17674","title":"Does the side of surgery and treatment have an effect on cardiovascular measurements in breast cancer survivors?","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Medicine; Radiation therapy; Chemotherapy; Surgery; Blood pressure; Side effect (computer science); Hormone therapy; Cancer; Breast cancer; Internal medicine","score_opus":0.17804367442507127,"score_gpt":0.47283594077418845,"score_spread":0.29479226634911715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907322496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926101,0.0007782441,0.0000022253619,0.004578013,0.0012902204,0.00023743455,0.0000050035696,0.0000028029297,0.0004959356],"genre_scores_gemma":[0.995735,0.002335839,0.00002169619,0.00073208637,0.00110098,0.00001555141,0.0000012734367,0.0000112080015,0.00004638871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641055,0.0018307606,0.0011061173,0.0001719547,0.00030713083,0.00017350582],"domain_scores_gemma":[0.99450606,0.004320934,0.00062469003,0.0001966015,0.00015699661,0.00019469924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005687118,0.00014294533,0.0018504516,0.00011161037,0.000025414154,0.0000036126771,0.00006870887,0.00018169911,0.000055618475],"category_scores_gemma":[0.0004414831,0.000058040194,0.00064778555,0.000067038825,0.00017773676,0.00004628766,0.000014817477,0.0003240495,0.0000011550575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00438128,0.0012269812,0.6812646,0.000018317247,0.001260299,0.000063428524,0.00007440258,0.000041928743,0.00014186658,0.0000017780199,0.0001007694,0.31142437],"study_design_scores_gemma":[0.00924233,0.012233969,0.9627492,0.00010232014,0.0013809906,0.00011592046,0.00003284973,0.000031543404,0.0006488667,0.000030102728,0.01337099,0.000060923274],"about_ca_topic_score_codex":0.001876626,"about_ca_topic_score_gemma":0.0038640904,"teacher_disagreement_score":0.31136346,"about_ca_system_score_codex":0.00022415652,"about_ca_system_score_gemma":0.00046367277,"threshold_uncertainty_score":0.283691},"labels":[],"label_agreement":null},{"id":"W2907871591","doi":"10.1200/jco.2014.32.15_suppl.e14627","title":"Treatment patterns and progression-free survival (PFS) in first-line metastatic colorectal (mCRC) patients (pts) on an oxaliplatin-based chemotherapy (OX-t): A Canadian retrospective chart review.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Bevacizumab; Oxaliplatin; FOLFIRI; FOLFOX; Internal medicine; Progression-free survival; Colorectal cancer; Irinotecan; Oncology; Retrospective cohort study; Chemotherapy; Capecitabine; Surgery; Cancer","score_opus":0.07739181201287954,"score_gpt":0.46429319807991426,"score_spread":0.3869013860670347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907871591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97710276,0.00033350557,0.0000057887232,0.020078711,0.0008347234,0.00092195737,0.000049577353,0.000008496992,0.00066447054],"genre_scores_gemma":[0.9887827,0.0035812282,0.00043999718,0.00638419,0.00064100686,0.00004578595,0.000043332366,0.000027355263,0.000054420925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966671,0.0007882738,0.0015111965,0.00033343353,0.00035434176,0.00034565097],"domain_scores_gemma":[0.99618644,0.0015259376,0.0010156704,0.00022671015,0.00027610757,0.00076912646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018573961,0.00025805758,0.0018748526,0.0002217221,0.000062159575,0.000008087652,0.00014130659,0.0002150286,0.0003923278],"category_scores_gemma":[0.0013349856,0.00017166686,0.00027487148,0.00015009397,0.00013226333,0.000068419184,0.000016286313,0.00056340237,0.000006842207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006803028,0.0069972896,0.83814734,0.00009490036,0.00033191993,0.00035289963,0.00015805027,0.000007007229,0.0000095584655,0.000019980449,0.0011968128,0.14588122],"study_design_scores_gemma":[0.040784337,0.10332817,0.8327283,0.00061111694,0.000489044,0.00004204132,0.000017040957,0.00040237958,0.000053073934,0.00009601277,0.021304935,0.00014352474],"about_ca_topic_score_codex":0.0037431428,"about_ca_topic_score_gemma":0.10911316,"teacher_disagreement_score":0.1457377,"about_ca_system_score_codex":0.0009977871,"about_ca_system_score_gemma":0.0012773041,"threshold_uncertainty_score":0.90714324},"labels":[],"label_agreement":null},{"id":"W2908002421","doi":"10.1200/jco.2014.32.15_suppl.e14576","title":"The impact of dose reduction on survival for colon cancer patients treated with adjuvant FOLFOX.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Baker Hughes (Canada)","funders":"","keywords":"Medicine; Oxaliplatin; FOLFOX; Colorectal cancer; Internal medicine; Gastroenterology; Cancer; Chemotherapy; Stage (stratigraphy); Surgery","score_opus":0.1290869723939355,"score_gpt":0.5346742928818136,"score_spread":0.40558732048787804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908002421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479425,0.0001242771,0.000011577973,0.0023562592,0.0013580867,0.00039697927,0.000011940851,0.0000039934803,0.0009426423],"genre_scores_gemma":[0.9976186,0.000555202,0.00007825774,0.00016195874,0.0011949157,0.000018668401,0.0000061521123,0.00001333741,0.00035291177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981341,0.00032994593,0.0010479856,0.00011863711,0.00018997173,0.00017936555],"domain_scores_gemma":[0.9952304,0.002345836,0.0015036971,0.000105281324,0.0006365115,0.0001782761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013213595,0.00011412312,0.0009851345,0.000058098474,0.000054384876,0.0000031746524,0.00008136192,0.00017715892,0.0000549433],"category_scores_gemma":[0.0006568996,0.000051803683,0.00043144205,0.00008786178,0.0001827234,0.00003625617,0.000009162208,0.00033785042,0.0000016039382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1806961,0.01028105,0.4467251,0.000027811935,0.0025476154,0.000020903588,0.00011699075,0.00025943396,0.0010053521,0.00006714164,0.02568319,0.3325693],"study_design_scores_gemma":[0.034716252,0.21324848,0.72592723,0.00007683928,0.0010444167,0.000030235733,0.000021702253,0.00013895132,0.00060578046,0.000100623634,0.024019914,0.000069589376],"about_ca_topic_score_codex":0.00016028101,"about_ca_topic_score_gemma":0.000110789515,"teacher_disagreement_score":0.3324997,"about_ca_system_score_codex":0.00028883162,"about_ca_system_score_gemma":0.0009250586,"threshold_uncertainty_score":0.21124929},"labels":[],"label_agreement":null},{"id":"W2910524550","doi":"10.1152/ajpcell.00384.2018","title":"Altered skeletal muscle microtubule-mitochondrial VDAC2 binding is related to bioenergetic impairments after paclitaxel but not vinblastine chemotherapies","year":2019,"lang":"en","type":"article","venue":"American Journal of Physiology-Cell Physiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada; James H. Cummings Foundation","keywords":"Vinblastine; Microtubule; Paclitaxel; Bioenergetics; Mitochondrion; Skeletal muscle; Cell biology; Chemistry; Internal medicine; Biology; Endocrinology; Medicine; Chemotherapy","score_opus":0.0059626385892648515,"score_gpt":0.2639500062040378,"score_spread":0.2579873676147729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910524550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99513316,0.00023797853,0.0000048310294,0.001834379,0.0019910343,0.00057929114,0.00006390302,0.000037969934,0.000117461896],"genre_scores_gemma":[0.9915292,0.00018900193,0.0011192177,0.004525196,0.0009969103,0.000040614308,0.000041988176,0.00008123022,0.0014765859],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970741,0.00027698115,0.00092512544,0.0006642322,0.00024360715,0.0008159218],"domain_scores_gemma":[0.9977951,0.00021249041,0.00089310686,0.00046389402,0.00024525126,0.0003901274],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013595648,0.00052069145,0.0015579137,0.00042585528,0.00007768203,0.000011810564,0.000329736,0.00018147282,0.0028597312],"category_scores_gemma":[0.00002369101,0.00041476026,0.00059779343,0.0004760501,0.00055423565,0.0001221227,0.00014309362,0.0006124927,0.0006079661],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006346759,0.0008921661,0.0007607286,0.000071176146,0.00072214357,0.000032612686,0.0008824936,0.00006063478,0.984818,0.0000021094334,0.0039148103,0.001496399],"study_design_scores_gemma":[0.026423952,0.049333673,0.26656902,0.0003213185,0.0009910439,0.0005445189,0.00128173,0.00013160525,0.63265014,0.0003505457,0.020123236,0.0012792117],"about_ca_topic_score_codex":0.00008426724,"about_ca_topic_score_gemma":0.0000020056516,"teacher_disagreement_score":0.35216781,"about_ca_system_score_codex":0.00021597545,"about_ca_system_score_gemma":0.00021400933,"threshold_uncertainty_score":0.9998304},"labels":[],"label_agreement":null},{"id":"W2913056912","doi":"10.1177/1534735419828823","title":"Impaired Postural Control and Altered Sensory Organization During Quiet Stance Following Neurotoxic Chemotherapy: A Preliminary Study","year":2019,"lang":"en","type":"article","venue":"Integrative Cancer Therapies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Division of Graduate Education; National Cancer Institute; Ministère de l'Économie, de la Science et de l'Innovation - Québec","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Balance (ability); Physical medicine and rehabilitation; Vestibular system; Balance problems; Peripheral neuropathy; Somatosensory system; Physical therapy; Audiology; Psychiatry","score_opus":0.011433277197377346,"score_gpt":0.30279037667263625,"score_spread":0.2913570994752589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913056912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99069875,0.0044960883,0.000011370902,0.0013685981,0.0005091777,0.0027313204,0.000037014113,0.000104345556,0.000043316522],"genre_scores_gemma":[0.99634933,0.0003776239,0.000028126924,0.0010201418,0.00019714134,0.00029853213,0.00001223373,0.00005183263,0.0016650117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988646,0.00014141436,0.00021393668,0.00037782147,0.00016711121,0.00023514756],"domain_scores_gemma":[0.99939555,0.000090570684,0.00010979092,0.0001756361,0.00015579193,0.00007267117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007347182,0.00028104815,0.0004722728,0.00008917022,0.00010525327,0.00003180118,0.000066233624,0.000057186746,0.00027769967],"category_scores_gemma":[0.000014698803,0.00020335904,0.00008163665,0.00020589297,0.000060496084,0.00016369316,0.000018435398,0.00018992447,0.00000790436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036785444,0.00026903907,0.5639431,0.000041559095,0.0010500374,0.00003497247,0.019212691,0.0000030423735,0.41023454,0.0000040099644,0.000106031424,0.0014224504],"study_design_scores_gemma":[0.01805366,0.0037316503,0.94174033,0.00018131825,0.00028871812,0.000032357348,0.007766892,0.000101598416,0.027580973,0.000019754383,0.0002389326,0.00026381307],"about_ca_topic_score_codex":0.0001640813,"about_ca_topic_score_gemma":0.00009243051,"teacher_disagreement_score":0.38265356,"about_ca_system_score_codex":0.00021532705,"about_ca_system_score_gemma":0.00009401433,"threshold_uncertainty_score":0.8292741},"labels":[],"label_agreement":null},{"id":"W2914802774","doi":"10.1158/1538-7445.sabcs18-p3-11-05","title":"Abstract P3-11-05: Predictive gene signatures of adjuvant capecitabine benefit in triple negative breast cancer in the FinXX trial","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Capecitabine; Epirubicin; Medicine; Oncology; Internal medicine; Docetaxel; Breast cancer; Triple-negative breast cancer; Hazard ratio; Cyclophosphamide; Fluorouracil; Cancer; Gene signature; Chemotherapy; Confidence interval; Gene expression; Colorectal cancer; Biology","score_opus":0.053868755868043065,"score_gpt":0.41678518531308084,"score_spread":0.36291642944503777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914802774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98558116,0.0044325697,2.8860282e-7,0.0039171805,0.0005433492,0.0032673122,0.0007186392,0.000010048376,0.0015294731],"genre_scores_gemma":[0.9947969,0.0017060769,0.0000073791707,0.00019121062,0.00066512614,0.0012476216,0.000035927158,0.000026364625,0.0013234066],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9976062,0.00020308816,0.00040248432,0.00043500774,0.00076462014,0.0005885963],"domain_scores_gemma":[0.9985683,0.00059204944,0.00010425075,0.00031895255,0.00031068258,0.00010579503],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089060713,0.00019298366,0.0005396007,0.00041220195,0.00005056029,0.000013846672,0.00028990832,0.00016655627,0.0045565492],"category_scores_gemma":[0.000055710276,0.00013033372,0.000106861335,0.0009642614,0.00021265897,0.00010445303,0.00007011161,0.00090924196,0.000015585909],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4656403,0.0048521953,0.18218699,0.0009436155,0.000835148,0.00060331135,0.016525552,0.0043582553,0.24980682,0.00033511085,0.02928852,0.044624176],"study_design_scores_gemma":[0.11108379,0.0023455352,0.8569054,0.00045123903,0.00009680512,0.000012974627,0.00130785,0.0003446216,0.02508499,0.00029647743,0.0018475243,0.00022279518],"about_ca_topic_score_codex":0.026555391,"about_ca_topic_score_gemma":0.016673066,"teacher_disagreement_score":0.67471844,"about_ca_system_score_codex":0.00084106723,"about_ca_system_score_gemma":0.001184757,"threshold_uncertainty_score":0.99635345},"labels":[],"label_agreement":null},{"id":"W2915409618","doi":"10.1158/1538-7445.sabcs15-p4-14-20","title":"Abstract P4-14-20: A phase 1b study of ONT 380, an oral HER2-specific inhibitor, combined with ado trastuzumab emtansine (T DM1), in HER2+ metastatic breast cancer (MBC)","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Lapatinib; Tolerability; Internal medicine; Metastatic breast cancer; Pertuzumab; Trastuzumab; Trastuzumab emtansine; Taxane; Capecitabine; Oncology; Context (archaeology); Cancer; Breast cancer; Gastroenterology; Adverse effect; Pharmacology","score_opus":0.12941939372273326,"score_gpt":0.47064189096229636,"score_spread":0.3412224972395631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915409618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921125,0.0015290508,0.000005173899,0.002859211,0.00023813537,0.002592597,0.00040246852,0.00004810937,0.00021271959],"genre_scores_gemma":[0.99602914,0.0010450454,0.000037666534,0.00007586669,0.00033352908,0.0012196226,0.000034871104,0.00009130824,0.0011329479],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9961136,0.00039117874,0.0006218156,0.0007879313,0.0011621702,0.0009232874],"domain_scores_gemma":[0.9979048,0.00022858298,0.00015160456,0.0005872103,0.00066553487,0.00046228955],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008118,0.00037818207,0.0009266216,0.0005701898,0.00012189708,0.00003259918,0.00027774245,0.000094988565,0.004312965],"category_scores_gemma":[0.00001964347,0.00024039645,0.00008519381,0.0010796738,0.0004419013,0.0002710992,0.00007078614,0.0006048536,0.00002441987],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12634353,0.09163655,0.10769818,0.0009684209,0.002341817,0.004358383,0.012631822,0.00007943428,0.45688492,0.000046747777,0.018418455,0.17859174],"study_design_scores_gemma":[0.3690428,0.074781075,0.45890495,0.0037718513,0.0009660949,0.0002082479,0.008274022,0.00007276989,0.06832683,0.0001297719,0.014101261,0.0014203149],"about_ca_topic_score_codex":0.016794443,"about_ca_topic_score_gemma":0.06796332,"teacher_disagreement_score":0.38855806,"about_ca_system_score_codex":0.0017827934,"about_ca_system_score_gemma":0.0016136119,"threshold_uncertainty_score":0.99659723},"labels":[],"label_agreement":null},{"id":"W2915509041","doi":"","title":"Le cancer un combat qui pourrait aussi etre le votre - Tome 1","year":2016,"lang":"fr","type":"book","venue":"Presses Académiques Francophones eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology; Humanities; Art","score_opus":0.018596204044243534,"score_gpt":0.296659477816777,"score_spread":0.2780632737725334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915509041","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014530418,0.16459218,0.00029922472,0.015174276,0.023587061,0.0041108746,0.002695207,0.0009104327,0.7741003],"genre_scores_gemma":[0.21517316,0.021346577,0.000301688,0.0032209747,0.014259623,0.001733343,0.00048990845,0.00054102537,0.7429337],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932996,0.0006318327,0.0014682323,0.0018466573,0.0007758484,0.0019778162],"domain_scores_gemma":[0.99485576,0.0011111,0.0010071401,0.0015516207,0.000502683,0.0009716729],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.00038256394,0.0018964395,0.0027392234,0.0004951381,0.00080412393,0.00011731492,0.0013822687,0.0021429,0.013271585],"category_scores_gemma":[0.00009796314,0.0016452565,0.00096425624,0.00017346477,0.0015831289,0.00032095326,0.00084957405,0.0021951427,0.0014177975],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033920584,0.0014864457,0.005206966,0.0061982945,0.0066064675,0.0015529802,0.0039143832,0.000020338832,0.052953094,0.01409492,0.64755553,0.2570185],"study_design_scores_gemma":[0.0100509785,0.00091375643,0.0019537595,0.005686408,0.0016920016,0.00015916613,0.00018996377,0.000023459934,0.04926596,0.0058870427,0.9225157,0.0016618365],"about_ca_topic_score_codex":0.0089735985,"about_ca_topic_score_gemma":0.001902818,"teacher_disagreement_score":0.2749601,"about_ca_system_score_codex":0.0010005467,"about_ca_system_score_gemma":0.0067786667,"threshold_uncertainty_score":0.99937797},"labels":[],"label_agreement":null},{"id":"W2916799720","doi":"10.3747/co.v13i3.88","title":"Natural Health Products That Inhibit Angiogenesis: A Potential Source for Investigational New Agents to Treat Cancer—Part 2","year":2006,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Traditional medicine; Scutellaria baicalensis; Pharmacology; Salvia officinalis; Ginseng; Camellia sinensis; Andrographolide; Biology; Officinalis; Traditional Chinese medicine; Botany","score_opus":0.17549476162861025,"score_gpt":0.44993683313735894,"score_spread":0.27444207150874866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916799720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89393836,0.022644611,0.0003420745,0.073735416,0.006103672,0.002784912,0.00014379241,0.00012586491,0.00018128942],"genre_scores_gemma":[0.95584065,0.00060788787,0.0017796509,0.007422066,0.01190888,0.0011934908,0.0019613325,0.00007365357,0.019212367],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984498,0.0000689187,0.00031136622,0.00047900094,0.000195924,0.0004949728],"domain_scores_gemma":[0.9991855,0.000044861976,0.00016015739,0.00014582758,0.00013059135,0.0003330801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011280156,0.00022544414,0.000451391,0.0001682289,0.00013482572,0.000011839633,0.00008476174,0.000072776995,0.00020192907],"category_scores_gemma":[0.000026727621,0.00020070968,0.00013703066,0.00024431918,0.00007163263,0.000053630432,0.000043779823,0.00012962637,0.00003183566],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008787693,0.0008828849,0.019406922,0.00020247838,0.000084923115,0.000009609161,0.00033761744,0.00012400254,0.0036273594,0.000072664945,0.8740583,0.10031449],"study_design_scores_gemma":[0.0067714932,0.0012576015,0.024895811,0.00009558863,0.00034586687,0.00006332754,0.000024651283,0.00012424045,0.0066856546,0.00013955131,0.95939946,0.00019675879],"about_ca_topic_score_codex":0.0008269021,"about_ca_topic_score_gemma":0.0005989714,"teacher_disagreement_score":0.100117736,"about_ca_system_score_codex":0.0008944947,"about_ca_system_score_gemma":0.0017738905,"threshold_uncertainty_score":0.8184703},"labels":[],"label_agreement":null},{"id":"W2920021859","doi":"10.1158/1538-7445.sabcs18-p1-13-08","title":"Abstract P1-13-08: A prospective non-randomized clinical trial of adjuvant carboplatin chemotherapy in triple negative breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Carboplatin; Medicine; Regimen; Internal medicine; Oncology; Triple-negative breast cancer; Taxane; Breast cancer; Docetaxel; Chemotherapy; Anthracycline; Cancer; Cisplatin","score_opus":0.08622547739423342,"score_gpt":0.503429888189596,"score_spread":0.4172044107953626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920021859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839921,0.0008570565,0.000001100763,0.0020534364,0.00087014935,0.007561469,0.00012855323,0.000017289347,0.0045188493],"genre_scores_gemma":[0.9903494,0.0035039403,0.000023108149,0.00015718781,0.0009046295,0.0021824173,0.000012343463,0.00004189896,0.0028250443],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969091,0.00047554725,0.0008086488,0.0005777805,0.00066207786,0.00056683715],"domain_scores_gemma":[0.9973682,0.001440216,0.00022543945,0.0003322338,0.0004363918,0.00019752819],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002850938,0.00022171561,0.0014957339,0.00031039855,0.00004357691,0.000012733436,0.00017757658,0.0002113769,0.006609314],"category_scores_gemma":[0.00019385271,0.00016705321,0.0003216426,0.0006842746,0.00063054776,0.00008582987,0.00005569312,0.0009849773,0.00004585964],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91511685,0.0013921575,0.051437873,0.00017193322,0.00064528687,0.00003419681,0.0026016564,0.000015935506,0.009603602,0.00001697289,0.0023797923,0.01658375],"study_design_scores_gemma":[0.80173415,0.0012615231,0.18526815,0.00035554133,0.00009195948,0.0000035109008,0.0003751264,0.00023505835,0.01016618,0.00015137932,0.0002032187,0.00015422782],"about_ca_topic_score_codex":0.016739817,"about_ca_topic_score_gemma":0.0025686512,"teacher_disagreement_score":0.13383026,"about_ca_system_score_codex":0.00080205244,"about_ca_system_score_gemma":0.002043598,"threshold_uncertainty_score":0.99429876},"labels":[],"label_agreement":null},{"id":"W2920981862","doi":"10.1590/1518-8345.2959.3126","title":"Acupuncture in adults with Chemotherapy-Induced Peripheral Neuropathy: a systematic review","year":2019,"lang":"en","type":"review","venue":"Revista Latino-Americana de Enfermagem","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemotherapy-induced peripheral neuropathy; Medicine; Acupuncture; Peripheral neuropathy; Cochrane Library; MEDLINE; Systematic review; Physical therapy; Meta-analysis; Chemotherapy; Randomized controlled trial; Alternative medicine; Scopus; Internal medicine; Pathology","score_opus":0.043430650564915525,"score_gpt":0.3696948508644634,"score_spread":0.3262642002995479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920981862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001662884,0.9874701,0.000010279406,0.00026384788,0.00009275283,0.0104078315,0.000041318985,0.00010874338,0.0014388346],"genre_scores_gemma":[0.0005157371,0.99219847,0.00015763327,0.0035405417,0.00023596459,0.0012147223,0.00030411012,0.00023646162,0.0015963657],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99568945,0.0008439332,0.0013570454,0.0009316141,0.00045383774,0.00072413776],"domain_scores_gemma":[0.99698,0.00030414024,0.0011432713,0.0011591366,0.000113889466,0.00029957705],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036848124,0.0012711512,0.008482894,0.00027499782,0.000043784643,0.00005769851,0.0003798345,0.00027360316,0.00060018804],"category_scores_gemma":[0.0001332065,0.0007003533,0.0009625507,0.001250719,0.00008178312,0.00008185852,0.00006509262,0.0010746827,0.00013036317],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000991141,0.00015095375,0.0001175481,0.90802294,0.00054496166,0.00073841127,0.0001921982,2.8946152e-7,0.0000028118995,0.00001184452,0.0007702851,0.08934865],"study_design_scores_gemma":[0.0015366464,0.00069049443,0.000056020468,0.6936543,0.010341595,0.0009744274,0.000024996401,0.000024826346,4.845313e-7,2.9342522e-7,0.2920868,0.0006091021],"about_ca_topic_score_codex":0.00013233941,"about_ca_topic_score_gemma":0.000014836792,"teacher_disagreement_score":0.29131654,"about_ca_system_score_codex":0.001079056,"about_ca_system_score_gemma":0.0013505617,"threshold_uncertainty_score":0.99954474},"labels":[],"label_agreement":null},{"id":"W2923959553","doi":"","title":"[A Survey to Compare the Specifications and Stability of Anticancer Drugs in Japan, the United States, Canada, and Australia].","year":2018,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vial; Pharmacy; Anticancer drug; Medicine; Drug; Pharmacology; Family medicine; Chemistry; Chromatography","score_opus":0.1396361872470051,"score_gpt":0.3311849594508765,"score_spread":0.1915487722038714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923959553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915906,0.00010775148,6.376988e-7,0.007184528,0.00007333572,0.00077238574,0.00014831421,0.0000032054832,0.00011923371],"genre_scores_gemma":[0.9988959,0.000061222716,0.000003536015,0.0005503356,0.000039744624,0.00018606154,0.000042297714,0.0000035162966,0.0002174136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994087,0.00010015832,0.00012966836,0.00011418243,0.000092479175,0.0001547899],"domain_scores_gemma":[0.9993386,0.00029881753,0.000031319647,0.00015733838,0.00009140411,0.00008249986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040318945,0.00005742722,0.00012412573,0.00003135069,0.000046847268,0.000005997026,0.000049546612,0.000009984933,0.0000728564],"category_scores_gemma":[0.000048403577,0.000032476815,0.0000065254612,0.00028434725,0.00024540295,0.000011578127,0.000023229779,0.000064356704,3.9410725e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016752521,0.000043724667,0.9882144,0.000010782035,0.00003127686,3.313043e-7,0.0013313881,8.6554996e-7,0.000019191824,0.000027060374,0.008259995,0.0018934874],"study_design_scores_gemma":[0.000544528,0.000024299512,0.9872169,0.0000030323097,0.00003279599,0.0000010072647,0.0004469319,0.000021365659,0.00051442086,0.000009402204,0.011153114,0.000032185293],"about_ca_topic_score_codex":0.8176508,"about_ca_topic_score_gemma":0.95600533,"teacher_disagreement_score":0.13835451,"about_ca_system_score_codex":0.000092498805,"about_ca_system_score_gemma":0.00007620713,"threshold_uncertainty_score":0.18356347},"labels":[],"label_agreement":null},{"id":"W2924827988","doi":"10.3332/ecancer.2019.ed88","title":"Drug interactions and oncological outcomes: a hidden adversary","year":2019,"lang":"en","type":"editorial","venue":"ecancermedicalscience","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Drug; Capecitabine; Intensive care medicine; Disease; Cancer drugs; Drug repositioning; Pharmacology; Cancer; Bioinformatics; Internal medicine; Colorectal cancer","score_opus":0.015977283763105744,"score_gpt":0.37735467005400375,"score_spread":0.361377386290898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924827988","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0091207465,0.0015320656,0.000012492893,0.0063409796,0.9675735,0.0008423535,0.0001594318,0.00012644503,0.014291964],"genre_scores_gemma":[0.01978962,0.0049091857,0.0004961956,0.0032848483,0.8645847,0.00034102023,0.00030403447,0.00005927515,0.10623112],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99711466,0.000075209275,0.000402838,0.00085286715,0.0010541659,0.0005002457],"domain_scores_gemma":[0.9968917,0.0019196548,0.00021471473,0.0003659728,0.000140322,0.00046763825],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003827413,0.00036087335,0.0009131337,0.00018302623,0.00014690947,0.00003420796,0.00031221122,0.00034935022,0.0027294736],"category_scores_gemma":[0.00092783174,0.00025889114,0.00017495823,0.00027830442,0.00085073203,0.00014072756,0.00024254834,0.0013649508,0.00026118063],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015882333,0.00023811444,0.0029650016,0.00013757833,0.000104577965,0.0001295991,0.00023693116,2.2524895e-7,0.000053285527,0.000010092846,0.98717934,0.008786461],"study_design_scores_gemma":[0.0023892308,0.0004108513,0.005066972,0.00029798524,0.0003430093,0.00003203193,0.0000699768,0.000058964084,0.0000122431475,0.000057868914,0.9910161,0.00024475332],"about_ca_topic_score_codex":0.00036447443,"about_ca_topic_score_gemma":0.00023682123,"teacher_disagreement_score":0.102988824,"about_ca_system_score_codex":0.00081678235,"about_ca_system_score_gemma":0.0026136378,"threshold_uncertainty_score":0.99998635},"labels":[],"label_agreement":null},{"id":"W2929448861","doi":"","title":"Synergistic antineoplastic activity of amonafide malate (Xanafide) with docetaxel and paclitaxel in human prostate cells","year":2005,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Irinotecan; Oxaliplatin; Etoposide; Medicine; Docetaxel; Colorectal cancer; Paclitaxel; Camptothecin; Pharmacology; Drug; Oncology; Cancer research; Cancer; Chemotherapy; Internal medicine; Chemistry","score_opus":0.008967955918337695,"score_gpt":0.2820612816458084,"score_spread":0.2730933257274707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2929448861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943802,0.00013691981,0.000033775337,0.00047573683,0.000027013602,0.0004134732,0.000012072842,0.000027340246,0.0044934736],"genre_scores_gemma":[0.9946701,0.00009483827,0.00043195844,0.000106937645,0.0000505115,0.000021359401,0.0000067557976,0.000016752798,0.004600794],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991647,0.000028882636,0.0002059503,0.00024178726,0.00012020467,0.00023847629],"domain_scores_gemma":[0.9995433,0.00009725528,0.000088435685,0.0001298198,0.000037658367,0.00010349354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008922054,0.00015991107,0.00037088318,0.00013236351,0.000029192634,0.0000062881436,0.00003076686,0.00004754447,0.00028462405],"category_scores_gemma":[0.000007810306,0.00011482772,0.000030282337,0.00015307979,0.00013705716,0.000083072715,0.000023990655,0.00012803948,0.000006823485],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015176268,0.0010414809,0.18304075,0.00032933016,0.00015758506,0.000175316,0.0003934463,0.0001843932,0.808587,0.00024412363,0.0005586162,0.0037703312],"study_design_scores_gemma":[0.011591109,0.0019252307,0.62088555,0.000211639,0.00043143993,0.00005103201,0.000058945836,0.0011413182,0.36233988,0.00006436343,0.0010184244,0.00028108805],"about_ca_topic_score_codex":0.00063285924,"about_ca_topic_score_gemma":0.0013663925,"teacher_disagreement_score":0.44624713,"about_ca_system_score_codex":0.000053688113,"about_ca_system_score_gemma":0.00006009734,"threshold_uncertainty_score":0.46825385},"labels":[],"label_agreement":null},{"id":"W2941757790","doi":"10.1093/neuonc/noz036.059","title":"DIPG-38. DIANHYDROGALACTITOL (VAL-083) WITH AZD1775 INCREASES SURVIVAL IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG), IN VIVO","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"In vivo; Cancer research; Wee1; DNA damage; Cell cycle checkpoint; Cancer; IC50; Cell cycle; Chemistry; Medicine; Pharmacology; In vitro; Internal medicine; Biology; DNA; Cyclin-dependent kinase 1; Biochemistry; Genetics","score_opus":0.013355405510796867,"score_gpt":0.29550850844423965,"score_spread":0.28215310293344276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941757790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97872436,0.00026838083,0.0000012313824,0.0033256651,0.0010758742,0.001259112,0.000021829861,0.00009932944,0.01522421],"genre_scores_gemma":[0.99690694,0.00024640726,0.000052661046,0.0015246628,0.00043232317,0.00018078144,0.00003337514,0.00006928524,0.00055359304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997346,0.00041446922,0.00052478124,0.0007041412,0.00029103056,0.00071960874],"domain_scores_gemma":[0.99801874,0.00095923,0.00019520667,0.0004409693,0.0000676413,0.0003182068],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002534345,0.00039310163,0.0011018512,0.0006422392,0.000039381914,0.000015762756,0.00019321474,0.00028751066,0.0018075292],"category_scores_gemma":[0.0001560468,0.00032941185,0.000107219115,0.0008087737,0.00016838106,0.00016433741,0.00013700857,0.0006680996,0.00019020854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009323054,0.006189939,0.69887197,0.000104199535,0.00013205277,0.008440358,0.0005799248,0.0000218719,0.2695731,0.00010652776,0.002386863,0.0042701294],"study_design_scores_gemma":[0.13448007,0.025157304,0.41179362,0.00026350538,0.00066195655,0.003090593,0.0006501415,0.0003211237,0.05867853,0.000102540376,0.36363065,0.00116993],"about_ca_topic_score_codex":0.0021618751,"about_ca_topic_score_gemma":0.0067015844,"teacher_disagreement_score":0.3612438,"about_ca_system_score_codex":0.0006207963,"about_ca_system_score_gemma":0.0006757013,"threshold_uncertainty_score":0.9999158},"labels":[],"label_agreement":null},{"id":"W2942660786","doi":"10.3747/co.26.4261","title":"A Systematic Review of Acupuncture for Chemotherapy-Induced Peripheral Neuropathy","year":2019,"lang":"en","type":"review","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; University of British Columbia","funders":"","keywords":"Medicine; Acupuncture; Chemotherapy-induced peripheral neuropathy; CINAHL; Randomized controlled trial; MEDLINE; Peripheral neuropathy; Alternative medicine; Quality of life (healthcare); Physical therapy; Clinical trial; Systematic review; Internal medicine; Psychiatry; Pathology; Psychological intervention","score_opus":0.23998888864208157,"score_gpt":0.5243745583293208,"score_spread":0.2843856696872392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942660786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005302835,0.98112684,0.000012383947,0.0002300028,0.0033289483,0.014788289,0.00009818548,0.00003446806,0.00037558787],"genre_scores_gemma":[0.0000016651861,0.994757,0.000040612205,0.0008523102,0.0006102912,0.002601355,0.0004745848,0.00007031278,0.0005918946],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973245,0.00040296075,0.001265297,0.00049085275,0.00017913348,0.00033723828],"domain_scores_gemma":[0.9973333,0.0005850696,0.0011925009,0.0005448409,0.00022147641,0.00012282362],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036347954,0.0006806738,0.008875234,0.00015255908,0.000025639334,0.000004159632,0.00024391241,0.00039018373,0.00037902128],"category_scores_gemma":[0.00020332113,0.00035108582,0.001986405,0.00024022494,0.000050557217,0.000021079635,0.00004764175,0.00047906773,0.000048209986],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004796005,0.00045048827,8.23836e-7,0.6893355,0.0005977695,0.000007566837,0.000037219343,3.5253358e-9,0.000002410457,0.000012636721,0.006857046,0.3026505],"study_design_scores_gemma":[0.0011235247,0.0014154582,2.1497969e-7,0.40721476,0.017570995,0.00016427382,0.0000023731388,0.0000017332331,0.000001057553,0.0000017463959,0.57237005,0.00013381823],"about_ca_topic_score_codex":0.00000104365,"about_ca_topic_score_gemma":9.1068756e-7,"teacher_disagreement_score":0.565513,"about_ca_system_score_codex":0.0006041299,"about_ca_system_score_gemma":0.0013180097,"threshold_uncertainty_score":0.99989414},"labels":[],"label_agreement":null},{"id":"W2942952407","doi":"","title":"Conception d'un dosimètre à fibre scintillante pour la curiethérapie","year":2008,"lang":"fr","type":"article","venue":"Corpus Université Laval (Université Laval)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Nuclear medicine; Surgery","score_opus":0.012547243761325417,"score_gpt":0.22693290349075318,"score_spread":0.21438565972942777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942952407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8343898,0.048406463,0.00023793825,0.020011786,0.0037850542,0.0009077827,0.00041280236,0.00043279634,0.09141558],"genre_scores_gemma":[0.6250763,0.075327516,0.0004186201,0.00044025088,0.0012480118,0.0000023035943,0.00018824435,0.000094027026,0.29720473],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99648565,0.00045259384,0.0003534684,0.0009904738,0.00058815075,0.00112969],"domain_scores_gemma":[0.9973843,0.00041321036,0.00034993846,0.0005926375,0.00041216527,0.0008477134],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002110922,0.0007514788,0.0009225689,0.0005461177,0.0010379856,0.00003325727,0.00055797596,0.0007213495,0.002728897],"category_scores_gemma":[0.00002721441,0.00089601625,0.0006482795,0.0010821181,0.0008934329,0.0005580143,0.0003956826,0.0008794659,0.0006544884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007950871,0.00340525,0.17365067,0.0008855614,0.004875073,0.072199464,0.0616693,0.00034763454,0.16070637,0.022023018,0.24464372,0.24764307],"study_design_scores_gemma":[0.021032315,0.0015971744,0.04088191,0.00065751496,0.0038133627,0.0043684323,0.003986246,0.0007242346,0.038862295,0.0001902055,0.88269305,0.0011932573],"about_ca_topic_score_codex":0.0068975687,"about_ca_topic_score_gemma":0.0014543557,"teacher_disagreement_score":0.63804936,"about_ca_system_score_codex":0.0020002734,"about_ca_system_score_gemma":0.0012456625,"threshold_uncertainty_score":0.99971557},"labels":[],"label_agreement":null},{"id":"W2943425953","doi":"10.1016/j.clon.2019.04.008","title":"Neurotoxicity Among Survivors of Testicular Cancer: A Population-based Study","year":2019,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of Calgary; Queen's University","funders":"PTC Therapeutics","keywords":"Medicine; Testicular cancer; Chemotherapy; Orchiectomy; Neurotoxicity; Cancer; Retrospective cohort study; Population; Cancer registry; Cohort; Internal medicine; Surgery; Toxicity; Environmental health","score_opus":0.08663527472442592,"score_gpt":0.48032696541173353,"score_spread":0.3936916906873076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943425953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952245,0.00006354527,0.000004512849,0.00069055427,0.0012279792,0.0015863442,0.00000849255,0.000037278285,0.0011567987],"genre_scores_gemma":[0.99789196,0.000015662783,0.00008604386,0.0010592531,0.00022460493,0.0001024402,0.000018808272,0.000015437918,0.00058576354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827296,0.00037319315,0.00069253653,0.00033097944,0.00014696164,0.00018339511],"domain_scores_gemma":[0.9975782,0.0016037902,0.00028993,0.00026114355,0.00011272959,0.00015419546],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005136714,0.0001215163,0.0008312964,0.000067170105,0.000022176555,0.0000017975708,0.00008703648,0.00018704192,0.0016759189],"category_scores_gemma":[0.00031451313,0.00009844349,0.00018869825,0.00017872149,0.00009809921,0.000022503144,0.000034429013,0.00029211893,0.00005348201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008969921,0.0054552546,0.98926497,0.000036819358,0.0001617787,0.00006605831,0.000033954886,0.000087567176,0.00019428812,0.000012265663,0.00027501833,0.0035150477],"study_design_scores_gemma":[0.007812875,0.0117297,0.9774299,0.000019197825,0.00043439085,0.0000016254112,0.000024674631,0.0007279488,0.00009237694,0.000012795917,0.0016367101,0.000077755336],"about_ca_topic_score_codex":0.0044097663,"about_ca_topic_score_gemma":0.0027374194,"teacher_disagreement_score":0.011835006,"about_ca_system_score_codex":0.00012997033,"about_ca_system_score_gemma":0.0004286496,"threshold_uncertainty_score":0.9992367},"labels":[],"label_agreement":null},{"id":"W2946249472","doi":"10.1007/s00520-019-04845-7","title":"Pain descriptors of taxane acute pain syndrome (TAPS) in breast cancer patients—a prospective clinical study","year":2019,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Health Sciences Centre; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; myalgia; Taxane; Pain medicine; Docetaxel; Breast cancer; Prospective cohort study; Cancer pain; Brief Pain Inventory; McGill Pain Questionnaire; Neuropathic pain; Chemotherapy; Chronic pain; Internal medicine; Cancer; Physical therapy; Anesthesia; Visual analogue scale; Anesthesiology","score_opus":0.018560946720652068,"score_gpt":0.3752612564688225,"score_spread":0.35670030974817046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946249472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99334157,0.0007982779,0.0000013127832,0.0003598336,0.0010915147,0.0034093424,0.0006564396,0.000024144836,0.00031755876],"genre_scores_gemma":[0.99713284,0.00039154806,0.000013346168,0.00073018397,0.00010847127,0.0010580017,0.00008279779,0.000044159067,0.00043867715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970294,0.0006075325,0.0008696015,0.00066654204,0.00035870675,0.00046819836],"domain_scores_gemma":[0.99854994,0.00023339866,0.0003229753,0.0002630601,0.00048060305,0.00015005267],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00095013407,0.00030114068,0.0009840877,0.0002603058,0.00002032243,0.00000597714,0.00013341891,0.00016425899,0.0028050274],"category_scores_gemma":[0.00007879032,0.00026112876,0.00016112762,0.00063168665,0.00013026067,0.00013449023,0.00006797347,0.0004612918,0.00001326768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002608349,0.0026210987,0.9739416,0.00017489558,0.0005240169,0.0003333476,0.004323713,0.000011347925,0.000120133656,0.0000020779835,0.0018452447,0.013494127],"study_design_scores_gemma":[0.0116560785,0.0056215217,0.9761496,0.0003645007,0.0002902004,0.0000064820024,0.005023441,0.000019311121,0.00017700554,0.000008138679,0.0004450142,0.00023867481],"about_ca_topic_score_codex":0.0051896125,"about_ca_topic_score_gemma":0.006958851,"teacher_disagreement_score":0.013255453,"about_ca_system_score_codex":0.0017394027,"about_ca_system_score_gemma":0.0008392353,"threshold_uncertainty_score":0.9999841},"labels":[],"label_agreement":null},{"id":"W2946893188","doi":"10.1200/jco.2019.37.15_suppl.2602","title":"Safety profile of INT230-6, a novel intratumoral (IT) formulation, during injections into a variety of refractory deep and superficial tumors with evidence of tumor regression and immune activation.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Common Terminology Criteria for Adverse Events; Pharmacokinetics; Leukopenia; Refractory (planetary science); Cancer; Internal medicine; Gastroenterology; Pharmacology; Pathology; Urology; Toxicity","score_opus":0.06102023954126988,"score_gpt":0.42982169381317836,"score_spread":0.36880145427190847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946893188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976655,0.00040177107,0.00016641557,0.0010733021,0.0002114445,0.0003330525,0.0000028927477,0.000002975305,0.0001426342],"genre_scores_gemma":[0.9955111,0.00032212932,0.0038358343,0.000088292516,0.00018323217,0.0000037053119,0.0000022186002,0.000009680961,0.000043796546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759436,0.00014908034,0.0017740304,0.00014910201,0.00022164897,0.000111760375],"domain_scores_gemma":[0.99562144,0.001438024,0.0020878124,0.00011993797,0.00061697816,0.00011582824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010554972,0.00011500627,0.0011806025,0.00015771008,0.00003816896,0.0000022166835,0.000063644824,0.00015438843,0.000105357896],"category_scores_gemma":[0.0010018139,0.00007612816,0.00012111305,0.000191362,0.0002734666,0.00026754534,0.000055439275,0.00051721133,2.5311766e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07724231,0.0033151794,0.50661176,0.00090465136,0.0006235586,0.000035897978,0.0024554643,0.00007843703,0.39844134,0.00025319523,0.00007317627,0.009965018],"study_design_scores_gemma":[0.012347243,0.026747229,0.9368704,0.0014819887,0.00041404663,0.00037142594,0.0006309991,0.00031013868,0.020459266,0.0001032714,0.00017863863,0.00008538417],"about_ca_topic_score_codex":0.00011514772,"about_ca_topic_score_gemma":0.00006159769,"teacher_disagreement_score":0.4302586,"about_ca_system_score_codex":0.00011973778,"about_ca_system_score_gemma":0.0011492014,"threshold_uncertainty_score":0.31044164},"labels":[],"label_agreement":null},{"id":"W2946984441","doi":"10.1134/s1607672919020145","title":"Detection of Taxuyunnanin C in Suspension Cell Culture of Taxuscanadensis","year":2019,"lang":"en","type":"article","venue":"Doklady Biochemistry and Biophysics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Taxoid; Suspension culture; Chemistry; Suspension (topology); Botany; Cell culture; Stereochemistry; Biology; Paclitaxel; Genetics; Cancer","score_opus":0.0051824330514105305,"score_gpt":0.23597985677889424,"score_spread":0.2307974237274837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946984441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976828,0.00040444735,0.0000012800567,0.000041194515,0.00005567351,0.00012336925,0.000015928475,0.0000040903374,0.0016712175],"genre_scores_gemma":[0.9985196,0.00016431637,0.000037716884,0.000029968727,0.00004712402,0.00000225968,0.000030616884,0.0000047221274,0.0011636516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99956584,0.0000070121505,0.00013141353,0.00013891424,0.00007277449,0.000084026964],"domain_scores_gemma":[0.99971724,0.000011554212,0.000086461594,0.000101822174,0.000046672765,0.000036264817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026214948,0.00008284403,0.0002020385,0.000022937267,0.000008428034,0.0000013677094,0.000023451868,0.000097735225,0.000038067712],"category_scores_gemma":[0.0000029427295,0.00006895976,0.000044508663,0.0001447575,0.000045126064,0.000016916205,0.000016947655,0.00008261956,0.0000021982075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023260615,0.00017887242,0.007324204,0.00035898483,0.000017732487,0.0000047522753,0.00013853818,7.898482e-7,0.9907723,0.0000036219792,0.00009850483,0.0008690627],"study_design_scores_gemma":[0.0013500996,0.00029041327,0.0042895796,0.0000586339,0.000058464804,0.000007351487,0.00018379065,0.000035122197,0.9934434,0.000022229071,0.00019977908,0.00006111609],"about_ca_topic_score_codex":0.00015859351,"about_ca_topic_score_gemma":0.0000096805725,"teacher_disagreement_score":0.003034624,"about_ca_system_score_codex":0.00002540391,"about_ca_system_score_gemma":0.000033461012,"threshold_uncertainty_score":0.2812097},"labels":[],"label_agreement":null},{"id":"W2947217282","doi":"10.1200/jco.2019.37.15_suppl.1002","title":"Neratinib + capecitabine versus lapatinib + capecitabine in patients with HER2+ metastatic breast cancer previously treated with ≥ 2 HER2-directed regimens: Findings from the multinational, randomized, phase III NALA trial.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Capecitabine; Medicine; Lapatinib; Internal medicine; Neratinib; Metastatic breast cancer; Gastroenterology; Clinical endpoint; Randomized controlled trial; Breast cancer; Oncology; Cancer; Trastuzumab; Colorectal cancer","score_opus":0.05348833309670203,"score_gpt":0.41720628720842934,"score_spread":0.3637179541117273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947217282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871031,0.00057530386,0.000006867646,0.007186586,0.0012313211,0.003318217,0.00010093917,0.000023913186,0.00045375768],"genre_scores_gemma":[0.9942057,0.0005614221,0.0013808067,0.0015958596,0.00091247953,0.00020914857,0.00017423696,0.000051727413,0.00090858457],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9941281,0.0015965316,0.0027196896,0.00043524872,0.00070517475,0.0004152447],"domain_scores_gemma":[0.9858708,0.010044122,0.0024326816,0.0002814739,0.0010516937,0.00031923817],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024609037,0.00039161666,0.0034241013,0.00017517363,0.000072349045,0.000022999424,0.00022908147,0.000242123,0.0027983545],"category_scores_gemma":[0.0011839892,0.0001960187,0.0004368319,0.00045349408,0.00037983907,0.00020797097,0.000036423113,0.0011073065,0.000017585886],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8797773,0.010376354,0.09410197,0.000016958063,0.003344326,0.00019749915,0.00035153553,0.0000700431,0.000025334524,0.000009401588,0.003600608,0.008128633],"study_design_scores_gemma":[0.86936176,0.031520087,0.09092001,0.00028662707,0.0032630437,0.000043129054,0.000113008035,0.00039436843,0.000019608911,0.000008648581,0.0038731052,0.00019663754],"about_ca_topic_score_codex":0.0013082749,"about_ca_topic_score_gemma":0.0017275976,"teacher_disagreement_score":0.021143733,"about_ca_system_score_codex":0.00048404804,"about_ca_system_score_gemma":0.0018716542,"threshold_uncertainty_score":0.9981132},"labels":[],"label_agreement":null},{"id":"W2947888232","doi":"10.1200/jco.2019.37.15_suppl.3142","title":"Effects of immune architecture on response to adjuvant capecitabine in triple-negative breast cancer (FinXX trial).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Capecitabine; Medicine; Epirubicin; Docetaxel; Triple-negative breast cancer; Internal medicine; Oncology; Cyclophosphamide; Breast cancer; Gene signature; Chemotherapy; Adjuvant; Cancer; Colorectal cancer; Gene expression","score_opus":0.04443171687605387,"score_gpt":0.47001652870276767,"score_spread":0.4255848118267138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947888232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97055525,0.0006185509,0.000005431532,0.023485009,0.0034762437,0.0013367197,0.000016282655,0.0000047077006,0.00050180603],"genre_scores_gemma":[0.99385476,0.00040455925,0.0003401302,0.0029035269,0.0010415906,0.000033168162,0.0000010461698,0.000019439796,0.0014017643],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99567133,0.00131862,0.0021956784,0.00022767698,0.00031883435,0.00026787719],"domain_scores_gemma":[0.98819256,0.009709457,0.0013467856,0.00017714364,0.0002611196,0.00031296382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028800885,0.00018526813,0.002374167,0.00038910226,0.000012971545,0.0000022808213,0.00016309478,0.00032912803,0.0006741364],"category_scores_gemma":[0.0025130871,0.00012255652,0.0005470646,0.00031555028,0.000111481604,0.00003856602,0.000043928598,0.0011418454,0.000033801643],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8863322,0.0054114684,0.0073787835,0.00008352502,0.00045618354,0.00067550095,0.00045482162,0.00012728994,0.018344985,0.000010790314,0.0013533359,0.07937113],"study_design_scores_gemma":[0.27871433,0.10642036,0.6015903,0.00042081697,0.00044480906,0.0001504555,0.00004731682,0.000010187956,0.0035074893,0.000114881295,0.008469926,0.00010919003],"about_ca_topic_score_codex":0.00014897811,"about_ca_topic_score_gemma":0.0001393021,"teacher_disagreement_score":0.60761786,"about_ca_system_score_codex":0.00041185357,"about_ca_system_score_gemma":0.0019291359,"threshold_uncertainty_score":0.7381321},"labels":[],"label_agreement":null},{"id":"W2949372190","doi":"10.1016/s0040-4020(01)00121-1","title":"The transannular Diels–Alder strategy: applications to total synthesis","year":2001,"lang":"en","type":"article","venue":"Tetrahedron","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Chemistry; Diels–Alder reaction; Total synthesis; Organic chemistry; Catalysis","score_opus":0.027185079799771156,"score_gpt":0.3382062996872534,"score_spread":0.31102121988748227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949372190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9130305,0.002524972,0.00133439,0.018647105,0.0002264658,0.0017935794,0.000026910744,0.00021006165,0.06220601],"genre_scores_gemma":[0.9889915,0.00031598727,0.00010563992,0.00041247567,0.0002782632,0.0005610087,0.000007743016,0.000017578954,0.009309815],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992994,0.000019863279,0.00013253358,0.00018099138,0.0001241011,0.00024307464],"domain_scores_gemma":[0.9994505,0.00013312975,0.000018631537,0.00022806533,0.00003060351,0.00013904378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007626137,0.000108926826,0.00013962589,0.000040450443,0.00016006897,0.000017467511,0.00007696364,0.000050070445,0.0007867718],"category_scores_gemma":[0.000008397739,0.000074057454,0.00007620515,0.000200676,0.000047016892,0.000029860506,0.000007874936,0.00009909835,0.00023816213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011809425,0.0012495184,0.010013122,0.00006366797,0.00054611143,0.0001511109,0.00074877334,0.00012312499,0.031199249,0.0026368462,0.026321081,0.92576647],"study_design_scores_gemma":[0.0015258975,0.000816206,0.06753408,0.000031346754,0.0005606039,0.00021722759,0.00033949123,0.00011711335,0.012715385,0.00042014426,0.9154505,0.00027196578],"about_ca_topic_score_codex":0.0000624168,"about_ca_topic_score_gemma":0.00007544178,"teacher_disagreement_score":0.9254945,"about_ca_system_score_codex":0.00007121287,"about_ca_system_score_gemma":0.000051953022,"threshold_uncertainty_score":0.86146},"labels":[],"label_agreement":null},{"id":"W2949565469","doi":"10.1002/chin.200221136","title":"ChemInform Abstract: Taxines from the Needles of Taxus wallichiana.","year":2002,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"","keywords":"Chemistry; Service (business); Nanotechnology; World Wide Web; Business; Marketing; Computer science","score_opus":0.03146296645399282,"score_gpt":0.2748375510935088,"score_spread":0.243374584639516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949565469","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12666243,0.0016173832,2.1369004e-8,0.0016240433,0.00015068517,0.00022536526,0.000048137386,0.000038519593,0.86963344],"genre_scores_gemma":[0.9276454,0.0005197211,0.000020151176,0.0009527903,0.000421756,0.00003231446,0.00010461759,0.0000131321585,0.07029015],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992345,3.235304e-8,0.0002819825,0.00010959177,0.00017016551,0.00020370971],"domain_scores_gemma":[0.9993221,0.00011782363,0.00014006926,0.00027115177,0.00005790509,0.00009094802],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000044210447,0.00015152381,0.00025222628,0.000027505926,0.000045181845,0.000008765634,0.00014139435,0.000095032876,0.015294179],"category_scores_gemma":[0.000033759105,0.00009616002,0.00012725478,0.00012527127,0.000116079325,0.000087223445,0.00003661071,0.00014253512,0.00015730613],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012319235,0.00018774573,0.0022883534,0.00007897654,0.00024307372,0.000011465307,0.0035021217,6.907695e-8,0.0058687,0.00003162545,0.45797893,0.52968574],"study_design_scores_gemma":[0.0027321025,0.00013571912,0.028421842,0.00008068004,0.0002947571,0.000029882349,0.0007957515,0.000021263755,0.48385608,0.000050296378,0.48339918,0.00018243502],"about_ca_topic_score_codex":0.0002740286,"about_ca_topic_score_gemma":0.00001998221,"teacher_disagreement_score":0.80098295,"about_ca_system_score_codex":0.00005896066,"about_ca_system_score_gemma":0.000031076695,"threshold_uncertainty_score":0.98560596},"labels":[],"label_agreement":null},{"id":"W2950436633","doi":"10.1055/s-2000-6291","title":"A Carbometallation-Intramolecular Cycloaddition Strategy for the AB-Taxane Ring and an Enone Accelerated Cope Rearrangement to Bicyclo[2.2.2]octanones","year":2000,"lang":"en","type":"article","venue":"Synthesis","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada; Government of Ontario","keywords":"Chemistry; Bicyclic molecule; Enone; Cycloaddition; Ketone; Isomerization; Intramolecular force; Lewis acids and bases; Medicinal chemistry; Stereochemistry; Ring (chemistry); Organic chemistry; Catalysis","score_opus":0.04904171598865918,"score_gpt":0.34985185732806845,"score_spread":0.30081014133940925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950436633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99135846,0.00068552076,0.00012227468,0.0026304969,0.000065333385,0.0012245544,0.00008539283,0.000059312035,0.0037686299],"genre_scores_gemma":[0.9968506,0.00054662884,0.00050048274,0.00040931237,0.00025686363,0.00052993494,0.000053477444,0.000025330386,0.0008273309],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991783,0.000048618425,0.00017019137,0.00026110752,0.0001263014,0.00021547523],"domain_scores_gemma":[0.9993823,0.0002124986,0.000037399303,0.00018723741,0.000053951946,0.0001266046],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014508718,0.00014791203,0.00022404053,0.00007761766,0.00015725328,0.000041767842,0.000056991597,0.000056865316,0.003380888],"category_scores_gemma":[0.000029521894,0.00010824763,0.00005181253,0.00017179444,0.000039922386,0.00006846397,0.000008687721,0.000054908363,0.0000256519],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024842527,0.00049475685,0.0007523699,0.00011561169,0.0009655415,0.000052811505,0.0007390212,0.0007319061,0.3000108,0.00015891217,0.0031825427,0.69031143],"study_design_scores_gemma":[0.012613188,0.0062754774,0.21561927,0.00049656036,0.0075777536,0.00023880346,0.0015980817,0.012421438,0.47957656,0.00059861795,0.26131,0.0016742352],"about_ca_topic_score_codex":0.00041127845,"about_ca_topic_score_gemma":0.00015063089,"teacher_disagreement_score":0.6886372,"about_ca_system_score_codex":0.0000625304,"about_ca_system_score_gemma":0.00004205722,"threshold_uncertainty_score":0.99753016},"labels":[],"label_agreement":null},{"id":"W2950463097","doi":"10.7164/antibiotics.57.97","title":"ICM0301s, New Angiogenesis Inhibitors from Aspergillus sp. F-1491: I. Taxonomy, Fermentation, Isolation and Biological Activities","year":2004,"lang":"en","type":"article","venue":"The Journal of Antibiotics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Angiogenesis; Umbilical vein; Microbiology; Cytotoxicity; Fermentation; Aspergillus; Pharmacology; Chemistry; Basic fibroblast growth factor; Angiogenesis inhibitor; Biology; Biochemistry; In vitro; Growth factor; Cancer research","score_opus":0.041888110378928804,"score_gpt":0.2870594799529177,"score_spread":0.24517136957398888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950463097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936208,0.0015810693,0.00069038814,0.0035049105,0.00033376142,0.0001466229,0.0000074302206,0.000008246389,0.00010674825],"genre_scores_gemma":[0.9944439,0.0025279685,0.0018059156,0.00035171662,0.0007461368,2.3990287e-8,0.00000811968,0.000007838851,0.00010841194],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994334,0.000043250973,0.00023683671,0.000067071014,0.00011221489,0.00010723509],"domain_scores_gemma":[0.9995194,0.000077341996,0.00019935129,0.00006634734,0.000045554993,0.000091975744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012105107,0.00010064906,0.0002103097,0.0000682789,0.00007490998,0.000014215345,0.000047966056,0.0000663478,0.00008057963],"category_scores_gemma":[0.000015496837,0.000060194023,0.000074205214,0.00008821194,0.00009340841,0.00009032488,0.000019401292,0.00011211339,0.0000037562106],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030778788,0.0006624765,0.3722306,0.000028080813,0.0011922172,0.00011461226,0.0028968765,0.0004470014,0.5942707,0.00016856995,0.008928935,0.01598205],"study_design_scores_gemma":[0.008930734,0.0033704112,0.5700715,0.00018716992,0.0016710224,0.00066313235,0.0018117997,0.00004503401,0.40590405,0.001356919,0.0057545356,0.00023369472],"about_ca_topic_score_codex":0.00022835154,"about_ca_topic_score_gemma":0.00003037732,"teacher_disagreement_score":0.1978409,"about_ca_system_score_codex":0.000097848795,"about_ca_system_score_gemma":0.00013714223,"threshold_uncertainty_score":0.2454641},"labels":[],"label_agreement":null},{"id":"W2950479189","doi":"10.1002/chin.200020205","title":"ChemInform Abstract: Antimitotic Diterpenes from Erythropodium caribaeorum Test Pharmacophore Models for Microtubule Stabilization.","year":2000,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Chemistry; Pharmacophore; Test (biology); Combinatorial chemistry; Stereochemistry","score_opus":0.022407291451047355,"score_gpt":0.2925089192109869,"score_spread":0.2701016277599395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950479189","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26003748,0.0018132157,0.000003959054,0.0018562825,0.00069092767,0.0024228755,0.0014520936,0.00031560005,0.7314076],"genre_scores_gemma":[0.91547406,0.0013542204,0.00026352878,0.0014858168,0.0010088913,0.0003457755,0.0032207759,0.0000737481,0.07677316],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851257,7.12686e-8,0.00046158436,0.00033471474,0.000201335,0.0004897066],"domain_scores_gemma":[0.99899113,0.00019398928,0.00011275798,0.0003080106,0.00015555402,0.00023853873],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006487787,0.00032668287,0.0004353457,0.000065189364,0.00013719626,0.000041519375,0.00015596887,0.00018335985,0.01761861],"category_scores_gemma":[0.000023537796,0.00029349886,0.00020470322,0.00016340955,0.00013327747,0.0003733505,0.00003266632,0.00016327048,0.00014284985],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011531279,0.0009139903,0.0009481688,0.00049256504,0.00034213386,0.000026433192,0.0019827054,0.000020924605,0.039238494,0.000013534275,0.30508476,0.64978313],"study_design_scores_gemma":[0.006272332,0.0002497389,0.001153545,0.000098727236,0.00047495688,0.00003334471,0.0001621616,0.0010047621,0.7512252,0.00018269815,0.23875049,0.00039207077],"about_ca_topic_score_codex":0.000138155,"about_ca_topic_score_gemma":0.000016480984,"teacher_disagreement_score":0.71198666,"about_ca_system_score_codex":0.0002452546,"about_ca_system_score_gemma":0.00022046012,"threshold_uncertainty_score":0.9999517},"labels":[],"label_agreement":null},{"id":"W2950763902","doi":"10.1002/chin.200146265","title":"ChemInform Abstract: Synthesis of the Racemic Tetracyclic Core (I) of CP‐225,917 — A Model Compound Lacking the Sidearms of the Natural Product.","year":2001,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemistry; Core (optical fiber); Natural product; Product (mathematics); Natural (archaeology); Service (business); Stereochemistry; Combinatorial chemistry; Computer science; Business; Telecommunications; Marketing","score_opus":0.03201229355811482,"score_gpt":0.30036701439082686,"score_spread":0.26835472083271206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950763902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8072665,0.00070853654,2.5709909e-8,0.0011803607,0.00021200487,0.0006360889,0.00002362832,0.000014599091,0.18995829],"genre_scores_gemma":[0.9883677,0.00020053172,0.000010126237,0.00022340092,0.000116003226,0.000038212027,0.0000089792,0.000017630526,0.011017432],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863744,3.7783292e-7,0.0005522191,0.00015236059,0.00039246609,0.0002651609],"domain_scores_gemma":[0.9982546,0.0002968405,0.000573937,0.00066140183,0.00016714032,0.000046109402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021932877,0.00020654756,0.00042520725,0.000041452407,0.00009389816,0.0000061581545,0.00044535755,0.00009359626,0.00022675507],"category_scores_gemma":[0.00021651652,0.00009746279,0.00030523108,0.00032993767,0.0005022041,0.00009959813,0.00013779687,0.00036518072,0.0000025640593],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024051464,0.0009513461,0.024429208,0.0020111098,0.0012263171,0.000009305465,0.012336755,0.0000909698,0.528913,0.0003094411,0.055210825,0.37210658],"study_design_scores_gemma":[0.0011333127,0.000035001172,0.018571397,0.0002887201,0.0004114438,0.000104980085,0.00053400407,0.00033165957,0.97406286,0.00009906955,0.004311678,0.000115863986],"about_ca_topic_score_codex":0.00012467087,"about_ca_topic_score_gemma":0.000032678778,"teacher_disagreement_score":0.44514987,"about_ca_system_score_codex":0.00013179074,"about_ca_system_score_gemma":0.00026446232,"threshold_uncertainty_score":0.39744172},"labels":[],"label_agreement":null},{"id":"W2951516539","doi":"10.1002/chin.200519063","title":"A Convenient Method of the Conversion of Hindered Carboxylic Acids to N‐Methoxy‐N‐methyl (Weinreb) Amides.","year":2005,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Chemistry; Citation; Library science; Stereochemistry; Computer science","score_opus":0.022171263548899648,"score_gpt":0.33331651534491985,"score_spread":0.3111452517960202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951516539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82036555,0.00061555335,0.00007613891,0.003964711,0.0005096409,0.0012709859,0.000041628366,0.000045927056,0.17310987],"genre_scores_gemma":[0.9878937,0.000043999942,0.0027121736,0.0011523364,0.00010799446,0.000029149782,0.000012505627,0.000013047883,0.008035063],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999071,0.0000033333924,0.00034389264,0.000147886,0.00023582872,0.00019805251],"domain_scores_gemma":[0.9991234,0.00012738955,0.00017168338,0.00032324417,0.00012732935,0.00012698263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002508039,0.00013980444,0.00038948611,0.00008427071,0.000027022406,0.0000021996761,0.00014834828,0.0001024088,0.00083714514],"category_scores_gemma":[0.00006998657,0.00009560943,0.00019117474,0.0002813973,0.00009211462,0.00004425615,0.00009869379,0.00012989619,0.000016085014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013254723,0.00043234546,0.0047125136,0.00059447304,0.0004905058,0.0000045600336,0.008044057,0.0000127371295,0.61868834,0.00016861023,0.02598401,0.3395424],"study_design_scores_gemma":[0.002522563,0.0002425172,0.003660908,0.000059801816,0.00024477125,0.00001828386,0.00022526017,0.0000643556,0.9222585,0.000011475085,0.0706117,0.00007986527],"about_ca_topic_score_codex":0.000097789794,"about_ca_topic_score_gemma":0.0000075766297,"teacher_disagreement_score":0.33946252,"about_ca_system_score_codex":0.00020616273,"about_ca_system_score_gemma":0.00016662848,"threshold_uncertainty_score":0.91661525},"labels":[],"label_agreement":null},{"id":"W2951793178","doi":"10.1139/v03-086","title":"Synthetic studies related to CP-225,917","year":2003,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemistry; Cope rearrangement; Furan; Ruthenium; Core (optical fiber); Olefin fiber; Stereochemistry; Strain (injury); Combinatorial chemistry; Organic chemistry; Catalysis; Internal medicine","score_opus":0.022384864914018043,"score_gpt":0.31641641560383993,"score_spread":0.2940315506898219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951793178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9630247,0.0068890075,8.4431696e-7,0.0033736257,0.00038089306,0.000058326932,0.0000044477224,0.000003934021,0.02626423],"genre_scores_gemma":[0.98951966,0.00009467809,0.00006795554,0.00056162407,0.00009943764,0.000002245732,0.0000011193105,0.00001115782,0.009642125],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99939716,0.000013554035,0.00022025908,0.00008398979,0.00007974319,0.00020529091],"domain_scores_gemma":[0.9988617,0.000034085493,0.00007742248,0.000100680656,0.00016214166,0.0007640195],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012256163,0.00009021119,0.00024453,0.00006149344,0.000049459526,0.000006824336,0.00005794814,0.00006110439,0.0016382695],"category_scores_gemma":[0.0002425963,0.00007762729,0.00008413785,0.000121999525,0.000062608306,0.000021342867,0.0000025490413,0.00018662465,0.000022935836],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038312867,0.00029263334,0.062177043,0.0006710516,0.0043158564,0.015874919,0.008334237,0.00012990083,0.42903152,0.00020863452,0.46962073,0.008960341],"study_design_scores_gemma":[0.0036979157,0.0004410345,0.0021472408,0.0005182922,0.0006452895,0.0076027196,0.0017537094,0.0000010176586,0.4686828,0.00059275597,0.51364654,0.00027069327],"about_ca_topic_score_codex":0.00008411987,"about_ca_topic_score_gemma":0.0002469733,"teacher_disagreement_score":0.060029805,"about_ca_system_score_codex":0.00036862987,"about_ca_system_score_gemma":0.0012356215,"threshold_uncertainty_score":0.9992744},"labels":[],"label_agreement":null},{"id":"W2951832268","doi":"10.1515/znb-2008-0814","title":"A New pseudo-Alkaloid Taxane and a New Rearranged Taxane from the Needles of Taxus canadensis","year":2008,"lang":"en","type":"article","venue":"Zeitschrift für Naturforschung B","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Hebei Medical University","keywords":"Taxane; Chemistry; Stereochemistry; Double bond; Taxus; Tetrahydrofuran; Botany; Biology; Organic chemistry","score_opus":0.026863947021318658,"score_gpt":0.2886093429611346,"score_spread":0.26174539593981594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951832268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9627461,0.021501709,0.000040684157,0.008340628,0.0005792343,0.0007378517,0.00010803038,0.000091530426,0.0058542346],"genre_scores_gemma":[0.9807978,0.0022970894,0.0033542996,0.0019220146,0.0011505589,0.000014259262,0.00010827179,0.000050102197,0.010305582],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982404,0.000074846925,0.0003990882,0.00043305205,0.00040727676,0.00044534987],"domain_scores_gemma":[0.9983674,0.00034827506,0.00022554166,0.0004626836,0.00010411236,0.0004919546],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012611726,0.0003322121,0.0006524793,0.000128965,0.00020272333,0.00001627352,0.00019821875,0.00026491928,0.0010401794],"category_scores_gemma":[0.00016076383,0.00023390396,0.00017264683,0.00043104103,0.00018609439,0.00010301635,0.00008205804,0.0005843862,0.000029969993],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030776805,0.0002775501,0.098543935,0.00009938292,0.0016061682,0.00069181237,0.007814797,0.000010078692,0.11136518,0.0007121914,0.7414716,0.034329634],"study_design_scores_gemma":[0.020075819,0.0015738655,0.30569327,0.0003953753,0.0021687378,0.0015555022,0.0010364073,0.00012490063,0.06154113,0.00013048662,0.6048834,0.0008211353],"about_ca_topic_score_codex":0.07706545,"about_ca_topic_score_gemma":0.005252889,"teacher_disagreement_score":0.20714934,"about_ca_system_score_codex":0.000025436575,"about_ca_system_score_gemma":0.0008847745,"threshold_uncertainty_score":0.999873},"labels":[],"label_agreement":null},{"id":"W2951978011","doi":"10.1515/znb-2015-0074","title":"Two new taxane-glycosides from the needles of <i>Taxus canadensis</i>","year":2015,"lang":"en","type":"article","venue":"Zeitschrift für Naturforschung B","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Japan Society for the Promotion of Science; Natural Science Foundation of Hebei Province; Youth Foundation of Hebei Educational Committee; Hebei Medical University; National Natural Science Foundation of China","keywords":"Taxane; Glycoside; Taxus; Chemistry; Stereochemistry; High resolution; Diterpene; Fast atom bombardment; Mass spectrometry; Botany; Chromatography; Biology; Geography","score_opus":0.034653872556819336,"score_gpt":0.3348569677313767,"score_spread":0.30020309517455734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951978011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9150091,0.025950087,0.000039691742,0.010793252,0.0022096974,0.00086925906,0.00015906821,0.0001477153,0.04482214],"genre_scores_gemma":[0.9894763,0.00019657904,0.0014437094,0.0035485274,0.0013327192,0.000014633626,0.0001309657,0.00004015177,0.0038163704],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99844044,0.00007565558,0.000353533,0.00031265523,0.00043352225,0.000384179],"domain_scores_gemma":[0.99841976,0.00031955136,0.0001823619,0.00045778064,0.0001852606,0.0004352609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020707911,0.0002603631,0.00048254675,0.00008291174,0.000082853665,0.000021056198,0.0002449945,0.0001598455,0.00036680113],"category_scores_gemma":[0.0001822904,0.0001723786,0.00016893235,0.0003375157,0.00013195223,0.00010120179,0.0000858189,0.0004636606,0.00007294873],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002040198,0.00032678497,0.09874187,0.000043969623,0.0010223606,0.00021951838,0.0034266182,0.00011161425,0.025852092,0.0039889915,0.85279614,0.011429867],"study_design_scores_gemma":[0.013912572,0.0008435638,0.023748895,0.00019504181,0.0014323005,0.00016256009,0.0015985254,0.00016296786,0.095200464,0.0003852041,0.861913,0.00044486672],"about_ca_topic_score_codex":0.044903982,"about_ca_topic_score_gemma":0.005145472,"teacher_disagreement_score":0.07499297,"about_ca_system_score_codex":0.000034668952,"about_ca_system_score_gemma":0.00097201666,"threshold_uncertainty_score":0.96145606},"labels":[],"label_agreement":null},{"id":"W2952638306","doi":"10.1002/chin.200429166","title":"First Three Examples of Taxane‐Derived Di‐propellanes in Taxus canadensis Needles.","year":2004,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Armand Frappier Museum","funders":"","keywords":"Chemistry; Taxane; Taxus; Stereochemistry; Botany","score_opus":0.028090808818259313,"score_gpt":0.2653163155665519,"score_spread":0.23722550674829257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952638306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89434916,0.00069141644,7.896538e-7,0.0007458323,0.00010084206,0.00030203548,0.000015153517,0.00002325763,0.103771515],"genre_scores_gemma":[0.99766815,0.00019410161,0.000065843364,0.00017895376,0.000091045775,0.00002692438,0.00004822539,0.0000114732475,0.0017152714],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99933267,1.9580087e-7,0.0002218186,0.000119699616,0.000113229566,0.0002123903],"domain_scores_gemma":[0.9996007,0.000031174466,0.00007910918,0.00015648804,0.000040613457,0.00009188517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036398545,0.00012414031,0.00028194988,0.00008143714,0.000022547229,0.0000036702852,0.00006843418,0.000077287856,0.0004884401],"category_scores_gemma":[0.000023138284,0.000102849095,0.00005669162,0.00015385609,0.00009144224,0.00003689249,0.000027553364,0.00008966973,0.000018878349],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004475657,0.0026045626,0.33612847,0.004540219,0.0015305179,0.0017957978,0.03355082,0.0004217466,0.18008798,0.0009869884,0.0529587,0.38091853],"study_design_scores_gemma":[0.010450108,0.00047869442,0.13635421,0.00030695988,0.00021225157,0.00013630353,0.0010630514,0.00001782096,0.81686634,0.00017631872,0.033627257,0.00031068208],"about_ca_topic_score_codex":0.015496281,"about_ca_topic_score_gemma":0.024943087,"teacher_disagreement_score":0.63677835,"about_ca_system_score_codex":0.00023258374,"about_ca_system_score_gemma":0.00019419183,"threshold_uncertainty_score":0.9928492},"labels":[],"label_agreement":null},{"id":"W2952693279","doi":"10.1139/v99-240","title":"A new short synthetic approach to chlorocyclopentenones related to cryptosporiopsin via a ring expansion strategy: first synthesis of a fungitoxic metabolite from <i>Sporormia affinis</i>","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemistry; Cycloaddition; Stereochemistry; Metabolite; Cyclopentene; Ring (chemistry); Yield (engineering); Total synthesis; Claisen rearrangement; Organic chemistry; Catalysis","score_opus":0.011236229308644171,"score_gpt":0.23876528724434778,"score_spread":0.2275290579357036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952693279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830379,0.0022905539,0.000044803568,0.00079504884,0.00012544946,0.00024319215,0.00006918674,0.000011495667,0.013382392],"genre_scores_gemma":[0.9963696,0.0001351629,0.0011859236,0.00017871213,0.00026668678,0.000013555991,0.000019191028,0.00003958569,0.0017915767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983878,0.000017582466,0.0006545664,0.00028332122,0.0002478174,0.00040890693],"domain_scores_gemma":[0.9975452,0.00006334845,0.00014245114,0.00028568076,0.00012227125,0.0018410422],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013908518,0.00026262418,0.0007222434,0.00015299114,0.000073862844,0.000024971992,0.00024981823,0.00016531302,0.0025334922],"category_scores_gemma":[0.000048891885,0.00024260704,0.0002205064,0.000374177,0.000042644562,0.000093056195,0.00001163344,0.00028267744,0.000020909534],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031799397,0.0005696213,0.011213292,0.0004147337,0.0018760166,0.0018354004,0.0041256226,0.002114421,0.82093346,0.000008402128,0.010065481,0.14366359],"study_design_scores_gemma":[0.0025788574,0.00034499678,0.021167787,0.0012462953,0.0015658523,0.0015066882,0.0007397817,0.00006608292,0.9351216,0.000060558734,0.035037644,0.0005638572],"about_ca_topic_score_codex":0.005705674,"about_ca_topic_score_gemma":0.00090154127,"teacher_disagreement_score":0.14309973,"about_ca_system_score_codex":0.0003009041,"about_ca_system_score_gemma":0.0014279522,"threshold_uncertainty_score":0.99837834},"labels":[],"label_agreement":null},{"id":"W2952768401","doi":"10.1002/chin.200007166","title":"ChemInform Abstract: Novel Taxanes from the Needles of Taxus canadensis","year":2000,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Armand Frappier Museum","funders":"","keywords":"Chemistry; Service (business); World Wide Web; Business; Computer science; Marketing","score_opus":0.022305774250084284,"score_gpt":0.2731788700655872,"score_spread":0.25087309581550293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952768401","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32662115,0.00045496403,8.9130205e-9,0.0009278275,0.000083755316,0.00017970821,0.00011005566,0.000024090756,0.67159843],"genre_scores_gemma":[0.9258422,0.00024470472,0.00001839579,0.0012066669,0.0003302362,0.000025868849,0.0001952172,0.000012666656,0.072124034],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992193,1.773862e-8,0.0002725137,0.000113014954,0.00017798622,0.00021719672],"domain_scores_gemma":[0.9993679,0.000115145136,0.00010318862,0.00025258271,0.000054135002,0.00010706553],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000047043315,0.00014890735,0.00025546656,0.000023112387,0.000048190024,0.000008204329,0.00012694696,0.00009854457,0.02049159],"category_scores_gemma":[0.00002052752,0.00009877569,0.00011067902,0.00012024443,0.00012400038,0.00007216618,0.000018244671,0.00013616357,0.00007453878],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034238648,0.000142529,0.0008462523,0.000058190606,0.00026201343,0.000012193661,0.002730944,3.3880767e-7,0.012806406,0.000014526377,0.21509935,0.7676849],"study_design_scores_gemma":[0.0021383492,0.00007196774,0.02965318,0.000059527236,0.00025278935,0.000042793457,0.00068859133,0.0000047377284,0.5087265,0.000015479764,0.4582114,0.00013472895],"about_ca_topic_score_codex":0.0073212897,"about_ca_topic_score_gemma":0.00042447617,"teacher_disagreement_score":0.7675501,"about_ca_system_score_codex":0.000096159696,"about_ca_system_score_gemma":0.00016393328,"threshold_uncertainty_score":0.99928904},"labels":[],"label_agreement":null},{"id":"W2952789992","doi":"10.1200/jco.2013.31.15_suppl.5055","title":"Interim safety analysis of a compassionate-use program (CUP) and early-access program (EAP) providing cabazitaxel (Cbz) plus prednisone (P) to patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cabazitaxel; Prostate cancer; Internal medicine; Adverse effect; Docetaxel; Interim analysis; Mitoxantrone; Febrile neutropenia; Surgery; Cancer; Toxicity; Neutropenia; Clinical trial; Chemotherapy; Androgen deprivation therapy","score_opus":0.12189504773126325,"score_gpt":0.48449588118517356,"score_spread":0.3626008334539103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952789992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929562,0.00025658484,0.000043797412,0.0014845356,0.00013388944,0.004917218,0.000053764656,0.000033631353,0.000120330056],"genre_scores_gemma":[0.9883793,0.0003818907,0.009795682,0.00027951234,0.00008622345,0.00074247475,0.000043783246,0.000036001667,0.00025513122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956361,0.00045802933,0.0024664619,0.00044541972,0.0005461622,0.00044780024],"domain_scores_gemma":[0.9939335,0.00075407,0.0024950425,0.0002260153,0.0018531061,0.000738293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007086554,0.0003500066,0.002697271,0.00045692816,0.000083584535,0.00010751688,0.00019810729,0.00016627702,0.00017021333],"category_scores_gemma":[0.00031671807,0.00019978943,0.0003134789,0.000974192,0.00037072873,0.0006364438,0.00008711424,0.0005563944,0.0000015530878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04512462,0.009743596,0.73451525,0.00021974255,0.00985843,0.00023983468,0.0008662623,0.00051917846,0.0002518988,0.0000059065287,0.00041124993,0.198244],"study_design_scores_gemma":[0.022179116,0.0816861,0.87871313,0.00044844655,0.011178392,0.000051397197,0.00013137767,0.0010352697,0.00011986306,0.0000045906413,0.004235422,0.00021689956],"about_ca_topic_score_codex":0.0037531003,"about_ca_topic_score_gemma":0.004827638,"teacher_disagreement_score":0.19802712,"about_ca_system_score_codex":0.0004688147,"about_ca_system_score_gemma":0.0015835183,"threshold_uncertainty_score":0.81471765},"labels":[],"label_agreement":null},{"id":"W2952970180","doi":"10.1002/chin.200320204","title":"First Example of a Taxane‐Derived Propellane in Taxus canadensis Needles.","year":2003,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Armand Frappier Museum","funders":"","keywords":"Chemistry; Taxane; Propellane; Terpene; Stereochemistry; Bicyclic molecule; Internal medicine","score_opus":0.028486562438362777,"score_gpt":0.2651354889410099,"score_spread":0.23664892650264713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952970180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5714624,0.00039182897,1.8393881e-7,0.00018880701,0.00008142936,0.00032094264,0.000006660022,0.000013534094,0.42753425],"genre_scores_gemma":[0.98627317,0.000101907586,0.00007810326,0.00020512995,0.000032305055,0.000032094995,0.000026561407,0.000009329484,0.013241377],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99941117,4.817996e-7,0.00019503715,0.00010763437,0.00009107767,0.00019460479],"domain_scores_gemma":[0.9996332,0.000031164072,0.000066757566,0.00014258022,0.000037530015,0.00008878045],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005683641,0.00009784032,0.00024107614,0.00006954507,0.000015595951,0.000002320281,0.000038652306,0.000062743784,0.0014982565],"category_scores_gemma":[0.000038545324,0.000082873215,0.000041898504,0.00016976392,0.000052400774,0.000024105862,0.000010751328,0.00008048904,0.000018387293],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002994587,0.0028153264,0.16683988,0.004176086,0.0011751819,0.0012784591,0.03667364,0.00002665753,0.18507068,0.0012677351,0.4144516,0.18323016],"study_design_scores_gemma":[0.004707154,0.0002605778,0.008192423,0.00008300908,0.000095616815,0.00010606383,0.0005681402,0.000010819691,0.70153177,0.000018184526,0.28427535,0.00015085869],"about_ca_topic_score_codex":0.0076715914,"about_ca_topic_score_gemma":0.003106186,"teacher_disagreement_score":0.51646113,"about_ca_system_score_codex":0.000158935,"about_ca_system_score_gemma":0.00018944404,"threshold_uncertainty_score":0.9994145},"labels":[],"label_agreement":null},{"id":"W2953000066","doi":"10.1002/chin.201340267","title":"ChemInform Abstract: Interactions of Laulimalide, Peloruside, and Their Derivatives with the Isoforms of β‐Tubulin","year":2013,"lang":"en","type":"article","venue":"ChemInform","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chemistry; Tubulin; Gene isoform; Stereochemistry; Microtubule; Computational chemistry; Biochemistry; Cell biology","score_opus":0.016693532007706725,"score_gpt":0.2766161309997846,"score_spread":0.25992259899207787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953000066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5657747,0.00015488119,2.7702444e-7,0.0011537463,0.000022449134,0.00031649257,0.000010258739,0.000012475151,0.43255472],"genre_scores_gemma":[0.98712146,0.00009857025,0.000036868874,0.00023400661,0.00004429955,0.00006586653,0.000027255195,0.0000092287955,0.0123624345],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945074,5.3744294e-8,0.00023758579,0.00008295416,0.000084839136,0.00014382495],"domain_scores_gemma":[0.99931186,0.00013639634,0.0001933894,0.00015809352,0.0001370486,0.000063229614],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000049735703,0.00013268706,0.00025048177,0.000045370733,0.000037548936,0.0000074008767,0.0000672193,0.00004284701,0.0020386926],"category_scores_gemma":[0.000016775091,0.00006485955,0.00005601414,0.00011587506,0.00024537113,0.00021443686,0.000030685853,0.00012524983,0.000009698368],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009868455,0.00045408495,0.0075109587,0.00084926357,0.0009512473,0.0000034203897,0.022480436,3.6672202e-7,0.112038635,0.00023957237,0.07889003,0.7755951],"study_design_scores_gemma":[0.0015208053,0.00031762448,0.057562236,0.00009610919,0.00008749364,0.000062539446,0.0057218266,0.0000087181825,0.9086278,0.000048174526,0.025848923,0.00009775096],"about_ca_topic_score_codex":0.00013465881,"about_ca_topic_score_gemma":0.00002761013,"teacher_disagreement_score":0.7965892,"about_ca_system_score_codex":0.00003118622,"about_ca_system_score_gemma":0.0000678583,"threshold_uncertainty_score":0.9988736},"labels":[],"label_agreement":null},{"id":"W2953404073","doi":"10.1158/1538-7445.am2019-3904","title":"Abstract 3904: Pharmacokinetic modeling of serum platinum reveals extent of long-term exposure and associated comorbidities after cisplatin treatment","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cisplatin; Medicine; Pharmacokinetics; Internal medicine; Oncology; Confidence interval; Adverse effect; Chemotherapy; Endocrinology; Urology","score_opus":0.09839875122151723,"score_gpt":0.43082938252517256,"score_spread":0.33243063130365536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953404073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99069273,0.006914411,0.00000100921,0.0002722808,0.00014603825,0.0009862927,0.00024317579,0.000013751218,0.0007303042],"genre_scores_gemma":[0.9936006,0.0031457753,0.000013553841,0.00003456057,0.000106652136,0.00020238484,0.000028364742,0.000028002081,0.0028400735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984096,0.0000979715,0.00037393346,0.00028817548,0.0004505964,0.000379667],"domain_scores_gemma":[0.9990493,0.00019523132,0.000111112684,0.00021517318,0.0002966322,0.00013257388],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033640148,0.0001694407,0.0005039495,0.00019340216,0.000038598944,0.000009520352,0.000074375545,0.000098189725,0.003556965],"category_scores_gemma":[0.000015772275,0.00013687993,0.00009178297,0.00018507072,0.00013008768,0.000060802347,0.00005682064,0.00023244254,0.000010444659],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022616785,0.0006404132,0.82232934,0.0010129107,0.0006896905,0.00010712643,0.0015093416,0.00047443522,0.15865394,0.0000054695747,0.00027163152,0.012044013],"study_design_scores_gemma":[0.0092411125,0.0022164523,0.92145336,0.00094217516,0.0002826985,0.000010143429,0.00017970424,0.0011594725,0.06426012,0.00003810205,0.00004689358,0.00016979886],"about_ca_topic_score_codex":0.00049302523,"about_ca_topic_score_gemma":0.00012265948,"teacher_disagreement_score":0.099123985,"about_ca_system_score_codex":0.00034675281,"about_ca_system_score_gemma":0.00022669963,"threshold_uncertainty_score":0.9973539},"labels":[],"label_agreement":null},{"id":"W2954238247","doi":"10.2147/jpr.s213912","title":"&lt;p&gt;Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification&lt;/p&gt;","year":2019,"lang":"en","type":"article","venue":"Journal of Pain Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Astellas Pharma; Astellas Pharma Europe; Imperial College London; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Capsaicin; Neuropathic pain; Peripheral neuropathy; Anesthesia; Chemotherapy-induced peripheral neuropathy; McGill Pain Questionnaire; Chemotherapy; Peripheral; Neuralgia; Visual analogue scale; Internal medicine","score_opus":0.0697280344784218,"score_gpt":0.37918776645444113,"score_spread":0.30945973197601934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954238247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98604983,0.0014692271,0.00018028259,0.010876453,0.000135984,0.00074607396,0.00004650929,0.000011306531,0.0004843597],"genre_scores_gemma":[0.99485826,0.00092878117,0.00054319936,0.0004041082,0.0007144866,0.0000448195,0.00007264723,0.00004165403,0.0023920608],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996227,0.0013282624,0.00054365414,0.00029642245,0.0012352811,0.00036935482],"domain_scores_gemma":[0.9974095,0.0006856129,0.00028299322,0.00036254775,0.0008384226,0.00042088234],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002397903,0.00021602905,0.00053913455,0.0003058656,0.00008768379,0.00003074116,0.00017904448,0.0000887288,0.0015456369],"category_scores_gemma":[0.00019870626,0.00014570981,0.0002143614,0.0003569663,0.00011957746,0.00010624156,0.000017945695,0.00030663528,0.000016690494],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027079755,0.0075519197,0.15801209,0.00021607871,0.0013265549,0.0009893887,0.0047022975,0.00032071464,0.7041595,0.00022453268,0.01628184,0.07913535],"study_design_scores_gemma":[0.042150438,0.055347066,0.7382403,0.0007151243,0.0006199768,0.000101987476,0.0008485509,0.018516134,0.032759838,0.000560206,0.10952414,0.00061622885],"about_ca_topic_score_codex":0.0002527485,"about_ca_topic_score_gemma":0.00006960035,"teacher_disagreement_score":0.67139965,"about_ca_system_score_codex":0.00063376,"about_ca_system_score_gemma":0.0014420268,"threshold_uncertainty_score":0.99936706},"labels":[],"label_agreement":null},{"id":"W2955206262","doi":"10.1249/01.mss.0000563124.62055.c0","title":"Impact of Aerobic and Resistance Exercise on Global Shoulder Function in Breast Cancer Survivors","year":2019,"lang":"en","type":"article","venue":"Medicine & Science in Sports & Exercise","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Physical therapy; Dash; Isometric exercise; Aerobic exercise; Randomized controlled trial; Range of motion; Mastectomy; Cancer; Internal medicine","score_opus":0.01361829212379172,"score_gpt":0.33156020032522193,"score_spread":0.3179419082014302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955206262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945028,0.00079729944,9.586455e-7,0.000870663,0.0007303761,0.0008361931,0.000011947277,0.0000204035,0.0022293641],"genre_scores_gemma":[0.99687797,0.0020088688,0.000018701463,0.00014864745,0.00006780536,0.000050673065,0.0000074420072,0.00001215073,0.0008077137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978419,0.000018420022,0.00043348118,0.0005762202,0.0006725298,0.00045747738],"domain_scores_gemma":[0.99912983,0.00003350832,0.00015371254,0.00033406587,0.00012546607,0.00022341928],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000697157,0.00023972975,0.00069352513,0.00044053287,0.00004110149,0.000006677095,0.00013637397,0.00008050116,0.0014339257],"category_scores_gemma":[0.000014803784,0.00016945752,0.000058191894,0.0017364661,0.000629033,0.00021531468,0.00003843555,0.00019381408,0.0000049594446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028325766,0.00029786016,0.9761266,0.000081131606,0.0000015460331,0.00007327758,0.00050927774,0.000090539594,0.0008790277,0.0000068805693,0.00059025374,0.018511048],"study_design_scores_gemma":[0.0031766277,0.00043080814,0.99380094,0.0018247215,0.00010101044,0.00001911992,0.00023140518,0.00006737853,0.00002073774,0.00010473754,0.00008646008,0.00013608336],"about_ca_topic_score_codex":0.0081807915,"about_ca_topic_score_gemma":0.002228608,"teacher_disagreement_score":0.018374965,"about_ca_system_score_codex":0.0006339151,"about_ca_system_score_gemma":0.00047145563,"threshold_uncertainty_score":0.9994789},"labels":[],"label_agreement":null},{"id":"W2955569507","doi":"10.21873/anticanres.13471","title":"A Systematic Review and Meta-analysis of the Combination of Vinorelbine and Lapatinib in Patients With Her2-positive Metastatic Breast Cancer","year":2019,"lang":"en","type":"review","venue":"Anticancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Essar Steel Algoma (Canada); Sault Area Hospital","funders":"","keywords":"Vinorelbine; Lapatinib; Medicine; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Cancer; Trastuzumab; Chemotherapy","score_opus":0.15644854051951979,"score_gpt":0.4910211439907729,"score_spread":0.3345726034712531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955569507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010915594,0.99126947,2.4574905e-7,0.00042500667,0.000011216422,0.0064479057,0.00069601065,0.0000018069348,0.0000567621],"genre_scores_gemma":[0.013198071,0.9855103,0.000007715412,0.00008183554,0.000003342469,0.00080064766,0.00007411047,0.000021885968,0.0003021134],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99703103,0.0010117256,0.00073725637,0.00034146613,0.00066537986,0.00021313275],"domain_scores_gemma":[0.99772316,0.00069844996,0.0005310782,0.00040132005,0.0005885597,0.00005741516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009274342,0.0002383611,0.0057306206,0.0004904367,0.000030149673,0.000007681132,0.00013294019,0.000060572806,0.00027125678],"category_scores_gemma":[0.00006534381,0.00011192674,0.0004453938,0.002011904,0.00030544234,0.000041593616,0.0001008765,0.00032758142,0.0000011019957],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000798096,0.00047527993,0.0033723526,0.8560189,0.1377248,0.0000024139215,0.00010367895,2.8564602e-7,1.6692263e-7,0.000058195626,0.000043619093,0.002120497],"study_design_scores_gemma":[0.0010886075,0.00046036518,0.010566336,0.074469976,0.9131026,0.0000053107387,0.000012476398,0.000008746312,0.0000014436532,0.0000033637502,0.00017311907,0.00010764672],"about_ca_topic_score_codex":0.0013677689,"about_ca_topic_score_gemma":0.00033647625,"teacher_disagreement_score":0.7815489,"about_ca_system_score_codex":0.00016736642,"about_ca_system_score_gemma":0.0003912504,"threshold_uncertainty_score":0.456424},"labels":[],"label_agreement":null},{"id":"W2956136764","doi":"10.1158/1538-7445.am2019-1282","title":"Abstract 1282: Understanding the kinomic contributions to tyrosine kinase inhibitor resistance in triple negative breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cabozantinib; Erlotinib; Triple-negative breast cancer; Cancer research; Epidermal growth factor receptor; EGFR inhibitors; Kinome; Receptor tyrosine kinase; Tyrosine-kinase inhibitor; Cancer; Tyrosine kinase; Medicine; Pharmacology; Breast cancer; Kinase; Biology; Internal medicine; Receptor; Cell biology","score_opus":0.08987593085900725,"score_gpt":0.4458685232074839,"score_spread":0.35599259234847663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956136764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9471924,0.0029958386,0.000011923306,0.042232625,0.00063255016,0.0023554575,0.00083279493,0.000028423752,0.0037180034],"genre_scores_gemma":[0.99104375,0.0006370551,0.000011371182,0.00060275674,0.00060273166,0.0008282515,0.000017423767,0.000028425122,0.0062282127],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99806696,0.00013446741,0.00025611883,0.00041598864,0.000439714,0.0006867382],"domain_scores_gemma":[0.9986882,0.00040711038,0.000052568703,0.00031338964,0.00031152807,0.0002271948],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00065576157,0.00016102959,0.0003160832,0.00028473334,0.00021922844,0.00004619848,0.00018088415,0.00008992687,0.0033961933],"category_scores_gemma":[0.0000793182,0.00011811432,0.00007276392,0.0010451967,0.0002023401,0.000100765385,0.000081770464,0.00067971676,0.000152676],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025711035,0.0010844376,0.13194226,0.00059327687,0.00057221093,0.00029034785,0.006046355,0.00038136265,0.50905806,0.007944984,0.31306973,0.003305936],"study_design_scores_gemma":[0.029384177,0.00073022343,0.8241299,0.0026006163,0.00017381134,0.000021705002,0.0036278805,0.00011119512,0.08248848,0.0032473642,0.05276561,0.00071904465],"about_ca_topic_score_codex":0.0050039627,"about_ca_topic_score_gemma":0.015689718,"teacher_disagreement_score":0.6921876,"about_ca_system_score_codex":0.005485072,"about_ca_system_score_gemma":0.0011401155,"threshold_uncertainty_score":0.9983327},"labels":[],"label_agreement":null},{"id":"W2956139542","doi":"10.1016/j.clbc.2019.05.013","title":"Effect of Exercise on Taxane Chemotherapy–Induced Peripheral Neuropathy in Women With Breast Cancer: A Randomized Controlled Trial","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of Alberta; University of British Columbia","funders":"University of British Columbia","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Taxane; Breast cancer; Randomized controlled trial; Oncology; Peripheral neuropathy; Internal medicine; Chemotherapy; Cancer; Physical therapy; Endocrinology; Diabetes mellitus","score_opus":0.011403874610716057,"score_gpt":0.355187699852125,"score_spread":0.34378382524140894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956139542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853583,0.00042227528,4.0353083e-7,0.0029644147,0.0015483437,0.009130233,0.00007936462,0.000042794723,0.00045387042],"genre_scores_gemma":[0.99061793,0.0014779753,0.0000041971653,0.0014789494,0.0008236921,0.0044092587,0.000006089173,0.00006213372,0.0011197471],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965267,0.0009012414,0.0010959734,0.0006130971,0.00037047674,0.00049251755],"domain_scores_gemma":[0.9970821,0.0015966927,0.0005374424,0.00037440512,0.0001292999,0.00028005036],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016228234,0.00041985986,0.0042774333,0.00012974486,0.00002526914,0.000012151717,0.00014482775,0.00021665945,0.0051667956],"category_scores_gemma":[0.00006452448,0.00024331376,0.0005759055,0.0002862853,0.00023245944,0.00006133028,0.000025024163,0.0005190363,0.000021708807],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89131695,0.0014311065,0.03126635,0.000153782,0.00077346596,0.00004224388,0.00017023846,0.000028893926,0.00097491534,0.0000021542467,0.00016527316,0.07367466],"study_design_scores_gemma":[0.95181763,0.008795212,0.03702569,0.0007071345,0.0008136399,0.0000332986,0.000015550248,0.00022305224,0.00024604428,0.0000028931129,0.000098699915,0.00022117032],"about_ca_topic_score_codex":0.00066992117,"about_ca_topic_score_gemma":0.000037238726,"teacher_disagreement_score":0.073453486,"about_ca_system_score_codex":0.00037783643,"about_ca_system_score_gemma":0.00056278886,"threshold_uncertainty_score":0.9957426},"labels":[],"label_agreement":null},{"id":"W2956941920","doi":"10.5430/jnep.v9n10p29","title":"Chemotherapy-induced peripheral neuropathy and its association with quality of life among cancer patients","year":2019,"lang":"en","type":"article","venue":"Journal of Nursing Education and Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Quality of life (healthcare); Cancer; Chemotherapy; Internal medicine; Complication; Physical therapy; Diabetes mellitus","score_opus":0.05768906473336144,"score_gpt":0.4372225270331339,"score_spread":0.3795334622997725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956941920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988151,0.0007934761,0.0000011195369,0.008677481,0.0006871883,0.00013758129,9.68929e-7,0.0000020134605,0.0015491535],"genre_scores_gemma":[0.99756426,0.0005007231,0.000102603706,0.0011626405,0.00017460885,0.0000015103903,0.0000014169558,0.0000064695746,0.00048577442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937814,0.00014452238,0.00019345178,0.00006284091,0.00016444603,0.00005656673],"domain_scores_gemma":[0.9984756,0.00021407616,0.0007319725,0.00003147941,0.0004681441,0.00007873949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003029245,0.00005312495,0.00016790563,0.000047110443,0.00003431066,0.000010516962,0.0000140501015,0.00003653002,0.00006802783],"category_scores_gemma":[0.0002540672,0.000040923205,0.000018872679,0.000067565925,0.000010747265,0.00028536865,0.0000020651025,0.00012985179,2.9731228e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040585045,0.00234931,0.9421281,0.00007818515,0.00019002832,4.4913213e-7,0.008747937,0.0000016737811,0.015622617,0.000015752015,0.001478324,0.025329083],"study_design_scores_gemma":[0.0031729385,0.0011240537,0.99113715,0.00017726887,0.00026649045,0.00003879423,0.001073736,0.000014431582,0.00092581235,0.0000057125067,0.0020160938,0.000047517522],"about_ca_topic_score_codex":0.000051011666,"about_ca_topic_score_gemma":0.0000025145102,"teacher_disagreement_score":0.049009014,"about_ca_system_score_codex":0.00016933786,"about_ca_system_score_gemma":0.00034782555,"threshold_uncertainty_score":0.16687998},"labels":[],"label_agreement":null},{"id":"W2962866878","doi":"10.1177/1545968319860486","title":"Neuropathic Pain in Taxane-Induced Peripheral Neuropathy: Evidence for Exercise in Treatment","year":2019,"lang":"en","type":"review","venue":"Neurorehabilitation and neural repair","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Peripheral neuropathy; Taxane; Neuropathic pain; Breast cancer; Adverse effect; Cancer; Oncology; Internal medicine; Anesthesia; Diabetes mellitus; Endocrinology","score_opus":0.17973320562789144,"score_gpt":0.44013948205369635,"score_spread":0.26040627642580494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962866878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.100412816,0.8914438,0.0000012312964,0.00042809462,0.0005756646,0.006976012,0.000020494877,0.00012000485,0.000021913214],"genre_scores_gemma":[0.014199159,0.98269767,0.000078454024,0.00035019516,0.00011172887,0.0019433362,0.000060552222,0.00009652589,0.0004624092],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99590075,0.001478925,0.0009035046,0.0010907744,0.00019514233,0.00043090372],"domain_scores_gemma":[0.99516505,0.003918615,0.000248698,0.00043804562,0.00006473074,0.00016485446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00084931275,0.00059473567,0.0018780081,0.0004899836,0.00004707841,0.000024511617,0.000097010845,0.00024415713,0.000029448593],"category_scores_gemma":[0.0014373558,0.00047182734,0.00067997904,0.0004863222,0.00006863112,0.00014985327,0.00003823735,0.00040789973,0.000007938344],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066084584,0.00043312483,0.0022990918,0.0160712,0.000018874385,0.00021980437,0.0003173088,0.0000056459835,0.00008987215,0.00000731982,0.00010600146,0.9797709],"study_design_scores_gemma":[0.01228887,0.03660558,0.021257278,0.03515225,0.0033894542,0.0003562911,0.00013999728,0.013960127,0.000017183747,0.00002782042,0.87526375,0.001541369],"about_ca_topic_score_codex":0.00009994424,"about_ca_topic_score_gemma":0.000083534454,"teacher_disagreement_score":0.9782295,"about_ca_system_score_codex":0.000434164,"about_ca_system_score_gemma":0.00038856984,"threshold_uncertainty_score":0.9997733},"labels":[],"label_agreement":null},{"id":"W2963208685","doi":"10.1200/jco.2006.24.18_suppl.3564","title":"Patient-reported neurotoxicity with FULV versus FLOX in patients with stage II or III carcinoma of the colon: Results of NSABP Protocol C-07","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Oxaliplatin; Neurotoxicity; Internal medicine; Bolus (digestion); Gastroenterology; Colorectal cancer; Logistic regression; Surgery; Cancer; Toxicity","score_opus":0.09326442666147912,"score_gpt":0.4403192307235135,"score_spread":0.34705480406203437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963208685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97831714,0.0000056002305,0.0000014520929,0.00086194853,0.00045436065,0.018354796,0.000021419208,0.0000040065975,0.001979283],"genre_scores_gemma":[0.99796003,0.0000024852784,0.000271322,0.00026324947,0.00019976475,0.000983028,0.0000039105257,0.000015664504,0.00030056344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99569976,0.00044039768,0.0028713515,0.0002179086,0.0005333394,0.0002372535],"domain_scores_gemma":[0.99351346,0.0010546407,0.0043233973,0.00027442802,0.0006888906,0.00014518818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082879415,0.00017886498,0.0013888505,0.00011352541,0.000041238218,0.0000020563564,0.00015452784,0.00023893335,0.00012105478],"category_scores_gemma":[0.0005854756,0.00008586676,0.00021790105,0.00033216,0.000420103,0.0000716584,0.00007384942,0.0007155633,6.3546673e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38194692,0.009070849,0.6035675,0.000048123646,0.00024946878,0.00046824035,0.000114140865,0.000072818264,0.000104750114,0.000006209965,0.001377401,0.0029735838],"study_design_scores_gemma":[0.12202753,0.1349727,0.72807735,0.000104441526,0.00034614082,0.00003486167,0.000042037944,0.000010692153,0.0011570184,0.000005410654,0.01315333,0.00006850304],"about_ca_topic_score_codex":0.00028911457,"about_ca_topic_score_gemma":0.0012518351,"teacher_disagreement_score":0.2599194,"about_ca_system_score_codex":0.00019123586,"about_ca_system_score_gemma":0.0022990447,"threshold_uncertainty_score":0.40784067},"labels":[],"label_agreement":null},{"id":"W2964348195","doi":"10.1200/jco.2006.24.18_suppl.10063","title":"Active <i>c</i>-Src has prognostic and therapeutic value in ER-negative breast cancer","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Proto-oncogene tyrosine-protein kinase Src; Oncology; Internal medicine; Tissue microarray; Trastuzumab; Immunohistochemistry; Chemotherapy; Grading (engineering); Tamoxifen; Immunostaining; Cancer; Pathology; Receptor","score_opus":0.12691142869742486,"score_gpt":0.48829145841286997,"score_spread":0.36138002971544514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964348195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96417063,0.0014406018,0.000009047009,0.030398192,0.0008069206,0.00031325198,0.000012256853,0.0000062059903,0.0028428773],"genre_scores_gemma":[0.99421746,0.0008529957,0.00033339782,0.0027841302,0.0014579833,0.000015292735,9.900042e-7,0.000013152374,0.00032460637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790204,0.00038830488,0.0011431581,0.00017322507,0.00017346161,0.00021979032],"domain_scores_gemma":[0.99617356,0.0025671893,0.0007949429,0.000064860746,0.00022348671,0.00017594361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078920386,0.00013455129,0.0010704402,0.00012074761,0.000034015815,0.0000069303505,0.0000663958,0.00025656776,0.00039437166],"category_scores_gemma":[0.00022896458,0.00009234859,0.00019303987,0.0001506887,0.00036720393,0.00007033838,0.000024524461,0.0007990501,0.0000057534985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01644721,0.0056441845,0.7301234,0.000036891386,0.0007989577,0.0011921795,0.0003764065,0.000085522435,0.0007606064,0.00021992589,0.005067593,0.23924714],"study_design_scores_gemma":[0.015176323,0.006600805,0.9632576,0.000095346986,0.00073695666,0.0007237671,0.00007643117,0.00010601099,0.00016810288,0.0017737292,0.011201589,0.00008329796],"about_ca_topic_score_codex":0.0007065653,"about_ca_topic_score_gemma":0.0006526481,"teacher_disagreement_score":0.23916385,"about_ca_system_score_codex":0.00027285927,"about_ca_system_score_gemma":0.0016123522,"threshold_uncertainty_score":0.4318093},"labels":[],"label_agreement":null},{"id":"W2964521989","doi":"10.1200/jco.2009.27.15_suppl.9607","title":"The predictive accuracy of survival between patient-reported versus clinician-reported pain in a cohort of 1,214 patients with metastatic cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cancer; Cohort; Prostate cancer; Breast cancer; Cancer pain; Logistic regression; Wilcoxon signed-rank test; Internal medicine; Performance status; Colorectal cancer; Randomized controlled trial; Lung cancer; Physical therapy; Mann–Whitney U test","score_opus":0.14912415074415636,"score_gpt":0.5031426434159173,"score_spread":0.35401849267176094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964521989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494314,0.00038166926,0.000037867325,0.001925619,0.0012343732,0.00075458037,0.00002445573,0.0000052086025,0.00069306773],"genre_scores_gemma":[0.99821097,0.0007520834,0.00031814844,0.0003380968,0.00031084564,0.000013234958,0.000016077767,0.000013242961,0.00002730641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931286,0.0011821986,0.0045546438,0.00021995387,0.00063465926,0.00027996258],"domain_scores_gemma":[0.9792557,0.012157419,0.0069085998,0.00024011123,0.0011981996,0.00023999145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051166317,0.00018649711,0.002223981,0.00014911089,0.00003400066,0.000003052135,0.00016211628,0.00021569029,0.00006836723],"category_scores_gemma":[0.008175467,0.000106602725,0.00039538433,0.00035319745,0.0003529643,0.000095163625,0.000027757116,0.00081306393,5.232785e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038424734,0.003154392,0.74202126,0.000013426932,0.0029810045,0.00020355737,0.0001342683,0.000027198905,0.00001584272,0.00000433711,0.0005912518,0.2124287],"study_design_scores_gemma":[0.028936395,0.07205961,0.892288,0.00013749787,0.0030858058,0.000008763439,0.00013332268,0.00003098017,0.00008115977,0.00009475047,0.0030652564,0.000078415695],"about_ca_topic_score_codex":0.00020420403,"about_ca_topic_score_gemma":0.00036125444,"teacher_disagreement_score":0.21235028,"about_ca_system_score_codex":0.00023771376,"about_ca_system_score_gemma":0.002642792,"threshold_uncertainty_score":0.97873884},"labels":[],"label_agreement":null},{"id":"W2964631730","doi":"10.1200/jco.2013.31.15_suppl.e13013","title":"Using ANG4043, a brain-penetrant anti-HER2 mab, to increase survival in a murine intracranial breast tumor model.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Angiochem (Canada)","funders":"","keywords":"Transcytosis; Medicine; Brain tumor; Blood–brain barrier; Radioimmunotherapy; Receptor; Breast cancer; LRP1; Cancer research; Human brain; Monoclonal antibody; Internal medicine; Pharmacology; Immunology; Antibody; Pathology; Central nervous system; Cancer; Lipoprotein; LDL receptor","score_opus":0.14273372103139548,"score_gpt":0.4914529120257182,"score_spread":0.34871919099432275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964631730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772691,0.00009656537,0.00023072974,0.019342694,0.0012180044,0.00050640415,0.000012224733,0.000011189703,0.0013130711],"genre_scores_gemma":[0.98057723,0.00007872584,0.008146255,0.008890821,0.002113799,0.000010171306,0.0000027138146,0.000028841658,0.00015146605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962057,0.0005135183,0.0022316873,0.00027491816,0.00033266217,0.0004415211],"domain_scores_gemma":[0.9964731,0.0013453679,0.0007919771,0.00017306996,0.0003877405,0.0008287954],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022326375,0.00021915036,0.0018826581,0.0002485656,0.000033886095,0.000014256961,0.00019366424,0.00026026685,0.0018828398],"category_scores_gemma":[0.0009175703,0.00016563066,0.00040417307,0.0002842185,0.00013865509,0.00017430002,0.00008231324,0.0010188658,0.000047702506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044062454,0.025655523,0.67986125,0.0001641279,0.0014450477,0.021845927,0.0005930996,0.0028674316,0.036066912,0.00016370785,0.028093887,0.15918064],"study_design_scores_gemma":[0.03486862,0.013201091,0.9128385,0.00019204458,0.000622306,0.007742995,0.000108213215,0.024555415,0.000092773196,0.00059926335,0.0048851063,0.00029368207],"about_ca_topic_score_codex":0.0015282196,"about_ca_topic_score_gemma":0.0005643343,"teacher_disagreement_score":0.23297726,"about_ca_system_score_codex":0.00035915046,"about_ca_system_score_gemma":0.002060852,"threshold_uncertainty_score":0.9990296},"labels":[],"label_agreement":null},{"id":"W2964957864","doi":"10.1007/s10549-019-05360-3","title":"A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Genentech; F. Hoffmann-La Roche","keywords":"Docetaxel; Taxane; Paclitaxel; Medicine; Adverse effect; Breast cancer; Lung cancer; Cancer; Metastatic breast cancer; Internal medicine; Pharmacology; Oncology","score_opus":0.05230859694138998,"score_gpt":0.42508213895852676,"score_spread":0.37277354201713675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964957864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990178,0.0003028487,0.0000012165821,0.0012775089,0.000045991805,0.0073808357,0.00073591166,0.00000557294,0.000072119685],"genre_scores_gemma":[0.99700975,0.0008404979,0.00006562465,0.000054543485,0.000015529104,0.0012413812,0.000031727297,0.000029348676,0.00071158475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783814,0.00037907038,0.00040261413,0.0004930917,0.0004957397,0.0003913418],"domain_scores_gemma":[0.9987727,0.00024124402,0.00021409657,0.00022477226,0.00040126828,0.00014592263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027423684,0.00027058387,0.0006786644,0.0002485738,0.00008411631,0.000018429362,0.00012299135,0.000046977093,0.00068730256],"category_scores_gemma":[0.000006360733,0.0001323493,0.000017069036,0.0008617664,0.0002933123,0.0002308701,0.0000986076,0.00020320095,9.006104e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.219169,0.03827156,0.67707586,0.00020565414,0.0009870072,0.000049333772,0.0015928068,0.00008040616,0.00035372376,0.000011539013,0.000037733265,0.062165357],"study_design_scores_gemma":[0.22915903,0.0318078,0.73648715,0.00045245435,0.00032747228,0.000025636757,0.00088496157,0.00016780748,0.00048685735,0.000010723949,0.00006227568,0.0001278562],"about_ca_topic_score_codex":0.017099768,"about_ca_topic_score_gemma":0.035592634,"teacher_disagreement_score":0.0620375,"about_ca_system_score_codex":0.00069336494,"about_ca_system_score_gemma":0.00079288735,"threshold_uncertainty_score":0.98944545},"labels":[],"label_agreement":null},{"id":"W2965042402","doi":"10.1200/jco.2012.30.15_suppl.3082","title":"A phase I study of R04929097, an oral gamma secretase inhibitor, in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gemcitabine; Tolerability; Nausea; Vomiting; Internal medicine; Pharmacokinetics; Gastroenterology; Adverse effect; Toxicity; Oncology; Pharmacology; Cancer","score_opus":0.07258309049514548,"score_gpt":0.4835584636050948,"score_spread":0.4109753731099493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965042402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791265,0.00009153243,0.000010702763,0.0004555358,0.000489027,0.00087581156,0.0000053426656,0.000006301166,0.00015312707],"genre_scores_gemma":[0.99849665,0.000029009007,0.0006796503,0.0003987045,0.00030857587,0.000020447449,0.000023983132,0.000022435112,0.000020535883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963291,0.0006584269,0.0020493984,0.0002023986,0.00042013227,0.00034048708],"domain_scores_gemma":[0.9968739,0.00051410863,0.001612452,0.00016613674,0.0004382853,0.0003951201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001804409,0.0001988215,0.0017206768,0.00035711788,0.000020322655,0.000003439385,0.00010975601,0.00017457905,0.00009864436],"category_scores_gemma":[0.00031403697,0.00012989057,0.000097597826,0.00036091483,0.00015699449,0.00040064604,0.00003076937,0.0008005569,0.000002047898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06151166,0.12185087,0.7865595,0.000022304905,0.00020503957,0.00038815592,0.0008351589,0.000047808146,0.000086046086,0.000007910978,0.000106831416,0.028378708],"study_design_scores_gemma":[0.16436672,0.21874067,0.61519957,0.0000825048,0.0003267112,0.000037477996,0.00040857852,0.00003895564,0.000108324704,0.000013006355,0.00058437296,0.00009309961],"about_ca_topic_score_codex":0.000075808726,"about_ca_topic_score_gemma":0.0007411373,"teacher_disagreement_score":0.17135993,"about_ca_system_score_codex":0.00029155728,"about_ca_system_score_gemma":0.000864164,"threshold_uncertainty_score":0.5296784},"labels":[],"label_agreement":null},{"id":"W2965053910","doi":"10.1200/jco.2012.30.15_suppl.8587","title":"A phase II, multicenter, open-label study of YM155 plus docetaxel in subjects with stage III (unresectable) or stage IV melanoma.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Docetaxel; Medicine; Tolerability; Clinical endpoint; Internal medicine; Phases of clinical research; Oncology; Melanoma; Gastroenterology; Survivin; Survival rate; Progression-free survival; Surgery; Chemotherapy; Adverse effect; Clinical trial; Cancer; Cancer research","score_opus":0.28348017463377767,"score_gpt":0.5572430561771021,"score_spread":0.27376288154332445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965053910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932772,0.00060636614,0.0000194236,0.000968119,0.0013839054,0.0014731529,0.000017171318,0.0000075754733,0.0022471044],"genre_scores_gemma":[0.9895561,0.00044179033,0.0010958604,0.00093770784,0.0007294333,0.000035461915,0.000004646872,0.000029759874,0.007169248],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995361,0.0008053636,0.002591457,0.0002695605,0.00043908542,0.00053356437],"domain_scores_gemma":[0.994414,0.0020617247,0.0022735463,0.00028515124,0.00034238887,0.000623214],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037903308,0.00025522133,0.0026426306,0.00028617197,0.000064483815,0.000010836473,0.00039044372,0.00028508014,0.001124736],"category_scores_gemma":[0.000766563,0.00014157503,0.00014261143,0.00036988079,0.0001952102,0.00040848725,0.00025323048,0.0011576525,0.0000073731544],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33772662,0.32877254,0.2951405,0.00012023379,0.0022552924,0.0050886194,0.0047798716,0.000021113008,0.0010183336,0.00002432618,0.0032744068,0.02177816],"study_design_scores_gemma":[0.5718801,0.32656002,0.051285885,0.00015924111,0.0013659864,0.00019963947,0.0031902771,0.00021440306,0.0002963662,0.0000037696052,0.04464622,0.00019811718],"about_ca_topic_score_codex":0.0006526505,"about_ca_topic_score_gemma":0.003927561,"teacher_disagreement_score":0.24385461,"about_ca_system_score_codex":0.0004010287,"about_ca_system_score_gemma":0.002429325,"threshold_uncertainty_score":0.99978834},"labels":[],"label_agreement":null},{"id":"W2965081956","doi":"10.1007/s00520-019-04987-8","title":"Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview","year":2019,"lang":"en","type":"review","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Pain medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Nursing research; Chemotherapy; Internal medicine; Oncology; Intensive care medicine; Physical therapy; Nursing; Psychiatry; Anesthesiology; Diabetes mellitus","score_opus":0.18063192063616412,"score_gpt":0.43423922164166107,"score_spread":0.25360730100549694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965081956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0122679975,0.98192596,0.0000014591022,0.00019821443,0.0012345237,0.0026580929,0.00030971447,0.00006170584,0.0013423327],"genre_scores_gemma":[0.020243863,0.9763766,0.000026066966,0.0009951193,0.0004923345,0.0010337477,0.00066264987,0.000077210745,0.00009244203],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970414,0.00036171847,0.00096854736,0.0008887656,0.00024894357,0.00049064535],"domain_scores_gemma":[0.9983832,0.00024969032,0.00060441735,0.00046116053,0.00014715757,0.00015435964],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001298637,0.0005876489,0.0025635047,0.00021566253,0.00004029346,0.000010187811,0.00028668228,0.0005335807,0.0015546707],"category_scores_gemma":[0.000032226733,0.0004239073,0.0008058596,0.0005754021,0.00018018075,0.00004242291,0.00011952015,0.00082556036,0.00001837083],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004192602,0.0005482193,0.0702371,0.009618384,0.0005113886,0.00016602731,0.0004650718,0.0000014846291,0.00004881203,0.000062126026,0.00073081703,0.9171913],"study_design_scores_gemma":[0.0016263345,0.0021656046,0.026716303,0.0047139283,0.001169033,0.00005298491,0.000053671076,0.0000034984116,0.0000070731458,0.000005220121,0.9631248,0.0003615587],"about_ca_topic_score_codex":0.00009576474,"about_ca_topic_score_gemma":0.00007703197,"teacher_disagreement_score":0.962394,"about_ca_system_score_codex":0.00059413037,"about_ca_system_score_gemma":0.00066102063,"threshold_uncertainty_score":0.99982125},"labels":[],"label_agreement":null},{"id":"W2965901058","doi":"10.1101/19003467","title":"Patient Benefit and Risk in Anticancer Drug Development: A Systematic Review of the Ixabepilone Trial Portfolio","year":2019,"lang":"en","type":"review","venue":"medRxiv","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ixabepilone; Medicine; Observational study; Clinical endpoint; Clinical trial; Adverse effect; Internal medicine; Interim analysis; Oncology; Intensive care medicine; Breast cancer; Cancer; Metastatic breast cancer","score_opus":0.0377960817767039,"score_gpt":0.3443438914266322,"score_spread":0.3065478096499283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965901058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010593227,0.97989315,9.087174e-8,0.000038497023,0.000538045,0.008631069,0.00002743282,0.000008450127,0.00027002627],"genre_scores_gemma":[0.00029507428,0.99783677,0.00001327837,0.00012579648,0.00006104286,0.0008020311,0.000025395973,0.00003238221,0.00080822874],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99742395,0.00033126166,0.0013811032,0.0003287731,0.00032597795,0.00020890996],"domain_scores_gemma":[0.9980263,0.0002621972,0.0011074774,0.00047698856,0.000056437068,0.000070612325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007347287,0.0003320275,0.0036637962,0.00014199576,0.000028985445,0.000004541832,0.00014057026,0.00011211981,0.0001790829],"category_scores_gemma":[0.00013618564,0.00017446288,0.00036319814,0.00040574148,0.00005253793,0.000019561368,0.00009750561,0.0003266406,0.000024998015],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002053728,0.00013969818,0.0011242501,0.96058136,0.00067676965,0.000012814691,0.00013754646,1.6769034e-8,7.0616004e-8,0.00000741371,0.00019161885,0.036923062],"study_design_scores_gemma":[0.0058869813,0.00014654406,0.00021078112,0.816545,0.013197763,0.0000344836,0.0000050070194,4.4913034e-7,0.0000029385403,0.0000024966037,0.16380568,0.0001618667],"about_ca_topic_score_codex":0.000045184162,"about_ca_topic_score_gemma":0.00003670729,"teacher_disagreement_score":0.16361406,"about_ca_system_score_codex":0.00018609446,"about_ca_system_score_gemma":0.0005405399,"threshold_uncertainty_score":0.71143895},"labels":[],"label_agreement":null},{"id":"W2966099035","doi":"10.1136/ijgc-00009577-200409001-00134","title":"134 Phase I Study of Patupilone Plus Carboplatin in Patients With Advanced Malignancies","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Oncology; Internal medicine; Urology; Chemotherapy; Cisplatin","score_opus":0.020496997130148475,"score_gpt":0.360257502046621,"score_spread":0.3397605049164725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966099035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800324,0.00026702505,0.000014727664,0.0005841834,0.0005292512,0.00037168912,0.00001842663,0.0000050430413,0.00020641802],"genre_scores_gemma":[0.99918556,0.000092236325,0.00024208557,0.00028353595,0.00011049695,0.000027499882,0.0000061677233,0.000007980632,0.000044408174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987338,0.00003106696,0.0004737138,0.00012681699,0.0004995475,0.00013503847],"domain_scores_gemma":[0.99880755,0.00008770631,0.00038335245,0.000058150592,0.0005862401,0.00007701164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009719219,0.000117559255,0.00039691746,0.00016876675,0.000014175256,0.000005626553,0.00013693163,0.00004892318,0.00056802033],"category_scores_gemma":[0.00007054276,0.00007582291,0.00006469536,0.0001346358,0.000056572986,0.00010207968,0.000029173496,0.00020189185,0.0000011918843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024064744,0.015906071,0.9288748,0.000016688915,0.0007801121,0.0009912348,0.0012761231,0.0068347533,0.0022260165,0.000047918336,0.00008111048,0.018900445],"study_design_scores_gemma":[0.076493755,0.018561361,0.9027166,0.00012867423,0.00014017716,0.00001819329,0.0002594188,0.000007746282,0.0012723207,0.00007831453,0.00023614166,0.000087290835],"about_ca_topic_score_codex":0.0001281545,"about_ca_topic_score_gemma":0.00033489199,"teacher_disagreement_score":0.052429013,"about_ca_system_score_codex":0.0007478632,"about_ca_system_score_gemma":0.000292015,"threshold_uncertainty_score":0.62194246},"labels":[],"label_agreement":null},{"id":"W2967695014","doi":"","title":"In vitro screening of anticancer drug penetration into tumor tissue: taxanes","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Paclitaxel; Docetaxel; Penetration (warfare); Spheroid; Tissue culture; Drug; In vitro; Cell; Cell culture; Pharmacology; Biology; Chemistry; Cancer research; Chemotherapy; Internal medicine; Medicine; Biochemistry","score_opus":0.07811166090812563,"score_gpt":0.490811470373672,"score_spread":0.4126998094655464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967695014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98234695,0.005671517,0.000013063591,0.009538166,0.00010119096,0.00050590205,0.000009092461,0.000013382272,0.0018007085],"genre_scores_gemma":[0.99352527,0.00071014324,0.0006944691,0.0003342607,0.00064675807,0.0002035061,0.0000126866835,0.000017013732,0.0038558675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986955,0.00009537097,0.00021636474,0.00023370025,0.00042814607,0.00033090462],"domain_scores_gemma":[0.999397,0.000114041366,0.000043525844,0.00015745025,0.00018592145,0.00010209253],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004696804,0.00008873061,0.0002386081,0.00029431484,0.000055512195,0.000009270444,0.00009574414,0.00003767403,0.0019452344],"category_scores_gemma":[0.000038979182,0.000080135505,0.000033354292,0.0005036821,0.0001664099,0.00012528544,0.00004146255,0.00029597312,0.000029484921],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001812707,0.00021478362,0.010947434,0.00016913518,0.000044261167,0.000059122154,0.0012979299,0.000063524836,0.9079665,0.00004736837,0.010316651,0.06706059],"study_design_scores_gemma":[0.0024397208,0.00018425318,0.0100156935,0.00010467262,0.0000261564,0.000008396655,0.00015346712,0.00030282207,0.91334075,0.00006119956,0.07328035,0.00008251632],"about_ca_topic_score_codex":0.004922212,"about_ca_topic_score_gemma":0.0016920756,"teacher_disagreement_score":0.066978075,"about_ca_system_score_codex":0.0003614555,"about_ca_system_score_gemma":0.00034871334,"threshold_uncertainty_score":0.9989671},"labels":[],"label_agreement":null},{"id":"W2968566719","doi":"10.1200/jco.2013.31.15_suppl.e16082","title":"Cabazitaxel in docetaxel-pretreated metastatic castration resistant prostate cancer (mCRPC): Canadian experience.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; Université de Montréal; Université Laval; Sanofi (Canada); Sunnybrook Health Science Centre; University of Toronto; Moncton Hospital; Grand River Hospital; London Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Docetaxel; Cabazitaxel; Prostate cancer; Adverse effect; Internal medicine; Neutropenia; Febrile neutropenia; Prednisone; Surgery; Cancer; Chemotherapy; Androgen deprivation therapy","score_opus":0.16341291541713204,"score_gpt":0.5157864465834574,"score_spread":0.35237353116632536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968566719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97829664,0.001120447,0.0000018342663,0.015295095,0.0011205705,0.0005502861,0.000012999437,0.00000615286,0.0035959668],"genre_scores_gemma":[0.9936752,0.0012053808,0.00075828034,0.0023835155,0.00040139866,0.00007774229,0.0000068131785,0.000015023567,0.0014766783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996908,0.00035325,0.001915741,0.00020235605,0.00023518567,0.00038547485],"domain_scores_gemma":[0.9972624,0.00054477254,0.0008818648,0.00012795489,0.00045331073,0.0007297024],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00094383257,0.00015853519,0.0011429713,0.00030005182,0.00004304302,0.000015639276,0.00011242023,0.00020375311,0.0026605772],"category_scores_gemma":[0.0006340946,0.000113191876,0.00022498291,0.00028243838,0.00018010633,0.00022515214,0.000013947764,0.00070024224,0.000042830372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009242513,0.0040904437,0.7135941,0.0001048502,0.0013349205,0.008583664,0.004280312,0.00011791119,0.012074957,0.000100966616,0.044784382,0.201691],"study_design_scores_gemma":[0.016876264,0.012004269,0.9110472,0.00015337154,0.0005831189,0.00041701595,0.0009846233,0.00019844451,0.0005996366,0.0003326854,0.056614123,0.00018923556],"about_ca_topic_score_codex":0.10678059,"about_ca_topic_score_gemma":0.25187436,"teacher_disagreement_score":0.20150177,"about_ca_system_score_codex":0.00083842146,"about_ca_system_score_gemma":0.0051774196,"threshold_uncertainty_score":0.99825114},"labels":[],"label_agreement":null},{"id":"W2969150729","doi":"","title":"Comparative in vitro analysis of C1311 activity in a panel of colorectal cell lines against standard colon cancer chemotherapies.","year":2004,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Colorectal cancer; Medicine; Capecitabine; Cancer research; In vivo; Cancer; Mitoxantrone; Oxaliplatin; Internal medicine; Oncology; Ovarian cancer; Pharmacology; Chemotherapy; Biology","score_opus":0.04042104460862335,"score_gpt":0.35794298216887205,"score_spread":0.3175219375602487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969150729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970925,0.0003937607,0.00001619943,0.00033258344,0.000036091973,0.0003823454,0.00011267322,0.000008514303,0.0016253438],"genre_scores_gemma":[0.9991245,0.00032855704,0.00022505413,0.00011005754,0.000013380656,0.00004494983,0.000025940593,0.0000060309894,0.00012148618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927294,0.000035450947,0.0002483829,0.00016752008,0.00012869503,0.00014703127],"domain_scores_gemma":[0.9995979,0.00007514014,0.00012859348,0.000080052836,0.000077999604,0.000040306648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089096444,0.00011786404,0.00084050285,0.0003578024,0.000008492746,0.0000014576186,0.000040213945,0.00006731194,0.0002319225],"category_scores_gemma":[0.0000036794095,0.00009672562,0.000115423354,0.0009680292,0.00009800333,0.00003383661,0.000013437523,0.00010431637,4.7644662e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010278285,0.0013382884,0.077061996,0.000064248714,0.000852377,0.000015245639,0.004111319,0.0025100682,0.90280694,0.0000036717065,0.000038290138,0.00091928215],"study_design_scores_gemma":[0.0077868775,0.00044911727,0.1233639,0.00002522809,0.00043267212,2.342295e-7,0.00027681064,0.0008756634,0.8666682,0.0000064110563,0.000045854627,0.000069014626],"about_ca_topic_score_codex":0.006568513,"about_ca_topic_score_gemma":0.021230113,"teacher_disagreement_score":0.0463019,"about_ca_system_score_codex":0.00040968866,"about_ca_system_score_gemma":0.0002857757,"threshold_uncertainty_score":0.9966299},"labels":[],"label_agreement":null},{"id":"W2972352807","doi":"10.1080/24740527.2019.1665992","title":"Quantitative sensory profiles of upper extremity chemotherapy induced peripheral neuropathy: Are there differences in sensory profiles for neuropathic versus nociceptive pain?","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Pain","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"CancerCare Manitoba Foundation","keywords":"Neuropathic pain; Quantitative sensory testing; Medicine; Peripheral neuropathy; Sensory system; Confidence interval; Odds ratio; Neuralgia; Nociception; Internal medicine; Physical therapy; Anesthesia; Psychology; Neuroscience","score_opus":0.06323877215973088,"score_gpt":0.3132347724412353,"score_spread":0.24999600028150443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972352807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960758,0.00078276,0.000040123174,0.0014881379,0.0005076578,0.0008149237,0.00008958057,0.000006295196,0.00019469041],"genre_scores_gemma":[0.9982389,0.00006389333,0.0002926358,0.00074252754,0.00020455103,0.0000189141,0.000007254287,0.000036020603,0.00039525962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977755,0.0010592061,0.00042695637,0.00022172464,0.00016815343,0.00034845812],"domain_scores_gemma":[0.9978523,0.0009505319,0.00043995059,0.00013652787,0.0003223077,0.00029838347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012345142,0.00022232531,0.00060857716,0.000298242,0.00005498538,0.000014486793,0.0001263923,0.00012313943,0.0003740394],"category_scores_gemma":[0.00056277285,0.00018112405,0.00019334153,0.00017054696,0.00012820456,0.00008990243,0.000005380379,0.00039758146,0.0000030636293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041288785,0.00015901096,0.9098438,0.00026549038,0.00023588022,0.0004183057,0.0057991035,0.000011187054,0.07083997,0.00007453893,0.0005226376,0.0077011953],"study_design_scores_gemma":[0.014146706,0.011126164,0.938367,0.0008490355,0.00021959968,0.000070338785,0.021634504,0.0024150228,0.009526844,0.00009644166,0.0010826798,0.0004656529],"about_ca_topic_score_codex":0.0010644177,"about_ca_topic_score_gemma":0.0048032366,"teacher_disagreement_score":0.061313123,"about_ca_system_score_codex":0.0002639433,"about_ca_system_score_gemma":0.0012678808,"threshold_uncertainty_score":0.7386024},"labels":[],"label_agreement":null},{"id":"W2973076369","doi":"10.1007/s00280-019-03956-6","title":"Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy","year":2019,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Fluidigm (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Oxaliplatin; FOLFOX; Medicine; Peripheral neuropathy; Cumulative dose; Colorectal cancer; Internal medicine; Neurotoxicity; Gastroenterology; Chemotherapy; Cancer; Oncology; Toxicity; Endocrinology","score_opus":0.012279270525962987,"score_gpt":0.3243970405063564,"score_spread":0.3121177699803934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973076369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919204,0.0030703004,0.0000030524004,0.0015772495,0.0015106025,0.0013127287,0.000037684862,0.000047634563,0.0005203079],"genre_scores_gemma":[0.98742425,0.0022080902,0.000063865366,0.009090921,0.0003147535,0.0005240671,0.00007545305,0.000043361764,0.00025524924],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869156,0.00008045619,0.00027425002,0.0004225003,0.00014402668,0.00038719468],"domain_scores_gemma":[0.9995256,0.00011899898,0.000113269874,0.00007024611,0.00004937765,0.00012250082],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008980463,0.00026374115,0.00046825068,0.00014769357,0.00006414696,0.0000107340065,0.00006855286,0.00018069778,0.004443994],"category_scores_gemma":[0.0000013906549,0.00023858903,0.00012182995,0.00024315149,0.000062680316,0.00008273623,0.000012451601,0.0002582156,0.000010531097],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004417176,0.00057355355,0.55266434,0.00006570058,0.00030322364,0.000015934069,0.00063054083,0.000080983824,0.41529062,0.0000023131,0.0014359255,0.024519665],"study_design_scores_gemma":[0.050329812,0.0014575204,0.3014522,0.00009643786,0.00016619462,0.000004117789,0.000026925156,0.0019350608,0.63579667,0.000016534706,0.008362802,0.0003557395],"about_ca_topic_score_codex":0.0003984019,"about_ca_topic_score_gemma":0.00012858605,"teacher_disagreement_score":0.25121215,"about_ca_system_score_codex":0.00031638905,"about_ca_system_score_gemma":0.00022103648,"threshold_uncertainty_score":0.9964661},"labels":[],"label_agreement":null},{"id":"W2978060560","doi":"10.1093/annonc/mdz242.077","title":"CONTESSA TRIO: A multinational, multicenter, phase II study of tesetaxel plus 3 different PD-(L)1 inhibitors in patients with metastatic triple negative breast cancer (TNBC) and tesetaxel monotherapy in elderly patients with her2- metastatic breast cancer (MBC)","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Atezolizumab; Pembrolizumab; Internal medicine; Tolerability; Taxane; Oncology; Cohort; Triple-negative breast cancer; Metastatic breast cancer; Breast cancer; Nivolumab; Cancer; Adverse effect; Immunotherapy","score_opus":0.03578482217766499,"score_gpt":0.37684929556269836,"score_spread":0.3410644733850334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978060560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919695,0.00041735725,0.0000030000942,0.0009931679,0.00014820795,0.005098204,0.0013333475,0.000011062568,0.00002609859],"genre_scores_gemma":[0.9982481,0.0001920882,0.00010089978,0.00039545592,0.000020915168,0.00079301797,0.00011001687,0.000045596385,0.00009393268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972233,0.00036839326,0.000883293,0.0005672018,0.00049045996,0.000467352],"domain_scores_gemma":[0.99759895,0.00042877003,0.00080513186,0.00022685522,0.00076719985,0.00017308458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021627531,0.0004402877,0.0015655315,0.00053436036,0.000050798702,0.000008090895,0.0001302167,0.00008269722,0.0003453647],"category_scores_gemma":[0.000031306605,0.0003018149,0.00007967979,0.00051542313,0.00022505473,0.0002305538,0.000060548973,0.000294973,0.0000010521736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05542956,0.051102743,0.83768034,0.00020312055,0.001449863,0.000026590678,0.0053025093,0.000118365126,0.00018442694,0.00000225482,0.00011608686,0.048384137],"study_design_scores_gemma":[0.19187985,0.049265526,0.7559884,0.00031070077,0.0004305681,0.0000036659412,0.0011596183,0.0004028936,0.0002766841,0.0000074078334,0.000047912756,0.00022674815],"about_ca_topic_score_codex":0.010185554,"about_ca_topic_score_gemma":0.013769176,"teacher_disagreement_score":0.13645029,"about_ca_system_score_codex":0.00037546753,"about_ca_system_score_gemma":0.000375256,"threshold_uncertainty_score":0.9999434},"labels":[],"label_agreement":null},{"id":"W2979559101","doi":"10.1182/blood.v118.21.3359.3359","title":"A Novel Polymer Based Antidote for Reversing the Anticoagulation Effect of Clinically Used Heparins,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Heparin; Pharmacology; Medicine; Antidote; Fondaparinux; Partial thromboplastin time; Platelet; Chemistry; Surgery; Immunology; Thrombosis; Internal medicine; Toxicity; Venous thromboembolism","score_opus":0.05991873752565248,"score_gpt":0.3479533794754216,"score_spread":0.28803464194976913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979559101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997204,0.00016049261,0.00061823055,0.0002675704,0.00013622467,0.0006365803,0.000014467012,0.000018805822,0.0009436085],"genre_scores_gemma":[0.9982464,0.000006773943,0.0012836297,0.00021461265,0.000100518664,0.000020318033,0.000018938837,0.000008756545,0.00010005229],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947536,0.000034343273,0.00019671577,0.00011281262,0.00007261761,0.00010817811],"domain_scores_gemma":[0.9993605,0.00033175002,0.000100150675,0.0001422168,0.00003199051,0.00003340544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026360445,0.00007315505,0.00021131568,0.00003227294,0.000043875683,0.00000204668,0.000041359544,0.00005071464,0.000060633545],"category_scores_gemma":[0.00005077632,0.000046151938,0.00012313506,0.00006740057,0.00004806231,0.000019270954,0.000006598629,0.00004976452,0.000002487946],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038314646,0.0017254769,0.6074383,0.00019514479,0.00044491113,0.000005916969,0.00028010798,7.5843303e-7,0.38328716,0.00004355384,0.0002843512,0.002462844],"study_design_scores_gemma":[0.026401537,0.0035725292,0.17967102,0.00008457477,0.00257433,0.000015716196,0.000006018814,0.00042163001,0.7868286,0.0000068210375,0.00033990954,0.00007733135],"about_ca_topic_score_codex":0.000108691645,"about_ca_topic_score_gemma":0.0000094226725,"teacher_disagreement_score":0.4277673,"about_ca_system_score_codex":0.0000073215583,"about_ca_system_score_gemma":0.00004480644,"threshold_uncertainty_score":0.18820213},"labels":[],"label_agreement":null},{"id":"W2982238418","doi":"10.1016/j.jtho.2019.08.543","title":"MA06.07 E1505: Adjuvant Chemotherapy +/- Bevacizumab for Early Stage NSCLC: Updated Chemotherapy Subset Analysis","year":2019,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Docetaxel; Bevacizumab; Gemcitabine; Regimen; Vinorelbine; Internal medicine; Chemotherapy; Pemetrexed; Histology; Oncology; Stage (stratigraphy); Adjuvant; Chemotherapy regimen; Cisplatin; Biology","score_opus":0.022987012161067022,"score_gpt":0.4307940233050613,"score_spread":0.40780701114399426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982238418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98566186,0.00084221724,0.00069137325,0.00934234,0.00084987417,0.0008723056,0.00007174345,0.00003136278,0.0016369172],"genre_scores_gemma":[0.9787967,0.000673069,0.0036539636,0.0038570978,0.0007068678,0.000023343577,0.00009393618,0.000059332735,0.012135698],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978182,0.00017141964,0.0008629462,0.00032926514,0.0003329784,0.00048519028],"domain_scores_gemma":[0.9976801,0.0002485304,0.00095955015,0.00034401694,0.00048309867,0.0002846596],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008100139,0.00030459592,0.0015924091,0.0006496053,0.00006420004,0.000023393406,0.0002610614,0.0003357224,0.0068228166],"category_scores_gemma":[0.000022685876,0.00023724265,0.0008378099,0.0006317818,0.00008894991,0.00016260578,0.000023503413,0.00046173288,0.0000922135],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14165902,0.007038015,0.23641996,0.00039453665,0.03278345,0.0009812989,0.004245826,0.0002800555,0.0723266,0.00010688948,0.067948006,0.43581635],"study_design_scores_gemma":[0.031873755,0.026496118,0.1906047,0.000087540495,0.01025491,0.00066694955,0.0005348526,0.0010624527,0.02676234,0.00024742333,0.7108131,0.0005958794],"about_ca_topic_score_codex":0.000045905006,"about_ca_topic_score_gemma":0.000047050653,"teacher_disagreement_score":0.64286506,"about_ca_system_score_codex":0.0006768265,"about_ca_system_score_gemma":0.00061083084,"threshold_uncertainty_score":0.9940851},"labels":[],"label_agreement":null},{"id":"W2982249510","doi":"10.1093/jnci/djz211","title":"A Systematic Review and Meta-Analysis of Bevacizumab in First-Line Metastatic Breast Cancer: Lessons for Research and Regulatory Enterprises","year":2019,"lang":"en","type":"review","venue":"JNCI Journal of the National Cancer Institute","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Harvard-MIT Center for Regulatory Science; Arnold Ventures","keywords":"Bevacizumab; Medicine; Hazard ratio; Internal medicine; Oncology; Metastatic breast cancer; Meta-analysis; Proportional hazards model; Clinical trial; Breast cancer; Progression-free survival; Cancer; Confidence interval; Overall survival; Chemotherapy","score_opus":0.4801933040482415,"score_gpt":0.5622275174975023,"score_spread":0.08203421344926082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982249510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004214919,0.9890585,0.000003674326,0.0057508415,0.00023789784,0.0027878867,0.0020969708,0.0000016080385,0.000020447342],"genre_scores_gemma":[0.0009889001,0.9969208,0.00004841118,0.00035296206,0.000127353,0.00074551825,0.000024404264,0.000019642148,0.0007719595],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968633,0.00030687195,0.0015097606,0.00025364372,0.00087915256,0.00018724341],"domain_scores_gemma":[0.99584806,0.0008392488,0.0017068237,0.00019027757,0.0013208227,0.00009475762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002090647,0.000277663,0.005788429,0.00096080056,0.00008057757,0.000016712698,0.00026863953,0.00009312582,0.00012658257],"category_scores_gemma":[0.0002845887,0.0001467341,0.0015145699,0.0011026651,0.00020167998,0.00013494372,0.0000841453,0.00044168238,3.9361976e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017338758,0.00021322788,0.000022088294,0.7770538,0.21819255,0.0000080444215,0.00007153962,0.0001246993,8.871178e-7,0.00022988333,0.0018372602,0.0020726807],"study_design_scores_gemma":[0.0011808224,0.00013933146,0.00008919696,0.07437111,0.87792844,0.00035385185,0.0000053338995,0.000022178103,0.0000013768407,0.00008437216,0.045700718,0.00012327933],"about_ca_topic_score_codex":0.00016891699,"about_ca_topic_score_gemma":0.0009520709,"teacher_disagreement_score":0.7026827,"about_ca_system_score_codex":0.001017943,"about_ca_system_score_gemma":0.0021264702,"threshold_uncertainty_score":0.59836435},"labels":[],"label_agreement":null},{"id":"W2984735937","doi":"10.1097/01.reo.0000000000000189","title":"Neuromuscular Electrical Stimulation (NMES) in the Management of Glioblastoma Multiforme: A Case Report","year":2019,"lang":"en","type":"article","venue":"Rehabilitation Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast; European Commission","keywords":"Medicine; Quality of life (healthcare); Adverse effect; Psychosocial; Physical therapy; Aerobic exercise; Intervention (counseling); Glioblastoma; Rehabilitation; Physical medicine and rehabilitation; Internal medicine; Nursing","score_opus":0.01198335727705173,"score_gpt":0.3594155886429487,"score_spread":0.34743223136589696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984735937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993918,0.00007010721,0.000038322298,0.0018620844,0.00015492678,0.0014563614,0.0000012067501,0.00001542708,0.0024835581],"genre_scores_gemma":[0.9974486,0.000014010214,0.0019366995,0.00021061023,0.000028605164,0.00012898337,0.000015205109,0.000007812669,0.00020946986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989162,0.0001900981,0.00037898382,0.00021212098,0.0001601916,0.00014236894],"domain_scores_gemma":[0.99888784,0.0006509925,0.00012406734,0.00023246968,0.000074062744,0.000030584608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048940734,0.00008306726,0.00024016635,0.00015629442,0.000020082729,0.0000021043397,0.000041798823,0.00008193979,0.00017447221],"category_scores_gemma":[0.000056794273,0.000061074774,0.0000880365,0.00037019778,0.000050357292,0.000043662847,0.000015154285,0.00012519,0.000027307127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010751699,0.013604471,0.64042133,0.0019762379,0.0008201671,0.10643987,0.01601541,0.004033048,0.014796409,0.008019423,0.0030781317,0.18004382],"study_design_scores_gemma":[0.013817918,0.022291226,0.9020508,0.00006727578,0.00047905862,0.021679956,0.0020433324,0.007957059,0.00028284773,0.0004884174,0.028672082,0.0001700316],"about_ca_topic_score_codex":0.00006088047,"about_ca_topic_score_gemma":0.00004646066,"teacher_disagreement_score":0.2616295,"about_ca_system_score_codex":0.00026215237,"about_ca_system_score_gemma":0.00007874759,"threshold_uncertainty_score":0.24905568},"labels":[],"label_agreement":null},{"id":"W2986452922","doi":"10.1182/blood-2019-127917","title":"Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Apixaban; Meta-analysis; Rivaroxaban; Relative risk; Randomized controlled trial; Internal medicine; Placebo; Subgroup analysis; Warfarin; Confidence interval; Atrial fibrillation","score_opus":0.11367015810697412,"score_gpt":0.4163979681811051,"score_spread":0.30272781007413097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986452922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99418205,0.004109432,0.000052179534,0.00007917066,0.000038957372,0.0012036479,0.00026625188,0.000007787844,0.000060532704],"genre_scores_gemma":[0.99886835,0.00039540796,0.000031180127,0.000027476199,0.000009207419,0.00025206155,0.00009384287,0.000007703653,0.0003148033],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99918574,0.00014168565,0.0002258112,0.00019099945,0.00014095349,0.00011479743],"domain_scores_gemma":[0.9988565,0.00054857176,0.00023555195,0.00018077459,0.00014947561,0.000029170013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004187615,0.00010694523,0.0013708678,0.00021070988,0.000026891912,0.0000041317207,0.000044616365,0.000052817963,0.00045358003],"category_scores_gemma":[0.000020730104,0.00006391372,0.0010807684,0.0009961581,0.000042750045,0.000026179621,0.000017429691,0.000038356164,3.6056096e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001653757,0.0008305169,0.43739152,0.00008198658,0.5368174,3.5372412e-7,0.00008026388,0.00019282677,0.024165414,0.0000047163126,0.000007104893,0.00026258992],"study_design_scores_gemma":[0.0021477945,0.00018723164,0.45272347,0.000005459519,0.5069824,8.766947e-8,0.000009641726,0.00071320933,0.037184842,0.00000407052,0.000008882135,0.000032891803],"about_ca_topic_score_codex":0.0017058147,"about_ca_topic_score_gemma":0.0015359754,"teacher_disagreement_score":0.029834928,"about_ca_system_score_codex":0.00002699388,"about_ca_system_score_gemma":0.00004360836,"threshold_uncertainty_score":0.49663833},"labels":[],"label_agreement":null},{"id":"W2990384780","doi":"10.1182/blood-2019-126306","title":"Enhanced VTE Risk Stratification in Ambulatory Patients with Cancer","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Ambulatory; Hazard ratio; Framingham Risk Score; Apixaban; Proportional hazards model; Incidence (geometry); Placebo; Confidence interval; Disease; Warfarin; Atrial fibrillation; Pathology","score_opus":0.006589515201571565,"score_gpt":0.2688415012112273,"score_spread":0.2622519860096557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990384780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99711347,0.00020750897,0.0000034841446,0.00004829727,0.000097849144,0.00045510294,0.00001290037,0.00001651088,0.0020448964],"genre_scores_gemma":[0.99887896,0.000089170244,0.00006792875,0.00010330724,0.000047441048,0.00006428441,0.00003752856,0.000008803741,0.0007025692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995728,0.000012852993,0.000085332256,0.00014393343,0.00008488932,0.00010016003],"domain_scores_gemma":[0.9997557,0.000012642423,0.00005165996,0.00011195255,0.00003416927,0.00003387939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000024524348,0.00006440188,0.000112000336,0.00003204073,0.0000117718755,0.000002779876,0.000021306898,0.000033008815,0.0004844297],"category_scores_gemma":[0.0000016930379,0.000049194437,0.000019178919,0.000086454645,0.000012453604,0.000035865723,0.000004169546,0.0000776485,0.00004387852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024130914,0.0008378175,0.98605484,0.00002369132,0.00009468323,0.0000013890894,0.00024312105,0.000012937337,0.0101107685,0.00000895395,0.000084821186,0.0022856875],"study_design_scores_gemma":[0.010971126,0.00042472433,0.95743996,0.00003616752,0.00019317801,3.2107098e-7,0.000014211498,0.000014745531,0.030454868,0.000007520195,0.00038211956,0.000061051935],"about_ca_topic_score_codex":0.00022317932,"about_ca_topic_score_gemma":0.00025949586,"teacher_disagreement_score":0.028614856,"about_ca_system_score_codex":0.000040492192,"about_ca_system_score_gemma":0.00006938245,"threshold_uncertainty_score":0.53041655},"labels":[],"label_agreement":null},{"id":"W2992699933","doi":"10.1200/jco.2009.27.15_suppl.5139","title":"A phase II study of patupilone in patients (pts) with metastatic castration- resistant prostate cancer (CRPC) who have progressed after docetaxel","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; London Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Clinical endpoint; Adverse effect; Taxane; Prostate cancer; Progression-free survival; Gastroenterology; Nausea; Chemotherapy; Surgery; Cancer; Oncology; Clinical trial; Breast cancer","score_opus":0.0965500528240619,"score_gpt":0.5084327799756414,"score_spread":0.4118827271515795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992699933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99536777,0.0004865112,0.0000016956118,0.0024791008,0.00020978224,0.0012170615,0.000022623473,0.000003971117,0.00021148082],"genre_scores_gemma":[0.9980031,0.00018851989,0.0005313128,0.00076242484,0.0001909623,0.00005550809,0.0000050629956,0.000012753858,0.00025032298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99642,0.00042059817,0.002252101,0.00022372344,0.00043076294,0.00025280874],"domain_scores_gemma":[0.99686813,0.00033082117,0.0017867599,0.00014790722,0.0006200488,0.00024633002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010072768,0.00018188797,0.001640788,0.00019699858,0.00003186972,0.000005825523,0.00008893493,0.00011122651,0.00015524146],"category_scores_gemma":[0.00021398821,0.00011406469,0.0001632239,0.00021436714,0.00013214444,0.00013073032,0.000019074863,0.0006134309,7.5758925e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2119554,0.15251802,0.50561106,0.000060670747,0.0011110966,0.0027614047,0.0027087438,0.00003206125,0.00021219501,0.000003147205,0.0013089684,0.12171722],"study_design_scores_gemma":[0.11113487,0.3372251,0.54846156,0.00017088752,0.0011502175,0.00002273685,0.0002652305,0.000025842948,0.00007609866,0.000032311556,0.0013516246,0.00008351159],"about_ca_topic_score_codex":0.00010020572,"about_ca_topic_score_gemma":0.001633002,"teacher_disagreement_score":0.1847071,"about_ca_system_score_codex":0.00021237537,"about_ca_system_score_gemma":0.0013233847,"threshold_uncertainty_score":0.4651423},"labels":[],"label_agreement":null},{"id":"W2999546558","doi":"10.1016/s0923-7534(20)32889-1","title":"Progression-Free Survival as a Surrogate for Overall Survival in Metastatic Breast Cancer","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National d'Excellence en Santé et en Services Sociaux; Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Medicine; Metastatic breast cancer; Oncology; Surrogate endpoint; Internal medicine; Breast cancer; Overall survival; Progression-free survival; Cancer","score_opus":0.14704478219920217,"score_gpt":0.4943423350120266,"score_spread":0.3472975528128245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999546558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96281,0.0033205992,0.000009019313,0.025013078,0.0013995701,0.0009883688,0.0002422311,0.000026138528,0.006191008],"genre_scores_gemma":[0.9950528,0.0010865357,0.00046280905,0.0016894409,0.0004746929,0.0003962376,0.00004367331,0.000027270342,0.0007665411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849176,0.0001756824,0.00036635966,0.00020255288,0.00019954184,0.0005640962],"domain_scores_gemma":[0.9986772,0.0005266455,0.00018708933,0.0002037789,0.00019961486,0.00020569646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007879237,0.0001716034,0.0007038164,0.00014243691,0.000030715382,0.0000029030812,0.000121680045,0.0001131765,0.00085277885],"category_scores_gemma":[0.00010877389,0.0001388211,0.00015557068,0.00015355098,0.000116240204,0.00010900271,0.00006548143,0.00014147756,0.000014757544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021986412,0.013560729,0.66548973,0.00073937234,0.0018570267,0.00019018813,0.0025849943,0.000020417672,0.009625992,0.005275222,0.04938842,0.22928151],"study_design_scores_gemma":[0.044312548,0.0122186355,0.67326987,0.00032908996,0.0010407538,0.0002987463,0.00044401654,0.00010253245,0.011642093,0.0038884971,0.25188285,0.00057037827],"about_ca_topic_score_codex":0.0010478443,"about_ca_topic_score_gemma":0.0009537462,"teacher_disagreement_score":0.22871113,"about_ca_system_score_codex":0.0001036019,"about_ca_system_score_gemma":0.00048781655,"threshold_uncertainty_score":0.93373305},"labels":[],"label_agreement":null},{"id":"W3000956560","doi":"10.1177/1545968319899918","title":"An Exploratory Randomized Trial of Physical Therapy for the Treatment of Chemotherapy-Induced Peripheral Neuropathy","year":2020,"lang":"en","type":"article","venue":"Neurorehabilitation and neural repair","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"CancerCare Manitoba Foundation","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Breast cancer; Randomized controlled trial; Peripheral neuropathy; Physical therapy; Odds ratio; Internal medicine; Taxane; Confidence interval; Population; Chemotherapy; Clinical trial; Cancer","score_opus":0.045389436860392506,"score_gpt":0.3545396141668244,"score_spread":0.3091501773064319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000956560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917557,0.00031012984,0.0000111955,0.004306287,0.00014919076,0.0033894898,0.00000869701,0.00005507523,0.000014181312],"genre_scores_gemma":[0.9974177,0.00055385934,0.00006364359,0.001215378,0.00028256446,0.00042818207,0.000007107752,0.000019521858,0.000012063298],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99898094,0.00027564037,0.00028136384,0.00024125178,0.00012466939,0.0000961386],"domain_scores_gemma":[0.9983226,0.0012263281,0.00011786559,0.00016117022,0.00008616956,0.00008584387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010651267,0.00014509523,0.0005472283,0.00002714221,0.000041901396,0.00000416179,0.00003797384,0.00002982848,0.000018647806],"category_scores_gemma":[0.000098396864,0.000081369755,0.0004397901,0.000095207746,0.0001794409,0.000055310502,0.0000031691018,0.0000456864,1.5770412e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79022783,0.001748253,0.0003255602,0.000045899735,0.000110006215,0.0000015151566,0.011762606,0.000014241377,0.16344121,0.000051456725,0.000055391683,0.032216035],"study_design_scores_gemma":[0.8470013,0.08640442,0.0030354308,0.0000041093176,0.00025540718,0.0000016477029,0.00033863165,0.03148272,0.029824255,0.000034247543,0.0015349499,0.00008289693],"about_ca_topic_score_codex":0.000008805581,"about_ca_topic_score_gemma":0.0000012909801,"teacher_disagreement_score":0.13361695,"about_ca_system_score_codex":0.000013632622,"about_ca_system_score_gemma":0.00004500963,"threshold_uncertainty_score":0.33181623},"labels":[],"label_agreement":null},{"id":"W3004486659","doi":"","title":"Clustering of anthracycline-containing lysosomes in drug-resistant MCF-7 cells in response to tesmilifene","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Laurentian University; Sudbury Regional Hospital","funders":"","keywords":"Doxorubicin; Epirubicin; Cytotoxicity; Anthracycline; Cancer research; Cytoplasm; Biology; Daunorubicin; Cancer cell; Clonogenic assay; Pharmacology; Cancer; Chemotherapy; Medicine; Apoptosis; In vitro; Cell biology; Internal medicine; Biochemistry; Breast cancer","score_opus":0.11304269958126131,"score_gpt":0.4622375099017531,"score_spread":0.3491948103204918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004486659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945514,0.0015332858,0.0000035749783,0.0024577351,0.00012665421,0.0007152503,0.000020837004,0.000012464527,0.00057879655],"genre_scores_gemma":[0.99483174,0.0010567455,0.00020806253,0.00017632541,0.00012150019,0.00026233186,0.0000032752,0.000023328597,0.0033167044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798566,0.00032759956,0.00038579985,0.00033649156,0.00041445668,0.0005499903],"domain_scores_gemma":[0.9987343,0.00065126794,0.00003856094,0.00025012778,0.00014438092,0.0001813851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012887658,0.00012406654,0.00041616306,0.00089012826,0.00006138937,0.0000045553525,0.00014378916,0.00006474377,0.00042170682],"category_scores_gemma":[0.00016844457,0.00011585858,0.00005114044,0.0010487546,0.00017249148,0.00005294407,0.00012303852,0.0003986876,0.00002398907],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03481778,0.00034302814,0.09576514,0.00013400045,0.000032409767,0.0010296479,0.0050441273,0.00056592305,0.8589143,0.000003289381,0.0019996988,0.0013506532],"study_design_scores_gemma":[0.014257914,0.0020129858,0.42000258,0.0010985709,0.000024626219,0.000028523531,0.0014705582,0.00046471006,0.54823124,0.00002506898,0.012095389,0.00028783854],"about_ca_topic_score_codex":0.00854115,"about_ca_topic_score_gemma":0.006959251,"teacher_disagreement_score":0.32423744,"about_ca_system_score_codex":0.0007726681,"about_ca_system_score_gemma":0.00065427227,"threshold_uncertainty_score":0.99806106},"labels":[],"label_agreement":null},{"id":"W3005429575","doi":"10.1016/j.actbio.2020.01.042","title":"Corrigendum to ‘Recent advances in musculoskeletal local drug delivery’ [Acta Biomaterialia 2019, 93, 135–151]","year":2020,"lang":"en","type":"erratum","venue":"Acta Biomaterialia","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Drug delivery; Materials science; Drug; Biomedical engineering; Medicine; Nanotechnology; Pharmacology","score_opus":0.017357174707034812,"score_gpt":0.3101460149195151,"score_spread":0.2927888402124803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005429575","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2767947,0.01196739,0.000010933675,0.021297429,0.6761077,0.0043065385,0.0042518205,0.00073608896,0.004527383],"genre_scores_gemma":[0.51150066,0.07821215,0.0005691823,0.010960564,0.03913961,0.0016720279,0.058574803,0.00128321,0.2980878],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948301,0.00028469617,0.0012462145,0.0015587818,0.00068903074,0.0013911836],"domain_scores_gemma":[0.99760807,0.000024282519,0.00049037696,0.00078197167,0.00019638617,0.00089889776],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00023788102,0.0012660208,0.0020358504,0.00065468345,0.00013826987,0.00016475112,0.0006585753,0.0009947332,0.007845585],"category_scores_gemma":[0.000042430052,0.0011441613,0.000386819,0.00080439984,0.00026452364,0.00031370608,0.00047448435,0.00042748512,0.0014195984],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023536684,0.00045511575,0.0001318088,0.0007654678,0.00032270848,0.00068185217,0.0004157072,8.899356e-8,0.17489031,0.0000042916386,0.8154522,0.0045267474],"study_design_scores_gemma":[0.003981022,0.0012521455,0.001819821,0.00055361696,0.0006903356,0.000070374525,0.00009826153,0.000013144026,0.025583511,0.000022517965,0.9648676,0.0010476711],"about_ca_topic_score_codex":0.0022016442,"about_ca_topic_score_gemma":0.0013720538,"teacher_disagreement_score":0.6369681,"about_ca_system_score_codex":0.0010970164,"about_ca_system_score_gemma":0.00090766733,"threshold_uncertainty_score":0.99935794},"labels":[],"label_agreement":null},{"id":"W3005908190","doi":"10.1158/1538-7445.sabcs19-gs1-01","title":"Abstract GS1-01: Tucatinib vs placebo, both combined with capecitabine and trastuzumab, for patients with pretreated HER2-positive metastatic breast cancer with and without brain metastases (HER2CLIMB)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Capecitabine; Medicine; Trastuzumab; Metastatic breast cancer; Internal medicine; Clinical endpoint; Oncology; Pertuzumab; Breast cancer; Neratinib; Regimen; Palbociclib; Cancer; Clinical trial; Colorectal cancer","score_opus":0.048273422772037035,"score_gpt":0.38689826831232316,"score_spread":0.3386248455402861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005908190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97958714,0.0011285057,0.000030116522,0.012430813,0.000026269545,0.0045059104,0.0020331338,0.000056061337,0.0002020247],"genre_scores_gemma":[0.99476993,0.0003532458,0.00056229305,0.0010125181,0.00012772933,0.0021945091,0.00033863928,0.00011198587,0.00052916893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735355,0.00017557805,0.00027120428,0.00081387453,0.0006579921,0.00072776753],"domain_scores_gemma":[0.99788535,0.0005273722,0.000140339,0.00020758067,0.0005968092,0.00064254267],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002721095,0.00043024815,0.0007943251,0.00016603226,0.00026695733,0.000082460436,0.00011150288,0.00006578412,0.00065556297],"category_scores_gemma":[0.00003875676,0.00026971806,0.0000406587,0.0005801526,0.0006553788,0.00020312492,0.000048839753,0.00045630307,0.0000024002925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3019784,0.0023688902,0.6533894,0.0021541447,0.005572942,0.00016922655,0.005171208,0.0000627164,0.0036904614,0.000042659853,0.014340174,0.011059762],"study_design_scores_gemma":[0.09657167,0.04139098,0.84716165,0.0013888885,0.0023910915,0.00010351459,0.0012550028,0.0002693046,0.005508694,0.00001496523,0.0031177811,0.0008264399],"about_ca_topic_score_codex":0.0025844679,"about_ca_topic_score_gemma":0.0030089177,"teacher_disagreement_score":0.20540674,"about_ca_system_score_codex":0.0003359008,"about_ca_system_score_gemma":0.0009111232,"threshold_uncertainty_score":0.9999755},"labels":[],"label_agreement":null},{"id":"W3006085704","doi":"10.1016/j.jocn.2020.01.020","title":"Pilot study of repetitive transcranial magnetic stimulation in patients with chemotherapy-induced peripheral neuropathy","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Neuroscience","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ministry of Health, Labour and Welfare","keywords":"Dysesthesia; Medicine; Chemotherapy-induced peripheral neuropathy; Transcranial magnetic stimulation; Neuropathic pain; Visual analogue scale; Peripheral neuropathy; McGill Pain Questionnaire; Adverse effect; Common Terminology Criteria for Adverse Events; Anesthesia; Neurostimulation; Internal medicine; Stimulation","score_opus":0.09715323459683775,"score_gpt":0.39305435766762004,"score_spread":0.2959011230707823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006085704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815446,0.000007665091,0.000022933606,0.00096523354,0.00037510562,0.0004130431,0.0000014139745,0.000004261563,0.00005588476],"genre_scores_gemma":[0.997647,0.000018143497,0.000059596583,0.002097159,0.00015751498,0.0000012106975,1.9190323e-7,0.000009235291,0.0000099762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982576,0.00019257591,0.00080404885,0.00021058366,0.0004201508,0.0001150908],"domain_scores_gemma":[0.9990821,0.00015890064,0.00035451376,0.00007955083,0.00015950404,0.00016542069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026776406,0.00009427213,0.0004469549,0.000056797147,0.000019656643,0.000006920626,0.000112961454,0.000017794797,0.00006239834],"category_scores_gemma":[0.00029928976,0.00006522794,0.000066768975,0.00032486158,0.0000935825,0.000108640386,0.000010459322,0.0003422626,3.8995472e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02010258,0.00734068,0.9515783,0.000009912778,0.0000074037816,0.00013665434,0.00056592573,0.00015812097,0.016430303,6.2959447e-7,0.000016333004,0.0036531242],"study_design_scores_gemma":[0.019195277,0.17441776,0.8056688,0.000020983927,0.0000683053,0.0000061535216,0.000031987547,0.00039096878,0.00013229216,0.0000014414115,0.000024615376,0.000041445546],"about_ca_topic_score_codex":0.000008821836,"about_ca_topic_score_gemma":0.000007233909,"teacher_disagreement_score":0.1670771,"about_ca_system_score_codex":0.00001267699,"about_ca_system_score_gemma":0.00014277852,"threshold_uncertainty_score":0.2659918},"labels":[],"label_agreement":null},{"id":"W3006388526","doi":"","title":"Rapport de stage en chimie au Canada - Synthèse d'un analogue de la deltorphine I ayant pour cible le récepteur delta","year":2020,"lang":"fr","type":"article","venue":"Publications Rapport de Stage","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Humanities; Chemistry; Art","score_opus":0.030175079722662278,"score_gpt":0.29539920909049316,"score_spread":0.2652241293678309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006388526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60862696,0.011339504,0.036350425,0.2576876,0.0014688871,0.0027070828,0.008784575,0.0006363139,0.07239868],"genre_scores_gemma":[0.892699,0.0015093038,0.0032381527,0.008745729,0.0018482697,0.0005174545,0.0023189727,0.00013846539,0.08898465],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99565536,0.00061909144,0.0008560559,0.0008355067,0.00043409638,0.0015998996],"domain_scores_gemma":[0.995989,0.0006113813,0.00040645307,0.0007664791,0.00025724576,0.0019694208],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016634122,0.00055994897,0.00072118297,0.00030303185,0.00045484488,0.00011215733,0.00062596926,0.00037364062,0.009690585],"category_scores_gemma":[0.00063037523,0.00062974286,0.00025465337,0.0011950774,0.0003172837,0.00033294002,0.00018627381,0.0008762824,0.000077569595],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002696038,0.0021366205,0.32419086,0.0005857227,0.0016865524,0.0016009031,0.004038889,0.00068679464,0.008617573,0.0156027,0.6316711,0.008912716],"study_design_scores_gemma":[0.0034194202,0.00021711145,0.0813086,0.000043343713,0.00080533384,0.00022522923,0.0016806781,0.0058655897,0.004569804,0.0000866428,0.9012522,0.0005260123],"about_ca_topic_score_codex":0.451108,"about_ca_topic_score_gemma":0.1935446,"teacher_disagreement_score":0.28407207,"about_ca_system_score_codex":0.0023533488,"about_ca_system_score_gemma":0.052558213,"threshold_uncertainty_score":0.9996154},"labels":[],"label_agreement":null},{"id":"W3007043352","doi":"10.4103/1735-5362.278710","title":"Development of a RP-HPLC method for analysis of docetaxel in tumor-bearing mice plasma and tissues following injection of docetaxel-loaded pH responsive targeting polymeric micelles","year":2020,"lang":"en","type":"article","venue":"Research in Pharmaceutical Sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chromatography; High-performance liquid chromatography; Docetaxel; Chemistry; Polyethylene glycol; Extraction (chemistry); Micelle; Biochemistry","score_opus":0.24752554995896492,"score_gpt":0.5306112159141528,"score_spread":0.2830856659551879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007043352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947289,0.0029767235,0.00016926347,0.0012352369,0.000036897356,0.00055723975,0.0000074156,0.0000065863724,0.0002817149],"genre_scores_gemma":[0.97549117,0.0001750452,0.024179397,0.000054240292,0.000025751373,0.000047105903,0.0000033333902,0.000005943332,0.00001803341],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975676,0.00039674866,0.0006058193,0.00039877585,0.00059975643,0.00043132357],"domain_scores_gemma":[0.99774384,0.0017838072,0.00013190976,0.000054143104,0.000112236165,0.00017407702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035690921,0.00011562064,0.000609631,0.0010162285,0.00009607093,0.000011965637,0.00016370005,0.00004778361,0.00004232448],"category_scores_gemma":[0.00063503144,0.00009708511,0.0001052799,0.0039156033,0.00037859794,0.00010507399,0.00013529288,0.00024337042,4.3050636e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019604247,0.00026140062,0.039989628,0.00042106872,0.00037968848,0.00002038894,0.00541838,0.00023383688,0.93646634,0.00006614716,0.00001773629,0.014764985],"study_design_scores_gemma":[0.002662685,0.00057258696,0.0067777894,0.00018372205,0.0003119745,0.0000035019598,0.0038414483,0.055055734,0.9299918,0.0000453365,0.00045441912,0.00009899739],"about_ca_topic_score_codex":0.0004951778,"about_ca_topic_score_gemma":0.000076602715,"teacher_disagreement_score":0.054821897,"about_ca_system_score_codex":0.00009740538,"about_ca_system_score_gemma":0.00039961617,"threshold_uncertainty_score":0.3959016},"labels":[],"label_agreement":null},{"id":"W3007141125","doi":"10.1158/1538-7445.sabcs19-ot1-08-08","title":"Abstract OT1-08-08: CONTESSA TRIO: A multinational, multicenter, phase 2 study of tesetaxel plus 3 different PD-(L)1 inhibitors in patients with metastatic triple-negative breast cancer (TNBC) and tesetaxel monotherapy in elderly patients with HER2- metastatic breast cancer (MBC)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Atezolizumab; Pembrolizumab; Tolerability; Internal medicine; Taxane; Oncology; Metastatic breast cancer; Cohort; Triple-negative breast cancer; Breast cancer; Chemotherapy; Clinical endpoint; Cancer; Clinical trial; Adverse effect; Immunotherapy","score_opus":0.05992016180778357,"score_gpt":0.40329152375285165,"score_spread":0.34337136194506807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007141125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862238,0.0011201437,0.000005390354,0.0015881222,0.000103356295,0.007830806,0.0030907087,0.000025025274,0.000012626753],"genre_scores_gemma":[0.9953014,0.0004158766,0.00005769002,0.00021394514,0.000079297184,0.0036300805,0.00013919862,0.00009813629,0.00006432205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951421,0.0005215309,0.0009037547,0.0010164264,0.0015338933,0.00088230346],"domain_scores_gemma":[0.9969817,0.00060655497,0.00043287643,0.00029361525,0.0011844306,0.0005008383],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037041996,0.000598604,0.0013395905,0.0006938346,0.0001286994,0.000056849105,0.00025228882,0.000080484584,0.0009114341],"category_scores_gemma":[0.000087706874,0.00041713155,0.000085668966,0.0014134477,0.00041591906,0.0003588799,0.00009505608,0.0009223596,0.0000034983975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07189591,0.017163906,0.8694117,0.0006432175,0.001515518,0.00010420146,0.009560316,0.0002435339,0.00074566924,0.0000011037463,0.00022791442,0.028487032],"study_design_scores_gemma":[0.17687535,0.0076957387,0.81053185,0.0007447702,0.0003469658,0.0000018941018,0.002146976,0.00066467485,0.0006026321,0.0000041427593,0.00003337609,0.00035161627],"about_ca_topic_score_codex":0.028443038,"about_ca_topic_score_gemma":0.021507122,"teacher_disagreement_score":0.10497945,"about_ca_system_score_codex":0.0015489352,"about_ca_system_score_gemma":0.0008124439,"threshold_uncertainty_score":0.99982804},"labels":[],"label_agreement":null},{"id":"W3009722442","doi":"10.1200/jco.2007.25.18_suppl.4028","title":"Bevacizumab (Bev) in combination with XELOX or FOLFOX4: Updated efficacy results from XELOX-1/ NO16966, a randomized phase III trial in first-line metastatic colorectal cancer","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Oxaliplatin; Medicine; FOLFOX; Capecitabine; Bevacizumab; Internal medicine; Oncology; Regimen; Colorectal cancer; Chemotherapy; Fluorouracil; Chemotherapy regimen; Cancer","score_opus":0.1315895413467038,"score_gpt":0.5133118688873759,"score_spread":0.3817223275406721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009722442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98485464,0.00037711542,0.00023172605,0.009589776,0.0020698286,0.0023577225,0.000043863736,0.000016196878,0.00045910515],"genre_scores_gemma":[0.9944268,0.0012087994,0.0016494306,0.00109466,0.0011341564,0.00006326462,0.00013042058,0.000028991331,0.00026351336],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9920676,0.0012338646,0.0053555113,0.00039774273,0.00049051363,0.0004548038],"domain_scores_gemma":[0.9789698,0.017126353,0.002945512,0.00015144098,0.0004113199,0.00039555453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008811241,0.0003020407,0.004124316,0.00053114473,0.000045141187,0.000011534886,0.0001885874,0.00042691876,0.00068699254],"category_scores_gemma":[0.005447248,0.00018560828,0.00048571755,0.00064869673,0.00035383014,0.00016039977,0.000039583054,0.0014234366,0.000007946927],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92018664,0.020900015,0.00097409973,0.000011887203,0.0013212721,0.0036388894,0.0006806276,0.000098565615,0.00013143873,0.000013581267,0.0012759606,0.05076703],"study_design_scores_gemma":[0.93112665,0.049860463,0.00880911,0.0002001078,0.0020260531,0.000095438154,0.00009422768,0.000867558,0.00036974315,0.00015249221,0.0062215826,0.00017658257],"about_ca_topic_score_codex":0.0013643485,"about_ca_topic_score_gemma":0.02189419,"teacher_disagreement_score":0.050590448,"about_ca_system_score_codex":0.0008060448,"about_ca_system_score_gemma":0.0029048882,"threshold_uncertainty_score":0.9959537},"labels":[],"label_agreement":null},{"id":"W3009814258","doi":"10.1158/1538-7445.sabcs19-p6-03-21","title":"Abstract P6-03-21: Identification of mechanisms driving acquired chemoresistance in preclinical breast cancer models of taxane resistance","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Taxane; Paclitaxel; Docetaxel; Cancer research; Cancer; Protein kinase B; PI3K/AKT/mTOR pathway; Breast cancer; Medicine; Biology; Pharmacology; Signal transduction; Internal medicine; Genetics","score_opus":0.16886145998551766,"score_gpt":0.47063370405509486,"score_spread":0.3017722440695772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009814258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827699,0.004357133,0.000144905,0.010592126,0.00015257276,0.0009273386,0.00023915671,0.000027129348,0.0007897126],"genre_scores_gemma":[0.99518114,0.0028435423,0.00017724436,0.00012521546,0.00021567555,0.00038545064,0.000020480311,0.000035005218,0.0010162644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973278,0.00012440013,0.0007909267,0.00054063986,0.0007726133,0.00044363027],"domain_scores_gemma":[0.9983576,0.00024430957,0.00028716552,0.0003494087,0.00054117147,0.00022032566],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008371803,0.00016253853,0.00057576003,0.00017805719,0.000052558185,0.0000118775515,0.0002930619,0.00014588797,0.00094201794],"category_scores_gemma":[0.000107040774,0.00015664358,0.00011353983,0.00087028457,0.00029874712,0.00016253394,0.00008744144,0.00036065077,0.000008555587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005119576,0.00042590793,0.0072821695,0.0013673705,0.00015306615,0.000037385336,0.0012559829,0.0005095642,0.9760975,0.00055023714,0.004154177,0.0030470563],"study_design_scores_gemma":[0.006729127,0.00030561065,0.24756444,0.0016180435,0.00016107492,0.00000403134,0.0004388912,0.0019129319,0.73770726,0.002768852,0.0004735371,0.00031620776],"about_ca_topic_score_codex":0.00093356706,"about_ca_topic_score_gemma":0.0016750451,"teacher_disagreement_score":0.24028227,"about_ca_system_score_codex":0.0004386441,"about_ca_system_score_gemma":0.0007919791,"threshold_uncertainty_score":0.9999713},"labels":[],"label_agreement":null},{"id":"W3009982165","doi":"10.1200/jco.2007.25.18_suppl.2554","title":"Pharmacokinetic (PK) interactions between capecitabine (X), oxaliplatin (O) and bevacizumab (A) when used in combination for first-line treatment of metastatic colorectal cancer (MCRC)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Capecitabine; Oxaliplatin; Irinotecan; Bevacizumab; Internal medicine; Colorectal cancer; Regimen; FOLFOX; Gastroenterology; Pharmacokinetics; Oncology; Cancer; Chemotherapy","score_opus":0.21257378462741217,"score_gpt":0.5383188680677896,"score_spread":0.32574508344037745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009982165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98895943,0.0008457855,0.0004926094,0.0077086715,0.0009799832,0.00077283726,0.000043236556,0.000005585129,0.00019186184],"genre_scores_gemma":[0.99506944,0.0012703914,0.0024040684,0.00019189669,0.00076771335,0.00004080379,0.000025022664,0.000016900962,0.00021373485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971148,0.00017140359,0.0021289417,0.00017613651,0.00017954202,0.00022922149],"domain_scores_gemma":[0.9922738,0.005774126,0.001329849,0.00006572333,0.0003217239,0.00023476925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013123143,0.00016327309,0.0015370783,0.00030761168,0.000034397184,0.0000036150009,0.00006113642,0.00013991537,0.00028821838],"category_scores_gemma":[0.0003999408,0.00012304261,0.00029418655,0.00015033055,0.00014986533,0.00009404916,0.000016066257,0.00030339637,0.0000011044851],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02084366,0.009980496,0.5119502,0.00012744735,0.0020128677,0.00023073837,0.0012253138,0.000059893347,0.0043533663,0.00004638619,0.0009148457,0.4482548],"study_design_scores_gemma":[0.118701495,0.073897935,0.73596954,0.00016117557,0.0046638967,0.00020372598,0.0002103422,0.00093223277,0.00850107,0.0008948296,0.055674072,0.00018969715],"about_ca_topic_score_codex":0.00019468249,"about_ca_topic_score_gemma":0.0029080003,"teacher_disagreement_score":0.44806507,"about_ca_system_score_codex":0.0005527343,"about_ca_system_score_gemma":0.0005406002,"threshold_uncertainty_score":0.5017532},"labels":[],"label_agreement":null},{"id":"W3010161595","doi":"10.1200/jco.2007.25.18_suppl.1003","title":"A randomized, double-blind phase II study of the oral tyrosine kinase inhibitor (TKI) axitinib (AG-013736) in combination with docetaxel (DOC) compared to DOC plus placebo (PL) in metastatic breast cancer (MBC)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Taxane; Adverse effect; Gastroenterology; Placebo; Nausea; Neutropenia; Febrile neutropenia; Stomatitis; Metastatic breast cancer; Anthracycline; Chemotherapy; Breast cancer; Pharmacology; Oncology; Cancer; Pathology","score_opus":0.17119473350791267,"score_gpt":0.5148333912451809,"score_spread":0.3436386577372682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010161595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98586977,0.00026658576,0.000042827993,0.008674954,0.0012529433,0.0035119688,0.000016297041,0.0000068571576,0.0003577776],"genre_scores_gemma":[0.9975012,0.00008998977,0.0003949611,0.0012289982,0.00046436072,0.00011674983,0.0000048345596,0.000023479495,0.00017542731],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99400175,0.0011834366,0.0035315822,0.00029963502,0.0005889401,0.00039464023],"domain_scores_gemma":[0.99402213,0.0027295481,0.0020989238,0.00021510845,0.00057145883,0.0003628127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071929824,0.00027420343,0.003303928,0.0005134026,0.00006068752,0.000009981035,0.00023658553,0.00018512143,0.00024434997],"category_scores_gemma":[0.00048532902,0.00015913075,0.00034232793,0.00081273826,0.00034116878,0.00014157822,0.00009841632,0.0011234803,0.0000025453903],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9181847,0.039464183,0.030759322,0.00004165727,0.00077984494,0.0009220884,0.0018704811,0.0005196083,0.00027108303,0.000048621034,0.00069713726,0.006441273],"study_design_scores_gemma":[0.906879,0.038753476,0.04955614,0.00028304238,0.001634811,0.00025137587,0.000987112,0.00021992363,0.00023976121,0.000053677213,0.0009964887,0.00014516256],"about_ca_topic_score_codex":0.001510682,"about_ca_topic_score_gemma":0.012595554,"teacher_disagreement_score":0.018796818,"about_ca_system_score_codex":0.000759741,"about_ca_system_score_gemma":0.0018521955,"threshold_uncertainty_score":0.7028614},"labels":[],"label_agreement":null},{"id":"W3010522503","doi":"10.1158/1538-7445.sabcs19-ot1-08-07","title":"Abstract OT1-08-07: CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel plus a reduced dose of capecitabine in patients with HER2-, HR+ metastatic breast cancer (MBC) who have not previously received a taxane","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University Health Centre","funders":"","keywords":"Capecitabine; Medicine; Taxane; Regimen; Internal medicine; Metastatic breast cancer; Clinical endpoint; Chemotherapy; Oncology; Dosing; Phases of clinical research; Chemotherapy regimen; Breast cancer; Cancer; Clinical trial","score_opus":0.10674752161737866,"score_gpt":0.4428524557434013,"score_spread":0.33610493412602266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010522503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906592,0.00082348706,0.0000016477617,0.002207771,0.000062024876,0.0051819594,0.0009679951,0.000017704922,0.00007822537],"genre_scores_gemma":[0.9973601,0.00029715107,0.00006778777,0.00015937151,0.000103523984,0.0015919522,0.00010070956,0.000054725406,0.0002646883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965528,0.00032656526,0.0006915073,0.00063896005,0.0011849421,0.0006051721],"domain_scores_gemma":[0.99706656,0.00037982123,0.0003687558,0.00031950048,0.0015065784,0.00035880186],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048719317,0.00030313514,0.000997171,0.00035308162,0.00006429423,0.000016409278,0.00025411576,0.00006676451,0.0020341794],"category_scores_gemma":[0.00025016698,0.00023993662,0.00009074491,0.0007739187,0.0002837923,0.00014724869,0.000102393795,0.00060798926,0.000009550948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23308393,0.0479645,0.4878934,0.0038869914,0.0038653775,0.0005413158,0.043031607,0.00087787013,0.13801432,0.0000040459195,0.004125798,0.036710866],"study_design_scores_gemma":[0.19637752,0.014247987,0.7636381,0.0014869996,0.00062583684,0.0000053568547,0.0042029787,0.0018789236,0.016857043,0.0000015698462,0.00029544698,0.00038225087],"about_ca_topic_score_codex":0.010948805,"about_ca_topic_score_gemma":0.0033871145,"teacher_disagreement_score":0.2757447,"about_ca_system_score_codex":0.0008566277,"about_ca_system_score_gemma":0.0010359761,"threshold_uncertainty_score":0.9988781},"labels":[],"label_agreement":null},{"id":"W3011242490","doi":"10.1200/jco.2013.31.15_suppl.1050","title":"Quality of life (QoL) in patients (pts) with locally advanced or metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes who received eribulin mesylate or capecitabine: A phase III, open-label, randomized study.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Eribulin; Capecitabine; Internal medicine; Metastatic breast cancer; Clinical endpoint; Taxane; Quality of life (healthcare); Anthracycline; Breast cancer; Adverse effect; Oncology; Phases of clinical research; Progression-free survival; Cancer; Clinical trial; Chemotherapy","score_opus":0.12441381449430199,"score_gpt":0.5084301453302427,"score_spread":0.38401633083594067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011242490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99062693,0.0006332807,0.00002999665,0.0030029844,0.00020185641,0.0053747213,0.000037068792,0.0000102195245,0.00008296736],"genre_scores_gemma":[0.99171257,0.003472458,0.002558253,0.001076224,0.00016375529,0.000370168,0.000011792469,0.00003747575,0.00059727416],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9922095,0.002189962,0.0043275305,0.00043789702,0.00045065847,0.00038445124],"domain_scores_gemma":[0.9883766,0.0048563145,0.004464059,0.00024231662,0.0014710267,0.0005896497],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003244658,0.00039283212,0.0063252645,0.00019299691,0.00005372888,0.000023795703,0.00025654203,0.00018573111,0.0011397649],"category_scores_gemma":[0.0023253455,0.00018305868,0.00015146754,0.00043359288,0.00066621485,0.00041209444,0.00008495871,0.0006513869,0.0000019411225],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71627307,0.029341241,0.177145,0.00010717739,0.0028054505,0.0003384434,0.00040263176,0.00002789615,0.000084638355,9.86572e-7,0.00040052016,0.07307292],"study_design_scores_gemma":[0.7289683,0.08458894,0.18275984,0.0004373584,0.002081183,0.00009960169,0.00039262683,0.00017380039,0.000021099833,0.00001019031,0.00027202925,0.00019504027],"about_ca_topic_score_codex":0.002850792,"about_ca_topic_score_gemma":0.0073828613,"teacher_disagreement_score":0.072877884,"about_ca_system_score_codex":0.00019024352,"about_ca_system_score_gemma":0.0028308933,"threshold_uncertainty_score":0.9997733},"labels":[],"label_agreement":null},{"id":"W3011568629","doi":"10.1016/j.annonc.2020.01.028","title":"19O A phase Ib trial of CFI-402257 in combination with weekly paclitaxel in patients with advanced HER2-negative (HER2-) breast cancer (aBC)","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Ottawa Hospital; Canadian Partnership Against Cancer; Princess Margaret Cancer Centre","funders":"Ontario Institute for Cancer Research; Canadian Cancer Society; Stand Up To Cancer Canada; Government of Ontario","keywords":"Medicine; Neutropenia; Internal medicine; Taxane; Breast cancer; Adverse effect; Nausea; Tolerability; Febrile neutropenia; Paclitaxel; Oncology; Cancer; Metastatic breast cancer; Chemotherapy; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Phases of clinical research","score_opus":0.05386763053986506,"score_gpt":0.4132210440111539,"score_spread":0.35935341347128885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011568629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98058087,0.00009324035,0.0000045547417,0.016437324,0.000099474186,0.0014513222,0.00014068297,0.0000109494,0.0011816142],"genre_scores_gemma":[0.9978122,0.00019228885,0.00015349896,0.001448819,0.00006232772,0.0001906026,0.00006547289,0.00001903889,0.00005572145],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986255,0.00017079554,0.00044616868,0.0002825285,0.00022039522,0.0002545688],"domain_scores_gemma":[0.998897,0.00017277413,0.00037192748,0.000111865775,0.0003259553,0.00012045952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001444276,0.00017540526,0.0007626913,0.00016061115,0.000015554575,0.0000016937803,0.0000765072,0.00011888896,0.00025265102],"category_scores_gemma":[0.00005252599,0.00013542638,0.000053931934,0.00048487316,0.0001995891,0.00011015865,0.00002313783,0.00021687444,0.0000021473181],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6545935,0.020305427,0.2074508,0.00018232656,0.00041159766,0.00010542279,0.004329179,0.000106860934,0.00067952374,0.000080199716,0.0016713333,0.11008378],"study_design_scores_gemma":[0.5192848,0.1349177,0.33799052,0.00024862212,0.00018057678,0.0000049131418,0.0004867294,0.00007633398,0.0035333205,0.00009429138,0.002978519,0.00020366593],"about_ca_topic_score_codex":0.0013175572,"about_ca_topic_score_gemma":0.0015888492,"teacher_disagreement_score":0.13530873,"about_ca_system_score_codex":0.00013897778,"about_ca_system_score_gemma":0.00047890312,"threshold_uncertainty_score":0.55225277},"labels":[],"label_agreement":null},{"id":"W3011656614","doi":"","title":"Mammalian Target of Rapamycin Inhibition Synergistically Increases Cytotoxicity of Vinorelbine in Breast Cancer Cells.","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Vinorelbine; RPTOR; Chemistry; Kinase; Cancer research; Phosphorylation; Pharmacology; Signal transduction; Biology; Cell biology; Biochemistry","score_opus":0.03415952101981392,"score_gpt":0.38252770423928323,"score_spread":0.34836818321946933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011656614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941053,0.0014385128,0.000008929986,0.0015437977,0.00007379829,0.00055668666,0.0006171307,0.00001413154,0.001641717],"genre_scores_gemma":[0.9974235,0.00087473297,0.000096026335,0.00007330586,0.00032949384,0.00025846963,0.000067579276,0.000023993009,0.00085285114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981261,0.00017593207,0.00042858624,0.00030018782,0.00052690244,0.00044227514],"domain_scores_gemma":[0.9989499,0.00016150612,0.000095104944,0.00020699501,0.0004534964,0.00013304083],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044349403,0.00014403886,0.00044943232,0.00041379198,0.000040902414,0.0000054322654,0.0000947631,0.00011539128,0.0033040491],"category_scores_gemma":[0.000024223866,0.00012665635,0.00008363777,0.000774957,0.00043413654,0.000056764027,0.00006615899,0.00032888446,0.0000065285744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025034861,0.0011402922,0.15842985,0.0004903134,0.000048004204,0.00009540532,0.000053385527,0.00019061418,0.82787305,0.00024147845,0.008476786,0.00045734813],"study_design_scores_gemma":[0.0032881787,0.00031163509,0.28012377,0.00034125545,0.0000505234,0.0000108900595,0.000032195974,0.00006780986,0.7149807,0.00024640086,0.00044854227,0.00009808839],"about_ca_topic_score_codex":0.06170004,"about_ca_topic_score_gemma":0.0038034678,"teacher_disagreement_score":0.121693924,"about_ca_system_score_codex":0.00055185513,"about_ca_system_score_gemma":0.0007171813,"threshold_uncertainty_score":0.99760705},"labels":[],"label_agreement":null},{"id":"W3011815213","doi":"10.1200/jco.2006.24.18_suppl.6019","title":"Measuring chemotherapy safety in a community oncology practice: Results of a three-year prospective study","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Cancer; Prospective cohort study; Lung cancer; Breast cancer; Neutropenia; Intensive care medicine; Oncology","score_opus":0.20793970800131584,"score_gpt":0.5302978625886811,"score_spread":0.3223581545873652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011815213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9551937,0.00026741155,0.000021269083,0.009562315,0.000653786,0.0008172909,0.0000057832563,0.000008881666,0.03346957],"genre_scores_gemma":[0.9956905,0.00033945046,0.002113496,0.0008000217,0.00087602565,0.0000110929905,0.0000024733085,0.000016705622,0.0001502107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99349755,0.002397699,0.0033229606,0.00018165426,0.00035697763,0.00024316825],"domain_scores_gemma":[0.9887224,0.0072203465,0.0028767558,0.00025293362,0.0007734878,0.0001541178],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.011239758,0.00015981315,0.0020462293,0.0002115249,0.00005522139,0.0000034619698,0.00019977088,0.00037675578,0.00007535774],"category_scores_gemma":[0.0038481671,0.000120175224,0.0003376041,0.0003021949,0.00027408832,0.00012652026,0.000064591695,0.0023153455,0.0000056962917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18616503,0.07683333,0.6826635,0.00003120742,0.0012160854,0.0012383454,0.002102323,0.000054558226,0.0004456261,0.000093230134,0.0025793337,0.046577413],"study_design_scores_gemma":[0.078801595,0.07805769,0.80674094,0.00006199858,0.0005923806,0.0002775436,0.0015893695,0.000014455541,0.00014840356,0.00061118335,0.03302258,0.00008184215],"about_ca_topic_score_codex":0.0017655343,"about_ca_topic_score_gemma":0.006887764,"teacher_disagreement_score":0.12407744,"about_ca_system_score_codex":0.0008575364,"about_ca_system_score_gemma":0.00229994,"threshold_uncertainty_score":0.99998635},"labels":[],"label_agreement":null},{"id":"W3011863200","doi":"10.1200/jco.2006.24.18_suppl.6129","title":"Drug interactions in ambulatory cancer patients receiving cancer-directed therapy","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cancer; Internal medicine; Ambulatory; Drug; Chemotherapy; Logistic regression; Breast cancer; Epidemiology; Pharmacology","score_opus":0.12448327550527227,"score_gpt":0.5302975286402103,"score_spread":0.405814253134938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011863200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98278505,0.0024584353,0.0000015652203,0.0068314164,0.004517014,0.00019510536,0.000005076087,0.000015738267,0.0031906206],"genre_scores_gemma":[0.9875199,0.005583739,0.0002867789,0.0024618183,0.002414262,0.000024258557,0.000004499576,0.000016189118,0.001688521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757797,0.00028824134,0.0015866549,0.00015576676,0.00018504173,0.0002063424],"domain_scores_gemma":[0.9972271,0.0010871227,0.0010946855,0.00007975288,0.00035993874,0.00015142502],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000687637,0.0001214679,0.0009514149,0.00015565894,0.000031616673,0.000004514994,0.00008523493,0.00011135928,0.0009337504],"category_scores_gemma":[0.00017372872,0.000089790105,0.0003492924,0.00019967198,0.00007816218,0.00011058181,0.000017784203,0.00086679775,0.0000060631105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028935885,0.0042012073,0.80115354,0.000007730213,0.00025428887,0.00008071804,0.00011619009,0.0000582257,0.0003790779,0.0000033511285,0.056516163,0.13433595],"study_design_scores_gemma":[0.011683399,0.0014049223,0.7771459,0.00009520916,0.00014424782,0.000014045147,0.000016042542,0.00007218899,0.00020531427,0.00005613851,0.20909902,0.00006354598],"about_ca_topic_score_codex":0.0025057164,"about_ca_topic_score_gemma":0.010578551,"teacher_disagreement_score":0.15258285,"about_ca_system_score_codex":0.0006418416,"about_ca_system_score_gemma":0.0013399479,"threshold_uncertainty_score":0.99997956},"labels":[],"label_agreement":null},{"id":"W3012324339","doi":"10.1200/jco.2012.30.15_suppl.604","title":"Lapatinib in HER2+ early breast cancer: Quality of life analysis.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lapatinib; Medicine; Placebo; Quality of life (healthcare); Population; Clinical endpoint; Internal medicine; Breast cancer; Randomized controlled trial; Adverse effect; Oncology; Cancer; Alternative medicine; Trastuzumab","score_opus":0.25999208827237974,"score_gpt":0.5899869266895392,"score_spread":0.3299948384171595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012324339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98815846,0.0014027279,0.000012242904,0.007214623,0.0011035608,0.00010496399,0.000017816981,0.0000035211997,0.0019820598],"genre_scores_gemma":[0.99467057,0.0010361696,0.00037764243,0.0020370213,0.0016799741,0.0000045059455,0.0000022084032,0.000007611829,0.000184319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957849,0.0007672109,0.0028229842,0.00010935955,0.00026694697,0.00024860096],"domain_scores_gemma":[0.9953157,0.0015685419,0.0021790143,0.0001318769,0.00030995463,0.00049494376],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004271168,0.000104616585,0.0023349598,0.00023896428,0.000011756415,0.0000016987251,0.0001083172,0.0002926101,0.0012977556],"category_scores_gemma":[0.00083971885,0.00007425558,0.00073384936,0.0004402649,0.00016092959,0.000109504595,0.000029317607,0.0006763997,0.000008189281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069765425,0.0045374273,0.9569815,0.000025827801,0.0021829025,0.000030033072,0.00022125835,0.00001758383,0.00014602208,0.000058882404,0.0016011603,0.027220886],"study_design_scores_gemma":[0.0091430135,0.0028940851,0.97877586,0.00002155661,0.0018303372,0.00002700932,0.00005595755,0.000012216078,0.00002629917,0.000032807708,0.007122343,0.000058513808],"about_ca_topic_score_codex":0.0013678542,"about_ca_topic_score_gemma":0.0009865757,"teacher_disagreement_score":0.027162371,"about_ca_system_score_codex":0.00017349755,"about_ca_system_score_gemma":0.0013388542,"threshold_uncertainty_score":0.9996152},"labels":[],"label_agreement":null},{"id":"W3013899227","doi":"10.1158/1538-7445.sabcs19-p4-14-09","title":"Abstract P4-14-09: Platinum-based chemotherapy in early-stage triple negative breast cancer: A meta-analysis","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Oncology; Triple-negative breast cancer; Breast cancer; Taxane; Anthracycline; Chemotherapy; Confidence interval; Meta-analysis; Cancer; Surgery","score_opus":0.22982111868810523,"score_gpt":0.4780810175425407,"score_spread":0.24825989885443545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013899227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93374586,0.003816985,0.00001643969,0.05792267,0.00007953401,0.0016029893,0.0010176633,0.00006658302,0.0017312915],"genre_scores_gemma":[0.99200565,0.0007855531,0.00006669005,0.0025197645,0.00034831392,0.0013027255,0.000045724308,0.000048719918,0.0028768817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719226,0.00021683634,0.00039925822,0.00068588014,0.00080857065,0.00069719873],"domain_scores_gemma":[0.9984476,0.0003383119,0.00011141619,0.00032333357,0.00034045023,0.00043887275],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005435567,0.0002718922,0.001175152,0.00050068623,0.00011229927,0.000046405312,0.00024221021,0.00013818571,0.03492806],"category_scores_gemma":[0.000045248333,0.00021702616,0.00066313153,0.002852709,0.00021374985,0.0001032317,0.000044794375,0.000867767,0.00007440956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052188437,0.0032838448,0.4119424,0.0014079046,0.30011117,0.0019616163,0.019099763,0.008662784,0.11704862,0.0001093481,0.059152044,0.025032064],"study_design_scores_gemma":[0.04329338,0.0017667125,0.7132626,0.00008558218,0.056218803,0.000005446187,0.0006568258,0.004427622,0.14429376,0.000087330925,0.034807898,0.001094016],"about_ca_topic_score_codex":0.031289335,"about_ca_topic_score_gemma":0.0062811677,"teacher_disagreement_score":0.30132023,"about_ca_system_score_codex":0.00072518,"about_ca_system_score_gemma":0.0011200324,"threshold_uncertainty_score":0.9751614},"labels":[],"label_agreement":null},{"id":"W3015494016","doi":"","title":"L'applicazione della Edmonton Symptom Assessment System (ESAS) nel paziente oncologico. Indagine presso l'Unità Operativa di Oncologia dell'Azienda ULSS 18 di Rovigo.","year":2018,"lang":"it","type":"article","venue":"Rivista Italiana di Cure Palliative","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.04018332912185468,"score_gpt":0.3678559698070109,"score_spread":0.3276726406851562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015494016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83269227,0.012371577,0.011815515,0.0072333557,0.008934072,0.0140937725,0.0046350067,0.0012282175,0.106996246],"genre_scores_gemma":[0.97081864,0.002018599,0.0007467614,0.00089776074,0.003988882,0.0012928257,0.0015630312,0.0002684378,0.018405067],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9890086,0.0016344078,0.0022772597,0.0028190003,0.0016792039,0.0025814946],"domain_scores_gemma":[0.99204147,0.0011503267,0.0017952247,0.0016772925,0.0017279019,0.0016077646],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0011572952,0.0021778862,0.0031802517,0.0004906737,0.0013501212,0.00045924276,0.0013248533,0.0013244876,0.0023050513],"category_scores_gemma":[0.00014399237,0.0018445703,0.0007515535,0.001643584,0.0015995377,0.0005761853,0.0009151349,0.0020569996,0.0012287592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009842313,0.024636239,0.5063169,0.0041641523,0.01979389,0.0061125397,0.027049135,0.0010454208,0.023814881,0.017485743,0.34353074,0.016208047],"study_design_scores_gemma":[0.034895435,0.027492298,0.3042155,0.004734338,0.010205268,0.00018797851,0.013066255,0.034751248,0.008939779,0.00013876894,0.55667216,0.004701027],"about_ca_topic_score_codex":0.001798929,"about_ca_topic_score_gemma":0.0014372783,"teacher_disagreement_score":0.21314138,"about_ca_system_score_codex":0.008459634,"about_ca_system_score_gemma":0.0025786795,"threshold_uncertainty_score":0.999972},"labels":[],"label_agreement":null},{"id":"W3023616387","doi":"","title":"PCN143 – Pcodr – the pointless canadian oncology drug review?","year":2015,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Drug; Oncology; Pharmacology","score_opus":0.07922609922640306,"score_gpt":0.4003947621710844,"score_spread":0.3211686629446813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023616387","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0099414755,0.019644072,0.0000023840614,0.31014445,0.00076821743,0.00068130565,0.000006646997,0.00006444142,0.658747],"genre_scores_gemma":[0.74587584,0.00856139,0.00017810463,0.16391867,0.00079270423,0.00014430075,0.000030908006,0.000043737124,0.08045431],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993711,0.000062930194,0.00012930596,0.00012277171,0.00009245667,0.00022140545],"domain_scores_gemma":[0.9992173,0.000058563717,0.000028728875,0.00018928258,0.00008854581,0.00041761753],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003040295,0.00008420186,0.00021684801,0.000038878126,0.000045083758,0.0000036393967,0.000078817226,0.00004008213,0.002867388],"category_scores_gemma":[0.000039168153,0.000046615034,0.000054280612,0.000115967174,0.00005870248,0.00002580809,0.000015903226,0.00012606103,0.00049998105],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040125633,0.000055252804,0.0025977741,0.000027119631,0.000055697714,0.00010647139,0.0002576072,2.1978059e-7,0.000021746348,0.00062207674,0.98017883,0.0160371],"study_design_scores_gemma":[0.0012430039,0.00019387949,0.0009148591,0.000055676075,0.00020593869,0.00014339651,0.000114931725,0.000009129898,0.00020929727,0.00008883073,0.9967656,0.000055433287],"about_ca_topic_score_codex":0.1306066,"about_ca_topic_score_gemma":0.42691594,"teacher_disagreement_score":0.7359344,"about_ca_system_score_codex":0.0005670934,"about_ca_system_score_gemma":0.0012983739,"threshold_uncertainty_score":0.99804413},"labels":[],"label_agreement":null},{"id":"W3026445041","doi":"10.1139/cjpp-2019-0380","title":"History of the Pharmacological Society of Canada 1956–2008","year":2020,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen's University; Dalhousie University","funders":"","keywords":"Clinical pharmacology; Political science; Public administration; Medicine; Pharmacology","score_opus":0.031073046022360846,"score_gpt":0.27002696406131776,"score_spread":0.2389539180389569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026445041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739776,0.006186964,0.000001995956,0.016857427,0.0020988332,0.00018688652,0.00005041343,0.0000022528989,0.00063757715],"genre_scores_gemma":[0.9830866,0.00036241076,0.000044803914,0.0157071,0.00044437763,0.0000029638418,0.0000027684187,0.0000081018325,0.00034085911],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989729,0.00015311257,0.00039163893,0.00012960483,0.00008734891,0.00026540042],"domain_scores_gemma":[0.9987202,0.00013802132,0.00036496975,0.00005445525,0.00018346205,0.00053884066],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011028865,0.0001303038,0.0005238179,0.000041031457,0.000056529523,5.1854573e-7,0.0001753582,0.000116739415,0.0041926815],"category_scores_gemma":[0.000019411369,0.00009118088,0.0001935846,0.00011637363,0.0006862461,0.000028683207,0.000025977215,0.00043625737,4.900245e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003748363,0.00004043888,0.0040487302,0.000119807446,0.00047482035,0.000043604436,0.0006115912,0.000026961648,0.5754301,0.000022802074,0.41866165,0.00014467632],"study_design_scores_gemma":[0.007542041,0.002125396,0.044964418,0.000033017546,0.0017111814,0.00037828647,0.00018194556,0.00028339057,0.38849202,0.00013065715,0.5539527,0.00020493272],"about_ca_topic_score_codex":0.025143623,"about_ca_topic_score_gemma":0.021222804,"teacher_disagreement_score":0.18693808,"about_ca_system_score_codex":0.0003502295,"about_ca_system_score_gemma":0.009023035,"threshold_uncertainty_score":0.99671763},"labels":[],"label_agreement":null},{"id":"W3028662611","doi":"10.3760/cma.j.issn.0254-1416.2011.06.011","title":"Efficacy of destruction of dorsal root ganglia with local doxorubicin Injection under the guidance of CT for postherpetic neuralgia involving thoracic back region","year":2011,"lang":"en","type":"article","venue":"Zhonghua mazuixue zazhi","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Postherpetic neuralgia; Medicine; Anesthesia; Lidocaine; Gabapentin; Neuralgia; Local anesthetic; Oxycodone; Surgery; Neuropathic pain; Opioid; Internal medicine","score_opus":0.043161060224063165,"score_gpt":0.3071492744596878,"score_spread":0.26398821423562463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028662611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942219,0.00057750865,0.0030670124,0.00021636173,0.00030902258,0.0008197591,0.0000062642275,0.000022621949,0.00075950613],"genre_scores_gemma":[0.9985708,0.000021257021,0.00080479746,0.00007096058,0.00009739678,0.000027683058,0.000013449705,0.000033774042,0.0003598769],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890006,0.000099544035,0.0003937882,0.00023278127,0.00017221212,0.00020161254],"domain_scores_gemma":[0.9989152,0.00014466274,0.00038324876,0.0003082044,0.00020235864,0.000046331188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017706015,0.00017706565,0.0003735816,0.00011374023,0.000053770294,0.0000030287333,0.000109135144,0.000067060595,0.00009228583],"category_scores_gemma":[0.000023857801,0.0001178032,0.00012627823,0.00023548363,0.00038994759,0.000092469134,0.000024207655,0.00014952791,0.0000031651273],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.095018044,0.005663125,0.33000532,0.006116271,0.0027569428,0.00015476318,0.016830001,0.003259084,0.4362548,0.015186886,0.0066797426,0.08207502],"study_design_scores_gemma":[0.008779627,0.008496783,0.46201894,0.00096255983,0.001604291,0.0004883919,0.0013982424,0.0010087957,0.5128628,0.0016860508,0.00037034112,0.0003231791],"about_ca_topic_score_codex":0.00068466755,"about_ca_topic_score_gemma":0.00014581585,"teacher_disagreement_score":0.13201363,"about_ca_system_score_codex":0.00007857537,"about_ca_system_score_gemma":0.00010197505,"threshold_uncertainty_score":0.48038754},"labels":[],"label_agreement":null},{"id":"W3029233318","doi":"10.1200/jco.2020.38.15_suppl.e14012","title":"Systematic analysis of chemotherapy agents for home-based administration.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy; Continuous infusion; Emergency medicine; Intensive care medicine; Internal medicine","score_opus":0.23374951722622045,"score_gpt":0.5476316261068798,"score_spread":0.3138821088806593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029233318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.952787,0.0005345008,0.0035119958,0.041189566,0.0007763748,0.0007150049,0.00002125275,0.000008131175,0.00045618354],"genre_scores_gemma":[0.9864454,0.00014037912,0.0025403516,0.010191662,0.00053816766,0.000010692265,0.000009988315,0.000008168073,0.0001151346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725646,0.00020561658,0.0021447479,0.000107343876,0.00018762746,0.00009818135],"domain_scores_gemma":[0.9946446,0.002616668,0.0020263114,0.00008693156,0.0003620922,0.00026344083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011386476,0.00008325136,0.0021715695,0.0001333931,0.000013385945,0.0000026822963,0.00009517888,0.0001713774,0.00046882208],"category_scores_gemma":[0.0012610063,0.00005708967,0.0011173598,0.00030600297,0.00007146013,0.000026399124,0.0000053225344,0.00019149986,0.0000026664197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18591423,0.03527765,0.44212714,0.024621962,0.14292741,0.0013427207,0.0018045226,0.0013964638,0.004690457,0.00063162076,0.12534805,0.033917777],"study_design_scores_gemma":[0.12653305,0.2658562,0.36830863,0.0014331116,0.12838642,0.00010140855,0.0004211783,0.032392368,0.004026576,0.0002261427,0.07188554,0.00042936509],"about_ca_topic_score_codex":0.0000019421514,"about_ca_topic_score_gemma":0.0000067183264,"teacher_disagreement_score":0.23057856,"about_ca_system_score_codex":0.000063390245,"about_ca_system_score_gemma":0.0012435907,"threshold_uncertainty_score":0.5133273},"labels":[],"label_agreement":null},{"id":"W3031809543","doi":"10.1200/jco.2020.38.15_suppl.1088","title":"Clinical predictors of long-term response to capecitabine in metastatic breast cancer (MBC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital; University of Alberta; Baker Hughes (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Capecitabine; Internal medicine; Metastatic breast cancer; Breast cancer; Cohort; Oncology; Cancer; Docetaxel; Proportional hazards model; Stage (stratigraphy); Hormonal therapy; Surgery","score_opus":0.18164664771792685,"score_gpt":0.5443573413343225,"score_spread":0.36271069361639563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031809543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92800534,0.00058300735,0.000046152516,0.06881849,0.0019529621,0.00034951782,0.00003839778,0.0000074680243,0.00019865796],"genre_scores_gemma":[0.9849989,0.001286051,0.0009834174,0.010157548,0.0023504223,0.000010657982,0.000002582977,0.000021328675,0.0001890955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937296,0.0013941035,0.003974744,0.00027042098,0.00035444906,0.00027670639],"domain_scores_gemma":[0.9925116,0.004445471,0.0015112214,0.00015345571,0.0003994024,0.000978902],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0041334783,0.00017309115,0.0024905228,0.00018960312,0.000013714315,0.0000031804357,0.00021815834,0.00026985677,0.0013206329],"category_scores_gemma":[0.003389867,0.00012503502,0.00063367654,0.00037325246,0.00025389288,0.00007957871,0.00008020021,0.0011022667,0.000023769328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.097981766,0.003946379,0.82107395,0.000059027952,0.00087062415,0.0024364265,0.00026817343,0.000035716937,0.001080419,0.0000027994784,0.008733907,0.06351083],"study_design_scores_gemma":[0.020368157,0.030405901,0.9340759,0.00013670283,0.001036477,0.00030577704,0.00004636906,0.000032244137,0.00009542639,0.000008559284,0.013399895,0.00008860762],"about_ca_topic_score_codex":0.000039730345,"about_ca_topic_score_gemma":0.00017614137,"teacher_disagreement_score":0.11300195,"about_ca_system_score_codex":0.00022684333,"about_ca_system_score_gemma":0.0031289926,"threshold_uncertainty_score":0.9995923},"labels":[],"label_agreement":null},{"id":"W3032371821","doi":"10.1200/jco.2020.38.15_suppl.tps1111","title":"CONTESSA TRIO: A multinational, multicenter, phase (P) II study of tesetaxel (T) plus three different PD-(L)1 inhibitors in patients (Pts) with metastatic triple-negative breast cancer (TNBC) and tesetaxel monotherapy in elderly pts with HER2-metastatic breast cancer (MBC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Atezolizumab; Pembrolizumab; Taxane; Internal medicine; Tolerability; Oncology; Cohort; Chemotherapy; Nivolumab; Metastatic breast cancer; Breast cancer; Cancer; Immunotherapy; Adverse effect","score_opus":0.09154226995387651,"score_gpt":0.4490843375037694,"score_spread":0.35754206754989293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032371821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98881716,0.0006396732,0.000048050224,0.0073136236,0.00029180353,0.0025458012,0.0003207415,0.000008573288,0.000014596698],"genre_scores_gemma":[0.99723417,0.00052192155,0.00051147724,0.0012119003,0.0002128622,0.00022149784,0.000011959064,0.000045356173,0.00002883696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99488133,0.00080106483,0.0026977055,0.00051195524,0.000693719,0.00041420932],"domain_scores_gemma":[0.99395204,0.002017786,0.0025517468,0.00015220305,0.00080626627,0.0005199737],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000789059,0.000449492,0.0029295792,0.00036107685,0.00006308686,0.000014023731,0.00019332107,0.00014237435,0.00026054718],"category_scores_gemma":[0.00035994942,0.0002761598,0.00020260458,0.0005354704,0.0003774179,0.0002595581,0.00006612483,0.0011083751,7.6403046e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.146509,0.048146952,0.67200035,0.00012863596,0.0022304882,0.0005260922,0.0034725142,0.0001943472,0.000119157514,0.0000015586751,0.00017751635,0.12649335],"study_design_scores_gemma":[0.27496445,0.10596346,0.6138553,0.00039457713,0.001238751,0.000060132832,0.0012898108,0.0019049601,0.00003974318,0.0000124979615,0.00007941328,0.00019691381],"about_ca_topic_score_codex":0.00278444,"about_ca_topic_score_gemma":0.020813068,"teacher_disagreement_score":0.12845543,"about_ca_system_score_codex":0.00069033774,"about_ca_system_score_gemma":0.0013233094,"threshold_uncertainty_score":0.99996907},"labels":[],"label_agreement":null},{"id":"W3034300226","doi":"10.2337/db20-543-p","title":"543-P: A Randomised Control Trial to Evaluate the Efficacy of Chinese Traditional Medicine for the Treatment of Diabetic Peripheral Neuropathy","year":2020,"lang":"en","type":"article","venue":"Diabetes","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Diabetes mellitus; Adverse effect; Internal medicine; Peripheral neuropathy; Randomized controlled trial; Clinical trial; Traditional Chinese medicine; Surgery; Diabetic neuropathy; Alternative medicine","score_opus":0.04734966850464823,"score_gpt":0.33069419984538767,"score_spread":0.28334453134073945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034300226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9642004,0.0017109576,0.000041211162,0.028911343,0.00034180694,0.0045898105,0.000104530685,0.000014337749,0.00008563166],"genre_scores_gemma":[0.99470747,0.00007416758,0.000016819651,0.0026322077,0.0013903674,0.0010780302,0.000042756776,0.000017061488,0.000041147567],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989515,0.00013746483,0.00034829395,0.00017414658,0.00020975195,0.00017882636],"domain_scores_gemma":[0.9963166,0.003233092,0.00009292951,0.00015746811,0.000088447705,0.0001114326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020715634,0.00016797769,0.0006401182,0.000029994904,0.00006233054,0.0000035403766,0.00010172675,0.000027736804,0.00047559754],"category_scores_gemma":[0.00033157348,0.00007115093,0.0003038669,0.00015768447,0.00017336286,0.000013443548,0.000005523338,0.00004722669,0.0000024031344],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6605325,0.003696819,0.017768586,0.00020221363,0.003619132,0.0000071274867,0.0136859035,0.00034587336,0.27054116,0.00011181962,0.0053901756,0.024098704],"study_design_scores_gemma":[0.91116303,0.030474398,0.03545284,0.000029375358,0.0028683376,7.3910576e-7,0.00005372594,0.0042104125,0.011940202,0.00011964624,0.0035871463,0.00010014774],"about_ca_topic_score_codex":0.000010553078,"about_ca_topic_score_gemma":0.000001246539,"teacher_disagreement_score":0.25860095,"about_ca_system_score_codex":0.000033218974,"about_ca_system_score_gemma":0.000074247335,"threshold_uncertainty_score":0.52074593},"labels":[],"label_agreement":null},{"id":"W3043096450","doi":"10.1200/jco.20.00147","title":"Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":609,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Puma Biotechnology; American Society of Clinical Oncology","keywords":"Capecitabine; Medicine; Lapatinib; Internal medicine; Neratinib; Hazard ratio; Metastatic breast cancer; Clinical endpoint; Gastroenterology; Oncology; Cancer; Breast cancer; Trastuzumab; Randomized controlled trial; Confidence interval; Colorectal cancer","score_opus":0.12862131070580513,"score_gpt":0.467998518340425,"score_spread":0.33937720763461987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043096450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96566427,0.0013839003,0.000031709074,0.027544105,0.0015934705,0.0019352052,0.00011098297,0.00005839851,0.001677982],"genre_scores_gemma":[0.9867949,0.0016937648,0.0016498856,0.004570308,0.0042464742,0.00016021643,0.000094152456,0.000076888784,0.0007134414],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934542,0.0013560749,0.003388042,0.00057958387,0.00060182705,0.00062025565],"domain_scores_gemma":[0.9928884,0.0025917196,0.0024440365,0.0002260292,0.0008374167,0.0010123801],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013587964,0.0004933127,0.0039609494,0.00021871108,0.00007673886,0.00002204002,0.00023975405,0.00038534333,0.002069716],"category_scores_gemma":[0.001023859,0.00034077934,0.00056760473,0.00075318065,0.00038153213,0.00021097355,0.000058058344,0.0017186694,0.00001907635],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93102497,0.009077248,0.0020058022,0.00007192568,0.0036658705,0.007380187,0.0014160341,0.00030746893,0.0004522916,0.0000147712,0.013286006,0.03129744],"study_design_scores_gemma":[0.8342323,0.13420704,0.00591717,0.00033485788,0.0049196645,0.000802552,0.00045593776,0.0024863116,0.00019673115,0.0000068668874,0.016057637,0.00038296316],"about_ca_topic_score_codex":0.0009939742,"about_ca_topic_score_gemma":0.002074658,"teacher_disagreement_score":0.12512979,"about_ca_system_score_codex":0.0012118343,"about_ca_system_score_gemma":0.005768008,"threshold_uncertainty_score":0.9999044},"labels":[],"label_agreement":null},{"id":"W3046679789","doi":"10.1002/macp.202000216","title":"The Next 100 Years of Polymer Science","year":2020,"lang":"en","type":"article","venue":"Macromolecular Chemistry and Physics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université Laval; University of Prince Edward Island","funders":"","keywords":"Polymer science; Polymer; Polymerization; Polymer chemistry; Macromolecule; Chemistry; Nanotechnology; Materials science; Organic chemistry","score_opus":0.020340171021888804,"score_gpt":0.28696466615670974,"score_spread":0.26662449513482095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046679789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324983,0.0018837495,0.000037748167,0.0010622761,0.000022168331,0.00005401648,0.0000046914997,0.000009237546,0.0036762834],"genre_scores_gemma":[0.9990844,0.000105574414,0.00002577637,0.0004418512,0.00011544911,0.000002908817,0.000004639256,0.0000050624617,0.0002143123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996051,0.0000041024286,0.000062168016,0.000118732125,0.00010605507,0.00010382235],"domain_scores_gemma":[0.99974626,0.000016992575,0.000028654296,0.000095207644,0.000024955598,0.000087953194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002923459,0.000052571213,0.000087411616,0.0000011601843,0.00006067627,0.000012263487,0.00006431987,0.000017885008,0.000037806632],"category_scores_gemma":[0.000008548455,0.00004221378,0.00003657031,0.00014809247,0.00031006424,0.000019717845,0.000040764502,0.00006794142,0.0000027593917],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006333693,0.000031007068,0.0002377182,0.000043234533,0.0000302818,0.00002064687,0.00018477223,3.0107208e-7,0.9775989,0.000092707596,0.00015306058,0.021544054],"study_design_scores_gemma":[0.00046874065,0.00005711407,0.00025483876,0.0000072259386,0.000058442893,0.000011192449,0.000032667776,0.00013789839,0.9949761,0.00007270793,0.0038820032,0.000041084197],"about_ca_topic_score_codex":0.0000059015233,"about_ca_topic_score_gemma":4.2520494e-8,"teacher_disagreement_score":0.02150297,"about_ca_system_score_codex":0.000007880434,"about_ca_system_score_gemma":0.00008063981,"threshold_uncertainty_score":0.17214279},"labels":[],"label_agreement":null},{"id":"W3083735926","doi":"10.1158/1538-7445.am2020-4130","title":"Abstract 4130: Improvement of drug efficacy of polo-like kinase 4 inhibitor in the treatment of uterine leiomyosarcoma","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Mitosis; Mitotic catastrophe; Cancer research; Cell cycle; Kinase; Cell growth; Apoptosis; Cell biology","score_opus":0.10802873920770342,"score_gpt":0.45531401868136095,"score_spread":0.3472852794736575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083735926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892185,0.002634621,4.0044944e-7,0.006400409,0.00009080596,0.0011349897,0.00010565996,0.0000058266737,0.00040880288],"genre_scores_gemma":[0.99726635,0.0018066594,0.000018907516,0.00013216965,0.0002437931,0.00019824177,0.000017864912,0.000014159865,0.00030182564],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985612,0.00007629566,0.00038501227,0.00022755329,0.0004632929,0.00028664773],"domain_scores_gemma":[0.9991312,0.0002489014,0.00009780934,0.00026347474,0.00014955025,0.00010904363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027678284,0.00012297992,0.0004001547,0.00015108766,0.000025596875,0.0000036494484,0.0001636442,0.00004199464,0.0007960354],"category_scores_gemma":[0.000021142252,0.000079600766,0.000119592034,0.0004761864,0.0002504073,0.000026995507,0.0000443206,0.00017047668,0.000004540792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052535525,0.0034804135,0.014913741,0.00084477867,0.00023088258,0.00012652305,0.008019541,0.0000129555365,0.9168484,0.000034321954,0.003692711,0.046542186],"study_design_scores_gemma":[0.011157157,0.006883176,0.07089372,0.0001245198,0.00006744443,0.0000019230008,0.00074048224,0.000015821692,0.87734294,0.000014394203,0.03268313,0.000075302545],"about_ca_topic_score_codex":0.0049572727,"about_ca_topic_score_gemma":0.00030087566,"teacher_disagreement_score":0.055979975,"about_ca_system_score_codex":0.00024222134,"about_ca_system_score_gemma":0.00041301217,"threshold_uncertainty_score":0.8716029},"labels":[],"label_agreement":null},{"id":"W3088311877","doi":"10.1016/j.annonc.2020.08.377","title":"275O Impact of tucatinib on health-related quality of life (HRQoL) in patients with HER2+ metastatic breast cancer (MBC) with and without brain metastases (BM)","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Medicine; Quality of life (healthcare); Capecitabine; Internal medicine; Visual analogue scale; Metastatic breast cancer; Placebo; Oncology; Depression (economics); Clinical trial; Breast cancer; Trastuzumab; Anxiety; Cancer; Surgery; Psychiatry; Alternative medicine; Pathology; Nursing","score_opus":0.13965578588046457,"score_gpt":0.4710488251463778,"score_spread":0.33139303926591324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088311877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97831523,0.00072647876,0.0000025986951,0.019393643,0.000024147932,0.0007472465,0.00060676667,0.000009201549,0.00017465393],"genre_scores_gemma":[0.99593896,0.00018829684,0.000168311,0.0035406612,0.000017246091,0.000033999124,0.00007608988,0.000020618829,0.000015803977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980165,0.00046435054,0.0007508415,0.00027472802,0.00022700534,0.00026659606],"domain_scores_gemma":[0.9981044,0.00035371925,0.0008488659,0.00015290183,0.0002625793,0.000277515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039541256,0.00020811099,0.0014602044,0.00014323034,0.000017922,0.0000015278196,0.00006573683,0.00006283323,0.00030398782],"category_scores_gemma":[0.000103921804,0.00013559939,0.00008939618,0.00037619116,0.0002786992,0.000057638044,0.000023298595,0.00017971233,9.464196e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035964977,0.0037414797,0.9397943,0.000535602,0.0019300457,0.000008076899,0.0023489632,0.00015181143,0.0003516937,0.000040078197,0.0031619743,0.011970974],"study_design_scores_gemma":[0.016219899,0.041992888,0.94049025,0.0001699909,0.00021247646,0.00000766353,0.00014396892,0.000016975333,0.00047496986,0.000022109783,0.00013897034,0.00010981602],"about_ca_topic_score_codex":0.012067959,"about_ca_topic_score_gemma":0.0019372704,"teacher_disagreement_score":0.038251407,"about_ca_system_score_codex":0.00008480107,"about_ca_system_score_gemma":0.0013001114,"threshold_uncertainty_score":0.99451077},"labels":[],"label_agreement":null},{"id":"W3088392406","doi":"10.1016/j.annonc.2020.08.451","title":"349TiP EPIK-B3: A phase III, randomised, double-blind (DB), placebo (PBO)-controlled study of alpelisib (ALP) + nab-paclitaxel (nab-PTX) in advanced triple-negative breast cancer (TNBC) with either PIK3CA mutation or phosphatase and tensin homolog (PTEN) loss without PIK3CA mutation","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; Ipsen; Daiichi Sankyo Europe; Servier; European Society for Medical Oncology; Chugai Pharmaceutical; Vifor Pharma; Oncolytics Biotech; Novo Nordisk; Astellas Pharma; Eisai; Seagen; Daiichi-Sankyo; MacroGenics; Japan Surgical Society; Puma Biotechnology; Pfizer; Incyte; Menarini Silicon Biosystems; Mylan; Clovis Oncology; Teva Pharmaceutical Industries; Sanofi; Foundation Medicine; Genomic Health; GlaxoSmithKline; Amgen; Novartis Pharmaceuticals Corporation; G1 Therapeutics; Jounce Therapeutics; Celgene; AstraZeneca; ImmunoMedics; Eli Lilly and Company; Samsung; Bristol-Myers Squibb","keywords":"Medicine; Triple-negative breast cancer; PTEN; Internal medicine; Oncology; Breast cancer; Population; Fulvestrant; Cancer; Cancer research; PI3K/AKT/mTOR pathway; Tamoxifen","score_opus":0.07964210492149927,"score_gpt":0.4290398262502009,"score_spread":0.3493977213287016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088392406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803568,0.0018779597,0.00007058825,0.007196229,0.0001861787,0.009517072,0.00029965086,0.00004540359,0.00045011088],"genre_scores_gemma":[0.9943844,0.00074878277,0.00027002857,0.0022648203,0.00017278647,0.0016128368,0.00014945862,0.00006134213,0.00033555957],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963195,0.0005591224,0.0013418768,0.000809107,0.0004084682,0.0005619643],"domain_scores_gemma":[0.9963972,0.0009144646,0.0011952744,0.00028174894,0.00086305727,0.0003482312],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007429467,0.0005418457,0.0025701162,0.00039480053,0.00009837835,0.000014583082,0.00015403153,0.0002769377,0.00053887453],"category_scores_gemma":[0.0002755321,0.0003919593,0.00017145603,0.00077616476,0.00048229814,0.00035099284,0.000058052738,0.0004223756,0.000005088834],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93183917,0.00749862,0.005603263,0.00018754555,0.002049604,0.0019646254,0.013442686,0.00052650284,0.0016930228,0.00001576064,0.00075317477,0.03442602],"study_design_scores_gemma":[0.93970716,0.03734409,0.005828892,0.00019391769,0.0019269959,0.0004339671,0.0058016297,0.0016401646,0.0063176043,0.00004997116,0.0003499053,0.00040569558],"about_ca_topic_score_codex":0.002934463,"about_ca_topic_score_gemma":0.0045481757,"teacher_disagreement_score":0.034020323,"about_ca_system_score_codex":0.00017356538,"about_ca_system_score_gemma":0.0010077351,"threshold_uncertainty_score":0.99985325},"labels":[],"label_agreement":null},{"id":"W3088957710","doi":"10.1016/j.annonc.2020.08.376","title":"274O Health-related quality of life (HRQoL) changes with veliparib in patients (pts) with metastatic or locally advanced breast cancer in the phase III BROCADE 3 study","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"AbbVie","keywords":"Medicine; Veliparib; Internal medicine; Breast cancer; Carboplatin; Brief Pain Inventory; Quality of life (healthcare); Oncology; Cancer; Metastatic breast cancer; Placebo; Hazard ratio; PARP inhibitor; Adverse effect; Paclitaxel; Physical therapy; Chemotherapy; Poly ADP ribose polymerase; Confidence interval; Chronic pain; Pathology","score_opus":0.17107674004817533,"score_gpt":0.47661155909900943,"score_spread":0.3055348190508341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088957710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96051687,0.00072022027,0.0000049813098,0.036506046,0.000043059736,0.0019714972,0.000115071,0.000010691621,0.000111558096],"genre_scores_gemma":[0.9889717,0.00031164414,0.000043725726,0.01032547,0.000028752082,0.000247889,0.0000302884,0.000016419135,0.000024081155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978378,0.000584071,0.0006757152,0.0002967629,0.00028565075,0.00032003963],"domain_scores_gemma":[0.99861866,0.00026869233,0.000583062,0.00016248866,0.00020845907,0.00015861713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005044985,0.00019096058,0.0011641379,0.00012189794,0.000026578662,0.000001923283,0.00013756014,0.000060965776,0.0002128618],"category_scores_gemma":[0.000050457093,0.00010768806,0.00003675129,0.00067479105,0.00016224403,0.000055598946,0.00002911672,0.0002707668,0.0000013769597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27865323,0.036640923,0.48268443,0.00079185487,0.0018191393,0.00027075782,0.042474974,0.00062143954,0.0003930036,0.00003497636,0.0025979672,0.15301731],"study_design_scores_gemma":[0.15122367,0.14060909,0.6984009,0.00023834367,0.00032134913,0.0000147433675,0.0069763376,0.00007669918,0.00025528015,0.00000823823,0.0016547699,0.00022056313],"about_ca_topic_score_codex":0.0039305678,"about_ca_topic_score_gemma":0.029572498,"teacher_disagreement_score":0.21571648,"about_ca_system_score_codex":0.00009342127,"about_ca_system_score_gemma":0.0010540037,"threshold_uncertainty_score":0.9881353},"labels":[],"label_agreement":null},{"id":"W3090064455","doi":"10.24095/hpcdp.29.2.06f","title":"Thérapies complémentaires pour les patients cancéreux :évaluer les besoins d'information et l'utilisation de l'information","year":2009,"lang":"fr","type":"article","venue":"Maladies chroniques au Canada","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Fondation pour la Recherche Médicale","keywords":"Medicine; Political science; Humanities; Gynecology; Philosophy","score_opus":0.01331057341557329,"score_gpt":0.27465247136509724,"score_spread":0.26134189794952395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090064455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85135424,0.007718604,0.0005721227,0.052884046,0.00360823,0.0018235891,0.0011569631,0.00019289009,0.08068932],"genre_scores_gemma":[0.9795648,0.0032618062,0.0005296475,0.010856299,0.00071846886,0.000079587415,0.0021559428,0.000019647297,0.0028138093],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99780244,0.00016785158,0.00063681335,0.00017683487,0.00044406197,0.0007720089],"domain_scores_gemma":[0.99881124,0.00011999285,0.00033839553,0.00020540877,0.00027242373,0.00025251764],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021693521,0.00039991926,0.00039280148,0.00017905135,0.00035499258,0.00008678985,0.00014209886,0.0001934094,0.0022570195],"category_scores_gemma":[0.000060679387,0.00040611415,0.00010171992,0.00015637408,0.00013963551,0.0014333703,0.000052270974,0.00029218214,0.000029996376],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036337628,0.00028569554,0.11741547,0.0008714397,0.0004313389,0.000018916982,0.008165169,0.00095632416,0.000059541537,0.004707027,0.58084416,0.28588155],"study_design_scores_gemma":[0.0025656098,0.00078890735,0.37013638,0.00041696537,0.00038146917,0.000020084473,0.0018627039,0.0018756918,0.0022068198,0.00016456397,0.6192405,0.00034026103],"about_ca_topic_score_codex":0.83090985,"about_ca_topic_score_gemma":0.8727074,"teacher_disagreement_score":0.2855413,"about_ca_system_score_codex":0.008539783,"about_ca_system_score_gemma":0.0042820256,"threshold_uncertainty_score":0.99983907},"labels":[],"label_agreement":null},{"id":"W3090590949","doi":"10.1016/j.bcp.2020.114255","title":"The active second-generation proteasome inhibitor oprozomib reverts the oxaliplatin-induced neuropathy symptoms","year":2020,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Università degli Studi di Firenze; Università di Bologna; Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Oxaliplatin; Neuropathic pain; Medicine; Proteasome; Allodynia; Pharmacology; Proteasome inhibitor; Oxidative stress; Downregulation and upregulation; Adverse effect; Peripheral neuropathy; Nociception; Internal medicine; Hyperalgesia; Endocrinology; Cancer; Chemistry; Colorectal cancer; Biology; Cell biology; Receptor","score_opus":0.03942767462896317,"score_gpt":0.3113601735748303,"score_spread":0.27193249894586713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090590949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9443716,0.0008415785,0.0000036212691,0.051160865,0.0012806219,0.0016889969,0.000027426799,0.00008871028,0.0005366216],"genre_scores_gemma":[0.9751726,0.00009033529,0.000017981518,0.018704144,0.004885303,0.0004584148,0.000060889182,0.000032315795,0.0005780395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984114,0.00024204626,0.00031729383,0.00044324447,0.00019561686,0.00039035906],"domain_scores_gemma":[0.9990629,0.00025335513,0.00014060271,0.00017490129,0.0001049314,0.0002632971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014180371,0.00024367108,0.00028533753,0.000023920444,0.00028947406,0.000023754923,0.00021353518,0.00015637667,0.0008061127],"category_scores_gemma":[0.00008995731,0.00014236943,0.00013768265,0.00023563087,0.0002056536,0.000057569818,0.00012842988,0.00055581826,0.00010571076],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009828942,0.000106933934,0.000047923266,0.00001837718,0.0001526809,0.000029164888,0.00023236955,5.299477e-7,0.70821756,0.000023289358,0.28853083,0.001657439],"study_design_scores_gemma":[0.0037210425,0.00080503954,0.00056914147,0.0000051657676,0.00029940778,0.00005748348,0.000028501296,0.00041453788,0.8865462,0.000019061974,0.10739219,0.0001422559],"about_ca_topic_score_codex":0.00000640806,"about_ca_topic_score_gemma":0.0000015749304,"teacher_disagreement_score":0.18113862,"about_ca_system_score_codex":0.00013187931,"about_ca_system_score_gemma":0.00018711608,"threshold_uncertainty_score":0.8826369},"labels":[],"label_agreement":null},{"id":"W3091560225","doi":"10.1158/1078-0432.ccr-20-2682","title":"Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health; University of Chicago","keywords":"Cisplatin; Medicine; Cancer; Oncology; Internal medicine; Chemotherapy","score_opus":0.3250167528719663,"score_gpt":0.5483750320847276,"score_spread":0.2233582792127613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091560225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98804283,0.0009937751,0.0000024143915,0.009251306,0.00022127196,0.00093316403,0.0002326556,0.000024939414,0.00029764284],"genre_scores_gemma":[0.98735696,0.008538584,0.000054057484,0.0030237925,0.00043943286,0.00026200726,0.000040957555,0.00003090701,0.00025327667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99572796,0.0010749525,0.0013062034,0.0007823781,0.00057686056,0.0005316292],"domain_scores_gemma":[0.9933073,0.0051393276,0.0001751587,0.00032930687,0.00045772103,0.0005912138],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018182466,0.0002070951,0.0013506976,0.00037268674,0.00007361331,0.000016608694,0.00022493121,0.0002709273,0.0013130473],"category_scores_gemma":[0.0025527542,0.00017323672,0.00037435256,0.0018893612,0.00072228006,0.000063133084,0.00023213062,0.0013643907,0.000011498611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004842412,0.00040311654,0.9848922,0.00016778064,0.001201668,0.00009109753,0.0005166045,0.0000551048,0.0007415866,0.000005427946,0.00090082065,0.0061822175],"study_design_scores_gemma":[0.005743787,0.0014413579,0.98658174,0.00006573296,0.0007154476,0.0000011296298,0.0002381805,0.0027161776,0.0003684376,0.000014637558,0.0019598617,0.00015352682],"about_ca_topic_score_codex":0.010169239,"about_ca_topic_score_gemma":0.030673318,"teacher_disagreement_score":0.020504078,"about_ca_system_score_codex":0.00010572771,"about_ca_system_score_gemma":0.0007434132,"threshold_uncertainty_score":0.9995999},"labels":[],"label_agreement":null},{"id":"W3093241270","doi":"10.1007/s00520-020-05791-5","title":"A randomized clinical trial comparing physician-directed or fixed-dose steroid replacement strategies for incomplete dexamethasone dosing prior to docetaxel chemotherapy","year":2020,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Docetaxel; Dexamethasone; Chemotherapy; Dosing; Randomized controlled trial; Internal medicine; Clinical trial; Oncology","score_opus":0.1663864591283641,"score_gpt":0.47502973690779965,"score_spread":0.30864327777943557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093241270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98375803,0.0010492285,0.00062322634,0.0044815755,0.00094695314,0.008295512,0.00011371347,0.00013050716,0.00060126226],"genre_scores_gemma":[0.9828328,0.00039299292,0.0020401608,0.010184847,0.001492633,0.0026991423,0.00012048269,0.000057948586,0.00017898696],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99728984,0.000325255,0.0010152189,0.0006815457,0.00024247375,0.00044564068],"domain_scores_gemma":[0.9980017,0.0009045959,0.00034625607,0.00019935546,0.00028517185,0.00026290794],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056105485,0.0003257823,0.0017398993,0.000099559125,0.000068575224,0.000041999236,0.00012132999,0.00011135814,0.0004731271],"category_scores_gemma":[0.0002509447,0.0002539372,0.0003832056,0.00035445797,0.00013341247,0.00011742219,0.000044376076,0.00027927596,0.00000682674],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9585151,0.0003558066,0.0027599682,0.0002586188,0.00066369836,0.000035196303,0.008255431,0.000044890017,0.00150945,0.0000112302605,0.004073437,0.023517191],"study_design_scores_gemma":[0.96479565,0.005919125,0.0014842211,0.00029106424,0.0006329195,0.0000018557622,0.0032897983,0.0011824064,0.004077112,0.000025409308,0.017959626,0.0003408331],"about_ca_topic_score_codex":0.000310304,"about_ca_topic_score_gemma":0.0009173333,"teacher_disagreement_score":0.023176359,"about_ca_system_score_codex":0.00051957916,"about_ca_system_score_gemma":0.0012033506,"threshold_uncertainty_score":0.9999913},"labels":[],"label_agreement":null},{"id":"W3096869953","doi":"10.2217/pgs-2020-0056","title":"Unraveling Heterogeneity of the Clinical Pharmacogenomic Guidelines in Oncology Practice Among Major Regulatory Bodies","year":2020,"lang":"en","type":"review","venue":"Pharmacogenomics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Clinical Oncology; Medicine; Clinical Practice; Personalized medicine; Drug response; Drug; Oncology; Intensive care medicine; Internal medicine; Pharmacology; Bioinformatics; Cancer; Family medicine; Genotype; Biology; Genetics","score_opus":0.2497313678221193,"score_gpt":0.5320333608091322,"score_spread":0.2823019929870129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096869953","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006538659,0.98491126,0.00000464444,0.0012936604,0.0028822003,0.0030188728,0.00023480534,0.000055661338,0.0010602231],"genre_scores_gemma":[0.0008036239,0.99264795,0.00089528586,0.0026649802,0.0022314119,0.0002147236,0.000085458225,0.00016374177,0.00029284143],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933294,0.0013926778,0.003368754,0.0009763172,0.00034471386,0.0005881486],"domain_scores_gemma":[0.9951882,0.0012802744,0.0022075768,0.0006235079,0.00032596904,0.00037447523],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017831504,0.0008070496,0.0039988356,0.00027319774,0.00010884115,0.000016440878,0.00072944554,0.0005972009,0.00017567659],"category_scores_gemma":[0.00052740256,0.0006004687,0.0018024739,0.00045102744,0.00049932057,0.000114787465,0.00059653976,0.0017468256,0.00007520477],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093281094,0.00083244004,0.0020296618,0.006287747,0.003987703,0.0004485075,0.00021490855,0.000019346577,0.00044269176,0.000010549637,0.0070373546,0.97775626],"study_design_scores_gemma":[0.004075349,0.00023346943,0.000102886595,0.0016274573,0.014725308,0.0004091169,0.000031347467,0.00011548307,0.0005241322,0.0000066155685,0.97772026,0.00042855096],"about_ca_topic_score_codex":0.00016085456,"about_ca_topic_score_gemma":0.00007725048,"teacher_disagreement_score":0.9773277,"about_ca_system_score_codex":0.0012061856,"about_ca_system_score_gemma":0.0033127286,"threshold_uncertainty_score":0.9996447},"labels":[],"label_agreement":null},{"id":"W3102553708","doi":"10.1093/oso/9780190200794.003.0028","title":"Reactions Involving Carbon–Carbon Bond Cleavage","year":2015,"lang":"en","type":"book-chapter","venue":"Oxford University Press eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry; Rhodium; Pyridine; Catalysis; Bond cleavage; Regioselectivity; Stereochemistry; Medicinal chemistry; Organic chemistry","score_opus":0.0595270012034639,"score_gpt":0.26693390514510124,"score_spread":0.20740690394163733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102553708","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011210678,0.0006956814,8.409622e-7,0.00007406229,0.0004317891,0.00054240803,0.000060270173,0.00017106121,0.9969028],"genre_scores_gemma":[0.0050605694,0.0006974906,0.00006188752,0.00007388982,0.0003708011,0.0000017325016,0.00008827644,0.000061455394,0.9935839],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99885154,0.000019830884,0.00017704623,0.0004191576,0.0002593147,0.00027313546],"domain_scores_gemma":[0.9989028,0.00004690446,0.000191093,0.00041430985,0.0001534985,0.00029136776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007216918,0.00034474937,0.0005049939,0.00023453955,0.000094219984,0.000011609285,0.0001534004,0.00044926122,0.00004945488],"category_scores_gemma":[0.00000556482,0.00038699943,0.000189646,0.000010580385,0.00016258884,0.000035847825,0.00017934352,0.00060961436,0.0000012416897],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006321402,0.0004161445,0.0005150932,0.0011123919,0.005293982,0.007891615,0.002046309,0.000007676792,0.0028086267,0.7795877,0.18214464,0.011854404],"study_design_scores_gemma":[0.0021949792,0.00031071078,0.000017911301,0.00018844834,0.0015942842,0.000047979636,0.000049328304,0.00003396661,0.00037229146,0.00036201795,0.99452335,0.00030472697],"about_ca_topic_score_codex":0.00067551096,"about_ca_topic_score_gemma":0.00014391325,"teacher_disagreement_score":0.8123787,"about_ca_system_score_codex":0.0006959151,"about_ca_system_score_gemma":0.00030420738,"threshold_uncertainty_score":0.9998582},"labels":[],"label_agreement":null},{"id":"W3103925870","doi":"10.1161/atvb.39.suppl_1.514","title":"Abstract 514: Treatment of Mice with ApoA1 Protects Them Against Doxorubicin Induced Cardiotoxicity in a Scavenger Receptor Class B Type I Dependent Manner","year":2019,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Cardiotoxicity; Doxorubicin; Scavenger receptor; Pharmacology; Apoptosis; Scavenger; Medicine; Receptor; Biology; Cancer research; Chemistry; Chemotherapy; Internal medicine; Biochemistry; Cholesterol; Antioxidant","score_opus":0.05007935317821518,"score_gpt":0.29747930145923096,"score_spread":0.24739994828101577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103925870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974257,0.00012663953,0.0000017325037,0.00031675035,0.00017791789,0.0014015863,0.000019521014,0.000024235023,0.0005059255],"genre_scores_gemma":[0.9967831,0.0025672154,0.00012566059,0.00021070983,0.00006898012,0.0001417108,0.000054122138,0.000029234718,0.000019276244],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986202,0.00011484282,0.00031007698,0.0004976594,0.00011625687,0.0003409387],"domain_scores_gemma":[0.99931616,0.00005274326,0.00012987423,0.00032590676,0.000069241025,0.00010609606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015103666,0.00028887106,0.00083510485,0.00011287794,0.000041276067,0.000010070763,0.00006752807,0.00022979047,0.00023637357],"category_scores_gemma":[0.0000048084776,0.00019674718,0.000148094,0.00018105717,0.00009792958,0.000052918847,0.00003273097,0.0001303838,0.000045544886],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014597511,0.0006894584,0.24938948,0.0000677367,0.0006670524,5.143494e-7,0.0004994027,0.000004032944,0.7475268,0.00001276466,0.000018634459,0.0009781402],"study_design_scores_gemma":[0.0065690055,0.0039502834,0.91351455,0.00016192075,0.00020547476,0.00000174323,0.00016138479,0.000019950297,0.07421975,0.0000050343115,0.0009737114,0.00021720266],"about_ca_topic_score_codex":0.00058794674,"about_ca_topic_score_gemma":0.00024372814,"teacher_disagreement_score":0.67330706,"about_ca_system_score_codex":0.00018573632,"about_ca_system_score_gemma":0.00008115329,"threshold_uncertainty_score":0.8023117},"labels":[],"label_agreement":null},{"id":"W3104220556","doi":"10.29289/259453942019v29s1cp03","title":"AXILLARY SURGICAL APPROACH IN METASTATIC BREAST CANCER PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2019,"lang":"en","type":"review","venue":"Mastology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Research Foundation","funders":"","keywords":"Breast cancer; Meta-analysis; Medicine; Metastatic breast cancer; Oncology; Cancer; Internal medicine","score_opus":0.12416491287155289,"score_gpt":0.4138942868391872,"score_spread":0.2897293739676343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104220556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003111293,0.9934805,0.0000027595977,0.0003540355,0.000068322355,0.005323744,0.00041676045,0.000017699918,0.00033303822],"genre_scores_gemma":[0.000035003144,0.9935868,0.000050437473,0.000673572,0.000020824122,0.0033115319,0.000643172,0.00004267015,0.0016360353],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99628615,0.0011433895,0.0012736004,0.00071842206,0.00020354026,0.00037487605],"domain_scores_gemma":[0.9983042,0.00034966014,0.0006393239,0.00048371012,0.00008512201,0.00013799053],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042661643,0.0005927489,0.01745392,0.00062199356,0.000022289361,0.0000087981725,0.00015044927,0.00024273417,0.0020854443],"category_scores_gemma":[0.000020829346,0.00034511782,0.0021382817,0.001064175,0.00009115081,0.000035216748,0.000094322604,0.00041690454,0.000056248973],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015585225,0.00035920562,0.000089093934,0.7886771,0.20894714,0.00012062587,0.000016600368,5.2117963e-7,1.0825849e-9,0.000021819307,0.0002652123,0.0014870885],"study_design_scores_gemma":[0.00077606936,0.000101489444,0.00001907157,0.008786325,0.93602103,0.0011049324,0.0000034463528,0.0000048417583,2.1936284e-9,0.0000014176414,0.052945897,0.00023545758],"about_ca_topic_score_codex":0.00012033009,"about_ca_topic_score_gemma":0.000039656297,"teacher_disagreement_score":0.7798908,"about_ca_system_score_codex":0.0002364163,"about_ca_system_score_gemma":0.00021967823,"threshold_uncertainty_score":0.9999001},"labels":[],"label_agreement":null},{"id":"W3105020049","doi":"10.1016/s0167-8140(20)31044-6","title":"152: Toxicity Assessment of Individualized Dosimetry Adjusted PRRT - Interim Report of the Ontario Consortium Trial OZM 067","year":2020,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Interim; Interim analysis; Medicine; Medical physics; Dosimetry; Toxicity; Nuclear medicine; Internal medicine; Clinical trial; Political science","score_opus":0.06600208622586254,"score_gpt":0.4013407703297132,"score_spread":0.3353386841038507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105020049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99082893,0.00056194246,0.0000803683,0.0034912252,0.000657856,0.0010163428,0.000016976264,0.000016708225,0.0033296205],"genre_scores_gemma":[0.9946431,0.00023893213,0.0012157792,0.0028179204,0.0002608469,0.000038266036,0.000017790413,0.000012676139,0.0007546751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870616,0.00021312591,0.00054012425,0.00023537056,0.0001548155,0.00015038862],"domain_scores_gemma":[0.9990714,0.00018062563,0.00041499833,0.00018193398,0.00004737154,0.000103662285],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002672766,0.00013865059,0.00075996056,0.000047546382,0.000036858542,0.0000031203142,0.000094659124,0.00017540062,0.0014330456],"category_scores_gemma":[0.000035501173,0.00009428932,0.00015649371,0.0001410319,0.00026245404,0.000022373342,0.00003980896,0.00025111047,2.77498e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13641942,0.0048711207,0.49292916,0.0003444316,0.003947435,0.00045678025,0.013846698,0.0000071906416,0.3091854,0.0004417321,0.016614309,0.02093634],"study_design_scores_gemma":[0.20200492,0.030026335,0.36753935,0.00007435958,0.0014096895,0.0006806656,0.0002603953,0.00015151457,0.053554613,0.000036305762,0.3439935,0.00026833243],"about_ca_topic_score_codex":0.0015328092,"about_ca_topic_score_gemma":0.002011485,"teacher_disagreement_score":0.32737923,"about_ca_system_score_codex":0.00041895753,"about_ca_system_score_gemma":0.0009264827,"threshold_uncertainty_score":0.9994798},"labels":[],"label_agreement":null},{"id":"W3112162239","doi":"10.1016/j.cct.2020.106242","title":"Recruitment strategies and design considerations in a trial of resistance training to prevent dose-limiting toxicities in colon cancer patients undergoing chemotherapy","year":2020,"lang":"en","type":"article","venue":"Contemporary Clinical Trials","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Limiting; Colorectal cancer; Chemotherapy; Cancer; Oncology; Internal medicine; Clinical trial; Intensive care medicine; Surgery","score_opus":0.6837395647107228,"score_gpt":0.5331751885168329,"score_spread":0.15056437619388996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112162239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781808,0.0016735486,0.00005393514,0.012735662,0.00029037337,0.006414972,0.000028899794,0.000020621443,0.00060117047],"genre_scores_gemma":[0.9946486,0.00081336364,0.00081755966,0.0027514684,0.00027874907,0.0005998064,0.000009621399,0.000015547634,0.00006530079],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99589753,0.0015444855,0.0018900955,0.00034722002,0.00014957646,0.00017109631],"domain_scores_gemma":[0.992039,0.0072034923,0.00045758655,0.00008928678,0.00005479713,0.00015579836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002973102,0.00015819495,0.0012620708,0.00009034719,0.000031293326,0.000026778163,0.00004255189,0.00011886931,0.000085365864],"category_scores_gemma":[0.0035420666,0.00013960763,0.000121717705,0.00017124483,0.00007945924,0.00012834423,0.000022621301,0.00018562916,5.6830845e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7490743,0.008434301,0.11176228,0.00086910604,0.0016914477,0.00028305434,0.05254562,0.00049582316,0.014506299,0.0017636769,0.016572287,0.04200181],"study_design_scores_gemma":[0.88208693,0.034124196,0.04329015,0.0036793924,0.00043404746,0.0000016446561,0.012462793,0.00023422956,0.012312354,0.005297728,0.0052323095,0.00084421557],"about_ca_topic_score_codex":0.000049313676,"about_ca_topic_score_gemma":0.00036701016,"teacher_disagreement_score":0.13301264,"about_ca_system_score_codex":0.00008826385,"about_ca_system_score_gemma":0.0013804298,"threshold_uncertainty_score":0.5693034},"labels":[],"label_agreement":null},{"id":"W3115338232","doi":"10.3389/fneur.2020.604688","title":"Impact of Cryotherapy on Sensory, Motor, and Autonomic Neuropathy in Breast Cancer Patients Receiving Paclitaxel: A Randomized, Controlled Trial","year":2020,"lang":"en","type":"article","venue":"Frontiers in Neurology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Singapore General Hospital; Terry Fox Foundation; Singapore Cancer Society","keywords":"Medicine; Tolerability; Cryotherapy; Randomized controlled trial; Chemotherapy-induced peripheral neuropathy; Clinical endpoint; Paclitaxel; Breast cancer; Chemotherapy; Peripheral neuropathy; Anesthesia; Surgery; Internal medicine; Cancer; Adverse effect","score_opus":0.011007693837429411,"score_gpt":0.2908498823704286,"score_spread":0.2798421885329992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115338232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896015,0.0005099967,0.0000066849093,0.005026405,0.001175504,0.0034570245,0.0000503928,0.00001943789,0.0001530627],"genre_scores_gemma":[0.9944961,0.0013310792,0.000028178396,0.003574599,0.00019035055,0.0003094377,0.0000053418476,0.000029445166,0.000035469227],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979707,0.00072183984,0.00056431873,0.00037152244,0.00009545268,0.00027619547],"domain_scores_gemma":[0.9991497,0.00036296665,0.00023069314,0.00010763778,0.00003008915,0.000118944394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021390524,0.00022072243,0.0017747361,0.00027222594,0.000015612099,0.0000045604424,0.0000631191,0.00012760978,0.00008932615],"category_scores_gemma":[0.0001304399,0.00016771552,0.0002678233,0.00013171344,0.00015965749,0.000036156394,0.00001999553,0.00032406137,0.0000010211913],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6665815,0.00039849733,0.32997704,0.000010711577,0.00017410151,0.0000434858,0.00038753287,0.00008436239,0.00046442283,0.00000149327,0.00070709817,0.0011697531],"study_design_scores_gemma":[0.77830607,0.0049608587,0.21283641,0.000011790957,0.00011627804,0.000005955009,0.0000047678027,0.0035891389,0.000010349396,0.000023240811,0.00005422906,0.00008090491],"about_ca_topic_score_codex":0.00030570192,"about_ca_topic_score_gemma":0.000017335737,"teacher_disagreement_score":0.117140636,"about_ca_system_score_codex":0.0000936366,"about_ca_system_score_gemma":0.00012976822,"threshold_uncertainty_score":0.6839241},"labels":[],"label_agreement":null},{"id":"W3118992528","doi":"10.32539/bsm.v5i1.162","title":"Efficacy of Alpha Lipoic Acid Supplementation In Chemotherapy-Induced Peripheral Neuropathy","year":2020,"lang":"en","type":"article","venue":"Bioscientia Medicina Journal of Biomedicine and Translational Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Peripheral neuropathy; Chemotherapy; Internal medicine; Clinical trial; Placebo; Alpha-Lipoic Acid; Hematology; Quality of life (healthcare); Double blind; Gastroenterology; Pathology; Diabetes mellitus; Oxidative stress; Alternative medicine; Nursing; Endocrinology","score_opus":0.11162516317728718,"score_gpt":0.43267608271011326,"score_spread":0.32105091953282605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118992528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94729215,0.0026734956,0.00015572929,0.049008913,0.00020644603,0.0003844293,0.000010327494,0.000003929067,0.00026455923],"genre_scores_gemma":[0.9973695,0.0009939921,0.00029714292,0.00073160673,0.00053183036,0.0000031897603,0.000027848799,0.0000117495465,0.00003314104],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976175,0.00014651404,0.0006157075,0.00020458167,0.0011606421,0.00025509484],"domain_scores_gemma":[0.99887043,0.00022669407,0.00014931987,0.0000706021,0.00035284227,0.00033009527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011686546,0.000116658804,0.00039293405,0.0006801425,0.00005594852,0.000008241614,0.000110279114,0.000060811053,0.0006057526],"category_scores_gemma":[0.00014477369,0.000085545544,0.00008295667,0.0011250185,0.00036112394,0.00010685119,0.000014576233,0.00037522338,0.0000014589809],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006261628,0.0007172378,0.05047204,0.00023407565,0.00014177762,0.00022937261,0.0054006153,0.0000013520656,0.8848848,0.00006893787,0.0022960133,0.049292192],"study_design_scores_gemma":[0.05949872,0.01686563,0.80838615,0.0005698768,0.00030545326,0.00033737093,0.0013421376,0.000779032,0.097821966,0.00013659846,0.013784163,0.0001729205],"about_ca_topic_score_codex":0.00003870281,"about_ca_topic_score_gemma":0.000008470904,"teacher_disagreement_score":0.7870628,"about_ca_system_score_codex":0.000036263078,"about_ca_system_score_gemma":0.000456455,"threshold_uncertainty_score":0.6632566},"labels":[],"label_agreement":null},{"id":"W3120723698","doi":"10.1016/j.esmoop.2020.100019","title":"Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)","year":2021,"lang":"en","type":"article","venue":"ESMO Open","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; European Society for Medical Oncology; Eisai; Eli Lilly and Company; Takeda Pharmaceutical Company; Roche; Teva Pharmaceutical Industries; Les Laboratories Pierre Fabre; AstraZeneca","keywords":"Eribulin; Gemcitabine; Medicine; Internal medicine; Metastatic breast cancer; Triple-negative breast cancer; Oncology; Neutropenia; Regimen; Clinical endpoint; Phases of clinical research; Febrile neutropenia; Breast cancer; Adverse effect; Clinical trial; Cancer; Toxicity","score_opus":0.08808522107393496,"score_gpt":0.45142079871338525,"score_spread":0.3633355776394503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120723698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863081,0.00010676991,0.000004918503,0.0013216515,0.0002026817,0.011167912,0.0008158285,0.0000035735068,0.000068556656],"genre_scores_gemma":[0.9972127,0.00045372828,0.000212451,0.00013865191,0.000027838858,0.0013805976,0.00008318239,0.000018159673,0.00047265305],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99792004,0.00041593387,0.0008749276,0.0003772757,0.0002504284,0.00016140746],"domain_scores_gemma":[0.9973403,0.0012358621,0.00068565167,0.00031162918,0.00036168334,0.000064835345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003993402,0.00020291007,0.0008976417,0.000045111276,0.00008999659,0.0000074216805,0.0001705376,0.000043797052,0.00013646629],"category_scores_gemma":[0.00012006929,0.00009120864,0.000083513325,0.00037867285,0.00024030899,0.00006455778,0.00007576434,0.000102227394,1.5163168e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7705467,0.09939826,0.059580687,0.000059026865,0.0017760885,0.00002601462,0.0026521883,0.00015424578,0.00006676431,0.0000061802116,0.00016069924,0.06557314],"study_design_scores_gemma":[0.5228265,0.17426719,0.29685214,0.00012713239,0.001977581,0.0000021182473,0.00076241506,0.000103833365,0.002530336,0.000008571688,0.00045276023,0.000089394096],"about_ca_topic_score_codex":0.0008366315,"about_ca_topic_score_gemma":0.0056859045,"teacher_disagreement_score":0.24772018,"about_ca_system_score_codex":0.00011544024,"about_ca_system_score_gemma":0.00060006743,"threshold_uncertainty_score":0.37193802},"labels":[],"label_agreement":null},{"id":"W3122730376","doi":"10.1016/j.eclinm.2021.100730","title":"A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer","year":2021,"lang":"en","type":"article","venue":"EClinicalMedicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Arnold Ventures","keywords":"Medicine; Surrogate endpoint; Breast cancer; Overall survival; Oncology; Correlation; Survival analysis; Event (particle physics); Internal medicine; Cancer","score_opus":0.14350677167944517,"score_gpt":0.45889658549403006,"score_spread":0.31538981381458486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122730376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9553561,0.00041735428,0.002083361,0.036098372,0.0030558426,0.0015201666,0.00047692182,0.00005124381,0.0009406355],"genre_scores_gemma":[0.9840556,0.00035520585,0.00043385738,0.002849103,0.0020154188,0.00042507154,0.00039544754,0.000040941577,0.009429391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707603,0.0002739044,0.0009856169,0.0006734931,0.000531898,0.00045903193],"domain_scores_gemma":[0.99664277,0.0016875479,0.00020972789,0.00057394564,0.0004612777,0.0004247075],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013650812,0.00026887018,0.0013090776,0.00031923497,0.000059021622,0.000018076345,0.0001679957,0.00021771685,0.001979813],"category_scores_gemma":[0.0014912456,0.00023250356,0.00044574155,0.0012892622,0.0000644604,0.00007826928,0.00010098893,0.00036006887,0.00003774023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11100526,0.0030577756,0.86116385,0.00010838871,0.0048177,0.0005484054,0.0006125885,0.0006506115,0.0011053445,0.00047201075,0.009101319,0.0073567163],"study_design_scores_gemma":[0.14258946,0.0020294,0.8456144,0.00017482472,0.004146357,0.00001739982,0.00007974065,0.0012923056,0.00010012356,0.00042304778,0.0032858818,0.00024705936],"about_ca_topic_score_codex":0.002681526,"about_ca_topic_score_gemma":0.007404087,"teacher_disagreement_score":0.03324927,"about_ca_system_score_codex":0.0003073109,"about_ca_system_score_gemma":0.00083348923,"threshold_uncertainty_score":0.99893254},"labels":[],"label_agreement":null},{"id":"W3126523341","doi":"10.1186/s13007-021-00714-9","title":"A hybrid model based on general regression neural network and fruit fly optimization algorithm for forecasting and optimizing paclitaxel biosynthesis in Corylus avellana cell culture","year":2021,"lang":"en","type":"article","venue":"Plant Methods","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Paclitaxel; Elicitor; Cell culture; Artificial neural network; Extracellular; Algorithm; Botany; Biology; Chemistry; Mathematics; Biochemistry; Computer science; Machine learning; Chemotherapy","score_opus":0.06050506789970764,"score_gpt":0.3522622749619371,"score_spread":0.2917572070622295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126523341","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059085246,0.0036123125,0.93497497,0.00054927124,0.00029428923,0.000695645,0.00022822552,0.000042983884,0.00051708595],"genre_scores_gemma":[0.014840609,0.0004733037,0.98308384,0.0006655195,0.00021392149,0.000052167205,0.00030852598,0.000023993827,0.0003380938],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988853,0.00021883695,0.0002056998,0.00034606922,0.00008439721,0.00025971915],"domain_scores_gemma":[0.9990864,0.00057922,0.00008974251,0.00009506125,0.00004291503,0.00010668418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040053457,0.00018196415,0.0003658592,0.00007493508,0.00010718935,0.00002291721,0.00002585421,0.00008985496,0.000017087119],"category_scores_gemma":[0.000068535956,0.00014383641,0.000054921675,0.00009520456,0.00002231229,0.000037177808,0.000027577074,0.0001439344,8.2096925e-8],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013695741,0.00021665382,0.00100371,0.00025682375,0.000071279086,0.00028029454,0.0004876754,0.72769755,0.016975297,0.000010894791,0.002069459,0.24956076],"study_design_scores_gemma":[0.0028310227,0.00022052703,0.000050510804,0.00016932513,0.00016745488,0.00008971502,0.00003656414,0.9787377,0.017304141,0.000059929047,0.00019311365,0.00014001325],"about_ca_topic_score_codex":0.00001642002,"about_ca_topic_score_gemma":0.000005109875,"teacher_disagreement_score":0.2510401,"about_ca_system_score_codex":0.000054703032,"about_ca_system_score_gemma":0.000059679565,"threshold_uncertainty_score":0.58654785},"labels":[],"label_agreement":null},{"id":"W3127026655","doi":"10.14740/jh771","title":"A Pilot Phase II Study of the Feasibility and Efficacy of Vincristine Sulfate Liposome Injection in Patients With Relapsed or Refractory Acute Myeloid Leukemia","year":2021,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Refractory (planetary science); Vincristine; Internal medicine; Myeloid leukemia; Pharmacology; Phases of clinical research; Toxicity; Clinical trial; Oncology; Chemotherapy; Cyclophosphamide","score_opus":0.031236258482425106,"score_gpt":0.34116056460276234,"score_spread":0.3099243061203372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127026655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987177,0.00038992433,0.0000021349817,0.0002313331,0.00022102662,0.00040947617,0.000005735389,0.0000027361718,0.00001992577],"genre_scores_gemma":[0.99971694,0.000065066095,0.000057583344,0.00004586183,0.000027269902,0.0000031506884,0.0000027693934,0.000008574923,0.00007281035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876165,0.00020676547,0.00060328475,0.00013490835,0.00018062963,0.000112737835],"domain_scores_gemma":[0.9986811,0.0001814865,0.000609564,0.00017067301,0.00030053811,0.00005660889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018792255,0.000106210486,0.00064095337,0.00012221273,0.000038395538,0.0000015867827,0.00005745894,0.000046573598,0.0000645476],"category_scores_gemma":[0.0001714216,0.000058867798,0.000051055464,0.00025871207,0.00009800051,0.000054373373,0.00005365308,0.00029731807,1.5033379e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.065675706,0.02010376,0.89754385,0.0001516875,0.00072506524,0.00040378506,0.0015971885,0.000008911267,0.012426274,0.0000064339265,0.00025018328,0.0011071361],"study_design_scores_gemma":[0.088723846,0.07838922,0.82254595,0.00017712606,0.00094061386,0.0011534469,0.000263893,0.000008205524,0.007671972,0.000018217515,0.000044746845,0.00006278396],"about_ca_topic_score_codex":0.00006818022,"about_ca_topic_score_gemma":0.0002908588,"teacher_disagreement_score":0.07499793,"about_ca_system_score_codex":0.00018928367,"about_ca_system_score_gemma":0.0004385992,"threshold_uncertainty_score":0.24005592},"labels":[],"label_agreement":null},{"id":"W3129274860","doi":"10.32553/ijmbs.v5i2.1746","title":"RANDOMIZED PHASE III TRIAL COMPARING EPIRUBICIN/ DOXORUBICIN PLUS DOCETAXEL AND EPIRUBICIN/ DOXORUBICIN PLUS PACLITAXEL AS FIRST LINE TREATMENT IN WOMEN WITH ADVANCED BREAST CANCER","year":2021,"lang":"en","type":"article","venue":"International Journal of Medical and Biomedical Studies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lions Gate Hospital","funders":"","keywords":"Epirubicin; Medicine; Docetaxel; Anthracycline; Doxorubicin; Regimen; Chemotherapy; Paclitaxel; Internal medicine; Breast cancer; Neutropenia; Gastroenterology; Urology; Cancer","score_opus":0.04402779330855026,"score_gpt":0.41228444571505113,"score_spread":0.36825665240650085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129274860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8940779,0.023288123,0.00007943777,0.08064502,0.0011686318,0.00058486,0.00003364371,0.000015894297,0.00010647341],"genre_scores_gemma":[0.9105336,0.08508535,0.000109693996,0.0020967694,0.0016623772,0.0001516383,0.000019024159,0.000018300943,0.0003232482],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959524,0.00020725542,0.0013017377,0.0004232718,0.0016578936,0.00045742956],"domain_scores_gemma":[0.9970307,0.001112637,0.00047201448,0.00010506131,0.0005010646,0.00077857554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00112814,0.00039415818,0.0022485596,0.000326493,0.00011406046,0.00003949203,0.00018489969,0.00018355095,0.0006547019],"category_scores_gemma":[0.0005355287,0.0002221324,0.0001798394,0.0002876412,0.0010962217,0.00013390557,0.00018502105,0.0005117984,0.0000020830169],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8540851,0.003232335,0.000949601,0.0001386852,0.0061129257,0.008060249,0.0042170472,0.000015649171,0.00048250757,0.000084985666,0.0007037047,0.12191725],"study_design_scores_gemma":[0.9729788,0.0050104368,0.0011666596,0.0019153145,0.0008084972,0.0035379222,0.0024546962,0.00051102333,0.0004197725,0.00026619935,0.010682121,0.00024859878],"about_ca_topic_score_codex":0.0008159962,"about_ca_topic_score_gemma":0.00069928257,"teacher_disagreement_score":0.121668644,"about_ca_system_score_codex":0.0010623307,"about_ca_system_score_gemma":0.0010427765,"threshold_uncertainty_score":0.9058296},"labels":[],"label_agreement":null},{"id":"W3130823265","doi":"10.1158/1538-7445.sabcs20-gs4-01","title":"Abstract GS4-01: Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor + (HR+) metastatic breast cancer (MBC) who have previously received a taxane","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Capecitabine; Medicine; Taxane; Metastatic breast cancer; Regimen; Internal medicine; Breast cancer; Chemotherapy; Cancer; Oncology; Chemotherapy regimen; Fluorouracil; Gastroenterology; Urology; Colorectal cancer","score_opus":0.08037823029429043,"score_gpt":0.4083962176252598,"score_spread":0.3280179873309694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130823265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834962,0.0058688982,7.1456714e-7,0.001458703,0.00023442591,0.0039123064,0.0047123176,0.00002427709,0.00029216317],"genre_scores_gemma":[0.99426776,0.0020587659,0.00012937615,0.000039073628,0.00022625706,0.0013606228,0.0008520611,0.000090276095,0.0009758286],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99453986,0.0005743692,0.0012560353,0.0011063035,0.0015644135,0.00095903716],"domain_scores_gemma":[0.99505764,0.00086963794,0.0005563163,0.0008815711,0.0021760364,0.0004588229],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00081064715,0.00047831566,0.0017356953,0.0004928915,0.000107488544,0.000028185907,0.00031664871,0.00014274011,0.0022516875],"category_scores_gemma":[0.0004572876,0.00039402593,0.00013844686,0.0015652274,0.0004212861,0.00019791123,0.000168139,0.0009282964,0.000009128836],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5672352,0.040961716,0.041862026,0.0008394369,0.006289034,0.0011428907,0.020642152,0.00026638596,0.2793362,0.0000019983643,0.012485345,0.028937645],"study_design_scores_gemma":[0.44030935,0.01765167,0.49394503,0.0020153308,0.0013173148,0.000008940122,0.0076901955,0.00013791086,0.035680927,0.0000068614077,0.00060028804,0.00063619367],"about_ca_topic_score_codex":0.063831575,"about_ca_topic_score_gemma":0.028431328,"teacher_disagreement_score":0.452083,"about_ca_system_score_codex":0.0017655365,"about_ca_system_score_gemma":0.0022947462,"threshold_uncertainty_score":0.99985117},"labels":[],"label_agreement":null},{"id":"W3134332329","doi":"10.1016/j.annonc.2021.01.053","title":"38MO IND.236: A Canadian Cancer Trial Group (CCTG) phase Ib trial of combined CFI-402257 and weekly paclitaxel (Px) in patients with HER2-negative (HER2-) advanced breast cancer (BC)","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University Health Network; Queen's University; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"Ontario Institute for Cancer Research; Canadian Cancer Society; Stand Up To Cancer Canada; Government of Ontario","keywords":"Medicine; Taxane; Internal medicine; Neutropenia; Febrile neutropenia; Chemotherapy; Breast cancer; Nausea; Adverse effect; Gastroenterology; Cancer; Oncology","score_opus":0.04667935103306406,"score_gpt":0.40746208288190044,"score_spread":0.36078273184883636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134332329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840229,0.00055604044,9.2820994e-7,0.010430952,0.00082912075,0.0020519888,0.00095302094,0.000011482743,0.0011435328],"genre_scores_gemma":[0.9958016,0.0012255255,0.000099946374,0.0015350623,0.00026709656,0.0004963582,0.00016807095,0.00003467865,0.00037164186],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976897,0.0003148186,0.0006888745,0.00048310883,0.00027290644,0.0005505733],"domain_scores_gemma":[0.99803853,0.0002875804,0.00046191338,0.00023799148,0.000591722,0.00038229008],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025938422,0.00030000336,0.0012618862,0.00028682893,0.000059152688,0.0000063219704,0.00010383503,0.00027397592,0.0010733638],"category_scores_gemma":[0.00010226692,0.0002604417,0.0001257955,0.000509816,0.0003443754,0.00012296729,0.000045844292,0.00032299035,0.0000017434129],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8103019,0.009675923,0.058099214,0.00013203925,0.0010311775,0.00021970969,0.0015400148,0.000010637936,0.00035702542,0.00008334195,0.0041552535,0.11439377],"study_design_scores_gemma":[0.7777364,0.054458164,0.15505639,0.0002495844,0.00044730378,0.000010913815,0.0003722748,0.000015687645,0.0016161696,0.00015199327,0.009594719,0.0002903639],"about_ca_topic_score_codex":0.21222508,"about_ca_topic_score_gemma":0.49523804,"teacher_disagreement_score":0.28301296,"about_ca_system_score_codex":0.00041425775,"about_ca_system_score_gemma":0.0029609022,"threshold_uncertainty_score":0.9999848},"labels":[],"label_agreement":null},{"id":"W3135671961","doi":"10.1016/j.clbc.2021.03.001","title":"Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Innovates - Health Solutions; Alberta Cancer Foundation","keywords":"Medicine; Epirubicin; Breast cancer; Pharmacogenetics; Oncology; Chemotherapy; Internal medicine; Dosing; Stage (stratigraphy); Glucuronosyltransferase; Cancer; Genotype; Genetics; Gene; Biology","score_opus":0.05108618909565029,"score_gpt":0.42020743389212056,"score_spread":0.3691212447964703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135671961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96530044,0.004542267,0.00014352548,0.025684554,0.001011298,0.0009386387,0.002240664,0.00004516014,0.00009344265],"genre_scores_gemma":[0.9862619,0.0026658196,0.00021870063,0.0083178785,0.0012479475,0.0003905133,0.00008900387,0.00008486329,0.00072339585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730843,0.00015907922,0.0009922667,0.00071902655,0.0002501718,0.00057103334],"domain_scores_gemma":[0.99832326,0.0004537095,0.00021199715,0.00034751877,0.00030182203,0.00036170313],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033432705,0.0003578858,0.0010396095,0.0001330974,0.00005855179,0.000012908056,0.00014537369,0.00021928393,0.0070527997],"category_scores_gemma":[0.000021523367,0.0003310429,0.00051600975,0.00048860314,0.00026633448,0.00006985613,0.000024932791,0.00036779098,0.0000075114826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014738006,0.002825568,0.7558588,0.00047845356,0.0006392466,0.00015870064,0.00012538764,0.0002576739,0.11657046,0.000012661622,0.001534997,0.10680005],"study_design_scores_gemma":[0.04019524,0.0004932411,0.7999945,0.000628887,0.0009205047,0.000072177565,0.000021660193,0.0010889268,0.1482495,0.000017442115,0.007903239,0.00041464999],"about_ca_topic_score_codex":0.0018383026,"about_ca_topic_score_gemma":0.00072036026,"teacher_disagreement_score":0.1063854,"about_ca_system_score_codex":0.00031828953,"about_ca_system_score_gemma":0.0016218645,"threshold_uncertainty_score":0.99991417},"labels":[],"label_agreement":null},{"id":"W3137566720","doi":"10.1007/s00520-021-06142-8","title":"A prospective multi-centre, randomized study comparing the addition of tapering dexamethasone to other standard of care therapies for taxane-associated pain syndrome (TAPS) in breast cancer patients","year":2021,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"Cancer Care Ontario","keywords":"Medicine; Taxane; Dexamethasone; Docetaxel; Discontinuation; Randomized controlled trial; Clinical endpoint; Premedication; Anesthesia; Internal medicine; Breast cancer; Chemotherapy; Surgery; Cancer","score_opus":0.020252400871443164,"score_gpt":0.3464352647913625,"score_spread":0.32618286391991935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137566720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890443,0.0029004477,0.000019111692,0.00029463635,0.00020718525,0.0048412792,0.0026441615,0.000011974109,0.0000369154],"genre_scores_gemma":[0.9966359,0.00014646995,0.000071489696,0.00015945597,0.000027551003,0.0027529693,0.00012840611,0.000033093944,0.000044636537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981337,0.0004454169,0.0005332928,0.00034490522,0.00026418382,0.00027846068],"domain_scores_gemma":[0.99791116,0.00041488666,0.00030989293,0.00013766623,0.0011737504,0.000052629315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004018705,0.00020671161,0.0011069247,0.00013500579,0.00003852019,0.000006615692,0.000070723,0.00006570528,0.00050310604],"category_scores_gemma":[0.00020930466,0.00015514132,0.00016681851,0.0004438502,0.000094099705,0.000054886736,0.000039915536,0.00014929072,2.3409518e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045418236,0.0010158694,0.8813723,0.00026389005,0.00078586466,0.000025679763,0.06684168,0.00018038812,0.00042635,0.0000027158258,0.00008143075,0.003585635],"study_design_scores_gemma":[0.20852777,0.0012946659,0.71594113,0.0011813786,0.0005096217,0.0000013814966,0.06667194,0.00007898589,0.0054835933,0.0000068919353,0.00009998123,0.00020266419],"about_ca_topic_score_codex":0.004520248,"about_ca_topic_score_gemma":0.055823013,"teacher_disagreement_score":0.16543114,"about_ca_system_score_codex":0.0015354577,"about_ca_system_score_gemma":0.00043727426,"threshold_uncertainty_score":0.96140575},"labels":[],"label_agreement":null},{"id":"W3138402725","doi":"10.36076/ppj.2008/11/863","title":"Pulsed Radiofrequency for Metastatic PainTreatment","year":2008,"lang":"en","type":"article","venue":"Pain Physician","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baylis Medical (Canada)","funders":"","keywords":"Cannula; Medicine; Zygapophyseal Joint; Neurolysis; Fluoroscopy; Imaging phantom; Image stitching; Lesion; Surgery; Radiology; Nuclear medicine; Biomedical engineering; Lumbar; Facet joint","score_opus":0.047764122951220164,"score_gpt":0.3242966672286543,"score_spread":0.2765325442774341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138402725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8740204,0.011117629,0.022408776,0.020463327,0.0014529882,0.01128599,0.00027215085,0.0008653923,0.05811334],"genre_scores_gemma":[0.98818797,0.00014223595,0.0020261758,0.005776645,0.00043865072,0.00046593582,0.00016299884,0.000029017268,0.00277037],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992207,0.000079918434,0.00014124042,0.00020081789,0.000099752535,0.00025756212],"domain_scores_gemma":[0.99942994,0.00021919546,0.000047920454,0.0001569112,0.000045522534,0.000100488054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015462858,0.00014526729,0.000289546,0.000048700575,0.0001151097,0.0000032931675,0.000039946084,0.000021780561,0.00011272866],"category_scores_gemma":[0.000027077509,0.00011866534,0.00016892668,0.00011327444,0.000057102767,0.00003466947,0.0000049989576,0.00005011116,0.00004485836],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001814493,0.006873515,0.01448589,0.00054446975,0.0033028924,0.00080618303,0.0037013136,0.000042922333,0.068700574,0.0020223935,0.1708445,0.7268609],"study_design_scores_gemma":[0.05137564,0.015056848,0.01944312,0.00024593863,0.004467878,0.00026380052,0.0006836557,0.008094676,0.09702941,0.015277763,0.78656775,0.0014935132],"about_ca_topic_score_codex":0.000050470895,"about_ca_topic_score_gemma":0.0000051392612,"teacher_disagreement_score":0.72536737,"about_ca_system_score_codex":0.00015521779,"about_ca_system_score_gemma":0.0001002434,"threshold_uncertainty_score":0.48390323},"labels":[],"label_agreement":null},{"id":"W3139800722","doi":"","title":"Chemotherapy: managing side effects and safe handling.","year":2009,"lang":"en","type":"article","venue":"The Canadian veterinary journal = La revue veterinaire canadienne","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Chemotherapy; Business; Risk analysis (engineering); Intensive care medicine; Computer science; Medicine; Surgery","score_opus":0.015654418868362673,"score_gpt":0.26560364698624495,"score_spread":0.24994922811788228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139800722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.949926,0.0026381733,0.000008644459,0.040057667,0.00053457875,0.00037771856,0.000008686511,0.00003051968,0.006418018],"genre_scores_gemma":[0.99054813,0.0009953236,0.0002579335,0.0061695366,0.000605969,0.000014313709,0.000006247282,0.000039631046,0.0013628989],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983748,0.00014395018,0.00027287335,0.0002873201,0.00009729842,0.0008237171],"domain_scores_gemma":[0.99804604,0.00011162961,0.00011290421,0.0002973096,0.00006687559,0.0013652572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041262672,0.00029822107,0.00040900637,0.00031706347,0.00066268904,0.00011604468,0.00020038661,0.00012027311,0.00009028971],"category_scores_gemma":[0.000037860515,0.00023910987,0.0001298289,0.00021681334,0.00015369616,0.00011959597,0.000022201613,0.00054410833,0.000010179832],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026614026,0.0001684343,0.0026345698,0.0006110161,0.0008563966,0.09142137,0.0069636945,0.00003067345,0.032376904,0.0011015398,0.008172344,0.85300165],"study_design_scores_gemma":[0.005552243,0.011602427,0.28182572,0.0009890249,0.0004888125,0.21149784,0.00021434268,0.00030554025,0.00019695522,0.0015839589,0.4850538,0.0006893097],"about_ca_topic_score_codex":0.0424723,"about_ca_topic_score_gemma":0.123549215,"teacher_disagreement_score":0.8523123,"about_ca_system_score_codex":0.0010822169,"about_ca_system_score_gemma":0.00047216268,"threshold_uncertainty_score":0.9750618},"labels":[],"label_agreement":null},{"id":"W3140545115","doi":"10.3390/toxins13040235","title":"Tetrodotoxin for Chemotherapy-Induced Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Finding Trial","year":2021,"lang":"en","type":"article","venue":"Toxins","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Placebo; Medicine; Neuropathic pain; Anesthesia; Adverse effect; Randomized controlled trial; Cohort; Pregabalin; Internal medicine; Pathology","score_opus":0.0721859294665846,"score_gpt":0.35824726107672694,"score_spread":0.28606133161014236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140545115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602735,0.0011688587,0.0029784401,0.011737919,0.0019612222,0.015820125,0.000020765725,0.00021806949,0.0058210907],"genre_scores_gemma":[0.9731266,0.00028926387,0.0008492924,0.0044698655,0.00224764,0.0044221627,0.00012253846,0.0000756493,0.014397003],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99720913,0.00086708664,0.00062302465,0.0005298736,0.0002600225,0.0005108505],"domain_scores_gemma":[0.9964816,0.002585182,0.0002164435,0.00035056303,0.00014755815,0.00021864423],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030494248,0.00034181753,0.0015346066,0.00015456228,0.00016225978,0.000051010153,0.000111440146,0.0002030387,0.0011684586],"category_scores_gemma":[0.0009916571,0.0002731803,0.0008300558,0.0002543486,0.0000643091,0.00006661074,0.000030725343,0.00031346089,0.000044276683],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9652771,0.0009150211,0.00002777243,0.000069845235,0.0008591321,0.00017055093,0.00039711889,0.000011164498,0.022551404,0.000238969,0.0030127221,0.0064692004],"study_design_scores_gemma":[0.9698122,0.001199965,0.0000047625485,0.00004458304,0.00095441664,0.000055328695,0.00006375197,0.0017274406,0.012156785,0.00010512888,0.013636712,0.00023889636],"about_ca_topic_score_codex":0.000028358489,"about_ca_topic_score_gemma":0.0000464065,"teacher_disagreement_score":0.012853079,"about_ca_system_score_codex":0.0001490933,"about_ca_system_score_gemma":0.00048066393,"threshold_uncertainty_score":0.99997205},"labels":[],"label_agreement":null},{"id":"W3142109413","doi":"10.6000/1929-2279.2012.01.01.16","title":"Treatment of Chemotherapy - Induced Peripheral Neuropathy: The Physicians Need Guidelines, the Patients Need Help","year":2012,"lang":"en","type":"article","venue":"Journal of cancer research updates","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Group B; Allodynia; Peripheral neuropathy; Group A; Chemotherapy-induced peripheral neuropathy; Amitriptyline; Gabapentin; Anesthesia; Oxycodone; Pregabalin; Internal medicine; Hyperalgesia; Opioid; Nociception","score_opus":0.11638956256335735,"score_gpt":0.461953186034648,"score_spread":0.34556362347129066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3142109413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579398,0.007358518,0.0000015987241,0.03333691,0.0005309531,0.0005390671,0.000015216849,0.000005241804,0.00027269946],"genre_scores_gemma":[0.98916495,0.0066405386,0.000033672248,0.0012072506,0.002279887,0.00004771115,0.0000062625445,0.000028309565,0.00059140276],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979665,0.00028185965,0.00047633966,0.00009919817,0.000745651,0.00043042266],"domain_scores_gemma":[0.99803495,0.0002066204,0.0003046767,0.00023995961,0.0010792525,0.00013450788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000569082,0.00015577975,0.00037600804,0.00012393565,0.0001552761,0.000023817076,0.00023220212,0.00004724906,0.00036236385],"category_scores_gemma":[0.00006767411,0.000070595794,0.00020571066,0.0003916469,0.00017737807,0.00014505857,0.000030366158,0.00031532813,0.0000046560135],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007050656,0.003530332,0.5133385,0.000048429647,0.0016491838,0.000025568688,0.008072501,0.00003863374,0.14776596,0.000064606415,0.07680505,0.24161056],"study_design_scores_gemma":[0.01904826,0.010897767,0.3758915,0.00017418481,0.000668635,0.00007182899,0.0030325532,0.00018137503,0.15792602,0.00009481859,0.43178946,0.00022357336],"about_ca_topic_score_codex":0.0006585861,"about_ca_topic_score_gemma":0.00003831354,"teacher_disagreement_score":0.35498443,"about_ca_system_score_codex":0.00037819578,"about_ca_system_score_gemma":0.00038064754,"threshold_uncertainty_score":0.396763},"labels":[],"label_agreement":null},{"id":"W3145070328","doi":"10.5430/jst.v10n2p30","title":"A pilot study to evaluate the efficacy of PEC blocks in minimising chronic post-mastectomy pain","year":2021,"lang":"en","type":"article","venue":"Journal of Solid Tumors","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Mastectomy; Blockade; Chronic pain; Prospective cohort study; Anesthesia; Block (permutation group theory); Surgery; Physical therapy; Internal medicine; Breast cancer; Cancer","score_opus":0.03725739247321615,"score_gpt":0.36790837557810724,"score_spread":0.3306509831048911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3145070328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942786,0.001304924,0.00000912447,0.0035584513,0.0002544137,0.0004152258,0.000002574366,0.0000037351213,0.00017296198],"genre_scores_gemma":[0.9987479,0.000030127203,0.00006248849,0.00045973455,0.0004128836,0.0000058923565,8.742601e-7,0.0000144436235,0.00026567918],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984251,0.0003321893,0.0005868795,0.00012307224,0.00032462823,0.00020809154],"domain_scores_gemma":[0.9987592,0.00041589673,0.00020560104,0.00015759573,0.00034304414,0.000118648626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001276048,0.00012159713,0.00048289707,0.00018271351,0.00003717278,0.000008521143,0.000111221,0.000012070927,0.00040308016],"category_scores_gemma":[0.0004260467,0.00007738171,0.00011615134,0.00036435365,0.00003458946,0.000044438017,0.000046755627,0.00030524557,0.000004382895],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02158377,0.03128099,0.14983585,0.00037677368,0.0028702235,0.01692587,0.03848253,0.0053746495,0.6901727,0.0000110230785,0.007398764,0.035686877],"study_design_scores_gemma":[0.046125725,0.08622575,0.7906249,0.001852195,0.0019270785,0.0027966888,0.012247615,0.00046106975,0.056351114,0.00005146234,0.0010069996,0.00032936095],"about_ca_topic_score_codex":0.00007648656,"about_ca_topic_score_gemma":0.00025642427,"teacher_disagreement_score":0.6407891,"about_ca_system_score_codex":0.00028033587,"about_ca_system_score_gemma":0.0008608247,"threshold_uncertainty_score":0.4413445},"labels":[],"label_agreement":null},{"id":"W3150802936","doi":"10.22033/esgf/cmip6.1305","title":"CCCma CanESM5 model output prepared for CMIP6 DAMIP","year":2019,"lang":"en","type":"dataset","venue":"Earth System Grid Federation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental science","score_opus":0.05460404728949472,"score_gpt":0.33625416784027073,"score_spread":0.281650120550776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3150802936","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006066692,0.00062399247,0.00050374086,0.0002642293,0.004343096,0.0041745952,0.9888167,0.00009073344,0.00057627785],"genre_scores_gemma":[0.0064778086,0.000058883412,0.00018237096,0.00035612893,0.0029127446,0.0007181606,0.9758307,0.000041544838,0.013421675],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982244,0.00007431508,0.0005115266,0.00055797474,0.00030973615,0.0003220429],"domain_scores_gemma":[0.9987527,0.00007944611,0.00031714598,0.00051284063,0.00020607759,0.00013179042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020092385,0.00037222117,0.00076225115,0.00015132292,0.00022120943,0.00009722359,0.00009768751,0.00042868123,0.000104909035],"category_scores_gemma":[0.0000248153,0.00033171807,0.0002106949,0.0000644041,0.000018508312,0.00009084295,0.000028182554,0.00020405279,0.00033158853],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006328554,0.000117226875,0.00002284598,0.0026795997,0.00027453524,0.000017241784,0.00006406514,0.0014401979,0.0000748866,0.000011763449,0.99450034,0.00016445026],"study_design_scores_gemma":[0.0039067725,0.0006918286,0.00004048495,0.0004212758,0.0008975091,0.000088428766,0.000034574517,0.03418023,0.00018512565,0.000001915875,0.95925426,0.0002975604],"about_ca_topic_score_codex":0.00027145955,"about_ca_topic_score_gemma":0.0009571685,"teacher_disagreement_score":0.03524604,"about_ca_system_score_codex":0.00028576454,"about_ca_system_score_gemma":0.0006512121,"threshold_uncertainty_score":0.9999135},"labels":[],"label_agreement":null},{"id":"W3155627233","doi":"10.2196/27502","title":"Chemotherapy-Induced Peripheral Neuropathy Detection via a Smartphone App: Cross-sectional Pilot Study","year":2021,"lang":"en","type":"article","venue":"JMIR mhealth and uhealth","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Peripheral neuropathy; Preprint; Medicine; Cross-sectional study; Smartphone app; mHealth; Computer science; Internet privacy; World Wide Web; Psychological intervention; Psychiatry; Pathology","score_opus":0.07611310804354308,"score_gpt":0.41649403263922335,"score_spread":0.34038092459568026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155627233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995721,0.000690384,0.000055736222,0.0011199997,0.0009636851,0.000960452,0.0000079152505,0.0001256016,0.00035523702],"genre_scores_gemma":[0.99304354,0.00035297635,0.000049357222,0.004450097,0.00094275386,0.00018803567,0.000030756757,0.000035012312,0.00090744975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823934,0.00017016474,0.0003840909,0.0005149473,0.000245425,0.0004460152],"domain_scores_gemma":[0.9990274,0.00004605233,0.00012027488,0.00020517308,0.00013237745,0.0004687638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002597821,0.00020558953,0.00036287803,0.00009128384,0.00037370485,0.00003491123,0.000036368394,0.00006942946,0.00037283124],"category_scores_gemma":[0.000011072909,0.0001908506,0.000052774445,0.00030299716,0.00004551883,0.00006949806,0.000024101015,0.00037976506,0.000018021045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008037029,0.0061753867,0.90849245,0.0006335237,0.00011226455,0.00019974133,0.0014945912,0.0000014127316,0.030443808,0.000008845178,0.00030547506,0.0440955],"study_design_scores_gemma":[0.009177929,0.012538523,0.97488725,0.000007972388,0.00007196852,0.0004477592,0.000103057006,0.00010861746,0.0009656247,0.000023072342,0.001542404,0.00012580567],"about_ca_topic_score_codex":0.0005478452,"about_ca_topic_score_gemma":0.00055568427,"teacher_disagreement_score":0.06639484,"about_ca_system_score_codex":0.0002912933,"about_ca_system_score_gemma":0.0005767205,"threshold_uncertainty_score":0.77826613},"labels":[],"label_agreement":null},{"id":"W3159181549","doi":"10.14283/cw.2021.1","title":"Psychological Disorders, Cognitive Impairment, and Quality of Life with Chemotherapy-induced Neuropathy in Colon and Rectal Carcinoma Patients","year":2021,"lang":"en","type":"article","venue":"Care weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oxaliplatin; Medicine; Internal medicine; Colorectal cancer; Chemotherapy; Quality of life (healthcare); Anxiety; Montreal Cognitive Assessment; Hospital Anxiety and Depression Scale; Depression (economics); Oncology; Gastroenterology; Cancer; Psychiatry; Cognitive impairment; Disease","score_opus":0.02942125168895163,"score_gpt":0.3358955092688345,"score_spread":0.30647425757988284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159181549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741,0.0008138166,7.505574e-7,0.00042324292,0.00005853594,0.0003909029,0.000035235757,0.000009695892,0.0008578124],"genre_scores_gemma":[0.9989839,0.00016103544,0.000018896852,0.0006818501,0.000024468316,0.000023625167,0.0000584352,0.000009894442,0.000037884012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928087,0.00010887154,0.00014856414,0.00025547456,0.000085477914,0.000120724944],"domain_scores_gemma":[0.9996072,0.00007736684,0.00005836986,0.00006914782,0.00009890684,0.000088994486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004033644,0.000104397106,0.0002742843,0.00003472958,0.000021399304,0.0000041908716,0.00001586475,0.000059293678,0.000048091464],"category_scores_gemma":[0.00003862761,0.000083044775,0.000026040458,0.000114682196,0.00008032385,0.0000228817,0.000020307332,0.00010623993,3.5733282e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030954755,0.0006056589,0.9813965,0.000093712624,0.00003505691,0.000032388336,0.001745346,2.1772902e-8,0.0037983528,0.000003956075,0.00005455704,0.009138953],"study_design_scores_gemma":[0.01369168,0.0044244444,0.9787205,0.000039921928,0.000053102296,0.000007749318,0.0012361436,0.0000015083498,0.001693163,0.0000049566847,0.000046755802,0.00008006027],"about_ca_topic_score_codex":0.00014470983,"about_ca_topic_score_gemma":0.00030328886,"teacher_disagreement_score":0.010596205,"about_ca_system_score_codex":0.000030671163,"about_ca_system_score_gemma":0.00005932863,"threshold_uncertainty_score":0.33864677},"labels":[],"label_agreement":null},{"id":"W3159637394","doi":"10.21037/pcm-20-69","title":"A narrative review of chemotherapy in advanced triple negative breast cancer","year":2021,"lang":"en","type":"review","venue":"Precision Cancer Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Eribulin; Medicine; Oncology; Internal medicine; Triple-negative breast cancer; Breast cancer; Anthracycline; Taxane; Olaparib; Gemcitabine; Chemotherapy; Capecitabine; Metastatic breast cancer; Cancer; Colorectal cancer","score_opus":0.05870134318040379,"score_gpt":0.4804741947722393,"score_spread":0.42177285159183553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159637394","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030186571,0.98730695,0.0000036072222,0.006137059,0.001344033,0.003801175,0.0002918747,0.000027019405,0.0010581],"genre_scores_gemma":[0.000009662537,0.9908902,0.000104393446,0.002671186,0.0008428426,0.002569874,0.00025734786,0.00008531779,0.00256917],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99604326,0.0003805337,0.0016508711,0.0008563786,0.0006649119,0.00040401967],"domain_scores_gemma":[0.9969561,0.0006122401,0.0010737253,0.0005459495,0.000571544,0.00024040935],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005236577,0.000703955,0.0063504,0.00042584297,0.000039796716,0.0000031286263,0.00024512078,0.00029975487,0.020299586],"category_scores_gemma":[0.00023651459,0.0004617244,0.0005782787,0.0019073155,0.0002311824,0.00007915732,0.00007278332,0.000743099,0.000006593865],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043225472,0.00025695816,0.000033978424,0.070063904,0.0006476413,0.000058170448,0.0013218961,4.1761695e-7,0.000010796085,0.0000037439308,0.040635068,0.88653517],"study_design_scores_gemma":[0.0046454547,0.0002938655,0.000082535036,0.4236452,0.0018430855,0.000075649856,0.00011700501,0.0000014941356,0.000020299336,0.000007950683,0.5690619,0.0002055786],"about_ca_topic_score_codex":0.0010911041,"about_ca_topic_score_gemma":0.00031587624,"teacher_disagreement_score":0.8863296,"about_ca_system_score_codex":0.0011950029,"about_ca_system_score_gemma":0.002379785,"threshold_uncertainty_score":0.99978346},"labels":[],"label_agreement":null},{"id":"W3160630885","doi":"10.3389/fphar.2021.642820","title":"Modulation of Pathological Pain by Epidermal Growth Factor Receptor","year":2021,"lang":"en","type":"review","venue":"Frontiers in Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University; St. Michael's Hospital; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; International Anesthesia Research Society","keywords":"Medicine; Epidermal growth factor receptor; Chronic pain; ErbB; Signal transduction; Bioinformatics; Cancer; Biology; Internal medicine; Psychiatry","score_opus":0.04597651062640735,"score_gpt":0.37699184041235384,"score_spread":0.3310153297859465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160630885","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030330836,0.9926053,0.0006477662,0.00029932032,0.004130211,0.0013645621,0.00039836683,0.000042608182,0.00020852794],"genre_scores_gemma":[0.00022294528,0.9935111,0.0020264925,0.0005939882,0.000483408,0.00038379387,0.0018453785,0.00005860011,0.00087432354],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960267,0.00166658,0.0009870371,0.00064770685,0.00018558897,0.00048641197],"domain_scores_gemma":[0.99867857,0.00039868616,0.0004673526,0.00017986742,0.00010058519,0.00017493046],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048707964,0.00048591403,0.0032666991,0.00040409417,0.000032978405,0.0000046704654,0.00018889397,0.0007777565,0.0025609254],"category_scores_gemma":[0.000121783436,0.00041471445,0.00057921273,0.00051319913,0.00020421828,0.0000519734,0.00008561317,0.0007770177,0.000014667893],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115356685,0.0006190177,0.0011288389,0.003935887,0.0005860645,0.00020403982,0.00004806586,5.247424e-7,0.00028741403,0.0000058182386,0.45334637,0.5397226],"study_design_scores_gemma":[0.0021983357,0.00047460306,0.0000544295,0.00095337856,0.0015945863,0.000056009667,0.00001586458,0.00006251212,0.0001826928,0.00001861522,0.9940899,0.0002991005],"about_ca_topic_score_codex":0.000012923177,"about_ca_topic_score_gemma":5.250664e-7,"teacher_disagreement_score":0.5407435,"about_ca_system_score_codex":0.00056257827,"about_ca_system_score_gemma":0.0004296607,"threshold_uncertainty_score":0.9998305},"labels":[],"label_agreement":null},{"id":"W3163182274","doi":"10.1016/j.ajem.2021.05.043","title":"Cardiotoxicity in yew berry poisoning","year":2021,"lang":"en","type":"article","venue":"The American Journal of Emergency Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Emergency department; Intensive care medicine; Psychological intervention; Intensive care unit; Refractory (planetary science)","score_opus":0.05165285271487655,"score_gpt":0.4033168906754099,"score_spread":0.3516640379605333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163182274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96525633,0.008170949,0.00005540437,0.019722776,0.0015025885,0.000082426806,0.000001049589,0.0000058392893,0.0052026133],"genre_scores_gemma":[0.9899842,0.006193332,0.000121676334,0.000957388,0.0015626053,0.0000028463146,0.0000020914647,0.000013513503,0.001162339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986006,0.0001786467,0.00059109833,0.000110776506,0.00030697748,0.00021189975],"domain_scores_gemma":[0.99892104,0.00012652672,0.00041035135,0.00018240385,0.00021818816,0.00014148712],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00056408404,0.00012021094,0.00066183467,0.00012710635,0.000039700313,9.4665717e-7,0.00011202858,0.000017695467,0.0023302543],"category_scores_gemma":[0.00022997627,0.00006977255,0.00016568699,0.00075442926,0.00018498226,0.000038689817,0.000025433035,0.0003748874,0.0000057602274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037592822,0.0010040039,0.6067248,0.00011219449,0.0020446463,0.003627498,0.00958302,0.00017620184,0.20380533,0.00018325659,0.10539443,0.063585326],"study_design_scores_gemma":[0.009896339,0.009181932,0.8786785,0.00090066873,0.0022153798,0.004108894,0.0103316065,0.00010022051,0.007931083,0.0007832554,0.07551903,0.0003530816],"about_ca_topic_score_codex":0.00027443154,"about_ca_topic_score_gemma":0.000056777462,"teacher_disagreement_score":0.2719537,"about_ca_system_score_codex":0.00010266662,"about_ca_system_score_gemma":0.0002101784,"threshold_uncertainty_score":0.99858177},"labels":[],"label_agreement":null},{"id":"W3166882697","doi":"10.1200/jco.2021.39.15_suppl.12018","title":"Long-term results from a randomized blinded sham- and waitlist-controlled trial of acupuncture for joint symptoms related to aromatase inhibitors in early stage breast cancer (S1200).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health","keywords":"Medicine; Acupuncture; Brief Pain Inventory; Randomized controlled trial; Breast cancer; Physical therapy; Internal medicine; WOMAC; Osteoarthritis; Cancer; Chronic pain","score_opus":0.07492004897205339,"score_gpt":0.4576652551877509,"score_spread":0.3827452062156975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166882697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768775,0.0011840467,0.000012176335,0.015788633,0.0027452426,0.0028652959,0.00040114607,0.0000072781822,0.00011869969],"genre_scores_gemma":[0.99458957,0.0012751822,0.00044468656,0.0012887231,0.0015587952,0.00012687243,0.00005546445,0.000023498164,0.00063720386],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9935634,0.0010130387,0.004494485,0.0003565084,0.0003018437,0.00027068346],"domain_scores_gemma":[0.988679,0.0077863135,0.0023803168,0.00019581971,0.0005276138,0.0004309693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038187825,0.00027108128,0.005467976,0.00022758877,0.000026139624,0.000012524736,0.00009564773,0.0006033347,0.00025667428],"category_scores_gemma":[0.005394436,0.00015069573,0.0011687762,0.00020690775,0.00020285357,0.000082278624,0.00005938444,0.0007879838,0.0000018038638],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9657867,0.0033260426,0.007332117,0.000034261106,0.0023875171,0.0011495424,0.0004845678,0.000019089772,0.0010605137,0.000009207915,0.0016532749,0.01675716],"study_design_scores_gemma":[0.9242464,0.010280153,0.061102428,0.00029492815,0.0025298686,0.000104622464,0.000035192177,0.000085016385,0.00035327376,0.0001364662,0.0007140549,0.00011765281],"about_ca_topic_score_codex":0.00025242817,"about_ca_topic_score_gemma":0.00063042814,"teacher_disagreement_score":0.05377031,"about_ca_system_score_codex":0.00020085352,"about_ca_system_score_gemma":0.0021442324,"threshold_uncertainty_score":0.64580333},"labels":[],"label_agreement":null},{"id":"W3167076087","doi":"10.1200/jco.2021.39.15_suppl.1061","title":"Results from CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel (T) plus a reduced dose of capecitabine (C) in patients (pts) with hormone receptor + (HR+), HER2- metastatic breast cancer (MBC) not previously treated with a taxane.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Taxane; Capecitabine; Metastatic breast cancer; Clinical endpoint; Internal medicine; Breast cancer; Phases of clinical research; Cancer; Oncology; Gastroenterology; Chemotherapy; Clinical trial","score_opus":0.09543072615978272,"score_gpt":0.4480371251360116,"score_spread":0.3526063989762289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167076087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526423,0.00053550786,0.000005772586,0.0019620813,0.00022685941,0.0012901543,0.0006492377,0.000006538174,0.000059628925],"genre_scores_gemma":[0.99636143,0.0006025708,0.0021372908,0.00032515975,0.00019297093,0.0000643115,0.00012760618,0.000030470135,0.00015816878],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9943443,0.0009772928,0.003324919,0.00042111002,0.00063970994,0.00029268744],"domain_scores_gemma":[0.99073356,0.0026280296,0.0038742332,0.00026737704,0.002157604,0.00033916766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010521071,0.0002858169,0.002701074,0.00022040564,0.000026985303,0.0000058712835,0.00016007153,0.00016786395,0.00030032135],"category_scores_gemma":[0.00149394,0.00018381426,0.00023030804,0.00047196704,0.00024994236,0.00013575183,0.000049985916,0.0006896633,0.0000017556497],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5780258,0.151164,0.191504,0.0000903681,0.0055013704,0.0018500346,0.0025921108,0.00014667404,0.007895494,8.4123064e-7,0.0010642617,0.060165007],"study_design_scores_gemma":[0.38213924,0.097882666,0.51361585,0.0005102498,0.0027749457,0.00007995862,0.0011734997,0.00027494482,0.0009828092,0.0000012730114,0.00040907727,0.00015546856],"about_ca_topic_score_codex":0.0026430213,"about_ca_topic_score_gemma":0.003081654,"teacher_disagreement_score":0.32211185,"about_ca_system_score_codex":0.00053136586,"about_ca_system_score_gemma":0.0023428595,"threshold_uncertainty_score":0.7495728},"labels":[],"label_agreement":null},{"id":"W3167816205","doi":"","title":"糖尿病性腎臓病(DKD)Basic & Clinical up-to-date2020~進化するDKD治療~II 糖尿病性腎臓病Clinical2020~Current and Future Therapeutic Strategies~ミネラルコルチコイド受容体拮抗薬への期待","year":2020,"lang":"ja","type":"article","venue":"Pharma Medica","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Current (fluid); Computer science; Internal medicine; Intensive care medicine; Engineering","score_opus":0.13313184280741894,"score_gpt":0.4615322600267572,"score_spread":0.3284004172193382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167816205","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3766077,0.16104561,0.00028868276,0.404085,0.045445193,0.0052960287,0.0006756574,0.00076205743,0.005794064],"genre_scores_gemma":[0.81896895,0.09479405,0.00012192755,0.048268575,0.036012214,0.00021499282,0.00031625282,0.0001975137,0.0011055527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9906001,0.0011795551,0.002653571,0.0023851045,0.0014161143,0.0017655713],"domain_scores_gemma":[0.9919667,0.0011746275,0.0006510352,0.00084870774,0.00030782406,0.0050510867],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0017004155,0.001326487,0.0025912013,0.00022614423,0.00056841096,0.00016838504,0.000944934,0.00075403345,0.01494685],"category_scores_gemma":[0.000344315,0.001145712,0.00078513165,0.0011897924,0.0009854592,0.000360222,0.00078650174,0.0037414276,0.001860212],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007664858,0.002652291,0.0071348515,0.0012650416,0.0032277752,0.00083148485,0.0131042125,0.0000031245233,0.0022403956,0.00044979327,0.33671,0.62471616],"study_design_scores_gemma":[0.020971052,0.0064462284,0.0066116513,0.00034603733,0.004664486,0.00008491994,0.002699731,0.0009353582,0.00043443515,0.00012593609,0.95563096,0.001049219],"about_ca_topic_score_codex":0.000047639216,"about_ca_topic_score_gemma":0.000019534622,"teacher_disagreement_score":0.62366694,"about_ca_system_score_codex":0.0002114095,"about_ca_system_score_gemma":0.0021977294,"threshold_uncertainty_score":0.9999486},"labels":[],"label_agreement":null},{"id":"W3169033212","doi":"10.1200/jco.2021.39.15_suppl.7016","title":"A mixed methods study exploring the role of perceived side effects on treatment decision-making in older adults with acute myeloid leukemia (AML).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada); Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Medicine; Myeloid leukemia; Internal medicine; Chemotherapy; Family medicine; Intensive care medicine","score_opus":0.0943905675052841,"score_gpt":0.500058440569318,"score_spread":0.40566787306403396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169033212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566054,0.0007393593,0.000069025686,0.00097096525,0.0012349137,0.000623078,0.0000012616356,0.0000058931546,0.00069496455],"genre_scores_gemma":[0.9870909,0.0011227845,0.010461326,0.00056514854,0.00060512853,0.00007132311,0.000001031586,0.000020996617,0.00006137439],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.995786,0.0018030237,0.0015629199,0.0002823221,0.000320512,0.00024521328],"domain_scores_gemma":[0.9815707,0.016811928,0.00090126996,0.00025862106,0.00028122606,0.00017621525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019065673,0.00021199095,0.0018227821,0.00015635572,0.00004549334,0.000006402939,0.00013714448,0.00016093139,0.000068597095],"category_scores_gemma":[0.0013408826,0.00010692524,0.0004197846,0.00026575875,0.0000898746,0.00007124848,0.000057844023,0.0007392502,0.000003673194],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030819647,0.00668883,0.04269395,0.000016035272,0.0019428054,0.0062999045,0.003986134,0.00008968059,0.001626672,0.0000060837624,0.00005565065,0.9057746],"study_design_scores_gemma":[0.03572052,0.063250996,0.88586974,0.00078725896,0.0022678773,0.0005672558,0.004955193,0.00009614379,0.0040610023,0.00015453906,0.0021655746,0.000103914215],"about_ca_topic_score_codex":0.00005321199,"about_ca_topic_score_gemma":0.0005832696,"teacher_disagreement_score":0.9056707,"about_ca_system_score_codex":0.00077632064,"about_ca_system_score_gemma":0.0019369504,"threshold_uncertainty_score":0.43602848},"labels":[],"label_agreement":null},{"id":"W3171111042","doi":"10.1007/978-3-030-71155-9_18","title":"Vascular Endothelial Growth Factor (VEGF) Bevacizumab and Hypertension","year":2021,"lang":"en","type":"book-chapter","venue":"Clinical cases in cardiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"","keywords":"Medicine; Bevacizumab; Blood pressure; Ramipril; Amlodipine; Folinic acid; Vascular endothelial growth factor; FOLFIRI; Ambulatory blood pressure; Sunitinib; Internal medicine; Chemotherapy; Fluorouracil; Urology; Cancer; VEGF receptors; Irinotecan; Colorectal cancer","score_opus":0.12113909535247906,"score_gpt":0.38361257241213387,"score_spread":0.2624734770596548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171111042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56425744,0.09052879,0.000022811666,0.002461317,0.01138532,0.0025110575,0.0011031558,0.00021248672,0.3275176],"genre_scores_gemma":[0.7937176,0.09317497,0.0001889277,0.0046416204,0.0073116273,0.00007052016,0.000741246,0.00017625406,0.09997723],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977149,0.00019716643,0.00076627266,0.0008498683,0.00015878578,0.00031300352],"domain_scores_gemma":[0.99672735,0.0023275458,0.00014657686,0.0004185419,0.00015435267,0.00022564748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024583054,0.0003920819,0.0021614195,0.00014351646,0.000039891584,0.0000066715475,0.000078268116,0.0011895061,0.00080798834],"category_scores_gemma":[0.00067663705,0.00033362588,0.0007801868,0.000027958873,0.00050928595,0.00002046643,0.00018537004,0.0010230243,0.000055856894],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012275938,0.0012171707,0.27831706,0.001686677,0.014911593,0.40343374,0.0001948592,0.0000051606235,0.0010973712,0.021729548,0.056463826,0.20866707],"study_design_scores_gemma":[0.015798336,0.0048951465,0.043456122,0.00042011906,0.0034870892,0.014504963,0.00002053509,0.000009194641,0.000059384325,0.0022981137,0.91424304,0.00080794265],"about_ca_topic_score_codex":0.000040489307,"about_ca_topic_score_gemma":0.000038592243,"teacher_disagreement_score":0.8577792,"about_ca_system_score_codex":0.00013410766,"about_ca_system_score_gemma":0.0002934536,"threshold_uncertainty_score":0.9999116},"labels":[],"label_agreement":null},{"id":"W3171740981","doi":"10.1200/jco.2021.39.15_suppl.e24080","title":"A randomized double-blind pilot study comparing cetirizine with diphenhydramine in the prevention of paclitaxel-associated infusion-related reactions.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Diphenhydramine; Cetirizine; Premedication; Placebo; Anesthesia; Adverse effect; Randomized controlled trial; Sedative; Paclitaxel; Context (archaeology); Chemotherapy; Internal medicine","score_opus":0.26571369849716064,"score_gpt":0.5104193089121388,"score_spread":0.24470561041497818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171740981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885959,0.00044290334,0.000014975151,0.0055905697,0.00053069653,0.001067211,8.2472127e-7,0.0000065053573,0.003750403],"genre_scores_gemma":[0.9981874,0.00042791673,0.00018198494,0.00030516807,0.00021108829,0.00003184341,0.000013872157,0.000011078681,0.0006296505],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9936845,0.0025384033,0.0030494903,0.0001704519,0.00038576854,0.00017142217],"domain_scores_gemma":[0.9917956,0.004813795,0.0025017601,0.000173086,0.0006003973,0.000115390554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007721944,0.00013950503,0.0024079524,0.00016373684,0.000040589148,0.000007167945,0.00011505954,0.00015552854,0.00023039749],"category_scores_gemma":[0.001937067,0.000076749995,0.00035065025,0.00053663517,0.0002186552,0.00008152822,0.000039566745,0.001078811,0.0000028579987],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8440217,0.05124388,0.09626301,0.000026968679,0.0028083473,0.0009978568,0.0007986976,0.00009487294,0.000739649,0.000068285924,0.00039593302,0.0025408238],"study_design_scores_gemma":[0.7988165,0.049827658,0.1461828,0.00020136073,0.00270585,0.0003011988,0.0006990971,0.00008889788,0.000075356395,0.00024205445,0.0007908839,0.00006836163],"about_ca_topic_score_codex":0.00017415658,"about_ca_topic_score_gemma":0.0013989706,"teacher_disagreement_score":0.0499198,"about_ca_system_score_codex":0.00015139021,"about_ca_system_score_gemma":0.0011976627,"threshold_uncertainty_score":0.4686957},"labels":[],"label_agreement":null},{"id":"W3172027519","doi":"10.1200/jco.2021.39.15_suppl.5025","title":"Factors associated with use of medications for anxiety and depression in testicular cancer survivors after cisplatin-based chemotherapy.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"National Institutes of Health","keywords":"Medicine; Anxiety; Common Terminology Criteria for Adverse Events; Depression (economics); Testicular cancer; Internal medicine; Quality of life (healthcare); Adverse effect; Cancer; Psychiatry","score_opus":0.1767086377752125,"score_gpt":0.48501139322897313,"score_spread":0.3083027554537606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172027519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569935,0.00067901023,0.00016664248,0.0029631108,0.00026645247,0.0001792802,0.000020711406,0.0000026198395,0.000022801722],"genre_scores_gemma":[0.9967827,0.0005311324,0.0011475907,0.0013086421,0.0001282339,0.000017525397,0.000011842312,0.000010318387,0.00006196633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986001,0.00018990025,0.00082903233,0.00012257091,0.00014555086,0.000112840695],"domain_scores_gemma":[0.9943266,0.004238102,0.00074059964,0.00007199997,0.00047493906,0.00014778947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006018715,0.00008509463,0.0008060985,0.00006424221,0.000014165782,0.0000025204477,0.000028150695,0.00022043049,0.00017102397],"category_scores_gemma":[0.0015700988,0.00005271249,0.00014502463,0.00013902118,0.00012554375,0.000043296575,0.0000086662085,0.0002833523,5.055269e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002652554,0.0016543518,0.9838282,0.000024876665,0.00047263637,0.000061054845,0.000100495134,0.000056874975,0.0005284762,9.684642e-7,0.0002704432,0.010349075],"study_design_scores_gemma":[0.012077552,0.0021146254,0.9792668,0.00020226563,0.00082403544,0.000009242166,0.000036556165,0.00041805915,0.0012499775,0.000015915533,0.003735307,0.000049624632],"about_ca_topic_score_codex":0.00007149332,"about_ca_topic_score_gemma":0.0018371565,"teacher_disagreement_score":0.010299451,"about_ca_system_score_codex":0.0000958138,"about_ca_system_score_gemma":0.0014652788,"threshold_uncertainty_score":0.25993416},"labels":[],"label_agreement":null},{"id":"W3172478157","doi":"10.1200/jco.2021.39.15_suppl.12004","title":"Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus and peripheral sensory neuropathy.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"National Institutes of Health","keywords":"Medicine; Tinnitus; Cisplatin; Internal medicine; Hearing loss; Peripheral neuropathy; Pharmacogenomics; Ototoxicity; Confounding; Neurotoxicity; Oncology; Auditory neuropathy; Cohort; Gastroenterology; Chemotherapy; Endocrinology; Toxicity; Pharmacology; Diabetes mellitus; Audiology","score_opus":0.22732918067206553,"score_gpt":0.4978560729158356,"score_spread":0.2705268922437701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172478157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99148375,0.0010748308,0.000014235386,0.0031657256,0.0017420854,0.00013481874,0.0000056229896,0.0000066062726,0.0023723114],"genre_scores_gemma":[0.99004567,0.0028350833,0.0011415761,0.0039698277,0.0014528501,0.0000018075834,0.0000016936461,0.000020360278,0.00053110486],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972904,0.00047798597,0.0016544143,0.00018709418,0.00018777706,0.00020235685],"domain_scores_gemma":[0.99679595,0.0013787716,0.0010042636,0.00011786192,0.00038416556,0.00031898113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086362957,0.0001358148,0.0012793326,0.00007299683,0.000036449404,0.0000063311304,0.00006902984,0.00019945235,0.0003953238],"category_scores_gemma":[0.0007663816,0.00011389138,0.00034160874,0.00009110794,0.00019373659,0.00006629115,0.00007075902,0.0008735662,0.0000028518668],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013774567,0.004837029,0.23101023,0.00023261581,0.0013749524,0.020888798,0.0007871221,0.000059563623,0.54651755,0.000094110736,0.002169508,0.17825393],"study_design_scores_gemma":[0.07780361,0.060769357,0.53979665,0.00030534124,0.0042989654,0.03095182,0.00080793095,0.0014190284,0.10204974,0.00035490034,0.18086092,0.0005817291],"about_ca_topic_score_codex":0.000010052634,"about_ca_topic_score_gemma":0.00000663179,"teacher_disagreement_score":0.44446784,"about_ca_system_score_codex":0.00007962022,"about_ca_system_score_gemma":0.0014753782,"threshold_uncertainty_score":0.46443555},"labels":[],"label_agreement":null},{"id":"W3174581043","doi":"10.1096/fasebj.2019.33.1_supplement.700.19","title":"Myotube Morphology and Protein Metabolism are Negatively Regulated by Chemotherapy Drugs","year":2019,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"York University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"mTORC1; Myogenesis; Ribosomal protein s6; Cachexia; Myofibril; Myosin; P70-S6 Kinase 1; Pharmacology; Chemotherapy; Endocrinology; Internal medicine; Biology; Chemistry; Cancer research; Phosphorylation; Protein kinase B; Medicine; Cancer; Myocyte; Cell biology","score_opus":0.009943037844000623,"score_gpt":0.2654006455240268,"score_spread":0.2554576076800262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174581043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828031,0.0025467009,0.000008464566,0.013033427,0.0001876551,0.00046723968,0.0000113380665,0.000018788938,0.000923275],"genre_scores_gemma":[0.9821928,0.00037805957,0.00009064172,0.0024284676,0.00025167712,0.000011482944,0.0000060930097,0.000019296871,0.014621493],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992489,0.000108833076,0.00015991426,0.00013421763,0.0001354031,0.00021269318],"domain_scores_gemma":[0.99950874,0.00003803686,0.0001532759,0.00012524356,0.000059475216,0.000115258634],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021681511,0.00013136191,0.00028198253,0.000050709317,0.0001036454,0.000019948042,0.00007999674,0.00006772443,0.0016625758],"category_scores_gemma":[0.000007030896,0.000076930446,0.00006496418,0.000096354146,0.000109880806,0.000057870682,0.000018338102,0.00034568014,0.000047796286],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012071845,0.000112063244,0.0030565548,0.000011309421,0.0003390362,0.00003900572,0.0010300663,0.0000012534396,0.9733143,0.000047221485,0.016746197,0.004095819],"study_design_scores_gemma":[0.02241426,0.0009470006,0.057232894,0.000111667294,0.00047314525,0.0022909744,0.00081741315,0.00012123531,0.8556586,0.0010753266,0.058585588,0.00027192978],"about_ca_topic_score_codex":0.000028901022,"about_ca_topic_score_gemma":9.898704e-7,"teacher_disagreement_score":0.117655724,"about_ca_system_score_codex":0.000047135694,"about_ca_system_score_gemma":0.000060802387,"threshold_uncertainty_score":0.99925005},"labels":[],"label_agreement":null},{"id":"W3174706170","doi":"10.1016/j.ejca.2021.05.025","title":"Preservation of quality of life in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial)","year":2021,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; BC Cancer Agency; Jewish General Hospital","funders":"Daiichi Sankyo Europe; EMD Serono; Genentech; European Society for Medical Oncology; Eisai; Seagen; G1 Therapeutics; MacroGenics; Silverback Therapeutics; Pfizer; NuCana; Regeneron Pharmaceuticals; Mylan; Unum Therapeutics; Helsinn Therapeutics; Amgen; Radius Health; Syndax Pharmaceuticals; Clovis Oncology; Teva Pharmaceutical Industries; Helsinn; Les Laboratories Pierre Fabre; Taiho Pharmaceutical; Eli Lilly and Company; AstraZeneca; Foundation Medicine; National Cancer Research Institute; Genomic Health; Mersana Therapeutics; Karyopharm Therapeutics; Puma Biotechnology","keywords":"Capecitabine; Trastuzumab; Metastatic breast cancer; Oncology; Medicine; Human Epidermal Growth Factor Receptor 2; Internal medicine; Placebo; Breast cancer; Cancer; Pathology; Colorectal cancer","score_opus":0.05052952878100639,"score_gpt":0.3440817760243052,"score_spread":0.29355224724329876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174706170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996543,0.00047365468,0.00001979051,0.0015275639,0.00007993148,0.0007173167,0.000417714,0.0000044005214,0.00021664081],"genre_scores_gemma":[0.9983582,0.000121589386,0.0005315975,0.00028372102,0.00015408768,0.00002342598,0.000036274887,0.00003651832,0.00045460268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976304,0.0007208457,0.00086670363,0.00020753984,0.00039330812,0.00018116191],"domain_scores_gemma":[0.99758905,0.00016994785,0.0008597151,0.0001167445,0.0010482911,0.0002162396],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034737485,0.00019867248,0.0008205675,0.00015405353,0.00003090976,0.000009766959,0.00007758368,0.000020236559,0.0016386003],"category_scores_gemma":[0.0001135049,0.00012568987,0.00006501523,0.0003040228,0.00008082326,0.00018018072,0.000022844873,0.00018315249,4.9334596e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3272972,0.001961232,0.64927894,0.00031246681,0.0017472439,0.00007785146,0.0050580897,0.00005379111,0.0065189893,0.0000054563075,0.0012021839,0.006486518],"study_design_scores_gemma":[0.10077379,0.0063705742,0.8866827,0.00058325846,0.00049336656,0.000009834362,0.0002674148,0.0000018601386,0.004569008,0.0000012967083,0.000117209114,0.00012968162],"about_ca_topic_score_codex":0.00077511143,"about_ca_topic_score_gemma":0.0013014798,"teacher_disagreement_score":0.23740375,"about_ca_system_score_codex":0.00021863029,"about_ca_system_score_gemma":0.0006155957,"threshold_uncertainty_score":0.999274},"labels":[],"label_agreement":null},{"id":"W3175511275","doi":"10.1186/s12885-021-08446-8","title":"Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer","year":2021,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Eisai Incorporated; Eisai","keywords":"Medicine; Internal medicine; Oncology; Metastatic breast cancer; Vinorelbine; Eribulin; Breast cancer; Hazard ratio; Gemcitabine; Ixabepilone; Cancer; Chemotherapy; Confidence interval","score_opus":0.1584458835225617,"score_gpt":0.4188219669357842,"score_spread":0.2603760834132225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175511275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9497542,0.04142666,0.00010456906,0.004079205,0.00070688024,0.001499834,0.0018609873,0.00006903278,0.0004986511],"genre_scores_gemma":[0.91281277,0.0041795718,0.0028354283,0.0040467223,0.0005086551,0.0025673138,0.00022002158,0.00013245492,0.072697036],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9981112,0.00014060283,0.0005607458,0.0005156221,0.00025594945,0.00041588143],"domain_scores_gemma":[0.99873394,0.00034853537,0.00024102333,0.00037955705,0.00016231164,0.00013464467],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012037825,0.0003685125,0.001964787,0.00017432391,0.000036471076,0.000013426828,0.000085360225,0.00008454677,0.12766181],"category_scores_gemma":[0.000013036106,0.00022904851,0.00069759623,0.0013719016,0.000082487735,0.0000709274,0.000027053457,0.00010526697,0.000013293969],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12572382,0.0042417706,0.05186073,0.0006396625,0.69797987,0.00078454765,0.0035752086,0.08047029,0.011092713,0.000063942156,0.0024246369,0.021142786],"study_design_scores_gemma":[0.08991297,0.0044772187,0.041228972,0.0001925985,0.7183448,0.00006905376,0.0008698284,0.003329091,0.05074044,0.00006972556,0.0895239,0.0012413879],"about_ca_topic_score_codex":0.003657519,"about_ca_topic_score_gemma":0.27046332,"teacher_disagreement_score":0.2668058,"about_ca_system_score_codex":0.0006086098,"about_ca_system_score_gemma":0.0015154217,"threshold_uncertainty_score":0.93403274},"labels":[],"label_agreement":null},{"id":"W3176123402","doi":"10.1096/fasebj.2018.32.1_supplement.536.14","title":"The Dose‐Related Effects of Doxorubicin Chemotherapy on Interstitial Amino Acid Concentrations in Skeletal Muscle","year":2018,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University; NOSM University","funders":"","keywords":"Microdialysis; Amino acid; Interstitial space; Doxorubicin; Pharmacology; Chemistry; Skeletal muscle; Saline; Metabolism; Chemotherapy; Medicine; Internal medicine; Extracellular; Biochemistry","score_opus":0.011109856655565775,"score_gpt":0.29898922838865394,"score_spread":0.28787937173308814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176123402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992523,0.00037117949,0.000029440283,0.0034412015,0.00083811587,0.00028169766,0.0000021652497,0.000008385963,0.002504789],"genre_scores_gemma":[0.99797404,0.00033221152,0.0000106051775,0.0006724667,0.0004972863,0.000006473462,0.0000025077761,0.0000091486045,0.0004952382],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992685,0.00011787163,0.00021283422,0.000075182616,0.00013665283,0.00018897047],"domain_scores_gemma":[0.9994618,0.00019979436,0.00011014362,0.00012018663,0.000048477574,0.00005959596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021787563,0.00009103516,0.0001476832,0.00004708522,0.00017452589,0.000014186117,0.00010681492,0.000043061944,0.00033645597],"category_scores_gemma":[0.000029839262,0.00004643452,0.0000846513,0.00012460696,0.00030732193,0.000032185566,0.000010707861,0.00030781393,0.000027075721],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009584909,0.0003498424,0.0017529769,0.000010683714,0.0002565633,0.000077818,0.002988155,0.0000062216823,0.962169,0.00045636634,0.0029087772,0.02806509],"study_design_scores_gemma":[0.010791688,0.0037908324,0.050696775,0.00017226605,0.00017377647,0.0002280482,0.00023381405,0.00026825062,0.9282751,0.00033442865,0.0049497485,0.000085237036],"about_ca_topic_score_codex":0.000024907573,"about_ca_topic_score_gemma":0.000041247513,"teacher_disagreement_score":0.0489438,"about_ca_system_score_codex":0.000103687984,"about_ca_system_score_gemma":0.00009143939,"threshold_uncertainty_score":0.3683957},"labels":[],"label_agreement":null},{"id":"W3178326122","doi":"10.1038/s41477-021-00963-5","title":"The Taxus genome provides insights into paclitaxel biosynthesis","year":2021,"lang":"en","type":"article","venue":"Nature Plants","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":243,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Wuhan University; Chinese Academy of Agricultural Sciences; Agricultural Science and Technology Innovation Program; Hunan Agricultural University; Chinese Academy of Sciences","keywords":"Taxus; Genome; Biology; Gene; Paclitaxel; Gene cluster; Biosynthesis; Gene duplication; Computational biology; Genetics; Botany; Cancer","score_opus":0.010124761287408907,"score_gpt":0.2943140098066403,"score_spread":0.2841892485192314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178326122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91071814,0.0699923,0.0000020006669,0.0089286715,0.00085789897,0.00031727133,0.000032787844,0.000061702296,0.009089239],"genre_scores_gemma":[0.9902003,0.0027955775,0.00014758398,0.0018577336,0.00041632366,0.000027695527,0.00008066589,0.00001319478,0.004460917],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992466,0.00005183321,0.00012123661,0.0002159466,0.00016869526,0.00019569077],"domain_scores_gemma":[0.99930125,0.0002827072,0.00004261791,0.00021193203,0.000068703695,0.00009278803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005958771,0.00012081942,0.00018218852,0.00003974012,0.00017327874,0.00002260775,0.00007918144,0.00021175764,0.00015832116],"category_scores_gemma":[0.000101369515,0.000070658556,0.000069171096,0.00012583625,0.00004955904,0.000033499633,0.000036084475,0.00037809892,0.0000778975],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029785468,0.001316142,0.018839367,0.00034400355,0.0023723412,0.0052603683,0.00467459,0.0000019710787,0.7485523,0.0019756923,0.09693432,0.11675031],"study_design_scores_gemma":[0.0012145385,0.00013907066,0.028769024,0.00004894517,0.00017034348,0.0001674154,0.0001905302,0.000013431581,0.08980596,0.0007474313,0.8786071,0.00012619232],"about_ca_topic_score_codex":0.000026310754,"about_ca_topic_score_gemma":0.0003135259,"teacher_disagreement_score":0.7816728,"about_ca_system_score_codex":0.000084378444,"about_ca_system_score_gemma":0.00017400851,"threshold_uncertainty_score":0.28813723},"labels":[],"label_agreement":null},{"id":"W3178613530","doi":"10.1158/1538-7445.am2021-1377","title":"Abstract 1377: Volume scanning, a rational approach to covalent PI3Kα inhibitors","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"PI3K/AKT/mTOR pathway; Chemistry; Covalent bond; Selectivity; Rational design; Combinatorial chemistry; Biochemistry; Kinase; Target protein; Stereochemistry; Biophysics; Nanotechnology; Signal transduction; Biology; Materials science; Organic chemistry","score_opus":0.1462639111395096,"score_gpt":0.4690487802446619,"score_spread":0.3227848691051523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178613530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9366109,0.003614795,0.00004301626,0.012160356,0.0005100099,0.0007838063,0.000052756797,0.00004648012,0.0461779],"genre_scores_gemma":[0.95088273,0.00029312965,0.00037499482,0.00091648457,0.0014924296,0.00071440765,0.00012062584,0.000030347093,0.045174826],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980498,0.00008207809,0.00019761978,0.00044223928,0.0007300369,0.00049820717],"domain_scores_gemma":[0.99872285,0.0000699172,0.00002470007,0.00024237233,0.0005690767,0.0003710997],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043249642,0.00012137686,0.00022508172,0.0001950569,0.00016935731,0.000044216595,0.00009961101,0.00008173732,0.005098759],"category_scores_gemma":[0.000083512874,0.00011276423,0.00008685215,0.00066650705,0.00011557981,0.000058386486,0.000103007245,0.00045679428,0.00031323018],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007994953,0.0010574604,0.02807632,0.00028509728,0.00026695224,0.00029457672,0.0011783672,0.00024570053,0.15742695,0.0003320298,0.79968816,0.01034891],"study_design_scores_gemma":[0.0038298175,0.00046599391,0.117076576,0.000218778,0.00008037439,0.00008022486,0.0005104016,0.00015022002,0.098709024,0.00008821663,0.7785248,0.00026555295],"about_ca_topic_score_codex":0.00048392662,"about_ca_topic_score_gemma":0.000082435625,"teacher_disagreement_score":0.089000255,"about_ca_system_score_codex":0.0007353844,"about_ca_system_score_gemma":0.0017798676,"threshold_uncertainty_score":0.9958107},"labels":[],"label_agreement":null},{"id":"W3183886430","doi":"10.3390/curroncol28040239","title":"Patterns and Predictors of First-Line Taxane Use in Patients with Metastatic Triple-Negative Breast Cancer in US Clinical Practice","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Triple-negative breast cancer; Taxane; Triple negative; Oncology; Metastatic breast cancer; Paclitaxel; Internal medicine; Breast cancer; Cancer; Clinical Practice; Family medicine","score_opus":0.1069257443243616,"score_gpt":0.46140730406580466,"score_spread":0.3544815597414431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183886430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99572885,0.0007484403,0.000011158365,0.0014150571,0.00097394444,0.00067084853,0.0004019153,0.0000075048415,0.00004228211],"genre_scores_gemma":[0.9965581,0.0026142627,0.0001950984,0.00022867453,0.00011942428,0.00010703372,0.00011436098,0.000014016712,0.00004899385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983419,0.0003713597,0.00055937615,0.00033964284,0.00016147621,0.00022623745],"domain_scores_gemma":[0.9980545,0.0011065626,0.00029929154,0.00013328546,0.00028184804,0.00012450562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002219587,0.0001568014,0.00066399353,0.00012802142,0.000015918344,0.0000042645042,0.00003954446,0.00008248206,0.0003114489],"category_scores_gemma":[0.000426512,0.00012318588,0.00004533315,0.0002831236,0.00012540103,0.00013804693,0.000055077566,0.00038100404,0.0000012881361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004812695,0.0071041784,0.9624999,0.0001459393,0.0002616898,0.0001776111,0.0005014089,0.000014960323,0.0000027808553,0.0000035998326,0.00032377345,0.024151439],"study_design_scores_gemma":[0.026491838,0.002459108,0.9635421,0.00024003552,0.00061572297,0.00004298578,0.0001385092,0.000084753185,0.000033161155,0.000004925216,0.006251135,0.000095724085],"about_ca_topic_score_codex":0.0008652346,"about_ca_topic_score_gemma":0.013714327,"teacher_disagreement_score":0.024055716,"about_ca_system_score_codex":0.0002896987,"about_ca_system_score_gemma":0.0004320226,"threshold_uncertainty_score":0.7652916},"labels":[],"label_agreement":null},{"id":"W3187178237","doi":"10.1017/cjn.2019.122","title":"P.022 Myasthenia gravis following dabrafenib and trametinib for metastatic melanoma","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Trametinib; Dabrafenib; Medicine; Myasthenia gravis; MEK inhibitor; Pyridostigmine; Melanoma; Internal medicine; Gastroenterology; MAPK/ERK pathway; Cancer research; Vemurafenib; Kinase; Metastatic melanoma; Biology","score_opus":0.04194767816253712,"score_gpt":0.3206121343342226,"score_spread":0.27866445617168545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187178237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98913217,0.0018471305,0.000019043953,0.0061176666,0.0011384628,0.00043719946,0.000015280477,0.00001269701,0.0012803584],"genre_scores_gemma":[0.99192154,0.00020177952,0.0036130394,0.003927805,0.00019005839,0.0000066214634,6.9267975e-7,0.000013386547,0.00012508925],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9968215,0.00041353574,0.0006878779,0.0004937446,0.0004903105,0.0010930225],"domain_scores_gemma":[0.9966453,0.0008640778,0.00048613545,0.00010853198,0.00022648212,0.0016695214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025933117,0.00029618564,0.0006982114,0.00076076377,0.0012769256,0.00034534562,0.00070976047,0.00011706148,0.00029157093],"category_scores_gemma":[0.0007759178,0.00019208668,0.0003689005,0.0007196242,0.0023777718,0.0005530051,0.0000344048,0.000693545,0.0000033247995],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044274656,0.00007355935,0.9850708,0.00002747434,0.000099027646,0.0041969395,0.0005160759,0.0003058462,0.00042321213,0.00079733424,0.0007324822,0.0073144925],"study_design_scores_gemma":[0.0067855422,0.43291757,0.38626316,0.00015879955,0.0010043737,0.09510551,0.0009962764,0.00309184,0.00056322134,0.031405807,0.040765703,0.0009422027],"about_ca_topic_score_codex":0.00057623145,"about_ca_topic_score_gemma":0.011278777,"teacher_disagreement_score":0.59880763,"about_ca_system_score_codex":0.00016173077,"about_ca_system_score_gemma":0.0024704263,"threshold_uncertainty_score":0.98212075},"labels":[],"label_agreement":null},{"id":"W3193530660","doi":"10.3390/curroncol28040273","title":"Chemotherapy-Induced Neuropathy and Diabetes: A Scoping Review","year":2021,"lang":"en","type":"review","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Peripheral neuropathy; Diabetes mellitus; Chemotherapy-induced peripheral neuropathy; Chemotherapy; Diabetic neuropathy; Internal medicine; Regimen; Cancer; Surgery; Endocrinology","score_opus":0.3235678917286284,"score_gpt":0.5553974951440349,"score_spread":0.23182960341540654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193530660","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005342007,0.993778,6.5551154e-7,0.00051801675,0.0019869723,0.0029415912,0.000012803795,0.000053704305,0.0006548205],"genre_scores_gemma":[9.472902e-7,0.9965201,0.000025074301,0.0014685694,0.00080589985,0.0007411426,0.0002558275,0.000063776155,0.00011867054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977075,0.00045334874,0.00067641545,0.0006462631,0.00012617961,0.0003902839],"domain_scores_gemma":[0.99863815,0.00033917918,0.00037560365,0.00033848512,0.000085849686,0.00022270218],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024775756,0.0004668078,0.003971401,0.00013855699,0.000052373074,0.0000110926785,0.00010576565,0.00027573004,0.0007180821],"category_scores_gemma":[0.00009954633,0.00036822676,0.0004958916,0.0003226494,0.00007780666,0.000026265054,0.00011369013,0.00067928806,0.000055251076],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004159889,0.0003458975,0.000025739768,0.2155719,0.00017012033,0.00008209342,0.00001555757,5.7550065e-10,0.0000015039163,0.0000029400767,0.004544599,0.7792355],"study_design_scores_gemma":[0.00075508404,0.00053416326,0.0000027463016,0.33979332,0.003373289,0.00018006339,0.0000011180907,4.3666535e-7,0.000001198884,8.4644194e-7,0.6551927,0.0001650696],"about_ca_topic_score_codex":0.0000010330847,"about_ca_topic_score_gemma":0.0000030288984,"teacher_disagreement_score":0.77907044,"about_ca_system_score_codex":0.0003045838,"about_ca_system_score_gemma":0.00161773,"threshold_uncertainty_score":0.999877},"labels":[],"label_agreement":null},{"id":"W3200457141","doi":"10.1101/2021.09.13.21263539","title":"Factors associated with chemotherapy-induced peripheral neuropathy-related reduced taxane dose or premature discontinuation in women with early-stage breast cancer","year":2021,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Waterloo; The Quebec Population Health Research Network; Centre for Interdisciplinary Research in Rehabilitation; Montreal Council on Foreign Relations; York University; University of Toronto; Université de Sherbrooke; Université de Montréal; Université Laval","funders":"Astellas Pharma; Disarm Therapeutics; Fondation du cancer du sein du Québec; GW Pharmaceuticals; National Institutes of Health; Boston Scientific Corporation; Biogen; AstraZeneca; Pfizer","keywords":"Medicine; Taxane; Peripheral neuropathy; Chemotherapy-induced peripheral neuropathy; Discontinuation; Breast cancer; Internal medicine; Odds ratio; Cancer; Physical therapy","score_opus":0.03265870034546732,"score_gpt":0.30180671114309104,"score_spread":0.26914801079762374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200457141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546933,0.00020267087,0.0000015490973,0.001623063,0.00048149552,0.0017601441,0.0001652807,0.00015791757,0.00013853336],"genre_scores_gemma":[0.9935108,0.00017884381,0.000014772934,0.00027939893,0.00015694331,0.0006293841,0.00039599917,0.00015210606,0.0046817516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971545,0.000292219,0.00048783698,0.0009518141,0.00048130634,0.00063236605],"domain_scores_gemma":[0.99841154,0.00007120703,0.0005498468,0.0004918856,0.00022281945,0.0002527283],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021187741,0.0006969917,0.0011887817,0.00020623625,0.000070124006,0.000088172565,0.00018694153,0.0005180126,0.002219152],"category_scores_gemma":[0.000039575105,0.00043447595,0.000109481574,0.0006680903,0.00009404501,0.0001317788,0.0000938006,0.0014072149,0.0000012144823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014561967,0.0020739287,0.8839837,0.0003034856,0.0026349947,0.0013613867,0.026797986,0.00033044015,0.06500253,0.0000010416195,0.000064088075,0.0028845079],"study_design_scores_gemma":[0.009739222,0.0010761902,0.9813796,0.00141432,0.00039420038,0.000023757948,0.00070882746,0.00012461109,0.0045941,0.0000014324422,0.000043490014,0.00050023664],"about_ca_topic_score_codex":0.00094503566,"about_ca_topic_score_gemma":0.002628356,"teacher_disagreement_score":0.097395964,"about_ca_system_score_codex":0.0012372728,"about_ca_system_score_gemma":0.0011052017,"threshold_uncertainty_score":0.9998107},"labels":[],"label_agreement":null},{"id":"W3202121966","doi":"10.1016/j.annonc.2021.08.728","title":"1840P Impact of age, comorbidities and polypharmacy on survival in advanced cancers","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Polypharmacy; Comorbidity; Oncology; Gerontology; Internal medicine; Overall survival; Intensive care medicine","score_opus":0.13906244305785645,"score_gpt":0.49876909455505103,"score_spread":0.3597066514971946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202121966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798913,0.0020607838,3.557118e-7,0.0020308879,0.00023841452,0.00014200427,0.000046712576,0.0000063463863,0.015583202],"genre_scores_gemma":[0.99393475,0.0045616454,0.00004633074,0.0008188101,0.00006533722,0.000012767075,0.00002828971,0.000008884004,0.00052317727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992333,0.00009905778,0.00023802574,0.00015242933,0.00008524512,0.00019196594],"domain_scores_gemma":[0.99935234,0.00024885606,0.00010929954,0.00010353339,0.000106119274,0.00007988517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011403348,0.000103107996,0.0005397972,0.00011613171,0.000012376136,9.4287157e-7,0.000035364712,0.000065652304,0.0004743966],"category_scores_gemma":[0.000042552518,0.00009009342,0.00009957163,0.00015330798,0.00015142135,0.000032946184,0.000025975522,0.00012471576,0.0000017665027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01792835,0.0044372673,0.4968643,0.00045861347,0.0017826442,0.0035707224,0.0036395667,0.00056281994,0.23173441,0.0010744283,0.022758117,0.21518876],"study_design_scores_gemma":[0.015877357,0.016894443,0.8005639,0.00015619438,0.00016682732,0.00010947373,0.00056677475,0.00004479501,0.13885765,0.00036020053,0.026207246,0.00019518673],"about_ca_topic_score_codex":0.0016471636,"about_ca_topic_score_gemma":0.0008937636,"teacher_disagreement_score":0.30369955,"about_ca_system_score_codex":0.00012086171,"about_ca_system_score_gemma":0.0006917257,"threshold_uncertainty_score":0.519431},"labels":[],"label_agreement":null},{"id":"W3206196696","doi":"10.1016/j.clinbiomech.2021.105512","title":"Influence of intermittent pneumatic compression on foot sensation and balance control in chemotherapy-induced peripheral neuropathy patients","year":2021,"lang":"en","type":"article","venue":"Clinical Biomechanics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute for Aging; University of Waterloo","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Medicine; Intermittent pneumatic compression; Peripheral neuropathy; Sensation; Massage; Balance (ability); Physical medicine and rehabilitation; Peripheral; Context (archaeology); Physical therapy; Surgery; Internal medicine; Psychology","score_opus":0.028541812671102385,"score_gpt":0.35208981141745077,"score_spread":0.3235479987463484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206196696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985845,0.000057540463,0.00003111777,0.0006996783,0.000254398,0.0003233395,0.000009741396,0.000012629788,0.00002705242],"genre_scores_gemma":[0.9967633,0.00023528635,0.000047985683,0.0028513654,0.0000385509,0.00001076423,0.000018387516,0.0000105667505,0.00002383373],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988875,0.0001471172,0.0004686616,0.00024976782,0.00012599443,0.00012100056],"domain_scores_gemma":[0.9992843,0.00022188642,0.00015049567,0.00015963215,0.00010389178,0.00007974592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015201069,0.00010666104,0.0003734563,0.000048621005,0.000016570917,0.0000047354724,0.00003876181,0.0001000103,0.000024639665],"category_scores_gemma":[0.00014466501,0.00008898379,0.00006553684,0.00013063586,0.00003314068,0.000027545302,0.000027919108,0.00017252305,0.0000032091132],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00289347,0.0038269975,0.278623,0.00022419084,0.00011396216,0.000096888434,0.00032430943,0.000024087387,0.58508027,0.00007119767,0.00011362424,0.128608],"study_design_scores_gemma":[0.026978873,0.005993422,0.8964194,0.0005975956,0.000115818024,0.000014360684,0.000038332655,0.026056042,0.042988222,0.00023117094,0.00036853773,0.00019824022],"about_ca_topic_score_codex":0.000006571973,"about_ca_topic_score_gemma":0.0000035980438,"teacher_disagreement_score":0.61779636,"about_ca_system_score_codex":0.00004462628,"about_ca_system_score_gemma":0.00004837976,"threshold_uncertainty_score":0.36286536},"labels":[],"label_agreement":null},{"id":"W3206895537","doi":"","title":"The effects of exercise training on antitumor efficacy of doxorubicin in MDA-MB-231 breast cancer xenografts","year":2005,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Chemotherapy; Breast cancer; Cancer; Doxorubicin; Internal medicine; Urology; Oncology; Surgery","score_opus":0.07046813172707168,"score_gpt":0.45713557103825403,"score_spread":0.38666743931118236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206895537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808608,0.011001004,3.4598617e-7,0.0056932713,0.0003049814,0.0011412452,0.000033557968,0.0000139649355,0.00095079036],"genre_scores_gemma":[0.98592395,0.011628268,0.0000132400455,0.00009233166,0.00044168008,0.0004331169,0.0000043540695,0.000027799988,0.0014352505],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980978,0.00015686266,0.00031622598,0.0002866051,0.00056222564,0.0005802975],"domain_scores_gemma":[0.9983965,0.0008674038,0.00008309391,0.00030429312,0.0002051938,0.00014347768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006119863,0.00014982882,0.0004504862,0.0003098298,0.00010316182,0.000009279599,0.0002088796,0.00009867247,0.00035262285],"category_scores_gemma":[0.000080826576,0.0001018799,0.00009984012,0.0007370865,0.00039249,0.000047844896,0.00005543374,0.0006029413,0.000011696113],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010591618,0.0016504624,0.032924112,0.0013904022,0.00031839107,0.00013313685,0.0063291206,0.00023132698,0.4221361,0.00028494978,0.015145903,0.50886446],"study_design_scores_gemma":[0.017918518,0.0015125755,0.3401976,0.0051907585,0.00020716515,0.000018382128,0.00045613272,0.00012459555,0.61137694,0.00003328513,0.022719253,0.00024478228],"about_ca_topic_score_codex":0.0028057331,"about_ca_topic_score_gemma":0.0011744916,"teacher_disagreement_score":0.50861967,"about_ca_system_score_codex":0.00042314103,"about_ca_system_score_gemma":0.00066286046,"threshold_uncertainty_score":0.42414477},"labels":[],"label_agreement":null},{"id":"W3207701638","doi":"10.1002/cnr2.1577","title":"Diagnostic tools should be used for the diagnosis of chemotherapy induced peripheral neuropathy in breast cancer patients receiving taxanes","year":2021,"lang":"en","type":"article","venue":"Cancer Reports","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Peripheral neuropathy; Breast cancer; Internal medicine; Docetaxel; Chemotherapy-induced peripheral neuropathy; Taxane; Oncology; Paclitaxel; Cancer; Chemotherapy","score_opus":0.062239493270620186,"score_gpt":0.35982611819895977,"score_spread":0.2975866249283396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207701638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98140347,0.0030063032,0.0000027231292,0.012857727,0.0014021198,0.0011252161,0.000112990754,0.000021809436,0.000067653215],"genre_scores_gemma":[0.9881736,0.00481166,0.000015431458,0.0035342656,0.00037956797,0.0027672618,0.000048148373,0.00004484581,0.00022520838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857044,0.00004815348,0.0004654882,0.00038968137,0.00023968061,0.00028656502],"domain_scores_gemma":[0.9983275,0.0007429727,0.00029567207,0.00029439316,0.00025621473,0.00008324251],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012929155,0.00019609745,0.0004433309,0.000049798102,0.0000629375,0.000019494053,0.00006162492,0.000089775596,0.0009981052],"category_scores_gemma":[0.00028850947,0.00014740626,0.00015199278,0.00029585112,0.00005488966,0.00008987388,0.000030013447,0.00016280964,1.9380452e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023228578,0.00048899814,0.94002193,0.000120075405,0.00016315027,0.00029338256,0.00083439,0.000065030996,0.0062402636,0.0000014475382,0.0042892154,0.04724983],"study_design_scores_gemma":[0.0030557092,0.0001819122,0.94282675,0.00028770822,0.00029215633,0.00008360361,0.00007104534,0.0000316973,0.037050113,0.000011145835,0.015949117,0.00015903445],"about_ca_topic_score_codex":0.0013753036,"about_ca_topic_score_gemma":0.0014470107,"teacher_disagreement_score":0.0470908,"about_ca_system_score_codex":0.00030941138,"about_ca_system_score_gemma":0.00050157256,"threshold_uncertainty_score":0.9999151},"labels":[],"label_agreement":null},{"id":"W3207704344","doi":"10.1177/17151635211050029","title":"Pharmacy, we have an image problem . . . (and here’s a solution)","year":2021,"lang":"en","type":"editorial","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacy; Image (mathematics); Computer science; Computer vision; Medicine; Nursing","score_opus":0.030612910968947724,"score_gpt":0.3198254235975019,"score_spread":0.28921251262855413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207704344","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02031931,0.034509916,0.000049788214,0.0022155447,0.9243536,0.002528403,0.008163057,0.00017649667,0.0076838965],"genre_scores_gemma":[0.060228627,0.13139383,0.001052564,0.003150164,0.78596497,0.0002020035,0.0027352667,0.00046933835,0.014803209],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99330133,0.0004938625,0.0012766673,0.0013711624,0.0013207387,0.0022362256],"domain_scores_gemma":[0.98918486,0.00034194498,0.0006807803,0.00053556665,0.002135953,0.0071208975],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0008113769,0.0013046998,0.0016431867,0.000799639,0.0014003328,0.00058218336,0.0007237997,0.000472291,0.0044317073],"category_scores_gemma":[0.0002455812,0.0013973507,0.0004608623,0.00060966396,0.0005661978,0.0007206661,0.00014543232,0.0039240858,0.000026576725],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00049477984,0.00018826831,0.00018306478,0.0009814007,0.0010419411,0.16793302,0.0006663926,0.000015706693,0.0019815094,0.000002730598,0.79721993,0.029291267],"study_design_scores_gemma":[0.0076901447,0.00020937921,0.0000012370203,0.00016137771,0.0019646194,0.24529338,0.000019179646,0.00062681444,0.00084683683,0.000032265656,0.74218,0.0009747821],"about_ca_topic_score_codex":0.101997316,"about_ca_topic_score_gemma":0.37858403,"teacher_disagreement_score":0.2765867,"about_ca_system_score_codex":0.008707901,"about_ca_system_score_gemma":0.03828084,"threshold_uncertainty_score":0.99997044},"labels":[],"label_agreement":null},{"id":"W3214344627","doi":"10.1182/blood-2021-154311","title":"Bleeding Outcomes in Patients with Gastrointestinal Malignancies Treated with Distally Absorbed Versus Proximally Absorbed Direct Oral Anticoagulants","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Rivaroxaban; Edoxaban; Apixaban; Dabigatran; Internal medicine; Cancer; Gastroenterology; Malignancy; Warfarin; Atrial fibrillation","score_opus":0.01688496194765079,"score_gpt":0.26532386837195676,"score_spread":0.24843890642430597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214344627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681056,0.000060534105,0.0000037331279,0.00014318383,0.000051100997,0.0004921806,0.000042122767,0.00009116734,0.0023053994],"genre_scores_gemma":[0.99707854,0.0000068718296,0.0017316414,0.00006285864,0.000033596152,0.00004732397,0.00018253598,0.000038258182,0.00081838673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863935,0.000038703496,0.00022888987,0.00038000025,0.00029128787,0.00042176974],"domain_scores_gemma":[0.99933404,0.00007669611,0.00009234342,0.00018448292,0.00018311568,0.000129308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053539687,0.00027026804,0.00058593444,0.00010157632,0.000052998734,0.00002861359,0.00006155414,0.00004015906,0.000120109085],"category_scores_gemma":[0.000039415223,0.00018404046,0.00005766994,0.00031246478,0.00008030417,0.00008704574,0.000032138167,0.00013904131,0.000008541149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059973607,0.0033888444,0.98502344,0.000059863134,0.0005069186,0.001588287,0.00010074745,0.000004596952,0.003175207,0.0000067707674,0.000028004244,0.00011994459],"study_design_scores_gemma":[0.04692067,0.004103724,0.9388038,0.000318312,0.00091988617,0.00010016099,0.00007436915,0.000007629406,0.008523939,0.0000013126934,0.00002534722,0.00020083862],"about_ca_topic_score_codex":0.00011659136,"about_ca_topic_score_gemma":0.00054739736,"teacher_disagreement_score":0.046219643,"about_ca_system_score_codex":0.00008260007,"about_ca_system_score_gemma":0.00021919918,"threshold_uncertainty_score":0.75049525},"labels":[],"label_agreement":null},{"id":"W3215368970","doi":"10.1161/res.129.suppl_1.p425","title":"Abstract P425: Sirtuin 3 Attenuates Doxorubicin Induced Cardiac Dysfunction By Regulating The Mitochondrial Acetylome And Alterations Of The Cardiac Lipidome","year":2021,"lang":"en","type":"article","venue":"Circulation Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; University of Manitoba; Children's Hospital Research Institute of Manitoba","funders":"","keywords":"SIRT3; Sirtuin; Cardiac function curve; Pharmacology; Mitochondrion; Cardiac fibrosis; Endocrinology; Chemistry; Internal medicine; Biology; Acetylation; Biochemistry; Medicine; Fibrosis; Heart failure","score_opus":0.06650778107713613,"score_gpt":0.37495808531434033,"score_spread":0.3084503042372042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215368970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98784435,0.0011548462,0.000009207593,0.008472619,0.0008087396,0.00076573517,0.000036806145,0.000014664423,0.0008930262],"genre_scores_gemma":[0.99776024,0.00010758738,0.000020773326,0.000087411456,0.00075426715,0.00008748791,0.00011296761,0.000015678213,0.0010536083],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998289,0.0004255579,0.00026377419,0.00026722174,0.00052083196,0.00023360315],"domain_scores_gemma":[0.998443,0.0006147075,0.0000809399,0.0003479341,0.0004399325,0.000073486444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005825677,0.00010180949,0.00023241769,0.00007827382,0.0003989448,0.00005212018,0.00006524113,0.00010548024,0.00016364166],"category_scores_gemma":[0.0002926451,0.00006763228,0.00012813888,0.0005574188,0.00015682275,0.000091175534,0.00007231819,0.00038726497,0.0000092013815],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007790365,0.00006587844,0.04294548,0.000046430952,0.00016234526,0.0000010686341,0.00060639984,0.00010489582,0.94560856,0.000116195384,0.005855421,0.004409407],"study_design_scores_gemma":[0.0018150986,0.000112003254,0.82643443,0.00008724332,0.00018882063,0.000007771192,0.0006678467,0.00058763596,0.16418125,0.00025954936,0.0055474266,0.00011093099],"about_ca_topic_score_codex":0.00030842505,"about_ca_topic_score_gemma":0.000033435426,"teacher_disagreement_score":0.7834889,"about_ca_system_score_codex":0.00013553731,"about_ca_system_score_gemma":0.00025203754,"threshold_uncertainty_score":0.30684012},"labels":[],"label_agreement":null},{"id":"W32676954","doi":"10.1023/a:1013050330608","title":"Drug-Drug Interactions Arising From the Use of Liposomal Vincristine in Combination with Other Anticancer Drugs","year":2001,"lang":"en","type":"article","venue":"Pharmaceutical Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Drug; Anticancer drug; Pharmacology; Vincristine; Liposome; Medicine; Drug interaction; Approved drug; Chemistry; Chemotherapy; Internal medicine","score_opus":0.27231962334222193,"score_gpt":0.5117446603891239,"score_spread":0.239425037046902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W32676954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748201,0.00042126,0.00007488522,0.021749996,0.00011278848,0.00061918405,0.000023915287,0.000020858639,0.0021570507],"genre_scores_gemma":[0.9962793,0.00038052004,0.00027361594,0.0008325955,0.00021138943,0.00005754872,0.000022516877,0.000022828248,0.001919664],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981558,0.00036852245,0.00024445791,0.0002535145,0.0005912972,0.00038643365],"domain_scores_gemma":[0.9968564,0.0025012216,0.00004021806,0.00020480585,0.0002500023,0.00014736736],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00054019626,0.000114372466,0.00022148759,0.00016818853,0.00010403981,0.00003113022,0.00011539497,0.00002587812,0.0018780794],"category_scores_gemma":[0.00016528639,0.00007384202,0.000046615856,0.000655366,0.00037544413,0.00014607405,0.000075142416,0.00079794804,0.000042459927],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01248,0.004090978,0.8721986,0.00007636024,0.0004202575,0.00020285812,0.003971637,0.000059921847,0.039928384,0.00088928285,0.017471211,0.04821052],"study_design_scores_gemma":[0.017893689,0.00049572455,0.21786511,0.00065892737,0.0004445284,0.00005949834,0.00090232113,0.020568218,0.054293886,0.00056857686,0.68594366,0.00030583036],"about_ca_topic_score_codex":0.006422321,"about_ca_topic_score_gemma":0.001292746,"teacher_disagreement_score":0.66847247,"about_ca_system_score_codex":0.00024222615,"about_ca_system_score_gemma":0.00016484235,"threshold_uncertainty_score":0.99903435},"labels":[],"label_agreement":null},{"id":"W39492073","doi":"10.1016/j.vaccine.2023.10.058","title":"Effets cellulaires de substances naturelles et synthétiques : identification des activités cytoprotectrices liées au stress oxydant en chimiothérapie","year":2008,"lang":"en","type":"dissertation","venue":"Vaccine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Molecular biology; Chemistry; Biology","score_opus":0.012347686330247297,"score_gpt":0.3276260767230536,"score_spread":0.3152783903928063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W39492073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96388716,0.032321982,0.000018405222,0.0006588571,0.0005683978,0.0009830854,0.00007356871,0.00019231638,0.0012962092],"genre_scores_gemma":[0.9535749,0.036666814,0.00022175188,0.00006849634,0.00065856456,0.00032646442,0.0019296863,0.000084191786,0.006469147],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801785,0.00020413045,0.0004514369,0.0005732323,0.00031553407,0.000437844],"domain_scores_gemma":[0.9985763,0.0003700036,0.00042665104,0.00031176666,0.00016512298,0.00015016223],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024462835,0.00049363554,0.00071672077,0.00042300505,0.00025425685,0.00004479475,0.00020534253,0.0005138371,0.0001648042],"category_scores_gemma":[0.000112200396,0.00041504903,0.00022328398,0.00031948177,0.000023844843,0.00018209546,0.000017403372,0.0006223815,0.000016450374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010217571,0.003239443,0.15952824,0.006070253,0.0029122292,0.0007936887,0.027614662,0.00004555143,0.726586,0.00030455593,0.0056363856,0.057051457],"study_design_scores_gemma":[0.0015600288,0.00033560308,0.4535048,0.000739104,0.00063846057,0.0000601444,0.0003737707,0.000049048736,0.54056025,0.0001440659,0.0017348769,0.00029984498],"about_ca_topic_score_codex":0.0018705993,"about_ca_topic_score_gemma":0.016051853,"teacher_disagreement_score":0.29397658,"about_ca_system_score_codex":0.000454683,"about_ca_system_score_gemma":0.00058953906,"threshold_uncertainty_score":0.9998301},"labels":[],"label_agreement":null},{"id":"W416563081","doi":"10.1016/b978-2-294-08855-1.50177-7","title":"10.1016/b978-2-294-08855-1.50177-7","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Philosophy","score_opus":0.0143094062707754,"score_gpt":0.23222719033937933,"score_spread":0.21791778406860393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W416563081","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000030226454,0.001213061,7.6558564e-8,0.000792543,0.000012728286,0.00076085486,0.00015095106,0.00017408993,0.9968927],"genre_scores_gemma":[0.0000019784507,0.000008882715,0.0000380963,0.0003414177,0.0013906982,0.00004929883,0.00044778234,0.00012792762,0.99759394],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985672,0.000012785592,0.00031255212,0.00048241642,0.0002711454,0.00035384827],"domain_scores_gemma":[0.9989893,0.00005987084,0.00009327845,0.00044267345,0.000070080794,0.00034481208],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006393628,0.0004568619,0.00072013354,0.0002493442,0.000060652594,0.000015813503,0.00015040145,0.0003775226,0.99946564],"category_scores_gemma":[0.0000057878474,0.0004286784,0.00026917324,0.00004255413,0.00007643786,0.000030118968,0.00006009306,0.00040322175,0.9962682],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071468105,0.0000679333,3.623468e-8,0.000029792407,0.0003181353,0.00019065606,0.000010152376,0.0000010673324,0.000022943646,0.00001640711,0.5646523,0.43397588],"study_design_scores_gemma":[0.0015551468,0.001055562,0.0000030202766,0.0001652654,0.0009395149,0.000105528474,1.2999777e-7,0.0000035772503,0.000048387716,0.000101249774,0.99565285,0.00036973352],"about_ca_topic_score_codex":0.000028580376,"about_ca_topic_score_gemma":8.193605e-7,"teacher_disagreement_score":0.43360615,"about_ca_system_score_codex":0.00023364712,"about_ca_system_score_gemma":0.00018737462,"threshold_uncertainty_score":0.9998165},"labels":[],"label_agreement":null},{"id":"W4200155196","doi":"10.14740/jmc3819","title":"High-Dose Gabapentin and Amitriptyline in the Treatment of Refractory Chemotherapy-Induced Peripheral Neuropathy in a Toddler","year":2021,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gabapentin; Peripheral neuropathy; Chemotherapy-induced peripheral neuropathy; Refractory (planetary science); Discontinuation; Pregabalin; Amitriptyline; Anesthesia; Internal medicine","score_opus":0.04247216451385996,"score_gpt":0.35377974673570267,"score_spread":0.31130758222184274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200155196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820006,0.0069166836,0.0000011070669,0.010669939,0.00023568214,0.00011718693,0.0000022772433,0.0000017385173,0.00005477004],"genre_scores_gemma":[0.9890517,0.008795515,0.00004761628,0.0015290283,0.00046215887,0.000004903797,0.0000032141045,0.000008217165,0.000097650365],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99869025,0.00019232873,0.00043964293,0.000102040016,0.00044515182,0.00013056611],"domain_scores_gemma":[0.9992339,0.0003486946,0.00014798222,0.000090866364,0.00006037898,0.00011815687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032882014,0.00010297922,0.0004251215,0.000100252866,0.000012715471,0.0000064036785,0.000058294252,0.000076345175,0.00084143446],"category_scores_gemma":[0.00018236326,0.00005897414,0.00009870972,0.00017632569,0.00005820364,0.0000362246,0.000009451648,0.00024128989,4.5797756e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01479513,0.0339965,0.18216956,0.00029242673,0.0007403137,0.21281028,0.013102228,0.000010282219,0.10270788,0.00008309074,0.005598215,0.43369412],"study_design_scores_gemma":[0.10709551,0.032808665,0.72529423,0.00096666807,0.0009506912,0.027278103,0.0048024696,0.00025132726,0.04173759,0.00010272587,0.05836945,0.00034255435],"about_ca_topic_score_codex":0.00018665248,"about_ca_topic_score_gemma":0.00029209236,"teacher_disagreement_score":0.5431247,"about_ca_system_score_codex":0.000104064566,"about_ca_system_score_gemma":0.0003277258,"threshold_uncertainty_score":0.92131174},"labels":[],"label_agreement":null},{"id":"W4200404431","doi":"10.17504/protocols.io.b2xbqfin","title":"[RETRACTED] HempLeafz CBD Gummies | &amp;#34;Scam Alert&amp;#34; v1","year":2021,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Product (mathematics); Order (exchange); Internet privacy; Ideal (ethics); Health professionals; Psychology; Business; Health care; Advertising; Medicine; Computer science; Law; Political science","score_opus":0.07772776466948145,"score_gpt":0.3819838712468033,"score_spread":0.3042561065773218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200404431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7611865,0.0074069346,0.0006701187,0.012145323,0.00649898,0.0019119735,0.00023108533,0.00067014317,0.20927894],"genre_scores_gemma":[0.4860106,0.0066368254,0.011130163,0.007139879,0.004414982,0.00055341766,0.008655717,0.00020163112,0.47525677],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99640614,0.00014218724,0.0007782927,0.0012677833,0.00063399744,0.00077161554],"domain_scores_gemma":[0.99726224,0.00025623295,0.00027647367,0.0013434633,0.00039565898,0.00046593128],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00024833286,0.000825006,0.001473986,0.00032707714,0.00014168203,0.00012962917,0.00034713803,0.001145732,0.064822845],"category_scores_gemma":[0.00012397884,0.00072049757,0.0007088751,0.00031440725,0.00019434959,0.00009438018,0.0007560274,0.0020165439,0.0017157998],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010947036,0.002545541,0.047756247,0.00177308,0.004278565,0.0005501463,0.002206993,0.000043044103,0.018954692,0.00027530134,0.90648216,0.01403954],"study_design_scores_gemma":[0.0036777155,0.0002588102,0.030089209,0.00048413407,0.0020398549,0.00029868234,0.00037665325,0.000022955144,0.0055916593,0.0003126482,0.95589066,0.0009570469],"about_ca_topic_score_codex":0.0019838111,"about_ca_topic_score_gemma":0.0056885974,"teacher_disagreement_score":0.2751759,"about_ca_system_score_codex":0.00070997415,"about_ca_system_score_gemma":0.0006938654,"threshold_uncertainty_score":0.9995246},"labels":[],"label_agreement":null},{"id":"W4205376135","doi":"10.1200/jco.2022.40.4_suppl.078","title":"Adjuvant oxaliplatin and fall-related injury in patients with colorectal cancer.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Institute of Health Services and Policy Research; Sunnybrook Health Science Centre; Mount Sinai Hospital; University of Toronto","funders":"Physicians' Services Incorporated Foundation","keywords":"Medicine; Oxaliplatin; Colorectal cancer; Cohort; Hazard ratio; Internal medicine; Proportional hazards model; Population; Retrospective cohort study; Adjuvant chemotherapy; Oncology; Cancer; Surgery; Confidence interval","score_opus":0.04708204055723457,"score_gpt":0.44939695461691265,"score_spread":0.40231491405967806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205376135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939209,0.0004204144,4.2850726e-7,0.003452612,0.001064548,0.00025665207,0.000015401729,0.000004912538,0.0008640994],"genre_scores_gemma":[0.99774796,0.00030200253,0.00014326442,0.001400456,0.00018343417,0.000017462424,0.0000067583273,0.0000116910705,0.00018694536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978699,0.00037337787,0.0011840789,0.00014686801,0.00025497298,0.00017080294],"domain_scores_gemma":[0.99818367,0.0005647677,0.0008754974,0.00005171754,0.00012538976,0.00019894131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010022959,0.000099909834,0.0009778494,0.00013339442,0.00004761785,0.0000023496987,0.00007055727,0.00012967944,0.00072924723],"category_scores_gemma":[0.00017421502,0.00006985027,0.0001096755,0.00018007042,0.00013850226,0.000051306422,0.00006937024,0.0010949823,0.0000016059782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024617879,0.002737695,0.9043427,0.0000071952713,0.00031738426,0.00033293894,0.00017587261,0.000032025175,0.000046140754,0.000016016564,0.0026329907,0.064741164],"study_design_scores_gemma":[0.025450472,0.052703574,0.9030818,0.000023244143,0.00031298082,0.00008289072,0.00005776116,0.00004098828,0.000012973078,0.000063435196,0.01810257,0.0000673585],"about_ca_topic_score_codex":0.00010500341,"about_ca_topic_score_gemma":0.00015679053,"teacher_disagreement_score":0.064673804,"about_ca_system_score_codex":0.0003397446,"about_ca_system_score_gemma":0.0011696095,"threshold_uncertainty_score":0.79847455},"labels":[],"label_agreement":null},{"id":"W4206240957","doi":"10.1093/ww/9780199540884.013.u13564","title":"Deslongchamps, Prof. Pierre, (born 8 May 1938), Professor of Organic Chemistry, Université de Sherbrooke, Canada, 1972–2006, now Emeritus; Executive Scientific Advisor, OmegaChem Inc., since 2008; Associate Professor, Laval University, Quebec, since 2008","year":2007,"lang":"en","type":"reference-entry","venue":"Who's Who","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Library science; Engineering; Engineering physics; Computer science","score_opus":0.013908111053815906,"score_gpt":0.25652482481397687,"score_spread":0.24261671376016097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206240957","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5177287,0.06108087,0.000076434204,0.018649245,0.007689479,0.011078137,0.011653596,0.0007316552,0.37131187],"genre_scores_gemma":[0.012932963,0.015802046,0.00009930918,0.00024167898,0.0005722925,0.00002331874,0.0034991472,0.00017017484,0.96665907],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99387765,0.00032370555,0.00087524345,0.0016007655,0.0014858482,0.001836815],"domain_scores_gemma":[0.9955333,0.00028782236,0.0012810108,0.0009789893,0.0010924534,0.00082642067],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058059004,0.0011735153,0.0020640132,0.0004941467,0.00081715133,0.000056224122,0.0010260183,0.0013882555,0.0015379454],"category_scores_gemma":[0.00010274155,0.0012665327,0.00038732268,0.0016133357,0.0009578968,0.0002358327,0.0007910602,0.0018617291,0.00004690935],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0018048405,0.001147381,0.013920368,0.0029711507,0.0017054706,0.0014982278,0.0013344644,0.0000023660582,0.0026202684,0.00004473254,0.9704855,0.0024652127],"study_design_scores_gemma":[0.0061167353,0.00026310456,0.00897357,0.0024375385,0.0018542783,0.00009632859,0.0008678021,0.000025375923,0.024294917,0.0000100089665,0.95392364,0.0011367041],"about_ca_topic_score_codex":0.26025242,"about_ca_topic_score_gemma":0.8923735,"teacher_disagreement_score":0.6321211,"about_ca_system_score_codex":0.011865692,"about_ca_system_score_gemma":0.022421276,"threshold_uncertainty_score":0.99990815},"labels":[],"label_agreement":null},{"id":"W4206834628","doi":"10.21203/rs.3.rs-1254626/v1","title":"The effect of trastuzumab on taxane-induced peripheral neuropathy in women with breast cancer: a population-based cohort study","year":2022,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Kingston Health Sciences Centre; Queen's University","funders":"Queen's University; Cancer Care Ontario","keywords":"Medicine; Taxane; Docetaxel; Trastuzumab; Internal medicine; Breast cancer; Population; Peripheral neuropathy; Oncology; Cohort; Cancer; Diabetes mellitus","score_opus":0.028280602293816685,"score_gpt":0.4117375393122459,"score_spread":0.3834569370184292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206834628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905433,0.00019584384,1.431523e-7,0.0009638459,0.00019671359,0.0076174745,0.00019294446,0.000031426047,0.0002583099],"genre_scores_gemma":[0.9890477,0.000082317456,0.0000010572019,0.00003418848,0.00013954494,0.010309623,0.00010534577,0.000057037618,0.0002231826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99478453,0.0021647324,0.00033019675,0.0006340165,0.0014848944,0.00060162036],"domain_scores_gemma":[0.9979764,0.00089647033,0.00014018107,0.0006474013,0.00017804555,0.00016150821],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018880131,0.00029781007,0.00071374193,0.00038572462,0.0002674874,0.00003437638,0.00028407437,0.000096114556,0.00095013145],"category_scores_gemma":[0.00007492039,0.0001833531,0.00009593799,0.00062147144,0.000084248524,0.000018188468,0.0002075232,0.0018731281,0.0000019966278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029612135,0.0011382182,0.95570844,0.0005434298,0.00032768905,0.0003917319,0.00096975,0.0021567,0.00013941259,0.0000012490796,0.00009663871,0.008914595],"study_design_scores_gemma":[0.006710601,0.0219222,0.969575,0.00030746282,0.00009885321,0.000007746408,0.0006913756,0.00035576103,0.00009372264,0.000002726355,0.0000998825,0.00013469596],"about_ca_topic_score_codex":0.016636979,"about_ca_topic_score_gemma":0.0023072474,"teacher_disagreement_score":0.022901535,"about_ca_system_score_codex":0.0034489878,"about_ca_system_score_gemma":0.001125774,"threshold_uncertainty_score":0.99996316},"labels":[],"label_agreement":null},{"id":"W4206848609","doi":"","title":"Docetaxel-associated myalgia&ndash;arthralgia syndrome in patients with breast cancer","year":2017,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"myalgia; Docetaxel; Medicine; Breast cancer; Oncology; Internal medicine; Dermatology; Cancer","score_opus":0.14566794732261912,"score_gpt":0.5450446510712325,"score_spread":0.39937670374861334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206848609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99116296,0.003555188,0.0000016212074,0.00088883255,0.00060910435,0.00093859085,0.0002376382,0.00002892329,0.0025771412],"genre_scores_gemma":[0.99522847,0.002838626,0.000020681202,0.00031077943,0.000092612565,0.00009926546,0.000048152517,0.00006259287,0.0012988348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975224,0.00013171701,0.0006493196,0.0004784877,0.0006737489,0.0005443171],"domain_scores_gemma":[0.99736404,0.00008912719,0.0011516184,0.0005959633,0.00044031767,0.0003589073],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004549099,0.00038455447,0.0011386952,0.0005433295,0.00036074998,0.000563815,0.0013710129,0.00015370615,0.018011218],"category_scores_gemma":[0.000082318824,0.00029904654,0.00015833581,0.00043342964,0.00022175405,0.0017105704,0.00045496545,0.00050796906,0.000021820204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020054416,0.0013864852,0.9750921,0.000091167116,0.0007617247,0.0002779398,0.000107845946,0.000017089298,0.0011658386,0.0000047919552,0.0129983425,0.0060912143],"study_design_scores_gemma":[0.009143849,0.0000904968,0.9871803,0.0011700327,0.00040153367,0.00003850702,0.000009983672,0.000010524569,0.0006761663,0.000152536,0.0007929075,0.00033314285],"about_ca_topic_score_codex":0.004554726,"about_ca_topic_score_gemma":0.0007647407,"teacher_disagreement_score":0.017989399,"about_ca_system_score_codex":0.0004337939,"about_ca_system_score_gemma":0.0003498631,"threshold_uncertainty_score":0.9999462},"labels":[],"label_agreement":null},{"id":"W4210602537","doi":"10.3917/pls.497.0072","title":"Pilules Orientales pour poitrine idéale","year":2019,"lang":"fr","type":"article","venue":"Pour la Science","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Society for the History of Medicine","funders":"","keywords":"Art","score_opus":0.013302565286484587,"score_gpt":0.3319507151853574,"score_spread":0.3186481498988728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210602537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8535945,0.014043492,0.00006126023,0.0117359,0.0048949234,0.00035651543,0.000030777635,0.000047348436,0.11523532],"genre_scores_gemma":[0.81864727,0.00095480797,0.0008757312,0.0006306707,0.0007911709,0.000011197808,0.0000048666525,0.000014906106,0.17806938],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99805707,0.000069569825,0.00020583573,0.0005223929,0.0004264544,0.00071868673],"domain_scores_gemma":[0.9988583,0.00027224957,0.00008709676,0.00030636395,0.00013762276,0.00033841547],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00064004236,0.00020231763,0.00028001622,0.0001728854,0.00013108437,0.000047429312,0.00034539413,0.00006395145,0.009501236],"category_scores_gemma":[0.00009222795,0.00017934482,0.00008934453,0.00069199025,0.0009918185,0.0002988219,0.00016655288,0.000209084,0.008244769],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025805243,0.0018563176,0.46731657,0.00030683388,0.00011022365,0.00040985047,0.0014226886,0.000059960727,0.3691328,0.048145674,0.024275392,0.08670565],"study_design_scores_gemma":[0.009504025,0.00083033514,0.33850423,0.00062491914,0.00040310097,0.000927227,0.0010201569,0.004737109,0.103901125,0.0024692041,0.5363796,0.0006989838],"about_ca_topic_score_codex":0.00031906698,"about_ca_topic_score_gemma":0.000037147955,"teacher_disagreement_score":0.5121042,"about_ca_system_score_codex":0.00036833328,"about_ca_system_score_gemma":0.0011098154,"threshold_uncertainty_score":0.9925274},"labels":[],"label_agreement":null},{"id":"W4210625548","doi":"10.1038/s41408-021-00602-4","title":"Patient-reported outcome measures are associated with health care utilization in patients with transplant ineligible multiple myeloma: a population-based study","year":2022,"lang":"en","type":"editorial","venue":"Blood Cancer Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"Hamilton Health Sciences Foundation; Cancer Care Ontario; Hamilton Health Sciences","keywords":"Multiple myeloma; Medicine; Outcome (game theory); Population; Internal medicine; MEDLINE; Health care; Intensive care medicine; Environmental health; Biology","score_opus":0.03334740798546452,"score_gpt":0.329829562829504,"score_spread":0.29648215484403945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210625548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9013726,0.0021452687,0.0000045413362,0.00013567603,0.09253065,0.002545522,0.0011927168,0.000063170446,0.000009855398],"genre_scores_gemma":[0.9660578,0.00008315131,0.000019059065,0.00016744115,0.02760831,0.0004596511,0.0054507474,0.00011206865,0.000041767493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954332,0.00040271415,0.0010569578,0.0005527757,0.0020416614,0.00051270827],"domain_scores_gemma":[0.9967319,0.00017465313,0.0017149944,0.00024173282,0.00087568094,0.00026107734],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029121255,0.0005125369,0.0011973828,0.00053505064,0.0003751085,0.00004797678,0.00012473715,0.00024358442,0.00021249104],"category_scores_gemma":[0.0001338151,0.000383431,0.00012649127,0.00064042304,0.00002079013,0.000091310016,0.000017082384,0.001462692,2.6709347e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066942177,0.004383028,0.9561067,0.00017555777,0.0016044641,0.00045611986,0.0022821173,0.0010286637,3.933666e-7,1.7657314e-8,0.02655767,0.00071105],"study_design_scores_gemma":[0.061431266,0.008288915,0.918487,0.0010194338,0.002820135,0.000007981371,0.0007654324,0.0000112046555,0.0000051505526,2.4296585e-7,0.0067496593,0.0004135425],"about_ca_topic_score_codex":0.00389378,"about_ca_topic_score_gemma":0.036445595,"teacher_disagreement_score":0.06492234,"about_ca_system_score_codex":0.0027569765,"about_ca_system_score_gemma":0.0034264743,"threshold_uncertainty_score":0.9998618},"labels":[],"label_agreement":null},{"id":"W4210847582","doi":"10.21203/rs.3.rs-1289285/v1","title":"Neuro Protective Effect of Baicalein Against Oxaliplatin-Induced Peripheral Neuropathy: Impact on Oxidative Stress, Neuro-inflammation and WNT/β-Catenin Signaling","year":2022,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Pharmaceutical Education and Research, Raebareli","keywords":"Baicalein; Oxidative stress; Oxaliplatin; Inflammation; Peripheral neuropathy; Wnt signaling pathway; Medicine; Catenin; Pharmacology; Immunology; Signal transduction; Internal medicine; Biology; Cell biology; Endocrinology; Cancer; Colorectal cancer","score_opus":0.05062817158793939,"score_gpt":0.41599832477808835,"score_spread":0.365370153190149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210847582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914845,0.0002208815,0.0000073604688,0.0007733169,0.00021715439,0.0062255664,0.0003225507,0.0000806889,0.000667954],"genre_scores_gemma":[0.9972789,0.00016951926,0.000017438912,0.00003670341,0.00045598918,0.0012856134,0.0005484557,0.00009726317,0.000110066234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9932929,0.0033524618,0.00048643976,0.000991993,0.0012433361,0.0006328413],"domain_scores_gemma":[0.996006,0.0025375371,0.00030679215,0.0004357779,0.000403231,0.00031065018],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012833839,0.0005281223,0.0009403028,0.00063042226,0.00029265112,0.00007287817,0.00024383736,0.0002554806,0.00053043757],"category_scores_gemma":[0.0011944629,0.00041730635,0.00032104994,0.000517945,0.00019377525,0.000083691986,0.00071192876,0.003265831,0.000007640394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014222913,0.00050256203,0.023953617,0.0029193114,0.00054558367,0.00093078346,0.0020156098,0.0050504836,0.93449557,0.000027205444,0.00024703972,0.015089339],"study_design_scores_gemma":[0.0076496876,0.03361318,0.088005,0.0014395749,0.00034743032,0.000019674113,0.000333035,0.008458827,0.85925454,0.0001618382,0.00013747254,0.0005797353],"about_ca_topic_score_codex":0.00046348295,"about_ca_topic_score_gemma":0.00001578565,"teacher_disagreement_score":0.07524101,"about_ca_system_score_codex":0.00070765655,"about_ca_system_score_gemma":0.0006050948,"threshold_uncertainty_score":0.99982786},"labels":[],"label_agreement":null},{"id":"W4210926374","doi":"10.21203/rs.3.rs-1321818/v1","title":"Tolerability of Eribulin and Correlation Between Polymorphisms and Neuropathy in an Unselected Population of Female Patients with Metastatic Breast Cancer: Results of The Multicenter, Single Arm, Phase IV PAINTER Study","year":2022,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Tolerability; Eribulin; Internal medicine; Neutropenia; Metastatic breast cancer; Gastroenterology; Breast cancer; Adverse effect; Febrile neutropenia; Oncology; Surgery; Cancer; Toxicity","score_opus":0.06823118358957378,"score_gpt":0.41629658134092973,"score_spread":0.3480653977513559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210926374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945649,0.00016645568,0.0000040775585,0.00012546722,0.000050027353,0.0032333194,0.0018453244,0.00000545427,0.0000049752625],"genre_scores_gemma":[0.99896705,0.000024932513,0.000022688664,0.000004104099,0.000019680327,0.000106573876,0.00082410243,0.000017848986,0.0000130009985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968417,0.0014587623,0.00054152246,0.00039823612,0.0005814452,0.00017830332],"domain_scores_gemma":[0.9984893,0.00029683145,0.00034792052,0.0003406828,0.00044748865,0.00007774527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007872185,0.00014915303,0.00050480786,0.00025738298,0.000054441953,0.000007492845,0.00008348279,0.00005041695,0.000055534372],"category_scores_gemma":[0.00012551957,0.00010737055,0.00003922317,0.00037772104,0.00016804886,0.000044489818,0.0002380774,0.00047844305,3.096229e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012280209,0.008597439,0.96955585,0.0005890806,0.0001220203,0.00000564684,0.003840209,0.00021931433,0.000499921,4.469047e-7,0.0000035982964,0.0042862897],"study_design_scores_gemma":[0.015027244,0.008688646,0.9737378,0.0003762174,0.0002248151,9.606846e-7,0.0005101592,0.0010796734,0.0002743618,0.000010229039,0.0000019380964,0.00006796503],"about_ca_topic_score_codex":0.0068328627,"about_ca_topic_score_gemma":0.0016770655,"teacher_disagreement_score":0.0051557976,"about_ca_system_score_codex":0.00020827222,"about_ca_system_score_gemma":0.0001576279,"threshold_uncertainty_score":0.9997807},"labels":[],"label_agreement":null},{"id":"W4211009850","doi":"10.1007/978-3-319-07311-8_18","title":"Toxic Neuropathies","year":2014,"lang":"en","type":"book-chapter","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Medicine","score_opus":0.027986202431647303,"score_gpt":0.2902252503081626,"score_spread":0.2622390478765153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211009850","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011374896,0.0006982257,0.000019706027,0.0010792308,0.00044609132,0.00018980465,0.0000040104655,0.000090442445,0.99735874],"genre_scores_gemma":[0.0060030944,0.00058893976,0.000046527603,0.0036180608,0.00081112725,0.0000059146423,0.000043034168,0.00003934704,0.988844],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995031,0.000004160792,0.00011693725,0.00018168807,0.00009434695,0.000099794306],"domain_scores_gemma":[0.99964666,0.00003272217,0.000042799435,0.00017048603,0.000028575047,0.00007877205],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00002599265,0.00016691105,0.00030527022,0.00007424475,0.000018834653,0.0000039782612,0.00003335901,0.00014251382,0.017161474],"category_scores_gemma":[0.0000029461103,0.00012632718,0.00012099793,0.000005760024,0.00004727038,0.000005494355,0.000022516175,0.00018084291,0.0014717133],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036950424,0.000067491885,0.00014849962,0.00025060945,0.00047961547,0.000647789,0.00005427432,2.5629208e-7,0.0014011696,0.27543178,0.65420103,0.06694798],"study_design_scores_gemma":[0.0006916828,0.0005287096,0.000062944586,0.00004340383,0.00038160366,0.00008640503,4.1351478e-7,0.000003295826,0.00036502973,0.001147157,0.9965813,0.00010803539],"about_ca_topic_score_codex":0.0000063482753,"about_ca_topic_score_gemma":0.000010770508,"teacher_disagreement_score":0.34238032,"about_ca_system_score_codex":0.000035527155,"about_ca_system_score_gemma":0.000047445308,"threshold_uncertainty_score":0.9993058},"labels":[],"label_agreement":null},{"id":"W4211210620","doi":"10.1007/s00520-022-06891-0","title":"Pre-medication protocols for the prevention of paclitaxel-induced infusion related reactions: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Discontinuation; Meta-analysis; Observational study; Relative risk; Adverse effect; Randomized controlled trial; Internal medicine; MEDLINE; Clinical endpoint; Systematic review; Cochrane Library; Confidence interval","score_opus":0.20743111679492188,"score_gpt":0.5192020584243411,"score_spread":0.3117709416294192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211210620","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002632145,0.9005248,0.0000053002586,0.00033753508,0.000060590577,0.09860968,0.00038348674,0.000012954234,0.000063003434],"genre_scores_gemma":[0.00003600472,0.67519456,0.000010336537,0.00008423491,0.000015315807,0.32313854,0.0005745088,0.000020392657,0.00092609815],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9969192,0.0006059544,0.0015915827,0.00042709167,0.00029536206,0.00016078292],"domain_scores_gemma":[0.9965114,0.0007300074,0.0019876116,0.00047051968,0.00024688256,0.000053553194],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010060902,0.00030170276,0.0045355037,0.00031612464,0.00007290239,0.000006007376,0.00012107875,0.00016798075,0.0028649813],"category_scores_gemma":[0.00033501882,0.00017141724,0.0018232723,0.0010493257,0.00004969696,0.000061304105,0.000050728126,0.00034212772,9.556477e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047715206,0.00011090955,0.000008271792,0.8960633,0.08365692,0.000002937156,0.0004022301,5.4501265e-7,0.0000010882261,0.000009532014,0.00029495225,0.019401575],"study_design_scores_gemma":[0.00043427685,0.0004760645,0.000010747458,0.039193697,0.7728739,0.000010824557,0.00016257861,0.000001867237,0.000003393935,0.000011313678,0.18670377,0.000117602656],"about_ca_topic_score_codex":0.00023734607,"about_ca_topic_score_gemma":0.00025067336,"teacher_disagreement_score":0.85686964,"about_ca_system_score_codex":0.00076742616,"about_ca_system_score_gemma":0.0008846784,"threshold_uncertainty_score":0.9980465},"labels":[],"label_agreement":null},{"id":"W4211244322","doi":"10.32920/ryerson.14655858","title":"The Influence Of The Epidermal Growth Factor Receptor On The DNA Damage Response As Examined Through Clathrin Affiliated Signalling Complexes","year":2021,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Cisplatin; Epidermal growth factor receptor; DNA damage; DNA repair; Cancer research; Context (archaeology); PI3K/AKT/mTOR pathway; Cancer; Cell biology; Biology; Signal transduction; DNA; Medicine; Internal medicine; Chemotherapy; Genetics","score_opus":0.053627716346361945,"score_gpt":0.33384774716136295,"score_spread":0.280220030815001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211244322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749557,0.0004202594,0.000010673923,0.020616092,0.0005573852,0.0015647495,0.000088016895,0.000073616095,0.0017135231],"genre_scores_gemma":[0.9917673,0.00059355295,0.000113429436,0.0028298895,0.00017759498,0.00015394995,0.00006415477,0.00004239377,0.004257721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965114,0.0014210164,0.00062113407,0.00054231175,0.0005126159,0.00039154518],"domain_scores_gemma":[0.9932203,0.004976101,0.00042665264,0.0009613973,0.00033278426,0.00008275516],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069811085,0.00044419075,0.00064230815,0.000048504913,0.00036370056,0.00006603555,0.00066869316,0.00027897736,0.0020401448],"category_scores_gemma":[0.0010237461,0.00019702813,0.0003783246,0.0002890832,0.00052337017,0.00005521976,0.0006591347,0.0011187722,0.00003358708],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015243601,0.00081792625,0.0055438946,0.00029501316,0.0019393151,0.000073455325,0.007344466,0.0012427098,0.95564806,0.0028366693,0.008692737,0.00032217757],"study_design_scores_gemma":[0.00301634,0.0010109545,0.33461407,0.0011048517,0.0006205353,0.000020921469,0.0015881599,0.00023326701,0.64853656,0.00077751454,0.0079859765,0.00049085513],"about_ca_topic_score_codex":0.0010529746,"about_ca_topic_score_gemma":0.00018215372,"teacher_disagreement_score":0.32907015,"about_ca_system_score_codex":0.00021642483,"about_ca_system_score_gemma":0.0007374277,"threshold_uncertainty_score":0.9988721},"labels":[],"label_agreement":null},{"id":"W4212810043","doi":"10.17504/protocols.io.b5ebq3an","title":"[RETRACTED] Nerve Rejuv Amazon: UK, USA, Australia, South Africa, Canada, NZ (Ingredients Updates) v1","year":2022,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Amazon rainforest; Business; Medicine; Advertising; Geography; Biology","score_opus":0.06591995734518499,"score_gpt":0.3319415243283123,"score_spread":0.2660215669831273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212810043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9191005,0.00078277604,0.000007900335,0.0029633527,0.0065704877,0.0015440526,0.0014996316,0.00012967632,0.06740158],"genre_scores_gemma":[0.7578464,0.000054266577,0.00022711208,0.00091503264,0.000858902,0.00025595745,0.0021886346,0.000057652993,0.23759604],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99631727,0.00011780479,0.0006814104,0.0010881108,0.00093840156,0.00085703254],"domain_scores_gemma":[0.99792707,0.00008161994,0.00037235167,0.00087620923,0.00017233065,0.0005704478],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002436009,0.0006526889,0.0009974716,0.0002474085,0.00018883767,0.000048000154,0.00045499223,0.0004984423,0.13099891],"category_scores_gemma":[0.00003723598,0.0006021518,0.00033617768,0.00031687308,0.0000891271,0.00004000708,0.00085565593,0.0023088693,0.0002266572],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062102266,0.00044072242,0.16581045,0.00027456335,0.0013569123,0.0022525848,0.001309128,0.00015661003,0.00027808355,0.000085340165,0.8269579,0.0004566996],"study_design_scores_gemma":[0.006137873,0.00090658554,0.16156462,0.00016978172,0.0030196041,0.000130644,0.00086340704,0.00017206142,0.0015531251,0.0001783388,0.8238807,0.0014233196],"about_ca_topic_score_codex":0.67578834,"about_ca_topic_score_gemma":0.44100344,"teacher_disagreement_score":0.2347849,"about_ca_system_score_codex":0.0020154258,"about_ca_system_score_gemma":0.0021890756,"threshold_uncertainty_score":0.99999285},"labels":[],"label_agreement":null},{"id":"W4212963976","doi":"10.3390/curroncol29020105","title":"Front-Line Bevacizumab plus Chemotherapy with or without Maintenance Therapy for Metastatic Breast Cancer: An Observational Study by the Hellenic Oncology Research Group","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"China Academy of Building Research","keywords":"Medicine; Bevacizumab; Internal medicine; Oncology; Maintenance therapy; Metastatic breast cancer; Neutropenia; Chemotherapy; Discontinuation; Breast cancer; Hormonal therapy; Adverse effect; Cancer; Surgery","score_opus":0.4896111016687083,"score_gpt":0.5627094855712466,"score_spread":0.07309838390253826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212963976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9557362,0.006363001,0.00030763628,0.026804164,0.0014253785,0.0084388,0.0007033493,0.000078064826,0.00014340215],"genre_scores_gemma":[0.9688792,0.0028471237,0.00045725724,0.0030293365,0.00091894687,0.018789971,0.0006826016,0.00009862656,0.004296923],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962134,0.0012107971,0.00047713128,0.0007326227,0.000608629,0.0007574352],"domain_scores_gemma":[0.99778175,0.0008761835,0.00026189248,0.0004346612,0.000445343,0.00020015634],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001633809,0.00032352828,0.00088417646,0.00015823751,0.0007629857,0.000018577715,0.00045802767,0.00007054145,0.004006701],"category_scores_gemma":[0.000022174308,0.00018881449,0.00011136483,0.00045922995,0.00040074493,0.000093669216,0.00011509631,0.0008948308,0.000008136603],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18432806,0.042650815,0.06451046,0.00012460783,0.0023856675,0.00013156324,0.013426034,0.00017056621,0.0015593314,0.00019865198,0.18728366,0.5032306],"study_design_scores_gemma":[0.07277458,0.07754903,0.011909075,0.000023447854,0.00048701878,0.0005647342,0.007788161,0.0033403402,0.00005595439,0.00015919647,0.82504797,0.00030051597],"about_ca_topic_score_codex":0.0006454448,"about_ca_topic_score_gemma":0.003453723,"teacher_disagreement_score":0.6377643,"about_ca_system_score_codex":0.003200088,"about_ca_system_score_gemma":0.0029267624,"threshold_uncertainty_score":0.9969038},"labels":[],"label_agreement":null},{"id":"W4212986327","doi":"10.1093/jac/47.suppl_2.38-a","title":"Pharmacokinetics (Abstracts P88-P93)","year":2001,"lang":"en","type":"article","venue":"Journal of Antimicrobial Chemotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Toronto; Hamilton Health Sciences; Dalhousie University; McMaster University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Pharmacokinetics; Pharmacology; Medicine","score_opus":0.018754747333220245,"score_gpt":0.3230575385151151,"score_spread":0.30430279118189485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212986327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817736,0.000380714,0.000057292178,0.013553325,0.0007513244,0.00013873052,0.0000030280448,0.00001701938,0.0033249806],"genre_scores_gemma":[0.97968334,0.005694767,0.0014838421,0.00970442,0.0016058265,5.2968625e-7,0.000004050861,0.00003191358,0.0017912913],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990375,0.000019505092,0.0004487912,0.000104195686,0.00016691173,0.0002230936],"domain_scores_gemma":[0.99918526,0.00003114573,0.0003174086,0.00009556734,0.00021249386,0.00015810857],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015033179,0.00015167215,0.00037201005,0.00014561183,0.0000377287,0.000018126242,0.00010116133,0.000081441074,0.0012384397],"category_scores_gemma":[0.000008775702,0.00012088213,0.00023455979,0.00016554372,0.00005812043,0.00009138308,0.000007704203,0.0002750547,0.000028221712],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036261086,0.0008209993,0.004502803,0.000021230784,0.0003341285,0.00056761544,0.00017543147,0.000035123583,0.86526364,0.0000027460599,0.11351003,0.01114013],"study_design_scores_gemma":[0.012448012,0.0010844001,0.011122323,0.00007673403,0.0002480178,0.0038837856,0.00001097051,0.000012313774,0.48105842,0.000020211715,0.48989978,0.00013502562],"about_ca_topic_score_codex":0.000011145086,"about_ca_topic_score_gemma":0.0000016823006,"teacher_disagreement_score":0.38420522,"about_ca_system_score_codex":0.00010343859,"about_ca_system_score_gemma":0.00016445787,"threshold_uncertainty_score":0.99967456},"labels":[],"label_agreement":null},{"id":"W4213064176","doi":"10.1200/jco.2022.40.6_suppl.082","title":"Daily symptom monitoring commonly leads to treatment modification in older adults receiving treatment for metastatic prostate cancer (mPC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Prostate Cancer Canada","keywords":"Medicine; Prostate cancer; Docetaxel; Internal medicine; Prospective cohort study; Quality of life (healthcare); Androgen deprivation therapy; Cancer; Cohort; Physical therapy","score_opus":0.20375292736056624,"score_gpt":0.5337860924145994,"score_spread":0.33003316505403313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213064176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804075,0.0017229916,0.000026265418,0.013797287,0.0022145105,0.0016339227,0.000047502064,0.000012125027,0.00013789025],"genre_scores_gemma":[0.99152833,0.0022726753,0.0021084985,0.0006635575,0.0008867885,0.0011532572,0.000018955669,0.000030000228,0.0013379527],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996872,0.0004647775,0.0017719233,0.00030234834,0.00025161635,0.00033732774],"domain_scores_gemma":[0.9965544,0.0017503158,0.0009944486,0.00017172658,0.00020546735,0.0003236839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011684628,0.00020869193,0.0014197427,0.00025801995,0.00010877602,0.000008496255,0.00012057259,0.000090785834,0.0001811458],"category_scores_gemma":[0.00020401826,0.0001550727,0.0004181606,0.00023209177,0.000048122663,0.0000788721,0.000036663227,0.00035744254,0.0000043968244],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025132166,0.010825772,0.39365712,0.000043502943,0.0008376821,0.0003524788,0.0038310972,0.0019903819,0.0006908462,0.0000104798355,0.001204549,0.56142396],"study_design_scores_gemma":[0.08075416,0.11333024,0.6873646,0.0002517819,0.0022127598,0.00022558442,0.0015902882,0.0006719221,0.001572468,0.000076061624,0.11167759,0.00027259084],"about_ca_topic_score_codex":0.00044404893,"about_ca_topic_score_gemma":0.00043561214,"teacher_disagreement_score":0.5611513,"about_ca_system_score_codex":0.003312697,"about_ca_system_score_gemma":0.0017299827,"threshold_uncertainty_score":0.86625874},"labels":[],"label_agreement":null},{"id":"W4213114293","doi":"10.26226/morressier.5cdbe0a8618793e647b12537","title":"13 - MEDICAL CANNABIS IMPROVES APPETITE AND STABILIZES WEIGHT IN CANCER PATIENTS","year":2019,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Appetite; Cannabis; Medicine; Medical cannabis; Internal medicine; Environmental health; Psychiatry","score_opus":0.013269203478115159,"score_gpt":0.32622283913583294,"score_spread":0.3129536356577178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213114293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97995865,0.003585796,0.0000020213963,0.0073400293,0.0015241936,0.0011692428,0.00007283948,0.00003923476,0.0063079796],"genre_scores_gemma":[0.97535527,0.007590292,0.000051007195,0.0018523542,0.0003928711,0.0004173795,0.00021273045,0.0000365558,0.014091558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985,0.000042944986,0.00031695198,0.00052072445,0.00033258233,0.00028681807],"domain_scores_gemma":[0.9993371,0.000045453606,0.00008806571,0.00022313073,0.00007638228,0.00022990267],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010788251,0.00026806456,0.00058546814,0.00014891075,0.000016757378,0.00001205122,0.000097011965,0.00039651906,0.004833046],"category_scores_gemma":[0.000033725588,0.00019758262,0.000075273056,0.00006924414,0.00010663402,0.00002992015,0.0003622613,0.00056766917,0.000018443208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048957346,0.00075842027,0.9484812,0.0010932909,0.0002599301,0.00003383783,0.00055239553,0.000003192453,0.0001657163,0.000027235277,0.02750913,0.020626074],"study_design_scores_gemma":[0.014652568,0.0009363767,0.87660253,0.001260083,0.00046510645,0.000007302906,0.00006157516,0.00088160735,0.0013224578,0.0002189251,0.10299602,0.00059544825],"about_ca_topic_score_codex":0.01342043,"about_ca_topic_score_gemma":0.009949163,"teacher_disagreement_score":0.07548689,"about_ca_system_score_codex":0.00029412968,"about_ca_system_score_gemma":0.0007767397,"threshold_uncertainty_score":0.99607664},"labels":[],"label_agreement":null},{"id":"W4214591090","doi":"10.3390/curroncol18030002","title":"In this issue of Current Oncology","year":2011,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Epirubicin; Docetaxel; Medicine; Cyclophosphamide; Fluorouracil; Regimen; Oncology; Internal medicine; Breast cancer; Cancer research; Chemotherapy; Cancer","score_opus":0.29259579014025716,"score_gpt":0.5149666930386047,"score_spread":0.2223709028983475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214591090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7640598,0.027108688,0.000049892522,0.0030426797,0.016705142,0.0014829437,0.000034513134,0.00008228246,0.18743408],"genre_scores_gemma":[0.9880411,0.0070991376,0.0005299993,0.0007535379,0.0012420489,0.00030211953,0.00006786327,0.000038699414,0.0019254617],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984749,0.0001821786,0.00051797664,0.000322139,0.00012203271,0.00038080467],"domain_scores_gemma":[0.9991423,0.00013908284,0.00021075655,0.00022582331,0.00011814651,0.00016391257],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025081367,0.00019024557,0.0007361642,0.00029972586,0.000022549317,0.0000010210732,0.00014020174,0.00019292338,0.013208338],"category_scores_gemma":[0.00004759714,0.00016628308,0.00013014377,0.00026574451,0.0002376653,0.00005873109,0.00008572229,0.00047262653,0.00035836184],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025351942,0.017805833,0.12549007,0.00041302378,0.00015851718,0.00027701916,0.009485871,4.026876e-7,0.0025850772,0.0017882498,0.21048236,0.6289784],"study_design_scores_gemma":[0.0060216566,0.004038496,0.015125203,0.0000600372,0.00023533161,0.00007632451,0.00010815556,0.000022076707,0.0037886724,0.0004327157,0.96996075,0.00013058576],"about_ca_topic_score_codex":0.00014192144,"about_ca_topic_score_gemma":0.00017721509,"teacher_disagreement_score":0.7594784,"about_ca_system_score_codex":0.0005982645,"about_ca_system_score_gemma":0.0006301326,"threshold_uncertainty_score":0.9876937},"labels":[],"label_agreement":null},{"id":"W4214668728","doi":"10.51731/cjht.2021.146","title":"Semaglutide (Rybelsus)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Semaglutide; Reimbursement; Medicine; Metformin; Glycemic; Drug; Type 2 diabetes; Family medicine; Diabetes mellitus; Pharmacology; Political science; Health care; Endocrinology","score_opus":0.03820972258412177,"score_gpt":0.34213541595885694,"score_spread":0.3039256933747352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214668728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42817807,0.2893693,0.00005715032,0.27878243,0.001054491,0.0001906979,0.000018027597,0.000104846455,0.002245013],"genre_scores_gemma":[0.99483895,0.001295498,0.00086288777,0.0022505808,0.00002669609,0.0000024868377,0.0000029715275,0.000009207874,0.0007106907],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99914366,0.0000315111,0.0003250558,0.00008912396,0.00008309191,0.0003275408],"domain_scores_gemma":[0.9993231,0.000043071857,0.00016666073,0.0001479831,0.00019611372,0.00012303822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019619797,0.000079675294,0.0003294998,0.00030362408,0.000113537186,0.0000095803725,0.00008889738,0.000091217546,0.00022200609],"category_scores_gemma":[0.00028019366,0.00006731479,0.00008178003,0.00028688175,0.00011473283,0.00002836481,0.000010082463,0.00032592914,0.000012163892],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044399698,0.000082335595,0.045331616,0.00018031316,0.00021643727,0.0060528126,0.0003179813,0.0000048295046,0.0008284327,0.0012455792,0.08133364,0.86436164],"study_design_scores_gemma":[0.0014036819,0.00069732784,0.024251878,0.00019990209,0.000063345695,0.0045712446,0.0017513264,0.0000022559898,0.0067580403,0.0016608922,0.9585532,0.00008688118],"about_ca_topic_score_codex":0.0014614274,"about_ca_topic_score_gemma":0.0053236117,"teacher_disagreement_score":0.8772196,"about_ca_system_score_codex":0.00047378722,"about_ca_system_score_gemma":0.0070750415,"threshold_uncertainty_score":0.99855393},"labels":[],"label_agreement":null},{"id":"W4220847074","doi":"10.5281/zenodo.5903087","title":"Antibody Characterization Report for Syntaxin-4","year":2022,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Antibody; Virology; Immunology; Medicine","score_opus":0.04077874315487583,"score_gpt":0.3199088571871349,"score_spread":0.27913011403225907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220847074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.675731,0.000284449,0.085616715,0.017905809,0.0019064868,0.00702832,0.0032550115,0.003242088,0.20503013],"genre_scores_gemma":[0.78880405,0.00007551028,0.00022759645,0.0008255586,0.0004735544,0.0000010187056,0.19579732,0.0013303475,0.012465062],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99888873,0.00012182638,0.00020438732,0.00030901015,0.0002427012,0.00023336336],"domain_scores_gemma":[0.99923664,0.00001556705,0.00011044228,0.00025315527,0.0002748633,0.00010934487],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040860084,0.000093429786,0.00014667818,0.0001652994,0.0018727051,0.000097299686,0.00021901092,0.000026750864,0.025076874],"category_scores_gemma":[0.00014515778,0.00010182283,0.00006438228,0.00032271235,0.00004951058,0.00008770571,0.00040337423,0.00015917484,0.0004965896],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094270764,0.00071520405,0.000113483016,0.000118793694,0.00016795447,0.00024376257,0.00089843647,0.000015754302,0.91214997,0.0010686211,0.04645203,0.037113313],"study_design_scores_gemma":[0.0012931467,0.0008482294,0.0027146512,0.0000071451177,0.00006573966,0.0013371641,0.000109530534,0.00021269903,0.0010523644,0.000031654632,0.9922315,0.00009615899],"about_ca_topic_score_codex":0.0000072320445,"about_ca_topic_score_gemma":5.1332197e-8,"teacher_disagreement_score":0.9457795,"about_ca_system_score_codex":0.0002435435,"about_ca_system_score_gemma":0.000009079607,"threshold_uncertainty_score":0.9994267},"labels":[],"label_agreement":null},{"id":"W4220872739","doi":"10.1158/1538-7445.sabcs21-ot1-11-02","title":"Abstract OT1-11-02: A pragmatic, randomised, multicentre trial evaluating the dose timing (morning vs evening) of endocrine therapy and its effects on tolerability and compliance (REaCT-CHRONO Study)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; McMaster University; Thunder Bay Regional Health Sciences Centre; University of Ottawa","funders":"","keywords":"Tolerability; Medicine; Evening; Clinical endpoint; Breast cancer; Morning; Internal medicine; Cancer; Clinical trial; Oncology; Adverse effect","score_opus":0.2686467496825231,"score_gpt":0.5216192358242293,"score_spread":0.2529724861417062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220872739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854107,0.00504455,3.016894e-7,0.0012303862,0.00021550778,0.007894316,0.000017612676,0.00001840062,0.0001682633],"genre_scores_gemma":[0.9962564,0.00042470318,0.000022126746,0.00010749547,0.000266745,0.0026661255,0.000007858575,0.000024892566,0.00022362142],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967504,0.0012030709,0.00037172073,0.00044194804,0.00081637356,0.00041647226],"domain_scores_gemma":[0.99538285,0.0038748977,0.00016776925,0.00026702537,0.00018297718,0.00012451402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030801103,0.000182765,0.0005440171,0.00011927315,0.00049383956,0.000027134645,0.00013923783,0.000027292203,0.0007263048],"category_scores_gemma":[0.00053995504,0.00012819906,0.000067581386,0.00026422896,0.00012117389,0.00005441024,0.00016993827,0.00069446757,0.0000020561047],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7013908,0.0026434907,0.017984703,0.0010968829,0.0007296158,0.00013976119,0.014380519,0.00036537024,0.13464744,0.000014754704,0.00045875506,0.12614788],"study_design_scores_gemma":[0.8221901,0.02642576,0.11252544,0.0006132886,0.00040226936,0.000038618586,0.002321011,0.006976811,0.025765669,0.000038632512,0.0023599372,0.00034244463],"about_ca_topic_score_codex":0.00049541827,"about_ca_topic_score_gemma":0.00006728222,"teacher_disagreement_score":0.12580544,"about_ca_system_score_codex":0.0003570309,"about_ca_system_score_gemma":0.00035107275,"threshold_uncertainty_score":0.7952528},"labels":[],"label_agreement":null},{"id":"W4220978230","doi":"10.1158/1538-7445.sabcs21-p4-10-15","title":"Abstract P4-10-15: Whole-body vibration combined with physical exercise to treat aromatase inhibitor-induced musculoskeletal symptoms in breast cancer women: Results of a pilot randomized controlled study","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Physical therapy; Whole body vibration; Randomized controlled trial; WOMAC; Cancer; Aromatase inhibitor; Osteoarthritis; Internal medicine; Physical medicine and rehabilitation; Tamoxifen; Alternative medicine; Pathology","score_opus":0.028336843282527033,"score_gpt":0.3870256262619594,"score_spread":0.35868878297943235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220978230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98482704,0.0001947348,2.4638223e-7,0.0029582584,0.00014855457,0.010848032,0.00066164776,0.00004303214,0.0003184689],"genre_scores_gemma":[0.9679171,0.000056376546,0.0000022746297,0.000079305304,0.0002878256,0.030274233,0.00015259156,0.00005425008,0.0011760668],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954526,0.0009615185,0.0007430982,0.00071824057,0.0013852272,0.00073933933],"domain_scores_gemma":[0.9978633,0.0007231504,0.00021372036,0.00046395947,0.00036343196,0.00037246113],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001979587,0.0003422345,0.002013336,0.000718077,0.00021534863,0.00003425928,0.0002279945,0.000050155602,0.0012484026],"category_scores_gemma":[0.000079665806,0.00024645252,0.00019657714,0.0013199818,0.00019734041,0.00013147917,0.0001718654,0.00066821155,0.000015306803],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78817993,0.0073936665,0.00084903504,0.00014621919,0.00052640814,0.0001957368,0.003612074,0.00023321857,0.19466393,0.000004818453,0.0026276836,0.0015672756],"study_design_scores_gemma":[0.95090216,0.016237333,0.020641223,0.0002843955,0.0004937535,0.000007999737,0.0021443681,0.00020527332,0.008684048,0.000018131897,0.00007761767,0.00030369693],"about_ca_topic_score_codex":0.006336328,"about_ca_topic_score_gemma":0.0005418328,"teacher_disagreement_score":0.18597987,"about_ca_system_score_codex":0.0019686366,"about_ca_system_score_gemma":0.0011574846,"threshold_uncertainty_score":0.99999875},"labels":[],"label_agreement":null},{"id":"W4223629792","doi":"10.1136/bmjopen-2021-057950","title":"Evaluation of the psychometric properties of patient-reported and clinician-reported outcome measures of chemotherapy-induced peripheral neuropathy: a COSMIN systematic review protocol","year":2022,"lang":"en","type":"article","venue":"BMJ Open","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université de Montréal; Université Laval","funders":"National Cancer Institute; Fondation Jean-Louis Lévesque","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; PsycINFO; MEDLINE; Prom; Checklist; Protocol (science); CINAHL; Patient-reported outcome; Quality of life (healthcare); Physical therapy; Alternative medicine; Peripheral neuropathy; Psychiatry; Pathology; Psychological intervention","score_opus":0.379683212875548,"score_gpt":0.4985042766355723,"score_spread":0.11882106376002427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223629792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64773434,0.0007842334,2.710507e-7,0.00040739393,0.00009952028,0.35056075,0.000005155685,0.000005745538,0.00040257696],"genre_scores_gemma":[0.7928181,0.000013869282,0.000011782011,0.00046569822,0.0000091616785,0.20653214,0.0000026180069,0.000014340492,0.00013226626],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9959508,0.001129777,0.0015278034,0.00020385011,0.0010909787,0.00009678881],"domain_scores_gemma":[0.9968212,0.000041845047,0.0019805778,0.0005250745,0.0005976657,0.00003360311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043166745,0.00012925219,0.00095120736,0.000102847094,0.000054095253,0.000005911619,0.00019506217,0.00002646291,0.00022686292],"category_scores_gemma":[0.0011455467,0.00007660712,0.00013381577,0.000654685,0.00005052091,0.000046121975,0.00014441177,0.00009424946,1.9999321e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0103480145,0.0060982537,0.35525942,0.46286193,0.0045650825,0.000029572966,0.005808302,0.000042944896,0.12850806,0.000013427122,0.0019075975,0.024557408],"study_design_scores_gemma":[0.11794084,0.02894638,0.48244354,0.15526009,0.050382365,0.0017015715,0.003850552,0.0036458499,0.15215565,0.000189015,0.0018698107,0.0016143317],"about_ca_topic_score_codex":0.000157528,"about_ca_topic_score_gemma":0.000015105202,"teacher_disagreement_score":0.30760184,"about_ca_system_score_codex":0.00009932028,"about_ca_system_score_gemma":0.00058609375,"threshold_uncertainty_score":0.31239474},"labels":[],"label_agreement":null},{"id":"W4224095649","doi":"10.1016/j.neurol.2022.02.414","title":"Les effets de l’évobrutinib, un inhibiteur de la tyrosine kinase de Bruton, sur les lésions à expansion lente : un nouveau marqueur d’imagerie de la perte tissulaire chronique dans la sclérose en plaques","year":2022,"lang":"fr","type":"article","venue":"Revue Neurologique","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada)","funders":"","keywords":"Chemistry; Molecular biology; Biology","score_opus":0.009699167280697777,"score_gpt":0.28257369329930127,"score_spread":0.2728745260186035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224095649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654215,0.016991401,0.0008179004,0.010171795,0.0006596694,0.0010274693,0.0003588233,0.00049236225,0.004059071],"genre_scores_gemma":[0.97051924,0.020298189,0.0012727967,0.002551629,0.0009701467,0.0006558362,0.00017503761,0.00021134154,0.0033457666],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9849688,0.011700333,0.00065042963,0.00096235005,0.0002672447,0.0014508528],"domain_scores_gemma":[0.99393797,0.00445495,0.0003148793,0.0005953904,0.00009698585,0.000599804],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002817572,0.00074839324,0.00086117693,0.00027624925,0.0008457913,0.00007957163,0.0004992349,0.0010255737,0.000987283],"category_scores_gemma":[0.0009067164,0.0008127228,0.0003777139,0.00045657458,0.000849572,0.00014980724,0.00054733455,0.003105217,0.000019186813],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035654942,0.004847673,0.18293783,0.0017071165,0.00037449223,0.05698947,0.011811094,0.002893239,0.6662488,0.0038044371,0.009477563,0.05534277],"study_design_scores_gemma":[0.013282771,0.007917508,0.38723028,0.0012745381,0.0021139185,0.035136655,0.0010499688,0.011411897,0.23727271,0.00082307705,0.30103707,0.0014496276],"about_ca_topic_score_codex":0.0050015673,"about_ca_topic_score_gemma":0.00048694128,"teacher_disagreement_score":0.42897612,"about_ca_system_score_codex":0.0020262976,"about_ca_system_score_gemma":0.0019001712,"threshold_uncertainty_score":0.999926},"labels":[],"label_agreement":null},{"id":"W4224305302","doi":"10.17504/protocols.io.8epv59n44g1b/v1","title":"[RETRACTED] Lisa Laflamme CBD Gummies Canada RESULT REVIEWS, 100% SAFE &amp;amp; RISK FREE! v1","year":2022,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sadness; Unrest; Key (lock); Computer science; Economics; Operations management; Psychology; Political science; Computer security; Social psychology; Law","score_opus":0.06408073193083959,"score_gpt":0.35314889745859734,"score_spread":0.28906816552775777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224305302","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14913626,0.08466806,0.00008559826,0.04489867,0.017464159,0.007931942,0.0069667464,0.0004746198,0.6883739],"genre_scores_gemma":[0.010161395,0.08053123,0.0036082515,0.0070627863,0.0028997418,0.0009848123,0.007937777,0.00011273937,0.8867013],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959745,0.00045514104,0.0010724231,0.0010483952,0.0007853599,0.0006641813],"domain_scores_gemma":[0.99638724,0.000389877,0.00066947046,0.0019444751,0.00018149534,0.00042745503],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007832621,0.00071043504,0.0015272398,0.00021181027,0.00026487,0.000042570646,0.00061746646,0.00047657013,0.16364679],"category_scores_gemma":[0.0006458594,0.0005941909,0.00044650648,0.0003007253,0.000100319776,0.00004727897,0.001158223,0.0029563787,0.0007490123],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048566132,0.00024974695,0.00866964,0.0005488454,0.000770803,0.00016548893,0.00029898738,0.000033208886,0.00013905573,0.00004954254,0.98355967,0.0050293636],"study_design_scores_gemma":[0.0023211988,0.000108324835,0.007932998,0.00020471655,0.0016045163,0.00003925117,0.000060275645,0.00000695845,0.00013709525,0.00019193417,0.9868669,0.00052584877],"about_ca_topic_score_codex":0.8003106,"about_ca_topic_score_gemma":0.9310846,"teacher_disagreement_score":0.19832733,"about_ca_system_score_codex":0.002119789,"about_ca_system_score_gemma":0.0019072682,"threshold_uncertainty_score":0.99965096},"labels":[],"label_agreement":null},{"id":"W4226287808","doi":"10.46747/cfp.6801e5","title":"Principes de base de la chimiothérapie à l’intention des médecins de famille","year":2022,"lang":"fr","type":"article","venue":"Canadian Family Physician","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology; Humanities; Philosophy","score_opus":0.020901111847830577,"score_gpt":0.2853805636465879,"score_spread":0.26447945179875737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226287808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7805298,0.024100395,0.00012104849,0.0024937806,0.0016336252,0.0005269475,0.0007576406,0.00006805584,0.18976869],"genre_scores_gemma":[0.90131,0.001584178,0.0005132887,0.07891797,0.0015683037,0.00026321967,0.00019736827,0.000106843254,0.015538798],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99703753,0.0005846188,0.0002517086,0.00041142153,0.00019966389,0.0015150472],"domain_scores_gemma":[0.9980344,0.00017551561,0.00009398589,0.00030812764,0.000060049733,0.0013279144],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005410025,0.00032458082,0.00037294472,0.00032872337,0.0007964668,0.0000513026,0.00025713939,0.00015207384,0.0005591301],"category_scores_gemma":[0.000028574294,0.00041282352,0.00026096683,0.0005140446,0.00044283623,0.00010726214,0.00006550552,0.0006628976,0.000103031976],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055421947,0.002892639,0.053134777,0.0006005766,0.0017950078,0.006390454,0.007922099,0.003199818,0.10914163,0.0182734,0.33049148,0.4656039],"study_design_scores_gemma":[0.003572483,0.00074155955,0.21203148,0.00019815142,0.0008665656,0.000093092094,0.004030269,0.0026777938,0.0017972519,0.0024961103,0.77101773,0.0004774897],"about_ca_topic_score_codex":0.16441919,"about_ca_topic_score_gemma":0.038293123,"teacher_disagreement_score":0.4651264,"about_ca_system_score_codex":0.009787638,"about_ca_system_score_gemma":0.005107737,"threshold_uncertainty_score":0.99983233},"labels":[],"label_agreement":null},{"id":"W4226399799","doi":"","title":"Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment","year":2022,"lang":"en","type":"review","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Cardiotoxicity; Medicine; Colorectal cancer; Chemotherapy; Oncology; Internal medicine; Cancer; Intensive care medicine","score_opus":0.44285396380527514,"score_gpt":0.6403797302577987,"score_spread":0.19752576645252357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226399799","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0079020895,0.9778134,0.0000014727025,0.00010241713,0.0015595123,0.0032344933,0.00033804032,0.000041176325,0.009007373],"genre_scores_gemma":[0.0016990233,0.9937533,0.000018717703,0.00015598073,0.0005882329,0.0021454028,0.00018966576,0.00014305931,0.001306579],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99559134,0.00071486854,0.0014399255,0.00087773625,0.00071696,0.0006591519],"domain_scores_gemma":[0.99722445,0.00056893675,0.0012746928,0.00046763598,0.0000861653,0.00037810038],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00078944606,0.0008644803,0.005078395,0.001817116,0.0002282008,0.00028760647,0.0014854998,0.00026331426,0.054681502],"category_scores_gemma":[0.000052539137,0.00069992826,0.0012400241,0.0017593446,0.0001273056,0.0005016398,0.0009204385,0.0010257742,0.000017344066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053001294,0.0010468885,0.03941834,0.004253754,0.0035021084,0.0012547123,0.00015086701,0.000033999873,0.00019756138,0.0000047214303,0.01476905,0.934838],"study_design_scores_gemma":[0.0020167383,0.000096848584,0.011470505,0.00600235,0.004555372,0.00015770544,0.000024862607,0.0000068128425,0.00033257983,0.000093402225,0.97465366,0.000589151],"about_ca_topic_score_codex":0.008180222,"about_ca_topic_score_gemma":0.00065022137,"teacher_disagreement_score":0.95988464,"about_ca_system_score_codex":0.0040315837,"about_ca_system_score_gemma":0.0015953343,"threshold_uncertainty_score":0.99979174},"labels":[],"label_agreement":null},{"id":"W4229367461","doi":"10.1007/s12035-022-02858-8","title":"Neuroprotective Effect of Baicalein Against Oxaliplatin-Induced Peripheral Neuropathy: Impact on Oxidative Stress, Neuro-inflammation and WNT/β-Catenin Signaling","year":2022,"lang":"en","type":"article","venue":"Molecular Neurobiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Oxaliplatin; Baicalein; Neuroprotection; Oxidative stress; Medicine; Pharmacology; Peripheral neuropathy; Wnt signaling pathway; Internal medicine; Endocrinology; Cancer; Chemistry; Signal transduction; Colorectal cancer; Biochemistry","score_opus":0.009142419085627998,"score_gpt":0.2795402926725754,"score_spread":0.2703978735869474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229367461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997473,0.0000551178,0.000027425582,0.000493486,0.00027087893,0.0012288854,0.00006633801,0.000062889776,0.00032198275],"genre_scores_gemma":[0.99889046,0.000013368646,0.000015243241,0.00060638745,0.00007811834,0.00016353994,0.0001482694,0.000055643795,0.00002895375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970188,0.0015418322,0.00033553632,0.0005850157,0.00017791816,0.0003408915],"domain_scores_gemma":[0.99896526,0.00040685272,0.00023849991,0.00020965385,0.00005844753,0.00012130059],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019255087,0.00034712424,0.0005860067,0.00020639195,0.00016001148,0.000010312181,0.00011905801,0.00008124369,0.00013838866],"category_scores_gemma":[0.00014114006,0.00028778292,0.00019658609,0.0002845017,0.00011408846,0.00003788975,0.00015758515,0.00061987736,0.000004139281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034887225,0.0001462197,0.0046657673,0.00004258868,0.00013831856,0.0006500282,0.0001689062,0.0035695997,0.98508453,0.00004756399,0.00002423765,0.001973527],"study_design_scores_gemma":[0.00384009,0.018375158,0.011996136,0.000015828724,0.00019806015,0.00011148509,0.000018079734,0.0012078906,0.9639165,0.000018794679,0.00010547236,0.00019653008],"about_ca_topic_score_codex":0.000039334314,"about_ca_topic_score_gemma":0.0000014423395,"teacher_disagreement_score":0.021168046,"about_ca_system_score_codex":0.00011334965,"about_ca_system_score_gemma":0.00007426252,"threshold_uncertainty_score":0.99995744},"labels":[],"label_agreement":null},{"id":"W4229664019","doi":"10.5489/cuaj.1324","title":"Moderated Poster Session 3: Oncology 2","year":2011,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Session (web analytics); Medicine; Internal medicine; Oncology; Psychology; Medical physics; Computer science; World Wide Web","score_opus":0.04464806038405039,"score_gpt":0.29980741598361843,"score_spread":0.25515935559956804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229664019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8864444,0.00019236711,0.000024455161,0.025339186,0.0008117945,0.00017698808,0.000013807944,0.000034096392,0.08696289],"genre_scores_gemma":[0.9830538,0.000063903266,0.0001704243,0.013888152,0.00037614448,0.000006555058,0.000017205813,0.000007781885,0.0024160119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903023,0.00014763995,0.00020979534,0.00012216307,0.00012663627,0.00036350894],"domain_scores_gemma":[0.99889344,0.00004656225,0.00014091423,0.00005005944,0.0001979,0.0006711159],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027033567,0.000092816466,0.00021043238,0.00013204057,0.00017002736,0.000016430386,0.000055143184,0.0002841224,0.007845069],"category_scores_gemma":[0.00009756262,0.00006910007,0.000087781926,0.00011224491,0.000020465839,0.00006357675,0.000008001673,0.0004628801,0.00017382167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052477943,0.0002770968,0.9090942,0.0000023334223,0.00025640376,0.0006946158,0.0006801177,0.0000029712085,0.00085934304,0.00012928619,0.07774446,0.0097343745],"study_design_scores_gemma":[0.002739488,0.0017628074,0.7670879,0.00000604773,0.00019597536,0.0009165915,0.00004733254,0.000077777346,0.00030742754,0.0010063661,0.2257297,0.00012259056],"about_ca_topic_score_codex":0.0011543531,"about_ca_topic_score_gemma":0.0008696251,"teacher_disagreement_score":0.14798525,"about_ca_system_score_codex":0.0015770629,"about_ca_system_score_gemma":0.0007416155,"threshold_uncertainty_score":0.9930619},"labels":[],"label_agreement":null},{"id":"W4230163924","doi":"10.1200/jco.2004.22.14_suppl.706","title":"Trastuzumab (T) and docetaxel (D) for the treatment of HER2 metastatic breast cancer (MBC): A literature based (LB) and individual patient data (IPD) meta-analysis (MA) of phase II trial","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Metastatic breast cancer; Oncology; Trastuzumab; Meta-analysis; Breast cancer; Clinical trial; MEDLINE; Cochrane Library; CINAHL; Systematic review; Cancer","score_opus":0.41150323797398336,"score_gpt":0.5572722318948445,"score_spread":0.14576899392086118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230163924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9581158,0.024078824,0.00027585283,0.013385493,0.00043279852,0.0012051096,0.0024873638,0.0000029009122,0.000015832156],"genre_scores_gemma":[0.9913009,0.0037066392,0.0034641966,0.0008969053,0.0004296215,0.0000672515,0.00008257901,0.000012557541,0.000039386607],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967717,0.0003809847,0.0020522259,0.00028299194,0.00032801184,0.00018409333],"domain_scores_gemma":[0.9938357,0.0031367894,0.0021201172,0.00031802637,0.00035271712,0.00023665019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015583694,0.00021649135,0.003256429,0.00020347194,0.00006672379,0.000010479887,0.00016916127,0.00016878241,0.00026895225],"category_scores_gemma":[0.00025963737,0.00010646851,0.0012888903,0.00029226491,0.00033485188,0.00010065134,0.000046981993,0.00026998232,8.526083e-8],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25485927,0.063628174,0.0013024547,0.0001389265,0.41486838,0.00025486213,0.002326732,0.00028635628,0.00018877423,0.000044957196,0.0013564407,0.26074466],"study_design_scores_gemma":[0.27333868,0.1566664,0.0042770873,0.000025295016,0.55224633,0.00016040477,0.00016514743,0.0003785396,0.00020643424,0.00011413496,0.01231699,0.000104557905],"about_ca_topic_score_codex":0.00014532222,"about_ca_topic_score_gemma":0.00032527448,"teacher_disagreement_score":0.26064008,"about_ca_system_score_codex":0.0001151769,"about_ca_system_score_gemma":0.0014067305,"threshold_uncertainty_score":0.43416598},"labels":[],"label_agreement":null},{"id":"W4230571109","doi":"10.1515/iupac.87.0518","title":"Peripheral Neuropathy","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Chemical nomenclature; Relation (database); Computer science; Psychology; Medicine; Chemistry; Linguistics; Philosophy; Data mining; Organic chemistry","score_opus":0.0183244224904887,"score_gpt":0.44372992708496123,"score_spread":0.4254055045944725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230571109","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006838141,0.0018033423,0.000008684206,0.002450143,0.0017149686,0.00043196869,0.99260783,0.0000794679,0.00021977253],"genre_scores_gemma":[0.00004953493,0.002862808,0.000016826143,0.0021602404,0.0031613295,0.000028791279,0.98741555,0.00004992909,0.0042549847],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980829,0.00006779001,0.00033368834,0.00047399628,0.0006325504,0.00040910873],"domain_scores_gemma":[0.9987103,0.000038828322,0.00014670416,0.0005671048,0.0002755718,0.00026152306],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014845574,0.00041466573,0.0007448402,0.00015770692,0.00006943877,0.000018991213,0.0001604999,0.00028628562,0.021197632],"category_scores_gemma":[0.00009751735,0.0002849752,0.0002477184,0.00012118264,0.0001403685,0.000039046492,0.00008774566,0.00046238376,0.0000072104526],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013708562,0.0005679336,0.00006767131,0.00015544557,0.0001731811,0.0009915498,0.000009519132,1.1606734e-7,0.00009056266,0.0000013492803,0.9909288,0.0056429813],"study_design_scores_gemma":[0.004484642,0.0015653333,0.00018243738,0.00021906212,0.0007243646,0.0001888409,0.0000045336033,0.0000013801155,0.000028405802,0.00001468974,0.99231815,0.00026816042],"about_ca_topic_score_codex":0.000091039044,"about_ca_topic_score_gemma":0.00024948697,"teacher_disagreement_score":0.021190422,"about_ca_system_score_codex":0.00063492655,"about_ca_system_score_gemma":0.0011101234,"threshold_uncertainty_score":0.99996024},"labels":[],"label_agreement":null},{"id":"W4230623844","doi":"10.1139/v00-080","title":"Synthesis of dimeric and tetrameric macrolactams with cytotoxic activity<sup>1</sup>","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemistry; Taxoid; Stereochemistry; Taxane; Cytotoxicity; Docetaxel; Cytotoxic T cell; Side chain; Paclitaxel; In vitro; Organic chemistry; Biochemistry","score_opus":0.0065285490804004725,"score_gpt":0.2302413065696946,"score_spread":0.22371275748929415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230623844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99261856,0.0008412656,0.0000014044592,0.00057966897,0.00001595166,0.000054069806,0.000014595238,0.0000028792442,0.005871633],"genre_scores_gemma":[0.99807745,0.00019360048,0.00008089226,0.00011100758,0.00012627893,0.0000029909431,0.0000013553594,0.000014859385,0.0013915617],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994281,0.0000128465,0.00016227263,0.00009583678,0.00010178733,0.00019917425],"domain_scores_gemma":[0.9991137,0.00006372306,0.00011306923,0.00009934924,0.000054547447,0.0005556318],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005216645,0.000116174015,0.0003274329,0.000059556103,0.00003691295,0.000008705332,0.0000630248,0.00006429623,0.003142021],"category_scores_gemma":[0.00002082875,0.0000932554,0.00006495394,0.00014332222,0.00018999355,0.000052314987,0.0000020317386,0.00020306365,0.0000022657978],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003230211,0.00044902184,0.15620068,0.00093959423,0.0020486824,0.0039900956,0.0018865734,0.00025991478,0.4680966,9.780588e-7,0.0072266026,0.35567102],"study_design_scores_gemma":[0.0048803627,0.0011404352,0.04864334,0.0006408442,0.0012416613,0.00918954,0.00050741056,0.00013583007,0.9011307,0.000014870628,0.032088056,0.00038696092],"about_ca_topic_score_codex":0.00085924513,"about_ca_topic_score_gemma":0.00012329445,"teacher_disagreement_score":0.43303406,"about_ca_system_score_codex":0.00012434085,"about_ca_system_score_gemma":0.0009393608,"threshold_uncertainty_score":0.99776924},"labels":[],"label_agreement":null},{"id":"W4231003726","doi":"10.1515/iupac.88.1076","title":"Morula","year":2017,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Terminology; Relation (database); Computer science; Linguistics; Philosophy; Data mining","score_opus":0.03012265849020757,"score_gpt":0.5193382229373927,"score_spread":0.48921556444718517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231003726","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002958907,0.0024714537,0.0000022273446,0.0021301864,0.0014423626,0.0004509086,0.99274015,0.000053379546,0.00041345553],"genre_scores_gemma":[0.00004969715,0.002487044,0.00003073953,0.0007193076,0.0023216158,0.000026755575,0.988524,0.000034974968,0.0058058174],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983022,0.000030502144,0.0002764321,0.0004124385,0.00062872045,0.00034965886],"domain_scores_gemma":[0.9982314,0.000027646598,0.00023690981,0.0009851943,0.00028185264,0.00023699351],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014942304,0.00037004007,0.0008196585,0.00015987262,0.00014839119,0.000037986887,0.00024752034,0.00037149474,0.009710362],"category_scores_gemma":[0.00016039053,0.00030365062,0.00023829522,0.000054459124,0.0001672972,0.000039692157,0.00011165266,0.00058260484,0.000012540296],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007956953,0.00063014706,0.00007104773,0.00023757639,0.00031361592,0.0013286987,0.0000066676607,1.7779504e-7,0.0000146620605,8.9013463e-7,0.99371463,0.0028861652],"study_design_scores_gemma":[0.0036730755,0.00079259305,0.00028669578,0.00025476416,0.0013627349,0.00019209621,0.000004479149,0.000002367899,0.000022236387,0.00002285785,0.99313706,0.000249034],"about_ca_topic_score_codex":0.00037620062,"about_ca_topic_score_gemma":0.00090364483,"teacher_disagreement_score":0.009697822,"about_ca_system_score_codex":0.00048330182,"about_ca_system_score_gemma":0.0013889667,"threshold_uncertainty_score":0.9999416},"labels":[],"label_agreement":null},{"id":"W4231306758","doi":"10.7748/cnp.14.5.15.s17","title":"Assessment of DN4 pain grading tool shows its reliability","year":2015,"lang":"en","type":"article","venue":"Cancer Nursing Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Grading (engineering); Medicine; Neuropathic pain; Physical therapy; Medical physics; Surgery; Engineering; Anesthesia","score_opus":0.09331572823394925,"score_gpt":0.47854005034899183,"score_spread":0.3852243221150426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231306758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76338416,0.010268406,0.0043737935,0.0661479,0.007022959,0.0022389954,0.000047364556,0.00025471105,0.14626172],"genre_scores_gemma":[0.9926927,0.00021475609,0.0037982024,0.0015127233,0.00041489903,0.000073976145,0.000011949299,0.000021431064,0.0012593747],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986183,0.00031516707,0.0002672006,0.00026919812,0.00030206778,0.0002280854],"domain_scores_gemma":[0.9984009,0.0005679216,0.0002173944,0.00024488004,0.00040365205,0.00016519836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014120652,0.00013282744,0.00030262308,0.000059783448,0.000050112023,0.000012817898,0.00006609611,0.00007565723,0.00026325384],"category_scores_gemma":[0.000931447,0.000121845034,0.00006765884,0.00021091843,0.000085231026,0.0002817784,0.000013570111,0.0002506918,0.000006075486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008241294,0.009475516,0.14196923,0.001189202,0.0013336062,0.00028897883,0.013199159,0.0013754179,0.06873212,0.003955033,0.32595766,0.4242828],"study_design_scores_gemma":[0.017311687,0.005722935,0.06268793,0.0020318616,0.005858,0.0003358142,0.0044680773,0.012290354,0.030478677,0.0014317455,0.8564556,0.0009272646],"about_ca_topic_score_codex":0.00020146053,"about_ca_topic_score_gemma":0.000006250334,"teacher_disagreement_score":0.53049797,"about_ca_system_score_codex":0.0013748043,"about_ca_system_score_gemma":0.00091619143,"threshold_uncertainty_score":0.49686962},"labels":[],"label_agreement":null},{"id":"W4232388491","doi":"10.1139/cjc-79-9-1381","title":"Reanalysis of the biotransformation of 4(20),11(12)-taxadiene derivatives","year":2001,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemistry; Biotransformation; Organic chemistry; Stereochemistry","score_opus":0.01406355443019332,"score_gpt":0.2578501507101483,"score_spread":0.24378659627995494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232388491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99037486,0.00061605265,0.000019531777,0.002026795,0.00006144726,0.00004064463,0.000018019535,9.203911e-7,0.006841728],"genre_scores_gemma":[0.9988624,0.00011844447,0.00004695122,0.00008225159,0.00009569787,5.820455e-7,0.0000055486107,0.0000045912525,0.0007835515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99942064,0.000012536734,0.00030659503,0.000041927895,0.00010833019,0.00010998401],"domain_scores_gemma":[0.99921715,0.000021328,0.00028840435,0.00011172674,0.00016641435,0.00019497825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009479713,0.00006348714,0.0002221334,0.0000646121,0.000029895713,0.0000025516435,0.00010103915,0.000051946154,0.0008129635],"category_scores_gemma":[0.000043008527,0.000044431705,0.00015742239,0.00019152589,0.0001222504,0.000043261414,0.0000026538535,0.00009942697,3.1790884e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014660123,0.0000735661,0.27652758,0.0002152008,0.00057768007,0.00007523544,0.0016921728,0.00007101394,0.7144351,0.00000870368,0.0032105802,0.0029665336],"study_design_scores_gemma":[0.0014716791,0.00009142323,0.043600142,0.00018495842,0.00048061876,0.0003571806,0.0004513941,0.00001900039,0.936305,0.000056125275,0.016922409,0.000060067327],"about_ca_topic_score_codex":0.00086784386,"about_ca_topic_score_gemma":0.0033167899,"teacher_disagreement_score":0.23292746,"about_ca_system_score_codex":0.000115753646,"about_ca_system_score_gemma":0.00077370077,"threshold_uncertainty_score":0.8901381},"labels":[],"label_agreement":null},{"id":"W4232434482","doi":"10.1200/jco.2004.22.14_suppl.633","title":"Patterns of trastuzumab (T) use in three Canadian provinces","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; McMaster University; BC Cancer Agency","funders":"","keywords":"Medicine; Vinorelbine; Trastuzumab; Taxane; Breast cancer; Cancer; Family medicine; Metastatic breast cancer; Cancer registry; Internal medicine; Chemotherapy","score_opus":0.18032151794858894,"score_gpt":0.4878412718449584,"score_spread":0.30751975389636943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232434482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98798364,0.00019031622,0.000023723016,0.009714117,0.00081609626,0.00017165004,0.000007884277,0.0000021788503,0.0010903664],"genre_scores_gemma":[0.99668604,0.0003087243,0.0006505292,0.0018254992,0.00042898254,0.000002348403,0.000001727871,0.000007598723,0.00008853299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800915,0.000104130355,0.001439355,0.00010236841,0.0001489011,0.00019609678],"domain_scores_gemma":[0.99803185,0.00066377776,0.0006934869,0.00008498836,0.00015656641,0.0003693129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008778287,0.0000825482,0.00096994406,0.00020877164,0.000012135924,0.0000026911528,0.000098029486,0.00023454726,0.00022326197],"category_scores_gemma":[0.0005533998,0.000058945312,0.00024729833,0.000093049784,0.000083893065,0.00009223492,0.000011740091,0.0005660633,0.0000051330726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019346882,0.0020548971,0.94414586,0.000018641764,0.00020794383,0.0019519738,0.00013785483,0.0000476902,0.000089729256,0.00015268741,0.0004355357,0.048822474],"study_design_scores_gemma":[0.013256315,0.015648937,0.9485896,0.00009391644,0.00020860221,0.00025412472,0.00005531944,0.000005178275,0.00013651121,0.00046096652,0.021241039,0.000049457733],"about_ca_topic_score_codex":0.060036324,"about_ca_topic_score_gemma":0.68598163,"teacher_disagreement_score":0.6259453,"about_ca_system_score_codex":0.0006537799,"about_ca_system_score_gemma":0.007029417,"threshold_uncertainty_score":0.9985998},"labels":[],"label_agreement":null},{"id":"W4232564297","doi":"10.1200/jco.2004.22.90140.624","title":"Risk of radiation pneumonitis in breast cancer patients treated with adjuvant taxanes and radiation","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Pneumonitis; Paclitaxel; Internal medicine; Cancer; Oncology; Retrospective cohort study; Adjuvant; Concomitant; Chemotherapy; Surgery; Lung","score_opus":0.03415493484110391,"score_gpt":0.41780437077431004,"score_spread":0.3836494359332061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232564297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523294,0.0008737737,0.000003994965,0.003257917,0.0002788068,0.0001863353,0.000028532822,0.0000028546312,0.00013486974],"genre_scores_gemma":[0.9873353,0.011884627,0.0001069124,0.0003197114,0.00031335338,0.000005728511,0.0000075033445,0.000007793403,0.000019025962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844134,0.00019005277,0.00100281,0.000106088686,0.00014826357,0.00011146089],"domain_scores_gemma":[0.9977469,0.0004086467,0.0014459108,0.00004695384,0.00020821978,0.00014336282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045050884,0.00008674656,0.00079832674,0.00013933059,0.000015967038,0.0000020162895,0.000032291704,0.00016345414,0.00005980201],"category_scores_gemma":[0.0001664133,0.000057155725,0.0000925219,0.0001333077,0.00011130858,0.00009143527,0.000007357974,0.00032640382,9.312397e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047318614,0.0015671535,0.7407843,0.000011811695,0.00020532185,0.000083603234,0.000109498724,0.00009442799,0.000071279974,0.000003327534,0.00010558188,0.2522318],"study_design_scores_gemma":[0.029471703,0.01224206,0.95596373,0.000086108834,0.00064171193,0.00012949109,0.00002340558,0.000020943196,0.00026184414,0.000044985405,0.0010660643,0.000047931324],"about_ca_topic_score_codex":0.0007959357,"about_ca_topic_score_gemma":0.00037783317,"teacher_disagreement_score":0.25218388,"about_ca_system_score_codex":0.00025220294,"about_ca_system_score_gemma":0.000680392,"threshold_uncertainty_score":0.23307428},"labels":[],"label_agreement":null},{"id":"W4232634311","doi":"10.5489/cuaj.1291","title":"Moderated Posters 5: Oncology-General 2","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Psychology; Oncology; Medical physics; Internal medicine","score_opus":0.017160850454919205,"score_gpt":0.27673711489584024,"score_spread":0.259576264440921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232634311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8770033,0.00013856291,0.0000074455943,0.10559796,0.00051378494,0.00021603332,0.000010236557,0.000025562822,0.016487122],"genre_scores_gemma":[0.9658518,0.00005802027,0.00022200993,0.027377458,0.0006501304,0.00002058671,0.00003155523,0.000008438351,0.005780038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893034,0.00012853362,0.00022262624,0.00012687777,0.00015063457,0.00044096544],"domain_scores_gemma":[0.99863607,0.00006170957,0.00012915656,0.00005007911,0.0002658877,0.0008571077],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019791363,0.0001032531,0.00022498559,0.00013107117,0.00018531481,0.000058285255,0.000060178445,0.0002529039,0.007832731],"category_scores_gemma":[0.00010878508,0.000079809164,0.0001020661,0.00012597167,0.000023210343,0.00009235921,0.0000069911125,0.00046715926,0.00046163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010361267,0.0001469003,0.5726385,0.0000019998688,0.0003376559,0.00019661553,0.00017018097,0.000060042094,0.0027765601,0.00010734204,0.41032,0.013140566],"study_design_scores_gemma":[0.002688897,0.0011679122,0.71114475,0.0000033578788,0.00014009763,0.0006148203,0.000039356477,0.00079459307,0.00008326281,0.0008762229,0.2823124,0.00013432959],"about_ca_topic_score_codex":0.0032548609,"about_ca_topic_score_gemma":0.0007243037,"teacher_disagreement_score":0.13850622,"about_ca_system_score_codex":0.0023001216,"about_ca_system_score_gemma":0.00075042224,"threshold_uncertainty_score":0.99307424},"labels":[],"label_agreement":null},{"id":"W4232961824","doi":"10.1007/978-3-662-44185-5_5236","title":"Suboxic","year":2015,"lang":"en","type":"book-chapter","venue":"Encyclopedia of Astrobiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Geology","score_opus":0.031986307379685164,"score_gpt":0.3054732787949637,"score_spread":0.27348697141527856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232961824","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017834016,0.0036880025,0.0000060502866,0.0003501559,0.0010306409,0.0003815579,0.0001264664,0.000042071766,0.9925917],"genre_scores_gemma":[0.003594882,0.0023037973,0.00048474284,0.00013882066,0.0010183997,0.000015635267,0.00063424394,0.000053222226,0.99175626],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989593,0.000017098266,0.00037055544,0.0003149458,0.000101289144,0.00023682098],"domain_scores_gemma":[0.9991115,0.00006433614,0.0002410463,0.00028055251,0.00014846957,0.0001540973],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008898207,0.0002934666,0.0008322129,0.00017166499,0.000014036942,9.4450206e-7,0.00010301862,0.0004772837,0.0060180714],"category_scores_gemma":[0.000015329593,0.00025096108,0.00020111255,0.00002003834,0.00024087244,0.000015326683,0.00006487428,0.00035137244,0.00039921596],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023413112,0.00044841008,0.005765176,0.00034089002,0.0022377851,0.00047825216,0.00032129663,0.0000052145137,0.0018524389,0.042746074,0.900666,0.04279715],"study_design_scores_gemma":[0.0016599449,0.0018897189,0.00035440826,0.0000598538,0.000546079,0.00011807205,0.00000406943,3.665774e-7,0.00006101445,0.0019098155,0.9932341,0.00016258254],"about_ca_topic_score_codex":0.000014512238,"about_ca_topic_score_gemma":0.00002054174,"teacher_disagreement_score":0.09256807,"about_ca_system_score_codex":0.00011534519,"about_ca_system_score_gemma":0.00043719812,"threshold_uncertainty_score":0.9999943},"labels":[],"label_agreement":null},{"id":"W4233084556","doi":"10.3747/co.6","title":"Current Oncology","year":2020,"lang":"en","type":"paratext","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical Oncology; Oncology; Internal medicine; Computational biology; Bioinformatics; Medical physics; Cancer; Biology","score_opus":0.23650474993072657,"score_gpt":0.5251220920733896,"score_spread":0.288617342142663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233084556","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003058596,0.2918242,0.00018614464,0.021429732,0.13950606,0.0037021001,0.0008799734,0.00028712017,0.5391261],"genre_scores_gemma":[0.021333052,0.56707734,0.00091777625,0.013039635,0.09947506,0.005209392,0.037509408,0.0009536275,0.25448468],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960125,0.00045169122,0.0009679896,0.0012363193,0.0003735631,0.0009579347],"domain_scores_gemma":[0.9973459,0.00037401184,0.00064789806,0.00050344545,0.00029785707,0.00083085196],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00019533705,0.00084217207,0.0025625261,0.00040100518,0.00012970349,0.000018234236,0.00040236517,0.001096424,0.03036759],"category_scores_gemma":[0.00008195598,0.0007582473,0.0006441007,0.00042579696,0.00039153962,0.000050346123,0.0003462098,0.0030607507,0.040793236],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008938748,0.0030053537,0.00023029336,0.00075769646,0.0003709239,0.00018926332,0.000351975,0.0000013843143,0.0001204521,0.00005158296,0.6733283,0.32069892],"study_design_scores_gemma":[0.00765898,0.00684736,0.00022681268,0.00028743062,0.0018593865,0.00025323703,0.000043311582,0.000044206074,0.00014287548,0.000046045352,0.9820421,0.0005482681],"about_ca_topic_score_codex":0.000021855036,"about_ca_topic_score_gemma":0.00003680434,"teacher_disagreement_score":0.32015064,"about_ca_system_score_codex":0.0029947395,"about_ca_system_score_gemma":0.005046995,"threshold_uncertainty_score":0.99948686},"labels":[],"label_agreement":null},{"id":"W4233437458","doi":"10.1200/jco.2012.30.27_suppl.129","title":"A review of clinical endpoints and use of quality-of-life outcomes in phase III metastatic breast cancer clinical trials.","year":2012,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Clinical endpoint; Clinical trial; Quality of life (healthcare); Metastatic breast cancer; Internal medicine; Breast cancer; Cancer; Disease; Oncology; Intensive care medicine","score_opus":0.8390301528975707,"score_gpt":0.7464270069315143,"score_spread":0.09260314596605634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233437458","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008420733,0.9826557,0.000009971289,0.0024200229,0.004118418,0.0018389348,0.00045466717,0.0000042257984,0.00007729871],"genre_scores_gemma":[0.0008172913,0.99232316,0.0013072965,0.0034231788,0.0018847786,0.00004246825,0.000029113571,0.0000482896,0.00012441652],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.92783195,0.025274199,0.04529382,0.00050889945,0.0006671037,0.00042405864],"domain_scores_gemma":[0.8647982,0.09156446,0.04105517,0.0005340531,0.00091994734,0.001128187],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.08903336,0.0005815558,0.0465335,0.00044311275,0.000015718715,0.000003921744,0.00038305097,0.0013984046,0.0013841578],"category_scores_gemma":[0.06362593,0.00034438015,0.00787078,0.0004044282,0.0011686863,0.00017474833,0.00018837136,0.0033798951,0.0000053837207],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011945276,0.018010795,0.04343538,0.05134015,0.00867194,0.00012491706,0.000021241614,6.503728e-8,3.5338556e-7,0.000035133067,0.004399339,0.8620154],"study_design_scores_gemma":[0.05246844,0.010722979,0.018618053,0.053706948,0.04252847,0.00028935712,0.0000123004165,0.0000017431264,2.4597549e-7,0.000026596277,0.82137704,0.00024781056],"about_ca_topic_score_codex":0.00021175532,"about_ca_topic_score_gemma":0.0001302062,"teacher_disagreement_score":0.8617676,"about_ca_system_score_codex":0.00016146494,"about_ca_system_score_gemma":0.010948902,"threshold_uncertainty_score":0.9999008},"labels":[],"label_agreement":null},{"id":"W4234129648","doi":"10.1002/jcph.72","title":"Issue Information","year":2013,"lang":"en","type":"paratext","venue":"The Journal of Clinical Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; University of Manitoba","funders":"","keywords":"Citation; Computer science; Information retrieval; World Wide Web","score_opus":0.07487596288625405,"score_gpt":0.4982250255603367,"score_spread":0.4233490626740827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234129648","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11281134,0.023783745,0.0002707632,0.12401096,0.30469117,0.0037014917,0.0001715668,0.000046426823,0.43051252],"genre_scores_gemma":[0.043188803,0.115968086,0.0003808298,0.12498387,0.085283086,0.00005407141,0.00024873004,0.00010104698,0.6297915],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961542,0.00077420345,0.0023404125,0.000099823956,0.0003287312,0.00030265824],"domain_scores_gemma":[0.994656,0.0017057518,0.0024447779,0.00018623337,0.00068953214,0.00031768548],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0016834268,0.00027119534,0.0014473659,0.00020235976,0.00006909346,0.000014016254,0.00040276418,0.0005648856,0.09370755],"category_scores_gemma":[0.00015038344,0.0001503282,0.00057072175,0.00014300473,0.00033057661,0.00022819494,0.00009132256,0.0024256248,0.029912995],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033694038,0.00038264663,0.000052817075,0.0001094276,0.0015207846,0.000022720367,0.00012491441,0.000035480225,0.0002282893,0.0000015455105,0.97699004,0.017161949],"study_design_scores_gemma":[0.00722751,0.0030278498,0.00059093226,0.00006208321,0.0032993625,0.0004811278,0.000034937813,0.000041728326,0.00049460994,0.000024595482,0.9845948,0.00012045241],"about_ca_topic_score_codex":0.000026443497,"about_ca_topic_score_gemma":8.050566e-7,"teacher_disagreement_score":0.2194081,"about_ca_system_score_codex":0.00010324807,"about_ca_system_score_gemma":0.0010109168,"threshold_uncertainty_score":0.99987584},"labels":[],"label_agreement":null},{"id":"W4234258422","doi":"10.1200/jco.2009.27.15_suppl.571","title":"Randomized, blinded, placebo-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Acupuncture; Breast cancer; Randomized controlled trial; Discontinuation; Adverse effect; Joint pain; Placebo; Physical therapy; Internal medicine; Aromatase inhibitor; Brief Pain Inventory; Osteoarthritis; WOMAC; Body mass index; Exemestane; Cancer; Tamoxifen; Chronic pain","score_opus":0.05758300344351331,"score_gpt":0.42965069926841143,"score_spread":0.3720676958248981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234258422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98444796,0.0004822666,0.000032166325,0.009445445,0.0009268575,0.0043083723,0.000043466578,0.000004728973,0.0003087701],"genre_scores_gemma":[0.9959189,0.0014934574,0.00018620324,0.001060343,0.00070694997,0.00026518162,0.000002863543,0.000012739293,0.00035335662],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957164,0.0006011176,0.0028477896,0.00016977855,0.00037833312,0.00028657104],"domain_scores_gemma":[0.99212915,0.003922222,0.00327855,0.00016112614,0.00033453476,0.00017443526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058345105,0.00022696926,0.0042091385,0.00016000328,0.000026424317,0.000004712421,0.0001509166,0.0003012581,0.0001732533],"category_scores_gemma":[0.00040266788,0.00009282207,0.0008261882,0.00018710751,0.00025213367,0.00005735586,0.000023312194,0.00057528995,5.034205e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96471065,0.005457385,0.00075438013,0.000051479798,0.0059607103,0.00017038343,0.0002561544,0.00015509513,0.00006287422,0.000046407324,0.0009822854,0.021392206],"study_design_scores_gemma":[0.9430563,0.02806339,0.02345429,0.00024809095,0.0036827961,0.000030026371,0.00014691366,0.00009226246,0.000054629796,0.00016444454,0.0009295436,0.000077313474],"about_ca_topic_score_codex":0.000054358985,"about_ca_topic_score_gemma":0.00006187747,"teacher_disagreement_score":0.02269991,"about_ca_system_score_codex":0.00035042546,"about_ca_system_score_gemma":0.0008876749,"threshold_uncertainty_score":0.37851742},"labels":[],"label_agreement":null},{"id":"W4234971132","doi":"10.2165/00128415-200510380-00011","title":"Apotex updates Canadian Apo-Mefloquine patient leaflet","year":2005,"lang":"en","type":"article","venue":"Reactions Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mefloquine; Leaflet (botany); Pharmacology; Medicine; Biology; Malaria; Immunology; Chloroquine","score_opus":0.014968951024025607,"score_gpt":0.2930518241767922,"score_spread":0.2780828731527666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234971132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7563527,0.0008657022,0.000014090357,0.07349055,0.00075747014,0.0005607467,0.00007987928,0.00017003121,0.1677088],"genre_scores_gemma":[0.9771765,0.00017438889,0.0004753888,0.0024650837,0.0005581381,0.000047360918,0.00016706352,0.000019715213,0.018916382],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992421,0.000016080849,0.00017271243,0.00018555377,0.000099944154,0.00028356104],"domain_scores_gemma":[0.9993457,0.000027527505,0.00004018124,0.00019949686,0.000056158136,0.00033092193],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00003906574,0.00011815649,0.00015928542,0.00020129123,0.00013133742,0.000011735386,0.000039894036,0.000073782394,0.0034493564],"category_scores_gemma":[0.000013189206,0.00010858506,0.00007476587,0.00018200737,0.000036541085,0.000083906394,0.0000098075,0.00016505785,0.0011105279],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002683909,0.0011846095,0.0068852007,0.000041032265,0.0004931255,0.0001709358,0.0005747094,0.0001493954,0.035089493,0.0011897045,0.70854414,0.24540927],"study_design_scores_gemma":[0.0009237711,0.00028758185,0.005201875,0.000014693787,0.00013536634,0.0001524661,0.00007429275,0.00011977267,0.003835811,0.000026251522,0.98912644,0.000101657206],"about_ca_topic_score_codex":0.0508023,"about_ca_topic_score_gemma":0.06868396,"teacher_disagreement_score":0.28058234,"about_ca_system_score_codex":0.0005488627,"about_ca_system_score_gemma":0.00029015657,"threshold_uncertainty_score":0.9996672},"labels":[],"label_agreement":null},{"id":"W4236026480","doi":"10.1016/j.jcjd.2013.03.432","title":"Neuropathie","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.013318773781377139,"score_gpt":0.2442167782382103,"score_spread":0.23089800445683317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236026480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98940176,0.0015640013,4.7030065e-7,0.0043860455,0.00044270445,0.00007354641,0.000002458077,0.0000027236467,0.0041262973],"genre_scores_gemma":[0.99669254,0.000007950645,0.00006734385,0.0021846204,0.00032594692,0.0000024072422,0.0000011917853,0.000008167136,0.00070986286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957454,0.00001616459,0.00013195165,0.000040732964,0.000050234234,0.00018639328],"domain_scores_gemma":[0.9991284,0.000028093003,0.000056797806,0.000053549385,0.00012506855,0.00060810696],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000049567258,0.00005332431,0.00014480451,0.00014774015,0.000031293144,0.0000158985,0.000048562542,0.000026337239,0.0028308204],"category_scores_gemma":[0.000039608443,0.000041662355,0.00006638275,0.000072181334,0.000044584845,0.00007039349,0.0000018901371,0.00011789918,0.00011305158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002274093,0.000028433218,0.86291605,0.000019459341,0.00011123008,0.00012535408,0.00013845533,0.0000019093507,0.0071936417,0.000040441937,0.11030537,0.019117374],"study_design_scores_gemma":[0.0015909809,0.0010848839,0.90731263,0.000066961,0.00019359824,0.00007351706,0.000042418775,0.00002633806,0.003848504,0.0004242437,0.08524388,0.00009206147],"about_ca_topic_score_codex":0.00045419074,"about_ca_topic_score_gemma":0.00064165815,"teacher_disagreement_score":0.044396553,"about_ca_system_score_codex":0.00006544189,"about_ca_system_score_gemma":0.0005636515,"threshold_uncertainty_score":0.99808073},"labels":[],"label_agreement":null},{"id":"W4236114868","doi":"10.1200/jco.2004.22.14_suppl.6052","title":"Does supportive-expressive group therapy for metastatic breast cancer patients lower health care services resource utilization","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Breast cancer; Mood; Psychosocial; Profile of mood states; Physical therapy; Quality of life (healthcare); Randomized controlled trial; Patient satisfaction; Metastatic breast cancer; Health care; Cancer; Family medicine; Internal medicine; Nursing; Psychiatry","score_opus":0.09892220443071154,"score_gpt":0.5150214318762829,"score_spread":0.4160992274455714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236114868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97246575,0.002280789,0.00011910898,0.021571936,0.0023653926,0.0008844322,0.00016103197,0.000012212025,0.00013935352],"genre_scores_gemma":[0.97938466,0.0034103247,0.0012863656,0.014300874,0.0013701482,0.00004438264,0.000082421415,0.000025611194,0.00009519398],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99752116,0.0002575887,0.0015042129,0.00021008367,0.00024865038,0.000258311],"domain_scores_gemma":[0.9962928,0.0005705819,0.0020085422,0.0001019765,0.00069938437,0.00032668858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006316701,0.00015469293,0.0011360937,0.000091300906,0.00007613107,0.0000073170813,0.0001149824,0.00015705638,0.000252798],"category_scores_gemma":[0.000079948266,0.000082188286,0.00039652927,0.000097338234,0.00010583325,0.00012151024,0.000020383422,0.00033655306,0.0000022983118],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07520796,0.023813916,0.28164238,0.00063757,0.0028706216,0.00025190203,0.0056622983,0.0001559953,0.00020559704,0.00009010829,0.011748908,0.59771276],"study_design_scores_gemma":[0.07788256,0.06797416,0.5307423,0.000353314,0.0009178246,0.00007163399,0.0013011809,0.0000127968415,0.00028353644,0.00039801243,0.31987578,0.00018693737],"about_ca_topic_score_codex":0.0001252139,"about_ca_topic_score_gemma":0.00032350127,"teacher_disagreement_score":0.5975258,"about_ca_system_score_codex":0.00046572948,"about_ca_system_score_gemma":0.001659471,"threshold_uncertainty_score":0.3351541},"labels":[],"label_agreement":null},{"id":"W4237000794","doi":"10.2165/00151234-201106310-00025","title":"Febuxostat, dexlansoprazole reimbursed in Quebec","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Febuxostat; Quality of Life Research; Business; Medicine; Public health; Internal medicine; Nursing","score_opus":0.04945966627069039,"score_gpt":0.36785061744353953,"score_spread":0.31839095117284916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237000794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94835985,0.00035883585,0.0000114468585,0.0054063727,0.0009973845,0.00066753285,0.000023679437,0.00010921696,0.04406566],"genre_scores_gemma":[0.9590702,0.00057321286,0.0007450871,0.024812443,0.00020455431,0.0001244067,0.00005973408,0.000060493283,0.01434988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985278,0.000045532674,0.0005033347,0.00039217182,0.00006996375,0.00046115374],"domain_scores_gemma":[0.9992285,0.00008193054,0.00013006326,0.00028033834,0.000026128237,0.0002530442],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012873164,0.0002820794,0.000582083,0.0002557306,0.000040795374,0.000016178012,0.00016133738,0.00009120302,0.004424545],"category_scores_gemma":[0.000009715102,0.00026355337,0.00019846944,0.000121856996,0.000055298944,0.00020324049,0.00005438461,0.00028483348,0.0005880751],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010746163,0.0007920787,0.94478554,0.000038644805,0.00036079326,0.00024466604,0.0017322002,0.0000100301695,0.002577114,0.00038343802,0.028945243,0.019055625],"study_design_scores_gemma":[0.022531407,0.00033102368,0.65100336,0.00002700561,0.00060923427,0.00006428265,0.0003871645,0.00041865022,0.020596016,0.0004361038,0.30291298,0.00068275974],"about_ca_topic_score_codex":0.045799058,"about_ca_topic_score_gemma":0.03183298,"teacher_disagreement_score":0.29378217,"about_ca_system_score_codex":0.00044631684,"about_ca_system_score_gemma":0.00022601034,"threshold_uncertainty_score":0.99998164},"labels":[],"label_agreement":null},{"id":"W4237242270","doi":"10.1016/s0009-9236(01)70992-7","title":"Red wine decreases cyclosporine bioavailability","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"","keywords":"Wine; Ciclosporin; Pharmacology; Bioavailability; CYP3A4; Pharmacokinetics; Crossover study; Chemistry; Grapefruit juice; Whole blood; Fluorescence polarization immunoassay; Medicine; Placebo; Chromatography; Cytochrome P450; Internal medicine; Food science; Biochemistry; Chemotherapy; Metabolism","score_opus":0.14501065618878375,"score_gpt":0.4814705665912841,"score_spread":0.33645991040250034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237242270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9344889,0.0016017562,0.000034367473,0.056484353,0.0027447164,0.00076382834,0.000012969142,0.0002561312,0.0036129793],"genre_scores_gemma":[0.8554168,0.008591439,0.0007076574,0.12580091,0.0042479876,0.000079045916,0.00008916552,0.00005854895,0.0050084633],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975522,0.00032076178,0.0008212278,0.00059192884,0.00018330284,0.00053055846],"domain_scores_gemma":[0.9979858,0.0007897754,0.00018359449,0.00039163826,0.0001959444,0.00045325316],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00051779125,0.0003108929,0.0007801085,0.00008963511,0.000115180694,0.000008060363,0.00019649693,0.00031489448,0.0074104127],"category_scores_gemma":[0.000030154497,0.00025919764,0.00037558126,0.00034914495,0.0007117245,0.000061416285,0.000085323656,0.00061918766,0.0003048867],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012693404,0.010123543,0.718852,0.000050636034,0.0033446422,0.0012906445,0.000072926654,0.000006773977,0.04675365,0.000013240317,0.17905737,0.02774116],"study_design_scores_gemma":[0.0116966115,0.0023555933,0.2210973,0.000012316277,0.0035813586,0.00028950535,0.000016069433,0.00022732654,0.0046914076,0.00019940118,0.75557894,0.00025416273],"about_ca_topic_score_codex":0.000019371988,"about_ca_topic_score_gemma":0.0000078707635,"teacher_disagreement_score":0.5765216,"about_ca_system_score_codex":0.00013423346,"about_ca_system_score_gemma":0.00025827732,"threshold_uncertainty_score":0.99998605},"labels":[],"label_agreement":null},{"id":"W4237273614","doi":"10.1515/iupac.79.1146","title":"Dimercaprol","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glossary; Chemical nomenclature; Toxicology; Computer science; Chemistry; Philosophy; Biology; Linguistics","score_opus":0.020189134738199783,"score_gpt":0.46837368076732955,"score_spread":0.44818454602912977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237273614","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020302896,0.0025469929,0.0000065097606,0.0029705444,0.0011836361,0.00055217324,0.99220794,0.00007293406,0.0002562313],"genre_scores_gemma":[0.000027112088,0.00302248,0.000018752558,0.0014556831,0.0024840923,0.00004488348,0.98805964,0.00004020241,0.0048471563],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99814874,0.000043925185,0.00032803076,0.00043972448,0.00065107987,0.0003884753],"domain_scores_gemma":[0.99868435,0.000050170154,0.00015000813,0.0005830426,0.00028325027,0.00024915795],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017618203,0.00038640515,0.0007657316,0.00019327198,0.00005937906,0.0000126399145,0.00014936079,0.00036943652,0.023681702],"category_scores_gemma":[0.000095995965,0.00025681438,0.0002310399,0.00012198124,0.00013616642,0.000033972836,0.000079680896,0.00042890877,0.000014416666],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011729224,0.0006156865,0.00004101757,0.00019124885,0.0003391124,0.00038389134,0.0000061387054,3.8880415e-8,0.000070366004,0.0000018343708,0.9904672,0.0067105815],"study_design_scores_gemma":[0.004558527,0.0010765514,0.00008074648,0.00032038565,0.0011329444,0.000091485286,0.0000038152275,4.933826e-7,0.00007243775,0.00003207858,0.99237204,0.0002585242],"about_ca_topic_score_codex":0.00012339099,"about_ca_topic_score_gemma":0.00029590458,"teacher_disagreement_score":0.023667285,"about_ca_system_score_codex":0.0006156872,"about_ca_system_score_gemma":0.0012066201,"threshold_uncertainty_score":0.99998844},"labels":[],"label_agreement":null},{"id":"W4237709015","doi":"10.1200/jco.2004.22.14_suppl.630","title":"A multi-centre phase II trial of pegylated liposomal doxorubicin and trastuzumab in HER-2 over-expressing metastatic breast cancer (MBC)","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Anthracycline; Metastatic breast cancer; Ejection fraction; Cardiotoxicity; Trastuzumab; Doxorubicin; Internal medicine; Heart failure; Breast cancer; Cancer; Oncology; Chemotherapy; Gastroenterology; Urology","score_opus":0.1422473115020502,"score_gpt":0.5265052184546788,"score_spread":0.3842579069526286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237709015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99043995,0.0012552956,0.00003178978,0.006603307,0.0010958283,0.00044681967,0.000029049279,0.0000064063356,0.00009152367],"genre_scores_gemma":[0.99503076,0.0011781995,0.0022427726,0.0006525,0.0007700377,0.000006375863,0.0000033531153,0.000017583736,0.000098392804],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965832,0.0003786921,0.0022874288,0.00021734096,0.00025516588,0.00027817077],"domain_scores_gemma":[0.9970823,0.0007838467,0.0014980165,0.000102932805,0.00019922701,0.00033369518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011025096,0.00018500272,0.0018800473,0.00020264446,0.000039781335,0.000005319939,0.000091832124,0.00025145325,0.00033776846],"category_scores_gemma":[0.00037533362,0.00013405642,0.00035133923,0.00019095534,0.00025266412,0.00012990047,0.000045029385,0.0008000253,0.0000011227272],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5181255,0.10322281,0.021914313,0.00016414956,0.0022832528,0.003680516,0.0023287917,0.00025314078,0.050818797,0.00002169203,0.00076142274,0.29642567],"study_design_scores_gemma":[0.86726236,0.06480657,0.059053693,0.0005383471,0.002188121,0.00093372347,0.000259558,0.00035530803,0.0015711962,0.00010655754,0.0027525981,0.00017193721],"about_ca_topic_score_codex":0.00043846926,"about_ca_topic_score_gemma":0.00062989676,"teacher_disagreement_score":0.34913695,"about_ca_system_score_codex":0.00037963895,"about_ca_system_score_gemma":0.002233856,"threshold_uncertainty_score":0.5466662},"labels":[],"label_agreement":null},{"id":"W4237936247","doi":"10.3410/f.718426882.793495799","title":"Faculty Opinions recommendation of A high throughput screen identifies Nefopam as targeting cell proliferation in β-catenin driven neoplastic and reactive fibroproliferative disorders.","year":2014,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Catenin; Cancer research; Cell growth; Throughput; Cell biology; Chemistry; Biology; Computer science; Wnt signaling pathway; Signal transduction; Biochemistry; Telecommunications","score_opus":0.017741187366115144,"score_gpt":0.3469871396183872,"score_spread":0.32924595225227204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237936247","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000093438764,0.0009920403,0.000033555156,0.12439658,0.0005021062,0.0024968204,0.87140304,0.000025311543,0.000057094712],"genre_scores_gemma":[0.0014656723,0.0010441785,0.0004168691,0.002077309,0.00034052602,0.0004484996,0.99348384,0.000028964205,0.0006941338],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996203,0.0005559513,0.0013452737,0.0007326268,0.0008351066,0.00032801367],"domain_scores_gemma":[0.99520296,0.00026107795,0.0013422027,0.0005517757,0.0024202873,0.00022167241],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007420448,0.0005191164,0.0011720638,0.0004224401,0.00019267442,0.00008862025,0.00041844146,0.0005757881,0.0002752789],"category_scores_gemma":[0.002830919,0.00035011544,0.0002991477,0.0012254623,0.0003417717,0.00036658123,0.00029035338,0.0009858466,0.000024280831],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014619353,0.0006237688,0.00014565582,0.006531546,0.00018124106,6.310754e-7,0.0005243416,6.4735724e-7,0.000019722931,0.00006790825,0.9910511,0.0007072375],"study_design_scores_gemma":[0.002516827,0.0006556431,0.0045990837,0.007052536,0.0004790932,0.000033249224,0.00008507932,0.000045487188,0.00017636105,0.000082710176,0.98398256,0.0002913718],"about_ca_topic_score_codex":0.00062108843,"about_ca_topic_score_gemma":0.0000998871,"teacher_disagreement_score":0.122319266,"about_ca_system_score_codex":0.00018137462,"about_ca_system_score_gemma":0.0005554022,"threshold_uncertainty_score":0.9998951},"labels":[],"label_agreement":null},{"id":"W4238325746","doi":"10.1515/iupac.87.0313","title":"Hypophysectomy","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Relation (database); Psychology; Computer science; Linguistics; Philosophy; Data mining","score_opus":0.020433534492741823,"score_gpt":0.46240867790457796,"score_spread":0.44197514341183614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238325746","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034713707,0.0020403804,0.000006159128,0.0019260403,0.0012519563,0.00048215018,0.99355394,0.0000776395,0.00031460225],"genre_scores_gemma":[0.000031070824,0.0026010736,0.000023322202,0.0012969045,0.0030602627,0.000037741334,0.9889785,0.00004230676,0.0039288276],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981663,0.000041625517,0.00031892146,0.0004400297,0.0006438986,0.00038922223],"domain_scores_gemma":[0.9986769,0.000057220437,0.00015368786,0.00058163196,0.0002862816,0.0002442583],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013719685,0.00039634586,0.00078105467,0.00020886424,0.00005881544,0.0000138760815,0.00015267266,0.00034050932,0.020012131],"category_scores_gemma":[0.000085178806,0.0002683814,0.00024818766,0.0001396305,0.00012681451,0.000035034886,0.00007852151,0.00040815648,0.000013942675],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010586675,0.0006101277,0.00003122605,0.0001998977,0.0003220098,0.00047219612,0.000004655075,3.921332e-8,0.00008946153,0.0000018047724,0.9919859,0.0052239876],"study_design_scores_gemma":[0.005013029,0.0010507604,0.00011453657,0.0003102086,0.00090179563,0.00009850878,0.0000032238754,3.293491e-7,0.000089891255,0.000048501584,0.9921011,0.0002681664],"about_ca_topic_score_codex":0.00014164181,"about_ca_topic_score_gemma":0.00030447604,"teacher_disagreement_score":0.019998187,"about_ca_system_score_codex":0.00067255384,"about_ca_system_score_gemma":0.0012175497,"threshold_uncertainty_score":0.9999768},"labels":[],"label_agreement":null},{"id":"W4238430268","doi":"10.1515/iupac.78.0335","title":"Glucuronides","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Glossary; Chemical nomenclature; Relation (database); Computer science; Management science; Data science; Environmental chemistry; Chemistry; Engineering; Data mining; Linguistics","score_opus":0.020763071778345896,"score_gpt":0.47012580560311734,"score_spread":0.44936273382477143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238430268","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026197318,0.003182266,0.000006850445,0.0029196073,0.0011345423,0.0004177923,0.99175584,0.000072873736,0.00024827273],"genre_scores_gemma":[0.00002698239,0.004535035,0.000022571961,0.001237519,0.0024338586,0.000029332476,0.98746437,0.00003788948,0.0042124614],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982261,0.000041495696,0.00032146962,0.00041718094,0.0006083975,0.0003853426],"domain_scores_gemma":[0.9987373,0.00006018205,0.00015159558,0.00054420874,0.0002745986,0.00023212639],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016790397,0.00037578036,0.00072952354,0.00018709029,0.000061028037,0.000015103227,0.00014864025,0.00032295892,0.021314748],"category_scores_gemma":[0.000117571646,0.00025222983,0.00022173107,0.00011398861,0.00014364725,0.000036104877,0.00008151928,0.00036978917,0.000012106805],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096377387,0.0005240749,0.000045742134,0.00020122765,0.000297171,0.00041474827,0.0000052598366,5.302551e-8,0.000054063676,0.0000027999824,0.99108326,0.006407804],"study_design_scores_gemma":[0.0039548688,0.0010743915,0.00009085731,0.0003685354,0.00094499125,0.00009930307,0.0000044526964,3.9238444e-7,0.000087768094,0.000045582085,0.9930783,0.00025054702],"about_ca_topic_score_codex":0.00013452453,"about_ca_topic_score_gemma":0.0004704864,"teacher_disagreement_score":0.02130264,"about_ca_system_score_codex":0.00070114137,"about_ca_system_score_gemma":0.0013032197,"threshold_uncertainty_score":0.99999297},"labels":[],"label_agreement":null},{"id":"W4238890016","doi":"10.21203/rs.2.11805/v3","title":"The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in colorectal cancer patients: study protocol for a single-blinded, randomized sham-controlled trial","year":2019,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Hospital Authority; Hong Kong Baptist University","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Acupuncture; Randomized controlled trial; Colorectal cancer; Protocol (science); Chemotherapy; Internal medicine; Cancer; Oncology; Peripheral; Physical therapy; Alternative medicine; Pathology","score_opus":0.08049126825956275,"score_gpt":0.46635391430938405,"score_spread":0.3858626460498213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238890016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5115669,0.00010161153,0.000008185221,0.0005071026,0.00018029928,0.4875178,0.00003886168,0.000014234513,0.000065043496],"genre_scores_gemma":[0.5022269,0.000034434437,0.00002042484,0.00002782243,0.0003860548,0.4971254,0.000036365505,0.000049601018,0.00009302307],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950663,0.0016329509,0.0010664077,0.0007655144,0.0007256892,0.00074313564],"domain_scores_gemma":[0.9914778,0.006517303,0.00051576615,0.00031965968,0.0010497441,0.00011974514],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037237802,0.0004943899,0.0024406163,0.00025951714,0.00024554558,0.000084635074,0.00025708313,0.0003276062,0.00005834171],"category_scores_gemma":[0.002275534,0.00026278125,0.00061089866,0.00023758503,0.00015520117,0.00003761,0.00017220121,0.001049307,2.6492492e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9782002,0.0050233,0.0017057833,0.0012087293,0.0011079768,0.0000033305903,0.0027209055,0.000032874155,0.0047472017,0.0000059823155,0.00015700285,0.005086725],"study_design_scores_gemma":[0.96829486,0.025510885,0.0012825311,0.000441979,0.00029780914,7.9915776e-7,0.00026753623,0.0014515608,0.0017272464,0.000048617592,0.0004764172,0.00019973896],"about_ca_topic_score_codex":0.00022964597,"about_ca_topic_score_gemma":0.00025815517,"teacher_disagreement_score":0.020487586,"about_ca_system_score_codex":0.0006715215,"about_ca_system_score_gemma":0.001271642,"threshold_uncertainty_score":0.9999824},"labels":[],"label_agreement":null},{"id":"W4239858202","doi":"10.1515/iupac.76.0199","title":"Cytochrome P450","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glossary; Toxicokinetics; Relation (database); Hazard; Computer science; Toxicology; Medicine; Chemistry; Pharmacology; Data mining; Biology; Linguistics; Philosophy","score_opus":0.02079004407645341,"score_gpt":0.4711151561286404,"score_spread":0.450325112052187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239858202","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030660557,0.002018463,0.0000102597305,0.0026342866,0.00070766034,0.00057903345,0.9933697,0.000085642714,0.00028836358],"genre_scores_gemma":[0.00003577723,0.0031111897,0.00002488119,0.0013680401,0.0030176505,0.000045143453,0.987394,0.000046833266,0.004956501],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978981,0.000047365593,0.00037819604,0.00049194536,0.0007364458,0.00044795877],"domain_scores_gemma":[0.9984909,0.00006166517,0.00017624907,0.00066140416,0.0003178821,0.00029184695],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019308944,0.0004388238,0.000896025,0.00024037514,0.000069310576,0.000016581575,0.00018012426,0.00041436226,0.028679576],"category_scores_gemma":[0.00010654652,0.00030058058,0.00025833247,0.0001500368,0.00015944113,0.00004146873,0.000099210745,0.0004564552,0.000019176676],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011280722,0.0006151048,0.000013349505,0.00023469745,0.00036864547,0.00068952085,0.0000066651583,5.5603127e-8,0.000362397,0.0000023205846,0.9931782,0.0034009556],"study_design_scores_gemma":[0.005219578,0.0013294751,0.00026559777,0.00042916057,0.0010449102,0.00016937425,0.000004131936,4.279378e-7,0.000068294576,0.00003955699,0.99112856,0.00030092883],"about_ca_topic_score_codex":0.0001228494,"about_ca_topic_score_gemma":0.0003559583,"teacher_disagreement_score":0.0286604,"about_ca_system_score_codex":0.00090729253,"about_ca_system_score_gemma":0.0014701779,"threshold_uncertainty_score":0.9999446},"labels":[],"label_agreement":null},{"id":"W4239887008","doi":"10.1016/s1701-2163(16)30697-1","title":"Archivée: Recours à l’hormonothérapie substitutive après un traitement contre le cancer du sein","year":2004,"lang":"fr","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology; Humanities","score_opus":0.024272845638380426,"score_gpt":0.2581612399536119,"score_spread":0.23388839431523148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239887008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58253306,0.3267648,0.00012659584,0.030988168,0.05644109,0.00044822987,0.0002464973,0.0000057600587,0.0024457679],"genre_scores_gemma":[0.9714625,0.023632104,0.0003031274,0.0022812528,0.0005997487,0.000016061853,0.000011181889,0.000029315483,0.0016647377],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976897,0.00013151692,0.00082736666,0.00027843346,0.00036611143,0.0007068661],"domain_scores_gemma":[0.9964674,0.0016112747,0.00068919535,0.00012552337,0.00042715107,0.0006794625],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032704367,0.00034161177,0.00087835366,0.00031301237,0.00023910253,0.000026519388,0.00018133092,0.00024576962,0.0013475103],"category_scores_gemma":[0.0005075534,0.0003135955,0.00016806203,0.0004460065,0.00032805247,0.00013780466,0.000044213917,0.0007589049,0.0000021966757],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00024473883,0.0021666563,0.06666929,0.00027557847,0.0051155784,0.043797463,0.001995787,0.0032731448,0.0002252186,0.0049598315,0.028040364,0.8432363],"study_design_scores_gemma":[0.048623893,0.0038082537,0.4558794,0.00015891813,0.003355796,0.0010296804,0.0019785678,0.00016168978,0.0012604685,0.0015877313,0.4815084,0.0006472185],"about_ca_topic_score_codex":0.22246492,"about_ca_topic_score_gemma":0.2720716,"teacher_disagreement_score":0.84258914,"about_ca_system_score_codex":0.0054831235,"about_ca_system_score_gemma":0.014376932,"threshold_uncertainty_score":0.99993163},"labels":[],"label_agreement":null},{"id":"W4240203973","doi":"10.1515/iupac.87.0123","title":"Carpel Tunnel Syndrome (CTS)","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Chemical nomenclature; Relation (database); Computer science; Psychology; Linguistics; Chemistry; Philosophy; Data mining; Organic chemistry","score_opus":0.02026787650016847,"score_gpt":0.4440031669268697,"score_spread":0.4237352904267012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240203973","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014661553,0.002517315,0.000005843104,0.0024325964,0.0017578166,0.0006497922,0.9908357,0.000098330434,0.00023643063],"genre_scores_gemma":[0.00024916645,0.0031852948,0.000022900334,0.0012218602,0.0016092213,0.000049175167,0.98743606,0.00006450538,0.006161814],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974331,0.000062090556,0.00046276886,0.0006157551,0.0008633646,0.0005628952],"domain_scores_gemma":[0.99817955,0.00007816492,0.00021208942,0.0007979786,0.00035288726,0.00037931476],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023979545,0.00054976693,0.0011460475,0.00029962178,0.00008609668,0.00002054802,0.00023508625,0.000505853,0.01863586],"category_scores_gemma":[0.000120243196,0.00038940724,0.0003160657,0.00018740352,0.00018132933,0.000054314572,0.00012703543,0.0005718628,0.000025666075],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008960878,0.0006828284,0.00005403727,0.0003358258,0.00051624776,0.0024694542,0.000008905572,1.7021365e-7,0.000054940298,0.0000024558715,0.9930302,0.0019488542],"study_design_scores_gemma":[0.005818362,0.0014869509,0.00038571103,0.0005916691,0.0014658236,0.0009132999,0.000009297455,7.9265305e-7,0.000026103007,0.000039808514,0.9888761,0.00038609077],"about_ca_topic_score_codex":0.00032706987,"about_ca_topic_score_gemma":0.00073819543,"teacher_disagreement_score":0.018610194,"about_ca_system_score_codex":0.001040225,"about_ca_system_score_gemma":0.0015861909,"threshold_uncertainty_score":0.99985576},"labels":[],"label_agreement":null},{"id":"W4241025105","doi":"10.1002/cncr.20897","title":"Author reply","year":2005,"lang":"en","type":"article","venue":"Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Hazard ratio; Medicine; Proportional hazards model; Confounding; Sample size determination; Observational study; Statistics; Constant (computer programming); Confidence interval; Event (particle physics); Trastuzumab; Internal medicine; Oncology; Cancer; Mathematics; Breast cancer; Computer science","score_opus":0.0476644770768043,"score_gpt":0.4159754248623061,"score_spread":0.3683109477855018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241025105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82233155,0.008410476,0.0000183543,0.10625798,0.00090539485,0.0002962121,0.000013048141,0.00012908567,0.061637893],"genre_scores_gemma":[0.8551451,0.00018690185,0.00029214806,0.0134974895,0.0016013011,0.00008101291,0.0000059280865,0.000010502223,0.12917963],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996688,0.000004844605,0.00006411495,0.000102892474,0.000051470237,0.000107924636],"domain_scores_gemma":[0.9997921,0.000008490344,0.000016394333,0.00009075242,0.000022556842,0.00006969802],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000024447801,0.000048276404,0.00008949022,0.000021907541,0.00002082175,0.0000024582898,0.0000197109,0.000022616821,0.0069177705],"category_scores_gemma":[0.0000040116697,0.000038854392,0.000035780165,0.00005479715,0.000019996098,0.000023609566,0.0000065565882,0.00005572408,0.00019742896],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022913153,0.00011305541,0.018644605,0.000018513862,0.00009354126,0.000023057883,0.00029324484,0.000011273217,0.009470916,0.0001503944,0.8031396,0.16781262],"study_design_scores_gemma":[0.0010561767,0.00007474929,0.014385013,0.00001175821,0.00008671459,0.000011956039,0.000006202036,0.00005218687,0.010347451,0.000014649562,0.9739117,0.000041469673],"about_ca_topic_score_codex":0.00005796925,"about_ca_topic_score_gemma":0.000041918887,"teacher_disagreement_score":0.17077203,"about_ca_system_score_codex":0.00013906228,"about_ca_system_score_gemma":0.000083423445,"threshold_uncertainty_score":0.99399006},"labels":[],"label_agreement":null},{"id":"W4241164232","doi":"10.1515/iupac.79.1689","title":"Neurotoxic","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glossary; Chemical nomenclature; Computer science; Toxicology; Chemistry; Philosophy; Biology; Linguistics; Organic chemistry","score_opus":0.0224309372106804,"score_gpt":0.47067368241760194,"score_spread":0.44824274520692153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241164232","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030386815,0.0012694717,0.000004983948,0.0029150858,0.001269118,0.00066141563,0.993301,0.00007487579,0.00020019429],"genre_scores_gemma":[0.000022020273,0.002747722,0.000011252365,0.0019908163,0.0023678192,0.00005023232,0.9888083,0.000041663672,0.0039602052],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982071,0.000050302315,0.0003166695,0.00043629576,0.0006144586,0.00037516415],"domain_scores_gemma":[0.9987305,0.00005358711,0.00014757714,0.000588102,0.00023060905,0.0002496611],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014288853,0.0003736395,0.0006999245,0.00020378032,0.000056190715,0.000013745892,0.00015429252,0.00030640198,0.01978551],"category_scores_gemma":[0.00011194699,0.0002548424,0.00022094847,0.00013029722,0.00012052303,0.000031845073,0.000082328304,0.00043029842,0.000012011873],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009956745,0.00056095026,0.00003312179,0.00018152551,0.00018830798,0.0009874183,0.0000034160705,4.795398e-8,0.00011442233,0.0000012607484,0.99337894,0.0035549277],"study_design_scores_gemma":[0.004180105,0.0012701182,0.00010843816,0.00026401583,0.0007402145,0.00020053211,0.0000019632844,5.1925997e-7,0.000085361906,0.000024796636,0.9928905,0.00023343871],"about_ca_topic_score_codex":0.00006876584,"about_ca_topic_score_gemma":0.00023857533,"teacher_disagreement_score":0.019773498,"about_ca_system_score_codex":0.000486035,"about_ca_system_score_gemma":0.0011039572,"threshold_uncertainty_score":0.9999904},"labels":[],"label_agreement":null},{"id":"W4241188965","doi":"10.1016/b0-12-369400-0/00746-8","title":"Pharmacokinetics/Toxicokinetics","year":2005,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Toxicokinetics; Pharmacokinetics; Pharmacology; Medicine","score_opus":0.0256362844768887,"score_gpt":0.3077204251711355,"score_spread":0.2820841406942468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241188965","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011258904,0.0062932745,8.8114734e-7,0.0007074521,0.0007946551,0.0009311965,0.0000676472,0.00014299288,0.99094933],"genre_scores_gemma":[0.0011565428,0.0022088944,0.00041177063,0.0034469648,0.0035537244,0.00004931616,0.00012359611,0.00017444881,0.98887473],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828815,0.00001330501,0.00046717998,0.0005032164,0.0003442079,0.00038395947],"domain_scores_gemma":[0.9988621,0.000047024558,0.00019813853,0.00046490715,0.00011826997,0.00030959654],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00007719158,0.0005652383,0.00078602217,0.00021141324,0.000059593876,0.000016894766,0.00015113121,0.00041750094,0.008542913],"category_scores_gemma":[0.0000040642512,0.00052050647,0.0003919376,0.000012854682,0.00017773685,0.000014949841,0.00009015692,0.00070971483,0.0010820715],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017502924,0.00006295253,0.0000125316665,0.00012868267,0.00057041406,0.0002800383,0.00007721444,6.765356e-7,0.00081148476,0.00087529665,0.009894909,0.9871108],"study_design_scores_gemma":[0.002530286,0.0004201753,0.000030263353,0.000248904,0.0020770426,0.00018438065,0.0000010490097,0.000007567466,0.0011018247,0.00074832526,0.9922276,0.00042259137],"about_ca_topic_score_codex":2.2672948e-7,"about_ca_topic_score_gemma":0.000007649366,"teacher_disagreement_score":0.9866882,"about_ca_system_score_codex":0.00024397031,"about_ca_system_score_gemma":0.00021083547,"threshold_uncertainty_score":0.9997246},"labels":[],"label_agreement":null},{"id":"W4241365950","doi":"10.2165/00128413-200514760-00056","title":"Ethinylestradiol/drospirenone [Yasmin; Berlex Canada] has been launched in Canada,","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drospirenone; Medicine; Launched; Ethinylestradiol; Gynecology; Environmental health; Population; Research methodology; Engineering","score_opus":0.030514620886917497,"score_gpt":0.2804845569241142,"score_spread":0.24996993603719672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241365950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93535095,0.0011468044,0.0000019242093,0.056566764,0.00071074074,0.00043184933,0.000098502,0.00003896199,0.0056535075],"genre_scores_gemma":[0.982596,0.00008697782,0.0001531573,0.010873864,0.00081543834,0.000058990852,0.00008416009,0.000036165697,0.005295294],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99815553,0.00005890491,0.0004224082,0.00036040615,0.00041859594,0.0005841615],"domain_scores_gemma":[0.9990868,0.00010725849,0.00009019106,0.00023872254,0.00008538484,0.00039165354],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001362966,0.00026863156,0.00047058682,0.000094391726,0.00008444153,0.000015037968,0.0001632387,0.00008766845,0.0018511267],"category_scores_gemma":[0.000028153889,0.0002630265,0.0000591087,0.00026995613,0.00006532647,0.00008821159,0.00003469782,0.00047542018,0.00002968547],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003704105,0.00036044384,0.13396145,0.000073470546,0.0002559107,0.0022927064,0.0005083901,0.0002310995,0.008999346,0.0000155844,0.81240946,0.04052172],"study_design_scores_gemma":[0.0077191163,0.0001769227,0.27438846,0.000056517703,0.00021782298,0.00016971152,0.0001863496,0.0007204184,0.014648989,0.000009280721,0.7013137,0.00039274053],"about_ca_topic_score_codex":0.9985098,"about_ca_topic_score_gemma":0.9998623,"teacher_disagreement_score":0.140427,"about_ca_system_score_codex":0.0035206205,"about_ca_system_score_gemma":0.011440113,"threshold_uncertainty_score":0.9999822},"labels":[],"label_agreement":null},{"id":"W4241390578","doi":"10.2165/00128415-200711570-00003","title":"New Avastin safety info issued in Canada","year":2007,"lang":"en","type":"article","venue":"Reactions Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business; Medicine","score_opus":0.015253657974784465,"score_gpt":0.30515369602394743,"score_spread":0.289900038049163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241390578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72245955,0.0006041277,0.0007296124,0.015318077,0.0016673591,0.0006148116,0.00001682332,0.000088703884,0.2585009],"genre_scores_gemma":[0.9498752,0.00009059661,0.0005125959,0.0006043412,0.0003311512,0.000004868365,0.000028719627,0.00001051535,0.04854203],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99936706,0.000008699007,0.00020363645,0.000112289825,0.000106222826,0.00020212185],"domain_scores_gemma":[0.99956745,0.00010177902,0.00003660919,0.000112568625,0.000021728496,0.00015989231],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008582651,0.0000760025,0.00014353216,0.00009938472,0.00003432442,0.0000025169368,0.00002833358,0.000037123114,0.0018278722],"category_scores_gemma":[0.00002133702,0.000072820265,0.000028390734,0.00025202992,0.000009967955,0.00003617805,0.000008089363,0.00015766663,0.000063030064],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019344139,0.0004639519,0.30440256,0.00006735819,0.00027191915,0.0012002006,0.000561144,0.000101699836,0.027400304,0.00070111715,0.4423562,0.22053911],"study_design_scores_gemma":[0.0015292683,0.00005895036,0.3124792,0.000018802037,0.000043136206,0.00008464605,0.00013291957,0.000015630298,0.0017789569,0.000011855533,0.683788,0.000058617232],"about_ca_topic_score_codex":0.96321917,"about_ca_topic_score_gemma":0.97908556,"teacher_disagreement_score":0.2414318,"about_ca_system_score_codex":0.0014970389,"about_ca_system_score_gemma":0.001756639,"threshold_uncertainty_score":0.9990846},"labels":[],"label_agreement":null},{"id":"W4241423121","doi":"10.1139/cjc-78-2-270","title":"A new short synthetic approach to chlorocyclopentenones related to cryptosporiopsin via a ring expansion strategy: first synthesis of a fungitoxic metabolite from &lt;i&gt;Sporormia affinis&lt;/i&gt;","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemistry; Cycloaddition; Stereochemistry; Cyclopentene; Metabolite; Ring (chemistry); Yield (engineering); Total synthesis; Organic chemistry; Catalysis","score_opus":0.011170288474983213,"score_gpt":0.23545235474117987,"score_spread":0.22428206626619665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241423121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97767645,0.004544024,0.000052085707,0.00078510586,0.00016650837,0.000324006,0.00009288548,0.000016912241,0.016342012],"genre_scores_gemma":[0.9952697,0.00024592207,0.0012266993,0.00012945938,0.00034782637,0.000021469968,0.000029258164,0.000056010536,0.0026736108],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978843,0.000027309687,0.00082538265,0.00037802666,0.00034075536,0.0005442521],"domain_scores_gemma":[0.9969162,0.00008675611,0.000198268,0.00037680333,0.00016780055,0.0022542207],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001938349,0.00035335423,0.00090983027,0.0002259114,0.00010625541,0.00003450885,0.00033158058,0.00022884115,0.0034094295],"category_scores_gemma":[0.00007411326,0.00033236298,0.0002917797,0.00047214556,0.00006448974,0.00012175013,0.00001714751,0.00030493666,0.000030795276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017251458,0.0003353757,0.0022314943,0.00022180722,0.0011569356,0.001112742,0.0021295766,0.0010799683,0.9228799,0.0000127286985,0.0057297098,0.06138462],"study_design_scores_gemma":[0.0044498025,0.0005919056,0.04355552,0.0020773625,0.002919445,0.0022259755,0.0005062516,0.00018467102,0.84669805,0.000108538756,0.09563435,0.001048135],"about_ca_topic_score_codex":0.0016102336,"about_ca_topic_score_gemma":0.0014261397,"teacher_disagreement_score":0.089904636,"about_ca_system_score_codex":0.00045014996,"about_ca_system_score_gemma":0.0018048586,"threshold_uncertainty_score":0.99991286},"labels":[],"label_agreement":null},{"id":"W4241484909","doi":"10.1200/jco.2004.22.14_suppl.6145","title":"Venous thrombosis in breast cancer patients receiving tamoxifen and/or chemotherapy: A systematic review","year":2004,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Chemotherapy; Venous thrombosis; Oncology; Cancer; Internal medicine; Venous thromboembolism; Thrombosis","score_opus":0.18865759497152587,"score_gpt":0.5531279521266581,"score_spread":0.3644703571551322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241484909","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002477073,0.9933073,4.1483594e-7,0.0028472636,0.0011997999,0.0021527219,0.00002216362,0.0000071629897,0.00021549696],"genre_scores_gemma":[0.00014174762,0.9946931,0.0001184327,0.0039368956,0.0007761052,0.00013147283,0.0000068609984,0.000051301864,0.00014406406],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9927147,0.0010958958,0.005260037,0.00030847886,0.00032155265,0.00029931113],"domain_scores_gemma":[0.99153143,0.0022643155,0.0053568585,0.00020866322,0.00029332258,0.00034538502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026566682,0.00038867502,0.012829104,0.00022878188,0.000025841937,0.000007792632,0.00022187272,0.000744786,0.0004261329],"category_scores_gemma":[0.0010965064,0.00021526501,0.0012031541,0.00034445635,0.00013077255,0.00007286166,0.000052927797,0.0015110252,0.000014299849],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041008522,0.0038197886,0.00071462436,0.5924372,0.0017577215,0.00030628836,0.000056316298,5.9432583e-8,4.0476692e-8,7.762963e-7,0.0013520094,0.3991451],"study_design_scores_gemma":[0.007147146,0.007544656,0.0028626958,0.8150718,0.019413702,0.0013328015,0.0000040747586,3.1211326e-7,2.913296e-8,0.000012490217,0.14641927,0.00019102899],"about_ca_topic_score_codex":0.000053032174,"about_ca_topic_score_gemma":0.000046762965,"teacher_disagreement_score":0.39895406,"about_ca_system_score_codex":0.0013507194,"about_ca_system_score_gemma":0.005676363,"threshold_uncertainty_score":0.99996054},"labels":[],"label_agreement":null},{"id":"W4241592018","doi":"10.1007/978-3-642-27833-4_5236-1","title":"Suboxic","year":2014,"lang":"en","type":"book-chapter","venue":"Encyclopedia of Astrobiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Geology","score_opus":0.011430834373929666,"score_gpt":0.2654768365959707,"score_spread":0.25404600222204105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241592018","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024025606,0.0011159129,0.000043321623,0.00038848195,0.0009855464,0.00036040496,0.00006675895,0.000043370448,0.9945936],"genre_scores_gemma":[0.008924114,0.0023829874,0.00052905915,0.00031623652,0.0012099016,0.000016529686,0.00048928574,0.00005619639,0.9860757],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99893975,0.000019926114,0.00038680164,0.00033395743,0.00007733043,0.00024222364],"domain_scores_gemma":[0.9991369,0.00011150365,0.0002645178,0.0003010905,0.000077269615,0.00010869318],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007394076,0.00030001704,0.0008738126,0.00017103618,0.000019024978,0.0000010146952,0.00010448872,0.0004783999,0.0065423814],"category_scores_gemma":[0.0000127319045,0.00025751384,0.00025233632,0.000016283178,0.0002445864,0.000008324657,0.000054850927,0.00034669918,0.00041267628],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003459031,0.0005866068,0.016820403,0.0011388342,0.0045069316,0.00044517123,0.00041029116,0.000008134268,0.007032464,0.18420093,0.6134484,0.16794287],"study_design_scores_gemma":[0.0013869522,0.0017817613,0.0008575558,0.00007673835,0.0005478949,0.00008942354,0.0000015219041,6.5164556e-7,0.00013828001,0.0008719669,0.99407864,0.00016864482],"about_ca_topic_score_codex":0.0000109311795,"about_ca_topic_score_gemma":0.00001806184,"teacher_disagreement_score":0.38063025,"about_ca_system_score_codex":0.00006325706,"about_ca_system_score_gemma":0.0001799657,"threshold_uncertainty_score":0.9999877},"labels":[],"label_agreement":null},{"id":"W4241933606","doi":"10.26434/chemrxiv.14195207","title":"Strategy for Lead Identification for Understudied Kinases","year":2021,"lang":"en","type":"preprint","venue":"ChemRxiv","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharma; Genentech; National Institutes of Health; Ministero dello Sviluppo Economico; Genome Canada; Fundação de Amparo à Pesquisa do Estado de São Paulo; Ontario Ministry of Economic Development and Innovation; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Gillings School of Public Health; North Carolina Biotechnology Center; Pfizer","keywords":"Kinase; Function (biology); Protein-Serine-Threonine Kinases; Pyrimidine; Identification (biology); Computational biology; Cancer research; Biology; Cell biology; Chemistry; Biochemistry; Protein kinase A; Botany","score_opus":0.18260391781741228,"score_gpt":0.42329379374983117,"score_spread":0.2406898759324189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241933606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9515645,0.0118804285,0.012537492,0.009580621,0.0037446397,0.00706531,0.00010554492,0.00022440118,0.0032970614],"genre_scores_gemma":[0.9861201,0.00057724304,0.00063506176,0.00026682773,0.0007972037,0.0020452756,0.0023238275,0.000037291647,0.0071971472],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999036,0.0000102228805,0.00023987649,0.00044607854,0.00007578788,0.00019199621],"domain_scores_gemma":[0.999167,0.00013449462,0.00013942117,0.0002748356,0.00022774881,0.000056488083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009755448,0.00018708341,0.00039983215,0.000053968874,0.000066466884,0.00003602139,0.00007279863,0.00020369542,0.00010181286],"category_scores_gemma":[0.000054954613,0.00018356745,0.00028444637,0.000051467337,0.000047662557,0.000021626096,0.000055301814,0.00013774612,0.0000050911435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046829656,0.004670874,0.0032857175,0.021323299,0.008365048,0.0000880563,0.0021353508,0.00036325847,0.5417455,0.0022694292,0.3507943,0.060276195],"study_design_scores_gemma":[0.014482485,0.0010366797,0.008279035,0.0005979657,0.006379675,0.0000211678,0.0017639202,0.001490193,0.9235588,0.00912672,0.032386944,0.00087645976],"about_ca_topic_score_codex":0.00002213421,"about_ca_topic_score_gemma":0.000045344932,"teacher_disagreement_score":0.38181326,"about_ca_system_score_codex":0.00019704601,"about_ca_system_score_gemma":0.0003250366,"threshold_uncertainty_score":0.7485663},"labels":[],"label_agreement":null},{"id":"W4241951868","doi":"10.1200/jco.2013.31.26_suppl.155","title":"Patient-reported physical, emotional, and social functioning in advanced breast cancer: Insights from BOLERO-2.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Cambridge Memorial Hospital","funders":"","keywords":"Medicine; Exemestane; Discontinuation; Quality of life (healthcare); Breast cancer; Internal medicine; Adverse effect; Clinical endpoint; Cancer; Oncology; Randomized controlled trial; Physical therapy; Tamoxifen","score_opus":0.07385496028442555,"score_gpt":0.44321140298550005,"score_spread":0.3693564427010745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241951868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857933,0.0004973766,0.0000058519886,0.011686397,0.0012320072,0.00018654478,0.0000060346874,0.0000075032376,0.00058500073],"genre_scores_gemma":[0.99483955,0.00044904943,0.00026023918,0.0023376697,0.0019962536,0.000016951655,0.0000074421623,0.000010595307,0.00008226197],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980718,0.00019000118,0.0012120638,0.00017838819,0.00019536143,0.00015240075],"domain_scores_gemma":[0.997635,0.0007361205,0.0010666767,0.000058499685,0.00032114956,0.00018256324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015931042,0.00011597589,0.0009909405,0.0000937525,0.000051533767,0.00000823403,0.000040361403,0.00019813147,0.0005537232],"category_scores_gemma":[0.00012294838,0.00008460161,0.00020083904,0.00010459637,0.00015504737,0.00019137449,0.000030274245,0.00063822785,0.000011182284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005186118,0.0051625026,0.38092324,0.000018323151,0.00091934385,0.000376598,0.001117179,0.00003795809,0.0051010954,0.000042687152,0.010101269,0.59101367],"study_design_scores_gemma":[0.0115909465,0.0036646423,0.9689214,0.00006351308,0.00031635087,0.000121796336,0.00023525108,0.00016745123,0.00004800739,0.0008405862,0.013952266,0.00007776781],"about_ca_topic_score_codex":0.00032339134,"about_ca_topic_score_gemma":0.00011111278,"teacher_disagreement_score":0.59093595,"about_ca_system_score_codex":0.0001836,"about_ca_system_score_gemma":0.0006864068,"threshold_uncertainty_score":0.6062881},"labels":[],"label_agreement":null},{"id":"W4242467441","doi":"10.1155/2011/412617","title":"Modeling of cytochrome P450 (Cyt P450, CYP) channels","year":2011,"lang":"en","type":"article","venue":"Spectroscopy An International Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"European Regional Development Fund; Université de Moncton","keywords":"Heme; Substrate (aquarium); Cytochrome P450; Chemistry; Hydroxylation; Cytochrome; Stereochemistry; Biophysics; Biological system; Crystallography; Biochemistry; Biology; Enzyme","score_opus":0.0674365193036656,"score_gpt":0.38238389485374724,"score_spread":0.3149473755500816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242467441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792748,0.00017874275,0.005104685,0.00041303126,0.0012224902,0.00013084339,0.000016695865,0.000028789387,0.013629893],"genre_scores_gemma":[0.99243027,0.00037252344,0.0046648355,0.0003342826,0.0017528926,0.0000068294976,0.000019971269,0.000020366533,0.00039804247],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887013,0.00003145465,0.00034573348,0.00016700866,0.00036710274,0.00021858608],"domain_scores_gemma":[0.99925774,0.000010645238,0.0001377807,0.00011730892,0.00029614268,0.00018036003],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015996906,0.00013455407,0.00023680655,0.0002470451,0.000057650144,0.000024613022,0.00023861663,0.00006156673,0.0041257255],"category_scores_gemma":[0.000014261241,0.000116381896,0.00014676565,0.00007008046,0.000055266173,0.00026670797,0.000032615793,0.00028999028,0.00003248647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068222047,0.0027212584,0.011655034,0.000033525088,0.002006757,0.001115804,0.0051196557,0.001136801,0.96056885,0.006379279,0.0011678032,0.0012730367],"study_design_scores_gemma":[0.020655787,0.011793104,0.07067316,0.0006174096,0.0010521638,0.0103402,0.000850742,0.0654371,0.79262817,0.0225077,0.0025397032,0.0009047365],"about_ca_topic_score_codex":0.00012494726,"about_ca_topic_score_gemma":0.000015257605,"teacher_disagreement_score":0.16794065,"about_ca_system_score_codex":0.00022136266,"about_ca_system_score_gemma":0.00017603819,"threshold_uncertainty_score":0.9967846},"labels":[],"label_agreement":null},{"id":"W4242714632","doi":"10.2165/00128415-200510380-00004","title":"Canadian Ezetrol label change reflects adverse event reports","year":2005,"lang":"en","type":"article","venue":"Reactions Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse effect; Event (particle physics); Medicine; Pharmacology","score_opus":0.048737922076682594,"score_gpt":0.36131843402236347,"score_spread":0.3125805119456809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242714632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6908991,0.003475704,0.000014548763,0.14406668,0.0022379763,0.0020398672,0.00006844409,0.00038192119,0.15681578],"genre_scores_gemma":[0.9542683,0.0002045011,0.0002380942,0.0026832283,0.00094051816,0.0002506122,0.00006207935,0.00001957772,0.04133309],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917734,0.000017620603,0.00019658393,0.0002113668,0.00011247737,0.0002846396],"domain_scores_gemma":[0.99923974,0.000019509142,0.0000720583,0.00024444502,0.000055875495,0.0003683545],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008610171,0.00011930385,0.00020044262,0.00021626198,0.00011998802,0.0000046543237,0.00002537742,0.00008252388,0.0021592595],"category_scores_gemma":[0.000016681919,0.00010741998,0.00011645698,0.00019880955,0.000017927476,0.00010484066,0.000007297103,0.00016015003,0.00030103148],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006245768,0.0047524306,0.069567986,0.00022098601,0.0076690116,0.0074029625,0.00296652,0.00006947637,0.047699608,0.00085942337,0.73921907,0.11894793],"study_design_scores_gemma":[0.0008213504,0.0002154643,0.012008154,0.0000158522,0.0011184444,0.0011326103,0.000034177734,0.00005600678,0.00081280846,0.000023082755,0.98365986,0.000102164],"about_ca_topic_score_codex":0.11373027,"about_ca_topic_score_gemma":0.24362062,"teacher_disagreement_score":0.26336923,"about_ca_system_score_codex":0.0010402445,"about_ca_system_score_gemma":0.00037760264,"threshold_uncertainty_score":0.9987529},"labels":[],"label_agreement":null},{"id":"W4243125367","doi":"10.3109/14733400410001728456","title":"Phase III study of N, N-Diethyl-2-[4-(Phenylmethyl) Phenoxyl] Ethanamine (BMS-2173801-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA-19","year":2004,"lang":"en","type":"article","venue":"The Women s Oncology Review","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Doxorubicin; Breast cancer; Medicine; Metastatic breast cancer; Cancer; Internal medicine; Oncology; Chemotherapy","score_opus":0.1757692435539034,"score_gpt":0.5063471901154966,"score_spread":0.3305779465615932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243125367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94504684,0.034908492,0.0000049319046,0.007431882,0.001674274,0.010352532,0.00034576177,0.000022016331,0.00021328001],"genre_scores_gemma":[0.96056587,0.032590657,0.00007433237,0.001867291,0.00028276735,0.004359131,0.00007192319,0.000040078285,0.00014793141],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99158585,0.0028960074,0.0031491276,0.0007043613,0.00096766197,0.0006969897],"domain_scores_gemma":[0.99515885,0.0015446612,0.0018874638,0.0005552396,0.00047195205,0.00038180593],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009443169,0.0005450194,0.004662412,0.00021726894,0.00011887099,0.00000550864,0.00044786726,0.00011163207,0.00076347124],"category_scores_gemma":[0.0004576971,0.00033830348,0.0002130826,0.0012316552,0.00046262986,0.00010341802,0.00014253538,0.0007414223,0.0000021798232],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3468843,0.23765385,0.02817049,0.006945309,0.038650498,0.0019077163,0.021828325,0.0015928936,0.0015726874,0.00046031293,0.019311974,0.29502162],"study_design_scores_gemma":[0.7727602,0.1301494,0.029812224,0.003979768,0.019707313,0.00015138187,0.011177551,0.00004572718,0.00023455743,0.00016327016,0.030706141,0.0011124642],"about_ca_topic_score_codex":0.21824402,"about_ca_topic_score_gemma":0.7283535,"teacher_disagreement_score":0.5101095,"about_ca_system_score_codex":0.0036239412,"about_ca_system_score_gemma":0.0070730783,"threshold_uncertainty_score":0.9999069},"labels":[],"label_agreement":null},{"id":"W4243402845","doi":"10.1139/cjm-46-2-143","title":"Is &lt;i&gt;Fusarium culmorum&lt;/i&gt; isotrichodermin-15-hydroxylase different from other fungal species?","year":2000,"lang":"en","type":"article","venue":"Canadian Journal of Microbiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Fusarium culmorum; Fusarium; Biology; Microbiology; Chemistry; Botany","score_opus":0.01703712716056224,"score_gpt":0.2480154688350384,"score_spread":0.23097834167447615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243402845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718488,0.008744255,0.000009821717,0.0054087453,0.001180033,0.0002466041,0.0012199291,0.000012621187,0.011329178],"genre_scores_gemma":[0.93845266,0.00048179476,0.00010508293,0.006789516,0.0015606878,0.000005266806,0.00014206603,0.00005065989,0.052412294],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980906,0.00015357288,0.00060780154,0.00033353776,0.00008109207,0.0007333524],"domain_scores_gemma":[0.9982458,0.00010470167,0.00024152714,0.000295324,0.00013992137,0.000972732],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012804392,0.0003469172,0.0007914024,0.00039504867,0.00013583136,0.000025489173,0.00028414614,0.00031246987,0.09630619],"category_scores_gemma":[0.000018787721,0.00028318967,0.0003640793,0.00017827564,0.00029838685,0.00006316714,0.0000151061895,0.00044822242,0.0009212558],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007717853,0.00022656898,0.013220442,0.000015766931,0.0010332108,0.002054703,0.0006433132,0.000006946046,0.6191482,0.000041403575,0.3582249,0.0046127443],"study_design_scores_gemma":[0.0044282535,0.0009750196,0.018889861,0.000056853274,0.00062748714,0.0025502574,0.00001492051,0.000010069164,0.022776412,0.00006436694,0.94934,0.0002664835],"about_ca_topic_score_codex":0.0011517559,"about_ca_topic_score_gemma":0.011802102,"teacher_disagreement_score":0.5963718,"about_ca_system_score_codex":0.0006045221,"about_ca_system_score_gemma":0.0010907963,"threshold_uncertainty_score":0.99996203},"labels":[],"label_agreement":null},{"id":"W4243585785","doi":"10.1142/9789812701848_0069","title":"SNOLAB","year":2005,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"","keywords":"Computer science","score_opus":0.017773306614777152,"score_gpt":0.3532266986803868,"score_spread":0.33545339206560965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243585785","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.393444,0.00027221692,0.000022296585,0.022117283,0.00007270015,0.000079253456,4.0545356e-7,0.00006377455,0.58392805],"genre_scores_gemma":[0.9008054,0.000025643876,0.00082114217,0.0037882316,0.0002630248,0.000003918121,0.000002447177,0.000002279375,0.09428788],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985844,0.0000015919795,0.000027981576,0.000038380127,0.000023791572,0.000049809445],"domain_scores_gemma":[0.99991727,0.0000051913885,0.0000033193137,0.000036495567,0.0000067422484,0.000030989493],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000009261084,0.000021195876,0.00003950524,0.000012783514,0.000007517276,9.603518e-7,0.0000075211065,0.000011593045,0.009997423],"category_scores_gemma":[9.3460324e-7,0.000014949791,0.000016175014,0.00002282445,0.0000062390964,0.000012237794,0.0000032335145,0.000020249232,0.0006694337],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024526217,0.0005911689,0.02930377,0.000010984627,0.00011749822,0.00003533257,0.000192825,0.000002445987,0.026543764,0.003985987,0.70063466,0.23833631],"study_design_scores_gemma":[0.0013832544,0.00012159802,0.014456301,0.0000013864674,0.000038374714,0.000026312022,0.0000060535126,0.000055697143,0.022428729,0.000016036536,0.96144354,0.000022715913],"about_ca_topic_score_codex":0.000013355078,"about_ca_topic_score_gemma":0.000018021437,"teacher_disagreement_score":0.5073614,"about_ca_system_score_codex":0.000022672097,"about_ca_system_score_gemma":0.00001353716,"threshold_uncertainty_score":0.99090755},"labels":[],"label_agreement":null},{"id":"W4243637855","doi":"10.1016/j.annonc.2020.08.518","title":"407P Long-term effect of peripheral sensory neuropathy (PSN) of 3 or 6 months oxaliplatin-based adjuvant chemotherapy for high-risk stage II colon cancer: ACHIEVE-2 as part of the IDEA collaboration","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Foundation Medicine; Sierra Oncology; INCLIVA Instituto de Investigación Sanitaria; European Society for Medical Oncology; BeiGene; Genentech; Les Laboratories Pierre Fabre; FibroGen; Eli Lilly and Company; Servier; Instituto de Salud Carlos III; Amgen","keywords":"Medicine; Oxaliplatin; FOLFOX; Incidence (geometry); Colorectal cancer; Surgery; Stage (stratigraphy); Internal medicine; Cancer; Randomization; Gastroenterology; Randomized controlled trial","score_opus":0.04931255489397637,"score_gpt":0.3929471690141371,"score_spread":0.3436346141201608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243637855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98556834,0.0007915965,0.000011177102,0.010448087,0.0003773127,0.0018735845,0.00079467834,0.000014768483,0.00012045428],"genre_scores_gemma":[0.9956782,0.0010916262,0.00007051164,0.0024054921,0.00018623254,0.0001560708,0.000051926458,0.000029438954,0.00033053212],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982718,0.00041639857,0.0006245152,0.0002574762,0.00021097009,0.00021882774],"domain_scores_gemma":[0.9976263,0.0006469525,0.0010150298,0.00022304684,0.00039855618,0.00009010723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030606982,0.00020616052,0.0010495876,0.000057338835,0.00006120633,0.0000017616453,0.00014260228,0.00016449187,0.000389174],"category_scores_gemma":[0.00019306848,0.00013873295,0.00021268653,0.000288071,0.0002703912,0.00003827738,0.000033774715,0.00014427358,4.9217766e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13043833,0.0021432727,0.18790352,0.0020556832,0.0012174346,0.000050209423,0.0034902631,0.0016131666,0.60340184,0.00006989528,0.008510512,0.05910591],"study_design_scores_gemma":[0.019063875,0.09012681,0.058798984,0.00011497061,0.00072234136,0.0000035083185,0.00007349176,0.0007437655,0.8213866,0.000010567106,0.008820181,0.0001349183],"about_ca_topic_score_codex":0.0005195358,"about_ca_topic_score_gemma":0.0006775585,"teacher_disagreement_score":0.21798477,"about_ca_system_score_codex":0.000060794744,"about_ca_system_score_gemma":0.0008516496,"threshold_uncertainty_score":0.56573653},"labels":[],"label_agreement":null},{"id":"W4243727353","doi":"10.31857/s0869-56524853374-376","title":"Detection of taxuyunnanin c in suspension cell culture of Taxus canadensis","year":2019,"lang":"en","type":"article","venue":"Доклады Академии наук","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Taxoid; Suspension culture; Taxus; Chemistry; Biomass (ecology); Botany; Suspension (topology); Cell culture; Stereochemistry; Biology; Paclitaxel; Genetics; Ecology","score_opus":0.008737153768554513,"score_gpt":0.26621866271397027,"score_spread":0.25748150894541577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243727353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989755,0.0008128992,0.0000040586738,0.00018093192,0.00035238508,0.0004394561,0.000012054004,0.000013536764,0.008429679],"genre_scores_gemma":[0.994356,0.00015504607,0.00008459618,0.00012226605,0.00005754886,0.0000093862955,0.00001959806,0.000014834507,0.005180753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999129,0.00003896577,0.00027478716,0.00019865404,0.0001719245,0.00018668614],"domain_scores_gemma":[0.9994531,0.000032774522,0.0001497979,0.00020029361,0.000095674644,0.00006831772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008721445,0.00012452916,0.00037994116,0.00015658846,0.00001278734,0.0000016904611,0.000053717104,0.0001316775,0.00064015144],"category_scores_gemma":[0.0000137156,0.00010574677,0.00008878246,0.00029127265,0.000039074162,0.000041061623,0.00002343423,0.00015974314,0.0000376616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048568746,0.00024879872,0.038694046,0.00018532106,0.000034514505,0.000026195381,0.00079590396,0.000022898783,0.955438,0.000014606128,0.0023414935,0.0017125149],"study_design_scores_gemma":[0.0040131034,0.0010316613,0.0580857,0.000102926744,0.00013096453,0.000022380495,0.00042607042,0.00011593414,0.9286732,0.000034286175,0.007251339,0.00011245186],"about_ca_topic_score_codex":0.005282293,"about_ca_topic_score_gemma":0.0042252406,"teacher_disagreement_score":0.026764836,"about_ca_system_score_codex":0.00013614312,"about_ca_system_score_gemma":0.00010491218,"threshold_uncertainty_score":0.79852825},"labels":[],"label_agreement":null},{"id":"W4243925059","doi":"10.1515/iupac.73.0185","title":"Cycloartenol","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan College","funders":"","keywords":"Chemistry; Table (database); Food science; Organic chemistry; Product (mathematics); Biochemistry; Computer science; Mathematics; Data mining","score_opus":0.019051045532076073,"score_gpt":0.4618151053569599,"score_spread":0.4427640598248838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243925059","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022118895,0.0019750178,0.0000067069836,0.003183875,0.001236267,0.00048235492,0.992498,0.000077330355,0.00031929932],"genre_scores_gemma":[0.000022463013,0.0031193988,0.000018168183,0.0013794607,0.0026782192,0.00003649432,0.98838884,0.00003945961,0.004317493],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981962,0.000039624225,0.00032346553,0.0004240431,0.00062446593,0.0003921887],"domain_scores_gemma":[0.998688,0.00004760184,0.00015046293,0.000585587,0.00028032676,0.000248052],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001493741,0.00037681358,0.00075024064,0.00019720658,0.000061072096,0.00001324794,0.00014781248,0.0003602511,0.019960236],"category_scores_gemma":[0.00008791624,0.00025505555,0.00022584957,0.00011875657,0.00013210019,0.000032766155,0.0000741366,0.00040208624,0.000015993352],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009181065,0.0005864249,0.00003220468,0.00016631183,0.00030716043,0.00059118634,0.000006222896,4.0776396e-8,0.00006330378,0.0000017867756,0.9905188,0.006808423],"study_design_scores_gemma":[0.0046771704,0.001031909,0.0000857051,0.00033205078,0.0010099491,0.00013467889,0.000004718582,4.1607214e-7,0.00005204232,0.000038499238,0.9923778,0.0002550528],"about_ca_topic_score_codex":0.00010795895,"about_ca_topic_score_gemma":0.00034815018,"teacher_disagreement_score":0.019944243,"about_ca_system_score_codex":0.00063258136,"about_ca_system_score_gemma":0.0011333413,"threshold_uncertainty_score":0.99999017},"labels":[],"label_agreement":null},{"id":"W4244170236","doi":"10.3747//co.19.1041","title":"E-manuscript Article Summaries","year":2012,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Citation; Download; Library science; World Wide Web; Computer science","score_opus":0.20311511197018953,"score_gpt":0.4693588786729594,"score_spread":0.26624376670276984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244170236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9512482,0.011682323,0.000037303875,0.0028938903,0.004872221,0.00027386623,0.000007671426,0.000087784436,0.028896714],"genre_scores_gemma":[0.99584633,0.0003224628,0.00014788425,0.0006211985,0.0013140135,0.000063579726,0.000038521546,0.000010787972,0.0016352487],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992325,0.000050190123,0.00014670008,0.00011727582,0.000079193065,0.00037417712],"domain_scores_gemma":[0.99951047,0.00006742429,0.000041170828,0.000119862045,0.00004227963,0.00021878303],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000119962446,0.00009705029,0.00022464935,0.0000541388,0.000051771378,0.00000396003,0.00003890682,0.000068933514,0.0022556244],"category_scores_gemma":[0.000031366097,0.000079973695,0.00006673248,0.0000953434,0.00010301566,0.000081471684,0.000036578742,0.00016709253,0.0006980662],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040086883,0.00354468,0.5846532,0.000056263096,0.00009914275,0.000018150198,0.0012262758,2.236177e-7,0.0042055063,0.0019520607,0.23934603,0.1644976],"study_design_scores_gemma":[0.001947499,0.00050389156,0.0901466,0.000007953824,0.0001963588,0.00006360769,0.0000793752,0.000016637741,0.0028363036,0.00009140634,0.90403926,0.00007107855],"about_ca_topic_score_codex":0.000010405628,"about_ca_topic_score_gemma":0.000012392807,"teacher_disagreement_score":0.66469324,"about_ca_system_score_codex":0.00021180887,"about_ca_system_score_gemma":0.000093871466,"threshold_uncertainty_score":0.99865645},"labels":[],"label_agreement":null},{"id":"W4244352323","doi":"10.32920/ryerson.14655858.v1","title":"The Influence Of The Epidermal Growth Factor Receptor On The DNA Damage Response As Examined Through Clathrin Affiliated Signalling Complexes","year":2021,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Cisplatin; Epidermal growth factor receptor; DNA damage; DNA repair; Cancer research; Context (archaeology); PI3K/AKT/mTOR pathway; Cancer; Cell biology; Signal transduction; Biology; DNA; Medicine; Internal medicine; Chemotherapy; Genetics","score_opus":0.053627716346361945,"score_gpt":0.33384774716136295,"score_spread":0.280220030815001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244352323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749557,0.0004202594,0.000010673923,0.020616092,0.0005573852,0.0015647495,0.000088016895,0.000073616095,0.0017135231],"genre_scores_gemma":[0.9917673,0.00059355295,0.000113429436,0.0028298895,0.00017759498,0.00015394995,0.00006415477,0.00004239377,0.004257721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965114,0.0014210164,0.00062113407,0.00054231175,0.0005126159,0.00039154518],"domain_scores_gemma":[0.9932203,0.004976101,0.00042665264,0.0009613973,0.00033278426,0.00008275516],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069811085,0.00044419075,0.00064230815,0.000048504913,0.00036370056,0.00006603555,0.00066869316,0.00027897736,0.0020401448],"category_scores_gemma":[0.0010237461,0.00019702813,0.0003783246,0.0002890832,0.00052337017,0.00005521976,0.0006591347,0.0011187722,0.00003358708],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015243601,0.00081792625,0.0055438946,0.00029501316,0.0019393151,0.000073455325,0.007344466,0.0012427098,0.95564806,0.0028366693,0.008692737,0.00032217757],"study_design_scores_gemma":[0.00301634,0.0010109545,0.33461407,0.0011048517,0.0006205353,0.000020921469,0.0015881599,0.00023326701,0.64853656,0.00077751454,0.0079859765,0.00049085513],"about_ca_topic_score_codex":0.0010529746,"about_ca_topic_score_gemma":0.00018215372,"teacher_disagreement_score":0.32907015,"about_ca_system_score_codex":0.00021642483,"about_ca_system_score_gemma":0.0007374277,"threshold_uncertainty_score":0.9988721},"labels":[],"label_agreement":null},{"id":"W4244525316","doi":"10.21203/rs.2.11805/v2","title":"The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in colorectal cancer patients: study protocol for a pilot single-blinded, randomized sham-controlled trial","year":2019,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Hospital Authority; Hong Kong Baptist University","keywords":"Chemotherapy-induced peripheral neuropathy; Medicine; Peripheral neuropathy; Acupuncture; Randomized controlled trial; Colorectal cancer; Chemotherapy; Protocol (science); Single blind; Peripheral; Cancer; Internal medicine; Oncology; Physical therapy; Alternative medicine; Pathology","score_opus":0.09526413833963833,"score_gpt":0.4650187963612227,"score_spread":0.36975465802158436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244525316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.515545,0.000097324686,0.000009933834,0.00052419014,0.00018524406,0.4835317,0.000039714698,0.000015475318,0.00005138946],"genre_scores_gemma":[0.50718355,0.000034937184,0.000022179749,0.00003077446,0.00040115448,0.49213704,0.00003619163,0.000052969594,0.000101216145],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9948176,0.0017484201,0.0011082076,0.00079731457,0.00075387495,0.0007745919],"domain_scores_gemma":[0.9911398,0.0067945947,0.0005347202,0.000332255,0.0010717759,0.00012682592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038818028,0.00051983487,0.0024969133,0.00027226034,0.00025977884,0.000088640874,0.00027127608,0.0002647839,0.000060365197],"category_scores_gemma":[0.0023086227,0.00027827083,0.00053801126,0.00024549424,0.00016399157,0.000039479874,0.00018055868,0.0010843097,2.9797863e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.977016,0.0071586384,0.0016251637,0.0012236106,0.0011375267,0.0000029629416,0.0022842276,0.00003290754,0.0049573253,0.000006685535,0.00018339112,0.0043715793],"study_design_scores_gemma":[0.9458431,0.04808617,0.0016950653,0.00044303824,0.0002960697,6.483356e-7,0.00021351973,0.0013572988,0.0013820211,0.0000529433,0.00042352217,0.00020659398],"about_ca_topic_score_codex":0.00030120288,"about_ca_topic_score_gemma":0.0003816801,"teacher_disagreement_score":0.040927533,"about_ca_system_score_codex":0.0007028674,"about_ca_system_score_gemma":0.0013087736,"threshold_uncertainty_score":0.9999669},"labels":[],"label_agreement":null},{"id":"W4244887701","doi":"10.2307/j.ctv1h0p09w.12","title":"PROFESSEUR DES DEUX ÉCOLES DE MÉDECINE FRANCOPHONES DE MONTRÉAL","year":2019,"lang":"fr","type":"book-chapter","venue":"Presses de l'Université Laval eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Art","score_opus":0.015884483847986866,"score_gpt":0.24241384290247853,"score_spread":0.22652935905449167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244887701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53329337,0.058635645,0.0008047049,0.001286864,0.0026432525,0.002317512,0.00036440266,0.00032678753,0.40032747],"genre_scores_gemma":[0.56140584,0.018061552,0.001590355,0.0008130736,0.001837916,0.00003992185,0.00010757873,0.00022254926,0.4159212],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99703366,0.0002220575,0.00042480763,0.00072162395,0.00034723707,0.0012506275],"domain_scores_gemma":[0.9976292,0.0006001005,0.00032899855,0.00056114374,0.00024125625,0.0006392617],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028455004,0.00085109717,0.0010833427,0.00029321134,0.00043712452,0.00004322014,0.000511963,0.0008853728,0.0058320705],"category_scores_gemma":[0.0000439863,0.00089418684,0.00047388196,0.000047921043,0.0005419089,0.0001157291,0.00037678838,0.0011453304,0.00074469304],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014761496,0.0013857784,0.5657225,0.007713349,0.008470098,0.012377,0.02248363,0.00094015285,0.14030837,0.027287396,0.03243345,0.16611679],"study_design_scores_gemma":[0.030339323,0.0042556557,0.12670594,0.0068910317,0.015145797,0.0021902933,0.005061263,0.0012339611,0.07008649,0.013861017,0.7212068,0.0030224402],"about_ca_topic_score_codex":0.011818007,"about_ca_topic_score_gemma":0.009050422,"teacher_disagreement_score":0.68877333,"about_ca_system_score_codex":0.0019554133,"about_ca_system_score_gemma":0.0015875604,"threshold_uncertainty_score":0.9993509},"labels":[],"label_agreement":null},{"id":"W4244999708","doi":"10.1200/jco.2014.32.15_suppl.e17648","title":"A comparative effectiveness analysis of single-agent cytotoxics in triple-negative metastatic breast cancer (TN-MBC) patients.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Internal medicine; Metastatic breast cancer; Oncology; Hazard ratio; Vinorelbine; Gemcitabine; Eribulin; Proportional hazards model; Performance status; Breast cancer; Discontinuation; Capecitabine; Chemotherapy; Surgery; Cancer; Confidence interval; Colorectal cancer","score_opus":0.16355271133825136,"score_gpt":0.5159438887030333,"score_spread":0.352391177364782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244999708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966014,0.000177743,0.0002580625,0.000804275,0.0008471158,0.0004367648,0.000052651005,0.0000037148666,0.0008182561],"genre_scores_gemma":[0.9982279,0.00018675541,0.00063465454,0.00064107374,0.00022106338,0.000022121485,0.000010126456,0.000010152268,0.000046159723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99494666,0.0020650204,0.0022111516,0.00022047103,0.0003332228,0.00022349744],"domain_scores_gemma":[0.98944503,0.007083571,0.0023012573,0.00013182515,0.00077638775,0.0002619192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002571531,0.0001823903,0.0035840608,0.00054221315,0.00002215808,0.0000036138383,0.000121421035,0.00017667488,0.00035242416],"category_scores_gemma":[0.0010368266,0.00012789099,0.0007887529,0.0008526761,0.00028471893,0.0000878651,0.000036151094,0.0005858308,0.0000038347816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029011536,0.021357039,0.88687015,0.00010129714,0.014578773,0.00012931778,0.0010699828,0.0014912199,0.0016661629,0.000057791796,0.00053683383,0.043129887],"study_design_scores_gemma":[0.02455625,0.018132135,0.9445951,0.000120489705,0.009056318,0.00001982932,0.0001051381,0.0009996886,0.0010047889,0.00012971075,0.0011767757,0.00010377319],"about_ca_topic_score_codex":0.00021940774,"about_ca_topic_score_gemma":0.00082183786,"teacher_disagreement_score":0.057724945,"about_ca_system_score_codex":0.00059249805,"about_ca_system_score_gemma":0.00082117383,"threshold_uncertainty_score":0.52152437},"labels":[],"label_agreement":null},{"id":"W4245447381","doi":"10.1200/jco.2012.30.18_suppl.lba1000","title":"NSABP B-38: Definitive analysis of a randomized adjuvant trial comparing dose-dense (DD) AC→paclitaxel (P) plus gemcitabine (G) with DD AC→P and with docetaxel, doxorubicin, and cyclophosphamide (TAC) in women with operable, node-positive breast cancer.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Cyclophosphamide; Gastroenterology; Breast cancer; Gemcitabine; Adjuvant; Paclitaxel; Urology; Cancer; Chemotherapy","score_opus":0.05828094261182096,"score_gpt":0.4145853904945108,"score_spread":0.3563044478826899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245447381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900755,0.004552678,0.00007280096,0.0024783155,0.00025981103,0.0012470112,0.000053628097,0.000009758377,0.0012504533],"genre_scores_gemma":[0.9928295,0.003990918,0.0012821612,0.0011544428,0.0004954463,0.00012310334,0.000008536172,0.000035833233,0.00008002867],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9949588,0.0010876897,0.0024247486,0.00041203006,0.00049246766,0.0006242355],"domain_scores_gemma":[0.9912679,0.0047409246,0.0024014616,0.00019380856,0.00064048613,0.0007554044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040799477,0.00042022538,0.006761277,0.00052216323,0.00007645545,0.00001924447,0.00012522176,0.00030606138,0.00017836421],"category_scores_gemma":[0.00040063393,0.00023513155,0.00030711602,0.0007610181,0.0011890992,0.00031571116,0.00007655273,0.001080525,9.02773e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7293303,0.0023399757,0.249957,0.00005131647,0.011411476,0.0005299546,0.002246978,0.00028692724,0.000099794815,0.00002514,0.00006525873,0.0036558907],"study_design_scores_gemma":[0.54491156,0.016142562,0.42651346,0.00033422266,0.009826398,0.0006882273,0.0009591738,0.0002387895,0.00004645436,0.000012068409,0.0001251907,0.00020187563],"about_ca_topic_score_codex":0.001011001,"about_ca_topic_score_gemma":0.0013052636,"teacher_disagreement_score":0.18441871,"about_ca_system_score_codex":0.00057293806,"about_ca_system_score_gemma":0.0017942443,"threshold_uncertainty_score":0.95883864},"labels":[],"label_agreement":null},{"id":"W4245795169","doi":"10.1515/iupac.87.0463","title":"Neurotoxin","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Chemical nomenclature; Relation (database); Computer science; Chemistry; Linguistics; Philosophy; Organic chemistry; Data mining","score_opus":0.022210281135016125,"score_gpt":0.4695049975641064,"score_spread":0.4472947164290903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245795169","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022143501,0.0011361779,0.000005548514,0.0031530934,0.0012238801,0.0006665982,0.99324906,0.000073079405,0.00027110905],"genre_scores_gemma":[0.000018964229,0.002460191,0.000013782111,0.0020398982,0.0023572438,0.000050640367,0.98941207,0.00004109593,0.0036061076],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982066,0.000052272928,0.00032066676,0.0004355788,0.00061454094,0.00037030166],"domain_scores_gemma":[0.9987338,0.00005500936,0.00014705001,0.000580235,0.00023849767,0.00024539564],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015087058,0.0003718274,0.00070394925,0.00019632513,0.00005429841,0.000013859913,0.00015316687,0.0003068725,0.026343314],"category_scores_gemma":[0.00011758495,0.0002538579,0.00021759985,0.00012536658,0.00011847629,0.00003150884,0.000083962565,0.0004329191,0.000011438611],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010981836,0.00056626956,0.000029372,0.00017490392,0.00018431137,0.00067241874,0.0000036239314,4.8404548e-8,0.000110653724,0.0000013017132,0.9920304,0.0051285145],"study_design_scores_gemma":[0.004317552,0.0012174908,0.0001086739,0.0002666563,0.0007056891,0.0001277694,0.0000021344638,5.118742e-7,0.00009516197,0.000020508884,0.9929044,0.00023344281],"about_ca_topic_score_codex":0.00007983804,"about_ca_topic_score_gemma":0.00021588916,"teacher_disagreement_score":0.026331875,"about_ca_system_score_codex":0.00047576678,"about_ca_system_score_gemma":0.0010820695,"threshold_uncertainty_score":0.99999136},"labels":[],"label_agreement":null},{"id":"W4245921256","doi":"10.1016/s0985-0562(11)70059-0","title":"O55 Impact des thérapies ciblées en cancérologie sur la masse musculaire et le tissu adipeux","year":2011,"lang":"fr","type":"article","venue":"Nutrition Clinique et Métabolisme","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Descriptive statistics; Statistics; Humanities; Medicine; Mathematics; Philosophy","score_opus":0.07568821206725736,"score_gpt":0.4081656790115094,"score_spread":0.33247746694425206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245921256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78067267,0.1620509,0.00026706987,0.031251647,0.004101692,0.0017958159,0.0011710615,0.00045027488,0.01823889],"genre_scores_gemma":[0.83362824,0.15476526,0.0024322723,0.0023848747,0.0020863502,0.00045111746,0.00034598308,0.000103037244,0.0038028767],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9958279,0.0016370198,0.00070541765,0.0006465464,0.0002735225,0.0009095925],"domain_scores_gemma":[0.99707127,0.0014152782,0.00027019353,0.00042248366,0.00033994182,0.00048082444],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013555669,0.00057827827,0.0009349739,0.0003039488,0.0001780772,0.00006154454,0.00025370263,0.0008453771,0.0043698507],"category_scores_gemma":[0.00033000275,0.0005600857,0.0005386166,0.0003845678,0.00070552406,0.0006633101,0.00010262208,0.0009792114,0.00020628322],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008836061,0.03230122,0.20147493,0.00504993,0.0045409105,0.0039535323,0.033528615,0.00004614474,0.0082191015,0.07279163,0.496764,0.13249391],"study_design_scores_gemma":[0.019749964,0.0025720766,0.47817963,0.0017968892,0.001399854,0.0004802563,0.0008769366,0.00006833527,0.0070617907,0.018194579,0.46880504,0.000814617],"about_ca_topic_score_codex":0.0074081398,"about_ca_topic_score_gemma":0.0028960658,"teacher_disagreement_score":0.27670473,"about_ca_system_score_codex":0.00032186936,"about_ca_system_score_gemma":0.0015439109,"threshold_uncertainty_score":0.99968505},"labels":[],"label_agreement":null},{"id":"W4246008022","doi":"10.1200/jco.2004.22.14_suppl.773","title":"Palliative chemotherapy with vinorelbine or capecitabine in women with anthracycline and taxane refractory metastatic breast cancer","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Vinorelbine; Capecitabine; Medicine; Anthracycline; Taxane; Metastatic breast cancer; Internal medicine; Oncology; Breast cancer; Chemotherapy; Cancer; Colorectal cancer","score_opus":0.07887157768887255,"score_gpt":0.4760803488222091,"score_spread":0.3972087711333366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246008022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96554744,0.00095881626,0.000043974003,0.032767367,0.00019926777,0.00030157002,0.000014680209,0.0000068780255,0.00016002757],"genre_scores_gemma":[0.9789658,0.011101593,0.0038821395,0.00504928,0.0006585735,0.000029727544,0.0000020495065,0.000027011456,0.00028379247],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9978353,0.00015885776,0.0012223495,0.00022766531,0.0002533762,0.00030247952],"domain_scores_gemma":[0.99715763,0.000838756,0.001217458,0.00010906453,0.00028409425,0.00039297197],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008651546,0.00020463901,0.0016549879,0.00015321953,0.00002636248,0.000005403294,0.00007762238,0.00014462773,0.0009209123],"category_scores_gemma":[0.0001339789,0.00010351794,0.000071221424,0.00025937255,0.0003997474,0.00013115567,0.000015891063,0.00081204914,0.0000020987165],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43287912,0.01854933,0.23100473,0.00016647369,0.0043729865,0.010622286,0.002254036,0.00027429234,0.0013134835,0.00002359312,0.00091068476,0.297629],"study_design_scores_gemma":[0.10438372,0.078323,0.8004852,0.0003953665,0.00073047646,0.002079975,0.00056357,0.000014013811,0.00011990736,0.00010142841,0.012630161,0.00017318879],"about_ca_topic_score_codex":0.00022665507,"about_ca_topic_score_gemma":0.0015642392,"teacher_disagreement_score":0.5694805,"about_ca_system_score_codex":0.00065635354,"about_ca_system_score_gemma":0.0027196533,"threshold_uncertainty_score":0.9999924},"labels":[],"label_agreement":null},{"id":"W4246038120","doi":"10.1007/978-0-387-39940-9_4091","title":"XPDL","year":2009,"lang":"en","type":"book-chapter","venue":"Encyclopedia of Database Systems","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Computer science","score_opus":0.02360826194090945,"score_gpt":0.2925866381306791,"score_spread":0.26897837618976966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246038120","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001279839,0.013960271,0.000010651068,0.00013540535,0.0016488122,0.0009781744,0.0013351755,0.000068512396,0.981735],"genre_scores_gemma":[0.0009455236,0.011870497,0.00015261993,0.00012555548,0.0021004342,0.000028276543,0.0027444274,0.0000650903,0.98196757],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983774,0.000019775049,0.0005865979,0.0004056172,0.0003812143,0.0002294402],"domain_scores_gemma":[0.9985918,0.00007831701,0.00035635463,0.0006647608,0.000112237976,0.00019652194],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013835987,0.00037142055,0.0009454474,0.00022345863,0.000029155595,0.000005429997,0.00012659263,0.00027048154,0.0015337922],"category_scores_gemma":[0.000015231502,0.00032324632,0.00021118157,0.000034460296,0.00007530971,0.00006016504,0.000050803545,0.00034010387,0.00037159363],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006797789,0.00045816685,0.0004581091,0.0028619347,0.0013689067,0.0016274692,0.00020832267,0.0000031679833,0.0005812673,0.03760959,0.924827,0.029316323],"study_design_scores_gemma":[0.0013575037,0.0004882956,0.00006654922,0.0009951694,0.00089264696,0.00013939086,0.0000083001005,0.00000562392,0.000039269096,0.000080631755,0.99568087,0.00024575196],"about_ca_topic_score_codex":0.0001562363,"about_ca_topic_score_gemma":0.000019854939,"teacher_disagreement_score":0.070853904,"about_ca_system_score_codex":0.00012142081,"about_ca_system_score_gemma":0.00030327536,"threshold_uncertainty_score":0.999922},"labels":[],"label_agreement":null},{"id":"W4246797495","doi":"10.1016/j.annonc.2020.10.024","title":"3MO IMpassion031: Results from a phase III study of neoadjuvant (neoadj) atezolizumab + chemo in early triple-negative breast cancer (TNBC)","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"EMD Serono; Samsung; Genentech; PharmaMar; Chugai Pharmaceutical; Vifor Pharma; Astellas Pharma; Eisai; Bayer HealthCare; G1 Therapeutics; Silverback Therapeutics; OncoSec Medical; Mersana Therapeutics; Amgen; Radius Health; Syndax Pharmaceuticals; Queen Mary University of London; Clovis Oncology; Daiichi Sankyo Europe; Servier; Calithera Biosciences; Mylan; MacroGenics; Celldex Therapeutics; Teva Pharmaceutical Industries; Les Laboratories Pierre Fabre; F. Hoffmann-La Roche; Ariad Pharmaceuticals; Exelixis; Sanofi; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company; Baxalta; Flatiron Health; Genomic Health; GlaxoSmithKline","keywords":"Medicine; Atezolizumab; Taxane; Internal medicine; Clinical endpoint; Anthracycline; Breast cancer; Cyclophosphamide; Triple-negative breast cancer; Oncology; Placebo; Phases of clinical research; Neoadjuvant therapy; Gastroenterology; Chemotherapy; Surgery; Cancer; Randomized controlled trial; Pathology; Immunotherapy; Nivolumab","score_opus":0.11921368673131624,"score_gpt":0.4494909992734035,"score_spread":0.33027731254208725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246797495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754666,0.00045871225,0.000001763531,0.020045053,0.0002524827,0.001213487,0.0010677633,0.00002553076,0.0014685944],"genre_scores_gemma":[0.9968943,0.0005473163,0.00004842601,0.0017681904,0.0003277795,0.00013365736,0.000073768475,0.000023339462,0.00018319584],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976885,0.00022054499,0.0009764919,0.0004941886,0.0002536824,0.00036664074],"domain_scores_gemma":[0.9982581,0.00036159757,0.00056976144,0.0002447183,0.0002974641,0.0002683696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019934776,0.00025271322,0.0012964768,0.00017178772,0.000032901924,0.0000033226067,0.000174501,0.00019798963,0.0007669186],"category_scores_gemma":[0.00011922003,0.00021030688,0.0001516631,0.00048795418,0.00015506413,0.00008638656,0.00010021246,0.00033780144,0.000012176141],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34958932,0.045860652,0.037079535,0.0001407904,0.0031874313,0.003002713,0.11106626,0.00009397476,0.06158196,0.000020185118,0.071334675,0.3170425],"study_design_scores_gemma":[0.41050848,0.09661481,0.4077489,0.00031408694,0.0011087464,0.0000548599,0.006377992,0.0006758978,0.063391745,0.0001719691,0.012486577,0.0005459048],"about_ca_topic_score_codex":0.02496044,"about_ca_topic_score_gemma":0.0021490406,"teacher_disagreement_score":0.3706694,"about_ca_system_score_codex":0.00014200846,"about_ca_system_score_gemma":0.00061898364,"threshold_uncertainty_score":0.98153245},"labels":[],"label_agreement":null},{"id":"W4246866429","doi":"10.1371/annotation/4a6a7d2c-e898-481c-b1e1-f6f1ad7fc6e2","title":"Correction: The Physical Interaction of Myoblasts with the Microenvironment during Remodeling of the Cytoarchitecture","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Fonds Québécois de la Recherche sur la Nature et les Technologies; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Cytoarchitecture; Myocyte; Cell biology; Biology; Neuroscience; Computational biology","score_opus":0.01744442296971446,"score_gpt":0.23430797532081385,"score_spread":0.2168635523510994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246866429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945429,0.000056311535,0.000009843678,0.004472681,0.000057862475,0.00042717933,0.0000013332447,0.0000061013247,0.00042582018],"genre_scores_gemma":[0.9981474,0.000022429593,0.000030448358,0.00012463419,0.00017987734,0.000040249888,9.985207e-7,0.000007528529,0.0014464073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99958026,0.000035843677,0.00008170837,0.000077666205,0.00015253366,0.00007198102],"domain_scores_gemma":[0.99963164,0.000071483846,0.00008216324,0.00017070939,0.000029581559,0.0000144364585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000025472164,0.00006122871,0.000116199946,0.000011812344,0.000060400234,0.000003073742,0.00005915993,0.00001524679,0.000103107544],"category_scores_gemma":[0.000005595792,0.000023935001,0.00004574024,0.000057617708,0.00010953369,0.000021351085,0.000029843546,0.00018015923,0.0000058468604],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043248438,0.0009170987,0.00831398,0.00006282194,0.00035911344,3.7672e-7,0.0020563323,0.0008314802,0.9858164,0.0000015244867,0.00024949713,0.00095887703],"study_design_scores_gemma":[0.00088918355,0.00033378956,0.11339484,0.00023106509,0.0004710342,0.000020047855,0.0002893799,0.0041326354,0.8801201,0.000012490515,0.00006857701,0.00003688386],"about_ca_topic_score_codex":0.000076219694,"about_ca_topic_score_gemma":0.00001987336,"teacher_disagreement_score":0.10569634,"about_ca_system_score_codex":0.000045288165,"about_ca_system_score_gemma":0.00001239307,"threshold_uncertainty_score":0.11289553},"labels":[],"label_agreement":null},{"id":"W4246954367","doi":"10.1515/iupac.84.1027","title":"Phytohemagglutinin (PHA)","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Immunotoxicology; Immunology; Medicine; Immune system; Philosophy; Linguistics","score_opus":0.022622351271312638,"score_gpt":0.4702252628590205,"score_spread":0.4476029115877079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246954367","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002392732,0.0028526564,0.000011089908,0.003098241,0.0014331779,0.00053811265,0.9912375,0.00009356208,0.0004963376],"genre_scores_gemma":[0.000045877296,0.003044157,0.00003672502,0.0014916168,0.0034415785,0.000043282962,0.9860438,0.000051305586,0.0058016297],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977021,0.00005401703,0.00042105807,0.0005438412,0.00077914656,0.00049979676],"domain_scores_gemma":[0.99838316,0.000073373834,0.00022410307,0.0006790129,0.0003426656,0.00029767232],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023826791,0.0004799274,0.000968259,0.00022844208,0.00007319431,0.00001602376,0.00018750058,0.00041143852,0.022670615],"category_scores_gemma":[0.00014384747,0.0003344781,0.0002888248,0.00016772392,0.00017112943,0.000042507327,0.000104409766,0.0004956843,0.000017660943],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012844314,0.00077292934,0.000052986485,0.00023834786,0.0003460916,0.00051698665,0.000007745722,5.0333007e-8,0.00008612554,0.0000027010187,0.98983765,0.0068539716],"study_design_scores_gemma":[0.006019821,0.0011858684,0.00011258267,0.0004865543,0.0010570775,0.00013626281,0.0000058853743,6.621797e-7,0.00015772122,0.000044958135,0.99046326,0.00032932393],"about_ca_topic_score_codex":0.00008091358,"about_ca_topic_score_gemma":0.00032474147,"teacher_disagreement_score":0.022652956,"about_ca_system_score_codex":0.0006980653,"about_ca_system_score_gemma":0.0014638691,"threshold_uncertainty_score":0.9999107},"labels":[],"label_agreement":null},{"id":"W4247460059","doi":"10.1186/isrctn83324925","title":"A Randomised Comparative Trial of Infusional ECF versus Conventional FEC as Adjuvant Chemotherapy in Patients with Poor Prognosis Breast Cancer","year":2013,"lang":"en","type":"dataset","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research","keywords":"Medicine; Oncology; Adjuvant; Chemotherapy; Breast cancer; Internal medicine; Adjuvant chemotherapy; Randomized controlled trial; Cancer","score_opus":0.027790521497617196,"score_gpt":0.3443023051578943,"score_spread":0.3165117836602771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247460059","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30018294,0.0000844668,1.4126823e-7,0.0005358532,0.00060349127,0.004978453,0.6933802,0.000009702289,0.00022478573],"genre_scores_gemma":[0.028270764,0.00026803327,0.000035857403,0.0004765395,0.00033779658,0.0018419585,0.9681898,0.000019179111,0.00056011043],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99835545,0.00008713754,0.00048098926,0.00034565877,0.0005019945,0.00022877129],"domain_scores_gemma":[0.99890035,0.00018644841,0.0003652598,0.00013911299,0.0002821425,0.00012665476],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008038813,0.00033903643,0.0011037695,0.00020359208,0.000028298358,0.000008305349,0.000104153645,0.00019573694,0.031842627],"category_scores_gemma":[0.000007284028,0.00022267591,0.00017493531,0.00017037336,0.00015749881,0.000055606277,0.00003037536,0.00025688854,0.00005586563],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.470224,0.00288466,0.0021481032,0.000059756705,0.0009036945,0.000003942908,0.000022168093,6.405544e-7,0.000004373629,0.0000015800917,0.5234782,0.00026888557],"study_design_scores_gemma":[0.85691315,0.0051438594,0.026935682,0.0002534985,0.00077498687,0.0000027340598,0.000018644207,0.000007667828,0.00008233236,0.0000019965366,0.10964456,0.00022086786],"about_ca_topic_score_codex":0.003757048,"about_ca_topic_score_gemma":0.00094786094,"teacher_disagreement_score":0.41383362,"about_ca_system_score_codex":0.00024987667,"about_ca_system_score_gemma":0.00085091434,"threshold_uncertainty_score":0.9690424},"labels":[],"label_agreement":null},{"id":"W4247634389","doi":"10.1016/j.jcjd.2013.07.028","title":"Neuropathie","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology; Medical screening","score_opus":0.013318773781377139,"score_gpt":0.2442167782382103,"score_spread":0.23089800445683317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247634389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98940176,0.0015640013,4.7030065e-7,0.0043860455,0.00044270445,0.00007354641,0.000002458077,0.0000027236467,0.0041262973],"genre_scores_gemma":[0.99669254,0.000007950645,0.00006734385,0.0021846204,0.00032594692,0.0000024072422,0.0000011917853,0.000008167136,0.00070986286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957454,0.00001616459,0.00013195165,0.000040732964,0.000050234234,0.00018639328],"domain_scores_gemma":[0.9991284,0.000028093003,0.000056797806,0.000053549385,0.00012506855,0.00060810696],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000049567258,0.00005332431,0.00014480451,0.00014774015,0.000031293144,0.0000158985,0.000048562542,0.000026337239,0.0028308204],"category_scores_gemma":[0.000039608443,0.000041662355,0.00006638275,0.000072181334,0.000044584845,0.00007039349,0.0000018901371,0.00011789918,0.00011305158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002274093,0.000028433218,0.86291605,0.000019459341,0.00011123008,0.00012535408,0.00013845533,0.0000019093507,0.0071936417,0.000040441937,0.11030537,0.019117374],"study_design_scores_gemma":[0.0015909809,0.0010848839,0.90731263,0.000066961,0.00019359824,0.00007351706,0.000042418775,0.00002633806,0.003848504,0.0004242437,0.08524388,0.00009206147],"about_ca_topic_score_codex":0.00045419074,"about_ca_topic_score_gemma":0.00064165815,"teacher_disagreement_score":0.044396553,"about_ca_system_score_codex":0.00006544189,"about_ca_system_score_gemma":0.0005636515,"threshold_uncertainty_score":0.99808073},"labels":[],"label_agreement":null},{"id":"W4247765498","doi":"10.1200/jco.2017.35.15_suppl.tps1107","title":"A randomized, double-blinded, controlled study of tucatinib (ONT-380) vs. placebo in combination with capecitabine (C) and trastuzumab (Tz) in patients with pretreated HER2+ unresectable locally advanced or metastatic breast carcinoma (mBC) (HER2CLIMB).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Capecitabine; Internal medicine; Rash; Taxane; Oncology; Placebo; Adverse effect; Trastuzumab; Pertuzumab; Population; Gastroenterology; Cancer; Breast cancer; Colorectal cancer; Pathology","score_opus":0.07203960633910661,"score_gpt":0.4295408083241917,"score_spread":0.3575012019850851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247765498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99254936,0.00015183755,0.000017430217,0.0011812049,0.00024324554,0.005277979,0.0000071567706,0.0000054100346,0.0005663729],"genre_scores_gemma":[0.99872386,0.00011842546,0.0005116139,0.00013209545,0.000069213536,0.00019410913,0.0000074394306,0.00002899553,0.00021422678],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99488443,0.0011822733,0.002748153,0.00034652677,0.0004990105,0.00033959723],"domain_scores_gemma":[0.9916674,0.003506845,0.0034634878,0.00028874812,0.0007934454,0.00028007012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003193868,0.00030636706,0.0046573584,0.0003665458,0.00007103261,0.000021853946,0.00020771132,0.00019519367,0.00012509555],"category_scores_gemma":[0.0011090755,0.00016781103,0.00018110413,0.0002173466,0.00044280043,0.00027635228,0.000047563066,0.00081495795,8.201924e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5721872,0.019302819,0.39923316,0.000045413184,0.0010006974,0.00044577717,0.00046562823,0.00006365635,0.000004119133,0.0000039333286,0.00001692442,0.0072307037],"study_design_scores_gemma":[0.5268527,0.06520229,0.40585265,0.0001652423,0.0011575607,0.00009534903,0.00038580445,0.00016918627,0.000008094498,0.000011451225,0.000013627185,0.00008599608],"about_ca_topic_score_codex":0.0009898867,"about_ca_topic_score_gemma":0.012532222,"teacher_disagreement_score":0.045899466,"about_ca_system_score_codex":0.00033382117,"about_ca_system_score_gemma":0.001781914,"threshold_uncertainty_score":0.6993274},"labels":[],"label_agreement":null},{"id":"W4247767630","doi":"10.1515/iupac.79.1688","title":"Neuropathy","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glossary; Chemical nomenclature; Computer science; Toxicology; Library science; Chemistry; Philosophy; Biology; Linguistics; Organic chemistry","score_opus":0.019746120641801,"score_gpt":0.45738067472048716,"score_spread":0.4376345540786862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247767630","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030544458,0.0016926057,0.000006447868,0.002562054,0.0015399691,0.0004116947,0.99317765,0.000074604344,0.00022954184],"genre_scores_gemma":[0.000024675137,0.0036047362,0.000011651505,0.0019992013,0.002653041,0.000023820356,0.98833466,0.000042840904,0.0033053875],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982232,0.00005693181,0.0003136488,0.00043628892,0.0006073732,0.00036254703],"domain_scores_gemma":[0.99871063,0.000052051688,0.00014721564,0.0005780267,0.00026925857,0.00024282695],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015624019,0.00036874102,0.0006917417,0.00019084135,0.00005598818,0.000013655125,0.00014934805,0.00027105206,0.014685889],"category_scores_gemma":[0.00012401116,0.00024999035,0.00021575863,0.0001252277,0.00011772751,0.000031049243,0.00008711584,0.0004196253,0.000012507652],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010292332,0.0005557081,0.00004050883,0.00015943387,0.0001580271,0.0009754222,0.000004721359,4.6039595e-8,0.00007283894,0.0000013956311,0.99118847,0.0058141733],"study_design_scores_gemma":[0.003898755,0.0013108007,0.00013101297,0.0002467769,0.0008357005,0.00015938644,0.0000025537745,5.461277e-7,0.00004558205,0.000020583058,0.9931161,0.0002322027],"about_ca_topic_score_codex":0.00007144299,"about_ca_topic_score_gemma":0.0001764954,"teacher_disagreement_score":0.014673381,"about_ca_system_score_codex":0.00044180677,"about_ca_system_score_gemma":0.0010299038,"threshold_uncertainty_score":0.99999523},"labels":[],"label_agreement":null},{"id":"W4248036055","doi":"10.1016/b978-0-12-386454-3.00419-x","title":"Pharmacokinetics","year":2014,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Intrinsik (Canada)","funders":"","keywords":"Xenobiotic; ADME; Pharmacokinetics; Biotransformation; Distribution (mathematics); Chemistry; Computational biology; Pharmacology; Biology; Mathematics; Biochemistry","score_opus":0.023453847220345492,"score_gpt":0.30453725080683064,"score_spread":0.28108340358648515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248036055","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052999367,0.0022171417,0.0000023166174,0.00035246045,0.0008357531,0.0006349031,0.000025157637,0.00010029245,0.995779],"genre_scores_gemma":[0.0012106377,0.0005453693,0.00013721325,0.0033358254,0.0019872112,0.000036740934,0.000087512686,0.000114017275,0.9925455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988457,0.000012321535,0.00030185556,0.00035804894,0.00023199081,0.0002500763],"domain_scores_gemma":[0.99916583,0.000045078254,0.00014544836,0.00034829264,0.00008292431,0.00021244468],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000078367746,0.00038183818,0.0006406092,0.00012921644,0.000045684053,0.000009895355,0.00009944435,0.00028452542,0.004403802],"category_scores_gemma":[0.0000033534227,0.0003351777,0.00029131697,0.0000062306335,0.00012113232,0.0000056174786,0.000056577097,0.00046714084,0.0009835273],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012445272,0.000017219681,0.000013159024,0.00015460457,0.00042234422,0.00014789884,0.000046381778,1.0838077e-7,0.0002860633,0.0018379827,0.0118218735,0.9851279],"study_design_scores_gemma":[0.001887455,0.0003553441,0.000016032067,0.00021235297,0.0016174179,0.00010449815,4.4554116e-7,0.0000049943324,0.00039986582,0.0011810019,0.9939447,0.00027586948],"about_ca_topic_score_codex":2.4177743e-7,"about_ca_topic_score_gemma":0.0000035417565,"teacher_disagreement_score":0.984852,"about_ca_system_score_codex":0.00012223484,"about_ca_system_score_gemma":0.00013297587,"threshold_uncertainty_score":0.99991},"labels":[],"label_agreement":null},{"id":"W4248055982","doi":"10.1515/iupac.87.0437","title":"Neurofibroma","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Chemical nomenclature; Relation (database); Computer science; Psychology; Chemistry; Linguistics; Philosophy; Data mining; Organic chemistry","score_opus":0.02020853640667629,"score_gpt":0.4585340919253211,"score_spread":0.43832555551864477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248055982","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043531117,0.0014665221,0.0000049389137,0.0031751296,0.0014096267,0.00043612436,0.9927507,0.000080381185,0.00024128053],"genre_scores_gemma":[0.000022107972,0.002370137,0.000016405293,0.0015370375,0.0023714635,0.000024446092,0.98939335,0.000043435466,0.0042216345],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981673,0.000050360664,0.0003224823,0.000450143,0.00062778796,0.0003819456],"domain_scores_gemma":[0.9986931,0.000058028847,0.00015024895,0.00059886154,0.00024473143,0.00025500287],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012547178,0.0003846262,0.0007250179,0.00019669566,0.00005777645,0.00001464829,0.00015352035,0.0003177271,0.017784216],"category_scores_gemma":[0.000099622994,0.00026315774,0.00022807888,0.0001294909,0.00012313735,0.000035351466,0.000090336376,0.00038640303,0.000012192957],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011849884,0.00048047112,0.00004445759,0.00020597487,0.00021191848,0.0007556866,0.000003624256,3.659238e-8,0.00011794115,0.0000017632383,0.993264,0.0037291339],"study_design_scores_gemma":[0.0041423338,0.001494289,0.00020444402,0.0002970812,0.00082806865,0.00017626406,0.0000023413663,4.7004278e-7,0.0000716322,0.000026487782,0.9925139,0.0002426661],"about_ca_topic_score_codex":0.00009319051,"about_ca_topic_score_gemma":0.00018060929,"teacher_disagreement_score":0.017772023,"about_ca_system_score_codex":0.00044819067,"about_ca_system_score_gemma":0.001061519,"threshold_uncertainty_score":0.99998206},"labels":[],"label_agreement":null},{"id":"W4248196662","doi":"10.1021/np020361n","title":"New Taxanes from the Needles of <i>Taxus canadensis</i>","year":2003,"lang":"en","type":"article","venue":"Journal of Natural Products","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de la Recherche Scientifique; McGill University; Queen's University; Université du Québec à Montréal","funders":"","keywords":"Taxane; Chemistry; Stereochemistry; Biology; Cancer; Genetics; Breast cancer","score_opus":0.017772080633307246,"score_gpt":0.2776186363002226,"score_spread":0.25984655566691534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248196662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93442637,0.04022372,0.0000017946687,0.022467224,0.0020803914,0.00014871592,0.0000048608936,0.000003877211,0.000643052],"genre_scores_gemma":[0.9936067,0.00034933936,0.001071538,0.0009931726,0.0013166964,2.8804988e-7,0.0000024477836,0.0000075782814,0.00265223],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992605,0.000053653366,0.000262226,0.00008389214,0.00021908668,0.00012068628],"domain_scores_gemma":[0.9991242,0.00011066225,0.000295442,0.00012631356,0.00026588415,0.00007746736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013969254,0.00009001424,0.0002696309,0.000044767763,0.000030313166,0.0000060269745,0.00008592891,0.0000360435,0.00014411102],"category_scores_gemma":[0.00031615808,0.000047699392,0.00008594832,0.00018342987,0.00003997083,0.000063363674,0.000008147443,0.00028808028,0.0000028217412],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000861061,0.00014125502,0.010285269,0.000034903118,0.00062131055,0.00020668935,0.001043301,0.000008262956,0.29724127,0.00010559681,0.67926294,0.0101881595],"study_design_scores_gemma":[0.0050278315,0.00077484926,0.05501104,0.00016165573,0.0010916501,0.0015286653,0.00044809814,0.0000019664722,0.587492,0.00062645937,0.34769207,0.0001437269],"about_ca_topic_score_codex":0.0009984473,"about_ca_topic_score_gemma":0.00014700502,"teacher_disagreement_score":0.33157083,"about_ca_system_score_codex":0.000055483793,"about_ca_system_score_gemma":0.0005321172,"threshold_uncertainty_score":0.19451247},"labels":[],"label_agreement":null},{"id":"W4248288235","doi":"10.1002/jcph.70","title":"Issue Information","year":2013,"lang":"en","type":"paratext","venue":"The Journal of Clinical Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Impact","funders":"","keywords":"Citation; Computer science; Information retrieval; World Wide Web","score_opus":0.07487596288625405,"score_gpt":0.4982250255603367,"score_spread":0.4233490626740827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248288235","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11281134,0.023783745,0.0002707632,0.12401096,0.30469117,0.0037014917,0.0001715668,0.000046426823,0.43051252],"genre_scores_gemma":[0.043188803,0.115968086,0.0003808298,0.12498387,0.085283086,0.00005407141,0.00024873004,0.00010104698,0.6297915],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961542,0.00077420345,0.0023404125,0.000099823956,0.0003287312,0.00030265824],"domain_scores_gemma":[0.994656,0.0017057518,0.0024447779,0.00018623337,0.00068953214,0.00031768548],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0016834268,0.00027119534,0.0014473659,0.00020235976,0.00006909346,0.000014016254,0.00040276418,0.0005648856,0.09370755],"category_scores_gemma":[0.00015038344,0.0001503282,0.00057072175,0.00014300473,0.00033057661,0.00022819494,0.00009132256,0.0024256248,0.029912995],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033694038,0.00038264663,0.000052817075,0.0001094276,0.0015207846,0.000022720367,0.00012491441,0.000035480225,0.0002282893,0.0000015455105,0.97699004,0.017161949],"study_design_scores_gemma":[0.00722751,0.0030278498,0.00059093226,0.00006208321,0.0032993625,0.0004811278,0.000034937813,0.000041728326,0.00049460994,0.000024595482,0.9845948,0.00012045241],"about_ca_topic_score_codex":0.000026443497,"about_ca_topic_score_gemma":8.050566e-7,"teacher_disagreement_score":0.2194081,"about_ca_system_score_codex":0.00010324807,"about_ca_system_score_gemma":0.0010109168,"threshold_uncertainty_score":0.99987584},"labels":[],"label_agreement":null},{"id":"W4248674962","doi":"10.21203/rs.2.11805/v1","title":"The efficacy and safety of acupuncture for alleviating chemotherapy-induced peripheral neuropathy in colorectal cancer patients: study protocol for a pilot single-blinded, randomized sham-controlled trial","year":2019,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Hospital Authority; Hong Kong Baptist University","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Acupuncture; Colorectal cancer; Randomized controlled trial; Chemotherapy; Protocol (science); Cancer; Internal medicine; Oncology; Peripheral; Physical therapy; Alternative medicine; Pathology","score_opus":0.11118557132805269,"score_gpt":0.47289813011174675,"score_spread":0.36171255878369407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248674962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50919604,0.000078032026,0.000007697145,0.0005422371,0.0002339903,0.48982063,0.000052777392,0.000014060023,0.000054547734],"genre_scores_gemma":[0.5042892,0.000028127964,0.000022749115,0.000029152416,0.00040626968,0.4950322,0.000033701694,0.000049214486,0.000109421606],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99499375,0.0017047642,0.0011035887,0.000770372,0.0007580863,0.0006694129],"domain_scores_gemma":[0.98975986,0.0081659695,0.00052710954,0.00033839326,0.0010812574,0.00012741717],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0040491326,0.00052563485,0.0025787551,0.00026130502,0.00025252532,0.00008690411,0.00027177433,0.00026619417,0.000065629734],"category_scores_gemma":[0.0027014094,0.00026049282,0.0005629047,0.0002163687,0.00017786639,0.00003972502,0.00022076863,0.0009910628,3.3418505e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9775423,0.0074481815,0.0021595526,0.0014016954,0.0011331125,0.000003196058,0.0030284014,0.000043257518,0.0018294163,0.000005153594,0.00016924969,0.0052365023],"study_design_scores_gemma":[0.95709294,0.03684571,0.0023167592,0.0005574316,0.00031227706,5.0334756e-7,0.00031687255,0.0013695792,0.0005798088,0.000046072262,0.00036642305,0.00019559907],"about_ca_topic_score_codex":0.00031361982,"about_ca_topic_score_gemma":0.00047728128,"teacher_disagreement_score":0.029397527,"about_ca_system_score_codex":0.00059768785,"about_ca_system_score_gemma":0.001138405,"threshold_uncertainty_score":0.99998474},"labels":[],"label_agreement":null},{"id":"W4248712378","doi":"10.2165/00128413-200515060-00051","title":"Safety updates to Canadian labelling for Duragesic","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Labelling; Medicine; Pharmacy; Medical emergency; Family medicine; Criminology; Psychology","score_opus":0.02394607577086246,"score_gpt":0.3393357333737358,"score_spread":0.31538965760287335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248712378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7354955,0.0015931283,0.00033315184,0.23802285,0.0011204424,0.002267177,0.0003426998,0.00018507574,0.020639988],"genre_scores_gemma":[0.961655,0.000086361215,0.0023624017,0.02247661,0.001315806,0.00012398743,0.00011535383,0.00003250989,0.011831963],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911976,0.000012706321,0.00018047138,0.0002117146,0.00007995604,0.0003954086],"domain_scores_gemma":[0.9992224,0.0000625953,0.000025613055,0.00012328694,0.00008066996,0.00048545783],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000107718326,0.00013042781,0.00019846663,0.00015341995,0.00011750203,0.000012764475,0.00007587857,0.000053576397,0.0018451003],"category_scores_gemma":[0.000017719549,0.00012277786,0.00007110157,0.00014976675,0.000017358947,0.000060563965,0.000011997696,0.00009599852,0.00051055715],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013749792,0.00025820584,0.0046583093,0.000076357406,0.00032370092,0.00010422281,0.0008582624,0.00027999142,0.04311016,0.0003369931,0.84337586,0.10524296],"study_design_scores_gemma":[0.0029060624,0.00024207338,0.0022792532,0.000018762734,0.00015836893,0.00002943339,0.000025638212,0.00034154806,0.02560659,0.000023696322,0.96823645,0.0001321076],"about_ca_topic_score_codex":0.0068078693,"about_ca_topic_score_gemma":0.025523786,"teacher_disagreement_score":0.22615953,"about_ca_system_score_codex":0.00040171377,"about_ca_system_score_gemma":0.00028671572,"threshold_uncertainty_score":0.99980587},"labels":[],"label_agreement":null},{"id":"W4249072217","doi":"10.1200/jco.2012.30.27_suppl.125","title":"BOLERO-2: Health-related quality-of-life (HRQoL) in metastatic breast cancer patients treated with everolimus and exemestane versus exemestane.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cambridge Memorial Hospital","funders":"","keywords":"Medicine; Exemestane; Internal medicine; Breast cancer; Hazard ratio; Aromatase inhibitor; Everolimus; Placebo; Oncology; Clinical endpoint; Quality of life (healthcare); Proportional hazards model; Interim analysis; Cancer; Randomized controlled trial; Confidence interval; Aromatase; Pathology","score_opus":0.21684305128424827,"score_gpt":0.5177775195784704,"score_spread":0.3009344682942221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249072217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98961073,0.0039508524,0.0000029436453,0.0045801713,0.0010136723,0.00038549496,0.000027475035,0.000007848887,0.00042080277],"genre_scores_gemma":[0.99508667,0.0028758908,0.00042067116,0.00121658,0.0002471402,0.000011416506,0.00001216988,0.00002256059,0.00010687733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99499464,0.0009863818,0.003047801,0.00018728344,0.00036191804,0.0004220006],"domain_scores_gemma":[0.9939453,0.0021139386,0.002669023,0.00012781986,0.00035774856,0.0007861887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002448508,0.00020750366,0.002373634,0.00020107829,0.00003208539,0.0000031759087,0.000085054344,0.00021711871,0.00034972356],"category_scores_gemma":[0.0005600191,0.00013867255,0.00019769851,0.0002886902,0.00027883166,0.00017388102,0.000030561667,0.00072132837,0.0000035916144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06179852,0.00634926,0.8953944,0.000102815335,0.0011069628,0.00009721019,0.00038523058,0.00000683371,0.000030422027,0.000039953473,0.00088354194,0.033804867],"study_design_scores_gemma":[0.05873028,0.01917427,0.9186315,0.00014847674,0.0007101568,0.00014155926,0.00013986089,0.000013848052,0.000010267305,0.000014674669,0.0021727497,0.000112373295],"about_ca_topic_score_codex":0.0012831542,"about_ca_topic_score_gemma":0.00075108936,"teacher_disagreement_score":0.033692494,"about_ca_system_score_codex":0.00041026445,"about_ca_system_score_gemma":0.0018591387,"threshold_uncertainty_score":0.56549025},"labels":[],"label_agreement":null},{"id":"W4249137086","doi":"10.1097/fpc.0b013e3283335277","title":"Taxane pathway","year":2009,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"National Institute of General Medical Sciences","keywords":"Taxane; Biology; Genetics; Cancer; Breast cancer","score_opus":0.01899387428273902,"score_gpt":0.3110434663305991,"score_spread":0.2920495920478601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249137086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98587286,0.0057022013,0.0000478626,0.002169337,0.00017201502,0.00023041316,0.00001785138,0.000029099287,0.0057583763],"genre_scores_gemma":[0.9878217,0.005315495,0.0009889537,0.0042673727,0.00034634626,0.0000052169275,0.000020346872,0.000010817285,0.0012237323],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994705,0.000009150832,0.00012016301,0.00016446415,0.000059294503,0.00017645487],"domain_scores_gemma":[0.99967515,0.000011560327,0.000031699354,0.00008486666,0.000027705146,0.00016898723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045831897,0.000108989196,0.00015059185,0.000042359654,0.000051199702,0.000011003411,0.000033289885,0.0000373235,0.00018584376],"category_scores_gemma":[0.0000019458666,0.00009967172,0.000043053507,0.00005365546,0.000030138623,0.000012372047,0.000015107898,0.000078686324,0.00002134567],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003072556,0.00030956438,0.0033175787,0.000019625262,0.00010333841,0.000086833155,0.00023951539,0.000019314699,0.6719213,0.0002411096,0.0034607768,0.31997377],"study_design_scores_gemma":[0.005567659,0.0011951316,0.021974606,0.000009015779,0.00042297793,0.00026578788,0.000026209738,0.0010287721,0.2756873,0.00072507653,0.6928252,0.00027224774],"about_ca_topic_score_codex":0.000003661662,"about_ca_topic_score_gemma":0.0000010553649,"teacher_disagreement_score":0.68936443,"about_ca_system_score_codex":0.00003318521,"about_ca_system_score_gemma":0.000054461005,"threshold_uncertainty_score":0.40644947},"labels":[],"label_agreement":null},{"id":"W4249550597","doi":"10.1515/iupac.76.0106","title":"Active Metabolite","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glossary; Toxicokinetics; Relation (database); Toxicology; Computer science; Medicine; Pharmacology; Biology; Data mining; Linguistics; Philosophy","score_opus":0.020066851033998818,"score_gpt":0.4712057248539894,"score_spread":0.4511388738199906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249550597","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019485342,0.003315594,0.000007190148,0.0021241398,0.001246957,0.00054376805,0.99218345,0.000063171836,0.00032089418],"genre_scores_gemma":[0.000017754895,0.005495754,0.000023211673,0.0012720682,0.0026204693,0.000046083787,0.986624,0.000040107647,0.0038605349],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980632,0.00006301259,0.00032156945,0.0004715918,0.0006684314,0.00041216862],"domain_scores_gemma":[0.99851525,0.00006705046,0.0001936438,0.0005616075,0.0003966158,0.00026581666],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015988562,0.00042369793,0.00094940193,0.00023760478,0.00006234193,0.000013240467,0.00015070694,0.00034954923,0.015123569],"category_scores_gemma":[0.00011930753,0.00028260305,0.00027820352,0.00015458577,0.00014293312,0.000054883996,0.00008799534,0.00046531312,0.00000973539],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022734562,0.0005823319,0.000012619612,0.00012921767,0.0007073318,0.0003039121,0.000012982875,3.5954063e-8,0.00009531285,0.000004324348,0.98120594,0.014672522],"study_design_scores_gemma":[0.0050318833,0.0006948744,0.00019197418,0.0001995867,0.0019782356,0.0000703849,0.000009173723,2.6676932e-7,0.00030904062,0.00005210281,0.99119145,0.0002710323],"about_ca_topic_score_codex":0.00014760035,"about_ca_topic_score_gemma":0.00024750194,"teacher_disagreement_score":0.015113834,"about_ca_system_score_codex":0.00068954274,"about_ca_system_score_gemma":0.0013403739,"threshold_uncertainty_score":0.9999626},"labels":[],"label_agreement":null},{"id":"W4249976545","doi":"10.1515/iupac.78.0472","title":"Pharmacodynamics","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Glossary; Computer science; Chemical nomenclature; Management science; Data science; Chemistry; Engineering","score_opus":0.01873516103566293,"score_gpt":0.47759721047744524,"score_spread":0.4588620494417823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249976545","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027926484,0.0018746104,0.00001914879,0.002453312,0.0017630215,0.0005249029,0.9927455,0.000089953515,0.00025029204],"genre_scores_gemma":[0.000023380195,0.007000092,0.00002584602,0.0017313648,0.0026409414,0.000033549768,0.9845127,0.000049858234,0.0039822767],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99798,0.000047318143,0.0003769746,0.00046421116,0.0006946805,0.00043679966],"domain_scores_gemma":[0.9986123,0.0000559304,0.00018398695,0.0005172751,0.00033714666,0.00029338337],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019019425,0.0004420865,0.00078875985,0.00023045122,0.00006770175,0.000015390742,0.00018123552,0.0003498076,0.02019907],"category_scores_gemma":[0.000069236485,0.00031176384,0.00026195592,0.0001492342,0.00014256228,0.000042187803,0.00009615513,0.0005161252,0.000010389855],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012888425,0.00073110906,0.000028655939,0.00024264897,0.00042797052,0.0005503201,0.0000051041134,2.0961727e-7,0.00011699673,0.0000022030838,0.98958063,0.00702528],"study_design_scores_gemma":[0.005931201,0.0007449985,0.000033945333,0.00028776933,0.0014816002,0.00013201729,0.0000036724548,0.0000065488593,0.00005378218,0.000029107909,0.9909879,0.00030745007],"about_ca_topic_score_codex":0.00008595485,"about_ca_topic_score_gemma":0.00028294948,"teacher_disagreement_score":0.02018868,"about_ca_system_score_codex":0.00095498736,"about_ca_system_score_gemma":0.0013621189,"threshold_uncertainty_score":0.9999334},"labels":[],"label_agreement":null},{"id":"W4250262361","doi":"10.1186/isrctn12237417","title":"Venlafaxine and gabapentin for the management of hot flashes in breast cancer survivors: a randomized crossover trial","year":2013,"lang":"en","type":"dataset","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Cancer Society","keywords":"Venlafaxine; Gabapentin; Crossover study; Randomized controlled trial; Medicine; Breast cancer; Oncology; Internal medicine; Anesthesia; Cancer; Antidepressant; Alternative medicine; Placebo","score_opus":0.02545339971309443,"score_gpt":0.34835253991839926,"score_spread":0.32289914020530486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250262361","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010077802,0.0029712156,0.0000061199,0.001940211,0.0012554833,0.0102603575,0.97330433,0.000010371265,0.00017408501],"genre_scores_gemma":[0.0020714994,0.03821186,0.00011667523,0.0008824982,0.0012080298,0.010705982,0.93226284,0.000048154605,0.014492471],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99881333,0.00006839717,0.00045111348,0.00027727007,0.00016720677,0.00022265618],"domain_scores_gemma":[0.9988624,0.0005668011,0.0002095068,0.00025355705,0.000056870467,0.00005090561],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004079076,0.0002442636,0.0010506564,0.00010261028,0.000033190252,0.00002086898,0.0001136203,0.00013123885,0.00519344],"category_scores_gemma":[0.0000092629125,0.00013313102,0.00021254049,0.00009751785,0.00017106552,0.00003158775,0.000079746744,0.00014004126,0.000010408797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42606977,0.00022461828,0.000013124225,0.00052534614,0.001143018,0.000006449161,0.000016630602,5.474803e-7,0.000003776854,0.000008720083,0.57126766,0.00072033313],"study_design_scores_gemma":[0.5589322,0.00012185221,0.00026168054,0.0001597092,0.002113382,0.000004978779,0.00002009393,0.00002471394,0.00001379334,0.000012855517,0.43824482,0.00008995183],"about_ca_topic_score_codex":0.0190641,"about_ca_topic_score_gemma":0.0046654264,"teacher_disagreement_score":0.13302283,"about_ca_system_score_codex":0.00007286913,"about_ca_system_score_gemma":0.00006997748,"threshold_uncertainty_score":0.995716},"labels":[],"label_agreement":null},{"id":"W4250599156","doi":"10.1200/jco.2012.30.18_suppl.lba671","title":"Open-label phase III randomized controlled trial comparing taxane-based chemotherapy (Tax) with lapatinib (L) or trastuzumab (T) as first-line therapy for women with HER2+ metastatic breast cancer: Interim analysis (IA) of NCIC CTG MA.31/GSK EGF 108919.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; BC Cancer Agency; Interior Health; Ottawa Hospital; Hamilton Health Sciences; University of Toronto","funders":"","keywords":"Medicine; Docetaxel; Metastatic breast cancer; Internal medicine; Taxane; Clinical endpoint; Trastuzumab; Lapatinib; Breast cancer; Oncology; Pertuzumab; Interim analysis; Surgery; Chemotherapy; Cancer; Randomized controlled trial","score_opus":0.17811336086588878,"score_gpt":0.5349206746260675,"score_spread":0.3568073137601787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250599156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98205435,0.00070023106,0.002573482,0.005142067,0.0007211114,0.008425652,0.00006130563,0.000013467371,0.0003083396],"genre_scores_gemma":[0.98790944,0.0011820191,0.004144889,0.0025289946,0.0011697647,0.0021687117,0.00002446388,0.000056736197,0.0008149933],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9930134,0.001275507,0.0042184866,0.00036505834,0.00051759306,0.0006099977],"domain_scores_gemma":[0.9831392,0.008726741,0.0063419775,0.0002936758,0.0008214707,0.00067689025],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0078026266,0.00047134038,0.011557043,0.00039839002,0.000096005446,0.000028685366,0.00042253383,0.00024317672,0.002797169],"category_scores_gemma":[0.0006000467,0.00023893538,0.0010315706,0.00056513725,0.0005272892,0.0002245381,0.000033775967,0.00065084867,0.0000017234495],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8905068,0.040001653,0.001997892,0.00007456607,0.03872723,0.00009661402,0.0005549273,0.00014973045,0.00025273635,0.0000066575058,0.00045477608,0.027176436],"study_design_scores_gemma":[0.8526409,0.12647872,0.0005807919,0.00013942113,0.014728511,0.00016743883,0.00020299929,0.0014783831,0.00034191433,0.000019382729,0.0030004352,0.00022105951],"about_ca_topic_score_codex":0.00029067363,"about_ca_topic_score_gemma":0.00056052534,"teacher_disagreement_score":0.08647706,"about_ca_system_score_codex":0.0005679249,"about_ca_system_score_gemma":0.0042346427,"threshold_uncertainty_score":0.9981144},"labels":[],"label_agreement":null},{"id":"W4250793702","doi":"10.1200/jco.2013.31.18_suppl.lba509","title":"Correlation of molecular alterations with efficacy of everolimus in hormone receptor–positive, HER2-negative advanced breast cancer: Results from BOLERO-2.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Exemestane; Medicine; Everolimus; PTEN; Oncology; Internal medicine; Breast cancer; Population; Progression-free survival; Hormone receptor; Cancer; Genetics; Tamoxifen; PI3K/AKT/mTOR pathway; Biology; Overall survival","score_opus":0.03618967590298205,"score_gpt":0.4164349621592653,"score_spread":0.38024528625628323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250793702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99086714,0.00044293542,0.00018786991,0.006715051,0.0004006325,0.00045849173,0.00010915673,0.000003684398,0.0008150546],"genre_scores_gemma":[0.994498,0.0011294716,0.0035309773,0.00044255465,0.0002662761,0.000014150546,0.000028768767,0.000012500633,0.000077276636],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970555,0.00038888262,0.0019834992,0.00018056226,0.00024194867,0.00014965057],"domain_scores_gemma":[0.9940572,0.002678241,0.0021642302,0.00012904982,0.0007945518,0.000176747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048541502,0.00013027806,0.0012024333,0.00013010048,0.000016347007,0.0000025498796,0.00008722794,0.00022414746,0.00024313608],"category_scores_gemma":[0.0005796069,0.00009373809,0.00019499045,0.00021981617,0.00022923344,0.00015525462,0.000020348225,0.00055785145,0.0000057341613],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26725113,0.020695772,0.22308268,0.00005243867,0.004125383,0.00045950053,0.0038499967,0.014927318,0.11197083,0.00011665556,0.008372405,0.3450959],"study_design_scores_gemma":[0.04521683,0.015198171,0.93356633,0.00030544456,0.000498222,0.000041366147,0.00012514052,0.00037411653,0.0040567094,0.00015515112,0.00037715607,0.00008535023],"about_ca_topic_score_codex":0.0014848944,"about_ca_topic_score_gemma":0.00029569693,"teacher_disagreement_score":0.7104837,"about_ca_system_score_codex":0.00020435931,"about_ca_system_score_gemma":0.00096753426,"threshold_uncertainty_score":0.38225284},"labels":[],"label_agreement":null},{"id":"W4251283077","doi":"10.4081/hpr.2013.1450","title":"Ten weeks of home-based exercise attenuates symptoms of chemotherapy-induced peripheral neuropathy in breast cancer patients","year":2013,"lang":"en","type":"article","venue":"Health psychology research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Quality of life (healthcare); Peripheral neuropathy; Physical therapy; Chemotherapy-induced peripheral neuropathy; Cancer; Analysis of variance; Chemotherapy; Internal medicine","score_opus":0.06070954127193492,"score_gpt":0.46254278573638935,"score_spread":0.40183324446445445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251283077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9615275,0.00051172863,3.8961326e-7,0.035866413,0.00023013816,0.001487,0.0000398409,0.000014741673,0.0003222047],"genre_scores_gemma":[0.9947606,0.0008241572,0.00003078524,0.0036128918,0.00007658129,0.00043742015,0.00002666519,0.000034101784,0.00019682528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757254,0.0004968994,0.00051345525,0.0003849582,0.0003618864,0.0006702555],"domain_scores_gemma":[0.9986867,0.00013366892,0.00015084626,0.0003373956,0.00045486935,0.0002365204],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006068913,0.00015210036,0.0005989688,0.00048054568,0.00006034901,0.000003551857,0.00016745123,0.00014836475,0.0018673989],"category_scores_gemma":[0.000014263461,0.00012685538,0.00007098524,0.0006518402,0.00027663904,0.00004485702,0.000029441882,0.0005798686,0.00002916837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026383854,0.0025082843,0.9170689,0.00037853906,0.00003843644,0.000006980323,0.00076039473,0.0000013407029,0.012268645,0.0000016826415,0.009570205,0.05475821],"study_design_scores_gemma":[0.010741939,0.0034385656,0.9840456,0.00022429661,0.000010050579,0.000005624397,0.000039544182,0.00007667409,0.0010397498,0.000020741005,0.00028053386,0.000076627475],"about_ca_topic_score_codex":0.0031760242,"about_ca_topic_score_gemma":0.0000787311,"teacher_disagreement_score":0.066976756,"about_ca_system_score_codex":0.00019713918,"about_ca_system_score_gemma":0.0005093809,"threshold_uncertainty_score":0.999045},"labels":[],"label_agreement":null},{"id":"W4252594977","doi":"10.1021/ol016581u","title":"Syn−Anti Isomerization of Aldols by Enolization","year":2001,"lang":"en","type":"article","venue":"Organic Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Keto–enol tautomerism; Isomerization; Chemistry; Adduct; Aldol reaction; Imidazole; Stereochemistry; Medicinal chemistry; Organic chemistry; Catalysis","score_opus":0.009603610595018474,"score_gpt":0.26401395046963094,"score_spread":0.2544103398746125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252594977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98677075,0.00014179325,0.0018402807,0.0105182035,0.00015138311,0.00016227283,0.000004445615,0.000032984848,0.00037789275],"genre_scores_gemma":[0.99456096,0.00028777297,0.000050196755,0.0044946875,0.00010710363,0.0000046625887,0.0001220681,0.000015296442,0.00035724934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99957144,0.00001506811,0.000119610195,0.0001038286,0.000086866,0.000103201215],"domain_scores_gemma":[0.9997843,0.000014280597,0.00005599387,0.00008924635,0.000021041944,0.000035146353],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000025403833,0.00006482141,0.00013109416,0.000047245107,0.000020064133,0.0000031428021,0.000030303281,0.0000337045,0.0014820579],"category_scores_gemma":[0.000009123064,0.00005975059,0.00002629235,0.00019931911,0.00002733022,0.000045361758,0.000007486903,0.000038587412,0.000041493717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036934085,0.00008967828,0.023457386,0.00001585283,0.000049812887,0.00000922172,0.0001359534,0.000002173649,0.9412867,0.000012134861,0.03410099,0.000803188],"study_design_scores_gemma":[0.0028091357,0.00019735131,0.013602674,0.000029093766,0.00023984387,0.000059277747,0.000027257194,0.000060081627,0.95294917,0.0000070596557,0.02990652,0.000112541245],"about_ca_topic_score_codex":0.000023155968,"about_ca_topic_score_gemma":0.0000019309184,"teacher_disagreement_score":0.011662487,"about_ca_system_score_codex":0.000057482895,"about_ca_system_score_gemma":0.00002250966,"threshold_uncertainty_score":0.9994307},"labels":[],"label_agreement":null},{"id":"W4252976727","doi":"10.1515/iupac.87.0266","title":"Giant Axonal Neuropathy","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Relation (database); Chemical nomenclature; Computer science; Psychology; Engineering ethics; Neuroscience; Chemistry; Linguistics; Engineering; Philosophy; Organic chemistry; Data mining","score_opus":0.020723497908299252,"score_gpt":0.44275415375141586,"score_spread":0.4220306558431166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252976727","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028384925,0.0018396474,0.000014545082,0.0036337606,0.001723657,0.00046468453,0.9917648,0.000071922375,0.00020312045],"genre_scores_gemma":[0.00003017862,0.0031740202,0.000026939188,0.002235468,0.0031731387,0.000030343006,0.9884874,0.000048215763,0.002794257],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977743,0.000071220304,0.00039044142,0.0005199963,0.00079928996,0.0004447615],"domain_scores_gemma":[0.99855393,0.00006724071,0.00018072377,0.00057885726,0.00031327194,0.00030598816],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020198611,0.00044142763,0.00079357653,0.00021789732,0.00007155613,0.000017341808,0.00017970125,0.0003029501,0.017657159],"category_scores_gemma":[0.0001284459,0.0003005944,0.00026333975,0.00013668172,0.00015871716,0.000037568483,0.000109046596,0.0005266085,0.000015250287],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015445582,0.00070581015,0.00003119641,0.00017716344,0.00021430368,0.0016001806,0.000005606735,9.427603e-8,0.00017431017,0.0000027744493,0.9876016,0.007942433],"study_design_scores_gemma":[0.0046370043,0.0014645567,0.00026663492,0.0003098042,0.0008848323,0.0002827011,0.0000033923081,0.0000018695748,0.000056131437,0.000022912107,0.9917845,0.00028567426],"about_ca_topic_score_codex":0.00008242331,"about_ca_topic_score_gemma":0.00022934937,"teacher_disagreement_score":0.017641908,"about_ca_system_score_codex":0.0005361113,"about_ca_system_score_gemma":0.0014476419,"threshold_uncertainty_score":0.9999446},"labels":[],"label_agreement":null},{"id":"W4253119700","doi":"10.1200/jco.2012.30.5_suppl.172","title":"A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cabazitaxel; Prednisone; Docetaxel; Prostate cancer; Cohort; Internal medicine; Interim analysis; Mitoxantrone; Abiraterone acetate; Cancer; Surgery; Oncology; Androgen deprivation therapy; Clinical trial; Chemotherapy","score_opus":0.16491443993143304,"score_gpt":0.509163103084779,"score_spread":0.3442486631533459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253119700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99275357,0.0002852705,0.00008203439,0.0031214072,0.00092035084,0.00241792,0.00016688266,0.000019348587,0.00023324077],"genre_scores_gemma":[0.9776812,0.00021511836,0.019888079,0.00061954005,0.0005227063,0.0003143322,0.00008631121,0.000029825436,0.0006428492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970347,0.00023769663,0.0017390902,0.00021354757,0.00038146833,0.00039344942],"domain_scores_gemma":[0.9949251,0.0014355839,0.0019301777,0.00014545613,0.0010225191,0.0005411787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001170206,0.0002102306,0.0014042347,0.000097975106,0.000068341695,0.000017165363,0.000091085436,0.00013145407,0.000067479006],"category_scores_gemma":[0.0005114281,0.00011510573,0.00021089394,0.0001376203,0.00026268873,0.00029285793,0.00002223307,0.0004912,0.0000024526748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27001205,0.01760405,0.6365766,0.00013291172,0.0034881895,0.00019606731,0.0005747919,0.0000666687,0.00007593948,0.000035126784,0.014960751,0.05627688],"study_design_scores_gemma":[0.06384072,0.098476924,0.70844215,0.00023344254,0.0030623553,0.00012220735,0.000112034395,0.00008750931,0.00005748749,0.0000116729625,0.12539579,0.0001577273],"about_ca_topic_score_codex":0.00011577326,"about_ca_topic_score_gemma":0.00036438546,"teacher_disagreement_score":0.20617135,"about_ca_system_score_codex":0.00045001213,"about_ca_system_score_gemma":0.0023479473,"threshold_uncertainty_score":0.46938753},"labels":[],"label_agreement":null},{"id":"W4253323776","doi":"10.1200/jco.2013.31.15_suppl.2053","title":"Phase II study of PX-866 in recurrent glioblastoma.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba; BC Cancer Agency; University of Alberta; Queen Elizabeth II Health Sciences Centre; University of Toronto; University Health Network; Dalhousie University; Cancer Care Ontario; Queen's University","funders":"","keywords":"Medicine; Temozolomide; Nausea; Internal medicine; Gastroenterology; Phases of clinical research; Adverse effect; Oncology; PTEN; Surgery; Toxicity; Chemotherapy; PI3K/AKT/mTOR pathway; Signal transduction","score_opus":0.17804300974857967,"score_gpt":0.5697458970082092,"score_spread":0.39170288725962954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253323776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99144137,0.00034334423,0.0000023336568,0.004719457,0.0016766159,0.0004928,0.0000012500028,0.0000040890573,0.0013187189],"genre_scores_gemma":[0.997601,0.00035968111,0.00021504809,0.00065656775,0.0007838734,0.000014004212,6.314953e-7,0.000008862924,0.00036035557],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9965989,0.00042116395,0.002417132,0.0001409095,0.00023744036,0.00018442854],"domain_scores_gemma":[0.99682784,0.0010706885,0.0013648876,0.0001302266,0.0003348265,0.0002715401],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014209915,0.000110841625,0.0014880053,0.00021488006,0.000019568937,0.0000020901437,0.000123469,0.00019998448,0.0012393008],"category_scores_gemma":[0.00070681446,0.00006819453,0.00027268816,0.00018684023,0.00010940117,0.000084105784,0.000058742455,0.0007896008,0.000024100314],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02756488,0.18234876,0.083205834,0.000029277186,0.00073744403,0.0009382065,0.0012060043,0.000008060557,0.0008604067,0.000012435553,0.03014624,0.67294246],"study_design_scores_gemma":[0.108007245,0.69493675,0.14437242,0.00007876398,0.0006692299,0.00018185232,0.0007310114,0.0000917989,0.00020009115,0.00019528397,0.050446734,0.00008879344],"about_ca_topic_score_codex":0.00008250565,"about_ca_topic_score_gemma":0.0003047041,"teacher_disagreement_score":0.67285365,"about_ca_system_score_codex":0.00013850896,"about_ca_system_score_gemma":0.0007174895,"threshold_uncertainty_score":0.9996737},"labels":[],"label_agreement":null},{"id":"W4253819800","doi":"10.1200/jco.2016.34.15_suppl.e18034","title":"Oxaliplatin associated neurotoxicity outcomes among older adults with colorectal cancer: a population-based study.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Women's College Hospital; Queen's University; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Oxaliplatin; Medicine; Hazard ratio; Internal medicine; Regimen; Colorectal cancer; Cancer registry; Cumulative incidence; Population; Cohort; Incidence (geometry); Cancer; Surgery; Oncology; Confidence interval","score_opus":0.06502031611701335,"score_gpt":0.46263581986832353,"score_spread":0.39761550375131016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253819800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99187547,0.000029392519,0.000015754245,0.006011635,0.001015045,0.000820965,0.00001320311,0.00002350458,0.00019504367],"genre_scores_gemma":[0.99742705,0.000030239597,0.00012756011,0.0015600811,0.0004810711,0.000046646455,0.0000033148797,0.000022291015,0.00030173396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968237,0.0006379139,0.0016353633,0.00023748183,0.00040653095,0.00025897485],"domain_scores_gemma":[0.99351025,0.0036047031,0.0019694383,0.000114060334,0.00045175554,0.00034979775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011829784,0.00018840474,0.0015889793,0.00012456399,0.000054643806,0.0000056879426,0.000117501346,0.0002802596,0.0007023737],"category_scores_gemma":[0.0015755651,0.0000938737,0.00036435542,0.00016415934,0.000121530065,0.00009912281,0.000021868353,0.0005402873,0.000005748842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011377881,0.0072074602,0.96131533,0.000008760347,0.000892087,0.0005712863,0.00010089726,0.000013035617,0.000053977106,0.0000014310898,0.0008328414,0.017624985],"study_design_scores_gemma":[0.04676094,0.028153602,0.9235077,0.00017992753,0.0008691511,0.000018929184,0.000045526045,0.000042945194,0.00006169949,0.000008817648,0.00024730034,0.000103500504],"about_ca_topic_score_codex":0.0004724913,"about_ca_topic_score_gemma":0.004809037,"teacher_disagreement_score":0.037807696,"about_ca_system_score_codex":0.00042700965,"about_ca_system_score_gemma":0.0012963334,"threshold_uncertainty_score":0.76904994},"labels":[],"label_agreement":null},{"id":"W4254182661","doi":"10.1200/jco.2013.31.26_suppl.142","title":"Correlation of molecular alterations with efficacy of everolimus in hormone-receptor–positive, HER2-negative advanced breast cancer: Results from BOLERO-2.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Exemestane; Medicine; Everolimus; Oncology; Internal medicine; PTEN; Breast cancer; Population; Hormone receptor; Progression-free survival; Cancer; Genetics; PI3K/AKT/mTOR pathway; Biology; Aromatase; Overall survival","score_opus":0.034563522283415374,"score_gpt":0.4159951434199039,"score_spread":0.38143162113648854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254182661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917352,0.00040526275,0.00019523226,0.0058495747,0.00042732348,0.0004623678,0.000119988465,0.0000037452792,0.00080125657],"genre_scores_gemma":[0.99540997,0.00083970465,0.002915517,0.00044324182,0.0002651965,0.000014632584,0.00002858392,0.000012692185,0.00007045518],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99706197,0.00037154177,0.0019834035,0.00018209286,0.00024716282,0.00015384602],"domain_scores_gemma":[0.9941568,0.002653818,0.0021080473,0.00012807031,0.00077177305,0.00018150375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045421478,0.00013456173,0.0012042696,0.0001319289,0.000016735914,0.0000027520052,0.00009140818,0.0002248422,0.0002437474],"category_scores_gemma":[0.0005211714,0.00009651262,0.00021335349,0.00021073161,0.00023326899,0.00016244607,0.00002061877,0.00055224134,0.0000062909708],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25276044,0.021328734,0.2722236,0.000055202414,0.004418308,0.0004804898,0.0041439775,0.019945571,0.10417764,0.00013091868,0.008018749,0.31231636],"study_design_scores_gemma":[0.044972192,0.014199071,0.9348795,0.0002872857,0.00051093445,0.00003981808,0.0001273753,0.0004750938,0.0039351718,0.00013943965,0.00034674542,0.00008739402],"about_ca_topic_score_codex":0.0015792495,"about_ca_topic_score_gemma":0.00033226577,"teacher_disagreement_score":0.6626559,"about_ca_system_score_codex":0.00020018988,"about_ca_system_score_gemma":0.00100922,"threshold_uncertainty_score":0.39356703},"labels":[],"label_agreement":null},{"id":"W4254247034","doi":"10.1515/iupac.87.0214","title":"Dystonia","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Chemical nomenclature; Relation (database); Computer science; Psychology; Engineering ethics; Chemistry; Linguistics; Engineering; Philosophy; Organic chemistry; Data mining","score_opus":0.018849080549440164,"score_gpt":0.4704113973277275,"score_spread":0.45156231677828734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254247034","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023145527,0.0021722605,0.0000074287004,0.0029164178,0.0013196918,0.00044562004,0.99255997,0.000072220544,0.00027492744],"genre_scores_gemma":[0.000020174106,0.002711858,0.000024216864,0.0012295508,0.0024165064,0.00003089183,0.9874543,0.000038128972,0.0060744043],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820596,0.000040989707,0.00032276954,0.00042052547,0.0006311331,0.0003786258],"domain_scores_gemma":[0.9986904,0.00004781204,0.0001525291,0.00057672686,0.00028610218,0.0002463812],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017077869,0.00037488263,0.00075298554,0.00019676055,0.00006157321,0.000013112786,0.00014863972,0.00036030402,0.022945402],"category_scores_gemma":[0.00008600478,0.00025103477,0.00021327045,0.000120031254,0.00013333396,0.000031470125,0.00007653968,0.00039661926,0.000014520615],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010082121,0.0005218166,0.000042933345,0.00019008773,0.00030558804,0.0005417245,0.0000057322463,3.8459305e-8,0.000052462226,0.00000253569,0.9926838,0.0046450617],"study_design_scores_gemma":[0.004507124,0.0010223116,0.000110333276,0.00036033764,0.0010017531,0.00013398871,0.000003301487,4.0937658e-7,0.00005941618,0.000031845622,0.9925178,0.00025136318],"about_ca_topic_score_codex":0.00015493712,"about_ca_topic_score_gemma":0.0005617263,"teacher_disagreement_score":0.022930881,"about_ca_system_score_codex":0.0007912278,"about_ca_system_score_gemma":0.0013570159,"threshold_uncertainty_score":0.9999942},"labels":[],"label_agreement":null},{"id":"W4254601055","doi":"10.3410/f.734552032.793578452","title":"Faculty Opinions recommendation of Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.","year":2020,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Apixaban; Venous thromboembolism; Medicine; Cancer; Internal medicine; Business; General surgery; Warfarin; Atrial fibrillation; Thrombosis","score_opus":0.02837011613257942,"score_gpt":0.3753954030679569,"score_spread":0.3470252869353775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254601055","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017001494,0.0005379033,0.0000018889716,0.21442482,0.00061302324,0.002761789,0.7815999,0.00001879825,0.000024866667],"genre_scores_gemma":[0.000049090166,0.00033025243,0.00022469267,0.010325153,0.00027867922,0.0006031357,0.98782694,0.000028938026,0.00033310553],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99658954,0.00024770357,0.0011375148,0.00061704696,0.0010862108,0.0003219688],"domain_scores_gemma":[0.99509794,0.00006367403,0.0008889952,0.0007633416,0.0027969459,0.0003890784],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035727586,0.0004591877,0.0013330979,0.00032362962,0.0000908714,0.000032603984,0.0006574021,0.00039775227,0.000587062],"category_scores_gemma":[0.0009955607,0.0002816621,0.00032442776,0.0020382728,0.00015666976,0.00013982595,0.00026569108,0.00083541597,0.000038253147],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014265098,0.0024849044,0.00016595508,0.0064598396,0.00033641496,6.188994e-7,0.00028157994,2.2438711e-7,8.217027e-7,0.000016110382,0.9871371,0.0029738147],"study_design_scores_gemma":[0.002187066,0.0010396709,0.041531686,0.011991002,0.0005296395,0.0000063740085,0.000011141935,0.0000010990484,0.000014966476,0.0000031758764,0.94244844,0.00023574792],"about_ca_topic_score_codex":0.00021201672,"about_ca_topic_score_gemma":0.00003943074,"teacher_disagreement_score":0.20622705,"about_ca_system_score_codex":0.00031654682,"about_ca_system_score_gemma":0.0008494769,"threshold_uncertainty_score":0.9999636},"labels":[],"label_agreement":null},{"id":"W4254787778","doi":"10.3410/f.1004615.76511","title":"Faculty Opinions recommendation of Combinatorial computational method gives new picomolar ligands for a known enzyme.","year":2002,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Computational biology; Enzyme; Computer science; Combinatorial chemistry; Chemistry; Data science; Biochemistry; Biology","score_opus":0.05165685488720307,"score_gpt":0.4176720180765428,"score_spread":0.36601516318933974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254787778","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.054816e-7,0.0020738593,0.00038534374,0.217345,0.0019332346,0.00220256,0.77598745,0.00003223826,0.00004012718],"genre_scores_gemma":[0.0000033601877,0.0004227677,0.005794376,0.004761759,0.00121456,0.00037455736,0.98473644,0.00003347008,0.0026586817],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961108,0.00024515213,0.0015408214,0.0006590608,0.0010953746,0.00034878706],"domain_scores_gemma":[0.9921365,0.00048155768,0.0014018726,0.00078543625,0.004771437,0.00042321134],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009429616,0.000541772,0.0013750709,0.00040524785,0.00021779219,0.00006896195,0.00075223274,0.0007400995,0.0011608378],"category_scores_gemma":[0.002968054,0.00036657447,0.0009352773,0.0013872641,0.0002220883,0.00019896426,0.0002277513,0.00083724613,0.00002653088],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012433568,0.0011835503,0.0000042847837,0.006637503,0.0005654214,3.939774e-7,0.00016067002,4.8537345e-7,0.000003631694,0.0005391895,0.9869604,0.0038201038],"study_design_scores_gemma":[0.005178785,0.00073758437,0.0002995907,0.0055887834,0.0010380375,0.000067491506,0.000012346577,0.00006511682,0.00006800199,0.00020723836,0.9864451,0.000291908],"about_ca_topic_score_codex":0.00006697767,"about_ca_topic_score_gemma":0.0000030038777,"teacher_disagreement_score":0.21258324,"about_ca_system_score_codex":0.00019382889,"about_ca_system_score_gemma":0.0010268195,"threshold_uncertainty_score":0.99987864},"labels":[],"label_agreement":null},{"id":"W4254984560","doi":"10.1515/iupac.81.0686","title":"Phytochelatin","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glossary; Ecotoxicology; Environmental risk assessment; Relation (database); Computer science; Ecology; Risk assessment; Biology; Data mining; Philosophy; Linguistics","score_opus":0.021362877524451797,"score_gpt":0.47079564697214543,"score_spread":0.4494327694476936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254984560","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016557558,0.0019726534,0.000011329718,0.002406136,0.00096606807,0.0005091225,0.99349105,0.00006764752,0.00041042696],"genre_scores_gemma":[0.000027483,0.0018115201,0.00003383297,0.0011634424,0.0026865208,0.00003858097,0.9887745,0.000037091966,0.0054270215],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99825215,0.000041487743,0.00032967541,0.00041001523,0.00060655776,0.00036012076],"domain_scores_gemma":[0.9987501,0.00005682825,0.00016685686,0.0005376051,0.00026816284,0.00022044906],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016538135,0.00037017313,0.0007309154,0.00017482793,0.000054733082,0.000011749912,0.00013073425,0.00035802193,0.024285825],"category_scores_gemma":[0.00011262725,0.00025276843,0.00022285875,0.00012543712,0.00011997676,0.000032181986,0.000072025854,0.00042754723,0.000013474393],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009607863,0.0005250064,0.000045601293,0.00018286105,0.00028071788,0.00030755924,0.000006248222,5.8060635e-8,0.00007740013,0.0000018016896,0.9919874,0.005624553],"study_design_scores_gemma":[0.004627421,0.0009594736,0.00012584098,0.00038980393,0.0008456695,0.00007489931,0.000003921061,6.129139e-7,0.00008571683,0.000047153077,0.992589,0.00025046125],"about_ca_topic_score_codex":0.000077007564,"about_ca_topic_score_gemma":0.00024507043,"teacher_disagreement_score":0.02427235,"about_ca_system_score_codex":0.00061699137,"about_ca_system_score_gemma":0.0011148762,"threshold_uncertainty_score":0.99999243},"labels":[],"label_agreement":null},{"id":"W4255159404","doi":"10.1385/1592599982","title":"Cytochrome P450 Protocols","year":2005,"lang":"en","type":"book","venue":"Humana Press eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Faculty of Pharmaceutical Sciences, University of British Columbia; Institute of Molecular and Cell Biology; School of Medicine, Vanderbilt University; Directorate for Biological Sciences; University of Ioannina; Vrije Universiteit Brussel; University of Surrey; Chiang Mai University; Karolinska Institutet; Institut National de la Santé et de la Recherche Médicale; Newcastle University; University College London; University of Dundee; University of Washington; Queen Mary University of London; Imperial College London; Showa Pharmaceutical University; University of Connecticut; Vanderbilt University; Sanofi","keywords":"Cytochrome P450; Computer science; Computational biology; Medicine; Biology; Internal medicine","score_opus":0.13918846533216817,"score_gpt":0.4007187621992431,"score_spread":0.2615302968670749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255159404","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013584825,0.0028356055,0.0000025332051,0.000043615986,0.00009592793,0.025225671,0.000056926838,0.00021723387,0.9715089],"genre_scores_gemma":[0.00006371847,0.00012730544,0.00008986164,0.0007537662,0.0034373023,0.022430886,0.00019488936,0.00012071366,0.97278154],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983329,0.0000320183,0.00038814702,0.0005149237,0.00033888104,0.0003930865],"domain_scores_gemma":[0.9988577,0.000039572104,0.00021386362,0.00059702765,0.00008740097,0.00020444565],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000073125244,0.0004566765,0.000781947,0.00014746301,0.000090509784,0.00003280209,0.0002058331,0.00044052163,0.0020765627],"category_scores_gemma":[0.0000035832659,0.00041192607,0.00028065965,0.000006146919,0.00016814683,0.000026148691,0.00010604255,0.0005909726,0.00019859748],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068700756,0.0002478245,0.0000010652092,0.001142948,0.0009994267,0.0006183887,0.00043340606,0.0000010337224,0.0005795727,0.009686161,0.9024331,0.08317006],"study_design_scores_gemma":[0.0033187142,0.0006672227,0.000067340705,0.0005723363,0.00077681267,0.00007237273,8.5702027e-7,0.0000036814793,0.0007219442,0.00044697477,0.99301636,0.0003353598],"about_ca_topic_score_codex":0.000040346105,"about_ca_topic_score_gemma":0.000049818445,"teacher_disagreement_score":0.09058328,"about_ca_system_score_codex":0.0004704443,"about_ca_system_score_gemma":0.000542473,"threshold_uncertainty_score":0.9998333},"labels":[],"label_agreement":null},{"id":"W4255993023","doi":"10.1200/jco.2017.35.15_suppl.tps1119","title":"SANDPIPER: Phase III study of the PI3-kinase (PI3K) inhibitor taselisib (GDC-0032) plus fulvestrant in patients (pts) with estrogen receptor (ER)-positive, HER2-negative locally advanced or metastatic breast cancer (BC) enriched for pts with <i>PIK3CA-</i>mutant tumors.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Fulvestrant; Medicine; Metastatic breast cancer; Aromatase inhibitor; Internal medicine; Cancer; Estrogen receptor; Placebo; Palbociclib; PI3K/AKT/mTOR pathway; Clinical endpoint; Oncology; Breast cancer; Cancer research; Randomized controlled trial; Aromatase; Biology; Pathology; Apoptosis; Genetics","score_opus":0.05892864188827659,"score_gpt":0.4421185958734921,"score_spread":0.38318995398521555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255993023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99219245,0.00011362405,0.000052110612,0.0029111234,0.00082410825,0.0034965016,0.00031267456,0.000008057302,0.00008932517],"genre_scores_gemma":[0.9967795,0.00022386553,0.0013413054,0.0007527356,0.0004890774,0.00021277629,0.000013712449,0.00005101191,0.00013599476],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99510485,0.00069531635,0.0025375995,0.000490864,0.0006694217,0.00050196843],"domain_scores_gemma":[0.99177665,0.0017603699,0.0043228786,0.00044774913,0.0012205146,0.0004718178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013273597,0.00043414006,0.0027989836,0.00014536185,0.00022599469,0.000023503066,0.00045294818,0.00019406657,0.0002221354],"category_scores_gemma":[0.00078576396,0.00021854285,0.00035282096,0.000251627,0.0007284234,0.00029352456,0.00009198926,0.0009629295,0.0000015243583],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6459013,0.057720464,0.20511386,0.00017765124,0.004593698,0.0015994078,0.002603564,0.00033792987,0.0015418425,0.0000127384565,0.0013791919,0.07901833],"study_design_scores_gemma":[0.43369362,0.22724618,0.32664812,0.0010871681,0.0046386546,0.00028500834,0.002063007,0.00013046489,0.0025841217,0.000034850145,0.0011841323,0.0004046731],"about_ca_topic_score_codex":0.0009066277,"about_ca_topic_score_gemma":0.0044944193,"teacher_disagreement_score":0.2122077,"about_ca_system_score_codex":0.0006594067,"about_ca_system_score_gemma":0.004635772,"threshold_uncertainty_score":0.89119184},"labels":[],"label_agreement":null},{"id":"W4256035456","doi":"10.2165/00128413-200715930-00041","title":"New Avastin safety info issued in Canada","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Traditional medicine; Family medicine; Optometry; Ophthalmology","score_opus":0.014390874321892982,"score_gpt":0.30848279498024395,"score_spread":0.294091920658351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256035456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9312113,0.0010545568,0.00016145506,0.009093858,0.0013266918,0.00051941886,0.000017239383,0.000057459172,0.056558043],"genre_scores_gemma":[0.98191595,0.00008196009,0.00037700686,0.0038682192,0.0005305755,0.0000057561983,0.000027398599,0.00001768565,0.013175434],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989043,0.000018069251,0.0003155456,0.00018099514,0.00020168745,0.00037943793],"domain_scores_gemma":[0.9993807,0.00011348205,0.00005164131,0.0001263598,0.000031147025,0.00029666565],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016230295,0.00014012009,0.00025334855,0.000106003725,0.00002765037,0.0000042414163,0.000075248696,0.00004642361,0.0050387965],"category_scores_gemma":[0.000019010247,0.00013210936,0.000039628874,0.00027426003,0.000018046421,0.00004908177,0.000026052123,0.00021975969,0.00009685231],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031316348,0.00019812367,0.332806,0.00006177351,0.00015637762,0.003300289,0.0007032252,0.00003521197,0.016809905,0.00006214749,0.48003376,0.16270155],"study_design_scores_gemma":[0.007836393,0.00014945409,0.34274668,0.00003697489,0.00008430519,0.000112953996,0.00013158497,0.00005005446,0.016765015,0.000018014101,0.6318964,0.00017220153],"about_ca_topic_score_codex":0.89090914,"about_ca_topic_score_gemma":0.91752625,"teacher_disagreement_score":0.16252935,"about_ca_system_score_codex":0.0012161734,"about_ca_system_score_gemma":0.0021393914,"threshold_uncertainty_score":0.9958707},"labels":[],"label_agreement":null},{"id":"W4256256284","doi":"10.1515/iupac.73.0187","title":"Cyclopropene Acid","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan College","funders":"","keywords":"Cyclopropene; Table (database); Chemistry; Product (mathematics); Organic chemistry; Fatty acid; Food science; Biochemistry; Commission; Polymer science; Computer science; Mathematics; Political science; Database; Law","score_opus":0.020537468530122255,"score_gpt":0.4578025510725623,"score_spread":0.43726508254244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256256284","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025229092,0.0034106416,0.000009123996,0.0037172707,0.0012623692,0.00058933883,0.9902553,0.00007804693,0.0004256245],"genre_scores_gemma":[0.00004078975,0.0049385424,0.000037409904,0.0015005994,0.0026158246,0.00004630815,0.9855411,0.000048382994,0.005231028],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99790734,0.00005006549,0.00038015543,0.0005053285,0.00071847055,0.00043864708],"domain_scores_gemma":[0.9984837,0.00003291181,0.00018224595,0.00067862537,0.00033892572,0.00028357495],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021086885,0.0004424982,0.0008794206,0.00020282604,0.00007262798,0.000020487165,0.00019885207,0.000384593,0.02565824],"category_scores_gemma":[0.00011057806,0.00028958966,0.00023231687,0.00014494323,0.00014326295,0.00005364877,0.00011967049,0.00045360546,0.000019690533],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015025655,0.00062548625,0.00003507818,0.00020568688,0.00035492028,0.00061770866,0.0000058056967,3.6173734e-8,0.0003212086,0.0000015628552,0.986927,0.009402979],"study_design_scores_gemma":[0.0052058124,0.0011750751,0.00010039144,0.0003992712,0.0010041605,0.00014285956,0.0000040325835,2.8657533e-7,0.00039016534,0.000030635456,0.99124134,0.0003059556],"about_ca_topic_score_codex":0.00013371273,"about_ca_topic_score_gemma":0.00048508972,"teacher_disagreement_score":0.025638549,"about_ca_system_score_codex":0.00073502556,"about_ca_system_score_gemma":0.001360729,"threshold_uncertainty_score":0.99995565},"labels":[],"label_agreement":null},{"id":"W4256299223","doi":"10.1002/ange.200250681","title":"The Total Synthesis of Racemic Teucvin and 12‐<i>epi</i>‐Teucvin","year":2003,"lang":"en","type":"article","venue":"Angewandte Chemie","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Science Council","keywords":"Total synthesis; Chemistry; Stereochemistry","score_opus":0.014831391551486795,"score_gpt":0.2716549413335883,"score_spread":0.25682354978210153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256299223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94585925,0.0059956107,0.0000016940415,0.0011249384,0.000148259,0.00022214348,0.00001297196,0.000024393807,0.046610713],"genre_scores_gemma":[0.99131185,0.0016148359,0.000087676846,0.00018571186,0.00009342106,0.000046929003,0.000004529189,0.000015044803,0.006640017],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993396,0.000026636802,0.00016478323,0.00016100697,0.000108387256,0.00019960038],"domain_scores_gemma":[0.99929,0.00034700593,0.00006581569,0.00017855622,0.000033732507,0.000084877225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015686166,0.00012015944,0.00023681793,0.000027587465,0.00008135125,0.000008034446,0.000042527987,0.000067573266,0.00025265155],"category_scores_gemma":[0.00013632413,0.00008001173,0.00007249126,0.00008226432,0.00015140392,0.000030012377,0.000019608586,0.000098602635,0.000008974852],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056723185,0.00026889358,0.0179925,0.00013657293,0.00038703927,0.00003731092,0.00041600544,7.1390724e-7,0.93875945,0.00031215118,0.03426185,0.0068602893],"study_design_scores_gemma":[0.0011272392,0.000120411634,0.0035099543,0.00003505427,0.0002459098,0.00008670875,0.00011448809,0.0000013664337,0.949876,0.00008955583,0.0447145,0.0000787852],"about_ca_topic_score_codex":0.000041756703,"about_ca_topic_score_gemma":0.000019437146,"teacher_disagreement_score":0.04545256,"about_ca_system_score_codex":0.000045035005,"about_ca_system_score_gemma":0.00007262906,"threshold_uncertainty_score":0.32627836},"labels":[],"label_agreement":null},{"id":"W4281652688","doi":"10.1200/jco.2022.40.16_suppl.7561","title":"Analysis of peripheral neuropathy (PN) using clinician- and patient-reported outcomes (ClinRO and PRO) in the POLARIX study.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Internal medicine; Vincristine; CHOP; Placebo; Incidence (geometry); Progression-free survival; Gastroenterology; Oncology; Lymphoma; Chemotherapy; Cyclophosphamide; Pathology","score_opus":0.20937681960913465,"score_gpt":0.5324843172641304,"score_spread":0.3231074976549957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281652688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949838,0.0006228699,0.0000028849115,0.0032984337,0.00060067966,0.00037854214,0.00000548228,0.0000023378875,0.00010499311],"genre_scores_gemma":[0.9956674,0.00017111612,0.00017060684,0.0038337903,0.000115412986,0.0000064342516,0.0000015696504,0.000007923207,0.000025747226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995399,0.0015414797,0.002392832,0.0001890792,0.00033045642,0.00014713388],"domain_scores_gemma":[0.9955611,0.0021623105,0.0018830688,0.00014743544,0.00013223475,0.00011384026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034149573,0.00011196376,0.0016427276,0.0002985321,0.000069937865,0.0000057559437,0.000100485864,0.000089574896,0.00013447618],"category_scores_gemma":[0.00090801826,0.00006901031,0.00036093305,0.00047183223,0.00016821742,0.000051391224,0.00010872593,0.000893545,7.423698e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035516792,0.005502143,0.9594277,0.000005847079,0.0021484648,0.0014012842,0.0021472957,0.00008961188,0.000063174324,0.0000029785754,0.00007768809,0.025582135],"study_design_scores_gemma":[0.008928849,0.0255044,0.9531174,0.0000044361923,0.0060466523,0.00030597203,0.0026015139,0.00068002817,0.0000011966752,0.000028682638,0.0027277905,0.000053105214],"about_ca_topic_score_codex":0.00023525684,"about_ca_topic_score_gemma":0.00026283658,"teacher_disagreement_score":0.02552903,"about_ca_system_score_codex":0.000088659035,"about_ca_system_score_gemma":0.00055158214,"threshold_uncertainty_score":0.3882058},"labels":[],"label_agreement":null},{"id":"W4281684131","doi":"10.1200/jco.2022.40.16_suppl.e12523","title":"Telehealth delivered Tai Chi intervention for managing aromatase inhibitor-induced arthralgia in breast cancer patients: <i>TaiChi4Joint</i> during the COVID-19 pandemic a Pilot study.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Brief Pain Inventory; Physical therapy; Breast cancer; Quality of life (healthcare); Pittsburgh Sleep Quality Index; WOMAC; Attendance; Internal medicine; Cancer; Osteoarthritis; Alternative medicine; Chronic pain; Psychiatry","score_opus":0.14073534185881623,"score_gpt":0.4863820886847931,"score_spread":0.34564674682597685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281684131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98256755,0.00036935817,0.000011673167,0.013486311,0.001999438,0.0014250071,0.00009781362,0.000015166586,0.00002767125],"genre_scores_gemma":[0.99144334,0.00039523272,0.0000425051,0.00689378,0.00086637965,0.00025290478,0.000020571095,0.000021940556,0.00006335022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99564636,0.0011988566,0.0022103437,0.0002782889,0.000337035,0.00032909878],"domain_scores_gemma":[0.9964847,0.0010780352,0.0017664679,0.00015642543,0.00016775011,0.00034663785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036840597,0.00017049741,0.0010435876,0.00021977154,0.00024086024,0.000008864877,0.00020537827,0.000076191965,0.00038193664],"category_scores_gemma":[0.0004578113,0.000120211094,0.00034124934,0.00024395675,0.00007661169,0.00010172756,0.00015965059,0.00124723,0.0000018232271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0536072,0.019687552,0.88702804,0.00013634335,0.0005899199,0.00035049414,0.0006813131,0.00018844179,0.00036336796,0.0000071403715,0.0054365573,0.031923655],"study_design_scores_gemma":[0.077306196,0.067302495,0.8442017,0.00007144452,0.00063403405,0.00062410237,0.0012454601,0.00011164189,0.0000091723805,0.00015552944,0.008199971,0.00013825395],"about_ca_topic_score_codex":0.00093988643,"about_ca_topic_score_gemma":0.0021034381,"teacher_disagreement_score":0.047614943,"about_ca_system_score_codex":0.0018648512,"about_ca_system_score_gemma":0.0014114203,"threshold_uncertainty_score":0.5418663},"labels":[],"label_agreement":null},{"id":"W4281727653","doi":"10.1200/jco.2022.40.16_suppl.e24066","title":"Building a model to predict the risk of multiple severe neurotoxicities in cancer survivors after cisplatin treatment.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"National Institutes of Health","keywords":"Medicine; Internal medicine; Oncology; Head and neck cancer; Concordance; Cancer","score_opus":0.13518160812579472,"score_gpt":0.4799018621242025,"score_spread":0.3447202539984078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281727653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99247533,0.0005791954,0.000054765653,0.0050258795,0.00093217194,0.00052142085,0.00009589576,0.0000046990845,0.00031065743],"genre_scores_gemma":[0.9949155,0.0009077449,0.0010129381,0.0020250152,0.00042812712,0.00018460807,0.0000010823242,0.000016018912,0.0005089716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971251,0.00079415576,0.0014268155,0.00016407334,0.00027753768,0.00021233654],"domain_scores_gemma":[0.99574625,0.0029003778,0.00093235966,0.00014402508,0.000106743304,0.000170212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015583204,0.00013217673,0.0010426486,0.00016237535,0.000057512043,0.0000027059696,0.00015265691,0.00010376624,0.00048871816],"category_scores_gemma":[0.00057878194,0.00008033156,0.00040580475,0.00020794511,0.00010627016,0.000045053177,0.00009744147,0.0007688205,0.0000010213524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021882843,0.002741713,0.8811001,0.000015478805,0.00055792974,0.00036893933,0.0012700902,0.055246413,0.000413491,0.000012336797,0.001628746,0.034761902],"study_design_scores_gemma":[0.032471374,0.056955256,0.80612427,0.000087435445,0.002005837,0.00035043427,0.00077337725,0.032834545,0.00038225952,0.0005467304,0.0672544,0.00021405713],"about_ca_topic_score_codex":0.0013270931,"about_ca_topic_score_gemma":0.003767442,"teacher_disagreement_score":0.074975826,"about_ca_system_score_codex":0.00044913677,"about_ca_system_score_gemma":0.0012488444,"threshold_uncertainty_score":0.53511214},"labels":[],"label_agreement":null},{"id":"W4282037661","doi":"10.1200/jco.2022.40.16_suppl.1545","title":"Impact of proactive symptom monitoring on quality of life (QoL) and treatment toxicity in patients with cancer receiving chemotherapy: A meta-analysis of randomized clinical trials.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Meta-analysis; Randomized controlled trial; Minimal clinically important difference; Quality of life (healthcare); Clinical trial; MEDLINE; Strictly standardized mean difference; Internal medicine; Odds ratio; Cancer; Physical therapy","score_opus":0.42822123247110955,"score_gpt":0.6059991463496031,"score_spread":0.1777779138784935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282037661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968662,0.00091817597,0.0000076217098,0.00080450036,0.00028716616,0.00096556015,0.00007759607,0.0000019852616,0.00007118652],"genre_scores_gemma":[0.9975774,0.0017051223,0.00028357885,0.00014245533,0.00018260506,0.00006519384,0.0000043595687,0.000011512698,0.000027743472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98302966,0.009890754,0.0061621177,0.00025342553,0.0005055072,0.00015851382],"domain_scores_gemma":[0.9648023,0.025460683,0.008852686,0.00018956502,0.00045707394,0.0002376457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023408126,0.00019674104,0.012757508,0.00038283985,0.000023379032,0.0000018641464,0.00009779342,0.0001865055,0.00065098784],"category_scores_gemma":[0.0060744584,0.00010434263,0.0045276396,0.0004330425,0.00028865616,0.000048513848,0.000035652316,0.00060490455,4.6966804e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3235583,0.008361249,0.47862166,0.000008532735,0.17900588,0.0000046761047,0.00028042414,0.0003069039,0.000028577335,0.0000017175392,0.000014014515,0.0098080775],"study_design_scores_gemma":[0.20681433,0.030745521,0.6588725,0.000010833297,0.10328356,7.338238e-7,0.000056617253,0.00005276506,0.000084654195,0.000011043092,0.000015704287,0.000051749033],"about_ca_topic_score_codex":0.0010790884,"about_ca_topic_score_gemma":0.00012566708,"teacher_disagreement_score":0.18025082,"about_ca_system_score_codex":0.0005529948,"about_ca_system_score_gemma":0.0018665125,"threshold_uncertainty_score":0.87207776},"labels":[],"label_agreement":null},{"id":"W4283022221","doi":"10.1093/oncolo/oyac106","title":"The Value of In Vivo Reflectance Confocal Microscopy as an Assessment Tool in Chemotherapy-Induced Peripheral Neuropathy: A Pilot Study","year":2022,"lang":"en","type":"article","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; RWTH Aachen University; Bundesministerium für Bildung und Forschung; Medical Research Foundation; Melville Charitable Trust","keywords":"Medicine; Peripheral neuropathy; Chemotherapy-induced peripheral neuropathy; In vivo; Confocal microscopy; Chemotherapy; Confocal; Pathology; Peripheral; Radiology; Internal medicine; Optics","score_opus":0.04574533894228266,"score_gpt":0.4373136524696243,"score_spread":0.3915683135273416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283022221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99115884,0.00011428678,0.0000014663722,0.0034640487,0.00033247878,0.0016143818,0.0000063709163,0.000020935187,0.0032871838],"genre_scores_gemma":[0.99653107,0.000059755745,0.000041463507,0.0019719026,0.00007743274,0.00052913855,0.0000029962432,0.000018628458,0.00076762476],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99813616,0.00078869396,0.00033148777,0.00025070575,0.00023549228,0.00025748377],"domain_scores_gemma":[0.9992337,0.00023961699,0.00013312743,0.00033796465,0.00002697262,0.000028570701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000986326,0.00014150463,0.00032709568,0.00004715346,0.00019802876,0.000014340848,0.00028295632,0.000021900181,0.00037281073],"category_scores_gemma":[0.00002444646,0.00008831251,0.000037586105,0.00030272227,0.00015755348,0.00002940579,0.0000947986,0.00044724575,0.0000014667004],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017879901,0.013471023,0.14026634,0.000016155762,0.00012576963,0.00045688156,0.0063324813,0.00028866445,0.81506515,0.0012062257,0.0007369434,0.004154488],"study_design_scores_gemma":[0.036202684,0.15721954,0.75859344,0.000026028452,0.00021329758,0.00015681042,0.011504388,0.0023653586,0.021265814,0.0008021536,0.011253584,0.0003969144],"about_ca_topic_score_codex":0.0018910506,"about_ca_topic_score_gemma":0.00250363,"teacher_disagreement_score":0.7937993,"about_ca_system_score_codex":0.0007656615,"about_ca_system_score_gemma":0.00052783353,"threshold_uncertainty_score":0.4082016},"labels":[],"label_agreement":null},{"id":"W4283325379","doi":"10.26355/eurrev_202206_28973","title":"Risk factors for oxaliplatin-induced peripheral neuropathy: a systematic review and meta-analysis.","year":2022,"lang":"en","type":"review","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Oxaliplatin; Odds ratio; Internal medicine; MEDLINE; Body mass index; Peripheral neuropathy; Oncology; Observational study; Regimen; Diabetes mellitus; Cancer; Colorectal cancer","score_opus":0.23999662731645166,"score_gpt":0.3869768595827417,"score_spread":0.14698023226629003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283325379","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008149945,0.9787538,0.0000027742103,0.000111735884,0.00014939136,0.020139053,0.00057293224,0.000051646803,0.00021049766],"genre_scores_gemma":[0.000051953368,0.9219573,0.000012484644,0.00053813786,0.00006343856,0.07327559,0.00052790163,0.00006687242,0.003506302],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968501,0.0008524895,0.0010231291,0.0006228326,0.00025794673,0.00039353373],"domain_scores_gemma":[0.99719787,0.00097284076,0.0010174101,0.0005293643,0.000043344706,0.0002391907],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008944369,0.0005718608,0.010891192,0.0002735834,0.00013123376,0.000029011673,0.00015941722,0.00011951807,0.0010148245],"category_scores_gemma":[0.0004963849,0.00034248503,0.004437125,0.00068272505,0.000023277344,0.000036850954,0.00007398954,0.00038111943,0.0000024781066],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000075114413,0.000070579976,0.0000063756565,0.724274,0.26152906,0.000016053831,0.000029935361,8.102008e-8,5.3369607e-9,0.000004560853,0.0003727817,0.013689084],"study_design_scores_gemma":[0.00023313386,0.0000664106,0.000023685434,0.0006288296,0.723388,0.000030794636,0.0000042920524,0.0000011392713,4.7790486e-8,0.0000013346378,0.2754424,0.00017989245],"about_ca_topic_score_codex":0.00004553766,"about_ca_topic_score_gemma":0.000010977777,"teacher_disagreement_score":0.72364515,"about_ca_system_score_codex":0.0002351293,"about_ca_system_score_gemma":0.00010215069,"threshold_uncertainty_score":0.9999027},"labels":[],"label_agreement":null},{"id":"W4286296056","doi":"10.1200/jco.2022.40.16_suppl.12056","title":"Remote symptom monitoring (RSM) during treatment for metastatic prostate cancer (mPC) in older men: Feasibility and efficacy.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Prostate Cancer Canada","keywords":"Medicine; Prostate cancer; Quality of life (healthcare); Cohort; Mood; Anxiety; Prospective cohort study; Cohort study; Physical therapy; Psychological intervention; Internal medicine; Cancer; Psychiatry","score_opus":0.22121105787326412,"score_gpt":0.5433773381928398,"score_spread":0.3221662803195757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286296056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987786,0.0040387264,0.000004626159,0.0056723976,0.0012928854,0.0010392267,0.000018050156,0.000007909544,0.0001401886],"genre_scores_gemma":[0.99227244,0.0042518186,0.0015595447,0.00026104992,0.0007299571,0.000078396835,0.000002919447,0.000019547982,0.0008243217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737966,0.00042133243,0.0014492292,0.00026667255,0.00020264217,0.00028047056],"domain_scores_gemma":[0.99701035,0.0016857529,0.0008154495,0.00012013528,0.00011383149,0.00025449682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016570719,0.00015510552,0.0012900457,0.00013983966,0.00009920311,0.000005747532,0.00007400942,0.000080495534,0.00017901152],"category_scores_gemma":[0.00032037892,0.00011539873,0.000312079,0.00012967816,0.00008981689,0.000059729955,0.00005953805,0.00052673306,6.229899e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036736734,0.008592379,0.68696785,0.00014939507,0.0014531049,0.0013384768,0.0017188512,0.0004197655,0.0017594995,0.000006161164,0.00051669125,0.2603411],"study_design_scores_gemma":[0.08267266,0.028176596,0.8626962,0.000086522516,0.0014150275,0.00043679195,0.00046777335,0.00028494498,0.0006987016,0.00016909934,0.022755908,0.00013977707],"about_ca_topic_score_codex":0.00013317965,"about_ca_topic_score_gemma":0.00006471492,"teacher_disagreement_score":0.26020133,"about_ca_system_score_codex":0.0014560327,"about_ca_system_score_gemma":0.001073506,"threshold_uncertainty_score":0.47058237},"labels":[],"label_agreement":null},{"id":"W4286298168","doi":"10.1200/jco.2022.40.16_suppl.e21559","title":"Whose mitochondria are more stable, male or female ones? Response of neurosteroid status of mitochondria of cerebral cortex cells to melanoma development in presense of chronic pain.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Estrone; Internal medicine; Endocrinology; Testosterone (patch); Medicine; Hormone; Cerebral cortex; Subcutaneous injection","score_opus":0.0911648732861474,"score_gpt":0.43104749565425093,"score_spread":0.3398826223681035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286298168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495345,0.0010496299,0.000019490435,0.0013551835,0.0015844612,0.00083998137,0.000117524476,0.0000034090567,0.00007683752],"genre_scores_gemma":[0.994182,0.00039302,0.0030751051,0.0005012297,0.00021306278,0.000033369324,0.000008436713,0.00003028208,0.0015634957],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9923032,0.0021995057,0.0040967925,0.0003085209,0.00063690136,0.00045511077],"domain_scores_gemma":[0.9903958,0.004510252,0.0038221567,0.00033503212,0.0005242475,0.00041250818],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028684267,0.00022406552,0.002548533,0.0004950969,0.0000310712,0.0000021475896,0.00030220195,0.00022825578,0.0015697058],"category_scores_gemma":[0.001634252,0.00017935624,0.00040290836,0.0005079827,0.000272408,0.00007151722,0.00025468966,0.000791874,0.0000020511434],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28995064,0.0144875115,0.32508534,0.0006302759,0.0009183827,0.0026242586,0.0035829253,0.0007243843,0.3324498,0.000005078486,0.018823033,0.010718387],"study_design_scores_gemma":[0.03121622,0.08830548,0.7388864,0.0003751041,0.00046739614,0.00033047586,0.0013998057,0.00010785605,0.058184173,0.000009771536,0.08051023,0.00020705115],"about_ca_topic_score_codex":0.00010626325,"about_ca_topic_score_gemma":0.00035843163,"teacher_disagreement_score":0.41380107,"about_ca_system_score_codex":0.00059164234,"about_ca_system_score_gemma":0.0058610216,"threshold_uncertainty_score":0.9997748},"labels":[],"label_agreement":null},{"id":"W4286853546","doi":"10.3791/54552-v","title":"A Simple and Efficient Protocol for the Catalytic Insertion Polymerization of Functional Norbornenes","year":2017,"lang":"en","type":"article","venue":"Journal of Visualized Experiments","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Norbornene; Polymerization; Monomer; Double bond; Polymer chemistry; Chemistry; Polymer; Copolymer; Catalysis; Organic chemistry","score_opus":0.08528256066835141,"score_gpt":0.5132603269641078,"score_spread":0.42797776629575646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286853546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96629673,0.00029544524,0.0025974736,0.0006434062,0.00034676166,0.02967037,0.000007614052,0.000005464985,0.00013674618],"genre_scores_gemma":[0.99270004,0.000008771384,0.00009708969,0.000081632934,0.00019124967,0.006806368,0.000004145447,0.000008281797,0.000102424696],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99942464,0.00001648808,0.00026120854,0.00006338136,0.00015925891,0.000075017335],"domain_scores_gemma":[0.9991761,0.000051767798,0.000490074,0.0000998624,0.00013453171,0.000047696052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012918586,0.00006813323,0.00017932545,0.000052494444,0.00015918998,0.00001798334,0.000052555348,0.000028051996,0.00006535746],"category_scores_gemma":[0.00004913987,0.000041021205,0.00007408262,0.000023802038,0.00007001965,0.00006076844,0.000019716723,0.000036739177,4.088895e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015621374,0.0015039714,0.019609222,0.00016069012,0.000564618,0.000005961076,0.0009072925,0.000059490365,0.9548438,0.00015681157,0.001675086,0.0048916354],"study_design_scores_gemma":[0.026923908,0.0023093526,0.13374765,0.00012746172,0.00033562028,0.000069516,0.00018805217,0.0027422104,0.82717013,0.000051771993,0.006252695,0.000081625105],"about_ca_topic_score_codex":0.000031212276,"about_ca_topic_score_gemma":0.0000010873467,"teacher_disagreement_score":0.1276737,"about_ca_system_score_codex":0.00004080422,"about_ca_system_score_gemma":0.000089624926,"threshold_uncertainty_score":0.16727963},"labels":[],"label_agreement":null},{"id":"W4289000605","doi":"","title":"Pilules Orientales pour poitrine idéale","year":2019,"lang":"fr","type":"preprint","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Society for the History of Medicine","funders":"","keywords":"Art","score_opus":0.018244937452025132,"score_gpt":0.27571412983419546,"score_spread":0.2574691923821703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289000605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5072071,0.04114612,0.020018084,0.067026354,0.005180878,0.0027092877,0.0006210544,0.0004940056,0.35559714],"genre_scores_gemma":[0.66234267,0.009812657,0.012047904,0.00042426438,0.00037568362,0.0001603227,0.0020828256,0.000120024524,0.31263363],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913519,0.0048561106,0.0009135065,0.0013526833,0.00061497634,0.00091080833],"domain_scores_gemma":[0.991584,0.0025838204,0.0007243935,0.0025138482,0.0020632178,0.0005307016],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0036276062,0.00075532874,0.0010333532,0.00030659628,0.0003704073,0.00018206061,0.001119483,0.0005889249,0.0058661695],"category_scores_gemma":[0.00077810424,0.00079508754,0.00055925833,0.0005122706,0.0005892634,0.00016950884,0.0014581444,0.001159249,0.002452161],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007788834,0.015261085,0.18856932,0.00310204,0.0030303309,0.00029780495,0.02257329,0.0004539253,0.051797673,0.39936614,0.066646375,0.24812314],"study_design_scores_gemma":[0.0121177295,0.000011303818,0.09741646,0.009728712,0.0016935783,0.00027847412,0.0008433601,0.014516482,0.16963294,0.004944087,0.6868424,0.0019745186],"about_ca_topic_score_codex":0.0032661688,"about_ca_topic_score_gemma":0.0019803934,"teacher_disagreement_score":0.620196,"about_ca_system_score_codex":0.00079460844,"about_ca_system_score_gemma":0.0011659098,"threshold_uncertainty_score":0.99945},"labels":[],"label_agreement":null},{"id":"W4289878771","doi":"10.1093/noajnl/vdac078.084","title":"SYST-05 OPTIMIZING HER2-TARGETED THERAPIES (TT) FOR BREAST CANCER (BC) LEPTOMENINGEAL METASTASES (LM): A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2022,"lang":"en","type":"review","venue":"Neuro-Oncology Advances","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Trastuzumab; Lapatinib; Trastuzumab emtansine; Hazard ratio; Internal medicine; Oncology; Confidence interval; Metastatic breast cancer; Breast cancer; Meta-analysis; Cancer","score_opus":0.10454557952041067,"score_gpt":0.4351710202606059,"score_spread":0.33062544074019523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289878771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000011620275,0.9856014,0.00003121061,0.0018817661,0.00048136862,0.009047889,0.002721184,0.00012918345,0.000104810824],"genre_scores_gemma":[0.000009391967,0.9682915,0.0008808305,0.003374525,0.00017040971,0.02591527,0.00050729234,0.000121548146,0.0007292336],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9941375,0.001865425,0.0016870996,0.0012636869,0.00038138698,0.00066486443],"domain_scores_gemma":[0.9940167,0.003095807,0.0018507864,0.00062610535,0.00016610706,0.00024446953],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008948408,0.0010800107,0.01621817,0.0006520954,0.00036560497,0.00003525376,0.00037192044,0.00025671575,0.005181385],"category_scores_gemma":[0.0001682012,0.000707718,0.003760673,0.0012502488,0.00024490352,0.0001895548,0.00016562146,0.00069141656,0.000007077155],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012277684,0.00027419016,0.0000032408093,0.698275,0.27326247,0.00019369966,0.00009918225,0.000017267434,0.0000028818781,0.000020218207,0.0015513471,0.026177699],"study_design_scores_gemma":[0.0005262316,0.0005208104,4.2092347e-7,0.0030709475,0.53065246,0.00057776936,0.00004545373,0.0000040820246,0.0000011321945,0.000003898776,0.46432102,0.0002757631],"about_ca_topic_score_codex":0.00007840175,"about_ca_topic_score_gemma":0.00014123868,"teacher_disagreement_score":0.6952041,"about_ca_system_score_codex":0.0005543585,"about_ca_system_score_gemma":0.0006380326,"threshold_uncertainty_score":0.9995374},"labels":[],"label_agreement":null},{"id":"W4292534152","doi":"10.21203/rs.3.rs-1859594/v1","title":"Physiotherapy intervention on changes in post-chemotherapy sensibility with taxanes","year":2022,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Taxane; Sensibility; Medicine; Chemotherapy; Physical therapy; Internal medicine; Breast cancer; Cancer","score_opus":0.07127199899828172,"score_gpt":0.4938026132663427,"score_spread":0.422530614268061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292534152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98379016,0.0010306612,0.0000019886857,0.010755629,0.00017437327,0.002669558,0.00011487921,0.000062302584,0.0014004537],"genre_scores_gemma":[0.992045,0.0017896448,0.00006136399,0.0005761237,0.00035826326,0.0009595212,0.0005810653,0.00006166145,0.0035673864],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99718267,0.0006643897,0.00018989811,0.0007010163,0.0008178104,0.00044419244],"domain_scores_gemma":[0.9987023,0.00022263685,0.00008554366,0.0006020333,0.00027484956,0.00011263212],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000893528,0.00025012504,0.0004686738,0.0006020712,0.00009473624,0.000028759976,0.00015325495,0.00016725718,0.005481075],"category_scores_gemma":[0.000036210575,0.00019552799,0.00015372927,0.0003895828,0.000134605,0.000021039452,0.0001975887,0.0016173356,0.000018834206],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13437591,0.029639509,0.3371871,0.016183132,0.0031342204,0.0037025283,0.01728023,0.00078780873,0.048092194,0.0002712149,0.017884899,0.39146122],"study_design_scores_gemma":[0.0227663,0.038113218,0.86466044,0.0038228903,0.00010381461,0.000044811633,0.0037360734,0.00037796728,0.021584503,0.0010260073,0.04296962,0.00079436623],"about_ca_topic_score_codex":0.0030191382,"about_ca_topic_score_gemma":0.0040934044,"teacher_disagreement_score":0.52747333,"about_ca_system_score_codex":0.00106264,"about_ca_system_score_gemma":0.00035045668,"threshold_uncertainty_score":0.995428},"labels":[],"label_agreement":null},{"id":"W4295818074","doi":"10.1016/j.annonc.2022.07.665","title":"537P A phase I/II study of oral chk1 inhibitor LY2880070 in combination with low-dose gemcitabine in patients with advanced or metastatic ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ozmosis Research (Canada); Alberta Health Services; Princess Margaret Cancer Centre; McGill University Health Centre; University Health Network; Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Gemcitabine; Oncology; Internal medicine; Phases of clinical research; Ovarian cancer; Cancer; Chemotherapy","score_opus":0.05685263538688413,"score_gpt":0.4240513685658881,"score_spread":0.367198733179004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295818074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996073,0.000112661306,0.0000014989068,0.0013900783,0.0001331705,0.0020711708,0.000061527135,0.000009227455,0.0001476528],"genre_scores_gemma":[0.9983261,0.000031209373,0.00015071178,0.0005015783,0.000012642056,0.0007281858,0.000089739646,0.000020141033,0.00013964582],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9984791,0.00023805836,0.00046855267,0.00026864329,0.00028839873,0.0002572074],"domain_scores_gemma":[0.9991396,0.000093347844,0.0003347295,0.00015473743,0.00021081248,0.00006678796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027172503,0.00016343474,0.0007392106,0.00040014496,0.000046391982,0.0000013261641,0.00008370286,0.00003338874,0.00057819195],"category_scores_gemma":[0.000024252106,0.000119891345,0.00002938158,0.00077196426,0.00008153388,0.00009449298,0.0000719487,0.00021200038,4.1992396e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20305716,0.19571722,0.46588936,0.00023477715,0.00095453614,0.00073037785,0.011519266,0.0014571598,0.0014508232,0.000053494354,0.0010553219,0.11788049],"study_design_scores_gemma":[0.251209,0.39720687,0.34457105,0.00010060592,0.00037295185,0.000010779141,0.00230766,0.00013553235,0.0012636122,0.000030343257,0.002587386,0.00020422778],"about_ca_topic_score_codex":0.0014704278,"about_ca_topic_score_gemma":0.0061963517,"teacher_disagreement_score":0.20148964,"about_ca_system_score_codex":0.00022826444,"about_ca_system_score_gemma":0.0006417645,"threshold_uncertainty_score":0.63307965},"labels":[],"label_agreement":null},{"id":"W4295828440","doi":"10.1016/j.annonc.2022.07.1492","title":"1360MO Quality of life and patient-relevant endpoints with darolutamide in the phase III ARASENS study","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Cliniques Universitaires Saint-Luc; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Medical Research Council; Université Catholique de Louvain; Bayer HealthCare; University College London; Bayer","keywords":"Medicine; Docetaxel; Prostate cancer; Internal medicine; Cumulative incidence; Incidence (geometry); Rash; Androgen deprivation therapy; Adverse effect; Clinical endpoint; Cancer; Randomized controlled trial; Cohort","score_opus":0.13070937859407863,"score_gpt":0.4640188743778277,"score_spread":0.333309495783749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295828440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917615,0.00055724377,9.0662604e-7,0.0053608436,0.00007100661,0.0007996972,0.00005517472,0.0000053815843,0.0013882247],"genre_scores_gemma":[0.9966895,0.000093326395,0.000019796315,0.0030091535,0.000023269447,0.00011042641,0.000014358706,0.00000651261,0.00003364795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984237,0.0005826044,0.0004294015,0.0001771775,0.00021848264,0.00016865865],"domain_scores_gemma":[0.99900264,0.00042362465,0.00026811563,0.00018131222,0.000064523956,0.000059803024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006657915,0.00009493766,0.0005238098,0.00010403607,0.000051085586,0.0000011642636,0.00007455332,0.000029147548,0.00024067034],"category_scores_gemma":[0.00005962718,0.00006315475,0.000044123775,0.00018168223,0.00014856322,0.000021672015,0.00006754949,0.00019029314,5.898712e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10413208,0.10084817,0.53358984,0.0002317351,0.0020741,0.001638436,0.09965383,0.00014437025,0.017605571,0.0005269693,0.02360634,0.11594859],"study_design_scores_gemma":[0.12316954,0.26282632,0.48286292,0.000031377287,0.0005875123,0.00023558586,0.06896773,0.00008112018,0.003902108,0.00037170306,0.05662166,0.00034240494],"about_ca_topic_score_codex":0.000697129,"about_ca_topic_score_gemma":0.00059570756,"teacher_disagreement_score":0.16197817,"about_ca_system_score_codex":0.000032485066,"about_ca_system_score_gemma":0.00025288746,"threshold_uncertainty_score":0.26351714},"labels":[],"label_agreement":null},{"id":"W4295865713","doi":"10.1136/spcare-2022-003815","title":"Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"BMJ Supportive & Palliative Care","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto","funders":"","keywords":"Duloxetine; Medicine; Chemotherapy-induced peripheral neuropathy; Placebo; Duloxetine Hydrochloride; Meta-analysis; Randomized controlled trial; Clinical trial; Internal medicine; Peripheral neuropathy; Alternative medicine; Diabetes mellitus","score_opus":0.22426579728075305,"score_gpt":0.4838111190861874,"score_spread":0.2595453218054343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295865713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000067901645,0.97970074,0.000018075738,0.00020367837,0.00004304768,0.018713087,0.0011510917,0.000019495663,0.00008288117],"genre_scores_gemma":[0.00023410868,0.98149514,0.00010163879,0.00026822818,0.000049477057,0.013831824,0.0020403701,0.000066093526,0.0019131254],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967904,0.0006998922,0.0012878728,0.0007225663,0.00025271124,0.0002465278],"domain_scores_gemma":[0.997143,0.0003925683,0.0016368385,0.0003975444,0.00028702832,0.00014303574],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024827057,0.0006765425,0.009675001,0.00023461258,0.00008934769,0.000011609522,0.00007822279,0.00012459101,0.001921141],"category_scores_gemma":[0.00009654117,0.00043692777,0.0034234233,0.00047228005,0.0000651127,0.000035074452,0.000042306565,0.00012687578,0.0000010471074],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010576172,0.00032660924,0.000081852115,0.76086915,0.2220086,0.000049179594,0.0011533111,7.411298e-8,0.0000014420983,0.000008039698,0.000106232284,0.015289779],"study_design_scores_gemma":[0.0014175002,0.0040478376,0.000054093834,0.0064999405,0.92136246,0.00002093992,0.0003541606,0.0000021455494,0.000011172893,0.000002435416,0.06592947,0.00029783172],"about_ca_topic_score_codex":0.000022521983,"about_ca_topic_score_gemma":0.000035986766,"teacher_disagreement_score":0.7543692,"about_ca_system_score_codex":0.00045694812,"about_ca_system_score_gemma":0.00028408002,"threshold_uncertainty_score":0.99980825},"labels":[],"label_agreement":null},{"id":"W4296465570","doi":"10.1158/1535-7163.1207.3.10","title":"Topoisomerase-IIα expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel","year":2004,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Docetaxel; Doxorubicin; Confidence interval; Medicine; Odds ratio; Internal medicine; Breast cancer; Chemotherapy; Cancer; Oncology; Paclitaxel; Population; Topoisomerase; Pharmacology; Chemistry; In vitro","score_opus":0.019418069999127794,"score_gpt":0.3001555046830174,"score_spread":0.28073743468388956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296465570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939775,0.0024538776,0.00016525677,0.0008922627,0.00021333183,0.0018569971,0.00015376367,0.000054527223,0.00023249038],"genre_scores_gemma":[0.99673605,0.00060535053,0.00019413975,0.0013562423,0.00006445635,0.0004955508,0.000116265845,0.00008909245,0.00034285238],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794745,0.00010456292,0.0005022432,0.0005081253,0.0005029804,0.00043465555],"domain_scores_gemma":[0.9989579,0.00003479987,0.00031843715,0.000294318,0.0002474297,0.00014717084],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006986235,0.00041687058,0.0006449184,0.00021956326,0.000060095415,0.00001515544,0.000104887935,0.0001594207,0.0003998186],"category_scores_gemma":[0.000005848038,0.00029185982,0.00013776921,0.0005317049,0.00009875077,0.000121652556,0.000032288193,0.0002041249,0.000002812733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07660706,0.004980081,0.21221253,0.00018101076,0.0011390854,0.00021405914,0.0019727862,0.0047382275,0.67202115,0.000006966478,0.00002533828,0.02590166],"study_design_scores_gemma":[0.08291593,0.006813283,0.28151152,0.0021097336,0.0018276224,0.000051961622,0.00019845058,0.0001696161,0.62237173,0.00008755595,0.0012795319,0.0006630839],"about_ca_topic_score_codex":0.002205747,"about_ca_topic_score_gemma":0.0009463462,"teacher_disagreement_score":0.069298975,"about_ca_system_score_codex":0.0013351002,"about_ca_system_score_gemma":0.0002536693,"threshold_uncertainty_score":0.9999533},"labels":[],"label_agreement":null},{"id":"W4299332341","doi":"10.5281/zenodo.6974577","title":"PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domain","year":2022,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sciex (Canada)","funders":"Medical Research Council","keywords":"Gene isoform; Phosphorylation; GTPase; Protein kinase C; Chemistry; Kinase; Domain (mathematical analysis); Cell biology; Biochemistry; Biology; Gene","score_opus":0.028267698779940183,"score_gpt":0.2665394141196706,"score_spread":0.2382717153397304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4299332341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745482,0.000673041,0.000047833062,0.006456639,0.0001262655,0.0008964574,0.00032943411,0.00039655346,0.016525565],"genre_scores_gemma":[0.9928147,0.0001337491,0.000096126794,0.0012881855,0.0000921179,7.276092e-7,0.0013191783,0.0006447392,0.0036104473],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982404,0.0004218611,0.00025559394,0.0003836223,0.00036183084,0.00033671004],"domain_scores_gemma":[0.9990967,0.000069233174,0.00015488669,0.00033764503,0.0001568008,0.00018474842],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00079906045,0.00017215774,0.00020312918,0.00010165645,0.0035748226,0.00020947403,0.00036042408,0.000041634015,0.012637664],"category_scores_gemma":[0.00016135466,0.00013780556,0.00004989093,0.00041704252,0.00025621548,0.00013410176,0.0009547671,0.0004926634,0.00031374823],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036250176,0.000813707,0.00056667137,0.0001663013,0.0003975858,0.00025448867,0.010953608,0.000058846468,0.17204653,0.002885977,0.7755556,0.03267564],"study_design_scores_gemma":[0.0036217908,0.0013901531,0.0014394344,0.000030090843,0.00009352331,0.00041266336,0.0035213823,0.00028873645,0.009914923,0.00040661593,0.97865885,0.00022184594],"about_ca_topic_score_codex":0.000115581606,"about_ca_topic_score_gemma":0.0000020762348,"teacher_disagreement_score":0.20310321,"about_ca_system_score_codex":0.00024203306,"about_ca_system_score_gemma":0.000013644048,"threshold_uncertainty_score":0.9977224},"labels":[],"label_agreement":null},{"id":"W4300424574","doi":"10.17615/nn8a-yn80","title":"Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy","year":2020,"lang":"en","type":"article","venue":"UNC Libraries","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; National Center for Advancing Translational Sciences; National Institutes of Health; National Cancer Institute; National Institute on Aging; University of Alberta; Breast Cancer Research Foundation","keywords":"Taxane; Medicine; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Chemotherapy; Toxicity; Cancer","score_opus":0.012601772211202514,"score_gpt":0.2434031850421806,"score_spread":0.23080141283097808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300424574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953307,0.00033451017,0.00007460796,0.0035149632,0.00007968834,0.00038150526,0.00008344231,0.00003641362,0.00016416995],"genre_scores_gemma":[0.9984382,0.000026010468,0.0003792095,0.0009411389,0.00006945354,0.000022065737,0.00006502829,0.000022308714,0.00003660806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992512,0.00004528721,0.00017135814,0.00018313777,0.00021790035,0.00013114921],"domain_scores_gemma":[0.99961954,0.000057289388,0.00008964483,0.00006983283,0.0000665793,0.000097133416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000038310885,0.00013159298,0.00028700495,0.00005950517,0.00002861567,0.000017290804,0.000044248136,0.000032294003,0.00035555984],"category_scores_gemma":[0.000028582093,0.00010010254,0.000026659587,0.00025565433,0.0001381241,0.00018914642,0.000016215059,0.000064028514,5.5165987e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009355966,0.00028728644,0.9940298,0.00013848333,0.00017583084,0.000004695116,0.0014211228,0.000046770154,0.00028040988,0.00020824374,0.0004333953,0.0020383664],"study_design_scores_gemma":[0.0071620685,0.0009413871,0.98713535,0.0000851503,0.0001391886,5.9634374e-7,0.000106900545,0.00008321671,0.0036949557,0.000108841996,0.0004328107,0.00010955579],"about_ca_topic_score_codex":0.00021936969,"about_ca_topic_score_gemma":0.00007760255,"teacher_disagreement_score":0.0068944716,"about_ca_system_score_codex":0.000029418221,"about_ca_system_score_gemma":0.00022630734,"threshold_uncertainty_score":0.40820628},"labels":[],"label_agreement":null},{"id":"W4301154975","doi":"","title":"Abstracts from the 2001 Annual Conference of the Canadian Pain Society. May 10-12, 2001. Montreal, Quebec, Canada.","year":2001,"lang":"en","type":"other","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gerontology; Psychology; Psychiatry; Library science; Computer science","score_opus":0.02810918024924491,"score_gpt":0.23976308317448847,"score_spread":0.21165390292524355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301154975","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019206668,0.0050514913,0.000001115564,0.0626885,0.0015641516,0.00351512,0.004807193,0.000064283864,0.92038745],"genre_scores_gemma":[0.03432752,0.0006672792,0.000010069178,0.0058804313,0.0010161868,0.00050861936,0.00036742867,0.00013494871,0.9570875],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817383,0.000140969,0.00026505103,0.00030902476,0.00035169438,0.0007594509],"domain_scores_gemma":[0.99849993,0.00020038677,0.0002744236,0.0004758941,0.00009443583,0.000454915],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030352335,0.000308417,0.00045765968,0.0000433952,0.000100277684,0.000021900818,0.00035770788,0.00033185925,0.015415329],"category_scores_gemma":[0.00009232144,0.00018619788,0.00015807617,0.00014055763,0.00020748145,0.000018862298,0.000033733384,0.0003567358,0.000011687352],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030754938,0.000058407306,0.005122429,0.000022184922,0.0005634576,0.00005507075,0.00020166955,0.0000017807943,0.0000011090807,0.0000018879011,0.97841364,0.015527605],"study_design_scores_gemma":[0.0008576771,0.000007933939,0.21124132,0.00004726324,0.00032930795,0.0000037861125,0.00015360919,0.0000037904522,0.000012184565,0.0000073751007,0.78720164,0.00013409012],"about_ca_topic_score_codex":0.99989873,"about_ca_topic_score_gemma":0.99999714,"teacher_disagreement_score":0.2061189,"about_ca_system_score_codex":0.0010394398,"about_ca_system_score_gemma":0.005332699,"threshold_uncertainty_score":0.9854847},"labels":[],"label_agreement":null},{"id":"W4302770549","doi":"","title":"Abstracts from the 2002 Annual Conference of the Canadian Pain Society. May 23-25, 2002, Winnipeg, Manitoba, Canada.","year":2002,"lang":"en","type":"other","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gerontology; Medicine; Family medicine; Psychology","score_opus":0.03281260093596796,"score_gpt":0.22661787894862595,"score_spread":0.19380527801265798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302770549","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014849597,0.0103570055,7.5027594e-7,0.030287255,0.0023679892,0.0033890542,0.0054406496,0.00005693798,0.9466154],"genre_scores_gemma":[0.09047893,0.00040001786,0.00001551452,0.007238874,0.0013430311,0.0005013274,0.00014111518,0.00015536726,0.89972585],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998226,0.00013450604,0.00027533981,0.00032271072,0.00041095266,0.0006305121],"domain_scores_gemma":[0.99858725,0.00017658659,0.00027537392,0.0005065324,0.000099971374,0.00035427345],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025010554,0.00032051388,0.00044032338,0.00004701305,0.000117700954,0.000022509983,0.0004046771,0.00033257797,0.01306636],"category_scores_gemma":[0.00007151541,0.00019717959,0.00016535586,0.00016262778,0.00022835836,0.00001976821,0.000038740076,0.00048780857,0.000048006634],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012358314,0.000049558454,0.003527604,0.000033710483,0.00048806967,0.000042320393,0.0002140863,0.0000010296862,0.0000011669085,0.000005594555,0.9800813,0.015543193],"study_design_scores_gemma":[0.00077124836,0.000011076026,0.16399065,0.000061626364,0.00035290065,0.0000058981946,0.00019017397,0.0000049684754,0.000023775814,0.0000040840077,0.83442855,0.0001550522],"about_ca_topic_score_codex":0.9955954,"about_ca_topic_score_gemma":0.99973285,"teacher_disagreement_score":0.16046305,"about_ca_system_score_codex":0.0007863392,"about_ca_system_score_gemma":0.0019333343,"threshold_uncertainty_score":0.9878358},"labels":[],"label_agreement":null},{"id":"W4303520542","doi":"10.30683/1927-7229.2022.11.06","title":"Retrospective Evaluation of the Analgesic Effects of Molecular Target Agents Against Cancer Pain and Oxaliplatin-Induced Chronic Peripheral Neuropathy","year":2022,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Oxaliplatin; Analgesic; Peripheral neuropathy; Bevacizumab; Neuropathic pain; Colorectal cancer; Panitumumab; Nociception; Chemotherapy; Cancer; Cetuximab; Internal medicine; Oncology; Pharmacology; Receptor; Endocrinology","score_opus":0.025996025064766823,"score_gpt":0.36276928919290896,"score_spread":0.3367732641281421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303520542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504465,0.0015638195,0.000023703033,0.0020560306,0.000465133,0.0003559869,0.0000057094476,0.0000019266226,0.0004830445],"genre_scores_gemma":[0.9988658,0.000107715845,0.000037723243,0.00076165004,0.00015664588,0.000011690231,0.0000018707424,0.000010785615,0.00004615117],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99749225,0.0011802044,0.00045106397,0.00013261384,0.00059034274,0.0001535484],"domain_scores_gemma":[0.99870074,0.0001909185,0.00056725234,0.000109423854,0.00033861567,0.00009307438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013420432,0.00010665704,0.00055661815,0.00012348285,0.00005936243,0.0000022183265,0.00009822411,0.000058640726,0.00048837665],"category_scores_gemma":[0.00033711645,0.00007498704,0.00020886264,0.00030712268,0.00011884201,0.000027744536,0.00006887289,0.0004134172,1.3172881e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036430687,0.003447035,0.2688183,0.00040410337,0.0036557354,0.0009947594,0.002172241,0.0096767405,0.64824283,0.00039673268,0.0040748236,0.054473612],"study_design_scores_gemma":[0.020238759,0.038052395,0.83590037,0.00015630345,0.006359969,0.00023550946,0.00029587146,0.07003109,0.025635652,0.00070463837,0.0021884511,0.00020099462],"about_ca_topic_score_codex":0.00002974106,"about_ca_topic_score_gemma":0.000014899001,"teacher_disagreement_score":0.6226072,"about_ca_system_score_codex":0.0014758708,"about_ca_system_score_gemma":0.001131185,"threshold_uncertainty_score":0.5347382},"labels":[],"label_agreement":null},{"id":"W4306165741","doi":"10.51731/cjht.2022.467","title":"Selinexor (Xpovio)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Dexamethasone; Multiple myeloma; Drug; Drug class; Family medicine; Intensive care medicine; Pharmacology; Health care; Political science; Internal medicine","score_opus":0.039031156922889484,"score_gpt":0.33490013292492893,"score_spread":0.29586897600203943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306165741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44382617,0.19572236,0.000047219477,0.35653007,0.0018796464,0.0004918771,0.00006870524,0.00016449452,0.0012694777],"genre_scores_gemma":[0.9961692,0.00036461753,0.00028922522,0.0026805187,0.000021858566,0.000013710616,0.0000042795255,0.000009494338,0.00044708158],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99914694,0.000043009863,0.0003192107,0.000077948134,0.0001147977,0.00029808172],"domain_scores_gemma":[0.99947405,0.000025636227,0.0002153633,0.00012297342,0.000068834546,0.000093167764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036585747,0.000071271985,0.00027136935,0.00052226643,0.00030249465,0.0000054808957,0.0001591943,0.000039950533,0.0005602605],"category_scores_gemma":[0.00007264603,0.00006183172,0.00006916968,0.0002904309,0.00008563565,0.000028339327,0.000020474634,0.00049446267,0.0000050388026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013139025,0.00011318327,0.02605373,0.00008305234,0.00015029503,0.0015788941,0.0005807216,0.000045947814,0.00019921715,0.0007704274,0.22037916,0.749914],"study_design_scores_gemma":[0.001032612,0.0017710758,0.004176842,0.000021281649,0.00003169122,0.0020531134,0.0023474037,0.0000061949904,0.00021492032,0.0007055588,0.9875836,0.000055757042],"about_ca_topic_score_codex":0.0028847794,"about_ca_topic_score_gemma":0.0012401651,"teacher_disagreement_score":0.7672044,"about_ca_system_score_codex":0.0008715238,"about_ca_system_score_gemma":0.004569148,"threshold_uncertainty_score":0.8105473},"labels":[],"label_agreement":null},{"id":"W4306359299","doi":"10.56588/iabcd.v1i2.66","title":"IN SILICO SCREENING OF MAJOR CANCER DRUG TARGETS (GROWTH FACTOR RECEPTORS) FOR NATURE DERIVED PHYTOCHEMICALS","year":2022,"lang":"en","type":"article","venue":"International Association of Biologicals and Computational Digest","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Drug target; In silico; Receptor; Biology; Chemistry; Pharmacology; Biochemistry; Gene","score_opus":0.013647804335840933,"score_gpt":0.32427777211326664,"score_spread":0.3106299677774257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306359299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98699963,0.0005572844,0.00010606797,0.010672663,0.00030540323,0.0003270063,0.00085477234,0.0000091237225,0.00016802133],"genre_scores_gemma":[0.99693376,0.00010498977,0.00088859274,0.0008320329,0.00010951215,0.0001664801,0.00052435545,0.0000050665176,0.00043522933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914813,0.000047044407,0.0002993127,0.00017151069,0.00023658169,0.00009742196],"domain_scores_gemma":[0.99874175,0.0005872887,0.00031786814,0.000022457416,0.0003005452,0.00003008474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014762412,0.00008243628,0.00023910547,0.00009141688,0.000045437275,0.000004325539,0.00007068107,0.00007203515,0.00058508484],"category_scores_gemma":[0.00014820012,0.00007231849,0.000085504566,0.00009967058,0.000028296776,0.000041418407,0.000050919352,0.00014066295,2.939793e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001040104,0.00081406743,0.91656923,0.00004617251,0.0004206665,0.0000021235483,0.00033885482,0.0013515953,0.06965238,0.0024097108,0.0060431683,0.0013119464],"study_design_scores_gemma":[0.0046428326,0.00040777645,0.9552259,0.00003958832,0.000054942222,0.0000034970744,0.0001139758,0.0015765622,0.022817928,0.0054814653,0.0094811395,0.00015438908],"about_ca_topic_score_codex":0.000070942755,"about_ca_topic_score_gemma":0.000008848761,"teacher_disagreement_score":0.04683445,"about_ca_system_score_codex":0.00020189304,"about_ca_system_score_gemma":0.000051538133,"threshold_uncertainty_score":0.64062685},"labels":[],"label_agreement":null},{"id":"W4308158641","doi":"10.1016/j.ejca.2022.10.017","title":"Measuring variation in the quality of systemic anti-cancer therapy delivery across hospitals: A national population-based evaluation","year":2022,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Cohort; Toxicity; Cancer; Population; Acute toxicity; Colorectal cancer; Internal medicine; Cohort study; Emergency medicine; Environmental health","score_opus":0.1279048075481206,"score_gpt":0.4373227682302942,"score_spread":0.3094179606821736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308158641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894211,0.008398289,0.000036838333,0.0011268808,0.00044070382,0.00032894404,0.000043023163,0.0000038022067,0.00020038665],"genre_scores_gemma":[0.9985436,0.0004519686,0.000024999747,0.0005509449,0.00033118724,0.000040481915,0.000011840179,0.000012748158,0.000032233766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967386,0.0014322321,0.00056614913,0.0000982941,0.001064279,0.00010041239],"domain_scores_gemma":[0.9984608,0.00012519592,0.0007174084,0.000078037985,0.0005938864,0.000024616023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00542532,0.00007939975,0.0002170931,0.00010659025,0.000095345844,0.000010806487,0.0001207368,0.000010739857,0.00045365107],"category_scores_gemma":[0.00006782751,0.000058229944,0.00010960035,0.00023968413,0.00001670371,0.00008427323,0.000012445795,0.00019479264,6.7336896e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022027784,0.0005379449,0.7723697,0.000093344504,0.00039613023,0.000023141862,0.007782721,0.11956494,0.064538114,0.00003353876,0.0006586869,0.03179899],"study_design_scores_gemma":[0.005817289,0.00027904948,0.99154633,0.00010239662,0.00007965652,0.000013886395,0.00033377434,0.0008090009,0.0005235653,0.000015529757,0.00042022712,0.00005929459],"about_ca_topic_score_codex":0.00035760782,"about_ca_topic_score_gemma":0.00003835997,"teacher_disagreement_score":0.21917665,"about_ca_system_score_codex":0.000689923,"about_ca_system_score_gemma":0.0004814683,"threshold_uncertainty_score":0.4967161},"labels":[],"label_agreement":null},{"id":"W4308834775","doi":"10.1200/jco.22.01637","title":"Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Common Terminology Criteria for Adverse Events; Oxaliplatin; Colorectal cancer; Cancer; Adverse effect; Peripheral neuropathy; Odds ratio; Oncology; Surgery; Diabetes mellitus","score_opus":0.09447792420464099,"score_gpt":0.45060245459565806,"score_spread":0.3561245303910171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308834775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98493415,0.0024414298,0.000007591938,0.005285754,0.006553382,0.0003982836,0.00019947698,0.0000109875045,0.00016893541],"genre_scores_gemma":[0.9895018,0.004710455,0.00028422248,0.0033986971,0.0017674078,0.000036667156,0.000037199447,0.000033445656,0.00023013231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99495316,0.0010462311,0.0026602484,0.0003623267,0.000624985,0.0003530403],"domain_scores_gemma":[0.99565,0.0016165031,0.0019922499,0.00020040522,0.0001925897,0.00034825515],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013621243,0.00024038392,0.0022658685,0.00014644262,0.000080476,0.0000063946773,0.00033093637,0.00031775222,0.0072344244],"category_scores_gemma":[0.0003001699,0.00019732505,0.0005750256,0.0002655648,0.00017719138,0.000099978985,0.00012596522,0.0018985936,0.0000035659984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07161017,0.0077531105,0.6883034,0.000019929003,0.0014678689,0.00638514,0.002751679,0.00065471133,0.107128225,0.000017359134,0.007927709,0.10598071],"study_design_scores_gemma":[0.07114356,0.041343153,0.8244853,0.000071108014,0.0007561404,0.00006821854,0.0008018201,0.0007245542,0.0035138398,0.0001952542,0.056607127,0.000289952],"about_ca_topic_score_codex":0.0033414087,"about_ca_topic_score_gemma":0.000903498,"teacher_disagreement_score":0.13618189,"about_ca_system_score_codex":0.0006285589,"about_ca_system_score_gemma":0.002510958,"threshold_uncertainty_score":0.9936731},"labels":[],"label_agreement":null},{"id":"W4311301274","doi":"10.1111/cbdd.14192","title":"Protective effect of a mitochondria‐targeting peptide against paclitaxel‐induced peripheral neuropathy","year":2022,"lang":"en","type":"letter","venue":"Chemical Biology & Drug Design","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"National Institute on Drug Abuse; Japan Society for the Promotion of Science; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Paclitaxel; Peripheral neuropathy; Medicine; Chemotherapy-induced peripheral neuropathy; Pharmacology; Chemotherapy; Mitochondrion; Concomitant; Tetrapeptide; Peripheral; Apoptosis; Cancer; Internal medicine; Peptide; Endocrinology; Chemistry","score_opus":0.019983420148005655,"score_gpt":0.2885066232253277,"score_spread":0.2685232030773221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311301274","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83429134,0.003188609,0.00014558127,0.14839466,0.0028888576,0.0084682405,0.0002909307,0.00038685228,0.0019449138],"genre_scores_gemma":[0.4770154,0.00030214217,0.0019592922,0.48197326,0.017840188,0.008684128,0.00760773,0.00063208176,0.0039857724],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99574995,0.0015906724,0.00062444044,0.0010375847,0.00024255911,0.0007548049],"domain_scores_gemma":[0.9973494,0.0015460419,0.00042426426,0.00043983563,0.00010377856,0.0001366713],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00044046162,0.0007000409,0.00160568,0.00018372365,0.00010940185,0.000008441381,0.0003389183,0.0009099166,0.0008796321],"category_scores_gemma":[0.00041188337,0.0005594866,0.0005995163,0.0002714157,0.0003405558,0.000029622752,0.00018829836,0.0034077754,0.000027946657],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001962419,0.00009955469,0.0002502232,0.00027668665,0.00042980365,0.0005396053,0.00019851475,0.0000011185562,0.6100075,4.9158484e-7,0.3854146,0.0008194475],"study_design_scores_gemma":[0.0070222686,0.0063378736,0.000023827064,0.00016660166,0.0014124073,0.00014529449,0.000032660413,0.000052873645,0.73259157,0.000106776475,0.2513096,0.0007982257],"about_ca_topic_score_codex":0.000055788994,"about_ca_topic_score_gemma":3.3953654e-7,"teacher_disagreement_score":0.35727596,"about_ca_system_score_codex":0.0005094638,"about_ca_system_score_gemma":0.00028027367,"threshold_uncertainty_score":0.99968565},"labels":[],"label_agreement":null},{"id":"W4311566589","doi":"10.5281/zenodo.7439018","title":"SDC4: A Target Enabling Package","year":2022,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Computer science","score_opus":0.042803861407230664,"score_gpt":0.28872400763245576,"score_spread":0.2459201462252251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311566589","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26827005,0.0013287954,0.0013795345,0.016206818,0.0007911659,0.0023387456,0.00099952,0.002878809,0.70580655],"genre_scores_gemma":[0.98731405,0.00006814406,0.00027231238,0.00095682824,0.00025843093,1.987675e-7,0.0026205007,0.0010199806,0.0074895327],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988049,0.00021468857,0.00014458083,0.00027137567,0.00028832143,0.00027610984],"domain_scores_gemma":[0.9993871,0.000019979352,0.00005264468,0.00024698777,0.00014594932,0.0001473334],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00036170235,0.00009230793,0.00013497751,0.00019394312,0.0020296343,0.00010544851,0.00028986973,0.000022640954,0.12857158],"category_scores_gemma":[0.00012275152,0.00009772755,0.000058798894,0.00044757334,0.00006596284,0.00007110629,0.00079169066,0.00029309661,0.0028569452],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063529983,0.00075338065,0.000064434294,0.00007311299,0.00015773016,0.00022391848,0.0021751502,0.000074891606,0.028893251,0.0017697538,0.9251395,0.040039573],"study_design_scores_gemma":[0.0014654789,0.0009431383,0.00035772927,0.0000058197393,0.00003734137,0.00035152736,0.00039239042,0.000121696794,0.0009208147,0.000093685296,0.99521875,0.00009164775],"about_ca_topic_score_codex":0.0000139603935,"about_ca_topic_score_gemma":7.6973436e-8,"teacher_disagreement_score":0.719044,"about_ca_system_score_codex":0.00028167045,"about_ca_system_score_gemma":0.0000069697626,"threshold_uncertainty_score":0.9992696},"labels":[],"label_agreement":null},{"id":"W4318938350","doi":"10.1007/s40278-023-32610-7","title":"Canadian product monographs for apomorphine and lurbinectedin updated","year":2023,"lang":"en","type":"article","venue":"Reactions Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Apomorphine; Computer science; Neuroscience; Psychology; Dopaminergic; Dopamine","score_opus":0.029778618625921984,"score_gpt":0.32089397946147746,"score_spread":0.2911153608355555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318938350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.939617,0.00032895108,0.000013163729,0.053663004,0.00068285264,0.0012027371,0.0002636871,0.00032720712,0.0039014216],"genre_scores_gemma":[0.9673447,0.00032701314,0.00025327955,0.00032390424,0.00033105072,0.00021915496,0.0012281027,0.000023784654,0.029949004],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994468,0.0000075721114,0.00010229165,0.00018206901,0.000045614644,0.0002156569],"domain_scores_gemma":[0.99956316,0.000036414556,0.000023021421,0.00011487719,0.00006359489,0.00019890467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006937654,0.00008243943,0.00013072681,0.00035186426,0.00012993441,0.000009482089,0.000021427619,0.000040374194,0.00017915638],"category_scores_gemma":[0.000026550113,0.00007551073,0.00004161475,0.00054751814,0.000027721551,0.000041509626,0.000006122231,0.000078203964,0.00005403061],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019304827,0.00012212856,0.020252418,0.00006218638,0.00031236192,0.00004879887,0.00013219859,0.0000049693504,0.03569955,0.00031307142,0.9339845,0.008874771],"study_design_scores_gemma":[0.0015239911,0.00024584366,0.056386687,0.000012615306,0.00021195103,0.00009533778,0.00005712102,0.00039325713,0.0018324935,0.00012198661,0.93902993,0.00008876392],"about_ca_topic_score_codex":0.03427199,"about_ca_topic_score_gemma":0.02996265,"teacher_disagreement_score":0.0533391,"about_ca_system_score_codex":0.00011118874,"about_ca_system_score_gemma":0.00018063621,"threshold_uncertainty_score":0.987738},"labels":[],"label_agreement":null},{"id":"W4318967494","doi":"10.1097/cad.0000000000001429","title":"Efficacy of Duloxetine on electrodiagnostic findings of Paclitaxel-induced peripheral neuropathy, does it have a prophylactic effect? A randomized clinical trial","year":2022,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; Island Health","funders":"","keywords":"Duloxetine; Peripheral neuropathy; Medicine; Chemotherapy-induced peripheral neuropathy; Paclitaxel; Randomized controlled trial; Peripheral; Clinical trial; Internal medicine; Chemotherapy; Alternative medicine; Diabetes mellitus; Pathology","score_opus":0.027619715702373142,"score_gpt":0.3820460627967212,"score_spread":0.35442634709434806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318967494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99059,0.0003405268,0.0000020022844,0.0025990426,0.0016370136,0.00413355,0.000044527278,0.000040229257,0.00061311224],"genre_scores_gemma":[0.996138,0.00045506444,0.00001550915,0.0008791087,0.00068280986,0.0008586362,0.000038413662,0.000050654882,0.0008818271],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958469,0.0015529835,0.0010705313,0.0005637647,0.0005508609,0.00041490598],"domain_scores_gemma":[0.99474186,0.0040983167,0.0005472855,0.00036810993,0.00010200236,0.0001424537],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017116381,0.00032766288,0.0019173763,0.00019657258,0.00011704894,0.000009633079,0.00018585018,0.00009470114,0.0016107082],"category_scores_gemma":[0.0011257516,0.0002258205,0.00080372085,0.00032348474,0.00025019192,0.00004389578,0.000098543045,0.0006609233,0.000007519052],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9554917,0.0037159182,0.0094339615,0.0002712909,0.0007401427,0.000085587744,0.0011548549,0.0000210923,0.021726377,0.000035746027,0.00096357096,0.006359754],"study_design_scores_gemma":[0.9130545,0.021478549,0.0039846054,0.00011039432,0.0020735243,0.000010582841,0.000091175054,0.0001893778,0.057400476,0.000020211797,0.0013269352,0.00025966775],"about_ca_topic_score_codex":0.00040126673,"about_ca_topic_score_gemma":0.0000133836675,"teacher_disagreement_score":0.042437203,"about_ca_system_score_codex":0.00018063952,"about_ca_system_score_gemma":0.00042960342,"threshold_uncertainty_score":0.99930197},"labels":[],"label_agreement":null},{"id":"W4320486525","doi":"10.1097/01.reo.0000000000000332","title":"Improving Evidence-Based Methods of Characterizing Shoulder-Related Quality of Life for Survivors of Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Rehabilitation Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo","funders":"","keywords":"Breast cancer; Quality of life (healthcare); Range of motion; Medicine; Physical therapy; Rehabilitation; Population; International Classification of Functioning, Disability and Health; Physical medicine and rehabilitation; Internal rotation; Cancer; Internal medicine; Environmental health; Nursing","score_opus":0.14602390516567995,"score_gpt":0.5049144695426756,"score_spread":0.3588905643769956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320486525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868329,0.00037809895,0.0010502219,0.010062562,0.00048341058,0.000977636,0.00013862996,0.000039242255,0.000037264617],"genre_scores_gemma":[0.989142,0.000066806824,0.010108915,0.00017698748,0.000055199085,0.00028468104,0.000041379008,0.000017708884,0.00010634908],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99782664,0.00067445973,0.0009455668,0.00023192057,0.00014355722,0.000177877],"domain_scores_gemma":[0.98952156,0.008906503,0.0007331754,0.00018038237,0.00058388745,0.00007448604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023986397,0.00011117674,0.0008058631,0.00027530134,0.00002554771,9.811858e-7,0.00006579608,0.00017664734,0.00022867713],"category_scores_gemma":[0.0021102678,0.00010111551,0.00023356621,0.0005279481,0.00023878214,0.00007391109,0.000022030421,0.00009139811,8.752815e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002892331,0.00050340197,0.17698526,0.0026609504,0.0002075787,3.849639e-7,0.0014620922,0.00012957756,0.7537273,0.00038042164,0.00016023288,0.06089045],"study_design_scores_gemma":[0.005351933,0.0044230963,0.95049036,0.00033604336,0.00037677813,0.0000013774229,0.00063930167,0.0034033202,0.03408172,0.00022325497,0.00055548,0.00011732513],"about_ca_topic_score_codex":0.002238232,"about_ca_topic_score_gemma":0.0001615593,"teacher_disagreement_score":0.7735051,"about_ca_system_score_codex":0.00020130415,"about_ca_system_score_gemma":0.00097000407,"threshold_uncertainty_score":0.4123371},"labels":[],"label_agreement":null},{"id":"W4322628515","doi":"","title":"Identification of taxanes in solvent extracts from leaves of Taxus baccata L. using 13C NMR spectroscopy","year":2009,"lang":"en","type":"preprint","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministère des Ressources naturelles et des Forêts (Québec)","funders":"","keywords":"Taxus; Chemistry; Identification (biology); Nuclear magnetic resonance spectroscopy; Stereochemistry; Botany; Biology","score_opus":0.028268699338527225,"score_gpt":0.3064491115604126,"score_spread":0.2781804122218854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322628515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808473,0.005260639,0.0064511793,0.0024736533,0.00022938549,0.00077615655,0.00017701887,0.000048229907,0.0037364278],"genre_scores_gemma":[0.97872216,0.002228879,0.017346904,0.000036768553,0.000044671087,0.000029762514,0.0007150991,0.000031226708,0.0008445356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99628663,0.0014705724,0.0009981825,0.0006114557,0.0003708932,0.0002622726],"domain_scores_gemma":[0.99572814,0.0005774525,0.0012393751,0.0014009107,0.00093932747,0.000114806426],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019436843,0.00029069604,0.0007094372,0.00035260955,0.000064310436,0.000046362362,0.0005050429,0.0002779431,0.000245411],"category_scores_gemma":[0.00041369963,0.00031258518,0.00022812492,0.000334746,0.000214228,0.00009172317,0.00032970178,0.00047219725,0.000006728379],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024501153,0.0032743644,0.022067063,0.0005508783,0.00025188638,0.000017202636,0.0062341257,0.0003389622,0.9544008,0.0016626844,0.0003277768,0.010629295],"study_design_scores_gemma":[0.0015602811,0.000002830705,0.08437668,0.0025851203,0.00032286823,0.00000738157,0.00011404269,0.00590372,0.90164524,0.0026892412,0.00054566696,0.00024691597],"about_ca_topic_score_codex":0.0057414933,"about_ca_topic_score_gemma":0.0015759348,"teacher_disagreement_score":0.06230961,"about_ca_system_score_codex":0.0002558739,"about_ca_system_score_gemma":0.00047298046,"threshold_uncertainty_score":0.99993265},"labels":[],"label_agreement":null},{"id":"W4322769430","doi":"10.1158/1538-7445.sabcs22-p3-07-10","title":"Abstract P3-07-10: CCTG IND.236: A Phase 1b trial of combined CFI-402257 and weekly paclitaxel in patients with HER2-negative (HER2-) advanced breast cancer (aBC)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; BC Cancer Agency; Princess Margaret Cancer Centre; Queen's University; Spinal Cord Injury BC; University Health Network","funders":"","keywords":"Paclitaxel; Taxane; Breast cancer; Medicine; Internal medicine; Cancer; Oncology","score_opus":0.0716905380113208,"score_gpt":0.46528426938408063,"score_spread":0.3935937313727598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322769430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99192387,0.00039728128,3.358685e-7,0.0030831115,0.00026123002,0.0027658946,0.0007285288,0.00004712034,0.0007926256],"genre_scores_gemma":[0.9941285,0.0012326856,0.00001764832,0.000078096215,0.00022127514,0.0014537888,0.00012541813,0.00005924019,0.002683342],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99705917,0.00020014675,0.00045613947,0.00060210767,0.0009020036,0.0007804572],"domain_scores_gemma":[0.99814487,0.00045015445,0.00016101504,0.00032322897,0.0006038155,0.00031691996],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00060467276,0.00028139565,0.00068461976,0.000518279,0.00013115062,0.0000245314,0.00017287105,0.00015006581,0.002285025],"category_scores_gemma":[0.000098302924,0.0002243588,0.00007675604,0.0013313988,0.0005319429,0.00018409324,0.00011372287,0.0006595995,0.000045161923],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72122014,0.009759982,0.13429889,0.0008688259,0.0009577272,0.0002579087,0.0036296647,0.00003620807,0.0065407003,0.000039114257,0.017365828,0.10502499],"study_design_scores_gemma":[0.42518288,0.011888687,0.5550721,0.00081758143,0.00013247029,0.000002654793,0.00071169855,0.000048497175,0.0035822822,0.00016347563,0.0020647168,0.00033294418],"about_ca_topic_score_codex":0.00705696,"about_ca_topic_score_gemma":0.001777599,"teacher_disagreement_score":0.4207732,"about_ca_system_score_codex":0.0006813544,"about_ca_system_score_gemma":0.0009915692,"threshold_uncertainty_score":0.9995551},"labels":[],"label_agreement":null},{"id":"W4322774088","doi":"10.1158/1538-7445.sabcs22-p1-01-04","title":"Abstract P1-01-04: Comparing the Effects of TC and Anthracycline-based Chemotherapy in Women with Breast Cancer HER2 Negative Treated in the Adjuvant Setting – An individual Patient Meta-Analysis","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto East General Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Anthracycline; Docetaxel; Taxane; Population; Meta-analysis; Regimen; Hazard ratio; Cancer; Confidence interval","score_opus":0.10972099519088875,"score_gpt":0.44410646641234774,"score_spread":0.334385471221459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322774088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913678,0.0018907768,4.5063902e-7,0.005295853,0.000018107705,0.0012606499,0.0001083466,0.000015749727,0.0000422544],"genre_scores_gemma":[0.9970677,0.0005954897,0.000006875617,0.00046298228,0.00004898802,0.0017401165,0.000032294956,0.000022294756,0.0000232862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976591,0.00053855346,0.00029276323,0.00036786776,0.00062362384,0.00051810377],"domain_scores_gemma":[0.9981065,0.0012742794,0.00011644522,0.00028303594,0.000120284174,0.00009947525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012780976,0.00018706154,0.0007411022,0.00050003483,0.000121504665,0.000033011584,0.000187128,0.000056482375,0.00035390593],"category_scores_gemma":[0.00002767938,0.00009325328,0.00009797015,0.0024176452,0.00031684394,0.00007337065,0.00004056613,0.0005006004,9.89227e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011120405,0.0014757002,0.825831,0.00060527667,0.035941005,0.00040452232,0.05396987,0.004992867,0.009385657,0.0000042759016,0.0009999803,0.055269465],"study_design_scores_gemma":[0.005192174,0.0007293646,0.97522104,0.00008965688,0.004112471,0.0000025541974,0.0036141276,0.00095172256,0.009891382,0.000012454686,0.00007349377,0.00010955972],"about_ca_topic_score_codex":0.02572698,"about_ca_topic_score_gemma":0.020555863,"teacher_disagreement_score":0.14939006,"about_ca_system_score_codex":0.00031324517,"about_ca_system_score_gemma":0.00026313393,"threshold_uncertainty_score":0.9973164},"labels":[],"label_agreement":null},{"id":"W4322775022","doi":"10.1158/1538-7445.sabcs22-p4-07-60","title":"Abstract P4-07-60: Identification of Optimal Carboplatin Containing Regimen for Triple Negative Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital; University of Windsor; Western University","funders":"","keywords":"Carboplatin; Medicine; Regimen; Triple-negative breast cancer; Breast cancer; Cyclophosphamide; Internal medicine; Oncology; Paclitaxel; Chemotherapy; Chemotherapy regimen; Cancer; Surgery; Cisplatin","score_opus":0.14303665979491595,"score_gpt":0.4943778950274041,"score_spread":0.35134123523248817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322775022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915773,0.00083180825,0.000012641632,0.00419276,0.0003573525,0.0015704496,0.00063449895,0.00005656389,0.00076660083],"genre_scores_gemma":[0.9897225,0.00082604896,0.000036342793,0.00005087181,0.000537578,0.002089369,0.0000969885,0.000035940055,0.00660439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983363,0.00006470306,0.00033722082,0.00035077523,0.00042742532,0.00048356637],"domain_scores_gemma":[0.9984316,0.0004289421,0.0001325126,0.00021582813,0.0006506587,0.00014045394],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008644471,0.00012281508,0.0003198686,0.00029856854,0.00015297315,0.000020391612,0.00013228874,0.00009209327,0.0013260603],"category_scores_gemma":[0.00010008417,0.00011235547,0.00009775555,0.000679627,0.00018941336,0.00009482354,0.000049243365,0.00027539517,0.000045053668],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009802748,0.00024082966,0.011228531,0.0007560683,0.00075555866,0.00005879429,0.0046785814,0.00066841475,0.8670535,0.00019485755,0.07306754,0.031494595],"study_design_scores_gemma":[0.014507369,0.0010549022,0.44358793,0.0005505194,0.00031348199,0.000014469618,0.0027465413,0.0032139656,0.526859,0.00038938806,0.0064314012,0.00033104577],"about_ca_topic_score_codex":0.0051073665,"about_ca_topic_score_gemma":0.00043642925,"teacher_disagreement_score":0.4323594,"about_ca_system_score_codex":0.0005591123,"about_ca_system_score_gemma":0.0008649199,"threshold_uncertainty_score":0.9995869},"labels":[],"label_agreement":null},{"id":"W4323050383","doi":"10.1158/1538-7445.sabcs22-p3-07-18","title":"Abstract P3-07-18: CCTG IND.239: A phase 2 study of combined CFI-400945 and durvalumab in patients with advanced triple negative breast cancer (aTNBC)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Juravinski Cancer Centre; University Health Network; Hamilton Health Sciences; Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Durvalumab; Medicine; Oncology; Breast cancer; Taxane; Cancer; Internal medicine; Immunotherapy; Pembrolizumab","score_opus":0.08534702685228639,"score_gpt":0.4775520246060658,"score_spread":0.39220499775377937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323050383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949018,0.00034586035,1.3878031e-7,0.0007047188,0.00015975759,0.0030954883,0.0003949575,0.000040309355,0.00035699684],"genre_scores_gemma":[0.9967292,0.0006340908,0.0000063452503,0.000047181962,0.00008869431,0.0013672037,0.00007148807,0.000045776396,0.0010100045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749815,0.00017461674,0.0003648875,0.0005309756,0.0008124449,0.0006189229],"domain_scores_gemma":[0.9985422,0.0002432404,0.0001182939,0.00028903014,0.00056555844,0.00024169736],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004427892,0.00022597966,0.000578158,0.0005587635,0.00012765195,0.00001840896,0.00014680046,0.00008375591,0.0014522972],"category_scores_gemma":[0.00005296371,0.00017962565,0.000035873512,0.0016668298,0.00026344426,0.00016029207,0.00011300668,0.0005609616,0.000017040074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067773,0.009708897,0.8336167,0.0004555349,0.00076981226,0.00024828035,0.007512636,0.00009909458,0.0044779335,0.0000066928424,0.007001496,0.068329975],"study_design_scores_gemma":[0.087082334,0.007128033,0.9014571,0.0002980945,0.00009186631,0.0000016909297,0.0018364515,0.00004608965,0.0016431949,0.000029518795,0.00021617128,0.00016948982],"about_ca_topic_score_codex":0.008524769,"about_ca_topic_score_gemma":0.0035875055,"teacher_disagreement_score":0.06816048,"about_ca_system_score_codex":0.00056954834,"about_ca_system_score_gemma":0.0006985059,"threshold_uncertainty_score":0.9994605},"labels":[],"label_agreement":null},{"id":"W4324130405","doi":"10.2174/0929867330666230313141452","title":"Oxocarbon Acids and their Derivatives in Biological and MedicinalChemistry","year":2023,"lang":"en","type":"article","venue":"Current Medicinal Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Chemistry; Squaric acid; Bioconjugation; Biological activity; Combinatorial chemistry; Organic chemistry; Stereochemistry; Biochemistry","score_opus":0.05574743216562191,"score_gpt":0.35486049300474515,"score_spread":0.29911306083912326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324130405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98545563,0.011411885,0.0000038064545,0.0013953338,0.00012500472,0.00013622855,0.000008033285,0.000058225018,0.0014058353],"genre_scores_gemma":[0.9934541,0.0057206643,0.0000095269215,0.00009228209,0.00038978836,0.000039669652,0.000112391004,0.0000102349495,0.0001713583],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989945,0.000017933504,0.0002171132,0.00035482924,0.00012677355,0.00028879545],"domain_scores_gemma":[0.9994211,0.0001547933,0.000048561706,0.000117802745,0.000024686698,0.00023304616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018533824,0.00020710847,0.00036848505,0.00005434268,0.000039623123,0.00000515505,0.000053872296,0.0001242854,0.00021878234],"category_scores_gemma":[0.00011928578,0.00014327413,0.000035071997,0.00026239705,0.00039997278,0.000022899514,0.00007816012,0.00035666165,0.00000422508],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003553805,0.00021697817,0.36233127,0.0008327762,0.00007492925,0.00019360549,0.0015834679,1.5464721e-7,0.5936573,0.000007403998,0.00147021,0.039276507],"study_design_scores_gemma":[0.014499126,0.0008422047,0.6157981,0.0019859802,0.00025699337,0.0011537618,0.0064408886,0.00057124294,0.32664225,0.0009323411,0.030157883,0.00071923714],"about_ca_topic_score_codex":0.000004244547,"about_ca_topic_score_gemma":6.2879155e-7,"teacher_disagreement_score":0.26701507,"about_ca_system_score_codex":0.000058119775,"about_ca_system_score_gemma":0.00007247585,"threshold_uncertainty_score":0.584255},"labels":[],"label_agreement":null},{"id":"W4327975269","doi":"10.31083/j.fbl2803058","title":"MDSCs: The Key Players in the Formation of Pre-Metastatic Niche","year":2023,"lang":"en","type":"review","venue":"Frontiers in Bioscience-Landmark","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Jining Medical University; Northeast Normal University","keywords":"Niche; Metastasis; Suppressor; Metastatic tumor; Primary tumor; Cancer research; Tumor microenvironment; Cancer; Tumor progression; Biology; Medicine; Tumor cells; Internal medicine; Ecology","score_opus":0.09182187031085254,"score_gpt":0.39535667811366904,"score_spread":0.3035348078028165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327975269","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005360415,0.9932715,0.00014183031,0.00042294143,0.0016897172,0.0025481286,0.00007217933,0.000019511106,0.0012981104],"genre_scores_gemma":[0.00039136386,0.99768716,0.0003271773,0.0002112189,0.00008798996,0.00035298977,0.0000917042,0.000017858536,0.00083251647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979097,0.00036758572,0.00066764734,0.0002988205,0.0003990175,0.00035720094],"domain_scores_gemma":[0.9988314,0.00038358892,0.0003444319,0.00037065486,0.000023510402,0.000046395257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013957737,0.0002588396,0.0010032892,0.0005072366,0.00007563873,0.000023841209,0.00055967807,0.00012671159,0.000023583827],"category_scores_gemma":[0.00014161417,0.00012366836,0.00023378374,0.0018263436,0.00029680697,0.00009647425,0.000059569815,0.000432021,0.0000136808285],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028560325,0.0004671507,0.0031595146,0.0146675175,0.0002619175,0.000121615354,0.009177708,0.000016118951,0.000003597739,0.000075194424,0.19635645,0.7754076],"study_design_scores_gemma":[0.0012038536,0.0002936413,0.0008737924,0.0040848413,0.0008618859,0.000059139245,0.0010869693,0.0005803449,0.000004203276,0.00013376343,0.99063236,0.00018522341],"about_ca_topic_score_codex":0.00011258814,"about_ca_topic_score_gemma":0.00013387739,"teacher_disagreement_score":0.7942759,"about_ca_system_score_codex":0.00026501977,"about_ca_system_score_gemma":0.00038670894,"threshold_uncertainty_score":0.50430495},"labels":[],"label_agreement":null},{"id":"W4361942958","doi":"10.1158/1078-0432.c.6517089","title":"Data from Preferential Killing of Breast Tumor Initiating Cells by &lt;i&gt;N,N&lt;/i&gt;-Diethyl-2-[4-(Phenylmethyl)Phenoxy]Ethanamine/Tesmilifene","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; University Health Network","funders":"National Cancer Institute","keywords":"CD44; Breast cancer; Internal medicine; CD24; Flow cytometry; Medicine; Chemistry; Cancer research; In vitro; Cancer; Molecular biology; Biology; Immunology; Biochemistry","score_opus":0.08498179919500738,"score_gpt":0.33827458147501643,"score_spread":0.25329278228000907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361942958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87929356,0.014546297,0.004659803,0.0021534069,0.010281911,0.0042741653,0.06965409,0.0013025566,0.0138342045],"genre_scores_gemma":[0.9182494,0.003791173,0.0077112727,0.000756943,0.003555573,0.00028925692,0.055511612,0.00041027094,0.009724443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99378127,0.0003354082,0.0017496821,0.0021956963,0.0009726862,0.0009652323],"domain_scores_gemma":[0.9945719,0.0009420762,0.0010630358,0.00250049,0.00038827414,0.00053417025],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000722785,0.0010722092,0.0021675634,0.00041402545,0.00014987215,0.000069463495,0.0013528799,0.0007190901,0.005863727],"category_scores_gemma":[0.00014753662,0.001011301,0.00045362106,0.0004138211,0.000288799,0.000179791,0.003414859,0.001317436,0.00026459052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012934818,0.0017713323,0.0019427725,0.0016296235,0.0048090317,0.00020963704,0.00068250875,0.000244479,0.8016557,0.00005138946,0.18073215,0.0049778637],"study_design_scores_gemma":[0.051874533,0.004189513,0.031048864,0.011181551,0.037011135,0.00022646438,0.0014384781,0.09499322,0.6075237,0.0047764634,0.14614291,0.009593169],"about_ca_topic_score_codex":0.0028157714,"about_ca_topic_score_gemma":0.0017489385,"teacher_disagreement_score":0.19413204,"about_ca_system_score_codex":0.000317962,"about_ca_system_score_gemma":0.00085869106,"threshold_uncertainty_score":0.9992337},"labels":[],"label_agreement":null},{"id":"W4361946665","doi":"10.1158/1078-0432.c.6529577","title":"Data from Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Cisplatin; Internal medicine; Neurotoxicity; Cumulative dose; Cancer; Gastroenterology; Endocrinology; Toxicity; Chemotherapy","score_opus":0.20863364170785656,"score_gpt":0.437044148083167,"score_spread":0.22841050637531043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361946665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986599,0.0003176841,0.000014131448,0.0010604826,0.000667118,0.0008947485,0.010204936,0.00006280984,0.00017906867],"genre_scores_gemma":[0.9852467,0.004114671,0.0003127686,0.0006985366,0.00019142656,0.00013895427,0.008141647,0.00004096634,0.0011142823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728924,0.00023762282,0.00096756575,0.0010113041,0.00024132435,0.00025291683],"domain_scores_gemma":[0.99638486,0.0019589865,0.00030678205,0.0010864135,0.00010804472,0.00015490904],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037127815,0.00031803088,0.0015543936,0.00053101475,0.000025003865,0.00001549658,0.00033683947,0.00037384292,0.0011702264],"category_scores_gemma":[0.00036739412,0.00027763727,0.00022040076,0.0004950944,0.00013385188,0.000044559016,0.0012259146,0.0006776204,0.000008710947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007789346,0.00022076379,0.99150544,0.00014630165,0.0048070876,0.00008113369,0.00033525538,0.00028376677,0.00031369543,7.7124537e-7,0.0010247311,0.00050209346],"study_design_scores_gemma":[0.0027761352,0.00010239202,0.9751211,0.00011020503,0.0051774816,8.4444616e-7,0.00021897472,0.015877543,0.00014557599,0.000039684634,0.0002052624,0.00022484107],"about_ca_topic_score_codex":0.121707916,"about_ca_topic_score_gemma":0.41218108,"teacher_disagreement_score":0.29047316,"about_ca_system_score_codex":0.00006868046,"about_ca_system_score_gemma":0.0003480361,"threshold_uncertainty_score":0.9999676},"labels":[],"label_agreement":null},{"id":"W4361948728","doi":"10.1158/1078-0432.c.6517089.v1","title":"Data from Preferential Killing of Breast Tumor Initiating Cells by &lt;i&gt;N,N&lt;/i&gt;-Diethyl-2-[4-(Phenylmethyl)Phenoxy]Ethanamine/Tesmilifene","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; University Health Network","funders":"National Cancer Institute","keywords":"CD44; Breast cancer; Flow cytometry; Chemistry; Internal medicine; Medicine; Cancer research; In vitro; Molecular biology; Cancer; Biology; Immunology; Biochemistry","score_opus":0.08498179919500738,"score_gpt":0.33827458147501643,"score_spread":0.25329278228000907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361948728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87929356,0.014546297,0.004659803,0.0021534069,0.010281911,0.0042741653,0.06965409,0.0013025566,0.0138342045],"genre_scores_gemma":[0.9182494,0.003791173,0.0077112727,0.000756943,0.003555573,0.00028925692,0.055511612,0.00041027094,0.009724443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99378127,0.0003354082,0.0017496821,0.0021956963,0.0009726862,0.0009652323],"domain_scores_gemma":[0.9945719,0.0009420762,0.0010630358,0.00250049,0.00038827414,0.00053417025],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000722785,0.0010722092,0.0021675634,0.00041402545,0.00014987215,0.000069463495,0.0013528799,0.0007190901,0.005863727],"category_scores_gemma":[0.00014753662,0.001011301,0.00045362106,0.0004138211,0.000288799,0.000179791,0.003414859,0.001317436,0.00026459052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012934818,0.0017713323,0.0019427725,0.0016296235,0.0048090317,0.00020963704,0.00068250875,0.000244479,0.8016557,0.00005138946,0.18073215,0.0049778637],"study_design_scores_gemma":[0.051874533,0.004189513,0.031048864,0.011181551,0.037011135,0.00022646438,0.0014384781,0.09499322,0.6075237,0.0047764634,0.14614291,0.009593169],"about_ca_topic_score_codex":0.0028157714,"about_ca_topic_score_gemma":0.0017489385,"teacher_disagreement_score":0.19413204,"about_ca_system_score_codex":0.000317962,"about_ca_system_score_gemma":0.00085869106,"threshold_uncertainty_score":0.9992337},"labels":[],"label_agreement":null},{"id":"W4361953704","doi":"10.1158/1078-0432.c.6529577.v1","title":"Data from Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Cisplatin; Internal medicine; Neurotoxicity; Cumulative dose; Cancer; Gastroenterology; Endocrinology; Toxicity; Chemotherapy","score_opus":0.20863364170785656,"score_gpt":0.437044148083167,"score_spread":0.22841050637531043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361953704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986599,0.0003176841,0.000014131448,0.0010604826,0.000667118,0.0008947485,0.010204936,0.00006280984,0.00017906867],"genre_scores_gemma":[0.9852467,0.004114671,0.0003127686,0.0006985366,0.00019142656,0.00013895427,0.008141647,0.00004096634,0.0011142823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728924,0.00023762282,0.00096756575,0.0010113041,0.00024132435,0.00025291683],"domain_scores_gemma":[0.99638486,0.0019589865,0.00030678205,0.0010864135,0.00010804472,0.00015490904],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037127815,0.00031803088,0.0015543936,0.00053101475,0.000025003865,0.00001549658,0.00033683947,0.00037384292,0.0011702264],"category_scores_gemma":[0.00036739412,0.00027763727,0.00022040076,0.0004950944,0.00013385188,0.000044559016,0.0012259146,0.0006776204,0.000008710947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007789346,0.00022076379,0.99150544,0.00014630165,0.0048070876,0.00008113369,0.00033525538,0.00028376677,0.00031369543,7.7124537e-7,0.0010247311,0.00050209346],"study_design_scores_gemma":[0.0027761352,0.00010239202,0.9751211,0.00011020503,0.0051774816,8.4444616e-7,0.00021897472,0.015877543,0.00014557599,0.000039684634,0.0002052624,0.00022484107],"about_ca_topic_score_codex":0.121707916,"about_ca_topic_score_gemma":0.41218108,"teacher_disagreement_score":0.29047316,"about_ca_system_score_codex":0.00006868046,"about_ca_system_score_gemma":0.0003480361,"threshold_uncertainty_score":0.9999676},"labels":[],"label_agreement":null},{"id":"W4361954206","doi":"10.1158/1078-0432.c.6532530.v1","title":"Data from Dose Escalation Data from the Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Japanese Patients with Advanced Solid Tumors","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"Eisai","keywords":"Medicine; Tolerability; Internal medicine; Limiting; Gastroenterology; Animal science; Adverse effect","score_opus":0.11807570324119707,"score_gpt":0.4081435852882266,"score_spread":0.2900678820470295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361954206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836728,0.00008384451,0.000030577336,0.00032399432,0.00042017872,0.0034679805,0.011926337,0.000031329026,0.00004294109],"genre_scores_gemma":[0.9447361,0.000033653327,0.00018292399,0.00004825543,0.0001474851,0.000070650676,0.05467085,0.000033319866,0.00007673137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976613,0.00017877492,0.0007410135,0.0007385797,0.0005086312,0.00017172113],"domain_scores_gemma":[0.9957965,0.00044232662,0.0006250172,0.00295939,0.0001282053,0.00004856439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022471289,0.00027549817,0.0006422586,0.00007731363,0.000046305173,0.000012122728,0.0010539271,0.00012229981,0.00031207438],"category_scores_gemma":[0.00012623022,0.00014723236,0.000043736876,0.00025585224,0.00006391562,0.00019914171,0.0022390608,0.0003964272,0.0000063469242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012830923,0.010111379,0.9575715,0.00011239245,0.0013131573,0.000015061291,0.006833643,0.0024002835,0.0013204847,0.0000016862095,0.001569415,0.0059200693],"study_design_scores_gemma":[0.023496294,0.0010452692,0.94938064,0.0003833642,0.0011211495,2.4717374e-7,0.0011937895,0.02273068,0.0003580684,0.00008024278,0.000052616353,0.00015761537],"about_ca_topic_score_codex":0.01484575,"about_ca_topic_score_gemma":0.018444043,"teacher_disagreement_score":0.042744514,"about_ca_system_score_codex":0.00008574804,"about_ca_system_score_gemma":0.00021063226,"threshold_uncertainty_score":0.9994668},"labels":[],"label_agreement":null},{"id":"W4361954463","doi":"10.1158/1078-0432.c.6532781.v1","title":"Data from Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Capecitabine; Triple-negative breast cancer; Internal medicine; Breast cancer; Oncology; Medicine; Basal (medicine); Adjuvant; Cancer; Colorectal cancer","score_opus":0.07879141937988557,"score_gpt":0.36353671468517146,"score_spread":0.2847452953052859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361954463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6633042,0.0055631776,0.0003469106,0.01782329,0.014678307,0.004392577,0.2886276,0.0009798447,0.0042840806],"genre_scores_gemma":[0.8307395,0.008388463,0.0021242213,0.0026118266,0.010519249,0.0011619322,0.10416996,0.00036771738,0.039917145],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9955666,0.000082379214,0.00082088093,0.0021480268,0.0006858581,0.00069624063],"domain_scores_gemma":[0.99589795,0.00058614335,0.00043111845,0.002248751,0.00030942066,0.00052663224],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001809349,0.0008586727,0.0016753684,0.00023514297,0.000106747335,0.00006119088,0.00094591954,0.00068446225,0.02736476],"category_scores_gemma":[0.000072171046,0.0007068738,0.00026500167,0.00028830682,0.00017363402,0.00014309661,0.0021145334,0.0012613665,0.00066116726],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016904814,0.0027999603,0.12319871,0.00047914012,0.013142167,0.0017636871,0.0021208595,0.00028905005,0.0071724253,0.000023631797,0.80155677,0.030548777],"study_design_scores_gemma":[0.016641084,0.00033605317,0.95221066,0.001096768,0.0053453334,0.0000110090305,0.00024990176,0.012861368,0.0024146347,0.0036745917,0.0041912966,0.0009672953],"about_ca_topic_score_codex":0.15299568,"about_ca_topic_score_gemma":0.052778117,"teacher_disagreement_score":0.829012,"about_ca_system_score_codex":0.00067299214,"about_ca_system_score_gemma":0.0015358,"threshold_uncertainty_score":0.99953824},"labels":[],"label_agreement":null},{"id":"W4361961198","doi":"10.1158/1078-0432.c.6518529","title":"Data from Potentiation of Taxol Efficacy by Discodermolide in Ovarian Carcinoma Xenograft-Bearing Mice","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Cancer Institute","keywords":"In vivo; Ovarian carcinoma; Matrigel; Paclitaxel; Chemistry; Ovarian cancer; Cancer research; Pharmacology; CD31; Apoptosis; Angiogenesis; Cancer; Internal medicine; Medicine; Biology; Biochemistry","score_opus":0.1202556091447616,"score_gpt":0.3734226369487314,"score_spread":0.2531670278039698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361961198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901402,0.0008430622,0.0011173998,0.0023461718,0.00078211277,0.0010899662,0.0022506295,0.00008281972,0.0013476403],"genre_scores_gemma":[0.9762913,0.00025411998,0.00087855855,0.00013037726,0.0002436587,0.00005122269,0.019488258,0.00004339213,0.0026191196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983218,0.00006887669,0.00047994367,0.0006840379,0.00021104606,0.0002342977],"domain_scores_gemma":[0.9986489,0.00015100063,0.00020381076,0.00087047217,0.00003718954,0.00008864832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016055918,0.0002350201,0.0005625843,0.00020498138,0.00002137844,0.000017372828,0.00035908274,0.00023824342,0.0006311437],"category_scores_gemma":[0.00004157699,0.00021892386,0.00009152146,0.00015997689,0.000038342176,0.000060834718,0.0010411481,0.00043332894,0.00004224982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024967333,0.003168848,0.5904714,0.0012656336,0.0026488646,0.00059287966,0.0020625647,0.0004607449,0.24888831,0.0000479873,0.13976327,0.00813277],"study_design_scores_gemma":[0.009290408,0.00015011274,0.94834924,0.0005286142,0.0016460906,0.000007688886,0.00020390109,0.007990345,0.028727353,0.00031928762,0.0023460968,0.00044086526],"about_ca_topic_score_codex":0.04834056,"about_ca_topic_score_gemma":0.0038728067,"teacher_disagreement_score":0.35787785,"about_ca_system_score_codex":0.000142788,"about_ca_system_score_gemma":0.00020656551,"threshold_uncertainty_score":0.9579966},"labels":[],"label_agreement":null},{"id":"W4361963257","doi":"10.1158/1078-0432.c.6532530","title":"Data from Dose Escalation Data from the Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Japanese Patients with Advanced Solid Tumors","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"Eisai","keywords":"Tolerability; Medicine; Internal medicine; Limiting; Eribulin; Breast cancer; Gastroenterology; Adverse effect; Cancer; Metastatic breast cancer","score_opus":0.11807570324119707,"score_gpt":0.4081435852882266,"score_spread":0.2900678820470295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361963257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836728,0.00008384451,0.000030577336,0.00032399432,0.00042017872,0.0034679805,0.011926337,0.000031329026,0.00004294109],"genre_scores_gemma":[0.9447361,0.000033653327,0.00018292399,0.00004825543,0.0001474851,0.000070650676,0.05467085,0.000033319866,0.00007673137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976613,0.00017877492,0.0007410135,0.0007385797,0.0005086312,0.00017172113],"domain_scores_gemma":[0.9957965,0.00044232662,0.0006250172,0.00295939,0.0001282053,0.00004856439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022471289,0.00027549817,0.0006422586,0.00007731363,0.000046305173,0.000012122728,0.0010539271,0.00012229981,0.00031207438],"category_scores_gemma":[0.00012623022,0.00014723236,0.000043736876,0.00025585224,0.00006391562,0.00019914171,0.0022390608,0.0003964272,0.0000063469242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012830923,0.010111379,0.9575715,0.00011239245,0.0013131573,0.000015061291,0.006833643,0.0024002835,0.0013204847,0.0000016862095,0.001569415,0.0059200693],"study_design_scores_gemma":[0.023496294,0.0010452692,0.94938064,0.0003833642,0.0011211495,2.4717374e-7,0.0011937895,0.02273068,0.0003580684,0.00008024278,0.000052616353,0.00015761537],"about_ca_topic_score_codex":0.01484575,"about_ca_topic_score_gemma":0.018444043,"teacher_disagreement_score":0.042744514,"about_ca_system_score_codex":0.00008574804,"about_ca_system_score_gemma":0.00021063226,"threshold_uncertainty_score":0.9994668},"labels":[],"label_agreement":null},{"id":"W4361971407","doi":"10.1158/1078-0432.22441467","title":"Supplementary Figure S2 from Potentiation of Taxol Efficacy by Discodermolide in Ovarian Carcinoma Xenograft-Bearing Mice","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Cancer Institute","keywords":"Long-term potentiation; Ovarian carcinoma; Cancer research; Bearing (navigation); Pharmacology; Internal medicine; Medicine; Oncology; Chemistry; Ovarian cancer; Receptor; Cancer; Computer science","score_opus":0.03555906193426502,"score_gpt":0.3214741373801006,"score_spread":0.2859150754458356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361971407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891672,0.00044938346,0.00027790442,0.0046498775,0.0006935349,0.0013837378,0.0026704513,0.000053854386,0.0006540246],"genre_scores_gemma":[0.97283345,0.00019225318,0.0007938344,0.00029487687,0.000269066,0.00014784058,0.0226213,0.000050878898,0.0027965151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982114,0.00007940822,0.0005696444,0.0005763956,0.0002537743,0.00030939086],"domain_scores_gemma":[0.999139,0.00013247677,0.0002139912,0.0003628301,0.00004336478,0.000108339176],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011845106,0.0003028293,0.0006253546,0.00026136762,0.00003053573,0.000015879861,0.00016801714,0.000258118,0.005087906],"category_scores_gemma":[0.000014175631,0.00028735463,0.00019689047,0.0001691412,0.000037446298,0.000034786914,0.0003476713,0.00049872394,0.000022058724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018433519,0.0019696865,0.69954276,0.000912985,0.0018942504,0.00046430388,0.0029407227,0.00040758523,0.15715018,0.000028934164,0.12861307,0.004232144],"study_design_scores_gemma":[0.013399956,0.00032625045,0.8654872,0.0005514872,0.001791224,0.0000075949815,0.0005364617,0.0012447636,0.11176233,0.00040671145,0.003945902,0.000540086],"about_ca_topic_score_codex":0.11951895,"about_ca_topic_score_gemma":0.0063738385,"teacher_disagreement_score":0.16594446,"about_ca_system_score_codex":0.00027422226,"about_ca_system_score_gemma":0.0001811266,"threshold_uncertainty_score":0.99995786},"labels":[],"label_agreement":null},{"id":"W4367362646","doi":"10.1111/j.1742-1241.2003.tb10544.x","title":"XELODA® AND TAXOTERE®: A REVIEW OF THE DEVELOPMENT OF THE COMBINATION FOR USE IN METASTATIC BREAST CANCER","year":2003,"lang":"en","type":"review","venue":"International Journal of Clinical Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Docetaxel; Capecitabine; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Anthracycline; Adverse effect; Hazard ratio; Chemotherapy; Cancer; Confidence interval; Colorectal cancer","score_opus":0.32721851629816345,"score_gpt":0.5989358573477391,"score_spread":0.2717173410495757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367362646","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000325108,0.9910735,0.00004413152,0.00566143,0.0017525093,0.00094373897,0.000067291585,6.46031e-7,0.00013165842],"genre_scores_gemma":[0.00027132433,0.99529684,0.002607626,0.001473872,0.00012739058,0.000033094966,0.000005084494,0.000011281469,0.00017347868],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962737,0.00067868375,0.002372726,0.0001144585,0.00049042364,0.00007000113],"domain_scores_gemma":[0.9897971,0.004327736,0.0045512957,0.000116236384,0.0011627963,0.000044807774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025385814,0.00013171244,0.0011858298,0.00008074419,0.000016835831,0.000008116273,0.00025552136,0.000075347256,0.000076683034],"category_scores_gemma":[0.0043441234,0.00006513259,0.000528276,0.000142428,0.00008590571,0.00015827392,0.00006005717,0.0004957195,4.2941105e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005700595,0.0012811867,0.0012265095,0.014394719,0.0026760276,0.000014347931,0.000049748567,3.843575e-7,7.595729e-7,0.00012882314,0.002367844,0.9772896],"study_design_scores_gemma":[0.0021821398,0.00010370661,0.003106631,0.06364421,0.0039296695,0.00073294423,0.0000085021975,0.0000023807543,0.0000028326667,0.000037349837,0.92619663,0.000053031374],"about_ca_topic_score_codex":0.00001885577,"about_ca_topic_score_gemma":0.000030585903,"teacher_disagreement_score":0.97723657,"about_ca_system_score_codex":0.00016954332,"about_ca_system_score_gemma":0.001968567,"threshold_uncertainty_score":0.5200635},"labels":[],"label_agreement":null},{"id":"W4375845874","doi":"10.1134/s1021443722602403","title":"Polyesters of 14-Hydroxylated Taxoids Found for the First Time in Taxus canadensis Intact Plants","year":2023,"lang":"en","type":"article","venue":"Russian Journal of Plant Physiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry; Polyester; Mass spectrometry; Secondary metabolism; Taxus; Nuclear magnetic resonance spectroscopy; Stereochemistry; Botany; Organic chemistry; Chromatography; Biology; Biosynthesis; Enzyme","score_opus":0.020871426017641675,"score_gpt":0.2859280231812252,"score_spread":0.2650565971635835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375845874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934592,0.00036628466,0.00000373607,0.0049087536,0.0005862866,0.0003002193,0.00024672938,0.00000890074,0.00011984212],"genre_scores_gemma":[0.99861544,0.00032903074,0.000022667258,0.00035616866,0.0002825824,0.000010552456,0.00007644966,0.0000139998365,0.00029312592],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99902475,0.000049440412,0.00042150522,0.00011498115,0.00010715577,0.0002821539],"domain_scores_gemma":[0.99894536,0.0005049176,0.00032173234,0.00011100782,0.00002864321,0.00008835433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020071134,0.00012922416,0.0005117694,0.00027150862,0.00005117864,0.000003476451,0.00013842214,0.000090421265,0.00014437798],"category_scores_gemma":[0.000027643384,0.00008084813,0.00014053153,0.00019968017,0.00008531187,0.00003832286,0.000021688953,0.00020979482,0.000015995784],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03279524,0.0009810736,0.025049387,0.0005280065,0.004945028,0.0025958118,0.0044138255,0.0023136232,0.6948595,0.00029477343,0.22680074,0.004422962],"study_design_scores_gemma":[0.02129188,0.0066681374,0.88252854,0.0007615461,0.0010278225,0.0025029941,0.00044731595,0.0055831787,0.015743146,0.0008388701,0.062192902,0.00041367093],"about_ca_topic_score_codex":0.00036388414,"about_ca_topic_score_gemma":0.00057313393,"teacher_disagreement_score":0.85747916,"about_ca_system_score_codex":0.00009843552,"about_ca_system_score_gemma":0.00019351144,"threshold_uncertainty_score":0.32968912},"labels":[],"label_agreement":null},{"id":"W4376613623","doi":"10.1016/j.esmoop.2023.101409","title":"220P Oral selective estrogen receptor degraders for metastatic hormone receptor-positive, HER2 negative breast cancer according to ESR1 mutation: A systematic review and meta-analysis of randomized control trials","year":2023,"lang":"en","type":"review","venue":"ESMO Open","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Meta-analysis; Oncology; Randomized controlled trial; Estrogen receptor; Breast cancer; Selective estrogen receptor modulator; Metastatic breast cancer; Fulvestrant; Cancer; Cochrane Library","score_opus":0.22772770467136944,"score_gpt":0.4902644295594634,"score_spread":0.262536724888094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376613623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004855569,0.9255903,0.00021589725,0.0017306911,0.00009886833,0.065307096,0.00698306,0.000031515217,0.000037723457],"genre_scores_gemma":[0.00007183413,0.93185586,0.0014804642,0.0007617788,0.0000641056,0.06320441,0.0011422124,0.00010791431,0.0013113954],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98953164,0.005668355,0.0031617722,0.0008614717,0.00037606078,0.00040072162],"domain_scores_gemma":[0.9846095,0.010795348,0.0032170822,0.00038464248,0.0007194964,0.00027395238],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0071392106,0.00083165214,0.039506614,0.000690146,0.00012706334,0.00009298345,0.0003737741,0.0001690034,0.00094566133],"category_scores_gemma":[0.00266464,0.0005031316,0.0056899874,0.0023821844,0.00012419872,0.00017234351,0.00010863225,0.00025398144,0.00002631687],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011794645,0.00011540544,6.9575174e-7,0.21410373,0.76825976,0.000008770762,0.00029207102,0.00000413785,9.703931e-7,0.000038824943,0.0025547403,0.0028262367],"study_design_scores_gemma":[0.04933394,0.00032917788,0.0000013200798,0.024072908,0.92454547,0.000027403541,0.00014456308,0.00001992874,0.000008200569,0.000017164708,0.0011318263,0.0003680988],"about_ca_topic_score_codex":0.0043211333,"about_ca_topic_score_gemma":0.0003117178,"teacher_disagreement_score":0.19003083,"about_ca_system_score_codex":0.00051308033,"about_ca_system_score_gemma":0.00071824825,"threshold_uncertainty_score":0.99996763},"labels":[],"label_agreement":null},{"id":"W4377091662","doi":"10.1016/j.jcjd.2023.05.007","title":"The Reponic Classification of Insulin","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Insulin; Internal medicine","score_opus":0.03561556174936899,"score_gpt":0.30364494623674976,"score_spread":0.2680293844873808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377091662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889696,0.0025368142,2.0009931e-7,0.0069843917,0.00036960238,0.000057007623,0.0000056878775,0.0000031227084,0.001073554],"genre_scores_gemma":[0.99894214,0.00011431951,0.000008940075,0.00011622368,0.00014890998,0.0000022690444,0.000003923101,0.0000053916574,0.0006578649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995301,0.000023980167,0.00020251806,0.00003581377,0.00006634683,0.00014128877],"domain_scores_gemma":[0.99934834,0.00012127514,0.00014050852,0.00007978442,0.00012137894,0.00018871778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024331082,0.00003690116,0.00011627244,0.00014380163,0.000059366484,0.0000069276493,0.00006198108,0.000027021752,0.00007229824],"category_scores_gemma":[0.00012951369,0.000024175635,0.00006293913,0.00022672098,0.00007532789,0.000024003026,0.0000022569939,0.00008834582,0.000014571693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002838556,0.000029945333,0.8216369,0.000049819653,0.00040086865,0.00005515546,0.000571889,0.0000114544655,0.024492946,0.000663398,0.09169312,0.06036609],"study_design_scores_gemma":[0.00074170524,0.000344393,0.9201383,0.00005201941,0.00011388433,0.000007060129,0.00015161578,0.00007622557,0.003514123,0.00040568973,0.0744239,0.000031059746],"about_ca_topic_score_codex":0.00011998416,"about_ca_topic_score_gemma":0.002274152,"teacher_disagreement_score":0.09850139,"about_ca_system_score_codex":0.00008435502,"about_ca_system_score_gemma":0.0008978458,"threshold_uncertainty_score":0.15927398},"labels":[],"label_agreement":null},{"id":"W4377103226","doi":"10.1097/01.gox.0000937824.10049.d5","title":"58. The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Enhances In Vitro and In Vivo Peripheral Nerve Regeneration in a Mouse Median Nerve Injury Model","year":2023,"lang":"en","type":"article","venue":"Plastic & Reconstructive Surgery Global Open","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Regeneration (biology); In vivo; Gefitinib; Nerve growth factor; Pharmacology; Epidermal growth factor receptor; Nerve injury; Medicine; Neurite; EGFR inhibitors; Biology; Cancer research; Receptor; In vitro; Internal medicine; Cell biology; Anesthesia","score_opus":0.031017146634097686,"score_gpt":0.3058278036731925,"score_spread":0.2748106570390948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377103226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99520963,0.00015197536,0.0000126342675,0.0014054136,0.0009851655,0.0010325802,0.00080577313,0.00003488474,0.0003619385],"genre_scores_gemma":[0.99834573,0.00020417267,0.0003159155,0.00020655655,0.00021731162,0.00037359967,0.0001287694,0.000022343333,0.00018562566],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976284,0.0003331479,0.00069304777,0.00057701423,0.00022163833,0.0005467873],"domain_scores_gemma":[0.99826854,0.0011483934,0.00018481685,0.00015032524,0.000076295844,0.00017163441],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005153215,0.00031477903,0.00077779224,0.00030082808,0.00008255901,0.00007996503,0.00014794317,0.00016794728,0.00026428225],"category_scores_gemma":[0.0005299168,0.00025151437,0.00009626449,0.00086264743,0.00024837663,0.0004952257,0.00017368984,0.0003177618,0.000013805041],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012449877,0.00042563197,0.78261673,0.00013439731,0.00020995659,0.00035708994,0.0019391855,0.0004535991,0.17391038,0.00022065041,0.004953655,0.022328844],"study_design_scores_gemma":[0.02023314,0.00094740133,0.37759328,0.0013317039,0.00026068982,0.00044819864,0.0047638332,0.067863,0.51909536,0.004407658,0.00071794895,0.0023377857],"about_ca_topic_score_codex":0.0022728068,"about_ca_topic_score_gemma":0.0049202796,"teacher_disagreement_score":0.40502346,"about_ca_system_score_codex":0.0006748596,"about_ca_system_score_gemma":0.0005730248,"threshold_uncertainty_score":0.9999937},"labels":[],"label_agreement":null},{"id":"W4377131253","doi":"10.1016/j.bmcl.2023.129345","title":"[18F]ONO-8430506: A novel radioligand for PET imaging of autotaxin (ATX)","year":2023,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Radioligand; Chemistry; Autotaxin; Potency; Radioligand Assay; Pet imaging; Pharmacology; Stereochemistry; Biochemistry; Receptor; Positron emission tomography; In vitro; Nuclear medicine; Lysophosphatidic acid; Medicine","score_opus":0.021097422483209578,"score_gpt":0.3009944322556821,"score_spread":0.27989700977247256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377131253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9621263,0.0005185824,0.00021186954,0.03566824,0.00038502456,0.00041623015,0.000082373605,0.0001606359,0.00043070523],"genre_scores_gemma":[0.9945866,0.000087006374,0.00033167025,0.0025436068,0.0011308208,0.00006235529,0.00025516763,0.000050030823,0.0009527602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985062,0.000008874417,0.00036742337,0.0003914204,0.00027811312,0.0004480037],"domain_scores_gemma":[0.99915576,0.00014512676,0.00015135949,0.00027642702,0.000065166285,0.00020615644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023643601,0.00024581593,0.00048475742,0.00008467092,0.00006689833,0.0000069164807,0.00015134564,0.00004944866,0.00046746284],"category_scores_gemma":[0.000102918544,0.00022032399,0.00016754237,0.00036922286,0.00021208686,0.00003671508,0.000044116197,0.00018909755,0.000020859801],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032558825,0.000115704264,0.0029685984,0.00058270025,0.00019594912,0.00020298123,0.00020928978,0.0000012010515,0.9429462,0.0000044509825,0.051941942,0.00050537835],"study_design_scores_gemma":[0.0100108655,0.00014389506,0.0074386178,0.0002973636,0.0007288694,0.0011236144,0.0003239796,0.0004320227,0.96107703,0.000017985247,0.01811182,0.00029393466],"about_ca_topic_score_codex":0.00004840365,"about_ca_topic_score_gemma":0.0000012012791,"teacher_disagreement_score":0.033830125,"about_ca_system_score_codex":0.00019050372,"about_ca_system_score_gemma":0.00019431047,"threshold_uncertainty_score":0.89845514},"labels":[],"label_agreement":null},{"id":"W4378627997","doi":"10.1080/2162402x.2023.2218782","title":"Eribulin mesylate exerts antitumor effects via CD103","year":2023,"lang":"en","type":"article","venue":"OncoImmunology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Tsukuba; Eisai Canada; Eisai","keywords":"Cancer research; Cytotoxic T cell; Granzyme B; Tumor microenvironment; TIGIT; CD8; Chemistry; T cell; Downregulation and upregulation; Immune system; Biology; Immunology; In vitro","score_opus":0.011743955864055916,"score_gpt":0.31917743913521274,"score_spread":0.3074334832711568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378627997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820567,0.0017560255,0.000027465287,0.0030743459,0.0019306993,0.00047310122,0.0000053750614,0.00044168744,0.01023465],"genre_scores_gemma":[0.98134714,0.00095350156,0.00011139793,0.000857187,0.00023054625,0.00011958335,0.00012977024,0.00003460073,0.016216286],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989169,0.00007105475,0.00019112088,0.00028712137,0.000093419185,0.00044035754],"domain_scores_gemma":[0.99941117,0.00013508157,0.000059590995,0.00027500011,0.000044189685,0.0000750015],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011121602,0.00017458384,0.00043616636,0.00019812825,0.0000843746,0.0000064131978,0.00009238236,0.00015441704,0.00086602167],"category_scores_gemma":[0.0000369158,0.00015161514,0.00010737432,0.0003910489,0.00012901443,0.000045031073,0.00007974994,0.00021495212,0.0033505596],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020320232,0.0007818204,0.029813651,0.0002815815,0.0011269435,0.0056666345,0.00079997233,0.000008060495,0.7695388,0.00056562654,0.071183436,0.11820145],"study_design_scores_gemma":[0.01224441,0.004191351,0.4504195,0.000117945136,0.0005919895,0.000951697,0.00004286198,0.00022054913,0.09123728,0.001062372,0.43847856,0.00044149425],"about_ca_topic_score_codex":0.00010714497,"about_ca_topic_score_gemma":0.000017275874,"teacher_disagreement_score":0.6783015,"about_ca_system_score_codex":0.00010943881,"about_ca_system_score_gemma":0.000098050354,"threshold_uncertainty_score":0.99742544},"labels":[],"label_agreement":null},{"id":"W4378674654","doi":"10.1152/physiol.2023.38.s1.5732754","title":"Electrical stimulation-induced muscle contraction does not reduce intramuscular accumulation of Doxorubicin 24 hours following administration","year":2023,"lang":"en","type":"article","venue":"Physiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; McMaster University; Laurentian University","funders":"","keywords":"Doxorubicin; Medicine; Stimulation; Pharmacology; Skeletal muscle; Contraction (grammar); Metabolite; Context (archaeology); Drug; Anesthesia; Internal medicine; Chemotherapy; Biology","score_opus":0.08696506435945868,"score_gpt":0.4138742210970389,"score_spread":0.32690915673758025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378674654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974703,0.000025193829,0.000043598204,0.001003408,0.00080711214,0.00044688495,0.000005608192,0.00011087784,0.00008699536],"genre_scores_gemma":[0.9988494,0.000033681707,0.000076074335,0.00015988393,0.00038854632,0.000051019106,0.00030218632,0.00001662397,0.00012257416],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989815,0.000094916526,0.00028898753,0.00026259263,0.0001452233,0.00022680861],"domain_scores_gemma":[0.99933064,0.00024636957,0.00013441498,0.00015262967,0.00007302803,0.000062924584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013480257,0.00012544905,0.00032244655,0.00016336319,0.00006446113,0.000005030757,0.00004245536,0.00014170229,0.00009250387],"category_scores_gemma":[0.00010262323,0.000101844555,0.0001453342,0.00035162902,0.000028180075,0.00010884241,0.0000127518815,0.00014986756,0.00003116491],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006787725,0.00019036929,0.0033417915,0.000020819243,0.00013643481,0.00001109285,0.000120817545,0.00028670562,0.98819566,0.00009160971,0.00021320686,0.006712746],"study_design_scores_gemma":[0.0020539647,0.00063648494,0.5937414,0.000015368889,0.00022137254,0.000003371119,0.000030117892,0.004801086,0.39793497,0.00032439028,0.00015088645,0.00008654192],"about_ca_topic_score_codex":0.00009622079,"about_ca_topic_score_gemma":0.000019547924,"teacher_disagreement_score":0.5903996,"about_ca_system_score_codex":0.00009112736,"about_ca_system_score_gemma":0.00012107555,"threshold_uncertainty_score":0.41531006},"labels":[],"label_agreement":null},{"id":"W4379281682","doi":"10.1200/jco.2023.41.16_suppl.e17075","title":"Darolutamide and time to pain progression by disease volume in ARASENS.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Docetaxel; Internal medicine; Hazard ratio; Prostate cancer; Placebo; Oncology; Confidence interval; Cancer; Pathology","score_opus":0.0763143164530647,"score_gpt":0.5133563349878346,"score_spread":0.4370420185347699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379281682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93688196,0.0004924329,0.0000087487615,0.06143202,0.00034330823,0.00024211296,0.0000073072315,0.000014440329,0.0005776876],"genre_scores_gemma":[0.98265624,0.00072181213,0.00048131874,0.008834443,0.0009302737,0.00001417694,0.000014852215,0.000017817296,0.0063290396],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799764,0.00049120846,0.0009819254,0.0001528731,0.00017307764,0.00020326504],"domain_scores_gemma":[0.99743474,0.0014131389,0.00034423222,0.00007751561,0.000074892625,0.0006555026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029558653,0.00008753242,0.00076467445,0.00015582373,0.000018974735,0.000004213084,0.000058260113,0.00015083014,0.00042215915],"category_scores_gemma":[0.0022813964,0.0000627945,0.00013638235,0.00020864919,0.00009372716,0.00004251567,0.00004523562,0.00041130654,0.00019326134],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007489643,0.0013724361,0.25662282,0.000022350845,0.000088733104,0.0026532174,0.0000532974,0.000008798104,0.0007573697,0.0000021318438,0.44155034,0.28937885],"study_design_scores_gemma":[0.007480832,0.012957102,0.47231057,0.000110866284,0.00019226577,0.000052475007,0.000019174307,0.0009942424,0.000020988404,0.00014732165,0.50564134,0.00007284988],"about_ca_topic_score_codex":0.000005429519,"about_ca_topic_score_gemma":0.000005985919,"teacher_disagreement_score":0.28930598,"about_ca_system_score_codex":0.000100150166,"about_ca_system_score_gemma":0.0005636903,"threshold_uncertainty_score":0.46223465},"labels":[],"label_agreement":null},{"id":"W4379283716","doi":"10.1200/jco.2023.41.16_suppl.e13033","title":"Incidence of interstitial lung disease and cardiotoxicity with trastuzumab-deruxtecan in patients with breast cancer: A systematic review and single-arm meta-analysis.","year":2023,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Oncology; Trastuzumab; Metastatic breast cancer; Cohort; Population; Incidence (geometry); Lung cancer; Interstitial lung disease; Cancer; Lung","score_opus":0.2038903981286359,"score_gpt":0.5079035114256127,"score_spread":0.30401311329697683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379283716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018443157,0.9950457,0.000010913103,0.00056031876,0.000112710135,0.0022315138,0.00017156171,0.0000052777814,0.000017691862],"genre_scores_gemma":[0.013680734,0.98546183,0.00007064092,0.00043390453,0.00013370709,0.00013128023,0.000015016343,0.000031894877,0.000040965853],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99372345,0.0014330555,0.0037841345,0.00038438445,0.0004541127,0.00022085622],"domain_scores_gemma":[0.9916639,0.0022139414,0.0049190884,0.0002486751,0.00046064306,0.00049379625],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0022345793,0.0003978135,0.019282438,0.00044035277,0.000021753685,0.00000862377,0.00016408549,0.00025536804,0.00008143478],"category_scores_gemma":[0.00059090497,0.0001976262,0.0017953471,0.000695519,0.00037653788,0.00008677411,0.000074130854,0.000911238,5.352779e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003310481,0.0028160287,0.013939505,0.6469779,0.31170204,0.0009730571,0.000046575948,0.000004488737,1.7352257e-8,0.000002466429,0.00015802318,0.020069387],"study_design_scores_gemma":[0.003252011,0.0077154175,0.008598577,0.09486191,0.884286,0.0002293295,0.000008295272,0.0000040944847,1.5336862e-8,0.0000025850559,0.0008784266,0.00016332597],"about_ca_topic_score_codex":0.000102804974,"about_ca_topic_score_gemma":0.0006069115,"teacher_disagreement_score":0.572584,"about_ca_system_score_codex":0.00046975721,"about_ca_system_score_gemma":0.0022576342,"threshold_uncertainty_score":0.99527735},"labels":[],"label_agreement":null},{"id":"W4379334895","doi":"10.1200/jco.2023.41.16_suppl.e15003","title":"Phase 1/2 study of tusamitamab ravtansine in patients with advanced solid tumors: Pooled safety analysis of corneal adverse events.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Adverse effect; Perforation; Carcinoembryonic antigen; Internal medicine; Oncology; Surgery; Gastroenterology; Ophthalmology; Cancer","score_opus":0.0696800325846888,"score_gpt":0.49284928820567564,"score_spread":0.42316925562098684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379334895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984018,0.000035842924,0.000012584154,0.00042219213,0.00039146002,0.0005280022,0.000037027785,0.0000068621766,0.00016422603],"genre_scores_gemma":[0.9992011,0.0001357311,0.0002095363,0.00019852794,0.00011453222,0.000005455897,0.00004447257,0.000013975434,0.00007666543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954009,0.00048877165,0.0032053504,0.00021290511,0.0004601545,0.00023189644],"domain_scores_gemma":[0.9949918,0.0013757565,0.0025767141,0.00020127295,0.0006346275,0.00021987357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001665609,0.00015905254,0.0029732457,0.0007682009,0.000017568658,5.2268996e-7,0.00013823484,0.00015660835,0.00024080365],"category_scores_gemma":[0.00070925185,0.000109800974,0.00045117232,0.0015423328,0.00013265105,0.0000843851,0.00004726351,0.0005085131,0.0000032053633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08928014,0.04820324,0.8277271,0.000025478923,0.0064548515,0.0005727677,0.00045884613,0.0018245179,0.00013033714,0.0000022265333,0.00015609761,0.025164424],"study_design_scores_gemma":[0.11848128,0.10205845,0.77173185,0.00006672786,0.006415815,0.000004997252,0.0005086409,0.00034444235,0.000042401643,0.000008083144,0.0002712179,0.00006610953],"about_ca_topic_score_codex":0.000044965698,"about_ca_topic_score_gemma":0.00028538628,"teacher_disagreement_score":0.055995226,"about_ca_system_score_codex":0.00018691628,"about_ca_system_score_gemma":0.0008323078,"threshold_uncertainty_score":0.4477554},"labels":[],"label_agreement":null},{"id":"W4379341012","doi":"10.1200/jco.2023.41.16_suppl.12100","title":"Patient- versus clinician-reported symptoms in the POLARIX study.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); University of Alberta","funders":"","keywords":"Medicine; Constipation; Nausea; Adverse effect; Vomiting; Placebo; Common Terminology Criteria for Adverse Events; Incidence (geometry); MedDRA; Quality of life (healthcare); Internal medicine; Diarrhea; Clinical trial; Physical therapy; Pharmacovigilance; Alternative medicine","score_opus":0.2938817515610744,"score_gpt":0.5797884005485378,"score_spread":0.2859066489874634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379341012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977811,0.00020077321,7.373311e-7,0.011801362,0.0054044933,0.00043108503,0.0000017334805,0.000015374531,0.0043334425],"genre_scores_gemma":[0.9946382,0.00032639495,0.000045578876,0.0033190984,0.0014133886,0.000011625669,0.000004364411,0.000011874116,0.00022949411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99564064,0.0009439899,0.0025801896,0.00017459727,0.0004002987,0.00026029727],"domain_scores_gemma":[0.9922622,0.0058128703,0.0013361439,0.00021386895,0.0001978369,0.00017709345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004845752,0.00011916438,0.0011081805,0.00021245782,0.000040031588,0.0000067746814,0.00017321877,0.00026079742,0.0002032934],"category_scores_gemma":[0.0027948064,0.000068694426,0.00042875775,0.00052897044,0.0001258587,0.000059640803,0.000051316136,0.0012045183,0.00009082427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020616896,0.010951843,0.7165704,0.0000071308586,0.0014204135,0.0121312635,0.0015449726,0.000013092221,0.000033475666,0.000030215688,0.029839074,0.20684123],"study_design_scores_gemma":[0.028450623,0.06724744,0.78772646,0.000019207959,0.00090091117,0.00020313579,0.0016799805,0.000028900753,0.000004017592,0.00009721147,0.11357972,0.000062395186],"about_ca_topic_score_codex":0.00006540481,"about_ca_topic_score_gemma":0.00028680704,"teacher_disagreement_score":0.20677884,"about_ca_system_score_codex":0.00012943111,"about_ca_system_score_gemma":0.0011419966,"threshold_uncertainty_score":0.52330995},"labels":[],"label_agreement":null},{"id":"W4379345342","doi":"10.1200/jco.2023.41.16_suppl.12092","title":"The impact of population pharmacogenomics and risk allele frequencies on cisplatin-induced peripheral sensory neuropathy (PSN).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University Health Network","funders":"National Institutes of Health","keywords":"Single-nucleotide polymorphism; Allele; Population; Allele frequency; Expression quantitative trait loci; Ancestry-informative marker; Genome-wide association study; Oncology; Genetics; Medicine; Biology; Pharmacogenomics; Internal medicine; Genotype; Gene; Environmental health","score_opus":0.1847579850841918,"score_gpt":0.5206790500866666,"score_spread":0.33592106500247476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379345342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962278,0.00029903755,0.0000014781124,0.0017495293,0.0009231323,0.00017318889,0.000012027257,0.000010258753,0.0006035736],"genre_scores_gemma":[0.9908293,0.0075619966,0.0000874254,0.00031169405,0.0009870604,0.0000021636845,0.0000053949866,0.00001472441,0.00020023002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997693,0.00059852924,0.0012113772,0.00012641508,0.00018225155,0.00018841594],"domain_scores_gemma":[0.99528325,0.0029301052,0.0013076591,0.00010677079,0.00017514994,0.00019704348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001954319,0.0001188953,0.00076845457,0.00009321868,0.000090918555,0.0000065026084,0.000080084596,0.0001602681,0.00007647964],"category_scores_gemma":[0.0011205121,0.00006724821,0.00042094264,0.00012285361,0.00013084078,0.000048541828,0.000029121229,0.0007038538,0.0000071912123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017071389,0.0011240755,0.6613487,0.000016685417,0.0015873208,0.000639614,0.00046186804,0.00079559046,0.026178535,0.00004212841,0.008636873,0.28209722],"study_design_scores_gemma":[0.007630196,0.02397742,0.9608481,0.000012793659,0.00054349244,0.00023080753,0.00008962063,0.0018076573,0.00027537116,0.00027394478,0.0042447574,0.00006583348],"about_ca_topic_score_codex":0.00018776109,"about_ca_topic_score_gemma":0.00004160584,"teacher_disagreement_score":0.29949942,"about_ca_system_score_codex":0.00016121917,"about_ca_system_score_gemma":0.00046191958,"threshold_uncertainty_score":0.30579334},"labels":[],"label_agreement":null},{"id":"W4379376363","doi":"10.1002/pmrj.13007","title":"Brachial plexopathy after breast cancer: A persistent late effect of radiotherapy","year":2023,"lang":"en","type":"review","venue":"PM&R","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Brachial Plexopathy; Breast cancer; Radiation therapy; Hypoesthesia; Weakness; Rehabilitation; Lymphedema; Surgery; Dysesthesia; Cancer; Physical therapy; Brachial plexus; Internal medicine","score_opus":0.03475781185850126,"score_gpt":0.39094667303833547,"score_spread":0.3561888611798342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379376363","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025593492,0.994327,2.1747412e-7,0.00011319855,0.00085814745,0.0013568053,0.0005516589,0.00006417032,0.00016944627],"genre_scores_gemma":[0.00021847,0.99352604,0.0000076004435,0.00009991968,0.0012110482,0.00085682987,0.00012239222,0.00009260314,0.0038651025],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868876,0.00016216075,0.00036478575,0.0003341968,0.00017970301,0.00027042298],"domain_scores_gemma":[0.9992405,0.00016493427,0.00019831173,0.0002447467,0.000029063493,0.00012244155],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001505388,0.00037322208,0.0020833185,0.00018360977,0.00002410833,0.0000066647763,0.00009840889,0.00020430014,0.0014324846],"category_scores_gemma":[0.000004700036,0.00024902765,0.0012293666,0.00025858582,0.000065842825,0.000017719412,0.000032204538,0.00026795815,0.00009549306],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011298393,0.00011510927,0.001115934,0.035939123,0.0030523837,0.00019392441,0.00015013124,6.526099e-7,0.0000080775035,8.96611e-7,0.0026162406,0.9556777],"study_design_scores_gemma":[0.0026383626,0.0011513375,0.0005751535,0.010115763,0.009714015,0.00023202717,0.0000013186242,0.000008135347,0.0000045529177,6.192996e-7,0.9753347,0.00022401047],"about_ca_topic_score_codex":0.00029126534,"about_ca_topic_score_gemma":0.000035159395,"teacher_disagreement_score":0.9727185,"about_ca_system_score_codex":0.00035580058,"about_ca_system_score_gemma":0.00028473182,"threshold_uncertainty_score":0.9999962},"labels":[],"label_agreement":null},{"id":"W4384789985","doi":"10.1007/978-3-031-29277-4_11","title":"Principles of Clinical Oncology and Systemic Treatments","year":2023,"lang":"en","type":"book-chapter","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Multidisciplinary approach; Specialty; Intensive care medicine; Systemic therapy; Immunotherapy; Oncology; Cancer; Internal medicine; Breast cancer; Pathology","score_opus":0.27799483519115437,"score_gpt":0.4768419341880442,"score_spread":0.19884709899688985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384789985","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008505731,0.0013257302,9.1431866e-7,0.0003379131,0.0006715515,0.00066228956,0.00004751996,0.000070891954,0.98837745],"genre_scores_gemma":[0.011170366,0.009124597,0.00011568711,0.00015275225,0.00035088148,0.000022572776,0.00009023305,0.00004225424,0.97893065],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987091,0.000022227408,0.0007232606,0.00030399224,0.00012087135,0.00012054045],"domain_scores_gemma":[0.9989478,0.00034917117,0.0003201039,0.00018586224,0.000060033566,0.00013705257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018598541,0.00020051205,0.0011781988,0.000111789515,0.0000154131,0.0000014923182,0.000038347167,0.0004963434,0.00089138653],"category_scores_gemma":[0.000019464718,0.00014375927,0.00020538783,0.000013565745,0.000154574,0.000009320227,0.00006310817,0.00020587609,0.00017254864],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006885037,0.0018936273,0.07922033,0.0034217979,0.02438433,0.0042388737,0.00053233106,0.0000015451376,0.0006098046,0.39918864,0.03508448,0.4445392],"study_design_scores_gemma":[0.013875219,0.008932483,0.013044535,0.0009228703,0.0068356204,0.00054718874,0.000036741974,0.000025814226,0.00011059372,0.0008694691,0.95447844,0.00032101572],"about_ca_topic_score_codex":0.000048234477,"about_ca_topic_score_gemma":0.000065129825,"teacher_disagreement_score":0.91939396,"about_ca_system_score_codex":0.000104837396,"about_ca_system_score_gemma":0.00036106977,"threshold_uncertainty_score":0.97600573},"labels":[],"label_agreement":null},{"id":"W4384963325","doi":"","title":"Pharmacogénétique-pharmacogénomique. La dualité hôte-tumeur","year":2012,"lang":"fr","type":"preprint","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Physics; Computer science","score_opus":0.02703725457329485,"score_gpt":0.30575072114727975,"score_spread":0.2787134665739849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384963325","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29339176,0.051498193,0.013813247,0.07085671,0.007123298,0.0034436,0.00071834103,0.0009820026,0.5581728],"genre_scores_gemma":[0.8090658,0.02036597,0.009510595,0.0013612992,0.000990509,0.00055855414,0.0017184032,0.0002486813,0.15618017],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97661114,0.018122172,0.001395983,0.001579956,0.00074531004,0.0015454488],"domain_scores_gemma":[0.98795664,0.0049611977,0.0010725874,0.0023102285,0.002377055,0.0013222933],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.011076352,0.0011757362,0.0013579451,0.00039032014,0.00057936675,0.00032479703,0.0014568851,0.0009760221,0.010399163],"category_scores_gemma":[0.00080580846,0.001289972,0.00083848543,0.000673849,0.00090743304,0.0003722452,0.0017425937,0.002499322,0.0015179781],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096412323,0.016979141,0.041990206,0.0033106292,0.0046329536,0.00048133233,0.041742153,0.00011396205,0.14428332,0.3136938,0.08478457,0.34702381],"study_design_scores_gemma":[0.006710684,0.0000028877598,0.011699569,0.0036252737,0.0023733699,0.00028308993,0.00018924939,0.0035500247,0.23267715,0.0012374264,0.73631644,0.001334857],"about_ca_topic_score_codex":0.0033438047,"about_ca_topic_score_gemma":0.00062241714,"teacher_disagreement_score":0.6515319,"about_ca_system_score_codex":0.0009042061,"about_ca_system_score_gemma":0.0012535667,"threshold_uncertainty_score":0.99980193},"labels":[],"label_agreement":null},{"id":"W4386033484","doi":"10.22201/fesi.23958979e.2023.12.24.85532","title":"Prevalencia e intensidad de síntomas en pacientes que reciben quimioterapia ambulatoria","year":2023,"lang":"es","type":"article","venue":"Revista CuidArte","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Humanities; Medicine; Philosophy","score_opus":0.019909686006555873,"score_gpt":0.34819240296453907,"score_spread":0.3282827169579832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386033484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633428,0.020523103,0.000047993042,0.0073915543,0.002362759,0.001492741,0.00022229337,0.00056680647,0.004049979],"genre_scores_gemma":[0.96147424,0.01729905,0.00009888048,0.0011024099,0.0028715304,0.000103141705,0.00019983943,0.000116191215,0.016734727],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99665356,0.00047266565,0.0006796353,0.00075222104,0.00042613674,0.0010157622],"domain_scores_gemma":[0.99785995,0.0004965491,0.00023492315,0.0007080042,0.00023107215,0.0004694983],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009888129,0.00051742786,0.0008916671,0.00035162424,0.0001909307,0.0001868633,0.0002809769,0.0003173925,0.0013531973],"category_scores_gemma":[0.00037137876,0.000476586,0.0003829952,0.00095793925,0.00018110308,0.00014656578,0.00016867237,0.0005118993,0.0023323868],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001379947,0.00076632947,0.21350619,0.004619493,0.0026343958,0.0020709625,0.007664452,0.000012216218,0.091511294,0.012221046,0.62083924,0.042774417],"study_design_scores_gemma":[0.0034052574,0.0010582363,0.19233285,0.0020678788,0.0018052536,0.00015236638,0.00030213167,0.00075844175,0.004289503,0.00037529194,0.79285485,0.00059795234],"about_ca_topic_score_codex":0.00020278146,"about_ca_topic_score_gemma":0.000015577174,"teacher_disagreement_score":0.17201559,"about_ca_system_score_codex":0.0006918178,"about_ca_system_score_gemma":0.0006168828,"threshold_uncertainty_score":0.99976856},"labels":[],"label_agreement":null},{"id":"W4386122856","doi":"10.11159/icepr23.132","title":"Encapsulation of Sertraline in Biodegradable Polymeric Nanoparticles","year":2023,"lang":"en","type":"article","venue":"Proceedings of the World Congress on New Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Encapsulation (networking); Nanoparticle; Sertraline; Materials science; Nanotechnology; Computer science; Computer security; Medicine","score_opus":0.027799375505903896,"score_gpt":0.30472048180490385,"score_spread":0.27692110629899996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386122856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98328894,0.0004522943,3.6211063e-8,0.014588147,0.00016145792,0.0002872537,0.0000029559505,0.00028333798,0.0009355636],"genre_scores_gemma":[0.991517,0.00019795432,0.0001412135,0.00004232862,0.000012482692,0.000026992751,0.0000012507658,0.000009029056,0.0080517335],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929404,0.0000022823228,0.00022993566,0.00015002338,0.00014691951,0.00017677226],"domain_scores_gemma":[0.9996321,0.000045288492,0.00016121156,0.00010301567,0.000041436506,0.00001690343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077413315,0.00010155453,0.00024823283,0.00045157413,0.000023974875,0.000004821004,0.00019205787,0.000057122226,0.000015281536],"category_scores_gemma":[0.000086521686,0.00006704644,0.000059120917,0.0017367825,0.00015884142,0.000058915757,0.00008904397,0.000115994706,0.0000039854285],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036918334,0.0001514369,0.16972129,0.000112205315,0.00005176693,0.0000019185286,0.00007730326,0.00000923754,0.79444474,0.0025881296,0.011080775,0.021392023],"study_design_scores_gemma":[0.0010373276,0.00021034194,0.02496161,0.00024702746,0.00004558969,0.0000024047886,0.0002728359,0.00013673486,0.96944237,0.0020590113,0.0015270507,0.000057704827],"about_ca_topic_score_codex":0.00009692077,"about_ca_topic_score_gemma":0.000049939914,"teacher_disagreement_score":0.17499763,"about_ca_system_score_codex":0.000037351423,"about_ca_system_score_gemma":0.000035539426,"threshold_uncertainty_score":0.27340746},"labels":[],"label_agreement":null},{"id":"W4386277530","doi":"10.1016/s2152-2650(23)00614-6","title":"POSTER: MDS-634 Efficacy and Safety of Oral Decitabine/Cedazuridine (ASTX727) in the CMML Subpopulation from Phase 2 and ASCERTAIN Phase 3 Studies","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Hôpital Maisonneuve-Rosemont; University of Alberta Hospital; Queen Elizabeth II Health Sciences Centre; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Decitabine; Phase (matter); Medicine; Internal medicine; Pharmacology; Chemistry; Biology; Genetics; Organic chemistry","score_opus":0.10738174308216894,"score_gpt":0.4665188563372431,"score_spread":0.35913711325507414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386277530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931051,0.002553534,0.0000032765415,0.0028839866,0.00034797867,0.0007516464,0.00014275646,0.00006230661,0.0001493867],"genre_scores_gemma":[0.9951355,0.002924053,0.00008926846,0.0007832295,0.0003937082,0.000045753983,0.0004726071,0.000027444734,0.0001284591],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99755573,0.00034054322,0.0010124401,0.00051405444,0.00024949564,0.00032771367],"domain_scores_gemma":[0.9964085,0.002749699,0.00022846853,0.00033612564,0.00010704164,0.00017012656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009575226,0.00027365406,0.0008979749,0.00015265329,0.00010435312,0.000017306,0.00012418041,0.000186857,0.00007328143],"category_scores_gemma":[0.00079153525,0.00019229288,0.0001251715,0.00055058673,0.00043201336,0.00009841257,0.00012950331,0.00018516011,0.000018708548],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016156644,0.0015574791,0.12984404,0.00010435592,0.0006235567,0.0005645356,0.0018763378,0.0000051729744,0.0029400452,0.00010248316,0.007149487,0.83907586],"study_design_scores_gemma":[0.06384502,0.0025283755,0.9234818,0.00015469373,0.00054052006,0.000044655695,0.00039812227,0.00081239996,0.000496215,0.0003685737,0.007144842,0.00018476314],"about_ca_topic_score_codex":0.0004491031,"about_ca_topic_score_gemma":0.00022518796,"teacher_disagreement_score":0.8388911,"about_ca_system_score_codex":0.0002316166,"about_ca_system_score_gemma":0.0002529641,"threshold_uncertainty_score":0.7841476},"labels":[],"label_agreement":null},{"id":"W4386277882","doi":"10.1016/s2152-2650(23)01205-3","title":"MDS-634 Efficacy and Safety of Oral Decitabine/Cedazuridine (ASTX727) in the CMML Subpopulation from Phase 2 and ASCERTAIN Phase 3 Studies","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Hôpital Maisonneuve-Rosemont; University of Alberta Hospital; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"University of Colorado School of Medicine, Anschutz Medical Campus; School of Medicine, Vanderbilt University; Yale Cancer Center; Yale University; Vanderbilt-Ingram Cancer Center; Vanderbilt University; London Health Sciences Centre; University of Texas MD Anderson Cancer Center; Roswell Park Cancer Institute","keywords":"Decitabine; Phase (matter); Medicine; Internal medicine; Oncology; Chemistry; Biology; Genetics; Organic chemistry","score_opus":0.11731023287305228,"score_gpt":0.4757566492205611,"score_spread":0.35844641634750884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386277882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936467,0.0025541575,0.0000061579294,0.002429213,0.0003357727,0.000706461,0.00011839213,0.00006269267,0.00014044698],"genre_scores_gemma":[0.9947622,0.0034237748,0.00013989974,0.0006278627,0.00041957296,0.000050573915,0.00041388345,0.000026098027,0.00013616538],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99762666,0.0003238444,0.0009795309,0.0005024572,0.00024753425,0.00031995864],"domain_scores_gemma":[0.9962867,0.0029021015,0.00021938566,0.00032447782,0.00010100586,0.00016635204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010099063,0.00026284307,0.00088432746,0.0001459921,0.00010558929,0.000015300517,0.000118993215,0.00018322746,0.00007968161],"category_scores_gemma":[0.00093558204,0.00018438934,0.000120645775,0.0005894015,0.0004547756,0.00009063024,0.000114966366,0.00018540178,0.000018205626],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013223302,0.0015437838,0.09587752,0.000095915806,0.0005944455,0.00049296353,0.0015893634,0.000009535948,0.0025150885,0.00016994208,0.009222061,0.8746661],"study_design_scores_gemma":[0.064453475,0.0021371173,0.91945094,0.00014288767,0.0005376712,0.000032658838,0.000471874,0.0015435454,0.0004266258,0.00053533015,0.010086164,0.00018171486],"about_ca_topic_score_codex":0.0004625052,"about_ca_topic_score_gemma":0.00022517705,"teacher_disagreement_score":0.87448436,"about_ca_system_score_codex":0.00023261471,"about_ca_system_score_gemma":0.0002659995,"threshold_uncertainty_score":0.7519179},"labels":[],"label_agreement":null},{"id":"W4387310638","doi":"10.22541/au.169633092.29115365/v1","title":"Physical therapy for deficits associated with chemotherapy-induced peripheral neuropathy in children with cancer: a systematic review","year":2023,"lang":"en","type":"review","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"University of Alberta","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Physical therapy; Clinical trial; Randomized controlled trial; Physical medicine and rehabilitation; Adverse effect; Psychological intervention; Peripheral neuropathy; Cancer; Systematic review; Inclusion and exclusion criteria; Quality of life (healthcare); Incidence (geometry); Range of motion; MEDLINE; Alternative medicine; Internal medicine","score_opus":0.05965829511089113,"score_gpt":0.3861156272695795,"score_spread":0.32645733215868833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387310638","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002421964,0.97677296,0.0000015900214,0.00020436458,0.00005533429,0.020208795,0.00008103342,0.00016944711,0.000084515166],"genre_scores_gemma":[0.00016018027,0.98530155,0.000010958123,0.0012411933,0.0002019417,0.01105515,0.00038422595,0.00023368277,0.0014110858],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99771273,0.0002631806,0.00062931987,0.0006290726,0.00030395112,0.00046176807],"domain_scores_gemma":[0.9986187,0.00026843042,0.0005227017,0.00036297992,0.00011114741,0.0001160156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002311565,0.0007227459,0.00543077,0.00014871772,0.000048407015,0.000019897228,0.00017712743,0.00016585168,0.00007334225],"category_scores_gemma":[0.000032757667,0.00036632046,0.0005159498,0.00093050685,0.000036504145,0.000036556336,0.000013993881,0.0003812099,0.000011449183],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003464923,0.0011644934,0.00034246038,0.91331434,0.007541157,0.000056274224,0.00014447155,4.4227303e-7,0.0000026255764,0.0000131689685,0.0007764119,0.07629766],"study_design_scores_gemma":[0.009289266,0.0042437874,0.00023363062,0.9608743,0.017466532,0.00017696834,0.000007698263,0.000022764745,0.000004554213,0.0000021112376,0.006943287,0.0007351041],"about_ca_topic_score_codex":0.0001531101,"about_ca_topic_score_gemma":0.00024057725,"teacher_disagreement_score":0.07556256,"about_ca_system_score_codex":0.0005087248,"about_ca_system_score_gemma":0.000782691,"threshold_uncertainty_score":0.9998789},"labels":[],"label_agreement":null},{"id":"W4387644499","doi":"10.1002/cm.21706","title":"Front Cover Image","year":2023,"lang":"en","type":"paratext","venue":"Cytoskeleton","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Actin; Biology; Front cover; Protein filament; Cover (algebra); Anatomy; Biophysics; Cell biology; Biochemistry; Engineering; Mechanical engineering","score_opus":0.02480909933930069,"score_gpt":0.3483045585586491,"score_spread":0.3234954592193484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387644499","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004043081,0.003409721,0.00005590677,0.0018395247,0.0081244195,0.0008185772,0.00038330682,0.00017114157,0.9811543],"genre_scores_gemma":[0.0012321913,0.003398397,0.00010134076,0.0012188912,0.0032415516,0.00014073982,0.0026850537,0.000125006,0.9878568],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986577,0.00003534576,0.00025009323,0.00044281385,0.000223443,0.0003906188],"domain_scores_gemma":[0.9992052,0.000075274234,0.00011214316,0.00035930405,0.000070889444,0.00017719933],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006368684,0.000334724,0.0006769089,0.00017826371,0.000055649456,0.000020370368,0.00010960125,0.0003849109,0.10768143],"category_scores_gemma":[0.000015877053,0.00029123743,0.00027408035,0.00012930762,0.00007902181,0.00003447415,0.00007391474,0.0004696861,0.47526294],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023902119,0.00011903668,0.00001482038,0.00034695573,0.00033870898,0.00023361777,0.00006657718,0.0000020057876,0.0047910833,0.000003351577,0.9919696,0.0018752405],"study_design_scores_gemma":[0.0021231286,0.00044034127,0.00037951858,0.00016110973,0.00048281625,0.000026311858,0.000009026018,0.000011653414,0.0037222651,0.000013182263,0.99238706,0.00024361564],"about_ca_topic_score_codex":0.00021601985,"about_ca_topic_score_gemma":0.000018068587,"teacher_disagreement_score":0.3675815,"about_ca_system_score_codex":0.0003514269,"about_ca_system_score_gemma":0.0003820225,"threshold_uncertainty_score":0.999954},"labels":[],"label_agreement":null},{"id":"W4387774241","doi":"10.3390/curroncol30100665","title":"Toxicities and Quality of Life during Cancer Treatment in Advanced Solid Tumors","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Sociedad Española de Oncología Médica; AstraZeneca","keywords":"Medicine; Cancer; Quality of life (healthcare); Solid tumor; Cancer research; Oncology; Internal medicine; Nursing","score_opus":0.21365993891603335,"score_gpt":0.5182036367719955,"score_spread":0.3045436978559622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387774241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99255097,0.00505324,3.926966e-7,0.00087385165,0.0005889634,0.00038991892,0.000034899247,0.000042897216,0.0004648648],"genre_scores_gemma":[0.99165666,0.007262558,0.000012059925,0.000048960977,0.00014301512,0.00028369634,0.000025471109,0.000009901583,0.0005576531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906147,0.00007894543,0.00033759093,0.00020739243,0.000075835924,0.00023877957],"domain_scores_gemma":[0.9995212,0.00014020523,0.00010936722,0.00009321627,0.000032414402,0.000103618826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009812804,0.00012145534,0.0005669872,0.00017330752,0.000028279199,0.0000015331103,0.0000299657,0.00005533724,0.00016087216],"category_scores_gemma":[0.00003785085,0.000102060694,0.00005472584,0.00019801872,0.00010877888,0.000029565774,0.000036125293,0.00009094837,0.0000071452623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001971493,0.0012361226,0.8959703,0.00056697376,0.00014142774,0.0000455046,0.0033476732,0.00007292196,0.030037481,0.000112002286,0.00033516414,0.066162944],"study_design_scores_gemma":[0.011365231,0.0014730918,0.9661008,0.00011334743,0.00008174809,0.000005974079,0.00079049345,0.000073178126,0.010801822,0.000060764087,0.009013178,0.000120350865],"about_ca_topic_score_codex":0.00031833095,"about_ca_topic_score_gemma":0.0011441144,"teacher_disagreement_score":0.07013053,"about_ca_system_score_codex":0.00042766734,"about_ca_system_score_gemma":0.00030119086,"threshold_uncertainty_score":0.41619143},"labels":[],"label_agreement":null},{"id":"W4387782509","doi":"10.21203/rs.3.rs-3432816/v1","title":"Patient Perceptions of Altering Chemotherapy Treatment Due to Peripheral Neuropathy","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"King's College London; Bowel Cancer UK","keywords":"Chemotherapy-induced peripheral neuropathy; Medicine; Chemotherapy; Peripheral neuropathy; Physical therapy; Internal medicine","score_opus":0.11219272509237521,"score_gpt":0.4667034907685857,"score_spread":0.3545107656762105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387782509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991241,0.00030563702,0.000048087724,0.0041427077,0.00042796467,0.0025489766,0.00024614038,0.000106177715,0.00093334215],"genre_scores_gemma":[0.9920108,0.0016068128,0.00032900524,0.00014076974,0.00052004337,0.0012024516,0.00023318159,0.00008929001,0.003867654],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99774015,0.00023321944,0.00032051431,0.00057704997,0.0006078287,0.00052122405],"domain_scores_gemma":[0.99855596,0.00012686821,0.00005653992,0.000596915,0.00033727882,0.00032646072],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021451277,0.00026101604,0.00057692354,0.0004894685,0.0001111942,0.00002721168,0.00012899094,0.00015585644,0.0013999986],"category_scores_gemma":[0.0000409535,0.00021953884,0.0002887462,0.00035465191,0.000096631105,0.000017653867,0.0003590227,0.00052159664,0.00016129954],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011397746,0.012496744,0.16092843,0.0074953083,0.0031808459,0.005823438,0.08252833,0.0064001484,0.19807568,0.00011874099,0.053765226,0.45778936],"study_design_scores_gemma":[0.010677802,0.04328611,0.84286094,0.0033936957,0.00045064045,0.00017555902,0.005564744,0.0021388703,0.024425795,0.00043193696,0.065540425,0.0010534583],"about_ca_topic_score_codex":0.0012628435,"about_ca_topic_score_gemma":0.00015042305,"teacher_disagreement_score":0.6819325,"about_ca_system_score_codex":0.0010441365,"about_ca_system_score_gemma":0.0004683024,"threshold_uncertainty_score":0.99951285},"labels":[],"label_agreement":null},{"id":"W4387809675","doi":"10.1016/j.annonc.2023.10.015","title":"LBA11 Datopotamab deruxtecan (Dato-DXd) vs chemotherapy in previously-treated inoperable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2–) breast cancer (BC): Primary results from the randomised phase III TROPION-Breast01 trial","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Foundation Medicine; Loxo Oncology; Jounce Therapeutics; Genentech; Gilead Sciences; Radius Health; MedImmune; Clovis Oncology; Eisai; Daiichi Sankyo Europe; Sanofi; Daiichi-Sankyo; Pfizer","keywords":"Medicine; Oncology; Metastatic breast cancer; HER2 negative; Internal medicine; Chemotherapy; Hormone receptor; Breast cancer; Cancer; Gynecology","score_opus":0.06623516967856484,"score_gpt":0.40216623548961317,"score_spread":0.3359310658110483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387809675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9526737,0.00088010955,0.000005197725,0.0380148,0.00040611034,0.004726343,0.0019670047,0.00010100249,0.0012257685],"genre_scores_gemma":[0.9610164,0.02419934,0.00025628065,0.0061649815,0.00082400744,0.001655299,0.002424514,0.00010208149,0.0033570565],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99577975,0.0011179533,0.0012323163,0.00075067463,0.00035666997,0.0007626595],"domain_scores_gemma":[0.9955542,0.002713518,0.000626713,0.00050607085,0.00034941817,0.0002500636],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009332739,0.0004814187,0.0018406925,0.0002599282,0.00014916596,0.000021342214,0.0003217427,0.00025800642,0.0018075325],"category_scores_gemma":[0.00023766038,0.00031445376,0.00028341782,0.0011346439,0.00040488108,0.00017493141,0.00009072785,0.000491159,0.000050960847],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8245586,0.0042895786,0.00041814955,0.000038410126,0.001989101,0.00032251954,0.0036685811,0.000016611433,0.008408664,0.0000047661056,0.086681895,0.06960311],"study_design_scores_gemma":[0.9148354,0.016624222,0.021304367,0.00029459156,0.000991794,0.000082542356,0.0006749023,0.00017833035,0.019342862,0.00011401495,0.025125373,0.00043159988],"about_ca_topic_score_codex":0.025138862,"about_ca_topic_score_gemma":0.0034645863,"teacher_disagreement_score":0.090276785,"about_ca_system_score_codex":0.000430304,"about_ca_system_score_gemma":0.0016047368,"threshold_uncertainty_score":0.99993074},"labels":[],"label_agreement":null},{"id":"W4387812407","doi":"10.5603/pmp.97647","title":"Can selected physiotherapeutic techniques really help in treating back pain and improving the quality of life of advanced cancer patients: a randomised controlled study","year":2023,"lang":"en","type":"article","venue":"Palliative Medicine in Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Physical therapy; Quality of life (healthcare); Cancer; Rating scale; Proprioception; Physical medicine and rehabilitation; Internal medicine; Nursing; Psychology","score_opus":0.03757804652903827,"score_gpt":0.4208004199338231,"score_spread":0.3832223734047848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387812407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98836017,0.000930034,0.000014947557,0.00519327,0.00005198729,0.004954641,0.0000089752175,0.000027620827,0.0004583808],"genre_scores_gemma":[0.9968287,0.0010910576,0.00014375855,0.0008138323,0.00006501333,0.0009390586,0.0000152302655,0.000019060826,0.00008433342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626356,0.0019828354,0.00092825707,0.00027664422,0.00033368092,0.00021504592],"domain_scores_gemma":[0.98849,0.009910819,0.00091505295,0.00015817274,0.00046836614,0.000057589663],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0032860124,0.00019266343,0.0010960016,0.00021536679,0.000035052373,0.0000028604866,0.00007349082,0.000050146602,0.000044798384],"category_scores_gemma":[0.010861112,0.000117303716,0.000043124266,0.0011039955,0.000147246,0.00008179719,0.000028466317,0.0002660631,2.6935976e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07941553,0.0018349425,0.81498575,0.0004811927,0.00080810545,0.000010007018,0.026170058,0.000019710822,0.05159253,0.0000102449985,0.00009648733,0.024575442],"study_design_scores_gemma":[0.2678963,0.0053400914,0.7014396,0.0006624846,0.0006239665,3.009926e-7,0.0215162,0.0008907207,0.0014057631,0.000029295585,0.000052432035,0.00014285183],"about_ca_topic_score_codex":0.014226724,"about_ca_topic_score_gemma":0.0038816838,"teacher_disagreement_score":0.18848076,"about_ca_system_score_codex":0.00017543299,"about_ca_system_score_gemma":0.00025782207,"threshold_uncertainty_score":0.9974708},"labels":[],"label_agreement":null},{"id":"W4388205306","doi":"10.1200/op.2023.19.11_suppl.275","title":"Feasibility and acceptability of an mHealth app integrating pain-cognitive behavioral therapy and pharmacologic support for patients with advanced cancer.","year":2023,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health; National Palliative Care Research Center","keywords":"Medicine; Cancer pain; McGill Pain Questionnaire; Physical therapy; Psychological intervention; Cancer; mHealth; Internal medicine; Psychiatry; Visual analogue scale","score_opus":0.11148505310438467,"score_gpt":0.5054033039505176,"score_spread":0.3939182508461329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388205306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947703,0.0002913769,0.00001763565,0.0013824509,0.00017963268,0.0028047068,0.00014639727,0.00007302127,0.00033450447],"genre_scores_gemma":[0.9929384,0.0011826953,0.0032221742,0.00165478,0.000068457484,0.0006825631,0.00018104246,0.0000193851,0.00005048092],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99831104,0.00049822143,0.0003045503,0.0004622078,0.00012643811,0.00029754228],"domain_scores_gemma":[0.9965679,0.0023241346,0.00036927417,0.000117120406,0.00044728222,0.00017426511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012676056,0.00018357312,0.00049111544,0.00007564284,0.00014080864,0.00000723493,0.00004837936,0.00013256632,0.000262532],"category_scores_gemma":[0.0004360342,0.00013715515,0.000038469487,0.00021437246,0.0002882233,0.00034426866,0.000038240923,0.0002708614,8.5958885e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02045245,0.00335786,0.47583166,0.00010666293,0.00013244593,0.000017216023,0.0014248423,6.675122e-7,0.00049471855,0.000005055097,0.00016386806,0.49801254],"study_design_scores_gemma":[0.027825715,0.046079826,0.908961,0.000018147948,0.0010128585,0.000023019114,0.0042647235,0.00016684162,0.00080536905,0.00004398902,0.010613812,0.00018469617],"about_ca_topic_score_codex":0.0002767954,"about_ca_topic_score_gemma":0.00033485354,"teacher_disagreement_score":0.49782786,"about_ca_system_score_codex":0.00026709223,"about_ca_system_score_gemma":0.0005247877,"threshold_uncertainty_score":0.55930245},"labels":[],"label_agreement":null},{"id":"W4388734631","doi":"10.11606/d.22.2023.tde-14112023-115104","title":"Neuropatia periférica induzida por quimioterápicos: sintomas e o risco de queda em mulheres idosas com câncer","year":2023,"lang":"pt","type":"dissertation","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.03387971318718226,"score_gpt":0.3652915117221109,"score_spread":0.33141179853492864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388734631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717062,0.0033909539,0.000088704015,0.0024376186,0.00796585,0.0021494315,0.00020777875,0.0006978257,0.011355607],"genre_scores_gemma":[0.75279295,0.0015791954,0.00010517502,0.0026132227,0.0012687942,0.0003805855,0.0034843136,0.00032922818,0.23744655],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9950416,0.00053721835,0.0011590413,0.0012950106,0.0007047204,0.0012624154],"domain_scores_gemma":[0.9970662,0.00059735763,0.0006078983,0.00073168735,0.00031860115,0.0006782434],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032020864,0.0011731923,0.0015063231,0.0006285351,0.00036029436,0.00016581752,0.00047874468,0.0010410225,0.016637182],"category_scores_gemma":[0.00017867475,0.0010599946,0.0005888501,0.0008383836,0.00014742636,0.00015113883,0.0001227411,0.001461242,0.0026767608],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0140319625,0.0065661436,0.15320668,0.005281357,0.008422938,0.008033817,0.094568186,0.00018665692,0.052710574,0.00055299763,0.52007943,0.13635924],"study_design_scores_gemma":[0.030718474,0.012416463,0.69355994,0.0036308472,0.015924832,0.00038904385,0.068577744,0.012053341,0.035346642,0.00026167862,0.12153946,0.0055815266],"about_ca_topic_score_codex":0.011297952,"about_ca_topic_score_gemma":0.011009876,"teacher_disagreement_score":0.5403533,"about_ca_system_score_codex":0.0007035542,"about_ca_system_score_gemma":0.0014119213,"threshold_uncertainty_score":0.999185},"labels":[],"label_agreement":null},{"id":"W4389704510","doi":"10.1017/s0266462323001848","title":"PP33 The Cost-effectiveness Of Regorafenib In The Treatment Of Advanced Hepatocellular Carcinoma From A Canadian Perspective","year":2023,"lang":"en","type":"article","venue":"International Journal of Technology Assessment in Health Care","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Regorafenib; Medicine; Hepatocellular carcinoma; Sorafenib; Cost effectiveness; Adverse effect; Quality-adjusted life year; Quality of life (healthcare); Cost-effectiveness analysis; Oncology; Internal medicine; Cancer; Colorectal cancer; Risk analysis (engineering)","score_opus":0.031428478712202806,"score_gpt":0.4230383136949414,"score_spread":0.3916098349827386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389704510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9661632,0.0041663884,0.0000073079937,0.027964955,0.00046635984,0.0009529921,0.00009575735,0.000006973225,0.00017607212],"genre_scores_gemma":[0.99799854,0.0015304567,0.00011457551,0.00014697725,0.00005840961,0.00008991982,0.000046188605,0.000008589928,0.000006370806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986625,0.00022336014,0.0004999531,0.0001361757,0.00029030308,0.00018775398],"domain_scores_gemma":[0.99854344,0.000392105,0.00038031154,0.00016681051,0.00046862158,0.00004869669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041077615,0.00011072104,0.00041058142,0.00089395104,0.000034017034,0.0000035666644,0.00031362928,0.00009491825,0.000023077211],"category_scores_gemma":[0.000045473073,0.00006939094,0.00011159113,0.0005225628,0.00011250482,0.000038720966,0.000019528481,0.00030586176,8.060746e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009601748,0.000624367,0.96950036,0.000062871244,0.0003900075,0.00106489,0.0075610657,0.00037614707,0.0009846267,0.003732904,0.0000814397,0.014661146],"study_design_scores_gemma":[0.008082501,0.0033640794,0.9252909,0.00047883755,0.00008151809,0.00013336292,0.05174446,0.00022967043,0.0037603944,0.0020720493,0.0046848017,0.00007742724],"about_ca_topic_score_codex":0.055403717,"about_ca_topic_score_gemma":0.027814006,"teacher_disagreement_score":0.04420946,"about_ca_system_score_codex":0.0034167226,"about_ca_system_score_gemma":0.0016019187,"threshold_uncertainty_score":0.98992586},"labels":[],"label_agreement":null},{"id":"W4390082929","doi":"10.1007/s00520-023-08209-0","title":"Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy","year":2023,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Institute for Health and Care Research","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Nursing research; Chemotherapy; Physical therapy; Intensive care medicine; Internal medicine; Nursing","score_opus":0.024814203176223164,"score_gpt":0.37247749659345863,"score_spread":0.34766329341723545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390082929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961661,0.00031937248,0.000003984713,0.001308179,0.00041776092,0.00063215324,0.00015308954,0.0000438207,0.0009555143],"genre_scores_gemma":[0.99707127,0.0007645075,0.00004658817,0.00079333654,0.00013907682,0.0005399476,0.00006844515,0.00002573344,0.00055111706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917406,0.000025959107,0.0002123363,0.00024014578,0.000112585105,0.00023490636],"domain_scores_gemma":[0.9996058,0.000019489918,0.000045446042,0.00013017631,0.0000981471,0.00010098453],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000021218355,0.00013519276,0.00028827426,0.00015444853,0.000025690591,0.000003184635,0.000029841618,0.000035873596,0.0019183253],"category_scores_gemma":[0.000005184848,0.00011570003,0.0001007596,0.00034158432,0.000034455687,0.000030412,0.000019745004,0.00005745656,0.000025698559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017734342,0.00052723824,0.52400327,0.00016466404,0.00019820522,0.0008478445,0.07524998,0.0007171378,0.072136834,0.000007797093,0.004546485,0.31982714],"study_design_scores_gemma":[0.004604756,0.0066120136,0.90273327,0.00016386184,0.00012282135,0.000024987658,0.009081592,0.0000786112,0.040965855,0.000007973803,0.035366908,0.000237341],"about_ca_topic_score_codex":0.0006634712,"about_ca_topic_score_gemma":0.0007656359,"teacher_disagreement_score":0.37873003,"about_ca_system_score_codex":0.00078521675,"about_ca_system_score_gemma":0.0001946276,"threshold_uncertainty_score":0.99899405},"labels":[],"label_agreement":null},{"id":"W4390261395","doi":"10.1016/j.jns.2023.122221","title":"Modelling the pathogenesis of widespread pain syndromes","year":2023,"lang":"en","type":"article","venue":"Journal of the Neurological Sciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Pathogenesis; Pain syndrome; Medicine; Neuroscience; Physical medicine and rehabilitation; Psychology; Physical therapy; Pathology","score_opus":0.10685306971262418,"score_gpt":0.3416423176652513,"score_spread":0.23478924795262715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390261395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97761697,0.00029386824,0.000038918577,0.021419395,0.00038351823,0.00007733814,0.0000010194647,0.000006833073,0.00016216602],"genre_scores_gemma":[0.9980708,0.0002985915,0.000082684885,0.0013435283,0.00009309294,0.0000015003072,4.812797e-8,0.0000018732254,0.000107877044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989987,0.00026009575,0.00021055512,0.000077695484,0.00031776036,0.00013520756],"domain_scores_gemma":[0.9987702,0.00088215957,0.00019127475,0.0000729508,0.00004175143,0.000041668318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016306875,0.000053603813,0.00016669532,0.00004829734,0.00013450239,0.000008808628,0.0003107137,0.000028652581,0.000055673834],"category_scores_gemma":[0.00023604697,0.000018533467,0.00016220233,0.0005112013,0.00034180545,0.000033369273,0.000057070327,0.00013519122,0.0000027423714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012042322,0.00067190634,0.49843413,0.00006020074,0.00022540227,0.00062491145,0.00082012307,0.35870427,0.09656579,0.0008346407,0.014098403,0.027756],"study_design_scores_gemma":[0.002836667,0.02142736,0.6186573,0.00020958748,0.0010354841,0.0027124048,0.0005118169,0.3005228,0.009239895,0.02150033,0.02106856,0.0002777654],"about_ca_topic_score_codex":0.000010978981,"about_ca_topic_score_gemma":8.795735e-7,"teacher_disagreement_score":0.120223194,"about_ca_system_score_codex":0.000008457988,"about_ca_system_score_gemma":0.000056884972,"threshold_uncertainty_score":0.12593964},"labels":[],"label_agreement":null},{"id":"W4390766126","doi":"10.55729/2000-9666.1289","title":"Comparative Study of the Effects of Duloxetine and Venlafaxine on Acute Symptomatic Taxane-induced Neuropathy in Breast Cancer Patients: a randomized clinical trial","year":2024,"lang":"en","type":"article","venue":"Journal of Community Hospital Internal Medicine Perspectives","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Duloxetine; Venlafaxine; Medicine; Neuropathic pain; Breast cancer; Taxane; Internal medicine; Adverse effect; Anesthesia; Anxiety; Oncology; Antidepressant; Cancer; Psychiatry","score_opus":0.028891393484244694,"score_gpt":0.41975775293647277,"score_spread":0.3908663594522281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390766126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991007,0.0017885369,0.0000017163868,0.003329024,0.0021066226,0.0016083973,0.000008584585,0.0000063201937,0.00014381211],"genre_scores_gemma":[0.9986328,0.0008120166,0.0000036266454,0.000096168544,0.00038492447,0.000028851828,6.834518e-7,0.000014278595,0.000026657455],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99578345,0.0023715852,0.0011780543,0.00011669131,0.0004283252,0.00012186725],"domain_scores_gemma":[0.9944699,0.0040028594,0.00081940286,0.00020305497,0.00040334306,0.000101438105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013012701,0.00021430734,0.0017116631,0.0003220155,0.000043266806,0.0000077449295,0.00023848486,0.00005384673,0.00003670206],"category_scores_gemma":[0.0010396143,0.00011172193,0.00029031924,0.00028784186,0.0005206572,0.00008782826,0.00010367387,0.0013579632,2.8653676e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6904594,0.029860647,0.07530658,0.00054596056,0.006214863,0.00031129178,0.19186826,0.0000032401624,0.0018288463,0.00006299208,0.0006374866,0.0029004859],"study_design_scores_gemma":[0.5112905,0.07271459,0.38921794,0.0045874137,0.002364948,0.00011494744,0.019005464,0.000085160274,0.00044891678,0.00007703633,0.000003396271,0.00008966405],"about_ca_topic_score_codex":0.00083656673,"about_ca_topic_score_gemma":0.000053008218,"teacher_disagreement_score":0.31391138,"about_ca_system_score_codex":0.00015745008,"about_ca_system_score_gemma":0.00011407632,"threshold_uncertainty_score":0.589975},"labels":[],"label_agreement":null},{"id":"W4392372006","doi":"10.1007/s00520-024-08416-3","title":"Equity, diversity, and inclusion in the Multinational Association for Supportive Care in Cancer: a global membership survey","year":2024,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Diversity (politics); Multinational corporation; Inclusion (mineral); Medicine; Health care; Equity (law); Multidisciplinary approach; Public relations; Political science; Psychology","score_opus":0.07244674065194123,"score_gpt":0.44486324833724505,"score_spread":0.3724165076853038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392372006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97468126,0.012894768,0.0000023076761,0.0050372262,0.0007940665,0.0015364897,0.0030989412,0.00002207239,0.0019328921],"genre_scores_gemma":[0.99656403,0.0009824954,0.000009497808,0.0008420566,0.00018206923,0.00053967274,0.00068888447,0.000012854711,0.00017843454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823874,0.0002073583,0.0002949922,0.00041537912,0.00046842906,0.00037508065],"domain_scores_gemma":[0.998883,0.00051341526,0.00010422732,0.000077804296,0.0003581045,0.00006344855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000848054,0.00018192684,0.00031298347,0.00017134688,0.00024481205,0.0000224276,0.00013621866,0.00016320155,0.00025234968],"category_scores_gemma":[0.00015695403,0.00015079291,0.000079776684,0.00057265727,0.000057857782,0.00015388033,0.0017317663,0.00026285497,0.000001264107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084152527,0.00009966101,0.92091876,0.00039301158,0.00007660168,0.00011819843,0.060147796,0.000036218647,0.000021940712,0.000098368575,0.0024927238,0.014755207],"study_design_scores_gemma":[0.004288445,0.00046199895,0.98286396,0.00035137846,0.000173024,0.000003606386,0.0071095913,0.00017384825,0.00019405088,0.00084798044,0.0033476125,0.00018450845],"about_ca_topic_score_codex":0.031129908,"about_ca_topic_score_gemma":0.43489027,"teacher_disagreement_score":0.40376034,"about_ca_system_score_codex":0.00791531,"about_ca_system_score_gemma":0.0009529528,"threshold_uncertainty_score":0.9958931},"labels":[],"label_agreement":null},{"id":"W4392377811","doi":"10.1158/1538-7445.ovarian23-a066","title":"Abstract A066: The cytotoxic effects of oxaliplatin and 5-fluorouracil against low-grade serous ovarian cancer cells","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Oxaliplatin; Fluorouracil; Serous fluid; Ovarian cancer; Cytotoxic T cell; Medicine; Oncology; Internal medicine; Cancer research; Colorectal cancer; Cancer; Biology; In vitro; Genetics","score_opus":0.05591241180573824,"score_gpt":0.42301676986968617,"score_spread":0.3671043580639479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392377811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.964018,0.028362555,0.0000030535955,0.004404358,0.0006521824,0.0011385104,0.00007176135,0.000047650043,0.0013019497],"genre_scores_gemma":[0.98428506,0.01119787,0.000014237366,0.00028720067,0.0006869439,0.0005956194,0.00001009008,0.00004161847,0.0028813416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982436,0.00013510988,0.00022671024,0.00038752312,0.0005072102,0.0004998826],"domain_scores_gemma":[0.99856704,0.00080330187,0.000038613776,0.00027233668,0.00012951589,0.00018918654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051117287,0.00017775482,0.00030684037,0.00018003813,0.00015097957,0.000055660596,0.00014868425,0.00011766434,0.00068895984],"category_scores_gemma":[0.00003211167,0.000116682386,0.00008941774,0.0005308579,0.00032846746,0.00007544975,0.00008716888,0.000726786,0.000036868456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036154315,0.00014223023,0.0013511028,0.002536587,0.000407212,0.00038069254,0.0015090437,0.000036077578,0.9333603,0.0000746434,0.017507939,0.042332653],"study_design_scores_gemma":[0.002664462,0.00043890972,0.023221133,0.0015559577,0.00021583344,0.00001890908,0.00014989483,0.0003527273,0.94916743,0.000141259,0.021884246,0.00018926221],"about_ca_topic_score_codex":0.0026744294,"about_ca_topic_score_gemma":0.0003969422,"teacher_disagreement_score":0.04214339,"about_ca_system_score_codex":0.00039009738,"about_ca_system_score_gemma":0.0007399296,"threshold_uncertainty_score":0.7543627},"labels":[],"label_agreement":null},{"id":"W4392399684","doi":"10.1016/b978-0-32-390644-9.00155-4","title":"Introduction—Chiral Auxiliaries","year":2024,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Materials science","score_opus":0.016295373888407735,"score_gpt":0.287305418496087,"score_spread":0.27101004460767925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392399684","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031519972,0.0074374396,1.9609853e-7,0.004235212,0.003248421,0.0005495849,0.000045254033,0.00018719831,0.98426515],"genre_scores_gemma":[0.00015257922,0.00034007904,0.000074979376,0.00075456296,0.009697224,0.000054382992,0.00013884125,0.000104856306,0.9886825],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99877685,0.0000063657685,0.00029475684,0.00048761125,0.00020691397,0.00022752526],"domain_scores_gemma":[0.9993505,0.000022257402,0.0000752489,0.00035336913,0.00006766398,0.000130972],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006877913,0.00036966358,0.00056310394,0.0001826901,0.00006315886,0.00002850991,0.000070686365,0.00028705175,0.0062952703],"category_scores_gemma":[0.000004621618,0.00030741122,0.0003144059,0.000011839169,0.00020204607,0.000018252293,0.00007017457,0.00063547416,0.0025429742],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019419612,0.000022035027,0.0000051200577,0.00035000138,0.0009783063,0.00034291422,0.00021552331,1.1557716e-7,0.00007900677,0.054782413,0.063100055,0.8799303],"study_design_scores_gemma":[0.0005431278,0.0002956317,0.000005880218,0.00019295723,0.0017052742,0.00021835524,0.00000369908,0.0000013424574,0.00014843284,0.026413571,0.9702377,0.00023405915],"about_ca_topic_score_codex":5.4874886e-7,"about_ca_topic_score_gemma":0.000015513873,"teacher_disagreement_score":0.90713763,"about_ca_system_score_codex":0.00021690689,"about_ca_system_score_gemma":0.00022331408,"threshold_uncertainty_score":0.9999378},"labels":[],"label_agreement":null},{"id":"W4393884706","doi":"10.5281/zenodo.1481254","title":"Cancermine","year":2018,"lang":"en","type":"dataset","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Computer science","score_opus":0.0489869270264531,"score_gpt":0.3233024353023956,"score_spread":0.27431550827594253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393884706","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020701918,0.0002470606,0.00000764578,0.00075559196,0.00040109715,0.0005983584,0.9736442,0.00034998532,0.02378906],"genre_scores_gemma":[0.00023636878,0.00085780525,0.000029494795,0.00059976504,0.0013615305,7.626358e-8,0.9925309,0.0010255515,0.0033585494],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984472,0.00014361579,0.00023849482,0.00047249536,0.0003275999,0.00037059328],"domain_scores_gemma":[0.9985135,0.000015722762,0.00012985444,0.0005938996,0.0004960764,0.00025095505],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00024161831,0.00022279976,0.00031327075,0.0002808806,0.0009958602,0.00018588146,0.0005648489,0.00017111706,0.13960914],"category_scores_gemma":[0.00017957872,0.00021597475,0.00008760588,0.00036229717,0.00023293716,0.00006231951,0.00070092554,0.000413547,0.020460164],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002687199,0.00026547778,3.0620592e-7,0.00019526017,0.00017292015,0.00009647097,0.00005371872,3.5714353e-7,0.0002238098,0.000010760956,0.9887981,0.009914127],"study_design_scores_gemma":[0.0013074477,0.0011088907,0.00005030764,0.000075361444,0.00024006111,0.00040707266,0.00001192501,0.0000055950086,0.00011625478,0.000010977413,0.99648386,0.0001822506],"about_ca_topic_score_codex":0.00013184409,"about_ca_topic_score_gemma":0.0000034023376,"teacher_disagreement_score":0.11914898,"about_ca_system_score_codex":0.00039756813,"about_ca_system_score_gemma":0.00001670974,"threshold_uncertainty_score":0.9803025},"labels":[],"label_agreement":null},{"id":"W4393988434","doi":"10.1158/1538-7445.am2024-ct131","title":"Abstract CT131: Effect of rivoceranib administered as 200 mg once daily on the pharmacokinetics of CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 substrates","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Altasciences (Canada)","funders":"","keywords":"CYP2C19; CYP2D6; Pharmacokinetics; CYP1A2; CYP3A4; Pharmacology; CYP2C9; Medicine; Chemistry; Cytochrome P450; Internal medicine; Metabolism","score_opus":0.10281463531614428,"score_gpt":0.4939783001597105,"score_spread":0.39116366484356624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680636,0.016361244,5.2522944e-7,0.0040027224,0.00035387278,0.0011663584,0.00015533171,0.00003701078,0.009859317],"genre_scores_gemma":[0.9907051,0.006162474,0.000007418944,0.0001653412,0.0004101446,0.00024400926,0.000021117747,0.000048750393,0.0022356594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99763894,0.00024948656,0.00039374284,0.00046883692,0.0007366973,0.0005122978],"domain_scores_gemma":[0.99698967,0.0021264292,0.00008093853,0.0003523493,0.00023842715,0.00021219175],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011264704,0.0002599665,0.00050386233,0.00027062895,0.000113253765,0.00004789431,0.00023590037,0.00012539049,0.002563177],"category_scores_gemma":[0.00011602611,0.00016572024,0.0001427866,0.00060481305,0.0006384922,0.00007007085,0.00008319962,0.00080097886,0.000064730695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008226655,0.00038115398,0.0070747985,0.0032182932,0.0010153009,0.00047699644,0.0016050556,0.000024087725,0.9231822,0.00072684657,0.030398365,0.023670232],"study_design_scores_gemma":[0.0041958787,0.0048236777,0.012390241,0.0012851743,0.00039664315,0.000053447715,0.00018709686,0.00020585411,0.9544124,0.00018620167,0.021664469,0.00019888664],"about_ca_topic_score_codex":0.000801937,"about_ca_topic_score_gemma":0.00006233898,"teacher_disagreement_score":0.031230215,"about_ca_system_score_codex":0.00020002406,"about_ca_system_score_gemma":0.0006102997,"threshold_uncertainty_score":0.9983486},"labels":[],"label_agreement":null},{"id":"W4393989233","doi":"10.1158/1538-7445.am2024-lb054","title":"Abstract LB054: A novel chemical proteomics approach toward the identification of kinase targets to sensitize tumour cells to the standard of care drug paclitaxel","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Paclitaxel; Proteomics; Identification (biology); Standard of care; Medicine; Pharmacology; Drug; Computational biology; Cancer research; Chemistry; Cancer; Biology; Biochemistry; Internal medicine","score_opus":0.06782009018706889,"score_gpt":0.41930999430651594,"score_spread":0.351489904119447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97013205,0.003304322,0.00030297076,0.021667864,0.0002778081,0.0030111345,0.00076255115,0.000022269665,0.00051905395],"genre_scores_gemma":[0.9976226,0.0001543716,0.0003677041,0.00012728682,0.00037863737,0.00070108176,0.00003067536,0.000027601209,0.0005900302],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982341,0.00007373177,0.00033588815,0.00034361205,0.00068212044,0.00033054108],"domain_scores_gemma":[0.9986583,0.00019735441,0.0000481799,0.000351926,0.0005957584,0.00014845804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001062143,0.00012356743,0.0002694936,0.00014121692,0.00006898164,0.00003644429,0.00023863613,0.00005587194,0.00009598991],"category_scores_gemma":[0.0000939652,0.00007293722,0.00010866204,0.0006059052,0.00017586235,0.000038141072,0.00012476873,0.00044261533,0.00002207875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015627749,0.00010452717,0.000031997737,0.0011721625,0.000107776985,0.0000120843,0.01499989,0.00013225949,0.95878774,0.000099807425,0.020782344,0.0022066145],"study_design_scores_gemma":[0.0005899231,0.00021645585,0.0006260356,0.00018326059,0.00007640785,0.000004498932,0.0033460853,0.000105456784,0.9838743,0.00003142702,0.010874169,0.00007194147],"about_ca_topic_score_codex":0.00072132255,"about_ca_topic_score_gemma":0.000055628476,"teacher_disagreement_score":0.027490586,"about_ca_system_score_codex":0.00052025967,"about_ca_system_score_gemma":0.0007542566,"threshold_uncertainty_score":0.29742935},"labels":[],"label_agreement":null},{"id":"W4394104687","doi":"10.6084/m9.figshare.23258805","title":"Additional file 2 of Analysis of the utilization value of different tissues of Taxus×Media based on metabolomics and antioxidant activity","year":2023,"lang":"en","type":"dataset","venue":"Open MIND","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Metabolomics; Antioxidant; Taxus; Value (mathematics); Chemistry; Computational biology; Computer science; Biology; Botany; Biochemistry; Chromatography; Machine learning","score_opus":0.06158169867422322,"score_gpt":0.3631834117211762,"score_spread":0.30160171304695294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394104687","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03550639,0.000027409484,6.6941334e-7,0.000027288208,0.000061575614,0.0003518905,0.9639585,3.0908706e-7,0.00006595585],"genre_scores_gemma":[0.005892602,0.00013011882,0.00011111656,0.0000088062825,0.000023878487,0.000043284203,0.9935623,0.000006250124,0.00022164773],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991194,0.00010017714,0.0002807621,0.00018533971,0.00024698477,0.0000673267],"domain_scores_gemma":[0.99784625,0.0011651235,0.00059014093,0.00028222927,0.0000861362,0.000030128687],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000078768055,0.00012779058,0.00078401575,0.0002458801,0.000015387252,0.0000028818877,0.00014622728,0.00010472624,0.24356626],"category_scores_gemma":[0.00020277008,0.00008584578,0.00015402521,0.00042202685,0.0001428641,0.00001947413,0.00009597135,0.00008896911,0.0000051809234],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041412268,0.00063366233,0.00011433991,0.000114330505,0.0013638205,0.0000017461356,0.000027090682,0.00002518543,0.00072464615,6.032657e-7,0.9938978,0.0026826551],"study_design_scores_gemma":[0.0018886292,0.00062048016,0.21785349,0.0008087205,0.01416831,8.492643e-7,0.00004321582,0.0017336578,0.03296602,0.00000687974,0.7297598,0.00014992156],"about_ca_topic_score_codex":0.00039324877,"about_ca_topic_score_gemma":0.0006625472,"teacher_disagreement_score":0.26413795,"about_ca_system_score_codex":0.000023584776,"about_ca_system_score_gemma":0.00017255619,"threshold_uncertainty_score":0.7571252},"labels":[],"label_agreement":null},{"id":"W4394109314","doi":"10.6084/m9.figshare.19962745","title":"Radiotherapy-induced bone deterioration is exacerbated in diabetic rats treated with streptozotocin","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Streptozotocin; Radiation therapy; Diabetes mellitus; Medicine; Internal medicine; Endocrinology","score_opus":0.03970293078839421,"score_gpt":0.318702161557957,"score_spread":0.2789992307695628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394109314","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013225492,0.000871063,4.3165134e-9,0.00021026061,0.000055052897,0.0018732921,0.9836673,0.00005899888,0.000038524304],"genre_scores_gemma":[0.0011595747,0.00008442276,0.000004699244,0.0008676029,0.00014703846,0.0027457147,0.9943655,0.000055258155,0.00057018583],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984164,0.00011826245,0.00031253902,0.0005316064,0.00028967854,0.00033149865],"domain_scores_gemma":[0.9990687,0.00007086612,0.00023086155,0.00044238553,0.000064052234,0.0001231678],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000034517303,0.0004008856,0.00067427865,0.00032193307,0.00006659768,0.000030004134,0.00012466773,0.0002783906,0.87250286],"category_scores_gemma":[0.00003382321,0.00034409898,0.00009215015,0.0005203317,0.000007694061,0.00006112599,0.00004725985,0.00053928705,0.00023091369],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070762064,0.00032022182,0.00012001809,0.00036489224,0.00021097787,0.00075570896,0.00007071496,0.0000025027298,0.0015528837,4.9335043e-9,0.9951118,0.0007826104],"study_design_scores_gemma":[0.005216085,0.002187332,0.0014508663,0.0011325306,0.00025403078,0.00005667588,0.000015120927,0.000024410816,0.0026195724,3.437817e-7,0.98668367,0.0003593439],"about_ca_topic_score_codex":0.00035139764,"about_ca_topic_score_gemma":0.00042277973,"teacher_disagreement_score":0.87227196,"about_ca_system_score_codex":0.0006746755,"about_ca_system_score_gemma":0.00038106675,"threshold_uncertainty_score":0.9999011},"labels":[],"label_agreement":null},{"id":"W4394887595","doi":"10.1515/9782763756592","title":"Robertine","year":2022,"lang":"en","type":"book","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.021981222096098766,"score_gpt":0.31726187599746475,"score_spread":0.295280653901366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394887595","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014659138,0.001531036,0.0000017909756,0.0013655855,0.00039753446,0.00023931557,0.00001363448,0.00007032675,0.99636614],"genre_scores_gemma":[0.000028141914,0.0002330177,0.00005408196,0.00301584,0.0005390988,0.000042142892,0.00064521807,0.000026106478,0.99541634],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995563,0.000005450574,0.00009403837,0.00014332718,0.000108343935,0.00009251417],"domain_scores_gemma":[0.99975103,0.000022947723,0.000032394324,0.00012445137,0.000013056072,0.000056121993],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000226609,0.000105672996,0.00023168951,0.000059938637,0.000024911067,0.0000015914972,0.000032111115,0.000069766225,0.30821654],"category_scores_gemma":[0.0000016368409,0.00008605325,0.000103517326,0.000020790369,0.000015861826,0.0000050276517,0.000042600634,0.00022663632,0.00032622094],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102004175,0.00006723819,0.00003118335,0.000037262766,0.00017737443,0.0001667581,0.000014490368,1.9692321e-7,0.000028617116,0.001135927,0.9938817,0.0043572667],"study_design_scores_gemma":[0.0010020079,0.00039604073,0.000027296825,0.000008911287,0.00040530012,0.00006598979,0.0000013379113,0.000003436027,0.00003642947,0.00023087102,0.99775016,0.00007221],"about_ca_topic_score_codex":0.000017497048,"about_ca_topic_score_gemma":0.000011586178,"teacher_disagreement_score":0.30789033,"about_ca_system_score_codex":0.0003180104,"about_ca_system_score_gemma":0.00039161206,"threshold_uncertainty_score":0.69241583},"labels":[],"label_agreement":null},{"id":"W4395019655","doi":"10.31857/s0015330322600401","title":"Polyesters of 14-Hydroxylated Taxoids Found for the First Time in &lt;i&gt;Taxus canadensis&lt;/i&gt; Intact Plants","year":2023,"lang":"en","type":"article","venue":"Физиология растений","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry; Polyester; Stereochemistry; Botany; Biology; Organic chemistry","score_opus":0.022831436125968246,"score_gpt":0.29155822286879274,"score_spread":0.26872678674282446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395019655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853179,0.0014562119,0.00000916127,0.0071070865,0.0009653002,0.0015939182,0.0002474866,0.0001358161,0.0031671342],"genre_scores_gemma":[0.98599607,0.00035541967,0.000033050204,0.0008078607,0.0003013167,0.00021885343,0.00022761068,0.000059737842,0.012000057],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981424,0.000048176782,0.00048297853,0.000388802,0.0003048821,0.0006327547],"domain_scores_gemma":[0.9985011,0.00067107205,0.000167817,0.00040621252,0.00007756949,0.00017618656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032840253,0.00029506252,0.00058459217,0.0003554851,0.00014957442,0.000016931614,0.00023342918,0.00018539798,0.0005211766],"category_scores_gemma":[0.000083991625,0.00022662868,0.00019103687,0.0006449066,0.00015376136,0.000074345655,0.000081876715,0.00020126966,0.00019413314],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068410337,0.0011034525,0.030429818,0.00062844803,0.0026505904,0.0009557216,0.005241825,0.0008010783,0.21390289,0.00045178802,0.7228153,0.01417807],"study_design_scores_gemma":[0.020750899,0.0022150993,0.19832586,0.0005010875,0.0011722704,0.00019506144,0.00019017079,0.012501268,0.016084693,0.0003117521,0.7469595,0.00079232105],"about_ca_topic_score_codex":0.0011064308,"about_ca_topic_score_gemma":0.009342294,"teacher_disagreement_score":0.19781819,"about_ca_system_score_codex":0.00031920974,"about_ca_system_score_gemma":0.00029036196,"threshold_uncertainty_score":0.9241649},"labels":[],"label_agreement":null},{"id":"W4395034817","doi":"10.1161/circ.144.suppl_1.9398","title":"Abstract 9398: Dantrolene Prevents Doxorubicin-Induced Cardiac Ryanodine Receptor Dyssynchrony","year":2021,"lang":"en","type":"article","venue":"Circulation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Dantrolene; Ryanodine receptor; Ryanodine receptor 2; Malignant hyperthermia; Cardiology; Internal medicine; Pharmacology; Receptor; Anesthesia; Calcium","score_opus":0.027568795474461467,"score_gpt":0.31415617423006703,"score_spread":0.2865873787556056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395034817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98927766,0.0010620509,0.00003580956,0.0009747822,0.0010456821,0.00035659305,0.000018306373,0.00006924222,0.0071599004],"genre_scores_gemma":[0.9973926,0.00013799906,0.00011569056,0.00025015586,0.00077165506,0.000033772507,0.000587924,0.000023785402,0.000686396],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990267,0.000046554385,0.00022772,0.00029167082,0.00020029617,0.00020704405],"domain_scores_gemma":[0.9994148,0.000042479485,0.00008270733,0.00023628627,0.00010856336,0.00011516189],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000099471225,0.00013767516,0.0002859988,0.00005884245,0.000069510104,0.000013959955,0.000032214764,0.00010940061,0.002544276],"category_scores_gemma":[0.000030911662,0.00013711552,0.00014097568,0.00017935861,0.000015996227,0.00008743762,0.000017119317,0.00012769552,0.00021040111],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001066984,0.0002470521,0.057994243,0.000064048225,0.0002214056,0.000037023237,0.00011574272,0.00003017606,0.92024183,0.000030016237,0.002964971,0.017946808],"study_design_scores_gemma":[0.0030908724,0.00008376364,0.69148266,0.00008205752,0.00038072586,0.000021690827,0.00004177396,0.00013505683,0.29447976,0.00005635681,0.009981451,0.0001638251],"about_ca_topic_score_codex":0.0000394996,"about_ca_topic_score_gemma":0.000005802889,"teacher_disagreement_score":0.6334884,"about_ca_system_score_codex":0.00021747794,"about_ca_system_score_gemma":0.00019166505,"threshold_uncertainty_score":0.99836755},"labels":[],"label_agreement":null},{"id":"W4395237039","doi":"10.15468/dl.4j4fq5","title":"Occurrence Download","year":2023,"lang":"en","type":"dataset","venue":"Global Biodiversity Information Facility","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Computer science; World Wide Web","score_opus":0.026970555402614272,"score_gpt":0.28410025626638435,"score_spread":0.25712970086377007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395237039","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008047393,0.000025259622,2.769554e-7,0.0005020895,0.0009822478,0.00045791882,0.99691117,0.00015602347,0.00016029929],"genre_scores_gemma":[0.000006150778,0.00025083614,4.743619e-7,0.00096123904,0.0000040636814,0.000007850261,0.99876803,1.4744882e-8,0.0000013363497],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99892855,0.000027847653,0.00027504348,0.00018237453,0.00033607977,0.0002501099],"domain_scores_gemma":[0.99914795,0.000019647356,0.00016203243,0.0003121269,0.00017455683,0.00018365629],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011886526,0.00022627536,0.00032519698,0.00010375048,0.00014150905,0.00003609356,0.00016157547,0.00030273286,0.001908979],"category_scores_gemma":[0.00005845731,0.00021702242,0.00017284689,0.00033644532,0.00012042873,0.00027765258,0.00016497965,0.00025114286,0.5831376],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026796715,0.000079112964,0.0020760794,0.00028461782,0.000121699464,0.00001805581,0.000022649767,0.0000012173049,9.607038e-8,1.5834113e-8,0.9961269,0.0010016054],"study_design_scores_gemma":[0.0012358507,0.00014739958,0.0007541805,0.000004187075,0.00031656522,0.000014461433,0.000047256333,6.31493e-8,0.0000027440465,2.9830724e-7,0.99731106,0.00016593313],"about_ca_topic_score_codex":0.0010467262,"about_ca_topic_score_gemma":0.00003139321,"teacher_disagreement_score":0.5812286,"about_ca_system_score_codex":0.0004932338,"about_ca_system_score_gemma":0.00024800174,"threshold_uncertainty_score":0.9990034},"labels":[],"label_agreement":null},{"id":"W4395932807","doi":"10.15468/dl.a275x3","title":"Occurrence Download","year":2022,"lang":"en","type":"dataset","venue":"Global Biodiversity Information Facility","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Computer science; World Wide Web","score_opus":0.021311865194612072,"score_gpt":0.2715757229429666,"score_spread":0.2502638577483545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395932807","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008696243,0.00005792469,2.0349088e-7,0.00041233524,0.0008201415,0.00048259037,0.9969745,0.00007017983,0.00031246681],"genre_scores_gemma":[0.000010743686,0.00019260883,4.3588847e-7,0.0016813164,0.0000022377178,0.0000132170735,0.9980987,1.05304165e-8,7.520131e-7],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887484,0.00004570271,0.00026685474,0.00018323964,0.00040336142,0.00022599589],"domain_scores_gemma":[0.99918836,0.000014624964,0.00018746789,0.00032621715,0.0001174343,0.0001658695],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012363284,0.00021870431,0.00031216667,0.00009000901,0.0002458902,0.000029764311,0.00019063262,0.00018798679,0.19274138],"category_scores_gemma":[0.000034484536,0.0002207401,0.00017845174,0.00026082498,0.00010607911,0.00028311578,0.00026048144,0.00034488708,0.06015656],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042656873,0.00014943098,0.0024777194,0.00020105812,0.00011281068,0.00001670891,0.000034824712,0.0000022179613,8.245966e-8,2.2515279e-8,0.99538714,0.0011914435],"study_design_scores_gemma":[0.0013646453,0.00023778543,0.00025212218,0.0000011223979,0.0003322686,0.000031136187,0.00007642772,3.0036215e-8,0.0000019528593,1.8158086e-7,0.9975325,0.00016984007],"about_ca_topic_score_codex":0.0005991441,"about_ca_topic_score_gemma":0.000010319815,"teacher_disagreement_score":0.13258481,"about_ca_system_score_codex":0.00083604007,"about_ca_system_score_gemma":0.00030645696,"threshold_uncertainty_score":0.94057524},"labels":[],"label_agreement":null},{"id":"W4395988032","doi":"10.15468/dl.efu6fb","title":"Occurrence Download","year":2022,"lang":"en","type":"dataset","venue":"Global Biodiversity Information Facility","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Computer science; World Wide Web","score_opus":0.021311865194612072,"score_gpt":0.2715757229429666,"score_spread":0.2502638577483545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395988032","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008696243,0.00005792469,2.0349088e-7,0.00041233524,0.0008201415,0.00048259037,0.9969745,0.00007017983,0.00031246681],"genre_scores_gemma":[0.000010743686,0.00019260883,4.3588847e-7,0.0016813164,0.0000022377178,0.0000132170735,0.9980987,1.05304165e-8,7.520131e-7],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887484,0.00004570271,0.00026685474,0.00018323964,0.00040336142,0.00022599589],"domain_scores_gemma":[0.99918836,0.000014624964,0.00018746789,0.00032621715,0.0001174343,0.0001658695],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012363284,0.00021870431,0.00031216667,0.00009000901,0.0002458902,0.000029764311,0.00019063262,0.00018798679,0.19274138],"category_scores_gemma":[0.000034484536,0.0002207401,0.00017845174,0.00026082498,0.00010607911,0.00028311578,0.00026048144,0.00034488708,0.06015656],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042656873,0.00014943098,0.0024777194,0.00020105812,0.00011281068,0.00001670891,0.000034824712,0.0000022179613,8.245966e-8,2.2515279e-8,0.99538714,0.0011914435],"study_design_scores_gemma":[0.0013646453,0.00023778543,0.00025212218,0.0000011223979,0.0003322686,0.000031136187,0.00007642772,3.0036215e-8,0.0000019528593,1.8158086e-7,0.9975325,0.00016984007],"about_ca_topic_score_codex":0.0005991441,"about_ca_topic_score_gemma":0.000010319815,"teacher_disagreement_score":0.13258481,"about_ca_system_score_codex":0.00083604007,"about_ca_system_score_gemma":0.00030645696,"threshold_uncertainty_score":0.94057524},"labels":[],"label_agreement":null},{"id":"W4396006386","doi":"10.15468/dl.cw5uj9","title":"Occurrence Download","year":2022,"lang":"en","type":"dataset","venue":"Global Biodiversity Information Facility","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Computer science; World Wide Web","score_opus":0.021311865194612072,"score_gpt":0.2715757229429666,"score_spread":0.2502638577483545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396006386","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008696243,0.00005792469,2.0349088e-7,0.00041233524,0.0008201415,0.00048259037,0.9969745,0.00007017983,0.00031246681],"genre_scores_gemma":[0.000010743686,0.00019260883,4.3588847e-7,0.0016813164,0.0000022377178,0.0000132170735,0.9980987,1.05304165e-8,7.520131e-7],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887484,0.00004570271,0.00026685474,0.00018323964,0.00040336142,0.00022599589],"domain_scores_gemma":[0.99918836,0.000014624964,0.00018746789,0.00032621715,0.0001174343,0.0001658695],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012363284,0.00021870431,0.00031216667,0.00009000901,0.0002458902,0.000029764311,0.00019063262,0.00018798679,0.19274138],"category_scores_gemma":[0.000034484536,0.0002207401,0.00017845174,0.00026082498,0.00010607911,0.00028311578,0.00026048144,0.00034488708,0.06015656],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042656873,0.00014943098,0.0024777194,0.00020105812,0.00011281068,0.00001670891,0.000034824712,0.0000022179613,8.245966e-8,2.2515279e-8,0.99538714,0.0011914435],"study_design_scores_gemma":[0.0013646453,0.00023778543,0.00025212218,0.0000011223979,0.0003322686,0.000031136187,0.00007642772,3.0036215e-8,0.0000019528593,1.8158086e-7,0.9975325,0.00016984007],"about_ca_topic_score_codex":0.0005991441,"about_ca_topic_score_gemma":0.000010319815,"teacher_disagreement_score":0.13258481,"about_ca_system_score_codex":0.00083604007,"about_ca_system_score_gemma":0.00030645696,"threshold_uncertainty_score":0.94057524},"labels":[],"label_agreement":null},{"id":"W4396094664","doi":"10.15468/dl.cvfbrb","title":"Occurrence Download","year":2022,"lang":"en","type":"dataset","venue":"Global Biodiversity Information Facility","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Computer science; World Wide Web","score_opus":0.021311865194612072,"score_gpt":0.2715757229429666,"score_spread":0.2502638577483545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396094664","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008696243,0.00005792469,2.0349088e-7,0.00041233524,0.0008201415,0.00048259037,0.9969745,0.00007017983,0.00031246681],"genre_scores_gemma":[0.000010743686,0.00019260883,4.3588847e-7,0.0016813164,0.0000022377178,0.0000132170735,0.9980987,1.05304165e-8,7.520131e-7],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887484,0.00004570271,0.00026685474,0.00018323964,0.00040336142,0.00022599589],"domain_scores_gemma":[0.99918836,0.000014624964,0.00018746789,0.00032621715,0.0001174343,0.0001658695],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012363284,0.00021870431,0.00031216667,0.00009000901,0.0002458902,0.000029764311,0.00019063262,0.00018798679,0.19274138],"category_scores_gemma":[0.000034484536,0.0002207401,0.00017845174,0.00026082498,0.00010607911,0.00028311578,0.00026048144,0.00034488708,0.06015656],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042656873,0.00014943098,0.0024777194,0.00020105812,0.00011281068,0.00001670891,0.000034824712,0.0000022179613,8.245966e-8,2.2515279e-8,0.99538714,0.0011914435],"study_design_scores_gemma":[0.0013646453,0.00023778543,0.00025212218,0.0000011223979,0.0003322686,0.000031136187,0.00007642772,3.0036215e-8,0.0000019528593,1.8158086e-7,0.9975325,0.00016984007],"about_ca_topic_score_codex":0.0005991441,"about_ca_topic_score_gemma":0.000010319815,"teacher_disagreement_score":0.13258481,"about_ca_system_score_codex":0.00083604007,"about_ca_system_score_gemma":0.00030645696,"threshold_uncertainty_score":0.94057524},"labels":[],"label_agreement":null},{"id":"W4396166580","doi":"10.15468/dl.d2xkpb","title":"Occurrence Download","year":2023,"lang":"en","type":"dataset","venue":"Global Biodiversity Information Facility","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Computer science; World Wide Web","score_opus":0.026970555402614272,"score_gpt":0.28410025626638435,"score_spread":0.25712970086377007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396166580","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008047393,0.000025259622,2.769554e-7,0.0005020895,0.0009822478,0.00045791882,0.99691117,0.00015602347,0.00016029929],"genre_scores_gemma":[0.000006150778,0.00025083614,4.743619e-7,0.00096123904,0.0000040636814,0.000007850261,0.99876803,1.4744882e-8,0.0000013363497],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99892855,0.000027847653,0.00027504348,0.00018237453,0.00033607977,0.0002501099],"domain_scores_gemma":[0.99914795,0.000019647356,0.00016203243,0.0003121269,0.00017455683,0.00018365629],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011886526,0.00022627536,0.00032519698,0.00010375048,0.00014150905,0.00003609356,0.00016157547,0.00030273286,0.001908979],"category_scores_gemma":[0.00005845731,0.00021702242,0.00017284689,0.00033644532,0.00012042873,0.00027765258,0.00016497965,0.00025114286,0.5831376],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026796715,0.000079112964,0.0020760794,0.00028461782,0.000121699464,0.00001805581,0.000022649767,0.0000012173049,9.607038e-8,1.5834113e-8,0.9961269,0.0010016054],"study_design_scores_gemma":[0.0012358507,0.00014739958,0.0007541805,0.000004187075,0.00031656522,0.000014461433,0.000047256333,6.31493e-8,0.0000027440465,2.9830724e-7,0.99731106,0.00016593313],"about_ca_topic_score_codex":0.0010467262,"about_ca_topic_score_gemma":0.00003139321,"teacher_disagreement_score":0.5812286,"about_ca_system_score_codex":0.0004932338,"about_ca_system_score_gemma":0.00024800174,"threshold_uncertainty_score":0.9990034},"labels":[],"label_agreement":null},{"id":"W4396570208","doi":"10.48252/jcr25","title":"SPECIAL ISSUE: JCR’S WEBINAR ON THE ROLE OF EXERCISE IN CANCER REHABILITATION - French Transcription","year":2021,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Rehabilitation; Transcription (linguistics); Physical medicine and rehabilitation; Medicine; Physical therapy; Philosophy; Linguistics","score_opus":0.15508723887291045,"score_gpt":0.5391637038495084,"score_spread":0.384076464976598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396570208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95853883,0.024547752,0.0000017423932,0.0028566658,0.001046456,0.0007334287,0.000046678248,0.0000089298155,0.012219505],"genre_scores_gemma":[0.97647315,0.020497657,0.000058694266,0.00023551878,0.0010514369,0.00014585785,0.000021813461,0.000025923136,0.0014899384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982552,0.00023800474,0.00058211485,0.0002832981,0.00043336197,0.00020804799],"domain_scores_gemma":[0.9987426,0.0003079138,0.0003139721,0.0002692383,0.00026599158,0.000100279125],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005265018,0.00018188893,0.00060637126,0.00036358307,0.00007862264,0.00008274041,0.00041276342,0.00009038361,0.059050564],"category_scores_gemma":[0.00011100247,0.00013959841,0.0001754227,0.000775616,0.00010800696,0.00044904507,0.0000771678,0.0003114218,0.000011241189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001603264,0.0015870577,0.4551896,0.00021366564,0.00018541893,0.00004999248,0.0020885724,0.00010642766,0.3088326,0.000098485114,0.17009346,0.059951477],"study_design_scores_gemma":[0.001895342,0.0000797268,0.7830849,0.0012653677,0.0002748697,0.000005423486,0.00044028237,0.00003128475,0.122412905,0.0024634567,0.087894015,0.00015239185],"about_ca_topic_score_codex":0.0025671548,"about_ca_topic_score_gemma":0.0005674466,"teacher_disagreement_score":0.32789534,"about_ca_system_score_codex":0.00022742744,"about_ca_system_score_gemma":0.00028819006,"threshold_uncertainty_score":0.9418096},"labels":[],"label_agreement":null},{"id":"W4396587059","doi":"10.1158/1538-7445.sabcs23-po5-05-14","title":"Abstract PO5-05-14: Survival in Young Women with De Novo or Recurrent Metastatic Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Cancer; Recurrent breast cancer; Gynecology","score_opus":0.12425201806634079,"score_gpt":0.4887938110640621,"score_spread":0.3645417929977213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851362,0.0055969628,0.0000034143204,0.0054095094,0.00069055986,0.00071979384,0.00026448382,0.000057450638,0.0021215982],"genre_scores_gemma":[0.9863321,0.0037762101,0.000026370508,0.000120493416,0.0005598539,0.0017613888,0.000016737418,0.000054788634,0.0073520676],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975946,0.00013317713,0.00022501725,0.000463236,0.0006247757,0.0009591929],"domain_scores_gemma":[0.9990073,0.00024880964,0.000023779725,0.00020292525,0.00018971607,0.0003274561],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009054973,0.00019215174,0.00035940786,0.00039635843,0.00007575358,0.00007323985,0.00014755817,0.00006102312,0.01163383],"category_scores_gemma":[0.000021728263,0.00012786798,0.000041860196,0.0010591958,0.00018203388,0.000118343494,0.000055574434,0.0008348517,0.000066637665],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08046866,0.00332979,0.26902413,0.009003049,0.004537505,0.024522888,0.03059451,0.00032502963,0.07687347,0.00035091094,0.09443282,0.40653723],"study_design_scores_gemma":[0.021540327,0.0046571754,0.8492096,0.0056848475,0.00048756218,0.00186234,0.0049125426,0.0005173075,0.007339063,0.00038601333,0.10231214,0.001091091],"about_ca_topic_score_codex":0.008305174,"about_ca_topic_score_gemma":0.027058968,"teacher_disagreement_score":0.5801855,"about_ca_system_score_codex":0.0034732115,"about_ca_system_score_gemma":0.0034012902,"threshold_uncertainty_score":0.9982986},"labels":[],"label_agreement":null},{"id":"W4396587819","doi":"10.1158/1538-7445.sabcs23-po3-16-12","title":"Abstract PO3-16-12: European real-world experience of patients with HER2+ advanced/metastatic breast cancer accessing trastuzumab deruxtecan through a named patient program: first interim analysis of EUROPA T-DXd","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Trastuzumab; Medicine; Metastatic breast cancer; Interim; Oncology; Breast cancer; Cancer; Interim analysis; Internal medicine; Clinical trial; Political science","score_opus":0.09008420133693715,"score_gpt":0.4725778209887704,"score_spread":0.38249361965183326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925099,0.0020863428,0.000028011653,0.00043899813,0.00021460837,0.0013423564,0.00053412956,0.000078251855,0.002767412],"genre_scores_gemma":[0.9968614,0.0014293883,0.00025494825,0.000061236846,0.00008234494,0.00071907346,0.00012317188,0.000083415856,0.00038499362],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996724,0.00022204072,0.0006656369,0.0007159646,0.0010050918,0.0006672293],"domain_scores_gemma":[0.99823254,0.00020769252,0.0002299353,0.00044433112,0.0006579917,0.00022752509],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027350846,0.00031266507,0.0007463513,0.0007748593,0.0001451689,0.000069822294,0.00029410786,0.000035364264,0.0021937017],"category_scores_gemma":[0.00002423714,0.00023287165,0.00020835128,0.003193077,0.0006349585,0.0003084303,0.00014139993,0.00047741408,0.000004947603],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007866776,0.004043796,0.2639862,0.0030546172,0.0059968424,0.00044417614,0.02151071,0.000816702,0.0075831986,0.000021440652,0.0015964864,0.68307906],"study_design_scores_gemma":[0.0045185396,0.0032891189,0.95990247,0.0037443622,0.0024566846,0.000008259164,0.0019377044,0.0003782515,0.012776545,0.000017957656,0.01048438,0.00048575804],"about_ca_topic_score_codex":0.008896042,"about_ca_topic_score_gemma":0.008164751,"teacher_disagreement_score":0.69591624,"about_ca_system_score_codex":0.0011413494,"about_ca_system_score_gemma":0.00065907807,"threshold_uncertainty_score":0.99871844},"labels":[],"label_agreement":null},{"id":"W4396587962","doi":"10.1158/1538-7445.sabcs23-po3-16-11","title":"Abstract PO3-16-11: Attrition rates from first- to third-line therapy in HER2+ metastatic breast cancer in Europe","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Metastatic breast cancer; Medicine; Cancer; Breast cancer; Attrition; Oncology; Internal medicine","score_opus":0.1729663906008388,"score_gpt":0.5016200254026022,"score_spread":0.3286536348017634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396587962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93453413,0.02480712,0.0000024884507,0.038099915,0.00040456446,0.0010448474,0.0005194011,0.00004763618,0.0005398723],"genre_scores_gemma":[0.97592956,0.019533306,0.000021900409,0.00072994444,0.0006630846,0.0010548322,0.00008427656,0.00005281368,0.0019302933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799716,0.00015753144,0.00031055819,0.0005312641,0.00044173154,0.00056175195],"domain_scores_gemma":[0.99899846,0.00034025498,0.00002119596,0.00021105516,0.00022966987,0.00019937864],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005705109,0.00018910867,0.00036137577,0.00056868466,0.000058455254,0.00006705912,0.00015121704,0.00006919452,0.0085534],"category_scores_gemma":[0.00003547278,0.00015317375,0.000057130346,0.0018663219,0.00008689111,0.00013074711,0.000052434196,0.0006247325,0.0001976044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012569304,0.0027136235,0.2786969,0.0014245387,0.00097599963,0.0047046663,0.0065618935,0.0011311413,0.26117787,0.00015366737,0.15886112,0.27102926],"study_design_scores_gemma":[0.008472392,0.00083365577,0.82633936,0.0028450263,0.00008023047,0.00002581173,0.0003223597,0.000464616,0.02986946,0.0004400008,0.12990339,0.00040368756],"about_ca_topic_score_codex":0.065024704,"about_ca_topic_score_gemma":0.058345016,"teacher_disagreement_score":0.54764247,"about_ca_system_score_codex":0.0012502599,"about_ca_system_score_gemma":0.00079912797,"threshold_uncertainty_score":0.9923529},"labels":[],"label_agreement":null},{"id":"W4396588160","doi":"10.1158/1538-7445.sabcs23-po1-11-02","title":"Abstract PO1-11-02: Reporting of Post-protocol Therapies in Metastatic Breast Cancer Registration Clinical Trials: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Metastatic breast cancer; Protocol (science); Breast cancer; Oncology; Cancer; Medical physics; Internal medicine; Alternative medicine; Pathology","score_opus":0.6962956463772917,"score_gpt":0.7109323885794232,"score_spread":0.014636742202131514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396588160","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022803279,0.8461721,3.187819e-7,0.0016767166,0.00030799038,0.15123193,0.0003633169,0.000031736075,0.00019310234],"genre_scores_gemma":[0.00003460833,0.7064957,0.000012723896,0.00010573289,0.00048341157,0.29158297,0.00008038939,0.0000758381,0.0011286142],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98189384,0.0048433496,0.010560108,0.0009131791,0.0011757895,0.0006137087],"domain_scores_gemma":[0.9889576,0.0030397717,0.0059338985,0.0008490161,0.0009852541,0.00023448766],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.038948916,0.0005442706,0.00992338,0.0007135439,0.00006101715,0.000059527396,0.00035373398,0.0003271995,0.0019895148],"category_scores_gemma":[0.0068218815,0.0003239395,0.0016642556,0.0014711173,0.00027275336,0.00009532549,0.000103715865,0.0018464453,0.000055446944],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002329331,0.00028474286,0.00003280401,0.8448023,0.0018874318,0.00042800055,0.00007547094,1.3378653e-7,0.000013548863,0.000017366432,0.0086844,0.14354086],"study_design_scores_gemma":[0.0012116452,0.00026153668,0.000054409673,0.85617113,0.010356158,0.00023122708,0.00006606155,0.0000022962818,0.00000406068,0.000024724997,0.1313893,0.00022746154],"about_ca_topic_score_codex":0.0032049506,"about_ca_topic_score_gemma":0.0012656233,"teacher_disagreement_score":0.1433134,"about_ca_system_score_codex":0.0012986389,"about_ca_system_score_gemma":0.008284627,"threshold_uncertainty_score":0.99992126},"labels":[],"label_agreement":null},{"id":"W4396591179","doi":"10.1158/1538-7445.sabcs23-gs02-02","title":"Abstract GS02-02: Are nodal ITCs after neoadjuvant chemotherapy an indication for axillary dissection? The OPBC05/EUBREAST-14R/ICARO study","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Axillary Dissection; NODAL; Dissection (medical); Chemotherapy; Oncology; Breast cancer; Internal medicine; Radiology; Cancer; Mastectomy","score_opus":0.09843576198026013,"score_gpt":0.5145686091155839,"score_spread":0.4161328471353237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977382,0.0054207677,0.000014682771,0.013346479,0.0005617203,0.0027501015,0.00010158828,0.000089712994,0.00033294864],"genre_scores_gemma":[0.9908731,0.0009091853,0.000012366283,0.0005156877,0.0017604687,0.00395543,0.00005918528,0.00006124836,0.0018533005],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99815404,0.000117865326,0.00022295711,0.0005141881,0.0005221607,0.0004687985],"domain_scores_gemma":[0.9988778,0.00024842756,0.00003919716,0.00039670436,0.00024899197,0.00018883913],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008033335,0.0001778513,0.00023607515,0.00022691833,0.000266295,0.000117130425,0.00018905099,0.00010106311,0.0014343946],"category_scores_gemma":[0.00002512763,0.00011624802,0.00011330071,0.00049967546,0.00016373278,0.00014116376,0.000043001313,0.00055536174,0.000050259267],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02201755,0.0063000973,0.2874647,0.0015819838,0.0030786598,0.0010535165,0.026858652,0.00004600316,0.08035638,0.00018078017,0.0841608,0.48690087],"study_design_scores_gemma":[0.004498408,0.0024521414,0.89285755,0.00025308042,0.00025580934,0.00006201637,0.0032329734,0.00026428115,0.0077511542,0.00029482233,0.08782156,0.00025621205],"about_ca_topic_score_codex":0.00040494945,"about_ca_topic_score_gemma":0.0005402498,"teacher_disagreement_score":0.6053928,"about_ca_system_score_codex":0.0005239732,"about_ca_system_score_gemma":0.00050440896,"threshold_uncertainty_score":0.99947846},"labels":[],"label_agreement":null},{"id":"W4396591270","doi":"10.1158/1538-7445.sabcs23-po1-06-03","title":"Abstract PO1-06-03: Efficacy of First-line Treatments for Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer: A Systematic Literature Review and Network Meta-analysis Feasibility Assessment","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Meta-analysis; Human Epidermal Growth Factor Receptor 2; Metastatic breast cancer; Oncology; Medicine; Hormone receptor; Breast cancer; Internal medicine; Cancer","score_opus":0.16044256383264885,"score_gpt":0.4900248596452728,"score_spread":0.329582295812624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396591270","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12336788,0.8393145,0.00006329046,0.010913617,0.00017837156,0.01243448,0.013500859,0.00007691681,0.00015005447],"genre_scores_gemma":[0.8512797,0.13763401,0.00040007688,0.0002622322,0.00039845236,0.0063493135,0.0016220409,0.00008441044,0.0019697996],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9953724,0.0008550148,0.0010792094,0.0010801468,0.00082065223,0.0007925585],"domain_scores_gemma":[0.9955233,0.0019798027,0.0003102067,0.0005299705,0.0012303705,0.00042635988],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017493844,0.0005447012,0.0033573874,0.00045934517,0.000340626,0.00012361543,0.00021533764,0.00014681187,0.0025555743],"category_scores_gemma":[0.00010209388,0.00036736677,0.0013471245,0.0021547948,0.0002653334,0.00023481048,0.00010263761,0.0006658507,0.000011591544],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003196136,0.003370486,0.008632442,0.2724259,0.6534766,0.00023500269,0.001790009,0.0000848145,0.010614161,0.00030840878,0.04447326,0.001392781],"study_design_scores_gemma":[0.009727547,0.0038730914,0.147539,0.03328124,0.80023986,0.00008449864,0.000117595424,0.0002774014,0.0030057267,0.00018385817,0.00065569236,0.0010144768],"about_ca_topic_score_codex":0.0009705911,"about_ca_topic_score_gemma":0.00028944245,"teacher_disagreement_score":0.7279118,"about_ca_system_score_codex":0.0015877411,"about_ca_system_score_gemma":0.00049525086,"threshold_uncertainty_score":0.9998778},"labels":[],"label_agreement":null},{"id":"W4396739232","doi":"10.1016/j.cca.2024.119020","title":"Macrotroponin interference in patients receiving cardiotoxic breast cancer therapy: A pilot study","year":2024,"lang":"en","type":"article","venue":"Clinica Chimica Acta","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Oncology; Cancer therapy; Internal medicine; Cancer","score_opus":0.05585533204993259,"score_gpt":0.38399887067794264,"score_spread":0.32814353862801005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396739232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931239,0.0003749629,3.3297374e-7,0.00278074,0.0012317183,0.001179815,0.000059848117,0.00010943429,0.0011392791],"genre_scores_gemma":[0.9963717,0.0013066827,0.000016235314,0.0005487123,0.00041253495,0.0002562851,0.000020224386,0.000043896263,0.0010237456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984046,0.00014900853,0.00044976483,0.00052968925,0.00015866032,0.00030822755],"domain_scores_gemma":[0.99923813,0.00021540592,0.00006218114,0.00031010105,0.000052221563,0.00012197598],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023134793,0.00022114009,0.00048314076,0.00016557318,0.000038936676,0.000038544385,0.00016188156,0.000059543538,0.0011407371],"category_scores_gemma":[0.000030394362,0.00017236768,0.00011042424,0.000324917,0.00007067219,0.00008462371,0.000086115295,0.0004941959,0.000045697117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042012995,0.004672517,0.9498203,0.000049687922,0.00057603343,0.000055826447,0.0011659539,4.0529847e-7,0.0062404703,0.0000015923189,0.0087846145,0.024431305],"study_design_scores_gemma":[0.006476101,0.0057799765,0.9837386,0.00036623236,0.0001768652,0.000011480882,0.000056126963,0.00005125437,0.000212734,0.000013276108,0.002941491,0.00017583583],"about_ca_topic_score_codex":0.00029943875,"about_ca_topic_score_gemma":0.0003890864,"teacher_disagreement_score":0.033918332,"about_ca_system_score_codex":0.00029183683,"about_ca_system_score_gemma":0.00024308087,"threshold_uncertainty_score":0.99977237},"labels":[],"label_agreement":null},{"id":"W4397046205","doi":"10.1681/asn.20223311s15b","title":"0.075% Capsaicin Lotion for the Treatment of Peripheral Neuropathy in ESRD Patients: A Multicenter Randomized Double-Blind Placebo-Controlled, Cross-Over Trial","year":2022,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lotion; Double blind; Capsaicin; Placebo; Peripheral neuropathy; Internal medicine; Pharmacology; Endocrinology; Pathology; Diabetes mellitus","score_opus":0.027881706333506142,"score_gpt":0.34954070250963665,"score_spread":0.32165899617613053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397046205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897964,0.00063045765,0.00005872335,0.0049549453,0.00069952925,0.0038127126,0.000028594251,0.0000029279413,0.00001572169],"genre_scores_gemma":[0.99460423,0.0007184301,0.00023485458,0.003313627,0.00041985058,0.00040015625,0.0000059326085,0.000019731046,0.00028320664],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978711,0.0005837189,0.0008863607,0.00014357385,0.0002920803,0.000223194],"domain_scores_gemma":[0.99658656,0.0011650687,0.001830382,0.0001837724,0.00018861337,0.00004561355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075199705,0.00017121014,0.0014234922,0.000056583933,0.00012231847,0.0000058152696,0.00019363641,0.000040175553,0.00019680678],"category_scores_gemma":[0.0000460777,0.00008931312,0.0015235518,0.00016182466,0.0007016784,0.000041720305,0.000045412064,0.00024398242,1.560945e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9766292,0.0029397637,0.0050198007,0.000013178819,0.0017504508,0.000003106639,0.0036826474,0.0008933891,0.0033116923,0.000004838651,0.004305167,0.0014467732],"study_design_scores_gemma":[0.96370804,0.014337671,0.0056374962,0.0000063980433,0.0015203891,0.000021302902,0.00045492922,0.0020055939,0.00015443648,0.000023054608,0.012071008,0.0000596774],"about_ca_topic_score_codex":0.00059223146,"about_ca_topic_score_gemma":0.000035316873,"teacher_disagreement_score":0.012921149,"about_ca_system_score_codex":0.00038302108,"about_ca_system_score_gemma":0.0002104312,"threshold_uncertainty_score":0.36420834},"labels":[],"label_agreement":null},{"id":"W4399058478","doi":"","title":"Presentation and management of docetaxel-related adverse effects in patients with breast cancer","year":2014,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Docetaxel; Presentation (obstetrics); Breast cancer; Adverse effect; Medicine; Oncology; Internal medicine; Cancer; General surgery; Surgery","score_opus":0.0699298032326448,"score_gpt":0.5124680099515403,"score_spread":0.4425382067188955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399058478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994316,0.0023652918,0.000013112247,0.00013201514,0.00019476128,0.0010337072,0.0000194598,0.000008590766,0.0019170647],"genre_scores_gemma":[0.9958352,0.0036195298,0.000068152905,0.00010317727,0.000029937986,0.00007012613,0.000018549832,0.000020523838,0.00023481394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998756,0.000119098906,0.0003918586,0.00023124489,0.00032357112,0.0001782153],"domain_scores_gemma":[0.9990846,0.000089870344,0.00040584686,0.0001544406,0.00014041642,0.00012481192],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024395551,0.00016624361,0.0004935774,0.00037294527,0.000040389543,0.00003673917,0.00023470396,0.000049886763,0.0019923956],"category_scores_gemma":[0.000009296612,0.00012688478,0.00004848769,0.00044859614,0.00008194986,0.0005303758,0.00015394535,0.0001366122,0.0000018351886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002047252,0.0006315681,0.96959454,0.0005451254,0.0005756832,0.000022132332,0.00011946464,0.000104784114,0.0015669896,0.000025270157,0.0017744759,0.022992745],"study_design_scores_gemma":[0.008876173,0.00006891807,0.9869802,0.0010299492,0.00048240533,0.000004010793,0.000014779243,0.000054610784,0.0019356195,0.00015938567,0.0002727203,0.0001212175],"about_ca_topic_score_codex":0.0010176187,"about_ca_topic_score_gemma":0.00007697962,"teacher_disagreement_score":0.022871526,"about_ca_system_score_codex":0.000091466645,"about_ca_system_score_gemma":0.000035643803,"threshold_uncertainty_score":0.9989199},"labels":[],"label_agreement":null},{"id":"W4400060891","doi":"","title":"Living with peripheral neuropathy following completion of cancer treatment.","year":2021,"lang":"en","type":"article","venue":"PubMed","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Peripheral neuropathy; Medicine; Peripheral; Cancer; Internal medicine; Diabetes mellitus","score_opus":0.03282162499685082,"score_gpt":0.2934406140165395,"score_spread":0.26061898901968866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400060891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931659,0.0017870463,0.000012214684,0.00058966165,0.000259922,0.00032177256,0.000006778399,0.000026703872,0.00383],"genre_scores_gemma":[0.9952981,0.00019427609,0.00007450679,0.0002593109,0.00014638131,0.0007058,0.000013935303,0.000014007465,0.0032936712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994452,0.000034915858,0.00009725052,0.00014960056,0.00009648096,0.00017652685],"domain_scores_gemma":[0.99971515,0.000038490343,0.00003877691,0.00009462157,0.0000409182,0.00007205904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003319613,0.0000848653,0.00021863579,0.000027741182,0.000031261403,0.0000057936527,0.00001711097,0.0000208535,0.00024142613],"category_scores_gemma":[0.000007734108,0.00006382802,0.00008373801,0.00012694663,0.00002130147,0.000032727203,0.000010411581,0.000037402926,9.509004e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019585757,0.00047738143,0.8990286,0.000038881182,0.00048241182,0.00025780126,0.0004241578,0.000019638053,0.004584041,0.000015627547,0.00016752318,0.094308086],"study_design_scores_gemma":[0.0024124393,0.00021968498,0.98546594,0.000028649594,0.00051261985,0.00003440263,0.000057205965,0.000031073574,0.0052368226,0.000001887528,0.005937212,0.00006204791],"about_ca_topic_score_codex":0.00026525636,"about_ca_topic_score_gemma":0.00030972948,"teacher_disagreement_score":0.09424604,"about_ca_system_score_codex":0.00015992668,"about_ca_system_score_gemma":0.00008104899,"threshold_uncertainty_score":0.2643447},"labels":[],"label_agreement":null},{"id":"W4400130556","doi":"10.3390/ph17070834","title":"Impact of Cannabidiol and Exercise on Clinical Outcomes and Gut Microbiota for Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors: A Case Report","year":2024,"lang":"en","type":"article","venue":"Pharmaceuticals","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Jewish General Hospital; McGill University; Royal Victoria Regional Health Centre; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Fondation du cancer des Cèdres","keywords":"Duloxetine; Medicine; Cannabidiol; Quality of life (healthcare); Internal medicine; Breast cancer; Peripheral neuropathy; Cancer; Chemotherapy-induced peripheral neuropathy; Gut flora; Oncology; Immunology; Cannabis; Psychiatry; Pathology","score_opus":0.1282861343355018,"score_gpt":0.524191456849437,"score_spread":0.39590532251393523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400130556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925591,0.0034121363,0.000002507137,0.002288618,0.00042217597,0.001129907,0.00010244713,0.000032051576,0.000051095656],"genre_scores_gemma":[0.9962384,0.0023265423,0.000050060848,0.0007023998,0.0001603276,0.00013689145,0.000008772751,0.000031362906,0.0003452605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868053,0.000070109214,0.0004796029,0.00042045687,0.000079393736,0.00026989394],"domain_scores_gemma":[0.9992033,0.00032373762,0.00006057943,0.00014375617,0.0000484328,0.00022015921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000419573,0.00021002244,0.00060277793,0.00011545911,0.000026013799,0.000018817609,0.000031694362,0.00009788245,0.00018186239],"category_scores_gemma":[0.00005723432,0.00015212307,0.00019771823,0.00013488009,0.00010796973,0.00004404931,0.000024946568,0.00023955276,7.9690415e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040260484,0.0010604019,0.80302346,0.00060846756,0.00075542525,0.017321166,0.0009830573,0.000003542131,0.090622805,0.000010020744,0.002148509,0.0794371],"study_design_scores_gemma":[0.025622273,0.0053343847,0.9179796,0.00074316736,0.002273359,0.014875229,0.000113483,0.0047837542,0.013948083,0.000051682156,0.013532495,0.0007425166],"about_ca_topic_score_codex":0.0017300749,"about_ca_topic_score_gemma":0.00024179177,"teacher_disagreement_score":0.11495612,"about_ca_system_score_codex":0.00010511263,"about_ca_system_score_gemma":0.00020285077,"threshold_uncertainty_score":0.6203399},"labels":[],"label_agreement":null},{"id":"W4400143961","doi":"10.1016/j.annonc.2024.05.021","title":"10P A placebo-controlled study comparing doses and efficacy of lentinula edodes mycelia for chemotherapy-induced peripheral neuropathy in colorectal cancer: The LEMON trial","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sanofi Genzyme; Genentech; Foundation Medicine; Sierra Oncology; INCLIVA Instituto de Investigación Sanitaria; European Society for Medical Oncology; PharmaMar; Daiichi Sankyo Europe; Gilead Sciences; Servier; FibroGen; Astellas Pharma; Eisai; Natera; F-star Therapeutics; Ribon Therapeutics; Ipsen; Sociedad Española de Oncología Médica; BeiGene; Clovis Oncology; Merck KGaA; Sanofi; Amgen; Pfizer; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Lentinula; Placebo; Chemotherapy; Colorectal cancer; Peripheral neuropathy; Cancer; Internal medicine; Oncology; Chemotherapy-induced peripheral neuropathy; Food science; Pathology; Endocrinology","score_opus":0.10373159142677914,"score_gpt":0.4469295965515289,"score_spread":0.3431980051247498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400143961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98940593,0.0023355593,0.000001324352,0.0030806134,0.0006498841,0.0040626265,0.000008879384,0.000020904074,0.0004342892],"genre_scores_gemma":[0.9981059,0.00054366235,0.000014323828,0.00025697958,0.00033746296,0.0006187591,0.0000043496684,0.000018042781,0.00010053753],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987039,0.00021186919,0.0004751714,0.0002655346,0.00010843962,0.00023507097],"domain_scores_gemma":[0.9988095,0.0008261415,0.0001510467,0.000094315656,0.00007767239,0.00004131601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005564431,0.00016251148,0.00095149555,0.0001318646,0.000040647305,0.00001073306,0.00008705112,0.00008458569,0.000051330568],"category_scores_gemma":[0.00007334091,0.000109450804,0.00017364969,0.00015832904,0.000113160364,0.00003549592,0.00003339457,0.0001674478,3.7327803e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76301354,0.004816857,0.020435167,0.0001967161,0.001359726,0.00007387687,0.009669359,0.00004308065,0.06704009,0.000046441604,0.0019366458,0.13136847],"study_design_scores_gemma":[0.817608,0.07086947,0.0666562,0.00017933907,0.0012590591,0.00003829045,0.0022427456,0.0044244863,0.028920995,0.00006550188,0.0074837552,0.00025214299],"about_ca_topic_score_codex":0.00033905215,"about_ca_topic_score_gemma":0.0007791167,"teacher_disagreement_score":0.13111633,"about_ca_system_score_codex":0.00005183651,"about_ca_system_score_gemma":0.0002641923,"threshold_uncertainty_score":0.44632742},"labels":[],"label_agreement":null},{"id":"W4400274087","doi":"10.1200/jco.2024.42.16_suppl.3081","title":"Long-term efficacy, safety and PK data of TH1902 (sudocetaxel zendusortide) in solid tumors: A novel SORT1-targeting peptide-drug-conjugate (PDC).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Theratechnologies (Canada)","funders":"","keywords":"Medicine; Conjugate; Drug; Peptide; Solid tumor; Cancer research; Pharmacology; Term (time); Safety profile; Oncology; Internal medicine; Cancer; Adverse effect; Biochemistry; Biology","score_opus":0.1771831390670611,"score_gpt":0.5125324242608817,"score_spread":0.3353492851938207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400274087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98359954,0.005211508,0.00017815712,0.007682047,0.00165604,0.00035027394,0.00005046878,0.000019967516,0.0012519698],"genre_scores_gemma":[0.9905445,0.004713748,0.0014509443,0.0009245255,0.00182329,0.0000028228383,0.000035854227,0.000034529945,0.00046975928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948209,0.00032455754,0.0037071388,0.00044868016,0.00031669918,0.0003820317],"domain_scores_gemma":[0.9939756,0.0037941781,0.0013408485,0.0003211873,0.00019179923,0.00037639218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046351105,0.00023813125,0.0021977096,0.00029022052,0.000035612476,0.000017072132,0.0003326796,0.00029584154,0.00033945157],"category_scores_gemma":[0.0019452745,0.00017533496,0.0003521511,0.00026710398,0.0003624352,0.00025270152,0.00028634825,0.0015356165,0.000015146125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023318915,0.009579583,0.71409595,0.0009158802,0.003072944,0.012225205,0.0010192211,0.00006685618,0.012441129,0.00017963669,0.017092992,0.2059917],"study_design_scores_gemma":[0.025442531,0.008937378,0.93183815,0.0015017401,0.0019370422,0.0020561742,0.00012813606,0.0014453791,0.00070855016,0.00012498641,0.025602078,0.00027785246],"about_ca_topic_score_codex":0.00009104381,"about_ca_topic_score_gemma":0.00032110699,"teacher_disagreement_score":0.2177422,"about_ca_system_score_codex":0.00015842885,"about_ca_system_score_gemma":0.002060229,"threshold_uncertainty_score":0.71499527},"labels":[],"label_agreement":null},{"id":"W4400875353","doi":"10.1186/s12885-024-12558-2","title":"Association of oxaliplatin-containing adjuvant duration with post-treatment fall-related injury and fracture in patients with stage III colon cancer: a population-based retrospective cohort study","year":2024,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Mount Sinai Hospital; Health Sciences Centre; Sinai Health System; Sunnybrook Health Science Centre; University of Toronto","funders":"Canadian Institutes of Health Research; Physicians' Services Incorporated Foundation","keywords":"Medicine; Oxaliplatin; FOLFOX; Internal medicine; Hazard ratio; Capecitabine; Retrospective cohort study; Colorectal cancer; Proportional hazards model; Oncology; Cohort; Population; Cancer; Surgery; Confidence interval","score_opus":0.006283467043504114,"score_gpt":0.29340427456957224,"score_spread":0.2871208075260681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400875353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961423,0.00049031497,0.000006942885,0.00029460798,0.00014458787,0.0025992275,0.0002341681,0.000042889897,0.000044904977],"genre_scores_gemma":[0.99818987,0.000048439848,0.000030718857,0.00009033351,0.0000489142,0.00061513024,0.00033247707,0.00002764838,0.0006164428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987788,0.000066416054,0.0003027292,0.00035207128,0.00032857686,0.00017138374],"domain_scores_gemma":[0.99930286,0.00008412349,0.0002448207,0.00010262391,0.00021253219,0.000053024523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012299791,0.00019743432,0.00045528376,0.00016086511,0.000054004668,0.000018027975,0.000020148462,0.00009597438,0.00018948864],"category_scores_gemma":[0.000012534479,0.00013795035,0.00003216292,0.00031598398,0.000018678058,0.000108542066,0.0000069938733,0.00015241816,5.821752e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006223713,0.0005352064,0.98861057,0.00006745921,0.00081005605,0.0000119256965,0.002015182,0.0008709108,0.000081160826,0.000004113224,0.000041066793,0.000728655],"study_design_scores_gemma":[0.010923243,0.005822632,0.9806922,0.00027865122,0.0009773455,3.7604147e-7,0.00019658159,0.00073133875,0.00015794593,0.0000020468358,0.00007950137,0.00013810706],"about_ca_topic_score_codex":0.03392885,"about_ca_topic_score_gemma":0.114508934,"teacher_disagreement_score":0.08058008,"about_ca_system_score_codex":0.0033032487,"about_ca_system_score_gemma":0.000520091,"threshold_uncertainty_score":0.9725043},"labels":[],"label_agreement":null},{"id":"W4400977834","doi":"10.1089/jicm.2024.0452","title":"The Society for Integrative Oncology-American Society of Clinical Oncology Joint Guidelines on Integrative Therapies for Symptom Management-Overview and Key Recommendations","year":2024,"lang":"en","type":"article","venue":"Journal of Integrative and Complementary Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Calgary","funders":"","keywords":"Clinical Oncology; Medicine; Key (lock); Oncology; Internal medicine; Cancer","score_opus":0.3065192811758582,"score_gpt":0.5582366200334965,"score_spread":0.2517173388576383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400977834","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06817967,0.06959038,0.024941236,0.826343,0.003327408,0.004478068,0.00063224655,0.000041064064,0.0024669238],"genre_scores_gemma":[0.12572847,0.63177186,0.17432424,0.057145838,0.0050497977,0.0008239584,0.00057185395,0.00010722562,0.004476743],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974001,0.00022880557,0.0016238271,0.0002970648,0.00021962383,0.00023056332],"domain_scores_gemma":[0.993818,0.004099972,0.0008579955,0.0001193969,0.00095797936,0.0001466632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024204676,0.00032284626,0.0013816017,0.00011558989,0.00025452834,0.000016657888,0.00012774799,0.00007655263,0.00013573344],"category_scores_gemma":[0.0001717728,0.00014128794,0.00085677,0.00021741826,0.0012079143,0.00010140383,0.00005684681,0.00053551316,3.4636898e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019309701,0.00031101488,0.0002792892,0.00015096366,0.007545839,0.000005996597,0.011131834,2.3473206e-7,0.0004091292,0.009147542,0.5272432,0.441844],"study_design_scores_gemma":[0.006815846,0.031395834,0.0008735174,0.0016929854,0.00191615,0.0000646741,0.14479373,0.0009240936,0.0002928904,0.0044047483,0.8067091,0.000116400974],"about_ca_topic_score_codex":0.000108519496,"about_ca_topic_score_gemma":0.00030314125,"teacher_disagreement_score":0.76919717,"about_ca_system_score_codex":0.0003011456,"about_ca_system_score_gemma":0.00035561752,"threshold_uncertainty_score":0.5761555},"labels":[],"label_agreement":null},{"id":"W4400989855","doi":"10.69645/oukm7723","title":"Cytotoxic chemotherapy","year":2009,"lang":"en","type":"article","venue":"˜The œbiomedical & life sciences collection.","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cytotoxic T cell; Biology; Genetics","score_opus":0.02450387734023167,"score_gpt":0.33666335329922636,"score_spread":0.3121594759589947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400989855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.631506,0.003129359,0.0018964963,0.27322644,0.0040403735,0.0021100398,0.0000117827185,0.00055184227,0.08352766],"genre_scores_gemma":[0.9638078,0.00025302515,0.0003618125,0.021968035,0.000933182,0.00003503837,0.0000055071755,0.000006307167,0.012629243],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99858904,0.0000511522,0.00021497249,0.00029749438,0.00051500835,0.00033231737],"domain_scores_gemma":[0.99934727,0.00010741321,0.000058786736,0.00014766942,0.000042872307,0.00029600988],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039822844,0.00012751184,0.0002076035,0.00016948477,0.00060764246,0.000027566315,0.00019781012,0.000085177126,0.001825318],"category_scores_gemma":[0.00003649811,0.00007524319,0.000103084836,0.0018585322,0.0007698082,0.00006136782,0.000015775178,0.00018181492,0.00010299523],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063935464,0.0015884062,0.0038850761,0.000013755252,0.00014018617,0.00003924665,0.00081958226,0.000008512352,0.02256162,0.000425531,0.933561,0.03631768],"study_design_scores_gemma":[0.0068647326,0.0074265567,0.07218764,0.00004047611,0.00017434281,0.00038156615,0.0002777856,0.003603377,0.002228557,0.002630721,0.9038678,0.00031644068],"about_ca_topic_score_codex":0.000058908652,"about_ca_topic_score_gemma":0.000021680306,"teacher_disagreement_score":0.33230186,"about_ca_system_score_codex":0.00012267526,"about_ca_system_score_gemma":0.0006154151,"threshold_uncertainty_score":0.99908715},"labels":[],"label_agreement":null},{"id":"W4400996848","doi":"10.69645/aavj5507","title":"Role of the lymphatic system in drug absorption","year":2023,"lang":"en","type":"article","venue":"˜The œbiomedical & life sciences collection.","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lymphatic system; Drug; Absorption (acoustics); Pharmacology; Medicine; Optics; Physics; Immunology","score_opus":0.017050475659600488,"score_gpt":0.2968312853489863,"score_spread":0.2797808096893858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400996848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831167,0.00055791496,0.000013274126,0.0063913856,0.0015541336,0.000648898,0.0000058006053,0.00009000123,0.007621883],"genre_scores_gemma":[0.9945633,0.000055356508,0.000014089443,0.00032216057,0.00020191901,0.00008365013,0.0000032404714,0.000004711579,0.004751571],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9986738,0.00012134598,0.00026677712,0.00018985974,0.0005284099,0.00021978337],"domain_scores_gemma":[0.99943167,0.0002155744,0.00008773748,0.00013597032,0.00003445193,0.00009460821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079314294,0.00007816513,0.00017511833,0.00024043341,0.00030441812,0.000009968569,0.00020655246,0.000048841703,0.0001319367],"category_scores_gemma":[0.000057300495,0.00004038382,0.00007732602,0.0042022946,0.00066159747,0.000040508912,0.000060693776,0.00009077869,0.000062400526],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011525955,0.002478311,0.26483235,0.0009770101,0.00051538687,0.000063156695,0.017351855,0.0010257151,0.08376795,0.0049890517,0.5980831,0.024763536],"study_design_scores_gemma":[0.010310354,0.0015339919,0.6710403,0.0007816046,0.0004912352,0.00027739877,0.019113984,0.14774063,0.003974685,0.0025340535,0.14176776,0.00043398523],"about_ca_topic_score_codex":0.00086228887,"about_ca_topic_score_gemma":0.00040306192,"teacher_disagreement_score":0.45631534,"about_ca_system_score_codex":0.0002011562,"about_ca_system_score_gemma":0.00058904686,"threshold_uncertainty_score":0.24376835},"labels":[],"label_agreement":null},{"id":"W4401029234","doi":"10.51731/cjht.2024.939","title":"Drospirenone (Slynd)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drospirenone; Medicine; Internal medicine","score_opus":0.03349572096903707,"score_gpt":0.35530262858401573,"score_spread":0.32180690761497865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401029234","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1900449,0.5595505,0.00012853272,0.24524611,0.0022071851,0.000287265,0.000020960633,0.0002949065,0.0022196488],"genre_scores_gemma":[0.9966234,0.0016815247,0.00028228277,0.0007729545,0.000040024293,0.0000037642794,0.0000020272003,0.000011894224,0.00058215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992193,0.000014723537,0.00030058945,0.00008944387,0.000077491786,0.0002984674],"domain_scores_gemma":[0.9996258,0.00003172203,0.00007646329,0.00010308372,0.00005901813,0.00010390758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024558156,0.00008219159,0.00027041335,0.00059564604,0.00008447341,0.000022115506,0.000097537966,0.00009203182,0.0001712234],"category_scores_gemma":[0.00006145298,0.000062886946,0.000079050136,0.00030604916,0.00013396484,0.000056513374,0.0000064892815,0.00037186232,0.000029124816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000200262,0.000020516194,0.0038663037,0.00024038074,0.00013460248,0.0019815867,0.00026067806,0.0000013824531,0.00017522964,0.0015194146,0.08387459,0.9079053],"study_design_scores_gemma":[0.0004765189,0.0011668983,0.004397312,0.00041214866,0.000058551006,0.0019006784,0.00046521844,0.000012106848,0.00086413097,0.002543771,0.9876351,0.000067596084],"about_ca_topic_score_codex":0.0018431868,"about_ca_topic_score_gemma":0.0016374977,"teacher_disagreement_score":0.9078377,"about_ca_system_score_codex":0.00052704033,"about_ca_system_score_gemma":0.004145108,"threshold_uncertainty_score":0.7353244},"labels":[],"label_agreement":null},{"id":"W4401108535","doi":"10.1080/15360288.2024.2383423","title":"Methadone for Pain Management in Chemotherapy-Induced Peripheral Neuropathy: A Retrospective Review","year":2024,"lang":"en","type":"review","venue":"Journal of Pain & Palliative Care Pharmacotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Duloxetine; Methadone; Chemotherapy-induced peripheral neuropathy; Neuropathic pain; Peripheral neuropathy; Cancer pain; Analgesic; Chemotherapy; Anesthesia; Intensive care medicine; Internal medicine; Cancer; Alternative medicine; Diabetes mellitus","score_opus":0.0894108614538968,"score_gpt":0.46636517855346593,"score_spread":0.3769543170995691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401108535","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024844561,0.9902484,0.0005387784,0.0017631974,0.001058478,0.005982788,0.00010209749,0.00004020558,0.00024124297],"genre_scores_gemma":[0.00004791838,0.98491937,0.001139843,0.010449243,0.0015455104,0.0008967232,0.00008264643,0.00025175605,0.0006670057],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99438936,0.0020185963,0.001779175,0.0006780085,0.0005829956,0.00055184076],"domain_scores_gemma":[0.9968397,0.0006184149,0.0013903169,0.00028853887,0.00060344697,0.00025958117],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038431373,0.0009549146,0.00418429,0.0007345772,0.00005769999,0.00004127253,0.00037450032,0.00024027564,0.0004861266],"category_scores_gemma":[0.000120180404,0.0006804383,0.0024084626,0.0010228473,0.000058153637,0.000090576184,0.000030804295,0.0013477515,0.000008556795],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006593842,0.00039689397,0.00007076738,0.09027325,0.0050251726,0.00094044016,0.0010559674,4.5740063e-7,0.00010005947,0.000018483894,0.031610303,0.86984885],"study_design_scores_gemma":[0.005728205,0.002707763,0.000026826729,0.07549805,0.008294033,0.000044330725,0.00016074287,0.000027199188,0.000037479585,0.00005507861,0.90693855,0.00048174243],"about_ca_topic_score_codex":0.000008346537,"about_ca_topic_score_gemma":0.000007817111,"teacher_disagreement_score":0.87532824,"about_ca_system_score_codex":0.002775846,"about_ca_system_score_gemma":0.0006814993,"threshold_uncertainty_score":0.9995647},"labels":[],"label_agreement":null},{"id":"W4401328578","doi":"10.1002/cmdc.202400437","title":"The French Medicinal Chemistry Society–SCT, an Historical Member of EFMC**","year":2024,"lang":"en","type":"editorial","venue":"ChemMedChem","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Society of Transplantation","keywords":"Nice; Chemistry; Library science; Political science; Engineering ethics; Engineering; Computer science","score_opus":0.02161798569034573,"score_gpt":0.3374337246193246,"score_spread":0.31581573892897885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401328578","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024392365,0.038206737,0.0000035722205,0.004148942,0.930932,0.000444115,0.00014004197,0.0001769381,0.023508448],"genre_scores_gemma":[0.00206733,0.0024578997,0.00009449072,0.00009586154,0.8606629,0.00014548271,0.0010395892,0.000108653134,0.13332784],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973553,0.000023078706,0.0005521675,0.0006193121,0.000988208,0.00046197488],"domain_scores_gemma":[0.9978064,0.0006933253,0.00023692797,0.00061886845,0.0003580458,0.00028644642],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036911527,0.00046213425,0.0008681891,0.000027916134,0.00010427769,0.000020351023,0.0003563089,0.0011741779,0.0008204556],"category_scores_gemma":[0.00023176523,0.00031022305,0.000501891,0.00024771286,0.00032386943,0.000033581404,0.00012691322,0.001701574,0.000040471416],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016530616,0.0002767581,0.000010919457,0.0014673524,0.0007413773,0.000073974945,0.00043793424,6.43292e-8,0.012350547,0.000002062338,0.9829095,0.0015642109],"study_design_scores_gemma":[0.0015346467,0.00025454562,0.0000052701275,0.00019906987,0.0016437378,0.000024011573,0.000054029,0.0000190068,0.108585194,0.00007115413,0.88738793,0.00022139397],"about_ca_topic_score_codex":0.000280592,"about_ca_topic_score_gemma":0.000021905145,"teacher_disagreement_score":0.1098194,"about_ca_system_score_codex":0.001812167,"about_ca_system_score_gemma":0.0015773098,"threshold_uncertainty_score":0.999935},"labels":[],"label_agreement":null},{"id":"W4401363999","doi":"10.5737/23688076343404","title":"Effectiveness of an Intervention (Effleurage and Petrissage) on severity of Chemotherapy Induced Peripheral Neuropathy (CIPN) among patients : a pilot randomized controlled trial","year":2024,"lang":"en","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemotherapy-induced peripheral neuropathy; Medicine; Peripheral neuropathy; Randomized controlled trial; Intervention (counseling); Physical therapy; Chemotherapy; Internal medicine; Peripheral; Oncology; Physical medicine and rehabilitation; Psychiatry","score_opus":0.015399905078331803,"score_gpt":0.3404048594157788,"score_spread":0.325004954337447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401363999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99357647,0.00055752473,0.000032503347,0.00033091626,0.0025609257,0.0022091535,0.000011183778,0.000012577023,0.0007087278],"genre_scores_gemma":[0.99939924,0.00008952588,0.000023141909,0.00008776919,0.00023576379,0.000053698022,0.000014148066,0.000024106781,0.00007260777],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997175,0.0017041183,0.0005400502,0.00020427302,0.0001437685,0.00023282325],"domain_scores_gemma":[0.9985774,0.0005702927,0.00025629517,0.00008667725,0.00014064022,0.00036870482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014892239,0.0001733523,0.001264936,0.00049365225,0.000084549974,0.000023117918,0.00006032856,0.00013157546,0.00017494588],"category_scores_gemma":[0.00018620772,0.00013580392,0.00031080897,0.00015018578,0.00027625938,0.00009882364,0.0000037904165,0.00044218247,4.7678895e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9401983,0.0014098028,0.001395316,0.000109936445,0.0005666388,0.0002372671,0.00090560486,0.0000027667331,0.0022255692,0.000021927546,0.00009939078,0.052827448],"study_design_scores_gemma":[0.9222405,0.023763577,0.049899437,0.0013518339,0.00078991207,0.00014850516,0.000054348708,0.0007174557,0.0007613038,0.00013026189,0.000045193436,0.00009769339],"about_ca_topic_score_codex":0.0015762133,"about_ca_topic_score_gemma":0.0006997137,"teacher_disagreement_score":0.052729756,"about_ca_system_score_codex":0.0013242038,"about_ca_system_score_gemma":0.0010136266,"threshold_uncertainty_score":0.5537923},"labels":[],"label_agreement":null},{"id":"W4401364396","doi":"10.5737/23688076343412","title":"Mesure de l’efficacité d’une intervention de massothérapie (par effleurage et pétrissage) sur l’intensité de la neuropathie périphérique induite par la chimiothérapie : essai clinique pilote randomisé","year":2024,"lang":"fr","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.015141523650745996,"score_gpt":0.3529744220570991,"score_spread":0.3378328984063531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401364396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68035674,0.10210559,0.011861038,0.17101736,0.014393709,0.0012876014,0.00022334779,0.00024676253,0.018507846],"genre_scores_gemma":[0.96949184,0.014395414,0.0009765388,0.0062326435,0.0040212455,0.00005912623,0.000058881153,0.0002265182,0.0045377826],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9868866,0.008742888,0.0012344357,0.0007220512,0.00027614986,0.002137869],"domain_scores_gemma":[0.99304086,0.0031109327,0.00045892756,0.00033928975,0.00028060688,0.0027693936],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.010129535,0.00072625093,0.0013137326,0.0011078018,0.00058306416,0.0004147577,0.00040556252,0.0017064634,0.0009195272],"category_scores_gemma":[0.0011079569,0.00076698774,0.0008547803,0.0007084006,0.0012140062,0.00031726353,0.00003624977,0.0060188626,0.000058343918],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.006812641,0.0029506776,0.01445206,0.00077301037,0.0032343483,0.18252112,0.021280618,0.00080645573,0.017062902,0.0019455096,0.29988286,0.4482778],"study_design_scores_gemma":[0.049223933,0.0057584713,0.121166155,0.018948346,0.0065356274,0.15970562,0.00080587226,0.012508731,0.0028540827,0.007888974,0.6133,0.0013041416],"about_ca_topic_score_codex":0.0089152735,"about_ca_topic_score_gemma":0.02266704,"teacher_disagreement_score":0.44697365,"about_ca_system_score_codex":0.012160079,"about_ca_system_score_gemma":0.017844118,"threshold_uncertainty_score":0.99999374},"labels":[],"label_agreement":null},{"id":"W4401668772","doi":"10.5121/ijbb.2024.14306","title":"Bioequivalence and Pharmacokinetic Evaluation of Ethambutol 400 Mg Film-Coated Tablet: A Single-Dose, Open-Label, Randomized, Two-Way Crossover Design Study","year":2024,"lang":"en","type":"article","venue":"International Journal on Bioinformatics & Biosciences","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bioequivalence; Pharmacokinetics; Crossover study; Ethambutol; Open label; Pharmacology; Medicine; Chromatography; Chemistry; Isoniazid; Adverse effect","score_opus":0.15841834261451096,"score_gpt":0.46024416857855505,"score_spread":0.30182582596404406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401668772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98372716,0.0017457012,0.001957031,0.0019911684,0.0034540244,0.0024265666,0.00006151605,0.00003941004,0.0045974245],"genre_scores_gemma":[0.99584156,0.0006367482,0.0023200975,0.0006380408,0.00017309473,0.000054723394,0.000010392085,0.000010689677,0.00031466706],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9968638,0.00025907595,0.0008340405,0.00022339694,0.0015844895,0.00023519887],"domain_scores_gemma":[0.9981043,0.00051741884,0.00040202538,0.000106763066,0.0007183829,0.00015110722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038241718,0.00021462452,0.0004309884,0.00055427855,0.00013666762,0.00064063165,0.00047681225,0.00005009703,0.00062674796],"category_scores_gemma":[0.00027120544,0.0001421157,0.00007674222,0.00045333922,0.00041120604,0.000843007,0.00013795607,0.00025839452,0.000026060721],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2559948,0.01667353,0.0036219377,0.0004882019,0.007840368,0.00084832247,0.028977642,0.0049577844,0.25324348,0.002326157,0.014714519,0.41031328],"study_design_scores_gemma":[0.23438978,0.006621402,0.00063472503,0.0008699824,0.0016274475,0.0008504138,0.00094841665,0.7288374,0.022565858,0.00085964345,0.0014369731,0.00035799996],"about_ca_topic_score_codex":0.000053131378,"about_ca_topic_score_gemma":0.0000058495793,"teacher_disagreement_score":0.7238796,"about_ca_system_score_codex":0.00023918806,"about_ca_system_score_gemma":0.00052691426,"threshold_uncertainty_score":0.6862451},"labels":[],"label_agreement":null},{"id":"W4401715201","doi":"10.1188/24.onf.445-450","title":"Exploring Analgesic Use Patterns Among Cancer Survivors With Chronic Chemotherapy-Induced Peripheral Neuropathy","year":2024,"lang":"en","type":"article","venue":"Oncology nursing forum","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Chemotherapy; Analgesic; Peripheral; Cancer chemotherapy; Oncology; Cancer; Internal medicine; Anesthesia; Diabetes mellitus","score_opus":0.08659785023606503,"score_gpt":0.3585534567688497,"score_spread":0.27195560653278467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401715201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98491925,0.0014388644,0.00010643089,0.009024898,0.0029913876,0.00047258666,0.0000124230055,0.00025625902,0.000777887],"genre_scores_gemma":[0.99559957,0.0010228902,0.000056866647,0.00067424204,0.0007872202,0.000266976,0.000027226766,0.00009344736,0.0014715353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984534,0.00008292874,0.00020645872,0.00048314047,0.00015859037,0.00061552215],"domain_scores_gemma":[0.99942124,0.00009086549,0.00005872978,0.00020860671,0.000045351495,0.0001751795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008270248,0.00027360706,0.0004127353,0.00018220003,0.00013291826,0.000049067887,0.0000787927,0.00012076361,0.00052308023],"category_scores_gemma":[0.0000036881163,0.00022028238,0.000117516436,0.0003137075,0.00016497272,0.00033632485,0.000014933375,0.0004188905,0.000013074179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015475565,0.0006787669,0.54896766,0.0001833621,0.00066401204,0.0018215001,0.0044429344,0.00007712633,0.0241528,0.00010087117,0.0026317602,0.41473165],"study_design_scores_gemma":[0.0075075137,0.011791338,0.8735718,0.0024019214,0.0014452431,0.00064428983,0.0010147272,0.0037047586,0.017514352,0.0000308801,0.07963019,0.00074298517],"about_ca_topic_score_codex":0.0020112433,"about_ca_topic_score_gemma":0.0064967936,"teacher_disagreement_score":0.41398868,"about_ca_system_score_codex":0.0023459704,"about_ca_system_score_gemma":0.00063193357,"threshold_uncertainty_score":0.89828545},"labels":[],"label_agreement":null},{"id":"W4402137407","doi":"10.1016/j.toxlet.2024.07.508","title":"P12-15 Eltrombopag: mechanism of clinical hepatotoxicity; mitigation strategies","year":2024,"lang":"en","type":"article","venue":"Toxicology Letters","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Eltrombopag; Mechanism (biology); Medicine; Pharmacology; Intensive care medicine; Internal medicine; Philosophy","score_opus":0.04376039383244327,"score_gpt":0.4019078637320621,"score_spread":0.3581474698996188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402137407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802383,0.00037960775,0.00065167306,0.013091303,0.0014016464,0.0003782455,0.000014486963,0.0001405875,0.0037041323],"genre_scores_gemma":[0.99210787,0.000100497375,0.000498573,0.006343871,0.0005008799,0.000049428316,0.0000367789,0.000021387794,0.00034072346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987117,0.0001331557,0.0004681873,0.00031129742,0.00013509241,0.00024055794],"domain_scores_gemma":[0.9993583,0.00026591847,0.000081869766,0.00016214339,0.000031192736,0.00010055946],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029930848,0.00014838534,0.00046059742,0.00014903123,0.00003122565,0.000013491828,0.000073530544,0.00019208186,0.0009859672],"category_scores_gemma":[0.000024785553,0.00012900417,0.00020101147,0.00016030358,0.00023747979,0.00009143681,0.000027165028,0.00031463525,0.00009834947],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035588886,0.00037919809,0.006608137,0.00019410798,0.00065960584,0.00056861737,0.0002889766,0.000009506674,0.9306489,0.02764016,0.030271098,0.0023757867],"study_design_scores_gemma":[0.016171372,0.013489449,0.11962936,0.00060860376,0.0042413995,0.0013570721,0.0007466115,0.004588277,0.7782668,0.022147145,0.037554737,0.0011991641],"about_ca_topic_score_codex":0.000023491186,"about_ca_topic_score_gemma":0.000023122191,"teacher_disagreement_score":0.1523821,"about_ca_system_score_codex":0.0000696733,"about_ca_system_score_gemma":0.00023323666,"threshold_uncertainty_score":0.9999273},"labels":[],"label_agreement":null},{"id":"W4402325391","doi":"10.1136/spcare-2024-anzspm.97","title":"P-49 Cancer induced bone pain – the use of edmonton classification system for cancer pain and management of refractory pain","year":2024,"lang":"en","type":"article","venue":"Poster presentations","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Refractory (planetary science); Cancer; Medicine; Pain management; Cancer pain; Bone cancer; Bone pain; Physical therapy; Surgery; Internal medicine; Materials science","score_opus":0.1412995387380517,"score_gpt":0.4006066395295091,"score_spread":0.25930710079145736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402325391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9468841,0.011363579,0.0037580794,0.029687112,0.0009222898,0.005826359,0.0005811902,0.00011694514,0.00086035265],"genre_scores_gemma":[0.99574757,0.00061734125,0.00015972475,0.00031670884,0.00011136836,0.0015385811,0.00008234114,0.000017839275,0.0014085151],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990085,0.00030847534,0.00026736766,0.0001762588,0.00012510638,0.000114319715],"domain_scores_gemma":[0.99882823,0.00077983085,0.00009967693,0.00015908755,0.00009287375,0.00004030159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006602384,0.000092739414,0.000167816,0.00009089218,0.000050485836,0.000018433462,0.000039051545,0.000043869237,0.000041918745],"category_scores_gemma":[0.00002664893,0.00006631047,0.000062312734,0.0001542366,0.000048560756,0.00008698395,0.000019505045,0.000062520885,6.3414075e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016394679,0.0008225813,0.08360958,0.019970495,0.0044033555,0.000028488714,0.011606274,0.00011250687,0.23273827,0.0048098243,0.115761176,0.524498],"study_design_scores_gemma":[0.008878126,0.0026154576,0.46998084,0.005837329,0.007484574,0.000015386107,0.011257916,0.059757598,0.032834727,0.00015027804,0.4005104,0.0006773788],"about_ca_topic_score_codex":0.0016927882,"about_ca_topic_score_gemma":0.0006338378,"teacher_disagreement_score":0.5238206,"about_ca_system_score_codex":0.000110335764,"about_ca_system_score_gemma":0.00006827848,"threshold_uncertainty_score":0.27040625},"labels":[],"label_agreement":null},{"id":"W4402325634","doi":"10.1136/spcare-2024-anzspm.11","title":"OP-11 A double-blind randomised controlled trial of dose-escalated CBD/THC oil for symptom management in advanced cancer","year":2024,"lang":"en","type":"article","venue":"Oral Presentations","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Double blind; Medicine; Cancer; Alternative medicine; Internal medicine","score_opus":0.06454688435615415,"score_gpt":0.44059640639391845,"score_spread":0.3760495220377643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402325634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715817,0.0013304251,0.0001457262,0.0045786,0.0015395329,0.010242546,0.000067674046,0.00008523314,0.0104285935],"genre_scores_gemma":[0.9639651,0.00062041334,0.00039319825,0.000103978244,0.00021448644,0.011245058,0.0002001479,0.000027246042,0.02323033],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99888545,0.00005220742,0.00044390268,0.0002514749,0.00015761654,0.00020935708],"domain_scores_gemma":[0.99934894,0.00030131574,0.00007568328,0.00012677188,0.00007442448,0.00007288005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015045493,0.00014136039,0.0005004165,0.00025994313,0.000040422725,0.00002055558,0.000060717317,0.00006226753,0.00061268365],"category_scores_gemma":[0.000015673137,0.000113298716,0.00022631581,0.00037079057,0.00004638767,0.000100164056,0.00001908046,0.00008569896,0.0000068648874],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9759452,0.0007888643,0.0002722805,0.00027341975,0.0012361837,0.000032749493,0.000388297,0.00052327197,0.0022255704,0.00083179586,0.004630148,0.012852261],"study_design_scores_gemma":[0.9865664,0.0003737457,0.00035376055,0.00010259709,0.0014614577,0.0000013955411,0.00010066414,0.0030941006,0.0010679549,0.00014465148,0.00663421,0.000099038065],"about_ca_topic_score_codex":0.00037283133,"about_ca_topic_score_gemma":0.00052922976,"teacher_disagreement_score":0.012801736,"about_ca_system_score_codex":0.00009753508,"about_ca_system_score_gemma":0.0001440858,"threshold_uncertainty_score":0.6708456},"labels":[],"label_agreement":null},{"id":"W4402501795","doi":"10.11159/icbb24.130","title":"Comparison of Reported Adverse Events for Two Plant-Derived Anti Cancer Therapeutics: Paclitaxel and Docetaxel","year":2024,"lang":"en","type":"article","venue":"Proceedings of the World Congress on New Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Docetaxel; Paclitaxel; Adverse effect; Medicine; Cancer; Oncology; Pharmacology; Internal medicine","score_opus":0.06794039534938733,"score_gpt":0.3975944316342401,"score_spread":0.32965403628485274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402501795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98323876,0.0051601385,0.0000013774851,0.009366344,0.00052880036,0.00090880436,0.00005822012,0.000312772,0.00042477582],"genre_scores_gemma":[0.9949366,0.00079390017,0.00034997566,0.00008072619,0.000042872234,0.000109951645,0.000003528335,0.000020496398,0.0036619743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901456,0.0000022648953,0.00034358597,0.0002783597,0.00016486806,0.00019636475],"domain_scores_gemma":[0.999356,0.00009542724,0.00028990014,0.0001306151,0.00010034152,0.000027753546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087479915,0.00018241766,0.0004724589,0.00024110294,0.000052258914,0.000008246699,0.00019576472,0.00008572478,0.000012740175],"category_scores_gemma":[0.000045506687,0.00011671278,0.00011956371,0.00031618797,0.0002476628,0.00006924297,0.000102121725,0.00020725532,4.6336768e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016711489,0.0003599666,0.3131262,0.0012300687,0.0017702454,0.000003998868,0.0004276439,0.0000046272244,0.6072493,0.005055083,0.022141313,0.04696039],"study_design_scores_gemma":[0.002326536,0.00044678053,0.0042335414,0.0011684671,0.0008126664,0.000011631151,0.0006507339,0.00038349122,0.9731656,0.0018566076,0.014811825,0.0001321699],"about_ca_topic_score_codex":0.000041639243,"about_ca_topic_score_gemma":0.000042137348,"teacher_disagreement_score":0.36591622,"about_ca_system_score_codex":0.000055149565,"about_ca_system_score_gemma":0.00007048125,"threshold_uncertainty_score":0.47594088},"labels":[],"label_agreement":null},{"id":"W4402514041","doi":"10.1097/io9.0000000000000064","title":"Pegulicianine: a game changer for image-guided breast cancer surgery","year":2024,"lang":"en","type":"article","venue":"International Journal of Surgery Open","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Medicine; Breast cancer; Cancer; General surgery; Oncology; Internal medicine","score_opus":0.12327069539616463,"score_gpt":0.44639782301600894,"score_spread":0.3231271276198443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402514041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7741959,0.0071178684,0.00039402203,0.19201967,0.021834128,0.00089686894,0.00077082455,0.000057006193,0.002713719],"genre_scores_gemma":[0.9827734,0.002633345,0.00025749323,0.0029516376,0.0056676622,0.00011329941,0.00007436319,0.000049860904,0.0054789227],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99872905,0.000031561463,0.0005426379,0.00016129312,0.00034809977,0.00018735294],"domain_scores_gemma":[0.9980269,0.0007674144,0.0002193969,0.000071259936,0.0007828066,0.00013219898],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006747707,0.00013496136,0.00046953934,0.0005029906,0.000023353907,0.00018177734,0.00022272955,0.000051250183,0.0036308765],"category_scores_gemma":[0.00007728324,0.00010494138,0.00044855062,0.00016928052,0.00004061935,0.00047411709,0.000067263696,0.00014572905,0.000028749713],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002493667,0.00030555483,0.023852175,0.000110349545,0.002278614,0.0022339213,0.00017545932,0.000005195652,0.0061938325,0.000088088,0.87714094,0.08512221],"study_design_scores_gemma":[0.0031477397,0.0001671356,0.103280805,0.0028771998,0.0009170326,0.017331589,0.00008354743,0.00044127347,0.0065617473,0.0006263007,0.8641583,0.00040734673],"about_ca_topic_score_codex":0.00022968712,"about_ca_topic_score_gemma":0.000018694536,"teacher_disagreement_score":0.20857751,"about_ca_system_score_codex":0.00030127275,"about_ca_system_score_gemma":0.000955954,"threshold_uncertainty_score":0.99727994},"labels":[],"label_agreement":null},{"id":"W4402551704","doi":"10.1158/1538-7445.pancreatic24-c008","title":"Abstract C008: Patient-derived organoids and precision medicine: Insights from the PASS-01 clinical trial in PDAC","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Organoid; Precision medicine; Medicine; Clinical trial; Internal medicine; Computational biology; Oncology; Bioinformatics; Biology; Pathology; Neuroscience","score_opus":0.22716179798124075,"score_gpt":0.5427648478731496,"score_spread":0.31560304989190885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402551704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9583508,0.025108233,0.0000012978692,0.0125165945,0.0015677518,0.0011974473,0.000022442413,0.00003196026,0.0012035229],"genre_scores_gemma":[0.9858913,0.010396539,0.0000102526255,0.0004421301,0.0026047437,0.00025135468,0.000037177862,0.000025440784,0.00034104977],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782157,0.00035914953,0.00045137721,0.00048230248,0.0005701846,0.00031542874],"domain_scores_gemma":[0.9966397,0.0027553944,0.000033328663,0.00027354594,0.000105683655,0.00019231728],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00080760976,0.0001371791,0.0003530841,0.0001641919,0.000101904705,0.0000409596,0.00013750372,0.0001673193,0.0026505948],"category_scores_gemma":[0.00037462366,0.00007593003,0.000063721076,0.0004930771,0.00045597024,0.000075822616,0.000115455776,0.0010513811,0.00006183042],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08082766,0.00071126135,0.01308006,0.00017246301,0.00054443354,0.0010308116,0.00849238,0.0000017541175,0.17218378,0.00013139038,0.23906602,0.48375797],"study_design_scores_gemma":[0.13664503,0.00930372,0.36348495,0.0024873298,0.00037276244,0.000017649818,0.0017169517,0.00019674895,0.019426271,0.0040237126,0.46190462,0.00042024767],"about_ca_topic_score_codex":0.0027371985,"about_ca_topic_score_gemma":0.0011451535,"teacher_disagreement_score":0.48333773,"about_ca_system_score_codex":0.0002601863,"about_ca_system_score_gemma":0.0006172703,"threshold_uncertainty_score":0.9982611},"labels":[],"label_agreement":null},{"id":"W4402554993","doi":"10.1080/14656566.2024.2402022","title":"Current approaches to the pharmacological management of metastatic breast cancer in older women","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Context (archaeology); Breast cancer; Intensive care medicine; Oncology; Cancer; Personalized medicine; Internal medicine; Bioinformatics","score_opus":0.2769222624376801,"score_gpt":0.49914402222175996,"score_spread":0.22222175978407988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402554993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005362468,0.98742956,0.00000797177,0.0036381711,0.0035763036,0.0045679384,0.00039109556,0.00006200457,0.00027333552],"genre_scores_gemma":[0.00012636413,0.986877,0.000046965826,0.0014349953,0.0010416063,0.009741198,0.00007787847,0.00010514197,0.0005488305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971894,0.00031647002,0.00077306735,0.00075128116,0.00043041707,0.0005393851],"domain_scores_gemma":[0.99913585,0.00010290833,0.00020039605,0.00029729007,0.000023902072,0.00023967489],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035399583,0.00067300315,0.0016622873,0.0004562805,0.00004632488,0.000022306103,0.00037161703,0.000097876764,0.004128148],"category_scores_gemma":[7.336768e-7,0.00036476023,0.0005079114,0.0008867449,0.000075574724,0.00003593687,0.00009256533,0.00064700586,0.00014508356],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005741642,0.0018431778,0.0000028361815,0.007005663,0.0026516533,0.00004920239,0.0012870339,0.000009813065,0.0000113881415,0.0001301811,0.050510157,0.9359247],"study_design_scores_gemma":[0.0030329647,0.00027644873,0.000020669519,0.009497948,0.0006166016,0.000040547588,0.0000863804,0.000038264767,0.00003935136,0.000009519854,0.9860189,0.0003223824],"about_ca_topic_score_codex":0.000021738337,"about_ca_topic_score_gemma":0.0000011697888,"teacher_disagreement_score":0.93560237,"about_ca_system_score_codex":0.0009253683,"about_ca_system_score_gemma":0.0002350919,"threshold_uncertainty_score":0.99988043},"labels":[],"label_agreement":null},{"id":"W4402558712","doi":"10.1016/j.annonc.2024.08.2123","title":"1905P Impact of proactive callback in patients with solid tumors receiving systemic therapy: A meta-analysis","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Systemic therapy; Callback; Meta-analysis; Oncology; Internal medicine; Intensive care medicine; Cancer","score_opus":0.1488304167108582,"score_gpt":0.4629236299410243,"score_spread":0.31409321323016615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402558712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935412,0.0041082767,0.000005503586,0.00060383993,0.000042353393,0.00062587345,0.000050828887,0.000021089156,0.0010010647],"genre_scores_gemma":[0.99921453,0.00027677426,0.00004570892,0.00014923807,0.000025343541,0.0000821554,0.00003269005,0.000020915812,0.00015264815],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9987546,0.00017988421,0.0004306016,0.0002519744,0.00015979113,0.00022312849],"domain_scores_gemma":[0.99910444,0.0002242143,0.00019977818,0.0001694029,0.00023252866,0.000069627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030014114,0.00016315616,0.001511087,0.00048171813,0.000008976154,0.000003242243,0.00006560269,0.000093391274,0.00039881532],"category_scores_gemma":[0.000019258641,0.000096447606,0.0007087933,0.0007786124,0.00008696338,0.00006396369,0.000017319651,0.00015512337,0.000003255818],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008036134,0.003881248,0.44132733,0.000260859,0.52515477,0.0001974141,0.0045138462,0.00072018005,0.0022485629,0.00003261635,0.00182115,0.011805912],"study_design_scores_gemma":[0.0063266666,0.03953941,0.83836985,0.000101020356,0.10761558,0.00003781043,0.00018665384,0.0002799975,0.006541531,0.00007627875,0.0006575442,0.00026766854],"about_ca_topic_score_codex":0.0008728259,"about_ca_topic_score_gemma":0.00018729891,"teacher_disagreement_score":0.41753915,"about_ca_system_score_codex":0.00015506393,"about_ca_system_score_gemma":0.000481658,"threshold_uncertainty_score":0.4366748},"labels":[],"label_agreement":null},{"id":"W4402561515","doi":"10.1016/j.annonc.2024.08.227","title":"286P Impact of adjuvant endocrine therapy on survival outcomes in female breast cancer patients over 50","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Ontario Institute for Cancer Research; Alberta Health; University of Alberta","funders":"","keywords":"Medicine; Oncology; Breast cancer; Adjuvant; Internal medicine; Endocrine system; Adjuvant therapy; Cancer; Overall survival; Gynecology; Hormone","score_opus":0.09601065234537197,"score_gpt":0.491891860198112,"score_spread":0.39588120785274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402561515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915922,0.001717149,1.9754805e-7,0.0030553367,0.0006382538,0.00032403177,0.0003433125,0.000015413909,0.002314087],"genre_scores_gemma":[0.99537796,0.0032374777,0.0000049942414,0.0006718253,0.000115425115,0.00004056734,0.00003431084,0.00001814864,0.0004993045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989761,0.00007888134,0.00032987344,0.00020282801,0.00015325575,0.0002590786],"domain_scores_gemma":[0.99936366,0.00023632922,0.00009550831,0.00012750819,0.00010127846,0.00007570729],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000114567534,0.00015696153,0.0006888349,0.00022683704,0.000009410115,0.0000021370151,0.000064746964,0.00007987427,0.0017912599],"category_scores_gemma":[0.000012385262,0.00010513835,0.00023853478,0.00017362363,0.000078824225,0.000044585475,0.000023487797,0.00015052511,0.000011073214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030914324,0.0032139132,0.90843266,0.00006162566,0.00070859265,0.00008678288,0.000420969,0.00002014934,0.0026991104,0.00007056291,0.0046360325,0.07655818],"study_design_scores_gemma":[0.00514461,0.009203828,0.9748571,0.00007845607,0.000053583102,0.000007966355,0.000011886589,0.000017312406,0.0026291327,0.000062176434,0.007856825,0.00007713758],"about_ca_topic_score_codex":0.0043417327,"about_ca_topic_score_gemma":0.00044621818,"teacher_disagreement_score":0.07648104,"about_ca_system_score_codex":0.00015712075,"about_ca_system_score_gemma":0.00035339792,"threshold_uncertainty_score":0.99912125},"labels":[],"label_agreement":null},{"id":"W4402561660","doi":"10.1016/j.annonc.2024.08.378","title":"431P Exposure-adjusted incidence rates (EAIRs) of adverse events (AEs) from the TROPION-Breast01 study of datopotamab deruxtecan (Dato-DXd) vs investigator’s choice of chemotherapy (ICC) in patients (pts) with pretreated, inoperable/metastatic HR+/HER2– breast cancer (BC)","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Incidence (geometry); Adverse effect; Internal medicine; Chemotherapy; Oncology; Family medicine","score_opus":0.055316604342201675,"score_gpt":0.3768241193797079,"score_spread":0.3215075150375062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402561660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945379,0.0012115453,0.000001961046,0.0019416,0.00021206235,0.0015318173,0.00048090098,0.000019597814,0.00006262452],"genre_scores_gemma":[0.9982913,0.0006569653,0.00008885797,0.00053037715,0.000061484876,0.00016545731,0.00008814364,0.00004243612,0.00007497056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972418,0.0004979666,0.0009866974,0.00048307178,0.0004445867,0.0003458812],"domain_scores_gemma":[0.9976003,0.0006242897,0.00059811457,0.00046838965,0.00054615235,0.0001627276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027195635,0.00034033702,0.0011989351,0.00027057092,0.000035476296,0.000002671395,0.00031859498,0.00014093678,0.0005118034],"category_scores_gemma":[0.00009647596,0.0002280308,0.000118386226,0.0008620094,0.00038137028,0.0001861982,0.00008319684,0.00030545323,0.0000035274606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006628013,0.006310453,0.9632122,0.00036568614,0.0017600697,0.00004968954,0.0066919513,0.0001539797,0.0020451301,0.000007003491,0.0010440975,0.011731749],"study_design_scores_gemma":[0.016347421,0.014196584,0.95285815,0.00095399946,0.00083424663,0.000015006653,0.0019993656,0.00016143547,0.012047631,0.000042481824,0.00035623074,0.00018746033],"about_ca_topic_score_codex":0.03965985,"about_ca_topic_score_gemma":0.009463166,"teacher_disagreement_score":0.030196685,"about_ca_system_score_codex":0.00016983045,"about_ca_system_score_gemma":0.0012124686,"threshold_uncertainty_score":0.9667351},"labels":[],"label_agreement":null},{"id":"W4402561714","doi":"10.1016/j.annonc.2024.08.376","title":"429P Brain imaging screening (BIS) in metastatic breast cancer (MBC): Patients’ and physicians’ perspectives","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Oncology; Cancer; Breast cancer; Internal medicine; Radiology","score_opus":0.05707386712719624,"score_gpt":0.4350356522901061,"score_spread":0.37796178516290985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402561714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91945344,0.014010887,0.00003052639,0.06282909,0.00021919484,0.0003068503,0.00009729546,0.000031495056,0.0030212114],"genre_scores_gemma":[0.99494374,0.0012960418,0.00019275135,0.0030113573,0.00013985245,0.000047423222,0.000017125769,0.000017753448,0.00033396328],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991136,0.00008529236,0.00020690479,0.00026261844,0.00009350236,0.00023805998],"domain_scores_gemma":[0.99947864,0.00023247434,0.000060115057,0.00006779421,0.0001027455,0.000058257097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016350899,0.00012437071,0.0003787611,0.00022423956,0.000024729366,0.000008183109,0.000039300896,0.00003534878,0.00025987483],"category_scores_gemma":[0.000021172447,0.00011007346,0.00007357302,0.00023594564,0.00015726942,0.00011869732,0.00003425351,0.00016279385,0.0000032749526],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009715203,0.0015740232,0.12945732,0.00030948207,0.00069728674,0.0003488374,0.0097264685,0.000016870308,0.0061851465,0.0007772985,0.034319773,0.81561595],"study_design_scores_gemma":[0.010228307,0.00413727,0.8621462,0.000886662,0.0007336524,0.00019967384,0.006481345,0.0019201578,0.0024804133,0.0007696329,0.10958007,0.00043663348],"about_ca_topic_score_codex":0.0008047731,"about_ca_topic_score_gemma":0.00023736479,"teacher_disagreement_score":0.81517935,"about_ca_system_score_codex":0.00008515857,"about_ca_system_score_gemma":0.00018184194,"threshold_uncertainty_score":0.44886655},"labels":[],"label_agreement":null},{"id":"W4402642904","doi":"10.1007/s00520-024-08878-5","title":"Exploring the reliability and validity of clinically-relevant outcome measures for chemotherapy-induced peripheral neuropathy","year":2024,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Medicine; Pain medicine; Peripheral neuropathy; Chemotherapy-induced peripheral neuropathy; Nursing research; Reliability (semiconductor); Chemotherapy; Peripheral; Oncology; Patient-reported outcome; Physical therapy; Internal medicine; Intensive care medicine; Physical medicine and rehabilitation; Anesthesia; Quality of life (healthcare); Anesthesiology; Pathology; Nursing","score_opus":0.21328150948830082,"score_gpt":0.4396497949564378,"score_spread":0.22636828546813698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402642904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921731,0.001824783,0.000018975097,0.003526076,0.0012909176,0.0008853802,0.00009368945,0.00003080732,0.00015627733],"genre_scores_gemma":[0.99667245,0.0016797512,0.000054361288,0.0005714164,0.00029996145,0.000604167,0.000008583712,0.000021539923,0.00008776028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987778,0.00008188405,0.00046808386,0.00033322553,0.00014448362,0.0001945296],"domain_scores_gemma":[0.99911535,0.0004037641,0.000070386246,0.00016874853,0.00018163532,0.00006011081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045799362,0.0001400953,0.00035015735,0.00004481979,0.00003332181,0.000009909464,0.000056841873,0.000047417525,0.00011224229],"category_scores_gemma":[0.00017366653,0.00009022077,0.00016048572,0.00012743635,0.0001130055,0.00007941045,0.000024431178,0.0002184195,6.161619e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027541567,0.00017466255,0.7928494,0.0012181165,0.000176517,0.000056296394,0.011997905,0.00001918936,0.010587115,0.000041427986,0.00063581753,0.17948936],"study_design_scores_gemma":[0.008492966,0.006190245,0.83426714,0.00064843486,0.000971132,0.000027858276,0.004455224,0.0005000592,0.04662563,0.0003762806,0.09693985,0.00050517067],"about_ca_topic_score_codex":0.0002522109,"about_ca_topic_score_gemma":0.00025127252,"teacher_disagreement_score":0.1789842,"about_ca_system_score_codex":0.00026673023,"about_ca_system_score_gemma":0.00028170875,"threshold_uncertainty_score":0.3679096},"labels":[],"label_agreement":null},{"id":"W4402670104","doi":"10.1200/op.24.00089","title":"Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma","year":2024,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Vincristine; Etoposide; Cyclophosphamide; Oncology; Internal medicine; Chemotherapy-induced peripheral neuropathy; Prednisone; Peripheral neuropathy; Chemotherapy; Vinca; Pharmacology","score_opus":0.01621319297402094,"score_gpt":0.3474002585708698,"score_spread":0.33118706559684885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402670104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9615241,0.00009651569,0.000044737113,0.005377617,0.0002355394,0.031637527,0.000008801373,0.00015015044,0.0009249969],"genre_scores_gemma":[0.9810072,0.00014292318,0.0010852132,0.002273262,0.00024600278,0.014836975,0.000032442884,0.000055108423,0.00032087075],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99824655,0.00034704967,0.00029993948,0.0006192196,0.00017330662,0.0003139295],"domain_scores_gemma":[0.9992309,0.00011839057,0.00015621987,0.00024616817,0.000082934705,0.00016536332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003139311,0.00025623525,0.00035241462,0.00023074918,0.000077488025,0.00004701266,0.00008417855,0.00018777019,0.000060027556],"category_scores_gemma":[0.00008485664,0.00020975851,0.00003553222,0.00051223225,0.00005439343,0.0002855716,0.00004260521,0.00039127053,0.000038908143],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08010956,0.0063329786,0.29371643,0.0005133625,0.0008706419,0.0030493257,0.007965972,0.00007327308,0.012873968,0.00017102569,0.001987931,0.5923355],"study_design_scores_gemma":[0.022858188,0.0061145145,0.9242348,0.00026116412,0.00054507266,0.0014971659,0.00019655621,0.0013494893,0.0006934168,0.000012066467,0.04196119,0.00027636634],"about_ca_topic_score_codex":0.002120244,"about_ca_topic_score_gemma":0.00035489272,"teacher_disagreement_score":0.6305184,"about_ca_system_score_codex":0.00053860986,"about_ca_system_score_gemma":0.00020782498,"threshold_uncertainty_score":0.8553704},"labels":[],"label_agreement":null},{"id":"W4402708995","doi":"10.1158/1538-7755.disp24-c051","title":"Abstract C051: Impact of population pharmacogenomics on cisplatin-induced neurotoxicities","year":2024,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacogenomics; Medicine; Cisplatin; Population; Environmental health; Internal medicine; Pharmacology; Chemotherapy","score_opus":0.12669799011986316,"score_gpt":0.4877148667696302,"score_spread":0.36101687664976706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402708995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98810947,0.007041017,0.000045632372,0.0013581829,0.0015694734,0.00084273075,0.000067355344,0.00010776205,0.00085836445],"genre_scores_gemma":[0.9969716,0.0009400922,0.00016277393,0.00031497434,0.00043552395,0.00016397137,0.00034908016,0.00003671132,0.0006252499],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982198,0.000247658,0.0006604281,0.00044355393,0.00009525909,0.00033328313],"domain_scores_gemma":[0.9987634,0.00060027605,0.00026189227,0.0001961589,0.00005015326,0.00012810765],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069559127,0.00025572823,0.0005735358,0.00029784467,0.000055665878,0.000005948433,0.00007154915,0.00020786,0.001724033],"category_scores_gemma":[0.00008909115,0.00020911866,0.000545525,0.00021420137,0.00008528122,0.00010888225,0.000020501098,0.0002481485,0.000042762877],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057003153,0.00051365566,0.32950172,0.0007724219,0.005022856,0.00007098132,0.00019109352,0.00062526204,0.39153132,0.00042979195,0.0321644,0.23347618],"study_design_scores_gemma":[0.0021846876,0.0018353427,0.9772739,0.00069005,0.0009421289,0.000038707338,0.000015720905,0.0033369502,0.010085236,0.0022119246,0.0011342401,0.00025112185],"about_ca_topic_score_codex":0.0009796782,"about_ca_topic_score_gemma":0.000044106186,"teacher_disagreement_score":0.64777213,"about_ca_system_score_codex":0.00060713966,"about_ca_system_score_gemma":0.00021872808,"threshold_uncertainty_score":0.99918854},"labels":[],"label_agreement":null},{"id":"W4402740022","doi":"10.1016/j.neurot.2024.e00418","title":"Neuropathology Evaluation of Olney Lesions in Regulatory Drug Development Toxicology Studies","year":2024,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Greenfield Research (Canada)","funders":"","keywords":"Neuropathology; Neurology; Medicine; Drug; Drug development; Neurochemistry; Toxicology; Pharmacology; Internal medicine; Biology; Psychiatry","score_opus":0.17460154155608504,"score_gpt":0.4482295772712218,"score_spread":0.2736280357151368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402740022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850433,0.010795348,0.0000067098526,0.0018958768,0.00086229213,0.0005117365,0.0000021779497,0.000046629164,0.00083594763],"genre_scores_gemma":[0.9968603,0.00068533595,0.0001494313,0.0013824926,0.000072511466,0.00009583281,0.0000048798893,0.00002329598,0.0007258808],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988704,0.00024361517,0.00028579705,0.00023055074,0.00021214884,0.00015751839],"domain_scores_gemma":[0.99951446,0.00017415552,0.000037926933,0.00013865488,0.000101110985,0.00003366357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044133217,0.000114024166,0.00025420793,0.00022949334,0.000025765788,0.0000030487577,0.000044458007,0.000056649922,0.00012934789],"category_scores_gemma":[0.000026906357,0.000098056415,0.00004433182,0.00020596899,0.000104398845,0.00002474306,0.000020113472,0.00016308225,0.000016258715],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006400099,0.001606974,0.0325301,0.0007745668,0.00079461094,0.00063797564,0.017941043,0.00039117568,0.31779385,0.0019342866,0.003760427,0.62119496],"study_design_scores_gemma":[0.009889716,0.0021223752,0.5625305,0.00049688603,0.0022931863,0.00048840325,0.00087701646,0.0057475823,0.18810926,0.0017324936,0.22520478,0.0005078191],"about_ca_topic_score_codex":0.0000027858064,"about_ca_topic_score_gemma":0.000065130065,"teacher_disagreement_score":0.6206871,"about_ca_system_score_codex":0.00016875892,"about_ca_system_score_gemma":0.0004348537,"threshold_uncertainty_score":0.39986244},"labels":[],"label_agreement":null},{"id":"W4402767152","doi":"10.1136/rapm-2024-esra.562","title":"C26 Anterior QLB for which surgery should we use it","year":2024,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.17875451984818697,"score_gpt":0.4210764028740764,"score_spread":0.24232188302588942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402767152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7107305,0.010392646,0.0010369096,0.25150406,0.0064571337,0.0017511073,0.0001449507,0.0007384912,0.017244205],"genre_scores_gemma":[0.90378046,0.002093777,0.0003270161,0.0041776993,0.0006949034,0.00013878969,0.000052650998,0.000030364692,0.08870434],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994071,0.000009534364,0.00014498447,0.00018770715,0.00006996845,0.00018068231],"domain_scores_gemma":[0.9992938,0.0004750975,0.000010846792,0.00009822792,0.000044274035,0.00007776278],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009274383,0.00009637434,0.00021817247,0.00009837469,0.000024841114,0.000031900894,0.000021347212,0.000061259474,0.0033195193],"category_scores_gemma":[0.000026434873,0.00006814267,0.00013045616,0.000150409,0.000015173828,0.00007945478,0.000012876356,0.00007146151,0.00011795705],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059932296,0.00013322396,0.009708092,0.00035162142,0.00030044754,0.00012779726,0.00018514958,3.1454186e-7,0.0075463317,0.00021125264,0.96379364,0.017042793],"study_design_scores_gemma":[0.0007131524,0.00027872398,0.0019981847,0.00017874855,0.00032300022,0.00005662801,0.00003348147,0.00051836687,0.0054295002,0.000047959038,0.9903262,0.000096039155],"about_ca_topic_score_codex":0.00008328512,"about_ca_topic_score_gemma":0.00028763592,"teacher_disagreement_score":0.24732636,"about_ca_system_score_codex":0.000054364653,"about_ca_system_score_gemma":0.0001433206,"threshold_uncertainty_score":0.99759156},"labels":[],"label_agreement":null},{"id":"W4402985353","doi":"10.1200/op.2024.20.10_suppl.397","title":"Health-related quality of life of Canadian patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer.","year":2024,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); McGill University Health Centre; McGill University","funders":"","keywords":"Human Epidermal Growth Factor Receptor 2; Metastatic breast cancer; Breast cancer; Medicine; Oncology; Cancer; Quality of life (healthcare); Internal medicine; Cancer research; Nursing","score_opus":0.05588669378253575,"score_gpt":0.414979273414401,"score_spread":0.35909257963186525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402985353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92232484,0.0016062079,0.0000052013943,0.0663311,0.0006594796,0.0011009582,0.0017758543,0.000045279503,0.0061510466],"genre_scores_gemma":[0.9957473,0.00031349895,0.0005194131,0.002605711,0.00008544251,0.000064118605,0.0002664421,0.000031896616,0.00036614024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973955,0.00087179284,0.0007766299,0.00033527336,0.00025223303,0.00036855615],"domain_scores_gemma":[0.99677724,0.0013880585,0.00067977497,0.00016311709,0.0005327701,0.00045903894],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052724825,0.00020567494,0.0009180371,0.00042055015,0.00010105835,0.0000068877866,0.000084077205,0.00013711744,0.0023640096],"category_scores_gemma":[0.00027723768,0.00016518329,0.000098643875,0.00068079756,0.00022559853,0.00026952647,0.000023588527,0.0004558312,0.000028287683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025312679,0.013350743,0.726335,0.004424169,0.022334443,0.00062732253,0.021312192,0.000026896296,0.004154209,0.007221558,0.11472637,0.060174398],"study_design_scores_gemma":[0.007961966,0.0060416083,0.95549273,0.0002264755,0.001541402,0.00010380833,0.0005975415,0.000012592863,0.00046760633,0.000032138436,0.027273463,0.00024864433],"about_ca_topic_score_codex":0.53012305,"about_ca_topic_score_gemma":0.12851183,"teacher_disagreement_score":0.40161124,"about_ca_system_score_codex":0.0011972171,"about_ca_system_score_gemma":0.004310504,"threshold_uncertainty_score":0.998548},"labels":[],"label_agreement":null},{"id":"W4402987295","doi":"10.1200/op.2024.20.10_suppl.391","title":"Treatment patterns of goserelin 3.6 mg once monthly and 10.8 mg every three months in women with breast cancer: A real-world analysis.","year":2024,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Goserelin; Medicine; Breast cancer; Cancer; Internal medicine; Oncology; Gynecology","score_opus":0.021120972590215396,"score_gpt":0.3761987553108591,"score_spread":0.3550777827206437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402987295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967354,0.0030787627,0.000011673675,0.017855179,0.00017825986,0.0007447461,0.00020207808,0.0000664259,0.010508869],"genre_scores_gemma":[0.9888472,0.0057903198,0.00031744986,0.00068664446,0.00020090744,0.00057250774,0.00003679455,0.000031540123,0.0035166596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982437,0.00020388713,0.00041833485,0.00053992146,0.00019493458,0.00039925723],"domain_scores_gemma":[0.998042,0.0011446036,0.00023594812,0.00027980574,0.00011578276,0.0001818668],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031961998,0.000273653,0.0008861778,0.0005100667,0.000046768746,0.000019310419,0.00007584465,0.00014670222,0.0009137233],"category_scores_gemma":[0.000025616608,0.00020216862,0.00008802338,0.00091958937,0.00010783864,0.00029710642,0.00004907561,0.0003092075,0.000015051873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03966409,0.0041877525,0.757838,0.00034632385,0.013201305,0.0059695086,0.006510135,0.000542785,0.0008690354,0.000200421,0.0018718834,0.16879876],"study_design_scores_gemma":[0.008949203,0.0058930293,0.8555587,0.00018221476,0.0095625995,0.00029846813,0.0011779249,0.0023553402,0.00011546404,0.0000355936,0.11559794,0.00027351844],"about_ca_topic_score_codex":0.037451282,"about_ca_topic_score_gemma":0.09338463,"teacher_disagreement_score":0.16852523,"about_ca_system_score_codex":0.002200012,"about_ca_system_score_gemma":0.0009309375,"threshold_uncertainty_score":0.9999996},"labels":[],"label_agreement":null},{"id":"W4403045738","doi":"10.1503/cmaj.240221-f","title":"Deux cas de zona atypique chez des personnes prenant des inhibiteurs de Janus kinases par voie orale","year":2024,"lang":"fr","type":"article","venue":"Canadian Medical Association Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine","score_opus":0.016298562639727603,"score_gpt":0.29636701199564586,"score_spread":0.28006844935591824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403045738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8369481,0.100684635,0.00012043688,0.055691637,0.0039701085,0.0002148696,0.00016265643,0.00004801662,0.0021595214],"genre_scores_gemma":[0.9429213,0.020500802,0.00041000755,0.0073940437,0.01325954,0.00003912805,0.0000427028,0.0000719185,0.015360589],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99628013,0.0005918689,0.00051410735,0.0002947105,0.0007263904,0.0015927845],"domain_scores_gemma":[0.994807,0.0006386283,0.00014539712,0.000090072106,0.00031818682,0.004000687],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023362366,0.00030193268,0.00042690718,0.0003230476,0.00058095687,0.00022113368,0.00018409449,0.0007652397,0.016915398],"category_scores_gemma":[0.0020060318,0.0002795485,0.00028049966,0.00047836482,0.00044738865,0.00024568572,0.00002180205,0.0016439529,0.00040856074],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00006621454,0.0001827534,0.50829667,0.000419335,0.001029509,0.02071071,0.015855055,0.000016766588,0.00031847885,0.00021869595,0.3178157,0.13507013],"study_design_scores_gemma":[0.0031091662,0.00084754877,0.1764014,0.0044959444,0.0016612975,0.014636353,0.0036760715,0.0025099653,0.001961339,0.0023976986,0.78774714,0.0005560784],"about_ca_topic_score_codex":0.043046374,"about_ca_topic_score_gemma":0.33774945,"teacher_disagreement_score":0.46993142,"about_ca_system_score_codex":0.013162916,"about_ca_system_score_gemma":0.016449329,"threshold_uncertainty_score":0.99996567},"labels":[],"label_agreement":null},{"id":"W4403075294","doi":"10.1016/j.athplu.2024.08.019","title":"Bempedoic acid: real-world efficacy and tolerability in lipid clinics across three UK Centres","year":2024,"lang":"en","type":"article","venue":"Atherosclerosis Plus","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Tolerability; Medicine; Internal medicine; Adverse effect","score_opus":0.05047745627176591,"score_gpt":0.38038505729493916,"score_spread":0.32990760102317324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403075294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99314684,0.0024052681,0.000008025614,0.0016217821,0.0007976824,0.0006303803,0.00005678214,0.00015698321,0.0011762831],"genre_scores_gemma":[0.99492216,0.0026849955,0.00010615953,0.00047409267,0.00042502227,0.00006688403,0.000036510537,0.000041208044,0.0012429488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831,0.000058264413,0.00042643552,0.0005692036,0.0001762208,0.00045984227],"domain_scores_gemma":[0.9989886,0.00041979784,0.000050590977,0.0003333828,0.000029335595,0.00017825769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032886746,0.0002486641,0.0005115109,0.000088402914,0.00008796894,0.00007089686,0.00009478765,0.00013846887,0.00046294826],"category_scores_gemma":[0.000049705905,0.00020907391,0.00012288308,0.00040253537,0.00018600913,0.00007784183,0.00010553042,0.00035438393,0.00008313025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009120166,0.00063957827,0.9201851,0.00024357569,0.0002260388,0.00004999351,0.0042426274,0.000015697477,0.012007179,0.00023005751,0.003042902,0.058205258],"study_design_scores_gemma":[0.00524351,0.00049838785,0.9795491,0.0004021263,0.0001921975,0.0000071361947,0.00008577987,0.0005955037,0.0017332147,0.00014999458,0.011319193,0.00022383606],"about_ca_topic_score_codex":0.0010920679,"about_ca_topic_score_gemma":0.008632758,"teacher_disagreement_score":0.059364043,"about_ca_system_score_codex":0.00033907316,"about_ca_system_score_gemma":0.00014372457,"threshold_uncertainty_score":0.8525787},"labels":[],"label_agreement":null},{"id":"W4403089800","doi":"10.26434/chemrxiv-2024-25k81","title":"Total Synthesis of LL-A03411-Beta1","year":2024,"lang":"en","type":"preprint","venue":"ChemRxiv","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Environmental science; Political science","score_opus":0.028569721522363277,"score_gpt":0.3329215473271281,"score_spread":0.30435182580476483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403089800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92790467,0.0052308864,0.0000027456895,0.00224663,0.0015484801,0.00043116772,0.000028195285,0.000116797,0.06249041],"genre_scores_gemma":[0.9886233,0.00038601385,0.0001787806,0.00010303404,0.0007144136,0.00016526548,0.000047167465,0.000042722066,0.009739297],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989996,0.000016449198,0.00026793248,0.00037814592,0.00015508605,0.0001827685],"domain_scores_gemma":[0.9992759,0.000102961225,0.0000942451,0.00036681126,0.000058037785,0.00010201992],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000087440865,0.00023237237,0.0006054942,0.00012554017,0.000013132425,0.000008944737,0.0000934376,0.00027405345,0.0017553311],"category_scores_gemma":[0.00003392097,0.00019738154,0.0003540286,0.00009820346,0.00009106338,0.0000076986025,0.00034905685,0.00047197362,0.00020037715],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025700438,0.0048250305,0.027665885,0.043025427,0.01914718,0.0019184764,0.0035492657,0.00014205438,0.37853655,0.0021513165,0.41893876,0.09753],"study_design_scores_gemma":[0.0011150532,0.00020820423,0.0063456646,0.0015004915,0.0049956213,0.00009933459,0.00004846072,0.00021236713,0.97245985,0.0019528089,0.010666073,0.00039606838],"about_ca_topic_score_codex":0.000074886135,"about_ca_topic_score_gemma":0.0000032544694,"teacher_disagreement_score":0.5939233,"about_ca_system_score_codex":0.00012945314,"about_ca_system_score_gemma":0.00028344677,"threshold_uncertainty_score":0.9991572},"labels":[],"label_agreement":null},{"id":"W4403227546","doi":"10.1016/j.cjca.2024.08.059","title":"THERAPEUTIC RECHALLENGE WITH ANTI-ANGINAL AGENTS IN PATIENTS EXPERIENCING FLUOROPYRIMIDINE-INDUCED CARDIOTOXICITY (TRAFIC): A RETROSPECTIVE CHART REVIEW","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cardiotoxicity; Retrospective cohort study; Pharmacology; Oncology; Internal medicine; Intensive care medicine; Anesthesia; Chemotherapy","score_opus":0.04974458200963158,"score_gpt":0.32640631288086197,"score_spread":0.27666173087123036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403227546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95899487,0.03342402,0.000037372934,0.001622433,0.0011530877,0.00054709334,0.000018473227,0.000013310717,0.004189375],"genre_scores_gemma":[0.99482,0.003740633,0.00001979115,0.00065804215,0.0006595112,0.000021577494,0.000009379895,0.000028008522,0.00004303849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998592,0.00018164405,0.00037695895,0.00025027283,0.00018307997,0.00041600916],"domain_scores_gemma":[0.99911654,0.000037530153,0.000098198296,0.00016091263,0.00019345681,0.00039336822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038588714,0.0002021924,0.0009243816,0.00041242247,0.0000524838,0.000012797455,0.00010649537,0.00012731725,0.00011831085],"category_scores_gemma":[0.000035142537,0.00015279069,0.0002454295,0.00030280548,0.00008262736,0.00009724667,0.000007431687,0.0005274628,0.000010271662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008113517,0.00006840387,0.9116136,0.0012950194,0.0042143655,0.013422183,0.0048274836,0.00011224015,0.0023933926,0.0001935517,0.025559196,0.03548924],"study_design_scores_gemma":[0.0049760696,0.005911436,0.8861289,0.0039214133,0.0014958469,0.0028431793,0.00037086967,0.000023608836,0.0010270781,0.00005235627,0.0928105,0.0004387209],"about_ca_topic_score_codex":0.00029016013,"about_ca_topic_score_gemma":0.0004950061,"teacher_disagreement_score":0.0672513,"about_ca_system_score_codex":0.0011859426,"about_ca_system_score_gemma":0.0013966232,"threshold_uncertainty_score":0.6230623},"labels":[],"label_agreement":null},{"id":"W4403302620","doi":"10.21203/rs.3.rs-4888430/v1","title":"Patient-reported Strategies for Prevention and Treatment of Chemotherapy- induced Peripheral Neuropathy","year":2024,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Peripheral neuropathy; Chemotherapy-induced peripheral neuropathy; Medicine; Chemotherapy; Peripheral; Intensive care medicine; Oncology; Physical medicine and rehabilitation; Internal medicine; Endocrinology; Diabetes mellitus","score_opus":0.12186299430374842,"score_gpt":0.46838301937153787,"score_spread":0.34652002506778945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403302620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896788,0.004273533,0.000009473354,0.0008744181,0.00028160663,0.0037819818,0.00008642564,0.000048080205,0.0009656971],"genre_scores_gemma":[0.9947185,0.0018366126,0.00012959857,0.000015980868,0.0002809486,0.00118863,0.0002306254,0.000047871665,0.001551216],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9984287,0.00013508822,0.00031625642,0.00048546915,0.00033858878,0.000295907],"domain_scores_gemma":[0.99906874,0.00010263518,0.00009633795,0.00028722777,0.00032829694,0.00011676155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016690753,0.00021892505,0.00045551156,0.00026481503,0.00005774146,0.000053637978,0.00004189538,0.00020165663,0.00013950643],"category_scores_gemma":[0.000020475472,0.00017107779,0.00021878486,0.00014854793,0.00009552806,0.00002541922,0.00011999721,0.0003322516,0.000001923382],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012974975,0.0071490705,0.012959372,0.015623784,0.004738161,0.0007295802,0.024474774,0.000050910097,0.16386433,0.00082006975,0.0043038083,0.75231117],"study_design_scores_gemma":[0.072464295,0.3058683,0.171386,0.012157207,0.0064952946,0.00050930335,0.02228103,0.00842427,0.213088,0.09067483,0.094011985,0.0026394755],"about_ca_topic_score_codex":0.00030117785,"about_ca_topic_score_gemma":0.00005839653,"teacher_disagreement_score":0.7496717,"about_ca_system_score_codex":0.00033235084,"about_ca_system_score_gemma":0.0009208024,"threshold_uncertainty_score":0.69763494},"labels":[],"label_agreement":null},{"id":"W4403420038","doi":"10.1016/j.jtho.2024.09.094","title":"MA01.07 Long-Term Analysis of NRG-LU001, Randomized Phase II Trial of Concurrent Chemoradiotherapy (ccrt) -/+ Metformin in Locally Advanced NSCLC.","year":2024,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Metformin; Oncology; Chemoradiotherapy; Internal medicine; Term (time); Phases of clinical research; Clinical trial; Overall survival; Astronomy","score_opus":0.03301604970201223,"score_gpt":0.49432315396629145,"score_spread":0.46130710426427923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403420038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97741175,0.016149295,0.0013396912,0.0014257733,0.0020042874,0.0010447203,0.000026966285,0.000012025349,0.0005855166],"genre_scores_gemma":[0.9933346,0.004573379,0.00087391125,0.00016140571,0.00046119024,0.000041394127,0.000030517065,0.000024169238,0.0004994443],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966678,0.0004925245,0.001934715,0.00023898197,0.00038428736,0.0002817006],"domain_scores_gemma":[0.9971543,0.0010151648,0.0011677992,0.0001920684,0.00029143892,0.000179259],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022034687,0.00024963787,0.00358698,0.0014620099,0.000023542176,0.0000070833466,0.00018769021,0.00022811472,0.0015014231],"category_scores_gemma":[0.00017527604,0.000178871,0.0012154557,0.0010791788,0.00029776327,0.00013626768,0.000029765155,0.00048887904,0.000002497964],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6132578,0.004615423,0.0001947118,0.00021621193,0.006783899,0.00084583357,0.0008995233,0.00007682095,0.0150561845,0.00002942388,0.0003212928,0.35770285],"study_design_scores_gemma":[0.92278224,0.02601755,0.00027118716,0.000545134,0.021012682,0.00038180492,0.00011671708,0.0019938122,0.021569934,0.00006620315,0.0050400035,0.00020272234],"about_ca_topic_score_codex":0.00002105447,"about_ca_topic_score_gemma":0.000066763685,"teacher_disagreement_score":0.35750014,"about_ca_system_score_codex":0.0005872313,"about_ca_system_score_gemma":0.0011238541,"threshold_uncertainty_score":0.99941134},"labels":[],"label_agreement":null},{"id":"W4403461604","doi":"10.6004/jnccn.2024.7028","title":"Sympathetic Blockade for Pain Associated With Nonaxial Bone Lesions in Patients With Cancer: An Uncontrolled Cohort","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cohort; Retrospective cohort study; Blockade; Cancer; Visual analogue scale; Cancer pain; Multimodal therapy; Anesthesia; Internal medicine; Surgery","score_opus":0.023184458604149603,"score_gpt":0.3193258889044194,"score_spread":0.2961414303002698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403461604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98677176,0.006342406,0.00006221334,0.0042796307,0.0011133595,0.001225532,0.00013303295,0.000016329623,0.000055740296],"genre_scores_gemma":[0.99587995,0.00017958508,0.00011780781,0.0018635866,0.0014289715,0.00015327969,0.000033410037,0.00003140401,0.00031201774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984388,0.00017996899,0.00036434442,0.00017739699,0.00059794314,0.00024155401],"domain_scores_gemma":[0.9975478,0.0006269193,0.0002924859,0.000064971195,0.0013652395,0.00010255848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000329775,0.00017541583,0.0004664901,0.00012297687,0.000116415875,0.000022667571,0.00010430496,0.000071271104,0.00008004554],"category_scores_gemma":[0.00005136016,0.00009817444,0.00014998108,0.0004500545,0.000070122325,0.00008720012,0.000015206838,0.0003417282,3.3582953e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014561198,0.0012315656,0.7186147,0.00010983843,0.00490682,0.000064981476,0.00052670715,0.20101018,0.00026178945,0.00013301277,0.051004913,0.007574268],"study_design_scores_gemma":[0.027809914,0.004412937,0.9275929,0.0029278523,0.0021458147,0.000035561043,0.00004849496,0.012623529,0.00005281664,0.0006910987,0.021356005,0.0003031294],"about_ca_topic_score_codex":0.000041328185,"about_ca_topic_score_gemma":0.00047709857,"teacher_disagreement_score":0.20897813,"about_ca_system_score_codex":0.001042241,"about_ca_system_score_gemma":0.0010308446,"threshold_uncertainty_score":0.40034375},"labels":[],"label_agreement":null},{"id":"W4403566765","doi":"10.1007/s12325-024-02985-9","title":"Differences Between Intravenous and Subcutaneous Modes of Administration in Oncology from the Patient, Healthcare Provider, and Healthcare System Perspectives: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Advances in Therapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Health care; Rheumatology; Administration (probate law); Internal medicine; Intensive care medicine","score_opus":0.06060773984211042,"score_gpt":0.4284270474126201,"score_spread":0.3678193075705097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403566765","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022147663,0.9899502,9.975537e-7,0.0012225135,0.000118008735,0.006235696,0.0002104768,0.000021975502,0.000025394838],"genre_scores_gemma":[0.117311895,0.8813689,0.000028162884,0.00013822752,0.00008574208,0.0009618715,0.000073333795,0.000025317582,0.0000065737154],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9971824,0.0009024972,0.0010612649,0.00048135294,0.00016577072,0.00020670216],"domain_scores_gemma":[0.99803114,0.0010296853,0.00056745386,0.00024300902,0.000057354257,0.00007137233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025610364,0.00035850418,0.0031840121,0.00012721264,0.000038389306,0.000012564379,0.00011136641,0.00020022968,0.0000034009352],"category_scores_gemma":[0.000035037985,0.00019683778,0.00012022029,0.0002775333,0.0001447079,0.000056619618,0.000027594942,0.0004485498,8.393446e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010181497,0.00007605362,0.0002771138,0.62824565,0.00020253299,0.0001132989,0.0028544147,1.8562304e-8,1.5313677e-7,0.00021145558,0.0000032716212,0.36791423],"study_design_scores_gemma":[0.0008803297,0.0062894523,0.00004505236,0.96880364,0.0025780075,0.0005858176,0.006373858,0.0000064902056,0.0000011291519,0.00032992486,0.013827269,0.0002790467],"about_ca_topic_score_codex":0.00064452796,"about_ca_topic_score_gemma":0.0014895273,"teacher_disagreement_score":0.3676352,"about_ca_system_score_codex":0.0005131879,"about_ca_system_score_gemma":0.0005600327,"threshold_uncertainty_score":0.80268115},"labels":[],"label_agreement":null},{"id":"W4403915835","doi":"10.1093/9780198925330.003.0006","title":"Diophantine Problems","year":2024,"lang":"en","type":"book-chapter","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mathematics; Computer science","score_opus":0.03175583290706256,"score_gpt":0.30715707152249255,"score_spread":0.27540123861543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403915835","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021343207,0.008612675,0.000002160578,0.0022135554,0.0006929742,0.00041258725,0.000019242016,0.00017239718,0.98785305],"genre_scores_gemma":[0.0010729975,0.0015375653,0.000044799664,0.0006636823,0.00092795875,0.000019110872,0.00013127485,0.00006072818,0.9955419],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993782,8.1268774e-7,0.00014930434,0.00024377227,0.00011037858,0.00011751541],"domain_scores_gemma":[0.99971384,0.000012309805,0.000028534865,0.00013779226,0.000029313842,0.00007820106],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000023814157,0.00019665985,0.00032033343,0.000103810075,0.000012203862,0.0000076175756,0.000030160789,0.00017378981,0.025070002],"category_scores_gemma":[6.2350784e-7,0.00013865739,0.00016077881,0.0000133158155,0.000036936864,0.000009347236,0.000033420325,0.00024120792,0.0037425342],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018331257,0.00010728248,0.0000393908,0.0013180266,0.0019604126,0.0013738201,0.000081246166,3.8399853e-7,0.0012760016,0.44430915,0.5365474,0.012803564],"study_design_scores_gemma":[0.000632831,0.00032999972,0.0000068890367,0.0002734209,0.000972734,0.00011733083,5.5647325e-7,0.0000062997115,0.00017965758,0.009437121,0.9879205,0.00012262638],"about_ca_topic_score_codex":0.000013912127,"about_ca_topic_score_gemma":0.000018618706,"teacher_disagreement_score":0.45137313,"about_ca_system_score_codex":0.00006411288,"about_ca_system_score_gemma":0.00007084849,"threshold_uncertainty_score":0.9970332},"labels":[],"label_agreement":null},{"id":"W4403966203","doi":"10.51731/cjht.2024.1015","title":"Epcoritamab (Epkinly)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.03514424862429699,"score_gpt":0.3569083070650617,"score_spread":0.3217640584407647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403966203","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13079892,0.6100553,0.00012860663,0.25308493,0.0027892352,0.00028857417,0.000022236396,0.0002878589,0.002544336],"genre_scores_gemma":[0.9965377,0.0018500909,0.00031118537,0.0007223465,0.00004811686,0.000003914642,0.000001957876,0.000011950813,0.0005127298],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99920034,0.000016726222,0.00030382336,0.00009192337,0.00007955986,0.00030761198],"domain_scores_gemma":[0.9996097,0.000039124065,0.000074650336,0.00010645154,0.00006697597,0.0001031018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024149405,0.000084615735,0.00026986457,0.00070065015,0.000082551705,0.000023024737,0.00010407436,0.000096670505,0.0001533035],"category_scores_gemma":[0.00007405889,0.00006448731,0.0000858453,0.00032699748,0.00012034611,0.000061686354,0.0000064161313,0.00040192297,0.000030057236],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021805874,0.000018660965,0.0031559924,0.00024137714,0.00013058148,0.002242108,0.00024029243,0.0000011461804,0.00009364895,0.0025628842,0.091326185,0.89996535],"study_design_scores_gemma":[0.00045060084,0.0010085718,0.0031410088,0.00036306694,0.00005365841,0.0019739137,0.00055401854,0.000011068857,0.0005151766,0.002431696,0.9894365,0.000060695183],"about_ca_topic_score_codex":0.0019295575,"about_ca_topic_score_gemma":0.0015699591,"teacher_disagreement_score":0.8999046,"about_ca_system_score_codex":0.0006005405,"about_ca_system_score_gemma":0.004730148,"threshold_uncertainty_score":0.83910793},"labels":[],"label_agreement":null},{"id":"W4404073942","doi":"10.1038/s41525-024-00443-7","title":"Genomic variations associated with risk and protection against vincristine-induced peripheral neuropathy in pediatric cancer patients","year":2024,"lang":"en","type":"article","venue":"npj Genomic Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Children's Hospital of Eastern Ontario; Centre Hospitalier Universitaire Sainte-Justine; London Health Sciences Centre; Alberta Children's Hospital; Hospital for Sick Children; University of British Columbia; Stollery Children's Hospital; BC Children's Hospital; Health Sciences Centre","funders":"Canadian Institutes of Health Research; Health Canada; University of British Columbia; Centers for Disease Control and Prevention; Genome British Columbia; BC Children’s Hospital Foundation; Michael Smith Health Research BC; BC Children's Hospital; Provincial Health Services Authority; Genome Canada; International Association for the Study of Pain; Government of Canada; Children's Hospital Foundation; U.S. Department of Health and Human Services","keywords":"Peripheral neuropathy; Medicine; Vincristine; Cancer; Internal medicine; Oncology; Genetics; Bioinformatics; Chemotherapy; Biology; Endocrinology; Diabetes mellitus; Cyclophosphamide","score_opus":0.018750058743133857,"score_gpt":0.28043040614022746,"score_spread":0.2616803473970936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404073942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940337,0.0021695683,0.000048008653,0.0010722374,0.0007744454,0.0010771197,0.00004078283,0.00009443855,0.0006896784],"genre_scores_gemma":[0.9959119,0.001846346,0.000023962828,0.0003775705,0.00095286034,0.00021193318,0.0000913443,0.00004741596,0.0005366996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867666,0.000116377574,0.00033515607,0.0004216345,0.00017830532,0.00027187067],"domain_scores_gemma":[0.9994536,0.000087464505,0.00011867349,0.00012139102,0.00007579256,0.0001431011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023177551,0.00022175112,0.0003612852,0.00030988254,0.00009306756,0.000014024308,0.000047169593,0.000095563075,0.00026817856],"category_scores_gemma":[0.00009744845,0.00016497057,0.00003258439,0.00045713823,0.000052117048,0.000052554024,0.000025331723,0.00040960396,0.000013456741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076149893,0.00043112086,0.92268765,0.0002530666,0.00029235016,0.00021464613,0.003419833,0.00008827905,0.04866736,0.000013512284,0.0014380721,0.021732604],"study_design_scores_gemma":[0.0069331927,0.0017421226,0.9844787,0.00016524406,0.0008747932,0.000014514115,0.000037215636,0.0042824857,0.000060807422,0.000021931246,0.001217007,0.00017196749],"about_ca_topic_score_codex":0.0011630349,"about_ca_topic_score_gemma":0.000809875,"teacher_disagreement_score":0.06179106,"about_ca_system_score_codex":0.0007064934,"about_ca_system_score_gemma":0.00028159318,"threshold_uncertainty_score":0.67273045},"labels":[],"label_agreement":null},{"id":"W4404183409","doi":"10.1136/jnnp-2024-abn.245","title":"Immune checkpoint inhibitor neurotoxicity clinic: a service evaluation","year":2024,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Neurotoxicity; Service (business); Computer science; Medicine; Business; Toxicity; Internal medicine","score_opus":0.07210992567287473,"score_gpt":0.4148161720280177,"score_spread":0.34270624635514296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404183409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9404127,0.0018967869,0.000021314076,0.016859358,0.0012782431,0.0010114976,0.0000042703764,0.00022471568,0.038291086],"genre_scores_gemma":[0.98865515,0.00006782982,0.000108290704,0.0021086961,0.0005471019,0.00014680941,0.000041208015,0.00001564997,0.008309273],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99920654,0.000044731874,0.00022123165,0.00021051127,0.00019292056,0.00012404288],"domain_scores_gemma":[0.9996196,0.00006494448,0.000020380396,0.00013263397,0.00009596579,0.00006645677],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00031166096,0.000091625785,0.00015318935,0.000062550585,0.000028545375,0.000017498824,0.000029439203,0.000056775014,0.012253266],"category_scores_gemma":[0.000023326369,0.00006865941,0.000093865274,0.00023707395,0.000014044849,0.000058960934,0.00002602432,0.00014914079,0.0012365663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012433976,0.0013448785,0.003401318,0.0008867598,0.0005997279,0.0001760673,0.001783467,0.000010723339,0.8400621,0.00017502066,0.058018304,0.09229827],"study_design_scores_gemma":[0.011204585,0.0029580127,0.055087857,0.00045140454,0.0027406297,0.00023715559,0.00028172325,0.0747771,0.62903565,0.00083147705,0.2219235,0.00047093275],"about_ca_topic_score_codex":0.00011589523,"about_ca_topic_score_gemma":0.0000573565,"teacher_disagreement_score":0.21102643,"about_ca_system_score_codex":0.00011284555,"about_ca_system_score_gemma":0.00021147814,"threshold_uncertainty_score":0.9995411},"labels":[],"label_agreement":null},{"id":"W4404230732","doi":"10.1093/neuonc/noae165.0956","title":"EXTH-25. OPTIMIZATION OF NEW CHEMOTHERAPEUTIC AGENTS BY INTRA-ARTERIAL INFUSION IN GLIOBLASTOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Pharmacology; Chemotherapeutic drugs; Cancer research; Internal medicine; Chemotherapy","score_opus":0.025620880079863576,"score_gpt":0.3435177750892911,"score_spread":0.3178968950094275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98381937,0.00093024096,0.00051501975,0.007421059,0.0026016743,0.0006962076,0.000013853748,0.00009993906,0.0039026188],"genre_scores_gemma":[0.9947598,0.00091206544,0.00039437844,0.0027745334,0.0005195531,0.000034188393,0.00006237861,0.00003761009,0.0005054709],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990179,0.00008470571,0.00030980812,0.00027007566,0.00011278767,0.00020475304],"domain_scores_gemma":[0.9995719,0.00012731928,0.00006252182,0.0001159841,0.000023951172,0.00009831284],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007486301,0.0001387898,0.0003381351,0.0001939648,0.000015852527,0.000007789869,0.0000635346,0.00017807884,0.0023327796],"category_scores_gemma":[0.000019060943,0.00012766453,0.00006272405,0.0002957694,0.000057359284,0.000060289654,0.000031348027,0.00019536423,0.000036509602],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015446325,0.00057182886,0.00064466824,0.00007944997,0.000071021335,0.00017699318,0.001195999,0.00025998912,0.86732,0.000025684662,0.054606643,0.0735031],"study_design_scores_gemma":[0.01362872,0.008172602,0.0013519255,0.00010775496,0.00042340354,0.00025987084,0.000060198992,0.014228654,0.15630277,0.000116104435,0.80511993,0.00022809362],"about_ca_topic_score_codex":0.00009569407,"about_ca_topic_score_gemma":0.000051789586,"teacher_disagreement_score":0.75051326,"about_ca_system_score_codex":0.00023639936,"about_ca_system_score_gemma":0.00035140404,"threshold_uncertainty_score":0.9985792},"labels":[],"label_agreement":null},{"id":"W4404363416","doi":"10.1161/circ.150.suppl_1.4141117","title":"Abstract 4141117: Semaglutide and cardiovascular outcomes by blood pressure in the SELECT trial","year":2024,"lang":"en","type":"article","venue":"Circulation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Semaglutide; Blood pressure; Cardiology; Internal medicine; Diabetes mellitus; Type 2 diabetes; Endocrinology; Liraglutide","score_opus":0.021216265972904984,"score_gpt":0.30678456023898193,"score_spread":0.28556829426607694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404363416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.961108,0.036014434,0.000011936861,0.0009590284,0.00021272454,0.00065321353,0.000008054093,0.000037584916,0.0009950208],"genre_scores_gemma":[0.9993172,0.00015428921,0.000005870229,0.00014875864,0.00017881853,0.000050929415,0.000038150178,0.000008580274,0.00009739359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943507,0.000043510292,0.00011408026,0.00016491936,0.00014762447,0.00009479239],"domain_scores_gemma":[0.9997408,0.00009807894,0.000012208344,0.00011592066,0.00001087892,0.000022104974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002518906,0.000075237265,0.00016750998,0.000048134607,0.000027858123,0.000024478064,0.000022947199,0.000054990585,0.000069099115],"category_scores_gemma":[0.000018113495,0.00005006815,0.0001077608,0.00011617136,0.000016872853,0.00003905697,0.000004414443,0.00011527621,0.0000061106125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004930329,0.0014200576,0.81129414,0.0013075703,0.015002352,0.00074226514,0.005742299,0.0011333647,0.031606305,0.00056598114,0.045000825,0.08125451],"study_design_scores_gemma":[0.027634677,0.00014955777,0.9063346,0.00005689355,0.00444368,0.00008605653,0.000045809094,0.000810585,0.0005235914,0.00016807308,0.05961587,0.0001306386],"about_ca_topic_score_codex":0.00012270026,"about_ca_topic_score_gemma":0.00001024006,"teacher_disagreement_score":0.09504043,"about_ca_system_score_codex":0.000013326078,"about_ca_system_score_gemma":0.00003652643,"threshold_uncertainty_score":0.20417199},"labels":[],"label_agreement":null},{"id":"W4405047039","doi":"10.1182/blood-2024-210101","title":"Performance Status, Cancer-Associated Thrombosis, and Bleeding: A Post-Hoc Analysis of the Avert Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Performance status; Deep vein; Pulmonary embolism; Cancer; Confidence interval; Thrombosis; Surgery","score_opus":0.029107800812314795,"score_gpt":0.3362708158909196,"score_spread":0.30716301507860483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99375945,0.003580042,8.044427e-8,0.001051542,0.00036946047,0.00029736507,0.000104545165,0.00003288891,0.0008045964],"genre_scores_gemma":[0.99488014,0.004123382,0.0000063415528,0.00015675217,0.0001236569,0.000036053534,0.000029643483,0.0000095089645,0.0006345468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934715,0.000023910732,0.00015774599,0.00015987239,0.00014723247,0.00016410829],"domain_scores_gemma":[0.9996795,0.00006349624,0.000050004455,0.000100956415,0.000052342228,0.00005369381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008982654,0.00009130378,0.00029567778,0.00012112545,0.000049023398,0.0000115624425,0.00004202461,0.000055797438,0.00032260414],"category_scores_gemma":[0.000012435303,0.00005780054,0.00014244854,0.0007059794,0.00005554225,0.000036856563,0.000029906141,0.000105450745,0.000001630259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008389562,0.0023098253,0.8920532,0.00037632964,0.03563418,0.00001376975,0.004027982,0.000015904183,0.048469972,0.0001002411,0.0039191525,0.0046899035],"study_design_scores_gemma":[0.06612387,0.0038961943,0.8434731,0.00027440776,0.06416371,0.0000050394215,0.00013677892,0.0027182898,0.011689022,0.000008897644,0.007308176,0.00020253102],"about_ca_topic_score_codex":0.00047817957,"about_ca_topic_score_gemma":0.00033277704,"teacher_disagreement_score":0.05773431,"about_ca_system_score_codex":0.0000630631,"about_ca_system_score_gemma":0.0001977039,"threshold_uncertainty_score":0.35322893},"labels":[],"label_agreement":null},{"id":"W4405107591","doi":"10.3390/curroncol31120577","title":"Peripheral Neuropathy Instruments for Individuals with Cancer: A COSMIN-Based Systematic Review of Measurement Properties","year":2024,"lang":"en","type":"review","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Systematic review; Radiation therapy; Quality of life (healthcare); Cancer; Physical therapy; MEDLINE; Medical physics; Intensive care medicine; Oncology; Physical medicine and rehabilitation; Internal medicine","score_opus":0.36920949434097494,"score_gpt":0.4725893028435873,"score_spread":0.10337980850261236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405107591","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001687185,0.982947,0.000008123893,0.00031188445,0.0019153183,0.014358371,0.00030534025,0.000051947503,0.00008515434],"genre_scores_gemma":[0.000052173036,0.9812083,0.000052473755,0.00034350596,0.00025967997,0.017666971,0.00019787822,0.000088618945,0.00013035002],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99672616,0.0004643724,0.0013363151,0.0005588873,0.00053542026,0.0003788605],"domain_scores_gemma":[0.9980129,0.00007728795,0.00095574267,0.00036969272,0.00043250716,0.00015189683],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066828827,0.00061792583,0.00526717,0.00024870265,0.00004549636,0.000012086412,0.0002263788,0.00018049931,0.00009047156],"category_scores_gemma":[0.00012031609,0.00034298265,0.00072240893,0.0003470663,0.00014819106,0.000024663874,0.000055748824,0.00042172745,0.000015428423],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008853619,0.00074246386,0.000023187416,0.80066144,0.0014795212,0.000013723572,0.000057652982,8.910599e-8,7.9517855e-7,0.00000564007,0.004113184,0.19281377],"study_design_scores_gemma":[0.0011250486,0.001849902,2.9865376e-7,0.48980445,0.035880506,0.00004936254,0.000004894347,0.0000060477155,0.0000032313637,7.3061494e-7,0.47112998,0.00014555897],"about_ca_topic_score_codex":0.000009763237,"about_ca_topic_score_gemma":0.000015367865,"teacher_disagreement_score":0.4670168,"about_ca_system_score_codex":0.0018022172,"about_ca_system_score_gemma":0.004835919,"threshold_uncertainty_score":0.99990225},"labels":[],"label_agreement":null},{"id":"W4405133624","doi":"","title":"Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification","year":2019,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Capsaicin; Peripheral neuropathy; Medicine; Pain relief; Peripheral; Disease; Chemotherapy-induced peripheral neuropathy; Chemotherapy; Anesthesia; Internal medicine; Endocrinology","score_opus":0.20080068029625364,"score_gpt":0.5229844981380706,"score_spread":0.32218381784181693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405133624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914535,0.00491879,0.00009639767,0.0010898277,0.00028404422,0.0012282128,0.00011972072,0.000024359713,0.0007851297],"genre_scores_gemma":[0.993714,0.0041724737,0.0001470835,0.00065498066,0.00026606288,0.00007849677,0.00019880178,0.00005241192,0.0007157067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979488,0.00029235892,0.0005628179,0.00043478239,0.0005271395,0.00023407447],"domain_scores_gemma":[0.9982641,0.00017124199,0.00056753994,0.0004385907,0.0002640893,0.0002944433],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031593238,0.0003109815,0.0007766178,0.0002614039,0.00007575976,0.00011737186,0.0004134012,0.000071883194,0.012482133],"category_scores_gemma":[0.000035021956,0.00023004998,0.00018945833,0.00036053944,0.00006996776,0.0004963905,0.000055700464,0.00014237697,0.000009540473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061298064,0.0019182529,0.7133074,0.00006001877,0.00050690887,0.00005740531,0.00060307694,0.00017567606,0.24660686,0.00001198444,0.0023866568,0.02823596],"study_design_scores_gemma":[0.006057655,0.0004649778,0.9279262,0.00019615455,0.00039503782,0.000005834033,0.000062305524,0.0008458408,0.06038702,0.00023755382,0.0031806552,0.000240773],"about_ca_topic_score_codex":0.003532693,"about_ca_topic_score_gemma":0.000058076024,"teacher_disagreement_score":0.21461879,"about_ca_system_score_codex":0.00029077643,"about_ca_system_score_gemma":0.0004992337,"threshold_uncertainty_score":0.9884206},"labels":[],"label_agreement":null},{"id":"W4405182261","doi":"10.1158/1538-8514.cancerchem24-a019","title":"Abstract A019: Discovery of a potent and brain-penetrable tubulin inhibitor SB-216 that shows efficacy in primary tumor growth and brain metastasis","year":2024,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Taxane; Medicine; Brain metastasis; Prostate cancer; Cancer; Breast cancer; Cancer research; Metastasis; Ovarian cancer; Pharmacology; Metastatic breast cancer; Internal medicine","score_opus":0.024585093130380844,"score_gpt":0.3082285957801095,"score_spread":0.2836435026497287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405182261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92651814,0.062483404,0.000103166305,0.009407098,0.00023146412,0.0006326097,0.00010647327,0.00003547128,0.00048214992],"genre_scores_gemma":[0.9906483,0.0029467945,0.00017648134,0.0057148566,0.00009044866,0.00006777164,0.0000318778,0.000055466146,0.00026797372],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986388,0.00006801676,0.00029820873,0.0004316606,0.00025488442,0.0003084001],"domain_scores_gemma":[0.9994046,0.00021847639,0.00006837814,0.00017914208,0.000026877218,0.00010250636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001918122,0.00027049103,0.0004755574,0.00019798633,0.000032145093,0.000057617875,0.00006994868,0.00008533524,0.000054232773],"category_scores_gemma":[0.000009517095,0.0002272362,0.00012122714,0.00024790427,0.00014564791,0.0001253957,0.00005757051,0.00027847555,0.0000013792541],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011173015,0.0006187191,0.0074503105,0.0013963241,0.0013201704,0.001002151,0.00094994775,0.00003073824,0.92998177,0.00024079008,0.0007284359,0.055163354],"study_design_scores_gemma":[0.0106568765,0.001280039,0.12551771,0.0011828342,0.001898837,0.00021337907,0.00019531228,0.00035180192,0.8400949,0.0005438122,0.017361527,0.00070292776],"about_ca_topic_score_codex":0.00034941497,"about_ca_topic_score_gemma":0.000085873835,"teacher_disagreement_score":0.1180674,"about_ca_system_score_codex":0.00017288857,"about_ca_system_score_gemma":0.00029152367,"threshold_uncertainty_score":0.92664236},"labels":[],"label_agreement":null},{"id":"W4405321781","doi":"10.30683/1927-7229.2024.13.09","title":"The Relief of Nociceptive Pain Induced by Panitumumab Could be Sustainable during Chemotherapy","year":2024,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Panitumumab; Colorectal cancer; Analgesic; Chemotherapy; Nociception; Epidermal growth factor receptor; Cancer; Cancer pain; Internal medicine; Oncology; Cetuximab; Pharmacology; Receptor","score_opus":0.021294008650601496,"score_gpt":0.3750127701912288,"score_spread":0.3537187615406273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405321781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92044866,0.0032715641,0.000095603005,0.06780364,0.0003651047,0.0002472763,0.000004333473,0.00001599765,0.0077478173],"genre_scores_gemma":[0.9886423,0.001463348,0.00006136268,0.0013776156,0.00044872452,0.0000045796864,0.000001941097,0.000018347462,0.007981823],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986008,0.00018310461,0.000545855,0.00012448743,0.00024309801,0.0003026922],"domain_scores_gemma":[0.9981524,0.0010659848,0.0002095495,0.00010063665,0.00031478246,0.00015669207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011360737,0.00012332639,0.00052636064,0.00013830837,0.00007663944,0.000017001235,0.00011399653,0.00017008383,0.0004317586],"category_scores_gemma":[0.0002219746,0.00007375188,0.0002510629,0.00028803604,0.00018386,0.00006709581,0.000025983845,0.0006059824,0.000004564079],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022309646,0.00536737,0.0029969371,0.0009248732,0.009902913,0.007494248,0.005182056,0.000022484852,0.20958184,0.0115929535,0.6615835,0.06304122],"study_design_scores_gemma":[0.009429109,0.023413477,0.003715969,0.0001720115,0.0017602973,0.0008549625,0.004370223,0.001138516,0.014827018,0.0012640958,0.9388529,0.0002013895],"about_ca_topic_score_codex":0.000040304076,"about_ca_topic_score_gemma":0.000009008487,"teacher_disagreement_score":0.27726945,"about_ca_system_score_codex":0.00072951947,"about_ca_system_score_gemma":0.00077978487,"threshold_uncertainty_score":0.47274542},"labels":[],"label_agreement":null},{"id":"W4405736154","doi":"10.3390/jpm15010002","title":"Personalized Risk Assessment for Taxane-Induced Hypersensitivity Reactions: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Journal of Personalized Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Taxane; Risk assessment; Bioinformatics; Oncology; Intensive care medicine; Internal medicine; Computer science; Cancer; Biology; Computer security; Breast cancer","score_opus":0.20605221238580662,"score_gpt":0.4988666928121446,"score_spread":0.29281448042633795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405736154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002507605,0.9878305,0.00016839131,0.0059047793,0.000369999,0.0051272307,0.00030497825,0.000029573088,0.00026200805],"genre_scores_gemma":[0.0000138604255,0.98770493,0.000977354,0.0014050603,0.00069310964,0.0007212785,0.00013622141,0.00009067831,0.008257532],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9940335,0.0011961033,0.0028340428,0.00061170635,0.0009512913,0.0003733634],"domain_scores_gemma":[0.99235857,0.001821352,0.0040280744,0.00044885627,0.00083368487,0.0005094953],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0045994376,0.0009146362,0.021434354,0.001301474,0.00013186788,0.000032199918,0.0001645331,0.00032967702,0.0011591632],"category_scores_gemma":[0.0011938781,0.00046480566,0.00859362,0.0012354743,0.00024146249,0.000103562066,0.000039518985,0.0013096717,0.000009459566],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077178884,0.00014270423,2.606016e-7,0.59413785,0.39848834,0.00031805708,0.00013856924,2.702371e-8,0.0000051165866,0.00005471812,0.0048480863,0.001789105],"study_design_scores_gemma":[0.0017622502,0.00085401675,3.241108e-7,0.07654892,0.63391376,0.0033595022,0.00014986447,0.000008165784,1.4413651e-7,0.000017989896,0.28318176,0.00020330546],"about_ca_topic_score_codex":0.00006567502,"about_ca_topic_score_gemma":0.000011295107,"teacher_disagreement_score":0.5175889,"about_ca_system_score_codex":0.00072622177,"about_ca_system_score_gemma":0.0010190861,"threshold_uncertainty_score":0.99978036},"labels":[],"label_agreement":null},{"id":"W4406416874","doi":"10.1016/s0246-1064(19)30188-4","title":"10.1016/s0246-1064(19)30188-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.011410983651304779,"score_gpt":0.24813887476696986,"score_spread":0.23672789111566508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406416874","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017595164,0.0002993328,1.4952667e-7,0.0020001167,0.0000035484911,0.00029807034,0.0000141947885,0.00011991249,0.99550515],"genre_scores_gemma":[0.00047358638,0.0000022522195,0.00006656307,0.0004388851,0.00039458225,0.000041368206,0.000042222542,0.000021639642,0.9985189],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993077,0.000020245778,0.00012555296,0.00019476115,0.00011593943,0.00023582528],"domain_scores_gemma":[0.9994895,0.000036292895,0.000015900965,0.00018478851,0.000025681782,0.00024783012],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000547087,0.00012244862,0.00020289914,0.00006476344,0.00004568919,0.00000849279,0.000065598695,0.000056139605,0.99949634],"category_scores_gemma":[0.0000073313863,0.00010743041,0.000069247886,0.00015224241,0.000029577328,0.000032174503,0.000015896994,0.00009321769,0.9946278],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005321296,0.0001422467,0.0000015223471,0.000008304003,0.000058638274,0.00004281049,0.00002409683,0.00000509727,0.00022415305,1.4619766e-7,0.77315074,0.2258101],"study_design_scores_gemma":[0.0015744711,0.0006636908,0.00014558318,0.000014803636,0.00015229112,0.000049396924,7.065819e-7,0.000031273066,0.0003898932,0.0000043010814,0.9968668,0.00010679341],"about_ca_topic_score_codex":0.000057627993,"about_ca_topic_score_gemma":3.8782002e-7,"teacher_disagreement_score":0.22570331,"about_ca_system_score_codex":0.00008617801,"about_ca_system_score_gemma":0.00006533436,"threshold_uncertainty_score":0.4380885},"labels":[],"label_agreement":null},{"id":"W4406418012","doi":"10.1016/s0029-7437(05)71319-7","title":"10.1016/s0029-7437(05)71319-7","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Tamoxifen; Internal medicine; Medicine; Breast cancer; Cancer","score_opus":0.010925323716180007,"score_gpt":0.24643326244259203,"score_spread":0.235507938726412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406418012","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036767076,0.00019572247,1.3150562e-7,0.0017353436,7.8570463e-7,0.00029576302,0.00001403763,0.00013302319,0.99394846],"genre_scores_gemma":[0.0004695049,0.0000016562335,0.000073517826,0.000364519,0.000389931,0.000040536703,0.000041678384,0.000022488059,0.9985962],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992979,0.000020416983,0.00012975371,0.00019443537,0.000115417955,0.00024203311],"domain_scores_gemma":[0.99953353,0.00003378889,0.00001666563,0.00018805785,0.000028334893,0.00019962982],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00005418022,0.0001253747,0.0002126522,0.00006180763,0.000043752145,0.0000083660125,0.000066387314,0.00005765789,0.9995409],"category_scores_gemma":[0.000007259668,0.00010998867,0.00007150754,0.00014980206,0.000028319972,0.0000330751,0.000015886435,0.000095423726,0.99503106],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050532655,0.00015388217,0.0000011828938,0.000007251746,0.000057575737,0.00003488846,0.00002007922,0.000004333293,0.00024665246,2.6837043e-7,0.79334766,0.20562087],"study_design_scores_gemma":[0.0015617955,0.00075515214,0.00015663399,0.000016397544,0.00015012769,0.000055865654,5.8273827e-7,0.00003928992,0.0005181713,0.0000035718842,0.9966337,0.00010872557],"about_ca_topic_score_codex":0.00004234407,"about_ca_topic_score_gemma":4.0946495e-7,"teacher_disagreement_score":0.20551215,"about_ca_system_score_codex":0.00007605972,"about_ca_system_score_gemma":0.000049079168,"threshold_uncertainty_score":0.44852078},"labels":[],"label_agreement":null},{"id":"W4406423789","doi":"10.1016/s1541-9800(06)71089-4","title":"10.1016/s1541-9800(06)71089-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Course (navigation); Engineering","score_opus":0.008990203248631074,"score_gpt":0.2357868402439816,"score_spread":0.22679663699535055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406423789","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044092806,0.00023094376,1.1436126e-7,0.0016180967,0.0000024927622,0.00029479375,0.000013999464,0.00011242456,0.99331784],"genre_scores_gemma":[0.00062152813,0.0000018830716,0.000055669898,0.0003560602,0.00037488606,0.000039120903,0.00005552972,0.000022234039,0.9984731],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930483,0.00002007339,0.00012666624,0.0001923706,0.00011665572,0.00023941795],"domain_scores_gemma":[0.99953777,0.000032241573,0.00001581928,0.00018613334,0.000028397575,0.00019964673],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000052403713,0.00012380052,0.00020862553,0.00006242853,0.00004281169,0.000008446238,0.000065659886,0.000057436115,0.9994286],"category_scores_gemma":[0.0000070739156,0.000108799,0.00007010552,0.00014893583,0.000027950036,0.000033348137,0.000015752114,0.00009498984,0.99615675],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042528415,0.00015341873,0.0000018960253,0.000007700459,0.00005948583,0.000036999536,0.000023142393,0.0000048166394,0.00029283002,2.546409e-7,0.6971661,0.30182806],"study_design_scores_gemma":[0.0015789462,0.00059824897,0.00019954919,0.000016352125,0.00014944823,0.000041509018,5.950468e-7,0.0000368359,0.00054484006,0.0000034997654,0.99672216,0.00010803182],"about_ca_topic_score_codex":0.000037982638,"about_ca_topic_score_gemma":3.12064e-7,"teacher_disagreement_score":0.30172002,"about_ca_system_score_codex":0.00007418644,"about_ca_system_score_gemma":0.00005259703,"threshold_uncertainty_score":0.44366947},"labels":[],"label_agreement":null},{"id":"W4406498593","doi":"10.1016/s0000-0000(06)47810-4","title":"10.1016/s0000-0000(06)47810-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Lamotrigine; Medicine; Epilepsy; Psychiatry","score_opus":0.008663809262238148,"score_gpt":0.23338828864041833,"score_spread":0.2247244793781802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406498593","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027813783,0.00030536065,1.319188e-7,0.0027644746,0.0000026207108,0.0003739413,0.000015986005,0.0001381557,0.99361795],"genre_scores_gemma":[0.00046410516,0.000003729472,0.00007003204,0.00035198143,0.0004838437,0.00004687717,0.0000578137,0.000025800859,0.9984958],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991899,0.000031432603,0.00013866005,0.00020776923,0.00014189842,0.00029031833],"domain_scores_gemma":[0.9994388,0.00004079528,0.000017119159,0.00020886173,0.00003637049,0.00025800167],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000763423,0.00013123083,0.00022195974,0.00007990718,0.00006731044,0.000012512682,0.000077410485,0.00007201227,0.999546],"category_scores_gemma":[0.00001100456,0.000121965146,0.00007541403,0.00016047645,0.000039609928,0.000040218267,0.000015650267,0.00010825305,0.995222],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043445255,0.00015608231,0.0000019843649,0.0000069062476,0.00005673177,0.000041210766,0.000032120657,0.000004170034,0.00014746265,5.035131e-7,0.5811255,0.41799286],"study_design_scores_gemma":[0.0015978127,0.0005267031,0.00016288538,0.000019828767,0.00015796495,0.0000328946,8.620149e-7,0.00001949025,0.00034689397,0.000003955509,0.9970105,0.00012018503],"about_ca_topic_score_codex":0.00007715893,"about_ca_topic_score_gemma":7.743634e-7,"teacher_disagreement_score":0.41787267,"about_ca_system_score_codex":0.0001130038,"about_ca_system_score_gemma":0.000097206714,"threshold_uncertainty_score":0.49735945},"labels":[],"label_agreement":null},{"id":"W4406521498","doi":"10.1016/s0029-7437(06)71491-4","title":"10.1016/s0029-7437(06)71491-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Disease; Breast cancer; Medicine; Oncology; Metastatic breast cancer; Internal medicine; Cancer","score_opus":0.01081559120924108,"score_gpt":0.2459003852081964,"score_spread":0.23508479399895532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406521498","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004082719,0.00021668569,1.2814523e-7,0.0014447768,3.5147212e-7,0.00029500911,0.000013898883,0.00012977606,0.9938167],"genre_scores_gemma":[0.000524359,0.0000018185074,0.000065563305,0.0003104704,0.00038344387,0.000040065748,0.000052567575,0.000022200375,0.9985995],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99931175,0.000019476978,0.00012618356,0.00019174052,0.00011487032,0.00023598553],"domain_scores_gemma":[0.99954414,0.000032193588,0.000016152697,0.00018520687,0.000028202221,0.00019412958],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000051228835,0.00012342923,0.00020732218,0.000061885185,0.000043137563,0.00000843125,0.000065400716,0.000057114812,0.99951184],"category_scores_gemma":[0.0000068290174,0.000108589804,0.00006986277,0.00014813415,0.00002785125,0.000033250122,0.000015705255,0.000094574934,0.9966714],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042939893,0.00016148345,0.0000019802208,0.000007791765,0.00006264963,0.000027598833,0.000022592225,0.000004448862,0.00029192702,2.7372192e-7,0.87316316,0.12582672],"study_design_scores_gemma":[0.0015200293,0.0006099123,0.00019342604,0.000016186492,0.00014910431,0.00004200227,5.626441e-7,0.000035940964,0.00048706814,0.0000033348724,0.99683464,0.000107803855],"about_ca_topic_score_codex":0.000034889137,"about_ca_topic_score_gemma":3.2479423e-7,"teacher_disagreement_score":0.1257189,"about_ca_system_score_codex":0.00007379535,"about_ca_system_score_gemma":0.000048885693,"threshold_uncertainty_score":0.44281638},"labels":[],"label_agreement":null},{"id":"W4406525024","doi":"10.1016/s0024-7804(97)85041-5","title":"10.1016/s0024-7804(97)85041-5","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.010604451534358317,"score_gpt":0.23589752661216534,"score_spread":0.22529307507780702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406525024","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022431095,0.00026943843,1.1001271e-7,0.0016087873,0.000003120283,0.0002923217,0.000014293862,0.00011030376,0.99545854],"genre_scores_gemma":[0.0004182458,0.0000018074829,0.000057298184,0.00033430886,0.0003830305,0.00004019709,0.00004085631,0.000021146385,0.9987031],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99931616,0.000019557658,0.00012493397,0.00019092472,0.00011452939,0.00023391208],"domain_scores_gemma":[0.9995476,0.000032230102,0.000015526848,0.00018397342,0.00002762148,0.00019302095],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000050660783,0.000122714,0.00020422672,0.00006220428,0.00004205186,0.000008526791,0.00006472299,0.000056118697,0.99958247],"category_scores_gemma":[0.000006861582,0.00010761921,0.00006960515,0.00014603374,0.000028171127,0.000032423097,0.000015303136,0.000094801406,0.9971816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004981123,0.00013917756,0.0000015981902,0.0000069728667,0.000058103822,0.000033581313,0.000016689613,0.0000032030503,0.00018925688,3.5870949e-7,0.49228665,0.5067663],"study_design_scores_gemma":[0.0015698199,0.0006893487,0.00012076864,0.000015888787,0.0001581364,0.000039283786,5.68841e-7,0.00003820733,0.00044591306,0.0000036970735,0.9968118,0.000106537605],"about_ca_topic_score_codex":0.000049627197,"about_ca_topic_score_gemma":4.2799024e-7,"teacher_disagreement_score":0.50665975,"about_ca_system_score_codex":0.000070925635,"about_ca_system_score_gemma":0.000046784982,"threshold_uncertainty_score":0.43885842},"labels":[],"label_agreement":null},{"id":"W4406543571","doi":"10.1016/s0024-7804(98)80004-3","title":"10.1016/s0024-7804(98)80004-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacology; Medicine","score_opus":0.008528636096497767,"score_gpt":0.23167398840472175,"score_spread":0.223145352308224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406543571","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033676175,0.0002191476,9.796563e-8,0.0018024622,0.0000030365968,0.0002857047,0.000012444523,0.000112438785,0.9941971],"genre_scores_gemma":[0.00061182736,0.0000015834707,0.00005912131,0.00032117873,0.00036748676,0.00003846204,0.000037327234,0.000021834596,0.9985412],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932766,0.000018939576,0.00012341715,0.0001878008,0.00011338002,0.00022879543],"domain_scores_gemma":[0.99955726,0.000030128216,0.000015174126,0.00018216047,0.000026908883,0.00018836444],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00004953598,0.00012040222,0.0002084709,0.00006132046,0.000040133018,0.000008385105,0.0000638359,0.000056502136,0.9996784],"category_scores_gemma":[0.0000063326725,0.00010578034,0.000069344664,0.00014568622,0.000027420154,0.000031832762,0.000015021325,0.00009338852,0.99586314],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004558105,0.00013182042,0.0000014738126,0.0000066544317,0.000057114747,0.000034376953,0.000016881615,0.0000031471382,0.0002061057,3.0851174e-7,0.6030414,0.39604488],"study_design_scores_gemma":[0.001437392,0.0005756384,0.00025438625,0.000016268901,0.00015538342,0.0000361443,4.640293e-7,0.000038284044,0.0005206304,0.0000045311526,0.9968557,0.00010519941],"about_ca_topic_score_codex":0.000055134195,"about_ca_topic_score_gemma":3.170791e-7,"teacher_disagreement_score":0.39593968,"about_ca_system_score_codex":0.00007469343,"about_ca_system_score_gemma":0.000049672144,"threshold_uncertainty_score":0.4313597},"labels":[],"label_agreement":null},{"id":"W4406544302","doi":"10.1016/s1553-3212(12)70130-9","title":"10.1016/s1553-3212(12)70130-9","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Drug; Dermatology; Psychiatry","score_opus":0.009539171293836832,"score_gpt":0.23262179708815348,"score_spread":0.22308262579431665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406544302","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004129021,0.00018239481,1.2091404e-7,0.0015193466,0.000003559416,0.00029887623,0.000012439506,0.00011198766,0.9937422],"genre_scores_gemma":[0.0005835467,0.0000018125786,0.000051120212,0.00034340672,0.00037676014,0.000040277755,0.000041268366,0.00002160711,0.9985402],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993109,0.00002148143,0.00012615712,0.00018942278,0.00011562884,0.00023642565],"domain_scores_gemma":[0.99954796,0.000030888605,0.000016284042,0.00018469477,0.000024453713,0.00019570753],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00005477642,0.00012316776,0.00020682109,0.00006170989,0.000042904114,0.000008523726,0.000065439686,0.000056339588,0.9994273],"category_scores_gemma":[0.0000066044454,0.00010815731,0.00006846541,0.00011730029,0.000027769378,0.00003486253,0.000015692496,0.000094199684,0.99390197],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055134675,0.00014194602,0.0000014531311,0.000007181738,0.000057463465,0.000038016868,0.00002134069,0.0000045549536,0.00023959833,2.3281504e-7,0.63545233,0.3634845],"study_design_scores_gemma":[0.001530845,0.00071141677,0.00024110865,0.00001531973,0.00014391361,0.00004135283,5.256255e-7,0.00003441397,0.00051568495,0.0000035857645,0.99665445,0.00010736536],"about_ca_topic_score_codex":0.000046203582,"about_ca_topic_score_gemma":6.200299e-7,"teacher_disagreement_score":0.36337715,"about_ca_system_score_codex":0.00007432943,"about_ca_system_score_gemma":0.000050252638,"threshold_uncertainty_score":0.4410527},"labels":[],"label_agreement":null},{"id":"W4406550127","doi":"10.1016/s1541-9800(05)70334-3","title":"10.1016/s1541-9800(05)70334-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Sciatica; Medicine; Radiology","score_opus":0.009126257941548064,"score_gpt":0.23611929952766114,"score_spread":0.22699304158611308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406550127","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004271851,0.00021263918,1.06936035e-7,0.0018200033,0.00000418003,0.0002942743,0.000014084786,0.00011296605,0.9932699],"genre_scores_gemma":[0.0006264075,0.0000017227441,0.00005959791,0.00039537292,0.00038334815,0.00003998659,0.000043850257,0.00002221813,0.9984275],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993084,0.000019894007,0.00012611732,0.00019164146,0.00011507308,0.0002388775],"domain_scores_gemma":[0.999542,0.00003146971,0.00001613446,0.00018598452,0.000028245186,0.00019616984],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00005148933,0.00012373272,0.00020801632,0.000062276704,0.000043181077,0.000008419113,0.00006562128,0.000057019017,0.9994125],"category_scores_gemma":[0.000006814389,0.00010853018,0.000069958056,0.00014714313,0.000028652195,0.000033389064,0.000015776503,0.00009389372,0.9944864],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004947795,0.00014017001,9.383883e-7,0.000006725881,0.000054263055,0.000045916495,0.000020218184,0.000003882267,0.0003571062,2.336072e-7,0.6311707,0.36770505],"study_design_scores_gemma":[0.0016218817,0.00076032965,0.00015703682,0.000016034664,0.0001507782,0.000055837616,5.660175e-7,0.000033558652,0.000785966,0.0000036992183,0.9963069,0.00010739059],"about_ca_topic_score_codex":0.000044535565,"about_ca_topic_score_gemma":3.304633e-7,"teacher_disagreement_score":0.36759767,"about_ca_system_score_codex":0.00007712602,"about_ca_system_score_gemma":0.000052243446,"threshold_uncertainty_score":0.44257322},"labels":[],"label_agreement":null},{"id":"W4406550251","doi":"10.1016/s1541-9800(05)70073-9","title":"10.1016/s1541-9800(05)70073-9","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science; Psychology; Medicine; Physical medicine and rehabilitation","score_opus":0.009141083813437286,"score_gpt":0.23713004757284734,"score_spread":0.22798896375941005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406550251","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003925304,0.00020049972,1.1675256e-7,0.0017363665,0.000004158675,0.00030579083,0.000013895998,0.00011242077,0.99370146],"genre_scores_gemma":[0.0006049508,0.0000015919405,0.00006109505,0.0004060321,0.00039035108,0.000041678828,0.000043532873,0.00002219042,0.9984286],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930537,0.000019600508,0.00012660779,0.00019152416,0.000116674506,0.00024021948],"domain_scores_gemma":[0.99953955,0.000032539057,0.000016178528,0.00018601619,0.000028365892,0.00019733471],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00005185593,0.00012358537,0.00020798633,0.00006285422,0.000042941407,0.000008529592,0.000065823406,0.00005732884,0.99944973],"category_scores_gemma":[0.000006852637,0.00010847518,0.00006988253,0.00014804737,0.000028308019,0.00003349148,0.000015756672,0.00009466525,0.99456507],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004942688,0.00014108805,0.0000010303689,0.0000066904777,0.00005305171,0.00004494851,0.000019906627,0.0000036731653,0.00027158033,2.4289383e-7,0.6358385,0.36312503],"study_design_scores_gemma":[0.0016142522,0.0007651913,0.0001734441,0.000016429773,0.00014648896,0.00005399145,5.8792097e-7,0.00003209922,0.0005892856,0.0000036631911,0.99649715,0.0001074189],"about_ca_topic_score_codex":0.000041937627,"about_ca_topic_score_gemma":3.9306624e-7,"teacher_disagreement_score":0.36301762,"about_ca_system_score_codex":0.000076058925,"about_ca_system_score_gemma":0.00005127788,"threshold_uncertainty_score":0.44234893},"labels":[],"label_agreement":null},{"id":"W4406552357","doi":"10.1016/s1553-3212(07)70199-1","title":"10.1016/s1553-3212(07)70199-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Drug; Medicine; Physical medicine and rehabilitation; Pharmacology","score_opus":0.008980656897264317,"score_gpt":0.23650032082382352,"score_spread":0.2275196639265592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406552357","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049987677,0.00022570157,1.1253789e-7,0.001551428,0.0000036652953,0.00029535705,0.000014193335,0.00011253815,0.9927982],"genre_scores_gemma":[0.0006772128,0.000001798254,0.00005695389,0.00035561097,0.00037947798,0.000038794453,0.0000445154,0.000022151475,0.99842346],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99931115,0.0000194304,0.00012574226,0.0001918693,0.00011569142,0.00023609531],"domain_scores_gemma":[0.99954593,0.00003233783,0.000016340155,0.00018579111,0.000027370603,0.00019222501],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000050936054,0.00012308932,0.00020843145,0.00005847454,0.000042280113,0.000008316848,0.00006530378,0.000056926387,0.99955255],"category_scores_gemma":[0.0000068211934,0.00010816573,0.00006856813,0.00013577698,0.000027562242,0.00003322173,0.000015656475,0.00009404004,0.99724877],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055445114,0.00015109606,0.0000012865504,0.000007441581,0.00005974096,0.000040894967,0.000023250996,0.000004649697,0.0002706093,2.4664598e-7,0.64526993,0.3536164],"study_design_scores_gemma":[0.0015342718,0.00069082476,0.00018749713,0.000015614407,0.00014678227,0.000043201853,6.000873e-7,0.000031617008,0.0005103211,0.0000031587167,0.9967286,0.00010750814],"about_ca_topic_score_codex":0.0000461201,"about_ca_topic_score_gemma":3.6516585e-7,"teacher_disagreement_score":0.35350886,"about_ca_system_score_codex":0.000074881245,"about_ca_system_score_gemma":0.000052966996,"threshold_uncertainty_score":0.44108707},"labels":[],"label_agreement":null},{"id":"W4406554405","doi":"10.1016/s1558-0164(12)70179-7","title":"10.1016/s1558-0164(12)70179-7","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.009783646173913746,"score_gpt":0.23374823914299583,"score_spread":0.22396459296908208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406554405","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031399834,0.00018100624,1.18111544e-7,0.0014617821,0.0000034958703,0.00029315887,0.000013013814,0.0001148599,0.9947926],"genre_scores_gemma":[0.0005459636,0.000001847634,0.000061714374,0.00031529364,0.00037278005,0.00003905832,0.000040480456,0.00002218962,0.99860066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930954,0.00001926595,0.00012540077,0.00019253853,0.000115874995,0.0002373963],"domain_scores_gemma":[0.99954456,0.000032452605,0.000016814332,0.00019075123,0.000024065032,0.00019133685],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000050838455,0.00012361971,0.00020768242,0.000061569575,0.000043781136,0.000008657992,0.000067814646,0.000055604993,0.999405],"category_scores_gemma":[0.000007162055,0.00010821903,0.00006966728,0.000111593916,0.0000282223,0.00003309087,0.00001618114,0.00009318958,0.99807984],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006855238,0.00015946086,4.4782055e-7,0.000008542161,0.0000694854,0.000048213322,0.000023996676,0.000005096474,0.00035795537,2.8341958e-7,0.84559983,0.15304117],"study_design_scores_gemma":[0.0015428626,0.000713844,0.00022343211,0.000016324566,0.00014582543,0.000042451986,5.526746e-7,0.000031049498,0.00055429054,0.0000033095625,0.99661785,0.00010822049],"about_ca_topic_score_codex":0.000043004547,"about_ca_topic_score_gemma":5.708263e-7,"teacher_disagreement_score":0.15293294,"about_ca_system_score_codex":0.00007566638,"about_ca_system_score_gemma":0.00005393109,"threshold_uncertainty_score":0.4413044},"labels":[],"label_agreement":null},{"id":"W4406617687","doi":"10.2147/jpr.s500717","title":"Efficacy of Transcutaneous Electrical Acupoint Stimulation on Modulating Upper Extremity Sympathetic Skin Response in Alleviating Cancer Survivors With Chemotherapy-Induced Peripheral Neuropathy: A Propensity Score-Matched Cohort Study","year":2025,"lang":"en","type":"article","venue":"Journal of Pain Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Medicine; Peripheral; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Propensity score matching; Chemotherapy; Cohort; Stimulation; Internal medicine; Oncology; Anesthesia; Diabetes mellitus; Endocrinology","score_opus":0.06804553324391915,"score_gpt":0.40178361071503055,"score_spread":0.3337380774711114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406617687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99622995,0.00010568021,0.000088625435,0.0015152884,0.000045390436,0.0019535518,0.0000010189783,0.000008980441,0.000051546216],"genre_scores_gemma":[0.9995026,0.000042112086,0.00012314596,0.000094045885,0.00007208856,0.000036289675,0.0000010942442,0.000024652632,0.000103967206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944265,0.0033292046,0.0006529302,0.00029088242,0.0009285128,0.00037200074],"domain_scores_gemma":[0.9969283,0.0019206683,0.00022315494,0.00025348586,0.00056324096,0.00011116231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008037612,0.00017924084,0.00068186945,0.000596326,0.00009894272,0.000021766355,0.00017094171,0.00008299221,0.00006401968],"category_scores_gemma":[0.0011006943,0.0001246008,0.00011429749,0.00094712694,0.0000665103,0.000051928924,0.000027477663,0.00096732297,3.3210767e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062451776,0.002783449,0.8337431,0.00006788054,0.0002695485,0.00062868185,0.0041228924,0.004245279,0.080218874,0.0000014642446,0.000013960171,0.011453111],"study_design_scores_gemma":[0.008992774,0.009339484,0.96279,0.0004977775,0.00010735014,0.00005396459,0.00036616277,0.013000021,0.0047419188,0.000012080188,0.000005410638,0.000093019255],"about_ca_topic_score_codex":0.0010982763,"about_ca_topic_score_gemma":0.0004677167,"teacher_disagreement_score":0.12904695,"about_ca_system_score_codex":0.0008284351,"about_ca_system_score_gemma":0.0008936683,"threshold_uncertainty_score":0.5081073},"labels":[],"label_agreement":null},{"id":"W4406643018","doi":"10.1016/b978-2-294-76306-9.50419-1","title":"10.1016/b978-2-294-76306-9.50419-1","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.014027716722857589,"score_gpt":0.23121214584389738,"score_spread":0.2171844291210398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406643018","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000034967295,0.0010840354,7.533027e-8,0.0008397328,0.00001290455,0.0007578989,0.00015398524,0.00017465427,0.9969732],"genre_scores_gemma":[0.0000022449556,0.00000851549,0.000036359397,0.0003628694,0.0014059904,0.000049286722,0.0004736144,0.0001288256,0.9975323],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99857074,0.000012737179,0.0003160939,0.000478703,0.00027090695,0.00035082086],"domain_scores_gemma":[0.9990048,0.000061523,0.00009168876,0.00043124982,0.00007012125,0.00034062527],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006228779,0.0004566644,0.00072390505,0.00024963557,0.00005777524,0.000015440513,0.00014735035,0.0003712218,0.9993645],"category_scores_gemma":[0.0000055294463,0.00042860373,0.00026906256,0.000044574237,0.00007586029,0.00003045202,0.00005874523,0.00040102057,0.99615043],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075643155,0.000071218295,5.3608396e-8,0.000031440788,0.0003405508,0.00020302732,0.000010763453,9.189967e-7,0.00002831281,0.000015982521,0.61560583,0.38293543],"study_design_scores_gemma":[0.0015975748,0.0010242276,0.000003902398,0.00016290949,0.00095343235,0.00010228548,1.3313617e-7,0.0000035676521,0.000039164832,0.000096411866,0.99564636,0.0003700198],"about_ca_topic_score_codex":0.000030756335,"about_ca_topic_score_gemma":8.719945e-7,"teacher_disagreement_score":0.3825654,"about_ca_system_score_codex":0.00022911403,"about_ca_system_score_gemma":0.00018197189,"threshold_uncertainty_score":0.9998166},"labels":[],"label_agreement":null},{"id":"W4406643172","doi":"10.1016/b978-2-294-76306-9.50324-0","title":"10.1016/b978-2-294-76306-9.50324-0","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medical prescription; Medicine; Pharmacology","score_opus":0.014062326421774917,"score_gpt":0.23135419043262012,"score_spread":0.21729186401084521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406643172","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000034850684,0.0011297982,8.171345e-8,0.0007808991,0.000012128882,0.0007609015,0.00013418114,0.00017613785,0.99700236],"genre_scores_gemma":[0.0000020230555,0.0000085282045,0.000035852452,0.0003523621,0.0013972525,0.000049500362,0.00042923455,0.00012913076,0.99759614],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985677,0.000012807747,0.00031389733,0.0004796785,0.00027415046,0.00035173757],"domain_scores_gemma":[0.9989978,0.000060454993,0.00009119502,0.00043210865,0.000070533526,0.00034790087],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000063365434,0.0004566483,0.00071944925,0.00024808577,0.000057892044,0.000015668247,0.00014837614,0.00037759895,0.999509],"category_scores_gemma":[0.000005641957,0.00042852887,0.00026801167,0.00004384667,0.00007522203,0.00003111691,0.000058436504,0.0003961811,0.99637043],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007432964,0.00006870387,5.255809e-8,0.00003156788,0.0003257589,0.00019693378,0.000011429481,0.0000010808895,0.000023082312,0.000017222292,0.55677736,0.4418035],"study_design_scores_gemma":[0.0015583725,0.0010326625,0.000003996316,0.00016703147,0.0009286215,0.00010273777,1.2587752e-7,0.0000032384357,0.000046447385,0.00010008994,0.99568635,0.00037032302],"about_ca_topic_score_codex":0.000030508269,"about_ca_topic_score_gemma":0.0000011523487,"teacher_disagreement_score":0.44143316,"about_ca_system_score_codex":0.00023988598,"about_ca_system_score_gemma":0.00018574469,"threshold_uncertainty_score":0.99981666},"labels":[],"label_agreement":null},{"id":"W4406643442","doi":"10.1016/b978-2-294-76306-9.50119-8","title":"10.1016/b978-2-294-76306-9.50119-8","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Geology","score_opus":0.014342846896414128,"score_gpt":0.23102920739712393,"score_spread":0.2166863605007098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406643442","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000026413873,0.0009709622,8.561856e-8,0.00091258413,0.000012606462,0.00075687363,0.00018201568,0.00017555557,0.9969867],"genre_scores_gemma":[0.0000016718577,0.000007843348,0.00003703075,0.00033811398,0.0013956768,0.00004960004,0.00049899984,0.00013049935,0.9975406],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99857515,0.000012800666,0.00031401525,0.00047905845,0.00026879687,0.00035019242],"domain_scores_gemma":[0.9990019,0.000060297305,0.00009117795,0.0004316735,0.00007047887,0.00034444107],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000062360195,0.00045646424,0.00071934756,0.00025116006,0.000057937305,0.000018430648,0.00014775715,0.00037700534,0.99951863],"category_scores_gemma":[0.0000055498053,0.00042860708,0.00026775603,0.00004318004,0.0000762219,0.000030487758,0.000059007616,0.00039627805,0.9952833],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007120793,0.00006764145,3.5380868e-8,0.0000293423,0.0003141119,0.00019016287,0.000010535121,0.0000010309363,0.000017873796,0.000019700137,0.58883625,0.40980121],"study_design_scores_gemma":[0.0015436867,0.0010366994,0.000002437213,0.00016148631,0.0009336632,0.00010328528,1.3080528e-7,0.0000035743694,0.00004149722,0.00010446614,0.9956988,0.00037028673],"about_ca_topic_score_codex":0.000024491163,"about_ca_topic_score_gemma":6.8274295e-7,"teacher_disagreement_score":0.40943092,"about_ca_system_score_codex":0.0002301376,"about_ca_system_score_gemma":0.00018483469,"threshold_uncertainty_score":0.9998166},"labels":[],"label_agreement":null},{"id":"W4406648659","doi":"10.1016/b978-2-294-76306-9.50759-6","title":"10.1016/b978-2-294-76306-9.50759-6","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.014016383764465961,"score_gpt":0.23127365897618693,"score_spread":0.21725727521172097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406648659","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000025199245,0.0011186884,8.684719e-8,0.0007797319,0.0000126363175,0.00076161034,0.00021441777,0.00017653305,0.99693376],"genre_scores_gemma":[0.000001618981,0.000008695703,0.000036659563,0.00035636325,0.0014184221,0.00004942761,0.0005637857,0.00013063283,0.9974344],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856687,0.000012874584,0.0003147804,0.00048071498,0.00027235708,0.00035238542],"domain_scores_gemma":[0.9989977,0.000061629034,0.000091394126,0.00043283284,0.000070660775,0.0003457923],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006307112,0.0004578629,0.0007228134,0.00025091262,0.000058556914,0.000015568821,0.00014823646,0.000378167,0.99947274],"category_scores_gemma":[0.000005697316,0.00042953854,0.00026603034,0.000044708642,0.00007599526,0.000030630566,0.00005922615,0.00040337443,0.9962603],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073224533,0.00006958662,4.5752696e-8,0.000030779443,0.0003241857,0.00019536255,0.000010957877,0.0000011339511,0.00002334151,0.000017469087,0.58552104,0.41307384],"study_design_scores_gemma":[0.0015571556,0.0010423013,0.0000036153137,0.0001661102,0.0009198049,0.00010478881,1.3547587e-7,0.0000035092016,0.000046288646,0.00010071833,0.99568427,0.00037133548],"about_ca_topic_score_codex":0.000023511013,"about_ca_topic_score_gemma":7.75238e-7,"teacher_disagreement_score":0.4127025,"about_ca_system_score_codex":0.00023569263,"about_ca_system_score_gemma":0.00018860455,"threshold_uncertainty_score":0.99981564},"labels":[],"label_agreement":null},{"id":"W4406649148","doi":"10.1016/b978-2-294-73068-9.00531-4","title":"10.1016/b978-2-294-73068-9.00531-4","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"History","score_opus":0.013911229146785475,"score_gpt":0.2312093027820703,"score_spread":0.21729807363528483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406649148","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003572846,0.0010539029,8.3685514e-8,0.00077286863,0.00001165291,0.0007462551,0.00012666117,0.00017504363,0.99710995],"genre_scores_gemma":[0.0000022188124,0.0000086624905,0.000036432324,0.000348607,0.0013928505,0.000044750712,0.00040937617,0.00012933362,0.9976278],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998588,0.000012410218,0.0003068868,0.00047957525,0.00026451447,0.00034861706],"domain_scores_gemma":[0.9990161,0.000059531823,0.000086400956,0.0004274003,0.000067611916,0.00034294452],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006158997,0.00045108784,0.0007101663,0.00025153923,0.00005722001,0.000015070403,0.00014784593,0.00037327918,0.99951005],"category_scores_gemma":[0.0000053340145,0.0004243743,0.00026407637,0.000042909338,0.000073249794,0.000030931922,0.000060905662,0.00039655739,0.9959428],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007161838,0.00006903665,3.410149e-8,0.000028511968,0.00031981242,0.00018727583,0.000011346731,0.0000010747833,0.000026789057,0.000017460707,0.57527095,0.4233515],"study_design_scores_gemma":[0.0015288433,0.0010272868,0.0000026240173,0.00015971118,0.0009233078,0.000102960395,1.286454e-7,0.0000038390435,0.00005849264,0.00010560038,0.9957205,0.00036672075],"about_ca_topic_score_codex":0.000023953977,"about_ca_topic_score_gemma":8.587516e-7,"teacher_disagreement_score":0.42298478,"about_ca_system_score_codex":0.00024276825,"about_ca_system_score_gemma":0.00019141145,"threshold_uncertainty_score":0.9998208},"labels":[],"label_agreement":null},{"id":"W4406650615","doi":"10.1016/b978-2-294-73068-9.00496-5","title":"10.1016/b978-2-294-73068-9.00496-5","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.013893331216032888,"score_gpt":0.23111898853512058,"score_spread":0.2172256573190877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406650615","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003255302,0.0011590315,7.4285445e-8,0.0008229966,0.00001204769,0.00074895367,0.0001377999,0.00017860584,0.9969372],"genre_scores_gemma":[0.0000020860273,0.000008586139,0.00003779377,0.00034259367,0.0013586037,0.000044747067,0.0004034387,0.0001292047,0.997673],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985933,0.000012520511,0.00030578105,0.0004762444,0.0002656581,0.00034652647],"domain_scores_gemma":[0.9990163,0.000059812603,0.00008954801,0.0004247803,0.00006848298,0.000341109],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000060706923,0.00045102247,0.0007076482,0.00025137773,0.00005758179,0.000015026853,0.00014634347,0.0003739,0.9994778],"category_scores_gemma":[0.0000053108115,0.0004246777,0.00026817562,0.000043147906,0.00007389865,0.000030822524,0.00005776536,0.00039682287,0.99588335],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074250717,0.00007237732,3.351022e-8,0.000030649113,0.0003384569,0.00020251269,0.000011119369,0.0000011959439,0.000031174226,0.000018231623,0.5796002,0.4189515],"study_design_scores_gemma":[0.0015350909,0.0010652523,0.0000023498512,0.00016523928,0.00092163484,0.00010386949,1.3519299e-7,0.0000030015021,0.00006466821,0.000106447245,0.99566543,0.00036690285],"about_ca_topic_score_codex":0.000023922406,"about_ca_topic_score_gemma":8.607787e-7,"teacher_disagreement_score":0.41858461,"about_ca_system_score_codex":0.0002488349,"about_ca_system_score_gemma":0.00019811088,"threshold_uncertainty_score":0.99982053},"labels":[],"label_agreement":null},{"id":"W4406652952","doi":"10.1016/b978-0-7506-3430-4.50024-9","title":"10.1016/b978-0-7506-3430-4.50024-9","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Superheterodyne receiver; Computer science; Telecommunications; Microwave","score_opus":0.014096913105306363,"score_gpt":0.23096065712219396,"score_spread":0.2168637440168876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406652952","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000023299044,0.0012431052,1.3663907e-7,0.0006718209,0.0000130499875,0.0007483136,0.00014419887,0.00017808175,0.99699897],"genre_scores_gemma":[0.0000026334353,0.000003315987,0.000029211822,0.00033576225,0.0012209191,0.000049556387,0.00041326712,0.00013072463,0.9978146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985811,0.000013407122,0.00031055819,0.00047990461,0.0002702677,0.00034476464],"domain_scores_gemma":[0.9990112,0.000063217674,0.00008928276,0.00042685278,0.000071630464,0.00033781337],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006602672,0.00045155187,0.0007119767,0.00024992097,0.000057405265,0.000014257996,0.00014509103,0.0003744908,0.9993699],"category_scores_gemma":[0.0000058614437,0.00042395128,0.0002687886,0.000044171025,0.00007518517,0.000029880262,0.000058983627,0.0004012114,0.9964265],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007144471,0.000072296854,6.11316e-8,0.000032955093,0.0003108062,0.00019276135,0.000010441438,0.0000014219476,0.000022025184,0.00001684396,0.36495057,0.6336754],"study_design_scores_gemma":[0.0014048042,0.0009969483,0.000003753945,0.00015339199,0.00091632694,0.00009301767,1.2324013e-7,0.0000072412768,0.000033741635,0.00008611232,0.99593776,0.0003667891],"about_ca_topic_score_codex":0.000047822177,"about_ca_topic_score_gemma":0.000001440804,"teacher_disagreement_score":0.6333086,"about_ca_system_score_codex":0.00023585014,"about_ca_system_score_gemma":0.00017244749,"threshold_uncertainty_score":0.99982125},"labels":[],"label_agreement":null},{"id":"W4406655258","doi":"10.1016/b978-0-444-90336-5.50016-0","title":"10.1016/b978-0-444-90336-5.50016-0","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Biology; Medicine","score_opus":0.01398723163953765,"score_gpt":0.23100879619618728,"score_spread":0.21702156455664962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406655258","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002200134,0.0014709042,8.2312766e-8,0.0007986054,0.000012330912,0.0007603637,0.0001405599,0.00018000607,0.99663496],"genre_scores_gemma":[0.0000014587283,0.0000094541,0.00003419067,0.00033860194,0.0012439686,0.000050123897,0.00045230208,0.00013146043,0.9977384],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985665,0.000012518646,0.0003109995,0.00048290502,0.00027050218,0.0003565747],"domain_scores_gemma":[0.99900085,0.000061597726,0.00009232357,0.00043280338,0.00007027007,0.00034217187],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006221207,0.0004600588,0.00071555615,0.0002513453,0.00005804921,0.000015486401,0.00014826433,0.00037742808,0.99952126],"category_scores_gemma":[0.000005625876,0.00042840673,0.0002687186,0.000044245768,0.00007622442,0.000030078294,0.00005955854,0.00039817937,0.9964501],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000738228,0.000064327054,2.8702958e-8,0.000027848153,0.00031223954,0.00017802045,0.000009373118,0.0000010433014,0.000022396942,0.000015768197,0.6034502,0.39518058],"study_design_scores_gemma":[0.0015510466,0.0011152015,0.0000027682545,0.00017275239,0.00093161763,0.000100800426,1.2694743e-7,0.0000038199223,0.000041371273,0.00008944062,0.9956179,0.00037314824],"about_ca_topic_score_codex":0.00002698522,"about_ca_topic_score_gemma":7.815311e-7,"teacher_disagreement_score":0.39480743,"about_ca_system_score_codex":0.00024064687,"about_ca_system_score_gemma":0.00018364769,"threshold_uncertainty_score":0.9998168},"labels":[],"label_agreement":null},{"id":"W4406660252","doi":"10.1016/b978-0-323-76033-1.00008-3","title":"10.1016/b978-0-323-76033-1.00008-3","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.013761846637671325,"score_gpt":0.229745232072932,"score_spread":0.21598338543526066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406660252","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000025323632,0.0013897782,7.252636e-8,0.0009335229,0.000012577934,0.00075929746,0.00016437794,0.00018479268,0.99655306],"genre_scores_gemma":[0.0000021713834,0.000010266756,0.00003237088,0.00033684177,0.0012267679,0.000051183782,0.00047148977,0.00013239757,0.9977365],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985375,0.000013068844,0.0003216615,0.00049138855,0.00027756675,0.000358833],"domain_scores_gemma":[0.99897397,0.00006214627,0.00009135781,0.00044600034,0.00007188593,0.0003546351],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000060250524,0.00046853657,0.0007307447,0.00025596723,0.00006015675,0.000015687017,0.00015212159,0.00038580093,0.99954486],"category_scores_gemma":[0.0000051148027,0.00044085542,0.00026726283,0.000047487734,0.000078286896,0.000031926305,0.000055768298,0.0003900446,0.99624294],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007625763,0.000067350375,3.0339006e-8,0.00002938586,0.00031120423,0.00019300725,0.000011227779,0.000001146836,0.000018516295,0.000015888121,0.52867055,0.46991915],"study_design_scores_gemma":[0.0015483684,0.0010272752,0.0000030390286,0.00016767645,0.0009285631,0.000104549974,1.4934211e-7,0.000003508359,0.000046879795,0.000078276586,0.9957109,0.00038081917],"about_ca_topic_score_codex":0.00003625181,"about_ca_topic_score_gemma":0.0000010790185,"teacher_disagreement_score":0.46953833,"about_ca_system_score_codex":0.00023538293,"about_ca_system_score_gemma":0.00020037025,"threshold_uncertainty_score":0.9998043},"labels":[],"label_agreement":null},{"id":"W4407080953","doi":"10.1007/s00520-025-09190-6","title":"Patient-reported strategies for prevention and treatment of chemotherapy-induced peripheral neuropathy","year":2025,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Guideline; Gabapentin; Pain medicine; Medical prescription; Peripheral neuropathy; Duloxetine; Intensive care medicine; Alternative medicine; Anesthesiology; Nursing; Psychiatry","score_opus":0.031056202105445168,"score_gpt":0.3857902453382773,"score_spread":0.35473404323283214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407080953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941467,0.0027281595,0.000015748674,0.00040811984,0.00029525993,0.0011786543,0.000038047612,0.000013481387,0.001175799],"genre_scores_gemma":[0.9976947,0.0008050315,0.00005339382,0.00019425609,0.000044115623,0.00060368946,0.00004844419,0.000010506558,0.0005458968],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993396,0.000021161108,0.00024050566,0.00021093283,0.000055017787,0.00013282649],"domain_scores_gemma":[0.99961036,0.00002578052,0.00010069108,0.00008488453,0.00014793068,0.000030354116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000017003496,0.00011790349,0.00027359545,0.00008402801,0.000020578766,0.0000051412653,0.000013671214,0.000050896422,0.0001334536],"category_scores_gemma":[0.0000051080738,0.00009872097,0.000080596015,0.00011286948,0.000039230934,0.00005081739,0.000005621268,0.00003209314,8.0984634e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005670647,0.00097061,0.31468382,0.00044227485,0.0006179775,0.000062220905,0.014565278,0.000013685647,0.06151056,0.00012930726,0.00055528455,0.60077834],"study_design_scores_gemma":[0.037006415,0.025450267,0.56890434,0.00055736164,0.0013232286,0.000016850128,0.0202532,0.00011975209,0.30809307,0.00070532336,0.037166357,0.0004038421],"about_ca_topic_score_codex":0.00035350065,"about_ca_topic_score_gemma":0.0007342494,"teacher_disagreement_score":0.60037446,"about_ca_system_score_codex":0.0003432886,"about_ca_system_score_gemma":0.0005062416,"threshold_uncertainty_score":0.40257245},"labels":[],"label_agreement":null},{"id":"W4407341078","doi":"10.3390/curroncol32020100","title":"Trends in Kampo Medicine Usage as Supportive Care During Anticancer Drug Treatment in Japanese Patients: A Nationwide Cohort Analysis from Fiscal Years 2015 to 2021","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Kampo; Medicine; Medical prescription; Adverse effect; Alternative medicine; Drug; Traditional medicine; Cancer; Internal medicine; Pharmacology","score_opus":0.028409353968328707,"score_gpt":0.435025681013385,"score_spread":0.4066163270450563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407341078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99005646,0.0019772854,0.0000014249237,0.0032535333,0.0009691759,0.0007068107,0.00011422868,0.000017061544,0.0029040333],"genre_scores_gemma":[0.99516946,0.0005202351,0.000018014807,0.0002477087,0.00019693389,0.00044817242,0.0015137139,0.000011792889,0.0018739727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981104,0.00018648752,0.00053958927,0.00058110437,0.00022174527,0.00036067804],"domain_scores_gemma":[0.9991646,0.00020129503,0.00010938529,0.00023913616,0.00011194023,0.00017367498],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000116372576,0.00024172035,0.0009395079,0.0016774728,0.000032800122,0.000005416189,0.000096227544,0.00011430254,0.0028840986],"category_scores_gemma":[0.0000712866,0.00020943127,0.00014862306,0.0019331697,0.000094540585,0.00005091477,0.00006585211,0.00021185022,0.000033981087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009663261,0.0016666643,0.9446283,0.000021161555,0.00069061096,0.00018444438,0.013227468,0.000045501907,0.00010808625,0.000003775703,0.002599523,0.035858124],"study_design_scores_gemma":[0.011343662,0.00087450934,0.9683475,0.00010915384,0.0017750604,9.83969e-7,0.001751679,0.000062821484,0.0001380516,0.00001398956,0.015441954,0.00014061613],"about_ca_topic_score_codex":0.007468508,"about_ca_topic_score_gemma":0.027836079,"teacher_disagreement_score":0.035717506,"about_ca_system_score_codex":0.003056569,"about_ca_system_score_gemma":0.00027873117,"threshold_uncertainty_score":0.99914086},"labels":[],"label_agreement":null},{"id":"W4407590206","doi":"10.1093/nop/npaf017","title":"Corrigendum to: The feasibility of a multi-site, clinic-supported, and tailored neuro-oncology exercise program","year":2025,"lang":"en","type":"erratum","venue":"Neuro-Oncology Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Cancer Foundation","keywords":"Medicine; Medical physics; Oncology","score_opus":0.09498768312600601,"score_gpt":0.4426270637157845,"score_spread":0.34763938058977845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407590206","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019060558,0.023702702,0.00012600182,0.26952785,0.33026347,0.056347903,0.0015390668,0.0014709738,0.29796147],"genre_scores_gemma":[0.016280042,0.07840857,0.01742894,0.17767511,0.01004228,0.01063191,0.0038910138,0.0007881566,0.684854],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99299026,0.0020735562,0.0015866635,0.0018353107,0.0005317371,0.0009824946],"domain_scores_gemma":[0.99010193,0.0049962634,0.001783087,0.0015265688,0.0010076489,0.00058448187],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0015651516,0.00089160935,0.0025680345,0.00047513927,0.0003074886,0.000044761575,0.00061650213,0.0019155451,0.0007703282],"category_scores_gemma":[0.0076197907,0.00070381776,0.00046149304,0.0009739405,0.0008430898,0.0002198971,0.0007812034,0.0044670887,0.00018369895],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0124252755,0.0068811257,0.003447338,0.0005367475,0.0006122595,0.0019659663,0.0009322037,0.0000011320666,0.0023816065,0.00000851217,0.9094425,0.06136532],"study_design_scores_gemma":[0.00833319,0.015348117,0.0044770674,0.00013636607,0.00777165,0.0012200774,0.00044249004,0.00019135606,0.00016861242,0.000010389657,0.9615046,0.00039609201],"about_ca_topic_score_codex":0.0004402071,"about_ca_topic_score_gemma":0.0009759574,"teacher_disagreement_score":0.3868925,"about_ca_system_score_codex":0.000615836,"about_ca_system_score_gemma":0.005565614,"threshold_uncertainty_score":0.9995413},"labels":[],"label_agreement":null},{"id":"W4407699857","doi":"10.1200/jco.2025.43.5_suppl.tps891","title":"ABLE-22: Safety and efficacy evaluation of nadofaragene firadenovec alone or in combination with chemotherapy or immunotherapy—A randomized, open-label, phase 2 study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McGill University Health Centre","funders":"","keywords":"Medicine; Chemotherapy; Immunotherapy; Oncology; Open label; Internal medicine; Randomized controlled trial; Pharmacology; Cancer","score_opus":0.17611272513261214,"score_gpt":0.5627920855961613,"score_spread":0.3866793604635492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407699857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846995,0.0016882645,0.0001814131,0.00893836,0.00046522988,0.0029900875,0.0000024852002,0.0000041210983,0.0010305624],"genre_scores_gemma":[0.99085224,0.004713312,0.0011516083,0.0020221986,0.00012667412,0.000041503383,0.000005258242,0.000014365664,0.0010728333],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9949242,0.0018033958,0.002524041,0.00021077588,0.00038709556,0.00015047888],"domain_scores_gemma":[0.9924452,0.005046551,0.0016417189,0.00015957606,0.000609576,0.00009742266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011880603,0.00015999976,0.0026344713,0.0002413841,0.000040492625,0.000011398182,0.00016831752,0.00020572935,0.00078415504],"category_scores_gemma":[0.001699907,0.00008882547,0.00010299066,0.0003849445,0.00024768515,0.0001242205,0.00003686483,0.00046647456,7.68775e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66400045,0.031296145,0.002769317,0.000020885263,0.0016204775,0.00012934157,0.0003869618,0.00001698884,0.00028051503,0.000024570067,0.0004603419,0.298994],"study_design_scores_gemma":[0.8962673,0.062433638,0.0331458,0.00017929613,0.001812399,0.00010396161,0.00018608541,0.00082576677,0.0001802423,0.00013525189,0.0046513933,0.00007889321],"about_ca_topic_score_codex":0.00009362495,"about_ca_topic_score_gemma":0.00025429708,"teacher_disagreement_score":0.29891512,"about_ca_system_score_codex":0.00029117748,"about_ca_system_score_gemma":0.0031591002,"threshold_uncertainty_score":0.8585948},"labels":[],"label_agreement":null},{"id":"W4407827083","doi":"10.1007/s11764-025-01763-y","title":"Impact of chemotherapy-induced peripheral neuropathy on physical function in pediatric cancer survivors: a systematic review","year":2025,"lang":"en","type":"review","venue":"Journal of Cancer Survivorship","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"","keywords":"Medicine; Peripheral neuropathy; Quality of Life Research; Chemotherapy-induced peripheral neuropathy; Public health; Chemotherapy; Cancer; Pain medicine; Health informatics; Peripheral; Physical therapy; Internal medicine; Pathology; Diabetes mellitus","score_opus":0.04792525501676669,"score_gpt":0.42288818760567476,"score_spread":0.37496293258890806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407827083","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018637832,0.97696567,0.0000017028848,0.00014404676,0.0016841905,0.002314962,0.00005332089,0.000013498895,0.0001847783],"genre_scores_gemma":[0.009401663,0.9877041,0.0000019016732,0.00030984703,0.001734859,0.0003686662,0.000011582377,0.00007998937,0.00038739239],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99535114,0.0011531531,0.0020238715,0.00038199677,0.00068393926,0.00040588994],"domain_scores_gemma":[0.99543554,0.0007721365,0.0027509946,0.00041366013,0.00042053396,0.00020711462],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092908525,0.0007132256,0.006765118,0.00085168076,0.000028457207,0.000016847724,0.00032088053,0.0002708835,0.0002916039],"category_scores_gemma":[0.00018914351,0.00045247626,0.0025184092,0.0016455643,0.000032499003,0.00010183892,0.000028106484,0.0011737413,0.000004034548],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009240422,0.00095803785,0.004451273,0.9389311,0.0017921717,0.00009187811,0.00014575449,0.000011285111,0.0000045782144,0.0000044618414,0.00052550144,0.052159917],"study_design_scores_gemma":[0.0029823638,0.0042810636,0.0042018313,0.9496922,0.03348939,0.000090892696,0.000007861773,0.000007879549,0.0000048093075,0.000010803437,0.0047135814,0.0005173559],"about_ca_topic_score_codex":0.003863061,"about_ca_topic_score_gemma":0.0019532926,"teacher_disagreement_score":0.051642563,"about_ca_system_score_codex":0.0015607097,"about_ca_system_score_gemma":0.003234945,"threshold_uncertainty_score":0.9997927},"labels":[],"label_agreement":null},{"id":"W4407850244","doi":"10.51731/cjht.2025.1085","title":"Clindamycin Plus Benzoyl Peroxide and Adapalene (Cabtreo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adapalene; Benzoyl peroxide; Clindamycin; Dermatology; Chemistry; Medicine; Organic chemistry; Antibiotics","score_opus":0.026654558932749726,"score_gpt":0.3470699517471535,"score_spread":0.3204153928144038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407850244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6264912,0.20275953,0.000055904544,0.16847359,0.0005798743,0.00030673415,0.000016101341,0.000058532976,0.0012585581],"genre_scores_gemma":[0.9931547,0.003357352,0.00047162414,0.0020710444,0.000017022114,0.000004126127,0.0000018050999,0.000007172516,0.0009151419],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99905336,0.000028874443,0.000398005,0.0001186556,0.00006748744,0.00033359637],"domain_scores_gemma":[0.99941057,0.000059686936,0.00017363833,0.00013680657,0.000104189814,0.00011511433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027623348,0.00010982932,0.00042852957,0.00069110503,0.00014908008,0.00001300781,0.000112259135,0.00013345371,0.000054356806],"category_scores_gemma":[0.00012712661,0.000090312795,0.000056796565,0.00025883925,0.00021339058,0.000045495777,0.000016179216,0.0003905881,0.0000033041977],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000226876,0.000050409777,0.07980317,0.0003762879,0.00027389036,0.0006432234,0.00047696737,0.0000069580774,0.00029954416,0.0016936434,0.06388044,0.8522686],"study_design_scores_gemma":[0.0064679487,0.0024183043,0.13180001,0.0009998003,0.00024622196,0.0011590853,0.0053198584,0.000024360053,0.0039013007,0.004127308,0.84332585,0.0002099419],"about_ca_topic_score_codex":0.0030576275,"about_ca_topic_score_gemma":0.009183651,"teacher_disagreement_score":0.85205865,"about_ca_system_score_codex":0.00061356544,"about_ca_system_score_gemma":0.004713322,"threshold_uncertainty_score":0.83612305},"labels":[],"label_agreement":null},{"id":"W4407947753","doi":"10.5737/2368807635189","title":"Programme pilote de rééducation sensitive des neuropathies périphériques induites par la chimiothérapie (NPIC) auprès d’une clientèle oncologique","year":2025,"lang":"fr","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Centre Intégré de Santé et Services Sociaux de Chaudière-Appalache; Université du Québec à Rimouski","funders":"","keywords":"Medicine; Humanities; Gynecology; Art","score_opus":0.03158974179252376,"score_gpt":0.3669483739962365,"score_spread":0.3353586322037127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407947753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6415283,0.05447962,0.0014629158,0.1927031,0.016959524,0.0013840909,0.000084005085,0.00013878089,0.09125966],"genre_scores_gemma":[0.96347415,0.011088189,0.0039331755,0.00850967,0.0036574895,0.00007566539,0.000051323732,0.000073044,0.009137275],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99449265,0.0021985539,0.000726773,0.0005052984,0.00016489596,0.0019118232],"domain_scores_gemma":[0.99603945,0.0011302354,0.0003916777,0.00023545891,0.0005280497,0.0016751308],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017435533,0.00048783654,0.0008346598,0.0010192448,0.001162738,0.00018305637,0.00025167348,0.0010195321,0.00033177578],"category_scores_gemma":[0.0008262541,0.0005194099,0.0002526105,0.0008783161,0.002426746,0.00026116817,0.00002725719,0.0023127662,0.00003999862],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0009024053,0.0022527715,0.037670143,0.00019011115,0.00089497323,0.0075946604,0.024794662,0.00008027725,0.0035197863,0.004007766,0.14044036,0.7776521],"study_design_scores_gemma":[0.008009917,0.008576262,0.25690532,0.0076836175,0.0031433133,0.017473124,0.01202095,0.0007956549,0.0041538253,0.01495611,0.6655067,0.00077517045],"about_ca_topic_score_codex":0.027749224,"about_ca_topic_score_gemma":0.116354205,"teacher_disagreement_score":0.7768769,"about_ca_system_score_codex":0.02653596,"about_ca_system_score_gemma":0.035871834,"threshold_uncertainty_score":0.9999889},"labels":[],"label_agreement":null},{"id":"W4407955481","doi":"10.21037/pm-24-42","title":"Physical therapy for deficits associated with chemotherapy induced peripheral neuropathy in children with cancer: a systematic review","year":2025,"lang":"en","type":"review","venue":"Pediatric Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Peripheral neuropathy; Medicine; Chemotherapy-induced peripheral neuropathy; Chemotherapy; Systematic review; Cancer therapy; Oncology; Cancer; Internal medicine; MEDLINE; Endocrinology; Diabetes mellitus","score_opus":0.033167198414578616,"score_gpt":0.3701007508465554,"score_spread":0.3369335524319768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407955481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024735362,0.9788311,0.0000051679544,0.0006487719,0.00016105306,0.017606251,0.00007884922,0.00008720913,0.0001080228],"genre_scores_gemma":[0.0002930616,0.9872186,0.000012021325,0.0021873,0.0014202669,0.0075473674,0.000578813,0.00012828685,0.000614286],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9968391,0.00035538827,0.0009798236,0.00077370903,0.00051415956,0.00053780683],"domain_scores_gemma":[0.9974426,0.0007870493,0.0009006261,0.00047496005,0.00020524369,0.00018954366],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044106832,0.00089444517,0.0069919857,0.00044740178,0.00006277084,0.000008771703,0.00025774568,0.0002311841,0.00009481703],"category_scores_gemma":[0.0002472373,0.0004583271,0.00037304097,0.0019748122,0.000068690955,0.00003710929,0.000018863124,0.000638774,0.0000024283977],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004044298,0.0009853067,0.0028241079,0.9254494,0.002334695,0.000055398024,0.00020536857,2.8806363e-7,6.234167e-7,0.0000054470684,0.0026947553,0.06504021],"study_design_scores_gemma":[0.022280319,0.0080613755,0.00084842945,0.8976779,0.061966885,0.00019726864,0.000009971154,0.000010668674,8.485119e-7,0.0000038340795,0.0081026545,0.00083986414],"about_ca_topic_score_codex":0.00012442676,"about_ca_topic_score_gemma":0.000041780935,"teacher_disagreement_score":0.06420035,"about_ca_system_score_codex":0.000516926,"about_ca_system_score_gemma":0.0016168173,"threshold_uncertainty_score":0.99978685},"labels":[],"label_agreement":null},{"id":"W4407964923","doi":"10.5737/23688076351103","title":"Sensory re-education pilot program following chemotherapy-induced peripheral neuropathy in cancer patients","year":2025,"lang":"en","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Sensory neuropathy; Medicine; Cancer; Sensory system; Chemotherapy; Oncology; Peripheral; Internal medicine; Physical therapy; Physical medicine and rehabilitation; Psychology; Neuroscience; Endocrinology","score_opus":0.03476836165448303,"score_gpt":0.4104621421885149,"score_spread":0.37569378053403185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407964923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563247,0.0011465235,0.0000023687294,0.019755794,0.0057158363,0.0006276011,0.0000028687955,0.000025300978,0.016398994],"genre_scores_gemma":[0.98874897,0.00016638501,0.00022216517,0.008339472,0.00045457258,0.000078640194,0.000013585011,0.000024275178,0.0019519642],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998739,0.00015073495,0.00029767535,0.00022362823,0.00009913261,0.00048981124],"domain_scores_gemma":[0.999229,0.000031415802,0.0000957883,0.00010089685,0.000119167504,0.00042371906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014868884,0.00016107496,0.00032115894,0.00056714733,0.00021594905,0.000031053107,0.000085637315,0.00014039243,0.00028879844],"category_scores_gemma":[0.000034837332,0.00016295441,0.00009501239,0.00036017294,0.00006267571,0.000077908386,0.0000038257385,0.0005736657,0.0000034920402],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00053244503,0.0022456835,0.18218249,0.000017970784,0.00012825815,0.0002852921,0.0019101895,0.000004968537,0.0023875157,0.000015560903,0.030210705,0.78007895],"study_design_scores_gemma":[0.016941292,0.0070627267,0.83951527,0.0018800222,0.0005426652,0.000231954,0.0011141003,0.00026836933,0.0006649019,0.00025615795,0.1311572,0.00036536614],"about_ca_topic_score_codex":0.0066435784,"about_ca_topic_score_gemma":0.034035947,"teacher_disagreement_score":0.7797136,"about_ca_system_score_codex":0.010592511,"about_ca_system_score_gemma":0.011408828,"threshold_uncertainty_score":0.9999713},"labels":[],"label_agreement":null},{"id":"W4408237108","doi":"10.1080/14796694.2025.2468578","title":"A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML","year":2025,"lang":"en","type":"article","venue":"Future Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Hôpital Maisonneuve-Rosemont; University of Alberta; Queen Elizabeth II Health Sciences Centre; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Decitabine; Medicine","score_opus":0.025476626718189566,"score_gpt":0.38500189559359743,"score_spread":0.35952526887540787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408237108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9540656,0.0046534,0.00004932421,0.026534447,0.0052223573,0.0028074796,0.00013684205,0.000052808755,0.006477746],"genre_scores_gemma":[0.9734297,0.0009644599,0.0025248588,0.004052512,0.0031355768,0.0006719946,0.00024351562,0.00005542524,0.014921976],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887,0.00013358505,0.00033264857,0.00027128521,0.000098657874,0.0002938306],"domain_scores_gemma":[0.99851125,0.0009256861,0.00012671582,0.00025111233,0.00010193479,0.00008330737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028681522,0.00019191786,0.0006424204,0.00013082715,0.00009001637,0.000005091417,0.00013353792,0.00025718947,0.00027372446],"category_scores_gemma":[0.0003025607,0.00011631503,0.00012626719,0.00037653593,0.00015587884,0.000024174797,0.00008353024,0.00021503012,0.0000014935489],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63842285,0.00232663,0.0007590862,0.00045348975,0.0013863246,0.00018942516,0.0020771744,0.000003819713,0.013645442,0.0040114922,0.19663937,0.1400849],"study_design_scores_gemma":[0.24173662,0.016159257,0.0029614542,0.00008811264,0.0015188104,0.00007413293,0.0014325199,0.00006577951,0.005023786,0.00017049258,0.7305946,0.00017443889],"about_ca_topic_score_codex":0.0001357754,"about_ca_topic_score_gemma":0.0021277631,"teacher_disagreement_score":0.5339552,"about_ca_system_score_codex":0.0002421309,"about_ca_system_score_gemma":0.0007491565,"threshold_uncertainty_score":0.47431895},"labels":[],"label_agreement":null},{"id":"W4408275105","doi":"10.37275/bsm.v9i6.1292","title":"Serum Nerve Growth Factor as a Biomarker for Chemotherapy-Induced Peripheral Neuropathy: A Cross-Sectional Study","year":2025,"lang":"en","type":"article","venue":"Bioscientia Medicina Journal of Biomedicine and Translational Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Peripheral neuropathy; Biomarker; Peripheral; Chemotherapy-induced peripheral neuropathy; Chemotherapy; Cross-sectional study; Oncology; Internal medicine; Nerve growth factor; Pathology; Endocrinology; Biology","score_opus":0.11304871936280521,"score_gpt":0.4823205871577496,"score_spread":0.3692718677949444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408275105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812243,0.0016739483,0.00037945536,0.013766247,0.0011065963,0.0012097356,0.000039509152,0.000011776457,0.00058842625],"genre_scores_gemma":[0.9973377,0.00016884966,0.00013460877,0.0005948587,0.0006036578,0.000030725274,0.000019935416,0.000015595233,0.0010940938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694055,0.00017713549,0.0007094072,0.00038264442,0.0013754675,0.00041476352],"domain_scores_gemma":[0.9972616,0.0005860808,0.00014535342,0.00013292869,0.0015383865,0.00033565084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023156994,0.00019745097,0.00045188927,0.0013822106,0.00034515024,0.000061159706,0.00017730337,0.00012196753,0.0004997258],"category_scores_gemma":[0.0003045222,0.00013843353,0.0001786221,0.0012063003,0.000531948,0.00015115475,0.00002700691,0.00043040156,0.0000019615527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0078964615,0.0018029094,0.84779173,0.00025286595,0.00080333237,0.0002209105,0.0011402443,2.1297123e-7,0.12028307,0.00024650714,0.0023979149,0.017163815],"study_design_scores_gemma":[0.02047129,0.0067836596,0.9625214,0.00013216893,0.00019437683,0.00029486624,0.00032410384,0.00020932496,0.0024454324,0.00056494994,0.0059628533,0.00009558317],"about_ca_topic_score_codex":0.000090061556,"about_ca_topic_score_gemma":0.00001323266,"teacher_disagreement_score":0.11783764,"about_ca_system_score_codex":0.00009548016,"about_ca_system_score_gemma":0.0011905403,"threshold_uncertainty_score":0.5645156},"labels":[],"label_agreement":null},{"id":"W4408519004","doi":"10.1188/25.cjon.113-118","title":"Optimizing Assessment of and Education About Chemotherapy-Induced Peripheral Neuropathy Among Breast Cancer Survivors","year":2025,"lang":"en","type":"article","venue":"Clinical journal of oncology nursing","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Medicine; Peripheral neuropathy; Breast cancer; Chemotherapy-induced peripheral neuropathy; Oncology; Chemotherapy; Internal medicine; Cancer; Peripheral; Diabetes mellitus","score_opus":0.04311397590925742,"score_gpt":0.4976242138566784,"score_spread":0.45451023794742096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408519004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98236835,0.0015123895,0.00017268184,0.009679572,0.0029987555,0.00018813078,0.0000019001963,0.000006178927,0.003072064],"genre_scores_gemma":[0.99395263,0.0017172747,0.0018279587,0.0017011224,0.000586791,0.000004938132,0.0000012391971,0.000011682261,0.00019637577],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998504,0.00026248742,0.00081073376,0.00015858817,0.000109891866,0.00015434518],"domain_scores_gemma":[0.9985497,0.00032264699,0.00058561354,0.00009129917,0.00030603644,0.00014468639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060123747,0.00011605246,0.0006607924,0.00014824598,0.000054415956,0.000008685486,0.00007439116,0.00016770267,0.000093698014],"category_scores_gemma":[0.000038293496,0.00009587741,0.00017041038,0.00015030963,0.00030257858,0.00008079065,0.000013697939,0.000504076,1.0276421e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010429646,0.0016568667,0.47897628,0.00003365281,0.00021239066,0.000020882331,0.00031813816,0.000015975827,0.003787971,0.000029787847,0.0007754725,0.51312965],"study_design_scores_gemma":[0.005393065,0.0021829973,0.9881282,0.00082918623,0.00069154426,0.00022884035,0.00036618847,0.00047171555,0.0002791965,0.000081811406,0.0012800118,0.00006728584],"about_ca_topic_score_codex":0.000049860537,"about_ca_topic_score_gemma":0.000023720604,"teacher_disagreement_score":0.51306236,"about_ca_system_score_codex":0.00040383852,"about_ca_system_score_gemma":0.0022104906,"threshold_uncertainty_score":0.39213154},"labels":[],"label_agreement":null},{"id":"W4408686924","doi":"10.26434/chemrxiv-2024-nmm8w-v2","title":"Machine learning reveals structural characteristics of stereochemistry-specific interdigitation of synthetic monomycoloyl glycerol analogs","year":2025,"lang":"en","type":"preprint","venue":"ChemRxiv","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Glycerol; Chemistry; Stereochemistry; Biochemistry","score_opus":0.022581448016313278,"score_gpt":0.3084476592570899,"score_spread":0.2858662112407766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408686924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938702,0.0011607956,0.00007865441,0.00019170815,0.00037613724,0.0004735204,0.00012764764,0.00003546513,0.003685868],"genre_scores_gemma":[0.9960217,0.00053764274,0.00028268754,0.00003105423,0.00013842878,0.000045564313,0.0009376619,0.000019079484,0.00198619],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985784,0.000044946002,0.0006730439,0.0003786332,0.00014958467,0.00017538766],"domain_scores_gemma":[0.9985028,0.0001454052,0.0006654481,0.0003693764,0.00024411085,0.00007286019],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010746097,0.00028303813,0.0009347667,0.00016510357,0.000024292423,0.000010234174,0.00016266026,0.00026079058,0.00046043843],"category_scores_gemma":[0.00007193684,0.00027035177,0.0002539857,0.00012350077,0.00013095522,0.000022688824,0.00022678968,0.0005313567,0.0000024387314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00512052,0.00080118055,0.39874113,0.017774168,0.0032494746,0.00008214046,0.0027288417,0.00013956062,0.50856096,0.00019503207,0.0016589587,0.060948044],"study_design_scores_gemma":[0.0076129986,0.0011905802,0.16420384,0.0054270704,0.0032377443,0.00006972717,0.00024386586,0.002742189,0.80756336,0.0017841968,0.004957839,0.00096659164],"about_ca_topic_score_codex":0.0000297368,"about_ca_topic_score_gemma":0.0000012326777,"teacher_disagreement_score":0.2990024,"about_ca_system_score_codex":0.0001768082,"about_ca_system_score_gemma":0.00015304706,"threshold_uncertainty_score":0.99997485},"labels":[],"label_agreement":null},{"id":"W4408731079","doi":"10.32000/2072-1757-2025-1-83-88","title":"Taxane-induced acute pain syndrome in patients with breast cancer","year":2025,"lang":"en","type":"article","venue":"Practical medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Taxane; Medicine; Breast cancer; Oncology; Internal medicine; Cancer","score_opus":0.018436983059207226,"score_gpt":0.3792075519894902,"score_spread":0.360770568930283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408731079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8635179,0.00014347254,0.00006148228,0.13147569,0.00035522436,0.00067368016,0.000012452065,0.000042372376,0.0037177324],"genre_scores_gemma":[0.99098593,0.00008162064,0.00013483306,0.0074675684,0.0001104712,0.00012454814,0.000035970468,0.000014724582,0.0010443229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987882,0.00011257781,0.00024884992,0.00028660157,0.0002715142,0.00029230583],"domain_scores_gemma":[0.99907714,0.00038894013,0.00007304545,0.00018228569,0.00011293566,0.00016562434],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029169075,0.00017159479,0.00044474087,0.00019223946,0.00003418756,0.00000396576,0.000048293467,0.00009047421,0.0016079783],"category_scores_gemma":[0.00019450307,0.00010806479,0.000026275151,0.0005083424,0.00010503611,0.00009303472,0.000025253961,0.00038080677,0.000017054119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008567053,0.001781383,0.9372733,0.00014248934,0.0009035879,0.0013564745,0.00012939487,5.6944043e-7,0.00070529827,0.00037580685,0.013519168,0.03524543],"study_design_scores_gemma":[0.015665557,0.0027647659,0.9747074,0.00058389164,0.0010550555,0.00015026875,0.000039272843,0.000049828115,0.00007446741,0.00005868982,0.004731919,0.00011887567],"about_ca_topic_score_codex":0.00059784454,"about_ca_topic_score_gemma":0.0001100701,"teacher_disagreement_score":0.12746803,"about_ca_system_score_codex":0.0002492826,"about_ca_system_score_gemma":0.0002473381,"threshold_uncertainty_score":0.9993047},"labels":[],"label_agreement":null},{"id":"W4408933349","doi":"10.1016/j.jpet.2024.101314","title":"In-Vitro Evaluation of Efficacy and Specificity of Novel Protein Inhibitors of the Oncogenic Myc/Max/E-box Network (Abstract ID: 157603)","year":2025,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"In vitro; Computational biology; Chemistry; Biology; Cancer research; Biochemistry","score_opus":0.051527384515127436,"score_gpt":0.4037711886759621,"score_spread":0.3522438041608347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408933349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98223805,0.015374517,0.0000042050165,0.0008001105,0.00075194257,0.0005995335,0.000006702887,0.0000015226375,0.0002233941],"genre_scores_gemma":[0.99869066,0.0004603423,0.0001650037,0.00043503864,0.00019747751,0.000008645144,0.0000011680194,0.0000070665606,0.000034598568],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988079,0.00013566001,0.0006015524,0.00010227981,0.00022098693,0.00013158636],"domain_scores_gemma":[0.99911153,0.00012575938,0.00051926565,0.00006491314,0.00014256283,0.000035938527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006104393,0.0001231819,0.00042647045,0.00011594861,0.000038138845,0.0000021829458,0.00007841146,0.000101356556,0.00012034294],"category_scores_gemma":[0.0000066307166,0.000087928456,0.00009416738,0.00018966866,0.0002864776,0.00005763305,0.000045774064,0.00025555398,9.19156e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005892426,0.0018813944,0.002151041,0.00006085335,0.00064140826,0.0000033891877,0.0006693898,0.00012371466,0.98525065,0.000037245783,0.00028881762,0.0029996734],"study_design_scores_gemma":[0.014062552,0.00064600504,0.008706847,0.00009992211,0.0008937448,0.000034530385,0.00025103442,0.0001851236,0.97416776,0.00007291019,0.000826396,0.000053171036],"about_ca_topic_score_codex":0.000014990959,"about_ca_topic_score_gemma":0.000001584898,"teacher_disagreement_score":0.016452588,"about_ca_system_score_codex":0.00012216438,"about_ca_system_score_gemma":0.00027284224,"threshold_uncertainty_score":0.35856184},"labels":[],"label_agreement":null},{"id":"W4408936584","doi":"10.1016/j.jpet.2024.100587","title":"Prophylactic Inhibition of Matrix Metalloproteinase-2 Attenuates Anthracycline-Induced Cardiotoxicity by Preventing Junctophilin-2 Proteolysis (Abstract ID: 161175)","year":2025,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Proteolysis; Cardiotoxicity; Matrix metalloproteinase; Anthracycline; Pharmacology; Matrix metalloproteinase inhibitor; Matrix metalloproteinase 9; Chemistry; Cancer research; Medicine; Internal medicine; Cancer; Biochemistry; Toxicity; Enzyme","score_opus":0.02369589794576152,"score_gpt":0.38325157296342605,"score_spread":0.3595556750176645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408936584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98184913,0.015134135,0.00002120086,0.001486222,0.00053650147,0.00077578257,0.000011621713,0.000012784369,0.00017260459],"genre_scores_gemma":[0.99782574,0.00060912105,0.00032944756,0.000737667,0.0002103654,0.000039098668,0.000008915467,0.0000162755,0.00022338936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985512,0.00013467448,0.0006975982,0.00019138606,0.00020222987,0.00022293557],"domain_scores_gemma":[0.99901354,0.00009434282,0.00057609315,0.000082921906,0.00015232193,0.000080770486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036152094,0.00022348616,0.0006549751,0.00020620484,0.00011309785,0.000011531307,0.000076605065,0.00015571385,0.0002161192],"category_scores_gemma":[0.000008198881,0.0001802103,0.00022515401,0.00019684779,0.00017568376,0.00015633258,0.000047669935,0.0004000659,0.0000015026808],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031117513,0.0018144456,0.0014412897,0.00021856022,0.001676997,0.000071419476,0.00026941692,0.000005702291,0.98844093,0.000008228484,0.00043114315,0.00251011],"study_design_scores_gemma":[0.00660325,0.0015967003,0.00058714795,0.000062275125,0.0018557276,0.00013537833,0.00029118216,0.000057275873,0.9872784,0.00007619595,0.001335727,0.00012075353],"about_ca_topic_score_codex":0.000020288886,"about_ca_topic_score_gemma":6.4114545e-7,"teacher_disagreement_score":0.015976572,"about_ca_system_score_codex":0.0001554082,"about_ca_system_score_gemma":0.00019686024,"threshold_uncertainty_score":0.73487633},"labels":[],"label_agreement":null},{"id":"W4408940911","doi":"10.51731/cjht.2025.1104","title":"Venetoclax (Venclexta)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Philosophy; Medicine; Psychology; Internal medicine; Leukemia","score_opus":0.025457065611933158,"score_gpt":0.36479889377678365,"score_spread":0.3393418281648505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408940911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35248598,0.32817414,0.00023709497,0.30726966,0.0021411174,0.00058758707,0.000015510002,0.00017229031,0.008916597],"genre_scores_gemma":[0.9961132,0.0008101452,0.0003012859,0.0020556499,0.000012194885,0.000004632261,0.0000012787166,0.000004754507,0.0006968824],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992844,0.000019746176,0.00029765588,0.00007200215,0.00005503457,0.0002711511],"domain_scores_gemma":[0.9995499,0.000028974586,0.00013740282,0.00012572603,0.00009256035,0.00006539145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020417187,0.00007101143,0.00028511675,0.0006245599,0.000116115036,0.000008004878,0.00012581467,0.00009346847,0.0000658012],"category_scores_gemma":[0.000114883354,0.000058857622,0.000064053515,0.0003170547,0.00013287828,0.00003074527,0.000008597319,0.00028267043,0.000005858954],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006282563,0.00002590406,0.026629714,0.00015424239,0.00015181536,0.00036470848,0.00012467093,0.000008177524,0.00016527966,0.0030352226,0.10002298,0.86925447],"study_design_scores_gemma":[0.0011430521,0.0007604949,0.025850618,0.000302066,0.00005424821,0.00026406013,0.00062805053,0.0000060663674,0.0014045787,0.004448767,0.9650825,0.000055442397],"about_ca_topic_score_codex":0.0025034612,"about_ca_topic_score_gemma":0.0023057824,"teacher_disagreement_score":0.86919904,"about_ca_system_score_codex":0.0010283879,"about_ca_system_score_gemma":0.008324998,"threshold_uncertainty_score":0.99729687},"labels":[],"label_agreement":null},{"id":"W4408996213","doi":"10.1016/s1556-0864(25)00631-8","title":"439P: Standardization of endpoints in early NSCLC randomized clinical trials (RCTs): The DATECAN initiative","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Standardization; Randomized controlled trial; Oncology; Internal medicine; Clinical endpoint; Medical physics; Intensive care medicine","score_opus":0.1275065917859283,"score_gpt":0.5891366432201496,"score_spread":0.4616300514342213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408996213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94978666,0.0025052947,0.0064461282,0.022906542,0.003181567,0.001621435,0.00002737749,0.000008782001,0.013516183],"genre_scores_gemma":[0.9958897,0.0014235075,0.0007072145,0.0011855128,0.00039311606,0.000019150873,0.00000548539,0.0000075753337,0.00036873532],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9901428,0.0071000503,0.0022705162,0.00012467039,0.00020786414,0.00015408198],"domain_scores_gemma":[0.988276,0.0093456535,0.001742488,0.00013991178,0.00042263477,0.00007330868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0216573,0.00011971479,0.0022362901,0.00036157633,0.000032289165,0.000007084029,0.00014119143,0.0001987612,0.00022948401],"category_scores_gemma":[0.006338358,0.000067038614,0.0004902548,0.00034929442,0.00032605557,0.00007936281,0.00004073756,0.0005651017,0.0000025378931],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72630125,0.0016995576,0.013073141,0.00008887294,0.0025355462,0.00029054348,0.0019965773,0.000044603854,0.0014560074,0.00053551776,0.009520277,0.24245813],"study_design_scores_gemma":[0.77890736,0.01520022,0.069687665,0.0015721445,0.013069495,0.00039483534,0.0020090248,0.00039645153,0.024746744,0.012797527,0.08090431,0.0003142227],"about_ca_topic_score_codex":0.00002390262,"about_ca_topic_score_gemma":0.000053366482,"teacher_disagreement_score":0.24214391,"about_ca_system_score_codex":0.000285158,"about_ca_system_score_gemma":0.0015542046,"threshold_uncertainty_score":0.75880647},"labels":[],"label_agreement":null},{"id":"W4409182905","doi":"10.1007/s00520-025-09387-9","title":"Practice patterns in the diagnosis and management of chemotherapy-induced peripheral neuropathy in adolescents and young adults with cancer: a survey of oncologists","year":2025,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Peripheral neuropathy; Vincristine; Cancer; Young adult; Medical record; Pediatric oncology; Chemotherapy; Nursing research; Internal medicine; Intensive care medicine; Cyclophosphamide; Nursing","score_opus":0.028437643587462307,"score_gpt":0.3798294281204562,"score_spread":0.3513917845329939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409182905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99269134,0.0047048186,5.9178956e-7,0.0010415182,0.00012498906,0.0011221437,0.00008856906,0.0000029168843,0.00022311816],"genre_scores_gemma":[0.9769124,0.021546012,0.000009055696,0.00083632657,0.000011149251,0.00064962247,0.000012241565,0.000008902156,0.000014329109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899185,0.00019191817,0.0002637361,0.00025938492,0.0001284856,0.00016464153],"domain_scores_gemma":[0.9994972,0.00009050795,0.00014071257,0.000108566805,0.00013868745,0.00002436298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019959875,0.00012918678,0.00032038026,0.000111198904,0.000011032415,0.0000042336787,0.00005879775,0.000048016907,0.000034328954],"category_scores_gemma":[0.000021640932,0.00009298106,0.00001758446,0.00036451645,0.00007655157,0.00005896876,0.00003213503,0.00015687804,2.8789735e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004763341,0.0004131688,0.94168264,0.0011071595,0.00008226792,0.00021250568,0.0083312495,0.0000043088276,0.000048457787,0.000002134154,0.000054611133,0.04329817],"study_design_scores_gemma":[0.0073664477,0.0007717331,0.9826379,0.0021700484,0.000106026084,0.0000036056592,0.0060413852,0.000011917314,0.00070382,8.005673e-7,0.000114541785,0.0000717808],"about_ca_topic_score_codex":0.060102902,"about_ca_topic_score_gemma":0.20019327,"teacher_disagreement_score":0.14009036,"about_ca_system_score_codex":0.00032561665,"about_ca_system_score_gemma":0.00019253307,"threshold_uncertainty_score":0.94615597},"labels":[],"label_agreement":null},{"id":"W4409209474","doi":"10.24875/recic.m25000505","title":"Seguimiento extendido del bal�n liberador de paclitaxel Essential Pro para restenosis intrastent","year":2025,"lang":"es","type":"letter","venue":"REC, Interventional cardiology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Paclitaxel; Oncology; Cancer research; Internal medicine; Chemotherapy","score_opus":0.03670316582772031,"score_gpt":0.3641109099535619,"score_spread":0.32740774412584156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409209474","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21613675,0.06977142,0.008235241,0.5985189,0.045940995,0.009627171,0.0073306635,0.00078138406,0.04365745],"genre_scores_gemma":[0.5259372,0.012968465,0.0016565595,0.14089546,0.06178899,0.0057109343,0.020305658,0.0005102937,0.23022641],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919019,0.0020635754,0.0018237616,0.0018144757,0.0007059658,0.0016903689],"domain_scores_gemma":[0.99641305,0.000977134,0.00072408526,0.0008903857,0.0005981647,0.0003972028],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0009576541,0.0012014541,0.0026594847,0.000924901,0.00028407722,0.000095109724,0.0007112473,0.002089091,0.006491724],"category_scores_gemma":[0.00027141944,0.0011490269,0.003418575,0.00043145387,0.00064534973,0.00013360885,0.0005537608,0.0026593013,0.00052003434],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024314662,0.0009993358,0.020647123,0.0026473342,0.011916065,0.0038827846,0.00012844527,0.000057714788,0.0011852214,0.0006955852,0.9494087,0.0060002212],"study_design_scores_gemma":[0.0076206955,0.004119801,0.060623106,0.0032951136,0.009359286,0.0024250543,0.00010358929,0.00013524998,0.0007428117,0.0016371787,0.9087341,0.0012040059],"about_ca_topic_score_codex":0.00045126266,"about_ca_topic_score_gemma":0.000042364958,"teacher_disagreement_score":0.45762345,"about_ca_system_score_codex":0.0021464517,"about_ca_system_score_gemma":0.0012361729,"threshold_uncertainty_score":0.9996416},"labels":[],"label_agreement":null},{"id":"W4409569512","doi":"10.3390/cancers17081359","title":"The Effect of Staging Intervals on Progression-Free Survival in Registration Studies of Oncologic Drugs: A Meta-Analysis","year":2025,"lang":"en","type":"article","venue":"Cancers","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Confidence interval; Hazard ratio; Meta-analysis; Internal medicine; Subgroup analysis; Random effects model; Proportional hazards model; Gastroenterology; Oncology; Urology","score_opus":0.08701339651513051,"score_gpt":0.46273568055379016,"score_spread":0.37572228403865965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409569512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718091,0.018133389,0.000009473345,0.0037924068,0.0004221636,0.0008114771,0.000015827783,0.00001353242,0.004992642],"genre_scores_gemma":[0.99797875,0.00051856076,0.000022368988,0.0000964681,0.00001635686,0.00021839359,0.0000045023753,0.0000029830417,0.0011416374],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99905944,0.00023619778,0.00029326303,0.00014748728,0.00016028047,0.00010335203],"domain_scores_gemma":[0.9983735,0.0011117756,0.00019023221,0.00024117736,0.00006716711,0.00001612754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079757895,0.00009609646,0.0007983013,0.00015584487,0.00003363369,0.0000028421464,0.00009290564,0.000031016603,0.00003338643],"category_scores_gemma":[0.00023070244,0.000049318733,0.00034802587,0.0005471674,0.00015626453,0.000016265489,0.000032896834,0.00008493844,2.3166008e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019369278,0.00035540396,0.24778987,0.0023629095,0.6172833,0.000067240886,0.0075291945,0.00728631,0.005835427,0.0015188672,0.028799161,0.061803024],"study_design_scores_gemma":[0.023630368,0.017215218,0.04407033,0.00082034717,0.6802622,0.0000011189092,0.009334759,0.0014001998,0.21404359,0.0013271137,0.0074504544,0.00044431325],"about_ca_topic_score_codex":0.00031352555,"about_ca_topic_score_gemma":0.0009010034,"teacher_disagreement_score":0.20820816,"about_ca_system_score_codex":0.00065728126,"about_ca_system_score_gemma":0.00020261761,"threshold_uncertainty_score":0.20111597},"labels":[],"label_agreement":null},{"id":"W4409625280","doi":"10.1158/1538-7445.am2025-3012","title":"Abstract 3012: A highly potent selective CDK9 inhibitor OBP-004 reduces metastatic tumor burden in bone, brain, lung and lymph nodes and decreases growth of triple-negative breast cancer cells in bone","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Lymph; Medicine; Cancer; Cancer research; Lung; Breast cancer; Lung cancer; Internal medicine; Pathology","score_opus":0.028284781724783745,"score_gpt":0.3899130281984032,"score_spread":0.3616282464736194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675652,0.023846017,6.4940474e-7,0.0064611067,0.00012879103,0.0013450261,0.00026779066,0.000015033691,0.0003704173],"genre_scores_gemma":[0.99212897,0.00574528,0.000062270796,0.00021048666,0.0001516355,0.00084183324,0.000010710217,0.00002670883,0.00082212867],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997647,0.0002778405,0.00047233223,0.00059315976,0.00042096578,0.00058870454],"domain_scores_gemma":[0.99816835,0.00086892105,0.00017201915,0.00014325549,0.0004294931,0.000217943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006776091,0.000252593,0.00072570547,0.00093068514,0.000093417395,0.00003347193,0.000099238176,0.00007956754,0.00015111866],"category_scores_gemma":[0.0002855338,0.00021808842,0.00005937685,0.001291806,0.0004993637,0.00015773562,0.00011619146,0.00045033655,0.0000011632151],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013755718,0.0012241667,0.15394828,0.0028133227,0.0008812508,0.00085565593,0.0050148587,0.000041145966,0.79237247,0.00013362724,0.010906992,0.018052537],"study_design_scores_gemma":[0.01490795,0.0002855681,0.62288266,0.0021724745,0.00022777132,0.000050928917,0.0015316976,0.00020591156,0.356845,0.0005483944,0.00009028513,0.00025135608],"about_ca_topic_score_codex":0.06788778,"about_ca_topic_score_gemma":0.004481331,"teacher_disagreement_score":0.4689344,"about_ca_system_score_codex":0.0011802561,"about_ca_system_score_gemma":0.0019748472,"threshold_uncertainty_score":0.9383192},"labels":[],"label_agreement":null},{"id":"W4409627228","doi":"10.1158/1538-7445.am2025-4357","title":"Abstract 4357: Disparities in neurotoxicities in cisplatin-treated cancer patients: a population pharmacogenomics approach","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Spinal Cord Injury BC; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacogenomics; Medicine; Cisplatin; Population; Cancer; Oncology; Internal medicine; Chemotherapy; Pharmacology; Environmental health","score_opus":0.08408665197021355,"score_gpt":0.45947699120615626,"score_spread":0.3753903392359427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409627228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98973763,0.002322902,8.839425e-7,0.000982104,0.00023869834,0.0015645304,0.00010347272,0.000028729164,0.005021052],"genre_scores_gemma":[0.9928357,0.0023989119,0.000013719709,0.00037085087,0.00012521114,0.0019118829,0.000167416,0.000025488149,0.002150818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982104,0.00013279417,0.00036921416,0.00040460643,0.00032306355,0.00055997074],"domain_scores_gemma":[0.99938124,0.00015705448,0.000047136135,0.00015955971,0.00016446003,0.00009057441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030398442,0.00017605406,0.00035424723,0.0008088318,0.00008995069,0.00003352425,0.00012928587,0.00011428355,0.0004337218],"category_scores_gemma":[0.000042295225,0.00016618634,0.000054379198,0.00101268,0.00012948975,0.00012546602,0.00007315156,0.00065103703,0.0000054900283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017078548,0.0007623215,0.9773494,0.00045969698,0.00007139334,0.00002998543,0.00034709726,0.0004077645,0.008989063,0.00012634802,0.0026189177,0.007130173],"study_design_scores_gemma":[0.006004381,0.00011064404,0.9857077,0.0003114937,0.000039006343,6.6128143e-7,0.00011047756,0.00057773024,0.005347215,0.00014547867,0.0015081862,0.00013702542],"about_ca_topic_score_codex":0.038230725,"about_ca_topic_score_gemma":0.004542515,"teacher_disagreement_score":0.03368821,"about_ca_system_score_codex":0.0015585668,"about_ca_system_score_gemma":0.0003904782,"threshold_uncertainty_score":0.9681738},"labels":[],"label_agreement":null},{"id":"W4409628026","doi":"10.1158/1538-7445.am2025-1605","title":"Abstract 1605: Pretreatment of bone anabolic agent delays or prevents multiple myeloma progression","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coquitlam College","funders":"","keywords":"Anabolism; Multiple myeloma; Medicine; Cancer research; Internal medicine","score_opus":0.11802903711022525,"score_gpt":0.5170269246188987,"score_spread":0.3989978875086734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409628026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832571,0.009184891,0.000005962631,0.0012005068,0.00025422435,0.0018433108,0.000054786506,0.00003417479,0.0041650375],"genre_scores_gemma":[0.978519,0.0030012757,0.00015440304,0.00008552569,0.0001404004,0.0010498872,0.000039794202,0.00002015548,0.016989559],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99824315,0.00009747138,0.00031964504,0.00036001683,0.00050502404,0.00047466706],"domain_scores_gemma":[0.99898887,0.00018151225,0.00007341343,0.0003303602,0.0002499069,0.00017593714],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003530419,0.00015482273,0.00037058146,0.00033417728,0.00012342393,0.0000118322705,0.000117386546,0.00010669493,0.0022633346],"category_scores_gemma":[0.0000622478,0.00010759965,0.00010326406,0.0006472411,0.00016869878,0.000049308932,0.000117402175,0.0002896564,0.00003227963],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014148909,0.004054271,0.1604937,0.0019625593,0.0011994822,0.0005603708,0.0010400901,0.000026336613,0.26981193,0.000074957476,0.06583435,0.48079306],"study_design_scores_gemma":[0.012659435,0.0021894074,0.4022061,0.0018818432,0.0002943799,0.0000147322235,0.00021290942,0.000116881696,0.49592572,0.00009399875,0.08421324,0.00019136381],"about_ca_topic_score_codex":0.00078966125,"about_ca_topic_score_gemma":0.00035267536,"teacher_disagreement_score":0.48060167,"about_ca_system_score_codex":0.000703572,"about_ca_system_score_gemma":0.0010097449,"threshold_uncertainty_score":0.9986487},"labels":[],"label_agreement":null},{"id":"W4409637253","doi":"10.1158/1538-7445.am2025-6919","title":"Abstract 6919: Targeting CLIC3 as a novel strategy to inhibit metastasis in breast cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Breast cancer; Metastasis; Medicine; Cancer; Breast cancer metastasis; Cancer research; Oncology; Internal medicine; Cancer metastasis","score_opus":0.11760117573500518,"score_gpt":0.5142735370755451,"score_spread":0.39667236134053996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409637253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95947874,0.0037775608,0.00000509807,0.020999163,0.0002751713,0.0010604738,0.00017090794,0.00003816207,0.014194713],"genre_scores_gemma":[0.9889045,0.0012099246,0.00004842446,0.0016171728,0.00037510245,0.0012093352,0.000021261874,0.000029488616,0.0065848213],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977467,0.00007436466,0.00034388472,0.0005446605,0.00047792916,0.00081243564],"domain_scores_gemma":[0.99889326,0.00017515486,0.00003803637,0.00024122921,0.00035865823,0.00029364304],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007742901,0.00019215957,0.0004003182,0.00069933856,0.00012895105,0.0000481157,0.00018702632,0.000116366835,0.006140463],"category_scores_gemma":[0.00006342619,0.00017107876,0.00008765766,0.0016919489,0.00011433037,0.000094260344,0.00013969597,0.0007564572,0.000116146926],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048508323,0.0011823655,0.060941458,0.00068211585,0.00060710235,0.00030557983,0.0008758236,0.0006173587,0.67490476,0.00064583827,0.14576857,0.10861817],"study_design_scores_gemma":[0.019321075,0.0011417324,0.5388524,0.0027678488,0.0003857415,0.00005108473,0.0023247232,0.00015762822,0.23405866,0.0006139059,0.199467,0.0008582214],"about_ca_topic_score_codex":0.034879316,"about_ca_topic_score_gemma":0.0056181233,"teacher_disagreement_score":0.4779109,"about_ca_system_score_codex":0.001329087,"about_ca_system_score_gemma":0.002065654,"threshold_uncertainty_score":0.9947681},"labels":[],"label_agreement":null},{"id":"W4409786349","doi":"10.70962/cis2025abstract.169","title":"Clinical and Genetic Characteristics of Global Cohort of 132 Individuals with Janus Kinase-3 Deficiency","year":2025,"lang":"en","type":"article","venue":"Journal of Human Immunity","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children’s Health Research Institute","funders":"","keywords":"Janus; Cohort; Medicine; Janus kinase; Genetics; Internal medicine; Kinase; Biology; Demography; Oncology; Environmental health; Materials science; Nanotechnology","score_opus":0.02760460059912138,"score_gpt":0.37842068128187706,"score_spread":0.35081608068275566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409786349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720246,0.0011898469,0.000015547508,0.000105431114,0.00013364006,0.00013908667,0.000022327093,0.0000022930005,0.0011893895],"genre_scores_gemma":[0.9989724,0.00043373037,0.00039035402,0.00007826741,0.000048825572,9.81998e-7,0.0000036726517,0.0000034885004,0.00006827971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886745,0.00011705045,0.00069572864,0.00006391599,0.00016032206,0.00009551154],"domain_scores_gemma":[0.9989216,0.000097758486,0.00052009977,0.00014631302,0.00025039213,0.000063876476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003926166,0.000085306376,0.0005424746,0.00007566193,0.00005220075,0.000004828899,0.00010119941,0.000060458126,0.000068438036],"category_scores_gemma":[0.000058302157,0.000062329906,0.00008982708,0.00013598138,0.0003274863,0.000027642183,0.000046246972,0.00025202855,3.0192282e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043136612,0.00083162024,0.9924018,0.00010447922,0.0003856097,0.00004405408,0.00008485471,3.4150787e-7,0.0020145676,0.00011007999,0.00022868288,0.0033625837],"study_design_scores_gemma":[0.00316243,0.0029156853,0.991381,0.00020127304,0.0011043715,0.00013974975,0.00006500285,0.0000011350616,0.00066703756,0.00013799623,0.00018300334,0.00004130617],"about_ca_topic_score_codex":0.00007069745,"about_ca_topic_score_gemma":0.00001657455,"teacher_disagreement_score":0.0033212774,"about_ca_system_score_codex":0.0000441131,"about_ca_system_score_gemma":0.00026979327,"threshold_uncertainty_score":0.25417396},"labels":[],"label_agreement":null},{"id":"W4409821253","doi":"10.1158/1538-7445.am2025-lb432","title":"Abstract LB432: Clinical-stage anticancer agent BOLD-100 demonstrates protective effects against oxaliplatin-induced peripheral neuropathy in an in-vivo rat model","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"iCo Therapeutics (Canada)","funders":"","keywords":"Oxaliplatin; In vivo; Peripheral neuropathy; Medicine; Pharmacology; Peripheral; Stage (stratigraphy); Cancer; Oncology; Internal medicine; Biology; Endocrinology; Colorectal cancer","score_opus":0.15867087670373162,"score_gpt":0.5111299242472217,"score_spread":0.3524590475434901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409821253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896667,0.00097181794,0.000017744745,0.0011769269,0.0005308649,0.0031362537,0.00002681579,0.000051900177,0.004420991],"genre_scores_gemma":[0.99451536,0.0010954011,0.00006968747,0.00084613875,0.0002621066,0.0016375658,0.000010395219,0.000045828943,0.0015175152],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965021,0.00062783645,0.0006131047,0.0008720459,0.00048691826,0.00089797337],"domain_scores_gemma":[0.99843264,0.0005036594,0.00008363184,0.00045064124,0.0002314709,0.0002979443],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013260676,0.00029709507,0.000665994,0.0005495907,0.00015624109,0.00006079542,0.00025771649,0.00024543153,0.0002968278],"category_scores_gemma":[0.00018046732,0.00026659144,0.00013259993,0.0010876362,0.00029836904,0.0001918102,0.00012107261,0.0016751302,0.000011544655],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004408918,0.0018840953,0.17942864,0.0007204752,0.00012290286,0.00110453,0.00091046526,0.002992457,0.78530294,0.00013994565,0.0011072346,0.021877412],"study_design_scores_gemma":[0.027443558,0.0039333347,0.4875073,0.0022937688,0.00014671289,0.0000056903878,0.0007383985,0.049326155,0.42523757,0.0006386464,0.0018744976,0.0008543587],"about_ca_topic_score_codex":0.0014311547,"about_ca_topic_score_gemma":0.0039205425,"teacher_disagreement_score":0.36006537,"about_ca_system_score_codex":0.001215169,"about_ca_system_score_gemma":0.0020178908,"threshold_uncertainty_score":0.9999786},"labels":[],"label_agreement":null},{"id":"W4409917815","doi":"10.1371/journal.pone.0322371","title":"A remotely delivered exercise-based rehabilitation program for patients with persistent chemotherapy-induced peripheral neuropathy (EX-CIPN): Protocol for a phase I feasibility trial","year":2025,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary; Canadian Breast Cancer Network; Princess Margaret Cancer Centre; University of Waterloo; Canadian Cancer Society; University of Toronto","funders":"Cancer Research Society","keywords":"Chemotherapy-induced peripheral neuropathy; Medicine; Physical therapy; Rehabilitation; Randomized controlled trial; Adverse effect; Intervention (counseling); Peripheral neuropathy; Internal medicine; Psychiatry","score_opus":0.07331928424602854,"score_gpt":0.37915361167379424,"score_spread":0.30583432742776573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409917815","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64219636,0.0000042808156,0.000057449928,0.0008476096,0.00004648711,0.35665476,0.00003758677,0.00009659975,0.00005889835],"genre_scores_gemma":[0.3556903,5.7411717e-7,0.01879268,0.00059971923,0.00012706724,0.62418085,0.00019726434,0.000044125034,0.00036742078],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984708,0.00007142508,0.00036504338,0.000521321,0.0002636486,0.000307771],"domain_scores_gemma":[0.99862,0.00019685418,0.0001484163,0.00030490232,0.0006132079,0.000116646304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014855187,0.00024183097,0.0005284382,0.00009976422,0.00012209572,0.000024940608,0.00007754491,0.00010037602,0.000047792953],"category_scores_gemma":[0.00016096087,0.00019522864,0.00028796328,0.00021368953,0.00006790431,0.000061922976,0.000009896306,0.00010385301,8.9263415e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85439336,0.097360976,0.0087181395,0.0022988184,0.00058898894,0.000001582681,0.0003787969,0.0000017839083,0.0054567466,0.0000029361584,0.00068013335,0.030117722],"study_design_scores_gemma":[0.81270105,0.16104178,0.007333084,0.00085179217,0.0018629516,1.9978312e-7,0.00006039665,0.0053476193,0.009286191,0.00004213681,0.0011863875,0.0002863901],"about_ca_topic_score_codex":0.000014159956,"about_ca_topic_score_gemma":0.000009240209,"teacher_disagreement_score":0.28650603,"about_ca_system_score_codex":0.00041135654,"about_ca_system_score_gemma":0.00040443428,"threshold_uncertainty_score":0.7961193},"labels":[],"label_agreement":null},{"id":"W4410642937","doi":"10.2196/65924","title":"Effect of Immersive Virtual Reality on Chemotherapy-Related Side Effects in Patients Receiving Paclitaxel-Carboplatin With or Without Bevacizumab: 2-Arm Randomized Controlled Trial","year":2025,"lang":"en","type":"article","venue":"Journal of Medical Internet Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Paclitaxel; Carboplatin; Bevacizumab; Randomized controlled trial; Medicine; Oncology; Internal medicine; Cancer; Chemotherapy; Cisplatin","score_opus":0.020467767564954525,"score_gpt":0.42765156547027355,"score_spread":0.407183797905319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410642937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98741305,0.00025797778,0.00004779087,0.0031135182,0.0006124907,0.005178001,0.000001219167,0.0000059140207,0.0033700631],"genre_scores_gemma":[0.997246,0.00027095954,0.000010857069,0.00020368832,0.00017421637,0.00016314392,0.000005252592,0.0000195309,0.0019063462],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9905897,0.0050217235,0.0014048524,0.00026452058,0.0023150728,0.00040418108],"domain_scores_gemma":[0.98083335,0.01762226,0.0005544195,0.00018995108,0.00048948335,0.00031053033],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.015134378,0.00024541822,0.002961919,0.0008096673,0.000029483354,0.000017482651,0.0002899869,0.00032483213,0.00059618533],"category_scores_gemma":[0.012053329,0.00012025487,0.00043941938,0.00052602426,0.00050495606,0.000054536387,0.000070343165,0.0018621378,0.0000038177695],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9693133,0.0021448748,0.0038463995,0.000242795,0.0027305458,0.00035812616,0.00083665794,0.000004378152,0.00020799172,0.00005814246,0.0012932164,0.018963538],"study_design_scores_gemma":[0.9307703,0.057229675,0.0011507219,0.0038920676,0.00052111945,0.000018724291,0.00007622034,0.0010895253,0.005076644,0.000046861463,0.000049941613,0.00007821813],"about_ca_topic_score_codex":0.00036896596,"about_ca_topic_score_gemma":0.00008092583,"teacher_disagreement_score":0.0550848,"about_ca_system_score_codex":0.0005335126,"about_ca_system_score_gemma":0.0009344252,"threshold_uncertainty_score":0.9962686},"labels":[],"label_agreement":null},{"id":"W4410818215","doi":"10.1200/jco.2025.43.16_suppl.tps4630","title":"ABLE-22: Safety and efficacy evaluation of nadofaragene firadenovec alone or in combination with chemotherapy or immunotherapy—A randomized, open-label, phase 2 study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McGill University Health Centre","funders":"","keywords":"Medicine; Oncology; Immunotherapy; Open label; Chemotherapy; Internal medicine; Randomized controlled trial; Cancer","score_opus":0.17611272513261214,"score_gpt":0.5627920855961613,"score_spread":0.3866793604635492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410818215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846995,0.0016882645,0.0001814131,0.00893836,0.00046522988,0.0029900875,0.0000024852002,0.0000041210983,0.0010305624],"genre_scores_gemma":[0.99085224,0.004713312,0.0011516083,0.0020221986,0.00012667412,0.000041503383,0.000005258242,0.000014365664,0.0010728333],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9949242,0.0018033958,0.002524041,0.00021077588,0.00038709556,0.00015047888],"domain_scores_gemma":[0.9924452,0.005046551,0.0016417189,0.00015957606,0.000609576,0.00009742266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011880603,0.00015999976,0.0026344713,0.0002413841,0.000040492625,0.000011398182,0.00016831752,0.00020572935,0.00078415504],"category_scores_gemma":[0.001699907,0.00008882547,0.00010299066,0.0003849445,0.00024768515,0.0001242205,0.00003686483,0.00046647456,7.68775e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66400045,0.031296145,0.002769317,0.000020885263,0.0016204775,0.00012934157,0.0003869618,0.00001698884,0.00028051503,0.000024570067,0.0004603419,0.298994],"study_design_scores_gemma":[0.8962673,0.062433638,0.0331458,0.00017929613,0.001812399,0.00010396161,0.00018608541,0.00082576677,0.0001802423,0.00013525189,0.0046513933,0.00007889321],"about_ca_topic_score_codex":0.00009362495,"about_ca_topic_score_gemma":0.00025429708,"teacher_disagreement_score":0.29891512,"about_ca_system_score_codex":0.00029117748,"about_ca_system_score_gemma":0.0031591002,"threshold_uncertainty_score":0.8585948},"labels":[],"label_agreement":null},{"id":"W4410851732","doi":"10.31027/odprn.2025.03","title":"Hydromorphone dispensing across Public Health Units in Ontario, Canada","year":2025,"lang":"en","type":"report","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hydromorphone; Business; Geography; Medicine","score_opus":0.1421986454523517,"score_gpt":0.390048475903994,"score_spread":0.2478498304516423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410851732","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36839262,0.003894815,0.0000059859512,0.025097914,0.007881722,0.0018951435,0.00029530068,0.00010123755,0.5924353],"genre_scores_gemma":[0.35658714,0.0011054091,0.000036761772,0.0046034087,0.00022323853,0.000034084078,0.0030646431,0.00003038707,0.6343149],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977622,0.00005276129,0.0005442581,0.00042275834,0.0005320326,0.0006860125],"domain_scores_gemma":[0.9988015,0.000084686515,0.00019149997,0.00029809744,0.0003072921,0.00031689872],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043069193,0.0002994038,0.0010097999,0.00016126703,0.00008987498,0.00002124204,0.000084093524,0.0002003977,0.002651351],"category_scores_gemma":[0.00007081106,0.00026322593,0.00006169717,0.00051436963,0.00003969911,0.000030725347,0.000088910536,0.00082611,0.000004157059],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000061019582,0.00019747243,0.10519168,0.00037363078,0.00035428882,0.0014304797,0.0004219179,0.0000012002919,0.0000080954105,0.0000073202623,0.8787144,0.013238491],"study_design_scores_gemma":[0.0017387178,0.00012159745,0.07570325,0.00034909934,0.00006517693,0.00024021506,0.00009672279,0.0000040513123,0.000015894691,0.000001941553,0.9214958,0.0001675528],"about_ca_topic_score_codex":0.9998906,"about_ca_topic_score_gemma":0.99999493,"teacher_disagreement_score":0.13988088,"about_ca_system_score_codex":0.01938044,"about_ca_system_score_gemma":0.15926132,"threshold_uncertainty_score":0.999982},"labels":[],"label_agreement":null},{"id":"W4411015928","doi":"10.1007/s00520-025-09553-z","title":"Cannabidiol and multi-modal exercise for chemotherapy-induced peripheral neuropathy in cancer survivors","year":2025,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Jewish General Hospital; McGill University; Concordia University; McGill University Health Centre","funders":"Fondation du cancer des Cèdres; Canadian Institutes of Health Research; Réseau de cancérologie Rossy","keywords":"Medicine; Pain medicine; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Nursing research; Cannabidiol; Chemotherapy; Cancer; Peripheral; Physical therapy; Internal medicine; Oncology; Physical medicine and rehabilitation; Intensive care medicine; Diabetes mellitus; Anesthesia; Pathology; Psychiatry","score_opus":0.02979570122995216,"score_gpt":0.39500522739729105,"score_spread":0.36520952616733887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411015928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98433113,0.009959164,0.000008188768,0.0025084182,0.0009733102,0.0017427963,0.00017980144,0.000026552083,0.00027064723],"genre_scores_gemma":[0.9903193,0.003502342,0.00006372158,0.00189489,0.00013365754,0.0023569737,0.000038359645,0.000030106426,0.001660637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868834,0.000040753974,0.00030060217,0.0004760602,0.00009559774,0.00039864128],"domain_scores_gemma":[0.99947464,0.000043713044,0.00006903139,0.00013775934,0.00018087782,0.00009394831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000853675,0.00023785491,0.0004956744,0.00020668891,0.00004172884,0.000010619784,0.000066510176,0.00012707707,0.00031344258],"category_scores_gemma":[0.0000203072,0.00022257122,0.00008902813,0.00032232428,0.00007430977,0.0000739104,0.000028982557,0.00021100114,5.409917e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030352077,0.00026400783,0.85818845,0.0005157781,0.00008821271,0.00009323243,0.0073447763,0.000037388243,0.010487565,0.000009267574,0.0013958411,0.118540265],"study_design_scores_gemma":[0.020930488,0.0007808646,0.9200145,0.00073887315,0.0002591579,0.000004174967,0.0033179517,0.00068622857,0.028534828,0.000024924533,0.024269022,0.00043896018],"about_ca_topic_score_codex":0.020466598,"about_ca_topic_score_gemma":0.09458497,"teacher_disagreement_score":0.118101306,"about_ca_system_score_codex":0.00095716974,"about_ca_system_score_gemma":0.0008570167,"threshold_uncertainty_score":0.9860562},"labels":[],"label_agreement":null},{"id":"W4411048955","doi":"10.1016/j.acci.2025.05.004","title":"Azul de metileno como terapia complementaria en el manejo del shock séptico refractario en los pacientes con cáncer: experiencia clínica","year":2025,"lang":"es","type":"article","venue":"Acta Colombiana de Cuidado Intensivo","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Information and Communications Technology Council","keywords":"Medicine; Humanities; Art","score_opus":0.013509889801242653,"score_gpt":0.35029425572198314,"score_spread":0.33678436592074046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411048955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96481276,0.004508829,0.00020547584,0.017375248,0.002136338,0.0022455335,0.00044777308,0.00023410063,0.008033964],"genre_scores_gemma":[0.96456444,0.0025296586,0.0009125306,0.02269992,0.00057605584,0.00039368807,0.00043805086,0.000118487726,0.007767152],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940526,0.00079437427,0.0013630639,0.0013151625,0.0005852573,0.0018895377],"domain_scores_gemma":[0.9950318,0.0018324399,0.0004662145,0.0011280054,0.0008345045,0.00070707715],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088045537,0.0010163492,0.0017034756,0.0006120794,0.0004913436,0.00024820093,0.000931573,0.0007186992,0.0052459124],"category_scores_gemma":[0.0008118935,0.0010435275,0.00053015567,0.00075102167,0.0006032724,0.00028253777,0.0006023164,0.0013707095,0.0001953396],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054621166,0.0029299196,0.27185172,0.000754902,0.0051678503,0.0013460197,0.015265469,0.000007907606,0.23419726,0.0046029156,0.44879052,0.009623411],"study_design_scores_gemma":[0.01488326,0.0037366536,0.13491791,0.0017735694,0.0051585506,0.00038723453,0.012304688,0.0030542305,0.03601807,0.0006439531,0.78575534,0.0013665227],"about_ca_topic_score_codex":0.0078104986,"about_ca_topic_score_gemma":0.002317608,"teacher_disagreement_score":0.33696485,"about_ca_system_score_codex":0.0039154105,"about_ca_system_score_gemma":0.0019954806,"threshold_uncertainty_score":0.9999084},"labels":[],"label_agreement":null},{"id":"W4411257548","doi":"10.1016/j.jbc.2025.108742","title":"Abstract 2631 Neutral sphingomyelinase 2 and Extracellular Vesicles in Doxorubicin-induced Cardiotoxicity","year":2025,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Cardiotoxicity; Doxorubicin; Extracellular vesicles; Vesicle; Extracellular; Sphingomyelin; Chemistry; Cancer research; Pharmacology; Cell biology; Medicine; Biochemistry; Internal medicine; Biology; Chemotherapy; Membrane","score_opus":0.032158003070425836,"score_gpt":0.320819838211508,"score_spread":0.2886618351410822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411257548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363273,0.0036511899,0.00000318265,0.0011063148,0.00009042921,0.00008325524,0.000003703918,0.000008277423,0.001420913],"genre_scores_gemma":[0.9988226,0.0005048554,0.00008370757,0.00018956316,0.0002572064,0.0000022935094,0.0000036056633,0.0000034419043,0.00013272278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992297,0.000020316204,0.00037163368,0.00014223691,0.000067833644,0.00016822097],"domain_scores_gemma":[0.9995174,0.000110026645,0.00013010844,0.00007620999,0.000049166276,0.00011711443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002471655,0.00012142098,0.00040098376,0.00004319226,0.000026547817,0.000009448939,0.00006666985,0.0001902546,0.000105169405],"category_scores_gemma":[0.00007672695,0.00008294932,0.00013057046,0.00010449432,0.000073327006,0.000030545925,0.000027643988,0.0004435956,7.702147e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000582183,0.00026608852,0.04371588,0.00008601169,0.00007830501,0.0006642969,0.000023322671,0.0000035000855,0.95134294,0.000006423058,0.00021274589,0.0030182777],"study_design_scores_gemma":[0.0022023567,0.00020453699,0.22333112,0.000110987916,0.00006777779,0.00019336032,0.00006655435,0.000006438971,0.7724041,0.00017566397,0.0011707038,0.00006640618],"about_ca_topic_score_codex":0.000018675471,"about_ca_topic_score_gemma":0.0000017464394,"teacher_disagreement_score":0.17961523,"about_ca_system_score_codex":0.00009847058,"about_ca_system_score_gemma":0.00009932274,"threshold_uncertainty_score":0.3382575},"labels":[],"label_agreement":null},{"id":"W4411302561","doi":"10.69854/jcq.2025.0014","title":"The Effectiveness of Cryotherapy or Compression Therapy in Preventing Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Network Meta-Analysis","year":2025,"lang":"en","type":"review","venue":"Journal of Clinical Question","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Meta-analysis; Peripheral neuropathy; Medicine; Chemotherapy-induced peripheral neuropathy; Peripheral; Systematic review; Chemotherapy; Oncology; Internal medicine; MEDLINE; Biology; Endocrinology","score_opus":0.20216772835175253,"score_gpt":0.5373493894484948,"score_spread":0.3351816610967422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411302561","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028200325,0.99619764,0.00005905329,0.00019284843,0.00025949973,0.0029802683,0.000002491779,0.000005373698,0.000020802221],"genre_scores_gemma":[0.00057548843,0.9984435,0.000089380446,0.00032903918,0.00020374246,0.00014322078,0.0000056296913,0.000021920247,0.00018811048],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98528373,0.010543863,0.0034877097,0.00024391971,0.0002829674,0.00015783402],"domain_scores_gemma":[0.9855235,0.0101454565,0.0036765505,0.00030246444,0.000269434,0.00008256299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012927388,0.00032189352,0.010742515,0.00017140116,0.000050985916,0.000020294654,0.00018537695,0.00023563315,0.000057597237],"category_scores_gemma":[0.001112517,0.00013630497,0.0034003737,0.00077998376,0.000059413276,0.000052909487,0.000023531598,0.00071579893,2.3069892e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027149601,0.00063877157,0.0004416392,0.693865,0.13219146,0.000047033736,0.000015861637,0.000009557306,0.0000023725008,0.000018670999,0.00006824678,0.16998646],"study_design_scores_gemma":[0.0026475715,0.0021746391,0.0011936198,0.36212835,0.6239998,0.00009295006,0.000001977706,0.000024379104,0.0000016106211,0.000066484885,0.0075195194,0.00014914948],"about_ca_topic_score_codex":0.000008699837,"about_ca_topic_score_gemma":0.0000074254312,"teacher_disagreement_score":0.4918083,"about_ca_system_score_codex":0.000072037874,"about_ca_system_score_gemma":0.00046397728,"threshold_uncertainty_score":0.7343369},"labels":[],"label_agreement":null},{"id":"W4411649910","doi":"10.1177/10732748251353327","title":"Enhancing Duloxetine With Mirogabalin for Treating Taxane-Induced Peripheral Neuropathy in Advanced Lung Cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Control","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"","keywords":"Medicine; Duloxetine; Chemotherapy-induced peripheral neuropathy; Interquartile range; Internal medicine; Lung cancer; Taxane; Oncology; Cancer; Peripheral neuropathy; Breast cancer","score_opus":0.008538142592791792,"score_gpt":0.3406774960586971,"score_spread":0.33213935346590534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411649910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833795,0.007337568,0.00092101673,0.004564241,0.00067421864,0.0022363875,0.000066865774,0.000076695585,0.0007435228],"genre_scores_gemma":[0.98939973,0.00024141927,0.00026019118,0.0030951302,0.0004022139,0.0039975573,0.00001755004,0.0000404127,0.0025457973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854946,0.000051933774,0.00033832205,0.0004642364,0.00011706762,0.0004789533],"domain_scores_gemma":[0.9992676,0.00016724474,0.00013166179,0.00018221562,0.00014648073,0.00010482999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010224938,0.0002733961,0.0006093185,0.00014601798,0.000099185476,0.000016203354,0.00007952714,0.0000828112,0.00025939138],"category_scores_gemma":[0.00004389248,0.00022552084,0.0001097597,0.00032702356,0.0000369824,0.00008012537,0.000013502428,0.00021127315,7.0590426e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014940653,0.0003626031,0.29538083,0.00074723235,0.0006840312,0.00016757648,0.0009273774,0.0014840955,0.6125518,0.00008603914,0.0007465357,0.071921244],"study_design_scores_gemma":[0.34149775,0.005880302,0.18903796,0.006227951,0.006281599,0.00006252794,0.0013289512,0.06425392,0.3486721,0.000054522152,0.034669284,0.0020331244],"about_ca_topic_score_codex":0.0009334204,"about_ca_topic_score_gemma":0.005318427,"teacher_disagreement_score":0.3265571,"about_ca_system_score_codex":0.0007141366,"about_ca_system_score_gemma":0.00062818493,"threshold_uncertainty_score":0.9196473},"labels":[],"label_agreement":null},{"id":"W4411995564","doi":"10.1136/bcr-2025-265205","title":"Multiday intravenous ketamine infusion therapy for the management of central sensitisation syndrome secondary to chronic chemotherapy–induced peripheral neuropathic pain","year":2025,"lang":"en","type":"article","venue":"BMJ Case Reports","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Ketamine; Chronic pain; Anesthesia; Refractory (planetary science); Analgesic; Neuropathic pain; Cancer pain; Cancer; Internal medicine; Physical therapy","score_opus":0.01782999677625906,"score_gpt":0.31770209473204847,"score_spread":0.2998720979557894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411995564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98900455,0.00071004126,0.0021661744,0.00298147,0.0007131287,0.004143785,0.0000058845776,0.000040554853,0.00023439342],"genre_scores_gemma":[0.99619377,0.00036076372,0.0002765667,0.0016279849,0.00014652,0.0003184306,0.000037091842,0.000023112503,0.0010157543],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987346,0.00012458664,0.0004398898,0.00029387255,0.00015237587,0.0002546598],"domain_scores_gemma":[0.999181,0.00014339547,0.00016876285,0.0003501734,0.00008448009,0.00007222884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009707345,0.00016815959,0.0003000328,0.00008482182,0.00010915125,0.000011823022,0.000029105298,0.00006670717,0.00018294311],"category_scores_gemma":[0.000025246149,0.00012398306,0.00013138134,0.00018717223,0.000031378157,0.000027472548,0.0000278722,0.00011122259,7.475428e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011380557,0.00049662206,0.0012182457,0.00069815974,0.00084154884,0.13625589,0.0009465034,0.00016485644,0.046335526,0.000019613975,0.0011173891,0.8107676],"study_design_scores_gemma":[0.02326435,0.010491849,0.40410158,0.0015481347,0.0018423949,0.40089196,0.0010161125,0.013964972,0.07266284,0.00012455795,0.06921002,0.00088125106],"about_ca_topic_score_codex":0.00018297991,"about_ca_topic_score_gemma":0.00006362883,"teacher_disagreement_score":0.80988634,"about_ca_system_score_codex":0.00026808752,"about_ca_system_score_gemma":0.0002482751,"threshold_uncertainty_score":0.50558823},"labels":[],"label_agreement":null},{"id":"W4412048074","doi":"10.51731/cjht.2025.1159","title":"Semaglutide (Wegovy)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Semaglutide; Medicine; Endocrinology","score_opus":0.02301648044997576,"score_gpt":0.35637882620294414,"score_spread":0.33336234575296836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412048074","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32250255,0.24447557,0.00018144377,0.4236061,0.0016136549,0.0004419455,0.000014378045,0.00016103653,0.0070033115],"genre_scores_gemma":[0.9948557,0.0006935634,0.00043042735,0.0028212902,0.000012128825,0.000004049695,0.0000011089487,0.000005208677,0.001176496],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99921477,0.000021452146,0.00033195864,0.00007647232,0.0000576717,0.0002976801],"domain_scores_gemma":[0.9994917,0.00004741775,0.00014878353,0.0001326742,0.000106352345,0.00007306144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022768325,0.00007861363,0.00031707092,0.0007270835,0.00012189616,0.0000080853,0.00012583543,0.000093436276,0.000068462745],"category_scores_gemma":[0.00021548639,0.00006339084,0.000069592636,0.00035450078,0.00014275084,0.00002402907,0.000009182168,0.00031097996,0.0000064528363],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059377817,0.000042070744,0.055865947,0.00017895877,0.00017668144,0.00046523687,0.00012214342,0.0000033785545,0.00015399934,0.002796503,0.14617085,0.79396486],"study_design_scores_gemma":[0.0012546219,0.00061629113,0.0346908,0.00030390808,0.00006560564,0.00034370506,0.0008229221,0.0000031182242,0.0016359845,0.0032175104,0.9569859,0.000059658178],"about_ca_topic_score_codex":0.002898864,"about_ca_topic_score_gemma":0.0039191092,"teacher_disagreement_score":0.81081504,"about_ca_system_score_codex":0.0005842311,"about_ca_system_score_gemma":0.00543191,"threshold_uncertainty_score":0.9635975},"labels":[],"label_agreement":null},{"id":"W4412166556","doi":"10.1017/cjn.2025.10214","title":"P.033 Long-term efficacy of Efgartigimod PH20 SC in patients with chronic inflammatory demyelinating polyneuropathy: interim results from the ADHERE+ study","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chronic inflammatory demyelinating polyneuropathy; Medicine; Interim; Term (time); Internal medicine; Immunology; Antibody; Political science; Physics","score_opus":0.027385750175935825,"score_gpt":0.3082753978035754,"score_spread":0.28088964762763957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412166556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950312,0.00086943165,0.000003294072,0.0024947852,0.0006031565,0.00052427844,0.000016398306,0.000009639344,0.00044781197],"genre_scores_gemma":[0.9982096,0.00009045835,0.00006379289,0.0014298563,0.00017683074,0.000004196112,0.000001001218,0.000008917718,0.00001535473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957946,0.0010463105,0.0011215217,0.00050953915,0.0006225571,0.0009054929],"domain_scores_gemma":[0.996687,0.0012280453,0.0008535474,0.00019765076,0.00039345914,0.00064027787],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0025376135,0.0002975592,0.00058611686,0.00073841686,0.0009042831,0.00015775191,0.0013014615,0.00010937638,0.00007266016],"category_scores_gemma":[0.0016467787,0.00016427282,0.00015143106,0.0013907406,0.003522489,0.0004155605,0.00009324063,0.0012252687,9.530205e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001437437,0.0002319563,0.99142486,0.000005696703,0.00004506309,0.0016118309,0.0006166896,0.00068235764,0.0000274288,0.000025053923,0.00008257178,0.003809044],"study_design_scores_gemma":[0.0035791185,0.06714894,0.92794484,0.00014355629,0.00011194343,0.00035004993,0.00012410339,0.00011775382,0.00007033109,0.00020292045,0.00008052589,0.00012590743],"about_ca_topic_score_codex":0.0030468951,"about_ca_topic_score_gemma":0.18238223,"teacher_disagreement_score":0.17933533,"about_ca_system_score_codex":0.00040507223,"about_ca_system_score_gemma":0.0048166593,"threshold_uncertainty_score":0.9991894},"labels":[],"label_agreement":null},{"id":"W4412443876","doi":"10.1016/j.jval.2025.04.227","title":"CO142 Association Between Event-Free/Distant Relapse-Free Survival and Overall Survival in Patients With Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Luminex (Canada)","funders":"","keywords":"Estrogen receptor; Oncology; Human Epidermal Growth Factor Receptor 2; Breast cancer; Stage (stratigraphy); Internal medicine; Medicine; Overall survival; Estrogen; Association (psychology); Cancer; Biology; Psychology; Psychotherapist","score_opus":0.021796428215652187,"score_gpt":0.3126796995815,"score_spread":0.2908832713658478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876352,0.00025729847,0.000009440695,0.006300174,0.00059972407,0.0016430327,0.0031465772,0.000047787493,0.0003607477],"genre_scores_gemma":[0.9973915,0.0003751667,0.00018150268,0.000291962,0.00021123071,0.000108948465,0.00039923177,0.000046247413,0.000994213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964717,0.00091915816,0.0007496436,0.00061463733,0.0005484074,0.0006964372],"domain_scores_gemma":[0.99811095,0.00063453015,0.00044187694,0.00032895544,0.0002167833,0.0002668775],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070964056,0.0003615823,0.00089836936,0.000288376,0.00017204207,0.000028645438,0.00019047676,0.00021657998,0.00025111414],"category_scores_gemma":[0.00017415915,0.0003300927,0.000075858006,0.0004969128,0.00009032232,0.00019658558,0.00012925966,0.0006005176,0.0000042220404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001832997,0.000507758,0.99329466,0.00026074683,0.00035357662,0.0000070840674,0.0010921865,0.000023524073,0.00005120454,0.00070659834,0.0012665518,0.00060309126],"study_design_scores_gemma":[0.017106961,0.0011235737,0.9799847,0.00056976406,0.00009231037,3.3707676e-7,0.00009782477,0.000018039811,0.00020955823,0.00029450297,0.00025681124,0.00024563872],"about_ca_topic_score_codex":0.074909285,"about_ca_topic_score_gemma":0.0040836185,"teacher_disagreement_score":0.070825666,"about_ca_system_score_codex":0.0036577347,"about_ca_system_score_gemma":0.00071940874,"threshold_uncertainty_score":0.9999151},"labels":[],"label_agreement":null},{"id":"W4412474024","doi":"10.3390/tomography11070081","title":"TACE Versus TARE in the Treatment of Liver-Metastatic Breast Cancer: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Tomography","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Breast cancer; Metastatic breast cancer; Internal medicine; Oncology; Cancer; Overall survival; Liver cancer","score_opus":0.0575185709616946,"score_gpt":0.4119265318816077,"score_spread":0.3544079609199131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412474024","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004368716,0.99039924,2.777389e-7,0.00023920118,0.00024933036,0.008000809,0.0005975755,0.000020962982,0.00048820663],"genre_scores_gemma":[0.000016192927,0.99436945,0.000017149276,0.00017839768,0.00006664506,0.0047839237,0.00021396996,0.000021388083,0.0003329014],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9978525,0.0005071919,0.00082174886,0.000324878,0.0002454279,0.0002482248],"domain_scores_gemma":[0.9980855,0.0007505593,0.0004543498,0.0005821018,0.0000656523,0.00006182754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001951976,0.00046112738,0.004055536,0.00049142644,0.000031363397,0.00000719555,0.00022454477,0.0000911772,0.00029498487],"category_scores_gemma":[0.000015213053,0.00024108915,0.0014059715,0.0017564459,0.00007152847,0.000020210282,0.000015013939,0.0001592993,0.000013279863],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072798444,0.0007972055,0.000017865963,0.87416214,0.002100575,0.00014572842,0.00014277034,3.873551e-8,1.9926826e-8,0.000015413152,0.0015843508,0.12096108],"study_design_scores_gemma":[0.0017392017,0.000792885,0.000017761164,0.6957331,0.058451384,0.00010997542,0.000027734668,4.4059016e-7,1.5002902e-7,0.0000014056615,0.24297374,0.00015225534],"about_ca_topic_score_codex":0.0005515271,"about_ca_topic_score_gemma":0.00027968118,"teacher_disagreement_score":0.2413894,"about_ca_system_score_codex":0.00028625978,"about_ca_system_score_gemma":0.00047086488,"threshold_uncertainty_score":0.983133},"labels":[],"label_agreement":null},{"id":"W4412479885","doi":"10.1016/j.annonc.2025.05.048","title":"36P BREAKWATER: Post-hoc subgroup efficacy analyses by chemotherapy ± bevacizumab regimens vs encorafenib plus cetuximab + mFOLFOX6","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Sunnybrook Health Science Centre","funders":"Cilag; MSD K.K.; Chugai Pharmaceutical; EMD Serono; Nordic Pharma Group; Novocure; Menarini Group; American Association for Cancer Research; Incyte; Servier; Pfizer Japan; Sociedad Española de Oncología Médica; PharmaMar; Novartis Farmacéutica; Daiichi Sankyo Europe; European Society for Medical Oncology; Astellas Pharma; Eisai; Miyarisan Pharmaceutical; Daiichi-Sankyo; AstraZeneca; Genentech; University of Oxford; Sirtex Medical; Cancer Research UK; Springworks Therapeutics; Seagen; Sysmex Corporation; BeiGene; Mirati Therapeutics; Takeda Pharmaceutical Company; Ono Pharmaceutical; Eli Lilly and Company; Les Laboratories Pierre Fabre; Pfizer; Taiho Pharmaceutical; Boehringer Ingelheim Japan; Merck KGaA; Natera; Regeneron Pharmaceuticals; Ipsen; Array BioPharma; Amgen; Bristol-Myers Squibb; American Society of Clinical Oncology; Revolution Medicines; Exelixis; Sanofi; Celgene","keywords":"Medicine; Bevacizumab; Cetuximab; Oncology; Post-hoc analysis; Internal medicine; Chemotherapy; Post hoc; Cancer; Colorectal cancer","score_opus":0.08269816231793721,"score_gpt":0.46742718925177834,"score_spread":0.38472902693384115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412479885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9135136,0.005813805,0.000042185187,0.058948796,0.00053373683,0.0007483366,0.00009092325,0.000104990075,0.020203656],"genre_scores_gemma":[0.9649504,0.004202761,0.00027481464,0.019024447,0.00020179029,0.0000582113,0.0002822299,0.00003578271,0.010969555],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99792963,0.00017435299,0.00061159435,0.00051104283,0.00020855827,0.0005648417],"domain_scores_gemma":[0.99833053,0.00038266237,0.00027412816,0.00045764798,0.00037334816,0.0001816807],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026022468,0.0003316842,0.0012102628,0.00035558047,0.000094309944,0.000011057033,0.00024530257,0.0003430271,0.0010190122],"category_scores_gemma":[0.000051540035,0.00028395432,0.00036004643,0.00048621066,0.00029275139,0.00008121843,0.0000756024,0.00027791798,0.000057741196],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03745692,0.0070520323,0.0023651812,0.00024240068,0.0034953787,0.00031256708,0.0017084007,0.000016637467,0.17214352,0.0004263246,0.6154996,0.159281],"study_design_scores_gemma":[0.03049179,0.02091411,0.0074380133,0.00009905385,0.00093519955,0.000107100765,0.00018394335,0.00006319322,0.17384183,0.00028357963,0.76530915,0.00033300402],"about_ca_topic_score_codex":0.00061389926,"about_ca_topic_score_gemma":0.000120919845,"teacher_disagreement_score":0.158948,"about_ca_system_score_codex":0.00025110153,"about_ca_system_score_gemma":0.0007541648,"threshold_uncertainty_score":0.99996126},"labels":[],"label_agreement":null},{"id":"W4412612589","doi":"10.51731/cjht.2025.1174","title":"Leuprolide Mesylate (Camcevi)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mesylate; Medicine; Medical physics; Chemistry","score_opus":0.024821458400973634,"score_gpt":0.36169274152501346,"score_spread":0.3368712831240398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412612589","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34572148,0.27163386,0.00020325472,0.37149405,0.0019172162,0.0005790671,0.000014845555,0.0001853621,0.008250865],"genre_scores_gemma":[0.9944186,0.0012682033,0.0003405866,0.0027951268,0.000014874449,0.0000056632202,0.0000014726128,0.000006413873,0.00114904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990981,0.00002572075,0.00038757361,0.00008955287,0.00006432843,0.00033472962],"domain_scores_gemma":[0.9994321,0.000035291945,0.0001823668,0.00014927395,0.0001188819,0.00008208376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027864764,0.0000922656,0.00037263933,0.0007750878,0.00013332929,0.000011474508,0.00014830202,0.00010775006,0.00006878034],"category_scores_gemma":[0.00015862499,0.00007334144,0.000080505044,0.00035473032,0.00014648745,0.000044354096,0.000010985876,0.00035685734,0.0000075689313],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010073083,0.00004303064,0.04768485,0.00021304858,0.00024301205,0.0005321626,0.00014688092,0.000005215605,0.00016913355,0.0027824363,0.10581467,0.84226483],"study_design_scores_gemma":[0.0016321683,0.00077696226,0.027777558,0.00036146055,0.00008741288,0.00038904688,0.00063540955,0.0000054839725,0.0020576098,0.004553489,0.9616468,0.00007659313],"about_ca_topic_score_codex":0.002894991,"about_ca_topic_score_gemma":0.0032783789,"teacher_disagreement_score":0.85583216,"about_ca_system_score_codex":0.0006036838,"about_ca_system_score_gemma":0.0052846656,"threshold_uncertainty_score":0.937477},"labels":[],"label_agreement":null},{"id":"W4412943763","doi":"10.3390/reports8030133","title":"Percutaneous Peripheral Nerve Stimulation in Chemotherapy-Induced Neuropathy: A Case Report","year":2025,"lang":"en","type":"article","venue":"Reports — Medical Cases Images and Videos","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Oxaliplatin; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Adverse effect; Percutaneous; Clinical trial; Chemotherapy; Surgery; Anesthesia; Oncology; Internal medicine; Colorectal cancer; Cancer","score_opus":0.01885543846147116,"score_gpt":0.3567036263699896,"score_spread":0.33784818790851845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412943763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99196506,0.001144952,0.00005593316,0.004211801,0.00040787784,0.0005161423,0.0000027347792,0.00006649928,0.0016290318],"genre_scores_gemma":[0.99547195,0.00019889542,0.00009776327,0.001963385,0.0002122417,0.000028188862,0.000031695516,0.00001853612,0.001977354],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99832964,0.000065412125,0.000593612,0.00046423622,0.00029371778,0.00025340586],"domain_scores_gemma":[0.9990721,0.00020883884,0.00013010687,0.000265384,0.00007753195,0.00024605886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003477287,0.00019202458,0.00041583835,0.00013387535,0.00008172065,0.000025889733,0.000025038305,0.00014856107,0.0007602957],"category_scores_gemma":[0.00074382697,0.00015767009,0.0000930748,0.000207785,0.00009951992,0.0000666357,0.000042374588,0.00028406948,9.057413e-7],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029846636,0.00025268373,0.050965343,0.00009246672,0.000047516754,0.9031546,0.00012534607,0.0000033795613,0.0034895819,0.000004648234,0.0013039408,0.040262006],"study_design_scores_gemma":[0.0015369357,0.00047253584,0.025968652,0.00014022633,0.00018673734,0.96440744,0.000096473625,0.0012421227,0.0009917542,0.000042803298,0.004773924,0.00014038039],"about_ca_topic_score_codex":0.001691245,"about_ca_topic_score_gemma":0.00019709149,"teacher_disagreement_score":0.061252832,"about_ca_system_score_codex":0.00011823286,"about_ca_system_score_gemma":0.00041152435,"threshold_uncertainty_score":0.83247054},"labels":[],"label_agreement":null},{"id":"W4413927988","doi":"10.51731/cjht.2025.1211","title":"Relugolix–Estradiol–Norethindrone Acetate (Myfembree)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry; Environmental chemistry; Chromatography","score_opus":0.029234205271672614,"score_gpt":0.34878129655109763,"score_spread":0.31954709127942504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413927988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47980642,0.19422352,0.00018810766,0.31736922,0.0014193031,0.0005585409,0.000022035068,0.00019301969,0.0062198304],"genre_scores_gemma":[0.99352825,0.0021434915,0.0005940578,0.0024131434,0.000019825424,0.0000063630705,0.0000032174812,0.000010160013,0.0012814961],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99877876,0.0000426059,0.00050773454,0.00013043177,0.000094201314,0.00044629123],"domain_scores_gemma":[0.999243,0.00005362032,0.00025080267,0.00021316185,0.0001144219,0.00012498451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038741573,0.00013249602,0.0004973613,0.0008717956,0.00017689278,0.000015124492,0.00021343266,0.00017540008,0.00006647209],"category_scores_gemma":[0.00017020665,0.00010949448,0.00010258501,0.00044329846,0.0002743007,0.00006238996,0.000013459866,0.0006281636,0.0000075654793],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019176256,0.000089306726,0.027617676,0.00040511225,0.00048580253,0.0014596282,0.0005328215,0.0000137353745,0.0006411563,0.004708093,0.13162753,0.8322274],"study_design_scores_gemma":[0.004171786,0.0019818987,0.055613663,0.0008932933,0.00022289949,0.0018248151,0.0018144052,0.000015696934,0.004683284,0.011492873,0.9170811,0.00020428636],"about_ca_topic_score_codex":0.0034564328,"about_ca_topic_score_gemma":0.002961941,"teacher_disagreement_score":0.8320231,"about_ca_system_score_codex":0.00075961417,"about_ca_system_score_gemma":0.0065272795,"threshold_uncertainty_score":0.9991048},"labels":[],"label_agreement":null},{"id":"W4413971696","doi":"10.5737/23688076354533","title":"Evaluating the effectiveness of an educational program on chemotherapy-induced peripheral neuropathy in enhancing competence among nurses in cancer care","year":2025,"lang":"en","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Competence (human resources); Chemotherapy-induced peripheral neuropathy; Peripheral neuropathy; Medicine; Chemotherapy; Oncology; Medical education; Psychology; Nursing; Internal medicine","score_opus":0.0312821815795119,"score_gpt":0.4631359078486351,"score_spread":0.4318537262691232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413971696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99076635,0.0009517387,0.0000010898526,0.003242913,0.0020350798,0.000782237,0.0000035303938,0.000005901378,0.0022111482],"genre_scores_gemma":[0.99878776,0.00003374865,0.000121869736,0.00065087,0.00018751755,0.00013819902,0.000008434651,0.000013147735,0.000058425467],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983072,0.000762129,0.00027633048,0.00020192054,0.00011635974,0.0003360603],"domain_scores_gemma":[0.99910134,0.00035564485,0.00010859143,0.000110167006,0.00015489441,0.00016936725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059805217,0.00013050763,0.00031660107,0.0004039254,0.00015591843,0.000016846081,0.00012452248,0.000105045736,0.000094689705],"category_scores_gemma":[0.000090780755,0.00010738839,0.000054463806,0.00039628285,0.00018332401,0.000061033716,0.0000033799354,0.0005765498,3.416106e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0019652627,0.0010827541,0.33299828,0.0000840623,0.00006492633,0.0001321087,0.0073582693,0.00076296146,0.023784036,0.00010186183,0.00008308932,0.6315824],"study_design_scores_gemma":[0.0038310934,0.0032506983,0.9835374,0.002636108,0.00008282178,0.000070987415,0.0018997277,0.0010749259,0.0032168075,0.0001435113,0.00016794664,0.000087984554],"about_ca_topic_score_codex":0.014092405,"about_ca_topic_score_gemma":0.1729233,"teacher_disagreement_score":0.6505391,"about_ca_system_score_codex":0.006928062,"about_ca_system_score_gemma":0.009192386,"threshold_uncertainty_score":0.99688417},"labels":[],"label_agreement":null},{"id":"W4414040538","doi":"10.1002/cam4.71218","title":"Impact of Population Pharmacogenomics on Cisplatin‐Induced Neurotoxicities in Testicular Cancer Survivors","year":2025,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"National Institute of General Medical Sciences; National Institutes of Health; National Cancer Institute; Regeneron Pharmaceuticals","keywords":"Pharmacogenomics; Population; Testicular cancer; Peripheral neuropathy; Allele; Allele frequency; Incidence (geometry); Cancer","score_opus":0.0466725608984853,"score_gpt":0.44975108906430644,"score_spread":0.4030785281658211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414040538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99170387,0.0026066352,0.00000458412,0.0020916166,0.000965107,0.00077703083,0.000038777885,0.000029432658,0.001782944],"genre_scores_gemma":[0.99616396,0.0013128803,0.000009823478,0.0012546823,0.00036539783,0.0002062703,0.00005490525,0.000021172895,0.0006109115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988134,0.00005501244,0.0004133141,0.00027573202,0.00018897044,0.00025359314],"domain_scores_gemma":[0.9992952,0.00017953051,0.00014060875,0.00018618385,0.000099741126,0.00009877316],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013050664,0.0002185416,0.0005858928,0.00041537924,0.000032567907,0.0000022715546,0.00007524229,0.00008288477,0.0010593713],"category_scores_gemma":[0.00007343457,0.00016373959,0.00009816882,0.0005928098,0.00008584335,0.00003768289,0.000018146533,0.00022926329,0.0000016869759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017078873,0.00025175783,0.7924401,0.00022725471,0.00031862958,0.000043600896,0.00044047178,0.0015527001,0.18354642,0.00008003901,0.001968501,0.017422622],"study_design_scores_gemma":[0.008370827,0.001300375,0.97120696,0.0009837017,0.0005247576,0.0000048165225,0.000054672615,0.0012414954,0.015544703,0.00008800175,0.0005392355,0.00014045247],"about_ca_topic_score_codex":0.03179905,"about_ca_topic_score_gemma":0.0014820113,"teacher_disagreement_score":0.17876685,"about_ca_system_score_codex":0.0007410859,"about_ca_system_score_gemma":0.0003188378,"threshold_uncertainty_score":0.9998538},"labels":[],"label_agreement":null},{"id":"W4414649848","doi":"10.1016/j.ygyno.2025.04.079","title":"Updated duration of response for patients receiving dostarlimab plus carboplatin-paclitaxel treatment compared with patients receiving placebo plus carboplatin-paclitaxel in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Placebo; Duration (music); Interim analysis; Interim; Clinical trial; Overall survival","score_opus":0.03125459928371742,"score_gpt":0.3467446620976846,"score_spread":0.3154900628139672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980835,0.00017537223,0.00003748167,0.0021717255,0.0015468133,0.010480453,0.00022677497,0.00009160281,0.0044347374],"genre_scores_gemma":[0.9929355,0.00009269,0.0011236977,0.00081749423,0.00014483274,0.0027260368,0.001290843,0.000044567045,0.00082436315],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9944188,0.0018430275,0.0015204904,0.0009045594,0.0004169949,0.00089614146],"domain_scores_gemma":[0.9902506,0.0075087664,0.0009686319,0.00061385916,0.0005061291,0.0001520544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015205505,0.00063336536,0.0017259475,0.0005660893,0.00032667106,0.00003314143,0.00033093893,0.0005673629,0.00017672691],"category_scores_gemma":[0.0020022492,0.00043813282,0.00026474075,0.0008521819,0.00028979752,0.00015462321,0.00010674626,0.0004772763,0.000007936983],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77058905,0.011642762,0.17069809,0.00023742073,0.0013721869,0.00014050315,0.014430883,0.0007142041,0.0012085385,0.000147606,0.0070507755,0.021767976],"study_design_scores_gemma":[0.45897412,0.06796416,0.4514258,0.00018671337,0.0016442947,0.0000143045645,0.0029591958,0.0021229915,0.0007132208,0.00020337274,0.013198715,0.00059310003],"about_ca_topic_score_codex":0.00074589526,"about_ca_topic_score_gemma":0.0059168967,"teacher_disagreement_score":0.31161493,"about_ca_system_score_codex":0.005304113,"about_ca_system_score_gemma":0.0021847086,"threshold_uncertainty_score":0.99980706},"labels":[],"label_agreement":null},{"id":"W4414696025","doi":"10.51731/cjht.2025.1245","title":"Venetoclax (Venclexta)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ibrutinib; Venetoclax; Mantle cell lymphoma; Drug; Lymphoma; Public health","score_opus":0.025457065611933158,"score_gpt":0.36479889377678365,"score_spread":0.3393418281648505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414696025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35248598,0.32817414,0.00023709497,0.30726966,0.0021411174,0.00058758707,0.000015510002,0.00017229031,0.008916597],"genre_scores_gemma":[0.9961132,0.0008101452,0.0003012859,0.0020556499,0.000012194885,0.000004632261,0.0000012787166,0.000004754507,0.0006968824],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992844,0.000019746176,0.00029765588,0.00007200215,0.00005503457,0.0002711511],"domain_scores_gemma":[0.9995499,0.000028974586,0.00013740282,0.00012572603,0.00009256035,0.00006539145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020417187,0.00007101143,0.00028511675,0.0006245599,0.000116115036,0.000008004878,0.00012581467,0.00009346847,0.0000658012],"category_scores_gemma":[0.000114883354,0.000058857622,0.000064053515,0.0003170547,0.00013287828,0.00003074527,0.000008597319,0.00028267043,0.000005858954],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006282563,0.00002590406,0.026629714,0.00015424239,0.00015181536,0.00036470848,0.00012467093,0.000008177524,0.00016527966,0.0030352226,0.10002298,0.86925447],"study_design_scores_gemma":[0.0011430521,0.0007604949,0.025850618,0.000302066,0.00005424821,0.00026406013,0.00062805053,0.0000060663674,0.0014045787,0.004448767,0.9650825,0.000055442397],"about_ca_topic_score_codex":0.0025034612,"about_ca_topic_score_gemma":0.0023057824,"teacher_disagreement_score":0.86919904,"about_ca_system_score_codex":0.0010283879,"about_ca_system_score_gemma":0.008324998,"threshold_uncertainty_score":0.99729687},"labels":[],"label_agreement":null},{"id":"W4414786598","doi":"10.1093/neuonc/noaf193.335","title":"P10.24.A TARGETING NON-GENETIC KINASE-DEPENDENT SIGNALING TO PREVENT GROUP 3 MEDULLOBLASTOMA RECURRENCE","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Manitoba","funders":"","keywords":"Medulloblastoma; Hedgehog signaling pathway; Downregulation and upregulation; Signal transduction; Kinase; Sonic hedgehog; In vivo; Hedgehog","score_opus":0.017074041001101076,"score_gpt":0.3307893227200309,"score_spread":0.3137152817189298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414786598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766443,0.0012093487,0.000815777,0.007900912,0.004699068,0.001712734,0.000014726927,0.00015406615,0.0068490896],"genre_scores_gemma":[0.98664397,0.0002503784,0.0024702272,0.008889004,0.0005535438,0.00042470283,0.000023622137,0.00003859857,0.00070595875],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772984,0.00024664562,0.0005192719,0.0006833311,0.00023573895,0.0005851997],"domain_scores_gemma":[0.99866414,0.0004986876,0.000138897,0.00029106325,0.00010967111,0.00029752808],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027382627,0.0002902285,0.000589683,0.00028377873,0.00014073987,0.000015974163,0.00022870193,0.00020066943,0.0005802691],"category_scores_gemma":[0.00018564859,0.0002787107,0.00014402214,0.00044842673,0.00007662887,0.00004030891,0.00020735516,0.00046929935,0.00019308426],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009065035,0.0013669183,0.0043690484,0.000119947676,0.00014034807,0.00081859017,0.0005219749,0.00019341949,0.89866954,0.00004864097,0.032995116,0.059849955],"study_design_scores_gemma":[0.0061592287,0.009843656,0.005474398,0.00024336891,0.0008128368,0.0002211971,0.00025999348,0.000509131,0.37662894,0.00022397847,0.5991838,0.00043946214],"about_ca_topic_score_codex":0.0000806977,"about_ca_topic_score_gemma":0.00009970948,"teacher_disagreement_score":0.5661887,"about_ca_system_score_codex":0.0005956869,"about_ca_system_score_gemma":0.0005064297,"threshold_uncertainty_score":0.9999665},"labels":[],"label_agreement":null},{"id":"W4414825731","doi":"10.1016/j.ijpharm.2025.126235","title":"Self-assembled leuprolide-oleic acid nanoparticles encapsulating docetaxel for synergistic drug delivery","year":2025,"lang":"en","type":"article","venue":"International Journal of Pharmaceutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Research Foundation of Korea; Ministry of Science and ICT, South Korea; Korea Health Industry Development Institute; Ministry of Health and Welfare","keywords":"Cytotoxicity; Drug delivery; Nanoparticle; Liposome; Drug carrier; Docetaxel; Dispersity; Amphiphile; Bioavailability; Particle size","score_opus":0.029062348444428687,"score_gpt":0.39374474259336323,"score_spread":0.36468239414893455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414825731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98768795,0.0028300593,0.0008966391,0.0045677656,0.0027532058,0.00028163544,0.000012626033,0.000032075706,0.0009380399],"genre_scores_gemma":[0.9924182,0.0006803716,0.003923933,0.0017457879,0.0007666611,0.000016552449,0.0000064957453,0.000015195946,0.00042675823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868476,0.00004402274,0.00057517807,0.00013498923,0.0003334507,0.0002275997],"domain_scores_gemma":[0.99831694,0.0002696784,0.00032121787,0.000073791445,0.00088726805,0.00013109091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035369548,0.00014829183,0.00029204792,0.00028315582,0.000065891145,0.00004168266,0.00023021581,0.000048231064,0.00008647901],"category_scores_gemma":[0.00009294383,0.00012963811,0.00022389033,0.00013258652,0.00002209645,0.00014227307,0.000050949056,0.00022328892,0.0000069032926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019905365,0.00077412394,0.009881715,0.00014513299,0.0023064222,0.00022218862,0.00033842874,0.00020915296,0.96455,0.00066965126,0.003192762,0.015719851],"study_design_scores_gemma":[0.010089568,0.000171392,0.00091846957,0.00020827126,0.0014291243,0.00018341368,0.00010328035,0.009587377,0.9348376,0.00094943354,0.04140225,0.00011985683],"about_ca_topic_score_codex":0.00000679644,"about_ca_topic_score_gemma":0.000005177575,"teacher_disagreement_score":0.038209487,"about_ca_system_score_codex":0.00039857428,"about_ca_system_score_gemma":0.0004615305,"threshold_uncertainty_score":0.52864885},"labels":[],"label_agreement":null},{"id":"W4414883356","doi":"10.1136/spcare-2024-005348","title":"Memantine efficacy in chemotherapy-induced peripheral neuropathy: double-blind placebo-controlled randomised clinical trial","year":2025,"lang":"en","type":"article","venue":"BMJ Supportive & Palliative Care","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Memantine; Clinical trial; Peripheral; Randomized controlled trial; Clinical Practice","score_opus":0.11171978564011496,"score_gpt":0.4790628836052997,"score_spread":0.3673430979651847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414883356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658302,0.0004509497,0.000044184555,0.0032828401,0.0014616967,0.01675272,0.000018842025,0.0000857671,0.012072792],"genre_scores_gemma":[0.9906423,0.00018079625,0.00006561208,0.0022749442,0.0008753918,0.0021324789,0.00019663291,0.00004652856,0.0035853279],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961233,0.00064983655,0.001550971,0.00080953736,0.0003303822,0.00053598115],"domain_scores_gemma":[0.9973472,0.0010961303,0.00050205324,0.00037389417,0.00047261213,0.00020813108],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008502649,0.0004782028,0.001984826,0.0002900543,0.0000973109,0.000033240718,0.00017530845,0.00028977805,0.0011175062],"category_scores_gemma":[0.000651161,0.00038357952,0.0008255599,0.0005009551,0.00014569347,0.0000730976,0.00006103474,0.00063648575,0.000029463246],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.939431,0.0016909505,0.04839292,0.00007925612,0.0010012443,0.00038173833,0.0022701542,0.00000683954,0.0011999937,0.000050923325,0.0015380293,0.003956963],"study_design_scores_gemma":[0.9240838,0.0028365261,0.06492549,0.00015549478,0.00082341913,0.000002085745,0.0008755167,0.0001278808,0.0038847707,0.0000108191525,0.0019865115,0.0002876552],"about_ca_topic_score_codex":0.000049454866,"about_ca_topic_score_gemma":0.00013010902,"teacher_disagreement_score":0.02481208,"about_ca_system_score_codex":0.00035417164,"about_ca_system_score_gemma":0.0011851435,"threshold_uncertainty_score":0.9998616},"labels":[],"label_agreement":null},{"id":"W4415314362","doi":"10.51731/cjht.2025.1255","title":"Semaglutide (Wegovy)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Weight loss; Comorbidity; Body mass index; Type 2 diabetes; Clinical Practice; Body weight","score_opus":0.025126934297497214,"score_gpt":0.35846029367518983,"score_spread":0.3333333593776926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415314362","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.043074403,0.6648703,0.00012389534,0.28234318,0.005212281,0.0005644656,0.000045146266,0.00007864877,0.0036876402],"genre_scores_gemma":[0.9786951,0.013009006,0.00026786534,0.00431424,0.0000614726,0.000009343009,0.0000026576333,0.00002029293,0.0036200043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99687696,0.00014431067,0.0013952916,0.00026073103,0.00018002564,0.0011426714],"domain_scores_gemma":[0.9978829,0.00023308204,0.00082345103,0.00040923306,0.00038426078,0.00026709825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096282654,0.0003205703,0.0011467631,0.0024591405,0.0005089374,0.00004418994,0.00055223354,0.00043471178,0.0004421341],"category_scores_gemma":[0.00090644805,0.0002881606,0.00025600183,0.0012335059,0.0007350296,0.0000796339,0.000043458516,0.0013166685,0.00003599948],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116863215,0.00009713396,0.026224865,0.0006372683,0.0006109905,0.00097427267,0.00035598563,0.000009442671,0.000058658043,0.0027879216,0.16219202,0.8059346],"study_design_scores_gemma":[0.0028960374,0.0019095846,0.017221842,0.0021099132,0.00039234606,0.00041509586,0.0043376097,0.000012356325,0.0012198024,0.004362296,0.96493053,0.00019261132],"about_ca_topic_score_codex":0.0131136775,"about_ca_topic_score_gemma":0.014653033,"teacher_disagreement_score":0.9356207,"about_ca_system_score_codex":0.002849082,"about_ca_system_score_gemma":0.03297763,"threshold_uncertainty_score":0.999957},"labels":[],"label_agreement":null},{"id":"W4415444744","doi":"10.1158/1535-7163.targ-25-a085","title":"Abstract A085: OBP-004, a novel small-molecule dual inhibitor of CDK9/13, reduces bone, brain, lung and lymph node metastases in vivo, with highest potency on bone metastases","year":2025,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Bioluminescence imaging; Lymph node; Prostate cancer; Bone marrow; Cancer; Breast cancer; Spleen; Metastatic breast cancer; Bone metastasis","score_opus":0.022776783337146733,"score_gpt":0.31268964073595384,"score_spread":0.2899128573988071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415444744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9646842,0.026339423,0.0002141103,0.0063978243,0.00021437577,0.00073335774,0.0003446335,0.00004833038,0.0010237279],"genre_scores_gemma":[0.9913221,0.0012490918,0.00074947806,0.0058612972,0.00007450283,0.00016787858,0.00005046071,0.000060512575,0.00046470657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998061,0.00008257714,0.0005096193,0.00056098204,0.0003401662,0.00044566853],"domain_scores_gemma":[0.9989998,0.0001567227,0.00022142188,0.0003472109,0.00014849589,0.00012635234],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001869548,0.000435845,0.00076864986,0.00039850632,0.00007349168,0.000029989646,0.00009991761,0.00013979196,0.00011061347],"category_scores_gemma":[0.00001833697,0.0003605622,0.00014651059,0.00056859193,0.00024410429,0.000062895386,0.000056872865,0.0002516382,0.000001064398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034022655,0.0017835273,0.003870231,0.00044742614,0.0019790716,0.0007608981,0.00033663388,0.00032334402,0.9795388,0.0003205496,0.00075254275,0.0064847344],"study_design_scores_gemma":[0.013479919,0.0008621121,0.01375383,0.0009147933,0.0025252327,0.00008230564,0.00020294984,0.00016755608,0.95976245,0.000052802417,0.007712672,0.0004833493],"about_ca_topic_score_codex":0.0013369969,"about_ca_topic_score_gemma":0.0004326106,"teacher_disagreement_score":0.026637854,"about_ca_system_score_codex":0.00024123657,"about_ca_system_score_gemma":0.00056691037,"threshold_uncertainty_score":0.9998846},"labels":[],"label_agreement":null},{"id":"W4415551402","doi":"10.1080/17512433.2025.2580349","title":"A review of current and emerging therapies in breast cancer: implications for older adults","year":2025,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Clinical trial; Breast cancer; Geriatric oncology; Alternative medicine; MEDLINE; Disease","score_opus":0.1191470631710012,"score_gpt":0.599206417123631,"score_spread":0.4800593539526298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415551402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002520206,0.97740495,0.000005896446,0.012442741,0.002092711,0.007413457,0.0005416366,0.000015661932,0.000080434445],"genre_scores_gemma":[0.0000013756735,0.9811967,0.00012074313,0.011360792,0.0009970175,0.0059788055,0.00025784096,0.000033241835,0.00005349374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994763,0.00067507464,0.003488329,0.0006605859,0.00010670259,0.00030626464],"domain_scores_gemma":[0.9952915,0.0022637295,0.0015633382,0.00034853801,0.00037303005,0.00015991932],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011458149,0.0004542131,0.006786973,0.00019830813,0.00002878855,0.0000014204043,0.00026605203,0.00023642482,0.0009271787],"category_scores_gemma":[0.00024793023,0.0003241426,0.0014101887,0.0005226903,0.00023613629,0.000035322842,0.0001234368,0.00052178133,0.000001844809],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006454617,0.00045416903,0.000073712916,0.40859133,0.00034555423,6.9607506e-7,0.000013087544,1.435138e-9,4.0430663e-7,0.000012418576,0.11046564,0.47997844],"study_design_scores_gemma":[0.0015828427,0.000093408176,0.00016052037,0.4448753,0.0029918058,0.000015222972,0.0000012655513,3.9432337e-7,5.1888276e-7,0.0000041602284,0.55016106,0.00011351989],"about_ca_topic_score_codex":0.000025127876,"about_ca_topic_score_gemma":0.000003969932,"teacher_disagreement_score":0.47986493,"about_ca_system_score_codex":0.00009603979,"about_ca_system_score_gemma":0.0013754864,"threshold_uncertainty_score":0.9999861},"labels":[],"label_agreement":null},{"id":"W4416454378","doi":"10.1007/978-3-031-93616-6_27","title":"Miscellaneous Agents","year":2025,"lang":"en","type":"book-chapter","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Waterloo; Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"","score_opus":0.03062335143220128,"score_gpt":0.3182470025553903,"score_spread":0.287623651123189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416454378","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012815469,0.00088462647,8.7705365e-7,0.0011072803,0.00045304376,0.00027928394,0.000018238914,0.00006250867,0.9971813],"genre_scores_gemma":[0.00032507017,0.00092251453,0.000062819825,0.003622339,0.0002681773,0.000005453447,0.00015774608,0.00001729812,0.9946186],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952763,0.00000183187,0.0001100907,0.00018222752,0.00008225156,0.00009599156],"domain_scores_gemma":[0.9997024,0.000025561316,0.000029024464,0.00014912372,0.000026651256,0.00006725872],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000011413868,0.00015484226,0.00027108408,0.00006579909,0.000016344628,0.0000030995102,0.000035091,0.00017998986,0.08506962],"category_scores_gemma":[0.0000013247167,0.00012444629,0.00012280952,0.000004634581,0.000023491577,0.0000012509198,0.000024011604,0.00014701803,0.0011047528],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010488032,0.000031669726,0.000019295478,0.000087108325,0.00037727528,0.0006402138,0.0000072948615,6.9769285e-8,0.0000129439,0.008059641,0.97833884,0.012320774],"study_design_scores_gemma":[0.00081293413,0.00016669073,0.000012088344,0.000084640706,0.0006457531,0.000059480222,5.124623e-7,0.0000036205538,0.00006233577,0.00074846635,0.9973148,0.00008868572],"about_ca_topic_score_codex":0.00004181086,"about_ca_topic_score_gemma":0.00003365565,"teacher_disagreement_score":0.08396487,"about_ca_system_score_codex":0.00008580522,"about_ca_system_score_gemma":0.00010503724,"threshold_uncertainty_score":0.999673},"labels":[],"label_agreement":null},{"id":"W4416538819","doi":"10.1097/pr9.0000000000001366","title":"Comparative study evaluating the efficacy of duloxetine, gabapentin, and lacosamide on oxaliplatin-induced peripheral neuropathy","year":2025,"lang":"en","type":"article","venue":"PAIN Reports","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lacosamide; Peripheral neuropathy; Duloxetine; Neuroprotection; Peripheral","score_opus":0.06668038684894914,"score_gpt":0.4238710606191592,"score_spread":0.3571906737702101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416538819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99244046,0.00019012231,0.00000775747,0.00057664525,0.00028834154,0.0013368503,7.5038014e-7,0.000027455715,0.0051316065],"genre_scores_gemma":[0.99826545,0.0000055561527,0.000041939158,0.0005443677,0.0000762369,0.00007163877,0.000007686858,0.000008367208,0.0009787461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984417,0.0005228927,0.0003995979,0.00028481032,0.00021156365,0.00013944747],"domain_scores_gemma":[0.9985308,0.0008487596,0.00022229768,0.00026211957,0.00009283186,0.000043192587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013777484,0.0001387314,0.00035033806,0.000059182345,0.0001106469,0.000011424021,0.000033840897,0.000026526168,0.0001027485],"category_scores_gemma":[0.00044747148,0.0000914704,0.000061392595,0.0001805679,0.000053062588,0.000015525886,0.000042142972,0.00015913542,0.0000010079616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020134388,0.0027772875,0.88317007,0.00010833236,0.0005925704,0.0008432691,0.0076941694,0.00012664161,0.082500584,0.00004105125,0.002547195,0.017585408],"study_design_scores_gemma":[0.0038778097,0.004742131,0.9806793,0.00011961546,0.0005645908,0.00007438133,0.0013852033,0.0017593447,0.0061011054,0.000046864112,0.00053945644,0.00011022405],"about_ca_topic_score_codex":0.00010606671,"about_ca_topic_score_gemma":0.00003121256,"teacher_disagreement_score":0.09750922,"about_ca_system_score_codex":0.000036350924,"about_ca_system_score_gemma":0.000104588864,"threshold_uncertainty_score":0.37300548},"labels":[],"label_agreement":null},{"id":"W4417362519","doi":"10.1177/10781552251405216","title":"Comparative incidence of peripheral neuropathy associated with taxane chemotherapy in patients with breast cancer: A network meta-analysis","year":2025,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research","funders":"","keywords":"Taxane; Peripheral neuropathy; Paclitaxel; Docetaxel; Incidence (geometry); Breast cancer; Chemotherapy-induced peripheral neuropathy","score_opus":0.05753993388737121,"score_gpt":0.4269587812516558,"score_spread":0.3694188473642846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417362519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982598,0.0020952383,0.00008074209,0.013212512,0.0001802809,0.0005229093,0.000029034127,0.000007694826,0.0012736069],"genre_scores_gemma":[0.99291533,0.00055663293,0.00082752446,0.00533118,0.00008668847,0.000030235053,0.000008036859,0.000012622806,0.00023173622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759936,0.0008334171,0.0007127481,0.00021309486,0.00038002737,0.00026137332],"domain_scores_gemma":[0.9953485,0.0010576866,0.0020261474,0.0001285785,0.0013262003,0.000112881804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080420997,0.00022667488,0.0019556799,0.0003311343,0.000053744458,0.000010355489,0.00014891977,0.0000612821,0.00072699256],"category_scores_gemma":[0.00007795906,0.0001444824,0.00031797125,0.0017019833,0.00016003502,0.0004210411,0.000024358264,0.0006876096,5.478727e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.066393435,0.0052657146,0.7226539,0.000021297077,0.19295788,0.00047655057,0.0008965662,0.0070508597,0.0002108311,0.000006563766,0.0027089498,0.0013574249],"study_design_scores_gemma":[0.035427075,0.004787491,0.64055616,0.00005396744,0.30731672,0.00020531063,0.00019042725,0.0004297419,0.00028438805,0.0000046665928,0.01058261,0.0001614587],"about_ca_topic_score_codex":0.0003051124,"about_ca_topic_score_gemma":0.00040627152,"teacher_disagreement_score":0.11435885,"about_ca_system_score_codex":0.0006205822,"about_ca_system_score_gemma":0.0012900437,"threshold_uncertainty_score":0.79600585},"labels":[],"label_agreement":null},{"id":"W4417481745","doi":"10.1016/j.jval.2025.09.314","title":"CO213 Review of Index Line Selection Methods in Hemato-Oncology Externally Controlled Trials: A Secondary Analysis of the Hermans et al Systematic Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada","funders":"","keywords":"Selection (genetic algorithm); Index (typography); Line (geometry); Time line","score_opus":0.10674046071374535,"score_gpt":0.5357651114473563,"score_spread":0.42902465073361096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481745","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006390734,0.93697023,0.0009594619,0.04494375,0.00032171476,0.009654246,0.000026136458,0.000013352226,0.0007203613],"genre_scores_gemma":[0.04595399,0.8392426,0.0021469253,0.11054885,0.000034322813,0.0014036881,0.000037316433,0.000020180833,0.00061216234],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98439187,0.011875651,0.0031548499,0.00021400306,0.00019249835,0.00017112095],"domain_scores_gemma":[0.99426264,0.0036698373,0.0015995271,0.0002791653,0.000141975,0.0000468872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022552846,0.00014607777,0.005840387,0.0005093011,0.000017523302,0.0000015629448,0.000111919864,0.00007316404,0.00021861204],"category_scores_gemma":[0.002747403,0.00008742561,0.0006067194,0.0022067204,0.00003573368,0.000021690726,0.000028538316,0.000329874,4.627779e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009304484,0.0007706557,0.0064683887,0.98152214,0.0035011722,0.0000068036584,0.00035271447,0.00031172432,0.0003410321,0.00022684055,0.002817443,0.002750609],"study_design_scores_gemma":[0.020798253,0.0011411456,0.00623848,0.93065804,0.020714369,0.00004118889,0.000073106195,0.015935605,0.00028177694,0.00016109455,0.0038131736,0.00014379217],"about_ca_topic_score_codex":0.0018191827,"about_ca_topic_score_gemma":0.0005634127,"teacher_disagreement_score":0.09772768,"about_ca_system_score_codex":0.00048569203,"about_ca_system_score_gemma":0.0018666005,"threshold_uncertainty_score":0.7816411},"labels":[],"label_agreement":null},{"id":"W4417501047","doi":"10.1186/s40478-025-02171-0","title":"Vincristine-induced brain toxicity is reduced with prevention of peripheral axon degeneration in Sarm1 knockout mice","year":2025,"lang":"en","type":"article","venue":"Acta Neuropathologica Communications","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Sciatic nerve; Axon; Knockout mouse; Neurotoxicity; Peripheral neuropathy; Myelin; Vincristine; White matter; Brain damage","score_opus":0.055004066787984626,"score_gpt":0.3718341388987574,"score_spread":0.31683007211077274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417501047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733975,0.00023700409,0.00006957315,0.018969579,0.00005584,0.00064452126,0.00001167743,0.000050185503,0.0065641105],"genre_scores_gemma":[0.99426883,0.00029993753,0.0022263394,0.0017433795,0.000019070898,0.00013557088,0.00009108514,0.000010883937,0.0012048878],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99869925,0.00046145427,0.000346495,0.00024911817,0.00009208772,0.00015159171],"domain_scores_gemma":[0.9986549,0.00019697697,0.00015479163,0.0008336002,0.00012095396,0.00003876959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020016183,0.00014157618,0.00028462967,0.0001578307,0.00013532702,0.000009889364,0.00028383793,0.000086272776,0.00006323061],"category_scores_gemma":[0.00013684772,0.00011996643,0.000065933324,0.0004990642,0.0001393907,0.00007457917,0.00014714117,0.0002825457,0.0000027792846],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036129664,0.0010568178,0.009000855,0.000029101187,0.000024391022,0.000011341185,0.0005414628,0.000005213297,0.98496383,0.00029713978,0.0010162325,0.002692321],"study_design_scores_gemma":[0.0067163743,0.003326609,0.5224906,0.00033281103,0.0005039559,0.00014762307,0.0004204652,0.0013293426,0.4555218,0.00033302928,0.008521475,0.0003558989],"about_ca_topic_score_codex":0.00006868123,"about_ca_topic_score_gemma":0.0002762603,"teacher_disagreement_score":0.529442,"about_ca_system_score_codex":0.000111268,"about_ca_system_score_gemma":0.00016894816,"threshold_uncertainty_score":0.4892089},"labels":[],"label_agreement":null},{"id":"W574944135","doi":"10.71781/11996","title":"Études vers la synthèse totale de l'indolizidine 223A","year":2007,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Indolizidine; Chemistry; Stereochemistry","score_opus":0.046775355274704306,"score_gpt":0.4360629892014676,"score_spread":0.38928763392676324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W574944135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68815523,0.0048828865,0.000005781752,0.00029283328,0.0019090234,0.0010043292,0.000091453694,0.0000028399766,0.30365562],"genre_scores_gemma":[0.7360936,0.001450946,0.002177547,0.00021287904,0.0012646848,0.00011020664,0.002083794,0.00008051715,0.25652587],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980699,0.0001287679,0.00040674282,0.0005282587,0.00023335224,0.0006329834],"domain_scores_gemma":[0.99861676,0.0004532685,0.0002133753,0.00026458604,0.00009810626,0.00035390627],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000550841,0.0004133971,0.0006539194,0.00017437618,0.00014928986,0.00010028591,0.0003616765,0.0005495796,0.042254586],"category_scores_gemma":[0.00008311098,0.00041922682,0.00017717064,0.00024176623,0.0001242073,0.00014893331,0.00007740916,0.00048173752,0.0024934148],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01007038,0.0035674805,0.014837523,0.00066248496,0.0028703318,0.005003956,0.018153835,0.00007168735,0.089553244,0.0009553979,0.012964604,0.84128904],"study_design_scores_gemma":[0.0065734535,0.00090603734,0.011779698,0.0011289605,0.0028291352,0.00020101218,0.004930039,0.000077525496,0.13296309,0.000018128756,0.8380649,0.0005279879],"about_ca_topic_score_codex":0.001963881,"about_ca_topic_score_gemma":0.0036343033,"teacher_disagreement_score":0.84076107,"about_ca_system_score_codex":0.0006986859,"about_ca_system_score_gemma":0.0013107586,"threshold_uncertainty_score":0.99982595},"labels":[],"label_agreement":null},{"id":"W596742190","doi":"10.1200/jco.2009.27.15_suppl.e20680","title":"Comorbidities, concominant medications, and clinical guidelines/algorithms in treating elderley patients with hormone receptor positive early breast cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sudbury Regional Hospital","funders":"","keywords":"Medicine; Guideline; Hormonal therapy; Comorbidity; Breast cancer; Internal medicine; Cancer; Hormone therapy; Adjuvant; Pathology","score_opus":0.08677737473387369,"score_gpt":0.4920250777672494,"score_spread":0.4052477030333757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W596742190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96418613,0.0017281163,0.00003740136,0.03247888,0.00073456083,0.00035772068,0.000046198547,0.000008514775,0.00042250328],"genre_scores_gemma":[0.9768574,0.010146995,0.004895729,0.0058825784,0.0019721524,0.000008900904,0.000020781541,0.00001642486,0.00019898612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99579275,0.00046698414,0.0028556783,0.00026316935,0.0003570999,0.00026435126],"domain_scores_gemma":[0.9950275,0.0017697922,0.0016706408,0.00012355682,0.000934888,0.00047361667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021048894,0.00018883885,0.0016089256,0.00013731586,0.00007250903,0.0000081825165,0.000119964054,0.00037103196,0.00013100849],"category_scores_gemma":[0.0006456167,0.00012216816,0.0002075583,0.00017434664,0.0003424708,0.00013915866,0.000046828434,0.0009995243,0.0000033323886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075582177,0.0026787731,0.6051964,0.00000386355,0.00033751474,0.00016908685,0.00013638148,9.328365e-7,0.000010117174,0.0000121399735,0.007046838,0.3768497],"study_design_scores_gemma":[0.02853539,0.03201198,0.9326311,0.00023035491,0.0007333344,0.00017836553,0.00008777397,0.000054849283,0.000004056306,0.000048305825,0.0053682853,0.00011625357],"about_ca_topic_score_codex":0.00042709138,"about_ca_topic_score_gemma":0.00020799486,"teacher_disagreement_score":0.37673345,"about_ca_system_score_codex":0.00028584595,"about_ca_system_score_gemma":0.0014780328,"threshold_uncertainty_score":0.4981873},"labels":[],"label_agreement":null},{"id":"W6419410","doi":"10.1177/070674370304800615","title":"Methylphenidate and the Cytochrome P450 System","year":2003,"lang":"en","type":"letter","venue":"The Canadian Journal of Psychiatry","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Methylphenidate; Psychology; Psychiatry; Medicine; Clinical psychology; Attention deficit hyperactivity disorder","score_opus":0.014644390905662124,"score_gpt":0.2641553958577898,"score_spread":0.24951100495212766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6419410","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024065196,0.022998614,0.000003819744,0.96480465,0.0037899695,0.00042072564,0.000042196116,0.000005151891,0.005528383],"genre_scores_gemma":[0.021147003,0.00028636132,0.00042895312,0.9577769,0.014168694,0.000017955115,0.000018173156,0.00007528434,0.006080655],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984669,0.00034696652,0.0004457041,0.00013774805,0.00023855107,0.00036410487],"domain_scores_gemma":[0.99865586,0.00013507863,0.000467112,0.0003160935,0.00012410812,0.00030177526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007005872,0.0002470536,0.00063493015,0.0002177048,0.00031364337,0.00006425317,0.00028123392,0.0003199304,0.00033902357],"category_scores_gemma":[0.000017205813,0.00011903934,0.00029263223,0.00014454348,0.00044073895,0.000029966839,0.000007831421,0.0020840308,0.000022537733],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013715916,0.0000047075123,0.00041932252,0.00017081214,0.0009184364,0.0006420657,0.00020309632,6.931792e-7,0.0000037153366,0.001314019,0.99606425,0.00012170869],"study_design_scores_gemma":[0.004578943,0.00025914755,0.00092395727,0.0003239084,0.003095301,0.010665019,0.0002028093,0.0000024897051,0.0000041466947,0.001875297,0.9779213,0.00014768323],"about_ca_topic_score_codex":0.01061244,"about_ca_topic_score_gemma":0.063701525,"teacher_disagreement_score":0.053089086,"about_ca_system_score_codex":0.00035112028,"about_ca_system_score_gemma":0.0046185,"threshold_uncertainty_score":0.995976},"labels":[],"label_agreement":null},{"id":"W6912356257","doi":"10.5281/zenodo.16575162","title":"Perspectives and Insights on Antineoplastic Agents from Plant Alkaloids and Other Natural Products (L01C): From Development to New Drug Submission (NDS) Application for Health Canada","year":2025,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vinca; Drug; Human health; Health claims on food labels; Pharmaceutical industry; Natural (archaeology); Food and drug administration; Good manufacturing practice","score_opus":0.02096300875185287,"score_gpt":0.2828287138600296,"score_spread":0.26186570510817675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6912356257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833789,0.0011204733,0.0005952204,0.011558293,0.000152752,0.0014755446,0.00036230066,0.00012327117,0.0012332309],"genre_scores_gemma":[0.9936616,0.00009765729,0.00061253086,0.001662772,0.00013101602,4.143258e-7,0.0017709888,0.00019005292,0.0018729889],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910176,0.000056762925,0.0001400215,0.0003905441,0.00014715144,0.00016377972],"domain_scores_gemma":[0.99949336,0.000039194765,0.000048175836,0.00012915392,0.00012178298,0.00016832275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007445429,0.000109793924,0.00014870046,0.00010979557,0.0005560888,0.00006578327,0.000100966434,0.000022081016,0.00024335636],"category_scores_gemma":[0.000105089115,0.000096855285,0.000008869125,0.0001761873,0.000025677726,0.00003377414,0.00014369881,0.00009660121,0.000044757697],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025818145,0.00035885104,0.0002655114,0.00019706054,0.0003081126,0.000010971433,0.02273431,0.0000071058066,0.0319737,0.0005966896,0.78759825,0.15336764],"study_design_scores_gemma":[0.0017354853,0.00018035957,0.01736079,0.00010023236,0.000027661908,0.0000052444625,0.00046789862,0.0001726191,0.0038710798,0.00003806432,0.975946,0.000094557974],"about_ca_topic_score_codex":0.016082723,"about_ca_topic_score_gemma":0.0019267526,"teacher_disagreement_score":0.18834777,"about_ca_system_score_codex":0.00032104706,"about_ca_system_score_gemma":0.000089452515,"threshold_uncertainty_score":0.9904693},"labels":[],"label_agreement":null},{"id":"W6920683022","doi":"10.6084/m9.figshare.14889342","title":"Additional file 1 of Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Eribulin; Metastatic breast cancer; Breast cancer; Cochrane Library; MEDLINE; Overall survival","score_opus":0.14348126166137817,"score_gpt":0.3813208909546553,"score_spread":0.23783962929327715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920683022","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012211676,0.0011976855,1.5613355e-7,0.00025808188,0.000022496906,0.00032343916,0.996658,0.000013258616,0.00030570658],"genre_scores_gemma":[0.008593425,0.000038091643,0.0009186421,0.00066510314,0.0001102687,0.0031763548,0.9633281,0.000037336897,0.023132645],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989205,0.00006557246,0.0003652541,0.00026809907,0.00017978935,0.00020078753],"domain_scores_gemma":[0.9979184,0.0013923321,0.00022663936,0.00020445735,0.00018582115,0.00007233096],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000018570316,0.00020616553,0.001153383,0.000109922665,0.000018221173,0.0000050214107,0.000057874546,0.000056989993,0.99935776],"category_scores_gemma":[0.00011855033,0.00013317316,0.0005122,0.0007971788,0.000017130988,0.000046939294,0.00002187437,0.00006487051,0.00010932623],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006181924,0.00085662183,0.000021294221,0.00017728248,0.11713014,0.00019668727,0.0002052933,0.0020612,0.00012651777,5.5140146e-7,0.87088823,0.0021542327],"study_design_scores_gemma":[0.012747067,0.0017863876,0.0038499176,0.00061125914,0.06474003,0.000028409624,0.00013888394,0.0007971425,0.005539971,0.00000734931,0.90945125,0.00030232867],"about_ca_topic_score_codex":0.00008011501,"about_ca_topic_score_gemma":0.010575365,"teacher_disagreement_score":0.99924845,"about_ca_system_score_codex":0.00014276305,"about_ca_system_score_gemma":0.00070728123,"threshold_uncertainty_score":0.5901302},"labels":[],"label_agreement":null},{"id":"W6922195932","doi":"10.1021/np020361n.s001","title":"New Taxanes from the Needles of &lt;i&gt;Taxus canadensis&lt;/i&gt;","year":2016,"lang":"en","type":"article","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Taxane; Double bond; Ring (chemistry); Methanol; Docetaxel","score_opus":0.03539712637794722,"score_gpt":0.2786272392488673,"score_spread":0.24323011287092006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6922195932","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19661288,0.040775716,0.000004746558,0.034938388,0.0012357276,0.0020829043,0.67680216,0.00029903665,0.047248434],"genre_scores_gemma":[0.95844775,0.00011276281,0.000079716854,0.0014549129,0.0014640244,0.00009755127,0.016154382,0.00003630072,0.022152595],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99921775,0.000030174342,0.00016889369,0.0001892223,0.00017768926,0.00021626773],"domain_scores_gemma":[0.9989597,0.00040676014,0.000108354645,0.00028489702,0.00008658009,0.00015370653],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000018908142,0.00014304582,0.0002459545,0.000035770176,0.000046795496,0.0000071045065,0.0001504028,0.00008677269,0.3349232],"category_scores_gemma":[0.00023453191,0.000076300734,0.00010549334,0.00010836965,0.000017175043,0.00004301195,0.000053892185,0.00006204237,0.00096792297],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008996542,0.000028263608,0.0005235724,0.000023340637,0.00014136649,0.000040900173,0.00024812666,3.6759843e-7,0.026978655,0.000013678871,0.95648533,0.015426403],"study_design_scores_gemma":[0.0018533514,0.00014404404,0.04185696,0.00087195495,0.00015470263,0.00001581078,0.000020599984,0.0000032304602,0.015747331,0.000059815437,0.93916595,0.000106225256],"about_ca_topic_score_codex":0.0009364964,"about_ca_topic_score_gemma":0.0037577825,"teacher_disagreement_score":0.76183486,"about_ca_system_score_codex":0.00007737763,"about_ca_system_score_gemma":0.00033965634,"threshold_uncertainty_score":0.9998099},"labels":[],"label_agreement":null},{"id":"W6930144206","doi":"10.5281/zenodo.12482719","title":"mcdonalds coupons pdf 2023 ontario","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Launched; Order (exchange); Ice cream; China; Mobile apps; The Internet","score_opus":0.040866210933963,"score_gpt":0.295677249557855,"score_spread":0.25481103862389204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930144206","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000075584925,0.0010089322,0.000034824978,0.0011332219,0.0004732278,0.0006094151,0.00037905257,0.0010138403,0.9952719],"genre_scores_gemma":[0.0008731824,0.00034939335,0.00007110091,0.00030777947,0.00071320956,9.950578e-8,0.0044865003,0.0074202497,0.9857785],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99860156,0.00008920077,0.00018212572,0.00048286404,0.0003153001,0.00032897413],"domain_scores_gemma":[0.9991834,0.0000091893535,0.00007742264,0.00037401952,0.00013359876,0.0002223299],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00018074554,0.00022645245,0.00028836148,0.0004140884,0.00031649577,0.00021017002,0.00033827184,0.00018552033,0.6692048],"category_scores_gemma":[0.000045122615,0.00021969926,0.00011145235,0.0003348117,0.00013325053,0.000031700183,0.000490645,0.00053687976,0.25974116],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010216743,0.00017652569,0.0000024442377,0.00021160519,0.00039365547,0.00023031361,0.00030283505,3.6793082e-7,0.0003010857,0.00036037195,0.99132174,0.006596864],"study_design_scores_gemma":[0.0008757342,0.0004300014,0.00007753416,0.00020038677,0.0002758685,0.00035601086,0.000031696924,0.0000070008205,0.000029275147,0.0000520059,0.99748194,0.0001825587],"about_ca_topic_score_codex":0.0016475262,"about_ca_topic_score_gemma":0.00021492808,"teacher_disagreement_score":0.4094636,"about_ca_system_score_codex":0.00055583083,"about_ca_system_score_gemma":0.00002451745,"threshold_uncertainty_score":0.8959076},"labels":[],"label_agreement":null},{"id":"W6930270977","doi":"10.5281/zenodo.11755733","title":"Simone thomalla playboy pdf","year":2024,"lang":"de","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Happening; Kingdom; Nice; Character (mathematics)","score_opus":0.03552001724424897,"score_gpt":0.29336595627818085,"score_spread":0.2578459390339319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930270977","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034380634,0.013123245,0.00009345509,0.0019263297,0.001956598,0.001293284,0.0008508187,0.0010888816,0.97932357],"genre_scores_gemma":[0.008043373,0.005227985,0.0000796936,0.00057147635,0.0046999725,1.6962643e-7,0.008038402,0.012812916,0.960526],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99669087,0.00044005978,0.0004690603,0.0010434473,0.00057560776,0.00078095106],"domain_scores_gemma":[0.9980994,0.00004046328,0.00020768768,0.0007275909,0.00043938268,0.0004855138],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00054261694,0.0005115965,0.00058653834,0.0006970649,0.0009842768,0.00072195043,0.0009073103,0.000377548,0.7142257],"category_scores_gemma":[0.00030013637,0.0005099641,0.00021824619,0.0007651824,0.00033386072,0.000086157386,0.0013500128,0.0009766365,0.79272735],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033928698,0.0004943853,0.0000027574795,0.00073871535,0.0013130144,0.00047123135,0.0008582385,0.0000039481743,0.0010179649,0.00077584584,0.95691293,0.03707165],"study_design_scores_gemma":[0.001962255,0.0011453548,0.000060986087,0.0004689778,0.00097564096,0.00013160091,0.00017959693,0.00009373925,0.00017636929,0.00011079025,0.9942654,0.00042930554],"about_ca_topic_score_codex":0.000042783737,"about_ca_topic_score_gemma":0.0000016521655,"teacher_disagreement_score":0.07850162,"about_ca_system_score_codex":0.0005852763,"about_ca_system_score_gemma":0.000020617128,"threshold_uncertainty_score":0.9997352},"labels":[],"label_agreement":null},{"id":"W6930353111","doi":"10.5281/zenodo.11088244","title":"Interactive figures for Lawlor-Forsyth et al. (2024)","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Truncation (statistics); RADIUS; Function (biology); Contrast (vision)","score_opus":0.041705744124566096,"score_gpt":0.34507318309689317,"score_spread":0.3033674389723271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930353111","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021918262,0.0013353433,0.00029935275,0.005963238,0.0007413611,0.001293836,0.0014792809,0.0011056978,0.98775995],"genre_scores_gemma":[0.00093696435,0.0009887007,0.00023505364,0.0030445652,0.0005930237,6.183333e-7,0.00597476,0.009388271,0.978838],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986441,0.00011798863,0.00018246777,0.00052180147,0.00022561026,0.00030802086],"domain_scores_gemma":[0.9991922,0.000031497493,0.000103916,0.00031298818,0.00019933471,0.00016007203],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00023597172,0.00023524801,0.00029786685,0.0004204617,0.00025480078,0.00023810583,0.00029928167,0.0001216406,0.13409011],"category_scores_gemma":[0.0001561013,0.00021667701,0.00013004431,0.00025528605,0.00010404975,0.0000563759,0.00040491336,0.00041970183,0.018120147],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032102046,0.00017225105,3.2209255e-7,0.00039026947,0.0004930873,0.000049998995,0.0004097223,5.559103e-7,0.00044439585,0.0009964703,0.9826276,0.014094323],"study_design_scores_gemma":[0.0012377582,0.0007591169,0.000007894088,0.00033614482,0.00021722823,0.00011483633,0.00009625262,0.000030870677,0.00013924175,0.000121921206,0.9967535,0.00018520355],"about_ca_topic_score_codex":0.000046664205,"about_ca_topic_score_gemma":0.0000030121835,"teacher_disagreement_score":0.115969956,"about_ca_system_score_codex":0.00021958131,"about_ca_system_score_gemma":0.0000117400095,"threshold_uncertainty_score":0.9826444},"labels":[],"label_agreement":null},{"id":"W6930680253","doi":"10.5281/zenodo.14812110","title":"Entre héritage réglementaire et imaginaire du risque: gestion des zones inondables et pratiques d'adaptation au Québec et à Lachute","year":2025,"lang":"fr","type":"report","venue":"Archipelago (University of Quebec in Montreal)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Western europe; Black sea; Turkish republic","score_opus":0.024844888969109198,"score_gpt":0.2824100367619338,"score_spread":0.25756514779282463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930680253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86313355,0.010382596,0.0029412024,0.039889663,0.0009499101,0.0022096687,0.0008530626,0.00017513726,0.0794652],"genre_scores_gemma":[0.88517505,0.036191963,0.0024103015,0.00038871568,0.00019324958,0.000017078488,0.0029264463,0.000053347274,0.07264384],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.995939,0.0013633728,0.0006383417,0.0008240849,0.0005630426,0.0006721521],"domain_scores_gemma":[0.997216,0.0009704376,0.00071649736,0.00043691794,0.00041329477,0.00024683666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010906325,0.0006742126,0.0012192791,0.0008703578,0.00037554666,0.000037146732,0.000351277,0.0005048294,0.00046732672],"category_scores_gemma":[0.0001832975,0.0007970428,0.0003994221,0.00047824762,0.0008219896,0.0008259351,0.00031957775,0.0010345358,0.000021205899],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0017302429,0.0021752198,0.14558661,0.0030667235,0.001456197,0.0023314147,0.23912986,0.0016275278,0.00022768427,0.005964241,0.0080497805,0.5886545],"study_design_scores_gemma":[0.007543752,0.0010395236,0.8672604,0.005904574,0.0032704044,0.00010924082,0.08601482,0.0028588679,0.00009645365,0.0038271744,0.021248536,0.0008262856],"about_ca_topic_score_codex":0.99299353,"about_ca_topic_score_gemma":0.99971604,"teacher_disagreement_score":0.7216737,"about_ca_system_score_codex":0.0049492763,"about_ca_system_score_gemma":0.0116672525,"threshold_uncertainty_score":0.99944806},"labels":[],"label_agreement":null},{"id":"W6931567091","doi":"10.5281/zenodo.5051418","title":"FIGURE 1 in A taxonomic revision of Piezura Rondani (Diptera: Fanniidae)","year":2005,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bishop's University","funders":"","keywords":"Male genitalia; Type (biology); Taxonomy (biology)","score_opus":0.030910984920870032,"score_gpt":0.28786707629374797,"score_spread":0.25695609137287795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931567091","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015650429,0.0018036292,0.00006529237,0.00068226486,0.00011408021,0.0009884515,0.00031456078,0.0003478582,0.9941188],"genre_scores_gemma":[0.10763739,0.0035897384,0.0006410579,0.0004541008,0.0012239221,1.5551971e-7,0.006771995,0.009343777,0.87033784],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869674,0.00014630935,0.0002985795,0.00037878507,0.00021434581,0.0002652601],"domain_scores_gemma":[0.9991877,0.000012225027,0.00019289406,0.00036733862,0.00011964482,0.00012020158],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00021136613,0.00019896717,0.00039211643,0.00054556376,0.00014587141,0.00005465285,0.00033990026,0.00017256336,0.21403718],"category_scores_gemma":[0.00008025366,0.00019621785,0.00008298858,0.00032849654,0.00010474926,0.00004878694,0.0003150477,0.00033509076,0.0060476577],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018382336,0.00026077696,0.000012246839,0.00024350814,0.0000871197,0.000033336597,0.00020634082,0.0000033737215,0.0011463969,0.00012335024,0.88459957,0.11310015],"study_design_scores_gemma":[0.0018353651,0.00042852457,0.00040331285,0.00040152884,0.00007132251,0.000051360195,0.000038101018,0.00002820781,0.00015534749,0.0000025581696,0.99643975,0.00014461321],"about_ca_topic_score_codex":0.00009037179,"about_ca_topic_score_gemma":0.00000323573,"teacher_disagreement_score":0.20798951,"about_ca_system_score_codex":0.00026230558,"about_ca_system_score_gemma":0.000010983987,"threshold_uncertainty_score":0.99472624},"labels":[],"label_agreement":null},{"id":"W6931662947","doi":"10.5683/sp3/jxutck","title":"Environics Focus Ontario 2002-3","year":2009,"lang":"en","type":"dataset","venue":"Borealis","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Innovative Research Group (Canada)","funders":"","keywords":"Focus (optics); Public opinion; Field (mathematics); Focus group; Government (linguistics)","score_opus":0.020736693375873257,"score_gpt":0.3002779631562972,"score_spread":0.27954126978042393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931662947","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013036813,0.00217235,4.5186056e-7,0.00082172186,0.00012237912,0.00037277534,0.9851804,0.000031109485,0.011285793],"genre_scores_gemma":[0.0000030598528,0.002508223,0.000044309465,0.0016642769,0.00072306814,0.00003786941,0.9898103,0.00001714182,0.005191765],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989065,0.000023915356,0.00022291961,0.00032367793,0.00021619094,0.00030682446],"domain_scores_gemma":[0.9990937,0.00002762937,0.00010679313,0.00056537654,0.000025199432,0.00018129888],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000056600536,0.00028832303,0.000497278,0.00010872956,0.000046893212,0.000012592653,0.00013476408,0.00036687654,0.009499345],"category_scores_gemma":[0.00000844415,0.00024896918,0.00017316795,0.00005379941,0.000048893053,0.000022889066,0.00003372911,0.00048919657,0.00019711921],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018977906,0.00035582276,0.000027109561,0.000028443648,0.00020136396,0.0005435448,0.000030158468,2.9987436e-7,0.0000022225058,0.0000030814401,0.9919924,0.006625748],"study_design_scores_gemma":[0.0016383659,0.0007826628,0.0023772276,0.000042124444,0.001285921,0.000101733174,0.0000016581724,3.2074925e-7,0.000027117187,0.000034348526,0.99350554,0.00020299962],"about_ca_topic_score_codex":0.8149011,"about_ca_topic_score_gemma":0.9313014,"teacher_disagreement_score":0.116400264,"about_ca_system_score_codex":0.00070829835,"about_ca_system_score_gemma":0.0005979234,"threshold_uncertainty_score":0.99999624},"labels":[],"label_agreement":null},{"id":"W6931706087","doi":"10.5683/sp3/nvqfmr","title":"A question of ethics. Canadians speak out. Public attitude towards political ethics 1996 data [Canada]","year":2014,"lang":"en","type":"dataset","venue":"Borealis","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"York University; Université de Montréal; University of Saskatchewan; University of Guelph","funders":"","keywords":"Respondent; Politics; Public opinion; Interview; Telephone survey; Survey methodology","score_opus":0.15716032733664317,"score_gpt":0.4278815861904258,"score_spread":0.2707212588537826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931706087","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009162107,0.00035975478,0.000013751471,0.070259385,0.00068223855,0.00036923029,0.9261528,0.000025145091,0.0021284998],"genre_scores_gemma":[0.0010443123,0.0007224511,0.000087516244,0.013855819,0.0013783489,0.000027634034,0.982565,0.000037237463,0.00028168992],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968264,0.0004343618,0.0005341541,0.00060768717,0.000913438,0.00068397186],"domain_scores_gemma":[0.9962057,0.0005809433,0.0002407894,0.0017884406,0.0003865621,0.00079755695],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011939841,0.00037629931,0.00084190816,0.00021628565,0.00010596339,0.000027843469,0.00073433726,0.0011494262,0.00042049715],"category_scores_gemma":[0.002220975,0.00034581666,0.00009422384,0.00012946279,0.00031370536,0.00006265355,0.00024465116,0.0023704097,0.000008486884],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071621376,0.0001602072,0.00020897522,0.00082925154,0.00041751243,0.00020278557,0.000073524054,2.06528e-7,0.000002179647,0.0019305692,0.9956539,0.00044923002],"study_design_scores_gemma":[0.0009840115,0.00023727599,0.0018871279,0.00022637323,0.0012365439,0.000059152655,0.00003166902,0.00001265454,0.000013295122,0.00008555729,0.99496114,0.00026520286],"about_ca_topic_score_codex":0.9989783,"about_ca_topic_score_gemma":0.9997689,"teacher_disagreement_score":0.056412157,"about_ca_system_score_codex":0.0010461817,"about_ca_system_score_gemma":0.021036325,"threshold_uncertainty_score":0.99993116},"labels":[],"label_agreement":null},{"id":"W6931716704","doi":"10.5281/zenodo.5791255","title":"Survival in women with de novo metastatic breast cancer: a comparison of real-world evidence from a publicly-funded Canadian province and the United States by insurance status","year":2021,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health insurance; Population; Breast cancer; MEDLINE; Disease; Socioeconomic status","score_opus":0.04286436815109104,"score_gpt":0.30959993904754857,"score_spread":0.2667355708964575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931716704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99136955,0.00060819054,0.000032656288,0.0048265704,0.00001930003,0.00043469536,0.0013050694,0.00004971031,0.0013542654],"genre_scores_gemma":[0.9965669,0.001676104,0.00006396073,0.00028669531,0.000018545423,6.0105845e-7,0.00087375863,0.00019981484,0.00031364948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984448,0.00049223786,0.00020930056,0.00026428443,0.00021523311,0.0003741391],"domain_scores_gemma":[0.9988921,0.00013869817,0.0000962067,0.00020899807,0.0003925919,0.0002713788],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038759568,0.00010816873,0.00027785284,0.0001925473,0.0002992753,0.00014262863,0.00018371922,0.00002012939,0.0026427289],"category_scores_gemma":[0.00014552458,0.00008394268,0.000013303101,0.00096906745,0.00026366394,0.000120203855,0.00013752659,0.00020736188,0.000017629742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041513655,0.0030740353,0.56703365,0.0014536211,0.002816771,0.0011332688,0.088426426,0.0017930997,0.01707916,0.001797917,0.117754154,0.15612426],"study_design_scores_gemma":[0.017435841,0.0009851956,0.59931564,0.0006268687,0.00023794311,0.00021067954,0.0075626187,0.0034749252,0.0019052154,0.00012852353,0.36772272,0.00039383027],"about_ca_topic_score_codex":0.306288,"about_ca_topic_score_gemma":0.07833975,"teacher_disagreement_score":0.24996856,"about_ca_system_score_codex":0.0007039575,"about_ca_system_score_gemma":0.00013793008,"threshold_uncertainty_score":0.99826896},"labels":[],"label_agreement":null},{"id":"W6939530163","doi":"10.6084/m9.figshare.28756932","title":"Additional file 2 of Results of the preclinical multicenter randomized controlled paclitaxel-induced neuropathy prevention replication study (PINPRICS)","year":2025,"lang":"en","type":"article","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"","keywords":"Randomized controlled trial; Replication (statistics); Peripheral neuropathy; Clinical trial; MEDLINE","score_opus":0.05133684051177635,"score_gpt":0.3821693012866753,"score_spread":0.330832460774899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939530163","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053461436,0.00005194477,1.8010233e-7,0.00034843435,0.00008482044,0.0048028277,0.98428,0.00001931347,0.0050663278],"genre_scores_gemma":[0.5114379,0.000002342201,0.0000290661,0.0001845325,0.00007791391,0.0059993556,0.4754548,0.000007654051,0.0068064355],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99835247,0.00046687535,0.0006856481,0.00023986446,0.00017455369,0.00008058429],"domain_scores_gemma":[0.9930303,0.0057104803,0.0005370288,0.00040708398,0.0002880297,0.00002706554],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002025815,0.00009502549,0.0006468299,0.000057455272,0.000033835335,0.0000036505733,0.00009619033,0.000061029412,0.7563484],"category_scores_gemma":[0.023299105,0.000058936126,0.00039615715,0.00017240625,0.000016935517,0.000026110805,0.000060563674,0.00012185797,0.000050342267],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09939432,0.0012945292,0.000026183865,0.00006408186,0.00030869374,0.00000124783,0.00006467585,8.8023364e-7,0.00011127786,9.438158e-7,0.8974327,0.0013004764],"study_design_scores_gemma":[0.8191622,0.0010280501,0.050908733,0.0036690307,0.0010049914,0.000002054751,0.00006455109,0.0011830518,0.0011686728,0.000041919964,0.12166729,0.00009947411],"about_ca_topic_score_codex":0.0000057124716,"about_ca_topic_score_gemma":0.000009625973,"teacher_disagreement_score":0.7757654,"about_ca_system_score_codex":0.000030394358,"about_ca_system_score_gemma":0.00019685076,"threshold_uncertainty_score":0.9849281},"labels":[],"label_agreement":null},{"id":"W6944998808","doi":"10.20381/ruor-29549","title":"Les familles en trans-formation : Les réalités vécues des parents trans et de leur famille en Ontario et au Québec","year":2023,"lang":"fr","type":"other","venue":"uO Research (University of Ottawa)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Perspective (graphical); Futures contract; Michel foucault","score_opus":0.11771835200405015,"score_gpt":0.3810843729934636,"score_spread":0.2633660209894134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6944998808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7051725,0.0008717597,0.0009603474,0.0048749917,0.00024471967,0.0009988355,0.0005153392,0.00014495001,0.2862166],"genre_scores_gemma":[0.5177069,0.009301136,0.00044527173,0.000039313498,0.00017792505,0.0000076277247,0.00026402005,0.00015079374,0.47190705],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959693,0.0016436323,0.00026472993,0.00047288835,0.0007574905,0.0008919412],"domain_scores_gemma":[0.99782765,0.0011694718,0.00012452588,0.0002950509,0.00022225332,0.0003610382],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015381792,0.00037411516,0.0006760114,0.0008868472,0.0005780732,0.000023634917,0.00055606425,0.0005858999,0.008359011],"category_scores_gemma":[0.000086156986,0.00041790374,0.00034731263,0.0004178062,0.0009022871,0.00028206053,0.000116537354,0.0011919072,0.00016612536],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030205544,0.00082872616,0.6174469,0.0016329421,0.0014882508,0.0004935158,0.2508762,0.00009799382,0.0018175265,0.0037202584,0.008806421,0.112489216],"study_design_scores_gemma":[0.0028400267,0.0007187991,0.458873,0.000717271,0.00036799835,0.000012407117,0.0264957,0.00008546136,0.00014488533,0.000058347265,0.50944513,0.00024097986],"about_ca_topic_score_codex":0.93396384,"about_ca_topic_score_gemma":0.996011,"teacher_disagreement_score":0.50063866,"about_ca_system_score_codex":0.0067862677,"about_ca_system_score_gemma":0.0038930005,"threshold_uncertainty_score":0.99982727},"labels":[],"label_agreement":null},{"id":"W6945111700","doi":"10.25384/sage.21754014.v1","title":"Visual abstract – Supplemental material for A Systematic Review and Meta-Analysis of Robot-Assisted Mitral Valve Repair","year":2022,"lang":"en","type":"other","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Mitral valve repair; Cardiothoracic surgery; Mitral valve; Mitral valve annuloplasty; Systematic review","score_opus":0.09381252800281335,"score_gpt":0.40026350052405274,"score_spread":0.3064509725212394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6945111700","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004104482,0.061093178,4.0935287e-8,0.00010140327,0.000041490825,0.0051818006,0.9281795,0.00008676275,0.005311734],"genre_scores_gemma":[0.00047194734,0.00015455837,0.00013003871,0.00067689974,0.00010462145,0.007477155,0.86375844,0.00019482014,0.1270315],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9987274,0.00007006794,0.0004994654,0.00033117677,0.0002032498,0.00016867634],"domain_scores_gemma":[0.9989566,0.00010373018,0.00057317025,0.0002511771,0.000041482355,0.000073805066],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000081223436,0.00028149394,0.0029918333,0.00025362847,0.000027452666,0.000008328565,0.00007973184,0.00011105364,0.958331],"category_scores_gemma":[0.00006594003,0.00020803048,0.0043412726,0.00016734724,0.000007387859,0.00001456563,0.00006004676,0.000083781306,0.000031284704],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025216106,0.000088242785,0.0000023579933,0.20878308,0.24216117,0.000012460545,0.0000073142883,6.9337645e-8,0.000005067391,1.9779635e-7,0.54891366,0.0000011535741],"study_design_scores_gemma":[0.00070314866,0.00028702023,0.00014412905,0.0053237313,0.9141107,0.00001794763,0.000013350404,0.0000030626538,0.000015756812,1.5776149e-7,0.079220265,0.00016073577],"about_ca_topic_score_codex":0.00013932797,"about_ca_topic_score_gemma":0.0002249883,"teacher_disagreement_score":0.9582997,"about_ca_system_score_codex":0.00008690139,"about_ca_system_score_gemma":0.00006770968,"threshold_uncertainty_score":0.8483237},"labels":[],"label_agreement":null},{"id":"W6945201704","doi":"10.25316/ir-14565","title":"Nanaimo Free Press [Saturday, June 19, 1886]","year":2020,"lang":"en","type":"other","venue":"VIUSpace (Vancouver Island University Library)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"","score_opus":0.010649458422789231,"score_gpt":0.2183261277355767,"score_spread":0.20767666931278747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6945201704","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016270511,0.00205834,0.00004360194,0.005379475,0.0020557987,0.00073819765,0.0008665351,0.00072252,0.98811924],"genre_scores_gemma":[0.0002000422,0.0037854493,0.00076955144,0.0012406607,0.0011117164,0.0000023477069,0.0001031867,0.00035103678,0.992436],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984296,0.00008041795,0.00013448342,0.0006557532,0.0002892654,0.00041047405],"domain_scores_gemma":[0.9986561,0.000052956002,0.00020016271,0.0006045434,0.000014672024,0.00047154486],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000013953857,0.000494937,0.00075531896,0.00032844458,0.00009791232,0.000027243586,0.00046831951,0.0005061473,0.011677086],"category_scores_gemma":[0.000009651691,0.00047157318,0.0002840344,0.0003829795,0.00014860203,0.00022739933,0.00041464972,0.0005308851,0.00014161933],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080101006,0.00015489584,0.00010667025,0.0002961992,0.00076676084,0.0017549192,0.00025421893,0.0000018522741,0.00002070411,0.00020611513,0.995432,0.00020462114],"study_design_scores_gemma":[0.0060499967,0.00029367543,0.000041649997,0.0001814378,0.0009115705,0.000008367884,0.00011856122,0.000014136154,0.0001677386,0.00003315831,0.99172956,0.00045012133],"about_ca_topic_score_codex":0.0017605968,"about_ca_topic_score_gemma":0.17248555,"teacher_disagreement_score":0.17072494,"about_ca_system_score_codex":0.0001482763,"about_ca_system_score_gemma":0.0005210453,"threshold_uncertainty_score":0.9997736},"labels":[],"label_agreement":null},{"id":"W6945264092","doi":"10.25316/ir-10072","title":"Nanaimo Free Press [Friday, August 6, 1897]","year":2019,"lang":"en","type":"other","venue":"VIUSpace (Vancouver Island University Library)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"","score_opus":0.009710918655201186,"score_gpt":0.21578980006829002,"score_spread":0.20607888141308883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6945264092","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033126787,0.0013475231,0.000034902376,0.0010028054,0.0020221835,0.00090848043,0.0007214512,0.0005533865,0.99337614],"genre_scores_gemma":[0.00029732994,0.0022871804,0.00036976504,0.00042639105,0.0007670604,0.00000219261,0.0000369996,0.00038409545,0.995429],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984696,0.0000713891,0.00012838408,0.0006116933,0.00027897875,0.00043994494],"domain_scores_gemma":[0.99862504,0.000057794543,0.00020434897,0.00083189365,0.000020955826,0.00025996836],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000016792737,0.00047833112,0.0007268653,0.00042296082,0.0000723434,0.000027392212,0.0004642772,0.0005513494,0.011846705],"category_scores_gemma":[0.000004909145,0.00045327967,0.00027451545,0.00027428614,0.00012400419,0.00027746832,0.00037995283,0.0004381626,0.00034810108],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005879921,0.00024124651,0.000120315635,0.00029355194,0.000692739,0.0006433215,0.0000989488,0.000002204762,0.000011872701,0.00031817047,0.99677926,0.00021034428],"study_design_scores_gemma":[0.0066554556,0.0003483353,0.000051713327,0.00026503004,0.0007863899,0.0000072706152,0.00011859181,0.000009314057,0.00015605227,0.000021377691,0.99112725,0.00045323456],"about_ca_topic_score_codex":0.0018534688,"about_ca_topic_score_gemma":0.09175866,"teacher_disagreement_score":0.08990519,"about_ca_system_score_codex":0.00012988459,"about_ca_system_score_gemma":0.00036349436,"threshold_uncertainty_score":0.9997919},"labels":[],"label_agreement":null},{"id":"W6945416801","doi":"10.24433/co.9571035.v1","title":"A Broad Review on Class Imbalance Learning Techniques","year":2023,"lang":"en","type":"other","venue":"Code Ocean","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Class (philosophy); Taxonomy (biology); Support vector machine; Statistical classification; One-class classification; Ensemble learning","score_opus":0.028189142237622068,"score_gpt":0.3642957447447873,"score_spread":0.33610660250716523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6945416801","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022390755,0.05101537,0.0000029724017,0.0025673255,0.0003873149,0.0009299015,0.00004044124,0.0023202728,0.94271404],"genre_scores_gemma":[0.00014582612,0.14230965,0.0000624976,0.0027517094,0.0006913583,0.000037529568,0.00009517337,0.0006071444,0.8532991],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99919546,0.000040551495,0.0001399731,0.00029333303,0.00013773478,0.00019294201],"domain_scores_gemma":[0.99950844,0.000038982933,0.00012542878,0.00023367231,0.00001857855,0.00007486737],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000087303175,0.00021695005,0.0005133223,0.00012405727,0.000023219884,0.0000041969815,0.00007807512,0.0001735882,0.002471448],"category_scores_gemma":[0.00003894349,0.0001787297,0.00011797834,0.00014760412,0.000039263436,0.0000066187795,0.000025786496,0.00038805197,0.00072588684],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003294869,0.000052650255,0.0006693666,0.0013028542,0.00011565319,0.00012509001,0.00000851731,3.9655248e-8,0.00004734715,0.000030339728,0.9851525,0.012462687],"study_design_scores_gemma":[0.00041478337,0.0003648382,0.0000786475,0.011155096,0.00029364065,0.000015249201,0.0000017489461,0.000002298296,0.00019210274,0.0000059306963,0.987333,0.00014269137],"about_ca_topic_score_codex":0.00004549196,"about_ca_topic_score_gemma":0.000061011575,"teacher_disagreement_score":0.09129429,"about_ca_system_score_codex":0.00011582836,"about_ca_system_score_gemma":0.0000622721,"threshold_uncertainty_score":0.99844044},"labels":[],"label_agreement":null},{"id":"W6945603724","doi":"10.25384/sage.23667810","title":"sj-docx-1-psp-10.1177_01461672231180450 – Supplemental material for In it Together: Relationship Transitions and Couple Concordance in Health and Well-Being","year":2023,"lang":"en","type":"article","venue":"Sage Journals Data","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Concordance; Personality; Association (psychology); Personality Assessment Inventory; Big Five personality traits; Social relation","score_opus":0.07495274882805165,"score_gpt":0.40538519943044815,"score_spread":0.3304324506023965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6945603724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95234114,0.0050770366,0.00011596988,0.03530943,0.00027572253,0.0010420908,0.0056231814,0.000030029887,0.00018537446],"genre_scores_gemma":[0.98058605,0.011049224,0.00056419265,0.0012236394,0.0002709007,0.000069821814,0.0055124434,0.00002446313,0.0006992906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988593,0.00008381003,0.00040976852,0.0002575646,0.00010425992,0.00028532767],"domain_scores_gemma":[0.99934024,0.00022642243,0.000089551824,0.00018175133,0.000015929014,0.00014613726],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008310165,0.000112293004,0.0002864924,0.00020046727,0.00012779643,0.000035968653,0.00008227527,0.000050011422,0.0041531217],"category_scores_gemma":[0.000046566925,0.00010899576,0.00002022498,0.00023221497,0.0000503777,0.0002154699,0.000060793092,0.00017060507,0.000008548222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003950484,0.00074653776,0.6923119,0.0011446041,0.00027281672,0.00071257557,0.01299896,0.000032315096,0.015291921,0.00016585283,0.23639858,0.035973452],"study_design_scores_gemma":[0.060892224,0.002944158,0.49399906,0.0045508305,0.00042362307,0.001021543,0.0110984035,0.008542362,0.001684022,0.004791342,0.40919027,0.00086215494],"about_ca_topic_score_codex":0.0003307086,"about_ca_topic_score_gemma":0.0021034987,"teacher_disagreement_score":0.19831283,"about_ca_system_score_codex":0.000090767186,"about_ca_system_score_gemma":0.00014674052,"threshold_uncertainty_score":0.9967572},"labels":[],"label_agreement":null},{"id":"W6945881801","doi":"10.3389/fphar.2024.1519522.s002","title":"Data Sheet 1_Association between penicillin allergy labels and serious adverse events in hospitalized patients: a systematic review and meta-analysis.docx","year":2025,"lang":"en","type":"dataset","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Funnel plot; Adverse effect; Penicillin; Allergy; Meta-analysis; Relative risk; Data extraction; Confidence interval","score_opus":0.07160547246490633,"score_gpt":0.3671827157821908,"score_spread":0.29557724331728447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6945881801","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030596533,0.056964956,1.779106e-8,0.00030350502,0.000021100755,0.0032765884,0.9393763,0.000014551519,0.000012412337],"genre_scores_gemma":[0.0000829081,0.0055004307,0.0000064111728,0.0013239769,0.000028090519,0.001134824,0.9913583,0.000011754699,0.0005533336],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9976482,0.0003326778,0.0007978887,0.0006665461,0.00032307507,0.00023164357],"domain_scores_gemma":[0.9978513,0.0002792815,0.0006833445,0.0009187882,0.00015166165,0.00011564111],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021731004,0.0004013965,0.003562938,0.0002833655,0.00004438888,0.000011144136,0.00031275654,0.00026565368,0.03569289],"category_scores_gemma":[0.0010300688,0.00031413863,0.00030799778,0.000524259,0.00000603105,0.00013045622,0.00045957125,0.00027038786,0.000039685758],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011318909,0.00010495153,0.00017191315,0.108300924,0.06802746,0.000016642845,0.000009268291,2.2389621e-7,6.757772e-9,2.0831143e-8,0.82335454,0.0000027070182],"study_design_scores_gemma":[0.0021691008,0.0001375269,0.004206575,0.016384259,0.72161406,0.0000014316408,0.0000036998078,0.0000065299437,1.196302e-7,0.0000015871773,0.25518015,0.0002949702],"about_ca_topic_score_codex":0.00022650033,"about_ca_topic_score_gemma":0.00084556534,"teacher_disagreement_score":0.6535866,"about_ca_system_score_codex":0.00018377858,"about_ca_system_score_gemma":0.00013537536,"threshold_uncertainty_score":0.9999311},"labels":[],"label_agreement":null},{"id":"W6946174010","doi":"10.3389/fnut.2024.1467751.s001","title":"Data_Sheet_1_Joint association of serum sodium and frailty with mild cognitive impairment among hospitalized older adults with chronic diseases: a cross-sectional study.docx","year":2024,"lang":"en","type":"dataset","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Logistic regression; Cognitive impairment; Sodium; Risk factor; Older people; Confidence interval; Cognition; High sodium","score_opus":0.016606342629779815,"score_gpt":0.32013459202497646,"score_spread":0.3035282493951966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6946174010","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.108154766,0.0009834084,1.8042595e-8,0.000033641856,0.00012464076,0.0030562177,0.88758016,0.00004630052,0.000020862713],"genre_scores_gemma":[0.110481806,0.000044979275,0.000001837618,0.00007242936,0.00038357492,0.0016581246,0.88702726,0.000040854797,0.00028910386],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9979187,0.000055728626,0.0003533301,0.0007295879,0.0006159136,0.0003266894],"domain_scores_gemma":[0.99862003,0.00013419912,0.00042615485,0.00027830366,0.00034590252,0.00019538937],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000056125948,0.00044135132,0.0006445348,0.0001602737,0.00008930053,0.00008703207,0.00010433489,0.00024329376,0.0921159],"category_scores_gemma":[0.000067601446,0.00031771307,0.00010734158,0.00022229266,0.000042182608,0.00014812974,0.00016527313,0.00047958587,0.00032027165],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018913766,0.0009799565,0.21232599,0.0028941492,0.0018312837,0.00025988638,0.00012787072,0.0000010044843,6.693457e-8,1.0436395e-8,0.77966046,0.0000279722],"study_design_scores_gemma":[0.015542047,0.005104067,0.91028315,0.008946592,0.0022326543,0.000017334982,0.00008534407,0.000012765518,0.000010633384,4.3877606e-7,0.057443347,0.00032162687],"about_ca_topic_score_codex":0.00031552333,"about_ca_topic_score_gemma":0.0015574164,"teacher_disagreement_score":0.7222171,"about_ca_system_score_codex":0.0007174501,"about_ca_system_score_gemma":0.0007076136,"threshold_uncertainty_score":0.9999275},"labels":[],"label_agreement":null},{"id":"W6946201193","doi":"10.3389/fcimb.2022.947486.s001","title":"DataSheet_1_Genomic characterization of two metagenome-assembled genomes of Tropheryma whipplei from China.pdf","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tropheryma whipplei; Genome; Phylogenetic tree; Phylogenetics; Metagenomics; Whole genome sequencing; Genotype; Bacterial genome size","score_opus":0.03462018715582865,"score_gpt":0.31468957245483603,"score_spread":0.2800693852990074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6946201193","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011261255,0.0014654043,8.2438426e-8,0.0000385054,0.00027950117,0.0009304716,0.9858922,0.00001934035,0.00011324882],"genre_scores_gemma":[0.00080018275,0.00071953126,0.000022919816,0.00011760395,0.00038906917,0.00044401744,0.9970108,0.000047191374,0.00044863345],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816203,0.000114361246,0.0006228076,0.0004996063,0.00034564076,0.0002555659],"domain_scores_gemma":[0.998056,0.000097907134,0.00085624406,0.0007912313,0.00008268912,0.000115909024],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005241849,0.00038296392,0.0011283774,0.00026097026,0.000057323286,0.000012445773,0.00043095413,0.00017723834,0.9730407],"category_scores_gemma":[0.0000455243,0.00037679335,0.00026018763,0.0002816907,0.000012210072,0.00007748439,0.00033844047,0.00036508444,0.00077735423],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034977018,0.0003729139,0.00004885433,0.0007685558,0.0009369225,0.00007511161,0.000054935976,0.000004690902,0.039076187,1.238486e-7,0.9575505,0.0007614143],"study_design_scores_gemma":[0.0025591087,0.00044205633,0.009602436,0.00032519383,0.0012915238,0.000010414685,0.000008403751,0.0000061073815,0.0032757735,0.0000028415868,0.982224,0.0002521295],"about_ca_topic_score_codex":0.00074218237,"about_ca_topic_score_gemma":0.0001264435,"teacher_disagreement_score":0.97226334,"about_ca_system_score_codex":0.00021206155,"about_ca_system_score_gemma":0.0004378934,"threshold_uncertainty_score":0.9998684},"labels":[],"label_agreement":null},{"id":"W6946280202","doi":"10.3389/fpsyt.2024.1414291.s001","title":"DataSheet_1_Targeting maternal gut microbiome to improve mental health outcomes—a pilot feasibility trial.pdf","year":2024,"lang":"en","type":"dataset","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mood; Anxiety; Psychological intervention; Depression (economics); Randomized controlled trial; Microbiome; Mental health; Gut flora","score_opus":0.07816319721669086,"score_gpt":0.40960999324039427,"score_spread":0.3314467960237034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6946280202","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003030363,0.0007510407,1.1203046e-8,0.0024383576,0.0026031153,0.0048324605,0.98888415,0.00010774655,0.000080060345],"genre_scores_gemma":[0.000036689602,0.000038144826,0.0000506934,0.0061080563,0.0013249771,0.0008315819,0.9882775,0.00006249696,0.0032698717],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997064,0.00009558957,0.00073486916,0.0010519706,0.00036031049,0.00069328],"domain_scores_gemma":[0.9981932,0.00008328518,0.00029117253,0.0008414433,0.00006467655,0.00052623096],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00018484211,0.0006138469,0.0011200133,0.00028580712,0.00013160349,0.000112600894,0.00041449352,0.00022412594,0.46373624],"category_scores_gemma":[0.000188472,0.00051285804,0.0002954202,0.0002429405,0.000011810149,0.00007148597,0.0006129551,0.0007228314,0.07744898],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006523874,0.0005914435,0.00002796694,0.0026108122,0.00038803523,0.00016998703,0.000020922069,6.693452e-8,0.00028252756,3.3331098e-8,0.9891164,0.00026796228],"study_design_scores_gemma":[0.019370152,0.0032712638,0.00061492075,0.0022427968,0.00022619872,0.00005727453,0.000006348812,8.3497156e-7,0.00014164428,0.0000011364057,0.9737053,0.00036215215],"about_ca_topic_score_codex":0.0007319152,"about_ca_topic_score_gemma":0.00040668444,"teacher_disagreement_score":0.38628727,"about_ca_system_score_codex":0.0012711729,"about_ca_system_score_gemma":0.0007674763,"threshold_uncertainty_score":0.9997323},"labels":[],"label_agreement":null},{"id":"W6946446326","doi":"10.34943/edda2d79-31ed-4841-858e-4976bdb54483","title":"Strait of Georgia East Hydrophone Deployed 2009-09-27","year":2009,"lang":"en","type":"dataset","venue":"Ocean Networks Canada Society","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hydrophone; Underwater; Sound (geography); Waveform; Data logger; Software deployment","score_opus":0.008496672297777478,"score_gpt":0.2410771219399118,"score_spread":0.2325804496421343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6946446326","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012484561,0.005462683,0.000011310663,0.0008749924,0.0015720621,0.00065779587,0.99004143,0.000043211632,0.00008806244],"genre_scores_gemma":[0.005520961,0.003589184,0.00009484459,0.003635082,0.0017954322,0.0000064428027,0.98321605,0.000060853265,0.0020811444],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975392,0.000057206114,0.0005787573,0.0005381447,0.00057673716,0.0007099605],"domain_scores_gemma":[0.99836636,0.0000817507,0.00039754756,0.00060094893,0.00012289385,0.00043048034],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014159101,0.0005558501,0.0010774649,0.000039662566,0.00011191391,0.000013441613,0.00028782172,0.00060348253,0.0006811517],"category_scores_gemma":[0.000007821516,0.0005293163,0.00048503533,0.00037223162,0.0001630868,0.000032691125,0.000060157952,0.001009402,0.0000017142048],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016979901,0.00025551798,0.00013632188,0.00022062275,0.0010248085,0.00022435018,0.00003205756,0.0008385648,0.000009953832,5.117629e-7,0.9963875,0.00070003147],"study_design_scores_gemma":[0.002554706,0.00036479154,0.00060158345,0.0001882662,0.0015052996,0.00006096678,0.00005078109,0.00047488883,0.000016441762,0.0000043985588,0.9937837,0.00039416482],"about_ca_topic_score_codex":0.3222319,"about_ca_topic_score_gemma":0.4004738,"teacher_disagreement_score":0.07824191,"about_ca_system_score_codex":0.0009973622,"about_ca_system_score_gemma":0.0037847327,"threshold_uncertainty_score":0.99971586},"labels":[],"label_agreement":null},{"id":"W6946476987","doi":"10.3389/fmars.2022.926442.s001","title":"DataSheet_1_Using larval connectivity to inform conservation management of the endemic and threatened Atlantic mud-piddock (Barnea truncata) in the Minas Basin Canada.docx","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metapopulation; Threatened species; Population; Structural basin; Marine conservation; Marine protected area; Marine reserve; Endemism; Propagule","score_opus":0.050226766250569634,"score_gpt":0.30861901493072447,"score_spread":0.2583922486801548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6946476987","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015768964,0.00023209932,1.3085158e-8,0.0018111707,0.00014389696,0.001473155,0.9804395,0.000006718338,0.00012450811],"genre_scores_gemma":[0.0069681285,0.000057992194,0.0000046452124,0.0035117639,0.000053911728,0.00042146904,0.98886615,0.000012047626,0.00010388999],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998642,0.000115402436,0.0002882824,0.00030036175,0.0004098652,0.0002440435],"domain_scores_gemma":[0.9988512,0.00028831963,0.0002013046,0.0005567931,0.000043714335,0.00005867542],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015931392,0.00023813013,0.00038611933,0.00009019296,0.00015301799,0.00002077826,0.00035344274,0.00008944312,0.081597365],"category_scores_gemma":[0.00013598576,0.00015985889,0.00005397723,0.00042736897,0.00001607299,0.000054855576,0.00040936426,0.00038156714,0.000012019953],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016211743,0.00007058531,0.0010762482,0.0010094023,0.00013670838,0.000167541,0.00007406339,0.0000065863574,0.0000030215483,0.0000019323106,0.99692136,0.0003704583],"study_design_scores_gemma":[0.0011751401,0.00010923374,0.04782578,0.00086022733,0.00035652987,0.000064431275,0.00015052955,0.000015221394,0.000034497938,0.000003081044,0.9492627,0.00014266992],"about_ca_topic_score_codex":0.1631073,"about_ca_topic_score_gemma":0.5254209,"teacher_disagreement_score":0.36231357,"about_ca_system_score_codex":0.00040395683,"about_ca_system_score_gemma":0.0005829376,"threshold_uncertainty_score":0.9192422},"labels":[],"label_agreement":null},{"id":"W6946579554","doi":"10.34989/sdp-2022-3","title":"Payment Coordination and Liquidity Efficiency in the New Canadian Wholesale Payments System","year":2022,"lang":"en","type":"article","venue":"Econstor (Econstor)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bank of Canada","funders":"","keywords":"Payment; Market liquidity; Settlement (finance); Payment system; Payment service provider","score_opus":0.015316754972193486,"score_gpt":0.26377668062816056,"score_spread":0.24845992565596708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6946579554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813293,0.0015036265,0.0000041240364,0.00567539,0.0011197957,0.0008533983,0.00007303497,0.000035839123,0.009405496],"genre_scores_gemma":[0.9959755,0.000023272152,0.00001632224,0.0012590506,0.00018002748,0.00018299159,0.00005222229,0.000013669336,0.0022969635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986983,0.00017254327,0.00027659288,0.00031266047,0.00019677174,0.00034311935],"domain_scores_gemma":[0.9992899,0.00012180879,0.00009414759,0.0002168078,0.000021869479,0.0002554756],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046873974,0.00016280297,0.00026486212,0.0002502175,0.0003372212,0.000022587068,0.0001334703,0.00005229809,0.0011414387],"category_scores_gemma":[0.000017600849,0.00013778692,0.00006152058,0.00022205617,0.000090759124,0.00006366606,0.000049770904,0.000263435,0.000036628986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010548488,0.00025816853,0.93472373,0.000050686274,0.00006971485,0.00022143686,0.0021057122,0.000026327958,0.00031730905,0.000681792,0.06024095,0.0011986573],"study_design_scores_gemma":[0.00932333,0.0015268646,0.65689987,0.00009229521,0.00032967978,0.0012662762,0.00533894,0.0008249738,0.00035135914,0.00004177819,0.3235324,0.000472231],"about_ca_topic_score_codex":0.03046889,"about_ca_topic_score_gemma":0.0284493,"teacher_disagreement_score":0.2778239,"about_ca_system_score_codex":0.001691595,"about_ca_system_score_gemma":0.0010201695,"threshold_uncertainty_score":0.99977165},"labels":[],"label_agreement":null},{"id":"W6947437112","doi":"10.3897/bdj.12.e120340.figure1a","title":"Figure 1a from: Douglas H, Renkema J, Smith T, Konstantinov A, Moisan-De Serres J (2024) Palearctic flea beetle and pest of hops and Cannabis, Psylliodes attenuata (Coleoptera, Chrysomelidae, Galerucinae), new to North America. Biodiversity Data Journal 12: e120340. https://doi.org/10.3897/BDJ.12.e120340","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Voltinism; PEST analysis; Coccinellidae; Range (aeronautics); Humulus lupulus; Flea beetle","score_opus":0.0538825984972584,"score_gpt":0.2903534393078463,"score_spread":0.2364708408105879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6947437112","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12827155,0.026662035,0.00023276021,0.0133404,0.0016164641,0.0036879631,0.010936887,0.0011718802,0.81408006],"genre_scores_gemma":[0.022245677,0.0150387045,0.00082948746,0.0005749085,0.002135926,3.8666164e-7,0.006835379,0.002508262,0.94983125],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729896,0.00026092335,0.0004124955,0.0009575057,0.00051847374,0.00055165566],"domain_scores_gemma":[0.9978624,0.000034606524,0.0002972797,0.00085660047,0.00024907524,0.0007000597],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00026438164,0.00044268827,0.0006715163,0.00058135565,0.00055071304,0.0004208777,0.00089230103,0.00019942256,0.11689633],"category_scores_gemma":[0.00022984481,0.00042201436,0.00008404425,0.0005947711,0.00039998587,0.0001905083,0.0018606151,0.0008865214,0.010039567],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061467505,0.00017299913,0.0036340852,0.0004940116,0.0006723749,0.000298648,0.0016615139,0.000002724203,0.00028809786,0.0000045228103,0.9786915,0.013464837],"study_design_scores_gemma":[0.0018637228,0.0009874126,0.021199211,0.0005810623,0.00069916685,0.0001072317,0.00036412643,0.000028866287,0.000032551558,0.000009187833,0.9737777,0.00034974967],"about_ca_topic_score_codex":0.0030825816,"about_ca_topic_score_gemma":0.00009190096,"teacher_disagreement_score":0.13575122,"about_ca_system_score_codex":0.00022518683,"about_ca_system_score_gemma":0.000095488365,"threshold_uncertainty_score":0.99982315},"labels":[],"label_agreement":null},{"id":"W6947656915","doi":"10.3932/ethz-a-000596014","title":"Kanada, Pont de Quebec","year":2001,"lang":"es","type":"other","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"","score_opus":0.015375188878213188,"score_gpt":0.31692760275888077,"score_spread":0.30155241388066756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6947656915","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009659941,0.007008011,0.00007115688,0.0030240717,0.001052703,0.00044634173,0.00002348315,0.00008909447,0.9873192],"genre_scores_gemma":[0.005565689,0.004165968,0.00018353379,0.0037962005,0.0030095011,0.000038174378,0.000077214274,0.00016273696,0.983001],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99883974,0.000047551646,0.00018680819,0.00031149993,0.00015319587,0.00046122755],"domain_scores_gemma":[0.9993254,0.00006161736,0.00008650713,0.0002494173,0.000024262603,0.00025282672],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006305311,0.0003211016,0.00049815024,0.00016060619,0.000036430865,0.0000151000495,0.00010184122,0.0003580032,0.46749994],"category_scores_gemma":[0.000007561857,0.00025435822,0.00014530712,0.00010501282,0.00007839704,0.000013770877,0.000025907751,0.00023371566,0.0034726423],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011832465,0.00034433603,0.013804969,0.00010680352,0.0007878344,0.00075996306,0.00008501779,4.671517e-7,0.00030039137,0.00094515446,0.9345221,0.04822463],"study_design_scores_gemma":[0.002536732,0.0002490653,0.004434935,0.00016432685,0.0009419644,0.000072848736,0.00006344769,0.000010632773,0.00026137664,0.00001913662,0.99101377,0.00023174947],"about_ca_topic_score_codex":0.5158218,"about_ca_topic_score_gemma":0.4338216,"teacher_disagreement_score":0.46402732,"about_ca_system_score_codex":0.0006934961,"about_ca_system_score_gemma":0.0007781898,"threshold_uncertainty_score":0.9999909},"labels":[],"label_agreement":null},{"id":"W6947768459","doi":"10.3897/zookeys.894.37862.figure41","title":"Figure 41 from: Pentinsaari M, Anderson R, Borowiec L, Bouchard P, Brunke A, Douglas H, Smith A, Hebert P (2019) DNA barcodes reveal 63 overlooked species of Canadian beetles (Insecta, Coleoptera). ZooKeys 894: 53-150. https://doi.org/10.3897/zookeys.894.37862","year":2019,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Scale (ratio); Biodiversity; DNA barcoding","score_opus":0.03479664510707907,"score_gpt":0.2533969660608693,"score_spread":0.21860032095379023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6947768459","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023728788,0.0031284231,0.000011780419,0.0012386363,0.00079872203,0.0020298369,0.001007162,0.00053968513,0.96751696],"genre_scores_gemma":[0.048391752,0.0028434447,0.00013509656,0.0004638967,0.0014894597,8.267135e-7,0.008440064,0.003602704,0.9346328],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959068,0.00045539744,0.0006689862,0.0011181602,0.0008506249,0.0010000428],"domain_scores_gemma":[0.9970976,0.000076956196,0.00050719595,0.0010636819,0.0005244621,0.00073006627],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00036570177,0.00071299187,0.0010932123,0.0015021114,0.0007972981,0.0003299205,0.0010184767,0.0005410154,0.56874067],"category_scores_gemma":[0.00019513755,0.00072460866,0.00030688607,0.0007432391,0.0004732563,0.0002016713,0.0005583515,0.00092980365,0.07754845],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000632027,0.00035446795,0.000485201,0.0005288584,0.00088300824,0.00023917205,0.0010618558,0.0000017640465,0.006077922,0.0002557602,0.9875564,0.0019235535],"study_design_scores_gemma":[0.0038939104,0.000979244,0.007446942,0.00065565004,0.00046001183,0.000016589269,0.00021191202,0.000023062812,0.0018667124,0.000013008259,0.98383254,0.00060041103],"about_ca_topic_score_codex":0.08514568,"about_ca_topic_score_gemma":0.001473495,"teacher_disagreement_score":0.4911922,"about_ca_system_score_codex":0.00075905246,"about_ca_system_score_gemma":0.0001874754,"threshold_uncertainty_score":0.9995205},"labels":[],"label_agreement":null},{"id":"W6947892687","doi":"10.4224/21274575","title":"Hygrothermal modelling benchmark: comparison of hygIRC simulation results with full scale experiment results: report to Research Consortium for Wood and Wood-Hybrid Mid-Rise Buildings","year":2014,"lang":"en","type":"report","venue":"NPARC","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"Natural Resources Canada; FPInnovations","keywords":"Benchmarking; Full scale; Task (project management); Measure (data warehouse); Parametric statistics; Scale (ratio); Simulation modeling","score_opus":0.11988483381714417,"score_gpt":0.43920326451251096,"score_spread":0.3193184306953668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6947892687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9438366,0.0013235394,0.0041012303,0.0013136835,0.0005728023,0.0053170784,0.00080852484,0.00007547184,0.042651042],"genre_scores_gemma":[0.9797233,0.0002911145,0.010662641,0.000041228996,0.0009193442,0.0005213057,0.001187688,0.000105238316,0.006548176],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99495006,0.0001466521,0.0016118715,0.0011726123,0.0014418365,0.0006769971],"domain_scores_gemma":[0.9952772,0.0008450883,0.0009150893,0.00077159,0.0017848363,0.00040615408],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028747206,0.00046116998,0.0014138877,0.0005088352,0.00019443665,0.00003793199,0.0001565172,0.00031480409,0.00008641406],"category_scores_gemma":[0.000367924,0.00039567807,0.00016908857,0.0002458377,0.00023498756,0.000067637004,0.00011404139,0.00056908437,0.000003152245],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24747883,0.005131241,0.008198105,0.0063964766,0.0035879365,0.0010437317,0.011231718,0.110858604,0.16646816,0.00006000896,0.40962622,0.029918984],"study_design_scores_gemma":[0.02601291,0.01697863,0.00042026988,0.0035451076,0.001866139,0.00064225105,0.00045949483,0.055074953,0.16338758,0.00016050904,0.7302866,0.0011655898],"about_ca_topic_score_codex":0.00071837736,"about_ca_topic_score_gemma":0.00010806529,"teacher_disagreement_score":0.32066035,"about_ca_system_score_codex":0.0005620761,"about_ca_system_score_gemma":0.0010555252,"threshold_uncertainty_score":0.9998495},"labels":[],"label_agreement":null},{"id":"W6947938144","doi":"10.4224/40002649","title":"An impact analysis for the National guide for wildland-urban-interface fires","year":2021,"lang":"en","type":"report","venue":"NPARC","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"Institute for Catastrophic Loss Reduction","keywords":"Research council; Reduction (mathematics); Government (linguistics); Work (physics)","score_opus":0.10122277738270094,"score_gpt":0.4765250050053514,"score_spread":0.3753022276226504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6947938144","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14154303,0.09007954,0.044536155,0.064143755,0.01712026,0.029514229,0.04259006,0.00083348557,0.5696395],"genre_scores_gemma":[0.81206477,0.0034000422,0.002380845,0.0011990287,0.008026708,0.0017500937,0.008987216,0.00010402503,0.16208726],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986242,0.00002637084,0.00031218157,0.0003578495,0.000443002,0.00023639158],"domain_scores_gemma":[0.99798256,0.0005952443,0.00018700003,0.00024233424,0.00089425757,0.00009861104],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045632187,0.00022259339,0.000614457,0.00015561335,0.000110951594,0.000032784857,0.000127204,0.00017560442,0.0027317007],"category_scores_gemma":[0.00022303083,0.0001373757,0.0008691436,0.0002186882,0.000040715593,0.000029411127,0.000019205412,0.00014357988,0.0000024691099],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047045524,0.0001916075,0.0088141095,0.00012711743,0.011009796,0.000007303699,0.000092608585,0.00023396504,0.0020286457,0.000007831352,0.9729699,0.0040466585],"study_design_scores_gemma":[0.0017587995,0.00083177706,0.0096432315,0.000048536298,0.011904331,0.00004543468,0.000024365354,0.0032495158,0.00072878256,0.00011889571,0.9714784,0.00016794239],"about_ca_topic_score_codex":0.0002895378,"about_ca_topic_score_gemma":0.000370957,"teacher_disagreement_score":0.67052174,"about_ca_system_score_codex":0.0006617194,"about_ca_system_score_gemma":0.0020689184,"threshold_uncertainty_score":0.9981799},"labels":[],"label_agreement":null},{"id":"W6947978506","doi":"10.4224/crm.2003.moos-1","title":"MOOS-1: Seawater certified reference material for nutrients","year":2003,"lang":"en","type":"other","venue":"NRC Digital Repository","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Seawater; Nutrient; Certified reference materials; Nitrate","score_opus":0.026769559002263424,"score_gpt":0.2959820051996737,"score_spread":0.2692124461974103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6947978506","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021522858,0.00034136378,0.000011154011,0.000036755162,0.003330418,0.0009784804,0.00043170294,0.00017863592,0.9925392],"genre_scores_gemma":[0.0139431,0.000038470684,0.00006586022,0.00014934981,0.0011785101,0.00021778715,0.0009634321,0.00029649617,0.98314697],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881035,0.000013765589,0.00022751055,0.00040604186,0.000254075,0.0002882786],"domain_scores_gemma":[0.9993402,0.00001916293,0.00012987542,0.00028585314,0.00007866694,0.00014626239],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000023921573,0.0002844022,0.00041717003,0.00008464922,0.000036283378,0.000078190365,0.000086656626,0.00033855825,0.0009712093],"category_scores_gemma":[0.00001436016,0.00023422622,0.00013973269,0.00004247255,0.00006749592,0.00005324112,0.000027376045,0.00010655746,0.00012698972],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070719456,0.0003874553,0.0003518532,0.00023510543,0.0002823338,0.00007507847,0.000014002571,2.775701e-8,0.0016240174,0.00003120961,0.99414647,0.0021452736],"study_design_scores_gemma":[0.0019393661,0.000503049,0.00004830143,0.00014189594,0.00024812706,0.00007225293,0.000004249634,6.0356916e-7,0.011238485,0.00003256014,0.9855576,0.0002134974],"about_ca_topic_score_codex":0.00007691872,"about_ca_topic_score_gemma":0.000006918432,"teacher_disagreement_score":0.011790815,"about_ca_system_score_codex":0.00021764703,"about_ca_system_score_gemma":0.00017671555,"threshold_uncertainty_score":0.99994206},"labels":[],"label_agreement":null},{"id":"W6948105744","doi":"10.48448/ywej-t259","title":"Progressive Gradient Pruning for Classification, Detection and Domain Adaptation","year":2020,"lang":"en","type":"other","venue":"Underline Science Inc.","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec","funders":"","keywords":"Pruning; Benchmark (surveying); Filter (signal processing); Convolutional neural network; Pattern recognition (psychology); Computational complexity theory; Artificial neural network; Kernel adaptive filter; Domain (mathematical analysis)","score_opus":0.053086511062157095,"score_gpt":0.35086075353029494,"score_spread":0.29777424246813783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6948105744","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031966574,0.023165483,0.40696222,0.048036482,0.009983047,0.037453964,0.00054784055,0.0031706428,0.43871376],"genre_scores_gemma":[0.80503964,0.0004840852,0.09268438,0.0014313267,0.0029301804,0.0012001003,0.00050701894,0.00042686332,0.095296375],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911493,0.000013252317,0.00013248254,0.00038282742,0.0001841596,0.00017232305],"domain_scores_gemma":[0.999498,0.00002888622,0.00017027548,0.0001009872,0.00007585043,0.00012596213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012676785,0.0001304385,0.00017732552,0.0002452565,0.0001357434,0.00002711976,0.00006266015,0.000085512926,0.00008104474],"category_scores_gemma":[0.00004060125,0.000110114204,0.000026070456,0.00029826353,0.00035675176,0.000047526355,0.00002076966,0.000095834126,0.000006760825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013864756,0.0010734017,0.0029690843,0.0016069346,0.00067264336,0.000096819065,0.0074214656,0.000021653988,0.22936445,0.013871014,0.09849517,0.64302087],"study_design_scores_gemma":[0.0064405757,0.0033625264,0.004341636,0.0004312781,0.00076531473,0.00013985278,0.0018347031,0.07668492,0.0035326483,0.0017548066,0.90012974,0.0005820068],"about_ca_topic_score_codex":0.00003750486,"about_ca_topic_score_gemma":0.00012701069,"teacher_disagreement_score":0.80163455,"about_ca_system_score_codex":0.00014471177,"about_ca_system_score_gemma":0.00028676738,"threshold_uncertainty_score":0.4490327},"labels":[],"label_agreement":null},{"id":"W6948228693","doi":"10.48660/17050087","title":"Donaldson-Thomas transformations for moduli spaces of local systems on surfaces","year":2017,"lang":"en","type":"other","venue":"PIRSA","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Perimeter Institute","funders":"","keywords":"Surface (topology); Space (punctuation); Moduli; Deformation (meteorology); Product (mathematics)","score_opus":0.03554836986628001,"score_gpt":0.3360074698001141,"score_spread":0.3004590999338341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6948228693","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008221111,0.010829942,0.0014444509,0.0011273645,0.0014168809,0.0019267736,0.00094953255,0.00009377968,0.98138916],"genre_scores_gemma":[0.111054376,0.0013530386,0.000166345,0.00006001255,0.0006366537,0.00020542197,0.00027773393,0.00014659789,0.8860998],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994194,0.000015434049,0.00013768955,0.00015084738,0.0001337568,0.00014288437],"domain_scores_gemma":[0.9994495,0.00006116067,0.00018301477,0.00021214799,0.000033230303,0.0000609695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060414208,0.00016626663,0.0004614816,0.000121795914,0.000041635107,0.000009589194,0.00008115302,0.00018037946,0.00037095087],"category_scores_gemma":[0.000004311264,0.0001286762,0.00012671482,0.000024213165,0.00009097002,0.000018380273,0.000004935123,0.0000803805,0.000030457591],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029406862,0.00022227484,0.000086519896,0.00136144,0.0006291719,0.0000065201652,0.00017364645,0.000059672708,0.00018215725,0.00058859936,0.99206847,0.0043274816],"study_design_scores_gemma":[0.002190673,0.00050979643,0.000052918836,0.0005457223,0.00049760245,0.000005898643,0.000046977726,0.0003580548,0.0007133973,0.000013143908,0.9949582,0.000107610795],"about_ca_topic_score_codex":0.00076964666,"about_ca_topic_score_gemma":0.00040800418,"teacher_disagreement_score":0.110232264,"about_ca_system_score_codex":0.00005222726,"about_ca_system_score_gemma":0.00009251721,"threshold_uncertainty_score":0.52472633},"labels":[],"label_agreement":null},{"id":"W6948524537","doi":"10.5061/dryad.63xsj3v1v","title":"Observational evidence of herbivore-specific associational effects between neighboring conspecifics in natural, dimorphic populations of Datura wrightii","year":2021,"lang":"en","type":"dataset","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Population; Exclosure; Intraspecific competition; Cannibalism","score_opus":0.17429175883816506,"score_gpt":0.3565134667975447,"score_spread":0.18222170795937964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6948524537","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03974352,0.006909195,0.00007116873,0.0013697424,0.0009153385,0.0016106216,0.9482553,0.00014483713,0.0009802487],"genre_scores_gemma":[0.095887974,0.0012779693,0.00021790634,0.00005301612,0.00041433034,2.389286e-7,0.9016926,0.00029624812,0.0001597059],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997619,0.0003829103,0.00062963885,0.00043752338,0.00066730386,0.00026367322],"domain_scores_gemma":[0.9976716,0.00036155386,0.0004497946,0.00044925447,0.00096176733,0.000106019164],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047157615,0.0002152468,0.0005668809,0.00043080573,0.00036482196,0.000087499764,0.0004748105,0.00018906288,0.0056365062],"category_scores_gemma":[0.00083296676,0.00022379786,0.00012015492,0.00095296133,0.00017431597,0.00018609125,0.00046495852,0.00064442557,0.0002035766],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018305231,0.00035501792,0.00069481664,0.00086372934,0.00021007683,0.000044030276,0.00009850993,0.00001808046,0.0024807795,0.00050630583,0.9926776,0.0018679552],"study_design_scores_gemma":[0.0012390757,0.00028731936,0.06937008,0.0010121956,0.00018852214,0.000026836979,0.00002750043,0.000018940551,0.0004538173,0.00006346545,0.9271304,0.00018182548],"about_ca_topic_score_codex":0.000072362986,"about_ca_topic_score_gemma":0.0000053516233,"teacher_disagreement_score":0.068675265,"about_ca_system_score_codex":0.00048177352,"about_ca_system_score_gemma":0.00004787797,"threshold_uncertainty_score":0.99527246},"labels":[],"label_agreement":null},{"id":"W6948718542","doi":"10.5281/zenodo.12090299","title":"Die prophezeiung des ra uru hu pdf","year":2024,"lang":"de","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reading (process); Subject (documents); Holy See; Kingdom","score_opus":0.04414482844277448,"score_gpt":0.29861463189202475,"score_spread":0.2544698034492503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6948718542","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007395017,0.022375338,0.00012648942,0.0013123339,0.0012873042,0.0016817382,0.0005173733,0.0011028692,0.970857],"genre_scores_gemma":[0.0092538,0.008867934,0.00014572682,0.00044321126,0.003435184,3.4288587e-7,0.0051346337,0.012312693,0.9604065],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996611,0.00048095823,0.00046990087,0.001018618,0.0005669213,0.00085262675],"domain_scores_gemma":[0.9981467,0.000033542347,0.00019625737,0.0006708397,0.00046375545,0.0004889084],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005526284,0.0005199266,0.00056727306,0.00062277843,0.0013465579,0.00077510846,0.0008595984,0.00032035587,0.5955862],"category_scores_gemma":[0.00030702908,0.00049196027,0.0002149329,0.0006907966,0.0006516242,0.000120500576,0.001310458,0.00091999816,0.65371245],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035459883,0.00051412045,0.0000065464465,0.0014242813,0.0012635574,0.0006078212,0.0018741282,0.0000027694543,0.0017529218,0.00049770874,0.9046993,0.08700221],"study_design_scores_gemma":[0.0018673588,0.0012369715,0.00010021812,0.0007444133,0.001038502,0.0001572288,0.000207676,0.00005343827,0.00036283513,0.00022214113,0.9935807,0.00042853208],"about_ca_topic_score_codex":0.000075460644,"about_ca_topic_score_gemma":0.000002231804,"teacher_disagreement_score":0.08888134,"about_ca_system_score_codex":0.0007722487,"about_ca_system_score_gemma":0.000026631858,"threshold_uncertainty_score":0.99995357},"labels":[],"label_agreement":null},{"id":"W6948776317","doi":"10.5281/zenodo.11853314","title":"giles tours 2024 brochure prices pdf download","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Work (physics); Paraphernalia; Government (linguistics); Pretext; Quality (philosophy)","score_opus":0.02835725750319028,"score_gpt":0.2939479869599686,"score_spread":0.2655907294567783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6948776317","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000070870876,0.003959276,0.000029819095,0.0015000043,0.00059315097,0.00069715554,0.00070606073,0.0013108209,0.99113286],"genre_scores_gemma":[0.00073564576,0.0014920422,0.00008797325,0.00029851936,0.0011028672,1.4548239e-7,0.004053163,0.005583976,0.98664564],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848676,0.00009238271,0.00019328242,0.00054613815,0.00033259724,0.00034881535],"domain_scores_gemma":[0.9991514,0.000010979458,0.00010067162,0.00037596235,0.00014302679,0.00021793773],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00015604544,0.0002591674,0.0003089863,0.00050125545,0.00031725288,0.00030230617,0.00040054147,0.00020257424,0.4858431],"category_scores_gemma":[0.0000673813,0.00023509812,0.00011475203,0.00045485463,0.00014892047,0.000045285986,0.00051110174,0.00047732075,0.21137567],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090451555,0.0001610432,0.0000012590293,0.0005493077,0.00038723391,0.00015243328,0.00025651263,4.2817896e-7,0.0006263914,0.00026340812,0.97647846,0.021033088],"study_design_scores_gemma":[0.0007462526,0.00041337323,0.000026229243,0.00028534356,0.00030520544,0.00022675827,0.00009506301,0.0000052196606,0.000091633665,0.00004621967,0.9975533,0.00020543554],"about_ca_topic_score_codex":0.000049593862,"about_ca_topic_score_gemma":0.0000022439142,"teacher_disagreement_score":0.27446744,"about_ca_system_score_codex":0.00019130648,"about_ca_system_score_gemma":0.000010831063,"threshold_uncertainty_score":0.9587023},"labels":[],"label_agreement":null},{"id":"W6948911925","doi":"10.5281/zenodo.11575074","title":"https://www.facebook.com/VidaCalmPills/","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Active listening; Component (thermodynamics); Natural (archaeology); Stress (linguistics); Natural materials","score_opus":0.04492699362946698,"score_gpt":0.3108033095064527,"score_spread":0.2658763158769857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6948911925","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003497202,0.0016974745,0.00006793096,0.0017965271,0.00045262752,0.0011493025,0.00041420298,0.002101016,0.99228597],"genre_scores_gemma":[0.0014017203,0.0009273475,0.00007521576,0.00046159344,0.001002136,2.3501912e-7,0.0032295568,0.012136545,0.98076564],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983135,0.00014252304,0.00022255542,0.0005845563,0.00034361333,0.0003932439],"domain_scores_gemma":[0.9990042,0.0000116316905,0.000098365475,0.00047776662,0.00014296945,0.00026508147],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00021484337,0.00028171123,0.00035195673,0.000490885,0.00035754524,0.0002687502,0.00042525804,0.00022494039,0.37829491],"category_scores_gemma":[0.000078030695,0.0002643279,0.00013345657,0.00035672035,0.0001859627,0.00003883761,0.0006440283,0.00056846545,0.23510337],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009989978,0.00017074065,6.9806765e-7,0.00039637895,0.00035157922,0.00017076006,0.0002224171,3.4007624e-7,0.00077229843,0.0007842677,0.9653377,0.031692915],"study_design_scores_gemma":[0.0010745318,0.00046675844,0.000015812504,0.00026361487,0.00026815519,0.00022885083,0.000037109454,0.000023662886,0.00013302862,0.00006415486,0.997201,0.00022331502],"about_ca_topic_score_codex":0.000039782433,"about_ca_topic_score_gemma":8.3276797e-7,"teacher_disagreement_score":0.14319155,"about_ca_system_score_codex":0.00025619776,"about_ca_system_score_gemma":0.000010407061,"threshold_uncertainty_score":0.99998087},"labels":[],"label_agreement":null},{"id":"W6949313636","doi":"10.5281/zenodo.12468292","title":"evolutionary computation pdf","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Human-based evolutionary computation; Evolutionary computation; Interactive evolutionary computation; Evolutionary algorithm; Evolutionary programming; Computation; Genetic representation; Evolutionary music","score_opus":0.03571109198576974,"score_gpt":0.3052525024612195,"score_spread":0.26954141047544977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6949313636","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032729145,0.001692657,0.00032057596,0.0009879881,0.0003638022,0.00055587525,0.00026527245,0.0012457429,0.9945354],"genre_scores_gemma":[0.0029241277,0.00039745244,0.00026191687,0.00022906529,0.00088161736,7.35175e-8,0.007856472,0.006716246,0.98073304],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989141,0.000101873644,0.0001504022,0.00037323276,0.0002461374,0.0002142036],"domain_scores_gemma":[0.9994475,0.0000075313064,0.00007093209,0.0001971885,0.00014204373,0.00013479685],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000113534705,0.00016076518,0.00019678223,0.00041034695,0.0002870144,0.00012881492,0.00018652248,0.0001337194,0.25565913],"category_scores_gemma":[0.000041734544,0.0001612425,0.00007554402,0.00031971556,0.00011019109,0.000032481716,0.00030564496,0.00028686965,0.19872892],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006405614,0.00014472865,6.9057415e-7,0.00028694636,0.00020734764,0.00007532862,0.000115797804,0.0000021642888,0.00022232102,0.00036520066,0.9785571,0.019958291],"study_design_scores_gemma":[0.000708129,0.00032968397,0.000065700246,0.00017489506,0.00016750563,0.00027327635,0.000030615745,0.000106765256,0.000015375856,0.00013501177,0.99786085,0.00013219405],"about_ca_topic_score_codex":0.000027670296,"about_ca_topic_score_gemma":3.6848522e-7,"teacher_disagreement_score":0.056930203,"about_ca_system_score_codex":0.00024875262,"about_ca_system_score_gemma":0.000007769831,"threshold_uncertainty_score":0.80189496},"labels":[],"label_agreement":null},{"id":"W6950052835","doi":"10.5281/zenodo.7888865","title":"Rosa sherardii Davies","year":2014,"lang":"lt","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université de Sherbrooke","funders":"","keywords":"Face (sociological concept); Perspective (graphical); Context (archaeology); Focus (optics)","score_opus":0.04013349967546066,"score_gpt":0.2904047175538307,"score_spread":0.25027121787837003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6950052835","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04988463,0.0024950248,0.0014059393,0.008623035,0.0014900519,0.0014568345,0.00063755654,0.0015811529,0.9324258],"genre_scores_gemma":[0.96951747,0.0011582643,0.00011118535,0.0011272689,0.0018238832,7.774268e-8,0.0034949905,0.0024641824,0.020302676],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973116,0.000665108,0.00036089422,0.0005908293,0.00043672058,0.00063486723],"domain_scores_gemma":[0.99830264,0.00006164649,0.00014024989,0.0005892476,0.0005088747,0.0003973517],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007993402,0.00027504782,0.0003737731,0.00024904296,0.0021225067,0.00053049927,0.00067619403,0.00014227079,0.07566617],"category_scores_gemma":[0.00045243083,0.00027916656,0.00013063606,0.00051630626,0.00031758274,0.00019543436,0.0008593261,0.00046292096,0.04678794],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043832583,0.0005800531,0.000032710857,0.00024386181,0.00031932216,0.00006177169,0.0020108274,0.000018702356,0.008389781,0.0029586777,0.72665125,0.25829473],"study_design_scores_gemma":[0.0027046804,0.0014423691,0.0013650779,0.000090976806,0.00022810115,0.00021029639,0.00022509535,0.0003726467,0.0011136122,0.00013036671,0.9918622,0.00025461722],"about_ca_topic_score_codex":0.000037576265,"about_ca_topic_score_gemma":6.276969e-7,"teacher_disagreement_score":0.91963285,"about_ca_system_score_codex":0.00031768903,"about_ca_system_score_gemma":0.000009675972,"threshold_uncertainty_score":0.999966},"labels":[],"label_agreement":null},{"id":"W6957928404","doi":"10.6084/m9.figshare.14889345","title":"Additional file 2 of Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Eribulin; Metastatic breast cancer; Breast cancer; Risk assessment; Overall survival; MEDLINE","score_opus":0.1391850297347036,"score_gpt":0.3806538797079082,"score_spread":0.2414688499732046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6957928404","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012135983,0.0012159755,1.529862e-7,0.0002568651,0.000022624932,0.00032295132,0.99664223,0.00001325791,0.0003123424],"genre_scores_gemma":[0.008450559,0.00003898841,0.0008983134,0.0006642256,0.00011165988,0.0031145464,0.9635125,0.00003723636,0.023171993],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989207,0.000065551416,0.0003654089,0.0002679089,0.00017974677,0.0002007175],"domain_scores_gemma":[0.99793744,0.0013737516,0.00022694256,0.00020408886,0.00018543289,0.000072321964],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000018474384,0.0002061035,0.00115365,0.00010985458,0.000018222436,0.000005031721,0.00005784407,0.000056990306,0.99934614],"category_scores_gemma":[0.00011719628,0.00013313198,0.0005121063,0.00079659297,0.000017130764,0.000046969726,0.00002187146,0.00006485638,0.00010822252],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006187089,0.0008614926,0.00002077867,0.0001798742,0.11783778,0.0002029855,0.00020668912,0.0020829756,0.00012310332,5.6393844e-7,0.8700723,0.0022243364],"study_design_scores_gemma":[0.012567546,0.0017502359,0.0037140055,0.0005918037,0.06320538,0.000027888711,0.0001347377,0.0007759491,0.0053951065,0.00000725366,0.9115345,0.00029557548],"about_ca_topic_score_codex":0.00008087856,"about_ca_topic_score_gemma":0.010633942,"teacher_disagreement_score":0.9992379,"about_ca_system_score_codex":0.00014280173,"about_ca_system_score_gemma":0.000704305,"threshold_uncertainty_score":0.5933989},"labels":[],"label_agreement":null},{"id":"W6958488379","doi":"10.6084/m9.figshare.14889342.v1","title":"Additional file 1 of Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Eribulin; Metastatic breast cancer; Breast cancer; Cochrane Library; MEDLINE; Overall survival","score_opus":0.14348126166137817,"score_gpt":0.3813208909546553,"score_spread":0.23783962929327715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958488379","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012211676,0.0011976855,1.5613355e-7,0.00025808188,0.000022496906,0.00032343916,0.996658,0.000013258616,0.00030570658],"genre_scores_gemma":[0.008593425,0.000038091643,0.0009186421,0.00066510314,0.0001102687,0.0031763548,0.9633281,0.000037336897,0.023132645],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989205,0.00006557246,0.0003652541,0.00026809907,0.00017978935,0.00020078753],"domain_scores_gemma":[0.9979184,0.0013923321,0.00022663936,0.00020445735,0.00018582115,0.00007233096],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000018570316,0.00020616553,0.001153383,0.000109922665,0.000018221173,0.0000050214107,0.000057874546,0.000056989993,0.99935776],"category_scores_gemma":[0.00011855033,0.00013317316,0.0005122,0.0007971788,0.000017130988,0.000046939294,0.00002187437,0.00006487051,0.00010932623],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006181924,0.00085662183,0.000021294221,0.00017728248,0.11713014,0.00019668727,0.0002052933,0.0020612,0.00012651777,5.5140146e-7,0.87088823,0.0021542327],"study_design_scores_gemma":[0.012747067,0.0017863876,0.0038499176,0.00061125914,0.06474003,0.000028409624,0.00013888394,0.0007971425,0.005539971,0.00000734931,0.90945125,0.00030232867],"about_ca_topic_score_codex":0.00008011501,"about_ca_topic_score_gemma":0.010575365,"teacher_disagreement_score":0.99924845,"about_ca_system_score_codex":0.00014276305,"about_ca_system_score_gemma":0.00070728123,"threshold_uncertainty_score":0.5901302},"labels":[],"label_agreement":null},{"id":"W6958548528","doi":"10.6084/m9.figshare.28756932.v1","title":"Additional file 2 of Results of the preclinical multicenter randomized controlled paclitaxel-induced neuropathy prevention replication study (PINPRICS)","year":2025,"lang":"en","type":"article","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"","keywords":"Randomized controlled trial; Replication (statistics); Peripheral neuropathy; Clinical trial; MEDLINE","score_opus":0.05133684051177635,"score_gpt":0.3821693012866753,"score_spread":0.330832460774899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958548528","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053461436,0.00005194477,1.8010233e-7,0.00034843435,0.00008482044,0.0048028277,0.98428,0.00001931347,0.0050663278],"genre_scores_gemma":[0.5114379,0.000002342201,0.0000290661,0.0001845325,0.00007791391,0.0059993556,0.4754548,0.000007654051,0.0068064355],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99835247,0.00046687535,0.0006856481,0.00023986446,0.00017455369,0.00008058429],"domain_scores_gemma":[0.9930303,0.0057104803,0.0005370288,0.00040708398,0.0002880297,0.00002706554],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002025815,0.00009502549,0.0006468299,0.000057455272,0.000033835335,0.0000036505733,0.00009619033,0.000061029412,0.7563484],"category_scores_gemma":[0.023299105,0.000058936126,0.00039615715,0.00017240625,0.000016935517,0.000026110805,0.000060563674,0.00012185797,0.000050342267],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09939432,0.0012945292,0.000026183865,0.00006408186,0.00030869374,0.00000124783,0.00006467585,8.8023364e-7,0.00011127786,9.438158e-7,0.8974327,0.0013004764],"study_design_scores_gemma":[0.8191622,0.0010280501,0.050908733,0.0036690307,0.0010049914,0.000002054751,0.00006455109,0.0011830518,0.0011686728,0.000041919964,0.12166729,0.00009947411],"about_ca_topic_score_codex":0.0000057124716,"about_ca_topic_score_gemma":0.000009625973,"teacher_disagreement_score":0.7757654,"about_ca_system_score_codex":0.000030394358,"about_ca_system_score_gemma":0.00019685076,"threshold_uncertainty_score":0.9849281},"labels":[],"label_agreement":null},{"id":"W6981874261","doi":"","title":"Fisheries, tourism, and marine protected areas : conflicting or synergistic interactions","year":2015,"lang":"en","type":"article","venue":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Marine protected area; Fishing; Sampling (signal processing); Context (archaeology); Data collection","score_opus":0.04435512989047324,"score_gpt":0.2988391767246766,"score_spread":0.25448404683420334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6981874261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73290503,0.00047918726,0.0011551272,0.05212865,0.001971283,0.001928075,0.00007608929,0.0008627974,0.20849374],"genre_scores_gemma":[0.9927814,0.0000721993,0.002316045,0.00035092002,0.0007638573,0.00035025593,0.00022423758,0.00004106472,0.0031000322],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99810386,0.00016357515,0.00044385833,0.00048574782,0.00036830702,0.00043465628],"domain_scores_gemma":[0.99820703,0.00020567478,0.00020900766,0.00029744368,0.00042442468,0.0006563996],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024539753,0.0003158375,0.00043408942,0.00026590604,0.0003138279,0.00010183898,0.00013638014,0.00021952852,0.00018610207],"category_scores_gemma":[0.0006863883,0.00026273238,0.00009245473,0.0004261185,0.000029228133,0.000246621,0.00017598666,0.00050577126,0.000008268829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033214983,0.010159028,0.063932784,0.0015697052,0.0048127137,0.012636795,0.019509783,0.000115016825,0.055242624,0.6745293,0.073685244,0.05059203],"study_design_scores_gemma":[0.003674504,0.00039286612,0.010593389,0.00011794205,0.0002791035,0.004486947,0.0004396457,0.0004695283,0.0012627298,0.0001488625,0.9778399,0.00029462136],"about_ca_topic_score_codex":0.000019059258,"about_ca_topic_score_gemma":0.0005307958,"teacher_disagreement_score":0.9041546,"about_ca_system_score_codex":0.0006456994,"about_ca_system_score_gemma":0.0007888286,"threshold_uncertainty_score":0.9999825},"labels":[],"label_agreement":null},{"id":"W6990572815","doi":"","title":"Docetaxel-associated myalgia&amp;amp;ndash;arthralgia syndrome in patients with breast cancer","year":2017,"lang":"en","type":"other","venue":"Dove Medical Press (Taylor and Francis Group)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Docetaxel; Adverse effect; Breast cancer; Regimen; Clinical trial; Cancer; Medical record; Incidence (geometry)","score_opus":0.014629426679049849,"score_gpt":0.2897363246098439,"score_spread":0.275106897930794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6990572815","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14757957,0.15698491,0.007349434,0.009451233,0.018374939,0.020779688,0.02073839,0.0024148293,0.616327],"genre_scores_gemma":[0.95431703,0.00039968218,0.0000657566,0.001106833,0.0008106185,0.00049517606,0.0018949226,0.00054627424,0.04036371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969472,0.00010243351,0.0004101872,0.00082088355,0.0009997868,0.0007194529],"domain_scores_gemma":[0.99814224,0.00008630729,0.00040031094,0.00058690313,0.0000892161,0.00069504924],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021872018,0.00065372797,0.0014167993,0.00023661379,0.00010802812,0.00004486047,0.0003146924,0.00092929683,0.014765303],"category_scores_gemma":[0.0000893169,0.00046696805,0.00015041187,0.00014094281,0.0005250507,0.000087200206,0.00013688227,0.00097026443,0.00008033218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033767212,0.00396446,0.5093399,0.001687596,0.003138847,0.00096618425,0.00048562078,6.7639695e-7,0.000010661988,0.000039259914,0.090190046,0.38680002],"study_design_scores_gemma":[0.048761223,0.0008972179,0.60005957,0.0008554013,0.002000392,0.0001825349,0.0000074582563,0.00035714696,0.0000021896312,0.000044294127,0.34541145,0.0014211321],"about_ca_topic_score_codex":0.0053691356,"about_ca_topic_score_gemma":0.0072182324,"teacher_disagreement_score":0.8067375,"about_ca_system_score_codex":0.00017032267,"about_ca_system_score_gemma":0.000018921271,"threshold_uncertainty_score":0.9997782},"labels":[],"label_agreement":null},{"id":"W7002200986","doi":"","title":"Mgr Józefa de Laval (ur. 1937) Gdańsk – AM","year":2013,"lang":"pl","type":"other","venue":"CYBRA (Lodz University of Technology)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Deformation (meteorology); Work (physics); Context (archaeology); Point (geometry)","score_opus":0.007200186693487449,"score_gpt":0.22502227151875775,"score_spread":0.2178220848252703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7002200986","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32126388,0.015184711,0.0004224278,0.017820414,0.0024053608,0.0028602632,0.00046656196,0.0014825496,0.6380938],"genre_scores_gemma":[0.07630108,0.008189243,0.0026356839,0.00029890184,0.00040810395,0.0000042468723,0.00013111204,0.00019034928,0.9118413],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997675,0.000076635806,0.00029757223,0.00081699085,0.0002628645,0.00087095395],"domain_scores_gemma":[0.99803805,0.00007369334,0.00053627725,0.00090821675,0.00016075482,0.0002829856],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00013636041,0.0006267931,0.001283188,0.0015076097,0.00020537592,0.000009488732,0.0009882322,0.0022012745,0.03157398],"category_scores_gemma":[0.00004544118,0.0007200468,0.0004072764,0.000736097,0.0016751885,0.00009102228,0.0005064166,0.0011428563,0.0030671835],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062480837,0.0014114135,0.028594906,0.00060466456,0.0032331243,0.0013945979,0.0005978842,0.0000033132112,0.013936886,0.0045275167,0.8991776,0.045893293],"study_design_scores_gemma":[0.005982372,0.0011643615,0.003046487,0.00056537933,0.0023507471,0.00009205924,0.001087591,0.00003823431,0.0044406913,0.00029516485,0.980358,0.0005788839],"about_ca_topic_score_codex":0.002317652,"about_ca_topic_score_gemma":0.0005428713,"teacher_disagreement_score":0.27374744,"about_ca_system_score_codex":0.0006793108,"about_ca_system_score_gemma":0.00065301394,"threshold_uncertainty_score":0.99952507},"labels":[],"label_agreement":null},{"id":"W7031579885","doi":"","title":"Cincinnati, Ohio","year":2009,"lang":"en","type":"other","venue":"OhioLink ETD Center (Ohio Library and Information Network)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reading (process); Government (linguistics); Legislation; Quarter (Canadian coin)","score_opus":0.009558345908054303,"score_gpt":0.23698795135256653,"score_spread":0.22742960544451224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7031579885","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022973001,0.0030876223,0.000050049908,0.0019843066,0.0009206607,0.00074944744,0.00014078298,0.0004664571,0.9925777],"genre_scores_gemma":[0.0046723257,0.034039456,0.0014843883,0.043533344,0.006511803,0.00007769686,0.00944735,0.0003179256,0.8999157],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99858266,0.000049860402,0.0004958838,0.0002368639,0.00018778212,0.00044695253],"domain_scores_gemma":[0.99905884,0.00003001259,0.00033556428,0.00029019732,0.000014747044,0.000270615],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005663567,0.0004204152,0.00056634215,0.00032830326,0.00008347767,0.000087666675,0.0001274359,0.0004654406,0.011865183],"category_scores_gemma":[0.0000027240108,0.00036017073,0.00014777997,0.00026378708,0.00006511319,0.0017987061,0.000086623404,0.0004246416,0.00024950094],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026158887,0.000091719936,0.00022855194,0.00020616446,0.00019030845,0.000015115327,0.000070975155,0.0000060366574,0.0000010208478,0.05199546,0.9226302,0.024302892],"study_design_scores_gemma":[0.003045186,0.00032098292,0.0012965876,0.0005555076,0.00015035787,0.00007230642,0.0000017559615,0.00016263363,0.000018148407,0.00012367117,0.9939437,0.0003091496],"about_ca_topic_score_codex":1.905924e-7,"about_ca_topic_score_gemma":0.0000017362004,"teacher_disagreement_score":0.092661984,"about_ca_system_score_codex":0.00002280295,"about_ca_system_score_gemma":0.00010812344,"threshold_uncertainty_score":0.999885},"labels":[],"label_agreement":null},{"id":"W7036834546","doi":"","title":"Collaborative Research Partnerships for Knowledge Mobilization","year":2013,"lang":"en","type":"dissertation","venue":"TSpace (University of Toronto)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Office of International Science and Engineering; University of Toronto; Strong","keywords":"General partnership; Mandate; Work (physics); Service (business); Dissemination; Face (sociological concept); Service provider; Organizational learning; Knowledge sharing; Organizational communication","score_opus":0.1001176590182759,"score_gpt":0.42018984454233976,"score_spread":0.32007218552406386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7036834546","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46130204,0.011389239,0.000055390094,0.0011210546,0.0008111379,0.0045031067,0.000101511076,0.00007770478,0.5206388],"genre_scores_gemma":[0.5488043,0.0019435793,0.0007024658,0.000007807152,0.00016167633,0.000019734427,0.0017182854,0.000027426404,0.4466147],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.9991174,0.00010415617,0.000083864856,0.00028205133,0.00018776374,0.00022476332],"domain_scores_gemma":[0.99804306,0.00019964446,0.00013452276,0.00017979648,0.0013246979,0.00011827544],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018667622,0.00014549977,0.00038227427,0.00009534502,0.00018538914,0.0000066415173,0.00011531483,0.00029125233,0.016117914],"category_scores_gemma":[0.000040412157,0.00016990953,0.00011771417,0.00013895008,0.000093795585,0.00015039607,0.00001999486,0.00015107164,0.000054292956],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017269842,0.002765186,0.0009878315,0.005004359,0.0023443731,0.000033578504,0.26711923,0.00000455687,0.040417716,0.006266743,0.55840766,0.09937891],"study_design_scores_gemma":[0.015452297,0.006810186,0.110553816,0.0009728251,0.00277191,0.0000035671474,0.51821375,0.0006978408,0.011002601,0.00017038606,0.3325197,0.0008311132],"about_ca_topic_score_codex":0.013109696,"about_ca_topic_score_gemma":0.13139507,"teacher_disagreement_score":0.25109455,"about_ca_system_score_codex":0.00069159037,"about_ca_system_score_gemma":0.0006562405,"threshold_uncertainty_score":0.9934621},"labels":[],"label_agreement":null},{"id":"W7066306365","doi":"","title":"Hvilke erfaringer er hverdagsrehabilitering basert på?","year":2019,"lang":"no","type":"dissertation","venue":"Duo Research Archive (University of Oslo)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Occupational accident; Research data; Elderly people","score_opus":0.04238307803496155,"score_gpt":0.3403818738690905,"score_spread":0.29799879583412897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7066306365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90452623,0.0011626912,0.00022482302,0.0010190544,0.0010887837,0.0024078512,0.00065163244,0.000058181464,0.08886073],"genre_scores_gemma":[0.8538819,0.00289207,0.0011729288,0.00006263121,0.0003700804,0.000008140873,0.003230293,0.000103144834,0.13827883],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9947618,0.0008803645,0.0003866927,0.0012150297,0.0014525728,0.0013035184],"domain_scores_gemma":[0.9955353,0.0017539432,0.00030294704,0.0009507258,0.0008409613,0.00061609],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012160351,0.00053052854,0.0011793748,0.0017729389,0.0006508331,0.000037179216,0.00092687923,0.000435187,0.015314476],"category_scores_gemma":[0.00018380563,0.0006375767,0.0006210888,0.0008411166,0.00090986793,0.0002964377,0.00061132526,0.0021157863,0.002039313],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04549164,0.0063818092,0.18886015,0.01751375,0.0072612986,0.0033570826,0.11513182,0.000116498784,0.43751666,0.0025001434,0.10282568,0.07304347],"study_design_scores_gemma":[0.019654699,0.009427208,0.6200656,0.004550249,0.0019164612,0.00003981403,0.054804593,0.0053483136,0.0035503318,0.00086824165,0.27811408,0.0016604066],"about_ca_topic_score_codex":0.007145509,"about_ca_topic_score_gemma":0.0024616607,"teacher_disagreement_score":0.43396634,"about_ca_system_score_codex":0.00066412485,"about_ca_system_score_gemma":0.0016138083,"threshold_uncertainty_score":0.99960756},"labels":[],"label_agreement":null},{"id":"W7067073702","doi":"","title":"Investigating large gray cast iron pipe failures: a step by step approach","year":2001,"lang":"en","type":"article","venue":"NPARC","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Cast iron; Water pipe; Pipeline transport; Gray (unit); Process (computing); Canalisation; Work (physics); Gray iron","score_opus":0.02232881541524079,"score_gpt":0.2956053366356067,"score_spread":0.2732765212203659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7067073702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83424324,0.00088521146,0.0019320967,0.00471845,0.00027045913,0.0008657691,0.00006488075,0.0001941204,0.15682577],"genre_scores_gemma":[0.9793561,0.00012481058,0.007438388,0.0020896692,0.00036146297,0.00009830862,0.0002069687,0.00003376157,0.010290533],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887127,0.000056212935,0.00018706321,0.0002889669,0.00020251443,0.00039394636],"domain_scores_gemma":[0.9994388,0.000044704782,0.00006488818,0.00019491036,0.00003492463,0.00022175058],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013207532,0.00017264803,0.000264535,0.000059447513,0.000106723004,0.000015901353,0.00007733596,0.00009659662,0.0013740476],"category_scores_gemma":[0.000023093995,0.0001455205,0.00006909892,0.00019757396,0.00007230692,0.000059595517,0.000037000824,0.00022772924,0.00007644072],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025415016,0.0013433972,0.115674086,0.00028224054,0.0002071857,0.00015596207,0.0014098772,0.0000023657096,0.19266525,0.0005736028,0.6707337,0.016698197],"study_design_scores_gemma":[0.010288513,0.000989845,0.0030765948,0.00006874491,0.0004069718,0.00029010227,0.0009057688,0.0024047121,0.0045864857,0.00014308072,0.9764785,0.0003606694],"about_ca_topic_score_codex":0.0001639003,"about_ca_topic_score_gemma":0.000084358406,"teacher_disagreement_score":0.30574483,"about_ca_system_score_codex":0.00010766516,"about_ca_system_score_gemma":0.000073722906,"threshold_uncertainty_score":0.99953884},"labels":[],"label_agreement":null},{"id":"W7067112653","doi":"","title":"Layered nanostructured coatings for aerospace applications: 2nd progress report","year":2001,"lang":"en","type":"report","venue":"NPARC","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Aerospace; Metal coating; Coating; Aerospace materials; Welding","score_opus":0.046210654189172744,"score_gpt":0.3935619237602408,"score_spread":0.34735126957106804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7067112653","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014465663,0.016497988,0.002130422,0.017171208,0.00855643,0.037129678,0.0013510461,0.001274273,0.9014233],"genre_scores_gemma":[0.123917684,0.0068693305,0.03338922,0.0008962877,0.012253733,0.02659501,0.0142062465,0.0004749223,0.7813976],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978502,0.000017482987,0.0005524238,0.0006518226,0.0005388539,0.00038926402],"domain_scores_gemma":[0.9977589,0.000071776674,0.00065400085,0.0005601051,0.0007746167,0.00018058851],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027250528,0.0003572002,0.0007899921,0.000119500684,0.00012498695,0.000024545892,0.00012096387,0.0004721182,0.0009850828],"category_scores_gemma":[0.00011376219,0.00031206643,0.00027604922,0.00020547987,0.0001280832,0.00002757258,0.000042089665,0.00031242525,0.000012886526],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054277864,0.00038486862,0.0088061625,0.0014132084,0.0005644991,0.00072556647,0.00010575308,3.3621637e-7,0.010188186,0.000049774862,0.8695673,0.107651584],"study_design_scores_gemma":[0.002158654,0.00042887728,0.0006100937,0.00015934424,0.0010277632,0.0031526992,0.000016589545,0.0000047720073,0.0049224542,0.0005903055,0.9866635,0.00026494215],"about_ca_topic_score_codex":0.0000712548,"about_ca_topic_score_gemma":0.000052327458,"teacher_disagreement_score":0.120025724,"about_ca_system_score_codex":0.0005032117,"about_ca_system_score_gemma":0.0016580153,"threshold_uncertainty_score":0.9999331},"labels":[],"label_agreement":null},{"id":"W7067703441","doi":"","title":"Nature's Past Episode 051: Has Environmental History Lost Its Way?","year":2016,"lang":"en","type":"other","venue":"York University Digital Library (York University)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental history; Scholarship; Power (physics); Politics; Environmental movement; Environmentalism; Social history (medicine); Materialism","score_opus":0.011958860210772936,"score_gpt":0.17734312070659947,"score_spread":0.16538426049582652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7067703441","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013046013,0.002799591,0.000010021553,0.0009830708,0.0008401732,0.00062274,0.0038908173,0.0006231452,0.9889258],"genre_scores_gemma":[0.018904803,0.0010970943,0.000075430245,0.0004451543,0.0007322263,1.9031032e-7,0.0018895004,0.00031788868,0.9765377],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99798876,0.00007393571,0.0001516119,0.00087931217,0.00032802156,0.0005783311],"domain_scores_gemma":[0.9985365,0.000085812775,0.00027957428,0.00050487753,0.000009946378,0.0005832694],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000012769975,0.0006503111,0.0007039475,0.0011885455,0.00015883626,0.000050168386,0.00066280353,0.0009750554,0.043629654],"category_scores_gemma":[0.000002511316,0.00069477304,0.00048862706,0.0003279673,0.0006581075,0.00095961976,0.0005051811,0.00070344197,0.004252032],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011413787,0.00055044104,0.007225686,0.00009252628,0.00078997586,0.0033612826,0.000059404905,2.0694692e-7,0.00006468552,0.0011158518,0.98433614,0.001262394],"study_design_scores_gemma":[0.0040163505,0.0003175194,0.00046688487,0.00027029176,0.0005917428,0.000048960283,0.00025945506,8.375981e-7,0.000092191185,0.000009265884,0.99325114,0.00067535054],"about_ca_topic_score_codex":0.00003161364,"about_ca_topic_score_gemma":0.000022581335,"teacher_disagreement_score":0.039377622,"about_ca_system_score_codex":0.0015317678,"about_ca_system_score_gemma":0.0004150521,"threshold_uncertainty_score":0.99955034},"labels":[],"label_agreement":null},{"id":"W7096959898","doi":"","title":"Yew Poisoning in Horses and Ruminants","year":2007,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ornamental plant; Taxus; Genus; Woody plant","score_opus":0.018929790186412603,"score_gpt":0.36687791814119697,"score_spread":0.34794812795478436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7096959898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96110296,0.00059980125,0.000016602076,0.00052032823,0.000057893696,0.00007187935,2.0726044e-7,0.000012417362,0.037617896],"genre_scores_gemma":[0.99385685,0.00010423795,0.00024725148,0.00043558746,0.000047981808,0.0000015135681,0.0000012842679,0.0000029256612,0.0053023812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999751,0.0000027781089,0.000056981426,0.00006205903,0.000027643915,0.000099541714],"domain_scores_gemma":[0.9998925,0.000029693403,0.0000071065515,0.000026414627,0.0000050201215,0.00003926387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006850814,0.000033322052,0.00007279798,0.00005097976,0.000009616576,0.000001591352,0.00000708841,0.000020817579,0.00030267815],"category_scores_gemma":[0.0000054198554,0.00002500051,0.000007975807,0.00005398531,0.000015694084,0.00001634546,0.000007145472,0.000035185312,0.000010212149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024172897,0.0001180273,0.93495035,0.000016816706,0.000016670661,0.00023101293,0.0004161655,5.978852e-8,0.012005333,0.00025023276,0.001868633,0.04988495],"study_design_scores_gemma":[0.002561616,0.00025820118,0.95580655,0.000028720497,0.00003070592,0.000065839406,0.0002502172,0.00001274065,0.027985552,0.000047671463,0.012901638,0.000050520393],"about_ca_topic_score_codex":0.00020014579,"about_ca_topic_score_gemma":0.00047319004,"teacher_disagreement_score":0.04983443,"about_ca_system_score_codex":0.000020984418,"about_ca_system_score_gemma":0.000010961467,"threshold_uncertainty_score":0.33141136},"labels":[],"label_agreement":null},{"id":"W7096964449","doi":"","title":"Pan-Canadian Oncology Drug Review","year":2016,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"","score_opus":0.030423650132107644,"score_gpt":0.3776439855204452,"score_spread":0.3472203353883376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7096964449","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011023169,0.02318566,0.000009409222,0.31696445,0.00042819662,0.0005668893,0.000009081485,0.000058185855,0.64775497],"genre_scores_gemma":[0.5437897,0.071544215,0.00027556397,0.091651514,0.00041135363,0.00009612175,0.00001370197,0.000016818938,0.29220098],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995534,0.000023724017,0.00009727216,0.000109222325,0.000041661726,0.0001747165],"domain_scores_gemma":[0.9995696,0.000054501816,0.000017040233,0.0001102526,0.000029845674,0.00021873995],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00008054762,0.000058685884,0.0001838004,0.000042876607,0.000019973626,8.5019985e-7,0.000032267468,0.000031413445,0.025198458],"category_scores_gemma":[0.00001619029,0.000030311876,0.000049075526,0.00005797508,0.00003070914,0.00002022689,0.0000070696906,0.00003528272,0.0017745653],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021020724,0.000044689015,0.003263722,0.00006134728,0.000041565283,0.000080410624,0.000013940124,5.258692e-10,0.0009514466,0.00039416587,0.73848975,0.25663796],"study_design_scores_gemma":[0.0011724441,0.0001722949,0.0031681205,0.0002473566,0.00013233145,0.00005428137,0.000003146862,1.4211422e-7,0.00076794444,0.000057042627,0.9941808,0.000044106542],"about_ca_topic_score_codex":0.010776738,"about_ca_topic_score_gemma":0.058352455,"teacher_disagreement_score":0.5327665,"about_ca_system_score_codex":0.00030358575,"about_ca_system_score_gemma":0.00046383127,"threshold_uncertainty_score":0.9990027},"labels":[],"label_agreement":null},{"id":"W7097389390","doi":"","title":"Taxus baccata L. var. procumbens Loud","year":2012,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pollen; Evergreen; Taxus; Bark (sound); Stamen; Stalk","score_opus":0.03613886832449913,"score_gpt":0.3568093581603192,"score_spread":0.3206704898358201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7097389390","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38515887,0.0016200249,0.00011063385,0.0038446395,0.0009332563,0.0005338056,0.000006240471,0.00015850025,0.60763407],"genre_scores_gemma":[0.9437726,0.00004648081,0.00064411137,0.0015923986,0.0007061312,0.000027194732,0.00002159498,0.0000097070115,0.05317976],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954206,0.000008454957,0.000074983385,0.00008337456,0.00006806679,0.00022304602],"domain_scores_gemma":[0.99967587,0.00001965623,0.000016238186,0.000115769275,0.000020559433,0.00015189145],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000051206764,0.000068803696,0.00011254553,0.00002618118,0.000023701787,0.0000029703015,0.00002716197,0.000038227943,0.010345226],"category_scores_gemma":[0.000006696417,0.000049415314,0.000038010214,0.000067113964,0.000019292258,0.00005803485,0.000018775949,0.0000611726,0.00091666705],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003266654,0.0015151701,0.40129647,0.00007599116,0.00026989044,0.000029854773,0.0007292888,3.4979362e-7,0.010620978,0.0031943766,0.5621149,0.019826056],"study_design_scores_gemma":[0.002708546,0.00031095892,0.072816186,0.000009682407,0.0002926177,0.00013880512,0.00006883706,0.000021572432,0.017136708,0.00006899516,0.9063002,0.00012688673],"about_ca_topic_score_codex":0.00009718527,"about_ca_topic_score_gemma":0.000017809658,"teacher_disagreement_score":0.5586138,"about_ca_system_score_codex":0.000044598524,"about_ca_system_score_gemma":0.000036099238,"threshold_uncertainty_score":0.99986124},"labels":[],"label_agreement":null},{"id":"W7099910180","doi":"","title":"Reserve Bank of Philadelphia, Université Laval, and University of Montreal. We also thank","year":2008,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Empirical research; Work (physics); Official cash rate; Central bank; Bank rate","score_opus":0.028214338395888255,"score_gpt":0.2547882993626513,"score_spread":0.22657396096676305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7099910180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9653094,0.0015782595,0.000006943731,0.00581695,0.000026700429,0.00013746475,0.0000212421,0.000017243083,0.027085809],"genre_scores_gemma":[0.97636944,0.010551943,0.00013043314,0.000039369017,0.000019026133,8.821054e-8,0.0000083401965,0.0000039753145,0.012877371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996322,0.000020100346,0.00007150276,0.00010869191,0.00008329928,0.00008424807],"domain_scores_gemma":[0.9996761,0.000039800954,0.00004893961,0.00010463218,0.00006193467,0.00006856595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002987995,0.000062602754,0.00021141932,0.00007071628,0.00003724048,3.0806675e-7,0.00004353463,0.000048407255,0.00077499595],"category_scores_gemma":[0.000002587872,0.000057058758,0.00005228568,0.000104662264,0.00013299832,0.000039203736,0.00004086391,0.000047709098,0.0000024968456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007281928,0.0015995303,0.5346332,0.00041978995,0.0013696251,0.0014124835,0.010375461,0.000016631757,0.068008095,0.0008741017,0.36889508,0.0051140664],"study_design_scores_gemma":[0.02746305,0.0037773643,0.7685688,0.00016714509,0.0015582396,0.00033665315,0.0043336106,0.00038996554,0.08350261,0.00024061659,0.10931443,0.00034749354],"about_ca_topic_score_codex":0.012088218,"about_ca_topic_score_gemma":0.0022396413,"teacher_disagreement_score":0.25958067,"about_ca_system_score_codex":0.000034495195,"about_ca_system_score_gemma":0.000076443765,"threshold_uncertainty_score":0.9944904},"labels":[],"label_agreement":null},{"id":"W7116331886","doi":"10.6084/m9.figshare.30925843.v1","title":"Additional file 1 of Vincristine-induced brain toxicity is reduced with prevention of peripheral axon degeneration in Sarm1 knockout mice","year":2025,"lang":"","type":"article","venue":"Open MIND","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Degeneration (medical); Peripheral; Wallerian degeneration; Axon; Axonal degeneration; Toxicity; Neurotoxicity","score_opus":0.03830301222465152,"score_gpt":0.36229533325953645,"score_spread":0.32399232103488496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116331886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88465357,0.0001287473,0.000013443188,0.0011040474,0.00017368546,0.0016654357,0.09427655,0.0000011381752,0.017983371],"genre_scores_gemma":[0.90247184,0.000017147784,0.004318578,0.00025267372,0.00019834965,0.00046607605,0.034976467,0.000019706782,0.057279136],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99808484,0.00023622003,0.00071677123,0.0004865235,0.00023003492,0.00024559296],"domain_scores_gemma":[0.9984796,0.00053149357,0.00045242833,0.00022900343,0.00023214276,0.000075299366],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020201293,0.00024791143,0.0006158757,0.0002059084,0.00007358039,0.0000235029,0.0002006136,0.00018594495,0.83236045],"category_scores_gemma":[0.00019559094,0.00024201833,0.000105827625,0.00056444074,0.00012681202,0.00019736495,0.00010528424,0.00020989121,0.000041506115],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003754009,0.0018110937,0.00018537557,0.00013219539,0.00030502153,0.000014288212,0.001267513,0.000024199953,0.27307642,0.000006042242,0.665091,0.054332845],"study_design_scores_gemma":[0.010451198,0.0036450461,0.010638923,0.0036484012,0.0006018189,0.000015966103,0.0008594394,0.0013245743,0.8260081,0.000035488698,0.14244254,0.0003285129],"about_ca_topic_score_codex":0.00038246418,"about_ca_topic_score_gemma":0.0021334733,"teacher_disagreement_score":0.8323189,"about_ca_system_score_codex":0.00035326966,"about_ca_system_score_gemma":0.0018417374,"threshold_uncertainty_score":0.9869221},"labels":[],"label_agreement":null},{"id":"W7116425450","doi":"10.6084/m9.figshare.30925843","title":"Additional file 1 of Vincristine-induced brain toxicity is reduced with prevention of peripheral axon degeneration in Sarm1 knockout mice","year":2025,"lang":"","type":"article","venue":"Figshare","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Degeneration (medical); Peripheral; Wallerian degeneration; Axon; Axonal degeneration; Toxicity; Neurotoxicity","score_opus":0.033756578870344896,"score_gpt":0.3244834700401362,"score_spread":0.29072689116979133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116425450","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05866982,0.00029256396,7.9647225e-7,0.00046859615,0.00008328142,0.00094289775,0.93559766,0.00001447691,0.0039298823],"genre_scores_gemma":[0.2896841,0.0000043576247,0.00018478942,0.00034788164,0.00020760675,0.0010201833,0.69911593,0.000017140781,0.009418055],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99821955,0.00017339944,0.0006334228,0.0004307866,0.00027041207,0.00027243758],"domain_scores_gemma":[0.9980644,0.00080219883,0.00045676582,0.00021686098,0.00038104563,0.00007875805],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000049274495,0.00027648738,0.00054308237,0.0002478137,0.000066491,0.000010389792,0.00012365096,0.00023771802,0.9878334],"category_scores_gemma":[0.0009716826,0.00027708954,0.0001586352,0.0006402771,0.000030397714,0.00013135365,0.000061502105,0.00025893122,0.0001061402],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001078501,0.0008426419,0.000027785423,0.0009415542,0.00018339092,0.000012612265,0.0003862782,0.000027000035,0.038725574,0.0000024476426,0.95367604,0.0040961495],"study_design_scores_gemma":[0.010226269,0.004242789,0.026709791,0.043263257,0.00044594647,0.000023375696,0.00040876304,0.0033479957,0.5248923,0.000040537132,0.385818,0.0005809651],"about_ca_topic_score_codex":0.00007444647,"about_ca_topic_score_gemma":0.0005312045,"teacher_disagreement_score":0.9877272,"about_ca_system_score_codex":0.00038427068,"about_ca_system_score_gemma":0.0014826312,"threshold_uncertainty_score":0.9999681},"labels":[],"label_agreement":null},{"id":"W7116883596","doi":"10.1093/jncics/pkaf119","title":"Assessment tools for chemotherapy-induced peripheral neuropathy: a narrative review of clinician, patient-reported, and objective measures","year":2025,"lang":"en","type":"article","venue":"JNCI Cancer Spectrum","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Rehabilitation Institute; University of Toronto","funders":"","keywords":"Narrative review; Selection (genetic algorithm); MEDLINE; Narrative; Health professionals","score_opus":0.042048921667640515,"score_gpt":0.412333420777878,"score_spread":0.3702844991102375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116883596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93753934,0.032828223,0.00014735907,0.015589906,0.0012390966,0.003641384,0.00005284972,0.000050905244,0.008910912],"genre_scores_gemma":[0.96821296,0.020549886,0.00021062701,0.009344865,0.00022161168,0.00076692353,0.00001647108,0.000019037985,0.0006576321],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99870646,0.00006789588,0.00046134653,0.00036341677,0.00017879267,0.00022206541],"domain_scores_gemma":[0.99911946,0.00012455278,0.00028174042,0.00020350651,0.00020189934,0.000068822665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017833927,0.00019771761,0.0006469527,0.00007333724,0.000074832526,0.000013207317,0.00005180135,0.000064139145,0.00020594618],"category_scores_gemma":[0.00008293171,0.00016396979,0.00016867663,0.00023202138,0.0000600994,0.00007833034,0.000023403069,0.00016268638,2.4288906e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008669968,0.0022750255,0.120650955,0.011294622,0.006235358,0.00013076371,0.008489016,0.000006368748,0.06302807,0.002432958,0.040750336,0.73603654],"study_design_scores_gemma":[0.035242744,0.015398958,0.559656,0.015205859,0.00510208,0.000102870865,0.002781498,0.0003049286,0.15676963,0.0018976054,0.20640053,0.0011372876],"about_ca_topic_score_codex":0.0002342328,"about_ca_topic_score_gemma":0.0001578497,"teacher_disagreement_score":0.7348993,"about_ca_system_score_codex":0.00035852654,"about_ca_system_score_gemma":0.00086193107,"threshold_uncertainty_score":0.6686494},"labels":[],"label_agreement":null},{"id":"W7120615709","doi":"","title":"Sensory and cognitive changes in occupational performance in adults and elderly submitted to neurotoxic chemotherapy","year":2020,"lang":"pt","type":"dissertation","venue":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Normality; Categorical variable; Cognition; Descriptive statistics; Neurotoxicity; Test (biology); Epidemiology; Peripheral neuropathy; Continuous variable","score_opus":0.023189169966795396,"score_gpt":0.28559422707330206,"score_spread":0.2624050571065067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7120615709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97998494,0.0012113823,0.000017967444,0.012217008,0.00058771,0.0022106254,0.00012774454,0.00007720608,0.0035653943],"genre_scores_gemma":[0.99331206,0.0022910459,0.00015187993,0.0011369247,0.00053247216,0.0008854725,0.0012652974,0.00008141761,0.00034343885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963547,0.0003490226,0.000765782,0.0012276925,0.0005855533,0.00071724335],"domain_scores_gemma":[0.99807316,0.00038328752,0.00036884134,0.00020933185,0.00033982197,0.0006255654],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029666926,0.00072978897,0.00093032385,0.0010887559,0.00026196396,0.00009351688,0.00019054025,0.00073582504,0.000060178485],"category_scores_gemma":[0.00029885417,0.00077654026,0.00009525579,0.0009344666,0.000030834562,0.00023018496,0.000090148395,0.0010601887,0.000009545012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.111606084,0.0072258636,0.5220032,0.009373395,0.0019454523,0.0043101464,0.1295855,0.00005994135,0.037960306,0.04059492,0.0005172899,0.1348179],"study_design_scores_gemma":[0.01455219,0.0019515753,0.8984505,0.0029975395,0.00031954664,0.00065373955,0.0029384035,0.0017634929,0.0039707418,0.000011451272,0.071385965,0.0010048617],"about_ca_topic_score_codex":0.000009617234,"about_ca_topic_score_gemma":0.0027291975,"teacher_disagreement_score":0.3764473,"about_ca_system_score_codex":0.00052212813,"about_ca_system_score_gemma":0.00076936535,"threshold_uncertainty_score":0.99946856},"labels":[],"label_agreement":null},{"id":"W7120681099","doi":"","title":"Peripheral neuropathy induced by chemotherapy: symptoms and the risk of falling in elderly women with cancer","year":2023,"lang":"pt","type":"dissertation","venue":"Digital Library of Theses and Dissertations  (Universidade de São Paulo)","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Peripheral neuropathy; Falling (accident); Elderly people; Cancer; Risk factor","score_opus":0.007411627230751816,"score_gpt":0.24348563191238937,"score_spread":0.23607400468163756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7120681099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951585,0.0018558207,0.0000031669922,0.000449957,0.000077808116,0.0006469137,0.000889008,0.000032899025,0.000885935],"genre_scores_gemma":[0.9900923,0.0037708294,0.000012340646,0.000076219425,0.00002425545,0.00006883842,0.0007611457,0.00007267522,0.0051214024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998687,0.00010253007,0.00034217525,0.00036276737,0.00018434053,0.00032113746],"domain_scores_gemma":[0.9987109,0.00049849873,0.00041844256,0.0001682847,0.000049623828,0.00015425858],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007066755,0.00034912422,0.00065811066,0.00030319465,0.00014302925,0.00009799224,0.00017293359,0.00016442187,0.00015839544],"category_scores_gemma":[0.000024603569,0.0002611885,0.00010268939,0.0006301933,0.00021317568,0.0006796956,0.00003046685,0.00030398628,0.0000010057016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043189477,0.0012801805,0.5572228,0.0017638399,0.0039863363,0.00010543029,0.28853577,0.00022533728,0.0068577663,0.0009561348,0.00018717258,0.09568978],"study_design_scores_gemma":[0.01359227,0.002849167,0.6788324,0.0010504565,0.0009560806,0.000009000809,0.29877236,0.0013197834,0.0014608251,0.0005451168,0.00009017715,0.000522332],"about_ca_topic_score_codex":0.0009400455,"about_ca_topic_score_gemma":0.00045565088,"teacher_disagreement_score":0.12160964,"about_ca_system_score_codex":0.000043619984,"about_ca_system_score_gemma":0.00025423875,"threshold_uncertainty_score":0.999984},"labels":[],"label_agreement":null},{"id":"W7133002764","doi":"","title":"A remotely delivered exercise-based rehabilitation program for patients with persistent chemotherapy-induced peripheral neuropathy (EX-CIPN): A phase I feasibility trial","year":2025,"lang":"","type":"dissertation","venue":"TSpace","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; European Oncology Nursing Society; European Association of Neuro-Oncology; European Society for Medical Oncology; European Organisation for Research and Treatment of Cancer; Cancer Research Society","keywords":"Chemotherapy-induced peripheral neuropathy; Rehabilitation; Peripheral neuropathy; Adverse effect; Randomized controlled trial; Pilot trial","score_opus":0.03387657429575589,"score_gpt":0.3985864567391276,"score_spread":0.3647098824433717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7133002764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94768935,0.0005946373,0.00006896856,0.0011284128,0.003002523,0.046611294,0.00016402676,0.00023122325,0.00050954474],"genre_scores_gemma":[0.97533804,0.00010989727,0.0037332242,0.00052840303,0.0005061886,0.005410913,0.0073652584,0.00020209982,0.006805985],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99446756,0.00047183028,0.0011706377,0.0019965381,0.00088089757,0.0010125529],"domain_scores_gemma":[0.9949922,0.00067180744,0.0010077743,0.0009575188,0.0018923907,0.00047833627],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00040917355,0.0012782806,0.0019050533,0.00042161992,0.00046538626,0.00011692733,0.000312515,0.0007196783,0.0004626434],"category_scores_gemma":[0.00039227126,0.0011612863,0.0013930579,0.0008307049,0.00017317879,0.00014682175,0.000023605597,0.0006673099,0.000008123388],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8218588,0.035769038,0.0019055946,0.00299586,0.0009665244,0.000015001249,0.013055024,0.00003491663,0.0012703985,0.000002366475,0.00109999,0.121026434],"study_design_scores_gemma":[0.7423118,0.21756318,0.0111272875,0.0022589746,0.00824845,0.0000011968235,0.006007126,0.0072672,0.001442915,0.000011760598,0.0024442154,0.001315935],"about_ca_topic_score_codex":0.00041907333,"about_ca_topic_score_gemma":0.00021031608,"teacher_disagreement_score":0.18179414,"about_ca_system_score_codex":0.0018381712,"about_ca_system_score_gemma":0.0027263064,"threshold_uncertainty_score":0.9999969},"labels":[],"label_agreement":null},{"id":"W857806473","doi":"10.1158/1538-7445.sabcs14-p1-10-05","title":"Abstract P1-10-05: A cost utility analysis from a Chinese health care perspective of Nab-paclitaxel or docetaxel, both as alternatives to solvent-based paclitaxel in metastatic breast cancer (MBC)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Docetaxel; Paclitaxel; Medicine; Oncology; Neutropenia; Febrile neutropenia; Internal medicine; Metastatic breast cancer; Chemotherapy; Breast cancer; Cancer","score_opus":0.1695356685572058,"score_gpt":0.5457196015391899,"score_spread":0.37618393298198405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W857806473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96422553,0.014440536,0.000031380565,0.012246675,0.00018991975,0.0024287102,0.005596819,0.000033977227,0.0008064592],"genre_scores_gemma":[0.99571925,0.0006405755,0.0002198866,0.0007209182,0.00026855542,0.0013657083,0.00020223836,0.000047558093,0.00081531756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99555117,0.00060951116,0.00065792206,0.0009613548,0.001281131,0.00093892857],"domain_scores_gemma":[0.9961607,0.0005530383,0.00023526602,0.000620506,0.0014363077,0.0009941998],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011848762,0.00038648673,0.0013246188,0.001133047,0.00012661998,0.000043863474,0.0003450751,0.000094483665,0.0060445205],"category_scores_gemma":[0.00035861493,0.00028750062,0.0002966282,0.003087103,0.00038592014,0.00016177326,0.00012455555,0.00065712177,0.000029810302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.11158526,0.009821244,0.6311408,0.002209283,0.015336447,0.001555896,0.12454091,0.0035814676,0.009797684,0.000125687,0.05507714,0.035228156],"study_design_scores_gemma":[0.03205933,0.0054979497,0.8876006,0.0011920955,0.0017455939,0.00001537775,0.057415325,0.0013812851,0.0055558505,0.00057778903,0.006063075,0.0008957378],"about_ca_topic_score_codex":0.3691267,"about_ca_topic_score_gemma":0.15847886,"teacher_disagreement_score":0.25645977,"about_ca_system_score_codex":0.005451614,"about_ca_system_score_gemma":0.0077681346,"threshold_uncertainty_score":0.99995774},"labels":[],"label_agreement":null},{"id":"W882957321","doi":"10.6000/1929-2279.2015.04.02.5","title":"The Clinical Efficacy and Safety of Paclitaxel in Adjuvant Therapy of Breast Cancer: A Systematic Review and Meta-Analysis","year":2015,"lang":"en","type":"review","venue":"Journal of cancer research updates","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Paclitaxel; Medicine; Meta-analysis; Breast cancer; Internal medicine; Inclusion and exclusion criteria; Oncology; Randomized controlled trial; Adverse effect; Adjuvant therapy; Cancer; Cochrane Library; Adjuvant; Alternative medicine; Pathology","score_opus":0.39836466501685047,"score_gpt":0.6138328843908791,"score_spread":0.21546821937402866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W882957321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014356476,0.99317724,2.2830865e-7,0.0036812278,0.000051800114,0.0025790876,0.0003420263,0.000001521424,0.000023316947],"genre_scores_gemma":[0.00045715988,0.99888927,0.000015152242,0.00009265642,0.0001125907,0.00020894011,0.000007987118,0.000024690973,0.00019153391],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9925523,0.0028225116,0.0030752944,0.00027081236,0.00096395856,0.000315162],"domain_scores_gemma":[0.99275,0.002845039,0.0022950429,0.0004232459,0.0014009957,0.00028569496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012126573,0.00030756148,0.011074316,0.0005592393,0.000052015293,0.000020676986,0.00034973642,0.00015930837,0.00030082118],"category_scores_gemma":[0.0003839499,0.00013277812,0.0015791021,0.0012173383,0.0005422555,0.000069783826,0.00010799313,0.0010390086,6.4439894e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001702032,0.0004954237,0.0007792972,0.5130823,0.33273387,0.000058826117,0.0001239058,9.477466e-7,0.0000012179593,0.000019744486,0.0039937436,0.14700867],"study_design_scores_gemma":[0.0031187963,0.0010716154,0.0005311266,0.079145275,0.72195333,0.00018957013,0.00005158921,0.0000017287251,0.0000019046736,0.000031817144,0.19374791,0.00015534554],"about_ca_topic_score_codex":0.0004920434,"about_ca_topic_score_gemma":0.00035458666,"teacher_disagreement_score":0.43393707,"about_ca_system_score_codex":0.00027179674,"about_ca_system_score_gemma":0.0021476918,"threshold_uncertainty_score":0.7570181},"labels":[],"label_agreement":null},{"id":"W895155927","doi":"","title":"Hierarchical Linear Modeling of Anatomical Change Over Time: Bevacizumab With or Without PDT","year":2008,"lang":"en","type":"article","venue":"Investigative Ophthalmology & Visual Science","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Concordia University; Université de Montréal","funders":"","keywords":"Bevacizumab; Medicine; Ophthalmology; Internal medicine","score_opus":0.10796250007377865,"score_gpt":0.4023168014464516,"score_spread":0.29435430137267293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W895155927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977191,0.00007568916,0.0000072636326,0.00051088614,0.00008537717,0.00054084137,0.000010669699,0.00003886723,0.0010113188],"genre_scores_gemma":[0.995714,0.000013279073,0.0029924714,0.0004968459,0.00016805428,0.000067774854,0.0000107126825,0.000020465584,0.0005163949],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980118,0.00010437614,0.00029864212,0.0005916289,0.0004939029,0.0004995947],"domain_scores_gemma":[0.9988711,0.00011928792,0.00012493608,0.00020633433,0.00023757138,0.000440812],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00026313108,0.00024138077,0.00056971336,0.00024711754,0.00023948644,0.000005068847,0.00022591898,0.00010905683,0.00062150013],"category_scores_gemma":[0.00013588506,0.00016017338,0.00006158829,0.00095230626,0.0064964434,0.00023811088,0.00012848915,0.0003424401,0.000039056384],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047023175,0.0011446084,0.49870417,0.00005758929,0.00017007049,0.00232819,0.0043873983,0.00009867323,0.4880101,0.00008401762,0.00008594786,0.00022693018],"study_design_scores_gemma":[0.012157727,0.019854503,0.25393087,0.00035575434,0.00042753248,0.015605426,0.00017550608,0.37812686,0.3175385,0.00082851504,0.000104640574,0.00089417817],"about_ca_topic_score_codex":0.00027138865,"about_ca_topic_score_gemma":0.000005248276,"teacher_disagreement_score":0.37802818,"about_ca_system_score_codex":0.00016070149,"about_ca_system_score_gemma":0.0011581093,"threshold_uncertainty_score":0.9962073},"labels":[],"label_agreement":null},{"id":"W951540943","doi":"10.1158/1538-7445.sabcs14-p1-09-29","title":"Abstract P1-09-29: A new model of care for breast cancer survivorship","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Psychosocial; Survivorship curve; Breast cancer; Cancer; Oncology; Disease; Adjuvant therapy; Family medicine; Health care; Adjuvant; Internal medicine; Gynecology; Psychiatry","score_opus":0.33005454113380644,"score_gpt":0.5245493284618102,"score_spread":0.1944947873280038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W951540943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96658266,0.014975425,0.000050488525,0.0077142213,0.00049187447,0.0016912504,0.0012408717,0.000044408003,0.007208779],"genre_scores_gemma":[0.98876095,0.00090968364,0.00014557716,0.00013391572,0.0009667697,0.00059611915,0.000039649054,0.00004313496,0.008404216],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983526,0.000042338135,0.00021304771,0.00031965267,0.0005380592,0.0005343304],"domain_scores_gemma":[0.9980663,0.00013258065,0.000054746353,0.00026001906,0.00097424584,0.0005121026],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040042892,0.00014274324,0.0003690035,0.00018076303,0.00006910414,0.000013103764,0.00017180103,0.000119665674,0.0009455376],"category_scores_gemma":[0.000038185357,0.00012024499,0.00011271328,0.00029825312,0.00014716262,0.00007234218,0.000054208424,0.00031246402,0.000015127909],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034658507,0.0010000073,0.07892382,0.00466905,0.0011805273,0.00006182288,0.018993407,0.00531272,0.14192393,0.0009137071,0.47884822,0.23351426],"study_design_scores_gemma":[0.11925009,0.009219679,0.12874562,0.004581052,0.002397785,0.00010919894,0.013281914,0.011840711,0.4323461,0.008736286,0.26674873,0.0027428274],"about_ca_topic_score_codex":0.029890835,"about_ca_topic_score_gemma":0.012758173,"teacher_disagreement_score":0.2904222,"about_ca_system_score_codex":0.00084442925,"about_ca_system_score_gemma":0.00419946,"threshold_uncertainty_score":0.99996775},"labels":[],"label_agreement":null}]}